FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gupta, CL
   Tiwari, RK
   Cytryn, E
AF Gupta, Chhedi Lal
   Tiwari, Rohit Kumar
   Cytryn, Eddie
TI Platforms for elucidating antibiotic resistance in single genomes and
   complex metagenomes
SO ENVIRONMENT INTERNATIONAL
LA English
DT Review
DE Antibiotic resistance genes; Bioinformatics; Environment; Metagenome;
   Resistome; Pathogen; Mobile genetic elements
ID ANTIMICROBIAL RESISTANCE; READ ALIGNMENT; ARG-ANNOT; GENES; RESISTOME;
   IDENTIFICATION; NETWORK; PACKAGE; SEARCH; WEB
AB Antibiotic or antimicrobial resistance (AR) facilitated by the vertical and/or horizontal transfer of antibiotic resistance genes (ARGs), is a serious global health challenge. While traditionally associated with pathogens in clinical environments, it is becoming increasingly clear that non-clinical environments may also be reservoirs of ARGs. The recent improvements in rapid and affordable next generation sequencing technologies along with sophisticated bioinformatics platforms has the potential to revolutionize diagnostic microbiology and microbial surveillance. Through the study and characterization of ARGs in bacterial genomes and complex metagenomes, we are now able to reveal the genetic scope of AR in single bacteria and complex communities, and obtain important insights into AR dynamics at species, population and community levels, providing novel epidemiological and ecological perspectives. A suite of bioinformatics pipelines and ARG databases are currently available for genomic and metagenomic data analyses. However, different platforms may significantly vary and therefore, it is crucial to choose the tools that are most suitable for the specific analysis being conducted. This review provides a detailed account of available bioinformatics platforms for identification and characterization of ARGs and associated genetic elements within single bacterial isolates and complex environmental samples. It focuses primarily on currently available ARG databases, employing a comprehensive benchmarking pipeline to identify ARGs in four bacterial genomes (Aeromonas salmonicida, Bacillus cereus, Burkholderia sp. and Escherichia coli) and three shotgun metagenomes (human gut, poultry litter and soil) providing insight into which databases should be used for different analytical scenarios.
C1 [Gupta, Chhedi Lal; Cytryn, Eddie] Agr Res Org, Volcani Res Ctr, Inst Soil Water & Environm Sci, IL-7528809 Rishon Leziyyon, Israel.
   [Tiwari, Rohit Kumar] Integral Univ, Dept Biosci, Lucknow 226026, UP, India.
RP Cytryn, E (reprint author), Agr Res Org, Volcani Res Ctr, Inst Soil Water & Environm Sci, IL-7528809 Rishon Leziyyon, Israel.
EM eddie@volcani.agri.gov.il
FU European Union ERANET JPI-AMR initiative project entitled "Intervention
   of antimicrobial resistance transfer into the food chain (INART)"
   through the Israel Ministry of Health [3-0000-14732]; Israel Ministry of
   Agriculture [33-08-0002]
FX This publication was supported by the European Union ERANET JPI-AMR
   initiative project entitled "Intervention of antimicrobial resistance
   transfer into the food chain (INART)" through the Israel Ministry of
   Health (3-0000-14732), and by the Chief Scientist of the Israel Ministry
   of Agriculture (33-08-0002).
CR Alcock B.P., 2020, CARD 2020 ANTIBIOTIC, P1, DOI [10.1093/nar/gkz935, DOI 10.1093/NAR/GKZ935]
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   [Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a
   Antipov D, 2016, BIOINFORMATICS, V32, P1009, DOI 10.1093/bioinformatics/btv688
   Arango-Argoty G.A., 2019, ARG MINER WEB PLATFO
   Arango-Argoty G, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0401-z
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Barwell LJ, 2015, J ANIM ECOL, V84, P1112, DOI 10.1111/1365-2656.12362
   Bengtsson-Palme J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0508-2
   Bengtsson-Palme J, 2017, J ANTIMICROB CHEMOTH, V72, P2690, DOI 10.1093/jac/dkx199
   Bengtsson-Palme J, 2016, SCI TOTAL ENVIRON, V572, P697, DOI 10.1016/j.scitotenv.2016.06.228
   Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439
   Berglund F, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0670-1
   Bertrand D, 2019, NAT BIOTECHNOL, V37, P937, DOI 10.1038/s41587-019-0191-2
   Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29
   Boolchandani M, 2019, NAT REV GENET, V20, P356, DOI 10.1038/s41576-019-0108-4
   Breitwieser FP, 2019, BRIEF BIOINFORM, V20, P1125, DOI 10.1093/bib/bbx120
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Caro-Quintero A, 2015, ISME J, V9, P958, DOI 10.1038/ismej.2014.193
   CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471
   Chao A., 1984, SCAND J STAT
   Chen HY, 2019, ENVIRON POLLUT, V245, P398, DOI 10.1016/j.envpol.2018.11.024
   Chen JR, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0714-6
   Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34
   Chu BTT, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02168-17
   Clausen PTLC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2336-6
   Clausen PTLC, 2016, J ANTIMICROB CHEMOTH, V71, P2484, DOI 10.1093/jac/dkw184
   Cytryn E, 2013, SOIL BIOL BIOCHEM, V63, P18, DOI 10.1016/j.soilbio.2013.03.017
   D'Costa VM, 2007, CURR OPIN MICROBIOL, V10, P481, DOI 10.1016/j.mib.2007.08.009
   D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800
   de Man TJB, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00050-15
   Dinsdale Elizabeth A., 2013, Frontiers in Genetics, V4, P41, DOI 10.3389/fgene.2013.00041
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2
   Dunivin TK, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy016
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Feng J, 2018, ENVIRON MICROBIOL, V20, P355, DOI 10.1111/1462-2920.14009
   Fitzpatrick D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv168
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761
   Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113
   Frade PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144702
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Garbisu C, 2018, SCI TOTAL ENVIRON, V621, P725, DOI 10.1016/j.scitotenv.2017.11.221
   Gatica J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00146
   Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106
   Giedraitiene A., 2011, MEDICINA, DOI [10.3390/medicina47030019., DOI 10.3390/MEDICINA47030019]
   Gillings MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00004
   Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108
   Goeman JJ, 2014, STAT MED, V33, P1946, DOI 10.1002/sim.6082
   Guo JH, 2017, WATER RES, V123, P468, DOI 10.1016/j.watres.2017.07.002
   Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13
   HENDRIKSEN RS, 2019, USING GENOMICS TRACK, V7, DOI DOI 10.3389/FPUBH.2019.00242
   Henson J, 2012, PHARMACOGENOMICS, V13, P901, DOI [10.2217/PGS.12.72, 10.2217/pgs.12.72]
   Hofer Ursula, 2019, Nat Rev Microbiol, V17, P3, DOI 10.1038/s41579-018-0125-x
   Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0
   Hu YF, 2016, APPL ENVIRON MICROB, V82, P6672, DOI 10.1128/AEM.01802-16
   Huijbers PMC, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.074
   Hunt M, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000131
   Huovinen P, 2001, CLIN INFECT DIS, V32, P1608, DOI 10.1086/320532
   Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6
   Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338
   Jee Y, 2018, LANCET INFECT DIS, V18, P939, DOI 10.1016/S1473-3099(18)30471-7
   Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004
   Jonsson V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2386-y
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Ju F, 2016, WATER RES, V91, P1, DOI 10.1016/j.watres.2015.11.071
   Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557
   Kleinheinz K.A., 2014, APPLYING RESFINDER V, P1
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038
   Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508
   Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]
   Lakin SM, 2017, NUCLEIC ACIDS RES, V45, pD574, DOI 10.1093/nar/gkw1009
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lanza VF, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0387-y
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656
   Liu TY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10780-2
   Liu XB, 2019, EUROSURVEILLANCE, V24, P27, DOI 10.2807/1560-7917.ES.2019.24.13.1800113
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luz Calle M., 2019, Genomics & Informatics, V17, DOI 10.5808/GI.2019.17.1.e6
   Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130
   Magesh S., 2019, METABARCODING METAGE, V3
   Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869
   Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399
   Mason A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01815-17, 10.1128/JCM.01815-17]
   McMurdie Paul J, 2018, Methods Mol Biol, V1849, P143, DOI 10.1007/978-1-4939-8728-3_10
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531
   Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822
   Munk P, 2018, NAT MICROBIOL, V3, P898, DOI 10.1038/s41564-018-0192-9
   Naas T, 2017, J ENZYM INHIB MED CH, V32, P917, DOI 10.1080/14756366.2017.1344235
   Nesme J, 2014, CURR BIOL, V24, P1096, DOI 10.1016/j.cub.2014.03.036
   Nowrotek M, 2019, FRONT ENV SCI ENG, V13, DOI 10.1007/s11783-019-1121-8
   Oh M, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy079
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5
   Paliy O, 2016, MOL ECOL, V25, P1032, DOI 10.1111/mec.13536
   Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672
   Perry JA, 2014, CURR OPIN MICROBIOL, V21, P45, DOI 10.1016/j.mib.2014.09.002
   Petersen TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176469
   Petersen TN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11444
   Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009
   Quince C, 2017, NAT BIOTECHNOL, V35, P1211, DOI 10.1038/nbt1217-1211b
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162
   Rowe W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133492
   Rowe WPM, 2018, BIOINFORMATICS, V34, P3601, DOI 10.1093/bioinformatics/bty387
   Ruppe E, 2019, NAT MICROBIOL, V4, P112, DOI 10.1038/s41564-018-0292-6
   Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109
   Singh RR, 2017, COMPREHENSIVE MEDICINAL CHEMISTRY III, VOL 2: DRUG DISCOVERY TECHNOLOGIES, P354, DOI 10.1016/B978-0-12-409547-2.12327-3
   Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571
   Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962
   Spellerberg I.F., 2008, ENCY ECOLOGY, P3249, DOI [10.1016/B978-008045405-4.00132-4, DOI 10.1016/B978-008045405-4.00132-4]
   Srivastava A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau111
   Stalder T, 2019, ISME J, V13, P2437, DOI 10.1038/s41396-019-0446-4
   Stoesser N, 2013, J ANTIMICROB CHEMOTH, V68, P2234, DOI 10.1093/jac/dkt180
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Surette MD, 2017, ANNU REV MICROBIOL, V71, P309, DOI 10.1146/annurev-micro-090816-093420
   Tacconelli E, 2018, LANCET INFECT DIS, V18, pE99, DOI 10.1016/S1473-3099(17)30485-1
   Tan L, 2019, J HAZARD MATER, V374, P35, DOI 10.1016/j.jhazmat.2019.04.020
   Tang JY, 2016, ECOTOX ENVIRON SAFE, V132, P260, DOI 10.1016/j.ecoenv.2016.06.016
   Thai QK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-563
   Thai QK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-390
   Tiedje JM, 2019, PEDOSPHERE, V29, P273, DOI 10.1016/S1002-0160(18)60062-1
   Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x
   Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923
   Sabino YNV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13118-0
   Waldron L, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00194-17
   Wallace JC, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw165
   Wang HL, 2017, INT J MOL MED, V39, P364, DOI 10.3892/ijmm.2016.2844
   Wang RB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03205-z
   Wang Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058793, 10.1371/journal.pone.0062571]
   Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y
   Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595
   Wright GD, 2019, CURR OPIN MICROBIOL, V51, P57, DOI 10.1016/j.mib.2019.06.005
   Xavier BB, 2016, J CLIN MICROBIOL, V54, P851, DOI 10.1128/JCM.02717-15
   Yang Y, 2016, BIOINFORMATICS, V32, P2346, DOI 10.1093/bioinformatics/btw136
   Yin XL, 2018, BIOINFORMATICS, V34, P2263, DOI 10.1093/bioinformatics/bty053
   Zankari E, 2014, ANTIMICROB AGENTS CH, V58, P4986, DOI 10.1128/AAC.02620-14
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhang An-Ni, 2019, CHOOSING YOUR BATTLE
NR 143
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD MAY
PY 2020
VL 138
AR UNSP 105667
DI 10.1016/j.envint.2020.105667
PG 16
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA KY7JN
UT WOS:000522749900056
PM 32234679
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Shepley-McTaggart, A
   Fan, H
   Sudol, M
   Harty, RN
AF Shepley-McTaggart, Ariel
   Fan, Hao
   Sudol, Marius
   Harty, Ronald N.
TI Viruses go modular
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Review
DE virus; microbiology; antiviral agent; E3 ubiquitin ligase; Ebola virus;
   budding; L domain; PPxY motif; virus-host interaction; WW domain;
   virus-like particle (VLP); virus budding; modular domains; host-oriented
   inhibitors; antiviral therapeutic; viral life cycle
ID ROUS-SARCOMA-VIRUS; VESICULAR STOMATITIS-VIRUS; MEMBRANE-PROTEIN 2A;
   EBOLA-VIRUS; WW-DOMAIN; IMMUNODEFICIENCY-VIRUS; UBIQUITIN LIGASE; MATRIX
   PROTEIN; HOST PROTEINS; OCULAR COMPLICATIONS
AB The WW domain is a modular protein structure that recognizes the proline-rich Pro-Pro-x-Tyr (PPxY) motif contained in specific target proteins. The compact modular nature of the WW domain makes it ideal for mediating interactions between proteins in complex networks and signaling pathways of the cell (e.g. the Hippo pathway). As a result, WW domains play key roles in a plethora of both normal and disease processes. Intriguingly, RNA and DNA viruses have evolved strategies to hijack cellular WW domain?containing proteins and thereby exploit the modular functions of these host proteins for various steps of the virus life cycle, including entry, replication, and egress. In this review, we summarize key findings in this rapidly expanding field, in which new virus-host interactions continue to be identified. Further unraveling of the molecular aspects of these crucial virus-host interactions will continue to enhance our fundamental understanding of the biology and pathogenesis of these viruses. We anticipate that additional insights into these interactions will help support strategies to develop a new class of small-molecule inhibitors of viral PPxY-host WW-domain interactions that could be used as antiviral therapeutics.
C1 [Shepley-McTaggart, Ariel; Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.
   [Fan, Hao] ASTAR, Bioinformat Inst, 30 Biopolis St,Matrix 07-01, Singapore 138671, Singapore.
   [Fan, Hao] Natl Univ Singapore, Dept Biol Sci, Singapore 119077, Singapore.
   [Sudol, Marius] Natl Univ Singapore, Dept Physiol, Singapore 119077, Singapore.
   [Fan, Hao] DUKE NUS Med Sch, Ctr Computat Biol, Singapore 169857, Singapore.
   [Sudol, Marius] Yong Loo Li Sch Med, Lab Canc Signaling & Domainopathies, Block MD9,2 Med Dr 04-01, Singapore 117597, Singapore.
   [Sudol, Marius] Mechanobiol Inst, T Lab, 5A Engn Dr 1, Singapore 117411, Singapore.
   [Sudol, Marius] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
RP Harty, RN (reprint author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.
EM rharty@vet.upenn.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI102104, AI138052,
   AI138630, AI139392]; University Research Foundation (URF) award;
   National University of SingaporeNational University of Singapore
   [R-185-000-2710-133, R-185-000-2710-733]; Mechanobiology Institute
   [R-714-018-006-271]; Biomedical Research Council of A*STARAgency for
   Science Technology & Research (ASTAR)
FX This work was supported in part by National Institutes of Health Grants
   AI102104, AI138052, AI138630, and AI139392 and a University Research
   Foundation (URF) award (to R. N. H.), by internal grants from the
   National University of Singapore (R-185-000-2710-133 and -733) and the
   Mechanobiology Institute (R-714-018-006-271) (to M. S.), and by the
   Biomedical Research Council of A*STAR (to H. F.). The authors declare
   that they have no conflicts of interest with the contents of this
   article. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health.
CR Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301
   Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099
   Barajas D, 2015, J VIROL, V89, P2064, DOI 10.1128/JVI.02719-14
   Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09
   Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   Basler CF, 2017, SEMIN IMMUNOPATHOL, V39, P551, DOI 10.1007/s00281-017-0637-x
   Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007
   Billioux BJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0573-x
   Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095
   Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003
   Caswell RJ, 2017, INT J STD AIDS, V28, P1352, DOI 10.1177/0956462417703572
   Cen O, 2015, CURR TOP MICROBIOL, V391, P151, DOI 10.1007/978-3-319-22834-1_5
   Chang NS, 2002, INT J MOL MED, V9, P19
   CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819
   Chen Szu-Jung, 2013, Transl Respir Med, V1, P15, DOI 10.1186/2213-0802-1-15
   Chen YA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00060
   Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095
   Chughtai AA, 2016, EPIDEMIOL INFECT, V144, P1652, DOI 10.1017/S0950268816000054
   Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07
   Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999
   Crozier I, 2016, J INFECT DIS, V214, P1467, DOI 10.1093/infdis/jiw079
   Dolnik O, 2010, J VIROL, V84, P7847, DOI 10.1128/JVI.00476-10
   Dorjbal B, 2011, J BIOL CHEM, V286, P31092, DOI 10.1074/jbc.M111.259945
   Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3
   Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x
   Fuchs M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005582
   Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b
   Gamier L, 1996, NATURE, V381, P744, DOI 10.1038/381744a0
   Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2
   GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195
   Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92
   Han ZY, 2017, J VIROL, V91, DOI 10.1128/JVI.00812-17
   Han ZY, 2016, J VIROL, V90, P9163, DOI 10.1128/JVI.01078-16
   Han ZY, 2014, J VIROL, V88, P7294, DOI 10.1128/JVI.00591-14
   Hartlieb B, 2006, VIROLOGY, V344, P64, DOI 10.1016/j.virol.2005.09.018
   Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297
   Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999
   Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001
   Harty RN, 2018, METHODS MOL BIOL, V1604, P209, DOI 10.1007/978-1-4939-6981-4_15
   Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245
   Heidecker G, 2004, J VIROL, V78, P6636, DOI 10.1128/JVI.78.12.6636-6648.2004
   Heidecker G, 2007, J VIROL, V81, P9769, DOI 10.1128/JVI.00642-07
   Hereth-Hebert E, 2017, AM J OPHTHALMOL, V175, P114, DOI 10.1016/j.ajo.2016.12.005
   Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619
   Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632
   Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484
   Ikeda M, 2000, VIROLOGY, V268, P178, DOI 10.1006/viro.1999.0166
   Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4
   Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436
   Irie T, 2005, VIROLOGY, V336, P291, DOI 10.1016/j.virol.2005.03.027
   Irie T, 2004, J VIROL, V78, P2657, DOI 10.1128/JVI.78.6.2657-2665.2004
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jamous A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00580
   Jampol LM, 2015, JAMA OPHTHALMOL, V133, P1105, DOI 10.1001/jamaophthalmol.2015.2400
   Jasenosky LD, 2004, VIRUS RES, V106, P181, DOI 10.1016/j.virusres.2004.08.014
   Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000
   Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009
   Jouvenet N, 2012, CELL MOL LIFE SCI, V69, P4121, DOI 10.1007/s00018-012-1035-0
   Kathage B, 2017, BBA-MOL CELL RES, V1864, P62, DOI 10.1016/j.bbamcr.2016.10.007
   Kay BK, 2000, FASEB J, V14, P231
   Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998
   Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295
   Kuang ZZ, 2011, J VIROL, V85, P7153, DOI 10.1128/JVI.02610-10
   Lan YY, 2013, BIOCHEM BIOPH RES CO, V436, P672, DOI 10.1016/j.bbrc.2013.06.014
   Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156
   Liang JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006132
   Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003
   Longnecker R, 2000, EXP CELL RES, V257, P332, DOI 10.1006/excr.2000.4900
   Loughran HM, 2016, BIOORG MED CHEM LETT, V26, P3429, DOI 10.1016/j.bmcl.2016.06.053
   Lu JH, 2013, J VIROL, V87, P7777, DOI 10.1128/JVI.00470-13
   Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200
   Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155
   Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004
   Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313
   McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058
   McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308
   McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532
   Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x
   Mercenne G, 2015, ELIFE, V4, DOI 10.7554/eLife.03778
   Montespan C, 2017, J VIROL, V91, DOI 10.1128/JVI.00581-17
   Montespan C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006217
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Moshirfar M, 2014, CLIN OPHTHALMOL, V8, P2355, DOI 10.2147/OPTH.S73583
   Muller Roman-Ulrich, 2019, Pediatr Nephrol, DOI 10.1007/s00467-019-04299-3
   Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002
   Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099
   Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103
   Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105
   Ott DE, 2005, J VIROL, V79, P9038, DOI 10.1128/JVI.79.14.9038-9045.2005
   Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998
   PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995
   Patnaik A, 2002, J VIROL, V76, P2789, DOI 10.1128/JVI.76.6.2789-2795.2002
   Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09
   Qin J, 2012, VIROLOGY, V426, P106, DOI 10.1016/j.virol.2012.01.020
   Rasmussen AL, 2018, CURR TOP MICROBIOL, V419, P113, DOI 10.1007/82_2017_27
   Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10
   Reuven N, 2015, EXP BIOL MED, V240, P375, DOI 10.1177/1535370214565991
   Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135
   Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24
   Rotin D, 2000, J MEMBRANE BIOL, V176, P1
   Rotin D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S5
   Sakurai A, 2004, MICROBES INFECT, V6, P150, DOI 10.1016/j.micinf.2003.10.011
   Salah Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.53
   Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930
   Sang YR, 2017, BIOCHEM CELL BIOL, V95, P350, DOI 10.1139/bcb-2016-0250
   Sang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep39776
   Sasvari Zsuzsanna, 2014, Front Plant Sci, V5, P383, DOI 10.3389/fpls.2014.00383
   Schoneberg J, 2017, NAT REV MOL CELL BIO, V18, P5, DOI 10.1038/nrm.2016.121
   Scourfield EJ, 2017, BIOCHEM SOC T, V45, P613, DOI 10.1042/BST20160479
   Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200
   Seo EJ, 2012, ADV VIROL, V2012, DOI 10.1155/2012/532723
   Sette P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-79
   Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10
   Shantha JG, 2017, CURR OPIN OPHTHALMOL, V28, P600, DOI 10.1097/ICU.0000000000000426
   Shantha JG, 2016, CURR OPIN OPHTHALMOL, V27, P538, DOI 10.1097/ICU.0000000000000313
   Sissoko D, 2017, CLIN INFECT DIS, V64, P513, DOI 10.1093/cid/ciw793
   Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x
   Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8
   Steptoe PJ, 2018, OPHTHALMOLOGY, V125, pE19, DOI 10.1016/j.ophtha.2017.09.009
   Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559
   Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063
   Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6
   Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039
   Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9
   SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S
   Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6
   Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8
   Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002
   Sudol M, 2012, FEBS LETT, V586, P2571, DOI 10.1016/j.febslet.2012.06.005
   Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010
   Sullivan BM, 2008, J VIROL, V82, P602, DOI 10.1128/JVI.01571-07
   Sullivan BM, 2010, J VIROL, V84, P1265, DOI 10.1128/JVI.01775-09
   Swedberg JE, 2018, ACS MED CHEM LETT, V9, P1258, DOI 10.1021/acsmedchemlett.8b00422
   Tan BX, 2015, SCI REP-UK, V5, DOI 10.1038/srep12116
   Tanna M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00420
   Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425
   Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7
   Ulbricht A, 2015, AUTOPHAGY, V11, P538, DOI 10.1080/15548627.2015.1017186
   Ulbricht Anna, 2013, Commun Integr Biol, V6, pe24925, DOI 10.4161/cib.24925
   Ulbricht A, 2013, AUTOPHAGY, V9, P920, DOI 10.4161/auto.24213
   Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064
   Urata S, 2007, J VIROL, V81, P4895, DOI 10.1128/JVI.02829-06
   Urata S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/180326
   Urata S, 2010, J GEN VIROL, V91, P228, DOI 10.1099/vir.0.015495-0
   Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07
   Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004
   Varlet AA, 2017, CELL STRESS CHAPERON, V22, P553, DOI 10.1007/s12192-017-0780-2
   Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118
   Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X
   Villarroya-Beltri C, 2017, J CELL SCI, V130, P2961, DOI 10.1242/jcs.205468
   Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012
   Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107
   WILLS JW, 1994, J VIROL, V68, P6605, DOI 10.1128/JVI.68.10.6605-6618.1994
   Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000
   Wirblich C, 2008, J VIROL, V82, P9730, DOI 10.1128/JVI.00889-08
   Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808
   Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836
   Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84
   Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003
   Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132
   Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000
   Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8
   Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153
   Zhang HT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-28
   Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7
NR 168
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 3
PY 2020
VL 295
IS 14
BP 4604
EP 4616
DI 10.1074/jbc.REV119.012414
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LB2WZ
UT WOS:000524499700020
PM 32111739
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Chao, WC
   Yen, CL
   Wu, CH
   Shieh, CC
AF Chao, Wen-Cheng
   Yen, Chia-Liang
   Wu, Chun-Hsin
   Shieh, Chi-Chang
TI How mycobacteria take advantage of the weakness in human immune system
   in the modern world
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Review
DE Tuberculosis; Immunology; Diabetes; Biologics; Primary immunodeficiency
   disease; Host-directed therapy
ID HOST-DIRECTED THERAPIES; DIABETES-MELLITUS; MENDELIAN SUSCEPTIBILITY;
   INFLAMMASOME ACTIVATION; PULMONARY TUBERCULOSIS; GLUCOSE; INTERLEUKIN-1;
   CONVERGENCE; MACROPHAGES; ARTHRITIS
AB Tuberculosis (TB) infection remains a global health threat in recent decades partly due to a marked increase in the number of susceptible patients, including those with diabetes mellitus (DM) and who receive biologics. Immunity in TB infection is complex as Mycobacterium tuberculosis (MTB) is a highly adaptive pathogen and may evade the immune defense through various ways. Recent advances in TB immunity have revealed that granulomatous inflammation in TB infection is highly dynamic and the early influx of neutrophils may lead to excessive inflammation and pulmonary cavitation, which provide niches for MTB not only to survive but also to spread to other sites. Furthermore, reactive oxygen species have been found to play a crucial role among pathogenesis of TB infection in diabetics (DM-TB) through regulating inflammasome activation and the production of IL-1b, which in turn modulates the inflammatory network in TB infection, leading to dysfunctional inflammatory responses and tissue remodeling. To understand the exact immunological mechanisms underlying TB infection hence is essential for developing novel adjunctive host-directed therapy (HDT) aiming to alleviate excessive inflammation and tissue destruction and, at the same time, enhance the efficacy of currently available choices of anti-mycobacterial agents. Here we reviewed current epidemiological challenges of global TB control, novel immunological mechanisms underlying dysregulated inflammation in TB infection, especially in DM-TB, and some potential applications of adjunctive HDT in TB treatment. Copyright (C) 2020, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
C1 [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Crit Care Med, Taichung, Taiwan.
   [Yen, Chia-Liang; Wu, Chun-Hsin; Shieh, Chi-Chang] Natl Cheng Kung Univ, Inst Clin Med, Med Coll, 138 Sheng Li Rd, Tainan 70403, Taiwan.
   [Wu, Chun-Hsin] Natl Cheng Kung Univ Hosp, Dept Internal Med, Sect Rheumatol, Tainan, Taiwan.
   [Shieh, Chi-Chang] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan.
RP Shieh, CC (reprint author), Natl Cheng Kung Univ, Inst Clin Med, Med Coll, 138 Sheng Li Rd, Tainan 70403, Taiwan.
EM cshieh@mail.ncku.edu.tw
CR Aksornchindarat Waralee, 2019, J Microbiol Immunol Infect, DOI 10.1016/j.jmii.2019.04.013
   Andrade BB, 2014, CHEST, V145, P1244, DOI 10.1378/chest.13-1799
   [Anonymous], 2018, GLOB TUB REP
   Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160
   Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008
   Cantini F, 2015, AUTOIMMUN REV, V14, P503, DOI 10.1016/j.autrev.2015.01.011
   Carow B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09816-4
   Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7
   Chao WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189453
   Chao WC, 2015, MICROBES INFECT, V17, P195, DOI 10.1016/j.micinf.2014.11.009
   Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292
   Chi CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003927
   Collison KS, 2002, J LEUKOCYTE BIOL, V71, P433
   Conti F, 2016, J ALLERGY CLIN IMMUN, V138, P241, DOI 10.1016/j.jaci.2015.11.041
   Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006
   Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010
   Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8
   Dorhoi A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00036
   Elkington PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001847
   Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903
   Friedland JS, 2014, NEW ENGL J MED, V371, P1354, DOI 10.1056/NEJMcibr1408663
   Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394
   Huang TY, 2019, J MICROBIOL IMMUNOL, V52, P312, DOI 10.1016/j.jmii.2018.10.007
   Huang YF, 2015, ANTIOXID REDOX SIGN, V23, P973, DOI 10.1089/ars.2014.6136
   Huang YF, 2009, FREE RADICAL BIO MED, V47, P932, DOI 10.1016/j.freeradbiomed.2009.06.037
   Huang YC, 2010, J MICROBIOL IMMUNOL, V43, P401, DOI 10.1016/S1684-1182(10)60063-1
   Hung Jia-Horung, 2019, J Microbiol Immunol Infect, DOI 10.1016/j.jmii.2018.12.011
   Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152
   Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771
   Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005
   Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110
   Kuo CY, 2018, J MICROBIOL IMMUNOL, V51, P88, DOI 10.1016/j.jmii.2017.05.008
   Lin CH, 2016, NAT MED, V22, P994, DOI 10.1038/nm.4158
   Lin CT, 2019, J MICROBIOL IMMUNOL, V52, P141, DOI 10.1016/j.jmii.2017.04.002
   Lin SY, 2019, J MICROBIOL IMMUNOL, V52, P158, DOI 10.1016/j.jmii.2018.05.003
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489
   Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002
   Mezouar S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01947
   Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030
   Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967
   Ong CWM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004917
   Pan SC, 2015, LANCET DIABETES ENDO, V3, P323, DOI 10.1016/S2213-8587(15)00042-X
   Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792
   Sherry CL, 2007, J IMMUNOL, V178, P663, DOI 10.4049/jimmunol.178.2.663
   Singhal A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009885
   Taiwan Centers for Disease Control, 2017, TAIW TUB CONTR REP
   Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0
   Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813
   Wang LH, 2012, J MICROBIOL IMMUNOL, V45, P411, DOI 10.1016/j.jmii.2012.08.017
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Yen CL, 2015, INT J OBESITY, V39, P270, DOI 10.1038/ijo.2014.93
   Yen CL, 2019, J IMMUNOL, V202, P3394, DOI 10.4049/jimmunol.1801599
   Zheng CL, 2017, GLOBAL HEALTH ACTION, V10, P1, DOI 10.1080/16549716.2016.1264702
   Zumla A, 2015, NAT REV DRUG DISCOV, V14, P511, DOI 10.1038/nrd4696
NR 58
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD APR
PY 2020
VL 53
IS 2
BP 209
EP 215
DI 10.1016/j.jmii.2019.10.008
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KZ9GE
UT WOS:000523566400002
PM 31926875
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Vandenberg, O
   Durand, G
   Hallin, M
   Diefenbach, A
   Gant, V
   Murray, P
   Kozlakidis, Z
   van Belkum, A
AF Vandenberg, Olivier
   Durand, Geraldine
   Hallin, Marie
   Diefenbach, Andreas
   Gant, Vanya
   Murray, Patrick
   Kozlakidis, Zisis
   van Belkum, Alex
TI Consolidation of Clinical Microbiology Laboratories and Introduction of
   Transformative Technologies
SO CLINICAL MICROBIOLOGY REVIEWS
LA English
DT Review
DE artificial intelligence; automation; biobanking; clinical microbiology;
   consolidation; surveillance
ID FLIGHT MASS-SPECTROMETRY; ANTIMICROBIAL STEWARDSHIP INTERVENTION;
   DESORPTION IONIZATION-TIME; ARTIFICIAL-INTELLIGENCE; SURVEILLANCE
   SYSTEM; INCOME COUNTRIES; BLOOD CULTURES; COPAN WASP; BIG DATA;
   AUTOMATION
AB Clinical microbiology is experiencing revolutionary advances in the deployment of molecular, genome sequencing-based, and mass spectrometry-driven detection, identification, and characterization assays. Laboratory automation and the linkage of information systems for big(ger) data management, including artificial intelligence (Al) approaches, also are being introduced. The initial optimism associated with these developments has now entered a more reality-driven phase of reflection on the significant challenges, complexities, and health care benefits posed by these innovations. With this in mind, the ongoing process of clinical laboratory consolidation, covering large geographical regions, represents an opportunity for the efficient and cost-effective introduction of new laboratory technologies and improvements in translational research and development. This will further define and generate the mandatory infrastructure used in validation and implementation of newer high-throughput diagnostic approaches. Effective, structured access to large numbers of well-documented biobanked biological materials from networked laboratories will release countless opportunities for clinical and scientific infectious disease research and will generate positive health care impacts. We describe why consolidation of clinical microbiology laboratories will generate quality benefits for many, if not most, aspects of the services separate institutions already provided individually. We also define the important role of innovative and large-scale diagnostic platforms. Such platforms lend themselves particularly well to computational (Al)-driven genomics and bioinformatics applications. These and other diagnostic innovations will allow for better infectious disease detection, surveillance, and prevention with novel translational research and optimized (diagnostic) product and service development opportunities as key results.
C1 [Vandenberg, Olivier] Univ Libre Bruxelles, Grp Hosp Univ Bruxelles, Innovat & Business Dev Unit, LHUB ULB, Brussels, Belgium.
   [Vandenberg, Olivier] UCL, Fac Med Sci, Div Infect & Immun, London, England.
   [Durand, Geraldine] BioMerieux, Microbiol Res & Dev, La Balme Les Grottes, France.
   [Hallin, Marie] Univ Libre Bruxelles, Grp Hosp Univ Bruxelles, Dept Microbiol, LHUB ULB, Brussels, Belgium.
   [Diefenbach, Andreas] Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Berlin, Germany.
   [Diefenbach, Andreas] Charite Vivantes GmbH, Lab Berlin, Berlin, Germany.
   [Gant, Vanya] Univ Coll London Hosp NHS Fdn Trust, Dept Clin Microbiol, London, England.
   [Murray, Patrick] BD Life Sci Integrated Diagnost Solut, Sci Affairs, Sparks, MD USA.
   [Kozlakidis, Zisis] WHO, Lab Serv & Biobank Grp, Int Agcy Res Canc, Lyon, France.
   [van Belkum, Alex] BioMerieux, Open Innovat & Partnerships, La Balme Les Grottes, France.
RP Vandenberg, O (reprint author), Univ Libre Bruxelles, Grp Hosp Univ Bruxelles, Innovat & Business Dev Unit, LHUB ULB, Brussels, Belgium.; Vandenberg, O (reprint author), UCL, Fac Med Sci, Div Infect & Immun, London, England.
EM olivier.vandenberg@lhub-ulb.be
FU UCLH Biomedical Research Centre
FX V.G. thanks the UCLH Biomedical Research Centre's support of his
   academic activities.
CR Abat C, 2015, EMERG INFECT DIS, V21, P1302, DOI 10.3201/eid2108.141419
   Albiger B, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00046
   Allcock RJN, 2017, J CLIN MICROBIOL, V55, P3175, DOI 10.1128/JCM.01155-17
   Andreini P, 2016, COMPUT BIOL MED, V70, P12, DOI 10.1016/j.compbiomed.2015.12.025
   Angeletti S, 2015, JALA-J LAB AUTOM, V20, P652, DOI 10.1177/2211068214566458
   Bailey AL, 2019, CLIN CHEM, V65, P634, DOI 10.1373/clinchem.2017.274522
   Bailey AL, 2019, EUR J CLIN MICROBIOL, V38, P1135, DOI 10.1007/s10096-019-03512-3
   Banz A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00452-18, 10.1128/jcm.00452-18]
   Barczak AK, 2012, P NATL ACAD SCI USA, V109, P6217, DOI 10.1073/pnas.1119540109
   Bastawrous A, 2013, J ROY SOC MED, V106, P130, DOI 10.1177/0141076812472620
   Beam AL, 2016, JAMA-J AM MED ASSOC, V316, P2368, DOI 10.1001/jama.2016.17217
   Beganovic M, 2017, J CLIN MICROBIOL, V55, P1437, DOI [10.1128/JCM.02245-16, 10.1128/jcm.02245-16]
   Besser J, 2018, CLIN MICROBIOL INFEC, V24, P335, DOI 10.1016/j.cmi.2017.10.013
   Blumenthal D, 2015, NEW ENGL J MED, V372, P1281, DOI 10.1056/NEJMp1410425
   Bourbeau PP, 2013, J CLIN MICROBIOL, V51, P1658, DOI 10.1128/JCM.00301-13
   Brecher SM, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01779-17
   Broyer P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00911
   Burnham CAD, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01036-19
   Burnham CAD, 2013, CLIN CHEM, V59, P1696, DOI 10.1373/clinchem.2012.201038
   Burns LR, 2017, CHINAS HEALTHCARE SY
   Burton RJ, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0878-9
   Caulfield T, 2014, J LAW BIOSCI, V1, P94, DOI 10.1093/jlb/lst004
   Chae S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081596
   Chang WH, 2014, LAB CHIP, V14, P3376, DOI 10.1039/c4lc00471j
   Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7
   Church D L, 1999, Can J Infect Dis, V10, P393
   Colson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144178
   Croxatto A, 2016, CLIN MICROBIOL INFEC, V22, P217, DOI 10.1016/j.cmi.2015.09.030
   Croxatto A, 2017, BIOMED J, V40, P317, DOI 10.1016/j.bj.2017.09.001
   Croxatto A, 2015, J CLIN MICROBIOL, V53, P2298, DOI 10.1128/JCM.03076-14
   Dakappa Pradeepa H., 2018, Critical Reviews in Biomedical Engineering, V46, P173, DOI 10.1615/CritRevBiomedEng.2018025917
   Dauwalder O, 2016, CLIN MICROBIOL INFEC, V22, P236, DOI 10.1016/j.cmi.2015.10.037
   De Socio GV, 2018, EUR J CLIN MICROBIOL, V37, P2313, DOI 10.1007/s10096-018-3377-5
   Delport JA, 2017, EUR J CLIN MICROBIOL, V36, P1181, DOI 10.1007/s10096-017-2906-y
   Diaz L, 2014, ANTIMICROB AGENTS CH, V58, P4527, DOI 10.1128/AAC.02686-14
   Doucet M., 2017, J BIOREPOSITORY SCI, V5, P1, DOI [10.2147/BSAM.S100899, DOI 10.2147/BSAM.S100899]
   Drancourt M, 2016, CLIN MICROBIOL REV, V29, P429, DOI 10.1128/CMR.00090-15
   Dubourg G, 2013, EUR J CLIN MICROBIOL, V32, P1099, DOI 10.1007/s10096-013-1843-7
   Dubourg G, 2013, EUR J CLIN MICROBIOL, V32, P637, DOI 10.1007/s10096-012-1787-3
   Dubourg G, 2016, EXPERT REV MOL DIAGN, V16, P97, DOI 10.1586/14737159.2016.1112274
   Gansel X, 2019, EUR J CLIN MICROBIOL, V38, P1023, DOI 10.1007/s10096-019-03501-6
   Glasson J, 2017, ANN LAB MED, V37, P499, DOI 10.3343/alm.2017.37.6.499
   Goggin KP, 2020, JAMA ONCOL, V6, P552, DOI 10.1001/jamaoncol.2019.4120
   Gordon NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13
   Greub G, 2012, CLIN MICROBIOL INFEC, V18, P1157, DOI 10.1111/1469-0691.12032
   Haak BW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02042
   Harvala H, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.8.30466
   Houlihan CF, 2018, J INFECT DIS, V218, P1485, DOI 10.1093/infdis/jiy335
   Hulsen T, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00034
   Humphreys H, 2010, EUR J CLIN MICROBIOL, V29, P617, DOI 10.1007/s10096-010-0906-2
   Iversen J, 2016, J CLIN MICROBIOL, V54, P328, DOI 10.1128/JCM.01718-15
   Jaillard M, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007758
   Jaillard M, 2017, INT J ANTIMICROB AG, V50, P210, DOI 10.1016/j.ijantimicag.2017.02.026
   Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011
   Kinkorova J, 2018, EPMA J, V9, P345, DOI 10.1007/s13167-018-0153-7
   Klein S, 2018, EUR J CLIN MICROBIOL, V37, P1305, DOI 10.1007/s10096-018-3250-6
   Lainhart W, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00546-18
   Landgrebe J, 2019, SYNTHESE, DOI [10.1007/s11229-019-02192-y, DOI 10.1007/S11229-019-02192-Y]
   Ledeboer NA, 2014, J CLIN MICROBIOL, V52, P3140, DOI 10.1128/JCM.00686-14
   Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14
   Li BY, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz186
   Libertin CR, 2017, AM J INFECT CONTROL, V45, P979, DOI 10.1016/j.ajic.2017.03.024
   Lina G, 2016, CLIN MICROBIOL INFEC, V22, P215, DOI 10.1016/j.cmi.2015.12.011
   Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4
   Logier J-C, 2018, New Microbes and New Infections, V26, pS89, DOI 10.1016/j.nmni.2018.08.006
   Macesic N, 2017, CURR OPIN INFECT DIS, V30, P511, DOI [10.1097/QCO.0000000000000406, 10.1097/qco.0000000000000406]
   Mahe P, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2403-z
   Mailhe M, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1304-7
   Markin RS, 2000, CLIN CHEM, V46, P764
   Martiny D, 2013, CLIN MICROBIOL INFEC, V19, pE568, DOI 10.1111/1469-0691.12282
   Mascart G, 2018, ANN BIOL CLIN-PARIS, V76, P365, DOI 10.1684/abc.2018.1366
   Mendy M, 2014, PATHOBIOLOGY, V81, P252, DOI 10.1159/000362093
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Miller MB, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00495-19
   Murali A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0521-5
   Naugler C, 2019, CRIT REV CL LAB SCI, V56, P98, DOI 10.1080/10408363.2018.1561640
   Nault V, 2017, J ANTIMICROB CHEMOTH, V72, P933, DOI 10.1093/jac/dkw468
   O'Brien TF, 2019, J GLOB ANTIMICROB RE, V17, P8, DOI 10.1016/j.jgar.2018.10.011
   Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P59
   Parize P, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.006
   Patel TS, 2017, J CLIN MICROBIOL, V55, P60, DOI 10.1128/JCM.01452-16
   Peeling RW, 2019, LANCET INFECT DIS, V19, pE172, DOI 10.1016/S1473-3099(18)30594-2
   Perez KK, 2014, J INFECTION, V69, P216, DOI 10.1016/j.jinf.2014.05.005
   Perry JD, 2017, CLIN MICROBIOL REV, V30, P449, DOI 10.1128/CMR.00097-16
   Petersen LM, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01315-19
   Plebani M, 2016, CRIT REV CL LAB SCI, V53, P184, DOI 10.3109/10408363.2015.1116851
   Poljak M, 2020, CLIN MICROBIOL INFEC, V26, P425, DOI 10.1016/j.cmi.2019.09.014
   Pollock NR, 2019, CLIN INFECT DIS, V68, P78, DOI 10.1093/cid/ciy415
   Proctor L, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0620-y
   Qu KY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00827
   Quiblier C, 2016, J CLIN MICROBIOL, V54, P585, DOI 10.1128/JCM.02577-15
   Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259
   Rateni G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061453
   Reuter S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/jamainternmed.2013.7734
   Revez J, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00347
   Rhoads DD, 2014, CLIN MICROBIOL REV, V27, P1025, DOI 10.1128/CMR.00049-14
   Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118
   Sautter RL, 2015, J CLIN MICROBIOL, V53, P1467, DOI 10.1128/JCM.02569-14
   Schultsz C, 2014, LANCET GLOB HEALTH, V2, pE78, DOI 10.1016/S2214-109X(13)70112-8
   Shapshak P, 2017, BIOINFORMATION, V13, P410, DOI 10.6026/97320630013410
   Sim I, 2019, NEW ENGL J MED, V381, P956, DOI 10.1056/NEJMra1806949
   Simeon-Dubach D, 2018, BIOPRESERV BIOBANK, V16, P1, DOI 10.1089/bio.2017.0126
   Simeon-Dubach D, 2014, BIOPRESERV BIOBANK, V12, P287, DOI 10.1089/bio.2014.1251
   Smith KP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01521-17
   Stoesser N, 2013, J ANTIMICROB CHEMOTH, V68, P2234, DOI 10.1093/jac/dkt180
   Su M, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01405-18
   Tamburini FB, 2018, NAT MED, V24, P1809, DOI 10.1038/s41591-018-0202-8
   Tanmoy AM, 2018, MBIO, V9, DOI [10.1128/mBio.02112-18, 10.1128/mbio.02112-18]
   Thomson S, 2014, EC CRISIS HLTH SYSTE
   Toklu HZ, 2013, J YOUNG PHARM, V5, P38, DOI 10.1016/j.jyp.2012.09.001
   Tornimbene B, 2018, LANCET INFECT DIS, V18, P241, DOI 10.1016/S1473-3099(18)30060-4
   Tou HX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2101-x
   U.S. FDA, PROP REG FRAM MOD AR
   van den Bogert B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00721
   Van den Wijngaert S, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00150
   Vandenberg O, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00015
   Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589
   Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518
   Wertheim BM, 2017, AM J MED, V130, P47, DOI 10.1016/j.amjmed.2016.08.021
   Wong ZSY, 2019, INFECT DIS HEALTH, V24, P44, DOI 10.1016/j.idh.2018.10.002
   Wright Jr, 2015, ACAD PATHOL, V2, DOI 10.1177/2374289515619944
   Yarbrough ML, 2018, EUR J CLIN MICROBIOL, V37, P2405, DOI 10.1007/s10096-018-3391-7
   Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496
   Zhang LX, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5910
NR 124
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0893-8512
EI 1098-6618
J9 CLIN MICROBIOL REV
JI Clin. Microbiol. Rev.
PD APR
PY 2020
VL 33
IS 2
AR e00057-19
DI 10.1128/CMR.00057-19
PG 22
WC Microbiology
SC Microbiology
GA KY8AX
UT WOS:000522795100008
PM 32102900
DA 2020-05-07
ER

PT J
AU Bierne, H
   Hamon, M
AF Bierne, Helene
   Hamon, Melanie
TI Targeting host epigenetic machinery: The Listeria paradigm
SO CELLULAR MICROBIOLOGY
LA English
DT Review
DE chromatin; histone modification; Listeria monocytogenes; nucleomodulin;
   patho-epigenetics; pathogenesis
ID PATHO-EPIGENETICS; DNA METHYLATION; MONOCYTOGENES; BACTERIA;
   REPLICATION; SECRETION; EVOLUTION; COMPLEX; PROTEIN; FAMILY
AB By modifying the host cell transcription programme, pathogenic bacteria disrupt a wide range of cellular processes and take control of the host's immune system. Conversely, by mobilising a network of defence genes, the host cells trigger various responses that allow them to tolerate or eliminate invaders. The study of the molecular basis of this crosstalk is crucial to the understanding of infectious diseases. Although research has long focused on the targeting of eukaryotic DNA-binding transcription factors, more recently, another powerful way by which bacteria modify the expression of host genes has emerged: chromatin modifications in the cell nucleus. One of the most prolific bacterial models in this area has been Listeria monocytogenes, a facultative intracellular bacterium responsible for serious food-borne infections. Here, we aim to highlight the contribution of this model to the field of bacteria-mediated chromatin modifications. We will first recall the general principles of epigenetic regulation and then illustrate five mechanisms that mobilise the epigenetic machinery in response to Listeria factors, either through bacterial molecular patterns, a toxin, an invasion protein, or nucleomodulins. Strategies used by Listeria to control the expression of host genes at the chromatin level, by activation of cytosolic signalling pathways or direct targeting of epifactors in the nucleus, have contributed to the emergence of a new discipline combining cellular microbiology and epigenetics: "patho-epigenetics."
C1 [Bierne, Helene] Univ Paris Saclay, INRAE, AgroParisTech, Epigenet & Cellular Microbiol Team,Micalis Inst, F-78350 Jouy En Josas, France.
   [Hamon, Melanie] Inst Pasteur, G5 Chromatin & Infect, F-75015 Paris, France.
RP Bierne, H (reprint author), Univ Paris Saclay, INRAE, AgroParisTech, Epigenet & Cellular Microbiol Team,Micalis Inst, F-78350 Jouy En Josas, France.; Hamon, M (reprint author), Inst Pasteur, G5 Chromatin & Infect, F-75015 Paris, France.
EM helene.bierne@inrae.fr; melanie.hamon@pasteur.fr
OI Bierne, Helene/0000-0002-0525-0848; Hamon, Melanie/0000-0001-5078-4083
FU Agence Nationale de la RechercheFrench National Research Agency (ANR);
   Institut national de recherche pour l'agriculture, l'alimentation et
   l'environnement; Institut Pasteur; iXcore foundation for research; Ligue
   Contre le CancerLigue nationale contre le cancer
FX Agence Nationale de la Recherche, Grant/Award Number: Epibactin;
   Institut national de recherche pour l'agriculture, l'alimentation et
   l'environnement; Institut Pasteur, Grant/Award Number: starting grant;
   iXcore foundation for research; Ligue Contre le Cancer
CR Bierne H, 2002, J CELL SCI, V115, P3357
   Bierne H, 2017, EPIGENETICS HUM HLTH, P113, DOI 10.1007/978-3-319-55021-3_6
   Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272
   Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x
   Bierne H, 2009, P NATL ACAD SCI USA, V106, P13826, DOI 10.1073/pnas.0901259106
   Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913
   Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479
   Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5
   Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231
   Ciarlo E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01037
   Connor M, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.BAI-0015-2019
   Cossart P, 1996, SCIENCE, V271, P315, DOI 10.1126/science.271.5247.315
   Deichmann U, 2016, DEV BIOL, V416, P249, DOI 10.1016/j.ydbio.2016.06.005
   Dortet L, 2018, NAT MICROBIOL, V3, P378, DOI 10.1038/s41564-018-0109-7
   Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858
   FELSENFELD G, 2014, COLD SPRING HARB PER, V6, DOI DOI 10.1101/CSHPERSPECT.A018200
   Gahan CGM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00009
   Garcia-Garcia JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000488
   Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06
   Glaser P, 2001, SCIENCE, V294, P849
   Gogoi M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007437
   Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104
   Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006
   Hamon MA, 2011, INFECT IMMUN, V79, P2839, DOI 10.1128/IAI.01243-10
   Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008
   Kortebi M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006734
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Lakisic G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005898
   Lebreton A, 2014, MBIO, V5, DOI 10.1128/mBio.00775-13
   Lebreton A, 2012, VIRULENCE, V3, P87, DOI 10.4161/viru.3.1.18531
   Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120
   Libertini E, 2015, FRONT GENET, V6, P1
   MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381
   Minarovits J, 2009, ACTA MICROBIOL IMM H, V56, P1, DOI 10.1556/AMicr.56.2009.1.1
   Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098
   Nguyen BN, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12988
   Niller HH, 2016, ADV EXP MED BIOL, V879, P107, DOI 10.1007/978-3-319-24738-0_6
   Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484
   Osborne SE, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0222
   Pereira JM, 2018, CELL REP, V23, P1124, DOI 10.1016/j.celrep.2018.03.116
   Pereira JM, 2016, CELL HOST MICROBE, V19, P579, DOI 10.1016/j.chom.2016.04.012
   Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009
   Prokop A, 2017, MBIO, V8, DOI 10.1128/mBio.01550-17
   Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126
   Rolando M, 2015, CELL MICROBIOL, V17, P1098, DOI 10.1111/cmi.12463
   Rolhion N, 2017, FUTURE MICROBIOL, V12, P621, DOI 10.2217/fmb-2016-0221
   Samba-Louaka A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004470
   Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577
   Schmeck B, 2005, J IMMUNOL, V175, P2843, DOI 10.4049/jimmunol.175.5.2843
   Sinclair SH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00274
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011
   Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011
   Yu HB, 2018, INT J MED SCI, V15, P1356, DOI 10.7150/ijms.26125
   Zhan SH, 2018, J CELL MOL MED, V22, P2046, DOI 10.1111/jcmm.13503
   2017, EFSA J, V15, DOI DOI 10.2903/J.EFSA.2017.5077
NR 56
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD APR
PY 2020
VL 22
IS 4
SI SI
AR e13169
DI 10.1111/cmi.13169
PG 9
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA KW5IG
UT WOS:000521198000001
PM 32185898
OA Bronze
DA 2020-05-07
ER

PT J
AU Papale, F
   Saget, J
   Bapteste, E
AF Papale, Francois
   Saget, Jordane
   Bapteste, Eric
TI Networks Consolidate the Core Concepts of Evolution by Natural Selection
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID TRANSCRIPTIONAL REGULATORY NETWORKS; HORIZONTAL GENE-TRANSFER; PROTEIN;
   DIVERSITY; TREE; LIFE; PERSPECTIVES; ARCHITECTURE; COMMUNITIES;
   COMPLEXITY
AB Microbiology has unraveled rich evidence of ongoing reticulate evolutionary processes and complex interactions both within and between cells. These phenomena feature real biological networks, which can logically be analyzed using network-based tools. It is thus not surprising that network sciences, a field independent from evolutionary biology and microbiology, have recently pervasively infused their methods into both fields. Importantly, network tools bring forward observations enhancing the understanding of three core evolutionary concepts: variation, fitness, and heredity. Consequently, our work shows how network sciences can enhance evolutionary theory by explaining the evolution by natural selection of a broad diversity of units of selection, while updating the popular figure of Darwin's tree of life with a comprehensive sketch of the networks of evolution.
C1 [Papale, Francois] Univ Montreal, Dept Philosophy, Montreal, PQ H3C 3J7, Canada.
   [Papale, Francois; Saget, Jordane; Bapteste, Eric] Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, CNRS, Museum Natl Hist Nat,EPHE,Univ Antilles, F-75005 Paris, France.
RP Bapteste, E (reprint author), Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, CNRS, Museum Natl Hist Nat,EPHE,Univ Antilles, F-75005 Paris, France.
EM epbapteste@gmail.com
FU Social Sciences and Humanities Research Council of CanadaSocial Sciences
   and Humanities Research Council of Canada (SSHRC)
FX We would like to thank Professors Ford Doolittle, Frederic Bouchard,
   Philippe Huneman, Philippe Lopez, Dr Andrew Watson, and Dr Aaron Novick
   for critical comments. The Social Sciences and Humanities Research
   Council of Canada provided financial support for this research.
CR Alvarez-Ponce D, 2017, GENOME BIOL EVOL, V9, P1742, DOI 10.1093/gbe/evx117
   Alvarez-Ponce D, 2013, P NATL ACAD SCI USA, V110, pE1594, DOI 10.1073/pnas.1211371110
   Archibald JM, 2015, P NATL ACAD SCI USA, V112, P10147, DOI 10.1073/pnas.1421374112
   Baidya AK, 2018, CURR OPIN MICROBIOL, V42, P1, DOI 10.1016/j.mib.2017.08.006
   Bapteste E, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0531-6
   Bapteste E, 2012, P NATL ACAD SCI USA, V109, P18266, DOI 10.1073/pnas.1206541109
   Barabasi AL, 2016, NETWORK SCI
   Booth A, 2016, ANNU REV MICROBIOL, V70, P279, DOI 10.1146/annurev-micro-102215-095456
   Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226
   Borges RM, 2017, J GENET, V96, P483, DOI 10.1007/s12041-017-0792-9
   Campos M, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0070-9
   Cancherini DV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S11
   Castelle CJ, 2018, NAT REV MICROBIOL, V16, P629, DOI 10.1038/s41579-018-0076-2
   Castelle CJ, 2018, CELL, V172, P1181, DOI 10.1016/j.cell.2018.02.016
   Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109
   Chiu L, 2015, BIOSEMIOTICS-NETH, V8, P191, DOI 10.1007/s12304-015-9232-5
   Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109
   Corel E, 2018, MOL BIOL EVOL, V35, P899, DOI 10.1093/molbev/msy001
   Corel E, 2016, TRENDS MICROBIOL, V24, P224, DOI 10.1016/j.tim.2015.12.003
   Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104
   Darwin C., 1859, ORIGIN SPECIES MEANS
   de Souza SJ, 2012, BIOESSAYS, V34, P655, DOI 10.1002/bies.201200006
   DeLong EF, 2007, SCIENCE, V317, P327, DOI 10.1126/science.1145970
   Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x
   Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104
   Doolittle WF, 2018, P NATL ACAD SCI USA, V115, P4006, DOI 10.1073/pnas.1722232115
   Doolittle WF, 2011, BIOESSAYS, V33, P427, DOI 10.1002/bies.201100039
   Doolittle WF, 2010, BIOSCIENCE, V60, P102, DOI 10.1525/bio.2010.60.2.5
   Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124
   Dordet-Frisoni E, 2014, MBIO, V5, DOI 10.1128/mBio.01958-14
   Dorrell RG, 2017, ELIFE, V6, DOI 10.7554/eLife.23717
   Douglas AE, 2016, MBIO, V7, DOI [10.1128/mBio.02099-15, 10.1128/mBio.02099]
   Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015
   Dupre J., 2012, PROCESSES LIFE ESSAY
   Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049
   Faria JP, 2014, BRIEF BIOINFORM, V15, P592, DOI 10.1093/bib/bbs071
   Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Fernandez-Lopez R, 2017, CURR OPIN MICROBIOL, V38, P106, DOI 10.1016/j.mib.2017.05.005
   Forterre P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00106
   Fragata I, 2019, TRENDS ECOL EVOL, V34, P69, DOI 10.1016/j.tree.2018.10.009
   Gavelis GS, 2015, NATURE, V523, P204, DOI 10.1038/nature14593
   Gilbert SF, 2015, NAT REV GENET, V16, P611, DOI 10.1038/nrg3982
   Godfrey-Smith Peter, 2009, DARWINIAN POPULATION
   Gould SJ, 1989, WONDERFUL LIFE BURGE
   Gouy A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx626
   Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594
   Halary S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-146
   Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107
   Halfon MS, 2017, TRENDS GENET, V33, P436, DOI 10.1016/j.tig.2017.04.005
   Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683
   Iranzo J, 2016, MBIO, V7, DOI 10.1128/mBio.00978-16
   Jha AR, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005396
   Johnson CM, 2015, ANNU REV GENET, V49, P577, DOI 10.1146/annurev-genet-112414-055018
   Keen EC, 2017, MBIO, V8, DOI 10.1128/mBio.02115-16
   Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297
   Koch C, 2017, CELL SYST, V4, P543, DOI 10.1016/j.cels.2017.04.010
   Koonin EV, 2014, RNA BIOL, V11, P197, DOI 10.4161/rna.27673
   Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Laland K, 2014, NATURE, V514, P161, DOI 10.1038/514161a
   Lallensack R, 2018, NATURE, V554, P19, DOI 10.1038/d41586-018-01400-y
   Lamm E., 2018, STANFORD ENCY PHILOS
   Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004
   Layeghifard M, 2017, TRENDS MICROBIOL, V25, P217, DOI 10.1016/j.tim.2016.11.008
   Lewontin RC, 1970, ANNU REV ECOL SYST, V1, P1, DOI DOI 10.1146/ANNUREV.ES.01.110170.000245
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023
   Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073
   Lopez-Garcia P, 2015, NAT REV MICROBIOL, V13, P447, DOI 10.1038/nrmicro3485
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489
   Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]
   Martin WF, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0330
   Martinez-Pastor M, 2017, ANNU REV GENET, V51, P143, DOI 10.1146/annurev-genet-120116-023413
   Mateos JL, 2017, P NATL ACAD SCI USA, V114, pE11037, DOI 10.1073/pnas.1618075114
   McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243
   McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110
   McInerney JO, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.40
   McMahon SA, 2009, NUCLEIC ACIDS RES, V37, P4887, DOI 10.1093/nar/gkp478
   Meheust R, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1454-9
   Meheust R, 2016, P NATL ACAD SCI USA, V113, P3579, DOI 10.1073/pnas.1517551113
   Merhej V, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00113
   Moran NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002311
   Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119
   Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381
   Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109
   Newman M. E. J., 2018, NETWORKS
   Nowack ECM, 2012, P NATL ACAD SCI USA, V109, P5340, DOI 10.1073/pnas.1118800109
   O'Connor R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00264
   O'Hara RJ, 1997, ZOOL SCR, V26, P323, DOI 10.1111/j.1463-6409.1997.tb00422.x
   Odling-Smee F.J., 2003, NICHE CONSTRUCTION N
   Osmanovic D, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0224-7
   Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135
   Patthy L, 2003, GENETICA, V118, P217, DOI 10.1023/A:1024182432483
   Pigliucci M, 2010, EVOLUTION EXTENDED S
   Popa O, 2017, ISME J, V11, P543, DOI 10.1038/ismej.2016.116
   Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110
   Qin H, 2003, P NATL ACAD SCI USA, V100, P12820, DOI 10.1073/pnas.2235584100
   Raoult D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00127
   Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439
   Rosenberg E, 2009, ENVIRON MICROBIOL, V11, P2959, DOI 10.1111/j.1462-2920.2009.01995.x
   Ruprecht C, 2017, PLANT J, V90, P447, DOI 10.1111/tpj.13502
   Ruprecht C, 2017, TRENDS PLANT SCI, V22, P298, DOI 10.1016/j.tplants.2016.12.011
   Sapp J., 2009, NEW FDN EVOLUTION TR
   Selosse MA, 2014, TRENDS MICROBIOL, V22, P607, DOI 10.1016/j.tim.2014.07.003
   Seshasayee ASN, 2006, CURR OPIN MICROBIOL, V9, P511, DOI 10.1016/j.mib.2006.08.007
   Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881
   Sicard A, 2019, ELIFE, V8, DOI 10.7554/eLife.43599
   Skinner MK, 2015, GENOME BIOL EVOL, V7, P1296, DOI 10.1093/gbe/evv073
   Skippington E, 2011, FEMS MICROBIOL REV, V35, P707, DOI 10.1111/j.1574-6976.2010.00261.x
   Stoltzfus A, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-35
   Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725
   Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tamames J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r94
   Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102
   Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109
   van Opstal EJ, 2015, SCIENCE, V349, P1172, DOI 10.1126/science.aab3958
   Venturelli OS, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178157
   Vigliotti C, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.MTBP-0008-2016
   Walsh D. M., 2015, ORGANISMS AGENCY EVO
   Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008
   Wanner G, 2008, J BACTERIOL, V190, P3721, DOI 10.1128/JB.00027-08
   Wei Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9413
   West-Eberhard Mary Jane, 2003, pi
   Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999
   Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-158
   Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306
NR 131
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD APR
PY 2020
VL 28
IS 4
BP 254
EP 265
DI 10.1016/j.tim.2019.11.006
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA KU3AC
UT WOS:000519578400005
PM 31866140
OA Other Gold
DA 2020-05-07
ER

PT J
AU Zhu, YY
   Li, JJ
   Reng, J
   Wang, SY
   Zhang, RQ
   Wang, B
AF Zhu, Yuanyuan
   Li, Jiao Jiao
   Reng, Jian
   Wang, Siyang
   Zhang, Ruiqing
   Wang, Bin
TI Global trends of Pseudomonas aeruginosa biofilm research in the past two
   decades: A bibliometric study
SO MICROBIOLOGYOPEN
LA English
DT Article; Early Access
DE bibliometric analysis; global trends; Pseudomonas aeruginosa biofilm;
   visualized analysis
ID VIRULENCE; BACTERIA
AB Pseudomonas aeruginosa biofilm formation is a primary cause of chronic infections. This has been a highly active area of research over the past two decades due to causing high mortality risks in immunocompromised patients. This study evaluates global trends in the dynamic and rapidly evolving field of P. aeruginosa biofilm research through bibliometric and visualized analyses. Publications from 1994 to 2018 on P. aeruginosa biofilm research were retrieved from Web of Science, Scopus, and PubMed, and their bibliometric data were systematically studied. The VOSviewer software was used to conduct global analyses of bibliographic coupling, coauthorship, cocitation, and co-occurrence. A total of 9,527 publications were included in this study. The overall number of publications and research interest in the field displayed a strongly rising trend. The USA made the greatest contributions to the field, with the highest h-index and number of citations compared with other countries, while Denmark had the highest average citation per publication. The Journal of Bacteriology had the highest number of publications in the field, while the University of Copenhagen was the institution with the highest contribution influence. Co-occurrence network maps revealed that the most prominent topics in P. aeruginosa biofilm research were mechanistic studies, in vitro/in vivo studies, and biofilm formation studies. Pseudomonas aeruginosa biofilms constitute a dynamic research area in microbiology with increasing global research interest. Future studies will likely focus on investigating the mechanisms of biofilm formation to solve infection-associated clinical problems.
C1 [Zhu, Yuanyuan; Reng, Jian; Wang, Siyang; Zhang, Ruiqing] Shanxi Med Univ, Dept Pharm, Affiliated Hosp 2, Taiyuan, Peoples R China.
   [Li, Jiao Jiao] Univ Sydney, Kolling Inst, Sydney, NSW, Australia.
   [Wang, Bin] Shanxi Med Univ, Dept Orthopaed, Affiliated Hosp 2, Taiyuan, Peoples R China.
RP Zhang, RQ (reprint author), Shanxi Med Univ, Dept Pharm, Affiliated Hosp 2, Taiyuan, Peoples R China.; Wang, B (reprint author), Shanxi Med Univ, Dept Orthopaed, Affiliated Hosp 2, Taiyuan, Peoples R China.
EM zhangruiqin5539@163.com; wangbin_pku@163.com
FU Scientific and Technological Innovation Programs of Higher Education
   Institutions in Shanxi [2019L0410]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [81802204,
   81973606]; National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [APP1120249]; Shanxi Medical
   University Second Affiliated Hospital Doctor's Funds [2017-105,
   201702-3]; Natural Science Foundation of Shanxi ProvinceNatural Science
   Foundation of Shanxi Province [201801D21221, 201801D221117]; Australian
   National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [APP1120249]
FX Scientific and Technological Innovation Programs of Higher Education
   Institutions in Shanxi, Grant/Award Number: 2019L0410; National Natural
   Science Foundation of China, Grant/Award Number: 81802204 and 81973606;
   National Health and Medical Research Council, Grant/Award Number:
   APP1120249; Shanxi Medical University Second Affiliated Hospital
   Doctor's Funds, Grant/Award Number: 2017-105 and 201702-3; Natural
   Science Foundation of Shanxi Province, Grant/Award Number: 201801D21221
   and 201801D221117; Australian National Health and Medical Research
   Council, Grant/Award Number: APP1120249
CR Bassetti Matteo, 2018, Drugs Context, V7, P212527, DOI 10.7573/dic.212527
   Billings N, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/3/036601
   Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099
   Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Guo Q, 2014, J BASIC MICROB, V54, P633, DOI 10.1002/jobm.201300091
   Head NE, 2004, INFECT IMMUN, V72, P133, DOI 10.1128/IAI.72.1.133-144.2004
   Jia ZW, 2015, EUR SPINE J, V24, P1806, DOI 10.1007/s00586-015-4030-y
   Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007
   Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Qu L, 2016, MICROBIOLOGYOPEN, V5, P402, DOI 10.1002/mbo3.338
   RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262
   Rybtke M, 2015, J MOL BIOL, V427, P3628, DOI 10.1016/j.jmb.2015.08.016
   Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441
   Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]
   Wang B, 2019, BIOMED RES INT, DOI 10.1155/2019/1495130
   Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627
   Zhai X, 2016, LANCET, V387, P1722, DOI 10.1016/S0140-6736(16)30261-6
   Zowawi HM, 2015, NAT REV UROL, V12, P570, DOI 10.1038/nrurol.2015.199
NR 20
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-8827
J9 MICROBIOLOGYOPEN
JI MicrobiologyOpen
AR e1021
DI 10.1002/mbo3.1021
EA MAR 2020
PG 11
WC Microbiology
SC Microbiology
GA KR1RE
UT WOS:000517395100001
PM 32120451
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Nguyen, TLC
   Kost, GJ
AF Nguyen, Thuy Loan Chi
   Kost, Gerald J.
TI The Status of Point-of-Care Testing and Coordinators in Vietnam Needs
   Assessment, Technologies, Education, Exchange, and Future Mission
SO POINT OF CARE
LA English
DT Article
DE bedside testing; blood gases; blood group; BNP; cardiac troponin I and
   T; CBC; coagulation; district hospital; emergency room; evidence-based
   medicine; glucose; hematocrit; hemoglobin; HIV; The International
   Organization for Standardization (ISO); hospital levels; Hue City;
   international symposium; JCI; ketone; microbiology; mission; needs
   assessment; point-of-care testing; primary care; quality control;
   small-world networks; survey; value proposition; workshop
ID EBOLA-VIRUS-DISEASE; CARDIAC BIOMARKERS
AB Objectives: The goals of this study were as follows: (a) to enhance point-of-care testing (POCT) and improve standards of care throughout Vietnam; (b) to educate point-of-care (POC) coordinators who provide leadership, oversight, and quality assurance; and (c) to promote international dialog and knowledge of POCT in limited-resource settings.
   Methods: Needs assessment of 16 provincial hospitals, 2 each randomly chosen from the 8 geographic regions of Vietnam, was performed. In Ho Chi Minh City, 10 referral, 5 provincial, and 7 district hospitals, and 8 community medical stations were surveyed. Emergency and intensive care unit nurses and doctors, and laboratorian were respondents.
   Results: Glucose meters and blood gas analyzers were the most frequent POC devices in the 16 provincial hospitals. Cardiac biomarker, coagulation, and human immunodeficiency tests were the highest needs. Biomedical engineers managed locations and quality. Point-of-care coordinators were deficient. Generally, hospitals with POCT had no laboratory oversight. Users performed POCT without internal or external quality control (QC). In Ho Chi Minh City, coagulation and cardiac biomarker tests were most desired.
   Conclusions: Clinicians were poorly informed about the availability of urgent, emergency department, and bedside POC tests. No provincial hospitals surveyed offered cardiac biomarker testing, despite the high prevalence of acute coronary syndromes. Challenges to the implementation of POCT comprise: (a) the quality assurance burden for non laboratory personnel; (b) limited human resources to support POCT programs, including virtually total absence of POC coordinators; and (c) no national POCT policy and guidelines. To rectify these deficiencies, we recommend fundamental education at all levels, promotion of POC coordinator user groups, heightened awareness of available POCT, and vigorous international exchanges to enhanced standards of care in Vietnam.
C1 [Nguyen, Thuy Loan Chi] Franco Vietnamese Hosp, Ho Chi Minh City, Vietnam.
   [Kost, Gerald J.] Univ Calif Davis, Sch Med, Point Of Care Testing Ctr Teaching & Res, 506 Citadel Dr, Davis, CA 95616 USA.
RP Kost, GJ (reprint author), Univ Calif Davis, Sch Med, Point Of Care Testing Ctr Teaching & Res, 506 Citadel Dr, Davis, CA 95616 USA.
EM GeraldKost@gmail.com
CR [Anonymous], 2015, NIEN NEWS       0519
   Tran BX, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20690
   Do NTT, 2016, LANCET GLOB HEALTH, V4, pE633, DOI 10.1016/S2214-109X(16)30142-5
   Nguyen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108998
   Institute for Health Metrics and Evaluation (University of Washington), 2010, GBD PROF VIETN
   Institute for Health Metrics and Evaluation (University of Washington) and the Human Development Network (The World Bank), 2013, GLOB BURD DIS GEN EV
   Kost GJ, 2006, POINT CARE, V5, P193
   Kost GJ, 2018, POINT CARE, V17, P73, DOI 10.1097/POC.0000000000000167
   Kost GJ, 2018, EXPERT REV MOL DIAGN, V18, P657, DOI 10.1080/14737159.2018.1491793
   Kost GJ, 2016, POINT CARE, V15, P43, DOI 10.1097/POC.0000000000000080
   Kost GJ, 2015, EXPERT REV MOL DIAGN, V15, P1245, DOI 10.1586/14737159.2015.1079776
   Kost Gerald J, 2015, Am J Disaster Med, V10, P121, DOI 10.5055/ajdm.2015.0196
   Kost GJ, 2010, POINT CARE, V9, P53, DOI 10.1097/POC.0b013e3181d9d45c
   Kost GJ, 2005, CARDIOL CLIN, V23, P467, DOI 10.1016/j.ccl.2005.08.005
   Kost GJ, 2019, PREPAREDNESS POINT O, P5
   KOST GJ, 2019, FRONT PUBLIC HEALTH, V6, P1
   Kost GJ, 2015, GLOBAL POINT CARE ST, P595
   Kost GJ, 2015, GLOBAL POINT CARE ST, P701
   Kost GJ, 2015, CLIN LAB INT, V39, P6
   Kost GJ, 2015, GLOBAL POINT CARE ST, P3
   Louie RF, 2015, GLOBAL POINT CARE ST, P625
   Vo LNQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209290
   Lubell Y, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0414-1
   Minh HV, 2006, THESIS
   Ministry of Health Vietnam, 2018, 392018TTBYT MIN HLTH
   Ministry of Health Vietnam, 2018, 372018TTBYT MIN HLTH
   Ministry of Public Health, 2015, THAIL NAT GUID POINT
   Cong ND, 2014, J ATHEROSCLER THROMB, V21, pS36
   Nguyen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095631
   Nguyen TP, 2015, VALUE HEALTH, V18, pA389, DOI 10.1016/j.jval.2015.09.857
   Nguyen TLC, 2019, POINT CAR LTD RES SE, P21
   Nguyen TLC, 2017, INT S SPONS POCT CTR
   The Point of Care Testing Steering Committee, 2012, NAT POINT CAR TEST P, P57
   Nguyen VTT, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21752
   Ventura IJ, 2019, POINT CARE, V18, P1, DOI 10.1097/POC.0000000000000178
   Weigl BH, 2012, POINT CARE, V11, P108
   World Health Organization (WHO), 2014, NONC DIS NCD COUNTR
NR 37
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1533-029X
EI 1533-0303
J9 POINT CARE
JI Point Care
PD MAR
PY 2020
VL 19
IS 1
BP 19
EP 24
DI 10.1097/POC.0000000000000196
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA LG3EK
UT WOS:000527988100004
DA 2020-05-07
ER

PT J
AU Wang, R
   Cao, B
   Sun, Q
   Song, LH
AF Wang, Rui
   Cao, Bing
   Sun, Quan
   Song, Lihua
TI Response of grass interplanting on bacterial and fungal communities in a
   jujube orchard in Ningxia, northwest China
SO HELIYON
LA English
DT Article
DE Agricultural sciences; Biochemistry; Microbiology; Plant biology;
   Bacteria; Fungi; Jujube; Network analysis; Redundancy analysis
ID SOIL MICROBIAL COMMUNITY; NUTRIENT MANAGEMENTS; NETWORK ANALYSIS; COVER
   CROPS; DIVERSITY; INDICATORS; FERTILIZER; ABUNDANCE; NITROGEN; QUALITY
AB Orchard grass is an important soil management method that improves pest resistance in fruit trees and it reduces the usage of chemical fertilizer to protect the environment. In this study, we investigated the bacterial and fungi communities in the rhizosphere of Ziziphus jujuba Mill cv. `lingwuchangzao' by high-throughput sequencing to test the effects of different sward types. The soil organic matter, available phosphorus, available potassium, and total nitrogen contents were higher with cleared tillage compared with the other planting grass treatments. Ascomycota, Basidiomycota, and Mortierellomycota were the dominant fungal groups. Most of the soil nutrient levels were lower in the treatments with grass (except for planting with ryegrass and pea grass) than cleared tillage, but there were no significant differences in the bacterial and fungi diversity. pH and total phosphorus were the main contributors to variations in the bacterial communities. The variations in the fungal communities were mainly attributed to the soil nutrient levels. The changes in the titratable acids and vitamin C contents were clearly correlated with the dynamics of the bacterial and fungi communities. Network analysis showed that 60% of the bacteria had close connections with fungi, including the dominant bacteria comprising Proteobacteria, Actinobacteria, and Bacteroidetes. Our findings demonstrated that different types of grass treatments affected the abundances of microbes rather than their composition.
C1 [Wang, Rui; Cao, Bing; Sun, Quan; Song, Lihua] Ningxia Univ, Sch Agr, Yinchuan 750021, Ningxia, Peoples R China.
RP Song, LH (reprint author), Ningxia Univ, Sch Agr, Yinchuan 750021, Ningxia, Peoples R China.
EM songlihuanx@126.com
FU Major Innovation Projects of Western Top Universities [ZKZD2017008]; Key
   Research and Development Program of Ningxia [2017BN0102]
FX This work was supported by the Major Innovation Projects of Western Top
   Universities (ZKZD2017008) and the Key Research and Development Program
   of Ningxia (2017BN0102).
CR Banerjee S, 2016, SOIL BIOL BIOCHEM, V97, P188, DOI 10.1016/j.soilbio.2016.03.017
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035
   BUGG RL, 1994, AGR ECOSYST ENVIRON, V50, P11, DOI 10.1016/0167-8809(94)90121-X
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Celette F, 2009, EUR J AGRON, V30, P41, DOI 10.1016/j.eja.2008.07.003
   Chinnadurai C, 2014, ARCH AGRON SOIL SCI, V60, P531, DOI 10.1080/03650340.2013.803072
   Colvan SR, 2001, BIOL FERT SOILS, V34, P258
   Ding JL, 2016, APPL SOIL ECOL, V105, P187, DOI 10.1016/j.apsoil.2016.04.010
   Fontaine S, 2011, SOIL BIOL BIOCHEM, V43, P86, DOI 10.1016/j.soilbio.2010.09.017
   Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058
   Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107
   Goldfarb KC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00094
   Krashevska V, 2015, BIOL FERT SOILS, V51, P697, DOI 10.1007/s00374-015-1021-4
   Kumar U, 2017, ECOL INDIC, V73, P536, DOI 10.1016/j.ecolind.2016.10.014
   Li HuiKe, 2008, Scientia Agricultura Sinica, V41, P2070
   Li HuiKe, 2007, Acta Horticulturae Sinica, V34, P477
   [刘富庭 Liu Futing], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P355
   Moreno B, 2009, AGR ECOSYST ENVIRON, V131, P333, DOI 10.1016/j.agee.2009.02.011
   Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847
   Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2
   Ren WJ, 2015, J HAZARD MATER, V297, P286, DOI 10.1016/j.jhazmat.2015.05.017
   Ros M, 2006, APPL SOIL ECOL, V34, P93, DOI 10.1016/j.apsoil.2006.03.010
   Sanchez EE, 2007, PLANT SOIL, V292, P193, DOI 10.1007/s11104-007-9215-7
   [宋丽华 Song Lihua], 2015, [西北林学院学报, Journal of Northwest Forestry University], V30, P129
   STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x
   Sutton NB, 2013, APPL ENVIRON MICROB, V79, P619, DOI 10.1128/AEM.02747-12
   Tamilselvi SM, 2015, ECOL INDIC, V48, P76, DOI 10.1016/j.ecolind.2014.08.001
   Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093
   Tripathi BM, 2014, INDIAN J MICROBIOL, V54, P65, DOI 10.1007/s12088-013-0398-8
   Wang JJ, 2014, EUR J SOIL BIOL, V65, P70, DOI 10.1016/j.ejsobi.2014.10.003
   Wang JJ, 2013, ANN MICROBIOL, V63, P335, DOI 10.1007/s13213-012-0479-7
   Whang Yan-ting, 2015, Yingyong Shengtai Xuebao, V26, P1892
   White T.J., 1994, PCR PROTOCOLS GUIDE, V38, P315
   [吴玉森 Wu Yusen], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P99
   Yang Y., 2014, J JILIN SCI TECHNOL, V43, P43
   Zhang XX, 2017, SOIL BIOL BIOCHEM, V104, P208, DOI 10.1016/j.soilbio.2016.10.023
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD MAR
PY 2020
VL 6
IS 3
AR e03489
DI 10.1016/j.heliyon.2020.e03489
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KY2SL
UT WOS:000522422500043
PM 32154422
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Feller, J
   Lund, BC
   Perencevich, EN
   Alexander, B
   Heintz, B
   Beck, B
   Nair, R
   Goto, M
   Livorsi, DJ
AF Feller, J.
   Lund, B. C.
   Perencevich, E. N.
   Alexander, B.
   Heintz, B.
   Beck, B.
   Nair, R.
   Goto, M.
   Livorsi, D. J.
TI Post-discharge oral antimicrobial use among hospitalized patients across
   an integrated national healthcare network
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Antimicrobial stewardship; Hospital discharge
ID ANTIBIOTIC PRESCRIBING PRACTICES; STEWARDSHIP; IMPACT; PNEUMONIA;
   DISCHARGE; DURATION; THERAPY; INTERVENTION; GUIDELINE; METRICS
AB Objectives: Antimicrobial stewardship programmes have focused on reducing inappropriate inpatient antimicrobial prescribing, but several small studies have found a large portion of antimicrobial exposure occurs immediately after hospital discharge. In this study, we describe the prescribing of oral antimicrobials at hospital discharge across an integrated national healthcare system. At the hospital level, we also compare total inpatient antimicrobial use and post-discharge oral antimicrobial use.
   Methods: This retrospective cross-sectional study used national administrative data to identify all acute-care admissions during 2014-2016 within the Veterans Health Administration (VHA). We evaluated inpatient days of therapy (DOT) and post-discharge DOT, defined as oral outpatient antimicrobials dispensed at the time of hospital discharge. At the hospital level, inpatient DOT/100 admissions were compared with post-discharge DOT/100 admissions using Spearman's rank-order correlation.
   Results: There were 1 681 701 acute-care admissions across 122 hospitals, and 335 369 (19.9%) were prescribed an oral antimicrobial at discharge. Fluoroquinolones (38.3%) were the most common post-discharge antimicrobial. At the hospital level, median inpatient antimicrobial use was 331.3 (interquartile range (IQR) 284.9-367.9) DOT/100 admissions and median post-discharge use was 209.5 (IQR 181.5-239.6) DOT/100 admissions. Thirty-nine per cent of the total duration of antimicrobial exposure occurred after discharge. At the hospital-level, the metrics of inpatient DOT/100 admissions and post-discharge DOT/100 admissions were weakly positively correlated with rho=0.44 (p < 0.001).
   Conclusions: A large proportion of antimicrobial exposure among hospitalized patients occurred immediately following discharge. Antimicrobial-prescribing at hospital discharge provides an opportunity for antimicrobial stewardship. Hospital-level stewardship metrics need to include both inpatient and post-discharge antimicrobial-prescribing to provide a comprehensive assessment of hospital-associated antimicrobial use. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Feller, J.; Lund, B. C.; Perencevich, E. N.; Alexander, B.; Heintz, B.; Beck, B.; Nair, R.; Goto, M.; Livorsi, D. J.] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA.
   [Perencevich, E. N.; Nair, R.] Univ Iowa, Div Gen Internal Med, Carver Coll Med, Iowa City, IA USA.
   [Goto, M.; Livorsi, D. J.] Univ Iowa, Div Infect Dis, Carver Coll Med, Iowa City, IA USA.
RP Livorsi, DJ (reprint author), 601 Hwy 6 West, Iowa City, IA 52246 USA.
EM daniel-livorsi@uiowa.edu
RI Goto, Michihiko/H-2652-2013
OI Goto, Michihiko/0000-0001-6612-5613; NAIR,
   RAJESHWARI/0000-0002-9406-7841
FU Iowa City VA Health Care System, Department of Pharmacy Services;
   Department of Veterans Affairs (VA) Health Services Research and
   Development ServiceUS Department of Veteran Affairs [CIN 13-412, 16-204]
FX This research was supported by the Iowa City VA Health Care System,
   Department of Pharmacy Services. Additional support was provided by the
   Department of Veterans Affairs (VA) Health Services Research and
   Development Service (Dr Lund CIN 13-412; Dr Livorsi Career Development
   Award 16-204). None of these sponsors had any role in the study design,
   methods, analyses, and interpretation, or in preparation of the
   manuscript and the decision to submit it for publication. The views
   expressed in this article are those of the authors and do not
   necessarily reflect the position or policy of the Department of Veterans
   Affairs. D.J.L. reports receiving grants from Merck outside of the
   submitted work.
CR Antonioli P, 2018, J Prev Med Hyg, V59, pE139
   Avdic E, 2012, CLIN INFECT DIS, V54, P1581, DOI 10.1093/cid/cis242
   Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118
   Caplinger C, 2016, AM J HEALTH-SYST PH, V73, P2043, DOI 10.2146/ajhp160011
   Chavada R, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3147-0
   Dyer AP, 2019, INFECT CONT HOSP EP, V40, P847, DOI 10.1017/ice.2019.118
   Haas MK, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw186
   Hoover Susan E, 2017, S D Med, V70, P177
   Howard P, 2017, J ANTIMICROB CHEMOTH, V72, P2910, DOI 10.1093/jac/dkx243
   Ibrahim OM, 2014, INFECT DIS CLIN N AM, V28, P195, DOI 10.1016/j.idc.2014.01.006
   Jenkins TC, 2013, INFECTION, V41, P135, DOI 10.1007/s15010-012-0362-2
   Jenkins TC, 2014, INFECT CONT HOSP EP, V35, P1241, DOI 10.1086/678056
   Jenkins TC, 2011, ARCH INTERN MED, V171, P1072, DOI 10.1001/archinternmed.2011.29
   Madaras-Kelly KJ, 2016, J HOSP MED, V11, P832, DOI 10.1002/jhm.2648
   Moehring RW, 2017, CLIN INFECT DIS, V64, P377, DOI 10.1093/cid/ciw787
   National Healthcare Safety Network, 2019, ANT US MOD
   O'Leary EN, 2017, CLIN INFECT DIS, V65, P1748, DOI 10.1093/cid/cix651
   Phatak A, 2016, J HOSP MED, V11, P39, DOI 10.1002/jhm.2493
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Roselle G, 2016, SURVEY ANTIMICROBIAL
   Scarpato SJ, 2017, INFECT CONT HOSP EP, V38, P353, DOI 10.1017/ice.2016.276
   Tamma PD, 2017, CLIN INFECT DIS, V64, P537, DOI 10.1093/cid/ciw780
   Walker PC, 2009, ARCH INTERN MED, V169, P2003, DOI 10.1001/archinternmed.2009.398
   Yi SH, 2018, CLIN INFECT DIS, V66, P1333, DOI 10.1093/cid/cix986
   Yogo N, 2017, INFECT CONT HOSP EP, V38, P534, DOI 10.1017/ice.2017.10
   Yogo N, 2015, INFECT CONT HOSP EP, V36, P474, DOI 10.1017/ice.2014.85
NR 26
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2020
VL 26
IS 3
BP 327
EP 332
DI 10.1016/j.cmi.2019.09.016
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA KQ2ND
UT WOS:000516764500011
PM 31600582
DA 2020-05-07
ER

PT J
AU Castello, E
   Ferraz-Junior, ADN
   Andreani, C
   Anzola-Rojas, MD
   Borzacconi, L
   Buitron, G
   Carrillo-Reyes, J
   Gomes, SD
   Maintinguer, SI
   Moreno-Andrade, I
   Palomo-Briones, R
   Razo-Flores, E
   Schiappacasse-Dasati, M
   Tapia-Venegas, E
   Valdez-Vazquez, I
   Vesga-Baron, A
   Zaiat, M
   Etchebehere, C
AF Castello, Elena
   Nunes Ferraz-Junior, Antonio Djalma
   Andreani, Cristiane
   Anzola-Rojas, Melida del Pilar
   Borzacconi, Liliana
   Buitron, German
   Carrillo-Reyes, Julian
   Gomes, Simone Damasceno
   Maintinguer, Sandra I.
   Moreno-Andrade, Ivan
   Palomo-Briones, Rodolfo
   Razo-Flores, Elias
   Schiappacasse-Dasati, Maria
   Tapia-Venegas, Estela
   Valdez-Vazquez, Idania
   Vesga-Baron, Alejandra
   Zaiat, Marcelo
   Etchebehere, Claudia
TI Stability problems in the hydrogen production by dark fermentation:
   Possible causes and solutions
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review
DE Biohydrogen production; Dark fermentation; H-2 production microbiology;
   Unstable H-2 production; Homoacetogenesis; Lactic acid bacteria
ID CONTINUOUS BIOHYDROGEN PRODUCTION; MICROBIAL COMMUNITY STRUCTURE;
   HYDRAULIC RETENTION TIME; LACTIC-ACID BACTERIA; ORGANIC LOADING RATE;
   PACKED-BED REACTORS; CHEESE WHEY; WASTE-WATER; ANAEROBIC-DIGESTION; UASB
   REACTOR
AB H-2 production by dark fermentation using mixed cultures has been studied intensively during the last two decades, and its feasibility has been demonstrated. Different substrates, operational conditions, and reactor technologies have been widely studied and there is a general agreement that the use of non-sterile fermentable substrates is required to make the process feasible for scaling up. Nonetheless, stability problems during long term operation may hinder its application at large scale. This work, written by members of the Latin American Biohydrogen Network, analyse and discuss instability causes and possible solutions in the H-2 production by dark fermentation. It is concluded that instability is mostly linked to the biotic aspects of the process (i.e., changes in the microbial community composition, presence of organisms that consume hydrogen and compete for the substrate, and accumulation of fermentation products); regardless of the reactor configuration. However, some problems like excessive growth of microorganisms and methanogens presence were mostly reported in fixed bed reactors and granular sludge reactors. The novelty of this work relies on the comprehensive revision of the main causes behind the unstable and low hydrogen production and how these causes are linked to the technology used. The strategies to overcome the problems as well as the potential implications are also analysed.
C1 [Castello, Elena; Borzacconi, Liliana] Univ Republica, Engn Fac, Chem Engn Inst, BioProA Lab, Herrera & Reissig 565, Montevideo, Uruguay.
   [Nunes Ferraz-Junior, Antonio Djalma; Etchebehere, Claudia] Minist Educ, Biol Res Inst Clemente Estable, BioGem Dept, Microbial Ecol Lab, Av Italia 3318, Montevideo, Uruguay.
   [Andreani, Cristiane; Gomes, Simone Damasceno] State Univ West Paran UNIOESTE, Grad Program Agr Engn, 2069 Univ St, BR-85819210 Cascavel, PR, Brazil.
   [Anzola-Rojas, Melida del Pilar; Zaiat, Marcelo] Univ Sao Paulo, Biol Proc Lab, Sao Carlos Sch Engn, LPB,EESC, Av Joao Dagnone 1100, BR-13563120 Sao Carlos, SP, Brazil.
   [Buitron, German; Carrillo-Reyes, Julian; Moreno-Andrade, Ivan; Valdez-Vazquez, Idania] Univ Nacl Autonoma Mexico, Lab Res Adv Proc Water Treatment, Unidad Acad Juriquilla, Inst Ingn, Blvd Juriquilla 3001, Queretaro 76230, Mexico.
   [Maintinguer, Sandra I.] UNESP, IPBEN, Bioenergy Res Inst, BR-13550230 Rio Claro, SP, Brazil.
   [Maintinguer, Sandra I.] Univ Araraquara, BR-14801320 Araraquara, SP, Brazil.
   [Palomo-Briones, Rodolfo; Razo-Flores, Elias] Inst Potosino Invest Cient & Tecnol AC, Div Ciencias Ambientales, Camino Presa San Jose 2055,Col Lomas 4a Secc, San Luis Potosi 78216, Slp, Mexico.
   [Schiappacasse-Dasati, Maria; Tapia-Venegas, Estela; Vesga-Baron, Alejandra] Pontificia Univ Catolica Valparaiso, Fac Ingn, Escuela Ingn Bioquim, Av Brasil 2085, Valparaiso, Chile.
RP Castello, E (reprint author), UdelaR, Engn Fac, Chem Engn Inst, Bioproa Lab, Herrera & Reisig 565,PC 11300, Montevideo, Uruguay.
EM elenacas@fing.edu.uy
RI Buitron, German/B-1118-2011; Zaiat, Marcelo/C-4752-2012
OI Buitron, German/0000-0003-3975-7644; Palomo-Briones,
   Rodolfo/0000-0002-7164-0756; Valdez-Vazquez, Idania/0000-0002-3654-7230;
   Zaiat, Marcelo/0000-0001-7336-9093
FU Fondo de Sustentabilidad Energetica SENER-CONACYT, Cluster
   Biocombustibles Gaseosos [247006]; CONACYTConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [255537]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [150403/2013-5, 428510/2016-7];
   Fundacao Araucaria/Fundacao Parque Tecnologico Itaipu (FPTI) [02/2013];
   Fondecyt, ChileComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [3160219]; Sao Paulo Research
   Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/06246-7]
FX Fondo de Sustentabilidad Energetica SENER-CONACYT, Cluster
   Biocombustibles Gaseosos, project 247006 and CONACYT 255537. Rodolfo
   Palomo-Briones is thankful for the PhD scholarship provided by CONACYT.
   CNPq grant number 150403/2013-5 and 428510/2016-7; Fundacao
   Araucaria/Fundacao Parque Tecnologico Itaipu (FPTI, grant number
   02/2013). Fondecyt 3160219, Chile. Sao Paulo Research Foundation (FAPESP
   -process 2015/06246-7).
CR Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002
   Abreu AA, 2011, BIOTECHNOL BIOENG, V108, P1766, DOI 10.1002/bit.23145
   Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006
   Anzola-Rojas MD, 2016, J CHEM TECHNOL BIOT, V91, P1551, DOI 10.1002/jctb.4754
   Anzola-Rojas MD, 2016, BIORESOURCE TECHNOL, V202, P42, DOI 10.1016/j.biortech.2015.11.084
   ANZOLAROJAS MP, 2015, BIOTECHNOL REP, V5, P46, DOI DOI 10.1016/J.BTRE.2014.10.010
   Arooj MF, 2008, INT J HYDROGEN ENERG, V33, P3289, DOI 10.1016/j.ijhydene.2008.04.022
   Arooj MF, 2008, INT J HYDROGEN ENERG, V33, P6509, DOI 10.1016/j.ijhydene.2008.06.077
   Azbar N, 2009, INT J HYDROGEN ENERG, V34, P7441, DOI 10.1016/j.ijhydene.2009.04.032
   Babu VL, 2009, INT J HYDROGEN ENERG, V34, P3305, DOI 10.1016/j.ijhydene.2009.02.011
   Baghchehsaraee B, 2010, INT J HYDROGEN ENERG, V35, P5021, DOI 10.1016/j.ijhydene.2009.08.072
   Balachandar G, 2013, BIOHYDROGEN PRODUCTI, V6, DOI [10.1016/B978-0-444-59555-3.00006-4, DOI 10.1016/B978-0-444-59555-3.00006-4]
   Balciunas EM, 2013, FOOD CONTROL, V32, P134, DOI 10.1016/j.foodcont.2012.11.025
   Banu JR, 2018, BIORESOURCE TECHNOL, V268, P787, DOI 10.1016/j.biortech.2018.07.034
   Barca C, 2016, BIORESOURCE TECHNOL, V221, P526, DOI 10.1016/j.biortech.2016.09.072
   BHAT JV, 1947, J BACTERIOL, V54, P381, DOI 10.1128/JB.54.3.381-391.1947
   Braga AFM, 2016, J CHEM TECHNOL BIOT, V91, P967, DOI 10.1002/jctb.4665
   Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361
   Buitron G, 2010, BIORESOURCE TECHNOL, V101, P9071, DOI 10.1016/j.biortech.2010.06.127
   Bundhoo MAZ, 2016, INT J HYDROGEN ENERG, V41, P6713, DOI 10.1016/j.ijhydene.2016.03.057
   Bundhoo MAZ, 2015, J ENVIRON MANAGE, V157, P20, DOI 10.1016/j.jenvman.2015.04.006
   Cabezas A, 2015, REV ENVIRON SCI BIO, V14, P555, DOI 10.1007/s11157-015-9380-8
   Cabrol L, 2017, FEMS MICROBIOL REV, V41, P158, DOI 10.1093/femsre/fuw043
   Carballa M, 2011, APPL MICROBIOL BIOT, V89, P303, DOI 10.1007/s00253-010-2858-y
   Carrillo-Reyes J, 2016, RENEW ENERG, V97, P266, DOI 10.1016/j.renene.2016.05.082
   Carrillo-Reyes J, 2014, INT J HYDROGEN ENERG, V39, P11423, DOI 10.1016/j.ijhydene.2014.05.099
   Carrillo-Reyes J, 2012, INT J HYDROGEN ENERG, V37, P5591, DOI 10.1016/j.ijhydene.2012.01.004
   Carrillo-Reyes J, 2014, BIOMASS BIOENERG, V63, P101, DOI 10.1016/j.biombioe.2014.01.050
   Castello E, 2011, WATER SCI TECHNOL, V64, P2265, DOI 10.2166/wst.2011.706
   Castello E, 2009, INT J HYDROGEN ENERG, V34, P5674, DOI 10.1016/j.ijhydene.2009.05.060
   Castello E, 2018, INT J HYDROGEN ENERG, V43, P2654, DOI 10.1016/j.ijhydene.2017.12.104
   Cato EPWLG, 1986, BERGEYS MAN SYST BAC, V3, P1149, DOI [10.1007/978-0-387-68489-5_3., DOI 10.1007/978-0-387-68489-5_3]
   Chang FY, 2004, INT J HYDROGEN ENERG, V29, P33, DOI 10.1016/S0360-3199(03)00082-X
   Cisneros-Perez C, 2017, INT J HYDROGEN ENERG, V42, P9589, DOI 10.1016/j.ijhydene.2017.03.157
   Cisneros-Perez C, 2015, INT J HYDROGEN ENERG, V40, P6329, DOI 10.1016/j.ijhydene.2015.03.048
   Barcenas-Ruiz CD, 2016, BIOCHEM ENG J, V107, P75, DOI 10.1016/j.bej.2015.12.010
   DATTA R, 1985, APPL ENVIRON MICROB, V49, P522, DOI 10.1128/AEM.49.3.522-529.1985
   Davila-Vazquez G, 2009, INT J HYDROGEN ENERG, V34, P4296, DOI 10.1016/j.ijhydene.2009.02.063
   Montoya-Rosales JD, 2019, BIORESOURCE TECHNOL, V283, P251, DOI 10.1016/j.biortech.2019.03.072
   DIEKERT G, 1994, ANTON LEEUW INT J G, V66, P209, DOI 10.1007/BF00871640
   DIEZGONZALEZ F, 1995, ARCH MICROBIOL, V164, P36, DOI 10.1007/BF02568732
   Dikshit PK, 2017, BIORESOURCE TECHNOL, V244, P362, DOI 10.1016/j.biortech.2017.07.136
   Dinamarca C, 2009, WATER SCI TECHNOL, V59, P1441, DOI 10.2166/wst.2009.135
   Drake HL, 2008, ANN NY ACAD SCI, V1125, P100, DOI 10.1196/annals.1419.016
   Drake HL, 1997, BIOFACTORS, V6, P13, DOI 10.1002/biof.5520060103
   Elbeshbishy E, 2017, RENEW SUST ENERG REV, V79, P656, DOI 10.1016/j.rser.2017.05.075
   Etchebehere C, 2016, APPL MICROBIOL BIOT, V100, P3371, DOI 10.1007/s00253-016-7325-y
   Fang HHP, 2002, BIORESOURCE TECHNOL, V82, P87, DOI 10.1016/S0960-8524(01)00110-9
   Fernandes BS, 2013, APPL BIOCHEM BIOTECH, V170, P1348, DOI 10.1007/s12010-013-0262-7
   Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3370
   Rosa PRF, 2016, CHEM ENG J, V284, P1, DOI 10.1016/j.cej.2015.08.088
   Lima DMF, 2013, INT J HYDROGEN ENERG, V38, P15074, DOI 10.1016/j.ijhydene.2013.09.003
   Lima DMF, 2012, INT J HYDROGEN ENERG, V37, P9630, DOI 10.1016/j.ijhydene.2012.03.097
   Fooks LJ, 1999, INT DAIRY J, V9, P53, DOI 10.1016/S0958-6946(99)00044-8
   Fritsch M, 2008, INT J HYDROGEN ENERG, V33, P6549, DOI 10.1016/j.ijhydene.2008.07.070
   Fuess LT, 2018, BIORESOURCE TECHNOL, V247, P426, DOI 10.1016/j.biortech.2017.09.121
   Fuess LT, 2016, INT J HYDROGEN ENERG, V41, P8132, DOI 10.1016/j.ijhydene.2015.10.143
   Gavala HN, 2006, INT J HYDROGEN ENERG, V31, P1164, DOI 10.1016/j.ijhydene.2005.09.009
   Gomes BC, 2015, INT J HYDROGEN ENERG, V40, P8650, DOI 10.1016/j.ijhydene.2015.05.035
   Gomes SD, 2015, BIORESOURCE TECHNOL, V197, P201, DOI 10.1016/j.biortech.2015.08.077
   Gomes SD, 2016, INT J HYDROGEN ENERG, V41, P8120, DOI 10.1016/j.ijhydene.2015.11.186
   Gu S, 2019, SOIL TILLAGE RES APP, P195
   Guo XM, 2010, INT J HYDROGEN ENERG, V35, P10660, DOI 10.1016/j.ijhydene.2010.03.008
   Hafez H, 2010, INT J HYDROGEN ENERG, V35, P81, DOI 10.1016/j.ijhydene.2009.10.051
   Hai RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090175
   Hallenbeck PC, 2009, TRENDS BIOTECHNOL, V27, P287, DOI 10.1016/j.tibtech.2009.02.004
   Hallenbeck PC, 2005, WATER SCI TECHNOL, V52, P21
   Han BC, 2018, PROCESS SAF ENVIRON, V117, P439, DOI 10.1016/j.psep.2018.05.022
   Hawkes FR, 2002, INT J HYDROGEN ENERG, V27, P1339, DOI 10.1016/S0360-3199(02)00090-3
   Hawkes FR, 2007, INT J HYDROGEN ENERG, V32, P172, DOI 10.1016/j.ijhydene.2006.08.014
   Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1
   Hernandez-Mendoza CE, 2014, J CHEM TECHNOL BIOT, V89, P143, DOI 10.1002/jctb.4143
   Hoelzle RD, 2014, BIOTECHNOL BIOENG, V111, P2139, DOI 10.1002/bit.25321
   Hung CH, 2007, APPL MICROBIOL BIOT, V75, P693, DOI 10.1007/s00253-007-0854-7
   Hung CH, 2011, INT J HYDROGEN ENERG, V36, P8704, DOI 10.1016/j.ijhydene.2010.06.010
   Jo JH, 2007, J BIOTECHNOL, V131, P300, DOI 10.1016/j.jbiotec.2007.07.492
   Jung KW, 2011, BIORESOURCE TECHNOL, V102, P8612, DOI 10.1016/j.biortech.2011.03.056
   Jung KW, 2010, INT J HYDROGEN ENERG, V35, P13370, DOI 10.1016/j.ijhydene.2009.11.120
   Kim DH, 2008, INT J HYDROGEN ENERG, V33, P1532, DOI 10.1016/j.ijhydene.2008.01.012
   Kim DH, 2006, INT J HYDROGEN ENERG, V31, P2158, DOI 10.1016/j.ijhydene.2006.02.012
   Kim DH, 2010, INT J HYDROGEN ENERG, V35, P1590, DOI 10.1016/j.ijhydene.2009.12.041
   Kisielewska M, 2015, BIOPROC BIOSYST ENG, V38, P1925, DOI 10.1007/s00449-015-1434-3
   Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001
   Konopka A, 2015, ISME J, V9, P1488, DOI 10.1038/ismej.2014.251
   Koskinen PEP, 2007, BIOTECHNOL BIOENG, V97, P742, DOI 10.1002/bit.21299
   Kraemer JT, 2006, BIOTECHNOL LETT, V28, P1485, DOI 10.1007/s10529-006-9114-7
   Kraemer JT, 2008, INT J HYDROGEN ENERG, V33, P6558, DOI 10.1016/j.ijhydene.2008.08.033
   Kumar G, 2018, INT J HYDROGEN ENERG, V43, P11452, DOI 10.1016/j.ijhydene.2017.06.050
   Kyazze G, 2006, BIOTECHNOL BIOENG, V93, P971, DOI 10.1002/bit.20802
   Lee J, 2017, WASTE MANAGE, V59, P498, DOI 10.1016/j.wasman.2016.10.005
   Lee JS, 2013, TOX RESEARCH, V29, P99, DOI 10.5487/TR.2013.29.2.099
   Lee KS, 2012, INT J HYDROGEN ENERG, V37, P15556, DOI 10.1016/j.ijhydene.2012.04.039
   Lee WS, 2014, CHEM ENG J, V235, P83, DOI 10.1016/j.cej.2013.09.002
   Lin CY, 2012, INT J HYDROGEN ENERG, V37, P15632, DOI 10.1016/j.ijhydene.2012.02.072
   Liu C, 2016, BIORESOURCE TECHNOL, V216, P87, DOI 10.1016/j.biortech.2016.05.048
   Liu XT, 2017, BIORESOURCE TECHNOL, V238, P407, DOI 10.1016/j.biortech.2017.04.045
   Liu Y, 2017, INT J HYDROGEN ENERG, V42, P4095, DOI 10.1016/j.ijhydene.2016.09.083
   LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215
   Ljungdahl LG, 1989, CLOSTRIDIA, P145, DOI DOI 10.1007/978-1-4757-9718-3_5
   Lucas SDM, 2015, RENEW ENERG, V75, P496, DOI 10.1016/j.renene.2014.10.025
   Lukajtis R, 2018, RENEW SUST ENERG REV, V91, P665, DOI 10.1016/j.rser.2018.04.043
   Luo G, 2011, BIOTECHNOL BIOENG, V108, P1816, DOI 10.1002/bit.23122
   Madigan M, 2012, BIOL MICROORGANSIMS
   Massanet-Nicolau J, 2016, BIORESOURCE TECHNOL, V218, P512, DOI 10.1016/j.biortech.2016.06.115
   Massanet-Nicolau J, 2010, INT J HYDROGEN ENERG, V35, P469, DOI 10.1016/j.ijhydene.2009.10.076
   Matsumoto M, 2007, J BIOSCI BIOENG, V103, P236, DOI 10.1263/jbb.103.236
   Mazzoli R, 2014, BIOTECHNOL ADV, V32, P1216, DOI 10.1016/j.biotechadv.2014.07.005
   Milferstedt K, 2017, INT J HYDROGEN ENERG, V42, P27801, DOI 10.1016/j.ijhydene.2017.07.176
   Monroy I, 2018, CLEAN TECHNOL ENVIR, V20, P1581, DOI 10.1007/s10098-018-1555-x
   Corona VM, 2018, BIORESOURCE TECHNOL, V249, P334, DOI 10.1016/j.biortech.2017.10.032
   Moreno-Andrade I, 2015, INT J HYDROGEN ENERG, V40, P17246, DOI 10.1016/j.ijhydene.2015.04.084
   Moscoviz R, 2018, MICROB BIOTECHNOL, V11, P74, DOI 10.1111/1751-7915.12747
   Moscoviz R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44334
   Mota VT, 2018, WATER RES, V128, P350, DOI 10.1016/j.watres.2017.10.060
   Mu Y, 2006, BIOTECHNOL BIOENG, V94, P980, DOI 10.1002/bit.20924
   Ning YY, 2013, RENEW ENERG, V53, P12, DOI 10.1016/j.renene.2012.10.051
   Noike T, 2002, INT J HYDROGEN ENERG, V27, P1367, DOI 10.1016/S0360-3199(02)00120-9
   Noonpakdee W, 2003, INT J FOOD MICROBIOL, V81, P137, DOI 10.1016/S0168-1605(02)00219-2
   Ferraz ADN, 2015, ANAEROBE, V34, P94, DOI 10.1016/j.anaerobe.2015.04.008
   Ferraz ADN, 2015, BIORESOURCE TECHNOL, V186, P81, DOI 10.1016/j.biortech.2015.03.035
   Palomo-Briones R, 2019, FUEL, V254, DOI 10.1016/j.fuel.2019.115648
   Palomo-Briones R, 2018, APPL MICROBIOL BIOT, V102, P2465, DOI 10.1007/s00253-018-8737-7
   Palomo-Briones R, 2017, APPL ENERG, V198, P77, DOI 10.1016/j.apenergy.2017.04.051
   Patel SKS, 2014, INT J HYDROGEN ENERG, V39, P14663, DOI 10.1016/j.ijhydene.2014.07.084
   PAUSS A, 1990, APPL ENVIRON MICROB, V56, P1636, DOI 10.1128/AEM.56.6.1636-1644.1990
   Pawar SS, 2013, APPL MICROBIOL BIOT, V97, P7999, DOI 10.1007/s00253-013-5141-1
   Peixoto G, 2011, INT J HYDROGEN ENERG, V36, P8953, DOI 10.1016/j.ijhydene.2011.05.014
   Penteado ED, 2013, INT J HYDROGEN ENERG, V38, P6137, DOI 10.1016/j.ijhydene.2013.01.067
   Perna V, 2013, INT J HYDROGEN ENERG, V38, P54, DOI 10.1016/j.ijhydene.2012.10.022
   Pugazhendhi Arivalagan, 2019, Biotechnol Rep (Amst), V21, pe00301, DOI 10.1016/j.btre.2018.e00301
   Rafieenia R, 2018, INT J HYDROGEN ENERG, V43, P12013, DOI 10.1016/j.ijhydene.2018.04.170
   Rafrafi Y, 2013, INT J HYDROGEN ENERG, V38, P4975, DOI 10.1016/j.ijhydene.2013.02.008
   Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012
   Ramirez-Morales JE, 2015, WATER SCI TECHNOL, V71, P1271, DOI 10.2166/wst.2015.104
   Reddy G, 2008, BIOTECHNOL ADV, V26, P22, DOI 10.1016/j.biotechadv.2007.07.004
   Ren NQ, 2007, CURR MICROBIOL, V55, P167, DOI 10.1007/s00284-007-0172-4
   RK Pachauri, 2014, CLIMATE CHANGE 2014
   RODRIGUEZ JM, 1995, J APPL BACTERIOL, V78, P109, DOI 10.1111/j.1365-2672.1995.tb02830.x
   Rodriguez-Valderrama S, 2019, INT J HYDROGEN ENERG, V44, P12346, DOI 10.1016/j.ijhydene.2018.09.215
   Rosengren A, 2013, INT J FOOD MICROBIOL, V162, P159, DOI 10.1016/j.ijfoodmicro.2013.01.006
   Roy S, 2014, APPL ENERG, V136, P51, DOI 10.1016/j.apenergy.2014.08.031
   Saady NMC, 2013, INT J HYDROGEN ENERG, V38, P13172, DOI 10.1016/j.ijhydene.2013.07.122
   Saraphirom P, 2011, INT J HYDROGEN ENERG, V36, P8765, DOI 10.1016/j.ijhydene.2010.08.058
   Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997
   Schleifer K-H, 2009, FIRMICUTES GIBBONS M, V5, DOI [10.1007/978-0-387-68489-5_3., DOI 10.1007/978-0-387-68489-5_3]
   SHELEF LA, 1994, J FOOD PROTECT, V57, P445, DOI 10.4315/0362-028X-57.5.445
   Show KY, 2011, BIORESOURCE TECHNOL, V102, P8524, DOI 10.1016/j.biortech.2011.04.055
   Si BC, 2015, INT J HYDROGEN ENERG, V40, P11414, DOI 10.1016/j.ijhydene.2015.04.035
   Sivagurunathan P, 2017, BIORESOURCE TECHNOL, V240, P207, DOI 10.1016/j.biortech.2017.03.062
   Sivagurunathan P, 2016, INT J HYDROGEN ENERG, V41, P21670, DOI 10.1016/j.ijhydene.2016.06.047
   Sivagurunathan P, 2014, INT J HYDROGEN ENERG, V39, P19232, DOI 10.1016/j.ijhydene.2014.03.260
   Skupin P, 2017, APPL MATH MODEL, V49, P48, DOI 10.1016/j.apm.2017.04.025
   Spagni A, 2010, J ENVIRON SCI HEAL A, V45, P1475, DOI 10.1080/10934529.2010.506091
   Srivastava N, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.04.006
   Sun L, 2015, MICROB BIOTECHNOL, V8, P815, DOI 10.1111/1751-7915.12298
   Tapia-Venegas E, 2015, REV ENVIRON SCI BIO, V14, P761, DOI 10.1007/s11157-015-9383-5
   Teo AYL, 2005, APPL ENVIRON MICROB, V71, P4185, DOI 10.1128/AEM.71.8.4185-4190.2005
   THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977
   Toledo-Alarcon J, 2019, INT J HYDROGEN ENERG, V44, P2230, DOI 10.1016/j.ijhydene.2018.07.091
   Tolvanen KES, 2008, INT J HYDROGEN ENERG, V33, P542, DOI 10.1016/j.ijhydene.2007.10.005
   Tolvanen KES, 2010, INT J HYDROGEN ENERG, V35, P3433, DOI 10.1016/j.ijhydene.2010.01.132
   Tomczak W, 2018, INT J HYDROGEN ENERG, V43, P18883, DOI 10.1016/j.ijhydene.2018.08.094
   Ueno Y, 2006, J APPL MICROBIOL, V101, P331, DOI 10.1111/j.1365-2672.2006.02939.x
   Valdez-Vazquez I, 2017, MICROB BIOTECHNOL, V10, P1569, DOI 10.1111/1751-7915.12678
   Valdez-Vazquez I, 2009, RENEW SUST ENERG REV, V13, P1000, DOI 10.1016/j.rser.2008.03.003
   Van Ginkel S, 2005, ENVIRON SCI TECHNOL, V39, P9351, DOI 10.1021/es0510515
   van Lier JB, 2015, REV ENVIRON SCI BIO, V14, P681, DOI 10.1007/s11157-015-9375-5
   Vinet L, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/8/085201
   Wang B, 2008, INT J HYDROGEN ENERG, V33, P7013, DOI 10.1016/j.ijhydene.2008.09.027
   Wang L, 2006, BIOMASS BIOENERG, V30, P177, DOI 10.1016/j.biombioe.2005.11.010
   Wang XH, 2018, ENVIRON POLLUT, V238, P516, DOI 10.1016/j.envpol.2018.03.034
   Wang Y, 2007, INT J HYDROGEN ENERG, V32, P1086, DOI 10.1016/j.ijhydene.2006.07.016
   Wang Y, 2015, J BIOSCI BIOENG, V119, P10, DOI 10.1016/j.jbiosc.2014.06.003
   WOOLFORD MK, 1984, SILAGE FERMENTATION
   Xu KW, 2009, ANAEROBE, V15, P204, DOI 10.1016/j.anaerobe.2009.03.005
   Xue C, 2019, BUTANOL PRODUCTION C, DOI [10.1016/bs.aibe.2018.12.001, DOI 10.1016/BS.AIBE.2018.12.001]
   Yang G, 2018, BIORESOURCE TECHNOL, V266, P413, DOI 10.1016/j.biortech.2018.07.004
   Yang PF, 2007, INT J HYDROGEN ENERG, V32, P4761, DOI 10.1016/j.ijhydene.2007.07.038
   Yu HQ, 2006, BIOTECHNOL BIOENG, V94, P988, DOI 10.1002/bit.20923
   Zhao CX, 2013, INT J HYDROGEN ENERG, V38, P9701, DOI 10.1016/j.ijhydene.2013.05.041
   Zhou J, 2017, BIORESOURCE TECHNOL, V244, P865, DOI 10.1016/j.biortech.2017.07.146
   Zigova J, 2000, J IND MICROBIOL BIOT, V24, P153, DOI 10.1038/sj.jim.2900795
NR 182
TC 1
Z9 1
U1 11
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD MAR
PY 2020
VL 119
AR 109602
DI 10.1016/j.rser.2019.109602
PG 16
WC Green & Sustainable Science & Technology; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA KJ9XK
UT WOS:000512406900059
DA 2020-05-07
ER

PT J
AU Kucukdemirci, M
   Sarris, A
AF Kucukdemirci, Melda
   Sarris, Apostolos
TI Deep learning based automated analysis of archaeo-geophysical images
SO ARCHAEOLOGICAL PROSPECTION
LA English
DT Article; Early Access
DE archaeo-geophysics; convolutional neural networks (CNNs); deep learning;
   feature extraction; GPR (ground-penetrating radar); U-Net
ID NEURAL-NETWORKS
AB Thanks to recent advances in deep learning (DL) and the increasing availability of large labeled/annotated datasets and trained network models, there has been impressive progress in the automated analysis of images from different scientific domains such as medicine, microbiology, astronomy and remote sensing. The automated analysis of archaeo-geophysical data is also considered important due to the large spatial extent of areas covered by landscape surveys using multi-sensor arrays driven by motorized carts and subsequently the large volume of collected data. In this work, a convolutional neural network (CNN) is built by Python 3.6 programming language using the Deep Learning Library of Keras with Tensorflow backends, a library that implements the building blocks for CNN. The network is trained from scratch adopting U-Net architecture to accomplish an automatic analysis of the archaeo-geophysical features with emphasis on ground-penetrating radar (GPR) anomalies.
C1 [Kucukdemirci, Melda] Istanbul Univ Cerrahpasa, Fac Engn, Geophys Engn Dept, TR-34320 Istanbul, Turkey.
   [Kucukdemirci, Melda; Sarris, Apostolos] Fdn Res & Technol FORTH, Lab Geophys Satellite Remote Sensing & Archaeoenv, Iraklion, Greece.
   [Sarris, Apostolos] Univ Cyprus, Dept Hist & Archaeol, Archaeol Res Unit, Nicosia, Cyprus.
RP Kucukdemirci, M (reprint author), Istanbul Univ Cerrahpasa, Fac Engn, Geophys Engn Dept, TR-34320 Istanbul, Turkey.
EM meldakd@istanbul.edu.tr
RI Kucukdemirci, Melda/C-7580-2019
OI Kucukdemirci, Melda/0000-0002-2937-1855
FU Stavros Niarchos Foundation-ARCHERS projects (Advancing Young
   Researchers' Human Capital in Cutting Edge Technologies in the
   Preservation of Cultural Heritage and the Tackling of Societal
   Challenges); Stavros Niarchos Foundation
FX Stavros Niarchos Foundation-ARCHERS projects (Advancing Young
   Researchers' Human Capital in Cutting Edge Technologies in the
   Preservation of Cultural Heritage and the Tackling of Societal
   Challenges); Stavros Niarchos Foundation
CR [Anonymous], 2019, TENSORFLOW END END O
   [Anonymous], 2019, KERAS PYTHON DEEP LE
   Bescoby D.J., 2004, ARCHAEOL PROSPECT, V11, P189, DOI DOI 10.1002/ARP.236
   Cahill Nicholas, 2002, HOUSEHOLD CITY ORG O
   Caixinha M, 2017, CURR EYE RES, V42, P1, DOI 10.1080/02713683.2016.1175019
   Conyers LB, 2010, ARCHAEOL PROSPECT, V17, P117, DOI 10.1002/arp.379
   Davis DS, 2019, ARCHAEOL PROSPECT, V26, P155, DOI 10.1002/arp.1730
   Davis DS, 2019, J ARCHAEOL SCI-REP, V23, P166, DOI 10.1016/j.jasrep.2018.10.035
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   Ding KM, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9152972
   Donati JC, 2017, J FIELD ARCHAEOL, V42, P450, DOI 10.1080/00934690.2017.1365565
   Donati JC, 2016, AM J ARCHAEOL, V120, P361, DOI 10.3764/aja.120.3.0361
   Dumoulin V., 2018, GUIDE CONVOLUTION AR
   Ernenwein EG, 2009, NEAR SURF GEOPHYS, V7, P147, DOI 10.3997/1873-0604.2009004
   Falk T, 2019, NAT METHODS, V16, P67, DOI 10.1038/s41592-018-0261-2
   Fougeres G., 1898, MANTINEE ARCADIE ORI
   Giannakis I., 2018, P 17 INT C GROUND PE
   Green A., 2017, 12 INT C ARCH PROSP, P89
   Gu JX, 2018, PATTERN RECOGN, V77, P354, DOI 10.1016/j.patcog.2017.10.013
   Guo YM, 2016, NEUROCOMPUTING, V187, P27, DOI 10.1016/j.neucom.2015.09.116
   He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI 10.1109/ICCV.2017.322
   HODKINSON S, 1981, BSA, V76, P239
   Jie Yang, 2018, 2018 IEEE 42nd Annual Computer Software and Applications Conference (COMPSAC). Proceedings, P492, DOI 10.1109/COMPSAC.2018.00076
   Jost M., 1985, SANCTUAIRES CULTES D
   Kingma D.P., 2015, ARXIV14126980
   Lambers K, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11070794
   Leckebusch J, 2008, NEAR SURF GEOPHYS, V6, P75, DOI 10.3997/1873-0604.2007033
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Linford N., 2017, 12 INT C ARCH PROSP, P138
   Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965
   Ma L, 2019, ISPRS J PHOTOGRAMM, V152, P166, DOI 10.1016/j.isprsjprs.2019.04.015
   Meyer MF, 2019, GEOSCIENCES, V9, DOI 10.3390/geosciences9030109
   Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044
   Mittal M, 2019, APPL SOFT COMPUT, V78, P346, DOI 10.1016/j.asoc.2019.02.036
   Nevett L., 2018, ARCH I AM ANN M BOST
   Opitz R, 2018, J COMPUT APPL ARCHAE, V1, P19, DOI [10.5334/jcaa.1, DOI 10.5334/jcaa.11]
   Pregesbauer M, 2014, NEAR SURF GEOPHYS, V12, P651, DOI 10.3997/1873-0604.2014014
   Qian S, 2018, NEUROCOMPUTING, V272, P204, DOI 10.1016/j.neucom.2017.06.070
   Qu KY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00827
   Reinders H. R., 2014, CITY NEW HALOS ITS S
   Reinders H. R., 2003, HOUSING NEW HALOS HE
   Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031
   Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28
   Sarris A., 2015, INTEGRATED REMOTE SE, V53, P351
   Sarris A., 2019, ONG ARCH INV LECH HA
   SARRIS A, 2015, 2015 8 INT WORKSH
   Scherer D., 2010, 20 INT C ART NEUR NE
   Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003
   Schmidt A., 2019, NEW GLOBAL PERSPECTI, DOI [10.32028/9781789693072, DOI 10.32028/9781789693072]
   Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI 10.1109/TPAMI.2016.2572683
   Sorensen T., 1948, BIOL SKR, V5, P1, DOI DOI 10.1016/J.NEUROIMAGE.2006.09.051
   Srinivas S, 2016, FRONT ROBOT AI, V2, DOI 10.3389/frobt.2015.00036
   Torrejon J., 2019, P 8 INT C ARCH COMP
   Trier O. D., 2018, OCEANS DATA, P221
   Trier OD, 2019, ARCHAEOL PROSPECT, V26, P165, DOI 10.1002/arp.1731
   Tsagkatakis G, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19183929
   Verdonck L, 2019, INNOVATION IN NEAR-SURFACE GEOPHYSICS: INSTRUMENTATION, APPLICATION, AND DATA PROCESSING METHODS, P151, DOI 10.1016/B978-0-12-812429-1.00006-4
   Verschoof-van der Vaart W.B., 2019, J COMPUT APPL ARCHAE, V2, P31, DOI [10.5334/jcaa.32., DOI 10.5334/JCAA.32, 10.5334/jcaa.32]
   Winter F. E., 1987, ECHCL, V31, P235
   WINTER FE, 1989, ECHCL, V35, P189
   Xu YY, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010144
   Yamashita R, 2018, INSIGHTS IMAGING, V9, P611, DOI 10.1007/s13244-018-0639-9
   Zhang W, 2019, IEEE ACCESS, V7, P85082, DOI 10.1109/ACCESS.2019.2924464
   Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061
   Zhang ZX, 2018, IEEE GEOSCI REMOTE S, V15, P749, DOI 10.1109/LGRS.2018.2802944
   Zingman I, 2016, IEEE T GEOSCI REMOTE, V54, P4580, DOI 10.1109/TGRS.2016.2545919
NR 66
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2196
EI 1099-0763
J9 ARCHAEOL PROSPECT
JI Archaeol. Prospect.
DI 10.1002/arp.1763
EA FEB 2020
PG 12
WC Archaeology; Geosciences, Multidisciplinary
SC Archaeology; Geology
GA KL1YH
UT WOS:000513225800001
DA 2020-05-07
ER

PT J
AU Fayans, I
   Motro, Y
   Rokach, L
   Oren, Y
   Moran-Gilad, J
AF Fayans, Iliya
   Motro, Yair
   Rokach, Lior
   Oren, Yossi
   Moran-Gilad, Jacob
TI Cyber security threats in the microbial genomics era: implications for
   public health
SO EUROSURVEILLANCE
LA English
DT Article
AB Next generation sequencing (NGS) is becoming the new gold standard in public health microbiology. Like any disruptive technology, its growing popularity inevitably attracts cyber security actors, for whom the health sector is attractive because it combines mission-critical infrastructure and high-value data with cybersecurity vulnerabilities. In this Perspective, we explore cyber security aspects of microbial NGS. We discuss the motivations and objectives for such attack, its feasibility and implications, and highlight policy considerations aimed at threat mitigation. Particular focus is placed on the attack vectors, where the entire process of NGS, from sample to result, could be vulnerable, and a risk assessment based on probability and impact for representative attack vectors is presented. Cyber attacks on microbial NGS could result in loss of confidentiality (leakage of personal or institutional data), integrity (misdetection of pathogens) and availability (denial of sequencing services). NGS platforms are also at risk of being used as propagation vectors, compromising an entire system or network. Owing to the rapid evolution of microbial NGS and its applications, and in light of the dynamics of the cyber security domain, frequent risk assessments should be carried out in order to identify new threats and underpin constantly updated public health policies.
C1 [Fayans, Iliya; Rokach, Lior; Oren, Yossi] Ben Gurion Univ Negev, Fac Engn Sci, Dept Software & Informat Syst Engn, Beer Sheva, Israel.
   [Motro, Yair; Moran-Gilad, Jacob] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Syst Management, Beer Sheva, Israel.
RP Moran-Gilad, J (reprint author), Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Syst Management, Beer Sheva, Israel.
EM giladko@post.bgu.ac.il
RI ; Oren, Yossi/M-7247-2015
OI Moran-Gilad, Jacob/0000-0001-9134-050X; Oren, Yossi/0000-0002-0423-802X
FU Israeli Ministry of Science and Technology
FX This work was carried out with funding support from the Israeli Ministry
   of Science and Technology.
CR Appelbaum J, 2015, DIGITAL ARMS RACE NS
   Bambrough B., 2019, BITCOIN CRYPTO WALLE
   Brumaghin E, 2017, CCLEANUP VAST NUMBER
   Castro-Wallace SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18364-0
   Chiu C, 2016, MOL MICROBIOLOGY DIA, P68, DOI [10.1128/9781555819071.ch6, DOI 10.1128/9781555819071.CH6]
   Coventry L, 2018, MATURITAS, V113, P48, DOI 10.1016/j.maturitas.2018.04.008
   Field M., 2018, TELEGRAPH
   Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399
   FIRST, COMM VULN SCOR SYST
   Hadjadj L, 2019, EXPERT REV MOL DIAGN, V19, P349, DOI 10.1080/14737159.2019.1592678
   ISO, 2012, 270322012 ISOIEC
   Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0
   Knetsch CW, 2019, MOL DIAGNOSTICS, P339, DOI [https://link.springer.com/chapter/10.1007/978-981-13-1604-3_8, DOI 10.1007/978-981-13-1604-3_8]
   Markowsky G, 2014, P 2014 INT C SEC MAN
   Martin G, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3179
   Mirsky Y, 2019, ARXIV190103597
   Moran-Gilad J, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.23.30547
   Moran-Gilad J, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.4.1900068
   Motro Yair, 2017, Biomol Detect Quantif, V14, P1, DOI 10.1016/j.bdq.2017.10.002
   Ney P, 2017, P 26 USENIX SEC S 16
   Robertson J, 2018, BLOOMBERG BUSINESSWE
   T Eisenbarth, 2017, LECT NOTES COMPUTER, V10728, DOI DOI 10.1007/978-3-319-75208-2_1
   Woolf Nicky, 2016, GUARDIAN
   Xiong MM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/370710
NR 24
TC 0
Z9 0
U1 1
U2 1
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 13
PY 2020
VL 25
IS 6
BP 27
EP 34
AR 1900574
DI 10.2807/1560-7917.ES.2020.25.6.1900574
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA KM9CR
UT WOS:000514439600005
PM 32070468
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Oscar, TP
AF Oscar, Thomas P.
TI Validation software tool (ValT) for predictive microbiology based on the
   acceptable prediction zones method
SO INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article; Early Access
DE Chicken; food safety; model; neural network; predictive microbiology;
   Salmonella; software tool; validation
ID SALMONELLA-TYPHIMURIUM DT104; NEURAL-NETWORK MODEL; GROUND CHICKEN;
   LISTERIA-MONOCYTOGENES; POTASSIUM LACTATE; INITIAL DENSITY; GROWTH;
   SURVIVAL; MEAT; TEMPERATURE
AB A study was undertaken to develop a user-friendly software tool (ValT) for validation of predictive models based on the acceptable prediction zones (APZ) method. ValT was developed in Excel and was demonstrated using a newly developed growth model for Salmonella and chicken skin. The model provided acceptable predictions when the proportion (p) of residuals in the APZ was >= 0.70 and there were no local prediction problems. The pAPZ were 0.97 for dependent data (n = 360), 0.93 for interpolation data (n = 160) and 0.88 for extrapolation data (n = 180) to kosher chicken skin. There were no local prediction problems, and all sets of data satisfied the test data criteria of the APZ method. Thus, the model was successfully validated for interpolation and for extrapolation to kosher chicken skin. It is hoped that the new software tool will make it easier to validate models using the APZ method.
C1 [Oscar, Thomas P.] Univ Maryland Eastern Shore, USDA, ARS, Poultry Food Safety Res Worksite,Ctr Food Sci & T, Room 2111, Princess Anne, MD 21853 USA.
RP Oscar, TP (reprint author), Univ Maryland Eastern Shore, USDA, ARS, Poultry Food Safety Res Worksite,Ctr Food Sci & T, Room 2111, Princess Anne, MD 21853 USA.
EM thomas.oscar@usda.gov
FU Agricultural Research Service of the U.S. Department of Agriculture
   [CRIS-8072-42000-079-00D]
FX The author appreciates the outstanding technical assistance provided by
   Jacquelyn Ludwig (retired) and Stacey Engster of the U.S. Department of
   Agriculture, Agricultural Research Service, and Sharif Walker, Celia
   Whyte, Catherine Katambo and Elsie Dennis of the University of Maryland
   Eastern Shore. This project was funded by in-house project
   CRIS-8072-42000-079-00D of the Agricultural Research Service of the U.S.
   Department of Agriculture. Mention of trade names or commercial products
   is solely for providing specific information and does not imply
   recommendation or endorsement by the U.S. Department of Agriculture,
   which is an equal opportunity provider and employer.
CR Abou-Zeid KA, 2009, J MICROBIOL BIOTECHN, V19, P718, DOI 10.4014/jmb.0809.534
   Baranyi J, 1999, INT J FOOD MICROBIOL, V48, P159, DOI 10.1016/S0168-1605(99)00035-5
   Baranyi J, 2004, J FOOD PROTECT, V67, P1967, DOI 10.4315/0362-028X-67.9.1967
   Baranyi J, 1996, FOOD MICROBIOL, V13, P83, DOI 10.1006/fmic.1996.0011
   BHADURI S, 1994, INT J FOOD MICROBIOL, V23, P333, DOI 10.1016/0168-1605(94)90161-9
   DELIGNETTEMULLER ML, 1995, INT J FOOD MICROBIOL, V27, P139, DOI 10.1016/0168-1605(94)00158-3
   Elias SD, 2018, FOOD MICROBIOL, V72, P206, DOI 10.1016/j.fm.2017.11.016
   Estilo EEC, 2018, FOOD MICROBIOL, V69, P72, DOI 10.1016/j.fm.2017.06.019
   Hu JY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01536
   Jia Z, 2019, J FOOD SCI, V84, P127, DOI 10.1111/1750-3841.14420
   Kuroda S, 2019, FOOD MICROBIOL, V78, P38, DOI 10.1016/j.fm.2018.09.013
   Li M, 2011, J FOOD PROTECT, V74, P1261, DOI 10.4315/0362-028X.JFP-10-474
   Martino KG, 2005, J FOOD PROTECT, V68, P2310, DOI 10.4315/0362-028X-68.11.2310
   MCKELLAR RC, 2004, MODELING MICROBIAL R
   Min KJ, 2010, J FOOD PROTECT, V73, P1626, DOI 10.4315/0362-028X-73.9.1626
   Mohr TB, 2015, J FOOD PROTECT, V78, P1512, DOI 10.4315/0362-028X.JFP-15-015
   Oscar TP, 2007, FOOD MICROBIOL, V24, P640, DOI 10.1016/j.fm.2006.11.003
   Oscar TP, 2006, J FOOD PROTECT, V69, P2048, DOI 10.4315/0362-028X-69.9.2048
   Oscar TP, 2017, J FOOD PROTECT, V80, P104, DOI [10.4315/0362-028x.jfp-16-199, 10.4315/0362-028X.JFP-16-199]
   Oscar TP, 2015, J FOOD PROTECT, V78, P1819, DOI 10.4315/0362-028X.JFP-15-093
   Oscar TP, 2013, J FOOD PROTECT, V76, P1035, DOI 10.4315/0362-028X.JFP-12-362
   Oscar TP, 2009, J FOOD PROTECT, V72, P304, DOI 10.4315/0362-028X-72.2.304
   Oscar T.P., 2017, AM J FOOD SCI TECHNO, V5, P135
   Oscar TP, 2018, INT J FOOD SCI TECH, V53, P2610, DOI 10.1111/ijfs.13856
   Oscar TP, 2018, INT J FOOD SCI TECH, V53, P1789, DOI 10.1111/ijfs.13767
   Oscar TP, 2014, J FOOD SCI, V79, pM978, DOI 10.1111/1750-3841.12435
   Oscar TP, 2011, J FOOD PROTECT, V74, P1630, DOI 10.4315/0362-028X.JFP-11-127
   Oscar TP, 2011, J FOOD PROTECT, V74, P279, DOI 10.4315/0362-028X.JFP-10-314
   Oscar TP, 2009, J FOOD PROTECT, V72, P2078, DOI 10.4315/0362-028X-72.10.2078
   Oscar TP, 2005, J FOOD PROTECT, V68, P2606, DOI 10.4315/0362-028X-68.12.2606
   Oscar TR, 2005, J FOOD SCI, V70, pM129, DOI 10.1111/j.1365-2621.2005.tb07103.x
   Ostergaard NB, 2014, INT J FOOD MICROBIOL, V188, P15, DOI 10.1016/j.ijfoodmicro.2014.07.012
   Oyarzabal OA, 2010, J FOOD PROTECT, V73, P1438, DOI 10.4315/0362-028X-73.8.1438
   Panisello PJ, 1998, FOOD MICROBIOL, V15, P425, DOI 10.1006/fmic.1998.0195
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8
   Tamplin ML, 2018, FOOD MICROBIOL, V75, P90, DOI 10.1016/j.fm.2017.12.001
   te Giffel MC, 1999, INT J FOOD MICROBIOL, V46, P135, DOI 10.1016/S0168-1605(98)00189-5
   ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P195, DOI 10.1128/AEM.60.1.195-203.1994
NR 39
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-5423
EI 1365-2621
J9 INT J FOOD SCI TECH
JI Int. J. Food Sci. Technol.
DI 10.1111/ijfs.14534
EA FEB 2020
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA KJ8AZ
UT WOS:000512279800001
DA 2020-05-07
ER

PT J
AU Ferreira-Coimbra, J
   Tejada, S
   Campogiani, L
   Rello, J
AF Ferreira-Coimbra, Joao
   Tejada, Sofia
   Campogiani, Laura
   Rello, Jordi
TI Levels of evidence supporting European and American community-acquired
   pneumonia guidelines
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article; Early Access
DE Community-acquired pneumonia; Diagnosis; Therapy; Prevention; Randomized
   controlled trial; Evidence-based medicine
AB Optimal clinical decisions should be supported by clinical practice guidelines (CPG) based on evidence generated from randomized clinical trials (RCT). We aimed to evaluate the class and level of evidence (LOE) supporting the international community-acquired pneumonia (CAP) guidelines and their variation over time. The 2019 Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) and the 2011 European Respiratory Society/European Society Clinical Microbiology Infectious Diseases (ERS/ESCMID) CPG and its immediate predecessors (2007 and 2005) were evaluated. The number of recommendations and distribution as LOE A (supported by multiple RCT or a single, large RCT), B (supported by data from a single RCT or observational studies) and C (expert opinion, case studies, or standard of care) was identified. Overall, recommendations for diagnosis, management, and prevention were graded as strong in 51.4%, 62.9%, and 23.5% in spite that they were supported by LOE A in 5.7%, 11.1%, and 52.9%, respectively. In the 2019 ATS/IDSA guidelines (39 recommendations), 7.7% (n = 3) recommendations were classified as LOE A, 30.8% (n = 12) as LOE B, and 61.5% (24%) as LOE C. Across the 2011 ERS/ESCMID guidelines (68 recommendations), 21.2% (n = 14) recommendations were classified as LOE A, 4.6% (n = 3) as LOE B, and 74.2% (n = 49) as LOE C. When comparing with prior versions, the proportion of recommendations that were LOE A did not significantly increase in ERS/ESCMID (21.2% vs 20%) and decreased in ATS/IDSA (7.7% vs 32.0%). In conclusion, large randomized trials or network meta-analysis including comparison of regimens to identify high probability of best cure and mortality is an unmet clinical need on CAP.
C1 [Ferreira-Coimbra, Joao] Ctr Hosp Univ Porto, Dept Internal Med, P-4099001 Porto, Portugal.
   [Tejada, Sofia; Rello, Jordi] Inst Salud Carlos III, CIBER Enfermedades Resp, CIBERES, Barcelona, Spain.
   [Tejada, Sofia; Rello, Jordi] VHIR, CRIPS, Barcelona, Spain.
   [Campogiani, Laura] Tor Vergata Univ, Dept Syst Med, Clin Infect Dis, Rome, Italy.
   [Rello, Jordi] Univ Montpellier, Dept Anesthesiol, Clin Res ICU, CHU Nimes, Montpellier, France.
RP Ferreira-Coimbra, J (reprint author), Ctr Hosp Univ Porto, Dept Internal Med, P-4099001 Porto, Portugal.
EM joaoferreiracoimbra@gmail.com
OI Ferreira Coimbra, Joao/0000-0002-5855-8600; , Tejada,
   S/0000-0002-2000-6587
FU CIBERES, Instituto Salud Carlos III, Madrid, Spain (Fondos FEDER)
   [CB06-06-036]
FX This work was funded in part by CIBERES, Instituto Salud Carlos III,
   Madrid, Spain (Fondos FEDER) (CB06-06-036).
CR Al-Abri SS, 2012, J INFECT PUBLIC HLTH
   Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38
   Barnett AS, 2017, JAMA CARDIOL
   Bhandari M, 2004, J BONE JOINT SURG AM
   Dean NC, 2006, CHEST
   Fanaroff AC, 2019, JAMA J AM MED ASS
   Jacobs AS, 2013, CIRCULATION, V127
   Koh C, 2013, HEPATOLOGY
   Lee DH, 2011, ARCH INTERN MED
   Mandell LA, 2007, CLIN INFECT DIS
   Mathenge PG, 2019, PARASITOL INT
   Menendez R, 2005, AM J RESP CRIT CARE
   Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST
   Meyer C, 2018, PLOS ONE
   Ramalho JN, 2015, AM J NEURORADIOL
   Triantafyllidis C, 2012, EUR REV MED PHARM SC
   Tricoci P, 2009, JAMA J AM MED ASS
   Turpen RM, 2010, BJU INT
   Witkowski M, 2018, DIABETES THER
   Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x
   Woodhead M, 2005, EUR RESP J
   Zhang Z, 2018, INTENSIVE CARE MED
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
DI 10.1007/s10096-020-03833-8
EA FEB 2020
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA KO9XP
UT WOS:000515899800002
PM 32030566
DA 2020-05-07
ER

PT J
AU Lindner, P
AF Lindner, Peter
TI Molecular Politics, Wearables, and the Aretaic Shift in Biopolitical
   Governance
SO THEORY CULTURE & SOCIETY
LA English
DT Article
DE biopolitics; governmentality; mobile health; molecular politics;
   self-tracking; wearables
ID SELF-TRACKING; HEALTH; TECHNOLOGIES; STEPS; WORK
AB Since the publication of Nikolas Rose's 'The Politics of Life Itself' (2001) there has been vivid discussion about how biopolitical governance has changed over the last decades. This article uses what Rose terms 'molecular politics', a new socio-technical grip on the human body, as a contrasting background to ask anew his question 'What, then, of biopolitics today?' - albeit focusing not on advances in genetics, microbiology, and pharmaceutics, as he does, but on the rapid proliferation of wearables and other sensor-software gadgets. In both cases, new technologies providing information about the individual body are the common ground for governance and optimization, yet for the latter, the target is habits of moving, eating and drinking, sleeping, working and relaxing. The resulting profound differences are carved out along four lines: 'somatic identities' and a modified understanding of the body; the role of 'expert knowledge' compared to that of networks of peers and self-experimentation; the 'types of intervention' by which new technologies become effective in our everyday life; and the 'post-discipline character' of molecular biopolitics. It is argued that, taken together, these differences indicate a remarkable shift which could be termed aretaic: its focus is not 'life itself' but 'life as it is lived', and its modality are new everyday socio-technical entanglements and their more-than-human rationalities of (self-)governance.
C1 [Lindner, Peter] Goethe Univ, Econ Geog, Frankfurt, Germany.
RP Lindner, P (reprint author), Goethe Univ, Econ Geog, Frankfurt, Germany.
EM plindner@uni-frankfurt.de
OI Lindner, Peter/0000-0003-3056-8441
CR Abend P., 2016, DIGITAL CULTURE SOC, V2, P5
   Amoore L, 2011, THEOR CULT SOC, V28, P24, DOI 10.1177/0263276411417430
   Andrejevic M, 2015, TELEV NEW MEDIA, V16, P19, DOI 10.1177/1527476414541552
   Ash J, 2013, BODY SOC, V19, P27, DOI 10.1177/1357034X11411737
   Bailey Jane, 2007, Ethics and Information Technology, V9, P129, DOI 10.1007/s10676-007-9135-5
   Barta K, 2015, INFORM COMMUNICATION, V19, P518
   Belli J., 2016, DIGITAL CULTURE SOC, V2, P89
   Belliger A, 2016, DIGITAL CULTURE SOC, V2, P25
   Bermingham-McDonogh N, 2015, DATA SCI QUANTIFIED
   Blencowe C., 2012, BIOPOLITICAL EXPERIE
   Braun B, 2007, CULT GEOGR, V14, P6, DOI 10.1177/1474474007072817
   British Petroleum, 2016, BP LIFEBENEFITS BP W
   Bruns Axel, 2008, BLOGS WIKIPEDIA 2 LI
   Bundesministerium fur Gesundheit, 2017, E HLTH GES
   Butler J., 1993, BODIES MATTER DISCUR
   CCS Insight, 2014, WEAR FOR SUMM
   Cetina KK, 2005, THEOR CULT SOC, V22, P213, DOI 10.1177/0263276405057200
   Cheney-Lippold J, 2011, THEOR CULT SOC, V28, P164, DOI 10.1177/0263276411424420
   Cohn S, 2010, TECHNOLOGIZED IMAGES
   Cook T, 2015, MADMONEY        0312
   Cooper Melinda, 2008, LIFE SURPLUS BIOTECH
   Cursgen D, 2014, PLATON LEXIKON
   Davies W, 2016, J CULTURAL EC, V10, P34
   DeBronkart D, 2014, GESUNDHEIT 2 0 EPATI
   Dobeson A, 2016, ECON SOC, V45, P454, DOI 10.1080/03085147.2016.1224143
   Dyer J, 2016, DIGITAL CULTURE SOC, V2, P161
   Edwards J, 2010, TECHNOLOGIZED IMAGES
   Ernst & Young, 2015, INTR PAY YOU LIV PAY
   European Commission, 2014, GREEN PAP MOB HLTH M
   FOUCAULT M, 1997, ESSENTIAL WORKS FOUC
   Foucault M, 1972, BIRTH CLIN ARCHAEOLO
   Foucault M, 1995, DISCIPLINE PUNISH BI
   Fourcade M, 2017, SOCIO-ECON REV, V15, P661, DOI 10.1093/ser/mwx032
   Fox NJ, 2017, HEALTH-LONDON, V21, P136, DOI 10.1177/1363459315590248
   Franklin S, 2000, GLOBAL NATURE GLOBAL
   Franklin S, 2006, BORN MADE ETHNOGRAPH
   Fuchs M, 2014, RETHINKING GAMIFICAT
   Fujieda Y, 2006, JPN J PHYS FIT SPORT, V55, P37
   Gardner P, 2016, BODY SOC, V22, P3, DOI 10.1177/1357034X15604030
   Gekker Alex, 2016, DIGITAL CULTURE SOC, V2, P107, DOI [10.14361/dcs-2016-0108, DOI 10.14361/DCS-2016-0108]
   Grew JC, 2017, BODY SOC, V23, P64, DOI 10.1177/1357034X16663005
   Halford S, 2010, INFORM COMMUN SOC, V13, P442, DOI [10.1080/13691180903090806, 10.1080/13691180903095856]
   Hannah MG, 2011, ANTIPODE, V43, P1034, DOI 10.1111/j.1467-8330.2010.00840.x
   Horton J, 1994, MACINTYRE CRITICAL P
   Isin E. F., 2015, BEING DIGITAL CITIZE
   Jones R., 2013, CHANGING BEHAV RISE
   Karanasiou AP, 2016, DIGITAL CULTURE SOC, V2, P123
   Kaspar MM, 2015, VERSICHERUNGSWI 1026
   Knorr-Cetina K, 2005, TECHNOLOGICAL EC
   Koopman C, 2014, FOUCAULT NOW CURRENT
   Kube J, 1969, TECHNE ARETE SOPHIST
   Larsen LT, 2011, GOVT CURRENT ISSUES
   Ledger D., 2014, INSIDE WEARABLES SCI
   Ledger D, 2016, INSIDE WEARABLES 3
   Lemke T, 2011, GOVT CURRENT ISSUES
   Little J, 2015, GEOGR J, V181, P121, DOI 10.1111/geoj.12083
   Lomborg S, 2016, INFORM COMMUN SOC, V19, P1015, DOI 10.1080/1369118X.2015.1067710
   Lupton D, 2014, P 26 AUSTR COMP HUM
   Lupton D., 2016, QUANTIFIED SELF SOCI
   Lupton D, 2016, ECON SOC, V45, P101, DOI 10.1080/03085147.2016.1143726
   Lupton D, 2012, SOC THEOR HEALTH, V10, P229, DOI 10.1057/sth.2012.6
   MacIntyre A., 2007, VIRTUE STUDY MORAL T
   Mamecke T, 2016, LEBEN NACH ZAHLEN SE
   Mann S, 2014, ENCY HUMAN COMPUTER
   Mann S., 2003, SURVEILLANCE SOC, V1, P331, DOI DOI 10.24908/SS.V1I3.3344
   MarketsAndMarkets, 2015, MHEALTH SOL MARK CON
   Meiner S, 2016, LIFELOGGING DIGITALE
   Milani RV, 2016, PROG CARDIOVASC DIS, V58, P579, DOI 10.1016/j.pcad.2016.01.001
   Missomelius P, 2016, LIFELOGGING DIGITALE
   Mol A, 2002, BODY MULTIPLE ONTOLO
   Moore P., 2017, QUANTIFIED SELF PREC
   Moore PV, 2018, BODY SOC, V24, P39, DOI 10.1177/1357034X18775203
   Munson SA, 2014, GAMEFUL WORLD: APPROACHES, ISSUES, APPLICATIONS, P597
   National Business Group on Health/Xerox Human Resources Services, 2016, 2016 EM TECHN PROM E
   New York Daily News, 2015, NEW YORK DAILY NEWS
   Office of the Privacy Commissioner of Canada, 2014, WEAR COMP CHALL OPP
   Ojakangas M., 2005, FOUCAULT STUDIES, V2, P5, DOI DOI 10.22439/fs.v0i2.856
   Philo C, 2000, AREA, V32, P11, DOI 10.1111/j.1475-4762.2000.tb00110.x
   Pink S, 2017, CULT GEOGR, V24, P375, DOI 10.1177/1474474016684127
   PricewaterhouseCoopers, 2015, MED TREND OUTL WEAR
   Pritz SM, 2016, LIFELOGGING DIGITALE
   Rabinow P, 1992, INCORPORATIONS
   Rabinow P, 2006, BIOSOCIETIES, V1, P195, DOI DOI 10.1017/S1745855206040014
   Research2Guidance, 2016, MHEALTH APP DEV EC 2
   Rose N, 2001, THEOR CULT SOC, V18, P1, DOI 10.1177/02632760122052020
   Rose N, 2004, POWERS FREEDOM REFRA
   Rose N. S., 2013, NEURO NEW BRAIN SCI
   Rose Nikolas, 2007, POLITICS LIFE ITSELF
   Ruckenstein M, 2017, ANNU REV ANTHROPOL, V46, P261, DOI 10.1146/annurev-anthro-102116-041244
   Ruckenstein M, 2014, SOCIETIES, V4, P68, DOI 10.3390/soc4010068
   Ruffino Paolo, 2016, DIGITAL CULTURE SOC, V2, P153, DOI [10.14361/dcs-2016-0111, DOI 10.14361/DCS-2016-0111]
   Sanders R, 2017, BODY SOC, V23, P36, DOI 10.1177/1357034X16660366
   Schollas S, 2016, LEBEN NACH ZAHLEN SE
   Schrape N, 2014, RETHINKING GAMIFICAT
   Schroder S, 2015, DIGITAL INSURANCE MO
   Schull ND, 2016, BIOSOCIETIES, V11, P317, DOI 10.1057/biosoc.2015.47
   Schull ND, 2014, ADDICTION DESIGN MAC
   Sharon T, 2017, PHILOS TECHNOLOGY, V30, P93, DOI DOI 10.1007/S13347-016-0215-5
   Shusterman R, 2014, ENCY HUMAN COMPUTER
   Stark D, 2009, SENSE DISSONANCE ACC
   Steinmann M, 2017, NEUE ZURCHER ZEITUNG
   Stemmer P, 1998, HIST WORTERBUCH PHIL
   Swan M, 2012, J PERS MED, V2, P93, DOI 10.3390/jpm2030093
   Terry NP, 2015, CHEST, V147, P1429, DOI 10.1378/chest.14-2459
   Thaler R. H., 2008, NUDGE IMPROVING DECI
   Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133
   Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80
   WALDBY C, 2000, VISIBLE HUMAN PROJEC
   Waldby C., 2006, TISSUE EC BLOOD ORGA
   Wehling P, 2011, GOVT CURRENT ISSUES
   Whitson JR, 2014, GAMEFUL WORLD: APPROACHES, ISSUES, APPLICATIONS, P339
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   World Health Organization, 2015, NONC DIS PROGR MON 2
   World Health Organization (WHO), 2013, GLOB ACT PLAN PREV C
NR 114
TC 0
Z9 0
U1 2
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0263-2764
EI 1460-3616
J9 THEOR CULT SOC
JI Theory Cult. Soc.
PD MAY
PY 2020
VL 37
IS 3
BP 71
EP 96
AR 0263276419894053
DI 10.1177/0263276419894053
EA FEB 2020
PG 26
WC Cultural Studies
SC Cultural Studies
GA LB6DS
UT WOS:000511554400001
DA 2020-05-07
ER

PT J
AU Calzetta, L
   Pistocchini, E
   Leo, A
   Roncada, P
   Ritondo, BL
   Palma, E
   di Cave, D
   Britti, D
AF Calzetta, Luigino
   Pistocchini, Elena
   Leo, Antonio
   Roncada, Paola
   Ritondo, Beatrice Ludovica
   Palma, Ernesto
   di Cave, David
   Britti, Domenico
TI Anthelminthic medicinal plants in veterinary ethnopharmacology: A
   network meta-analysis following the PRISMA-P and PROSPERO
   recommendations
SO HELIYON
LA English
DT Article
DE Bioinformatics; Ecology; Microbiology; Plant biology; Systematics;
   Medicinal plants; Drugs; Anthelminthic; Veterinary ethnopharmacology;
   Livestock
ID ALLIUM-SATIVUM; IN-VITRO; ETHNOVETERINARY; GUIDELINES; EXTRACTS
AB Medicinal plants may be effective against helminthic infestation in animals, but to date few studies have investigated the real impact of anthelminthic medicinal plants in veterinary ethnopharmacology.
   The aim of this study was to assess the geographical use of anthelminthic medicinal plants in livestock in European Union (EU), and to quantify the anthelminthic efficacy of medicinal plants in comparison with anthelminthic drugs. Surveys on the use of anthelminthic traditional medicinal plants in livestock in the EU were included in the qualitative synthesis. Studies that investigated the efficacy of anthelminthic traditional medicinal plants in animals, compared with negative control and/or anthelminthic drugs, were included in the quantitative synthesis (network meta-analysis).
   Twelve surveys (9 in Italy, 2 in Spain, 1 in Austria) reported the use of anthelminthic medicinal plants in livestock living in EU Countries. Data obtained from 256 animals and extracted from 6 studies were included in the network meta-analysis. Medicinal plants and drugs were more effective than negative control (standardized mean difference [SMD]: -0.60 95%CrI-0.88 to -0.31, -0.73 95%CrI-1.08 to -0.38, respectively, P < 0.001). Overall, no difference was detected between anthelminthic medicinal plants and anthelminthic drugs, namely albendazole, ivermectin, fenbendazole, and doramectin (SMD: 0.26 95%CrI -0.02 to 0.55, P > 0.05). The most effective anthelminthic medicinal plants were Artemisia absintihium, Allium sativum, and Duranta erecta.
   There is the strong medical need of performing adequately powered randomized controlled trials in different livestock species aimed to improve the quality of the current evidence concerning the anthelminthic efficacy of medicinal plants compared to that of the currently available antiparasitic drugs.
C1 [Calzetta, Luigino; Ritondo, Beatrice Ludovica] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy.
   [Calzetta, Luigino; Pistocchini, Elena] Vet Hosp Gregorio VII, Unit Lab Med, Rome, Italy.
   [Leo, Antonio; Roncada, Paola; Palma, Ernesto; Britti, Domenico] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.
   [di Cave, David] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.
RP Calzetta, L (reprint author), Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy.; Calzetta, L (reprint author), Vet Hosp Gregorio VII, Unit Lab Med, Rome, Italy.; Palma, E (reprint author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.
EM luigino.calzetta@uniroma2.it; palma@unicz.it
RI Roncada, Paola/C-5263-2013; Leo, Antonio/K-4654-2016
OI Roncada, Paola/0000-0002-0114-5872; Leo, Antonio/0000-0002-0061-1608
CR Abo-El-Sooud K, 2018, INT J VET SCI MED, V6, P1, DOI 10.1016/j.ijvsm.2018.04.001
   Alderson P., 2004, ABSENCE EVIDENCE IS
   Altman DG, 1996, AUST VET J, V74, P311, DOI 10.1111/j.1751-0813.1996.tb13786.x
   Ayaz Erol, 2008, Recent Pat Antiinfect Drug Discov, V3, P149, DOI 10.2174/157489108784746605
   Ayrle H, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0714-8
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Bonet MA, 2007, J ETHNOPHARMACOL, V110, P130, DOI 10.1016/j.jep.2006.09.016
   Boxall A.B., 2003, PEER REVIEWED ARE VE
   Bullitta S, 2007, GENET RESOUR CROP EV, V54, P1447, DOI 10.1007/s10722-006-9130-4
   Bullitta S, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0250-7
   Calzetta L, 2018, CURR OPIN PHARMACOL, V40, P95, DOI 10.1016/j.coph.2018.03.011
   Calzetta L, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0043-2016
   Cazzola M, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0010-2018
   Cazzola M, 2017, COPD, V14, P552, DOI 10.1080/15412555.2017.1347918
   Dereli FTG, 2019, EXP PARASITOL, V196, P63, DOI 10.1016/j.exppara.2018.09.006
   Dobler CC, 2018, EUR RESP J, V52
   Githiori John B., 2005, Animal Health Research Reviews, V6, P91, DOI 10.1079/AHR2005099
   Gonzalez JA, 2011, VET RES COMMUN, V35, P283, DOI 10.1007/s11259-011-9473-y
   Guarino C., 2008, ETHNOBOTANICAL STUDY
   Guarrera PM, 2005, J ETHNOPHARMACOL, V99, P367, DOI 10.1016/j.jep.2005.01.039
   Guarrera PM, 1999, J ETHNOPHARMACOL, V68, P183, DOI 10.1016/S0378-8741(99)00089-6
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Idolo M, 2010, J ETHNOPHARMACOL, V127, P379, DOI 10.1016/j.jep.2009.10.027
   ISE Sao Paulo Brazil, 2008, 10 INT C INT SOC ETH
   ISE Technische Universitat Dresden Germany, 2019, 19 INT C INT SOC ETH
   Kanojiya D, 2015, VET QUART, V35, P200, DOI 10.1080/01652176.2015.1099080
   Katerere D.R., 2010, ETHNOVETERINARY BOT
   Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x
   Kools Stefan A. E., 2008, Integrated Environmental Assessment and Management, V4, P399, DOI 10.1897/IEAM_2008-002.1
   Laing R, 2017, TRENDS PARASITOL, V33, P463, DOI 10.1016/j.pt.2017.02.004
   Lumaret JP, 2012, CURR PHARM BIOTECHNO, V13, P1004, DOI 10.2174/138920112800399257
   Manganelli REU, 2001, J ETHNOPHARMACOL, V78, P171, DOI 10.1016/S0378-8741(01)00341-5
   Maroyi A, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0173-8
   Mayer M, 2014, FORSCH KOMPLEMENTMED, V21, DOI 10.1159/000370216
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moher D, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-1
   Mudgal S., 2013, BIO INTELL SERV
   Palacios-Landin Josefina, 2015, Turkiye Parazitoloji Dergisi, V39, P260, DOI 10.5152/tpd.2015.4523
   Pedder H, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0368-4
   Pieroni A, 2004, VET RES COMMUN, V28, P55, DOI 10.1023/B:VERC.0000009535.96676.eb
   Piluzza G, 2015, J ETHNOPHARMACOL, V168, P87, DOI 10.1016/j.jep.2015.03.056
   Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16
   Shoop W., 2002, P1, DOI 10.1079/9780851996172.0001
   Suroowan S, 2017, VET RES COMMUN, V41, P147, DOI 10.1007/s11259-017-9683-z
   Tariq KA, 2009, VET PARASITOL, V160, P83, DOI 10.1016/j.vetpar.2008.10.084
   Tremblay L.A., 2002, EFFECTS IVERMECTIN D
   Udobi MI, 2018, J ETHNOPHARMACOL, V216, P57, DOI 10.1016/j.jep.2018.01.030
   van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054
   Vesterinen HM, 2013, ENVIRON HEALTH PERSP, V121, pA325, DOI 10.1289/ehp.1307775
   Vogl CR, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0104-0
NR 53
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD FEB
PY 2020
VL 6
IS 2
AR e03256
DI 10.1016/j.heliyon.2020.e03256
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KS5SJ
UT WOS:000518367800011
PM 32055724
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Yeh, YC
   Wang, HY
   Lan, CY
AF Yeh, Ying-Chieh
   Wang, Hung-Yen
   Lan, Chung-Yu
TI Candida albicans Aro1 affects cell wall integrity, biofilm formation and
   virulence
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Candida albicans; Aro1; Cell wall; Biofilm; Virulence
ID AMINO-ACID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; SURFACE
   HYDROPHOBICITY; GALLERIA-MELLONELLA; GENE; SYSTEM; PATHOGENICITY;
   NETWORK; HOST
AB Background: Candida albicans is an opportunistic pathogen capable of causing life-threatening systemic infections. The C. albicans ARO1 gene encodes an arom multifunctional enzyme, which can possibly catalyze reactions of the shikimate pathway to synthesize aromatic amino acids. However, the functions of C. albicans Aro1 have not been extensively characterized.
   Methods: ARO1 knockdown mutant strain was constructed, using a tetracycline-regulated (TR) expression system. Cell growth of the mutant strain was compared with wild type. Effects of the ARO1 gene knockdown on cell wall properties, adhesion to polystyrene and biofilm formation were further investigated. Finally, Galleria mellonella was used as a model host to study the role of ARO1 in virulence of C. albicans.
   Results: We showed that defective growth in the ARO1 knockdown strain was rescued by supplemental aromatic amino acids. In addition, the ARO1 knockdown strain was easily aggregated and precipitated. The knockdown of ARO1 also caused changes in cell wall properties and compositions and promoted C. albicans cell adhesion to polystyrene and biofilm formation. Finally, the ARO1 knockdown strain showed attenuation of C. albicans virulence.
   Conclusion: This work provides new insights into C. albicans metabolism, cell wall and virulence. Copyright (C) 2018, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
C1 [Yeh, Ying-Chieh; Wang, Hung-Yen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.
   [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.
RP Lan, CY (reprint author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.
EM cylan@life.nthu.edu.tw
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST104-2311-B-007-005, MOST105-2311-B-007-007-MY3]
FX We are grateful to Hironobu Nakayama (Suzuka University of Medical
   Sciences, Japan), and Joachim Morschhauser (Universitat Wurzburg,
   Germany) for generously providing strains and plasmids. We also thank
   Jia-Ching Shieh (Chung Shan Medical University, Taiwan) for providing
   Galleria mellonella. CYL was supported by MOST104-2311-B-007-005 and
   MOST105-2311-B-007-007-MY3 (from Ministry of Science and Technology,
   Taiwan).
CR Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294
   BRANDT ME, 2002, EMERG INFECT DIS, V8, P876
   BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991
   Brown AJP, 2014, TRENDS MICROBIOL, V22, P614, DOI 10.1016/j.tim.2014.07.001
   Brown AJP, 2014, J EXP BIOL, V217, P144, DOI 10.1242/jeb.088930
   Chen HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129903
   de Souza RD, 2009, GERODONTOLOGY, V26, P157, DOI 10.1111/j.1741-2358.2008.00229.x
   DUNCAN K, 1988, FEBS LETT, V241, P83, DOI 10.1016/0014-5793(88)81036-6
   Ene IV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019695
   Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x
   Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475
   Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457
   Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985
   Ha Y-s, 2006, EUKARYOT CELL, V5
   HAZEN KC, 1989, INFECT IMMUN, V57, P1894, DOI 10.1128/IAI.57.7.1894-1900.1989
   HOBDEN C, 1995, MICROBIOL-UK, V141, P1875, DOI 10.1099/13500872-141-8-1875
   Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10
   Huang GH, 2012, VIRULENCE, V3, P251, DOI 10.4161/viru.20010
   Hudson DA, 2004, MICROBIOL-SGM, V150, P3041, DOI 10.1099/mic.0.27121-0
   Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003
   Kurtz MB, 1997, J MED VET MYCOL, V35, P79
   Lai WC, 2016, CURR GENET, V62, P213, DOI 10.1007/s00294-015-0526-6
   Li X, 2016, PLOS ONE, V11, P12
   Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913
   Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0
   Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625
   Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000
   Nather K, 2008, FEMS MICROBIOL LETT, V285, P137, DOI 10.1111/j.1574-6968.2008.01263.x
   Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034
   Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048
   O'Meara TR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7741
   ODDS FC, 1987, CRC CR REV MICROBIOL, V15, P1
   Ramachandra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092734
   Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021
   Rowbottom L, 2004, MICROBIOL-SGM, V150, P3243, DOI 10.1099/mic.0.27167-0
   Sandini S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-106
   Sasse A, 2016, VIRULENCE, V7, P56, DOI 10.1080/21505594.2015.1109766
   Sheehan G, 2018, VIRULENCE, V9, P163, DOI 10.1080/21505594.2017.1370174
   Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008
   Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x
NR 40
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD FEB
PY 2020
VL 53
IS 1
BP 115
EP 124
DI 10.1016/j.jmii.2018.04.002
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KQ2ZS
UT WOS:000516797400014
PM 29807722
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Stogios, PJ
   Savchenko, A
AF Stogios, Peter J.
   Savchenko, Alexei
TI Molecular mechanisms of vancomycin resistance
SO PROTEIN SCIENCE
LA English
DT Review
DE antibiotic resistance; enzymes; glycopeptides; microbiology; structural
   biology; vancomycin
ID 2-COMPONENT REGULATORY SYSTEM; ENTEROCOCCUS-FAECIUM BM4147; CYTOPLASMIC
   PEPTIDOGLYCAN PRECURSORS; D-LACTATE DEHYDROGENASE; ALANYL-D-LACTATE;
   D-ALANINE LIGASE; GLYCOPEPTIDE RESISTANCE; GENE-CLUSTER;
   LEUCONOSTOC-MESENTEROIDES; SUBSTRATE-SPECIFICITY
AB Vancomycin and related glycopeptides are drugs of last resort for the treatment of severe infections caused by Gram-positive bacteria such as Enterococcus species, Staphylococcus aureus, and Clostridium difficile. Vancomycin was long considered immune to resistance due to its bactericidal activity based on binding to the bacterial cell envelope rather than to a protein target as is the case for most antibiotics. However, two types of complex resistance mechanisms, each comprised of a multi-enzyme pathway, emerged and are now widely disseminated in pathogenic species, thus threatening the clinical efficiency of vancomycin. Vancomycin forms an intricate network of hydrogen bonds with the d-Ala-d-Ala region of Lipid II, interfering with the peptidoglycan layer maturation process. Resistance to vancomycin involves degradation of this natural precursor and its replacement with d-Ala-d-lac or d-Ala-d-Ser alternatives to which vancomycin has low affinity. Through extensive research over 30 years after the initial discovery of vancomycin resistance, remarkable progress has been made in molecular understanding of the enzymatic cascades responsible. Progress has been driven by structural studies of the key components of the resistance mechanisms which provided important molecular understanding such as, for example, the ability of this cascade to discriminate between vancomycin sensitive and resistant peptidoglycan precursors. Important structural insights have been also made into the molecular evolution of vancomycin resistance enzymes. Altogether this molecular data can accelerate inhibitor discovery and optimization efforts to reverse vancomycin resistance. Here, we overview our current understanding of this complex resistance mechanism with a focus on the structural and molecular aspects.
C1 [Stogios, Peter J.; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   [Stogios, Peter J.; Savchenko, Alexei] CSGID, Calgary, AB, Canada.
   [Savchenko, Alexei] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.
RP Savchenko, A (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
EM alexei.savchenko@ucalgary.ca
OI Stogios, Peter/0000-0001-8663-1425
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272201700060C]
FX National Institute of Allergy and Infectious Diseases, Grant/Award
   Number: HHSN272201700060C
CR ALLEN NE, 1995, FEMS MICROBIOL LETT, V132, P107, DOI 10.1111/j.1574-6968.1995.tb07819.x
   [Anonymous], 2013, ANT RES THREATS US
   Antonyuk SV, 2009, ACTA CRYSTALLOGR F, V65, P1209, DOI 10.1107/S1744309109044935
   Arias CA, 2000, ANTIMICROB AGENTS CH, V44, P1660, DOI 10.1128/AAC.44.6.1660-1666.2000
   Arias CA, 1999, MOL MICROBIOL, V31, P1653, DOI 10.1046/j.1365-2958.1999.01294.x
   Arias CA, 2003, J ANTIMICROB CHEMOTH, V51, P557, DOI 10.1093/jac/dkg128
   Arias CA, 2000, MICROBIOL-SGM, V146, P1727, DOI 10.1099/00221287-146-7-1727
   Arthur M, 1997, J BACTERIOL, V179, P97, DOI 10.1128/jb.179.1.97-106.1997
   ARTHUR M, 1991, GENE, V103, P133, DOI 10.1016/0378-1119(91)90405-Z
   Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x
   Arthur M, 1998, MOL MICROBIOL, V30, P819, DOI 10.1046/j.1365-2958.1998.01114.x
   ARTHUR M, 1994, ANTIMICROB AGENTS CH, V38, P1899, DOI 10.1128/AAC.38.9.1899
   ARTHUR M, 1995, GENE, V154, P87, DOI 10.1016/0378-1119(94)00851-I
   ARTHUR M, 1992, GENE, V120, P111, DOI 10.1016/0378-1119(92)90017-J
   ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992
   Arthur M, 1999, MICROBIOL-UK, V145, P1849, DOI 10.1099/13500872-145-8-1849
   Azam AA, 2018, EUR BIOPHYS J BIOPHY, V47, P723, DOI 10.1007/s00249-018-1325-z
   Baptista M, 1996, ANTIMICROB AGENTS CH, V40, P2291, DOI 10.1128/AAC.40.10.2291
   Biarrotte-Sorin S, 2004, STRUCTURE, V12, P257, DOI 10.1016/j.str.2004.01.006
   BILLOTKLEIN D, 1994, BIOCHEM J, V304, P1021, DOI 10.1042/bj3041021
   Binda E, 2014, ANTIBIOTICS-BASEL, V3, P572, DOI 10.3390/antibiotics3040572
   Blaskovich MAT, 2018, ACS INFECT DIS, V4, P715, DOI 10.1021/acsinfecdis.7b00258
   Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P2667, DOI 10.1128/AAC.01516-07
   BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002
   BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007
   Bussiere DE, 1998, MOL CELL, V2, P75, DOI 10.1016/S1097-2765(00)80115-X
   Butler MS, 2014, J ANTIBIOT, V67, P631, DOI 10.1038/ja.2014.111
   Casadewall B, 1999, J BACTERIOL, V181, P3644, DOI 10.1128/JB.181.12.3644-3648.1999
   D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388
   Dengler U, 1997, J MOL BIOL, V267, P640, DOI 10.1006/jmbi.1996.0864
   Depardieu F, 2003, MOL MICROBIOL, V50, P931, DOI 10.1046/j.1365-2958.2003.03737.x
   Depardieu F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005170
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Espaillat A, 2014, ACTA CRYSTALLOGR D, V70, P79, DOI 10.1107/S1399004713024838
   FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684
   Fines M, 1999, ANTIMICROB AGENTS CH, V43, P2161, DOI 10.1128/AAC.43.9.2161
   Garnier F, 2000, MICROBIOL-UK, V146, P1481, DOI 10.1099/00221287-146-6-1481
   Haldimann A, 1997, J BACTERIOL, V179, P5903, DOI 10.1128/jb.179.18.5903-5913.1997
   HANDWERGER S, 1990, FEMS MICROBIOL LETT, V70, P167, DOI 10.1016/S0378-1097(05)80033-3
   HANDWERGER S, 1994, J BACTERIOL, V176, P260, DOI 10.1128/JB.176.1.260-264.1994
   Healy VL, 2000, CHEM BIOL, V7, pR109, DOI 10.1016/S1074-5521(00)00116-2
   HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024
   Holton SJ, 2013, J STRUCT BIOL, V181, P179, DOI 10.1016/j.jsb.2012.10.009
   Hong HJ, 2005, J BIOL CHEM, V280, P13055, DOI 10.1074/jbc.M413801200
   Hong HJ, 2004, MOL MICROBIOL, V52, P1107, DOI 10.1111/j.1365-2958.2004.04032.x
   Hughes CS, 2017, BBA-GEN SUBJECTS, V1861, P1951, DOI 10.1016/j.bbagen.2017.05.011
   Hussain R, 2016, BIOCHEM SOC T, V44, P810, DOI 10.1042/BST20160023
   Kim HS, 2018, INT J BIOL MACROMOL, V119, P335, DOI 10.1016/j.ijbiomac.2018.07.081
   Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350
   Kouidmi I, 2014, MOL MICROBIOL, V94, P242, DOI 10.1111/mmi.12758
   Kuzin AP, 2000, STRUCT FOLD DES, V8, P463, DOI 10.1016/S0969-2126(00)00129-5
   Kwun MJ, 2013, ANTIMICROB AGENTS CH, V57, P4470, DOI 10.1128/AAC.00523-13
   Lebreton F, 2011, ANTIMICROB AGENTS CH, V55, P4606, DOI 10.1128/AAC.00714-11
   LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307
   Lessard IAD, 1999, BIOCHEMISTRY-US, V38, P14006, DOI 10.1021/bi991384c
   Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709
   Marshall CG, 1999, BIOCHEMISTRY-US, V38, P8485, DOI 10.1021/bi982843x
   McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u
   McGuinness WA, 2017, YALE J BIOL MED, V90, P269
   McKessar SJ, 2000, ANTIMICROB AGENTS CH, V44, P3224, DOI 10.1128/AAC.44.11.3224-3228.2000
   Meziane-Cherif D, 2015, MBIO, V6, DOI 10.1128/mBio.00806-15
   Meziane-Cherif D, 2014, P NATL ACAD SCI USA, V111, P5872, DOI 10.1073/pnas.1402259111
   Meziane-Cherif D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405522
   Nguyen MP, 2015, CAN J MICROBIOL, V61, P799, DOI 10.1139/cjm-2015-0345
   Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517
   Nitanai Y, 2009, J MOL BIOL, V385, P1422, DOI 10.1016/j.jmb.2008.10.026
   Novotna G, 2012, ANTIMICROB AGENTS CH, V56, P1784, DOI 10.1128/AAC.05869-11
   Park IS, 1997, J BIOL CHEM, V272, P9210
   Patel R, 2000, ANTIMICROB AGENTS CH, V44, P705, DOI 10.1128/AAC.44.3.705-709.2000
   Patino LA, 2002, J BACTERIOL, V184, P6457, DOI 10.1128/JB.184.23.6457-6464.2002
   Patrick WM, 2002, CHEMBIOCHEM, V3, P789, DOI 10.1002/1439-7633(20020802)3:8<789::AID-CBIC789>3.0.CO;2-D
   Perichon B, 2011, ANTIBIOTIC DISCOVERY, V48, P515
   Perichon B, 2009, INFECT DIS, P229, DOI 10.1007/978-1-59745-180-2_20
   Peters K, 2016, MBIO, V7, DOI 10.1128/mBio.00819-16
   Phillips-Jones MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46180
   Podmore AHB, 2002, EUR J BIOCHEM, V269, P2740, DOI 10.1046/j.1432-1033.2002.02946.x
   Razeto A, 2002, J MOL BIOL, V318, P109, DOI 10.1016/S0022-2836(02)00086-4
   REYNOLDS PE, 1994, BIOCHEM J, V301, P5, DOI 10.1042/bj3010005
   Reynolds PE, 1999, MOL MICROBIOL, V34, P341, DOI 10.1046/j.1365-2958.1999.01604.x
   Roper DI, 2000, P NATL ACAD SCI USA, V97, P8921, DOI 10.1073/pnas.150116497
   SAHM DF, 1995, ANTIMICROB AGENTS CH, V39, P1480, DOI 10.1128/AAC.39.7.1480
   Sarkar P, 2019, GLYCOPEPTIDE ANTIBIO, P73
   Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830
   Smith JD, 2013, ANTIMICROB AGENTS CH, V57, P3137, DOI 10.1128/AAC.00505-13
   Stoll VS, 1998, PROTEIN SCI, V7, P1147, DOI 10.1002/pro.5560070508
   Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677
   Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996
   Upton EC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210627
   Waglechner N, 2019, NAT MICROBIOL, V31, P922
   Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200
   WHO, 2014, ANT RES GLOB REP SUR
   Woods EC, 2018, ANAEROBE, V53, P108, DOI 10.1016/j.anaerobe.2018.06.013
   WRIGHT GD, 1993, BIOCHEMISTRY-US, V32, P5057, DOI 10.1021/bi00070a013
   WRIGHT GD, 1992, ANTIMICROB AGENTS CH, V36, P1514, DOI 10.1128/AAC.36.7.1514
   Wright Gerard D, 2012, Handb Exp Pharmacol, P13, DOI 10.1007/978-3-642-28951-4_2
   Wu HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048301
   WU Z, 1995, BIOCHEMISTRY-US, V34, P2455, DOI 10.1021/bi00008a008
   Yim G, 2014, J ANTIBIOT, V67, P31, DOI 10.1038/ja.2013.117
   Zeng D, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026989
NR 99
TC 0
Z9 0
U1 26
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
EI 1469-896X
J9 PROTEIN SCI
JI Protein Sci.
PD MAR
PY 2020
VL 29
IS 3
SI SI
BP 654
EP 669
DI 10.1002/pro.3819
EA JAN 2020
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KL3AR
UT WOS:000508679600001
PM 31899563
DA 2020-05-07
ER

PT J
AU Mascarenhas, R
   Ruziska, FM
   Moreira, EF
   Campos, AB
   Loiola, M
   Reis, K
   Trindade-Silva, AE
   Barbosa, FAS
   Salles, L
   Menezes, R
   Veiga, R
   Coutinho, FH
   Dutilh, BE
   Guimaraes, PR
   Assis, APA
   Ara, A
   Miranda, JGV
   Andrade, RFS
   Vilela, B
   Meirelles, PM
AF Mascarenhas, Rilquer
   Ruziska, Flavia M.
   Moreira, Eduardo Freitas
   Campos, Amanda B.
   Loiola, Miguel
   Reis, Kaike
   Trindade-Silva, Amaro E.
   Barbosa, Felipe A. S.
   Salles, Lucas
   Menezes, Rafael
   Veiga, Rafael
   Coutinho, Felipe H.
   Dutilh, Bas E.
   Guimaraes, Paulo R., Jr.
   Assis, Ana Paula A.
   Ara, Anderson
   Miranda, Jose G. V.
   Andrade, Roberto F. S.
   Vilela, Bruno
   Meirelles, Pedro Milet
TI Integrating Computational Methods to Investigate the Macroecology of
   Microbiomes
SO FRONTIERS IN GENETICS
LA English
DT Review
DE microbial community modeling; microbial macroecology; spatial scales;
   machine learning; co-occurrence networks
ID SPECIES DISTRIBUTION MODELS; BAYESIAN BELIEF NETWORKS; RNA GENE
   DATABASE; FUNCTIONAL DIVERSITY; COOCCURRENCE PATTERNS; BACTERIAL
   COMMUNITIES; BIOTIC INTERACTIONS; DISTANCE-DECAY; BIG QUESTIONS; SPATIAL
   SCALE
AB Studies in microbiology have long been mostly restricted to small spatial scales. However, recent technological advances, such as new sequencing methodologies, have ushered an era of large-scale sequencing of environmental DNA data from multiple biomes worldwide. These global datasets can now be used to explore long standing questions of microbial ecology. New methodological approaches and concepts are being developed to study such large-scale patterns in microbial communities, resulting in new perspectives that represent a significant advances for both microbiology and macroecology. Here, we identify and review important conceptual, computational, and methodological challenges and opportunities in microbial macroecology. Specifically, we discuss the challenges of handling and analyzing large amounts of microbiome data to understand taxa distribution and co-occurrence patterns. We also discuss approaches for modeling microbial communities based on environmental data, including information on biological interactions to make full use of available Big Data. Finally, we summarize the methods presented in a general approach aimed to aid microbiologists in addressing fundamental questions in microbial macroecology, including classical propositions (such as "everything is everywhere, but the environment selects") as well as applied ecological problems, such as those posed by human induced global environmental changes.
C1 [Mascarenhas, Rilquer; Ruziska, Flavia M.; Moreira, Eduardo Freitas; Campos, Amanda B.; Loiola, Miguel; Trindade-Silva, Amaro E.; Barbosa, Felipe A. S.; Vilela, Bruno; Meirelles, Pedro Milet] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil.
   [Reis, Kaike] Univ Fed Bahia, Polytech Sch, Dept Chem Engn, Salvador, BA, Brazil.
   [Trindade-Silva, Amaro E.; Menezes, Rafael; Meirelles, Pedro Milet] Univ Sao Paulo, Biosci Inst, Dept Ecol, Sao Paulo, Brazil.
   [Salles, Lucas] Univ Fed Bahia, Inst Geol, Salvador, BA, Brazil.
   [Menezes, Rafael; Miranda, Jose G. V.; Andrade, Roberto F. S.] Univ Fed Bahia, Inst Phys, Salvador, BA, Brazil.
   [Veiga, Rafael; Andrade, Roberto F. S.] Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Ctr Data & Knowledge Integrat Hlth CIDACS, Rio De Janeiro, Brazil.
   [Coutinho, Felipe H.] Univ Miguel Hernandez Elche, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alacant, Spain.
   [Dutilh, Bas E.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands.
   [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen, Netherlands.
   [Guimaraes, Paulo R., Jr.; Assis, Ana Paula A.] Univ Sao Paulo, Dept Ecol, Biosci Inst, Butanta, Brazil.
   [Ara, Anderson] Univ Fed Bahia, Inst Math, Salvador, BA, Brazil.
RP Meirelles, PM (reprint author), Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil.; Meirelles, PM (reprint author), Univ Sao Paulo, Biosci Inst, Dept Ecol, Sao Paulo, Brazil.
EM pmeirelles@ufba.br
RI Meirelles, Pedro/AAL-4542-2020; Vilela, Bruno/L-1594-2015; Moreira,
   Eduardo/AAF-6779-2020; Assis, Ana Paula A/K-2172-2016
OI Vilela, Bruno/0000-0003-4072-0558; Guimaraes,,
   Paulo/0000-0001-9161-8305; Assis, Ana Paula A/0000-0001-8170-6352
FU Serrapilheira Institute [Serra-1709-17818]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)CAPES [001];
   CAPESCAPES [88887.301758/2018-00, 88882.460937/2019-01]; PROPESQ-UFBA
   [11268]; Generalitat ValencianaGeneralitat Valenciana [APOSTD/2018/186];
   Netherlands Organization for Scientific Research (NWO)Netherlands
   Organization for Scientific Research (NWO) [864.14.004]; FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/08406-7];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [132261/2018-9, 151157/2018-9]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016/14277-2]
FX This work was primarily supported by the Serrapilheira Institute (grant
   number Serra-1709-17818). Further support was provided by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)-Finance Code 001. AT-S thanks CAPES (88887.301758/2018-00). PMM
   thanks to PROPESQ-UFBA (11268). FC was supported by APOSTD/2018/186
   Postdoctoral fellowship from Generalitat Valenciana. BD was supported by
   the Netherlands Organization for Scientific Research (NWO) Vidi grant
   864.14.004. PG was supported by FAPESP (2017/08406-7) and CNPq. AC was
   supported by CNPq (132261/2018-9). RM was supported by CAPES
   (88882.460937/2019-01). AA was supported by Sao Paulo Research
   Foundation (FAPESP) grant number 2016/14277-2, and CAPES. RV was
   supported by CNPq, grant number 151157/2018-9.
CR Aguilera PA, 2011, ENVIRON MODELL SOFTW, V26, P1376, DOI 10.1016/j.envsoft.2011.06.004
   Alameddine I, 2011, ENVIRON MODELL SOFTW, V26, P163, DOI 10.1016/j.envsoft.2010.08.007
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Amend AS, 2013, J BIOGEOGR, V40, P800, DOI 10.1111/jbi.12034
   Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x
   Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x
   Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x
   Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x
   Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x
   Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x
   Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364
   Banerjee S, 2018, NAT REV MICROBIOL, V16, P567, DOI 10.1038/s41579-018-0024-1
   Banerjee S, 2016, SOIL BIOL BIOCHEM, V97, P188, DOI 10.1016/j.soilbio.2016.03.017
   BARBERAN A, 2014, FRONT MICROBIOL, V5, DOI DOI 10.3389/FMICB.2014.00203
   Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Bastida F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11472-7
   Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77
   Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219
   Beuzen T, 2018, ENVIRON MODELL SOFTW, V108, P61, DOI 10.1016/j.envsoft.2018.07.007
   Blaser MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00714-16
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599
   Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6
   Bovallius A, 1980, Ann N Y Acad Sci, V353, P186, DOI 10.1111/j.1749-6632.1980.tb18922.x
   Bowman JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135868
   BRAY JR, 1957, ECOL MONOGR, V27, P326
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brown SM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz020
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cardona C, 2016, CURR OPIN MICROBIOL, V31, P124, DOI 10.1016/j.mib.2016.03.008
   Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x
   Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a
   Chen SH, 2012, ENVIRON MODELL SOFTW, V37, P134, DOI 10.1016/j.envsoft.2012.03.012
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x
   Cohen WB, 2003, REMOTE SENS ENVIRON, V88, P233, DOI 10.1016/j.rse.2003.06.006
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106
   Comte J, 2016, BIOGEOSCIENCES, V13, P175, DOI 10.5194/bg-13-175-2016
   Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602
   Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864
   de Araujo CB, 2014, J BIOGEOGR, V41, P513, DOI 10.1111/jbi.12234
   Death RG, 2015, FRESHWATER BIOL, V60, P2297, DOI 10.1111/fwb.12655
   Debastiani VJ, 2012, BIOINFORMATICS, V28, P2067, DOI 10.1093/bioinformatics/bts325
   Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516
   Delgado-Baquerizo M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602008
   Delgado-Baquerizo M, 2016, ECOL MONOGR, V86, P373, DOI 10.1002/ecm.1216
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x
   Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2
   Didan K., 2015, MOD13A3 MODIS TERRA, DOI [10.5067/MODIS/MOD13A3.006, DOI 10.5067/MODIS/MOD13A3.006]
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Drenovsky RE, 2010, GLOBAL ECOL BIOGEOGR, V19, P27, DOI 10.1111/j.1466-8238.2009.00486.x
   Duarte LD, 2009, GLOBAL ECOL BIOGEOGR, V18, P314, DOI 10.1111/j.1466-8238.2009.00448.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Engelen RJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010739
   Fan KK, 2018, SOIL BIOL BIOCHEM, V121, P185, DOI 10.1016/j.soilbio.2018.03.017
   Fang HY, 2015, BIOINFORMATICS, V31, P3172, DOI 10.1093/bioinformatics/btv349
   Faure D, 2016, INSIGHT ON ENVIRONMENTAL GENOMICS: THE HIGH-THROUGHPUT SEQUENCING REVOLUTION, P93
   Faust Karoline, 2016, F1000Res, V5, P1519
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086
   Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1
   Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103
   Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1
   Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616
   Friedl M., 2015, MCD12C1 MODIS TERRA, DOI [10.5067/MODIS/MCD12C1.006, DOI 10.5067/MODIS/MCD12C1.006]
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Fu H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08844-8
   Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105
   Galand PE, 2018, ISME J, V12, P2470, DOI 10.1038/s41396-018-0158-1
   Giglio L., 2015, NASA EOSDIS LAND PRO, DOI [10.5067/MODIS/MCD64A1.006, DOI 10.5067/MODIS/MCD64A1.006]
   Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107
   Grace J.B., 2006, STRUCTURAL EQUATION
   Grenie M, 2017, DIVERS DISTRIB, V23, P1365, DOI 10.1111/ddi.12629
   Guimaraes PR, 2017, NATURE, V550, P511, DOI 10.1038/nature24273
   Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288
   Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x
   Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103
   Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795
   Harris DJ, 2015, METHODS ECOL EVOL, V6, P465, DOI 10.1111/2041-210X.12332
   Hartemink A. J., 2001, THESIS
   Hartman K, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0389-9
   Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12
   Hendershot JN, 2017, ECOLOGY, V98, P1757, DOI 10.1002/ecy.1829
   Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748
   Hijmans R.J., 2017, CIRCLES, V9, P1, DOI DOI 10.1002/joc.5086
   Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004
   Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106
   Hong Y, 2004, J APPL METEOROL, V43, P1834, DOI 10.1175/JAM2173.1
   Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286
   Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073
   Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400
   Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1
   Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.48, 10.1038/NMICROBIOL.2016.48]
   Hug LA, 2016, ENVIRON MICROBIOL, V18, P159, DOI 10.1111/1462-2920.12930
   Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a
   Huson DH, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0208-7
   Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103
   Jackson MA, 2018, PEERJ, V6, DOI 10.7717/peerj.4303
   Jarzyna MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04889-z
   Jay CV, 2011, POLAR BIOL, V34, P1065, DOI 10.1007/s00300-011-0967-4
   Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008
   Jiao S, 2016, SOIL BIOL BIOCHEM, V98, P64, DOI 10.1016/j.soilbio.2016.04.005
   Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1
   Kass JM, 2018, METHODS ECOL EVOL, V9, P1151, DOI 10.1111/2041-210X.12945
   Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x
   Keller CK, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000157
   Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267
   Koslicki D, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00020-16
   Koza J.R., 1992, GENETIC PROGRAMMING
   Koza JR, 2000, COMPUT METHOD APPL M, V186, P459, DOI 10.1016/S0045-7825(99)00397-7
   Kultima JR, 2016, BIOINFORMATICS, V32, P2520, DOI 10.1093/bioinformatics/btw183
   Kumar SV, 2006, ENVIRON MODELL SOFTW, V21, P1402, DOI 10.1016/j.envsoft.2005.07.004
   Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226
   Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]
   Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09
   Layeghifard M, 2017, TRENDS MICROBIOL, V25, P217, DOI 10.1016/j.tim.2016.11.008
   Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549
   Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019
   Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967
   LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447
   Li D, 2017, IEEE T AERO ELEC SYS, V53, P2140, DOI 10.1109/TAES.2017.2683599
   Liaw A, 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516
   Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073
   Lin H, 2013, FRONT EARTH SCI-PRC, V7, P295, DOI 10.1007/s11707-013-0365-z
   Lin HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24175
   Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x
   Louca S, 2018, NAT ECOL EVOL, V2, P936, DOI 10.1038/s41559-018-0519-1
   Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507
   Lupatini M, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00010
   Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006
   Maddy ES, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009402
   Marasco R, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0391-2
   Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341
   MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x
   McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528
   McGill BJ, 2010, OIKOS, V119, P591, DOI 10.1111/j.1600-0706.2009.17771.x
   Mendes LW, 2018, ISME J, V12, P3038, DOI 10.1038/s41396-018-0234-6
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Mitchell AL, 2018, NUCLEIC ACIDS RES, V46, pD726, DOI 10.1093/nar/gkx967
   Morgan CG, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003402
   Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x
   Nabout JC, 2012, NAT CONSERVACAO, V10, P177, DOI 10.4322/natcon.2012.034
   Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881
   Nelson MB, 2016, P NATL ACAD SCI USA, V113, P8033, DOI 10.1073/pnas.1601070113
   Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723
   Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x
   Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x
   Nojavan AF, 2017, ENVIRON MODELL SOFTW, V87, P64, DOI 10.1016/j.envsoft.2016.10.007
   Nojavan AF, 2014, MAR POLLUT BULL, V83, P107, DOI 10.1016/j.marpolbul.2014.04.011
   Nottingham AT, 2018, ECOLOGY, V99, P2455, DOI 10.1002/ecy.2482
   Ofori BY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13245-y
   Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523
   Oliver TH, 2015, TRENDS ECOL EVOL, V30, P673, DOI 10.1016/j.tree.2015.08.009
   Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2
   PAINE RT, 1969, ECOLOGY, V50, P950, DOI 10.2307/1936888
   PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400
   Pearl J., 2014, PROBABILISTIC REASON
   Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1
   Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214
   Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226
   Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x
   Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x
   Peters-Lidard CD, 2007, INNOV SYST SOFTW ENG, V3, P157, DOI 10.1007/s11334-007-0028-x
   Peterson AT, 2010, SYST BIODIVERS, V8, P159, DOI 10.1080/14772001003739369
   Phan TD, 2016, ENVIRON MODELL SOFTW, V85, P98, DOI 10.1016/j.envsoft.2016.08.006
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180
   Poudel R, 2016, PHYTOPATHOLOGY, V106, P1083, DOI 10.1094/PHYTO-02-16-0058-FI
   Qian SS, 2015, ENVIRON MODELL SOFTW, V69, P14, DOI 10.1016/j.envsoft.2015.03.001
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x
   Ramirez KS, 2018, NAT MICROBIOL, V3, P189, DOI 10.1038/s41564-017-0062-x
   Ramirez KS, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00091
   Ren Z, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02319
   Ricotta C, 2016, METHODS ECOL EVOL, V7, P1386, DOI 10.1111/2041-210X.12604
   Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216
   Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381
   Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238
   Running S., 2017, MOD16A3 MODIS TERRA, DOI [10.5067/MODIS/MOD16A3.006, DOI 10.5067/MODIS/MOD16A3.006]
   Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024
   Savtchenko A, 2004, ADV SPACE RES, V34, P710, DOI 10.1016/j.asr.2004.03.012
   Scher JU, 2014, CURR OPIN RHEUMATOL, V26, P424, DOI 10.1097/BOR.0000000000000076
   Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1
   SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/nmeth.4458, 10.1038/NMETH.4458]
   Shade A, 2018, TRENDS ECOL EVOL, V33, P731, DOI 10.1016/j.tree.2018.08.005
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Silva DP, 2016, BIOL INVASIONS, V18, P3137, DOI 10.1007/s10530-016-1204-4
   Silva DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113246
   Silva GGZ, 2016, BIOINFORMATICS, V32, P354, DOI 10.1093/bioinformatics/btv584
   Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x
   Snyder LAS, 2009, MICROB ECOL, V57, P1, DOI 10.1007/s00248-008-9465-9
   Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x
   Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106
   Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x
   Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x
   Song HS, 2014, PROCESSES, V2, P711, DOI 10.3390/pr2040711
   Speth DR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11172
   Staniczenko PPA, 2017, ECOL LETT, V20, P693, DOI 10.1111/ele.12770
   Stocker EF, 2018, J ATMOS OCEAN TECH, V35, P1181, DOI 10.1175/JTECH-D-17-0166.1
   Succurro A, 2018, BIOCHEM SOC T, V46, P403, DOI 10.1042/BST20170265
   Sugimoto M, 2005, BIOSYSTEMS, V80, P155, DOI 10.1016/j.biosystems.2004.11.003
   Taudiere A, 2016, ECOGRAPHY, V39, P699, DOI 10.1111/ecog.01433
   Texeira J, 2008, MONTH CO2 FREE TROP, DOI [10.5067/Aqua/AIRS/DATA336, DOI 10.5067/AQUA/AIRS/DATA336]
   Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017
   Ugarte A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0532-2
   Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033
   Vazquez-Castellanos JF, 2015, MUCOSAL IMMUNOL, V8, P760, DOI 10.1038/mi.2014.107
   Veiga RV, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2233-z
   Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.88, 10.1038/NMICROBIOL.2016.88]
   von Meijenfeldt F.A.B., 2019, BIORXIV, DOI DOI 10.1101/530188
   Wan Z., 2015, MOD11B3 MODIS TERRA, DOI [10.5067/MODIS/MOD11B3.006, DOI 10.5067/MODIS/MOD11B3.006]
   Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358
   Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448
   Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323
   Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235
   Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45
   WILHEIT TT, 1991, J ATMOS OCEAN TECH, V8, P118, DOI 10.1175/1520-0426(1991)008<0118:ROMRIF>2.0.CO;2
   Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032
   Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x
   Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992
   Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638
   Xiong XZ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000500
   Xue PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30005-8
   Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823
   Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083
NR 236
TC 0
Z9 0
U1 9
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 17
PY 2020
VL 10
AR 1344
DI 10.3389/fgene.2019.01344
PG 24
WC Genetics & Heredity
SC Genetics & Heredity
GA KH8NZ
UT WOS:000510908800001
PM 32010196
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Bastian, I
   Shephard, L
   Lumb, R
AF Bastian, Ivan
   Shephard, Lisa
   Lumb, Richard
CA Natl TB Advisory Comm
TI Revised guidelines for Australian laboratories performing
   mycobacteriology testing
SO COMMUNICABLE DISEASES INTELLIGENCE
LA English
DT Article
ID DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; TUBERCULOSIS
   COMPLEX; XPERT MTB/RIF; MOLECULAR-DETECTION; SUSCEPTIBILITY;
   IDENTIFICATION; PYRAZINAMIDE; RESISTANCE; DIAGNOSIS
AB Mycobacteriology laboratories play a key role in tuberculosis (TB) control by providing phenotypic and molecular diagnostics, by performing molecular typing to aid contact tracing, and by supporting research and similar laboratories in Australia's neighbouring countries where TB is prevalent. The National Tuberculosis Advisory Committee (NTAC) published a set of laboratory guidelines in 2006 aiming to document the infrastructure, equipment, staffing and work practices required for safe high-quality work in Australian mycobacteriology laboratories. These revised guidelines have the same aims and have been through a similar extensive consultative peer-review process involving the Mycobacterium Reference Laboratory (MRL) network, the Mycobacterium Special Interest Group (SIG) of the Australian Society for Microbiology (ASM), and other relevant national bodies.
   This revised document contains several significant changes reflecting the publication of new biosafety guidelines and tuberculosis standards by various national and international organisations, technology developments - such as the MPT64-based immunochromatographic tests (ICTs) and the Xpert MTB/RIF assay, and updated work practices in mycobacteriology laboratories. The biosafety recommendations affirm the latest Australian/ New Zealand Standard 2243.3: 2010 and promote a biorisk assessment approach that, in addition to the risk categorisation of the organism, also considers the characteristics of the procedure being performed. Using this biorisk assessment approach, limited manipulations, such as Ziehl-Neelsen (ZN) microscopy, MPT64 ICTs, and culture inactivation/DNA extraction for molecular testing, may be performed on a positive TB culture in a PC2 laboratory with additional features and work practices. Other significant changes include recommendations on the integration of MPT64 ICTs and novel molecular tests into TB laboratory workflows to provide rapid accurate results that improve the care of TB patients. This revised document supersedes the original 2006 publication. NTAC will periodically review these guidelines and provide updates as new laboratory technologies become available.
C1 [Bastian, Ivan; Shephard, Lisa; Lumb, Richard] SA Pathol, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.
RP Bastian, I (reprint author), SA Pathol, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.
EM Ivan.Bastian@sa.gov.au
CR Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016
   [Anonymous], 2013, COMMUN DIS INTELL, V37, pE65
   [Anonymous], 2014, COMP HDB WHO GUID PR
   Association of Public Health Laboratories, MYC TUB ASS YOUR LAB
   Association of Public Health Laboratories Tuberculosis Steering Committee, 2009, COR TB LAB SERV PUBL
   Australian/New Zealand Standard, 22433 AUSTR NZ STAND
   Australian Society for Microbiology, 2012, GUID ASS QUAL SOL ME
   Aziz MA, 2002, EXT QUAL ASS AFB SME
   Bahr NC, 2018, LANCET INFECT DIS, V18, P68, DOI [10.1016/s1473-3099(17)30474-7, 10.1016/S1473-3099(17)30474-7]
   Bastian I, 2017, COMMUN DIS INTELL, V41, pE322
   Blauwendraat C, 2012, EUR J CLIN MICROBIOL, V31, P1847, DOI 10.1007/s10096-011-1510-9
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847
   Brent AJ, 2011, J CLIN MICROBIOL, V49, P4343, DOI 10.1128/JCM.05995-11
   Brigden G, 2015, INFECT DRUG RESIST, V8, P367, DOI 10.2147/IDR.S68351
   Buckwalter SP, 2016, J CLIN MICROBIOL, V54, P376, DOI 10.1128/JCM.02128-15
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P413
   CHAISSON RE, 1994, ANN INTERN MED, V121, P905, DOI 10.7326/0003-4819-121-12-199412150-00001
   Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11
   Chien JY, 2016, ANTIMICROB AGENTS CH, V60, P4708, DOI 10.1128/AAC.00425-16
   Coeck N, 2016, J ANTIMICROB CHEMOTH, V71, P1233, DOI 10.1093/jac/dkv499
   Coulter C, 2016, COMMUN DIS INTELL, V40, pE360
   de Boer AS, 2002, J CLIN MICROBIOL, V40, P4004, DOI 10.1128/JCM.40.11.4004-4009.2002
   den Hertog AL, 2016, ANTIMICROB AGENTS CH, V60, P4956, DOI 10.1128/AAC.00654-16
   Drobniewski FA, 2006, EUR RESPIR J, V28, P903, DOI 10.1183/09031936.06.00084906
   European Centre for Disease Prevention and Control, 2018, HDB TB LAB DIAGN MET
   European Committee for Standardization, 2011, 0710001 ICS EUR COMM
   Floto RA, 2016, THORAX, V71, P1, DOI 10.1136/thoraxjnl-2015-207360
   Giampaglia CMS, 2007, INT J TUBERC LUNG D, V11, P803
   Girard V, 2016, DIAGN MICR INFEC DIS, V86, P277, DOI 10.1016/j.diagmicrobio.2016.07.027
   Gitterman S, 2015, MMWR-MORBID MORTAL W, V64, P193
   Global Laboratory Initiative, 2013, THE HDB
   Global Laboratory Initiative (GLI), 2012, UPD INT CRIT CONC 1
   Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST
   Hopprich R, 2012, PATHOLOGY, V44, P642, DOI 10.1097/PAT.0b013e328359d565
   Hughes R, 2012, RESP MED, V106, P300, DOI 10.1016/j.rmed.2011.10.005
   Kim SJ, 2007, INT J TUBERC LUNG D, V11, P138
   Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]
   Macheras E, 2009, J CLIN MICROBIOL, V47, P2596, DOI 10.1128/JCM.00037-09
   Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1
   National Committee for Clinical Laboratory Standards, 2003, M24A NAT COMM CLIN L
   National Institute for Health and Care Excellence (NICE), 2016, NICE GUID TUB NG33
   National Pathology Accreditation Advisory Council (NPAAC), 2013, REQ MED TEST MICR NU
   National Pathology Accreditation Advisory Council (NPAAC), 2018, REQ MED PATH SERV
   National Tuberculosis Advisory Committee, 2006, Commun Dis Intell Q Rep, V30, P116
   New Zealand Ministry of Health, GUID TUB CONTR NZ
   Noor KM, 2015, PATHOLOGY, V47, P250, DOI 10.1097/PAT.0000000000000232
   Palomino JC, 2009, FEMS IMMUNOL MED MIC, V56, P103, DOI 10.1111/j.1574-695X.2009.00555.x
   Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12
   Preece CL, 2016, J CLIN MICROBIOL, V54, P1797, DOI 10.1128/JCM.00471-16
   Public Health Agency of Canada and Canadian Lung Association/Canadian Thoracic Society, 2014, CANADIAN TUBERCULOSI
   Public Health England, 2014, UK STAND MICR INV IN
   Public Health Laboratory Network (PHLN), 2016, PHLN GUID REG MYC CH
   RATNAM S, 1986, J CLIN MICROBIOL, V23, P582, DOI 10.1128/JCM.23.3.582-585.1986
   Rossau R, 1997, ANTIMICROB AGENTS CH, V41, P2093, DOI 10.1128/AAC.41.10.2093
   Sassi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-359
   Simons SO, 2012, J CLIN MICROBIOL, V50, P428, DOI 10.1128/JCM.05435-11
   Standards Australia, 48342007 AS
   Therapeutic Goods Administration (TGA), 2011, OV NEW REG FRAM IN V
   Therapeutic Goods Administration (TGA), 2015, CLASS IVD MED DEV
   Toms C, 2015, COMMUN DIS INTELL, V39, pE217
   Tortoli E, 2014, CLIN MICROBIOL REV, V27, P727, DOI 10.1128/CMR.00035-14
   Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06
   US Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention and the National Institutes of Health, 2009, HHS PUBL
   van Ingen J, 2015, CLIN CHEST MED, V36, P43, DOI 10.1016/j.ccm.2014.11.005
   Woods GL, 2000, CLIN INFECT DIS, V31, P1209
   Woods GL, 2018, M24 CLSI
   World Health Organization, 2017, WHO M TECHN EXP CONS
   World Health Organization, 2012, WHOHTMTB201211
   World Health Organization, 2008, MOL LIN PROB ASS RAP
   World Health Organization, 2016, WHOHTMTB201613
   World Health Organization, 2018, WHOCDSTB20185
   World Health Organization, 2008, WHOHTMTB2008392
   World Health Organization, 2013, WHOHTMTB201316
   Yin XM, 2013, J INFECTION, V67, P369, DOI 10.1016/j.jinf.2013.06.009
   2009, MMWR MORB MORTAL WKL, V58, P7
NR 75
TC 0
Z9 0
U1 0
U2 0
PU AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING
PI CANBERRA
PA OFFICE HEALTH PROTECTION SURVEILLANCE BRANCH, GPO BOX 9848, CANBERRA,
   ACT 2601, AUSTRALIA
SN 0725-3141
EI 1445-4866
J9 COMMUN DIS INTELL
JI Commun. Dis. Intell.
PD JAN 15
PY 2020
VL 44
DI 10.33321/cdi.2020.44.2
PG 28
WC Infectious Diseases
SC Infectious Diseases
GA KG1UF
UT WOS:000509725700002
OA Bronze
DA 2020-05-07
ER

PT J
AU Kotb, S
   Lyman, M
   Ismail, G
   Abd El Fattah, M
   Girgis, SA
   Etman, A
   Hafez, S
   El-Kholy, J
   Zaki, ME
   Rashed, HAG
   Khalil, GM
   Sayyouh, O
   Talaat, M
AF Kotb, Sara
   Lyman, Meghan
   Ismail, Ghada
   Abd El Fattah, Mohammad
   Girgis, Samia A.
   Etman, Ahmed
   Hafez, Soad
   El-Kholy, Jehan
   Zaki, Maysaa El Sayed
   Rashed, Hebat-allah G.
   Khalil, Ghada M.
   Sayyouh, Omar
   Talaat, Maha
TI Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian
   intensive care units using National Healthcare-associated Infections
   Surveillance Data, 2011-2017
SO ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
LA English
DT Article
DE Antimicrobial resistance; Carbapenem resistance Enterobacteriaceae;
   Healthcare-associated infections
ID RISK-FACTORS; SAFETY NETWORK; HOSPITALS; PROGRAM
AB Objective To describe the epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) healthcare-associated infections (HAI) in Egyptian hospitals reporting to the national HAI surveillance system. Methods Design: Descriptive analysis of CRE HAIs and retrospective observational cohort study using national HAI surveillance data. Setting: Egyptian hospitals participating in the HAI surveillance system. The patient population included patients admitted to the intensive care unit (ICU) in participating hospitals. Enterobacteriaceae HAI cases were Klebsiella, Escherichia coli, and Enterobacter isolates from blood, urine, wound or respiratory specimen collected on or after day 3 of ICU admission. CRE HAI cases were those resistant to at least one carbapenem. For CRE HAI cases reported during 2011-2017, a hospital-level and patient-level analysis were conducted using only the first CRE isolate by pathogen and specimen type for each patient. For facility, microbiology, and clinical characteristics, frequencies and means were calculated among CRE HAI cases and compared with carbapenem-susceptible Enterobacteriaceae HAI cases through univariate and multivariate logistic regression using STATA 13. Results There were 1598 Enterobacteriaceae HAI cases, of which 871 (54.1%) were carbapenem resistant. The multivariate regression analysis demonstrated that carbapenem resistance was associated with specimen type, pathogen, location prior to admission, and length of ICU stay. Between 2011 and 2017, there was an increase in the proportion of Enterobacteriaceae HAI cases due to CRE (p-value = 0.003) and the incidence of CRE HAIs (p-value = 0.09). Conclusions This analysis demonstrated a high and increasing burden of CRE in Egyptian hospitals, highlighting the importance of enhancing infection prevention and control (IPC) programs and antimicrobial stewardship activities and guiding the implementation of targeted IPC measures to contain CRE in Egyptian ICU's .
C1 [Kotb, Sara; Sayyouh, Omar; Talaat, Maha] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Cairo, Egypt.
   [Lyman, Meghan] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Ismail, Ghada] Supreme Council Univ, Cairo, Egypt.
   [Abd El Fattah, Mohammad; Etman, Ahmed] Minist Hlth & Populat, Cairo, Egypt.
   [Girgis, Samia A.] Ain Shams Univ Hosp, Cairo, Egypt.
   [Hafez, Soad] Alexandria Univ Hosp, Alexandria, Egypt.
   [El-Kholy, Jehan] Cairo Univ Hosp, Cairo, Egypt.
   [Zaki, Maysaa El Sayed] Mansoura Univ Hosp, Mansoura, Egypt.
   [Rashed, Hebat-allah G.] Assiut Univ Hosp, Assiut, Egypt.
   [Khalil, Ghada M.] Zagazig Univ Hosp, Banha, Egypt.
RP Kotb, S (reprint author), US Ctr Dis Control & Prevent, Div Global Hlth Protect, Cairo, Egypt.
EM sarakotb1@yahoo.com
FU U.S. Agency for International Development (USAID-Egypt)United States
   Agency for International Development (USAID) [263-T-14-0001]
FX Supported by the U.S. Agency for International Development
   (USAID-Egypt), Work Unit 263-T-14-0001.
CR [Anonymous], 2012, SURV DEF HEALTHC ASS
   [Anonymous], 2014, ANT RES GLOB REP SUR
   [Anonymous], 2013, ANT RES THREATS US
   Brennan BM, 2014, INFECT CONT HOSP EP, V35, P342, DOI 10.1086/675611
   CDC, 2015, FAC GUID CONTR CARB
   Centers for Disease Control and Prevention, 2017, NAT HEALTHC SAF NETW
   [CLSI Clinical and Laboratory Standards Institute (CLSI).], 2015, PERF STAND ANT SUSC
   Correa L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-80
   Dudeck MA, 2015, AM J INFECT CONTROL, V43, P206, DOI 10.1016/j.ajic.2014.11.014
   El-Sweify M. A., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P10
   Elbadawi LI, 2016, MMWR-MORBID MORTAL W, V65, P906, DOI 10.15585/mmwr.mm6534a5
   ElMahallawy HA, 2018, INFECT DIS-NOR, V50, P560, DOI 10.1080/23744235.2018.1428824
   Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004
   Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165
   Kofteridis DP, 2014, J INFECT CHEMOTHER, V20, P293, DOI 10.1016/j.jiac.2013.11.007
   Ling ML, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0066-3
   Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282
   Mataseje LF, 2016, ANTIMICROB AGENTS CH, V60, P6787, DOI 10.1128/AAC.01359-16
   Mitgang EA, 2018, INT J ANTIMICROB AG, V52, P372, DOI 10.1016/j.ijantimicag.2018.05.019
   Moemen D, 2017, EGYPT J BASIC APPL S, V4, P37
   Moghnieh RA, 2018, LANCET INFECT DIS, V18, pE379, DOI 10.1016/S1473-3099(18)30414-6
   MuralidharVarmaa L, 2018, J MED SPEC, V9, P178, DOI [10.1016/j.injms.2018.05.009, DOI 10.1016/J.INJMS.2018.05.009]
   Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11
   Seale Anna C, 2017, Wellcome Open Res, V2, P92, DOI 10.12688/wellcomeopenres.12527.1
   See I, 2013, INFECT CONT HOSP EP, V34, P1281, DOI 10.1086/673985
   Sopirala M, 2016, OPEN FORUM INFECT S1, V3, P334, DOI [10.1093/ofid/ofw172.199, DOI 10.1093/OFID/OFW172.199]
   Ssekatawa Kenneth, 2018, BMC Res Notes, V11, P629, DOI 10.1186/s13104-018-3738-2
   StataCorp, 2013, STATA STAT SOFTW REL
   Talaat M, 2016, AM J INFECT CONTROL, V44, P1296, DOI 10.1016/j.ajic.2016.04.212
   Thaden JT, 2014, INFECT CONT HOSP EP, V35, P978, DOI 10.1086/677157
   Vardakas KZ, 2015, J INFECTION, V70, P592, DOI 10.1016/j.jinf.2014.11.003
   Wang Q, 2016, EUR J CLIN MICROBIOL, V35, P1679, DOI 10.1007/s10096-016-2710-0
   Wang X, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00595
   Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174
   World Health Organization, GUID PREV CONTR CARB
   Xu YL, 2015, J THORAC DIS, V7, P376, DOI 10.3978/j.issn.2072-1439.2014.12.33
   Zhang YW, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01882-17
NR 37
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2047-2994
J9 ANTIMICROB RESIST IN
JI Antimicrob. Resist. Infect. Control
PD JAN 3
PY 2020
VL 9
IS 1
AR 2
DI 10.1186/s13756-019-0639-7
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Microbiology; Pharmacology & Pharmacy
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Microbiology; Pharmacology & Pharmacy
GA KL1FV
UT WOS:000513177800001
PM 31911830
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Sokolovska, N
   Permiakova, O
   Forslund, SK
   Zucker, JD
AF Sokolovska, Nataliya
   Permiakova, Olga
   Forslund, Sofia K.
   Zucker, Jean-Daniel
TI Using Unlabeled Data to Discover Bivariate Causality with Deep
   Restricted Boltzmann Machines
SO IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS
LA English
DT Article
DE Causal inference; semi-supervised learning; probabilistic models;
   metagenomic data
ID METFORMIN; INFERENCE; ALGORITHM
AB An important question in microbiology is whether treatment causes changes in gut flora, and whether it also affects metabolism. The reconstruction of causal relations purely from non-temporal observational data is challenging. We address the problem of causal inference in a bivariate case, where the joint distribution of two variables is observed. We consider, in particular, data on discrete domains. The state-of-the-art causal inference methods for continuous data suffer from high computational complexity. Some modern approaches are not suitable for categorical data, and others need to estimate and fix multiple hyper-parameters. In this contribution, we introduce a novel method of causal inference which is based on the widely used assumption that if X causes Y, then P(X) and P(Y vertical bar X) are independent. We propose to explore a semi-supervised approach where P(Y vertical bar X) and P(X) are estimated from labeled and unlabeled data respectively, whereas the marginal probability is estimated potentially from much more (cheap unlabeled) data than the conditional distribution. We validate the proposed method on the standard cause-effect pairs. We illustrate by experiments on several benchmarks of biological network reconstruction that the proposed approach is very competitive in terms of computational time and accuracy compared to the state-of-the-art methods. Finally, we apply the proposed method to an original medical task where we study whether drugs confound human metagenome.
C1 [Sokolovska, Nataliya] Sorbonne Univ, NutriOm Team, INSERM, F-75013 Paris, France.
   [Permiakova, Olga] Univ Grenoble Alpes, CEA, BIG, BGE,EDyP, F-38400 St Martin Dheres, France.
   [Forslund, Sofia K.] Charite Univ Med Berlin, Expt & Clin Res Ctr, D-13125 Berlin, Germany.
   [Forslund, Sofia K.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.
   [Forslund, Sofia K.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.
   [Zucker, Jean-Daniel] IRD, UMMISCO, F-93143 Bondy, France.
RP Sokolovska, N (reprint author), Sorbonne Univ, NutriOm Team, INSERM, F-75013 Paris, France.
EM nataliya.sokolovska@sorbonne-universite.fr; Olga.Permiakova@cea.fr;
   forslund@embl.de; Jean-Daniel.Zucker@ird.fr
RI ZUCKER, Jean-Daniel/K-3008-2016
OI ZUCKER, Jean-Daniel/0000-0002-5597-7922; Forslund, Sofia
   K/0000-0003-4285-6993
FU European Union's Seventh Framework ProgramEuropean Union (EU)
   [HEALTH-F4-2012-305312]
FX This work is supported by the European Union's Seventh Framework Program
   under grant agreement HEALTH-F4-2012-305312 (MetaCardis project).
CR Affeldt S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0856-x
   Ben-Nun T., 2018, DEMYSTIFYING PARALLE
   Budhathoki K, 2016, IEEE DATA MINING, P41, DOI [10.1109/ICDM.2016.146, 10.1109/ICDM.2016.0015]
   Buhlmann P, 2014, ANN STAT, V42, P2526, DOI 10.1214/14-AOS1260
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Goodfellow I, 2016, DEEP LEARNING
   Hauser A, 2012, J MACH LEARN RES, V13, P2409
   Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527
   Hoyer P. O., 2009, ADV NEURAL INFORM PR, V21, P689
   Janzing D, 2012, ARTIF INTELL, V182, P1, DOI 10.1016/j.artint.2012.01.002
   Janzing D, 2010, IEEE T INFORM THEORY, V56, P5168, DOI 10.1109/TIT.2010.2060095
   Lauritzen S., 2012, J ROY STAT SOC SERIE, V2, P157
   Liu FR, 2016, NEURAL COMPUT, V28, P801, DOI 10.1162/NECO_a_00820
   Louizos C., 2017, P INT C NEUR INF PRO, P6446
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7
   McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9
   Mooij JM, 2016, J MACH LEARN RES, V17
   Pearl Judea, 2009, CAUSALITY MODELS REA
   Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25
   Peters J, 2014, J MACH LEARN RES, V15, P2009
   Ramsey J., 2006, P 22 C UNC ART INT, P282
   Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809
   Salakhutdinov R, 2010, INT C ART INT STAT, P693
   Salakhutdinov R., 2008, P 25 INT C MACH LEAR, V25, P872, DOI DOI 10.1145/1390156.1390266
   Salakhutdinov R., 2009, ARTIF INTELL, P448, DOI DOI 10.1109/CVPRW.2009.5206577
   Scholkopf B., 2012, P 29 INT C MACH LEAR, P459
   Sgouritsa E., 2013, P 29 C UNC ART INT, P556
   Sgouritsa E., 2015, P UAI 2015 C ADV CAU, P89
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shimizu S, 2006, J MACH LEARN RES, V7, P2003
   Sokolovska N., 2008, P 25 INT C MACH LEAR, P984
   Spirtes P., 2000, CAUSATION PREDICTION
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Xu YH, 2018, THIRTY-SECOND AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTIETH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / EIGHTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P4335
   Zhang K., 2009, P 25 C UNC ART INT, P647
   Zscheischler J., 2009, P 27 C UNC ART INT, P839
NR 37
TC 0
Z9 0
U1 1
U2 4
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN 1545-5963
EI 1557-9964
J9 IEEE ACM T COMPUT BI
JI IEEE-ACM Trans. Comput. Biol. Bioinform.
PD JAN-FEB
PY 2020
VL 17
IS 1
BP 358
EP 364
DI 10.1109/TCBB.2018.2879504
PG 7
WC Biochemical Research Methods; Computer Science, Interdisciplinary
   Applications; Mathematics, Interdisciplinary Applications; Statistics &
   Probability
SC Biochemistry & Molecular Biology; Computer Science; Mathematics
GA LD8MD
UT WOS:000526280900035
PM 30403636
DA 2020-05-07
ER

PT J
AU Karimi, E
   Geslain, E
   KleinJan, H
   Tanguy, G
   Legeay, E
   Corre, E
   Dittami, SM
AF Karimi, Elham
   Geslain, Enora
   KleinJan, Hetty
   Tanguy, Gwenn
   Legeay, Erwan
   Corre, Erwan
   Dittami, Simon M.
TI Genome Sequences of 72 Bacterial Strains Isolated from Ectocarpus
   subulatus: A Resource for Algal Microbiology
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE brown algae; holobiont; alga-associated bacteria; biosynthetic gene
   clusters; detoxification; metabolic networks
ID BROWN; MICROORGANISMS; SILICULOSUS; EVOLUTION; CYANATE
AB Brown algae are important primary producers and ecosystem engineers in the ocean, and Ectocarpus has been established as a laboratory model for this lineage. Like most multicellular organisms, Ectocarpus is associated with a community of microorganisms, a partnership frequently referred to as holobiont due to the tight interconnections between the components. Although genomic resources for the algal host are well established, its associated microbiome is poorly characterized from a genomic point of view, limiting the possibilities of using these types of data to study host-microbe interactions. To address this gap in knowledge, we present the annotated draft genome sequences of seventy-two cultivable Ectocarpus-associated bacteria. A screening of gene clusters related to the production of secondary metabolites revealed terpene, bacteriocin, NRPS, PKS-t3, siderophore, PKS-t1, and homoserine lactone clusters to be abundant among the sequenced genomes. These compounds may be used by the bacteria to communicate with the host and other microbes. Moreover, detoxification and provision of vitamin B pathways have been observed in most sequenced genomes, highlighting potential contributions of the bacterial metabolism toward host fitness and survival. The genomes sequenced in this study form a valuable resource for comparative genomic analyses and evolutionary surveys of alga-associated bacteria. They help establish Ectocarpus as a model for brown algal holobionts and will enable the research community to produce testable hypotheses about the molecular interactions within this complex system.
C1 [Karimi, Elham; Geslain, Enora; KleinJan, Hetty; Dittami, Simon M.] Sorbonne Univ, CNRS, UMR 8227, Stn Biol Roscoff,Integrat Biol Marine Models, Roscoff, France.
   [Geslain, Enora; Tanguy, Gwenn; Legeay, Erwan; Corre, Erwan] Sorbonne Univ, CNRS, FR2424, Stn Biol Roscoff, Roscoff, France.
   [KleinJan, Hetty] CEBEDEAU, Res & Expertise Ctr Water, Liege, Belgium.
RP Karimi, E (reprint author), Sorbonne Univ, CNRS, UMR 8227, Stn Biol Roscoff,Integrat Biol Marine Models, Roscoff, France.
EM elham.karimi@sb-roscoff.fr
FU Investissement d'Avenir programFrench National Research Agency (ANR)
   [ANR-10-INBS09, ANR-11-INBS-0013]; CNRS Momentum call; ANR project
   IDEALGFrench National Research Agency (ANR) [ANR-10-BTBR-04]; European
   Union's Horizon 2020 research and innovation Programme under the Marie
   Sklodowska-Curie grantEuropean Union (EU) [624575]
FX We appreciate the LABGeM (CEA/Genoscope & CNRS UMR8030), the France
   Genomique and French Bioinformatics Institute national infrastructures
   (funded as part of Investissement d'Avenir program managed by Agence
   Nationale pour la Recherche, contracts ANR-10-INBS09 and
   ANR-11-INBS-0013) for their technical support within the MicroScope
   annotation platform and thank to Sylvie Rousvoal for help with DNA
   extractions.; This study was supported partially by the CNRS Momentum
   call, the ANR project IDEALG [ANR-10-BTBR-04] "Investissements d'Avenir,
   Biotechnologies-Bioressources," and the European Union's Horizon 2020
   research and innovation Programme under the Marie Sklodowska-Curie grant
   agreement [624575 (ALFF)]. The funders had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR Andrews S., 2010, BABRAHAM BIOINFORMAT
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Behringer G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00659
   Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319
   Brodie J, 2017, TRENDS PLANT SCI, V22, P726, DOI 10.1016/j.tplants.2017.05.005
   Burgunter-Delamare B, 2019, PREPRINT, DOI [10.1101/813683, DOI 10.1101/813683]
   Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935
   Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x
   Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016
   Cosse A, 2007, ADV BOT RES, P221, DOI DOI 10.1016/S0065-2296(07)46006-2
   Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056
   Dittami SM, 2016, ISME J, V10, P51, DOI 10.1038/ismej.2015.104
   Dittami SM, 2014, MOL ECOL, V23, P1656, DOI 10.1111/mec.12670
   Dittami SM, 2019, BIORXIV821579, DOI [10.1101/821579, DOI 10.1101/821579]
   Douglas AE, 2016, MBIO, V7, DOI [10.1128/mBio.02099-15, 10.1128/mBio.02099]
   Frioux C, 2018, BIOINFORMATICS, V34, P934, DOI 10.1093/bioinformatics/bty588
   Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5
   Kamennaya NA, 2008, LIMNOL OCEANOGR, V53, P2485, DOI 10.4319/lo.2008.53.6.2485
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   KIM SK, 2015, HDB MARINE MICROALGA, P1
   KleinJan H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02456
   Klemetsen T, 2018, NUCLEIC ACIDS RES, V46, pD692, DOI 10.1093/nar/gkx1036
   Koru E, 2013, SEAWEEDS FOOD IND AP, P735
   Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109
   Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519
   Nasrolahi A, 2012, FEMS MICROBIOL ECOL, V81, P583, DOI 10.1111/j.1574-6941.2012.01384.x
   Netzker T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00299
   Paix B, 2019, ENVIRON MICROBIOL, V21, P3346, DOI 10.1111/1462-2920.14617
   Palatinszky M, 2015, NATURE, V524, P105, DOI 10.1038/nature14856
   Saez LP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123008
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   PEDERSEN M, 1968, NATURE, V218, P776, DOI 10.1038/218776a0
   Peters AF, 2004, J PHYCOL, V40, P1079, DOI 10.1111/j.1529-8817.2004.04058.x
   Raja A., 2013, INT J CURR MICROBIOL, V2, P222
   REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1
   Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681
   Robertsen E., 2017, F1000RESEARCH, V6, DOI [10.12688/f1000research.10443.1, DOI 10.12688/F1000RESEARCH.10443.1]
   Susilowati R, 2015, PROCEDIA ENVIRON SCI, V23, P240, DOI 10.1016/j.proenv.2015.01.036
   Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107
   Tapia JE, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00107, 10.3389/fmicb.2016.00197]
   Vallenet D, 2017, NUCLEIC ACIDS RES, V45, pD517, DOI 10.1093/nar/gkw1101
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   West John A., 1996, Muelleria, V9, P29
   Wiese J, 2009, MAR BIOTECHNOL, V11, P287, DOI 10.1007/s10126-008-9143-4
   Yamada Y, 2015, P NATL ACAD SCI USA, V112, P857, DOI 10.1073/pnas.1422108112
   Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x
NR 46
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PD JAN
PY 2020
VL 12
IS 1
BP 3647
EP 3655
DI 10.1093/gbe/evz278
PG 9
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA KY8YA
UT WOS:000522860800009
PM 31841132
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Castor, K
   Mota, FB
   da Silva, RM
   Cabral, BP
   Maciel, EL
   de Almeida, IN
   Arakaki-Sanchez, D
   Andrade, KB
   Testov, V
   Vasilyeva, I
   Zhao, YL
   Zhang, H
   Singh, M
   Rao, R
   Tripathy, S
   Gray, G
   Padayatchi, N
   Bhagwandin, N
   Swaminathan, S
   Kasaeva, T
   Kritski, A
AF Castor, Kamaiaji
   Mota, Fabio Batista
   da Silva, Roseli Monteiro
   Cabral, Bernardo Pereira
   Maciel, Ethel Leonor
   de Almeida, Isabela Neves
   Arakaki-Sanchez, Denise
   Andrade, Kleydson Bonfim
   Testov, Vadim
   Vasilyeva, Irina
   Zhao, Yanlin
   Zhang, Hui
   Singh, Manjula
   Rao, Raghuram
   Tripathy, Srikanth
   Gray, Glenda
   Padayatchi, Nesri
   Bhagwandin, Niresh
   Swaminathan, Soumya
   Kasaeva, Tereza
   Kritski, Afranio
TI Mapping the tuberculosis scientific landscape among BRICS countries: a
   bibliometric and network analysis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE tuberculosis; scientific landscape; BRICS; bibliometrics; research
   network analysis
AB BACKGROUND The five BRICS (Brazil, Russian, Indian, China, and South Africa) countries bear 49% of the world's tuberculosis (TB) burden and they are committed to ending tuberculosis.
   OBJECTIVES The aim of this paper is to map the scientific landscape related to TB research in BRICS countries.
   METHODS Were combined bibliometrics and social network analysis techniques to map the scientific publications related to TB produced by the BRICS. Was made a descriptive statistical data covering the full period of analysis (1993-2016) and the research networks were made for 2007-2016 (8,366 records). The bubble charts were generated by VantagePoint and the networks by the Gephi 0.9.1 software (Gephi Consortium 2010) from co-occurrence matrices produced in VantagePoint. The FruchtermanReingold algorithm provided the networks' layout.
   FINDINGS During the period 1993-2016, there were 38,315 peer-reviewed, among them, there were 11,018 (28.7%) articles related by one or more authors in a BRICS: India 38.7%; China 23.8%; South Africa 21.1%; Brazil 13.0%; and Russia 4.5% (The total was greater than 100% because our criterion was all papers with at least one author in a BRICS). Among the BRICS, there was greater interaction between India and South Africa and organisations in India and China had the highest productivity; however, South African organisations had more interaction with countries outside the BRICS. Publications by and about BRICS generally covered all research areas, especially those in India and China covered all research areas, although Brazil and South Africa prioritised infectious diseases, microbiology, and the respiratory system.
   MAIN CONCLUSIONS An overview of BRICS scientific publications and interactions highlighted the necessity to develop a BRICS TB research plan to increase efforts and funding to ensure that basic science research successfully translates into products and policies to help end the TB epidemic.
C1 [Castor, Kamaiaji; Mota, Fabio Batista; da Silva, Roseli Monteiro; Cabral, Bernardo Pereira] Fundacao Oswaldo Cruz Fiocruz, Ctr Estudos Estrategicos, Rio De Janeiro, RJ, Brazil.
   [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [de Almeida, Isabela Neves] Univ Fed Minas Gerais, Fac Med, Lab Pesquisa Micobacterias, Belo Horizonte, MG, Brazil.
   [Arakaki-Sanchez, Denise; Andrade, Kleydson Bonfim] Minist Saude, Programa Nacl Controle TB, Brasilia, DF, Brazil.
   [Testov, Vadim; Vasilyeva, Irina] Natl Med Res Ctr Pthtisiopulmonol & Infect Dis, MoH, Moscow, Russia.
   [Zhao, Yanlin; Zhang, Hui] Natl Ctr TB Control & Prevent, China CDC, Beijing, Peoples R China.
   [Singh, Manjula] Indian Council Med Res, New Delhi, India.
   [Rao, Raghuram] Govt India, Minist Hlth & Family Welf, Cent TB Div, New Delhi, India.
   [Tripathy, Srikanth] Natl Inst Res TB, Chennai, Tamil Nadu, India.
   [Gray, Glenda; Padayatchi, Nesri; Bhagwandin, Niresh] Univ KwaZulu Natal, Doris Duke Med Res Inst, South African Med Res Council, HIV TB Pathogenesis & Treatment Res Unit, Congella, South Africa.
   [Swaminathan, Soumya; Kasaeva, Tereza] Cent TB Res Inst, Phthisiol, Moscow, Russia.
   [Kritski, Afranio] Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
   [Swaminathan, Soumya; Kasaeva, Tereza] World Hlth Org, Geneva, Switzerland.
RP de Almeida, IN (reprint author), Univ Fed Minas Gerais, Fac Med, Lab Pesquisa Micobacterias, Belo Horizonte, MG, Brazil.
EM isabelanalmeida@gmail.com
RI Kritski, Afranio/I-6760-2016
FU National Science and Technology Institute for Tuberculosis (CNPq/INCT)
   [465318/2014-2]
FX Dr IA received funds for this work as a post-doc scholarship from the
   National Science and Technology Institute for Tuberculosis (CNPq/INCT
   465318/2014-2).
CR Atkins S, 2016, GLOB HLTH ACTION, V9, P1
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gephi, 2010, OP GRAPH VIZ PLATF
   Golbeck J., 2013, ANAL SOCIAL WEB
   Golbeck J., 2013, ANAL SOCIAL WEB, V1
   Gonzalez-Albo B, 2011, J INFORMETR, V5, P369, DOI 10.1016/j.joi.2011.01.011
   Gorin S. V., 2016, EUROPEAN SCI EDITING, V42, P60
   Government of India, 2016, IND TAK LEAD TB RES, P10
   Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021
   Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679
   Kirton J, 2012, BRICS NEW DELHI SUMM
   Kochi A, 1996, Kekkaku, V71, P319
   Kritski A, 2016, REV SOC BRAS MED TRO, V49, P135, DOI 10.1590/0037-8682-0330-2015
   Lienhardt C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001135
   Mike Brennan, 2011, INT ROADMAP TUBERCUL, P1
   Nafade V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199706
   Pai M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002544
   Raviglione M, 2018, LANCET GLOB HEALTH, V6, pE20, DOI 10.1016/S2214-109X(17)30449-7
   Santoro FS, 2011, PROSPETTIVA, P3
   Sweileh WM, 2016, MULTIDISCIP RESP MED, V11, P1
   United Nations General Assembly, 2015, TRANSF OUR WORLD 203
   United Nations General Assembly, 2018, POL DECL HIGH LEV M
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Wasserman S, 1994, SOCIAL NETWORK ANAL, V1
   WHO-World Health Organization, GLOB INV TUB RES DEV
   World Health Organization, 2015, GLOB ACT FRAM TB RES
   Xiaodong W., 2017, TIANJ HOST 7 BRICS H
NR 29
TC 0
Z9 0
U1 1
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190342
DI 10.1590/0074-02760190342
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KX0LP
UT WOS:000521575300001
PM 32187325
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Vincent, F
   Bowler, C
AF Vincent, Flora
   Bowler, Chris
TI Diatoms Are Selective Segregators in Global Ocean Planktonic Communities
SO MSYSTEMS
LA English
DT Article
DE cooccurrence networks; environmental microbiology; marine microbiology;
   phytoplankton; protists
ID MICROBIAL INTERACTIONS; SKELETONEMA-COSTATUM; BIOLOGICAL NETWORKS;
   BIOTIC INTERACTIONS; DYNAMICS; PHYTOPLANKTON; DIVERSITY; ADAPTATIONS;
   INSIGHTS; PATTERNS
AB Diatoms are a major component of phytoplankton, believed to be responsible for around 20% of the annual primary production on Earth. As abundant and ubiquitous organisms, they are known to establish biotic interactions with many other members of plankton. Through analyses of cooccurrence networks derived from the Tara Oceans expedition that take into account both biotic and abiotic factors in shaping the spatial distributions of species, we show that only 13% of diatom pairwise associations are driven by environmental conditions; the vast majority are independent of abiotic factors. In contrast to most other plankton groups, on a global scale, diatoms display a much higher proportion of negative correlations with other organisms, particularly toward potential predators and parasites, suggesting that their biogeography is constrained by top-down pressure. Genus-level analyses indicate that abundant diatoms are not necessarily the most connected and that species-specific abundance distribution patterns lead to negative associations with other organisms. In order to move forward in the biological interpretation of cooccurrence networks, an open-access extensive literature survey of diatom biotic interactions was compiled, of which 18.5% were recovered in the computed network. This result reveals the extent of what likely remains to be discovered in the field of planktonic biotic interactions, even for one of the best-known organismal groups.
   IMPORTANCE Diatoms are key phytoplankton in the modern ocean that are involved in numerous biotic interactions, ranging from symbiosis to predation and viral infection, which have considerable effects on global biogeochemical cycles. However, despite recent large-scale studies of plankton, we are still lacking a comprehensive picture of the diversity of diatom biotic interactions in the marine microbial community. Through the ecological interpretation of both inferred microbial association networks and available knowledge on diatom interactions compiled in an open-access database, we propose an ecosystems approach for exploring diatom interactions in the ocean.
C1 [Vincent, Flora; Bowler, Chris] Univ PSL, Inst Biol ENS, Dept Biol, Ecole Normale Super,CNRS,INSERM, Paris, France.
   [Bowler, Chris] FR2022 Tara Oceans GOSEE, Res Federat Study Global Ocean Syst Ecol & Evolut, Paris, France.
   [Vincent, Flora] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel.
RP Bowler, C (reprint author), Univ PSL, Inst Biol ENS, Dept Biol, Ecole Normale Super,CNRS,INSERM, Paris, France.; Bowler, C (reprint author), FR2022 Tara Oceans GOSEE, Res Federat Study Global Ocean Syst Ecol & Evolut, Paris, France.
EM cbowler@biologie.ens.fr
FU French Government Investissements d'Avenir programs OceanomicsFrench
   National Research Agency (ANR) [ANR-11-BTBR-0008]; Memo Life
   [ANR-10-LABX-54]; Paris Sciences et Lettres Research University
   [ANR-11-IDEX-0001-02]; European Union Framework Programme 7
   (MicroB3)European Union (EU) [287589]; European Research Council
   advanced awards Diatomite and Diatomic under the European Union's
   Horizon 2020 Research and Innovation Programme [294823, 835067]; LouisD
   Foundation of the Institut de France; Radcliffe Institute for Advanced
   Study at Harvard University
FX C.B. acknowledges funding from the French Government Investissements
   d'Avenir programs Oceanomics (ANR-11-BTBR-0008), Memo Life
   (ANR-10-LABX-54), and Paris Sciences et Lettres Research University
   (ANR-11-IDEX-0001-02) as well as European Union Framework Programme 7
   (MicroB3/no. 287589), European Research Council advanced awards
   Diatomite and Diatomic under the European Union's Horizon 2020 Research
   and Innovation Programme (grant agreement no. 294823 and 835067), the
   LouisD Foundation of the Institut de France, and a fellowship from the
   Radcliffe Institute for Advanced Study at Harvard University. F.V.
   acknowledges the Fondation de la Mer.
CR ALBRIGHT LJ, 1993, AQUACULTURE, V117, P215, DOI 10.1016/0044-8486(93)90321-O
   Alexander H, 2015, P NATL ACAD SCI USA, V112, pE5972, DOI 10.1073/pnas.1518165112
   Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255
   Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325
   Bork P, 2015, SCIENCE, V348, P873, DOI 10.1126/science.aac5605
   Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86
   Carotenuto Y, 2014, HARMFUL ALGAE, V31, P153, DOI 10.1016/j.hal.2013.11.002
   Cazelles K, 2016, ECOGRAPHY, V39, P921, DOI 10.1111/ecog.01714
   Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109
   Darwin CH, 1859, ORIGIN SPECIES
   Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004
   Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113
   Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213
   Falkowski PG, 2002, SCI AM, V287, P54, DOI 10.1038/scientificamerican0802-54
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237
   Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x
   Foster RA, 2006, ENVIRON MICROBIOL, V8, P1913, DOI 10.1111/j.1462-2920.2006.01068.x
   Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26
   Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222
   Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058
   Gastineau R, 2014, MAR DRUGS, V12, P3161, DOI 10.3390/md12063161
   Gomez F, 2011, ENVIRON MICROBIOL, V13, P193, DOI 10.1111/j.1462-2920.2010.02320.x
   Gsell AS, 2013, ISME J, V7, P2057, DOI 10.1038/ismej.2013.73
   Guillard R. L., 1977, BIOL DIATOMS, P372
   Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1
   HARPER HE, 1975, GEOLOGY, V3, P175, DOI 10.1130/0091-7613(1975)3<175:SDACRE>2.0.CO;2
   Hendry KR, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00022
   Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x
   Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011
   Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177
   Kemp AES, 2018, PROG OCEANOGR, V167, P138, DOI 10.1016/j.pocean.2018.08.002
   Kraberg A., 2010, COASTAL PHYTOPLANKTO
   Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x
   Li CH, 2016, METHODS, V102, P12, DOI 10.1016/j.ymeth.2016.02.019
   Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073
   Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113
   MARGALEF R, 1978, OCEANOL ACTA, V1, P493
   MARGALEF R, 1979, OIKOS, V33, P152, DOI 10.2307/3543992
   Milici M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00649
   Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023
   Morales-Castilla I, 2015, TRENDS ECOL EVOL, V30, P347, DOI 10.1016/j.tree.2015.03.014
   Morueta-Holme N, 2016, ECOGRAPHY, V39, P1139, DOI 10.1111/ecog.01892
   Nakayama T, 2014, P NATL ACAD SCI USA, V111, P11407, DOI 10.1073/pnas.1405222111
   Nakov T, 2018, ISME J, V12, P2807, DOI 10.1038/s41396-018-0221-y
   Naviner M, 1999, AQUACULTURE, V174, P15, DOI 10.1016/S0044-8486(98)00513-4
   NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032
   Platt T, 2009, ECOL MODEL, V220, P3057, DOI 10.1016/j.ecolmodel.2008.11.022
   Poelen JH, 2014, ECOL INFORM, V24, P148, DOI 10.1016/j.ecoinf.2014.08.005
   Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348
   Poulson-Ellestad KL, 2014, P NATL ACAD SCI USA, V111, P9009, DOI 10.1073/pnas.1402130111
   Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004
   RUNGE JA, 1988, HYDROBIOLOGIA, V167, P61, DOI 10.1007/BF00026294
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161
   Smetacek V, 1998, NATURE, V391, P224, DOI 10.1038/34528
   Smetacek V, 2012, J BIOSCIENCES, V37, P589, DOI 10.1007/s12038-012-9240-4
   Tammilehto A, 2015, AQUAT TOXICOL, V159, P52, DOI 10.1016/j.aquatox.2014.11.026
   Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321
   Treguer P, 2018, NAT GEOSCI, V11, P27, DOI 10.1038/s41561-017-0028-x
   Turner JT, 2014, HARMFUL ALGAE, V32, P81, DOI 10.1016/j.hal.2013.12.001
   Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x
   Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060
   Vincent FJ, 2018, ISME J, V12, P1094, DOI 10.1038/s41396-017-0029-1
   Wang JT, 2013, J PLANKTON RES, V35, P367, DOI 10.1093/plankt/fbs098
   Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358
   Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533
   Zehr JP, 2017, SCIENCE, V357, P646, DOI 10.1126/science.aan5764
   Zhang SW, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00202
NR 76
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD JAN-FEB
PY 2020
VL 5
IS 1
AR e00444-19
DI 10.1128/mSystems.00444-19
PG 14
WC Microbiology
SC Microbiology
GA KT2OI
UT WOS:000518855000044
PM 31964765
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU James, JB
   Gunn, AL
   Akob, DM
AF James, Joseph B.
   Gunn, Amanda L.
   Akob, Denise M.
TI Binning Singletons: Mentoring through Networking at ASM Microbe 2019
SO MSPHERE
LA English
DT Editorial Material
DE Microbe; mentoring; networking
AB The American Society for Microbiology (ASM) national conference, Microbe, is the flagship meeting for microbiologists across the globe. The presence of roughly 10,000 attendees provides enormous opportunities for networking and learning. However, such a large meeting can be intimidating to many, especially early career scientists, students, those attending alone, and those from historically underrepresented groups. While mentorship is widely valued by ASM and its members, finding concrete ways to develop new and diverse mentoring opportunities can be a challenge. We recognized the need for an initiative aimed at expanding peer-to-peer mentoring, facilitating networking, and providing support for Microbe attendees; therefore, we created the program Binning Singletons for ASM Microbe 2019. The program consisted of five steps named after tools or phenomena in the profession of microbiology: (i) Identify the Singletons (e.g., individuals attending alone), (ii) Bin the Singletons, (iii) Horizontal Transfer, (iv) Quorum Sensing, and (v) Exponential Growth. These steps resulted in the matching of participants unsure of how to get the most out of their conference experience (e.g., singletons) with mentors who assisted with meeting planning, networking, and/or impostor syndrome. Started on social media only a month before ASM Microbe 2019, the program successfully launched despite limited time and resources. Binning Singletons improved inclusivity and networking opportunities for participants at the conference. Here, we discuss what worked, and what can be improved, with an eye toward development of the Binning Singletons model for future conferences to provide opportunities to increase inclusivity, networking, and accessibility for singletons and build a stronger scientific community.
C1 [James, Joseph B.] US EPA, Gulf Ecol Div, Gulf Breeze, FL 32561 USA.
   [Gunn, Amanda L.] Grays Harbor Coll, Aberdeen, WA USA.
   [Gunn, Amanda L.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Akob, Denise M.] US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA.
RP James, JB (reprint author), US EPA, Gulf Ecol Div, Gulf Breeze, FL 32561 USA.
EM james.joe@epa.gov
RI Akob, Denise/D-9478-2013
OI Akob, Denise/0000-0003-1534-3025
CR Annual Biomedical Research Conference for Minority Students, 2019, ANN BIOM RES C MIN S
   Blum L, 2019, CERF 2019 MENT PROGR
   Canuel E, 2015, CERF 2015 MENT PROGR
   CERF, 2013, CERF 2013 MENT PROGR
   Goldschmidt, 2015, MENT PROGR GOLDSCHMI
   Goldschmidt, 2017, MENT PROGR GOLDSCHMI
   Goldschmidt, 2018, MENT PROGR GOLDSCHMI
   Goldschmidt, 2019, MENT PROGR GOLDSCHMI
   Goldschmidt, 2016, MENT PROGR GOLDSCHMI
   Grayson T., 2017, 2017 CERF RIS TIDES
   Microbe Academy for Professional Development, 2019, MICR AC PROF DEV MAP
   SACNAS, 2019, AG 2019 SACNAS STEM
   Tremblay P., 2014, ELEMENTS, V10, P313
NR 13
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JAN-FEB
PY 2020
VL 5
IS 1
AR e00643-19
DI 10.1128/mSphere.00643-19
PG 8
WC Microbiology
SC Microbiology
GA KH7SM
UT WOS:000510849900007
PM 31915213
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Schweitzer, VA
   van Werkhoven, CH
   Bano, JR
   Bielicki, J
   Harbarth, S
   Hulscher, M
   Huttner, B
   Islam, J
   Little, P
   Pulcini, C
   Savoldi, A
   Tacconelli, E
   Timsit, JF
   van Smeden, M
   Wolkewitz, M
   Bonten, MJM
   Walker, AS
   Llewelyn, MJ
AF Schweitzer, V. A.
   van Werkhoven, C. H.
   Rodriguez Bano, J.
   Bielicki, J.
   Harbarth, S.
   Hulscher, M.
   Huttner, B.
   Islam, J.
   Little, P.
   Pulcini, C.
   Savoldi, A.
   Tacconelli, E.
   Timsit, J-F
   van Smeden, M.
   Wolkewitz, M.
   Bonten, M. J. M.
   Walker, A. S.
   Llewelyn, M. J.
CA Joint Programming Initiative Antim
TI Optimizing design of research to evaluate antibiotic stewardship
   interventions: consensus recommendations of a multinational working
   group
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Antimicrobial resistance; Antimicrobial stewardship; Appropriate
   antimicrobial use; Methodology; Quality; Research design
ID INTERRUPTED TIME-SERIES; ANTIMICROBIAL STEWARDSHIP; RANDOMIZED-TRIALS;
   RESISTANCE; IMPACT; QUALITY; NONINFERIORITY; IMPROVEMENT; CARE
AB Background: Antimicrobial stewardship interventions and programmes aim to ensure effective treatment while minimizing antimicrobial-associated harms including resistance. Practice in this vital area is undermined by the poor quality of research addressing both what specific antimicrobial use interventions are effective and how antimicrobial use improvement strategies can be implemented into practice. In 2016 we established a working party to identify the key design features that limit translation of existing research into practice and then to make recommendations for how future studies in this field should be optimally designed. The first part of this work has been published as a systematic review. Here we present the working group's final recommendations.
   Methods: An international working group for design of antimicrobial stewardship intervention evaluations was convened in response to the fourth call for leading expert network proposals by the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). The group comprised clinical and academic specialists in antimicrobial stewardship and clinical trial design from six European countries. Group members completed a structured questionnaire to establish the scope of work and key issues to develop ahead of a first face-to-face meeting that (a) identified the need for a comprehensive systematic review of study designs in the literature and (b) prioritized key areas where research design considerations restrict translation of findings into practice. The working group's initial outputs were reviewed by independent advisors and additional expertise was sought in specific clinical areas. At a second face-to-face meeting the working group developed a theoretical framework and specific recommendations to support optimal study design. These were finalized by the working group co-ordinators and agreed by all working group members.
   Results: We propose a theoretical framework in which consideration of the intervention rationale the intervention setting, intervention features and the intervention aims inform selection and prioritization of outcome measures, whether the research sets out to determine superiority or non-inferiority of the intervention measured by its primary outcome(s), the most appropriate study design (e.g. experimental or quasi- experimental) and the detailed design features. We make 18 specific recommendation in three domains: outcomes, objectives and study design.
   Conclusions: Researchers, funders and practitioners will be able to draw on our recommendations to most efficiently evaluate antimicrobial stewardship interventions. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Schweitzer, V. A.; van Werkhoven, C. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Rodriguez Bano, J.] Univ Seville, Hosp Univ Virgen Macarena, Dept Med, Unit Infect Dis Clin Microbiol & Prevent Med, Seville, Spain.
   [Rodriguez Bano, J.] Biomed Inst Sevilla IBiS, Seville, Spain.
   [Bielicki, J.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England.
   [Harbarth, S.; Huttner, B.] Hop Univ Geneve, Dept Infect Dis & Infect Control, Geneva, Switzerland.
   [Hulscher, M.] Radboud Univ Nijmegen, Sci Ctr Qual Healthcare, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands.
   [Islam, J.] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Falmer, England.
   [Little, P.; Llewelyn, M. J.] Univ Southampton, Dept Primary Care Res, Southampton, Hants, England.
   [Pulcini, C.] Univ Lorraine, CHRU Nancy, Infect Dis Dept, APEMAC, Nancy, France.
   [Savoldi, A.; Tacconelli, E.] Dept Diagnost & Publ Hlth, Infect Dis, Verona, Italy.
   [Savoldi, A.; Tacconelli, E.] Tuebingen Univ, Univ Hosp, Internal Med, Tubingen, Germany.
   [Timsit, J-F] Hop Xavier Bichat, AP HP, Med & Infect Dis ICU, Paris, France.
   [Timsit, J-F] Paris Diderot Univ, Infect Antimicrobials Modelling Evolut, UMR 1137, Paris, France.
   [van Smeden, M.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands.
   [Wolkewitz, M.] Univ Freiburg, Inst Med Biometry & Stat, Freiburg, Germany.
   [Bonten, M. J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.
   [Walker, A. S.] UCL, MRC Clin Trials Unit, London, England.
   [Walker, A. S.] Univ Oxford, Nuffield Dept Med, Oxford, England.
RP Llewelyn, MJ (reprint author), Univ Sussex, Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Falmer BN1 9PS, England.
EM m.j.llewelyn@bsms.ac.uk
RI Savoldi, Alessia/R-3981-2019; Huttner, Benedikt/M-5616-2014
OI Savoldi, Alessia/0000-0003-1873-5323; Huttner,
   Benedikt/0000-0002-1749-9464; van Smeden, Maarten/0000-0002-5529-1541
FU Joint Programming Initiative on Antimicrobial Resistance [JPIAMRWG-010];
   NIHR Oxford Biomedical Research CentreNational Institute for Health
   Research (NIHR); Health Protection Research Unit in Healthcare
   Associated Infections and Antimicrobial Resistance at the University of
   Oxford; Public Health England (PHE) [HPRU-2012-10041]
FX The authors declare no conflicts of interest. The presented work was
   supported by a grant (JPIAMRWG-010) from the Joint Programming
   Initiative on Antimicrobial Resistance. A.S.W. is supported by the NIHR
   Oxford Biomedical Research Centre and the Health Protection Research
   Unit in Healthcare Associated Infections and Antimicrobial Resistance at
   the University of Oxford in partnership with Public Health England (PHE)
   [HPRU-2012-10041], and is an NIHR Senior Investigator. The views
   expressed are those of the author(s) and not necessarily those of the
   NHS, the NIHR, the Department of Health or PHE.
CR [Anonymous], 2014, REV ANTIMICROBIAL RE
   Baur D, 2017, LANCET INFECT DIS, V17, P990, DOI 10.1016/S1473-3099(17)30325-0
   Bernal JL, 2018, J CLIN EPIDEMIOL, V103, P82, DOI 10.1016/j.jclinepi.2018.05.026
   Boel J, 2016, J ANTIMICROB CHEMOTH, V71, P2047, DOI 10.1093/jac/dkw055
   Burke JP, 1998, JAMA-J AM MED ASSOC, V280, P1270, DOI 10.1001/jama.280.14.1270
   Cochrane Effective Practice and Organisation of Care (EPOC), 2017, WHAT STUD DES CAN BE
   Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096
   Cranendonk DR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-235
   Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812
   Davey P, 2015, INT J ANTIMICROB AG, V45, P203, DOI 10.1016/j.ijantimicag.2014.11.014
   de Kraker MEA, 2017, CLIN MICROBIOL INFEC, V23, P819, DOI 10.1016/j.cmi.2017.05.019
   Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361
   Dyar OJ, 2017, CLIN MICROBIOL INFEC, V23, P793, DOI 10.1016/j.cmi.2017.08.026
   Evans SR, 2015, CLIN INFECT DIS, V61, P800, DOI 10.1093/cid/civ495
   Gillespie D, 2018, LANCET INFECT DIS, V18, P595, DOI 10.1016/S1473-3099(18)30289-5
   Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0
   Hemming K, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k1614
   Hemming K, 2016, J CLIN EPIDEMIOL, V69, P137, DOI 10.1016/j.jclinepi.2015.08.015
   Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]
   Hulscher MEJL, 2017, CLIN MICROBIOL INFEC, V23, P799, DOI 10.1016/j.cmi.2017.07.017
   Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40
   Kumar M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02023
   Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972
   Lawes T, 2017, LANCET INFECT DIS, V17, P194, DOI 10.1016/S1473-3099(16)30397-8
   Lennox L, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0707-4
   Littmann J, 2018, EUR J PUBLIC HEALTH, V28, P359, DOI 10.1093/eurpub/ckx165
   Mauri L, 2017, NEW ENGL J MED, V377, P1357, DOI 10.1056/NEJMra1510063
   McGowan J E Jr, 1996, New Horiz, V4, P370
   McGregor JC, 2014, CLIN INFECT DIS, V59, pS185, DOI 10.1093/cid/ciu540
   Medical Research Council, 2019, DEV EV COMPL INT
   Molina J, 2015, CLIN INFECT DIS, V61, P807, DOI 10.1093/cid/civ496
   Ogrinc Greg, 2016, BMJ Qual Saf, V25, P986, DOI 10.1136/bmjqs-2015-004411
   Peterson LR, 2005, CLIN MICROBIOL INFEC, V11, P4, DOI 10.1111/j.1469-0691.2005.01238.x
   Phillips PPJ, 2016, CLIN INFECT DIS, V62, P814, DOI 10.1093/cid/civ1002
   Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802
   Ramsay C, 2003, J ANTIMICROB CHEMOTH, V52, P764, DOI 10.1093/jac/dkg460
   Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7
   Schweitzer VA, 2019, CLIN MICROBIOL INFEC, V25, P555, DOI 10.1016/j.cmi.2018.11.002
   Schweitzer VA, 2017, CLIN MICROBIOL INFEC, V23, P980, DOI 10.1016/j.cmi.2017.05.003
   Tacconelli E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010134
   Taggart LR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1223-2
   Toma M, 2017, J ANTIMICROB CHEMOTH, V72, P3223, DOI 10.1093/jac/dkx312
   Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297
   Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x
NR 44
TC 1
Z9 1
U1 6
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JAN
PY 2020
VL 26
IS 1
BP 41
EP 50
DI 10.1016/j.cmi.2019.08.017
PG 10
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA JZ4DV
UT WOS:000505052600008
PM 31493472
OA Green Accepted, Other Gold
DA 2020-05-07
ER

PT J
AU Jettakul, A
   Wichadakul, D
   Vateekul, P
AF Jettakul, Amarin
   Wichadakul, Duangdao
   Vateekul, Peerapon
TI Relation extraction between bacteria and biotopes from biomedical texts
   with attention mechanisms and domain-specific contextual representations
SO BMC BIOINFORMATICS
LA English
DT Article
DE Biomedical text mining; Relation extraction; Deep learning; Attention
   networks; Contextual word-embeddings; Domain-specific language
ID DRUG INTERACTION EXTRACTION; NEURAL-NETWORKS
AB Background: The Bacteria Biotope (BB) task is a biomedical relation extraction (RE) that aims to study the interaction between bacteria and their locations. This task is considered to pertain to fundamental knowledge in applied microbiology. Some previous investigations conducted the study by applying feature-based models; others have presented deep-learning-based models such as convolutional and recurrent neural networks used with the shortest dependency paths (SDPs). Although SDPs contain valuable and concise information, some parts of crucial information that is required to define bacterial location relationships are often neglected. Moreover, the traditional word-embedding used in previous studies may suffer from word ambiguation across linguistic contexts.
   Results: Here, we present a deep learning model for biomedical RE. The model incorporates feature combinations of SDPs and full sentences with various attention mechanisms. We also used pre-trained contextual representations based on domain-specific vocabularies. To assess the model's robustness, we introduced a mean F1 score on many models using different random seeds. The experiments were conducted on the standard BB corpus in BioNLP-ST'16. Our experimental results revealed that the model performed better (in terms of both maximum and average F1 scores; 60.77% and 57.63%, respectively) compared with other existing models.
   Conclusions: We demonstrated that our proposed contributions to this task can be used to extract rich lexical, syntactic, and semantic features that effectively boost the model's performance. Moreover, we analyzed the trade-off between precision and recall to choose the proper cut-off to use in real-world applications.
C1 [Jettakul, Amarin; Wichadakul, Duangdao; Vateekul, Peerapon] Chulalongkorn Univ, Chulalongkorn Univ Big Data Analyt & IoT Ctr CUBI, Fac Engn, Dept Comp Engn, Bangkok, Thailand.
RP Vateekul, P (reprint author), Chulalongkorn Univ, Chulalongkorn Univ Big Data Analyt & IoT Ctr CUBI, Fac Engn, Dept Comp Engn, Bangkok, Thailand.
EM peerapon.v@chula.ac.th
CR Ambartsoumian A., 2018, P 9 WORKSH COMP APPR, P130, DOI [10.18653/v1/P17, DOI 10.18653/V1/P17, 10.18653/v1/W18-6219]
   Berant J, 2018, P 2018 C N AM CHAPT, V2, P554
   Bjorne J, 2013, P BIONLP SHAR TASK 2, P16
   Bjorne J, 2018, BIOMEDICAL EVENT EXT, P1, DOI [10.18653/v1/w18-2311, DOI 10.18653/V1/W18-2311]
   Bjorne J, 2013, 2 JOINT C LEX COMP S, P651
   Bossy R, 2011, BIONLP SHARED TASK 2, P56
   Bossy R, 2013, BIONLP SHARED TASK 2, P153
   Bridle J. S., 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28
   Charniak E, 2005, P 43 ANN M ASS COMP, P173, DOI DOI 10.3115/1219840.1219862
   Chowdhury FM, 2013, 7 INT WORKSH SEM EV
   Clark K., 2018, P 2018 C EMP METH NA, P1914
   Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020
   Colas C, 2018, HOW MANY RANDOM SEED, P1
   De Marneffe M-C, 2006, GENERATING TYPED DEP, P449
   Deleger L, 2016, OVERVIEW BACTERIA BI, V2016, P12
   Devlin J, 2018, BERT PRE TRAINING DE
   Graves A., 2014, ARXIV14105401, DOI DOI 10.3389/NEUR0.12.006.2007
   Huang CC, 2016, BRIEF BIOINFORM, V17, P132, DOI 10.1093/bib/bbv024
   Huang Z, 2015, BIDIRECTIONAL LSTM C, DOI [10.1061/(ASCE)CO.1943-7862.0000274, DOI 10.1061/(ASCE)CO.1943-7862.0000274]
   Jiang Z, 2015, P 2015 IEEE INT C BI, DOI [10.1109/BIBM.2015.7359756, DOI 10.1109/BIBM.2015.7359756]
   Kavuluru R, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P5, DOI 10.1109/ICHI.2017.15
   Kim Y, 2014, P 2014 C EMP METH NA, V2014, P1746, DOI DOI 10.3115/V1/D14-1181
   Kumar S., 2017, SURVEY DEEP LEARNING, DOI [10.1016/j.jpowsour.2006.03.077, DOI 10.1016/J.JPOWSOUR.2006.03.077]
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Lever J, 2016, VERSE EVENT RELATION, P42
   Li H, 2016, UTILIZING CONVOLUTIO, P93
   Li L, 2018, END TO END ENTITY RE, P136
   Li LS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2275-2
   Li LS, 2016, IEEE INT C BIOINFORM, P739, DOI 10.1109/BIBM.2016.7822612
   Lim S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190926
   Liu SY, 2016, COMPUT MATH METHOD M, DOI 10.1155/2016/6918381
   Liu Y, 2015, DEPENDENCY BASED NEU, DOI [10.3115/v1/P15-45, DOI 10.3115/V1/P15-45]
   Long Y, 2017, P 2017 C EMP METH NA, DOI [10.18653/v1/D17-1048, DOI 10.18653/V1/D17-1048]
   Luong M-T, 2015, EFFECTIVE APPROACHES, DOI [10.18653/v1/D15-1166, DOI 10.18653/V1/D15-1166]
   Ma X, 2016, END TO END SEQUENCE, DOI [10.18653/v1/P16-1101, DOI 10.18653/V1/P16-1101]
   Mehryary F, 2016, DEEP LEARNING MINIMA
   Mikolov T., 2013, ADV NEURAL INFORM PR, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951
   Miwa M, 2016, END TO END RELATION, DOI [10.18653/v1/P16-354, DOI 10.18653/V1/P16-354]
   Paszke A., 2017, NIPS W
   Pennington J, 2014, GLOVE GLOBAL VECTORS, P1532, DOI [10.3115/v1/D14-1162, DOI 10.3115/V1/D14-1162]
   Peters M., 2018, P 2018 C EMP METH NA, P1499
   Peters ME, 2018, DEEP CONTEXTUALIZED, DOI [10.18653/v1/N18-1202, DOI 10.18653/V1/N18-1202]
   Pyysalo S, 2013, LANG BIOL MED, DOI [10.1074/jbc.M700492200, DOI 10.1074/JBC.M700492200]
   Quan CQ, 2016, BIOMED RES INT, DOI 10.1155/2016/1850404
   Radford A., 2018, IMPROVING LANGUAGE U
   Raihani A, 2016, J THEOR APPL INFORM
   Ruder S., 2019, THESIS
   Sahu SK, 2018, J BIOMED INFORM, V86, P15, DOI 10.1016/j.jbi.2018.08.005
   Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093
   Segura-Bedmar I, 2013, 2 JOINT C LEX COMP S, V2
   Singhal A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005017
   Singhal A, 2016, J AM MED INFORM ASSN, V23, P766, DOI 10.1093/jamia/ocw041
   Stevenson M, 2010, J BIOMED INFORM, V43, P972, DOI 10.1016/j.jbi.2010.08.009
   Tsafnat G, 2013, ENCY SYST BIOL, P2275
   Vaswani A., 2017, ADV NEURAL INFORM PR, P5998, DOI DOI 10.1017/S0140525X16001837
   Vu NT, 2016, COMBINING RECURRENT, DOI [10.18653/v1/N16-1065, DOI 10.18653/V1/N16-1065]
   Wang YS, 2018, J BIOMED INFORM, V87, P12, DOI 10.1016/j.jbi.2018.09.008
   Yan X, 2015, CLASSIFYING RELATION
   Yin W, 2017, CORR
   Zamani H, 2017, RELEVANCE BASED WORD
   Zeng D, 2014, P 25 INT C COMP LING
   Zhang S, 2015, BIDIRECTIONAL LONG S, P73, DOI 10.18653/v1/P16-2034
   Zhang Y, 2016, P INT JOINT C NEUR N, DOI [10.1109/IJCNN.2016.7727384, DOI 10.1109/IJCNN.2016.7727384]
   Zhang YJ, 2018, J BIOMED INFORM, V81, P83, DOI 10.1016/j.jbi.2018.03.011
   Zhang YJ, 2018, BIOINFORMATICS, V34, P828, DOI 10.1093/bioinformatics/btx659
   Zhao ZH, 2016, INT J DATA MIN BIOIN, V15, P145, DOI 10.1504/IJDMB.2016.076534
   Zhao ZW, 2016, INTERSPEECH, P705, DOI 10.21437/Interspeech.2016-354
   Zheng SC, 2017, NEUROCOMPUTING, V257, P59, DOI 10.1016/j.neucom.2016.12.075
   Zheng W, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1855-x
   Zhou P, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P207, DOI 10.18653/v1/p16-2034
   Zhu C, 2018, CORR
NR 71
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD DEC 3
PY 2019
VL 20
IS 1
AR 627
DI 10.1186/s12859-019-3217-3
PG 17
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA KI8KY
UT WOS:000511608000004
PM 31795930
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Sovljanski, O
   Tomic, A
   Pezo, L
   Markov, S
AF Sovljanski, Olja
   Tomic, Ana
   Pezo, Lato
   Markov, Sinisa
TI Temperature and pH growth profile prediction of newly isolated bacterial
   strains from alkaline soils
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE bacterial isolation; alkaliphilic sporogenic bacteria; alkaline soils;
   mathematical modelling
ID NEURAL-NETWORKS; CAROTENOIDS; UREASE; ANN
AB BACKGROUND Soil microorganisms can form complex and varied communities which interact with each other in many different ways depending on environmental conditions. These microbial diversities are accompanied by different metabolic paths and adaptability reflected even in extreme environments. In recent decades, the biodiversity of microbes in extreme environments has been in scientific focus because such specifically adapted bacteria can improve bioremediation processes in industrial and agricultural applications. Instead of the time-consuming process of identification of new bacterial strains from habitats rich in microbiota, artificial neural networks have been proposed as a mapping model for resolving the problem of prediction of microbial behaviour. RESULTS The occurrence and diversity of alkaliphilic sporogenic bacteria in alkaline soils were investigated. For this purpose, soil samples were collected from various locations: leached soil from the Danube river, cement factory wastewater accumulation, deposit of limestone near the Besenovo lake and the Beli Majdan cave in the Fruska gora mountain. According to the obtained results, two empirical models were developed that gave a good fit to experimental data and were able to predict successfully the pH and temperature growth profiles of the natural isolates. The artificial neural network models showed a reasonably good predictive capability (overall R-2 for temperature growth profile was 0.727, while the overall R-2 for pH growth profile was 0.906). CONCLUSIONS The developed mathematical models provided adequate precision for practical study in the microbiology laboratory and scale-up processes for a wide range of laboratory and industrial applications, where specifically adapted microbial communities are needed. (c) 2019 Society of Chemical Industry
C1 [Sovljanski, Olja; Tomic, Ana; Markov, Sinisa] Univ Novi Sad, Fac Technol Novi Sad, Novi Sad, Serbia.
   [Pezo, Lato] Univ Belgrade, Inst Gen & Phys Chem, Belgrade, Serbia.
RP Tomic, A (reprint author), Univ Novi Sad, Fac Technol, Bul Cara Lazara 1, Novi Sad 21000, Serbia.
EM anav@uns.ac.rs
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [III45008]
FX The financial support of the Ministry of Education, Science and
   Technological Development of the Republic of Serbia (contract no.
   III45008) is gratefully acknowledged.
CR Abatenh E, 2017, J ENV MICROBIOL, V1, P2, DOI DOI 10.17352/OJEB.000007
   Abrougui K, 2019, SOIL TILL RES, V190, P202, DOI 10.1016/j.still.2019.01.011
   Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Bhaduri S, 2016, JOVE-J VIS EXP, V110, P1
   BUCK JD, 1982, APPL ENVIRON MICROB, V44, P992, DOI 10.1128/AEM.44.4.992-993.1982
   Chattopadhyay PB, 2014, AGR WATER MANAGE, V133, P81, DOI 10.1016/j.agwat.2013.11.007
   Chinnathambi A., 2015, BIOSCI BIOTECHNOL RE, V12, P2007
   Coico R., 2005, CURR PROTOC MICROBIO, pA3C1, DOI [10.1002/9780471729259.mca03cs00, DOI 10.1002/9780471729259.MCA03CS00]
   Dhami NK, 2014, APPL BIOCHEM BIOTECH, V172, P2552, DOI 10.1007/s12010-013-0694-0
   Godinho A, 2008, INDIAN J MAR SCI, V37, P307
   Gok S, 2015, FOOD CHEM, V170, P234, DOI 10.1016/j.foodchem.2014.08.040
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Horikoshi K, 1998, EXTREMOPHILES MICROB
   Ivanov V, 2015, ENV MICROBIOLOGY ENG, P119
   Jonkers HM, 2010, ECOL ENG, V36, P230, DOI 10.1016/j.ecoleng.2008.12.036
   Kim G, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8081277
   Kollo T, 2005, ADV MULTIVARIATE STA
   Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x
   Li M, 2013, INT BIODETER BIODEGR, V76, P81, DOI 10.1016/j.ibiod.2012.06.016
   LIU D, 2018, FRONT PSYCHOL, V9, P1, DOI DOI 10.3389/FMICB.2018.02456
   Lopez-Bucio J, 2000, DEV PL GEN, V5, P159
   Maier RM, 2009, ENVIRON MICROBIOL, P38
   Merma AG, 2019, J MATER RES TECHNOL, V8, P3076, DOI 10.1016/j.jmrt.2019.02.022
   Nautiyal CS, 2000, FEMS MICROBIOL LETT, V182, P291, DOI 10.1111/j.1574-6968.2000.tb08910.x
   Pezo LL, 2013, HEM IND, V67, P465, DOI 10.2298/HEMIND120529082P
   Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002
   Prevolnik M, 2014, MEAT SCI, V96, P14, DOI 10.1016/j.meatsci.2013.06.013
   Sahin N, 2006, FOLIA MICROBIOL, V51, P87, DOI 10.1007/BF02932161
   Sarethy IP, 2011, J IND MICROBIOL BIOT, V38, P769, DOI 10.1007/s10295-011-0968-x
   Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194
   SPANKA R, 1993, INT J SYST BACTERIOL, V43, P150, DOI 10.1099/00207713-43-1-150
   Stevens KA, 2004, CRIT REV MICROBIOL, V30, P7, DOI 10.1080/10408410490266410
   Takaichi S, 2001, PHOTOSYNTH RES, V67, P207, DOI 10.1023/A:1010666406176
   Turnbull GA, 2001, FEMS MICROBIOL ECOL, V36, P21, DOI 10.1111/j.1574-6941.2001.tb00822.x
   Ulukanli Z., 2002, TURK J BIOL, V26, P181
   Whiffin VS, 2007, GEOMICROBIOL J, V24, P417, DOI 10.1080/01490450701436505
NR 37
TC 0
Z9 0
U1 17
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD FEB
PY 2020
VL 100
IS 3
BP 1155
EP 1163
DI 10.1002/jsfa.10124
EA DEC 2019
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA KA6EP
UT WOS:000500026800001
PM 31680254
DA 2020-05-07
ER

PT J
AU Tremblay, J
   Yergeau, E
AF Tremblay, Julien
   Yergeau, Etienne
TI Systematic processing of ribosomal RNA gene amplicon sequencing data
SO GIGASCIENCE
LA English
DT Article
DE rRNA gene amplicons; bioinformatics; metagenomics; High Performance
   Computing
ID GENOMICS
AB Background: With the advent of high-throughput sequencing, microbiology is becoming increasingly data-intensive. Because of its low cost, robust databases, and established bioinformatic workflows, sequencing of 16S/18S/ITS ribosomal RNA (rRNA) gene amplicons, which provides a marker of choice for phylogenetic studies, has become ubiquitous. Many established end-to-end bioinformatic pipelines are available to perform short amplicon sequence data analysis. These pipelines suit a general audience, but few options exist for more specialized users who are experienced in code scripting, Linux-based systems, and high-performance computing (HPC) environments. For such an audience, existing pipelines can be limiting to fully leverage modern HPC capabilities and perform tweaking and optimization operations. Moreover, a wealth of stand-alone software packages that perform specific targeted bioinformatic tasks are increasingly accessible, and finding a way to easily integrate these applications in a pipeline is critical to the evolution of bioinformatic methodologies. Results: Here we describe AmpliconTagger, a short rRNA marker gene amplicon pipeline coded in a Python framework that enables fine tuning and integration of virtually any potential rRNA gene amplicon bioinformatic procedure. It is designed to work within an HPC environment, supporting a complex network of job dependencies with a smart-restart mechanism in case of job failure or parameter modifications. As proof of concept, we present end results obtained with AmpliconTagger using 16S, 18S, ITS rRNA short gene amplicons and Pacific Biosciences long-read amplicon data types as input. Conclusions: Using a selection of published algorithms for generating operational taxonomic units and amplicon sequence variants and for computing downstream taxonomic summaries and diversity metrics, we demonstrate the performance and versatility of our pipeline for systematic analyses of amplicon sequence data.
C1 [Tremblay, Julien] Natl Res Council Canada, Energy Min & Environm, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.
   [Yergeau, Etienne] Inst Natl Rech Sci, Ctr INRS, Inst Armand Frappier, 531Ad Boul Prairies, Laval, PQ H7V 1B7, Canada.
RP Tremblay, J (reprint author), Natl Res Council Canada, Energy Min & Environm, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.
EM julien.tremblay@nrc-cnrc.gc.ca
OI Yergeau, Etienne/0000-0002-7112-3425; Tremblay,
   Julien/0000-0002-6085-3481
CR Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343
   Alkema W, 2016, BRIEF BIOINFORM, V17, P283, DOI 10.1093/bib/bbv034
   Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16
   Bokulich NA, 2013, J CLIN MICROBIOL, V51, P2617, DOI 10.1128/JCM.00898-13
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Bourgey M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz037
   Callahan BJ, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz569
   Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Daber R, 2013, CANCER GENET-NY, V206, P441, DOI 10.1016/j.cancergen.2013.11.005
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Deurenberg RH, 2017, J BIOTECHNOL, V243, P16, DOI 10.1016/j.jbiotec.2016.12.022
   Earl JP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0569-2
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Filippidou S, 2015, COMPUT STRUCT BIOTEC, V13, P299, DOI 10.1016/j.csbj.2015.04.002
   Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271
   Glassman SI, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00148-18
   He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x
   Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650
   Kuczynski Justin, 2011, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1007s36
   Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529
   Leipzig J, 2017, BRIEF BIOINFORM, V18, P530, DOI 10.1093/bib/bbw020
   Li PE, 2017, NUCLEIC ACIDS RES, V45, P67, DOI 10.1093/nar/gkw1027
   Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243
   Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237
   MacPherson CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29229-5
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Manaka A, 2017, J PHARM HEALTH CARE, V3, DOI 10.1186/s40780-017-0074-y
   Martineau C, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00235-18, 10.1128/jcm.00235-18]
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Nearing JT, 2018, PEERJ, V6, DOI 10.7717/peerj.5364
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Riley Margaret A., 2009, V532, P367, DOI 10.1007/978-1-60327-853-9_21
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Searle D, 2016, DATA BRIEF, V6, P526, DOI 10.1016/j.dib.2015.12.042
   Segata N, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00190-17
   Shringarpure SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129277
   Singer E, 2016, ISME J, V10, P2020, DOI 10.1038/ismej.2015.249
   Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621
   Tremblay J, 2019, GIGASCIENCE DATABASE, DOI [10.5524/100658, DOI 10.5524/100658]
   Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wang Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02244
   Watson-Haigh NS, 2013, BRIEF BIOINFORM, V14, P563, DOI 10.1093/bib/bbt022
   Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y
   Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19
   Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487
   Yergeau E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42242
   Yergeau E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01436
NR 58
TC 2
Z9 2
U1 3
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2047-217X
J9 GIGASCIENCE
JI GigaScience
PD DEC
PY 2019
VL 8
IS 12
AR giz146
DI 10.1093/gigascience/giz146
PG 14
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA KB9KC
UT WOS:000506804600011
PM 31816087
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Pickering, BS
   Spengler, JR
   Shadabi, E
   Dalziel, AE
   Lautner, EA
   Silva, P
AF Pickering, Brad S.
   Spengler, Jessica R.
   Shadabi, Elnaz
   Dalziel, Antonia E.
   Lautner, Elizabeth A.
   Silva, Primal
TI The Biosafety Level 4 Zoonotic Laboratory Network (BSL4ZNet): Report of
   a workshop on live animal handling
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID MOUTH-DISEASE VIRUS; INFECTION DYNAMICS; INOCULATION;
   INTRANASOPHARYNGEAL; CONTACT
AB The Biosafety Level 4 Zoonotic Laboratory Network (BSL4ZNet) was established in 2016, to provide a means of communication and support for the global high-containment laboratory community. Its working groups focus on international response, institutional cooperation and knowledge sharing, scientific excellence and training. In the latter role, BSL4ZNet sponsored its first international workshop in February 2018, held at the USDA National Centers for Animal Health, Ames, Iowa, USA, focused on necropsy procedures in high-containment laboratories. A second workshop, in November 2018, was held at the National Microbiology Laboratories (CFIA/PHAC) in Winnipeg, Canada, and focused on decontamination. A third workshop, held at the Australian Animal Health Laboratory in Geelong, Australia, in February 2019, was devoted to handling methods and ethical concerns for live animals in high-containment laboratories. The third workshop brought together 12 laboratorians from seven partner organizations in Australia, Canada, Germany, the United Kingdom and the United States. It included both discussion-based and hands-on training sessions on animal welfare, animal models, site-specific infrastructure constraints, health monitoring and humane endpoints, sampling procedures, and carcass disposal. This report summarizes the inception, development, and structure of the BSL4ZNet, and highlights the aims and results of the Geelong workshop.
C1 [Pickering, Brad S.] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.
   [Pickering, Brad S.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.
   [Pickering, Brad S.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Coll Vet Med, Ames, IA USA.
   [Spengler, Jessica R.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
   [Shadabi, Elnaz; Silva, Primal] Canadian Food Inspect Agcy, Ottawa, ON, Canada.
   [Dalziel, Antonia E.] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Clayton, Vic, Australia.
   [Lautner, Elizabeth A.] US Anim & Plant Hlth Inspect Serv, USDA, Ames, IA USA.
RP Pickering, BS (reprint author), 1015 Arlington St, Winnipeg, MB R3E 3M4, Canada.
EM bradley.pickering@canada.ca
FU Canadian Safety and Security Program (CSSP) [CSSP-2018-CP-2341]; CSSP;
   USDAUnited States Department of Agriculture (USDA); CSIRO-AAHL
FX BSL4ZNet is funded by the Canadian Safety and Security Program (CSSP;
   CSSP-2018-CP-2341) led by the Canadian Defense Research and Development,
   Canada's Centre for Security Science (DRDC CSS). BSL4ZNet training
   workshops have been funded partly by CSSP, with additional support from
   host organizations, including USDA and CSIRO-AAHL.
CR Cemma M., 2017, ASM BIOTHR C
   Howey EB, 2013, VIRUS RES, V178, P328, DOI 10.1016/j.virusres.2013.09.024
   Kasloff S.B., 2018, APPL BIOSAF, V23, P223
   Kroeker AL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120709
   Michelotti J.M., 2018, TROP MED INFECT DIS, V3, P55
   Pacheco JM, 2016, J COMP PATHOL, V155, P314, DOI 10.1016/j.jcpa.2016.08.005
   Pickering B.S, 2018, CAN BIOS S CABS ACSB
   Stenfeldt C, 2014, RES VET SCI, V96, P396, DOI 10.1016/j.rvsc.2014.01.009
   Velazquez-Salinas L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01891
NR 9
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR UNSP 104640
DI 10.1016/j.antiviral.2019.104640
PG 6
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700014
PM 31669332
DA 2020-05-07
ER

PT J
AU Downs, DM
AF Downs, Diana M.
TI Balancing cost and benefit: How E. coli cleverly averts disulfide stress
   caused by cystine
SO MOLECULAR MICROBIOLOGY
LA English
DT Editorial Material
ID ESCHERICHIA-COLI; CYSTEINE; INHIBITION
AB Building a robust, stable network must include strategies to minimize perturbations caused by environmental stress, while optimizing cellular fitness. The introduction of oxygen into the Earth's atmosphere brought challenges for the microbes that had evolved enzyme machinery and metabolic network stability in the anoxic world. Unable to generate new enzyme paradigms and metabolic networks de novo, organisms have evolved strategies to neutralize the impact of oxygen that can be added to and integrated into the existing metabolic framework. This issue of Molecular Microbiology includes a paper by Korshunov et al. in which the authors describe an elegant strategy that Escherichia coli has evolved to minimize metabolic stress that results from the acquisition and use of cystine, the oxidized form of cysteine, as a source of cellular sulfur. This study highlights how a strategy involving both cost and benefit can result in a functional, but energy intensive mechanism for this bacterium to thrive in an oxic world.
C1 [Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30606 USA.
RP Downs, DM (reprint author), Univ Georgia, Dept Microbiol, Athens, GA 30606 USA.
EM dmdowns@uga.edu
FU National Science FoundationNational Science Foundation (NSF)
   [MCB1615373]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [GM095837]
FX National Science Foundation, Grant/Award Number: MCB1615373; National
   Institutes of Health, Grant/Award Number: GM095837
CR Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019
   Alvarez-Vasquez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028344
   Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100
   Benov L, 1996, J BIOL CHEM, V271, P21037, DOI 10.1074/jbc.271.35.21037
   de Lorenzo V, 2015, FEMS MICROBIOL REV, V39, P96, DOI 10.1111/1574-6976.12089
   Downs DM, 2018, AIMS MICROBIOL, V4, P289, DOI 10.3934/microbiol.2018.2.289
   Du B, 2018, TRENDS BIOCHEM SCI, V43, P960, DOI 10.1016/j.tibs.2018.09.009
   Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14
   Forte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23788
   HARRIS CL, 1981, J BACTERIOL, V145, P1031, DOI 10.1128/JB.145.2.1031-1035.1981
   Hori H, 2011, APPL ENVIRON MICROB, V77, P4027, DOI 10.1128/AEM.00003-11
   Imlay KRC, 2015, J BACTERIOL, V197, P3629, DOI 10.1128/JB.00277-15
   Kawano Y, 2018, APPL MICROBIOL BIOT, V102, P8203, DOI 10.1007/s00253-018-9246-4
   Keller MA, 2015, CURR OPIN BIOTECH, V34, P153, DOI 10.1016/j.copbio.2014.12.020
   Korshunov S., 2019, MOL MICROBIOLOGY
   Korshunov S, 2016, MOL MICROBIOL, V101, P62, DOI 10.1111/mmi.13372
   NEWMAN EB, 1995, ANNU REV MICROBIOL, V49, P747, DOI 10.1146/annurev.mi.49.100195.003531
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003
   Torres NV, 2002, PATHWAY ANAL OPTIMIZ
NR 20
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JAN
PY 2020
VL 113
IS 1
BP 1
EP 3
DI 10.1111/mmi.14422
EA NOV 2019
PG 3
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA KJ2SN
UT WOS:000499136500001
PM 31710395
OA Bronze
DA 2020-05-07
ER

PT J
AU Pei, LY
   Ke, YS
   Zhao, HH
   Liu, WZ
   Wang, L
   Jia, C
   Shi, MN
   Fu, QH
   Cui, J
   Li, SC
AF Pei, Ling-yan
   Ke, Yu-shi
   Zhao, Huan-hu
   Liu, Wei-zhi
   Wang, Lin
   Jia, Chao
   Shi, Meng-ni
   Fu, Qian-hui
   Cui, Jian
   Li, Shu-chun
TI Regulatory effect of Garidisan on dysbiosis of the gut microbiota in the
   mouse model of ulcerative colitis induced by dextran sulfate sodium
SO BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
DE Ulcerative colitis; Gut microbiota; Microbiology
ID INFLAMMATORY-BOWEL-DISEASE; FECAL MICROBIOTA; MUCOSAL FLORA; BACTERIA;
   LACHNOSPIRACEAE; BUTYRATE; DIVERSITY; ARTICLE
AB Background Ulcerative colitis (UC) is a modern refractory disease, and its etiology has been difficult to discern. Studies have shown that UC is closely associated with the gut microbiota. Garidisan is composed of wild poppy and Artemisia frigida Willd and is commonly used for the treatment of UC in Inner Mongolia, China. In clinical settings, Garidisan has been found to treat UC effectively, with low recurrence. Previous studies have shown that Garidisan has a good therapeutic effect on mice with UC, but the therapeutic mechanism is still unclear. In this study, we investigated the regulatory effect of Garidisan on dysbiosis of the gut microbiota in a UC mouse model and explored the possible mechanism of the therapeutic effect of Garidisan on UC. Methods The UC mouse model was established by the dextran sulfate sodium (DSS) circulating free water drinking method, and the luminal contents were sampled under sterile conditions. High-throughput sequencing of the 16S rRNA gene V3 + V4 region of the luminal contents of the control group, model group, and Garidisan group was conducted, and clustering of operational taxonomic units (OTUs) and species annotation were performed. The differences in species composition and microbial community structure between individual groups of samples were analyzed using MetaStat, LefSe, rank sum test, and Bayesian causal network analysis. Results The UC mouse model was successfully established and the sequencing results were of adequate quality. There were significant differences in the diversity of luminal contents between the control group, model group, and Garidisan group, and the differences between groups were greater than those within any group. The therapeutic effect of Garidisan on UC is attributed to the direct effect on the Lachnospiraceae family of bacteria. Conclusion Garidisan has a good regulatory effect on the gut microbiota, and Lachnospiraceae could be an important direct target of Garidisan for the treatment of UC.
C1 [Pei, Ling-yan; Zhao, Huan-hu; Liu, Wei-zhi; Jia, Chao; Shi, Meng-ni; Fu, Qian-hui; Cui, Jian; Li, Shu-chun] Minzu Univ China, Sch Pharm, 27 South St, Beijing 100081, Peoples R China.
   [Pei, Ling-yan; Zhao, Huan-hu; Liu, Wei-zhi; Jia, Chao; Shi, Meng-ni; Fu, Qian-hui; Cui, Jian; Li, Shu-chun] Minzu Univ China, Minist Educ, Key Lab Ethnomed, Beijing 100081, Peoples R China.
   [Ke, Yu-shi] China Food & Drug Adm, Ctr Drug Evaluat, Beijing 100081, Peoples R China.
   [Wang, Lin] Xinxiang Med Univ, Dept Histol & Embryol, Xinxiang 453003, Henan, Peoples R China.
   [Jia, Chao] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Pathol, Beijing 100045, Peoples R China.
RP Li, SC (reprint author), Minzu Univ China, Sch Pharm, 27 South St, Beijing 100081, Peoples R China.; Li, SC (reprint author), Minzu Univ China, Minist Educ, Key Lab Ethnomed, Beijing 100081, Peoples R China.
EM jason@muc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81473796, 81774449]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grant numbers 81473796, 81774449).
CR Borody TJ, 2011, EXPERT REV GASTROENT, V5, P653, DOI [10.1586/egh.11.71, 10.1586/EGH.11.71]
   Bueno-Hernandez N, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0014-3
   Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104
   Cui J., 2012, TIANJIN J TRADITIONA, V29, P17
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   De Cruz P, 2012, INFLAMM BOWEL DIS, V18, P372, DOI 10.1002/ibd.21751
   Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237
   Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x
   Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447
   Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054
   Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879
   Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009
   Krogius-Kurikka L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-95
   Li GP, 2015, J MICROBIOL BIOTECHN, V25, P1136, DOI 10.4014/jmb.1412.12047
   Li KY, 2016, WORLD J GASTROENTERO, V22, P8929, DOI 10.3748/wjg.v22.i40.8929
   Li SY, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0383-4
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231
   OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H
   Pei LY, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0930-3
   Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x
   RASMUSSEN H S, 1988, Ugeskrift for Laeger, V150, P2635
   Seksik P, 2006, ALIMENT PHARM THER, V24, P11, DOI 10.1111/j.1365-2036.2006.03053.x
   Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61
   Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294
   Tomasello G, 2014, WORLD J GASTROENTERO, V20, P18121, DOI 10.3748/wjg.v20.i48.18121
   WANG L, 2015, [No title captured], V43, P104, DOI DOI 10.16366/j.cnki.1000-2367.2015.04.020
   [王琳 Wang Lin], 2017, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V40, P399
   Wang L, 2017, EVID-BASED COMPL ALT, DOI 10.1155/2017/8721257
   Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13
   Worthley DL, 2009, AM J CLIN NUTR, V90, P578, DOI 10.3945/ajcn.2009.28106
   Ye JX, 2008, INFLAMM BOWEL DIS, V14, P1041, DOI 10.1002/ibd.20442
NR 35
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6882
J9 BMC COMPLEM ALTERN M
JI BMC Complement. Altern. Med.
PD NOV 21
PY 2019
VL 19
IS 1
AR 329
DI 10.1186/s12906-019-2750-y
PG 11
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA JR8RH
UT WOS:000499885000009
PM 31752807
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Vondra, M
   Tous, M
   Teng, SY
AF Vondra, Marek
   Tous, Michal
   Teng, Sin Yong
TI Digestate evaporation treatment in biogas plants: A techno-economic
   assessment by Monte Carlo, neural networks and decision trees
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Anaerobic digestion; Machine learning; Vacuum evaporation; Liquid
   digestate; Biogas plant; Energy consumption; Nutrient recovery; Circular
   economy; Ammonium sulphate solution
ID ANAEROBIC-DIGESTION; ENERGY PERFORMANCE; LIQUID DIGESTATE; CO-DIGESTION;
   LIFE-CYCLE; NUTRIENT; RECOVERY; TECHNOLOGIES; SEPARATION; EFFICIENCY
AB Biogas production is one of the most promising pathways toward fully utilizing green energy within a circular economy. The anaerobic digestion process is the industry standard technology for biogas production due to its lowered energy consumption and its reliance on microbiology. Even in such an environmental-friendly process, liquid digestate is still produced from the remains of digested bio-feedstock and will require treatment. With unsuitable treatment procedure for liquid digestate, the mass of bio-feedstock can potentially escape the circular supply chain within the economy. This paper recommends the implementation of evaporator systems to provide a sustainable liquid digestate treating mechanism within the economy. Studied evaporator systems are represented by vacuum evaporation in combination with ammonia scrubber, stripping and reverse osmosis. Nevertheless, complex multi-dimensional decisions should be made by stakeholders before implementing such systems. Our work utilizes a novel techno-economics model to study the techno-economics robustness in implementing recent state-of-art vacuum evaporation systems with exploitation of waste heat from combined heat and power (CHP) units in biogas plants (BGP). To take into the account the stochasticity of the real world and robustness of the analysis, we used the Monte-Carlo simulation technique to generate more than 20,000 of different possibilities for the implementation of the evaporation system. Favourable decision pathways are then selected using a novel methodology which utilizes the artificial neural network and a hyper-optimized decision tree classifier. Two pathways that give the highest probability of providing a fast payback period are identified. Descriptive statistics are also used to analyse the distributions of decision parameters that lead to success in implementing the evaporator system. The results highlighted that integration of evaporation system are favourable when transport costs and incentives for CHP units are large and while feed-in tariffs for electricity production and specific investment costs are low. The result of this work is expected to pave the way for BGP stakeholders and decision makers in implementing liquid digestate treating technologies within the currently existing infrastructure. (c) 2019 Elsevier Ltd. All rights reserved.
C1 [Vondra, Marek] Brno Univ Technol, Inst Proc Engn, Tech 2896-2, Brno 61669, Czech Republic.
   NETME Ctr, Tech 2896-2, Brno 61669, Czech Republic.
RP Vondra, M (reprint author), Brno Univ Technol, Inst Proc Engn, Tech 2896-2, Brno 61669, Czech Republic.
EM m.vondra@vut.cz
RI Yong, Teng Sin/V-3902-2019
OI Yong, Teng Sin/0000-0002-2988-8053
FU Ministry of Education, Youth and Sports of the Czech Republic under OP
   RDE [CZ.02.1.01/0.0/0.0/16_026/0008413]; TACR under the EPSILON
   programme [TH02020109]
FX The research leading to these results has received funding from the
   Ministry of Education, Youth and Sports of the Czech Republic under OP
   RDE grant number CZ.02.1.01/0.0/0.0/16_026/0008413 "Strategic
   Partnership for Environmental Technologies and Energy Production" and
   from the TACR under the EPSILON programme (Project TH02020109).
CR Al Seadi T, 2013, WOODHEAD PUBL SER EN, P267, DOI 10.1533/9780857097415.2.267
   [Anonymous], 2018, CDPQ DEC TOOLS
   Auburger S, 2015, AIMS ENERGY, V3, P740, DOI 10.3934/energy.2015.4.740
   Azouma Y.O., 2018, CHEM ENG T, V70, P445, DOI [10.3303/cet1870075, DOI 10.3303/CET1870075]
   Bamelis L., 2015, TECHNIQUES NUTR RECO
   Berglund M, 2006, BIOMASS BIOENERG, V30, P254, DOI 10.1016/j.biombioe.2005.11.011
   Bolzonella D, 2018, J ENVIRON MANAGE, V216, P111, DOI 10.1016/j.jenvman.2017.08.026
   Chen yucheng, 2009, CHINA BIOGAS, V28, P14
   Chiumenti A, 2013, WASTE MANAGE, V33, P1339, DOI 10.1016/j.wasman.2013.02.023
   Cordes F., 2018, PROGR TREATMENT APPL
   CZBA-Czech Biogas Association, 2014, STRAT VYZK AG OB BIO
   Dahlin J, 2015, RESOUR CONSERV RECY, V104, P152, DOI 10.1016/j.resconrec.2015.08.013
   Daniel-Gromke J., 2017, ANLAGENBESTAND BIOGA
   Dasa K.T., 2016, BIOMED RES INT, DOI [DOI 10.1155/2016/7263974, 10.1155/2016/7263974]
   Deremince B, 2017, STAT REPORT EUROPEAN
   Drosg B., 2015, IEA BIOENERGY
   Durdevic D, 2018, ENVIRON ENG SCI, V35, P1286, DOI 10.1089/ees.2018.0123
   European Commission, 2019, HOR 2020 WORK PROGR
   European Commission, 2018, EN COG HEAT POW
   European Commission, 2019, REN EN POL DAT SUPP
   Fagerstrom A., 2018, IEA BIOENERGY TASK, V37, P8
   Fuchs W, 2013, WATER SCI TECHNOL, V67, P1984, DOI 10.2166/wst.2013.075
   Gebrezgabher SA, 2010, NJAS-WAGEN J LIFE SC, V57, P109, DOI 10.1016/j.njas.2009.07.006
   Ghafoori E, 2007, BIOMASS BIOENERG, V31, P168, DOI 10.1016/j.biombioe.2006.07.007
   Golkowska K, 2014, WATER SCI TECHNOL, V69, P656, DOI 10.2166/wst.2013.742
   Gomez X, 2006, RENEW ENERG, V31, P2017, DOI 10.1016/j.renene.2005.09.029
   Guercini S, 2014, WATER SCI TECHNOL, V70, P479, DOI 10.2166/wst.2014.247
   Hung CY, 2017, WASTE MANAGE, V66, P53, DOI 10.1016/j.wasman.2017.04.034
   Kiran EU, 2016, WOODHEAD PUBL SER EN, P259, DOI 10.1016/B978-0-08-100455-5.00010-2
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Koszel M, 2015, AGRIC AGRIC SCI PROC, V7, P119, DOI 10.1016/j.aaspro.2015.12.004
   Liguori R, 2016, BIORESOURCE TECHNOL, V215, P13, DOI 10.1016/j.biortech.2016.04.054
   Maier C., 2018, PROGR TREATMENT APPL
   Masa V, 2013, CLEAN TECHNOL ENVIR, V15, P445, DOI 10.1007/s10098-013-0618-2
   Melse RW, 2005, BIOSYST ENG, V92, P47, DOI 10.1016/j.biosystemseng.2005.05.004
   Miltner M., 2013, BIOMETHANE CALCULATO
   Mohan SV, 2016, BIORESOURCE TECHNOL, V215, P2, DOI 10.1016/j.biortech.2016.03.130
   Moller HB, 2000, BIORESOURCE TECHNOL, V74, P223, DOI 10.1016/S0960-8524(00)00016-X
   Moller HB, 2002, BIORESOURCE TECHNOL, V85, P189, DOI 10.1016/S0960-8524(02)00047-0
   Monfet E, 2018, BIOFUELS-UK, V9, P247, DOI 10.1080/17597269.2017.1336348
   Monlau F, 2015, ENERG ENVIRON SCI, V8, P2600, DOI [10.1039/C5EE01633A, 10.1039/c5ee01633a]
   Noel V., 2017, EUROVENT RATING STAN
   Pablo-Romero MD, 2017, RENEW SUST ENERG REV, V73, P1366, DOI 10.1016/j.rser.2017.01.132
   Plana PV, 2016, WIT TRANS ECOL ENVIR, V202, P345, DOI 10.2495/WM160311
   Potting J, 2017, 2544 PBL NETH ENV AS
   Ragazzi M, 2017, ENRGY PROCED, V119, P602, DOI 10.1016/j.egypro.2017.07.086
   Rehl T, 2011, RESOUR CONSERV RECY, V56, P92, DOI 10.1016/j.resconrec.2011.08.007
   Scarlat N, 2018, RENEW ENERG, V129, P457, DOI 10.1016/j.renene.2018.03.006
   Tampio E, 2016, J CLEAN PROD, V125, P22, DOI 10.1016/j.jclepro.2016.03.127
   Vaneeckhaute C, 2017, WASTE BIOMASS VALORI, V8, P21, DOI 10.1007/s12649-016-9642-x
   vanHaeff J., 2015, ROLE BIOWASTE EMERGI
   Vondra M., 2018, CHEM ENG T, P769, DOI [10.3303/CET1870129, DOI 10.3303/CET1870129]
   Vondra M, 2018, ENERGY, V146, P141, DOI 10.1016/j.energy.2017.06.135
   Vondra M, 2016, CHEM ENGINEER TRANS, V52, P787, DOI 10.3303/CET1652132
   Xia A, 2016, TRENDS BIOTECHNOL, V34, P264, DOI 10.1016/j.tibtech.2015.12.010
   Zhang QG, 2016, RENEW ENERG, V98, P108, DOI 10.1016/j.renene.2016.02.029
NR 56
TC 1
Z9 1
U1 27
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD NOV 20
PY 2019
VL 238
AR UNSP 117870
DI 10.1016/j.jclepro.2019.117870
PG 26
WC Green & Sustainable Science & Technology; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA IZ6YK
UT WOS:000487231200035
DA 2020-05-07
ER

PT J
AU O'Brien, TJ
   Welch, M
AF O'Brien, Thomas J.
   Welch, Martin
TI Recapitulation of polymicrobial communities associated with cystic
   fibrosis airway infections: a perspective
SO FUTURE MICROBIOLOGY
LA English
DT Article
DE coculture; cystic fibrosis; in silico; in vitro; in vivo; infection
   model; interspecies interactions; microbiology; polymicrobial
ID PSEUDOMONAS-AERUGINOSA VIRULENCE; STAPHYLOCOCCUS-AUREUS; LUNG
   INFECTIONS; CAENORHABDITIS-ELEGANS; MODEL; BACTERIAL; MOUSE;
   PATHOGENESIS; MICROBIOTA; PHENOTYPE
AB The airways of persons with cystic fibrosis are prone to infection by a diverse and dynamic polymicrobial consortium. Currently, no models exist that permit recapitulation of this consortium within the laboratory. Such microbial ecosystems likely have a network of interspecies interactions, serving to modulate metabolic pathways and impact upon disease severity. The contribution of less abundant/fastidious microbial species on this cross-talk has often been neglected due to lack of experimental tractability. Here, we critically assess the existing models for studying polymicrobial infections. Particular attention is paid to 3Rs-compliant in vitro and in silico infection models, offering significant advantages over mammalian infection models. We outline why these models will likely become the 'go to' approaches when recapitulating polymicrobial cystic fibrosis infection.
C1 [O'Brien, Thomas J.; Welch, Martin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.
RP Welch, M (reprint author), Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.
EM mw240@cam.ac.uk
FU National Centre for the Replacement, Refinement and Reduction of Animals
   in Research (NC3Rs) [NC/P001564/1]; Medical Research CouncilMedical
   Research Council UK (MRC); Venture and Innovation Award (VIA) from the
   UK Cystic Fibrosis Trust; BLF Pump Primer Award from The British Lung
   Foundation
FX We thank the National Centre for the Replacement, Refinement and
   Reduction of Animals in Research (NC3Rs) for funding this work (grant
   NC/P001564/1 to MW). Article processing charges were paid from the
   Medical Research Council contribution to the RCUK block grant to The
   University of Cambridge. This work was also supported by a Venture and
   Innovation Award (VIA) from the UK Cystic Fibrosis Trust and by the BLF
   Pump Primer Award from The British Lung Foundation. The authors have no
   other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614
   BARTH AL, 1995, J CLIN MICROBIOL, V33, P37, DOI 10.1128/JCM.33.1.37-40.1995
   Bayes HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35838
   Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011
   Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8
   Boutin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116029
   Bragonzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052330
   Bruscia EM, 2016, J INNATE IMMUN, V8, P550, DOI 10.1159/000446825
   Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9
   Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC
   CASH HA, 1979, AM REV RESPIR DIS, V119, P453
   Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101
   Chattoraj SS, 2010, INFECT IMMUN, V78, P984, DOI 10.1128/IAI.01192-09
   Cheng YY, 2019, NPJ BIOFILMS MICROME, V5, DOI 10.1038/s41522-018-0076-z
   Cigana C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21465
   Conrad D, 2012, AM J RESP CELL MOL B, V48, P105
   Cornforth DM, 2018, P NATL ACAD SCI USA, V115, pE5125, DOI 10.1073/pnas.1717525115
   Defoirdt T, 2013, TRENDS MICROBIOL, V21, P619, DOI 10.1016/j.tim.2013.09.006
   Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x
   Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8
   Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6
   Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x
   Fan ZQ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123529
   Filkins LM, 2015, J BACTERIOL, V197, P2252, DOI 10.1128/JB.00059-15
   Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19
   Fothergill JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5780
   Frapwell CJ, 2018, INCREASED RATES GENO, DOI [10.1101/387233, DOI 10.1101/387233]
   Garge S, 2018, MICROBIOL-SGM, V164, P764, DOI 10.1099/mic.0.000659
   Ghio AJ, 2013, J CYST FIBROS, V12, P390, DOI 10.1016/j.jcf.2012.10.010
   GOVAN JRW, 1993, J ROY SOC MED, V86, P11
   Grahl N, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00292-18
   Grasemann H, 1998, ARCH DIS CHILD, V78, P49, DOI 10.1136/adc.78.1.49
   Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR
   Haley CL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-181
   Harrison F, 2016, MICROBIOL-SGM, V162, P1755, DOI 10.1099/mic.0.000352
   Harrison F, 2014, INFECT IMMUN, V82, P3312, DOI 10.1128/IAI.01554-14
   Henson MA, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00026-19
   Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259
   Hill L, 2014, INT J ANTIMICROB AG, V43, P254, DOI 10.1016/j.ijantimicag.2013.11.001
   Hoffman LR, 2018, AM J RESP CRIT CARE, V197, P1243, DOI 10.1164/rccm.201801-0053ED
   Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005
   Ibberson CB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.79
   Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000
   Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1
   Jorth P, 2019, CELL REP, V27, P1190, DOI 10.1016/j.celrep.2019.03.086
   Keiser NW, 2015, AM J RESP CELL MOL, V52, P683, DOI 10.1165/rcmb.2014-0250OC
   Knowles MR, 2002, NEW ENGL J MED, V347, P439, DOI 10.1056/NEJMe020070
   Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110
   Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94
   Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639
   Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390
   Limoli DH, 2016, EUR J CLIN MICROBIOL, V35, P947, DOI 10.1007/s10096-016-2621-0
   Lopes SP, 2017, INT J MED MICROBIOL, V307, P460, DOI 10.1016/j.ijmm.2017.09.018
   Lopes SP, 2012, INT J ANTIMICROB AG, V40, P260, DOI 10.1016/j.ijantimicag.2012.04.020
   Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002
   Magalhaes AP, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02146
   Makovcova J, 2017, MICROB BIOTECHNOL, V10, P819, DOI 10.1111/1751-7915.12705
   Malhotra S, 2018, MBIO, V9, DOI 10.1128/mBio.00275-18
   Marsh EK, 2007, APPL ENV BIO, V78, P2075
   Moser C, 2009, APMIS, V117, P95, DOI 10.1111/j.1600-0463.2008.00018.x
   Mou H, 2015, PEDIATR PULM, V50, pS14, DOI 10.1002/ppul.23233
   Munder A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-148
   Nguyen AT, 2016, APPL MICROBIOL BIOT, V100, P6141, DOI 10.1007/s00253-016-7596-3
   Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07
   Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11
   Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24
   Quinn RA, 2015, ISME J, V9, P1024, DOI 10.1038/ismej.2014.234
   Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13
   Racey D, 2010, EVOLUTION, V64, P515, DOI 10.1111/j.1558-5646.2009.00821.x
   RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262
   Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245
   Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690
   Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600
   Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005
   Rogers GB, 2010, EXPERT REV MOL DIAGN, V10, P187, DOI [10.1586/erm.09.81, 10.1586/ERM.09.81]
   Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0
   Rosen BH, 2018, J CYST FIBROS, V17, pS28, DOI 10.1016/j.jcf.2017.09.001
   Semaniakou A, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01475
   Short FL, 2014, TRENDS MICROBIOL, V22, P508, DOI 10.1016/j.tim.2014.05.007
   Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105
   Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184
   SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083
   Sousa AM, 2018, INT J MED MICROBIOL, V308, P1053, DOI 10.1016/j.ijmm.2018.10.003
   Spasenovski T, 2010, EUR J CLIN MICROBIOL, V29, P319, DOI 10.1007/s10096-009-0861-y
   Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0
   Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928
   Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC
   Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052
   Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715
   Tata M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147811
   Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926
   Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748
   Turner KH, 2015, P NATL ACAD SCI USA, V112, P4110, DOI 10.1073/pnas.1419677112
   van Heeckeren AM, 2006, AM J RESP CRIT CARE, V173, P288, DOI 10.1164/rccm.200506-917OC
   Vega NM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000633
   Weigand MR, 2012, P NATL ACAD SCI USA, V109, P13680, DOI 10.1073/pnas.1205357109
   Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149
   Wine JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001130
   Woods PW, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03291
   Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870
   Zhao J, 2012, P NATL ACAD SCI USA, V109, P5089
   Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0
NR 102
TC 1
Z9 1
U1 1
U2 1
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD NOV
PY 2019
VL 14
IS 16
BP 1437
EP 1450
DI 10.2217/fmb-2019-0200
PG 14
WC Microbiology
SC Microbiology
GA KD6YF
UT WOS:000508010500009
PM 31778075
DA 2020-05-07
ER

PT J
AU Lim, AKH
   Paramaswaran, S
   Jellie, LJ
   Junckerstorff, RK
AF Lim, Andy K. H.
   Paramaswaran, Sahira
   Jellie, Lucy J.
   Junckerstorff, Ralph K.
TI A Cross-Sectional Study of Hyponatremia Associated with Acute Central
   Nervous System Infections
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE sodium; hyponatremia; water-electrolyte imbalance; central nervous
   system infection; encephalitis; meningitis; meningoencephalitis;
   microbiology; herpes simplex
ID HERPES-SIMPLEX ENCEPHALITIS; VIRUS ENCEPHALITIS; MENINGITIS; ADULTS;
   BACTERIAL; INJURY; COHORT
AB Hyponatremia can occur with central nervous system (CNS) infections, but the frequency and severity may depend on the organism and nature of CNS involvement. In this cross-sectional study at a large Australian hospital network from 2015 to 2018, we aimed to determine the prevalence and severity of hyponatremia associated with CNS infection clinical syndromes, and the association with specific organisms. We examined the results of cerebrospinal fluid analysis from lumbar punctures performed in 184 adult patients with a serum sodium below 135 mmol/L who had abnormal cerebrospinal fluid analysis and a clinical syndrome consistent with an acute CNS infection (meningitis or encephalitis). Hyponatremia affected 39% of patients and was more severe and frequent in patients with encephalitis compared to meningitis (odds ratio = 3.03, 95% CI: 1.43-6.39, after adjusting for age). Hyponatremia was present on admission in 85% of cases. Herpes simplex virus infection was associated with the highest odds of hyponatremia (odds ratio = 3.25, 95% CI: 1.13-7.87) while enterovirus infection was associated with the lowest (odds ratio = 0.36, 95% CI: 0.14-0.92), compared to cases without an isolated organism. We concluded that the risk of hyponatremia may vary by the organism isolated but the clinical syndrome was a useful surrogate for predicting the probability of developing hyponatremia.
C1 [Lim, Andy K. H.; Paramaswaran, Sahira; Jellie, Lucy J.; Junckerstorff, Ralph K.] Monash Hlth, Gen Med, Clayton, Vic 3168, Australia.
   [Junckerstorff, Ralph K.] Monash Hlth, Infect Dis, Clayton, Vic 3168, Australia.
   [Lim, Andy K. H.] Monash Univ, Dept Med, Clayton, Vic 3168, Australia.
RP Lim, AKH (reprint author), Monash Hlth, Gen Med, Clayton, Vic 3168, Australia.; Lim, AKH (reprint author), Monash Univ, Dept Med, Clayton, Vic 3168, Australia.
EM Andy.lim@monash.edu; sahirapw@gmail.com; Lucy.jellie@monashhealth.org;
   Ralph.junckerstorff@monashhealth.org
CR Basaran S, 2019, TOHOKU J EXP MED, V247, P189, DOI 10.1620/tjem.247.189
   Bloch KC, 2019, CURR OPIN INFECT DIS, V32, P277, DOI 10.1097/QCO.0000000000000541
   Brouwer MC, 2007, QJM-INT J MED, V100, P37, DOI 10.1093/qjmed/hcl131
   Choi N.L.J., 2017, J KOREAN NEUROL ASS, V35, P162, DOI [10.17340/jkna.2017.3.10, DOI 10.17340/JKNA.2017.3.10]
   Cohen Christopher, 1998, Current Opinion in Pediatrics, V10, P449, DOI 10.1097/00008480-199808000-00021
   Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105
   Cortejoso Lucia, 2014, Am J Ther, V21, pe151, DOI 10.1097/MJT.0b013e3182691aca
   Czupryna P, 2016, SCAND J CLIN LAB INV, V76, P159, DOI 10.3109/00365513.2015.1129669
   Gennai S, 2016, EUR J CLIN MICROBIOL, V35, P935, DOI 10.1007/s10096-016-2619-7
   Giuliani C, 2014, J CLIN MED, V3, P1163, DOI 10.3390/jcm3041163
   Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Holland-Bill L, 2015, EUR J ENDOCRINOL, V173, P71, DOI 10.1530/EJE-15-0111
   Hoorn EJ, 2013, AM J KIDNEY DIS, V62, P139, DOI 10.1053/j.ajkd.2012.09.019
   Ingole Rajan, 2019, Indian J Tuberc, V66, P49, DOI 10.1016/j.ijtb.2017.05.011
   Joosen D A W A, 2017, Acute Med, V16, P156
   KARANDANIS D, 1976, SOUTHERN MED J, V69, P449, DOI 10.1097/00007611-197604000-00021
   Khatib U, 2017, J INFECTION, V74, P1, DOI 10.1016/j.jinf.2016.09.007
   Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y
   Kleindienst A, 2016, J NEUROTRAUM, V33, P615, DOI 10.1089/neu.2015.3981
   Liamis G, 2008, AM J KIDNEY DIS, V52, P144, DOI 10.1053/j.ajkd.2008.03.004
   MANGOS JA, 1964, PEDIATRICS, V34, P503
   McGill F, 2018, LANCET INFECT DIS, V18, P992, DOI 10.1016/S1473-3099(18)30245-7
   Michael BD, 2010, QJM-INT J MED, V103, P749, DOI 10.1093/qjmed/hcq121
   Misra UK, 2018, INT J TUBERC LUNG D, V22, P452, DOI 10.5588/ijtld.17.0479
   Misra UK, 2019, J INTENSIVE CARE MED, V34, P411, DOI 10.1177/0885066617701422
   National Institute for Health and Care Excellence, 2017, INTR FLUID THER AD H
   Olsen SJ, 2015, EMERG INFECT DIS, V21, P280, DOI 10.3201/eid2102.140291
   Ostergaard AA, 2017, BMC CLIN PATHOL, V17, DOI 10.1186/s12907-017-0053-0
   PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57
   Poissy J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-356
   Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89
   Riancho J, 2013, NEUROL SCI, V34, P1879, DOI 10.1007/s10072-013-1475-9
   ROVIT RL, 1964, ARCH NEUROL-CHICAGO, V10, P595, DOI 10.1001/archneur.1964.00460180061006
   Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819
   Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010
   Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Zheng FX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00421
NR 39
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD NOV
PY 2019
VL 8
IS 11
AR 1801
DI 10.3390/jcm8111801
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA JV3VR
UT WOS:000502294400044
PM 31717875
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Hussien, E
   Juhmani, AS
   AlMasri, R
   Al-Horani, F
   Al-Saghir, M
AF Hussien, Emad
   Juhmani, Abdul-Salam
   AlMasri, Ruba
   Al-Horani, Fuad
   Al-Saghir, Mohannad
TI Metagenomic analysis of microbial community associated with coral mucus
   from the Gulf of Aqaba
SO HELIYON
LA English
DT Article
DE Microbiology; Coral health; Coral damage; Coral; Jordanian coast; Red
   sea coral; Pyrosequencing; Marine science station; Gulf of Aqaba;
   Microbial community shift
ID BACTERIAL COMMUNITIES; JORDANIAN COAST; SURFACE MUCUS; DEEP-SEA;
   DIVERSITY; DISEASE; NITROGEN; HEALTH; CYANOBACTERIA; SEAWATER
AB Coral-associated microbial communities contribute to a wide variety of useful roles regarding the their host, and therefore, the arrangement of the general microbiome network can emphatically impact coral wellbeing and survival. Various pollution sources can interfere and disrupt the microbial relationship with corals. Here, we adopted the bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP (R)) technique to investigate the shift of microbial communities associated with the mucus of the coral Stylophora pistillata collected from five sites (Marine Science Station, Industrial Complex, Oil Terminal, Public Beach, and Phosphate Port) along the Gulf of Aqaba (Red Sea). Our results revealed a high diversity in bacterial populations associated with coral mucus. Proteo-bacteria were observed to be the dominating phylum among all sampling sites. The identified bacterial taxa belong to the pathogenic bacteria from the genus Vibrio was presented in varying abundances at all sampling sites. Diversity and similarity analysis of microbial communists based on rarefaction curve and UniFrac cluster respectively demonstrated that there are variances in microbial groups associated with coral mucus along sites. The pollution sources among different locations along the Gulf of Aqaba seem to affect the coral-associated holobiont leading to changes in bacterial populations due to increasing human activities.
C1 [Hussien, Emad; Juhmani, Abdul-Salam; AlMasri, Ruba] Yarmouk Univ, Dept Biol Sci, Irbid, Jordan.
   [Hussien, Emad] ASharqiyah Univ, Dept Food Sci & Human Nutr, Coll Appl & Hlth Sci, Ibra, Oman.
   [Juhmani, Abdul-Salam] Ca Foscari Univ Venice, Dept Environm Sci Informat & Stat, Venice, Italy.
   [Al-Horani, Fuad] Univ Jordan, Dept Marine Biol, Aqaba, Jordan.
   [Al-Saghir, Mohannad] Ohio Univ, Dept Biol Sci, Zanesville, OH 43701 USA.
RP Al-Saghir, M (reprint author), Ohio Univ, Dept Biol Sci, Zanesville, OH 43701 USA.
EM al-saghi@ohio.edu
RI hussein, emad/AAE-4703-2020; Al-Horani, Fuad A./M-9216-2015
OI hussein, emad/0000-0003-2019-2495; Al-Horani, Fuad
   A./0000-0001-9717-6640
FU Yarmouk University
FX This work was supported by Yarmouk University.
CR Al-Absi E, 2016, FRESEN ENVIRON BULL, V25, P3461
   Al-Horani Fuad A., 2006, Zoology in the Middle East, V38, P99
   Al-Rousan SA, 2005, CHEM ECOL, V21, P227, DOI 10.1080/02757540500211277
   Al-Rousan SA, 2007, MAR POLLUT BULL, V54, P1912, DOI 10.1016/j.marpolbul.2007.08.014
   Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x
   Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291
   Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123
   Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624
   CHAO A, 1984, SCAND J STAT, V11, P265
   Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-125
   ElAhwany AMD, 2015, J BASIC MICROB, V55, P2, DOI 10.1002/jobm.201300195
   Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002
   Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050
   Garren M, 2010, APPL ENVIRON MICROB, V76, P6128, DOI 10.1128/AEM.01100-10
   Glasl B, 2016, ISME J, V10, P2280, DOI 10.1038/ismej.2016.9
   Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0
   Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2
   Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97
   Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91
   Hong MJ, 2009, APPL ENVIRON MICROB, V75, P7797, DOI 10.1128/AEM.01418-09
   Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046
   Hussein EI, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.521
   Jaber F.M., 2012, THESIS
   Jacob JH, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.500
   Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091
   Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111
   Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06
   Kysela DT, 2005, ENVIRON MICROBIOL, V7, P356, DOI 10.1111/j.1462-2920.2004.00712.x
   Lampert Y, 2006, FEMS MICROBIOL ECOL, V58, P99, DOI 10.1111/j.1574-6941.2006.00136.x
   Lema KA, 2012, APPL ENVIRON MICROB, V78, P3136, DOI 10.1128/AEM.07800-11
   Lesser MP, 2007, MAR ECOL PROG SER, V346, P143, DOI 10.3354/meps07008
   Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128
   Meyer JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100316
   Mulhall Marjorie, 2009, DUKE ENVTL L POLY F, V19, P321
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Olson ND, 2009, J EXP MAR BIOL ECOL, V371, P140, DOI 10.1016/j.jembe.2009.01.012
   Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706
   Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x
   Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001
   Rohwer F, 2001, CORAL REEFS, V20, P85
   Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x
   Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635
   Rosenberg E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P451, DOI 10.1007/978-94-007-0114-4_26
   Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103
   Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554
   Tang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048013
   Telfah M.A., 2012, THESIS
   Wahsha M, 2017, ENRGY PROCED, V125, P19, DOI 10.1016/j.egypro.2017.08.041
   Wang WP, 2014, APPL MICROBIOL BIOT, V98, P7253, DOI 10.1007/s00253-014-5817-1
   Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001
   Welsh RM, 2016, ISME J, V10, P1540, DOI 10.1038/ismej.2015.219
   Wilkinson CR, 1999, MAR FRESHWATER RES, V50, P867, DOI 10.1071/MF99121
   Wilkinson CR, 2004, STATUS CORAL REEFS W
   Yakimov MM, 2006, DEEP-SEA RES PT I, V53, P62, DOI 10.1016/j.dsr.2005.07.005
   Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833
   Zhang YY, 2015, ECOTOXICOLOGY, V24, P1467, DOI 10.1007/s10646-015-1454-4
   Ziegler M, 2016, MAR POLLUT BULL, V105, P629, DOI 10.1016/j.marpolbul.2015.12.045
NR 57
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD NOV
PY 2019
VL 5
IS 11
AR e02876
DI 10.1016/j.heliyon.2019.e02876
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JS8CO
UT WOS:000500530100130
PM 31844749
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Igwaran, A
   Okoh, AI
AF Igwaran, Aboi
   Okoh, Anthony Ifeanyi
TI Human campylobacteriosis: A public health concern of global importance
SO HELIYON
LA English
DT Review
DE Campylobacter; Gastrointestinal; Pathogenesis; Infection; Toxins;
   Resistance; Microbiology
ID ACTIVE SURVEILLANCE NETWORK; BULK TANK MILK; 10 US SITES; ANTIMICROBIAL
   RESISTANCE; RAW-MILK; GENETIC DIVERSITY; JEJUNI STRAINS; GUILLAIN-BARRE;
   UNITED-STATES; ANTIBIOTIC-RESISTANCE
AB Campylobacter species are among the leading cause of bacterial foodborne and waterborne infections. In addition, Campylobacter is one of the major causative agent of bacterial gastrointestinal infections and the rise in the incidence of Campylobacter infections have been reported worldwide. Also, the emergence of some Campylobacter species as one of the main causative agent of diarrhea and the propensity of these bacteria species to resist the actions of antimicrobial agents; position them as a serious threat to the public health. This paper reviews Campylobacter pathogenicity, infections, isolation and diagnosis, their reservoirs, transmission pathways, epidemiology of Campylobacter outbreaks, prevention and treatment option, antibiotics resistance and control of antibiotics use.
C1 [Igwaran, Aboi; Okoh, Anthony Ifeanyi] Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, ZA-5700 Alice, South Africa.
   [Igwaran, Aboi; Okoh, Anthony Ifeanyi] Univ Ft Hare, Dept Biochem & Microbiol, Appl & Environm Microbiol Res Grp AEMREG, Private Bag X1314, ZA-5700 Alice, Eastern Cape, South Africa.
RP Igwaran, A (reprint author), Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, ZA-5700 Alice, South Africa.
EM aboi.igwaran@yahoo.com
RI Okoh, Anthony I/P-1502-2016
FU South African Medical Research Council
FX This work was supported by the South African Medical Research Council.
CR AbuOun M, 2005, INFECT IMMUN, V73, P3053, DOI 10.1128/IAI.73.5.3053-3062.2005
   Acke E, 2018, NEW ZEAL VET J, V66, P221, DOI 10.1080/00480169.2018.1475268
   Adedayo O., 2008, HOSP PHYS, V44, P9
   Allos B.M., 2011, MICROBIOLOGY PATHOGE
   Allos B.M., 2009, MANDELL DOUGLAS BENN
   Allos B.M., 2013, CLIN MANIFESTATIONS
   Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760
   Alnimr AM, 2014, INFECT DRUG RESIST, V7, P37, DOI 10.2147/IDR.S58645
   Amenu K, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0163-7
   Asakura M, 2008, FEMS IMMUNOL MED MIC, V52, P260, DOI 10.1111/j.1574-695X.2007.00369.x
   Aung WW, 2015, PAK VET J, V35, P470
   Avci FY, 2016, GLYCOBIOLOGY, V26, P1137, DOI 10.1093/glycob/cww097
   Ayrapetyan M, 2016, CURR OPIN FOOD SCI, V8, P127, DOI 10.1016/j.cofs.2016.04.010
   Baars T, 2019, EUR NEUROPSYCHOPHARM, V29, pS226, DOI 10.1016/j.euroneuro.2018.11.367
   Backert S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-72
   Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644
   Bardon J, 2009, ZOONOSES PUBLIC HLTH, V56, P111, DOI 10.1111/j.1863-2378.2008.01176.x
   Bartholomew N, 2014, J WATER HEALTH, V12, P555, DOI 10.2166/wh.2014.155
   Baylis CL, 2000, J APPL MICROBIOL, V89, P884, DOI 10.1046/j.1365-2672.2000.01203.x
   Beier RC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202100
   Benoit SR, 2014, J EPIDEMIOL GLOB HEA, V4, P51, DOI 10.1016/j.jegh.2013.10.001
   Berger S.A., 2012, INFECT DIS NZ
   Bhavsar S., 2006, INTERNET J MICROBIOL, V3, P1
   Bianchini V, 2014, APPL ENVIRON MICROB, V80, P1832, DOI 10.1128/AEM.03784-13
   Bingham-Ramos LK, 2008, INFECT IMMUN, V76, P1105, DOI 10.1128/IAI.01430-07
   Biswas D, 2011, INT MICROBIOL, V14, P25, DOI 10.2436/20.1501.01.132
   Blaser M.J., 2008, PRINCIPLES HARRISONS, P965
   BLEREAU E, 2017, [No title captured], V8, P1, DOI DOI 10.1016/J.GSF.2016.07.003
   Bolton DJ, 2015, FOOD MICROBIOL, V48, P99, DOI 10.1016/j.fm.2014.11.017
   BOLTON FJ, 1982, J CLIN PATHOL, V35, P462, DOI 10.1136/jcp.35.4.462
   Borie C, 2014, ARCH MED VET, V46, P167, DOI 10.4067/S0301-732X2014000200002
   Bourke B, 1998, CLIN MICROBIOL REV, V11, P440, DOI 10.1128/CMR.11.3.440
   Bouwknegt M, 2013, INT J ENV RES PUB HE, V10, P2888, DOI 10.3390/ijerph10072888
   Braeye T, 2015, EPIDEMIOL INFECT, V143, P711, DOI 10.1017/S0950268814001629
   Bruzzese E., 2018, F1000 RES, V7
   Bullman S, 2011, FEMS IMMUNOL MED MIC, V61, P228, DOI 10.1111/j.1574-695X.2010.00760.x
   Burnham P.M., 2018, NAT REV MICROBIOL, V11
   Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200
   CASABONNE C, 2016, INT J INFECT, V3, P1
   Cecil R.L.F., 2012, GOLDMANS CECIL MED, V24
   Center for Disease Control and Prevention, 2016, INF DIS CAMP CLIN FO
   Center for Disease Control and Prevention, 2014, CAMPYLOBACTER
   Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05
   Chen J, 2011, CHINESE MED J-PEKING, V124, P1508, DOI 10.3760/cma.j.issn.0366-6999.2011.10.013
   Clark CG, 2003, EMERG INFECT DIS, V9, P1232
   Connerton IF, 2017, FOODBORNE DISEASES, 3RD EDITION, P209, DOI 10.1016/B978-0-12-385007-2.00008-5
   Coorevits A, 2008, SYST APPL MICROBIOL, V31, P126, DOI 10.1016/j.syapm.2008.03.002
   Couturier B.A., 2012, J CLIN MICROBIOL, V1807
   Crim SM, 2015, MMWR-MORBID MORTAL W, V64, P495
   da Silva DT, 2016, INT J FOOD MICROBIOL, V217, P189, DOI 10.1016/j.ijfoodmicro.2015.10.025
   Damborg P, 2008, J CLIN MICROBIOL, V46, P1504, DOI 10.1128/JCM.00079-08
   Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002
   Datta S, 2003, J MED MICROBIOL, V52, P345, DOI 10.1099/jmm.0.05056-0
   Davis L., 2017, CURRENT PROTOC MICRO, V10, P1
   de Carvalho AF, 2013, BRAZ J MICROBIOL, V44, P693, DOI 10.1590/S1517-83822013000300005
   de Vries SPW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194481
   Dearlove BL, 2016, ISME J, V10, P721, DOI 10.1038/ismej.2015.149
   Debruyne L, 2010, INT J SYST EVOL MICR, V60, P1870, DOI 10.1099/ijs.0.013748-0
   Debruyne L, 2009, INT J SYST EVOL MICR, V59, P1126, DOI 10.1099/ijs.0.000851-0
   Del Collo LP, 2017, J DAIRY SCI, V100, P3470, DOI 10.3168/jds.2016-12084
   Dingle KE, 2001, J CLIN MICROBIOL, V39, P3346, DOI 10.1128/JCM.39.9.3346-3349.2001
   Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676
   Drenthen J, 2011, J NEUROL NEUROSUR PS, V82, P300, DOI 10.1136/jnnp.2010.226639
   Duarte A, 2014, INT J ANTIMICROB AG, V44, P306, DOI 10.1016/j.ijantimicag.2014.06.012
   Duim B, 2004, APPL ENVIRON MICROB, V70, P18, DOI 10.1128/AEM.70.1.18-24.2004
   EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4191
   El-Gendy AM, 2013, AFR J LAB MED, V2, DOI 10.4102/ajlm.v2i1.34
   El-Zamkan MA, 2016, VET WORLD, V9, P1147, DOI 10.14202/vetworld.2016.1147-1151
   Elhadidy M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01014
   Epps SVR, 2013, INT J ENV RES PUB HE, V10, P6292, DOI 10.3390/ijerph10126292
   ESR, 2016, NOT DIS NZ ANN REP 2, P1179
   Fitzgerald C, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P933
   Fitzgerald C, 2014, INT J SYST EVOL MICR, V64, P2944, DOI 10.1099/ijs.0.057778-0
   Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881
   Founou RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189621
   Frirdich E, 2017, MOL MICROBIOL, V104, P948, DOI 10.1111/mmi.13672
   Frost JA, 2002, EPIDEMIOL INFECT, V128, P111, DOI 10.1017/S0950268802006799
   Garcia S, 2013, GUIDE TO FOODBORNE PATHOGENS, 2ND EDITION, P188
   Garcia-Sanchez L, 2019, FOOD MICROBIOL, V83, P193, DOI 10.1016/j.fm.2019.05.016
   Garcia-Sanchez L, 2017, FOOD MICROBIOL, V65, P185, DOI 10.1016/j.fm.2017.02.009
   Garenaux A, 2008, CURR MICROBIOL, V56, P293, DOI 10.1007/s00284-007-9082-8
   Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x
   Geissler AL, 2017, CLIN INFECT DIS, V65, P1624, DOI 10.1093/cid/cix624
   Gilber D.N., 2007, ANTIMICROBIAL THERAP
   Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283
   Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002
   Golz G., 2018, CURR CLIN MICROBIOL, P1, DOI [DOI 10.1007/S40588-018-0085-Y, 10.1007/s40588-018-0085-y]
   Goni MD, 2017, ADV ANIMAL VET SCI, V5, P239, DOI DOI 10.17582/J0URNAL.AAVS/2017/5.6.239.248
   Grant A.J., 2018, PHYLOGENETIC ANAL AN
   Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356
   Grzybowska-Chlebowczyk KB, 2013, PEDIATR POL, V88, P329, DOI DOI 10.1016/J.PEP0.2013.05.004
   Guarino A, 2014, J PEDIATR GASTR NUTR, V59, P132, DOI 10.1097/MPG.0000000000000375
   Guzman-Herrador B, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21160
   Haddock G, 2010, MICROBIOL-SGM, V156, P3079, DOI 10.1099/mic.0.039867-0
   Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3
   Hansson I, 2018, TRANSBOUND EMERG DIS, V65, P30, DOI 10.1111/tbed.12870
   Hartley-Tassell LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30604-5
   Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13
   Hati S., 2018, RES REV J DAIRY SCI, V4, P28
   Hauri AM, 2013, DEUT MED WOCHENSCHR, V138, P357, DOI 10.1055/s-0032-1332884
   Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x
   Henry R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00074
   Heredia N., 2018, ANIMAL NUTR
   Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82
   Hernandez Lincoln, 2006, Curr Gastroenterol Rep, V8, P383, DOI 10.1007/s11894-006-0023-7
   Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06
   Hsieh YH, 2018, HANDB FOOD BIOENG, V15, P119, DOI 10.1016/B978-0-12-811444-5.00005-1
   Hudson A., 2014, ESR EUR SURG RES, P1
   Hurd S, 2012, CLIN INFECT DIS, V54, pS440, DOI 10.1093/cid/cis245
   Hussain I, 2007, FOOD MICROBIOL, V24, P219, DOI 10.1016/j.fm.2006.06.001
   Iglesias-Torrens Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01676
   Iraola G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01449-9
   Iraola G, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0913-3
   Irena J., 2008, LARGE WATERBORNE OUT
   Jagannathan A, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P331
   Jain D, 2008, J MED MICROBIOL, V57, P267, DOI 10.1099/jmm.0.47317-0
   Jakopanec I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-128
   Jamshidi A, 2008, IRAN J VET RES, V9, P132
   Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x
   Johansson C., 2018, APPL ENV MICROBIOL, V2993
   Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15
   Kaakoush NO, 2009, ANTON LEEUW INT J G, V96, P545, DOI 10.1007/s10482-009-9370-3
   Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442
   Kashappanavar S., 2018, INT J LIVESTOCK RES, V8, P102
   Keegan VA, 2009, CAN J INFECT DIS MED, V20, P79, DOI 10.1155/2009/978784
   Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005
   Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580
   KETLEY JM, 1995, J MED MICROBIOL, V42, P312, DOI 10.1099/00222615-42-5-312
   Khan IUH, 2013, INLAND WATERS, V3, P93, DOI 10.5268/IW-3.1.582
   Khan JR, 2019, INT J ENVIRON HEAL R, DOI 10.1080/09603123.2019.1593328
   Kienesberger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085491
   Koneman E.W., 1997, DIAGNOSTIC MICROBIOL, P253
   Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004
   Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09
   Korsak D, 2015, J FOOD PROTECT, V78, P1024, DOI 10.4315/0362-028X.JFP-14-353
   Kubota K, 2011, J FOOD PROTECT, V74, P1592, DOI 10.4315/0362-028X.JFP-10-387
   Kuhn KG, 2017, EPIDEMIOL INFECT, V145, P701, DOI 10.1017/S0950268816002788
   Kuijper EJ, 2003, J CLIN MICROBIOL, V41, P3732, DOI 10.1128/JCM.41.8.3732-3736.2003
   Kum JMKJ, 2017, CRIT REV FOOD SCI, V57, P3971, DOI 10.1080/10408398.2016.1266297
   Kumar A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00405
   Kuusi M, 2004, J EPIDEMIOL COMMUN H, V58, P273, DOI 10.1136/jech.2003.009928
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Labarca JA, 2002, CLIN INFECT DIS, V34, pE59, DOI 10.1086/340266
   Lagler H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1743-4
   Lahti E, 2017, ZOONOSES PUBLIC HLTH, V64, P14, DOI 10.1111/zph.12272
   Larson CL, 2008, MICROBIOL-SGM, V154, P3835, DOI 10.1099/mic.0.2008/021279-0
   Lee G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002036
   Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908
   Levesque S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083731
   Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258
   Liu F, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00243
   Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
   Liu KC, 2017, FOODBORNE PATHOG DIS, V14, P371, DOI 10.1089/fpd.2016.2245
   Llarena AK, 2017, J CLIN MICROBIOL, V55, P1269, DOI [10.1128/JCM.00017-17, 10.1128/jcm.00017-17]
   Loshaj-Shala A, 2015, J NEUROIMMUNOL, V289, P168, DOI 10.1016/j.jneuroim.2015.11.005
   Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189
   Lund M, 2016, PREV VET MED, V128, P58, DOI 10.1016/j.prevetmed.2016.04.006
   Magana M., 2017, Veterinary Sciences, V4, P36
   Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191
   Marchant J, 2002, TRENDS MICROBIOL, V10, P155, DOI 10.1016/S0966-842X(02)02323-5
   Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48
   Martinez I, 2006, INT J MED MICROBIOL, V296, P45, DOI 10.1016/j.ijmm.2005.08.003
   Martinot M, 2001, CLIN MICROBIOL INFEC, V7, P96, DOI 10.1046/j.1469-0691.2001.00212.x
   Mason J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059663
   Maziero MT, 2010, BRAZ J MICROBIOL, V41, P501, DOI [10.1590/S1517-83822010000200034, 10.1590/S1517-838220100002000034]
   Mezher Z, 2016, ITAL J FOOD SAF, V5, DOI 10.4081/ijfs.2016.5495
   Miller WG, 2014, GENOME BIOL EVOL, V6, P3252, DOI 10.1093/gbe/evu249
   Modi S, 2015, VET WORLD, V8, P1, DOI 10.14202/vetworld.2015.1-8
   Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012
   Morishita S, 2013, J INFECT CHEMOTHER, V19, P333, DOI 10.1007/s10156-012-0471-y
   Mossong J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20939
   Moyane J. N., 2013, African Journal of Microbiology Research, V7, P2990
   Mshelia GD, 2010, REPROD DOMEST ANIM, V45, pE221, DOI 10.1111/j.1439-0531.2009.01546.x
   Mukherjee P, 2013, EMERG INFECT DIS, V19, P1155, DOI 10.3201/eid1907.121278
   Mungai EA, 2015, EMERG INFECT DIS, V21, P119, DOI 10.3201/eid2101.140447
   Neeta P.N., 2014, INT J MED SCI PUBLIC, V3, P1093
   Newell DG, 2017, CAMPYLOBACTER: FEATURES, DETECTION, AND PREVENTION OF FOODBORNE DISEASE, P85, DOI 10.1016/B978-0-12-803623-5.00005-8
   Nielsen EM, 2006, EPIDEMIOL INFECT, V134, P758, DOI 10.1017/S0950268805005509
   Nielsen HL, 2013, CLIN MICROBIOL INFEC, V19, P445, DOI 10.1111/j.1469-0691.2012.03852.x
   Nisar M, 2018, ACTA TROP, V185, P42, DOI 10.1016/j.actatropica.2018.04.030
   Nishiguchi S, 2017, INTERNAL MED, V56, P967, DOI 10.2169/internalmedicine.56.7906
   O'Callaghan T.F., 2019, RAW MILK, P127
   O'Reilly CE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001256
   Oh E, 2018, EMERG INFECT DIS, V24, P1037, DOI 10.3201/eid2406.171587
   Oliver SP, 2005, FOODBORNE PATHOG DIS, V2, P115, DOI 10.1089/fpd.2005.2.115
   On S L, 2001, Symp Ser Soc Appl Microbiol, p1S
   On SLW, 2013, J MICROBIOL METH, V95, P3, DOI 10.1016/j.mimet.2013.06.011
   OYOFO BA, 1992, J CLIN MICROBIOL, V30, P2613, DOI 10.1128/JCM.30.10.2613-2619.1992
   Pacanowski J, 2008, CLIN INFECT DIS, V47, P790, DOI 10.1086/591530
   Pal M., 2017, J EXCIP FOOD CHEM, V3, P1, DOI DOI 10.4172/2472-0542.1000133
   Parker CT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-50
   Patel R, 2019, J FUNGI, V5, DOI 10.3390/jof5010004
   Patrick ME, 2013, EMERG INFECT DIS, V19, P1678, DOI 10.3201/eid1910.130883
   Peres-Boto D, 2010, J ANTIMICROB CHEMOTH, V65, P2083, DOI 10.1093/jac/dkq268
   Piddock LJV, 2003, J ANTIMICROB CHEMOTH, V51, P19, DOI 10.1093/jac/dkg033
   Pitkanen T, 2013, J MICROBIOL METH, V95, P39, DOI 10.1016/j.mimet.2013.06.008
   Platts-Mills JA, 2014, CURR OPIN INFECT DIS, V27, P444, DOI 10.1097/QCO.0000000000000091
   Poly F, 2008, CURR OPIN GASTROEN, V24, P27, DOI 10.1097/MOG.0b013e3282f1dcb1
   Prescott L.M., 2005, MICROBIOLOGY, P430
   Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307
   Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030
   Rahimi E, 2013, REV MED VET-TOULOUSE, V164, P283
   Rahimi E, 2010, FOODBORNE PATHOG DIS, V7, P443, DOI 10.1089/fpd.2009.0421
   Rahman G., 2018, IMPLICATIONS FOODBOR
   Randremanana RV, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-372
   Ravel A., 2016, BMC PUBLIC HEALTH, V16, P1
   Reddy S, 2017, ONDERSTEPOORT J VET, V84, DOI 10.4102/ojvr.v84i1.1411
   Riddle MS, 2016, VACCINE, V34, P2903, DOI 10.1016/j.vaccine.2016.02.080
   Rollins D.M., 2000, PATHOGENIC MICROBIOL, P424
   Rosner B.M., 2017, SCI REP, V7, P1
   Rouger A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030050
   Sadkowska-Todys Malgorzata, 2014, Przegl Epidemiol, V68, P239
   Sails AD, 2002, APPL ENVIRON MICROB, V68, P1319, DOI 10.1128/AEM.68.3.1319-1324.2002
   Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P663, DOI 10.1289/ehp.9760
   Sarkar S, 2016, BIOMED ENG COMPUT BI, V7, P1, DOI 10.4137/BECB.S34255
   Scallan E, 2015, EPIDEMIOL INFECT, V143, P2795, DOI 10.1017/S0950268814003185
   Schulze F, 1998, ZBL BAKT-INT J MED M, V288, P225
   Schurch AC, 2018, CLIN MICROBIOL INFEC, V24, P350, DOI 10.1016/j.cmi.2017.12.016
   Sears A, 2011, EMERG INFECT DIS, V17, P1007, DOI [10.3201/eid1706.101272, 10.3201/eid/1706.101272]
   Seguino A, 2018, FOOD MICROBIOL, V74, P163, DOI 10.1016/j.fm.2018.04.002
   Seliwiorstow T, 2015, INT J FOOD MICROBIOL, V194, P25, DOI 10.1016/j.ijfoodmicro.2014.11.004
   Seliwiorstow T, 2014, J FOOD PROTECT, V77, P2111, DOI 10.4315/0362-028X.JFP-14-237
   Shane SM, 2000, REV SCI TECH OIE, V19, P376, DOI 10.20506/rst.19.2.1224
   SHARMA KP, 2016, INT J AGR ENV BIOTEC, V9, P535
   Shawky H.M., 2015, J GLOBAL BIOSCI, V4, P2087
   Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200
   Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791
   Skarp CPA, 2016, CLIN MICROBIOL INFEC, V22, P103, DOI 10.1016/j.cmi.2015.11.019
   SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9
   Steens A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-57
   Steinhauserova I, 2000, LETT APPL MICROBIOL, V31, P209, DOI 10.1046/j.1365-2672.2000.00799.x
   Stuart TL, 2010, EPIDEMIOL INFECT, V138, P1695, DOI 10.1017/S095026881000049X
   Sugrue I., 2019, RAW MILK, P259
   Swierczewski BE, 2013, J MED MICROBIOL, V62, P1774, DOI 10.1099/jmm.0.059139-0
   Szosland-Faltyn A, 2018, POL J MICROBIOL, V67, P117, DOI 10.5604/01.3001.0011.6152
   Taheri N, 2019, J PROTEOMICS, V195, P33, DOI 10.1016/j.jprot.2019.01.005
   Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386
   Taylor P, 2013, INT J HUM RESOUR MAN, V24, P436, DOI 10.1080/09585192.2011.561216
   Thomas GD, 2005, J CLIN PATHOL, V58, P413, DOI 10.1136/jcp.2004.019042
   Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7
   Tribble DR, 2010, INFECT IMMUN, V78, P1750, DOI 10.1128/IAI.01021-09
   Unicomb LE, 2009, FOODBORNE PATHOG DIS, V6, P1241, DOI 10.1089/fpd.2009.0300
   Vacheyrou M., 2011, FOODBORNE PATHOG DIS, V6, P1241
   van Vliet AHM, 2001, J APPL MICROBIOL, V90, p45S, DOI 10.1046/j.1365-2672.2001.01353.x
   Veras HD, 2016, J MICROBIOL METH, V128, P7, DOI 10.1016/j.mimet.2016.06.026
   Vihavainen E, 2007, APPL ENVIRON MICROB, V73, P1136, DOI 10.1128/AEM.01644-06
   Wagenaar JA, 2014, CLIN INFECT DIS, V58, P1579, DOI 10.1093/cid/ciu085
   Walsh T.J., 2011, TROP MED INFECT DIS, V3, P597
   Wang Y, 2014, ANTIMICROB AGENTS CH, V58, P5405, DOI 10.1128/AAC.03039-14
   Wei B., 2018, PLOS ONE, V13, P1
   Wei B., 2018, BIOMED RES INT, P1
   Weinberger M, 2013, EMERG INFECT DIS, V19, P1828, DOI 10.3201/eid1911.120900
   Werno AM, 2002, J CLIN MICROBIOL, V40, P1053, DOI 10.1128/JCM.40.3.1053-1055.2002
   Westermarck E, 2016, TOP COMPANION ANIM M, V31, P78, DOI 10.1053/j.tcam.2016.03.001
   WHO, 2018, WHO EST GLOB BURD FO
   WHO, 2013, 57 WHO, V57
   Wieczorek K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01508
   Wieczorek K, 2013, BIOMED RES INT, DOI 10.1155/2013/340605
   Wieczorek K, 2015, INT J FOOD MICROBIOL, V210, P24, DOI 10.1016/j.ijfoodmicro.2015.06.006
   Wilkinson DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20889-x
   Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203
   Wong TL, 2007, J FOOD PROTECT, V70, P566, DOI 10.4315/0362-028X-70.3.566
   Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13
   Zaidi MB, 2012, CLIN INFECT DIS, V55, P51, DOI 10.1093/cid/cis300
   이양순, 2018, Annals of Clinical Microbiology, V21, P20
NR 265
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD NOV
PY 2019
VL 5
IS 11
AR e02814
DI 10.1016/j.heliyon.2019.e02814
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JS8CO
UT WOS:000500530100090
PM 31763476
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Maraolo, AE
   Ong, DSY
   Cimen, C
   Howard, P
   Kofteridis, DP
   Schouten, J
   Mutters, NT
   Pulcini, C
   Harxhi, A
AF Maraolo, Alberto Enrico
   Ong, David S. Y.
   Cimen, Cansu
   Howard, Philip
   Kofteridis, Diamantis P.
   Schouten, Jeroen
   Mutters, Nico T.
   Pulcini, Celine
   Harxhi, Arjan
TI Organization and training at national level of antimicrobial stewardship
   and infection control activities in Europe: an ESCMID cross-sectional
   survey
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
DE Antimicrobial stewardship; Infection prevention and control; Clinical
   microbiology; Infectious diseases; Questionnaire
ID PREVENTION; DISEASES
AB Antimicrobial stewardship (AMS) and Infection prevention and control (IPC) are two key complementary strategies that combat development and spread of antimicrobial resistance. The ESGAP (ESCMID Study Group for AMS), EUCIC (European Committee on Infection Control) and TAE (Trainee Association of ESCMID) investigated how AMS and IPC activities and training are organized, if present, at national level in Europe. From February 2018 to May 2018, an internet-based cross-sectional survey was conducted through a 36-item questionnaire, involving up to three selected respondents per country, from 38 European countries in total (including Israel), belonging to the ESGAP/EUCIC/TAE networks. All 38 countries participated with at least one respondent, and a total of 81 respondents. Education and involvement in AMS programmes were mandatory during the postgraduate training of clinical microbiology and infectious diseases specialists in up to one-third of countries. IPC was acknowledged as a specialty in 32% of countries. Only 32% of countries had both guidance and national requirements regarding AMS programmes, in contrast to 61% for IPC. Formal national staffing standards for AMS and IPC hospital-based activities were present in 24% and 63% of countries, respectively. The backgrounds of professionals responsible for AMS and IPC programmes varied tremendously between countries. The organization and training of AMS and IPC in Europe are heterogeneous and national requirements for activities are frequently lacking.
C1 [Maraolo, Alberto Enrico] Univ Naples Federico II, Sect Infect Dis, Dept Clin Med & Surg, Naples, Italy.
   [Ong, David S. Y.] Dept Med Microbiol & Infect Control, Franciscus Gasthuis Vlietland, Kleiweg 500, NL-3045 PM Rotterdam, Netherlands.
   [Ong, David S. Y.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Cimen, Cansu] Ardahan Publ Hosp, Infect Dis & Clin Microbiol Clin, Minist Hlth, Ardahan, Turkey.
   [Howard, Philip] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England.
   [Kofteridis, Diamantis P.] Univ Hosp Herakl, Dept Internal Med, Fac Med, Iraklion, Greece.
   [Schouten, Jeroen] Radboud Univ Nijmegen, Sci Ctr Qual Healthcare, IQ Healthcare, Med Ctr, Nijmegen, Netherlands.
   [Mutters, Nico T.] Univ Freiburg, Inst Infect Prevent & Hosp Epidemiol, Med Ctr, Fac Med, Freiburg, Germany.
   [Pulcini, Celine] Univ Lorraine, APEMAC & Infect Dis Dept, Nancy, France.
   [Pulcini, Celine] CHRU Nancy, Nancy, France.
RP Ong, DSY (reprint author), Dept Med Microbiol & Infect Control, Franciscus Gasthuis Vlietland, Kleiweg 500, NL-3045 PM Rotterdam, Netherlands.; Ong, DSY (reprint author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
EM davidsyong@gmail.com
RI Huttner, Benedikt/M-5616-2014; Cevik, Muge/N-6588-2019; Civljak,
   Rok/AAL-4002-2020; Milevska Kostova, Neda/E-9151-2017
OI Huttner, Benedikt/0000-0002-1749-9464; Cevik, Muge/0000-0003-1133-3874;
   Civljak, Rok/0000-0001-8766-7438; Tsioutis,
   Constantinos/0000-0002-7865-8529; Trojanek, Milan/0000-0003-1488-6546;
   Szabo, Balint Gergely/0000-0003-1775-1356; Milevska Kostova,
   Neda/0000-0003-1596-9036; Ergonul, Onder/0000-0003-1935-9235
CR [Anonymous], 2013, COR COMP INF CONTR H
   Beovic B, 2018, INT J ANTIMICROB AG, V52, P616, DOI 10.1016/j.ijantimicag.2018.07.019
   Brusaferro S, 2014, EURO SURVEILL, V19
   Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4
   Dickstein Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.06.014
   Dyar OJ, 2019, CLIN MICROBIOL INFEC, V25, P13, DOI 10.1016/j.cmi.2018.09.022
   Howard P, 2015, J ANTIMICROB CHEMOTH, V70, P1245, DOI 10.1093/jac/dku497
   Humphreys H, 2010, EUR J CLIN MICROBIOL, V29, P617, DOI 10.1007/s10096-010-0906-2
   McKendrick MW, 2005, CLIN MICROBIOL INFEC, V11, P28, DOI 10.1111/j.1469-0691.2005.01087.x
   Mutters NT, 2015, CLIN MICROBIOL INFEC, V21, P1045, DOI 10.1016/j.cmi.2015.06.012
   Palacios-Baena ZR, 2018, EUR J CLIN MICROBIOL, V37, P2381, DOI 10.1007/s10096-018-3386-4
   Pulcini C, 2019, CLIN MICROBIOL INFEC, V25, P20, DOI 10.1016/j.cmi.2018.03.033
   Read RC, 2011, LANCET INFECT DIS, V11, P408, DOI 10.1016/S1473-3099(10)70294-2
   Rodriguez-Bano J, 2015, CLIN MICROBIOL INFEC, V21, P1072, DOI 10.1016/j.cmi.2015.08.025
   Tacconelli E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027683
   van Woezik AFG, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0119-2
   Watkins RR, 2016, INFECT DIS CLIN N AM, V30, P313, DOI 10.1016/j.idc.2016.02.001
   WHO, 2017, GLOB ANT RES SURV SY
   Yusuf E, 2017, EUR J CLIN MICROBIOL, V36, P233, DOI 10.1007/s10096-016-2791-9
   Zingg W, 2015, CLIN MICROBIOL INFEC, V21, P1052, DOI 10.1016/j.cmi.2015.09.001
   Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD NOV
PY 2019
VL 38
IS 11
BP 2061
EP 2068
DI 10.1007/s10096-019-03648-2
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA JG2ZS
UT WOS:000491944700009
PM 31396830
OA Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Aminzadeh, Z
   Simpson, P
   Athan, E
AF Aminzadeh, Z.
   Simpson, P.
   Athan, E.
TI Central venous catheter associated blood stream infections (CVC-BSIs) in
   the non-intensive care settings: Epidemiology, microbiology and outcomes
SO INFECTION DISEASE & HEALTH
LA English
DT Article
DE Central venous catheter; Blood stream infection; Intensive care unit;
   Mortality; Risk factor; Bacteremia
ID INSERTED CENTRAL CATHETERS; SURVEILLANCE PROGRAM; RISK-FACTORS; UNIT;
   PREVALENCE; RATES; TIME
AB Background: Most studies have examined central venous catheter associated blood stream infections (CVC-BSIs) in Intensive Care Units (ICUs) but information on CVC-BSIs in non-ICU settings is sparse. This study aimed to determine the burden, microbiologic patterns, and associations of CVC-BSIs in non-ICU settings in a tertiary regional centre, University Hospital Geelong (UHG), Victoria, Australia.
   Methods: A retrospective study was conducted in the UHG from October 2016 to April 2018. Based on the National Healthcare Safety Network definition, 23 CVC-BSIs occurred in non-ICU settings. Data analysed using SPSS-v25 with a P value < 0.05 was deemed as significant.
   Results: The incidence rate was 1.2 per 10,000 bed-days. The mean age of patients was 57.22 +/- 18 years. 43.5% of patients had Charlson index score of >= 5 and 78% received appropriate empiric antibiotics. The 90-day mortality rate was zero. In total, 26 microorganisms were isolated. Gram-negative bacilli were more common than Gram-positive cocci. The mean catheter duration was 45.22 +/- 8.99 days. Hickman lines contributed to 52.2% of BSIs. Within the first two weeks of line insertion, 53.84% of CVC-BSIs occurred with 76.92% of CVC-Gram-negative bacteraemia and 71.4% of BSIs were related to Hickman lines. Also, 69.2% of CVC-BSIs occurred within <= 4 weeks of line insertion including 84.6% of CVC-Gram-negative bacteraemia.
   Conclusion: CVC-BSIs constitute a significant burden on high risk patients in non-ICU settings, with Gram negative bacilli predominating. A prospective surveillance program for all patients with CVC in the non-ICU setting may improve CVC management processes and influence educational measures. (C) 2019 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All rights reserved.
C1 [Aminzadeh, Z.] Univ Hosp Geelong, Infect Dis Dept, Geelong, Vic 3220, Australia.
   [Simpson, P.] Univ Hosp Geelong, Infect Prevent Serv, Geelong, Vic 3220, Australia.
   [Athan, E.] Barwon Hlth, Infect Dis Dept, Geelong, Vic 3220, Australia.
   [Athan, E.] Deakin Univ, Geelong, Vic 3220, Australia.
RP Aminzadeh, Z (reprint author), 2-21 Highland Crescent, Goonellabah, NSW 2480, Australia.
EM zohrehaminzadeh@yahoo.com
CR Almuneef MA, 2006, J HOSP INFECT, V62, P207, DOI 10.1016/j.jhin.2005.06.032
   Bell T, 2017, INFECT DIS CLIN N AM, V31, P551, DOI 10.1016/j.idc.2017.05.007
   Braun E, 2014, CLIN MICROBIOL INFEC, V20, pO627, DOI 10.1111/1469-0691.12565
   Chee L, 2008, J INFECTION, V56, P227, DOI 10.1016/j.jinf.2008.01.046
   Chopra V, 2014, AM J MED, V127, P319, DOI 10.1016/j.amjmed.2014.01.001
   Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737
   Climo M, 2003, INFECT CONT HOSP EP, V24, P942, DOI 10.1086/502163
   Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P229, DOI 10.1001/archsurg.136.2.229
   Entesari-Tatafi D, 2015, MED J AUSTRALIA, V202, P247, DOI 10.5694/mja14.01644
   Gahlot R, 2014, INT J CRIT ILLN INJ, V4, P162, DOI DOI 10.4103/2229-5151.134184
   Gunst M, 2011, SURG INFECT, V12, P279, DOI 10.1089/sur.2008.058
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Kontula KSK, 2016, INFECT DIS-NOR, V48, P379, DOI 10.3109/23744235.2015.1131329
   Li L, 2016, INFECT CONT HOSP EP, V37, P1186, DOI 10.1017/ice.2016.150
   Lin KY, 2017, J MICROBIOL IMMUNOL, V50, P339, DOI 10.1016/j.jmii.2015.07.001
   Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
   Milstone AM, 2013, PEDIATRICS, V132, pE1609, DOI 10.1542/peds.2013-1645
   Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489
   Sagana R, 2013, CRIT CARE CLIN, V29, P1, DOI 10.1016/j.ccc.2012.10.003
   Saliba P, 2018, J HOSP INFECT, V99, P48, DOI 10.1016/j.jhin.2017.11.002
   Sato A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2536-0
   Spelman T, 2017, EPIDEMIOL INFECT, V145, P3047, DOI 10.1017/S095026881700187X
   Suljagic V, 2018, AM J INFECT CONTROL, V33, P333
   Takeshita N, 2017, J HOSP INFECT, V96, P29, DOI 10.1016/j.jhin.2017.02.022
   Tedja R, 2014, INFECT CONT HOSP EP, V35, P164, DOI 10.1086/674856
   Tsuboi M, 2017, C ESCMID APR, P20
   Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D
   Worth LJ, 2018, J HOSP INFECT, V99, P55, DOI 10.1016/j.jhin.2017.11.021
   Worth LJ, 2015, AM J INFECT CONTROL, V43, P848, DOI 10.1016/j.ajic.2015.03.036
   Worth LJ, 2012, CURR OPIN INFECT DIS, V25, P650, DOI 10.1097/QCO.0b013e32835a0d1a
   Yamaguchi RS, 2017, INTENS CARE MED, V43, P1097, DOI 10.1007/s00134-017-4852-7
   Yap HY, 2018, J VASC ACCESS, V19, P602, DOI 10.1177/1129729818765055
   Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481
   Zhang SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10037-2
NR 34
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2468-0451
J9 INFECT DIS HEALTH
JI Infect. Dis. Health
PD NOV
PY 2019
VL 24
IS 4
BP 222
EP 228
DI 10.1016/j.idh.2019.07.003
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JH4GO
UT WOS:000492727100007
PM 31401054
DA 2020-05-07
ER

PT J
AU Wang, BB
   Wang, YF
   Cui, XY
   Zhang, YM
   Yu, ZS
AF Wang, Bobo
   Wang, Yanfen
   Cui, Xiaoyong
   Zhang, Yiming
   Yu, Zhisheng
TI Bioconversion of coal to methane by microbial communities from soil and
   from an opencast mine in the Xilingol grassland of northeast China
SO BIOTECHNOLOGY FOR BIOFUELS
LA English
DT Article
DE Opencast coal mine; Coal; Grassland soil; Microbial community;
   Biomethane
ID BIOGENIC METHANE; BACTERIAL; WATER; GAS; DIVERSITY; BASIN; BED;
   CONSORTIUM; GENERATION; NUTRIENT
AB Background The Xilingol grassland ecosystem has abundant superficial coal reserves. Opencast coal mining and burning of coal for electricity have caused a series of environmental challenges. Biogenic generation of methane from coal possesses the potential to improve economic and environmental outcomes of clean coal utilization. However, whether the microbes inhabiting the grassland soil have the functional potential to convert coal into biomethane is still unclear. Results Microbial communities in an opencast coal mine and in grassland soil covering and surrounding this mine and their biomethane production potential were investigated by Hiseq sequencing and anaerobic cultivation. The microbial communities in covering soil showed high similarity to those in the surrounding soil, according to the pairwise weighted UniFrac distances matrix. The majority of bacterial communities in coal and soil samples belonged to the phyla Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria. The dominant bacterial genera in grassland soil included Gaiella, Solirubrobacter, Sphingomonas and Streptomyces; whereas, the most abundant genus in coal was Pseudarthrobacter. In soil, hydrogenotrophic Methanobacterium was the dominant methanogen, and this methanogen, along with acetoclastic Methanosarcina and methylotrophic Methanomassiliicoccus, was detected in coal. Network-like Venn diagram showed that an average of 28.7% of microbial communities in the samples belonged to shared genera, indicating that there is considerable microbial overlap between coal and soil samples. Potential degraders and methanogens in the soil efficiently stimulated methane formation from coal samples by the culturing-based approach. The maximum biogenic methane yields from coal degradation by the microbial community cultured from grassland soil reached 22.4 mu mol after 28 day. Conclusion The potential microbial coal degraders and methanogenic archaea in grassland soil were highly diverse. Significant amounts of biomethane were generated from coal by the addition of grassland soil microbial communities. The unique species present in grassland soil may contribute to efficient methanogenic coal bioconversion. This discovery not only contributes to a better understanding of global microbial biodiversity in coal mine environments, but also makes a contribution to our knowledge of the synthetic microbiology with regard to effective methanogenic microbial consortia for coal degradation.
C1 [Wang, Bobo; Yu, Zhisheng] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
   [Wang, Yanfen; Cui, Xiaoyong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.
   [Zhang, Yiming] Beijing Municipal Ecol Environm Bur, Beijing 100048, Peoples R China.
RP Yu, ZS (reprint author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
EM yuzs@ucas.ac.cn
FU Strategic Priority Research Program (B) of the Chinese Academy of
   Sciences [XDB05010200]
FX Funding was provided by the Strategic Priority Research Program (B) of
   the Chinese Academy of Sciences (Grant No. XDB05010200).
CR Nguyen AD, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5487-6
   Avsejs LA, 1998, ORG GEOCHEM, V28, P749, DOI 10.1016/S0146-6380(98)00026-6
   Beckmann S, 2019, ISME J, V13, P632, DOI 10.1038/s41396-018-0296-5
   da Fonseca MMB, 2019, FUEL, V236, P1311, DOI 10.1016/j.fuel.2018.09.107
   Bonnetti C, 2014, CRETACEOUS RES, V48, P177, DOI 10.1016/j.cretres.2013.09.013
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chen P, 2000, FUEL PROCESS TECHNOL, V62, P77, DOI 10.1016/S0378-3820(99)00115-0
   Colosimo F, 2016, INT J COAL GEOL, V165, P106, DOI 10.1016/j.coal.2016.08.011
   Dai GS, 2014, ENERG POLICY, V67, P146, DOI 10.1016/j.enpol.2013.12.033
   De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079
   Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197
   Duran R, 2010, HDB HYDROCARBON LIPI, P1725, DOI DOI 10.1007/978-3-540-77587-4_122
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011
   Elshahed MS, 2001, APPL ENVIRON MICROB, V67, P5520, DOI 10.1128/AEM.67.12.5520-5525.2001
   Eren AM, 2015, ISME J, V9, P90, DOI 10.1038/ismej.2014.97
   Fakoussa RM, 1999, APPL MICROBIOL BIOT, V52, P25, DOI 10.1007/s002530051483
   Falagan C, 2016, MINING MEETS WATER - CONFLICTS AND SOLUTIONS, P796
   Fallgren PH, 2013, INT J COAL GEOL, V115, P92, DOI 10.1016/j.coal.2013.01.014
   Gan HM, 2011, CHEMOSPHERE, V82, P507, DOI 10.1016/j.chemosphere.2010.10.094
   Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665
   Gasparich GE, 2014, FAMILY ENTOMOPLASMAT, P505
   Ghose MK, 2000, ENVIRON MONIT ASSESS, V61, P255, DOI 10.1023/A:1006127407401
   Green MS, 2008, INT J COAL GEOL, V76, P34, DOI 10.1016/j.coal.2008.05.001
   Guo HG, 2015, INT J COAL GEOL, V150, P120, DOI 10.1016/j.coal.2015.08.012
   Guo HG, 2012, INT J COAL GEOL, V93, P56, DOI 10.1016/j.coal.2012.01.014
   GUPTA RK, 1988, CAN J MICROBIOL, V34, P667, DOI 10.1139/m88-110
   Hang I, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-201
   Harris RF, 1981, SOIL SCI SOC AM J, P23, DOI DOI 10.2136/SSSASPECPUB9.C2
   He H, 2016, ENERG SOURCE PART A, V38, P1377, DOI 10.1080/15567036.2014.927541
   Heinz B, 2009, ENVIRON GEOL, V57, P797, DOI 10.1007/s00254-008-1359-0
   Hosseini SE, 2013, RENEW SUST ENERG REV, V19, P454, DOI 10.1016/j.rser.2012.11.008
   Hvistendahl M, 2007, SCI AM, P13
   in 't Zandt MH, 2018, MICROB BIOTECHNOL, V11, P626, DOI 10.1111/1751-7915.12853
   Kasai Y, 2002, ENVIRON MICROBIOL, V4, P141, DOI 10.1046/j.1462-2920.2002.00275.x
   Kirk MF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01287
   Kuroda K, 2015, MICROB ECOL, V69, P586, DOI 10.1007/s00248-014-0525-z
   Leys NM, 2005, APPL MICROBIOL BIOT, V66, P726, DOI 10.1007/s00253-004-1766-4
   Li DM, 2008, INT J COAL GEOL, V76, P14, DOI 10.1016/j.coal.2008.04.007
   Lockwood AH, 2009, PHYS SOCIAL RESPONSI
   Ma Q, 2015, MICROBIOL RES, V175, P1, DOI 10.1016/j.micres.2014.12.013
   Mayumi D, 2016, SCIENCE, V354, P222, DOI 10.1126/science.aaf8821
   Mesle M, 2013, RES MICROBIOL, V164, P959, DOI 10.1016/j.resmic.2013.07.004
   Midgley DJ, 2010, INT J COAL GEOL, V82, P232, DOI 10.1016/j.coal.2010.01.009
   Mishra VK, 2008, BIORESOURCE TECHNOL, V99, P930, DOI 10.1016/j.biortech.2007.03.010
   Nunoura T, 2010, APPL ENVIRON MICROB, V76, P1198, DOI 10.1128/AEM.00924-09
   O'Mara FP, 2012, ANN BOT-LONDON, V110, P1263, DOI 10.1093/aob/mcs209
   Park C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01081
   Penger J, 2012, APPL ENVIRON MICROB, V78, P7596, DOI 10.1128/AEM.01773-12
   Penner TJ, 2010, INT J COAL GEOL, V82, P81, DOI 10.1016/j.coal.2010.02.002
   Petro C, 2017, AQUAT MICROB ECOL, V79, P177, DOI 10.3354/ame01826
   Prabhu Y, 2003, APPL MICROBIOL BIOT, V61, P342, DOI 10.1007/s00253-002-1218-y
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Robbins SJ, 2016, INT J COAL GEOL, V154, P205, DOI 10.1016/j.coal.2016.01.001
   Ross DE, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01024-16
   Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58
   Schimel JP, 2018, ANNU REV ECOL EVOL S, V49, P409, DOI 10.1146/annurev-ecolsys-110617-062614
   Scott S, 2007, INT J COAL GEOL, V70, P209, DOI 10.1016/j.coal.2006.04.010
   Sekhohola LM, 2014, BIOSCI BIOTECH BIOCH, V78, P1797, DOI 10.1080/09168451.2014.930325
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shimizu S, 2007, GEOBIOLOGY, V5, P423, DOI 10.1111/j.1472-4669.2007.00123.x
   Singh DN, 2012, APPL MICROBIOL BIOT, V93, P1337, DOI 10.1007/s00253-011-3778-1
   Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073
   Stott MB, 2016, CHTHONOMONAS BERGEYS
   Strapoc D, 2008, APPL ENVIRON MICROB, V74, P2424, DOI 10.1128/AEM.02341-07
   Strapoc D, 2011, ANNU REV EARTH PL SC, V39, P617, DOI 10.1146/annurev-earth-040610-133343
   Su XB, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1237-2
   Tang YQ, 2012, INT J COAL GEOL, V90, P21, DOI 10.1016/j.coal.2011.09.009
   Tiwary RK, 2001, WATER AIR SOIL POLL, V132, P185, DOI 10.1023/A:1012083519667
   Vick SHW, 2018, INT J COAL GEOL, V186, P41, DOI 10.1016/j.coal.2017.12.003
   Wang BB, 2019, INT J COAL GEOL, V202, P85, DOI 10.1016/j.coal.2018.12.004
   Wang H, 2016, INT J COAL GEOL, V154, P107, DOI 10.1016/j.coal.2015.12.006
   Wang JM, 2015, ENVIRON EARTH SCI, V73, P4749, DOI 10.1007/s12665-014-3761-0
   Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08
   Wegner CE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01023
   Wei M, 2014, INT J COAL GEOL, V134, P96, DOI 10.1016/j.coal.2014.09.008
   Welte C, 2014, BBA-BIOENERGETICS, V1837, P1130, DOI 10.1016/j.bbabio.2013.12.002
   Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x
   Youtcheff J. S, 1983, ORG GEOCHEM, V5, P157
   Zeri C, 2009, CONT SHELF RES, V29, P886, DOI 10.1016/j.csr.2009.01.007
   Zhalnina KV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101648
   Zhang H, 2017, J HAZARD MATER, V327, P1, DOI 10.1016/j.jhazmat.2016.12.038
   Zhang J, 2016, APPL ENERG, V165, P559, DOI 10.1016/j.apenergy.2015.12.067
   Zhao ZQ, 2013, EUR J SOIL BIOL, V55, P40, DOI 10.1016/j.ejsobi.2012.08.006
   Zhu H, 2017, BIORESOURCE TECHNOL, V245, P786, DOI 10.1016/j.biortech.2017.09.029
NR 85
TC 1
Z9 1
U1 4
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1754-6834
J9 BIOTECHNOL BIOFUELS
JI Biotechnol. Biofuels
PD OCT 8
PY 2019
VL 12
IS 1
AR 236
DI 10.1186/s13068-019-1572-y
PG 15
WC Biotechnology & Applied Microbiology; Energy & Fuels
SC Biotechnology & Applied Microbiology; Energy & Fuels
GA JC2SM
UT WOS:000489126800003
PM 31624498
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Tebano, G
   Dyar, OJ
   Beovic, B
   Claudot, F
   Beraud, G
   Thilly, N
   Pulcini, C
AF Tebano, Gianpiero
   Dyar, Oliver J.
   Beovic, Bojana
   Claudot, Frederique
   Beraud, Guillaume
   Thilly, Nathalie
   Pulcini, Celine
CA ESCMID Study Grp
   Antimicrobial StewardshiP ESGAP
TI Practices, organisation, and regulatory aspects in advising on
   antibiotic prescription: the international ESCMID AntibioLegalMap survey
SO INFECTION
LA English
DT Article
DE Antibiotic prescribing; Consultation; Antibiotic stewardship;
   Regulation; Professional liability
ID CURBSIDE CONSULTATIONS; IMPACT; COMMUNICATION; MANAGEMENT; OUTCOMES;
   PROGRAM
AB Purpose Giving advice about antibiotic prescription through dedicated consultations is a cornerstone of antibiotic stewardship programmes. Our objective was to explore practices, organisation, and regulatory requirements related to antibiotic advising.
   Methods We performed an international, exploratory, Internet-based, cross-sectional survey targeting infectious diseases and clinical microbiology specialists. It was disseminated through ESCMID and ESGAP networks.
   Results Answers from 830 participants (74 countries, 77% of participants from Europe) were collected. Consultations were mostly given on demand (81%, 619/764), while unsolicited consultations targeting specific conditions (e.g., positive blood culture) were less frequent (66%, 501/764). Consultations usually included indications on diagnostic work-up and follow-up (>79%). Curbside consultations (i.e., without examining the patient) were reported by 82% (598/733) of respondents, mainly by phone (89%, 531/598). The referring physician was considered authorised not to follow the advice by 57% (383/676). Direct consultations (i.e., after examining the patient) were recorded in the medical file more frequently than curbside consultations (69%, 472/689 vs 35%, 206/592). Concerning legal liability, the majority of respondents considered that it is shared between the adviser and the referring physician, who, however, is considered primarily responsible. The advisers' liability was considered to be lower in cases of curbside and unrecorded consultations. Significant inter-countries and intra-country variability were identified, suggesting that the setting markedly influenced practices.
   Conclusion Significant variability exists in the practice of antibiotic advising. This concerns both the organisation of care and how advisers perceive regulatory requirements. These elements must be taken into account when implementing antibiotic stewardship programmes and when training stewards.
C1 [Tebano, Gianpiero; Claudot, Frederique; Thilly, Nathalie; Pulcini, Celine] Univ Lorraine, APEMAC, F-54000 Nancy, France.
   [Dyar, Oliver J.] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth Hlth Syst & Policy, Stockholm, Sweden.
   [Beovic, Bojana] Univ Ljubljana, Fac Med, Ljubljana, Slovenia.
   [Beovic, Bojana] Univ Med Ctr Ljubljana, Ljubljana, Slovenia.
   [Claudot, Frederique] Univ Lorraine, CHRU Nancy, Plateforme Aide Rech Clin, F-54000 Nancy, France.
   [Beraud, Guillaume] Univ Laval, CHU Quebec, Ctr Rech, Hop St Sacrement, Chemin Sainte Foy, PQ, Canada.
   [Beraud, Guillaume] CHU Poitiers, Med Interne & Malad Infectieuses, Poitiers, France.
   [Beraud, Guillaume] Hasselt Univ, Bioinformat Censtat, Interuniv Inst Biostat & Stat, Hasselt, Belgium.
   [Pulcini, Celine] Univ Lorraine, CHRU Nancy, Dept Infect Dis, F-54000 Nancy, France.
   [Tebano, Gianpiero] Hop La Pitie Salpetriere, AP HP, Dept Infect Dis, Paris, France.
RP Tebano, G (reprint author), Univ Lorraine, APEMAC, F-54000 Nancy, France.; Tebano, G (reprint author), Hop La Pitie Salpetriere, AP HP, Dept Infect Dis, Paris, France.
EM gianpiero.tebano@gmail.com
RI Beraud, Guillaume/O-6062-2017
OI Beraud, Guillaume/0000-0002-4705-0916
CR [Anonymous], OP VIRT LEARN COMM
   Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13
   Beovic B, 2009, J CHEMOTHERAPY, V21, P46, DOI 10.1179/joc.2009.21.1.46
   Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520
   Cook DA, 2014, MAYO CLIN PROC, V89, P602, DOI 10.1016/j.mayocp.2014.01.015
   Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393
   Diallo K, 2018, INT J ANTIMICROB AG, V51, P794, DOI 10.1016/j.ijantimicag.2017.12.010
   Dickstein Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.06.014
   Dyar OJ, 2017, CLIN MICROBIOL INFEC, V23, P793, DOI 10.1016/j.cmi.2017.08.026
   Dyar OJ, 2016, FUTURE MICROBIOL, V11, P1057, DOI 10.2217/fmb-2016-0041
   Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35
   Forsblom E, 2013, CLIN INFECT DIS, V56, P527, DOI 10.1093/cid/cis889
   Fox BC, 1996, CLIN INFECT DIS, V23, P616, DOI 10.1093/clinids/23.3.616
   General Medical Coucil, GOOD MED PRACTICE
   Grace C, 2010, CLIN INFECT DIS, V51, P651, DOI 10.1086/655829
   Howard P, 2015, J ANTIMICROB CHEMOTH, V70, P1245, DOI 10.1093/jac/dku497
   Ingram PR, 2014, CLIN MICROBIOL INFEC, V20, pO737, DOI 10.1111/1469-0691.12581
   Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9
   Linkin DR, 2007, INFECT CONT HOSP EP, V28, P1374, DOI 10.1086/523861
   Manian FA, 1996, JAMA-J AM MED ASSOC, V275, P145
   Manian FA, 1996, CLIN INFECT DIS, V22, P303, DOI 10.1093/clinids/22.2.303
   Pulcini C, 2019, CLIN MICROBIOL INFEC, V25, P20, DOI 10.1016/j.cmi.2018.03.033
   Pulcini C, 2014, CLIN MICROBIOL INFEC, V20, P963, DOI 10.1111/1469-0691.12751
   Rieg S, 2019, INFECTION, V47, P27, DOI 10.1007/s15010-018-1191-8
   Sellier E, 2010, J ANTIMICROB CHEMOTH, V65, P156, DOI 10.1093/jac/dkp406
   Shanks L, 2012, INT J TUBERC LUNG D, V16, P1066, DOI 10.5588/ijtld.11.0240
   Tebano G, 2018, J ANTIMICROB CHEMOTH, V73, P1989, DOI 10.1093/jac/dky098
   Uckay I, 2009, J INFECTION, V58, P205, DOI 10.1016/j.jinf.2009.01.012
   Yam P, 2012, AM J HEALTH-SYST PH, V69, P1142, DOI 10.2146/ajhp110512
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
PD OCT
PY 2019
VL 47
IS 5
BP 749
EP 760
DI 10.1007/s15010-019-01298-2
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA KF2TZ
UT WOS:000509101900006
PM 30903590
DA 2020-05-07
ER

PT J
AU Imam, N
   Alam, A
   Ali, R
   Siddiqui, MF
   Ali, S
   Malik, MZ
   Ishrat, R
AF Imam, Nikhat
   Alam, Aftab
   Ali, Rafat
   Siddiqui, Mohd Faizan
   Ali, Sher
   Malik, Md Zubbair
   Ishrat, Romana
TI In silico characterization of hypothetical proteins from Orientia
   tsutsugamushi str. Karp uncovers virulence genes
SO HELIYON
LA English
DT Article
DE Biochemistry; Bioinformatics; Genetics; Microbiology; Functional
   annotation; Hypothetical proteins (HPs); Scrub typhus; ROC analysis;
   Virulence
ID DNA-BINDING-PROTEIN; SCRUB TYPHUS; INTERACTION NETWORKS; PREDICTION;
   TARGETS
AB Scrub typhus also known as bush typhus is a disease with symptoms similar to Chikungunya infection. It is caused by a gram-negative bacterium Orientia tsutsugamushi which resides in its vertebrate host, Mites. The genome of Orientia tsutsugamushi str. Karp encodes for 1,563 proteins, of which 344 are characterized as hypothetical ones. In the present study, we tried to identify the probable functions of these 344 hypothetical proteins (HPs). All the characterized hypothetical proteins (HPs) belong to the various protein classes like enzymes, transporters, binding proteins, metabolic process and catalytic activity and kinase activity. These hypothetical proteins (HPs) were further analyzed for virulence factors with 62 proteins identified as the most virulent proteins among these hypothetical proteins (HPs). In addition, we studied the protein sequence similarity network for visualizing functional trends across protein superfamilies from the context of sequence similarity and it shows great potential for generating testable hypotheses about protein structure-function relationships. Furthermore, we calculated toplogical properties of the network and found them to obey network power law distributions showing a fractal nature. We also identifed two highly interconnected modules in the main network which contained five hub proteins (KJV55465, KJV56211, KJV57212, KJV57203 and KJV57216) having 1.0 clustering coefficient. The structural modeling (2D and 3D structure) of these five hub proteins was carried out and the catalytic site essential for its functioning was analyzed. The outcome of the present study may facilitate a better understanding of the mechanism of virulence, pathogenesis, adaptability to host and up-to-date annotations will make unknown genes easy to identify and target for experimentation. The information on the functional attributes and virulence characteristic of these hypothetical proteins (HPs) are envisaged to facilitate effective development of novel antibacterial drug targets of Orientia tsutsugamushi.
C1 [Imam, Nikhat] Magadh Univ, Inst Comp Sci & Informat Technol, Bodhgaya, India.
   [Imam, Nikhat; Alam, Aftab; Ali, Rafat; Ali, Sher; Ishrat, Romana] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.
   [Siddiqui, Mohd Faizan] Osh State Univ, Int Med Fac, Osh City 723500, Kyrgyzstan.
   [Malik, Md Zubbair] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, Delhi 110067, India.
RP Ishrat, R (reprint author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.
EM rishrat@jmi.ac.in
OI Siddiqui, Mohd Faizan/0000-0001-6634-076X
FU Senior Research Fellowship (SRF) of the Indian Council of Medical
   Research (ICMR); Department of Health Research (DHR)
FX R.A, S.A and MZM are grateful to the Centre for Interdisciplinary
   Research in Basic Sciences (CIRBSc), Jamia Millia Islamia for providing
   the research infrastructure. Nikhat Imam is supported by a Senior
   Research Fellowship (SRF) of the Indian Council of Medical Research
   (ICMR), AA and MZM are supported by the Department of Health Research
   (DHR) under Young Scientist Fellowships.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685
   Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309
   Briani F, 2016, WIRES RNA, V7, P241, DOI 10.1002/wrna.1328
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x
   Cheng S., 2014, FRONT ECOL EVOL, V2
   Chu H, 2006, INFECT IMMUN, V74, P4246, DOI 10.1128/IAI.01620-05
   Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111
   de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124
   Desler C, 2012, METHODS MOL BIOL, V815, P25, DOI 10.1007/978-1-61779-424-7_3
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471250953.bi0506s15, 10.1002/cpbi.3, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]
   Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6
   Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62
   Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424
   Griffith M, 2014, INDIAN J CRIT CARE M, V18, P497, DOI 10.4103/0972-5229.138145
   GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155
   Hawkins T, 2009, PROTEINS, V74, P566, DOI 10.1002/prot.22172
   Ijaq J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00119
   Islam Md. Saiful, 2015, Genomics & Informatics, V13, P53, DOI 10.5808/GI.2015.13.2.53
   Jain Deepak, 2019, Med Pharm Rep, V92, P36, DOI 10.15386/cjmed-1088
   Jeong YJ, 2007, RADIOGRAPHICS, V27, P161, DOI 10.1148/rg.271065074
   Jian Huahua, HISTONE LIKE NUCLEOI
   Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x
   Kedar GC, 2007, ANTIMICROB AGENTS CH, V51, P1708, DOI 10.1128/AAC.01180-06
   Khan IK, 2015, BIOINFORMATICS, V31, P271, DOI 10.1093/bioinformatics/btu646
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lee CS, 2009, AM J TROP MED HYG, V81, P484, DOI 10.4269/ajtmh.2009.81.484
   Lee TK, 2013, CURR OPIN MICROBIOL, V16, P760, DOI 10.1016/j.mib.2013.08.005
   Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949
   Luce-Fedrow Alison, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3010008
   Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x
   Min CK, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/623145
   Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479
   Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628
   Sanchez-Rodriguez A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-349
   Sharma D, 2019, J MOL RECOGNIT, V32, DOI 10.1002/jmr.2766
   Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007
   Singh T, 2011, J CHEM INF MODEL, V51, P2515, DOI 10.1021/ci200193z
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Vetrivel Umashankar, 2011, Hugo J, V5, P25, DOI 10.1007/s11568-011-9152-7
   Wang G, 2015, J BACTERIOL, V197, P973, DOI 10.1128/JB.02489-14
   Weber MM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00001
   Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498
   Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006062
   Yang Xiaoliang, 2010, Weishengwu Xuebao, V50, P774
   Younis HS, 2013, COMPREHENSIVE GUIDE TO TOXICOLOGY IN PRECLINICAL DRUG DEVELOPMENT, P647, DOI 10.1016/B978-0-12-387815-1.00026-5
   Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018
   Zeng XM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00128
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD OCT
PY 2019
VL 5
IS 10
AR e02734
DI 10.1016/j.heliyon.2019.e02734
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JK1XQ
UT WOS:000494641300115
PM 31720472
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Ndzi, EN
   Nkenfou, CN
   Pefura, EWY
   Mekue, LCM
   Guiedem, E
   Nguefeu, CN
   Ngoufack, MN
   Elong, E
   Yatchou, LG
   Ndjolo, A
   Kuiate, JR
AF Ndzi, Elvis Ndukong
   Nkenfou, Celine Nguefeu
   Pefura, Eric Walter Yone
   Mekue, Linda Chapdeleine Mouafo
   Guiedem, Elise
   Nguefeu, Carine Nkenfou
   Ngoufack, Marie Nicole
   Elong, Elise
   Yatchou, Laeticia Grace
   Ndjolo, Alexis
   Kuiate, Jules-Roger
TI Tuberculosis diagnosis: algorithm that May discriminate latent from
   active tuberculosis
SO HELIYON
LA English
DT Article
DE Immunology; Microbiology; Genetics; Clinical genetics; Infectious
   disease; Tuberculosis; Diagnosis; Latency; Active TB; quantiFERON;
   HLA-Haplotypes; Epitope; Algorithm
ID PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; ALLELES; SUSCEPTIBILITY;
   METAANALYSIS; ASSOCIATION; MARKERS
AB Diagnosis of tuberculosis still faces a lot of challenges and is one of the priorities in the field of tuberculosis management. Deciphering the complex tuberculosis pathogenicity network could provide biomarkers for diagnosis. We discussed the distribution of HLA-B17, -DQB and -DRB together with QuantiFERON test results in tuberculosis infection. A case control study was done during which a total of 337 subjects were enrolled comprising 227 active tuberculosis (ATB), 46 latent tuberculosis infection (LTBI) and 64 healthy controls (HC). Sequence-specific primer polymerase chain reaction and immune epitope database were used to genotype samples and determine the epitope binding ability of the over-represented alleles respectively. QuantiFERON test was done according to manufacturer's instructions. The peptides HLA-B*5801 and HLA-DRB1*12 and the peptides HLA-B*5802 and HLA-DQB1*03 were found to be associated with latent tuberculosis while the haplotypes DRB1*10-DQB1*02 and DRB1*13-DQB1*06 were found to be associated with active tuberculosis (All p-values <= 0.05). The association of HLA-B*5801 and HLA-B*5802 with latent tuberculosis was linked to their ability to bind or not mycobacterial antigens. DRB1*10-DQB1*02 haplotype was found to be over-represented in LTBI compared to ATB (p-value = 0.0015) while DRB1*13-DQB1*06 was found to be under-represented in LTBI compared to ATB (p-value = 0.0335). The DRB1*10-DQB1*02 haplotype was only found in the LTBI when compared with the ATB group. The present study suggests the following algorithm to discriminate LTBI from ATB: QuantiFERON+ and DRB1*10-DQB1*02 haplotype + may indicate LTBI; QuantiFERON+ and DRB1*10DQB1*02 haplotype - may indicate ATB.
C1 [Ndzi, Elvis Ndukong; Nkenfou, Celine Nguefeu; Mekue, Linda Chapdeleine Mouafo; Ngoufack, Marie Nicole; Elong, Elise; Yatchou, Laeticia Grace; Ndjolo, Alexis] Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.
   [Ndzi, Elvis Ndukong; Mekue, Linda Chapdeleine Mouafo; Kuiate, Jules-Roger] Univ Dschang, Fac Sci, Dept Biochem, Dschang, Cameroon.
   [Nkenfou, Celine Nguefeu] Univ Yaounde I, Higher Teachers Training Coll, Dept Biol, Yaounde, Cameroon.
   [Pefura, Eric Walter Yone] Yaounde Jamot Hosp, Pneumol Serv, Yaounde, Cameroon.
   [Pefura, Eric Walter Yone; Ndjolo, Alexis] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.
   [Guiedem, Elise] CSCCD, Yaounde, Cameroon.
   [Guiedem, Elise; Nguefeu, Carine Nkenfou; Ngoufack, Marie Nicole] Univ Yaounde I, Fac Sci, Dept Biochem, Yaounde, Cameroon.
RP Nkenfou, CN (reprint author), Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.; Nkenfou, CN (reprint author), Univ Yaounde I, Higher Teachers Training Coll, Dept Biol, Yaounde, Cameroon.
EM nkenfou@yahoo.com
FU Chantal Biya International Reference Centre, Yaounde, Cameroon
FX This work was supported by the Chantal Biya International Reference
   Centre, Yaounde, Cameroon.
CR Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990
   Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046
   Ayubi E, 2017, EPIDEMIOL INFECT, V145, P1824, DOI 10.1017/S0950268817000334
   Ayubi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161983
   Chen BF, 2015, GENET MOL RES, V14, P15859, DOI 10.4238/2015.December.1.37
   Doosti-Irani A, 2016, OCCUP MED-OXFORD, V66, P437, DOI 10.1093/occmed/kqw035
   Duarte R, 2011, REV PORT PNEUMOL, V17, P15
   Dye C., 2008, GLOBAL TUBERCULOSIS, V1, P17
   Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981
   HIROKAWA K, 1992, ACTA PATHOL JAPON, V42, P537
   Kettaneh A, 2006, INT J TUBERC LUNG D, V10, P717
   Kumar V, 2007, ROBBINS BASIC PATHOL, P516
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10
   Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071
   Ndzi EN, 2016, INT J MYCOBACT, V5, P177, DOI 10.1016/j.ijmyco.2016.02.005
   Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124
   Oliveira-Cortez A, 2016, EUR J CLIN MICROBIOL, V35, P1567, DOI 10.1007/s10096-016-2713-x
   Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499
   Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121
   UNDP, 2015, DISC PAP GEND TUB
   Wamala D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1346-0
   Welin A, 2015, INFECT IMMUN, V83, P205, DOI 10.1128/IAI.02493-14
   WHO, 2017, WHO GLOB TUB REP
   Yuliwulandari R, 2010, HUM IMMUNOL, V71, P697, DOI 10.1016/j.humimm.2010.04.005
   Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18
NR 26
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD OCT
PY 2019
VL 5
IS 10
AR e02559
DI 10.1016/j.heliyon.2019.e02559
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JK1XQ
UT WOS:000494641300185
PM 31692671
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Alghooneh, A
   Behrouzian, F
   Yazdi, FT
   Hashemi, SMB
   Razavi, SMA
   Behbahani, BA
AF Alghooneh, Ali
   Behrouzian, Fatane
   Yazdi, Farideh Tabatabaei
   Hashemi, Seyed M. B.
   Razavi, Seyed M. A.
   Behbahani, Behrooz Alizadeh
TI Kinetic pattern and microbial population dynamic characterization of
   Escherichia coli and Salmonella enteritidis in Frankfurter sausage: An
   experimental and modeling study
SO JOURNAL OF FOOD SAFETY
LA English
DT Article
ID ARTIFICIAL NEURAL-NETWORK; ANTIBACTERIAL ACTIVITY; S. AUREUS; E. COLI;
   PREDICTION; NITRITE; DRY
AB Concerns over the safety of nitrite and its role in the formation of nitrosamines have aroused considerable interest in developing alternative antimicrobial agents to replace nitrite. Plant-derived antimicrobial agents could serve against food spoilage and pathogens. For the first time in this study, three semiempirical kinetic models, that is, exponential, homographic, and n-order kinetic models were established to describe the microbiological population pattern and dynamic behavior. The Escherichia coli and Salmonella enteritidis population dynamics were investigated in Frankfurter sausage as a complex food system, contained four different antimicrobial redcurrant extract (RE) concentrations (0, 0.1, 0.2, and 0.4% wt/wt) at two temperatures (4 and 25 degrees C) during 17 days storage. Furthermore, the results were compared with a neuro-fuzzy system. Although, all three kinetic models showed a reasonable prediction accuracy, homographic kinetic model was the best for predicting antibacterial effects of RE against E. coli (R-2 = 0.94-1, Radj2 = 0.93-0.99, Q-squared = 0.80-0.89, and RMSE = 0.21-0.68) and the n-order kinetic model did the best in describing the kinetic pattern of S. enteritidis (R-2 = 0.97-0.99, Radj2 = 0.94-0.99, Q-squared = 0.85-0.93, RMSE = 0.06-0.74). The increase in the RE concentration and temperature resulted in the increase of kinetic parameters of microbial population decline rate and extent for both bacteria, significantly. Furthermore, all the homographic model parameters (except of equilibrium population, p(infinity)) and all the kinetic model parameters with n order (except of reaction order) the synergistic effect of temperature and concentration was clear. RE at 0.4% concentration induced 0.12 log colony forming unit (CFU)/g E. coli and 0.45 log CFU/g S. enteritidis equilibrium population (p(infinity)) at 17th day of storage at 25 degrees C. Compared to S. enteritidis, E. coli was more sensitive to RE concentration at both temperatures. Practical applications Most formulations of the meat products contain nitrite as a main ingredient to prohibit the pathogenic bacteria growth. The results of the present study showed that all the three studied kinetic models (exponential, homographic, and n-order kinetic models) appropriately modeled the S. enteritidis and E. coli population dynamics. Regarding the statistical parameters, n-order and homographic kinetic models were found to be the best models for predicting antibacterial effects of RE against S. enteritidis and E. coli, respectively. Furthermore, E. coli was more sensitive against RE than S. enteritidis in Frankfurter sausage samples at 4 and 25 degrees C during 17 days storage. With the increase in the RE concentration at the constant temperature and with the increase in temperature at the constant extract concentration, the decline rate of E. coli population increased significantly (p < .05), while the needed time for 50% reduction decreased; besides, S. enteritidis population dynamics showed the increase in the rate and extent of decline, and a decrease in the equilibrium microbial population at these conditions (p < .05). No significant differences were observed between the neuro-fuzzy system results and semiempirical kinetic models in the prediction of microbiological population dynamic.
   Nevertheless, the novel semiempirical models presented important biological parameters, which provided a better understanding of the systems biological state than the neuro-fuzzy system. These results could offer new perspectives in the field of microbiology.
C1 [Alghooneh, Ali; Behrouzian, Fatane; Yazdi, Farideh Tabatabaei; Razavi, Seyed M. A.] Ferdowsi Univ Mashhad, Fac Agr, Dept Food Sci & Technol, Mashhad, Razavi Khorasan, Iran.
   [Hashemi, Seyed M. B.] Fasa Univ, Fac Agr, Dept Food Sci & Technol, Fasa, Iran.
   [Behbahani, Behrooz Alizadeh] Agr Sci & Nat Resources Univ Khuzestan, Fac Anim Sci & Food Technol, Dept Food Sci & Technol, Mollasani, Iran.
RP Yazdi, FT (reprint author), Ferdowsi Univ Mashhad, Fac Agr, Dept Food Sci & Technol, Mashhad, Razavi Khorasan, Iran.
EM tabatabai@um.ac.ir
RI Hashemi, Seyed Mohammad Bagher/H-7751-2019; Razavi, Seyed
   M.A./O-3690-2015; tabatabaee, Farideh/L-1314-2018
OI Razavi, Seyed M.A./0000-0003-2450-6623; tabatabaee,
   Farideh/0000-0002-0387-8690
CR Alghooneh A, 2015, MICROB PATHOGENESIS, V85, P58, DOI 10.1016/j.micpath.2015.06.003
   Atsamnia D, 2017, LWT-FOOD SCI TECHNOL, V82, P287, DOI 10.1016/j.lwt.2017.04.053
   Aziz K, 2013, BOARD, V1, P11
   Behbahani BA, 2018, J FOOD SAFETY, V38, DOI 10.1111/jfs.12443
   Benvenuti S, 2004, J FOOD SCI, V69, pC164
   COLLINSTHOMPSON DL, 1984, CAN I FOOD SC TECH J, V17, P102, DOI 10.1016/S0315-5463(84)72364-9
   Enchev E., 2007, J POWER SOURCES, V170, P122
   Feiner G., 2006, MEAT PRODUCTS HDB PR, V627, P239
   Fernandes FC, 2012, BIOPOLYMERS, V98, P280, DOI 10.1002/bip.22066
   Frum A., 2017, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, V6, P30, DOI 10.18052/www.scipress.com/IJPPE.6.30
   Gungor E, 2010, TURK J VET ANIM SCI, V34, P53, DOI 10.3906/vet-0805-28
   Kartal M, 2003, J ETHNOPHARMACOL, V86, P69, DOI 10.1016/S0378-8741(03)00042-4
   Kavuncuoglu H, 2018, J MICROBIOL METH, V148, P78, DOI 10.1016/j.mimet.2018.04.003
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   Marco A, 2006, MEAT SCI, V73, P660, DOI 10.1016/j.meatsci.2006.03.011
   Mashrei MA, 2010, ENG STRUCT, V32, P1723, DOI 10.1016/j.engstruct.2010.02.024
   PALUMBO SA, 1974, APPL MICROBIOL, V27, P724, DOI 10.1177/0038038593027004030
   Pinto MD, 2010, J FOOD BIOCHEM, V34, P639, DOI 10.1111/j.1745-4514.2009.00305.x
   Razavi S. M. A., 2017, J MEMBRANE SCI RES, V3, P296
   Razavi SMA, 2018, DESALIN WATER TREAT, V102, P38, DOI 10.5004/dwt.2018.21872
   Ruguo H., 1999, FOOD PRODUCT DESIGN, P70
   Sagdic O, 2012, EXPERT SYST APPL, V39, P6792, DOI 10.1016/j.eswa.2011.12.047
   Soleimanzadeh B, 2015, J FOOD SAFETY, V35, P220, DOI 10.1111/jfs.12174
   Yolmeh M, 2014, MICROB PATHOGENESIS, V67-68, P36, DOI 10.1016/j.micpath.2014.02.003
   Zduni G., 2015, NUTR COMPOSITION FRU, P101
NR 25
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0149-6085
EI 1745-4565
J9 J FOOD SAFETY
JI J. Food Saf.
PD OCT
PY 2019
VL 39
IS 5
AR e12669
DI 10.1111/jfs.12669
PG 11
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA JF0VK
UT WOS:000491104900008
DA 2020-05-07
ER

PT J
AU Lawley, B
   Otal, A
   Moloney-Geany, K
   Diana, A
   Houghton, L
   Heath, ALM
   Taylor, RW
   Tannock, GW
AF Lawley, Blair
   Otal, Anna
   Moloney-Geany, Kit
   Diana, Aly
   Houghton, Lisa
   Heath, Anne-Louise M.
   Taylor, Rachael W.
   Tannock, Gerald W.
TI Fecal Microbiotas of Indonesian and New Zealand Children Differ in
   Complexity and Bifidobacterial Taxa during the First Year of Life
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE bifidobacteria; gut; infants; microbiota
ID HUMAN GUT MICROBIOME; NICHE; MILK; DIVERSITY; INVASION; INFANTS; SAMPLE;
   COHORT
AB The biological succession that occurs during the first year of life in the gut of infants in Western countries is broadly predictable in terms of the increasing complexity of the composition of microbiotas. Less information is available about microbiotas in Asian countries, where environmental, nutritional, and cultural influences may differentially affect the composition and development of the microbial community. We compared the fecal microbiotas of Indonesian (n = 204) and New Zealand (NZ) (n = 74) infants 6 to 7 months and 12 months of age. Comparisons were made by analysis of 165 rRNA gene sequences and derivation of community diversity metrics, relative abundances of bacterial families, enterotypes, and cooccurrence correlation networks. Abundances of Bifidobacterium longum subsp. infantis and B. Iongum subsp. longum were determined by quantitative PCR. All observations supported the view that the Indonesian and NZ infant microbiotas developed in complexity over time, but the changes were much greater for NZ infants. B. Iongum subsp. infantis dominated the microbiotas of Indonesian children, whereas B. longum subsp. longum was dominant in NZ children. Network analysis showed that the niche model (in which trophic adaptation results in preferential colonization) of the assemblage of microbiotas was supported in Indonesian infants, whereas the neutral (stochastic) model was supported by the development of the microbiotas of NZ infants. The results of the study show that the development of the fecal microbiota is not the same for infants in all countries, and they point to the necessity of obtaining a better understanding of the factors that control the colonization of the gut in early life.
   IMPORTANCE This study addresses the microbiology of a natural ecosystem (the infant bowel) for children in a rural setting in Indonesia and in an urban environment in New Zealand. Analysis of DNA sequences generated from the microbial community (microbiota) in the feces of the infants during the first year of life showed marked differences in the composition and complexity of the bacterial collections. The differences were most likely due to differences in the prevalence and duration of breastfeeding of infants in the two countries. These kinds of studies are essential for developing concepts of microbial ecology related to the influence of nutrition and environment on the development of the gut microbiota and for determining the long-term effects of microbiological events in early life on human health and well-being.
C1 [Lawley, Blair; Otal, Anna; Moloney-Geany, Kit; Tannock, Gerald W.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.
   [Diana, Aly; Houghton, Lisa; Heath, Anne-Louise M.] Univ Otago, Dept Human Nutr, Dunedin, New Zealand.
   [Houghton, Lisa; Heath, Anne-Louise M.; Taylor, Rachael W.; Tannock, Gerald W.] Univ Otago, Microbiome Otago, Dunedin, New Zealand.
   [Taylor, Rachael W.] Univ Otago, Dept Med, Dunedin, New Zealand.
   [Tannock, Gerald W.] Massey Univ, Riddet Ctr Res Excellence, Palmerston North, New Zealand.
RP Tannock, GW (reprint author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.; Tannock, GW (reprint author), Univ Otago, Microbiome Otago, Dunedin, New Zealand.; Tannock, GW (reprint author), Massey Univ, Riddet Ctr Res Excellence, Palmerston North, New Zealand.
EM gerald.tannock@otago.ac.nz
RI Houghton, Lisa/F-5305-2011
OI Houghton, Lisa/0000-0002-2276-6205
FU Meat and Livestock AustraliaMeat and Livestock Australia; University of
   Otago; Lottery Health Research; Karitane Products Society; New Zealand
   Women's Institute; Perpetual Trustees; Riddet CORE; Microbiome Otago
FX The Indonesian study was supported by a grant from Meat and Livestock
   Australia and the University of Otago; the BLISS study was supported by
   Lottery Health Research, Meat and Livestock Australia, the Karitane
   Products Society, Perpetual Trustees, the New Zealand Women's Institute,
   and the University of Otago. Supplementary support was provided by the
   Riddet CORE. K.M.-G. was supported by a summer student scholarship
   provided by Microbiome Otago.
CR Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x
   Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x
   Arrieta MC, 2018, J ALLERGY CLIN IMMUN, V142, P424, DOI 10.1016/j.jaci.2017.08.041
   Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Autran CA, 2018, GUT, V67, P1064, DOI 10.1136/gutjnl-2016-312819
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI 10.1016/j.chom.2015.04.004
   Bauer E, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00209-17
   Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14
   BIAVATI B, 1984, MICROBIOLOGICA, V7, P341
   Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z
   Bolyen E, 2018, PEERJ PREPR, DOI DOI 10.7287/PEERJ.PREPRINTS.27295V2
   Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Castanys-Munoz E, 2013, NUTR REV, V71, P773, DOI 10.1111/nure.12079
   Castro T, 2017, NEW ZEAL MED J, V130, P34
   Centanni M, 2019, APPL ENVIRON MICROB, V85, DOI [10.1128/aem.02783-18, 10.1128/AEM.02783-18]
   Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Daniels L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0491-8
   Diana A, 2017, BRIT J NUTR, V118, P830, DOI 10.1017/S0007114517002860
   Diana A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175952
   DUBOS R, 1966, PEDIATRICS, V38, P789
   Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0
   Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100
   Faust Karoline, 2016, F1000Res, V5, P1519
   Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002
   Fisher CK, 2014, P NATL ACAD SCI USA, V111, P13111, DOI 10.1073/pnas.1405637111
   Gay MCL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091151
   Gomez-Gallego C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101355
   Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347
   Gronlund MM, 2011, GUT MICROBES, V2, P227, DOI 10.4161/gmic.2.4.16799
   Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106
   Health Canada, 2014, NUTR HLTH TERM INF R
   Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937
   Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662
   Laursen MF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01934
   Laursen MF, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00069-15
   Lawley B, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00336-18
   Lawley B, 2017, PEERJ, V5, DOI 10.7717/peerj.3375
   Leong C, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00914-18, 10.1128/aem.00914-18]
   Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331
   Martin L, 2016, IMPLEMENT SCI, V11
   Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049
   Marx C, 2014, J HUM LACT, V30, P54, DOI 10.1177/0890334413513923
   Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004
   McGuire MK, 2017, AM J CLIN NUTR, V105, P1086, DOI 10.3945/ajcn.116.139980
   Milani C, 2015, APPL ENVIRON MICROB, V81, P7078, DOI 10.1128/AEM.02037-15
   National Health and Medical Research Council, 2012, INF FEED GUID INF HL
   New Zealand Ministry of Health, 2008, FOOD NUTR GUID HLTH
   Null C., 2016, MCC INDONESIA NUTR P
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Qasem W, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0805-0
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0
   Rottjers L, 2018, FEMS MICROBIOL REV, V42, P761, DOI 10.1093/femsre/fuy030
   Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105
   Smilowitz JT, 2014, ANNU REV NUTR, V34, P143, DOI 10.1146/annurev-nutr-071813-105721
   Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000
   Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458
   Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421
   Tannock G.W., 2017, UNDERSTANDING GUT MI
   Tannock GW, 2012, ISME J, V6, P927, DOI 10.1038/ismej.2011.161
   Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957
   van Leeuwen SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34882-x
   Vangay P, 2018, CELL, V175, P962, DOI 10.1016/j.cell.2018.10.029
   Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373
   Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008
   Walker WA, 2017, PEDIATR RES, V82, P387, DOI 10.1038/pr.2017.111
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Youn SY, 2008, LETT APPL MICROBIOL, V46, P7, DOI 10.1111/j.1472-765X.2007.02263.x
   Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004
NR 74
TC 0
Z9 0
U1 5
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD OCT
PY 2019
VL 85
IS 19
AR e01105-19
DI 10.1128/AEM.01105-19
PG 14
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA JB8TO
UT WOS:000488849800011
PM 31375480
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Esposito, A
   Tamburini, S
   Triboli, L
   Ambrosino, L
   Chiusano, ML
   Jousson, O
AF Esposito, Alfonso
   Tamburini, Sabrina
   Triboli, Luca
   Ambrosino, Luca
   Chiusano, Maria Luisa
   Jousson, Olivier
TI Insights into the genome structure of four acetogenic bacteria with
   specific reference to the Wood-Ljungdahl pathway
SO MICROBIOLOGYOPEN
LA English
DT Article
DE Acetogens; Comparative genomics; NGS; Wood-Ljungdahl pathway
ID GENE DUPLICATION; ACETOBACTERIUM
AB Acetogenic bacteria are obligate anaerobes with the ability of converting carbon dioxide and other one-carbon substrates into acetate through the Wood-Ljungdahl (WL) pathway. These substrates are becoming increasingly important feedstock in industrial microbiology. The main potential industrial application of acetogenic bacteria is the production of metabolites that constitute renewable energy sources (biofuel); such bacteria are of particular interest for this purpose thanks to their low energy requirements for large-scale cultivation. Here, we report new genome sequences for four species, three of them are reported for the first time, namely Acetobacterium paludosum DSM 8237, Acetobacterium tundrae DSM 917, Acetobacterium bakii DSM 8239, and Alkalibaculum bacchi DSM 221123. We performed a comparative genomic analysis focused on the WL pathway's genes and their encoded proteins, using Acetobacterium woodii as a reference genome. The Average Nucleotide Identity (ANI) values ranged from 70% to 95% over an alignment length of 5.4-6.5 Mbp. The core genome consisted of 363 genes, whereas the number of unique genes in a single genome ranged from 486 in A. tundrae to 2360 in A.bacchi. No significant rearrangements were detected in the gene order for the Wood-Ljungdahl pathway however, two species showed variations in genes involved in formate metabolism: A. paludosum harbor two copies of fhs1, and A. bakii a truncated fdhF1. The analysis of protein networks highlighted the expansion of protein orthologues in A. woodii compared to A. bacchi, whereas protein networks involved in the WL pathway were more conserved. This study has increased our understanding on the evolution of the WL pathway in acetogenic bacteria.
C1 [Esposito, Alfonso; Triboli, Luca; Jousson, Olivier] Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Via Sommar 9, I-38123 Trento, Italy.
   [Tamburini, Sabrina] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Ambrosino, Luca] Res Infrastruct Marine Biol Resources RIMAR, Stn Zool Anton Dohrn, Naples, Italy.
   [Chiusano, Maria Luisa] Univ Naples Federico II, Dept Agr Sci, Portici, Italy.
RP Jousson, O (reprint author), Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Via Sommar 9, I-38123 Trento, Italy.
EM olivier.jousson@unitn.it
RI Ambrosino, Luca/AAC-6352-2020
OI Ambrosino, Luca/0000-0003-1756-9538; Esposito,
   Alfonso/0000-0003-0726-5290; Triboli, Luca/0000-0002-1261-0637
FU National Research Council
FX National Research Council
CR Adam PS, 2018, P NATL ACAD SCI USA, V115, pE1166, DOI 10.1073/pnas.1716667115
   Ambrosino L, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2420-y
   Andrews S, 2010, FASTQC QUALITY CONTR
   BALCH WE, 1977, INT J SYST BACTERIOL, V27, P355, DOI 10.1099/00207713-27-4-355
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Bengelsdorf FR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01036
   Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10
   Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319
   Borrel G, 2016, GENOME BIOL EVOL, V8, P1706, DOI 10.1093/gbe/evw114
   Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x
   DRAKE HL, 1994, ACETOGENESIS
   Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004
   Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413
   Hagberg A. A., 2008, 7 PYTH SCI C SCIPY20, V2008, P11, DOI DOI 10.1016/J.JELECTROCARD.2010.09.003
   Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148
   Hug LA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-22
   Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102
   Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849
   Hwang S, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01070-15
   Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108
   Krueger F., 2016, BABRAHAM BIOINFORMAT
   Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896
   Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421
   Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439
   Pritchard L, 2016, ANAL METHODS-UK, V8, P12, DOI [10.1039/C5AY02550H, 10.1039/c5ay02550h]
   R Core Team, 2012, R LANG ENV STAT COMP
   Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012
   Rosenfeld JA, 2012, MOL PHYLOGENET EVOL, V63, P342, DOI 10.1016/j.ympev.2012.01.003
   Schuchmann K, 2016, APPL ENVIRON MICROB, V82, P4056, DOI 10.1128/AEM.00882-16
   Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shin J, 2018, RNA, V24, P1839, DOI 10.1261/rna.068239.118
   Shin J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01531
   Simankova MV, 2000, ARCH MICROBIOL, V174, P440, DOI 10.1007/s002030000229
   Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647
   Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631
   Weiss M. C., 2016, NAT MICROBIOL, V1, P1, DOI [10.1038/nmicrobiol.2016.11627562259, DOI 10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]
NR 40
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-8827
J9 MICROBIOLOGYOPEN
JI MicrobiologyOpen
PD DEC
PY 2019
VL 8
IS 12
AR e938
DI 10.1002/mbo3.938
EA OCT 2019
PG 15
WC Microbiology
SC Microbiology
GA KA0ZA
UT WOS:000488341600001
PM 31573151
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Long, CP
   Antoniewicz, MR
AF Long, Christopher P.
   Antoniewicz, Maciek R.
TI High-resolution( 13)C metabolic flux analysis
SO NATURE PROTOCOLS
LA English
DT Article
ID PARALLEL LABELING EXPERIMENTS; MASS ISOTOPOMER DISTRIBUTIONS;
   ESCHERICHIA-COLI; NETWORK MODEL; UNITS EMU; C-13; FRAMEWORK; GLUCOSE;
   BIOMASS; FERMENTATION
AB Precise quantification of metabolic pathway fluxes in biological systems is of major importance in guiding efforts in metabolic engineering, biotechnology, microbiology, human health, and cell culture. C-13 metabolic flux analysis (C-13-MFA) is the predominant technique used for determining intracellular fluxes. Here, we present a protocol for C- 13-MFA that incorporates recent advances in parallel labeling experiments, isotopic labeling measurements, and statistical analysis, as well as best practices developed through decades of experience. Experimental design to ensure that fluxes are estimated with the highest precision is an integral part of the protocol. The protocol is based on growing microbes in two (or more) parallel cultures with( 13)C-labeled glucose tracers, followed by gas chromatography-mass spectrometry (GC-MS) measurements of isotopic labeling of protein-bound amino acids, glycogen-bound glucose, and RNA-bound ribose. Fluxes are then estimated using software for( )(13)C-MFA, such as Metran, followed by comprehensive statistical analysis to determine the goodness of fit and calculate confidence intervals of fluxes. The presented protocol can be completed in 4 d and quantifies metabolic fluxes with a standard deviation of <= 2%, a substantial improvement over previous implementations. The presented protocol is exemplified using an Escherichia coli -Delta tpiA case study with full supporting data, providing a hands-on opportunity to step through a complex troubleshooting scenario. Although applications to prokaryotic microbial systems are emphasized, this protocol can be easily adjusted for application to eukaryotic organisms.
C1 [Long, Christopher P.; Antoniewicz, Maciek R.] Univ Delaware, Dept Chem & Biomol Engn, Metab Engn & Syst Biol Lab, Newark, DE 19716 USA.
   [Long, Christopher P.] Ginkgo Bioworks, Boston, MA USA.
RP Antoniewicz, MR (reprint author), Univ Delaware, Dept Chem & Biomol Engn, Metab Engn & Syst Biol Lab, Newark, DE 19716 USA.
EM mranton@udel.edu
OI Antoniewicz, Maciek/0000-0002-0087-2875
FU NSFNational Science Foundation (NSF) [MCB-1616332]
FX This work was supported by grant NSF MCB-1616332.
CR Ahn WS, 2016, METAB ENG, V37, P72, DOI 10.1016/j.ymben.2016.05.005
   Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893
   Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003
   Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001
   Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004
   Antoniewicz MR, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0060-y
   Antoniewicz MR, 2015, CURR OPIN BIOTECH, V36, P91, DOI 10.1016/j.copbio.2015.08.014
   Antoniewicz MR, 2015, J IND MICROBIOL BIOT, V42, P317, DOI 10.1007/s10295-015-1585-x
   Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P973, DOI 10.1016/j.copbio.2013.03.018
   Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P1116, DOI 10.1016/j.copbio.2013.02.003
   Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P48, DOI 10.1016/j.copbio.2012.10.011
   Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p
   Au J, 2014, METAB ENG, V26, P23, DOI 10.1016/j.ymben.2014.08.002
   Badur MG, 2018, METAB ENG, V45, P95, DOI [10.1016/j.ymben.2017.09.002, 10.1016/j.ymben.2017.11.013]
   Boghigian BA, 2010, METAB ENG, V12, P81, DOI 10.1016/j.ymben.2009.10.004
   Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003
   Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014
   Cordova LT, 2017, METAB ENG, V44, P182, DOI 10.1016/j.ymben.2017.10.007
   Cordova LT, 2016, METAB ENG, V37, P63, DOI 10.1016/j.ymben.2016.05.001
   Cordova LT, 2016, METAB ENG, V33, P148, DOI 10.1016/j.ymben.2015.06.004
   Crown SB, 2016, METAB ENG, V38, P10, DOI 10.1016/j.ymben.2016.06.001
   Crown SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145850
   Crown SB, 2015, METAB ENG, V28, P151, DOI 10.1016/j.ymben.2015.01.001
   Crown SB, 2012, METAB ENG, V14, P150, DOI 10.1016/j.ymben.2011.12.005
   Crown SB, 2011, BIOTECHNOL J, V6, P300, DOI 10.1002/biot.201000282
   DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4
   Enjalbert B, 2017, SCI REP-UK, V7, DOI 10.1038/srep42135
   Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200
   Gebreselassie NA, 2015, METAB ENG, V31, P132, DOI 10.1016/j.ymben.2015.07.005
   Gonzalez JE, 2017, CURR OPIN BIOTECH, V43, P86, DOI 10.1016/j.copbio.2016.10.002
   Gonzalez JE, 2017, METAB ENG, V39, P9, DOI 10.1016/j.ymben.2016.11.003
   Gopalakrishnan S, 2015, METAB ENG, V32, P12, DOI 10.1016/j.ymben.2015.08.006
   He L, 2017, METAB ENG, V39, P247, DOI 10.1016/j.ymben.2016.12.008
   Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2
   Hollinshead WD, 2016, BIOTECHNOL BIOENG, V113, P91, DOI 10.1002/bit.25702
   Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067
   Kajihata S, 2014, BIOMED RES INT, DOI 10.1155/2014/627014
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Leighty RW, 2012, METAB ENG, V14, P533, DOI 10.1016/j.ymben.2012.06.003
   Leighty RW, 2011, METAB ENG, V13, P745, DOI 10.1016/j.ymben.2011.09.010
   Long CP, 2018, P NATL ACAD SCI USA, V115, P222, DOI 10.1073/pnas.1716056115
   Long CP, 2017, METAB ENG, V44, P191, DOI 10.1016/j.ymben.2017.10.008
   Long CP, 2017, METAB ENG, V44, P100, DOI 10.1016/j.ymben.2017.09.012
   Long CP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14316
   Long CP, 2016, METAB ENG, V38, P65, DOI 10.1016/j.ymben.2016.06.007
   Long CP, 2016, METAB ENG, V37, P102, DOI 10.1016/j.ymben.2016.05.006
   Long CP, 2014, ANAL CHEM, V86, P9423, DOI 10.1021/ac502734e
   Martin HG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004363
   McCloskey D, 2016, ANAL CHEM, V88, P1362, DOI 10.1021/acs.analchem.5b03887
   McConnell BO, 2016, ANAL CHEM, V88, P4624, DOI 10.1021/acs.analchem.6b00779
   Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010
   Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109
   Shupletsov MS, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0152-x
   Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101
   Swarup A, 2014, METAB ENG, V24, P173, DOI 10.1016/j.ymben.2014.05.013
   Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802
   van Winden W, 2001, METAB ENG, V3, P322, DOI 10.1006/mben.2001.0193
   Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646
   Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188
   Wolfsberg E, 2018, METAB ENG, V49, P242, DOI 10.1016/j.ymben.2018.08.013
   Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200
   Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015
   Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632
   Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131
   Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58
NR 67
TC 4
Z9 4
U1 15
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PD OCT
PY 2019
VL 14
IS 10
BP 2856
EP 2877
DI 10.1038/s41596-019-0204-0
PG 22
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA JA6QU
UT WOS:000487967700004
PM 31471597
DA 2020-05-07
ER

PT J
AU Nielsen, J
   Vestergaard, LS
   Richter, L
   Schmid, D
   Bustos, N
   Asikainen, T
   Trebbien, R
   Denissov, G
   Innos, K
   Virtanen, MJ
   Fouillet, A
   Lytras, T
   Gkolfinopoulou, K
   an der Heiden, M
   Grabenhenrich, L
   Uphoff, H
   Paldy, A
   Bobvos, J
   Domegan, L
   O'Donnell, J
   Scortichini, M
   de Martino, A
   Mossong, J
   England, K
   Melillo, J
   van Asten, L
   Lange, MMA
   Tonnessen, R
   White, RA
   Silva, SP
   Rodrigues, AP
   Larrauri, A
   Mazagatos, C
   Farah, A
   Carnahan, AD
   Junker, C
   Sinnathamby, M
   Pebody, RG
   Andrews, N
   Reynolds, A
   McMenamin, J
   Brown, CS
   Adlhoch, C
   Penttinen, P
   Molbak, K
   Krause, TG
AF Nielsen, J.
   Vestergaard, L. S.
   Richter, L.
   Schmid, D.
   Bustos, N.
   Asikainen, T.
   Trebbien, R.
   Denissov, G.
   Innos, K.
   Virtanen, M. J.
   Fouillet, A.
   Lytras, T.
   Gkolfinopoulou, K.
   an der Heiden, M.
   Grabenhenrich, L.
   Uphoff, H.
   Paldy, A.
   Bobvos, J.
   Domegan, L.
   O'Donnell, J.
   Scortichini, M.
   de Martino, A.
   Mossong, J.
   England, K.
   Melillo, J.
   van Asten, L.
   de lange, M. M. A.
   Tonnessen, R.
   White, R. A.
   da Silva, S. P.
   Rodrigues, A. P.
   Larrauri, A.
   Mazagatos, C.
   Farah, A.
   Carnahan, A. D.
   Junker, C.
   Sinnathamby, M.
   Pebody, R. G.
   Andrews, N.
   Reynolds, A.
   McMenamin, J.
   Brown, C. S.
   Adlhoch, C.
   Penttinen, P.
   Molbak, K.
   Krause, T. G.
TI European all-cause excess and influenza-attributable mortality in the
   2017/18 season: should the burden of influenza B be reconsidered?
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE B/Yamagata; EuroMOMO; FluMOMO; Influenza; Mortality
AB Objectives: Weekly monitoring of European all-cause excess mortality, the EuroMOMO network, observed high excess mortality during the influenza B/Yamagata dominated 2017/18 winter season, especially among elderly. We describe all-cause excess and influenza-attributable mortality during the season 2017/18 in Europe.
   Methods: Based on weekly reporting of mortality from 24 European countries or sub-national regions, representing 60% of the European population excluding the Russian and Turkish parts of Europe, we estimated age stratified all-cause excess morality using the EuroMOMO model. In addition, age stratified all-cause influenza-attributable mortality was estimated using the FluMOMO algorithm, incorporating influenza activity based on clinical and virological surveillance data, and adjusting for extreme temperatures.
   Results: Excess mortality was mainly attributable to influenza activity from December 2017 to April 2018, but also due to exceptionally low temperatures in February-March 2018. The pattern and extent of mortality excess was similar to the previous A( H3N2) dominated seasons, 2014/15 and 2016/17. The 2017/18 overall all-cause influenza-attributable mortality was estimated to be 25.4 ( 95% CI 25.0-25.8) per 100,000 population; 118.2 ( 116.4-119.9) for persons aged 65. Extending to the European population this translates into over-all 152,000 deaths.
   Conclusions: The high mortality among elderly was unexpected in an influenza B dominated season, which commonly are considered to cause mild illness, mainly among children. Even though A( H3N2) also circulated in the 2017/18 season and may have contributed to the excess mortality among the elderly, the common perception of influenza B only having a modest impact on excess mortality in the older population may need to be reconsidered. (c) 2019 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under the CC BY-NC-ND license
C1 [Nielsen, J.; Vestergaard, L. S.; Trebbien, R.; Molbak, K.; Krause, T. G.] Statens Serum Inst, Copenhagen, Denmark.
   [Richter, L.; Schmid, D.] Austrian Agcy Hlth & Food Safety, Vienna, Austria.
   [Bustos, N.; Asikainen, T.] Sciensano, Brussels, Belgium.
   [Denissov, G.; Innos, K.] Natl Inst Hlth Dev, Tallinn, Estonia.
   [Virtanen, M. J.] Finnish Natl Inst Hlth & Welf, Helsinki, Finland.
   [Fouillet, A.] French Publ Hlth Agcy, St Publ France, St Maurice, France.
   [Lytras, T.; Gkolfinopoulou, K.] Hellen Ctr Dis Control & Prevent, Athens, Greece.
   [an der Heiden, M.; Grabenhenrich, L.] Robert Koch Inst, Berlin, Germany.
   [Uphoff, H.] Hess Landesprufungs & Untersuchungsamt Gesundheit, Dillenburg, Germany.
   [Paldy, A.] Natl Publ Hlth Inst, Budapest, Hungary.
   [Bobvos, J.] Minist Human Capac, Budapest, Hungary.
   [Domegan, L.; O'Donnell, J.] Hlth Serv Execut Hlth Protect Surveillance Ctr, Dublin, Ireland.
   [Scortichini, M.] Lazio ASL Roma 1, Dipartimento Epidemiol SSR, Rome, Italy.
   [de Martino, A.] Minist Salute, Rome, Italy.
   [Mossong, J.] Lab Natl Sante, Luxembourg, Luxembourg.
   [England, K.] Directorate Hlth Informat & Res, Pieta, Malta.
   [Melillo, J.] Dept Hlth Regulat, Pieta, Malta.
   [van Asten, L.; de lange, M. M. A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.
   [Tonnessen, R.; White, R. A.; da Silva, S. P.] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Rodrigues, A. P.] Inst Nacl Saude Doutor Ricardo Jorge, Lisbon, Portugal.
   [Larrauri, A.; Mazagatos, C.] Carlos III Hlth Inst, CIBER Epidemiol Salud Publ CIBERESP, Natl Ctr Epidemiol, Madrid, Spain.
   [Farah, A.; Carnahan, A. D.] Publ Hlth Agcy Sweden, Stockholm, Sweden.
   [Junker, C.] Fed Stat Off, Neuchatel, Switzerland.
   [Sinnathamby, M.; Pebody, R. G.; Andrews, N.] Publ Hlth England, Colindale, England.
   [Reynolds, A.; McMenamin, J.] Hlth Protect Scotland, Glasgow, Lanark, Scotland.
   [Brown, C. S.] WHO, Reg Off Europe, Copenhagen, Denmark.
   [Adlhoch, C.; Penttinen, P.] European Ctr Dis Prevent & Control, Solna, Sweden.
   [Molbak, K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark.
RP Nielsen, J (reprint author), Statens Serum Inst, Infect Dis Epidemiol & Prevent, Artillerivej 5, DK-2300 Copenhagen, Denmark.
EM nls@ssi.dk
RI Larrauri, Amparo/Q-9613-2017; Silva, Susana P/A-6684-2018; SCORTICHINI,
   MATTEO/AAB-6323-2019; Mossong, Joel/D-4998-2009
OI Larrauri, Amparo/0000-0002-1704-2245; Silva, Susana
   P/0000-0003-2524-0548; SCORTICHINI, MATTEO/0000-0002-6413-7706; Mossong,
   Joel/0000-0003-0717-9835; Trebbien, Ramona/0000-0003-2352-5726;
   Mazagatos, Clara/0000-0002-6909-6923; Grabenhenrich,
   Linus/0000-0002-9300-6625; an der Heiden, Matthias/0000-0001-5863-4549;
   Lytras, Theodore/0000-0002-4146-4122
FU World Health OrganizationWorld Health Organization [001]
CR Adlhoch C, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.13.18-00146
   Ballester J, 2016, NAT CLIM CHANGE, V6, P927, DOI 10.1038/NCLIMATE3070
   Cassini A, 2018, EUROSURVEILLANCE, V23, P15, DOI 10.2807/1560-7917.ES.2018.23.16.17-00454
   Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578
   Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137
   Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda
   Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x
   Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2
   Mazick A, 2012, EURO SURVEILL, V17
   Molbak K., 2015, EURO SURVEILL, V20
   Muscatello DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098446
   Nelsen KE, INFECT DIS EPIDEMIOL, P583
   Nielsen J, 2013, EPIDEMIOL INFECT, V141, P1996, DOI 10.1017/S0950268812002580
   Nielsen J, 2018, INFLUENZA OTHER RESP, V12, P591, DOI 10.1111/irv.12564
   Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350
   Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661
   Redlberger-Fritz M, 2012, EUR J EPIDEMIOL, V27, P567, DOI 10.1007/s10654-012-9701-y
   Rondy M, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.9.18-00086
   Skowronski DM, 2017, J INFECT DIS, V216, P697, DOI 10.1093/infdis/jix393
   Snacken R, 2015, EURO SURVEILL, V20
   Tafalla M, 2016, HUM VACC IMMUNOTHER, V12, P993, DOI 10.1080/21645515.2015.1111494
   van Asten L, 2012, J INFECT DIS, V206, P628, DOI 10.1093/infdis/jis415
   Vega T, 2015, INFLUENZA OTHER RESP, V9, P234, DOI 10.1111/irv.12330
   Vestergaard LS, 2017, EURO SURVEILL, V22
   Wilson JD, HARRISONS PRINCIPLES, P697
   World Health Organization, 2018, REC COMP INFL VIR VA
NR 26
TC 6
Z9 8
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2019
VL 25
IS 10
BP 1266
EP 1276
DI 10.1016/j.cmi.2019.02.011
PG 11
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IZ7ZS
UT WOS:000487320800018
PM 30790685
OA Other Gold, Green Published
DA 2020-05-07
ER

PT J
AU Rohn, JL
   Mostow, S
   King, JS
   Unnikrishnan, M
   Gutierrez, MG
AF Rohn, Jennifer L.
   Mostow, Serge
   King, Jason S.
   Unnikrishnan, Meera
   Gutierrez, Maximiliano G.
TI The UK cellular microbiology network: Exploring the host-bacterial
   interface
SO CELLULAR MICROBIOLOGY
LA English
DT Article
AB The UK Cellular Microbiology Network held its inaugural conference in February 2019. This stimulating day of scientific exchange will be the first of many, its organisers hope.
C1 [Rohn, Jennifer L.] UCL, Dept Renal Med, Div Med, London, England.
   [Mostow, Serge] London Sch Hyg & Trop Med, Dept Infect Biol, London, England.
   [King, Jason S.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England.
   [Unnikrishnan, Meera] Univ Warwick, Div Biomed Sci, Coventry, W Midlands, England.
   [Gutierrez, Maximiliano G.] Francis Crick Inst, Host Pathogen Interact TB Lab, London, England.
RP Rohn, JL (reprint author), UCL, Dept Renal Med, Div Med, London, England.
EM j.rohn@ucl.ac.uk
RI ; King, Jason/D-6228-2011
OI Unnikrishnan, Meera/0000-0001-5417-9331; King,
   Jason/0000-0003-0596-4506; Mostowy, Serge/0000-0002-7286-6503;
   Gutierrez, Maximiliano/0000-0003-3199-0337; Rohn,
   Jennifer/0000-0001-8766-6056
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD SEP
PY 2019
VL 21
IS 9
AR e13081
DI 10.1111/cmi.13081
PG 3
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA IS9OH
UT WOS:000482477200001
PM 31283093
OA Green Accepted, Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Jaba, A
   Dagher, F
   Oskouei, AMH
   Guertin, C
   Constant, P
AF Jaba, Asma
   Dagher, Fadi
   Oskouei, Amir Mehdi Hamidi
   Guertin, Claude
   Constant, Philippe
TI Physiological traits and relative abundance of species as explanatory
   variables of co-occurrence pattern of cultivable bacteria associated
   with chia seeds
SO CANADIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE microbial ecology; microbiome; microbial communities
ID IDENTIFICATION; NETWORKS; DATABASE; TOOLS
AB Deciphering the rules defining microbial community assemblage is envisioned as a promising strategy to improve predictions of pathogens colonization and proliferation in food. Despite the increasing number of studies reporting microbial co-occurrence patterns, only a few attempts have been made to challenge them in experimental or theoretical frameworks. Here, we tested the hypothesis that observed variations in co-occurrence patterns can be explained by taxonomy, relative abundance, and physiological traits of microbial species. We used PCR amplicon sequencing of taxonomic markers to assess distribution and co-occurrence patterns of bacterial and fungal species found in 25 chia (Salvia hispanica L.) samples originating from eight different sources. The use of nutrient-rich and oligotrophic media enabled isolation of 71 strains encompassing 16 bacterial species, of which five corresponded to phylotypes represented in the molecular survey. Tolerance to different growth inhibitors and antibiotics was tested to assess the physiological traits of these isolates. Divergence of physiological traits and relative abundance of each pair of species explained 69% of the co-occurrence profile displayed by cultivable bacterial phylotypes in chia. Validation of this ecological network conceptualization approach to more food products is required to integrate microbial species co-occurrence patterns in predictive microbiology.
C1 [Jaba, Asma; Guertin, Claude; Constant, Philippe] Inst Armand Frappier, Inst Natl Rech Sci, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.
   [Dagher, Fadi; Oskouei, Amir Mehdi Hamidi] Agri Neo Inc, 435 Horner Ave,Unit 1, Toronto, ON M8W 4W3, Canada.
RP Guertin, C; Constant, P (reprint author), Inst Armand Frappier, Inst Natl Rech Sci, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.
EM Claude.Guertin@iaf.inrs.ca; Philippe.Constant@iaf.inrs.ca
FU Natural Sciences and Engineering Research Council of Canada Engage
   grantNatural Sciences and Engineering Research Council of Canada
   [493409-16]; Natural Sciences and Engineering Research Council of Canada
   Engage Plus grantNatural Sciences and Engineering Research Council of
   Canada [508707-17]
FX This work was supported by a Natural Sciences and Engineering Research
   Council of Canada Engage grant (493409-16) and a Natural Sciences and
   Engineering Research Council of Canada Engage Plus grant (508707-17) to
   PC. The authors are grateful to Sarah Piche-Choquette who introduced AJ
   to the bioinformatics tools utilized in this study and submitted raw
   sequence reads to the Sequence Read Archive repository (NCBI). The
   authors acknowledge the contribution of the McGill University and Genome
   Quebec Innovation Centre (Montreal, Canada) for PCR amplicon library
   preparation and sequencing services.
CR Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028
   Berg G, 2015, MICROB BIOTECHNOL, V8, P5, DOI 10.1111/1751-7915.12235
   Bokulich NA, 2016, CURR OPIN BIOTECH, V37, P182, DOI 10.1016/j.copbio.2015.12.008
   Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119
   Cardinale M, 2015, ENVIRON MICROBIOL, V17, P239, DOI 10.1111/1462-2920.12686
   Chaillou S, 2015, ISME J, V9, P1105, DOI 10.1038/ismej.2014.202
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492
   De Filippis F, 2018, ANNU REV FOOD SCI T, V9, P589, DOI 10.1146/annurev-food-030117-012312
   Salgado-Cruz MD, 2013, IND CROP PROD, V51, P453, DOI 10.1016/j.indcrop.2013.09.036
   Deshpande V, 2016, MYCOLOGIA, V108, P1, DOI 10.3852/14-293
   Edgar R. C., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161]
   Edgar R.C., 2016, PREPRINT, DOI [10.1101/081257, DOI 10.1101/081257, 10.1101/081257.]
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x
   Guidone A, 2016, INT J FOOD MICROBIOL, V216, P9, DOI 10.1016/j.ijfoodmicro.2015.09.002
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Ho A, 2014, ISME J, V8, P1945, DOI 10.1038/ismej.2014.74
   Ho A, 2013, ENV MICROBIOL REP, V5, P335, DOI 10.1111/j.1758-2229.2012.00370.x
   Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286
   Ixtaina VY, 2008, IND CROP PROD, V28, P286, DOI 10.1016/j.indcrop.2008.03.009
   Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274
   Kamneva OK, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005366
   Kaul A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02114
   Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251
   Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226
   Lane D, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0
   Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310
   Malakar PK, 2003, INT J FOOD MICROBIOL, V84, P263, DOI 10.1016/S0168-1605(02)00424-5
   Mandakovic D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23931-0
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Mejlholm O, 2010, INT J FOOD MICROBIOL, V141, P137, DOI 10.1016/j.ijfoodmicro.2010.04.026
   Midani FS, 2018, J INFECT DIS, V218, P645, DOI 10.1093/infdis/jiy192
   Munoz LA, 2012, J FOOD ENG, V108, P216, DOI 10.1016/j.jfoodeng.2011.06.037
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993
   Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114
   Parente E, 2018, FOOD MICROBIOL, V73, P49, DOI 10.1016/j.fm.2017.12.010
   Parente E, 2016, INT J FOOD MICROBIOL, V219, P28, DOI 10.1016/j.ijfoodmicro.2015.12.001
   Poisot T, 2015, OIKOS, V124, P243, DOI 10.1111/oik.01719
   R development Core Team, 2008, R LANG ENV STAT COMP
   Tamber S, 2016, J FOOD PROTECT, V79, P703, DOI 10.4315/0362-028X.JFP-15-529
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tenenhaus-Aziza F, 2015, FOOD MICROBIOL, V45, P290, DOI 10.1016/j.fm.2014.06.026
   Teplitski M, 2011, TRENDS MICROBIOL, V19, P121, DOI 10.1016/j.tim.2010.11.007
   Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863
   Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x
   Wassermann B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17949-z
   White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112
   Zoellner C, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00813-18, 10.1128/aem.00813-18]
NR 55
TC 0
Z9 0
U1 2
U2 8
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4166
EI 1480-3275
J9 CAN J MICROBIOL
JI Can. J. Microbiol.
PD SEP
PY 2019
VL 65
IS 9
BP 668
EP 680
DI 10.1139/cjm-2019-0052
PG 13
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
GA IT1OM
UT WOS:000482615500004
PM 31158321
OA Bronze, Green Accepted
DA 2020-05-07
ER

PT J
AU Souty, C
   Masse, S
   Valette, M
   Behillil, S
   Bonmarin, I
   Pino, C
   Turbelin, C
   Capai, L
   Vilcu, AM
   Lina, B
   van der Werf, S
   Blanchon, T
   Falchi, A
   Hanslik, T
AF Souty, C.
   Masse, S.
   Valette, M.
   Behillil, S.
   Bonmarin, I.
   Pino, C.
   Turbelin, C.
   Capai, L.
   Vilcu, A. M.
   Lina, B.
   van der Werf, S.
   Blanchon, T.
   Falchi, A.
   Hanslik, T.
TI Baseline characteristics and clinical symptoms related to respiratory
   viruses identified among patients presenting with influenza-like illness
   in primary care
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Influenza; Influenza-like illness; Primary care; Respiratory infections;
   Respiratory viruses; Surveillance
ID SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; SEASONAL INFLUENZA; INFECTIONS;
   EPIDEMIOLOGY; ETIOLOGIES
AB Objectives: We aimed to identify patients' clinical characteristics associated with respiratory viruses identified among patients presenting with influenza-like illness (ILI).
   Methods: A sample of patients of all ages presenting with ILI was included by physicians of the French Sentinelles network during two seasons (2015/16 and 2016/17). Nasopharyngeal samples were tested for the presence of influenza virus (IV), respiratory syncytial virus (RSV), human rhinovirus (HRV) and human metapneumovirus (HMPV). Patients' characteristics associated with each of the four virus classes were studied using multivariate logistic regressions.
   Results: A total of 5859 individuals were included in the study: 48.0% tested positive for IV, 7.9% for HRV, 7.5% for RSV and 4.1% for HMPV. Cough was associated with IV (OR 2.14, 95% CI 1.81-2.52) RSV (OR 2.52, 95% CI 1.75-3.74) and HMPV detection (OR 2.15, 95% CI 1.40-3.45). Rhinorrhoea was associated mainly with HRV detection (OR 1.75, 95% CI 1.34-2.32). Headache was associated with IV detection (OR 1.75, 95% CI 1.34-2.32), whereas absence of headache was associated with RSV and HMPV detection. Dyspnoea was associated with RSV detection (OR 2.33, 95% CI 1.73-3.12) and absence of dyspnoea with IV detection. Conjunctivitis was associated with IV detection (OR 1.27, 95% CI 1.08-1.50). Some associations were observed only in children: dyspnoea and cough with RSV detection (age < 5 years), conjunctivitis with IV detection (age < 15 years). Period of onset of symptoms differed among aetiological diagnoses. Seasonal influenza vaccination decreased the risk of IV detection (OR, 0.67, 95% CI 0.51-0.86).
   Conclusions: This study allowed the identification of symptoms associated with several viral aetiologies in patients with ILI. A proper knowledge and understanding of these clinical signs may improve the medical management of patients. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Souty, C.; Masse, S.; Pino, C.; Turbelin, C.; Capai, L.; Vilcu, A. M.; Blanchon, T.; Hanslik, T.] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, Paris, France.
   [Masse, S.; Capai, L.; Falchi, A.] Univ Corse, INSERM, Lab Virol, EA7310, Corte, France.
   [Valette, M.; Lina, B.] Hosp Civils Lyon, Ctr Natl Reference Virus Resp Dont Grippe, Ctr Biol & Pathol Nord, Lab Virol,IAI,Grp Hosp Nord, Lyon, France.
   [Valette, M.; Lina, B.] Univ Claude Bernard Lyon 1, Univ Lyon, Vitpath, CIRI,INSERM,U1111,CNRS,UMR5308,ENS Lyon, Lyon, France.
   [Behillil, S.; van der Werf, S.] Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France.
   [Behillil, S.; van der Werf, S.] Inst Pasteur, Ctr Coordonnateur Ctr Natl Reference Virus Infect, Paris, France.
   [Behillil, S.; van der Werf, S.] UMR CNRS 3569, F-75015 Paris, France.
   [Behillil, S.; van der Werf, S.] Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, Paris, France.
   [Bonmarin, I.] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.
   [Hanslik, T.] Univ Versailles St Quentin En Yvelines, UVSQ, UFR Med, Versailles, France.
   [Hanslik, T.] Hop Ambroise Pare, AP HP, Serv Med Interne, Boulogne Billancourt, France.
RP Souty, C (reprint author), Sorbonne Univ, IPLESP, UMRS 1136, 27 Rue Chaligny, F-75571 Paris 12, France.
EM cecile.souty@upmc.fr
RI BLANCHON, Thierry/AAK-6254-2020
OI Capai, Lisandru/0000-0002-3618-1582; lina, bruno/0000-0002-8959-2123
FU European UnionEuropean Union (EU) [634446]; Sante publique France, the
   national public health agency in France
FX This project has received funding from the European Union's Horizon 2020
   Research and Innovation Programme under grant agreement No 634446 to
   conduct the study in individuals aged 65 years or older and from Sante
   publique France, the national public health agency in France.
CR Blanchon T, 2015, ANTIVIR THER, V20, P753, DOI 10.3851/IMP2945
   Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117
   Casalegno JS, 2017, EURO SURVEILL, V22
   Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07
   COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97
   Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6
   Gonzalez-Parra G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192645
   Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657
   Li XC, 2018, J MED VIROL, V90, P828, DOI 10.1002/jmv.25040
   Mandell LA, 2005, CLIN INFECT DIS, V41, P503, DOI 10.1086/432019
   MONTO AS, 1971, AM J EPIDEMIOL, V94, P280, DOI 10.1093/oxfordjournals.aje.a121321
   Monto AS, 2002, AM J MED, V112, p4S
   Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243
   Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186
   Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555
   Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014
   Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651
   Souty C, 2018, INFLUENZA OTHER RESP
   Souty C, 2017, J CLIN VIROL, V95, P1, DOI 10.1016/j.jcv.2017.08.002
   Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316
   Valenciano M, 2018, INFLUENZA OTHER RESP, V12, P567, DOI 10.1111/irv.12562
   Vilcu AM, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.003
   Wegst-Uhrich SR, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-5
   Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X
   Zimmerman RK, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0806-2
NR 25
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD SEP
PY 2019
VL 25
IS 9
BP 1147
EP 1153
DI 10.1016/j.cmi.2019.01.014
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IR7TE
UT WOS:000481643000014
PM 30703528
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Htun, HL
   Hon, PY
   Holden, MTG
   Ang, B
   Chow, A
AF Htun, H. L.
   Hon, P. Y.
   Holden, M. T. G.
   Ang, B.
   Chow, A.
TI Chlorhexidine and octenidine use, carriage of qac genes, and reduced
   antiseptic susceptibility in methicillin-resistant Staphylococcus aureus
   isolates from a healthcare network
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Antiseptic resistance; Biocide tolerance and resistance; Chlorhexidine;
   Octenidine; Methicillin-resistant S. aureus (MRSA); Antiseptic
   resistance genes; qac genes
ID MRSA; MUPIROCIN; DIHYDROCHLORIDE; TRANSMISSION; EVOLUTION; BIOCIDES;
   SPREAD
AB Objectives: With the widespread use of antiseptics in healthcare facilities for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) transmission, there are concerns for antiseptic tolerance and resistance. We sought to understand the use of chlorhexidine and octenidine, carriage of qac genes, and reduced antiseptic susceptibilities.
   Methods: A serial cross-sectional study was conducted in an acute care hospital and three extended-care facilities of a healthcare network in June-July, 2014-2016. Two of the extended-care facilities were exposed to intranasal octenidine and universal daily chlorhexidine/octenidine bathing. The minimum inhibitory concentration (MIC) levels and qac genes were determined by broth microdilution tests and whole genome sequencing respectively. Multivariable logistic regression was used to assess for the independent associations between antiseptic exposures, qac genes, and reduced antiseptic susceptibilities.
   Results: A total of 878 MRSA isolates were obtained. There were associations between qacA/B carriage and chlorhexidine (adjusted odds ratio (aOR) 7.80; 95% confidence interval (CI) 3.25-18.71) and octenidine (aOR 11.79; 95% CI 5.14-27.04) exposures. Chlorhexidine exposure was associated with reduced chlorhexidine susceptibility (MIC >= 4 mg/L) (aOR 3.15; 95% CI 1.14-8.74). Carriage of qacA/B (aOR 10.65; 95% CI 4.14-27.40) or qacC (aOR 2.55; 95% CI 1.22-5.32) had an association with reduced chlorhexidine susceptibility; while MRSA sequence type modified the association. However, we found no direct association between (i) antiseptics use and qacC carriage, (ii) octenidine exposure and reduced susceptibility, and (iii) reduced octenidine susceptibility and qacA/B or qacC carriage.
   Conclusions: Antiseptic exposures were associated with carriage of qac genes. Chlorhexidine exposure was associated with reduced chlorhexidine susceptibility, requiring continued surveillance for the emergence of resistance. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Htun, H. L.; Hon, P. Y.; Chow, A.] Tan Tock Seng Hosp, Off Clin Epidemiol Analyt & Knowledge OCEAN, Dept Clin Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
   [Holden, M. T. G.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland.
   [Ang, B.] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.
RP Chow, A (reprint author), Tan Tock Seng Hosp, Off Clin Epidemiol Analyt & Knowledge OCEAN, Dept Clin Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
EM angela_chow@ttsh.com.sg
RI Holden, Matthew/K-6449-2014
OI Holden, Matthew/0000-0002-4958-2166
FU Small Innovative Grant - National Healthcare Group [SIG/15033];
   Communicable Diseases e Public Health Research Grant - Ministry of
   Health Singapore [CDPHRG/0008/2014]
FX No conflicts of interest to declare. This research was supported by the
   Small Innovative Grant (SIG/15033) and Communicable Diseases e Public
   Health Research Grant (CDPHRG/0008/2014) awarded by the National
   Healthcare Group and Ministry of Health Singapore respectively.
CR Aanensen DM, 2016, MBIO, V7, DOI 10.1128/mBio.00444-16
   Bilavsky E, 2012, CLIN MICROBIOL INFEC, V18, pE164, DOI 10.1111/j.1469-0691.2012.03851.x
   Block C, 2002, J HOSP INFECT, V51, P201, DOI 10.1053/jhin.2002.1246
   Chow A, 2018, EPIDEMIOL INFECT, V146, P2036, DOI 10.1017/S0950268818002522
   Chow A, 2017, CLIN INFECT DIS, V64, pS76, DOI 10.1093/cid/cix072
   Clinical and Laboratory Standard Institute, 2015, M02A12 CLSI, P1
   EMMERSON M, 1994, SCAND J INFECT DIS, P47
   Hardy K, 2018, MBIO, V9, DOI [10.1128/mBio.00894-18, 10.1128/mbio.00894-18]
   Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395
   Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112
   Hon PY, 2014, J GLOB ANTIMICROB RE, V2, P53, DOI 10.1016/j.jgar.2013.10.002
   Horner C, 2012, J ANTIMICROB CHEMOTH, V67, P2547, DOI 10.1093/jac/dks284
   Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P244, DOI 10.1159/000314699
   Huet AA, 2008, MICROBIOL-SGM, V154, P3144, DOI 10.1099/mic.0.2008/021188-0
   Hughes C, 2017, PATHOLOGY, V49, P633, DOI 10.1016/j.pathol.2017.05.008
   Hunt M, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000131
   Kampf G, 2016, J HOSP INFECT, V94, P213, DOI 10.1016/j.jhin.2016.08.018
   Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en
   Krishna BVS, 2010, J HOSP INFECT, V74, P199, DOI 10.1016/j.jhin.2009.08.022
   Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233
   Lee SS, 2007, J INFECTION, V55, P358, DOI 10.1016/j.jinf.2007.06.011
   Liu QZ, 2009, SCAND J INFECT DIS, V41, P403, DOI 10.1080/00365540902856545
   Morrissey I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086669
   Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201
   Noguchi N, 1999, FEMS MICROBIOL LETT, V172, P247, DOI 10.1111/j.1574-6968.1999.tb13475.x
   Ott E, 2010, J HOSP INFECT, V76, P300, DOI 10.1016/j.jhin.2010.07.007
   Otter JA, 2013, J ANTIMICROB CHEMOTH, V68, P992, DOI 10.1093/jac/dks500
   Spencer C, 2013, J HOSP INFECT, V83, P156, DOI 10.1016/j.jhin.2012.10.007
   Vali L, 2008, J ANTIMICROB CHEMOTH, V61, P524, DOI 10.1093/jac/dkm520
   Warren DK, 2016, INFECT CONT HOSP EP, V37, P590, DOI 10.1017/ice.2016.1
NR 30
TC 2
Z9 2
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD SEP
PY 2019
VL 25
IS 9
DI 10.1016/j.cmi.2018.12.036
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IR7TE
UT WOS:000481643000015
PM 30625411
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Dhar, R
   Singh, S
   Talwar, D
   Mohan, M
   Tripathi, SK
   Swarnakar, R
   Trivedi, S
   Rajagopala, S
   D'Souza, G
   Padmanabhan, A
   Baburao, A
   Mahesh, PA
   Ghewade, B
   Nair, G
   Jindal, A
   Jayadevappa, GDH
   Sawhney, H
   Sarmah, KR
   Saha, K
   Anantharaj, S
   Khanna, A
   Gami, S
   Shah, A
   Shah, A
   Dutt, N
   Garg, H
   Vyas, S
   Venugopal, K
   Prasad, R
   Aleemuddin, NM
   Karmakar, S
   Singh, V
   Jindal, SK
   Sharma, S
   Prajapat, D
   Chandrashekaria, S
   McDonnell, MJ
   Mishra, A
   Rutherford, R
   Ramanathan, RP
   Goeminne, PC
   Vasudev, P
   Dimakou, K
   Crichton, ML
   Jayaraj, BS
   Kungwani, R
   Das, A
   Sawhney, M
   Polverino, E
   Torres, A
   Gulecha, NS
   Shteinberg, M
   De Soyza, A
   Mangala, A
   Shah, P
   Chauhan, NK
   Jajodia, N
   Singhal, A
   Batra, S
   Hasan, A
   Limaye, S
   Salvi, S
   Aliberti, S
   Chalmers, JD
AF Dhar, Raja
   Singh, Sheetu
   Talwar, Deepak
   Mohan, Murali
   Tripathi, Surya Kant
   Swarnakar, Rajesh
   Trivedi, Sonali
   Rajagopala, Srinivas
   D'Souza, George
   Padmanabhan, Arjun
   Baburao, Archana
   Mahesh, Padukudru Anand
   Ghewade, Babaji
   Nair, Girija
   Jindal, Aditya
   Jayadevappa, Gayathri Devi H.
   Sawhney, Honney
   Sarmah, Kripesh Ranjan
   Saha, Kaushik
   Anantharaj, Suresh
   Khanna, Arjun
   Gami, Samir
   Shah, Arti
   Shah, Arpan
   Dutt, Naveen
   Garg, Himanshu
   Vyas, Sunil
   Venugopal, Kummannoor
   Prasad, Rajendra
   Aleemuddin, Naveed M.
   Karmakar, Saurabh
   Singh, Virendra
   Jindal, Surinder Kumar
   Sharma, Shubham
   Prajapat, Deepak
   Chandrashekaria, Sagar
   McDonnell, Melissa J.
   Mishra, Aditi
   Rutherford, Robert
   Ramanathan, Ramanathan Palaniappan
   Goeminne, Pieter C.
   Vasudev, Preethi
   Dimakou, Katerina
   Crichton, Megan L.
   Jayaraj, Biiligere Siddaiah
   Kungwani, Rahul
   Das, Akanksha
   Sawhney, Mehneet
   Polverino, Eva
   Torres, Antoni
   Gulecha, Nayan Sri
   Shteinberg, Michal
   De Soyza, Anthony
   Mangala, Anshul
   Shah, Palak
   Chauhan, Nishant Kumar
   Jajodia, Nikita
   Singhal, Ashutosh
   Batra, Sakshi
   Hasan, Ashfaq
   Limaye, Sneha
   Salvi, Sundeep
   Aliberti, Stefano
   Chalmers, James D.
TI Bronchiectasis in India: results from the European Multicentre
   Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory
   Research Network of India Registry
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID CYSTIC FIBROSIS BRONCHIECTASIS; EXACERBATIONS
AB Background Bronchiectasis is a common but neglected chronic lung disease. Most epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income and middle-income countries. We therefore aimed to describe the characteristics, severity of disease, microbiology, and treatment of patients with bronchiectasis in India.
   Methods The Indian bronchiectasis registry is a multicentre, prospective, observational cohort study. Adult patients (>= 18 years) with CT-confirmed bronchiectasis were enrolled from 31 centres across India. Patients with bronchiectasis due to cystic fibrosis or traction bronchiectasis associated with another respiratory disorder were excluded. Data were collected at baseline (recruitment) with follow-up visits taking place once per year. Comprehensive clinical data were collected through the European Multicentre Bronchiectasis Audit and Research Collaboration registry platform. Underlying aetiology of bronchiectasis, as well as treatment and risk factors for bronchiectasis were analysed in the Indian bronchiectasis registry. Comparisons of demographics were made with published European and US registries, and quality of care was benchmarked against the 2017 European Respiratory Society guidelines.
   Findings From June 1, 2015, to Sept 1, 2017, 2195 patients were enrolled. Marked differences were observed between India, Europe, and the USA. Patients in India were younger (median age 56 years [IQR 41-66] vs the European and US registries; p<0.0001]) and more likely to be men (1249 [56.9%] of 2195). Previous tuberculosis (780 [35.5%] of 2195) was the most frequent underlying cause of bronchiectasis and Pseudomonas aeruginosa was the most common organism in sputum culture (301 [13.7%]) in India. Risk factors for exacerbations included being of the male sex (adjusted incidence rate ratio 1.17, 95% CI 1.03-1.32; p=0.015), P aeruginosa infection (1.29, 1.10-1.50; p=0.001), a history of pulmonary tuberculosis (1.20, 1.07-1.34; p=0.002), modified Medical Research Council Dyspnoea score (1.32, 1.25-1.39; p<0.0001), daily sputum production (1.16, 1.03-1.30; p=0.013), and radiological severity of disease (1.03, 1.01-1.04; p<0.0001). Low adherence to guideline-recommended care was observed; only 388 patients were tested for allergic bronchopulmonary aspergillosis and 82 patients had been tested for immunoglobulins.
   Interpretation Patients with bronchiectasis in India have more severe disease and have distinct characteristics from those reported in other countries. This study provides a benchmark to improve quality of care for patients with bronchiectasis in India. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.
C1 [Dhar, Raja; Sharma, Shubham] Fortis Hosp, Dept Chest & TB, Kolkata, W Bengal, India.
   [Singh, Sheetu] SMS Med Coll & Hosp, Inst Resp Dis, Jaipur, Rajasthan, India.
   [Talwar, Deepak; Prajapat, Deepak] Metro Ctr Resp Dis, Dept Resp Med, Noida, Uttar Pradesh, India.
   [Mohan, Murali; Chandrashekaria, Sagar] Narayana Hrudayalaya, Mazumdar Shaw Med Ctr, Bengaluru, Karnataka, India.
   [Tripathi, Surya Kant] King Georges Med Univ, Dept Resp Med, Lucknow, Uttar Pradesh, India.
   [Swarnakar, Rajesh; Mishra, Aditi] Getwell Hosp & Res Ctr, Dept Resp Med, Nagpur, Maharashtra, India.
   [Trivedi, Sonali] Jawaharlal Nehru Hosp & Res Ctr, Dept Resp Med, Bhilai, Chhattisgarh, India.
   [Rajagopala, Srinivas; Ramanathan, Ramanathan Palaniappan] PSG Inst Pulm Med, Dept Pulmonol, Coimbatore, Tamil Nadu, India.
   [D'Souza, George] St John Med Coll, Dept Pulm Med, Bengaluru, Karnataka, India.
   [Padmanabhan, Arjun; Vasudev, Preethi] Kerala Inst Med Sci, Dept Resp Med, Trivandrum, Kerala, India.
   [Baburao, Archana] Kempegowda Inst Med Sci, Dept Pulm Med, Bengaluru, Karnataka, India.
   [Mahesh, Padukudru Anand; Jayaraj, Biiligere Siddaiah] JSS Med Coll, Dept Resp Med, Mysuru, Karnataka, India.
   [Ghewade, Babaji; Kungwani, Rahul] Datta Meghe Inst Med Sci, Dept Resp Med, Wardha, Maharashtra, India.
   [Nair, Girija; Das, Akanksha] DY Patil Sch Med, Dept Pulm Med, Navi Mumbai, Maharashtra, India.
   [Jindal, Aditya; Jindal, Surinder Kumar] Jindal Clin, Chandigarh, Punjab, India.
   [Jindal, Aditya; Jindal, Surinder Kumar] Jindal Clin, Chandigarh, Haryana, India.
   [Jayadevappa, Gayathri Devi H.] MS Ramaiah Med Coll, Dept Resp Med, Bengaluru, Karnataka, India.
   [Sawhney, Honney; Sawhney, Mehneet] Govt Multispecial Hosp, Dept Med, Chandigarh, Punjab, India.
   [Sawhney, Honney; Sawhney, Mehneet] Govt Multispecial Hosp, Dept Med, Chandigarh, Haryana, India.
   [Sarmah, Kripesh Ranjan] Apollo Hosp, Dept Pulm Med, Gauhati, Assam, India.
   [Saha, Kaushik] Burdwan Med Coll, Chest Med Dept, Burdwan, W Bengal, India.
   [Anantharaj, Suresh; Gulecha, Nayan Sri] Sundaram Med Fdn, Dept Pulm Med, Chennai, Tamil Nadu, India.
   [Anantharaj, Suresh; Gulecha, Nayan Sri] SRM Inst Med Sci, Dept Gen Med, Chennai, Tamil Nadu, India.
   [Khanna, Arjun] Galaxy Hosp, Dept Internal Med, Delhi, India.
   [Khanna, Arjun] Super Special Hosp Kaushambi, Dept Internal Med, Ghaziabad, Uttar Pradesh, India.
   [Gami, Samir] Unique Hosp Multispecial & Res Inst, Dept Pulm Med & Crit Care, Surat, Gujarat, India.
   [Shah, Arti; Mangala, Anshul] Sumandeep Univ, Dhiraj Hosp, Dept Resp Med, Vadodara, Gujarat, India.
   [Shah, Arpan; Shah, Palak] Pranayam Lung & Heart Inst & Res Ctr, Dept Resp Med, Vadodara, Gujarat, India.
   [Dutt, Naveen; Chauhan, Nishant Kumar] All India Inst Med Sci, Dept Pulm Med, Jodhpur, Rajasthan, India.
   [Garg, Himanshu; Jajodia, Nikita] Artemis Hosp, Dept Resp & Sleep Med, New Delhi, India.
   [Vyas, Sunil; Singhal, Ashutosh] Dr SN Med Coll, Dept Pulm Med, Jodhpur, Rajasthan, India.
   [Venugopal, Kummannoor] Govt Med Coll, Dept Pulm Med, Kottayam, Kerala, India.
   [Prasad, Rajendra; Batra, Sakshi] Eras Lucknow Med Coll & Hosp, Dept Pulm Med, Lucknow, Uttar Pradesh, India.
   [Aleemuddin, Naveed M.; Hasan, Ashfaq] Deccan Coll Med Sci, Dept Resp Med, Hyderabad, Telangana, India.
   [Karmakar, Saurabh] All India Inst Med Sci Patna, Dept Pulm Med, Patna, Bihar, India.
   [Singh, Virendra] Asthma Bhawan, Dept Resp Med, Jaipur, Rajasthan, India.
   [McDonnell, Melissa J.; Rutherford, Robert] Galway Univ Hosp, Dept Resp Med, Galway, Ireland.
   [Goeminne, Pieter C.] AZ Nikolaas, Dept Resp Dis, St Niklaas, Belgium.
   [Dimakou, Katerina] Sotiria Chest Dis Hosp, Dept Pulm Med 5, Athens, Greece.
   [Crichton, Megan L.; Chalmers, James D.] Univ Dundee, Scottish Ctr Resp Res, Dundee DD1 9SY, Scotland.
   [Polverino, Eva] Hosp Univ Vall dHebron, Pneumol Dept, Barcelona, Spain.
   [Polverino, Eva; Torres, Antoni] Univ Barcelona, Inst Biomed Res August Pi i Sunyer, Thorax Inst, Barcelona, Spain.
   [Shteinberg, Michal] Carmel Hosp, Pulm Inst, Haifa, Israel.
   [De Soyza, Anthony] Freeman Rd Hosp, Adult Bronchiectasis Serv, Newcastle Upon Tyne, Tyne & Wear, England.
   [De Soyza, Anthony] Freeman Rd Hosp, Sir William Leech Ctr Lung Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [De Soyza, Anthony] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Limaye, Sneha; Salvi, Sundeep] Chest Res Fdn, Resp Res Network India, Pune, Maharashtra, India.
   [Aliberti, Stefano] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
RP Chalmers, JD (reprint author), Univ Dundee, Scottish Ctr Resp Res, Dundee DD1 9SY, Scotland.; Dhar, R (reprint author), Fortis Hosp, Resp & Sleep Med, Kolkata 700107, W Bengal, India.
EM docaardee@yahoo.com; jchalmers@dundee.ac.uk
RI Torres, Antoni/H-6128-2017; Aliberti, Stefano/K-9115-2016
OI Torres, Antoni/0000-0002-8643-2167; HJ, Gayathri
   Devi/0000-0001-8744-7208; Ghewade, Babaji/0000-0003-1553-7268; Aliberti,
   Stefano/0000-0002-0090-4531; Arjun, Padmanabhan/0000-0001-7729-6637
FU EU/European Federation of Pharmaceutical Industries and Associations
   Innovative Medicines Initiative inhaled Antibiotics in Bronchiectasis
   and Cystic Fibrosis Consortium; European Respiratory Society; British
   Lung Foundation
FX EU/European Federation of Pharmaceutical Industries and Associations
   Innovative Medicines Initiative inhaled Antibiotics in Bronchiectasis
   and Cystic Fibrosis Consortium, European Respiratory Society, and the
   British Lung Foundation.
CR Aksamit T, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02053-2017
   Aksamit TR, 2017, CHEST, V151, P982, DOI 10.1016/j.chest.2016.10.055
   Aliberti S, 2016, EUR RESPIR J, V48, P244, DOI 10.1183/13993003.00232-2016
   Araujo D, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01953-2017
   Boaventura R, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01269-2018
   Chalmers JD, 2018, LANCET RESP MED, V6, P715, DOI 10.1016/S2213-2600(18)30053-5
   Chalmers JD, 2018, AM J RESP CRIT CARE, V197, P1410, DOI 10.1164/rccm.201711-2202OC
   Chalmers JD, 2016, RESP MED, V112, P51, DOI 10.1016/j.rmed.2016.01.016
   Chalmers JD, 2016, EUROPEAN RESP J, V2, P00081, DOI [10.1183/23120541.00081-2015, DOI 10.1183/23120541.00081-2015]
   Chandrasekaran R, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0638-0
   Chang AB, 2002, MED J AUSTRALIA, V177, P200, DOI 10.5694/j.1326-5377.2002.tb04733.x
   Chotirmall SH, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02444-2017
   Cohen DB, 2018, INT J TUBERC LUNG D, V22, P1127, DOI 10.5588/ijtld.17.0705
   De Soyza A, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02052-2017
   Gao YH, 2015, CHEST, V147, P1635, DOI 10.1378/chest.14-1961
   Hall GL, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02277-2018
   Henkle E, 2018, CHEST, V154, P1311, DOI [10.1016/j.chest.2018.07.014, 10.1016/j.chest2018.07.014]
   Jabeen Kauser, 2016, Int J Mycobacteriol, V5 Suppl 1, pS73, DOI 10.1016/j.ijmyco.2016.08.016
   Mac Aogain M, 2019, AM J RESP CRIT CARE, V199, P842, DOI 10.1164/rccm.201807-1355OC
   Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313
   McDonnell MJ, 2016, THORAX, V71, P1110, DOI 10.1136/thoraxjnl-2016-208481
   McDonnell MJ, 2016, LANCET RESP MED, V4, P969, DOI 10.1016/S2213-2600(16)30320-4
   Meghji J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161176
   Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC
   Monson BB, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0380-17.2017
   Munoz G, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01926-2017
   Polverino E, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00629-2017
   Quittner AL, 2015, THORAX, V70, P12, DOI 10.1136/thoraxjnl-2014-205918
   Saha SK, 2009, INDIAN J MED RES, V129, P99
   Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2
NR 30
TC 7
Z9 8
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD SEP
PY 2019
VL 7
IS 9
BP E1269
EP E1279
DI 10.1016/S2214-109X(19)30327-4
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IP8JB
UT WOS:000480291600030
PM 31402007
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Hemdan, BA
   El-Liethy, MA
   ElMahdy, MEI
   EL-Taweel, GE
AF Hemdan, Bahaa A.
   El-Liethy, Mohamed Azab
   ElMahdy, M. E. I.
   EL-Taweel, Gamila E.
TI Metagenomics analysis of bacterial structure communities within natural
   biofilm
SO HELIYON
LA English
DT Article
DE Microbiology; Biofilm; NGS analysis; Bacterial lineages; PCR; Public
   health
ID DRINKING-WATER BIOFILMS; MICROBIAL-CONTAMINATION;
   PSEUDOMONAS-AERUGINOSA; IDENTIFICATION; SYSTEM; DISINFECTION; PATHOGEN;
   SURVIVAL; NETWORK; QUALITY
AB The bacterial profiles of natural household biofilm have not been widely investigated. The majorities of these bacterial lineages are not cultivable. Thus, this study aims (i) to enumerate some potential bacterial lineages using culture based method within biofilm samples and confirmed using Biolog GEN III and polymerase chain reaction (PCR). (ii) To investigate the bacterial profiles of communities in two biofilm samples using next generation sequencing (NGS). Forty biofilm samples were cultured and colonies of each selected prevailing potential lineages (E. coif, Salmonella entrica, Pseudomonas aeruginosa, Staphylococcus aureus and Listeria monocytogenes) were selected for confirmation. From obtained results, the counts of the tested bacterial lineages in kitchen biofilm samples were greater than those in bathroom samples. Precision of PCR was higher than Biolog GEN III to confirm the bacterial isolates. Using NGS analysis, the results revealed that a total of 110,554 operational taxonomic units (OTUs) were obtained for two biofilm samples, representing kitchen and bathroom biofilm samples. The numbers of phyla in the kitchen biofilm sample (35 OTUs) was higher than that in bathroom sample (18 OTUs). A total of 435 genera were observed in the bathroom biofilm sample compared to only 256 in the kitchen sample. Evidences have shown that the empirical gadgets for biofilm investigation are becoming convenient and affordable. Many distinct bacterial lineages observed in biofilm are one of the most significant issues that threaten human health and lead to disease outbreaks.
C1 [Hemdan, Bahaa A.; El-Liethy, Mohamed Azab; EL-Taweel, Gamila E.] Natl Res Ctr, Water Pollut Res Dept, Environm Microbiol Lab, Giza 12622, Egypt.
   [ElMahdy, M. E. I.] Natl Res Ctr, Water Pollut Res Dept, Environm Virol Lab, Giza 12622, Egypt.
RP Hemdan, BA (reprint author), Natl Res Ctr, Water Pollut Res Dept, Environm Microbiol Lab, Giza 12622, Egypt.
EM bahaa_nrc@yahoo.com
OI Mohamed Elmahdy, Elmahdy/0000-0002-0896-6753; /0000-0002-1138-9571;
   El-Liethy, Mohamed/0000-0002-8392-2355
FU Science and Technology Development Fund (STDF)Science and Technology
   Development Fund (STDF) [15031]
FX This work was supported by the Science and Technology Development Fund
   (STDF) - grant Number 15031.
CR AABO S, 1993, MOL CELL PROBE, V7, P171, DOI 10.1006/mcpr.1993.1026
   Al-Dhabaan FAM, 2017, SAUDI J BIOL SCI, V24, P901, DOI 10.1016/j.sjbs.2016.01.043
   AMERICAN PUBLIC HEALTH ASSOCIATION (APHA); AMERICAN WATER WORKS ASSOCIATION (AWWA); WATER ENVIRONMENT FEDERATION (WEF), 2012, STANDARD METHODS EXA, P1082
   Armbruster CR, 2012, BIOFOULING, V28, P1129, DOI 10.1080/08927014.2012.735231
   Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005
   BANERJEE A, 1995, WORLD J MICROB BIOT, V11, P618, DOI 10.1007/BF00361002
   BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991
   Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x
   Besemer K, 2015, RES MICROBIOL, V166, P774, DOI 10.1016/j.resmic.2015.05.006
   Bitton G., 2011, WASTEWATER MICROBIOL, P781
   Blom K, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-014-0056-6
   Bloomfield S, 2001, J INFECTION, V43, P23, DOI 10.1053/jinf.2001.0848
   Bosshard PP, 2006, J CLIN MICROBIOL, V44, P1359, DOI 10.1128/JCM.44.4.1359-1366.2006
   Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45
   Chao YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10044
   Chojniak J, 2015, ACTA BIOCHIM POL, V62, P799, DOI 10.18388/abp.2015_1138
   Cogan TA, 2002, J APPL MICROBIOL, V92, P885, DOI 10.1046/j.1365-2672.2002.01598.x
   Cogan TA, 1999, LETT APPL MICROBIOL, V29, P354, DOI 10.1046/j.1472-765X.1999.00656.x
   D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9
   Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047
   Douterelo I, 2017, SCI TOTAL ENVIRON, V581, P277, DOI 10.1016/j.scitotenv.2016.12.118
   Douterelo I, 2016, APPL MICROBIOL BIOT, V100, P3301, DOI 10.1007/s00253-015-7155-3
   Douterelo I, 2014, WATER RES, V65, P134, DOI 10.1016/j.watres.2014.07.008
   El-Liethy M. A., 2018, ACTA ECOL SIN
   Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]
   Farber JM, 1996, INT J FOOD MICROBIOL, V30, P145, DOI 10.1016/0168-1605(96)01107-5
   Fish KE, 2016, ENVIRON SCI-WAT RES, V2, P614, DOI [10.1039/c6ew00039h, 10.1039/C6EW00039H]
   Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94
   Fontana C, 2005, J CLIN MICROBIOL, V43, P615, DOI 10.1128/JCM.43.2.615-619.2005
   Francis GA, 1999, INT J FOOD SCI TECH, V34, P1, DOI 10.1046/j.1365-2621.1999.00253.x
   Garza DR, 2015, CELL MOL LIFE SCI, V72, P4287, DOI 10.1007/s00018-015-2004-1
   Giao MS, 2008, APPL ENVIRON MICROB, V74, P5898, DOI 10.1128/AEM.00827-08
   Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037
   Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497
   Hemdan B. A., 2017, Journal of Environmental Science and Technology, V10, P131, DOI 10.3923/jest.2017.131.138
   Hemdan B. A., 2016, WORLD APPL SCI J, V34, P214
   Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11
   Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07
   Jang HJ, 2011, J MICROBIOL BIOTECHN, V21, P115, DOI 10.4014/jmb.1010.10012
   Jarvinen AK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-161
   Juhna T, 2007, APPL ENVIRON MICROB, V73, P3755, DOI 10.1128/AEM.00313-07
   Kelly JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100121
   Keshri J, 2018, MICROB ECOL, V75, P662, DOI 10.1007/s00248-017-1074-z
   Kisand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043630
   Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032
   Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022
   Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009
   Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168
   Lucena-Aguilar G, 2016, BIOPRESERV BIOBANK, V14, P264, DOI 10.1089/bio.2015.0064
   Madigan M, 2005, BROCK BIOL MICROORGA
   Maes S, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1451-5
   McBain AJ, 2001, INT BIODETER BIODEGR, V47, P55, DOI 10.1016/S0964-8305(01)00037-3
   Medrano-Felix A, 2011, J APPL MICROBIOL, V110, P463, DOI 10.1111/j.1365-2672.2010.04901.x
   Meli K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39176
   Momba MNB, 2002, WATER RES, V36, P3023, DOI 10.1016/S0043-1354(02)00011-8
   Moraes PM, 2013, BRAZ J MICROBIOL, V44, P109, DOI 10.1590/S1517-83822013000100015
   Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003
   Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06
   Oliver JD, 2005, J MICROBIOL, V43, P93
   Paillard D., 2003, APPL ENVIRON MICROB, P6386
   Pathak E, 2012, FUNGAL BIOL-UK, V116, P563, DOI 10.1016/j.funbio.2012.02.005
   Pollack M, 2000, PRINCIPLES PRACTICE, P2310
   Reynolds KA, 2005, INT J ENVIRON HEAL R, V15, P225, DOI 10.1080/09603120500115298
   Sandle T., 2013, EUR J PARENTER PHARM, V18, P1
   Schmeisser C, 2003, APPL ENVIRON MICROB, V69, P7298, DOI 10.1128/AEM.69.12.7298-7309.2003
   Schmeisser C, 2007, APPL MICROBIOL BIOT, V75, P955, DOI 10.1007/s00253-007-0945-5
   Schmid-Hempel P, 2007, PLOS PATHOG, V3, P1372, DOI 10.1371/journal.ppat.0030147
   Simoes LC, 2006, BIOFOULING, V22, P91, DOI 10.1080/08927010600598603
   Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10
   Sinclair RG, 2011, LETT APPL MICROBIOL, V52, P144, DOI 10.1111/j.1472-765X.2010.02978.x
   Sinclair RG, 2008, ADV APPL MICROBIOL, V65, P249, DOI 10.1016/S0065-2164(08)00609-6
   Smeltzer MS, 1997, GENE, V196, P249, DOI 10.1016/S0378-1119(97)00237-0
   Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004
   Swan JS, 2016, J HOSP INFECT, V94, P169, DOI 10.1016/j.jhin.2016.07.007
   Wingender J, 2004, WATER SCI TECHNOL, V49, P277
   Wingender J., 2011, INT J HYG ENVIR HEAL, V213, P190
   Wragg P, 2014, J MICROBIOL METH, V105, P16, DOI 10.1016/j.mimet.2014.07.003
NR 77
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD AUG
PY 2019
VL 5
IS 8
AR e02271
DI 10.1016/j.heliyon.2019.e02271
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IV6PV
UT WOS:000484391200122
PM 31485510
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Paterson, JS
   Smith, RJ
   McKerral, JC
   Dann, LM
   Launer, E
   Goonan, P
   Kleinig, T
   Fuhrman, JA
   Mitchell, JG
AF Paterson, James S.
   Smith, Renee J.
   McKerral, Jody C.
   Dann, Lisa M.
   Launer, Elise
   Goonan, Peter
   Kleinig, Tavis
   Fuhrman, Jed A.
   Mitchell, James G.
TI A hydrocarbon-contaminated aquifer reveals a Piggyback-the-Persistent
   viral strategy
SO FEMS MICROBIOLOGY ECOLOGY
LA English
DT Article
DE microbial ecology; bacteria; viruses; pollution microbiology
ID LOCAL SIMILARITY ANALYSIS; NUCLEIC-ACID CONTENT; MARINE VIRUSES;
   FLOW-CYTOMETRY; MICROBIAL COMMUNITY; BACTERIAL; TRICHLOROETHENE;
   DIVERSITY; BIODEGRADATION; DECHLORINATION
AB Subsurface environments hold the largest reservoir of microbes in the biosphere. They play essential roles in transforming nutrients, degrading contaminants and recycling organic matter. Here, we propose a previously unrecognised fundamental microbial process that influences aquifer bioremediation dynamics and that applies to all microbial communities. In contrast to previous models, our proposed Piggyback-the-Persistent (PtP) mechanism occurs when viruses become more dominated by those exhibiting temperate rather than lytic lifestyles driven by persistent chemicals (in our case chlorinated-hydrocarbon pollutants) that provide long-term carbon sources and that refocus the aquifer carbon cycle, thus altering the microbial community. In this ultra-oligotrophic system, the virus: microbial ratio (VMR) ranges from below the detection limit of 0.0001 to 0.6, well below the common aquatic range of 3-10. Shortest-average-path network analysis revealed VMR and trichlorethene (TCE) as nodes through which ecosystem information and biomass most efficiently pass. Novel network rearrangement revealed a hierarchy of Kill-the-Winner (KtW), Piggyback-the-Winner (PtW) and PtP nodes. We propose that KtW, PtW and PtP occur simultaneously as competing strategies, with their relative importance depending on conditions at a particular time and location with unusual nutrient sources, such as TCE, appearing to contribute to a shift in this balance between viral mechanisms.
C1 [Paterson, James S.; Smith, Renee J.; McKerral, Jody C.; Dann, Lisa M.; Launer, Elise; Mitchell, James G.] Flinders Univ S Australia, Coll Sci & Engn, GPO Box 2100, Adelaide, SA 5001, Australia.
   [Smith, Renee J.] Flinders Univ S Australia, Coll Med & Publ Hlth, GPO Box 2100, Adelaide, SA 5001, Australia.
   [Goonan, Peter; Kleinig, Tavis] South Australia Environm Protect Author, GPO Box 2607, Adelaide, SA 5001, Australia.
   [Fuhrman, Jed A.] Univ Southern Calif, Dept Biol Sci, 3616 Trousdale Pkwy, Los Angeles, CA 90089 USA.
RP Paterson, JS (reprint author), Flinders Univ S Australia, Coll Sci & Engn, GPO Box 2100, Adelaide, SA 5001, Australia.
EM james.paterson@flinders.edu.au
OI Fisher, Jody/0000-0002-1830-6695; Paterson, James/0000-0002-1193-5739;
   Dann, Lisa/0000-0002-2525-5523; Mitchell, Jim/0000-0002-8445-0935
FU Australian Research CouncilAustralian Research Council [LP130100508]
FX This project was funded by the Australian Research Council LP130100508.
CR Adetutu EM, 2015, J HAZARD MATER, V300, P48, DOI 10.1016/j.jhazmat.2015.06.055
   Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47
   AMERICAN PUBLIC HEALTH ASSOCIATION (APHA), 2005, STANDARD METHODS EXA
   Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156
   BLAST, 2010, BIOINFORMATICS, V26, P2460
   Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805
   Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004
   Butler EC, 2013, GROUND WATER MONIT R, V33, P52, DOI 10.1111/gwmr.12015
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x
   Clarke KR, 2001, CHANGE MARINE COMMUN
   Deng L, 2014, ENV MICROBIOL REP, V6, P325, DOI 10.1111/1758-2229.12119
   Doughari HJ, 2011, MICROBES ENVIRON, V26, P101, DOI 10.1264/jsme2.ME10179
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Fetzner S, 1998, APPL MICROBIOL BIOT, V50, P633, DOI 10.1007/s002530051346
   Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119
   Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475
   Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197
   Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2
   Gleeson T, 2016, NAT GEOSCI, V9, P161, DOI 10.1038/NGEO2590
   Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x
   Guerrero-Barajas C, 2014, INT BIODETER BIODEGR, V94, P182, DOI 10.1016/j.ibiod.2014.07.015
   Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577
   Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193
   Konopka A, 2013, MICROB ECOL, V66, P889, DOI 10.1007/s00248-013-0283-3
   Kuppardt A, 2014, MICROB ECOL, V68, P222, DOI 10.1007/s00248-014-0403-8
   Larentis M, 2013, ENV MICROBIOL REP, V5, P225, DOI 10.1111/1758-2229.12004
   Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001
   Lee PKH, 2008, APPL ENVIRON MICROB, V74, P2728, DOI 10.1128/AEM.02199-07
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997
   Nedashkovskaya OI, 2015, ALGORIPHAGUS BERGEYS, P1
   Novarino G, 1997, FEMS MICROBIOL REV, V20, P261, DOI 10.1016/S0168-6445(97)00046-6
   Orth WS, 1996, ENVIRON SCI TECHNOL, V30, P66, DOI 10.1021/es950053u
   Paterson JS, 2016, J BIOTECHNOL, V219, P90, DOI 10.1016/j.jbiotec.2015.12.033
   Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018
   Rodrigues LM, 2014, FAMILY OPITUTACEAE P, P751
   Rossi P, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00260
   Roudnew B, 2014, GROUNDWATER, V52, P118, DOI 10.1111/gwat.12044
   Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417
   Seymour JR, 2006, J MAR BIOL ASSOC UK, V86, P551, DOI 10.1017/S0025315406013464
   Skidmore M, 2005, APPL ENVIRON MICROB, V71, P6986, DOI 10.1128/AEM.71.11.6986-6997.2005
   Smith RWA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125344
   South Australian Environmental Protection Authority, 2014, ADD ENV ASS
   South Australian Environmental Protection Authority, 2015, HEND INV AR ENV INV
   Srividhya KV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001193
   Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750
   Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019
   Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320
   TUOMI P, 1995, FEMS MICROBIOL ECOL, V16, P123, DOI 10.1111/j.1574-6941.1995.tb00276.x
   Weitz JS, 2017, NATURE, V549, pE1, DOI 10.1038/nature23295
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   Wigington CH, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.24, 10.1038/nmicrobiol.2015.24]
   Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09
   Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000
   Wrighton KC, 2014, ISME J, V8, P1452, DOI 10.1038/ismej.2013.249
   Xia LC, 2013, BIOINFORMATICS, V29, P230, DOI 10.1093/bioinformatics/bts668
   Yagi JM, 2010, ISME J, V4, P131, DOI 10.1038/ismej.2009.101
   Yang Y, 2015, ENVIRON SCI TECHNOL, V49, P12087, DOI 10.1021/acs.est.5b02663
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
NR 62
TC 0
Z9 0
U1 4
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0168-6496
EI 1574-6941
J9 FEMS MICROBIOL ECOL
JI FEMS Microbiol. Ecol.
PD AUG
PY 2019
VL 95
IS 8
AR fiz116
DI 10.1093/femsec/fiz116
PG 10
WC Microbiology
SC Microbiology
GA IV6QH
UT WOS:000484392400021
PM 31314089
DA 2020-05-07
ER

PT J
AU Raghuvanshi, R
   Grayson, AG
   Schena, I
   Amanze, O
   Suwintono, K
   Quinn, RA
AF Raghuvanshi, Ruma
   Grayson, Allyssa G.
   Schena, Isabella
   Amanze, Onyebuchi
   Suwintono, Kezia
   Quinn, Robert A.
TI Microbial Transformations of Organically Fermented Foods
SO METABOLITES
LA English
DT Article
DE Fermented Food; metabolomics; GNPS; molecular networking; microbiome
ID MASS-SPECTROMETRY; HEALTH; CURATION
AB Fermenting food is an ancient form of preservation ingrained many in human societies around the world. Westernized diets have moved away from such practices, but even in these cultures, fermented foods are seeing a resurgent interested due to their believed health benefits. Here, we analyze the microbiome and metabolome of organically fermented vegetables, using a salt brine, which is a common 'at-home' method of food fermentation. We found that the natural microbial fermentation had a strong effect on the food metabolites, where all four foods (beet, carrot, peppers and radishes) changed through time, with a peak in molecular diversity after 2-3 days and a decrease in diversity during the final stages of the 4-day process. The microbiome of all foods showed a stark transition from one that resembled a soil community to one dominated by Enterobacteriaceae, such as Erwinia spp., within a single day of fermentation and increasing amounts of Lactobacillales through the fermentation process. With particular attention to plant natural products, we observed significant transformations of polyphenols, triterpenoids and anthocyanins, but the degree of this metabolism depended on the food type. Beets, radishes and peppers saw an increase in the abundance of these compounds as the fermentation proceeded, but carrots saw a decrease through time. This study showed that organically fermenting vegetables markedly changed their chemistry and microbiology but resulted in high abundance of Enterobacteriaceae which are not normally considered as probiotics. The release of beneficial plant specialized metabolites was observed, but this depended on the fermented vegetable.
C1 [Raghuvanshi, Ruma; Grayson, Allyssa G.; Schena, Isabella; Amanze, Onyebuchi; Suwintono, Kezia; Quinn, Robert A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
RP Quinn, RA (reprint author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM quinnrob@Msu.edu
CR Amir A., 2017, MSYSTEMS, V2, DOI DOI 10.1128/mSystems.00191-16
   CAMPBELLPLATT G, 1994, FOOD RES INT, V27, P253, DOI 10.1016/0963-9969(94)90093-0
   Chilton SN, 2015, NUTRIENTS, V7, P390, DOI 10.3390/nu7010390
   Daniel M., 2018, MSYSTEMS, V3
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Fang F, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1369-3
   Gilbert J., 2017, DIRT IS GOOD ADVANTA
   Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9
   Hartmann AC, 2017, P NATL ACAD SCI USA, V114, P11685, DOI 10.1073/pnas.1710248114
   Hostetler G, 2012, MOL NUTR FOOD RES, V56, P558, DOI 10.1002/mnfr.201100596
   Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027
   Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10
   Justesen U, 2000, LEBENSM-WISS TECHNOL, V33, P424, DOI 10.1006/fstl.2000.0681
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310
   Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Mugula JK, 2003, INT J FOOD MICROBIOL, V80, P187, DOI 10.1016/S0168-1605(02)00141-1
   Park SE, 2016, LWT-FOOD SCI TECHNOL, V68, P313, DOI 10.1016/j.lwt.2015.12.046
   Perez Diaz I.M., 2015, COMPENDIUM METHODS M, V51
   Pojer E, 2013, COMPR REV FOOD SCI F, V12, P483, DOI 10.1111/1541-4337.12024
   Rezac S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01785
   Selhub EM, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-2
   Shi J, 2004, J MED FOOD, V7, P67, DOI 10.1089/109662004322984734
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Tamang JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00377
   Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621
   TOLAN JS, 1987, APPL ENVIRON MICROB, V53, P2033, DOI 10.1128/AEM.53.9.2033-2038.1987
   Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109
   Wolfe BE, 2015, CELL, V161, P49, DOI 10.1016/j.cell.2015.02.034
   Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861
   Wuyts S, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00134-18, 10.1128/aem.00134-18]
   Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7
   Zabat MA, 2018, FOODS, V7, DOI 10.3390/foods7050077
NR 36
TC 0
Z9 0
U1 2
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD AUG
PY 2019
VL 9
IS 8
AR 165
DI 10.3390/metabo9080165
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IT5XH
UT WOS:000482941400001
PM 31405168
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Ward, L
   Andreassen, S
   Astrup, JJ
   Rahmani, Z
   Fantini, M
   Sambri, V
AF Ward, Logan
   Andreassen, Steen
   Astrup, Jesper Johnsen
   Rahmani, Zakia
   Fantini, Michela
   Sambri, Vittorio
TI Clinical- vs. model-based selection of patients suspected of sepsis for
   direct-from-blood rapid diagnostics in the emergency department: a
   retrospective study
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
DE Risk-based stratification; Sepsis; Rapid molecular microbiology;
   Mathematical models
ID INTERNATIONAL CONSENSUS DEFINITIONS; PROBABILISTIC NETWORK; PREDICTION;
   CULTURE; METAANALYSIS; TREAT
AB Selecting high-risk patients may improve the cost-effectiveness of rapid diagnostics. Our objective was to assess whether model-based selection or clinical selection is better for selecting high-risk patients with a high rate of bacteremia and/or DNAemia. This study involved a model-based, retrospective selection of patients from a cohort from which clinicians selected high-risk patients for rapid direct-from-blood diagnostic testing. Patients were included if they were suspected of sepsis and had blood cultures ordered at the emergency department. Patients were selected by the model by adding those with the highest probability of bacteremia until the number of high-risk patients selected by clinicians was reached. The primary outcome was bacteremia rate. Secondary outcomes were DNAemia rate, and 30-day mortality. Data were collected for 1395 blood cultures. Following exclusion, 1142 patients were included in the analysis. In each high-risk group, 220/1142 were selected, where 55 were selected both by clinicians and the model. For the remaining 165 in each group, the model selected for a higher bacteremia rate (74/165, 44.8% vs. 45/165, 27.3%, p = 0.001), and a higher 30-day mortality (49/165, 29.7% vs. 19/165, 11.5%, p = 0.00004) than the clinically selected group. The model outperformed clinicians in selecting patients with a high rate of bacteremia. Using such a model for risk stratification may contribute towards closing the gap in cost between rapid and culture-based diagnostics.
C1 [Ward, Logan; Andreassen, Steen] Treat Syst ApS, Aalborg, Denmark.
   [Ward, Logan; Andreassen, Steen; Astrup, Jesper Johnsen; Rahmani, Zakia] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.
   [Fantini, Michela; Sambri, Vittorio] Greater Romagna Area Hub Lab, Unit Microbiol, Pievesestina, Italy.
   [Sambri, Vittorio] Univ Bologna, DIMES, Bologna, Italy.
RP Ward, L (reprint author), Treat Syst ApS, Aalborg, Denmark.; Ward, L (reprint author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.
EM lw@treatsystems.com
OI Ward, Logan/0000-0002-2697-3922
FU Innovation Fund Denmark [5190-00011B]
FX This work was supported by a grant from Innovation Fund Denmark (grant
   number 5190-00011B) to L. W. and S. A.
CR Andreassen S, 2005, ADV INFO KNOW PROC, P451
   Bloos F, 2014, VIRULENCE, V5, P154, DOI 10.4161/viru.27393
   Calle P, 2012, J EMERG MED, V42, P379, DOI 10.1016/j.jemermed.2011.03.033
   Eliakim-Raz N, 2015, CLIN MICROBIOL INFEC, V21, P295, DOI 10.1016/j.cmi.2015.01.023
   Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05
   Howell MD, 2007, INTENS CARE MED, V33, P1892, DOI 10.1007/s00134-007-0680-5
   Jessen MK, 2016, EUR J EMERG MED, V23, P44, DOI 10.1097/MEJ.0000000000000203
   Jin SJ, 2013, SCAND J INFECT DIS, V45, P672, DOI 10.3109/00365548.2013.799287
   Kirn TJ, 2013, CLIN MICROBIOL INFEC, V19, P513, DOI 10.1111/1469-0691.12180
   Leibovici L, 2000, IEEE T KNOWL DATA EN, V12, P517, DOI 10.1109/69.868905
   Leli C, 2014, J MED MICROBIOL, V63, P649, DOI 10.1099/jmm.0.064097-0
   Liesenfeld O, 2014, EUR J MICROBIOL IMMU, V4, P1, DOI 10.1556/EuJMI.4.2014.1.1
   National Institute for Health and Care Excellence, 2016, TESTS RAP ID BLOODST
   Paul M, 2006, CLIN INFECT DIS, V42, P1274, DOI 10.1086/503034
   Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10
   Paul M, 2006, J ANTIMICROB CHEMOTH, V58, P1238, DOI 10.1093/jac/dkl372
   Perl B, 1999, CLIN INFECT DIS, V29, P1483, DOI 10.1086/313525
   Peterson LKN, 2017, EMERG MED CLIN N AM, V35, P185, DOI 10.1016/j.emc.2016.09.008
   POSES RM, 1991, MED DECIS MAKING, V11, P159, DOI 10.1177/0272989X9101100303
   Pulia MS, 2017, EMERG MED CLIN N AM, V35, P199, DOI 10.1016/j.emc.2016.09.007
   Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288
   Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Tassinari M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197436
   Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005
   Ward L, 2018, IFAC PAPERSONLINE, V51, P116, DOI [10.1016/j.ifacol.2018.11.657, DOI 10.1016/J.IFACOL.2018.11.657]
   Ward LM, 2016, GRADATION SEVERITY S, DOI DOI 10.5278/VBN.PHD.MED.00064
   Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003
NR 28
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD AUG
PY 2019
VL 38
IS 8
BP 1515
EP 1522
DI 10.1007/s10096-019-03581-4
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IK3MD
UT WOS:000476492200016
PM 31079313
DA 2020-05-07
ER

PT J
AU Tauzin, M
   Ouldali, N
   Levy, C
   Bechet, S
   Cohen, R
   Caeymaex, L
AF Tauzin, M.
   Ouldali, N.
   Levy, C.
   Bechet, S.
   Cohen, R.
   Caeymaex, L.
TI Combination therapy with ciprofloxacin and third-generation
   cephalosporin versus third-generation cephalosporin monotherapy in
   Escherichia coli meningitis in infants: a multicentre propensity
   score-matched observational study
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Children; Ciprofloxacin; Escherichia coli; Meningitis; Propensity score
ID GRAM-NEGATIVE BACTEREMIA; BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID;
   PENETRATION; PEDIATRICS
AB Objectives: Escherichia coli is the second cause of bacterial meningitis in neonates. Despite the use for 35 years of third-generation cephalosporins (3GCs), high morbidity and mortality rates with E. coli meningitis continue to occur. Because ciprofloxacin has good microbiologic activity against E. coli and good penetration in cerebrospinal fluid and brain, some authors have suggested adding ciprofloxacin to a 3GC regimen. The objective of this study was to assess combining 3GCs with ciprofloxacin versus 3GCs alone in a cohort of infants with E. coli meningitis.
   Methods: We included all cases of E. coli meningitis diagnosed in infants < 12 months of age that were prospectively collected through the French paediatric meningitis surveillance network between 2001 and 2016. The main outcome was the proportion of short-term neurologic complications with versus without ciprofloxacin. The analysis was conducted retrospectively by multivariable regression and propensity score (PS) analysis.
   Results: Among the 367 infants enrolled, 201 (54.8%) of 367 had ciprofloxacin and 3GC cotreatment and 166 (45.2%) of 367 only a 3GC. Median age and weight were 15 days (range, 1-318 days) and 3.42 kg (range, 0.66-9.4 kg). A total of 86 (23.4%) of 367 infants presented neurologic complications (seizures, strokes, empyema, abscesses, hydrocephalus, arachnoiditis); 57 received ciprofloxacin cotreatment. Complications were associated with ciprofloxacin cotreatment on multivariable analysis (odds ratio (OR) = 1.9; 95% confidence interval (CI), 1.1-3.4) and PS analysis (OR = 1.9; 95% CI, 1.1-3.3). Mortality rate did not differ with and without ciprofloxacin: 22 (10.9%) of 201 versus 16 (9.6%) of 166 deaths (OR = 0.7; 95% CI, 0.3-1.6; PS analysis).
   Conclusions: Ciprofloxacin added to 3GCs at least offers no advantage for neurologic outcome and mortality in infants with E. coli meningitis. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Tauzin, M.; Cohen, R.; Caeymaex, L.] Neonatal Intens Care Unit, Creteil, France.
   [Levy, C.; Cohen, R.; Caeymaex, L.] Ctr Hosp Intercommunal Creteil, Ctr Rech Clin, Creteil, France.
   [Cohen, R.; Caeymaex, L.] Univ Paris Est Creteil, Creteil, France.
   [Ouldali, N.; Levy, C.; Bechet, S.; Cohen, R.] Assoc Clin & Therapeut Infantile Val de Marne, ACTIV, Paris, France.
   [Ouldali, N.; Levy, C.; Cohen, R.] GPIP, Paris, France.
   [Ouldali, N.] Hop Robert Debre, AP HP, Unite Epidemiol Clin, ECEVE INSERM UMR 1145, Paris, France.
   [Ouldali, N.] Univ Paris 05, Hop Necker Enfants Malad, Urgences Pediat, Paris, France.
RP Cohen, R (reprint author), Univ Paris XII, GRC Gemini, 40 Ave Verdun, F-94000 Creteil, France.; Cohen, R (reprint author), Hop Intercommunal Creteil, Serv Reanimat Neonatale, 40 Ave Verdun, F-94000 Creteil, France.
EM robert.cohen@wanadoo.fr
FU PfizerPfizer
FX SB reports grants for Activ from Pfizer during the conduct of the study
   and grants from Pfizer, GSK, Sanofi and MSD outside the submitted work.
   CL and RC report grants for Activ, personal fees and nonfinancial
   support from Pfizer during the conduct of the study and grants, personal
   fees and nonfinancial support from Pfizer, GSK, Sanofi and MSD outside
   the submitted work. MT, NO and LC report no conflict of interest
   relevant to this article.
CR Adefurin A, 2011, ARCH DIS CHILD, V96, P874, DOI 10.1136/adc.2010.208843
   Aujard Y., 2016, EMC PEDIAT, V11, P1
   Basmaci R, 2015, CLIN INFECT DIS, V61, P779, DOI 10.1093/cid/civ367
   Berkowitz NM, 2015, PEDIATR INFECT DIS J, V34, P1203, DOI 10.1097/INF.0000000000000885
   Collins GS, 2012, EUR HEART J, V33, P1867, DOI 10.1093/eurheartj/ehs186
   Durrmeyer X, 2012, ARCH PEDIATRIE, V19, pS140, DOI 10.1016/S0929-693X(12)71288-5
   European Medicines Agency, CIPR SUMM PROD CHAR
   GARRAFFO R, 1991, ANTIMICROB AGENTS CH, V35, P2215, DOI 10.1128/AAC.35.11.2215
   Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7
   Gendrel D, 2003, LANCET INFECT DIS, V3, P537, DOI 10.1016/S1473-3099(03)00736-9
   GOGOS CA, 1991, EUR J CLIN MICROBIOL, V10, P511, DOI 10.1007/BF01963940
   Goldwater PN, 2005, INT J ANTIMICROB AG, V26, P408, DOI 10.1016/j.ijantimicag.2005.08.005
   GREEN SDR, 1993, J INFECTION, V26, P253, DOI 10.1016/0163-4453(93)95291-P
   Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399
   Ilgin S, 2015, TOXICOL MECH METHOD, V25, P374, DOI 10.3109/15376516.2015.1026008
   ISAACS D, 1986, J ANTIMICROB CHEMOTH, V17, P535, DOI 10.1093/jac/17.4.535
   Krcmery V, 1999, DIAGN MICR INFEC DIS, V35, P75, DOI 10.1016/S0732-8893(99)00052-8
   LEHUIDOUX P, 1999, JOURNEES PARISIENNES, P15
   Loron G, 2011, ANN NEUROL, V69, P341, DOI 10.1002/ana.22190
   Malla L, 2018, J COMP EFFECT RES, V7, P271, DOI 10.2217/cer-2017-0071
   Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945
   Ogunlesi TA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010435.pub2
   Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514
   Paul M, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003344.PUB3
   Perrocheau A, 2006, NULL EPIDEMIOL HEBD, V3, P16
   Romain O, 2017, ARCH PEDIATRIE, V24, pS24, DOI 10.1016/S0929-693X(18)30041-1
   Ross ME, 2015, AM J EPIDEMIOL, V181, P989, DOI 10.1093/aje/kwu469
   Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9
   Sick AC, 2014, PEDIATRICS, V133, pE1148, DOI 10.1542/peds.2013-3363
   Tamma PD, 2013, JAMA PEDIATR, V167, P903, DOI 10.1001/jamapediatrics.2013.196
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   van den Oever HLA, 1998, EUR J PEDIATR, V157, P843, DOI 10.1007/s004310050949
   WESSALOWSKI R, 1993, PEDIATR INFECT DIS J, V12, P683, DOI 10.1097/00006454-199308000-00010
NR 33
TC 2
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD AUG
PY 2019
VL 25
IS 8
BP 1006
EP 1012
DI 10.1016/j.cmi.2018.12.026
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IF8FV
UT WOS:000473325700015
PM 30593862
DA 2020-05-07
ER

PT J
AU Janies, D
AF Janies, Daniel
TI Phylogenetic Concepts and Tools Applied to Epidemiologic Investigations
   of Infectious Diseases
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; TRANSMISSION NETWORKS; EVOLUTIONARY TREES;
   INFLUENZA-A; PARSIMONY; LIKELIHOOD; GENOME; SPREAD; VISUALIZATION;
   PERFORMANCE
AB In this review, which is a part of the Microbiology Spectrum Curated Collection: Advances in Molecular Epidemiology of Infectious Diseases, I present an overview of the principles used to classify organisms in the field of phylogenetics, highlight the methods used to infer the interrelationships of organisms, and summarize how these concepts are applied to molecular epidemiologic analyses. I present steps in analyses that come downstream of the assembly of a set of genomes or genes and the production of a multiple-sequence alignment or other matrices of putative orthologs for comparison. I focus on the history of the problem of phylogenetic reconstruction and debates within the field about the most appropriate methods. I illustrate methods that bridge the gap between molecular epidemiology and traditional epidemiology, including phylogenetic character evolution and geographic visualization. Finally, I provide practical advice on how to conduct an example analysis in the appendix. *This article is part of a curated collection.
C1 [Janies, Daniel] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.
RP Janies, D (reprint author), Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.
EM djanies@uncc.edu
CR Ahrenfeldt J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3407-6
   Alkhamis MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00067
   Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16
   Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI DOI 10.1098/RSTL.1763.0053
   Bokhari SH, 2012, IEEE ACM T COMPUT BI, V9, P214, DOI 10.1109/TCBB.2011.95
   CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441
   Carroll LN, 2014, J BIOMED INFORM, V51, P287, DOI 10.1016/j.jbi.2014.04.006
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cheng JM, 2015, EPIDEMIOL INFECT, V143, P3220, DOI 10.1017/S0950268815000825
   Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018
   Darwin C. R., 1859, ORIGIN SPECIES PRESE
   de Bernardi Schneider A, 2018, STRAINHUB PHYLOGENET, DOI [10.1101/650283, DOI 10.1101/650283]
   de Bernardi Schneider A., 2018, THESIS
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897
   Ezeoke I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202615
   FARRIS JS, 1977, SYST ZOOL, V26, P77, DOI 10.2307/2412867
   FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028
   FDA, 2018, GENOMETRAKR FAST FAC
   FDA, 2018, GENOMETRAKR DAT
   FELSENSTEIN J, 1983, ANNU REV ECOL SYST, V14, P313, DOI 10.1146/annurev.es.14.110183.001525
   FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Felsenstein Joseph, 2004, INFERRING PHYLOGENIE
   FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116
   Gardy JL, 2010, FUTURE VIROL, V5, P251, DOI 10.2217/FVL.10.15
   Giribet G, 1999, MOL PHYLOGENET EVOL, V13, P132, DOI 10.1006/mpev.1999.0643
   GOLDMAN N, 1990, SYST ZOOL, V39, P345, DOI 10.2307/2992355
   Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x
   Goloboff PA, 2003, CLADISTICS, V19, P91, DOI 10.1016/S0748-3007(03)00017-3
   Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x
   Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12
   Graffelman AW, 2004, BRIT J GEN PRACT, V54, P15
   Graur D, 2000, FUNDAMENTALS MOL EVO
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Habib F, 2007, BIOINFORMATICS, V23, P785, DOI 10.1093/bioinformatics/btm003
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Handelman SK, 2015, COMPUT BIOL MED, V58, P1, DOI 10.1016/j.compbiomed.2014.12.013
   Harvey P., 2001, INT ENCY SOCIAL BEHA, P11405, DOI [10.1016/B0-08-043076-7/03133-8, DOI 10.1016/B0-08-043076-7/03133-8]
   Hedge J, 2014, MBIO, V5, DOI 10.1128/mBio.02158-14
   Hennig W, 1966, PHYLOGENETIC SYSTEMA
   Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006
   Hillis D. M., 1996, MOL SYSTEMATICS
   Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297
   Hovmoller R, 2010, CLADISTICS, V26, P1, DOI 10.1111/j.1096-0031.2009.00297.x
   Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366
   HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481
   Janies DA, 2001, CLADISTICS, V17, pS71, DOI 10.1006/clad.2000.0160
   Janies DA, 2017, ONLINE J PUBLIC HLTH, V9, DOI 10.5210/ojphi.v9i1.7581
   Janies D, 2008, CLADISTICS, V24, P111, DOI 10.1111/j.1096-0031.2008.00199.x
   Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848
   Janies DA, 2015, CLADISTICS, V31, P679, DOI 10.1111/cla.12107
   Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x
   Janies Daniel A., 2010, Animal Health Research Reviews, V11, P73, DOI 10.1017/S1466252310000083
   JUKES T H, 1969, P21
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432
   KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407
   Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917
   Kong LY, 2016, OPEN FORUM INFECT S1, V3, P2063
   Kosiol C, 2006, J BIOMED INFORM, V39, P51, DOI 10.1016/j.jbi.2005.08.003
   Kumar SB, 2011, J VIROL, V85, P7142, DOI 10.1128/JVI.01955-10
   Maddison WP, 2018, MESQUITE MODULAR SYS
   Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x
   Meade A, 2017, BAYESTRAITS V3 0 1
   Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544
   Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381
   Nei M, 2000, MOL EVOLUTION PHYLOG
   Nelson G, 1981, SYSTEMATICS BIOGEOGR
   Owen R, 1843, LECT COMP ANATOMY PH
   Pettengill JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166162
   Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50
   Phillips A, 2000, MOL PHYLOGENET EVOL, V16, P317, DOI 10.1006/mpev.2000.0785
   Ragonnet-Cronin M, 2018, LANCET HIV, V5, pE309, DOI 10.1016/S2352-3018(18)30062-6
   Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839
   Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14
   SANKOFF D, 1976, J MOL EVOL, V7, P133, DOI 10.1007/BF01732471
   Schneider AD, 2017, CLADISTICS, V33, P1, DOI 10.1111/cla.12178
   Siddall ME, 1998, CLADISTICS, V14, P209, DOI 10.1006/clad.1998.0063
   SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364
   Swofford D., 2018, PHYLOGENETIC ANAL US
   Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086
   Timme RE, 2017, PEERJ, V5, DOI 10.7717/peerj.3893
   Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   WATROUS LE, 1981, SYST ZOOL, V30, P1, DOI 10.2307/2992297
   Wheeler W., 2012, SYSTEMATICS COURSE L, DOI [10.1002/9781118301081, DOI 10.1002/9781118301081]
   Wheeler WC, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0675-0
   WHEELER WC, 1993, MOL BIOL EVOL, V10, P707
   WHEELER WC, 2006, DYNAMIC HOMOLOGY PHY
   Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549
NR 95
TC 0
Z9 0
U1 1
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUL
PY 2019
VL 7
IS 4
AR UNSP AME-0006-2018
DI 10.1128/microbiolspec.AME-0006-2018
PG 11
WC Microbiology
SC Microbiology
GA IT2VO
UT WOS:000482711900001
PM 31325287
DA 2020-05-07
ER

PT J
AU Kanafani, ZA
   El Zakhem, A
   Zahreddine, N
   Ahmadieh, R
   Kanj, SS
AF Kanafani, Zeina A.
   El Zakhem, Aline
   Zahreddine, Nada
   Ahmadieh, Rihab
   Kanj, Souha S.
TI Ten-year surveillance study of ventilator-associated pneumonia at a
   tertiary care center in Lebanon
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Ventilator; Pneumonia; Intensive care; Acinetobacter; Lebanon
ID SAFETY NETWORK; UNIT; ACINETOBACTER; INFECTIONS; PREVENTION; COUNTRIES;
   EVENTS; IMPACT
AB Background: Ventilator-associated pneumonia (VAP) is associated with significant adverse outcomes in critically-ill patients admitted to the Intensive Care Unit (ICU). Systematic data from Lebanon on VAP are not available and large epidemiological studies from the region are scarce.
   Methods: We conducted a retrospective study over a 10-year period at the American University of Beirut Medical Center (AUBMC), a tertiary referral center in Lebanon in order to describe the incidence, microbiology, and temporal trends of VAP in the medical/surgical ICU.
   Results: A total of 162 patients developed VAP over the study period and the overall incidence of VAP was 7.9 per 1000 ventilator-days. There was a statistically significant decrease over time in the incidence of VAP, from 13.1 in 2008 to 1.1 per 1000 ventilator-days in 2017. Multidrug-resistant (MDR) Acinetobacter spp. was the predominant pathogen, both in early- as well as late-onset VAP, followed by Pseudomonas aeruginosa.
   Conclusions: Following significant efforts from the Infection Control and Prevention Program, a considerable reduction in the incidence of VAP was achieved at AUBMC. The predominance of MDR Acinetobacter spp. should be taken into consideration when deciding on empirical therapy in patients with VAP. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Kanafani, Zeina A.; El Zakhem, Aline; Kanj, Souha S.] Amer Univ Beirut, Div Infect Dis, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon.
   [Kanafani, Zeina A.; Zahreddine, Nada; Ahmadieh, Rihab; Kanj, Souha S.] Amer Univ Beirut, Infect Control & Prevent Program, Med Ctr, Beirut, Lebanon.
RP Kanj, SS (reprint author), Amer Univ Beirut, Div Infect Dis, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon.
EM sk11@aub.edu.lb
OI Kanj, Souha/0000-0001-6413-3396
CR Al-Dorzi HM, 2012, AM J INFECT CONTROL, V40, P794, DOI 10.1016/j.ajic.2011.10.004
   Azzab MM, 2016, E MEDITERR HEALTH J, V22, P894, DOI 10.26719/2016.22.12.894
   Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711
   Chaari A, 2013, INT J INFECT DIS, V17, pE1225, DOI 10.1016/j.ijid.2013.07.014
   Dudeck MA, 2015, AM J INFECT CONTROL, V43, P206, DOI 10.1016/j.ajic.2014.11.014
   El-Saed A, 2016, AM J INFECT CONTROL, V44, P794, DOI 10.1016/j.ajic.2016.01.042
   El-Saed A, 2013, INT J INFECT DIS, V17, pE696, DOI 10.1016/j.ijid.2013.02.004
   Evans CR, 2018, SURG INFECT, V19, P672, DOI 10.1089/sur.2018.087
   Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053
   Kanafani ZA, 2003, INFECT CONT HOSP EP, V24, P864, DOI 10.1086/502151
   Kanafani ZA, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0297-6
   Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049
   Magill SS, 2013, INFECT CONT HOSP EP, V34, P1239, DOI 10.1086/673463
   Nowak J, 2017, J ANTIMICROB CHEMOTH, V72, P3277, DOI 10.1093/jac/dkx322
   Orgeas MG, 2008, CRIT CARE MED, V36, P2041, DOI 10.1097/CCM.0b013e31817b879c
   Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795
   Rosenthal VD, 2012, CRIT CARE MED, V40, P3121, DOI 10.1097/CCM.0b013e3182657916
   See I, 2013, INFECT CONT HOSP EP, V34, P1281, DOI 10.1086/673985
   Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770
   Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174
   Xie JF, 2018, CLIN INFECT DIS, V67, pS153, DOI 10.1093/cid/ciy692
   2006, CRIT CARE NURS Q, V29, P157
NR 22
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JUL-AUG
PY 2019
VL 12
IS 4
BP 492
EP 495
DI 10.1016/j.jiph.2019.01.057
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IF9LO
UT WOS:000473414800008
PM 30737129
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Diekema, DJ
   Hsueh, PR
   Mendes, RE
   Pfaller, MA
   Rolston, KV
   Sader, HS
   Jones, RN
AF Diekema, Daniel J.
   Hsueh, Po-Ren
   Mendes, Rodrigo E.
   Pfaller, Michael A.
   Rolston, Kenneth V.
   Sader, Helio S.
   Jones, Ronald N.
TI The Microbiology of Bloodstream Infection: 20-Year Trends from the
   SENTRY Antimicrobial Surveillance Program
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE antimicrobial resistance; bloodstream infection; surveillance
ID RESISTANT STAPHYLOCOCCUS-AUREUS; CARE-ASSOCIATED INFECTIONS;
   METHICILLIN-RESISTANT; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; BACTEREMIA;
   NETWORK; VACCINE; HISTORY; ENGLAND
AB Bloodstream infection (BSI) organisms were consecutively collected from >200 medical centers in 45 nations between 1997 and 2016. Species identification and susceptibility testing followed Clinical and Laboratory Standards Institute broth microdilution methods at a central laboratory. Clinical data and isolates from 264,901 BSI episodes were collected. The most common pathogen overall was Staphylococcus aureus (20.7%), followed by Escherichia coli (20.5%), Klebsiella pneumoniae (7.7%), Pseudomonas aeruginosa (5.3%), and Enterococcus faecalis (5.2%). S. aureus was the most frequently isolated pathogen overall in the 1997-to-2004 period, but E. colt was the most common after 2005. Pathogen frequency varied by geographic region, hospital-onset or community-onset status, and patient age. The prevalence of S. aureus isolates resistant to oxacillin (ORSA) increased until 2005 to 2008 and then declined among hospital-onset and community-acquired BSI in all regions. The prevalence of vancomycin-resistant enterococci (VRE) was stable after 2012 (16.4% overall). Daptomycin resistance among S. aureus and enterococci (DRE) remained rare (<0.1%). In contrast, the prevalence of multidrug-resistant (MDR) Enterobacteriaceae increased from 6.2% in 1997 to 2000 to 15.8% in 2013 to 2016. MDR rates were highest among nonfermentative Gram-negative bacilli (GNB), and colistin was the only agent with predictable activity against Acinetobacter baumannii-Acinetobacter calcoaceticus complex (97% susceptible). In conclusion, S. aureus and E. toll were the predominant causes of BSI worldwide during this 20-year surveillance period. Important resistant phenotypes among Gram-positive pathogens (MRSA, VRE, or DRE) were stable or declining, whereas the prevalence of MDR-GNB increased continuously during the monitored period. MDR-GNB represent the greatest therapeutic challenge among common bacterial BSI pathogens.
C1 [Diekema, Daniel J.; Pfaller, Michael A.] Univ Iowa, Iowa City, IA 52242 USA.
   [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Mendes, Rodrigo E.; Pfaller, Michael A.; Sader, Helio S.; Jones, Ronald N.] JMI Labs, North Liberty, IA USA.
   [Rolston, Kenneth V.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
RP Diekema, DJ (reprint author), Univ Iowa, Iowa City, IA 52242 USA.
EM daniel-diekema@uiowa.edu
OI Sader, Helio/0000-0001-7022-6644; Diekema, Daniel/0000-0003-1273-0724;
   Mendes, Rodrigo/0000-0002-8648-1137; HSUEH, PO-REN/0000-0002-7502-9225;
   Pfaller, Michael/0000-0003-4501-6068
CR Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153
   Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P4770, DOI 10.1128/AAC.00540-16
   Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200
   Chatterjee Som S, 2013, Clin Epidemiol, V5, P205, DOI 10.2147/CLEP.S37071
   Clinical and Laboratory Standards Institute (CLSI), 2017, M100S27 CLSI
   Clinical and Laboratory Standards Institute (CLSI), 2018, M07ED11E CLSI
   Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476
   Diekema DJ, 2019, OPEN FORUM INFECT DI, V6, pS47, DOI 10.1093/ofid/ofy270
   Diekema DJ, 2000, INT J ANTIMICROB AG, V13, P257, DOI 10.1016/S0924-8579(99)00131-4
   Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234
   Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004
   Gagliotti C, 2011, EUROSURVEILLANCE, V16, P20
   Giersing BK, 2016, VACCINE, V34, P2962, DOI 10.1016/j.vaccine.2016.03.110
   Huttner A, 2017, LANCET INFECT DIS, V17, P528, DOI [10.1016/S1473-3099(17)30108-1, 10.1016/s1473-3099(17)30108-1]
   Isler B, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01110-18
   Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165
   Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561
   Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115
   Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763
   Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007
   Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144
   Magill SS, 2018, NEW ENGL J MED, V379, P1732, DOI 10.1056/NEJMoa1801550
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   McDanel J, 2017, INFECT CONT HOSP EP, V38, P1209, DOI 10.1017/ice.2017.156
   McNamara JF, 2018, J INFECTION, V77, P1, DOI 10.1016/j.jinf.2018.03.005
   Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464
   Perencevich EN, 2010, JAMA-J AM MED ASSOC, V304, P687, DOI 10.1001/jama.2010.1125
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06
   Planet PJ, 2017, J INFECT DIS, V215, pS71, DOI 10.1093/infdis/jiw444
   Ray MJ, 2018, CLIN INFECT DIS, V67, P407, DOI 10.1093/cid/ciy084
   Rolain JM, 2015, CLIN MICROBIOL INFEC, V21, P515, DOI 10.1016/j.cmi.2015.04.017
   Rosen JB, 2011, CLIN INFECT DIS, V53, P137, DOI 10.1093/cid/cir326
   Sader HS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01043-17, 10.1128/aac.01043-17]
   Skogberg K, 2012, CLIN MICROBIOL INFEC, V18, pE170, DOI 10.1111/j.1469-0691.2012.03845.x
   Slayton RB, 2015, MMWR-MORBID MORTAL W, V64, P826, DOI 10.15585/mmwr.mm6430a4
   Stewardson AJ, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.33.30319
   Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342
   The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MICS
   van Duin D, 2017, VIRULENCE, V8, P460, DOI 10.1080/21505594.2016.1222343
   Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174
   Wilson J, 2011, CLIN MICROBIOL INFEC, V17, P451, DOI 10.1111/j.1469-0691.2010.03262.x
NR 41
TC 15
Z9 15
U1 3
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUL
PY 2019
VL 63
IS 7
AR e00355-19
DI 10.1128/AAC.00355-19
PG 10
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA IE8KP
UT WOS:000472622600026
PM 31010862
OA Other Gold, Green Published
DA 2020-05-07
ER

PT J
AU Nicolas, D
   Ambrosioni, J
   de Lazzari, E
   Suarez, A
   Manzardo, C
   Aguero, F
   Mosquera, MM
   Costa, J
   Ligero, C
   Marcos, MA
   Sanchez-Palomino, S
   Fernandez, E
   Plana, M
   Yerly, S
   Gatell, JM
   Miro, JM
AF Nicolas, D.
   Ambrosioni, J.
   de lazzari, E.
   Suarez, A.
   Manzardo, C.
   Aguero, F.
   Mosquera, M. M.
   Costa, J.
   Ligero, C.
   Marcos, M. A.
   Sanchez-Palomino, S.
   Fernandez, E.
   Plana, M.
   Yerly, S.
   Gatell, J. M.
   Miro, J. M.
CA Hosp Clinic Acute Recent HIV Study
TI Epidemiological changes of acute/recent human immunodeficiency virus
   type 1 infection in Barcelona, Spain (1997-2015): a prospective cohort
   study
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Acute/Recent human immunodeficiency virus infection; Cohort; Human
   immunodeficiency virus epidemiology; Human immunodeficiency virus
   infection; Primary human immunodeficiency virus infection
ID ANTIRETROVIRAL THERAPY; TRANSMISSION NETWORKS; HIV-1 INFECTION; MEN; SEX
AB Objective: To describe the epidemiology of acute/recent human immunodeficiency virus (HIV) infection over two decades in Barcelona (Spain).
   Methods: Prospective, single-centre cohort including all patients with an acute/recent HIV infection (<180 days) since 1997. Patients were stratified into four periods. Phylogenetic analysis was performed to determine clusters of transmission.
   Results: A total of 346 consecutive acute/recently infected patients were included. The annual proportion of recent infections among total new HIV diagnoses increased over time from 1% (29 out of 1964) to 8% (112 out of 1474) (p <0.001). Proportion of men who have sex with men (MSM) in the cohort increased from 62% (18 out of 29) to 89% (100 out of 112) (p <0.001). The proportion of migrants showed a nonsignificant increasing trend (24% (7 of 29) to 40% (45 of 112)) likewise the non-B subtype (0% to 22% (22 of 112)). The mean time from infection to diagnosis was 53.6 days (interquartile range (IQR) 50-57), comparable among all periods. Mean time from infection to treatment decreased over the years from 575 (IQR 467-683) to 471 (IQR 394-549) days (p <0.001) without significant differences between migrants and non-migrants (133 (IQR 71-411) versus 208 (IQR 90-523) days p 0.089). Almost 50% (152 of 311) of recently infected individuals were included in a cluster of transmission, and 92% (137 of 149) of them were MSM.
   Conclusion: The MSM population has progressively grown within acutely/recently infected patients in Barcelona, and is frequently involved in transmission clusters. Although the time between diagnosis and treatment has been reduced, the time between infection and diagnosis still needs to be shortened. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Nicolas, D.; Ambrosioni, J.; de lazzari, E.; Suarez, A.; Manzardo, C.; Aguero, F.; Ligero, C.; Fernandez, E.; Gatell, J. M.; Miro, J. M.] Univ Barcelona, Hosp Clin IDIBAPS, Infect Dis Serv, Barcelona, Spain.
   [Mosquera, M. M.; Costa, J.; Marcos, M. A.] Univ Barcelona, CIBERehd, Hosp Clin Barcelona, Lab Virol,Microbiol Serv, Barcelona, Spain.
   [Sanchez-Palomino, S.; Plana, M.] Univ Barcelona, Hosp Clin, IDIBAPS, Retrovirol & Viral Immunopathol Lab,AIDS Res Grp, Barcelona, Spain.
   [Yerly, S.] Geneva Univ Hosp, Div Infect Dis, Virol Lab, Geneva, Switzerland.
RP Miro, JM (reprint author), Hosp Clin Barcelona, Infect Dis Serv, Villarroel 170, Barcelona 08036, Spain.
EM jmmiro@ub.edu
RI Plana, Montserrat/AAA-5124-2020
OI Nicolas, David/0000-0002-1968-5287
FU Fondo de Investigaciones Sanitarias (FIS) grant from the Instituto de
   Salud Carlos III, Madrid, Spain [04/0363]; Instituto de Salud Carlos
   III, Ministerio de Economia y Competitividad, Madrid (Spain)
   [INT15/00168]; Institut d'Investigacions Biomediques August Pi i Sunyer
   (IDIBAPS), Barcelona, Spain; Ministerio de Competitividad, Spain
   [CM12/00195]; 'Departament de Salut de la Generalitat de Catalunya',
   Barcelona, Spain
FX This work was supported in part by the Fondo de Investigaciones
   Sanitarias (FIS) grant 04/0363 from the Instituto de Salud Carlos III,
   Madrid, Spain awarded to JMM. Instituto de Salud Carlos III, Ministerio
   de Economia y Competitividad, Madrid (Spain) provided JMM with a
   personal intensification research grant #INT15/00168 during 2016-17. JMM
   received a personal 80: 20 research grant from the Institut
   d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona,
   Spain, during 2017-19. JA developed this work in the frame of a Juan de
   la Cierva 2012 post-doctoral program, Ministerio de Competitividad,
   Spain. DN developed this work in the frame of a post-residency
   Scholarship Ajuts a la Recerca 'Josep Font' 2014, Hospital Clinic,
   Barcelona, Spain. FA developed this work in the frame of a Rio Hortega
   2012 grant CM12/00195, Ministerio de Competitividad, Spain. C.M. has
   been the holder of a personal postdoctoral research grant (Pla
   Estrategic de Recerca i Innovacio en Salut -PERIS-2016/2020) from the
   'Departament de Salut de la Generalitat de Catalunya', Barcelona, Spain.
   When this article was submitted, JMG started to work in ViiV Healthcare,
   Barcelona, Spain as Senior Global Medical Director.
CR Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7
   Ambrosioni J, 2015, PLOS ONE, V10
   Ambrosioni J, 2017, J NEUROVIROL, V23, P679, DOI 10.1007/s13365-017-0548-6
   Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6
   Barrio G, 2012, ADDICTION, V107, P1111, DOI 10.1111/j.1360-0443.2011.03759.x
   Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90
   Chan PA, 2015, JAIDS-J ACQ IMM DEF, V70, P428, DOI 10.1097/QAI.0000000000000786
   Dauwe K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1217-0
   Department of Health and Human Services, 2017, PUBL INT ASS PURS, P1
   European AIDS Clinical Society, 2017, EUR AIDS CLIN SOC EA, DOI [10.1002/oby.21371, DOI 10.1002/OBY.21371]
   Ferrer L, 2016, SEX TRANSM INFECT, V92, P70, DOI 10.1136/sextrans-2015-052042
   Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039
   Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005
   Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012
   Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5
   Reyes-Uruena JM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018533
   Marzel A, 2016, CLIN INFECT DIS, V62, P115, DOI 10.1093/cid/civ732
   Cachafeiro SP, 2009, CLIN INFECT DIS, V48, P1467, DOI 10.1086/598333
   Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952
   Romero A, 2012, EUR J PUBLIC HEALTH, V22, P802, DOI 10.1093/eurpub/ckr179
   Sued O, 2006, ENFERM INFEC MICR CL, V24, P238, DOI 10.1016/S0213-005X(06)73769-7
   von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491
NR 22
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUL
PY 2019
VL 25
IS 7
BP 878
EP 884
DI 10.1016/j.cmi.2018.10.021
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IC3HM
UT WOS:000470850400018
PM 30472421
DA 2020-05-07
ER

PT J
AU Happonen, L
   Hauri, S
   Birkedal, GS
   Karlsson, C
   de Neergaard, T
   Khakzad, H
   Nordenfelt, P
   Wikstrom, M
   Wisniewska, M
   Bjorck, L
   Malmstrom, L
   Malmstrom, J
AF Happonen, Lotta
   Hauri, Simon
   Birkedal, Gabriel Svensson
   Karlsson, Christofer
   de Neergaard, Therese
   Khakzad, Hamed
   Nordenfelt, Pontus
   Wikstrom, Mats
   Wisniewska, Magdalena
   Bjorck, Lars
   Malmstrom, Lars
   Malmstrom, Johan
TI A quantitative Streptococcus pyogenes-human protein-protein interaction
   map reveals localization of opsonizing antibodies
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GROUP-A STREPTOCOCCUS; MEMBRANE ATTACK COMPLEX; MASS-SPECTROMETRY;
   CYSTEINE PROTEINASE; TARGETED PROTEOMICS; BINDING; HOST; SURFACE;
   ENZYME; IMPROVEMENTS
AB A fundamental challenge in medical microbiology is to characterize the dynamic protein-protein interaction networks formed at the host-pathogen interface. Here, we generate a quantitative interaction map between the significant human pathogen, Streptococcus pyogenes, and proteins from human saliva and plasma obtained via complementary affinity-purification and bacterial-surface centered enrichment strategies and quantitative mass spectrometry. Perturbation of the network using immunoglobulin protease cleavage, mixtures of different concentrations of saliva and plasma, and different S. pyogenes serotypes and their isogenic mutants, reveals how changing microenvironments alter the interconnectivity of the interaction map. The importance of host immunoglobulins for the interaction with human complement proteins is demonstrated and potential protective epitopes of importance for phagocytosis of S. pyogenes cells are localized. The interaction map confirms several previously described protein-protein interactions; however, it also reveals a multitude of additional interactions, with possible implications for host-pathogen interactions involving other bacterial species.
C1 [Happonen, Lotta; Hauri, Simon; Birkedal, Gabriel Svensson; Karlsson, Christofer; de Neergaard, Therese; Nordenfelt, Pontus; Bjorck, Lars; Malmstrom, Lars; Malmstrom, Johan] Lund Univ, Fac Med, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.
   [Khakzad, Hamed; Malmstrom, Lars] Univ Zurich, S3IT, CH-8057 Zurich, Switzerland.
   [Khakzad, Hamed; Malmstrom, Lars] Univ Zurich, Inst Computat Sci, CH-8057 Zurich, Switzerland.
   [Khakzad, Hamed; Malmstrom, Lars] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.
   [Wikstrom, Mats; Wisniewska, Magdalena] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark.
   [Birkedal, Gabriel Svensson] Cantargia AB, SE-22381 Lund, Sweden.
   [Wikstrom, Mats] Amgen Inc, Attributes Sci, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.
RP Malmstrom, J (reprint author), Lund Univ, Fac Med, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.
EM johan.malmstrom@med.lu.se
RI ; Nordenfelt, Pontus/E-8572-2011; Malmstrom, Johan/B-7660-2009
OI Khakzad, Hamed/0000-0002-8556-0650; Malmstrom, Lars/0000-0001-9885-9312;
   Hauri, Simon/0000-0002-7249-2011; Nordenfelt,
   Pontus/0000-0002-9481-9951; de Neergaard, Therese/0000-0002-6969-0375;
   Malmstrom, Johan/0000-0002-2889-7169; Happonen,
   Lotta/0000-0002-5922-4549
FU Foundation of Knut and Alice WallenbergKnut & Alice Wallenberg
   Foundation [2016.0023]; European research councilEuropean Research
   Council (ERC) [ERC-2012-StG-309831]; Swedish Research CouncilSwedish
   Research Council [2015-02481, 7480, 2016-01071]; Wallenberg Academy
   Fellow program KAW [2012.0178, 2017.0271]; Olle Engkvist Byggmastare;
   Medical Faculty of Lund University; Foundation of Knut and Alice
   WallenbergKnut & Alice Wallenberg Foundation; Foundation of Torsten
   Soderberg; Foundation of Alfred Osterlund; Swedish Government Funds for
   Clinical Research (ALF); Hansa Medical AB; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [SNF 200021 160188];
   foundation of Crafoord; foundation of Groschinsky; foundation of
   Gyllenstierna-Krapperup; Swedish Society of Medicine; Royal
   Physiographic Society; Craaford Foundation; LUNARC [SNIC 2018/3-553,
   SNIC 2018/10-12, SNIC 2017/1-538]
FX Gene cloning, protein expression, and purification of the M1 protein,
   GRAB, CovR, Sortase A, and sfGFP was performed at the Lund Protein
   Production Platform (LP3), Lund University, Sweden (www.lu.se/lp3).The
   TEV protease used in this study was a kind gift from LP3. We acknowledge
   Rawya Antar Hussein and Annika Rogstam for purification of the GRAB
   mutants. We thank Professor Gunnar Lindahl for access to the S. pyogenes
   strains M1 SF370, M3, M5, and the respective M protein deletion mutants.
   The antibodies used in the fibrinogen western Blot analysis and in the
   ELISA experiments were kindly provided by Oonagh Shannon. Frida Palm is
   acknowledged for guidance in performing western Blot and ELISA
   experiments. This work was supported by Foundation of Knut and Alice
   Wallenberg (2016.0023), European research council starting grant
   (ERC-2012-StG-309831), the Swedish Research Council (project
   2015-02481), the Wallenberg Academy Fellow program KAW (2012.0178 and
   2017.0271), Olle Engkvist Byggmastare and the Medical Faculty of Lund
   University to J.M.; Foundations of Knut and Alice Wallenberg, Torsten
   Soderberg, Alfred Osterlund, as well as the Swedish Research Council
   (project 7480), the Swedish Government Funds for Clinical Research
   (ALF), the Medical Faculty of Lund University and Hansa Medical AB to
   L.B.; and in part supported by the Swiss National Science Foundation
   (grant no. SNF 200021 160188) to L.M., the foundations of Alfred
   Osterlund, Crafoord, Groschinsky, Gyllenstierna-Krapperup, as well as
   the Swedish Research Council (project 2016-01071), the Swedish Society
   of Medicine, and the Royal Physiographic Society to P.N.; and the
   Craaford Foundation and the Royal Physiographic Society to L.H. We thank
   S3IT, University of Zurich for computational infrastructure and
   technical support. Part of the computations were performed on resources
   provided by SNIC through SSC (UPPMAX, HPC2N, C3SE) and LUNARC under
   Projects SNIC 2018/3-553, SNIC 2018/10-12, and SNIC 2017/1-538.
CR Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x
   Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949
   Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081
   AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877
   Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125
   Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800
   Berends ETM, 2013, CELL MICROBIOL, V15, P1955, DOI 10.1111/cmi.12170
   BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269
   Brandt ER, 1996, IMMUNOLOGY, V89, P331, DOI 10.1046/j.1365-2567.1996.d01-754.x
   BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   CHOI NH, 1990, INT IMMUNOL, V2, P413, DOI 10.1093/intimm/2.5.413
   Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x
   Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046
   Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]
   Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198
   Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI 10.1093/nar/gkj040
   FALCONER AE, 1993, IMMUNOLOGY, V79, P89
   Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717
   Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003
   Hauri S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07986-1
   Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x
   Johnsson E, 1998, J IMMUNOL, V161, P4894
   Karlsson C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2297
   Karlsson CAQ, 2018, MOL CELL PROTEOMICS, V17, P1097, DOI 10.1074/mcp.RA117.000525
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kilsgard O, 2016, INT J MED MICROBIOL, V306, P504, DOI 10.1016/j.ijmm.2016.06.007
   Koroleva IV, 1997, ADV EXP MED BIOL, V418, P581
   Koroleva IV, 1998, FEMS IMMUNOL MED MIC, V20, P11, DOI 10.1016/S0928-8244(97)00101-6
   Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Malmstrom L, 2015, J PROTEOMICS, V129, P98, DOI 10.1016/j.jprot.2015.09.012
   Malmstrom E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10261
   Malmstrom J, 2012, J BIOL CHEM, V287, P1415, DOI 10.1074/jbc.M111.267674
   Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158
   Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771
   Mortensen R, 2015, J IMMUNOL, V195, P1657, DOI 10.4049/jimmunol.1500804
   Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]
   Nicod C, 2017, CURR OPIN MICROBIOL, V39, P7, DOI 10.1016/j.mib.2017.07.005
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325
   Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899
   PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301
   Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280
   Rasmussen M, 1999, J BIOL CHEM, V274, P15336, DOI 10.1074/jbc.274.22.15336
   RETNONINGRUM DS, 1993, J IMMUNOL, V150, P2332
   Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841
   Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260
   Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x
   Schodel F, 2017, VACCINE, V35, P2007, DOI 10.1016/j.vaccine.2017.02.060
   Schweppe DK, 2015, CHEM BIOL, V22, P1521, DOI 10.1016/j.chembiol.2015.09.015
   Serna M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10587
   Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005
   Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126
   Sjoholm K, 2017, MOL CELL PROTEOMICS, V16, pS29, DOI 10.1074/mcp.M116.063966
   Sjoholm K, 2014, MOL BIOSYST, V10, P1698, DOI 10.1039/c3mb70555b
   Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1
   Su Gang, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0813s47
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Teleman J, 2017, J PROTEOME RES, V16, P2384, DOI 10.1021/acs.jproteome.6b00928
   Teleman J, 2015, BIOINFORMATICS, V31, P555, DOI 10.1093/bioinformatics/btu686
   Teleman J, 2014, MOL CELL PROTEOMICS, V13, P1537, DOI 10.1074/mcp.O114.037879
   Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607
   Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279
   Waldetoft KW, 2016, INFECT IMMUN, V84, P2813, DOI 10.1128/IAI.00307-16
   Wisniewska M, 2014, J BIOL CHEM, V289, P18175, DOI 10.1074/jbc.M114.565978
NR 70
TC 2
Z9 2
U1 2
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 21
PY 2019
VL 10
AR 2727
DI 10.1038/s41467-019-10583-5
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IE6IQ
UT WOS:000472480200001
PM 31227708
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Hicks, DJ
   Coil, DA
   Stahmer, CG
   Eisen, JA
AF Hicks, Daniel J.
   Coil, David A.
   Stahmer, Carl G.
   Eisen, Jonathan A.
TI Network analysis to evaluate the impact of research funding on research
   community consolidation
SO PLOS ONE
LA English
DT Article
ID INNOVATION; SCIENCE
AB In 2004, the Alfred P. Sloan Foundation launched a new program focused on incubating a new field, "Microbiology of the Built Environment" (MoBE). By the end of 2017, the program had supported the publication of hundreds of scholarly works, but it was unclear to what extent it had stimulated the development of a new research community. We identified 307 works funded by the MoBE program, as well as a comparison set of 698 authors who published in the same journals during the same period of time but were not part of the Sloan Foundation-funded collaboration. Our analysis of collaboration networks for both groups of authors suggests that the Sloan Foundation's program resulted in a more consolidated community of researchers, specifically in terms of number of components, diameter, density, and transitivity of the coauthor networks. In addition to highlighting the success of this particular program, our method could be applied to other fields to examine the impact of funding programs and other large-scale initiatives on the formation of research communities.
C1 [Hicks, Daniel J.; Coil, David A.; Stahmer, Carl G.; Eisen, Jonathan A.] Univ Calif Davis, Davis, CA 95616 USA.
RP Hicks, DJ (reprint author), Univ Calif Davis, Davis, CA 95616 USA.
EM hicks.daniel.j@gmail.com
OI Hicks, Daniel/0000-0001-7945-4416; Coil, David/0000-0001-6049-8240
FU Alfred P. Sloan FoundationAlfred P. Sloan Foundation; Elsevier
FX Funding for DAC and JAE came from the Alfred P. Sloan Foundation. DJH's
   postdoctoral fellowship was funded by a gift to UC Davis from Elsevier.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bettencourt LMA, 2009, J INFORMETR, V3, P210, DOI 10.1016/j.joi.2009.03.001
   Bromham L, 2016, NATURE, V534, P684, DOI 10.1038/nature18315
   Chamberlain S, 2018, RCROSSREF CLIENT VAR
   Citron DT, 2018, J INFORMETR, V12, P181, DOI 10.1016/j.joi.2017.12.008
   Fujita M, 2017, 2017 IEEE INT C BIG
   Gilbert JA, 2018, NAT REV MICROBIOL, V16, P661, DOI 10.1038/s41579-018-0065-5
   Gorman M. E., 2010, TRADING ZONES INTERA
   Hicks DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168597
   Hicks DJ, IEEE ROBOTICS AUTOMA
   Holbrook JB, 2013, SYNTHESE, V190, P1865, DOI 10.1007/s11229-012-0179-7
   Kastrin A, 2018, SCIENTOMETRICS, V117, P1157, DOI 10.1007/s11192-018-2900-x
   Koseoglu MA, 2016, SCIENTOMETRICS, V109, P203, DOI 10.1007/s11192-016-1894-5
   KUHN TS, 1970, STRUCTURE SCI REVOLU
   Liang XN, 2018, RES POLICY, V47, P1295, DOI 10.1016/j.respol.2018.04.012
   National Academies, 2017, MICR BUILT ENV
   R Core Team, 2018, R LANG ENV STAT COMP
   Rosenstock S, 2017, PHILOS SCI, V84, P234, DOI 10.1086/690717
   STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001
   Taskin Z, 2015, SCIENTOMETRICS, V103, P1003, DOI 10.1007/s11192-015-1576-8
   Zoss AM, 2012, SCIENTOMETRICS, V91, P631, DOI 10.1007/s11192-011-0574-8
NR 20
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2019
VL 14
IS 6
AR e0218273
DI 10.1371/journal.pone.0218273
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW3OQ
UT WOS:000484891700019
PM 31211808
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Van den Wijngaert, S
   Bossuyt, N
   Ferns, B
   Busson, L
   Serrano, G
   Wautier, M
   Thomas, I
   Byott, M
   Dupont, Y
   Nastouli, E
   Hallin, M
   Kozlakidis, Z
   Vandenberg, O
AF Van den Wijngaert, Sigi
   Bossuyt, Nathalie
   Ferns, Bridget
   Busson, Laurent
   Serrano, Gabriela
   Wautier, Magali
   Thomas, Isabelle
   Byott, Matthew
   Dupont, Yves
   Nastouli, Eleni
   Hallin, Marie
   Kozlakidis, Zisis
   Vandenberg, Olivier
TI Bigger and Better? Representativeness of the Influenza A Surveillance
   Using One Consolidated Clinical Microbiology Laboratory Data Set as
   Compared to the Belgian Sentinel Network of Laboratories
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE Belgium; influenza A; surveillance; clinical microbiology laboratory;
   sequencing
ID VIRUS; EPIDEMIOLOGY
AB Infectious diseases remain a serious public health concern globally, while the need for reliable and representative surveillance systems remains as acute as ever. The public health surveillance of infectious diseases uses reported positive results from sentinel clinical laboratories or laboratory networks, to survey the presence of specific microbial agents known to constitute a threat to public health in a given population. This monitoring activity is commonly based on a representative fraction of the microbiology laboratories nationally reporting to a single central reference point. However, in recent years a number of clinical microbiology laboratories (CML) have undergone a process of consolidation involving a shift toward laboratory amalgamation and closer real-time informational linkage. This report aims to investigate whether such merging activities might have a potential impact on infectious diseases surveillance. Influenza data was used from Belgian public health surveillance 2014-2017, to evaluate whether national infection trends could be estimated equally as effectively from only just one centralized CML serving the wider Brussels area (LHUB-ULB). The overall comparison reveals that there is a close correlation and representativeness of the LHUB-ULB data to the national and international data for the same time periods, both on epidemiological and molecular grounds. Notably, the effectiveness of the LHUB-ULB surveillance remains partially subject to local regional variations. A subset of the Influenza samples had their whole genome sequenced so that the observed epidemiological trends could be correlated to molecular observations from the same period, as an added-value proposition. These results illustrate that the real-time integration of high-throughput whole genome sequencing platforms available in consolidated CMLs into the public health surveillance system is not only credible but also advantageous to use for future surveillance and prediction purposes. This can be most effective when implemented for automatic detection systems that might include multiple layers of information and timely implementation of control strategies.
C1 [Van den Wijngaert, Sigi; Busson, Laurent; Wautier, Magali; Hallin, Marie] Univ Libre Bruxelles, Univ Bruxelles, Pole Hosp, Dept Microbiol,LHUB, Brussels, Belgium.
   [Bossuyt, Nathalie; Dupont, Yves] Sciensano, Serv Epidemiol Infect Dis, SD Epidemiol & Surveillance, Brussels, Belgium.
   [Ferns, Bridget; Nastouli, Eleni] Univ Coll London Hosp NHS Fdn Trust, Dept Clin Virol, London, England.
   [Ferns, Bridget] UCLH, UCL, Biomed Res Ctr, NIHR, London, England.
   [Serrano, Gabriela; Vandenberg, Olivier] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Environm & Occupat Hlth, Brussels, Belgium.
   [Thomas, Isabelle] Sciensano, Natl Influenza Ctr, Brussels, Belgium.
   [Byott, Matthew; Kozlakidis, Zisis; Vandenberg, Olivier] UCL, Fac Med Sci, Div Infect & Immun, London, England.
   [Nastouli, Eleni] UCL, Inst Child Hlth, Dept Populat Policy & Practice, Eat Ormond St, London, England.
   [Kozlakidis, Zisis] WHO, Int Agcy Res Canc, Lyon, France.
   [Vandenberg, Olivier] Univ Libre Bruxelles, Pole Hosp Univ Bruxelles, Innovat & Business Dev Unit,LHUB, Brussels, Belgium.
RP Vandenberg, O (reprint author), Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Environm & Occupat Hlth, Brussels, Belgium.; Vandenberg, O (reprint author), UCL, Fac Med Sci, Div Infect & Immun, London, England.; Vandenberg, O (reprint author), Univ Libre Bruxelles, Pole Hosp Univ Bruxelles, Innovat & Business Dev Unit,LHUB, Brussels, Belgium.
EM olivier.vandenberg@ulb.ac.be
OI Kozlakidis, Zisis/0000-0002-3836-7209
FU UCL Global Engagement Fund
FX We wish to thank the personnel of the Department of Microbiology of
   LHUB-ULB for its daily technical assistance. This work has been
   supported in part by a UCL Global Engagement Fund award to OV and ZK,
   which is gratefully acknowledged. The authors would like to thank Gaetan
   Muyldermans for his help in the preparation of the manuscript. This work
   was partly presented at the 28th European Congress of Clinical
   Microbiology and Infectious Diseases, 2018 April 21-24, Madrid, Spain.
   p.112: P0001.
CR Berger N, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0145-9
   Bijlsma MW, 2014, LANCET INFECT DIS, V14, P805, DOI 10.1016/S1473-3099(14)70806-0
   Broberg Eeva, 2016, Euro Surveill, V21, DOI 10.2807/1560-7917.ES.2016.21.41.30370
   Colson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144178
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Enki DG, 2013, EMERG INFECT DIS, V19, P35, DOI 10.3201/eid1901.120493
   Gerard C, 2010, ARCH PUBLIC HEALTH, V68, P68, DOI 10.1186/0778-7367-68-2-68
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Grammens T, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.17.30524
   Harvala H, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.8.30466
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865
   Houlihan CF, 2018, J INFECT DIS, V218, P1485, DOI 10.1093/infdis/jiy335
   Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Keech M, 2008, PHARMACOECONOMICS, V26, P911, DOI 10.2165/00019053-200826110-00004
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Kiyaga C, 2015, J PUBLIC HEALTH POL, V36, P153, DOI 10.1057/jphp.2015.7
   Koski E, 2011, INTEGR SER INFORM SY, V27, P67, DOI 10.1007/978-1-4419-6892-0_4
   Masys DR, 2012, J BIOMED INFORM, V45, P419, DOI 10.1016/j.jbi.2011.12.005
   Muyldermans G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160429
   Niesters HG, 2013, EUROSURVEILLANCE, V18, P51
   Quan TP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01480-17
   Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558
   Struelens MJ, 2013, EUROSURVEILLANCE, V18, P3
   Van Casteren V, 2010, ARCH PUBLIC HEALTH, V68, P62, DOI 10.1186/0778-7367-68-2-62
   Vandenberg O, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00015
   Vega T, 2015, INFLUENZA OTHER RESP, V9, P234, DOI 10.1111/irv.12330
   Verhaegen J, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.31.20869
   WALCKIERS D, 1991, EPIDEMIOL INFECT, V106, P297, DOI 10.1017/S0950268800048445
   Yebra G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192081
   Zhou K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20840
NR 32
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JUN 18
PY 2019
VL 7
AR 150
DI 10.3389/fpubh.2019.00150
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IE9DC
UT WOS:000472674100001
PM 31275914
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Wages, JA
   Feye, KM
   Park, SH
   Kim, SA
   Ricke, SC
AF Wages, Jennifer A.
   Feye, Kristina M.
   Park, Si Hong
   Kim, Sun Ae
   Ricke, Steven C.
TI Comparison of 16S rDNA Next Sequencing of Microbiome Communities From
   Post-scalder and Post-picker Stages in Three Different Commercial
   Poultry Plants Processing Three Classes of Broilers
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE microbiome; poultry processing; next generation sequencing; indicator
   organism; poultry
ID CROSS-CONTAMINATION; ARCOBACTER; FOOD; IDENTIFICATION; PREVALENCE;
   PATHOGENS; SLAUGHTER; CARCASSES; SPOILAGE
AB Poultry processing systems are a complex network of equipment and automation systems that require a proactive approach to monitoring in order to protect the food supply. Process oversight requires the use of multi-hurdle intervention systems to ensure that any undesirable microorganisms are reduced or eliminated by the time the carcasses are processed into final products. In the present study, whole bird carcass rinses (WBCR) collected at the post-scalder and post-picker locations from three different poultry processing facilities (Plant A: mid-weight broiler processing, B: large-weight broiler processing, C: young broiler (Cornish) processing) were subjected to next generation sequencing (NGS) and microbial quantification using direct plating methods to assess the microbial populations present during these stages of the poultry process. The quantification of aerobic plate counts (APC) and Enterobacteriaceae (EB) demonstrated that reductions for these microbial classes were not consistent between the two sampling locations for all facilities, but did not provide a clear picture of what microorganism(s) may be affecting those shifts. With the utilization of NGS, a more complete characterization of the microbial communities present including microorganisms that would not have been identified with the employed direct plating methodologies were identified. Although the foodborne pathogens typically associated with raw poultry, Salmonella and Campylobacter, were not identified, sequence analysis performed by Quantitative Insights of Microbiology Ecology (QIIME) indicated shifts of Erwinia, Serratia, and Arcobacter, which are microorganisms closely related to Salmonella and Campylobacter. Additionally, the presence of Chryseobacterium and Pseudomonas at both sampling locations and at all three facilities provides evidence that these microorganisms could potentially be utilized to assess the performance of multi-hurdle intervention systems.
C1 [Ricke, Steven C.] Univ Arkansas, Ctr Food Safety, Fayetteville, AR 72701 USA.
   Univ Arkansas, Dept Food Sci, Fayetteville, AR 72701 USA.
   [Park, Si Hong; Kim, Sun Ae] Oregon State Univ, Dept Food Sci & Technol, Corvallis, OR 97331 USA.
   [Kim, Sun Ae] Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea.
RP Ricke, SC (reprint author), Univ Arkansas, Ctr Food Safety, Fayetteville, AR 72701 USA.
EM sricke@uark.edu
CR Allen VM, 2003, BRIT POULTRY SCI, V44, P53, DOI 10.1080/0007166031000085436
   Allen VM, 2003, BRIT POULTRY SCI, V44, P567, DOI [10.1080/00071660310001616183, NO_DOI]
   Assanta MA, 2002, J FOOD PROTECT, V65, P1240, DOI 10.4315/0362-028X-65.8.1240
   Atabay HI, 1998, J APPL MICROBIOL, V84, P1007, DOI 10.1046/j.1365-2672.1998.00437.x
   BARNES EM, 1972, VET REC, V90, P720, DOI 10.1136/vr.90.26.720
   Batz MB, 2012, J FOOD PROTECT, V75, P1278, DOI 10.4315/0362-028X.JFP-11-418
   Berrang ME, 2001, J FOOD PROTECT, V64, P2063, DOI 10.4315/0362-028X-64.12.2063
   Buncic S, 2012, FOOD RES INT, V45, P641, DOI 10.1016/j.foodres.2011.10.018
   Chao K, 2014, COMPUT STAND INTER, V36, P271, DOI 10.1016/j.csi.2011.03.006
   Corry JEL, 2007, FOOD MICROBIOL, V24, P230, DOI 10.1016/j.fm.2006.05.003
   Davies R. H., 2005, Food safety control in the poultry industry, P101
   DAVIES RH, 1994, INT J FOOD MICROBIOL, V24, P147, DOI 10.1016/0168-1605(94)90114-7
   De Cesare A, 2018, ITAL J FOOD SAF, V7, P62, DOI 10.4081/ijfs.2018.6923
   Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005
   Dickens JA, 1997, POULTRY SCI, V76, P657, DOI 10.1093/ps/76.4.657
   Firildak G., 2015, Asian Journal of Biological Sciences, V8, P16
   Geornaras I, 1999, APPL ENVIRON MICROB, V65, P3828
   Grau F. H, 1986, ADV MEAT RES MEAT PO, P1, DOI 10.1007/978-1-349-09145-4_1
   Habimana O, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-48
   Han GG, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2604-8
   Handley J. A., 2015, FOOD SAFETY EMERGING, P81, DOI 10.1016/b978-0-12-800245-2.00006-x
   Handley JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00345
   Kabeya H, 2004, INT J FOOD MICROBIOL, V90, P303, DOI 10.1016/S0168-1605(03)00322-2
   Kim SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43354
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   LYON CE, 1991, POULTRY SCI, V70, P1020, DOI 10.3382/ps.0701020
   Moberg L, 2013, COMPENDIUM METHODS M
   Nychas GJE, 2008, MEAT SCI, V78, P77, DOI 10.1016/j.meatsci.2007.06.020
   Oakley BB, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00011
   Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608
   Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190
   Oyarzabal O. A, 2010, HDB POULTRY SCI TECH, V2, P527, DOI [10.1002/9780470504475.ch36, DOI 10.1002/9780470504475.CH36]
   Park SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151944
   Phillips CA, 2001, TRENDS FOOD SCI TECH, V12, P263, DOI 10.1016/S0924-2244(01)00090-5
   Rinttila T, 2013, J APPL POULTRY RES, V22, P647, DOI 10.3382/japr.2013-00742
   Rouger A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030050
   Schilling M.W., 2014, ENCY MEAT SCI, P303, DOI [10.1016/b978-0-12-384731-7.00159-8, DOI 10.1016/B978-0-12-384731-7.00159-8]
   Sinclair RG, 2012, APPL ENVIRON MICROB, V78, P1969, DOI 10.1128/AEM.06582-11
   USDA, 2013, SALM CAMP VER PROGR
   Van Driessche E, 2007, POULTRY SCI, V86, P744, DOI 10.1093/ps/86.4.744
   Zweifel C, 2012, WOODHEAD PUBL FOOD S, P60
   Zweifel C, 2015, FOOD CONTROL, V51, P37, DOI 10.1016/j.foodcont.2014.11.002
NR 43
TC 1
Z9 1
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 4
PY 2019
VL 10
AR 972
DI 10.3389/fmicb.2019.00972
PG 11
WC Microbiology
SC Microbiology
GA IB2XR
UT WOS:000470132500001
PM 31214127
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Rampelotto, PH
   Sereia, AFR
   de Oliveira, LFV
   Margis, R
AF Rampelotto, Pabulo H.
   Sereia, Aline F. R.
   de Oliveira, Luiz Felipe V.
   Margis, Rogerio
TI Exploring the Hospital Microbiome by High-Resolution 16S rRNA Profiling
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE microbiota; nosocomial pathogens; hospital-acquired infections; 16S
   rRNA; clinical microbiology; Acinetobacter; Staphylococcus; Pseudomonas
ID CARE-ASSOCIATED INFECTIONS; BACTERIAL COMMUNITIES; CONTAMINATED
   SURFACES; ENVIRONMENT; DIVERSITY; PATTERNS; IDENTIFICATION;
   METAGENOMICS; TRANSMISSION; TECHNOLOGIES
AB The aim of this work was to analyze and compare the bacterial communities of 663 samples from a Brazilian hospital by using high-throughput sequencing of the 16S rRNA gene. To increase taxonomic profiling and specificity of 16S-based identification, a strict sequence quality filtering process was applied for the accurate identification of clinically relevant bacterial taxa. Our results indicate that the hospital environment is predominantly inhabited by closely related species. A massive dominance of a few taxa in all taxonomic levels down to the genera was observed, where the ten most abundant genera in each facility represented 64.4% of all observed taxa, with a major predominance of Acinetobacter and Pseudomonas. The presence of several nosocomial pathogens was revealed. Co-occurrence analysis indicated that the present hospital microbial network had low connectedness, forming a clustered topology, but not structured among groups of nodes (i.e., modules). Furthermore, we were able to detect ecologically relevant relationships between specific microbial taxa, in particular, potential competition between pathogens and non-pathogens. Overall, these results provide new insight into different aspects of a hospital microbiome and indicate that 16S rRNA sequencing may serve as a robust one-step tool for microbiological identification and characterization of a wide range of clinically relevant bacterial taxa in hospital settings with a high resolution.
C1 [Rampelotto, Pabulo H.; Margis, Rogerio] Univ Fed Rio Grande do Sul, Ctr Biotechnol, PPGBCM, BR-91501970 Porto Alegre, RS, Brazil.
   [Rampelotto, Pabulo H.] HCPA, Lab Expt Hepatol & Gastroenterol, BR-90035903 Porto Alegre, RS, Brazil.
   [Sereia, Aline F. R.; de Oliveira, Luiz Felipe V.] Neoprospecta Microbiome Technol, BR-88057260 Florianopolis, SC, Brazil.
RP Margis, R (reprint author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, PPGBCM, BR-91501970 Porto Alegre, RS, Brazil.
EM prampelotto@hcpa.edu.br; aline@neoprospecta.com;
   felipe@neoprospecta.com; rogerio.margis@ufrgs.br
RI Margis, Rogerio/A-7230-2008
OI Margis, Rogerio/0000-0002-2871-4473
FU Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [309030/2015-3]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES
FX R.M. is the recipient of a research fellowship 309030/2015-3 from
   Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico
   (CNPq). P.H.R. was the recipient of a research fellowship from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Al-Ghalith Gabriel A., 2015, Yale Journal of Biology and Medicine, V88, P359
   Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4
   Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA182, DOI 10.1289/ehp.122-A182
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Bastian M., 2009, AAI PUBLICATIONS
   Bock LJ, 2016, J HOSP INFECT, V93, P42, DOI 10.1016/j.jhin.2015.12.019
   Bomar L, 2016, MBIO, V7, DOI 10.1128/mBio.01725-15
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caselli E, 2017, MICROB BIOTECHNOL, V10, P1079, DOI 10.1111/1751-7915.12755
   Caselli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148857
   Castelino M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0927-4
   Chen CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08679-3
   Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004
   Cobrado L, 2017, EUR J CLIN MICROBIOL, V36, P2053, DOI 10.1007/s10096-017-3042-4
   Cottee-Jones H. E. W., 2012, FRONTIERS BIOGEOGRAP, V4, P117, DOI DOI 10.21425/F54312533
   D'Accolti M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071535
   Dancer SJ, 2014, CLIN MICROBIOL REV, V27, P665, DOI 10.1128/CMR.00020-14
   Dijkshoorn L., 2013, MOL TYPING BACTERIAL
   Eremeeva M.E., 2016, RICKETTSIALES BIOL M
   Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6
   Falagas ME, 2009, J HOSP INFECT, V71, P301, DOI 10.1016/j.jhin.2008.12.008
   Fournier PE, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0114-2
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703
   Hilton SK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00484
   Jenkins C, 2012, J MED MICROBIOL, V61, P483, DOI 10.1099/jmm.0.030387-0
   Kalia VC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-18
   Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500
   MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]
   Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x
   Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413
   Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004
   Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363
   Padmanabhan R, 2013, J MICROBIOL METH, V95, P415, DOI 10.1016/j.mimet.2013.10.006
   Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/nmeth.2658, 10.1038/NMETH.2658]
   Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09
   da Fonseca TAP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020152
   Poza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044105
   Rampelotto PH, 2015, MICROB ECOL, V69, P684, DOI 10.1007/s00248-014-0510-6
   Shaughnessy MK, 2011, INFECT CONT HOSP EP, V32, P201, DOI 10.1086/658669
   Suleyman G, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0620-2
   Tang CY, 2015, APPL MICROBIOL BIOT, V99, P2871, DOI 10.1007/s00253-014-6176-7
   Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621
   Vandini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108598
   Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16
   Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923
   W. H. Organization, 2011, REP BURD END HLTH CA
   Wand ME, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01162-16, 10.1128/aac.01162-16]
   Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04
   Weigand MR, 2015, APPL ENVIRON MICROB, V81, P5420, DOI 10.1128/AEM.01159-15
   Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358
   Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763
NR 59
TC 3
Z9 3
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN 2
PY 2019
VL 20
IS 12
AR 3099
DI 10.3390/ijms20123099
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IG4ED
UT WOS:000473756000249
PM 31242612
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Das, S
   Bhuyan, R
   Bagchi, A
   Saha, T
AF Das, Sanjib
   Bhuyan, Rajabrata
   Bagchi, Angshuman
   Saha, Tanima
TI Network analysis of hyphae forming proteins in Candida albicans
   identifies important proteins responsible for pathovirulence in the
   organism
SO HELIYON
LA English
DT Article
DE Bioinformatics; Microbiology
AB Candida albicans causes two types of major infections in humans: superficial infections, such as skin and mucosal infection, and life-threatening systemic infections, like airway and catheter-related blood stream infections. It is a polymorphic fungus with two distinct forms (yeast and hyphal) and the morphological plasticity is strongly associated with many disease causing proteins. In this study, 137 hyphae associated proteins from Candida albicans (C. albicans) were collected from different sources to create a Protein-Protein Interaction (PPI) network. Out of these, we identified 18 hub proteins (Hog1, Hsp90, Cyr1, Cdc28, Pkc1, Cla4, Cdc42, Tpk1, Act1, Pbs2, Bem1, Tpk2, Ras1, Cdc24, Rim101, Cdc11, Cdc10 and Cln3) that were the most important ones in hyphae development. Ontology and functional enrichment analysis of these proteins could categorize these hyphae associated proteins into groups like signal transduction, kinase activity, biofilm formation, filamentous growth, MAPK signaling etc. Functional annotation analysis of these proteins showed that the protein kinase activity to be essential for hyphae formation in Candida. Additionally, most of the proteins from the network were predicted to be localized on cell surface or periphery, suggesting them as the main protagonists in inducing infections within the host. The complex hyphae formation phenomenon of C. albicans is an attractive target for exploitation to develop new antifungals and anti-virulence strategies to combat C. albicans infections. We further tried to characterize few of the most crucial proteins, especially the kinases by their sequence and structural prospects. Therefore, through this article an attempt to understand the hyphae forming protein network analysis has been made to unravel and elucidate the complex pathogenesis processes with the principal aim of systems biological research involving novel Bioinformatics strategies to combat fungal infections.
C1 [Das, Sanjib; Saha, Tanima] Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India.
   [Bhuyan, Rajabrata; Bagchi, Angshuman] Univ Kalyani, Dept Biochem & Biophys, Kalyani 741235, W Bengal, India.
RP Saha, T (reprint author), Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India.; Bagchi, A (reprint author), Univ Kalyani, Dept Biochem & Biophys, Kalyani 741235, W Bengal, India.
EM angshumanb@gmail.com; sahatanima@klyuniv.ac.in
FU BTIS net programme of DBT, Ministry of Science and Technology,
   Government of India, New Delhi; University of Kalyani
FX This work was supported by grants from BTIS net programme of DBT,
   Ministry of Science and Technology, Government of India, New Delhi.
   Angshuman Bagchi and Tanima Saha also received financial assistance from
   Personal Research Grant 2018-2019 provided by University of Kalyani.
CR Assenov Y., 2008, BIOINFORMATICS
   Bader G. D., 2003, BMC BIOINF
   Banerjee M., 2008, MOL BIOL CELL
   Barabasi A. - L., 2004, NAT REV GENET
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Behzadi P., 2015, CENT EUR J UROL
   Berman J., 2002, NAT REV GENET
   BINDEA G, 2009, BIOINFORMATICS
   Butler G., 2009, NATURE
   Calderone Richard, 2002, P67
   Calera J. A., 1999, MICROBIOLOGY
   Calera J. A., 1999, INFECT IMMUN
   Carlisle P. L., 2009, P NATL ACAD SCI US
   Chatr- Aryamontri A., 2017, NUCL ACIDS RES
   Chauhan N., 2007, AGENTS CHEMOTHER
   Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11
   Dalle F., 2010, CELL MICROBIOL
   Deng F. S., 2018, MED MYCOL
   Dennis G., 2003, GENOME BIOL
   Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909
   Doncheva N. T., 2012, NAT PROTOC
   Edmond M. B., 1999, CLIN INFECT DIS
   Eggimann P., 2003, LANCET INFECT DIS
   Foxman B., 1998, J WOMENS HLTH
   Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691
   Gudlaugsson O., 2003, CLIN INFECT DIS
   Gutierrez-Escribano P., 2011, MOL BIOL CELL
   Han T. L., 2011, FUNGAL GENET BIOL
   Hazan I., 2002, EUKARYOT CELL
   He X., 2006, PLOS GENET
   Hurley R., 1979, POSTGRAD MED J
   Kadosh D., 2005, MOL BIOL CELL, DOI DOI 10.1091
   Karthikeyan B. S., 2016, MOL BIOSYST
   Klippel N., 2010, MICROBIOLOGY
   Kruppa M., 2003, FEMS YEAST RES
   Kruppa M., 2004, FEMS YEAST RES
   Kruppa M., 2009, MYCOSES
   Kumar A., 2018, VIRULENCE
   Lai M. H., 1997, YEAST
   Larone D. H., 1995, MED IMPORTANT FUNGI, V1995
   Leberer E., 1997, CURR BIOL
   Lee JA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006452
   Li D., 2002, INFECT IMMUN
   Li D., 2004, MICROBIOLOGY
   Li X., 2015, AGENTS CHEMOTHER
   Lin CJ, 2018, J FUNGI, V4, DOI 10.3390/jof4020068
   Lo H. J., 1997, CELL
   Lorenz M. C., 2004, EUKARYOT CELL
   Lu Y., 2014, TRENDS MICROBIOL
   Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984
   Moran G., 2002, ANTIMICROB AGENTS CH
   Moudgal V., 2010, EXPERT OPIN PHARMACO
   Nantel A., 2002, MOL BIOL CELL
   Navarro- Garcia F., 2001, FEMS MICROBIOL REV
   Navarro- Garcia F., 2005, MICROBIOLOGY
   Noble S. M., 2007, ANN REV GENET
   Park H. - O., 2007, MICROBIOL MOL BIOL R
   Perlroth J., 2007, MED MYCOL
   Pfaller M. A., 2000, AGENTS CHEMOTHER
   Pfaller M. A., 2007, CLIN MICROBIOL REV
   Ravasz E., 2002, SCIENCE, V80
   Romani L., 2003, CURR OPIN MICROBIOL
   Roy A., 2010, NAT PROTOC
   Samaranayake L. P., 2002, DERMATOL THER
   Saville S. P., 2003, EUKARYOT CELL
   Shannon P, 2003, GENOME RES
   Shapiro R. S., 2009, CURR BIOL
   Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924
   Sobel J. D., 2007, LANCET
   Su C., 2013, MOL BIOL CELL
   Sudbery P. E., 2011, NAT REV MICROBIOL
   SUTTON DA, 1998, GUIDE CLIN SIGNIFICA
   Szklarczyk D., 2017, NUCL ACIDS RES
   Vazquez A., 2004, P NATL ACAD SCI US
   Wang Y., 2016, J MICROBIOL
   Wey S. B., 1988, ARCH INTERN MED
   Winterbach W, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-90
   Yamada- Okabe T., 1999, J BACTERIOL
   Yang Y. - L., 2003, J MICROBIOL IMMUNOL
   Yoon J., 2006, BIOINFORMATICS
   Zeidler U., 2009, FEMS YEAST RES
NR 81
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD JUN
PY 2019
VL 5
IS 6
AR e01916
DI 10.1016/j.heliyon.2019.e01916
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IG5BK
UT WOS:000473818300126
PM 31338453
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Mohammadi, R
   Zahiri, J
   Niroomand, MJ
AF Mohammadi, Reza
   Zahiri, Javad
   Niroomand, Mohammad Javad
TI iMet: A graphical user interface software tool to merge metabolic
   networks
SO HELIYON
LA English
DT Article
DE Bioinformatics; Biotechnology; Microbiology; Systems biology
ID SP PCC 6803; CYANOBACTERIA; MODELS; DATABASE
AB Nowadays, studying microorganisms has become faster and deeper than the last decades, thanks to the modeling of genome-scale metabolic networks. Completed genome sequencing projects of microorganisms and annotating these sequences have provided a worthwhile platform for reconstructing and modeling genome-scale metabolic networks. The genome-scale metabolic network reconstruction is a laborious and time-consuming task which needs an extensive study and search in different types of databases. Furthermore, it also requires an iterative process of creating and curating the obtained network, particularly with experimental methods. Hence, different types of reconstructions and models of a targeted microorganism can be found with different qualifies, as the goal and need of researchers differ.
   Due to these circumstances, scientists have to continue with only one of the reconstructed metabolic networks of each microorganism and ignore the rest in their in silica works. It is clear that having a tool which merges different metabolic networks of a single organism can be a useful and effective way to study them with minimal cost and time. To meet this need, we have developed iMet, the standalone graphical user interface (GUI) software tool to merge multiple reconstructed metabolic networks of microorganisms. As a case study, we merged three reconstructed metabolic networks of a cyanobacterium using iMet, and then all of them (including the new merged one) became modeled. The results of our evaluations including Flux Balance Analysis (FBA), revealed enhancing metabolic network coverage as well as increasing yield of desired products in the new obtained model.
C1 [Mohammadi, Reza] Malek Ashlar Univ Technol, Shahin Shahr, Iran.
   [Zahiri, Javad] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Bioinformat & Computat Omics Lab BioCOOL, Tehran, Iran.
   [Niroomand, Mohammad Javad] Univ Tehran, Sch Elect & Comp Engn, Learning Intelligent Syst Lab, Tehran, Iran.
RP Mohammadi, R (reprint author), Malek Ashlar Univ Technol, Shahin Shahr, Iran.
EM rezamohanunadi@mut.ac.ir
CR Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020
   Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586
   Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304
   Chindelevitch L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r6
   Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791
   Dias O, 2015, NUCLEIC ACIDS RES, V43, P3899, DOI 10.1093/nar/gkv294
   Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003
   Erdrich P, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0128-x
   Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949
   Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007
   Fleming RMT, 2011, BIOINFORMATICS, V27, P142, DOI 10.1093/bioinformatics/btq607
   Fritzemeier CJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005494
   Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720
   Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015
   Joshi CJ, 2017, ALGAL RES, V27, P295, DOI 10.1016/j.algal.2017.09.013
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081
   Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198
   Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109
   Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737
   Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001
   Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005
   Mardinoglul A, 2015, CURR OPIN BIOTECH, V34, P91, DOI 10.1016/j.copbio.2014.12.013
   Mohammadi R, 2016, MOL BIOSYST, V12, P2552, DOI 10.1039/c6mb00119j
   Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Pitkanen E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003465
   Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0
   Ravikrishnan A., 2015, BRIEFINGS BIOINF, V16
   Rosgaard L, 2012, J BIOTECHNOL, V162, P134, DOI 10.1016/j.jbiotec.2012.05.006
   Saha R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048285
   Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308
   Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213
   Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186
   Yu Y, 2013, MAR DRUGS, V11, P2894, DOI 10.3390/md11082894
   Zhang HW, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43163
   Zhou J, 2010, PROTEIN CELL, V1, P207, DOI 10.1007/s13238-010-0043-9
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD JUN
PY 2019
VL 5
IS 6
AR e01766
DI 10.1016/j.heliyon.2019.e01766
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IG5BK
UT WOS:000473818300105
PM 31286073
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Bernabe, KG
   Lu, KT
   Handley, FG
   Griffin, DE
   Kurane, I
   Iwamoto, A
   Gao, GE
   Krammer, F
AF Bernabe, K. Gayle
   Lu, Kristina T.
   Handley, F. Gray
   Griffin, Diane E.
   Kurane, Ichiro
   Iwamoto, Aikichi
   Gao, George E.
   Krammer, Florian
CA USJCMSP AIDS Panel
   ARI Panel
   Canc Hepatitis Immunology Viral Di
TI 20th International Conference on Emerging Infectious Diseases in the
   Pacific Rim Organized by the United States-Japan Cooperative Medical
   Sciences Program (USJCMSP)
SO VACCINES
LA English
DT Article
DE emerging infectious diseases; pacific rim
AB The 20th International Conference on Emerging Infectious Diseases in the Pacific Rim to3ok place in Shenzhen, China on January 8-9, 2018 followed by meetings of the acquired immunodeficiency syndrome (AIDS)/immunology, acute respiratory infections, cancer, hepatitis, and viral diseases panels on January 10-11. The conference was organized as part of the United States-Japan Cooperative Medical Sciences Program (USJCMSP) by the Japan Agency for Medical Research and Development (AMED) and the U.S. National Institutes of Health (NIH) and was locally hosted by the Shenzhen Third People's Hospital and the Chinese Academy of Sciences (CAS) Institute of Microbiology. The conference provides the basis for networking and fostering of collaboration opportunities between researchers in Southeast Asia and the United States based on the scientific and interactive platform of the USJCMSP and takes place in the region on an annual basis. This report summarizes the discussions and conclusions from the conference.
C1 [Krammer, Florian; USJCMSP AIDS Panel; ARI Panel; Canc Hepatitis Immunology Viral Di] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Bernabe, K. Gayle] NIAID, Off Global Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Lu, Kristina T.] NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Handley, F. Gray] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
   [Kurane, Ichiro] Natl Inst Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan.
   [Iwamoto, Aikichi] Japan Agcy Med Res & Dev, Dept Res Promot, Chiyoda Ku, Tokyo 1000004, Japan.
   [Gao, George E.] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China.
RP Krammer, F (reprint author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Bernabe, KG (reprint author), NIAID, Off Global Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM gbernabe@niaid.nih.gov; lukr@mail.nih.gov; handleygr@niaid.nih.gov;
   dgriffi6@jhmi.edu; kurane@niid.go.jp; aikichi@zj9.so-net.ne.jp;
   gaof@im.ac.cn; florian.krammer@mssm.edu
RI Krammer, Florian/H-3237-2019
OI Krammer, Florian/0000-0003-4121-776X
FU Japan Agency for Medical Research and Development, the Ministry of
   Foreign Affairs; Ministry of Health, Labour, and WelfareMinistry of
   Health, Labour and Welfare, Japan; Ministry of Education, Culture,
   Sports, Science, and TechnologyMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT); United States National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX The conference series is supported by the Japan Agency for Medical
   Research and Development, the Ministry of Foreign Affairs; the Ministry
   of Health, Labour, and Welfare; and the Ministry of Education, Culture,
   Sports, Science, and Technology and the United States National
   Institutes of Health.
CR Brennan Patrick J, 2015, Nihon Hansenbyo Gakkai Zasshi, V84, P79
   Brennan Patrick J, 2014, Nihon Hansenbyo Gakkai Zasshi, V83, P63
   CARPENTER CC, 1968, SCIENCE, V159, P1262, DOI 10.1126/science.159.3820.1262
   Conference on Emerging Diseases Proceedings, 1997, FEMS IMMUNOL MED MIC, V18, P219
   Dixon D M, 2001, Nihon Ishinkin Gakkai Zasshi, V42, P75
   Mori T, 2007, TUBERCULOSIS, V87, pS5, DOI 10.1016/j.tube.2007.05.007
   Umenai T, 1997, J ACQ IMMUN DEF SYND, V14, pS58, DOI 10.1097/00042560-199700002-00011
NR 7
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD JUN
PY 2019
VL 7
IS 2
AR 35
DI 10.3390/vaccines7020035
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA II1AM
UT WOS:000474937000002
PM 30987042
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Salmanov, AG
   Vdovychenko, SY
   Litus, OI
   Litus, VI
   Bisyuk, YA
   Bondarenko, TM
   Davtian, LL
   Olifirova, TF
   Leleka, MV
   Kovalchuk, OI
   Dzevulska, IV
   Moroz, VV
   Kaminsky, RF
   Zhegulovych, ZE
   Kerechanyn, IV
AF Salmanov, Aidyn Gurbanovych
   Vdovychenko, Sergiy Yuriovych
   Litus, Oleksandr Ivanovych
   Litus, Victor Ivanovych
   Bisyuk, Yuriy Anatoliovych
   Bondarenko, Tetiana Mykolaivna
   Davtian, Lena Levonivna
   Olifirova, Tetiana F.
   Leleka, Mariya V.
   Kovalchuk, Oleksandr Ivanovych
   Dzevulska, Iryna Viktorivna
   Moroz, Vladyslav Vladyslavovych
   Kaminsky, Rostislav Felixovich
   Zhegulovych, Zinaida Egorovna
   Kerechanyn, Iryna Valeriivna
TI Prevalence of health care-associated infections and antimicrobial
   resistance of the responsible pathogens in Ukraine: Results of a
   multicenter study (2014-2016)
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Prevalence; Death; Antibiotic resistance; Surveillance; health
   care-associated infections
ID LENGTH-OF-STAY; MORTALITY; COHORT; SURVEILLANCE; HOSPITALS; IMPACT
AB Background: The aim of this study was to obtain the first national estimates of the current prevalence and incidence and death of health care-associated infections (HAIs) of all types in acute care hospitals in Ukraine.
   Methods: Prospective surveillance was conducted from January 2014 to December 2016 in 17 hospitals. Surveillance case definitions were derived from the Centers for Disease Control and Prevention's National Healthcare Safety Network HAI case definitions. The identification and antimicrobial susceptibility of cultures were determined using a automated microbiology analyzer. Some antimicrobial susceptibility tests used Kirby-Bauer antibiotic testing.
   Results: Of 97,340 patients, 10,986 (11.3%) HAIs were observed. The most frequently reported HAI types were surgical site infections (60%), respiratory tract infections (pneumonia and lower respiratory tract, 18.4%), bloodstream infections (10.2%), and urinary tract infections (9.5%). Death during hospitalization was reported in 9.7% of HAI cases. The most common organism reported was Escherichia coli, accounting for 21.8% of all organisms, followed by Staphylococcus aureus (18.4%), Enterococcus spp (15.7%), and Pseudomonas aeruginosa (12.4%). Antimicrobial resistance among the isolates associated with HAIs showed that 42.1% and 3.6% of coagulase-negative Staphylococcus spp isolates were beta-lactam (oxacillin)- and glycopeptide (teicoplanin)-resistant, respectively. Meticillin resistance was reported in 39.2% of S aureus isolates.
   Conclusions: HAIs and increasing antimicrobial resistance present a significant burden to the Ukraine hospital system. Infection control priorities in hospitals should include preventing surgical site infections, respiratory tract infections (which also include PNEU and LRTI), bloodstream infections, and urinary tract infections, as well preventing infections due to antimicrobial-resistant pathogens. (C) 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Salmanov, Aidyn Gurbanovych] Shupyk Natl Med Acad Postgrad Educ, Dept Microbiol Epidemiol & Infect Control, 9 Dorogozhytskaya St, UA-04112 Kiev, Ukraine.
   [Vdovychenko, Sergiy Yuriovych] Shupyk Natl Med Acad Postgrad Educ, Dept Obstet Gynecol & Perinatol, Kiev, Ukraine.
   [Litus, Oleksandr Ivanovych] Shupyk Natl Med Acad Postgrad Educ, Dept Dermatovenereol, Kiev, Ukraine.
   [Litus, Victor Ivanovych] Shupyk Natl Med Acad Postgrad Educ, Dept Clin Lab Immunol & Allergy, Kiev, Ukraine.
   [Bisyuk, Yuriy Anatoliovych; Bondarenko, Tetiana Mykolaivna] Shupyk Natl Acad Postgrad Educ, Dept Clin Lab Immunol & Allergol, Kiev, Ukraine.
   [Davtian, Lena Levonivna; Olifirova, Tetiana F.; Leleka, Mariya V.] Shupyk Natl Med Acad Postgrad Educ, Dept Pharmaceut Technol & Biopharmaceut, Kiev, Ukraine.
   [Kovalchuk, Oleksandr Ivanovych] Shupyk Natl Med Acad Postgrad Educ, Act Qual Monitoring Div, Kiev, Ukraine.
   [Dzevulska, Iryna Viktorivna; Kaminsky, Rostislav Felixovich] Bogomolets Natl Med Univ, Dept Human Anat, Kiev, Ukraine.
   [Moroz, Vladyslav Vladyslavovych] Bogomolets Natl Med Univ, Dept Surg 1, Kiev, Ukraine.
   [Kerechanyn, Iryna Valeriivna] Kyiv Med Univ, Private Higher Educ Estab, Dept Anat Topog Anat & Operat Surg, Kiev, Ukraine.
RP Salmanov, AG (reprint author), Shupyk Natl Med Acad Postgrad Educ, Dept Microbiol Epidemiol & Infect Control, 9 Dorogozhytskaya St, UA-04112 Kiev, Ukraine.
EM mozsago@gmail.com
RI ; Litus, Viktor/U-4052-2018; Kovalchuk, Oleksandr/K-9993-2015
OI Moroz, Vladyslav/0000-0003-3409-4239; Davtan, Lena/0000-0001-7827-2418;
   Litus, Viktor/0000-0002-1006-2489; Kovalchuk,
   Oleksandr/0000-0002-6311-3518; Salmanov, Aidyn
   Gurbanovich/0000-0002-4673-1154
CR Bianco A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0337-x
   Brown J, 2009, CLIN INFECT DIS, V49, P743, DOI 10.1086/604719
   European Centre for Disease Prevention and Control, SURV HEALTHC ASS INF
   Fabbro-Peray P, 2007, INFECT CONT HOSP EP, V28, P265, DOI 10.1086/512626
   Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Kanerva M, 2008, J HOSP INFECT, V70, P353, DOI 10.1016/j.jhin.2008.08.009
   Khan MA, 2012, INT J PATH, V10, P64
   Koch AM, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0097-9
   Kritsotakis EI, 2017, INFECT DRUG RESIST, V10, P317, DOI 10.2147/IDR.S147459
   Mitchell BG, 2016, J HOSP INFECT, V93, P92, DOI 10.1016/j.jhin.2016.01.012
   Mitchell Brett G, 2015, Nurs Stand, V29, P52, DOI 10.7748/ns.29.23.52.e9609
   Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1
   Reilly J, 2008, J HOSP INFECT, V69, P62, DOI 10.1016/j.jhin.2008.02.019
   Rubio FG, 2013, BRAZ J INFECT DIS, V17, P480, DOI 10.1016/j.bjid.2012.12.004
   Salmanov A., 2009, EpiNorth - Journal of the Network for Communicable Disease Control in Northern and Eastern Europe, V10, P120
   Salmanov AG, 2018, INT J ANTIBIOTICS PR, V2, P18
   Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770
   van Bunnik BAD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2172-9
   van der Kooi TII, 2010, J HOSP INFECT, V75, P168, DOI 10.1016/j.jhin.2009.11.020
   Vrijens F, 2012, EPIDEMIOL INFECT, V140, P126, DOI 10.1017/S0950268811000100
   World Health Organization, REP BURD END HLTH CA
   World Health Organization, HEALTHC ASS INF FACT
   Zarb P, 2012, EUROSURVEILLANCE, V17, P4
NR 24
TC 0
Z9 0
U1 1
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD JUN
PY 2019
VL 47
IS 6
BP E15
EP E20
DI 10.1016/j.ajic.2019.03.007
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HZ7ET
UT WOS:000469016500001
PM 31000318
DA 2020-05-07
ER

PT J
AU Nurjadi, D
   Fleck, R
   Lindner, A
   Schafer, J
   Gertler, M
   Mueller, A
   Lagler, H
   Van Genderen, PJJ
   Caumes, E
   Boutin, S
   Kuenzli, E
   Gascon, J
   Kantele, A
   Grobusch, MP
   Heeg, K
   Zanger, P
AF Nurjadi, D.
   Fleck, R.
   Lindner, A.
   Schaefer, J.
   Gertler, M.
   Mueller, A.
   Lagler, H.
   Van Genderen, P. J. J.
   Caumes, E.
   Boutin, S.
   Kuenzli, E.
   Gascon, J.
   Kantele, A.
   Grobusch, M. P.
   Heeg, K.
   Zanger, P.
CA StaphTrav Network
TI Import of community-associated, methicillin-resistant Staphylococcus
   aureus to Europe through skin and soft-tissue infection in
   intercontinental travellers, 2011-2016
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Communicable disease control; Communicable diseases (emerging);
   Cross-sectional studies; Emerging; Methicillin-resistant Staphylococcus
   aureus; Panton-Valentine leucocidin sentinel surveillance;
   Staphylococcal skin infections; Travel medicine
ID VALENTINE LEUKOCIDIN GENES; MULTIPLEX PCR ASSAY; MRSA USA300; OUTBREAK;
   TRANSMISSION; PREVALENCE; SPREAD; CLONE; DISCRIMINATION; CARRIAGE
AB Objectives: Recently, following import by travel and migration, epidemic community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has caused nosocomial outbreaks in Europe, sometimes with a fatal outcome. We describe clinico-epidemiological characteristics of CA-MRSA detected by the European Network for the Surveillance of imported S. aureus (www.staphtrav.eu) from May 2011 to November 2016.
   Methods: Sentinel surveillance at 13 travel clinics enrolling patients with travel-associated skin and soft-tissue infection (SSTI) and analysing lesion and nose swabs at one central laboratory.
   Results: A total of 564 independent case-patients with SSTI were enrolled and had 374 (67%) S. aureus-positive lesions, of which 14% (51/374) were MRSA. The majority of CA-MRSA isolates from SSTI were Panton-Valentine leucocidin (PVL)-positive (43/51, 84%). The risk of methicillin-resistance in imported S. aureus varied by travel region (p<0.001) and was highest in Latin America (16/57, 28%, 95% CI 17.0-41.5) and lowest in Sub-Saharan Africa (4/121, 3%, 95% CI 0.9-8.3). Major epidemic clones (USA300/USA300 Latin-American Variant, Bengal Bay, South Pacific) accounted for more than one-third (19/51, 37%) of CA-MRSA imports. CAMRSA SSTI in returneeswas complicated (31/51 multiple lesions, 61%; 22/50 recurrences, 44%), led to healthcare contact (22/51 surgical drainage, 43%; 7/50 hospitalization, 14%), was transmissible (13/47 reported similar SSTI in non-travelling contacts, 28%), and associated with S. aureus nasal colonization (28 of 51 CAMRSA cases, 55%; 24 of 28 colonized with identical spa-type in nose and lesion, 85%).
   Conclusions: Travel-associated CA-MRSA SSTI is a transmissible condition that leads to medical consultations and colonization of the infected host. (c) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
EM philipp.zanger@uni-heidelberg.de
RI Zanger, Philipp G/B-8033-2010; Gascon, Joaquim/M-3598-2015; Nurjadi,
   Dennis/J-5292-2014; Ramharter, Michael/C-5273-2013; Gabrysch,
   Sabine/A-3503-2013
OI Gascon, Joaquim/0000-0002-5045-1585; Nurjadi,
   Dennis/0000-0002-1278-5939; Ramharter, Michael/0000-0002-9259-1885;
   Zanger, Philipp/0000-0001-6193-1966; Lagler, Heimo/0000-0003-3240-7385;
   Kuenzli, Esther/0000-0003-0368-464X; Boutin,
   Sebastien/0000-0002-0499-2460; Gabrysch, Sabine/0000-0002-7081-0506
FU German Research Council (DFG)German Research Foundation (DFG) [NU
   403/1-1]; Agencia de Gestio d'Ajuts Universitaris i de RecercaAgencia de
   Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR) [2014SGR026];
   European Society of Clinical Microbiology and Infection
FX Part of this work was supported by the German Research Council (DFG
   grant no. NU 403/1-1 to DN, Heidelberg, Germany), and Agencia de Gestio
   d'Ajuts Universitaris i de Recerca, (grant no. 2014SGR026 to J.G.
   Barcelona, Spain). DN received a travel grant of the European Society of
   Clinical Microbiology and Infection to present parts of this study at
   27th ECCMID, 22-25 April 2017, Vienna.
CR Ali H, 2012, J HOSP INFECT, V80, P293, DOI 10.1016/j.jhin.2011.12.019
   Arias CA, 2017, ANTIMICROB AGENTS CH, P61
   Artzi O, 2015, J TRAVEL MED, V22, P21, DOI 10.1111/jtm.12151
   Baez M, 2017, INT J ANTIMICROB AG, V49, P259, DOI 10.1016/j.ijantimicag.2016.12.001
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Bartels MD, 2010, CLIN MICROBIOL INFEC, V16, P78, DOI 10.1111/j.1469-0691.2009.02829.x
   Baud O, 2014, EUR J CLIN MICROBIOL, V33, P1757, DOI 10.1007/s10096-014-2127-6
   Blomfeldt A, 2017, J HOSP INFECT, V95, P253, DOI 10.1016/j.jhin.2016.12.006
   Chung DR, 2015, INT J ANTIMICROB AG, V46, P338, DOI 10.1016/j.ijantimicag.2015.03.009
   Coombs GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043037
   Daum RS, 2017, NEW ENGL J MED, V376, P2545, DOI 10.1056/NEJMoa1607033
   DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1
   Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7
   Elston JWT, 2009, J INFECTION, V59, P149, DOI 10.1016/j.jinf.2009.07.001
   Ghaznavi-Rad E, 2010, J MED MICROBIOL, V59, P1135, DOI 10.1099/jmm.0.021956-0
   He WQ, 2013, DIAGN MICR INFEC DIS, V77, P267, DOI 10.1016/j.diagmicrobio.2013.07.001
   Ho WY, 2017, MICROB DRUG RESIST, V23, P215, DOI 10.1089/mdr.2015.0250
   Hogan B, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1733-6
   Huh K, 2016, EXPERT REV ANTI-INFE, V14, P1007, DOI 10.1080/14787210.2016.1236684
   Joshi NA, 2011, SICKLE SLIDING WINDO
   Kairet K, 2017, EUR J CLIN MICROBIOL, V36, P905, DOI 10.1007/s10096-016-2883-6
   Last JM, 2001, DICT EPIDEMIOLOGY
   Layer F, 2018, EPID B, V5, P57
   Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98
   Mendes RE, 2016, MICROB DRUG RESIST, V22, P53, DOI 10.1089/mdr.2014.0307
   Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0
   Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576
   Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x
   Nurjadi D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.01.016
   Nurjadi Dennis, 2017, N Engl J Med, V377, pe36, DOI 10.1056/NEJMc1711124
   Nurjadi D, 2017, INFECT CONT HOSP EP, V38, P883, DOI 10.1017/ice.2017.88
   Orendi JM, 2010, J HOSP INFECT, V75, P258, DOI 10.1016/j.jhin.2010.03.023
   Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421
   Planet PJ, 2015, J INFECT DIS, V212, P1874, DOI 10.1093/infdis/jiv320
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077
   Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Seidl K, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0075-3
   Stegger M, 2010, CLIN MICROBIOL INFEC, V16, P1018, DOI 10.1111/j.1469-0691.2009.03003.x
   Stenhem M, 2010, EMERG INFECT DIS, V16, P189, DOI 10.3201/eid1602.081655
   Sunagar R, 2016, J GLOB ANTIMICROB RE, V7, P46, DOI 10.1016/j.jgar.2016.07.008
   Talan DA, 2016, NEW ENGL J MED, V374, P823, DOI 10.1056/NEJMoa1507476
   Toleman MS, 2016, J INFECT DIS, V214, P447, DOI 10.1093/infdis/jiw166
   Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316
   Vandenesch F, 2003, EMERG INFECT DIS, V9, P978
   Zanger P, 2014, J TRAVEL MED, V21, P225, DOI 10.1111/jtm.12140
   Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822
   Zarfel G, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw137
   Zhang K, 2008, J CLIN MICROBIOL, V46, P1118, DOI 10.1128/JCM.01309-07
   Zhou YP, 2014, J TRAVEL MED, V21, P272, DOI 10.1111/jtm.12133
   2017, EUR J CLIN MICROBIOL, V36, P2495, DOI DOI 10.1007/S10096-017-3092-7
NR 51
TC 6
Z9 6
U1 5
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2019
VL 25
IS 6
BP 739
EP 746
DI 10.1016/j.cmi.2018.09.023
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HY4KU
UT WOS:000468097700017
PM 30315958
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Singh, NK
   Wood, JM
   Mhatre, SS
   Venkateswaran, K
AF Singh, Nitin Kumar
   Wood, Jason M.
   Mhatre, Snehit S.
   Venkateswaran, Kasthuri
TI Metagenome to phenome approach enables isolation and genomics
   characterization of Kalamiella piersonii gen. nov., sp. nov. from the
   International Space Station
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Kalamiella piersonii; Metagenome-resolved genomes; Genome-inferred
   phenotype; Phylogenomics; MLSA
ID FAMILY ENTEROBACTERIACEAE; IDENTIFICATION SYSTEM; PRIMARY ENDOSYMBIONTS;
   MASS-SPECTROMETRY; BACTERIA; PERSPECTIVES; VIABILITY; VERSATILE;
   TAXONOMY; PROPOSAL
AB Several evolutionarily distinct, near full-length draft metagenome-resolved genomes (MRG), were assembled from sequences recovered from the International Space Station (ISS) environments. The retrieval of MRGs facilitated the exploration of a large collection of archived strains (similar to 500 isolates) and assisted in isolating seven related strains. The whole genome sequences (WGS) of seven ISS strains exhibited 100% identity to the 4.85x10(6)bp of four MRGs. The metagenome to phenome approach led to the description of a novel bacterial genus from the ISS samples. The phylogenomics and traditional taxonomic approaches suggested that these seven ISS strains and four MRGs were not phylogenetically affiliated to any validly described genera of the family Erwiniaceae, but belong to a novel genus with the proposed name Kalamiella. Comparative genomic analyses of Kalamiella piersonii strains and MRGs showed genes associated with carbohydrate (348 genes), amino acid (384), RNA (59), and protein (214) metabolisms; membrane transport systems (108), pathways for biosynthesis of cofactors, vitamins, prosthetic groups, and pigments (179); as well as mechanisms for virulence, disease, and defense (50). Even though Kalamiella genome annotation and disc diffusion tests revealed multidrug resistance, the PathogenFinder algorithm predicted that K. piersonii strains are not human pathogens. This approach to isolating microbes allows for the characterization of functional pathways and their potential virulence properties that can directly affect human health. The isolation of novel strains from the ISS has broad applications in microbiology, not only because of concern for astronaut health but it might have a great potential for biotechnological relevance. The metagenome to phenome approach will help to improve our understanding of complex metabolic networks that control fundamental life processes under microgravity and in deep space.
C1 [Singh, Nitin Kumar; Wood, Jason M.; Mhatre, Snehit S.; Venkateswaran, Kasthuri] CALTECH, Jet Prop Lab, Biotechnol & Planetary Protect Grp, M-S 89-2,4800 Oak Grove Dr, Pasadena, CA 91109 USA.
RP Venkateswaran, K (reprint author), CALTECH, Jet Prop Lab, Biotechnol & Planetary Protect Grp, M-S 89-2,4800 Oak Grove Dr, Pasadena, CA 91109 USA.
EM nitin.k.singh@jpl.nasa.gov; jason.wood@jpl.nasa.gov;
   snehit.s.mhatre@jpl.nasa.gov; kjvenkat@jpl.nasa.gov
FU 2012 Space Biology [NNH12ZTT001N, 19-12829-26, NNN13D111T]
FX Part of the research described in this publication was carried out at
   the Jet Propulsion Laboratory, California Institute of Technology, under
   a contract with National Aeronautics and Space Administration. This
   research was funded by a 2012 Space Biology NNH12ZTT001N grant no.
   19-12829-26 under Task Order NNN13D111T award to KV, which also funded
   the post-doctoral fellowships for NKS, JMW and SSM.
CR Adeolu M, 2016, INT J SYST EVOL MICR, V66, P5575, DOI 10.1099/ijsem.0.001485
   AKSOY S, 1995, INT J SYST BACTERIOL, V45, P848, DOI 10.1099/00207713-45-4-848
   Andersen MH, 2019, SYST APPL MICROBIOL, V42, P77, DOI 10.1016/j.syapm.2018.08.001
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Barber MF, 2015, TRENDS GENET, V31, P627, DOI 10.1016/j.tig.2015.09.001
   Bargoma E, 2013, ASTROBIOLOGY, V13, P189, DOI 10.1089/ast.2012.0917
   Barnum TP, 2018, ISME J, V12, P1568, DOI 10.1038/s41396-018-0081-5
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonetta S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050467
   Bowers RM, 2017, NAT BIOTECHNOL, V35, P725, DOI 10.1038/nbt.3893
   Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Checinska A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0116-3
   Chen CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41564
   Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0
   Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302
   Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188
   Doijad S, 2016, INT J SYST EVOL MICR, V66, P968, DOI 10.1099/ijsem.0.000821
   Felsenstein J, 2004, PHYLIP PHYLOGENY INF, V5
   Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
   Gardan L, 2004, INT J SYST EVOL MICR, V54, P107, DOI 10.1099/ijs.0.02718-0
   Gerhardt P, 1981, J CLIN PATHOL, V34, P1069, DOI DOI 10.1136/jcp.34.9.1069-c
   Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0
   Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086
   Halpern M, 2013, INT J SYST EVOL MICR, V63, P268, DOI 10.1099/ijs.0.033654-0
   Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9
   HOLLIS DG, 1981, J CLIN MICROBIOL, V14, P79, DOI 10.1128/JCM.14.1.79-88.1981
   Leon MJ, 2014, APPL ENVIRON MICROB, V80, P3850, DOI 10.1128/AEM.00430-14
   Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165
   Kibbee RJ, 2017, J MICROBIOL METH, V132, P139, DOI 10.1016/j.mimet.2016.12.004
   Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0
   Krishnamurthi S, 2009, INT J SYST EVOL MICR, V59, P1054, DOI 10.1099/ijs.0.65742-0
   La Duc MT, 2004, J MICROBIOL METH, V56, P383, DOI 10.1016/j.mimet.2003.11.004
   Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11
   Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60
   Mergaert J, 1999, INT J SYST BACTERIOL, V49, P377, DOI 10.1099/00207713-49-2-377
   Muller KD, 1998, J CLIN MICROBIOL, V36, P2477
   MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566, DOI 10.1099/00207713-41-4-566
   NIES DH, 1992, PLASMID, V27, P17, DOI 10.1016/0147-619X(92)90003-S
   Norgan AP, 2016, ANTIMICROB AGENTS CH, V60, P3141, DOI 10.1128/AAC.03055-15
   Nurk Sergey, 2013, Research in Computational Molecular Biology. 17th Annual International Conference (RECOMB 2013). Proceedings, P158, DOI 10.1007/978-3-642-37195-0_13
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Palmer M, 2018, INT J SYST EVOL MICR, V68, P1396, DOI 10.1099/ijsem.0.002540
   Pandey KK, 2002, INT J SYST EVOL MICR, V52, P1559, DOI [10.1099/ijs.0.01943-0, 10.1099/00207713-52-5-1559]
   Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Rezzonico F, 2016, INT J SYST EVOL MICR, V66, P1583, DOI 10.1099/ijsem.0.000920
   Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413
   Sangwan N, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0154-5
   Schumann P, 2014, METHOD MICROBIOL, V41, P275, DOI 10.1016/bs.mim.2014.06.002
   Seuylemezian A, 2017, MICROBIOL RESOUR ANN, V5, DOI 10.1128/genomeA.00696-17
   Seuylemezian A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00780
   Sielaff AC, 2017, INT J SYST EVOL MICR, V67, P896, DOI 10.1099/ijsem.0.001706
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Singh NK, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1325-2
   Singh NK, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0609-y
   Singh NK, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00553-16
   Skerman VBD, 1967, GUIDE IDENTIFICATION
   Stackebrandt E., 2006, MICROBIOLOGY TODAY, V33, P152, DOI DOI 10.1038/MSB.2013.22
   STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541
   Stewart RD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03317-6
   Suzuki MT, 2001, ENVIRON MICROBIOL, V3, P323, DOI 10.1046/j.1462-2920.2001.00198.x
   Tracz DM, 2015, INT J SYST EVOL MICR, V65, P1959, DOI 10.1099/ijs.0.000207
   Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059
   Urbaniak C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18506-4
   Uritskiy GV, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0541-1
   Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114
   Venkateswaran K, 2017, 47 INT C ENV SYST CH
   Vesper S, 2008, J MICROBIOL METH, V72, P180, DOI 10.1016/j.mimet.2007.11.017
   Walterson AM, 2015, FEMS MICROBIOL REV, V39, P968, DOI 10.1093/femsre/fuv027
   Weinmaier T, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0129-y
   Wragg P, 2014, J MICROBIOL METH, V105, P16, DOI 10.1016/j.mimet.2014.07.003
   Xu P, 1955, INT J SYST EVOL MI 3, V55, P1149
NR 75
TC 1
Z9 1
U1 3
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUN
PY 2019
VL 103
IS 11
BP 4483
EP 4497
DI 10.1007/s00253-019-09813-z
PG 15
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA HX2GE
UT WOS:000467209500018
PM 31011775
DA 2020-05-07
ER

PT J
AU Clark, CM
   Costa, MS
   Conley, E
   Li, E
   Sanchez, LM
   Murphy, BT
AF Clark, Chase M.
   Costa, Maria S.
   Conley, Erin
   Li, Emma
   Sanchez, Laura M.
   Murphy, Brian T.
TI Using the Open-Source MALDI TOF-MS IDBac Pipeline for Analysis of
   Microbial Protein and Specialized Metabolite Data
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Biochemistry; Issue 147; Mass spectrometry; microbiology; natural
   products; specialized metabolites; MALDI-TOF MS; bioinformatics
ID MASS-SPECTROMETRY; IDENTIFICATION; BACTERIA; CLASSIFICATION
AB In order to visualize the relationship between bacterial phylogeny and specialized metabolite production of bacterial colonies growing on nutrient agar, we developed IDBac-a low-cost and high-throughput matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) bioinformatics pipeline. IDBac software is designed for non-experts, is freely available, and capable of analyzing a few to thousands of bacterial colonies. Here, we present procedures for the preparation of bacterial colonies for MALDI-TOF MS analysis, MS instrument operation, and data processing and visualization in IDBac. In particular, we instruct users how to cluster bacteria into dendrograms based on protein MS fingerprints and interactively create Metabolite Association Networks (MANs) from specialized metabolite data.
C1 [Clark, Chase M.; Costa, Maria S.; Conley, Erin; Li, Emma; Sanchez, Laura M.; Murphy, Brian T.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60680 USA.
   [Costa, Maria S.] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland.
RP Murphy, BT (reprint author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60680 USA.
EM btmurphy@uic.edu
OI Costa, Maria Sofia/0000-0002-1830-9925; Sanchez,
   Laura/0000-0001-9223-7977
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01 GM125943];
   National Geographic GrantNational Geographic Society [CP-044R-17];
   Icelandic Research Fund [152336-051]; University of Illinois at Chicago
   startup funds
FX This work was supported by National Institute of General Medical
   Sciences Grant R01 GM125943, National Geographic Grant CP-044R-17;
   Icelandic Research Fund Grant 152336-051; and University of Illinois at
   Chicago startup funds. Also, we thank the following contributors: Dr.
   Amanda Bulman for assistance with MALDI-TOF MS protein acquisition
   parameters; Dr. Terry Moore and Dr. Atul Jain for recrystallizing
   alpha-cyano-4-hydroxycinnamic acid matrix (CHCA).
CR CAIN TC, 1994, RAPID COMMUN MASS SP, V8, P1026, DOI 10.1002/rcm.1290081224
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   Clark CM, 2018, P NATL ACAD SCI USA, V115, P4981, DOI 10.1073/pnas.1801247115
   Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37
   Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6
   Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323
   Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133
   Rahi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01359
   Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359
   Schulthess B, 2014, J CLIN MICROBIOL, V52, P1089, DOI 10.1128/JCM.02399-13
   Schumann P, 2014, METHOD MICROBIOL, V41, P275, DOI 10.1016/bs.mim.2014.06.002
   Silva R, 2016, PLANTA MED, V82, P671, DOI 10.1055/s-0042-104800
NR 12
TC 1
Z9 1
U1 1
U2 6
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2019
IS 147
AR e59219
DI 10.3791/59219
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IB0US
UT WOS:000469977600035
PM 31157770
OA Bronze
DA 2020-05-07
ER

PT J
AU Bagcioglu, M
   Fricker, M
   Johler, S
   Ehling-Schulz, M
AF Bagcioglu, Murat
   Fricker, Martina
   Johler, Sophia
   Ehling-Schulz, Monika
TI Detection and Identification of Bacillus cereus, Bacillus cytotoxicus,
   Bacillus thuringiensis, Bacillus mycoides and Bacillus
   weihenstephanensis via Machine Learning Based FTIR Spectroscopy
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Bacillus cereus; FTIR spectroscopy; machine learning; artificial neural
   networks; diagnostics
ID RAPID IDENTIFICATION; STRAINS; DIVERSITY; BACTERIA; DIFFERENTIATION;
   DISCRIMINATION; OUTBREAKS; ANTHRACIS; FOODS
AB The Bacillus cereus group comprises genetical closely related species with variable toxigenic characteristics. However, detection and differentiation of the B. cereus group species in routine diagnostics can be difficult, expensive and laborious since current species designation is linked to specific phenotypic characteristic or the presence of species-specific genes. Especially the differentiation of Bacillus cereus and Bacillus thuringiensis, the identification of psychrotolerant Bacillus mycoides and Bacillus weihenstephanensis, as well as the identification of emetic B. cereus and Bacillus cytotoxicus, which are both producing highly potent toxins, is of high importance in food microbiology. Thus, we investigated the use of a machine learning approach, based on artificial neural network (ANN) assisted Fourier transform infrared (FTIR) spectroscopy, for discrimination of B. cereus group members. The deep learning tool box of Matlab was employed to construct a one-level ANN, allowing the discrimination of the aforementioned B. cereus group members. This model resulted in 100% correct identification for the training set and 99.5% correct identification overall. The established ANN was applied to investigate the composition of B. cereus group members in soil, as a natural habitat of B. cereus, and in food samples originating from foodborne outbreaks. These analyses revealed a high complexity of B. cereus group populations, not only in soil samples but also in the samples from the foodborne outbreaks, highlighting the importance of taking multiple isolates from samples implicated in food poisonings. Notable, in contrast to the soil samples, no bacteria belonging to the psychrotolerant B. cereus group members were detected in the food samples linked to foodborne outbreaks, while the overall abundancy of B. thuringiensis did not significantly differ between the sample categories. None of the isolates was classified as B. cytotoxicus, fostering the hypothesis that the latter species is linked to very specific ecological niches. Overall, our work shows that machine learning assisted (FTIR) spectroscopy is suitable for identification of B. cereus group members in routine diagnostics and outbreak investigations. In addition, it is a promising tool to explore the natural habitats of B. cereus group, such as soil.
C1 [Bagcioglu, Murat; Fricker, Martina; Ehling-Schulz, Monika] Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Funct Microbiol, Vienna, Austria.
   [Bagcioglu, Murat; Johler, Sophia] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland.
   [Fricker, Martina] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany.
RP Ehling-Schulz, M (reprint author), Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Funct Microbiol, Vienna, Austria.
EM Monika.Ehling-Schulz@vetmeduni.ac.at
RI Bagcioglu, Murat/N-7791-2019
OI Bagcioglu, Murat/0000-0003-0575-9246; Ehling-Schulz,
   Monika/0000-0001-7384-0594
FU Bavarian Ministry for Agriculture and Forestry [AZ M2-7606.2-256]
FX This work has been partially supported by funds from the Bavarian
   Ministry for Agriculture and Forestry (AZ M2-7606.2-256).
CR Altayar M, 2006, J APPL MICROBIOL, V100, P7, DOI 10.1111/j.1365-2672.2005.02764.x
   Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x
   Bauer T, 2010, J AGR FOOD CHEM, V58, P1420, DOI 10.1021/jf9033046
   Beattie SH, 1998, FEMS MICROBIOL LETT, V164, P201, DOI 10.1111/j.1574-6968.1998.tb13086.x
   Bosch A, 2008, J CLIN MICROBIOL, V46, P2535, DOI 10.1128/JCM.02267-07
   BOURQUE SN, 1993, APPL ENVIRON MICROB, V59, P523, DOI 10.1128/AEM.59.2.523-527.1993
   Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006
   Carlin F, 2006, INT J FOOD MICROBIOL, V109, P132, DOI 10.1016/j.ijfoodmicro.2006.01.022
   CARLSON CR, 1994, APPL ENVIRON MICROB, V60, P1719, DOI 10.1128/AEM.60.6.1719-1725.1994
   Carroll LM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00144
   Contzen M, 2014, INT J FOOD MICROBIOL, V174, P19, DOI 10.1016/j.ijfoodmicro.2013.12.024
   Demsar J, 2013, J MACH LEARN RES, V14, P2349
   Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0
   Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055
   Ehling-Schulz M, 2004, FEMS MICROBIOL LETT, V232, P189, DOI 10.1016/S0378-1097(04)00066-7
   Ehling-Schulz M, 2011, BACILLUS CEREUS GENO, P147
   Ehling-Schulz M, 2019, MICROBIOL SPECTR, V7, DOI [10.1128/microbiolspec.gpp3-0032-2018, 10.1128/microbiolspec.GPP3-0032-2018]
   Ehling-Schulz M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00704
   Francis KP, 1998, APPL ENVIRON MICROB, V64, P3525
   Frederiksen K, 2006, APPL ENVIRON MICROB, V72, P3435, DOI 10.1128/AEM.72.5.3435-3440.2006
   Fricker M, 2007, THESIS
   Fricker M, 2007, APPL ENVIRON MICROB, V73, P1892, DOI 10.1128/AEM.02219-06
   Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025
   Grunert T, 2013, J CLIN MICROBIOL, V51, P2261, DOI 10.1128/JCM.00581-13
   Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x
   Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0
   Hagan M. T., 1996, NEURAL NETWORK DESIG
   HAUGE S, 1955, J APPL BACTERIOL, V18, P591, DOI DOI 10.1111/J.1365-2672.1955.TB02116.X
   Heini N, 2018, INT J FOOD MICROBIOL, V283, P59, DOI 10.1016/j.ijfoodmicro.2018.06.019
   Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   Hendriksen NB, 2006, FEMS MICROBIOL LETT, V257, P106, DOI 10.1111/j.1574-6968.2006.00159.x
   Hendriksen NB, 2006, ANTON LEEUW INT J G, V89, P239, DOI 10.1007/s10482-005-9025-y
   HOLMES JR, 1981, ARCH INTERN MED, V141, P766, DOI 10.1001/archinte.141.6.766
   JACKSON SG, 1995, LETT APPL MICROBIOL, V21, P103, DOI 10.1111/j.1472-765X.1995.tb01017.x
   Johler S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01915
   Johler S, 2016, SYST APPL MICROBIOL, V39, P189, DOI 10.1016/j.syapm.2016.03.003
   Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255
   KRONSTAD JW, 1983, J BACTERIOL, V154, P419, DOI 10.1128/JB.154.1.419-428.1983
   Lasch P, 2018, ANAL CHEM, V90, P8896, DOI 10.1021/acs.analchem.8b01024
   Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373
   Liu Y, 2017, INT J SYST EVOL MICR, V67, P2499, DOI 10.1099/ijsem.0.001821
   Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x
   Maquelin K, 2002, HDB VIBRATIONAL SPEC, P1
   McIntyre L, 2008, APPL ENVIRON MICROB, V74, P7451, DOI 10.1128/AEM.01284-08
   Mecklin CJ, 2004, INT STAT REV, V72, P123
   Naumann D., 1991, MODERN TECHNIQUES RA, P43
   Pirhonen TI, 2005, FOOD MICROBIOL, V22, P87, DOI 10.1016/j.fm.2004.04.002
   Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004
   Pruss BM, 1999, APPL ENVIRON MICROB, V65, P5436
   Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005
   Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006
   Rebuffo-Scheer CA, 2007, J MICROBIOL METH, V68, P282, DOI 10.1016/j.mimet.2006.08.011
   Schabauer L, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-156
   Schmid D, 2016, INT J FOOD MICROBIOL, V232, P80, DOI 10.1016/j.ijfoodmicro.2016.05.011
   Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998
   von Stetten F, 1999, ENVIRON MICROBIOL, V1, P503, DOI 10.1046/j.1462-2920.1999.00070.x
   Wagener K, 2014, VET J, V202, P527, DOI 10.1016/j.tvjl.2014.08.023
   Wenning M, 2008, VIBRATIONAL SPECTROS
   Zheng JS, 2017, MBIO, V8, DOI 10.1128/mBio.00822-17
   2011, EUROSURVEILLANCE, V16, P11
   FEMS MICROBIOL LETT, V190, P151, DOI DOI 10.1111/J.1574-6968.2000.TB09278.X
NR 62
TC 2
Z9 2
U1 6
U2 18
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 26
PY 2019
VL 10
AR 902
DI 10.3389/fmicb.2019.00902
PG 10
WC Microbiology
SC Microbiology
GA HV3AY
UT WOS:000465862700001
PM 31105681
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Robinson-Garcia, N
   Arroyo-Machado, W
   Torres-Salinas, D
AF Robinson-Garcia, Nicolas
   Arroyo-Machado, Wenceslao
   Torres-Salinas, Daniel
TI Mapping social media attention in Microbiology: identifying main topics
   and actors
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Article
DE altmetrics; science mapping; Twitter; news media; policy documents;
   microbiology
ID ALTMETRICS; IMPACT
AB This paper aims to map and identify topics of interest within the field of Microbiology and identify the main sources driving such attention. We combine data from Web of Science and Altmetric.com, a platform which retrieves mentions to scientific literature from social media and other non-academic communication outlets. We focus on the dissemination of microbial publications in Twitter, news media and policy briefs. A two-mode network of social accounts shows distinctive areas of activity. We identify a cluster of papers mentioned solely by regional news media. A central area of the network is formed by papers discussed by the three outlets. A large portion of the network is driven by Twitter activity. When analyzing top actors contributing to such network, we observe that more than half of the Twitter accounts are bots, mentioning 32% of the documents in our dataset. Within news media outlets, there is a predominance of popular science outlets. With regard to policy briefs, both international and national bodies are represented. Finally, our topic analysis shows that the thematic focus of papers mentioned varies by outlet. While news media cover the wider range of topics, policy briefs are focused on translational medicine and bacterial outbreaks.
C1 [Robinson-Garcia, Nicolas] Univ Politecn Valencia, CSIC, INGENIO, Carni de Vera S-N, E-46022 Valencia, Spain.
   [Robinson-Garcia, Nicolas] Georgia Inst Technol, Sch Publ Policy, 685 Cherry St, Atlanta, GA 30332 USA.
   [Arroyo-Machado, Wenceslao; Torres-Salinas, Daniel] Univ Granada, Vicerrectorado Invest & Transferencia, Gran Via 48, E-18071 Granada, Spain.
   [Torres-Salinas, Daniel] Univ Granada, EC3metr Spin Off, Gran Via 48, E-18071 Granada, Spain.
RP Robinson-Garcia, N (reprint author), Univ Politecn Valencia, CSIC, INGENIO, Carni de Vera S-N, E-46022 Valencia, Spain.
EM elrobinster@gmail.com
RI Arroyo-Machado, Wenceslao/AAB-5998-2019; Robinson-Garcia,
   Nicolas/B-3590-2012
OI Arroyo-Machado, Wenceslao/0000-0001-9437-8757; Robinson-Garcia,
   Nicolas/0000-0002-0585-7359
FU Juan de la Cierva-Incorporacion grant from the Spanish Ministry of
   Science, Innovation and Universities
FX Nicolas Robinson-Garcia is currently supported by a Juan de la
   Cierva-Incorporacion grant from the Spanish Ministry of Science,
   Innovation and Universities.
CR Alperin J. P., 2013, B AM SOC INFORM SCI, V39, P18, DOI DOI 10.1002/BULT.2013.1720390407
   Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005
   Brandt C, 2014, INT J ANTIMICROB AG, V44, P424, DOI 10.1016/j.ijantimicag.2014.08.001
   Cassi L, 2017, J INFORMETR, V11, P1095, DOI 10.1016/j.joi.2017.09.010
   Cobo MJ, 2011, J AM SOC INF SCI TEC, V62, P1382, DOI 10.1002/asi.21525
   Didegah F, 2018, J ASSOC INF SCI TECH, V69, P959, DOI 10.1002/asi.24028
   Haustein S, 2016, J ASSOC INF SCI TECH, V67, P232, DOI 10.1002/asi.23456
   Klavans R, 2014, J INFORMETR, V8, P431, DOI 10.1016/j.joi.2014.02.002
   Nai C, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx162
   Noyons E, 2018, STI 2018 C P, P1049
   Priem J, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P263
   Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368
   Redfern J, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny061
   Robinson-Garcia N, 2018, SCI PUBL POLICY, V45, P815, DOI 10.1093/scipol/scy024
   Robinson-Garcia N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183551
   Robinson-Garcia N, 2014, PROF INFORM, V23, P359, DOI 10.3145/epi.2014.jul.03
   Rotolo D, SSRN, DOI [10.2139/ssrn.2742125, DOI 10.2139/SSRN.2742125]
   Sugimoto CR, 2017, J ASSOC INF SCI TECH, V68, P2037, DOI 10.1002/asi.23833
   Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841
   Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a
   Vergidis PI, 2005, EUR J CLIN MICROBIOL, V24, P342, DOI 10.1007/s10096-005-1306-x
   Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0
   Wouters P., 2018, HDB QUANTITATIVE SCI
NR 23
TC 3
Z9 3
U1 2
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD APR
PY 2019
VL 366
IS 7
AR fnz075
DI 10.1093/femsle/fnz075
PG 7
WC Microbiology
SC Microbiology
GA IA7VE
UT WOS:000469764900006
PM 30977791
DA 2020-05-07
ER

PT J
AU Wang, X
   Xia, K
   Yang, XJ
   Tang, C
AF Wang, Xin
   Xia, Kang
   Yang, Xiaojing
   Tang, Chao
TI Growth strategy of microbes on mixed carbon sources
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PHOSPHOTRANSFERASE SYSTEM; METABOLITE CONCENTRATIONS; CATABOLITE
   REPRESSION; FLUX; INFORMATION; MECHANISMS; OPTIMALITY
AB A classic problem in microbiology is that bacteria display two types of growth behavior when cultured on a mixture of two carbon sources: the two sources are sequentially consumed one after another (diauxie) or they are simultaneously consumed (co-utilization). The search for the molecular mechanism of diauxie led to the discovery of the lac operon. However, questions remain as why microbes would bother to have different strategies of taking up nutrients. Here we show that diauxie versus co-utilization can be understood from the topological features of the metabolic network. A model of optimal allocation of protein resources quantitatively explains why and how the cell makes the choice. In case of coutilization, the model predicts the percentage of each carbon source in supplying the amino acid pools, which is quantitatively verified by experiments. Our work solves a long-standing puzzle and provides a quantitative framework for the carbon source utilization of microbes.
C1 [Wang, Xin; Xia, Kang; Yang, Xiaojing; Tang, Chao] Peking Univ, Ctr Quantitat Biol, Sch Phys, Beijing 100871, Peoples R China.
   [Wang, Xin; Xia, Kang; Yang, Xiaojing; Tang, Chao] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.
   [Wang, Xin] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Wang, Xin] Harvard Med Sch, Boston, MA 02115 USA.
   [Xia, Kang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
RP Tang, C (reprint author), Peking Univ, Ctr Quantitat Biol, Sch Phys, Beijing 100871, Peoples R China.; Tang, C (reprint author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.
EM tangc@pku.edu.cn
OI Xia, Kang/0000-0002-5942-5594; Tang, Chao/0000-0003-1474-3705; Wang,
   Xin/0000-0001-6479-395X
FU Chinese Ministry of Science and TechnologyMinistry of Science and
   Technology, China [2015CB910300]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [91430217]
FX We thank Yiping Wang for providing us the strain NCM3722, and Terence
   Hwa, Yuan Yuan, Haoyuan Sun, Xiaohui Liu, Yanjun Li, Shaoqi Zhu, and
   Yimiao Qu for helpful discussions. This work was supported by Chinese
   Ministry of Science and Technology (2015CB910300) and National Natural
   Science Foundation of China (91430217).
CR Aidelberg G, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0133-z
   Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186
   Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161
   Dauner M, 2000, BIOTECHNOL PROGR, V16, P642, DOI 10.1021/bp000058h
   de Jong IG, 2011, BIOESSAYS, V33, P215, DOI 10.1002/bies.201000127
   Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842
   Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007
   Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06
   Duclaux E., 1899, TRAITE MICROBIOLOGIE
   Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379
   Escalante-Chong R, 2015, P NATL ACAD SCI USA, V112, P1636, DOI 10.1073/pnas.1418058112
   Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998
   Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932
   Hermsen R, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145537
   Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697
   JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747
   KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533
   Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383
   Lambert G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004556
   LEHNINGER A, 2008, LEHNINGER PRINCIPLES
   Li SHJ, 2018, NAT MICROBIOL, V3, P939, DOI 10.1038/s41564-018-0199-2
   Liu XL, 2015, ELIFE, V4, DOI 10.7554/eLife.03977
   MAGASANIK B, 1961, COLD SPRING HARB SYM, V26, P249, DOI 10.1101/SQB.1961.026.01.031
   Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112
   MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103
   MONOD J, 1947, GROWTH, V11, P223
   Monod J., 1942, THESIS
   Muller S, 2014, J THEOR BIOL, V347, P182, DOI 10.1016/j.jtbi.2013.11.015
   Muller-Hill B, 1996, THE LAC OPERON
   Narang A, 2007, J THEOR BIOL, V244, P326, DOI 10.1016/j.jtbi.2006.08.007
   NEIDHARDT FC, 1956, NATURE, V178, P801, DOI 10.1038/178801b0
   NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL
   New AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001764
   Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]
   Peyraud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048271
   Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106
   POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993
   Schonheit P, 2016, TRENDS MICROBIOL, V24, P12, DOI 10.1016/j.tim.2015.10.003
   Schuster S., 1994, J BIOL SYST, V2, P165, DOI DOI 10.1142/S0218339094000131
   Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379
   Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588
   Siegal ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002068
   Solopova A, 2014, P NATL ACAD SCI USA, V111, P7427, DOI 10.1073/pnas.1320063111
   Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2
   Towbin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14123
   Venturelli OS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002042
   Wang J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002041
   Wortel MT, 2014, FEBS J, V281, P1547, DOI 10.1111/febs.12722
   You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446
   Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58
NR 51
TC 3
Z9 5
U1 6
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 20
PY 2019
VL 10
AR 1279
DI 10.1038/s41467-019-09261-3
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP5XV
UT WOS:000461757800002
PM 30894528
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Tierrafria, VH
   Mejia-Almonte, C
   Camacho-Zaragoza, JM
   Salgado, H
   Alquicira, K
   Ishida, C
   Gama-Castro, S
   Collado-Vides, J
AF Tierrafria, V. H.
   Mejia-Almonte, C.
   Camacho-Zaragoza, J. M.
   Salgado, H.
   Alquicira, K.
   Ishida, C.
   Gama-Castro, S.
   Collado-Vides, J.
TI MCO: towards an ontology and unified vocabulary for a framework-based
   annotation of microbial growth conditions
SO BIOINFORMATICS
LA English
DT Article
ID ESCHERICHIA-COLI; MINIMUM INFORMATION; GENE; EXPRESSION; STRESS
AB Motivation A major component in increasing our understanding of the biology of an organism is the mapping of its genotypic potential into its phenotypic expression profiles. This mapping is executed by the machinery of gene regulation, which is essentially studied by changes in growth conditions. Although many efforts have been made to systematize the annotation of experimental conditions in microbiology, the available annotations are not based on a consistent and controlled vocabulary, making difficult the identification of biologically meaningful comparisons of knowledge derived from different experiments or laboratories.
   Results We curated terms related to experimental conditions that affect gene expression in Escherichia coli K-12. Since this is the best-studied microorganism, the collected terms are the seed for the Microbial Conditions Ontology (MCO), a controlled and structured vocabulary that can be expanded to annotate microbial conditions in general. Moreover, we developed an annotation framework to describe experimental conditions, providing the foundation to identify regulatory networks that operate under particular conditions.
C1 [Tierrafria, V. H.; Mejia-Almonte, C.; Camacho-Zaragoza, J. M.; Salgado, H.; Alquicira, K.; Ishida, C.; Gama-Castro, S.; Collado-Vides, J.] Univ Nacl Autonoma Mexico, Programa Genom Computac, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico.
   [Collado-Vides, J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Gama-Castro, S; Collado-Vides, J (reprint author), Univ Nacl Autonoma Mexico, Programa Genom Computac, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico.; Collado-Vides, J (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM sgama@ccg.unam.mx; collado@ccg.unam.mx
RI Tierrafria, Victor H./AAG-3662-2020
OI Collado-Vides, Julio/0000-0001-8780-7664; Mejia-Almonte,
   Citlalli/0000-0002-0142-5591
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [5R01GM110597-03]; FOINS CONACyT Fronteras de la Ciencia [15];
   CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [576333]
FX This work was supported by the National Institute of Health (NIH) [grant
   number 5R01GM110597-03] and FOINS CONACyT Fronteras de la Ciencia
   [project 15]. C.M.A. received fellowship 576333 from CONACyT.
CR [Anonymous], 2017, NAT GENET, V49, P971, DOI 10.1038/ng.3910
   Bandrowski A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154556
   Blank CE, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0060-6
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Courtot M, 2011, APPL ONTOL, V6, P23, DOI 10.3233/AO-2011-0087
   Fuentes AM, 2001, FEMS MICROBIOL LETT, V201, P271, DOI 10.1016/S0378-1097(01)00283-X
   Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156
   Gkoutos GV, 2009, IEEE ENG MED BIO, P7069, DOI 10.1109/IEMBS.2009.5333362
   Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968
   Grenon P, 2004, STUD HEALTH TECHNOL, V102, P20
   Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146
   Huwiler SG, 2012, BIOELECTROMAGNETICS, V33, P488, DOI 10.1002/bem.21709
   Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999
   Kieser T., 2000, MEDIA BUFFERS SUPPLI
   Lamy JB, 2017, ARTIF INTELL MED, V80, P11, DOI 10.1016/j.artmed.2017.07.002
   Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x
   LOMOVSKAYA OL, 1994, J BACTERIOL, V176, P3928, DOI 10.1128/JB.176.13.3928-3935.1994
   Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996
   MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103
   Moretto M, 2016, NUCLEIC ACIDS RES, V44, pD620, DOI 10.1093/nar/gkv1251
   Musen M. A., 1994, P ANN S COMP APPL ME, V1065
   MUSEN MA, 2015, AI MATTERS, V1, P4, DOI DOI 10.1145/2757001.2757003
   Neidhardt F. C, 1996, ESCHERICHIA COLI SAL
   NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL
   Neidhardt FC, 2006, NAT REV MICROBIOL, V4, P876, DOI 10.1038/nrmicro1554
   Noy N.F., 2001, ONTOLOGY DEV
   Ong E, 2017, NUCLEIC ACIDS RES, V45, pD347, DOI 10.1093/nar/gkw918
   Overton J. A., 2015, INT C BIOM ONT LISB
   Richards MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103548
   Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201
   Santos-Zavaleta A, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0555-y
   Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346
   Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09
   Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18
   Zhang YQ, 2017, GENOM PROTEOM BIOINF, V15, P324, DOI 10.1016/j.gpb.2017.04.005
NR 35
TC 1
Z9 1
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD MAR 1
PY 2019
VL 35
IS 5
BP 856
EP 864
DI 10.1093/bioinformatics/bty689
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA HX2MY
UT WOS:000467227300017
PM 30137210
DA 2020-05-07
ER

PT J
AU Rabinowicz, S
   O'Hare, M
   Moore, LSP
   Mughal, N
AF Rabinowicz, Simon
   O'Hare, Matthew
   Moore, Luke S. P.
   Mughal, Nabeela
TI Xpert MRSA screening in surgical patient flow; time for a rethink for
   hub-and-spoke laboratory models?
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE molecular diagnostics; laboratory centralisation; infection prevention
   and control; meticillin resistant Staphylococcus aureus
AB The move towards pathology networks and hub-and-spoke models of medical laboratory service provision has significantly changed the flow of samples, and the impact of results on patients, over recent years. At the same time advances in technology, including rapid, simple to use molecular platforms, are changing the way microbiology results can be utilized. Like many other medical microbiology laboratories, we struggle with this balance for many different sample types and test requests. Work published by Neilson et al. in Journal of Medical Microbiology last year looked at this balance for methicillin-resistant Staphylococcus aureus (MRSA) genotypic diagnostics and suggested significant cost savings when a whole-healthcare economy perspective was adopted. However, as with all changes, implementing MRSA molecular diagnostics in different clinical settings must be considered carefully. We add to this discussion in our accompanying letter, detailing our experience (in a hub-and-spoke medical microbiology laboratory setting) of 'rapid' MRSA molecular diagnostics for day-case surgery where pre-operative assessment had been missed, exploring the impact and costs of these tests. We find no impact on patient care, but at considerable additional cost. We hope this will add a cautionary note to those considering implementing molecular microbiology diagnostics, and reopen the debate on where, in hub-and-spoke laboratory models, such devices should be situated.
C1 [Rabinowicz, Simon; O'Hare, Matthew; Moore, Luke S. P.; Mughal, Nabeela] Imperial Coll London, London SW7 2AZ, England.
   [Moore, Luke S. P.; Mughal, Nabeela] Chelsea & Westminster NHS Fdn Trust, 369 Fulham Rd, London SW10 9NH, England.
   [Moore, Luke S. P.; Mughal, Nabeela] Imperial Coll Healthcare NHS Trust, North West London Pathol, Fulham Palace Rd, London W6 8RF, England.
RP Mughal, N (reprint author), Imperial Coll London, London SW7 2AZ, England.; Mughal, N (reprint author), Chelsea & Westminster NHS Fdn Trust, 369 Fulham Rd, London SW10 9NH, England.; Mughal, N (reprint author), Imperial Coll Healthcare NHS Trust, North West London Pathol, Fulham Palace Rd, London W6 8RF, England.
EM nabeela.mughal@nhs.net
RI Moore, Luke/O-2540-2019
OI Moore, Luke/0000-0001-7095-7922; Rabinowicz, Simon/0000-0002-3593-3770
CR Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305
   Jenks PJ, 2014, J HOSP INFECT, V86, P24, DOI 10.1016/j.jhin.2013.09.012
   National Institute for Health and Care Excellence, 2013, NICE SUPP COMM SURG, V49
   Nielsen XC, 2017, J MED MICROBIOL, V66, P90, DOI 10.1099/jmm.0.000411
NR 4
TC 0
Z9 0
U1 0
U2 2
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD MAR
PY 2019
VL 68
IS 3
BP 290
EP 291
DI 10.1099/jmm.0.000919
PG 2
WC Microbiology
SC Microbiology
GA HQ3XF
UT WOS:000462343100002
PM 30628880
OA Bronze
DA 2020-05-07
ER

PT J
AU Sloan, TJ
   Turton, JC
   Tyson, J
   Musgrove, A
   Fleming, VM
   Lister, MM
   Loose, MW
   Sockett, RE
   Diggle, M
   Game, FL
   Jeffcoate, W
AF Sloan, Tim J.
   Turton, James C.
   Tyson, Jess
   Musgrove, Alison
   Fleming, Vicki M.
   Lister, Michelle M.
   Loose, Matthew W.
   Sockett, R. Elizabeth
   Diggle, Mathew
   Game, Frances L.
   Jeffcoate, William
TI Examining diabetic heel ulcers through an ecological lens: microbial
   community dynamics associated with healing and infection
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE diabetic foot ulcers; chronic wounds; microbiome; wound healing;
   polymicrobial interactions
ID CHRONIC WOUND MICROBIOTA; CLASSIFICATION; MANAGEMENT; DISEASE
AB Purpose. While some micro-organisms, such as Staphylococcus aureus, are clearly implicated in causing tissue damage in diabetic foot ulcers (DFUs), our knowledge of the contribution of the entire microbiome to clinical outcomes is limited. We profiled the microbiome of a longitudinal sample series of 28 people with diabetes and DFUs of the heel in an attempt to better characterize the relationship between healing, infection and the microbiome.
   Methodology. In total, 237 samples were analysed from 28 DFUs, collected at fortnightly intervals for 6 months or until healing. Microbiome profiles were generated by 16S rRNA gene sequence analysis, supplemented by targeted nanopore sequencing.
   Result/Key findings. DFUs which failed to heal during the study period (20/28, 71.4%) were more likely to be persistently colonized with a heterogeneous community of micro-organisms including anaerobes and Enterobacteriaceae (log-likelihood ratio 9.56, P=0.008). During clinically apparent infection, a reduction in the diversity of micro-organisms in a DFU was often observed due to expansion of one or two taxa, with recovery in diversity at resolution. Modelling of the predicted species interactions in a single DFU with high diversity indicated that networks of metabolic interactions may exist that contribute to the formation of stable communities.
   Conclusion. Longitudinal profiling is an essential tool for improving our understanding of the microbiology of chronic wounds, as community dynamics associated with clinical events can only be identified by examining changes over multiple time points. The development of complex communities, particularly involving Enterobacteriaceae and strict anaerobes, may be contributing to poor outcomes in DFUs and requires further investigation.
C1 [Sloan, Tim J.; Turton, James C.; Tyson, Jess; Loose, Matthew W.; Sockett, R. Elizabeth] Univ Nottingham, Sch Life Sci, Nottingham, England.
   [Sloan, Tim J.; Turton, James C.; Fleming, Vicki M.; Lister, Michelle M.; Diggle, Mathew] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Clin Microbiol, Nottingham, England.
   [Sloan, Tim J.] Northern Lincolnshire & Goole NHS Fdn Trust, Path Links Pathol, Scunthorpe, Lincs, England.
   [Musgrove, Alison; Game, Frances L.; Jeffcoate, William] Nottingham Univ Hosp NHS Trust, Dept Diabet & Endocrinol, Foot Ulcer Trials Unit, Nottingham, England.
   [Game, Frances L.] Derby Teaching Hosp NHS Fdn Trust, Dept Diabet & Endocrinol, Derby, England.
RP Sloan, TJ (reprint author), Univ Nottingham, Sch Life Sci, Nottingham, England.; Sloan, TJ (reprint author), Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Clin Microbiol, Nottingham, England.; Sloan, TJ (reprint author), Northern Lincolnshire & Goole NHS Fdn Trust, Path Links Pathol, Scunthorpe, Lincs, England.
EM tim.sloan@nottingham.ac.uk
RI Diggle, Mathew/V-7678-2019
OI Diggle, Mathew/0000-0001-5773-0686; Lister,
   Michelle/0000-0002-5221-4102; Sloan, Tim/0000-0003-3668-7775; Turton,
   James/0000-0003-2681-0477
FU National Institute for Health Research Health Technology Assessment
   [09/01/53]; Foot Ulcer Trials Unit; Department of Clinical Microbiology
   at Nottingham University Hospitals NHS Trust
FX The parent trial ISRCTN62524796 'Evaluation of lightweight fibreglass
   heel casts in the management of ulcers of the heel in diabetes' was
   funded by the National Institute for Health Research Health Technology
   Assessment 09/01/53. This study was funded by research funds held by the
   Foot Ulcer Trials Unit and Department of Clinical Microbiology at
   Nottingham University Hospitals NHS Trust.
CR Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105
   Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2
   Carr R, 2012, BIOINFORMATICS, V28, P734, DOI 10.1093/bioinformatics/btr721
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017
   Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2
   Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096
   Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771
   Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562
   Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008
   Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107
   Ince P, 2008, DIABETES CARE, V31, P964, DOI 10.2337/dc07-2367
   Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0
   Jeffcoate W, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21340
   Kerr M, 2017, DIABETIC FOOTCARE EN
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Lipsky BA, 2016, DIABETES-METAB RES, V32, P45, DOI 10.1002/dmrr.2699
   Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009
   Milner P, 1996, FEMS MICROBIOL LETT, V140, P125, DOI 10.1111/j.1574-6968.1996.tb08325.x
   Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608
   Nelson A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019437
   Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0
   Ramsey MM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01230
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Smith K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0665-z
   Tan Q, 2016, CLIN ENDOCRINOL, V85, P54, DOI 10.1111/cen.13047
   Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27
   Wolcott R, 2016, J WOUND CARE, V25, pS33, DOI 10.12968/jowc.2016.25.Sup10.S33
   Wolcott RD, 2016, WOUND REPAIR REGEN, V24, P163, DOI 10.1111/wrr.12370
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
   Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112
   Zykova SN, 2000, DIABETES, V49, P1451, DOI 10.2337/diabetes.49.9.1451
NR 41
TC 0
Z9 0
U1 1
U2 9
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD FEB
PY 2019
VL 68
IS 2
BP 230
EP 240
DI 10.1099/jmm.0.000907
PG 11
WC Microbiology
SC Microbiology
GA HK4DW
UT WOS:000457872000018
PM 30624175
OA Bronze
DA 2020-05-07
ER

PT J
AU Stecher, M
   Chaillon, A
   Eis-Hubinger, AM
   Lehmann, C
   Fatkenheuer, G
   Wasmuth, JC
   Knops, E
   Vehreschild, JJ
   Mehta, S
   Hoenigl, M
AF Stecher, M.
   Chaillon, A.
   Eis-Hubinger, A. M.
   Lehmann, C.
   Fatkenheuer, G.
   Wasmuth, J-C.
   Knops, E.
   Vehreschild, J. J.
   Mehta, S.
   Hoenigl, M.
TI Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance
   in transmission clusters of the Cologne-Bonn region, Germany
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Cluster; Drug-resistant mutations; Human immunodeficiency virus; Network
   analysis; Phylogenetic analysis
ID IMPACT
AB Objectives: In Germany, previous reports have demonstrated transmitted human immunodeficiency virus type 1 (HIV-1) drug-resistance mutations (DRM) in 11% of newly diagnosed individuals, highlighting the importance of drug-resistance screening before the initiation of antiretroviral therapy (ART). Here, we sought to understand the molecular epidemiology of HIV DRM transmission in the Cologne-Bonn region of Germany, given one of the highest rates of new HIV diagnoses in western Europe (13.7 per 100 000 habitants).
   Methods: We analysed 714 HIV-1 ART-naive infected individuals diagnosed at the University Hospitals Cologne and Bonn between 2001 and 2016. Screening for DRM was performed according to the Stanford University Genotypic Resistance Interpretation. Shared DRM were defined as any DRM present in genetically linked individuals (<1.5% genetic distance). Phylogenetic and network analyses were performed to infer putative relationships and shared DRM.
   Results: The prevalence of any DRM at time of diagnosis was 17.2% (123/714 participants). Genetic transmission network analyses showed comparable frequencies of DRM in clustering versus non-clustering individuals (17.1% (85/497) versus 17.5% (38/217)). The observed rate of DRM in the region was higher than previous reports 10.8% (87/809) (p < 0.001), revealing the need to reduce onward transmission in this area. Genetically linked individuals harbouring shared DRM were more likely to live in suburban areas (24/38) than in central Cologne (1/38) (p < 0.001).
   Conclusion: The rate of DRM was exceptionally high. Network analysis elucidated frequent cases of shared DRM among genetically linked individuals, revealing the potential spread of DRM and the need to prevent onward transmission of DRM in the Cologne-Bonn area. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Stecher, M.; Lehmann, C.; Fatkenheuer, G.; Vehreschild, J. J.] Univ Hosp Cologne, Dept Internal Med 1, Herderstr 52-54, D-50931 Cologne, Germany.
   [Stecher, M.; Lehmann, C.; Fatkenheuer, G.; Vehreschild, J. J.] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany.
   [Chaillon, A.; Mehta, S.; Hoenigl, M.] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA.
   [Eis-Hubinger, A. M.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Eis-Hubinger, A. M.; Wasmuth, J-C.] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany.
   [Wasmuth, J-C.] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany.
   [Knops, E.] Univ Hosp Cologne, Inst Virol, Cologne, Germany.
   [Mehta, S.] San Diego VA Med Ctr, Dept Med, San Diego, CA USA.
   [Hoenigl, M.] Med Univ Graz, Div Pulmonol, Graz, Austria.
   [Hoenigl, M.] Med Univ Graz, Infect Dis Sect, Graz, Austria.
RP Stecher, M (reprint author), Univ Hosp Cologne, Dept Internal Med 1, Herderstr 52-54, D-50931 Cologne, Germany.; Chaillon, A (reprint author), Univ Calif San Diego, Dept Med, Div Infect Dis, 200 West Arbor Dr 8208, San Diego, CA USA.
EM melanie.stecher@uk-koeln.de; achaillon@ucsd.edu
RI Hoenigl, Martin/E-8802-2010
OI Hoenigl, Martin/0000-0002-1653-2824
FU German Centre for Infection Research (DZIF); NIH grants, United States
   [R25 MH081482, P30 AI036214, P50DA026306, MH113477, AI106039, MH100974]
FX This work was supported by the German Centre for Infection Research
   (DZIF) (NCT02149004) and supported by NIH grants, United States (R25
   MH081482, P30 AI036214, P50DA026306, MH113477, AI106039, and MH100974).
CR Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718
   Chaillon A, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0339-4
   Hauser A, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.2.30436
   Hoenigl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151478
   Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963
   Lyss LT, 2010, C RETR OPP INF CROI
   Novitsky V, 2014, AIDS RES HUM RETROV, V30, P1226, DOI 10.1089/aid.2014.0173
   Pond SLK, 2018, MOL BIOL EVOL, V35, P1812, DOI 10.1093/molbev/msy016
   Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581
   Robert-Koch-Institut, 2017, SURVSTAT RKI 2 0
   Robert-Koch-Institute, 2017, EPIDEMIOLOGISCHES B, V39
   Schmidt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104474
   Stecher M, 2018, CLIN INFECT DIS
   Stecher M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25004-8
   Thielen A, 2014, 12 EUR HIV HEP WORKS
NR 15
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD FEB
PY 2019
VL 25
IS 2
DI 10.1016/j.cmi.2018.09.025
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HI9AP
UT WOS:000456747400028
PM 30315957
OA Bronze, Green Accepted
DA 2020-05-07
ER

PT S
AU Mihasan, M
   Babii, C
   Aslebagh, R
   Channaveerappa, D
   Dupree, EJ
   Darie, CC
AF Mihasan, Marius
   Babii, Cornelia
   Aslebagh, Roshanak
   Channaveerappa, Devika
   Dupree, Emmalyn J.
   Darie, Costel C.
BE Woods, AG
   Darie, CC
TI Exploration of Nicotine Metabolism in Paenarthrobacter nicotinovorans
   pAO1 by Microbial Proteomics
SO ADVANCEMENTS OF MASS SPECTROMETRY IN BIOMEDICAL RESEARCH, 2ND EDITION
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Microbial proteomics; Mass spectrometry; Nicotine metabolism;
   Paenarthrobacter nicotinovorans
ID POLYACRYLAMIDE-GEL ELECTROPHORESIS; ARTHROBACTER-NICOTINOVORANS;
   MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; OXIDATIVE STRESS; CATABOLISM;
   RESISTANCE; SEQUENCE; STRAIN; NOV.
AB Proteomics, or the large-scale study of proteins, is a post-genomics field that, together with transcriptomics and metabolomics, has moved the study of bacteria to a new era based on system-wide understanding of bacterial metabolic and regulatory networks. The study of bacterial proteins or microbial proteomics has found a wide array of applications in many fields of microbiology, from food, clinical, and industrial microbiology to microbial ecology and physiology. The current chapter makes a brief technical introduction into the available approaches for the largescale study of bacterial proteins using mass-spectrometry. Furthermore, the advantages and disadvantages of using bacteria for proteomics studies are indicated as well as several example studies where MS-based bacterial proteomics had a fundamental role in deciphering the scientific question. Finally, the proteomics study of nicotine catabolism in Paenarthrobacter nicotinovorans pAO1 using nanoLC-MS/MS is given as an in-depth example for possible applications of microbial proteomics.
   The nicotine degradation pathway functioning in Paenarthrobacter nicotinovorans is encoded by the catabolic megaplasmid pAO1 that contains about 40 nicotine-related genes making out the nic-gens cluster. Despite the promising biotechnological potential for the production of green-chemicals, only half of the nic-genes have been experimentally linked to nicotine. In an attempt to systematically identify all the proteins involved in nicotine degradation, a gel-based proteomics approach was used to identify a total of 801 proteins when Paenarthrobacter nicotinovorans was grown on three carbon sources: citrate, nicotine and nicotine and citrate. The differences in protein abundance showed that the bacterium is able to switch between deamination and demethylation in the lower nicotine pathway based on the available C source. Several pAO1 putative genes including a hypothetical polyketide cyclase have been shown to have a nicotine-dependent expression and we hypothesize that the polyketide cyclase would hydrolyze the N1-C6 bond from the pyridine ring with the formation of alpha-keto-glutaramate. Two chromosomal proteins, a malate dehydrogenase, and a D-3-phosphoglycerate dehydrogenase were shown to be strongly upregulated when nicotine was the sole carbon source and could be related to the production of the alpha-keto-glutaramate by the polyketide cyclase.
C1 [Mihasan, Marius; Babii, Cornelia] Alexandru Ioan Cuza Univ, Dept Biol, BioAct Grp, Iasi, Romania.
   [Mihasan, Marius; Aslebagh, Roshanak; Channaveerappa, Devika; Dupree, Emmalyn J.; Darie, Costel C.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.
RP Mihasan, M (reprint author), Alexandru Ioan Cuza Univ, Dept Biol, BioAct Grp, Iasi, Romania.; Mihasan, M (reprint author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.
EM marius.mihasan@uaic.ro
RI Mihasan, Marius/B-1119-2010
OI Mihasan, Marius/0000-0003-4439-4251
FU Fulbright Senior Postdoctoral Fellowship awarded by the Romania-USA
   Fulbright Commission
FX We thank the past and present members of BioActive Group and the
   Biochemistry & Proteomics Group for the pleasant environment and
   fruitful discussions. MM was supported by the Fulbright Senior
   Postdoctoral Fellowship awarded by the Romania-USA Fulbright Commission
   to MM (guest) and CCD (host).
CR Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103
   Ansong C, 2013, MOL BIOSYST, V9, P44, DOI 10.1039/c2mb25287b
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Bennett GM, 2013, GENOME BIOL EVOL, V5, P1675, DOI 10.1093/gbe/evt118
   Biot FV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016892
   Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1
   Borodina E, 2002, ARCH MICROBIOL, V177, P173, DOI 10.1007/s00203-001-0373-3
   Boulund F, 2017, MOL CELL PROTEOMICS, V16, P1052, DOI 10.1074/mcp.M116.061721
   Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0
   Broadbent JA, 2016, EXPERT REV PROTEOMIC, V13, P355, DOI 10.1586/14789450.2016.1155986
   Burnett BJ, 2014, J BIOL CHEM, V289, P23917, DOI 10.1074/jbc.M114.583385
   Busse HJ, 2016, INT J SYST EVOL MICR, V66, P9, DOI 10.1099/ijsem.0.000702
   Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012
   Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164
   Channaveerappa D, 2017, J CELL MOL MED, V21, P2223, DOI 10.1111/jcmm.13145
   Chao TC, 2012, PROTEOMICS, V12, P638, DOI 10.1002/pmic.201100381
   Charretier Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13944
   Chaussee MA, 2006, J ANTIMICROB CHEMOTH, V58, P752, DOI 10.1093/jac/dkl319
   Chen B, 2017, EUR J CLIN MICROBIOL, V36, P403, DOI 10.1007/s10096-016-2816-4
   Chen HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066880
   Chenau J, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-9
   Chiribau CB, 2006, FEBS J, V273, P1528, DOI 10.1111/j.1742-4658.2006.05173.x
   Chiribau CB, 2004, EUR J BIOCHEM, V271, P4677, DOI 10.1111/j.1432-1033.2004.04432.x
   Cobzaru C, 2011, RES MICROBIOL, V162, P285, DOI 10.1016/j.resmic.2011.01.001
   DECKER K, 1960, H-S Z PHYSIOL CHEM, V319, P279, DOI 10.1515/bchm2.1960.319.1.279
   Delahunty CM, 2007, BIOTECHNIQUES, V43, P563
   Demirev PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/annurev.anchem.1.031207.112838
   Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c
   Fernandez-Reyes M, 2009, PROTEOMICS, V9, P1632, DOI 10.1002/pmic.200800434
   Fisunov GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021964
   Ganas P, 2007, MICROBIOL-SGM, V153, P1546, DOI 10.1099/mic.0.2006/004234-0
   Ganas Petra, 2009, V11, P271, DOI 10.1007/7171_2008_2
   Gil C, 2014, J PROTEOMICS, V97, P1, DOI 10.1016/j.jprot.2013.12.015
   Graham RL, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-26
   Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364
   Han K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02101
   Han XM, 2008, CURR OPIN CHEM BIOL, V12, P483, DOI 10.1016/j.cbpa.2008.07.024
   Hausner G, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-8
   Herbst FA, 2016, PROTEOMICS, V16, P783, DOI 10.1002/pmic.201500305
   Hritcu L., 2019, NEUROSCIENCE NICOTIN
   Hritcu L, 2017, BIOMED PHARMACOTHER, V86, P102, DOI 10.1016/j.biopha.2016.12.008
   Igloi GL, 2003, J BACTERIOL, V185, P1976, DOI 10.1128/JB.185.6.1976-1986.2003
   Kallimanis A, 2009, INT J SYST EVOL MICR, V59, P275, DOI 10.1099/ijs.0.000984-0
   KODAMA Y, 1992, INT J SYST BACTERIOL, V42, P234, DOI 10.1099/00207713-42-2-234
   Kurnasov O, 2003, FEMS MICROBIOL LETT, V227, P219, DOI 10.1016/S0378-1097(03)00684-0
   Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4
   Liu JL, 2015, APPL MICROBIOL BIOT, V99, P3775, DOI 10.1007/s00253-015-6525-1
   Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200
   Maria-Neto S, 2012, ANTIMICROB AGENTS CH, V56, P1714, DOI 10.1128/AAC.05558-11
   Meng J., 2017, GENOME ANNOUNCEMENTS, V5
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990
   Mihasan M, 2007, APPL ENVIRON MICROB, V73, P2479, DOI 10.1128/AEM.02668-06
   Mihasan M, 2016, MICROBIOL RES, V191, P32, DOI 10.1016/j.micres.2016.05.008
   Mihasan M, 2015, CELL MOL BIOL LETT, V20, P612, DOI 10.1515/cmble-2015-0036
   Mihasan M, 2013, J MOL EVOL, V77, P22, DOI 10.1007/s00239-013-9576-x
   Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004
   Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214
   Neidhardt FC, 2011, PROTEOMICS, V11, P2943, DOI 10.1002/pmic.201000780
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Oren A, 2016, INT J SYST EVOL MICR, V66, P2455, DOI 10.1099/ijsem.0.001179
   Otto A, 2012, CURR OPIN MICROBIOL, V15, P364, DOI 10.1016/j.mib.2012.02.005
   Perez-Llarena FJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00410
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125
   Potel CM, 2018, NAT METHODS, V15, P187, DOI [10.1038/NMETH.4580, 10.1038/nmeth.4580]
   Rao AA, 2014, J PROTEOMICS, V97, P222, DOI 10.1016/j.jprot.2013.08.013
   Sagarkar S, 2016, APPL MICROBIOL BIOT, V100, P903, DOI 10.1007/s00253-015-6975-5
   Sahoo NK, 2010, INT BIODETER BIODEGR, V64, P474, DOI 10.1016/j.ibiod.2010.05.008
   Shah NH, 2014, CHEM SCI, V5, P446, DOI 10.1039/c3sc52951g
   Soufi Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00181
   Stekhoven DJ, 2014, J PROTEOMICS, V99, P123, DOI 10.1016/j.jprot.2014.01.015
   Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009
   Tiwari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039451
   Unell M, 2009, J PROTEOME RES, V8, P1953, DOI 10.1021/pr800897c
   Vaitekunas J, 2016, APPL ENVIRON MICROB, V82, P1264, DOI 10.1128/AEM.02975-15
   Vandera E, 2015, J PROTEOMICS, V113, P73, DOI 10.1016/j.jprot.2014.08.018
   Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262
   Vranakis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033599
   Wang SN, 2005, ENVIRON SCI TECHNOL, V39, P6877, DOI 10.1021/es0500759
   Wang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep16411
   Weinstock GM, 2000, EMERG INFECT DIS, V6, P496, DOI 10.3201/eid0605.000509
   Wetie AGN, 2015, J CELL MOL MED, V19, P2664, DOI 10.1111/jcmm.12658
   Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x
   Woodson SA, 1998, GENE DEV, V12, P1243, DOI 10.1101/gad.12.9.1243
   Yang L, 2015, P NATL ACAD SCI USA, V112, P10810, DOI 10.1073/pnas.1501384112
   Yu WJ, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0976-9
   ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505
NR 88
TC 0
Z9 0
U1 4
U2 5
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-3-030-15950-4; 978-3-030-15949-8
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2019
VL 1140
BP 515
EP 529
DI 10.1007/978-3-030-15950-4_30
D2 10.1007/978-3-030-15950-4
PG 15
WC Biochemical Research Methods; Medicine, Research & Experimental;
   Spectroscopy
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Spectroscopy
GA BO4FE
UT WOS:000514082500031
PM 31347068
DA 2020-05-07
ER

PT J
AU Zhang, YF
   Shi, WY
   Song, YQ
   Wang, JF
AF Zhang, Yifei
   Shi, Wenyu
   Song, Yeqing
   Wang, Jinfeng
TI Metatranscriptomic analysis of an in vitro biofilm model reveals
   strain-specific interactions among multiple bacterial species
SO JOURNAL OF ORAL MICROBIOLOGY
LA English
DT Article
DE Biofilm; periodontitis; periodontal microbiology; bacteria interaction;
   periodontal pathogen
ID PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; PERIODONTAL HEALTH;
   COAGGREGATION; IDENTIFICATION; MICROBIOME; INFECTION; VIRULENCE
AB Interactions among bacteria can affect biofilm properties. Method: Here, we investigated the role of different bacteria in functional dysbiosis of an in vitro polymicrobial subgingival plaque model using both 16S rRNA and metatranscriptomic sequencing. Results: We found that high-virulence Porphyromonas gingivalis W83 had greater effects on the symbiotic species than the low-virulence P. gingivalis ATCC33277, and that Prevotella intermedia exacerbated the effects of W83. P. gingivalis significantly influenced the expression of genes related to metabolic pathways and quorum sensing of commensal oral species in a strain-specific manner. P. intermedia exerted synergistic effects with P. gingivalis W83 but antagonistic effects with strain ATCC33277, which may regulate the expression of virulence factors of P. gingivalis through the clp regulator. Discussion: The interaction networks indicated that the strongest correlation was between Fusobacterium nucleatum and Streptococcus mitis, which demonstrated their bridge and cornerstone roles in biofilm. Changes in the expression of genes relating to outer membrane proteins in F. nucleatum indicated that the addition of different bacteria can interfere with the co-adherence among F. nucleatum and other partners. Conclusion: We report here the existence of strain-specific interactions in subgingival plaque, which may enhance our understanding of periodontal micro-ecology and facilitate the development of improved plaque control strategies.
C1 [Zhang, Yifei; Song, Yeqing] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing, Peoples R China.
   [Zhang, Yifei; Song, Yeqing] Chinese Acad Sci, Natl Clin Res Ctr Oral Dis, Beijing, Peoples R China.
   [Zhang, Yifei; Song, Yeqing] Chinese Acad Sci, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.
   [Zhang, Yifei; Song, Yeqing] Chinese Acad Sci, Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.
   [Shi, Wenyu; Wang, Jinfeng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China.
RP Zhang, YF (reprint author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing, Peoples R China.; Zhang, YF (reprint author), Chinese Acad Sci, Natl Clin Res Ctr Oral Dis, Beijing, Peoples R China.; Zhang, YF (reprint author), Chinese Acad Sci, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Zhang, YF (reprint author), Chinese Acad Sci, Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.; Wang, JF (reprint author), Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China.
EM wingsflying@bjmu.edu.cn; wangjf@biols.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [NSFC 81300880]; NSFCNational Natural Science
   Foundation of China [31670119]; Interdisciplinary Medicine Seed Fund of
   Peking University [BMU 2018MB005]
FX This work was supported by grants from the National Natural Science
   Foundation of China (NSFC 81300880) to YZ and NSFC grant (31670119) to
   JW, and the Interdisciplinary Medicine Seed Fund of Peking University
   (BMU 2018MB005) to YZ.
CR Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174
   Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Barbosa GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138687
   Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006
   de Smit MJ, 2015, J PERIODONTOL, V86, P1013, DOI 10.1902/jop.2015.150088
   Decsi G, 2018, PATHOL ONCOL RES
   Defoirdt T, 2018, TRENDS MICROBIOL, V26, P313, DOI 10.1016/j.tim.2017.10.005
   Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23
   Frias-Lopez J, 2012, J BACTERIOL, V194, P2082, DOI 10.1128/JB.06328-11
   Gursoy UK, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00273
   Ha DG, 2015, REVIEW, V3, DOI 10.1128/microbiolspec.MB-0003-2014
   Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873
   Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006
   Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005
   Hope CK, 2006, J MICROBIOL METH, V66, P390, DOI 10.1016/j.mimet.2006.01.003
   Jung YJ, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1320193
   Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002
   Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413
   Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x
   Liu PF, 2010, VACCINE, V28, P3496, DOI 10.1016/j.vaccine.2010.02.047
   Marsh P D, 1994, Adv Dent Res, V8, P263
   Pinho MM, 2013, J PERIODONTAL RES, V48, P452, DOI 10.1111/jre.12026
   Nowicki EM, 2018, MBIO, P9
   Polak D, 2017, J PERIODONTOL, V88, P502, DOI 10.1902/jop.2016.160397
   Polak D, 2012, J CLIN PERIODONTOL, V39, P617, DOI 10.1111/j.1600-051X.2012.01889.x
   Riep B, 2009, J CLIN MICROBIOL, P1705
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rosier BT, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00092
   Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x
   Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x
   Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09
   Uzel NG, 2011, J CLIN PERIODONTOL, V38, P612, DOI 10.1111/j.1600-051X.2011.01730.x
   van der Ploeg JR, 2005, J BACTERIOL, V187, P3980, DOI 10.1128/JB.187.12.3980-3989.2005
   Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843
   Wang YH, 2014, APPL MICROBIOL BIOT, V98, P411, DOI 10.1007/s00253-013-5394-8
   Yang CX, 2017, P NATL ACAD SCI USA, V114, P13006, DOI 10.1073/pnas.1709048114
   Zhang YF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00409
   Zhao L, 2007, J PERIODONTAL RES, V42, P511, DOI 10.1111/j.1600-0765.2007.00975.x
NR 44
TC 1
Z9 1
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2000-2297
J9 J ORAL MICROBIOL
JI J. Oral Microbiology
PD JAN 1
PY 2019
VL 11
IS 1
AR 1599670
DI 10.1080/20002297.2019.1599670
PG 11
WC Microbiology
SC Microbiology
GA HS8LW
UT WOS:000464122200001
PM 31007867
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Pancholi, V
AF Pancholi, Vijay
TI Group A Streptococcus-Mediated Host Cell Signaling
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID NF-KAPPA-B; FIBRONECTIN-BINDING PROTEIN; HUMAN PHARYNGEAL CELL;
   GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; EPITHELIAL-CELLS; BACTERIAL
   PATHOGENS; INDUCED APOPTOSIS; SURFACE PROTEIN; MOLECULAR-BASIS;
   ALPHA-ENOLASE
AB In the past decade, the field of the cellular microbiology of group A Streptococcus (S. pyogenes) infection has made tremendous advances and touched upon several important aspects of pathogenesis, including receptor biology, invasive and evasive phenomena, inflammasome activation, strain-specific autophagic bacterial killing, and virulence factor-mediated programmed cell death. The noteworthy aspect of S. pyogenes-mediated cell signaling is the recognition of the role of M protein in a variety of signaling events, starting with the targeting of specific receptors on the cell surface and on through the induction and evasion of NETosis, inflammasome, and autophagy/xenophagy to pyroptosis and apoptosis. Variations in reports on S. pyogenes-mediated signaling events highlight the complex mechanism of pathogenesis and underscore the importance of the host cell and S. pyogenes strain specificity, as well as in vitro/in vivo experimental parameters. The severity of S. pyogenes infection is, therefore, dependent on the virulence gene expression repertoire in the host environment and on host-specific dynamic signaling events in response to infection. Commonly known as an extracellular pathogen, S. pyogenes finds host macrophages as safe havens wherein it survives and even multiplies. The fact that endothelial cells are inherently deficient in autophagic machinery compared to epithelial cells and macrophages underscores the invasive nature of S. pyogenes and its ability to cause severe systemic diseases. S. pyogenes is still one of the top 10 causes of infectious mortality. Understanding the orchestration of dynamic host signaling networks will provide a better understanding of the increasingly complex mechanism of S. pyogenes diseases and novel ways of therapeutically intervening to thwart severe and often fatal infections.
C1 [Pancholi, Vijay] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA.
RP Pancholi, V (reprint author), Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA.
EM vijay.pancholi@osumc.edu
CR Agarwal S, 2012, J BIOL CHEM, V287, P9147, DOI 10.1074/jbc.M111.316554
   AJIRO K, 1985, J BIOL CHEM, V260, P5379
   AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877
   Alameda JP, 2010, ONCOGENE, V29, P6522, DOI 10.1038/onc.2010.378
   Alameda JP, 2013, J INVEST DERMATOL, V133, P1870, DOI 10.1038/jid.2013.76
   Alouf JE, 2003, INT J MED MICROBIOL, V292, P429, DOI 10.1078/1438-4221-00232
   Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7
   Barnett TC, 2015, CELL MICROBIOL, V17, P1721, DOI 10.1111/cmi.12531
   Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003
   Bastiat-Sempe B, 2014, MBIO, V5, DOI 10.1128/mBio.01690-14
   Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x
   Bhattacharya S, 2014, BIOMED RES INT, DOI 10.1155/2014/435197
   BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z
   Bolscher JGM, 1999, J DENT RES, V78, P1362, DOI 10.1177/00220345990780071101
   Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514
   Braun JS, 2001, J INFECT DIS, V184, P1300, DOI 10.1086/324013
   Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brown AO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004383
   Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419
   Bryant AE, 2005, J INFECT DIS, V192, P1014, DOI 10.1086/432729
   Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039
   CAPARON MG, 1992, J BACTERIOL, V174, P5693, DOI 10.1128/JB.174.17.5693-5701.1992
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004
   Cauwels A, 1997, INFECT IMMUN, V65, P3255, DOI 10.1128/IAI.65.8.3255-3260.1997
   CHEN CC, 1989, INFECT IMMUN, V57, P1740, DOI 10.1128/IAI.57.6.1740-1745.1989
   Cheng YL, 2017, MBIO, V8, DOI 10.1128/mBio.00899-17
   Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670
   Ciccarelli A, 2014, NEUROPHARMACOLOGY, V80, P34, DOI 10.1016/j.neuropharm.2014.01.039
   CLEARY PP, 1992, INFECT IMMUN, V60, P5219, DOI 10.1128/IAI.60.12.5219-5223.1992
   Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648
   Cole JN, 2016, APOPTOSIS, V4
   Coleman FT, 2017, J INFECT DIS, V216, P425, DOI 10.1093/infdis/jix159
   Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730
   Cossart P, 1997, J CLIN INVEST, V99, P2307, DOI 10.1172/JCI119409
   COURTNEY HS, 1991, INFECT IMMUN, V59, P1661, DOI 10.1128/IAI.59.5.1661-1666.1991
   COURTNEY HS, 1994, INFECT IMMUN, V62, P3937, DOI 10.1128/IAI.62.9.3937-3946.1994
   Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1
   Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998
   Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000
   Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195
   Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a
   D'Costa SS, 2000, BIOCHEM BIOPH RES CO, V278, P826, DOI 10.1006/bbrc.2000.3884
   da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014
   da Silva F, 2009, APOPTOSIS, V14, P509, DOI 10.1007/s10495-009-0320-3
   Pellegrina DVD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128341
   Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630
   DAVIS L, 1979, INFECT IMMUN, V24, P780, DOI 10.1128/IAI.24.3.780-786.1979
   DEMUTH DR, 1990, J BIOL CHEM, V265, P7120
   DENNY PC, 1991, J DENT RES, V70, P1320, DOI 10.1177/00220345910700100201
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590
   Dohrmann S, 2014, INFECT IMMUN, V82, P4011, DOI 10.1128/IAI.01921-14
   Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6
   Dohrmann S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43039
   Dohrmann S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005682
   Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x
   DORING G, 1983, J INFECT DIS, V147, P744, DOI 10.1093/infdis/147.4.744
   Doster RS, 2018, J INNATE IMMUN, V10, P3, DOI 10.1159/000480373
   DUDANI AK, 1993, THROMB RES, V69, P185, DOI 10.1016/0049-3848(93)90044-O
   Eigenbrod T, 2015, J IMMUNOL, V195, P1092, DOI 10.4049/jimmunol.1403173
   Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013
   Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266
   Fieber C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119727
   Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013
   Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718
   Fischetti V.A., 2006, GRAM POSITIVE PATHOG, P12
   FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101
   Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231
   FRICK IM, 1995, EMBO J, V14, P1674, DOI 10.1002/j.1460-2075.1995.tb07156.x
   Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617
   Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034
   Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707
   Gaidt MM, 2016, EMBO J, V35, P2167, DOI 10.15252/embj.201695415
   Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906
   Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22
   Gamradt P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006032
   Garcia-Ponce A, 2015, THROMB HAEMOSTASIS, V113, P20, DOI 10.1160/TH14-04-0298
   GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Giannakis E, 2002, J IMMUNOL, V168, P4585, DOI 10.4049/jimmunol.168.9.4585
   Gonzalez-Juarbe N, 2017, CELL DEATH DIFFER, V24, P917, DOI 10.1038/cdd.2017.49
   Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200
   Guzman CA, 1996, MOL MICROBIOL, V20, P119, DOI 10.1111/j.1365-2958.1996.tb02494.x
   Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200
   Hakansson AP, 2017, J INFECT DIS, V216, P402, DOI 10.1093/infdis/jix161
   HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172
   Haobam B, 2014, CELL MICROBIOL, V16, P1806, DOI 10.1111/cmi.12329
   Hara H, 2018, CELL, V175, P1651, DOI 10.1016/j.cell.2018.09.047
   Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444
   Henningham A, 2015, FEMS MICROBIOL REV, V39, P488, DOI 10.1093/femsre/fuu009
   Hertzen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035218
   Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1
   Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895
   HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z
   HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925
   Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899
   Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160
   Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hytonen J, 2000, MICROBIOL-SGM, V146, P31, DOI 10.1099/00221287-146-1-31
   Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003
   Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7
   ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624
   Ishitani R, 1997, MOL PHARMACOL, V51, P542
   Ito C, 2013, MOL CELL, V52, P794, DOI 10.1016/j.molcel.2013.10.024
   Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x
   Jadoun J, 1997, ADV EXP MED BIOL, V418, P511
   Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x
   Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063
   Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147
   Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006
   Jounai N, 2011, J IMMUNOL, V186, P1646, DOI 10.4049/jimmunol.1001654
   Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002
   Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019
   Kant S, 2015, MOL MICROBIOL, V97, P515, DOI 10.1111/mmi.13047
   KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849
   KAPLAN EL, 1981, J LAB CLIN MED, V98, P326
   Kasper KJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004155
   Kazmierczak BI, 2001, ANNU REV MICROBIOL, V55, P407, DOI 10.1146/annurev.micro.55.1.407
   Kehoe M. A., 1994, BACTERIAL CELL WALL, V27, P217, DOI DOI 10.1016/S0167-7306(08)60414-7
   Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002
   Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41749
   Klenk M, 2005, CELL MICROBIOL, V7, P1237, DOI 10.1111/j.1462-5822.2005.00548.x
   KLINGER JD, 1984, J CLIN INVEST, V74, P1669, DOI 10.1172/JCI111583
   Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100
   Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200
   Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563
   Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800
   Kovarik P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00652
   Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200
   Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2
   Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294
   LaRock CN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3539
   LaRock CN, 2015, CELL HOST MICROBE, V18, P471, DOI 10.1016/j.chom.2015.09.004
   LaRock CN, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00518
   Latvala S, 2014, CLIN EXP IMMUNOL, V178, P320, DOI 10.1111/cei.12425
   LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426
   Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032
   Lin AE, 2015, MBIO, V6, DOI 10.1128/mBio.00133-15
   LITVINOV SV, 1993, J BIOL CHEM, V268, P21364
   LOOMIS RE, 1987, ARCH BIOCHEM BIOPHYS, V258, P452, DOI 10.1016/0003-9861(87)90366-3
   Lu SL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006444
   Lu SL, 2015, MBIO, V6, DOI 10.1128/mBio.01435-15
   Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998
   MACKINNON FG, 1993, MICROB PATHOGENESIS, V15, P359, DOI 10.1006/mpat.1993.1085
   Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2
   Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296
   Mancuso G, 2002, J IMMUNOL, V169, P1401, DOI 10.4049/jimmunol.169.3.1401
   Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023
   Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170
   MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J
   MCIVER KS, 1995, INFECT IMMUN, V63, P4540, DOI 10.1128/IAI.63.11.4540-4542.1995
   Medina E, 2002, MICROB PATHOGENESIS, V33, P307, DOI 10.1006/mpat.2002.0532
   Medvedev AE, 1998, J IMMUNOL, V160, P4535
   Mehta K, 1996, FASEB J, V10, P1408
   Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733
   Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998
   MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034
   Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x
   Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997
   Morshed M, 2014, J IMMUNOL, V192, P5314, DOI 10.4049/jimmunol.1303418
   MOSQUERA JA, 1985, J INFECT DIS, V151, P259, DOI 10.1093/infdis/151.2.259
   MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303
   Mueller NJ, 2002, INFECT IMMUN, V70, P2657, DOI 10.1128/IAI.70.5.2657-2664.2002
   Murakami J, 2012, J BIOL CHEM, V287, P22266, DOI 10.1074/jbc.M112.350082
   Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7
   Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966
   Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x
   Nakajima S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170138
   NATANSON C, 1994, ANN INTERN MED, V120, P771, DOI 10.7326/0003-4819-120-9-199405010-00009
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999
   Neff L, 2001, CELL MICROBIOL, V3, P703, DOI 10.1046/j.1462-5822.2001.00148.x
   Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011
   Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]
   Nerlich A, 2009, J BIOL CHEM, V284, P20319, DOI 10.1074/jbc.M109.016501
   Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661
   Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720
   Nishanth G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003455
   Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005
   Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200
   Norrby-Teglund A, 2000, EUR J IMMUNOL, V30, P3247, DOI 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D
   Nozawa T, 2017, AUTOPHAGY, V13, P57, DOI 10.1080/15548627.2016.1241924
   Nozawa T, 2012, CELL MICROBIOL, V14, P1149, DOI 10.1111/j.1462-5822.2012.01792.x
   Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214
   Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610
   O'Neill AM, 2016, MBIO, V7, DOI 10.1128/mBio.00020-16
   O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394
   Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200
   OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489
   Okada N, 1997, J BIOL CHEM, V272, P26978, DOI 10.1074/jbc.272.43.26978
   Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/nchembio.2229, 10.1038/NCHEMBIO.2229]
   Okumura CYM, 2014, ANNU REV MICROBIOL, V68, P439, DOI 10.1146/annurev-micro-092412-155711
   Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963
   Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x
   Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x
   Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503
   Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283
   Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633
   PANCHOLI V, 1993, P NATL ACAD SCI USA, V90, P8154, DOI 10.1073/pnas.90.17.8154
   PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415
   Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004
   Pancholi V, 2001, 101 ASM GEN M ORL FL, V177, P80
   Pancholi V., 2017, MOONLIGHTING PROTEIN, P169
   PARSONNET J, 1989, REV INFECT DIS, V11, pS263
   Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x
   Purushothaman SS, 2003, INFECT IMMUN, V71, P5823, DOI 10.1128/IAI.71.10.5823-5830.2003
   Quattroni P, 2012, CELL MICROBIOL, V14, P1657, DOI 10.1111/j.1462-5822.2012.01838.x
   RAKONJAC JV, 1995, INFECT IMMUN, V63, P622, DOI 10.1128/IAI.63.2.622-631.1995
   Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280
   Rathkey JK, 2017, J BIOL CHEM, V292, P14649, DOI 10.1074/jbc.M117.797217
   REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x
   Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531
   Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150
   Reyes LF, 2017, AM J RESP CRIT CARE, V196, P609, DOI 10.1164/rccm.201701-0104OC
   Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70
   RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330
   Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x
   Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005
   Rosenquist M, 2003, BRAZ J MED BIOL RES, V36, P403, DOI 10.1590/S0100-879X2003000400001
   Rubinsztein DC, 2015, J EXP MED, V212, P979, DOI 10.1084/jem.20150956
   Ruhl S, 2005, J DENT RES, V84, P29, DOI 10.1177/154405910508400104
   Russell S, 2004, TISSUE ANTIGENS, V64, P111, DOI 10.1111/j.1399-0039.2004.00277.x
   Ryan PA, 2001, INFECT IMMUN, V69, P7402, DOI 10.1128/IAI.69.12.7402-7412.2001
   Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636
   SAJJAN SU, 1992, INFECT IMMUN, V60, P1434, DOI 10.1128/IAI.60.4.1434-1440.1992
   Sanderson-Smith ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003469
   Sawicka A, 2014, BBA-GENE REGUL MECH, V1839, P711, DOI 10.1016/j.bbagrm.2014.04.013
   Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696
   Schmeck B, 2004, INFECT IMMUN, V72, P4940, DOI 10.1128/IAI.72.9.4940-4947.2004
   Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018
   Schommer NN, 2014, J BIOL CHEM, V289, P26914, DOI 10.1074/jbc.M114.575621
   Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121
   Schwarz F, 2017, EMBO J, V36, P751, DOI 10.15252/embj.201695581
   Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x
   Secundino I, 2016, J MOL MED, V94, P219, DOI 10.1007/s00109-015-1341-8
   SEGER R, 1995, FASEB J, V9, P726
   Shahnazari S, 2011, CURR OPIN MICROBIOL, V14, P68, DOI 10.1016/j.mib.2010.11.001
   Shaler CR, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001930
   Shannon O, 2007, MOL MICROBIOL, V65, P1147, DOI 10.1111/j.1365-2958.2007.05841.x
   Shelburne SA, 2004, CURR OPIN MICROBIOL, V7, P283, DOI 10.1016/j.mib.2004.04.013
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Shuter J, 1996, INFECT IMMUN, V64, P310, DOI 10.1128/IAI.64.1.310-318.1996
   SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cellbio.10.1.405
   Siles-Lucas MD, 2003, TRENDS PARASITOL, V19, P575, DOI 10.1016/j.pt.2003.10.003
   Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52
   SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K
   Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399
   Soderholm AT, 2018, J LEUKOCYTE BIOL, V103, P193, DOI 10.1189/jlb.4MR0617-227RR
   Steinberg BE, 2007, SCI STKE, V2007, ppe11, DOI [10.1126/stke.3792007pe11, DOI 10.1126/STKE.3792007PE11]
   STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463
   Stevens DL, 2017, NEW ENGL J MED, V377, P2253, DOI 10.1056/NEJMra1600673
   STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101
   STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559
   Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124
   Sun J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00569-6
   Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009
   TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555
   Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200
   Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200
   TaylorPapadimitriou J, 1997, IMMUNOL TODAY, V18, P105, DOI 10.1016/S0167-5699(97)01028-1
   Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200
   Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731
   Thamphiwatana S, 2017, P NATL ACAD SCI USA, V114, P11488, DOI 10.1073/pnas.1714267114
   Tikoo K, 2001, MOL PHARMACOL, V60, P394
   Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200
   TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9
   Tsai PJ, 2006, MICROBES INFECT, V8, P1440, DOI 10.1016/j.micinf.2006.01.002
   Tsai PJ, 1999, INFECT IMMUN, V67, P4334, DOI 10.1128/IAI.67.9.4334-4339.1999
   Uchiyama S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002736
   Ueki S, 2013, BLOOD, V121, P2074, DOI 10.1182/blood-2012-05-432088
   Valderrama JA, 2018, FUTURE MICROBIOL, V13, P119, DOI 10.2217/fmb-2017-0142
   Valderrama JA, 2017, NAT MICROBIOL, V2, P1425, DOI 10.1038/s41564-017-0005-6
   van Wijk XM, 2017, MBIO, V8, DOI 10.1128/mBio.02128-16
   Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761
   Vigano E, 2013, EUR J IMMUNOL, V43, P2240, DOI 10.1002/eji.201343800
   von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018
   von Mering M, 2001, BRAIN PATHOL, V11, P282
   von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944
   Voyich JM, 2004, J IMMUNOL, V173, P1194, DOI 10.4049/jimmunol.173.2.1194
   Voyich JM, 2003, P NATL ACAD SCI USA, V100, P1996, DOI 10.1073/pnas.0337370100
   Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13
   Wang B, 1997, INFECT IMMUN, V65, P2119, DOI 10.1128/IAI.65.6.2119-2126.1997
   Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107
   Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25
   Westman J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005319
   WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144
   WICK MJ, 1991, CELL, V67, P651
   Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685
   Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311
   Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9
   Wolffe AP, 1997, GENES CELLS, V2, P291, DOI 10.1046/j.1365-2443.1997.1260323.x
   Wood DN, 2009, J BACTERIOL, V191, P6242, DOI 10.1128/JB.00440-09
   Zeppa JJ, 2017, P NATL ACAD SCI USA, V114, P10226, DOI 10.1073/pnas.1700858114
   Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854
   Zinkernagel AS, 2012, J INNATE IMMUN, V4, P213, DOI 10.1159/000329550
   Zychlinsky A, 1997, TRENDS MICROBIOL, V5, P201, DOI 10.1016/S0966-842X(97)01044-5
   Zychlinsky A, 1996, INFECT IMMUN, V64, P5357, DOI 10.1128/IAI.64.12.5357-5365.1996
   Zysk G, 2000, CLIN EXP IMMUNOL, V122, P61, DOI 10.1046/j.1365-2249.2000.01336.x
NR 304
TC 0
Z9 0
U1 2
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JAN
PY 2019
VL 7
IS 1
AR GPP3-0021-2018
DI 10.1128/microbiolspec.GPP3-0021-2018
PG 27
WC Microbiology
SC Microbiology
GA HN4GJ
UT WOS:000460142100003
PM 30767846
DA 2020-05-07
ER

PT J
AU Held, NA
   McIlvin, MR
   Moran, DM
   Laub, MT
   Saito, MA
AF Held, Noelle A.
   McIlvin, Matthew R.
   Moran, Dawn M.
   Laub, Michael T.
   Saito, Mak A.
TI Unique Patterns and Biogeochemical Relevance of Two-Component Sensing in
   Marine Bacteria
SO MSYSTEMS
LA English
DT Article
DE biogeochemistry; cell signaling; gene regulation; marine microbiology;
   proteomics; regulatory network; two-component system
ID ORPHAN RESPONSE REGULATOR; GENE-EXPRESSION; GROWTH-RATES; IRON;
   PROCHLOROCOCCUS; NUTRIENT; SYSTEMS; TRICHODESMIUM; EVOLUTION; PHOSPHATE
AB Two-component sensory (TCS) systems link microbial physiology to the environment and thus may play key roles in biogeochemical cycles. In this study, we surveyed the TCS systems of 328 diverse marine bacterial species. We identified lifestyle traits such as copiotrophy and diazotrophy that are associated with larger numbers of TCS system genes within the genome. We compared marine bacterial species with 1,152 reference bacterial species from a variety of habitats and found evidence of extra response regulators in marine genomes. Examining the location of TCS genes along the circular bacterial genome, we also found that marine bacteria have a large number of "orphan" genes, as well as many hybrid histidine kinases. The prevalence of "extra" response regulators, orphan genes, and hybrid TCS systems suggests that marine bacteria break with traditional understanding of how TCS systems operate. These trends suggest prevalent regulatory networking, which may allow coordinated physiological responses to multiple environmental signals and may represent a specific adaptation to the marine environment. We examine phylogenetic and lifestyle traits that influence the number and structure of two-component systems in the genome, finding, for example, that a lack of two-component systems is a hallmark of oligotrophy. Finally, in an effort to demonstrate the importance of TCS systems to marine biogeochemistry, we examined the distribution of Prochlorococcus/Synechococcus response regulator PMT9312_0717 in metaproteomes of the tropical South Pacific. We found that this protein's abundance is related to phosphate concentrations, consistent with a putative role in phosphate regulation.
   IMPORTANCE Marine microbes must manage variation in their chemical, physical, and biological surroundings. Because they directly link bacterial physiology to environmental changes, TCS systems are crucial to the bacterial cell. This study surveyed TCS systems in a large number of marine bacteria and identified key phylogenetic and lifestyle patterns in environmental sensing. We found evidence that, in comparison with bacteria as a whole, marine organisms have irregular TCS system constructs which might represent an adaptation specific to the marine environment. Additionally, we demonstrate the biogeochemical relevance of TCS systems by correlating the presence of the PMT9312_0717 response regulator protein to phosphate concentrations in the South Pacific. We highlight that despite their potential ecological and biogeochemical relevance, TCS systems have been understudied in the marine ecosystem. This report expands our understanding of the breadth of bacterial TCS systems and how marine bacteria have adapted to survive in their unique environment.
C1 [Held, Noelle A.] MIT WHOI Joint Program Oceanog Appl Ocean Sci & E, Woods Hole, MA USA.
   [McIlvin, Matthew R.; Moran, Dawn M.; Saito, Mak A.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA.
   [Laub, Michael T.] MIT, Dept Biol, Cambridge, MA USA.
   [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA USA.
RP Saito, MA (reprint author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA.
EM msaito@whoi.edu
OI /0000-0003-1073-0851; /0000-0002-8288-7607
FU National Science Foundation Graduate Research FellowshipNational Science
   Foundation (NSF) [1122274]; Gordon and Betty Moore FoundationGordon and
   Betty Moore Foundation [3782]; National Science FoundationNational
   Science Foundation (NSF) [OCE-1657766, EarthCube 1639714, OCE-1658030,
   OCE-1260233]
FX This material is based on work supported by a National Science
   Foundation Graduate Research Fellowship under grant number 1122274 (N.
   A. Held). It was also supported by the Gordon and Betty Moore Foundation
   (grant number 3782 [M. Saito]) and by the National Science Foundation
   (grant numbers OCE-1657766, EarthCube 1639714, OCE-1658030, and
   OCE-1260233).
CR Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143
   Barakat M, 2011, NUCLEIC ACIDS RES, V39, pD771, DOI 10.1093/nar/gkq1023
   Browning TJ, 2017, NATURE, V551, P242, DOI 10.1038/nature24063
   Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039
   Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188
   Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998
   Dupont CL, 2015, ISME J, V9, P1076, DOI 10.1038/ismej.2014.198
   Espinosa J, 2015, P NATL ACAD SCI USA, V112, P2198, DOI 10.1073/pnas.1424632112
   Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223
   Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002
   Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057
   Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12
   HEERMANN R, 2010, BACTERIAL SIGNALING, P135, DOI DOI 10.1002/9783527629237.CH8
   Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293
   Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003
   Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74
   Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851
   Kirchman DL, 2016, ANNU REV MAR SCI, V8, P285, DOI 10.1146/annurev-marine-122414-033938
   Koch AL, 2001, BIOESSAYS, V23, P657, DOI 10.1002/bies.1091
   Kusian B, 1997, FEMS MICROBIOL REV, V21, P135, DOI 10.1111/j.1574-6976.1997.tb00348.x
   Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106
   Lehti TA, 2012, J BACTERIOL, V194, P3475, DOI 10.1128/JB.06596-11
   Lopez-Perez M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-483
   Lu YH, 2011, J BACTERIOL, V193, P3020, DOI 10.1128/JB.00017-11
   Luo CW, 2011, P NATL ACAD SCI USA, V108, pE62, DOI 10.1073/pnas.1018662108
   Lyon P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00264
   Lyons NA, 2015, CURR OPIN MICROBIOL, V24, P21, DOI 10.1016/j.mib.2014.12.007
   Mackey KRM, 2015, P NATL ACAD SCI USA, V112, P9944, DOI 10.1073/pnas.1509448112
   Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103
   Mary I, 2003, FEMS MICROBIOL LETT, V226, P135, DOI 10.1016/S0378-1097(03)00587-1
   Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268
   Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308
   Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]
   MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259
   Mourino-Perez RR, 2003, APPL ENVIRON MICROB, V69, P6923, DOI 10.1128/AEM.69.11.6923-6931.2003
   Mukherjee S, 2017, NAT BIOTECHNOL, V35, P676, DOI 10.1038/nbt.3886
   Noble AE, 2012, LIMNOL OCEANOGR, V57, P989, DOI 10.4319/lo.2012.57.4.0989
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200
   Orchard ED, 2009, ENVIRON MICROBIOL, V11, P2400, DOI 10.1111/j.1462-2920.2009.01968.x
   Overgaard M, 2006, J BACTERIOL, V188, P4384, DOI 10.1128/JB.00189-06
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Pernthaler A, 2001, APPL ENVIRON MICROB, V67, P4077, DOI 10.1128/AEM.67.9.4077-4083.2001
   Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917
   Reynolds TB, 2008, EUKARYOT CELL, V7, P122, DOI 10.1128/EC.00310-06
   Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181
   Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276
   Saito MA, 2015, PROTEOMICS, V15, P3521, DOI 10.1002/pmic.201400630
   Saito MA, 2014, SCIENCE, V345, P1173, DOI 10.1126/science.1256450
   Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108
   Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041
   Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103
   STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541
   Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929
   Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110
   Teira E, 2008, ENVIRON MICROBIOL, V10, P906, DOI 10.1111/j.1462-2920.2007.01509.x
   Walworth NG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12081
   Webb EA, 2009, ENVIRON MICROBIOL, V11, P338, DOI 10.1111/j.1462-2920.2008.01771.x
   Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x
   Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011
   YAMADA M, 1989, J BACTERIOL, V171, P5601, DOI 10.1128/jb.171.10.5601-5606.1989
   Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200
NR 66
TC 3
Z9 3
U1 2
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD JAN-FEB
PY 2019
VL 4
IS 1
AR e00317-18
DI 10.1128/mSystems.00317-18
PG 16
WC Microbiology
SC Microbiology
GA HN7BQ
UT WOS:000460343800030
PM 30746496
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Jones, CM
   Hallin, S
AF Jones, Christopher M.
   Hallin, Sara
TI Geospatial variation in co-occurrence networks of nitrifying microbial
   guilds
SO MOLECULAR ECOLOGY
LA English
DT Article
DE ammonia-oxidizing communities; network analysis; nitrite-oxidizing
   communities; soil microbiology; spatial mapping
ID NITRITE-OXIDIZING BACTERIA; 16S RIBOSOMAL-RNA; AMMONIA-OXIDIZERS; NICHE
   DIFFERENTIATION; COMPLETE NITRIFICATION; COMMUNITY STRUCTURE; SOIL;
   NITROSPIRA; PATTERNS; DIVERSITY
AB Microbial communities transform nitrogen (N) compounds, thereby regulating the availability of N in soil. The N cycle is defined by interacting microbial functional groups, as inorganic N-products formed in one process are the substrate in one or several other processes. The nitrification pathway is often a two-step process in which bacterial or archaeal communities oxidize ammonia to nitrite, and bacterial communities further oxidize nitrite to nitrate. Little is known about the significance of interactions between ammonia-oxidizing bacteria (AOB) and archaea (AOA) and nitrite-oxidizing bacterial communities (NOB) in determining the spatial variation of overall nitrifier community structure. We hypothesize that non-random associations exist between different AO and NOB lineages that, along with edaphic factors, shape field-scale spatial patterns of nitrifying communities. To address this, we sequenced and quantified the abundance of AOA, AOB, and Nitrospira and Nitrobacter NOB communities across a 44-hectare site with agricultural fields. The abundance of Nitrobacter communities was significantly associated only with AOB abundance, while that of Nitrospira was correlated to AOA. Network analysis and geostatistical modelling revealed distinct modules of co-occurring AO and NOB groups occupying disparate areas, with each module dominated by different lineages and associated with different edaphic factors. Local communities were characterized by a high proportion of module-connecting versus module-hub nodes, indicating that nitrifier assemblages in these soils are shaped by fluctuating conditions. Overall, our results demonstrate the utility of network analysis in accounting for potential biotic interactions that define the niche space of nitrifying communities at scales compatible to soil management.
C1 [Jones, Christopher M.; Hallin, Sara] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.
RP Jones, CM (reprint author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden.
EM Chris.jones@slu.se
RI Jones, Chris/G-7687-2011; Hallin, Sara/H-4648-2012
OI Jones, Chris/0000-0002-2723-6019; Hallin, Sara/0000-0002-9069-9024
FU Svenska Forskningsradet FormasSwedish Research Council Formas [2009-741]
FX Svenska Forskningsradet Formas, Grant/Award Number: 2009-741
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Attard E, 2010, ENVIRON MICROBIOL, V12, P315, DOI 10.1111/j.1462-2920.2009.02070.x
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Beeckman F, 2018, CURR OPIN BIOTECH, V50, P166, DOI 10.1016/j.copbio.2018.01.014
   Blois JL, 2014, ECOGRAPHY, V37, P1095, DOI 10.1111/ecog.00779
   Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40
   Csardi G, 2006, INT J COMPLEX SYST, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191
   Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001
   Daims H, 2016, TRENDS MICROBIOL, V24, P699, DOI 10.1016/j.tim.2016.05.004
   Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461
   DAmen M., 2017, ECOGRAPHY, V23, P311, DOI DOI 10.1111/EC0G.03148
   Deng Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-113
   Diamond J.M., 1975, P342
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102
   Gilarranz LJ, 2017, SCIENCE, V357, P199, DOI 10.1126/science.aal4122
   Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2
   Gruber-Dorninger C, 2015, ISME J, V9, P643, DOI 10.1038/ismej.2014.156
   Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108
   Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12
   Hawkes CV, 2015, ECOL LETT, V18, P612, DOI 10.1111/ele.12451
   Hink L, 2018, ISME J, V12, P1084, DOI 10.1038/s41396-017-0025-5
   Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286
   Jeanbille M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01637
   Juhanson J, 2017, SOIL BIOL BIOCHEM, V115, P82, DOI 10.1016/j.soilbio.2017.08.013
   Ke XB, 2013, ENVIRON MICROBIOL, V15, P2275, DOI 10.1111/1462-2920.12098
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Le Roux X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00628
   Lehtovirta-Morley LE, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw057
   Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108
   Li YY, 2018, SOIL BIOL BIOCHEM, V116, P290, DOI 10.1016/j.soilbio.2017.10.023
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma B, 2016, ISME J, V10, P1891, DOI 10.1038/ismej.2015.261
   Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x
   Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044
   Mintie AT, 2003, APPL ENVIRON MICROB, V69, P3129, DOI 10.1128/AEM.69.6.3129-3136.2003
   MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142
   Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529
   Nowka B, 2015, APPL ENVIRON MICROB, V81, P745, DOI 10.1128/AEM.02734-14
   Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614
   Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104
   Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012
   Pester M, 2014, ENVIRON MICROBIOL, V16, P3055, DOI 10.1111/1462-2920.12300
   Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001
   Purkhold U, 2003, INT J SYST EVOL MICR, V53, P1485, DOI 10.1099/ijs.0.02638-0
   Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105
   Rottjers L, 2018, FEMS MICROBIOL REV, V42, P761, DOI 10.1093/femsre/fuy030
   Sauder LA, 2017, ISME J, V11, P1142, DOI 10.1038/ismej.2016.192
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schramm A, 2000, ENVIRON MICROBIOL, V2, P680, DOI 10.1046/j.1462-2920.2000.00150.x
   Shi SJ, 2016, ECOL LETT, V19, P926, DOI 10.1111/ele.12630
   Simonin M, 2015, MICROB ECOL, V70, P809, DOI 10.1007/s00248-015-0604-9
   Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955
   Soderstrom M., 2004, P 12 INT C MECH FIEL
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Stempfhuber B., 2016, FRONTIERS MICROBIOLO, V6, P861
   Stempfhuber B, 2017, BIOL FERT SOILS, V53, P691, DOI 10.1007/s00374-017-1215-z
   Stenberg M, 2012, SCI TOTAL ENVIRON, V434, P79, DOI 10.1016/j.scitotenv.2011.12.039
   Sterngren AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01350
   Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108
   Strona G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5114
   Tourna M, 2010, APPL ENVIRON MICROB, V76, P2468, DOI 10.1128/AEM.01964-09
   van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459
   Vanparys B, 2007, SYST APPL MICROBIOL, V30, P297, DOI 10.1016/j.syapm.2006.11.006
   Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358
   Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235
   Wertz S, 2012, FEMS MICROBIOL ECOL, V79, P142, DOI 10.1111/j.1574-6941.2011.01204.x
   Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206
   Wu J, 2006, GEODERMA, V134, P187, DOI 10.1016/j.geoderma.2005.11.002
   Yao HY, 2013, ENVIRON MICROBIOL, V15, P2545, DOI 10.1111/1462-2920.12141
NR 82
TC 5
Z9 5
U1 7
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1083
EI 1365-294X
J9 MOL ECOL
JI Mol. Ecol.
PD JAN
PY 2019
VL 28
IS 2
SI SI
BP 293
EP 306
DI 10.1111/mec.14893
PG 14
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA HM3AS
UT WOS:000459345000011
PM 30307658
OA Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Kociolek, LK
   Perdue, ER
   Fawley, WN
   Wilcox, MH
   Gerding, DN
   Johnson, S
AF Kociolek, Larry K.
   Perdue, Eric R.
   Fawley, Warren N.
   Wilcox, Mark H.
   Gerding, Dale N.
   Johnson, Stuart
TI Correlation between restriction endonuclease analysis and PCR ribotyping
   for the identification of Clostridioides (Clostridium) difficile
   clinical strains
SO ANAEROBE
LA English
DT Article
DE Clostridium difficile; Molecular epidemiology; Typing; Restriction
   endonuclease analysis; PCR ribotyping
ID FIELD GEL-ELECTROPHORESIS; EPIDEMIC
AB Restriction endonuclease analysis (REA) and PCR ribotyping are two typing systems that have been frequently utilized for molecular epidemiologic characterization of Clostridioides (Clostridium) difficile. To correlate typing data obtained from each method, we performed both REA and PCR ribotyping on a large and diverse set of historical and contemporary C. difficile infection clinical isolates. Eighty isolates were selected from each reference laboratory in the United States (Microbiology Reference Laboratory, Hines VA Medical Center) and United Kingdom (Clostridium difficile Network for England and Northern Ireland laboratory, University of Leeds). The 160 isolates were assigned to 82 unique ribotypes and 51 unique REA groups (116 unique REA types). In general, concordance between typing methods was good. Dendrogram analysis of PCR ribotype band patterns demonstrated close genetic relationships among strain types with discordant REA and ribotype assignments. While REA typing was more discriminatory, several REA types in this study were further discriminated by PCR ribotyping, indicating that discriminatory value of these typing methods may be strain dependent. These data will assist with molecular epidemiologic surveillance of strains identified by these two commonly used C. difficile typing systems. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Kociolek, Larry K.] Northwestern Univ, Feinberg Sch Med, 420 E Super St, Chicago, IL 60611 USA.
   [Kociolek, Larry K.] Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA.
   [Perdue, Eric R.; Gerding, Dale N.; Johnson, Stuart] Edward Hines Jr VA Hosp, 5000 5th Ave, Hines, IL 60141 USA.
   [Fawley, Warren N.; Wilcox, Mark H.] Leeds Teaching Hosp, Leeds LS2 9JT, W Yorkshire, England.
   [Fawley, Warren N.; Wilcox, Mark H.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England.
   [Gerding, Dale N.; Johnson, Stuart] Loyola Univ, Chicago Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA.
RP Kociolek, LK (reprint author), Searle Med Res Bldg,320 E Super St 15-560, Chicago, IL 60611 USA.
EM larry-kociolek@northwestern.edu; eric.perdue2@gmail.com;
   warren.fawley@nhs.net; mark.wilcox@nhs.net; Dale.Gerding2@va.gov;
   Stuart.Johnson2@va.gov
FU US Department of Veterans Affairs Research ServiceUS Department of
   Veteran Affairs; National Institute of Allergy and Infectious Diseases
   at the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [K23 AI123525]
FX The authors acknowledge Adam Cheknis, Laurica Petrella-Zitko, and Susan
   Sambol for their assistance with performance of REA. D.N.G. and S.J. are
   both supported by the US Department of Veterans Affairs Research
   Service. L.K.K. is supported by a grant from the National Institute of
   Allergy and Infectious Diseases at the National Institutes of Health
   [K23 AI123525].
CR CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993
   Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064
   Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150
   Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09
   He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478
   Huber CA, 2013, J CLIN MICROBIOL, V51, P2810, DOI 10.1128/JCM.00143-13
   Karlsson M., 2014, 13 BIENN C AN SOC AM
   Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500
   Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07
   Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003
   KRISTJANSSON M, 1994, J CLIN MICROBIOL, V32, P1963
   Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639
   Manzo CE, 2014, ANAEROBE, V28, P4, DOI 10.1016/j.anaerobe.2014.04.005
   McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590
   Public Health England, 2013, CLOSTR DIFF RIB NETW
   Sambol SP, 2016, METHODS MOL BIOL, V1476, P1, DOI 10.1007/978-1-4939-6361-4_1
   Sambrook J., 2001, MOL CLONING LAB MANU
   Tenover FC, 2011, J CLIN MICROBIOL, V49, P1831, DOI 10.1128/JCM.02446-10
NR 18
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1075-9964
EI 1095-8274
J9 ANAEROBE
JI Anaerobe
PD DEC
PY 2018
VL 54
SI SI
BP 1
EP 7
DI 10.1016/j.anaerobe.2018.07.004
PG 7
WC Microbiology
SC Microbiology
GA HG1XA
UT WOS:000454753200001
PM 30009944
OA Green Accepted, Green Published
DA 2020-05-07
ER

PT J
AU Cambau, E
   Saunderson, P
   Matsuoka, M
   Cole, ST
   Kai, M
   Suffys, P
   Rosa, PS
   Williams, D
   Gupta, UD
   Lavania, M
   Cardona-Castro, N
   Miyamoto, Y
   Hagge, D
   Srikantam, A
   Hongseng, W
   Indropo, A
   Vissa, V
   Johnson, RC
   Cauchoix, B
   Pannikar, VK
   Cooreman, EAWD
   Pemmaraju, VRR
   Gillini, L
AF Cambau, E.
   Saunderson, P.
   Matsuoka, M.
   Cole, S. T.
   Kai, M.
   Suffys, P.
   Rosa, P. S.
   Williams, D.
   Gupta, U. D.
   Lavania, M.
   Cardona-Castro, N.
   Miyamoto, Y.
   Hagge, D.
   Srikantam, A.
   Hongseng, W.
   Indropo, A.
   Vissa, V.
   Johnson, R. C.
   Cauchoix, B.
   Pannikar, V. K.
   Cooreman, E. A. W. D.
   Pemmaraju, V. R. R.
   Gillini, L.
CA WHO Surveillance Network Antimi
TI Antimicrobial resistance in leprosy: results of the first prospective
   open survey conducted by a WHO surveillance network for the period
   2009-15
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Antibiotic; Dapsone; Mycobacterium leprae; Ofloxacin; Resistance;
   Rifampicin
ID MYCOBACTERIUM-LEPRAE; DRUG-RESISTANCE; DIHYDROPTEROATE SYNTHASE;
   MULTIDRUG-RESISTANCE; DAPSONE RESISTANCE; MUTATIONS; RIFAMPIN;
   OFLOXACIN; THERAPY
AB Objectives: Antimicrobial resistance (AMR) is a priority for surveillance in bacterial infections. For leprosy, AMR has not been assessed because Mycobacterium leprae does not grow in vitro. We aim to obtain AMR data using molecular detection of resistance genes and to conduct a prospective open survey of resistance to antileprosy drugs in countries where leprosy is endemic through a WHO surveillance network.
   Methods: From 2009 to 2015, multi-bacillary leprosy cases at sentinel sites of 19 countries were studied for resistance to rifampicin, dapsone and ofloxacin by PCR sequencing of the drug-resistance-determining regions of the genes rpoB, folP1 and gyrA.
   Results: Among 1932 (1143 relapse and 789 new) cases studied, 154 (8.0%) M. leprae strains were found with mutations conferring resistance showing 182 resistance traits (74 for rifampicin, 87 for dapsone and 21 for ofloxacin). Twenty cases showed rifampicin and dapsone resistance, four showed ofloxacin and dapsone resistance, but no cases were resistant to rifampicin and ofloxacin. Rifampicin resistance was observed among relapse (58/1143, 5.1%) and new (16/789, 2.0%) cases in 12 countries. India, Brazil and Colombia reported more than five rifampicin-resistant cases.
   Conclusions: This is the first study reporting global data on AMR in leprosy. Rifampicin resistance emerged, stressing the need for expansion of surveillance. This is also a call for vigilance on the global use of antimicrobial agents, because ofloxacin resistance probably developed in relation to the general intake of antibiotics for other infections as it is not part of the multidrug combination used to treat leprosy. (C) 2018 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Cambau, E.] Univ Paris Diderot, APHP Lariboisiere, APHP Pitie Salpetriere,UMR 1137,IAME,Inserm, Ctr Reference Mycobacteries & Resistance Mycobact, Paris, France.
   [Saunderson, P.] Amer Leprosy Missions, Greenville, SC USA.
   [Matsuoka, M.; Kai, M.; Miyamoto, Y.] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan.
   [Cole, S. T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.
   [Cole, S. T.; Johnson, R. C.; Cauchoix, B.] Fdn Raoul Follereau, Paris, France.
   [Suffys, P.] Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Rosa, P. S.] Inst Lauro de Souza Lima, Sao Paulo, Brazil.
   [Williams, D.] Natl Hansens Dis Programs, Baton Rouge, LA USA.
   [Gupta, U. D.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India.
   [Lavania, M.] TLM Community Hosp, Stanley Browne Lab, Delhi, India.
   [Cardona-Castro, N.] Inst Colombiano Med Trop, Sabaneta, Antioquia, Colombia.
   [Hagge, D.] Anandaban Hosp, Mycobacterial Res Labs, Kathmandu, Nepal.
   [Srikantam, A.] Lepra Blue Peter Publ Hlth & Res Ctr, Hyderabad, India.
   [Hongseng, W.] Chinese Acad Med Sci, Inst Dermatol, Natl Ctr STD & Leprosy Control, Beijing, Peoples R China.
   [Indropo, A.] Airlangga Univ, Surabaya, Indonesia.
   [Vissa, V.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Pannikar, V. K.; Cooreman, E. A. W. D.; Pemmaraju, V. R. R.; Gillini, L.] WHO Reg Off South East Asia, Global Leprosy Programme, New Delhi, India.
RP Cambau, E (reprint author), Lariboisiere Hosp, Bacteriol Dept, 2 Rue Ambroise Pare, F-75010 Paris, France.
EM emmanuelle.cambau@aphp.fr
RI suffys, philip/E-3009-2013; Suzuki, Yasuhiko/F-6890-2012;
   Cardona-Castro, Nora/L-6846-2015
OI Cardona-Castro, Nora/0000-0002-4716-6636
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [IZRJZ3_164174]; ministries of health; Fondation Raoul Follereau;
   American Leprosy Missions; National Hansen's Disease Programs; Sasakawa
   Memorial Health Foundation; Damien Foundation; Lepra
FX Logistics, materials and meetings benefit from annual grants from
   ministries of health from all countries and from non-governmental
   agencies supporting leprosy, including Fondation Raoul Follereau,
   American Leprosy Missions, National Hansen's Disease Programs, Sasakawa
   Memorial Health Foundation, Damien Foundation and Lepra. Specific grants
   were also used to support the study: Swiss National Science Foundation
   grant IZRJZ3_164174.
CR Andre E, 2017, CLIN MICROBIOL INFEC, V23, P167, DOI [10.1016, 10.1016/j.cmi.2016.09.006]
   [Anonymous], 2010, Wkly Epidemiol Rec, V85, P281
   Avanzi C, 2016, CLIN INFECT DIS, V63, P1482, DOI 10.1093/cid/ciw572
   Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13
   Beltran-Alzate C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005041
   Cambau E, 1997, LANCET, V349, P103, DOI 10.1016/S0140-6736(05)60888-4
   Cambau E, 2006, CLIN INFECT DIS, V42, P238, DOI 10.1086/498506
   Cambau E, 2002, CLIN INFECT DIS, V34, P39, DOI 10.1086/324623
   Cambau E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001739
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cooreman E., 2016, WEEKLY EPIDEMIOLOGIC, V91, P400
   CROFTON J, 1948, BMJ-BRIT MED J, V2, P1009, DOI 10.1136/bmj.2.4588.1009
   GROSSET J, 1985, INT J LEPROSY, V53, P118
   GUELPALAURAS CC, 1987, INT J LEPROSY, V55, P672
   HONORE N, 1993, ANTIMICROB AGENTS CH, V37, P414, DOI 10.1128/AAC.37.3.414
   Inoue H, 2017, B WORLD HEALTH ORGAN, V95, P242, DOI 10.2471/BLT.17.191890
   JACOBSON RR, 1976, LANCET, V2, P1304
   Ji B, 1998, LEPROSY REV, V69, P106
   Kai M, 1999, FEMS MICROBIOL LETT, V177, P231, DOI 10.1111/j.1574-6968.1999.tb13737.x
   Kai M, 2011, CLIN INFECT DIS, V52, pE127, DOI 10.1093/cid/ciq217
   Li W, 2012, J CLIN MICROBIOL, V50, P742, DOI 10.1128/JCM.05183-11
   Maeda S, 2001, ANTIMICROB AGENTS CH, V45, P3635, DOI 10.1128/AAC.45.12.3635-3639.2001
   Matsuoka M, 2008, J MED MICROBIOL, V57, P1213, DOI 10.1099/jmm.0.2008/002600-0
   Matsuoka M, 2007, LEPROSY REV, V78, P343
   PEARSON JMH, 1975, LANCET, V2, P69
   Rocha AD, 2012, J CLIN MICROBIOL, V50, P1912, DOI 10.1128/JCM.06561-11
   Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8
   SHEPARD CC, 1968, AM J TROP MED HYG, V17, P192, DOI 10.4269/ajtmh.1968.17.192
   Smith CS, 2017, LANCET INFECT DIS, V17, pE293, DOI 10.1016/S1473-3099(17)30418-8
   WHO, 2017, MON EV GUID
   WHO, 2011, WEEKLY EPIDEM REC, V23, P233
   WHO, 2017, GUID SURV ANT RES LE
   WHO, 1982, CHEM LEPR CONTR PROG
   WHO. Global leprosy strategy, 2016, GLOB LEPR STRAT 2006
   Williams DL, 2014, CLIN INFECT DIS, V58, P72, DOI 10.1093/cid/cit628
   Williams DL, 2000, ANTIMICROB AGENTS CH, V44, P1530, DOI 10.1128/AAC.44.6.1530-1537.2000
   World Health Organization, 2009, GUID GLOB SURV DRUG
   WorldHealth Organization, 2016, GLOB LEPR STRAT 2016
   You EY, 2005, J INFECTION, V50, P6, DOI 10.1016/j.jinf.2004.03.012
   Zignol M, 2016, NEW ENGL J MED, V375, P1081, DOI 10.1056/NEJMsr1512438
NR 40
TC 18
Z9 18
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD DEC
PY 2018
VL 24
IS 12
BP 1305
EP 1310
DI 10.1016/j.cmi.2018.02.022
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HB4UU
UT WOS:000451052700015
PM 29496597
OA Other Gold, Green Published
DA 2020-05-07
ER

PT J
AU Mataragas, M
   Alessandria, V
   Ferrocino, I
   Rantsiou, K
   Cocolin, L
AF Mataragas, Marios
   Alessandria, Valentina
   Ferrocino, Ilario
   Rantsiou, Kalliopi
   Cocolin, Luca
TI A bioinformatics pipeline integrating predictive metagenomics profiling
   for the analysis of 16S rDNA/rRNA sequencing data originated from foods
SO FOOD MICROBIOLOGY
LA English
DT Article
DE Amplicon sequencing; Food microbiology; Metabolic network; Meta-omics;
   Microbial risk assessment; Molecular microbiology; Predictive functional
   profiling
ID LACTIC-ACID BACTERIA; GRANA PADANO CHEESE; PROCESSING ENVIRONMENT;
   SPOILAGE MICROBIOTA; WHEY STARTERS; PROPIONIBACTERIA; METABOLISM;
   GENERATION; PROTEOLYSIS; ALIGNMENT
AB The recent advances in molecular biology, such as the advent of next-generation sequencing (NGS) platforms, have paved the way to new exciting tools which rapidly transform food microbiology. Nowadays, NGS methods such as 16S rDNA/rRNA metagenomics or amplicon sequencing are used for the taxonomic profiling of the food microbial communities. Although 16S rDNA/rRNA NGS-based microbial data are not suited for the investigation of the functional potential of the identified operational taxonomic units as compared to shotgun metagenomics, advances in the bioinformatics discipline allow now the performance of such studies. In this paper, a bioinformatics workflow is described integrating predictive metagenomics profiling with specific application to food microbiology data. Bioinformatics tools pertinent to each sub-module of the pipeline are suggested as well. The published 16S rDNA/rRNA amplicon data originated from an Italian Grana-type cheese, using an NGS platform, was employed to demonstrate the predictive metagenomics profiling approach. The pipeline identified the microbial community and the changes that occurred in the microbial profile during manufacture of the food product studied (taxonomic profiling). The workflow also indicated significant changes in the functional profiling of the community. The tool may help to investigate the functional potential, alterations, and interactions of a microbial community. The proposed workflow may also find an application in the investigation of the ecology of foodborne pathogens encountered in various food products.
C1 [Mataragas, Marios] Inst Technol Agr Prod, Hellen Agr Org DEMETER, Dept Dairy Res, Ethnikis Antistaseos 3, Ioannina 45221, Greece.
   [Alessandria, Valentina; Ferrocino, Ilario; Rantsiou, Kalliopi; Cocolin, Luca] Univ Turin, Dept Agr Forest & Food Sci, Lab Food Microbiol, Largo P Braccini 2, I-10095 Turin, Italy.
RP Mataragas, M (reprint author), Inst Technol Agr Prod, Hellen Agr Org DEMETER, Dept Dairy Res, Ethnikis Antistaseos 3, Ioannina 45221, Greece.
EM mmatster@gmail.com
RI Cocolin, Luca/H-5091-2012
OI Cocolin, Luca/0000-0003-4799-7074
CR Alessandria V, 2016, APPL ENVIRON MICROB, V82, P3988, DOI 10.1128/AEM.00999-16
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497
   Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287
   Baer A, 1995, LAIT, V75, P391, DOI 10.1051/lait:19954-529
   Balvociute M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3501-4
   Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185
   BRENDEHAUG J, 1985, J DAIRY SCI, V68, P281, DOI 10.3168/jds.S0022-0302(85)80823-7
   Brul S, 2012, TRENDS FOOD SCI TECH, V27, P12, DOI 10.1016/j.tifs.2012.04.004
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Carcano M, 1995, LAIT, V75, P415, DOI 10.1051/lait:19954-531
   Cocolin L, 2018, INT J FOOD MICROBIOL, V287, P10, DOI 10.1016/j.ijfoodmicro.2017.11.008
   Coughlan LM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00672
   Courtin P, 2004, LAIT, V84, P125, DOI 10.1051/lait:2003031
   De Filippis F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21871
   De Filippo C, 2012, BRIEF BIOINFORM, V13, P696, DOI 10.1093/bib/bbs070
   Delcenserie V, 2014, J DAIRY SCI, V97, P6046, DOI 10.3168/jds.2014-8225
   Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295
   Dudhagara P, 2015, GENOM PROTEOM BIOINF, V13, P296, DOI 10.1016/j.gpb.2015.10.003
   Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74
   Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12
   Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348
   Ferrocino I, 2017, CURR OPIN FOOD SCI, V13, P10, DOI 10.1016/j.cofs.2017.01.002
   Ferrocino I, 2016, APPL ENVIRON MICROB, V82, P549, DOI 10.1128/AEM.03093-15
   Frohlich-Wyder MT, 2002, LAIT, V82, P1, DOI 10.1051/lait:2001001
   Gagnaire V, 2001, J AGR FOOD CHEM, V49, P4402, DOI 10.1021/jf000895z
   Gonzalez-Olivares L, 2014, J BIOSCIENCES MED, V2, P7, DOI DOI 10.4236/JBM.2014.23002
   HAMMER O., 2001, PALAEONTOL ELECTRON, V4, P1, DOI DOI 10.1016/J.BCP.2008.05.025
   Heinken A, 2015, APPL ENVIRON MICROB, V81, P4049, DOI 10.1128/AEM.00101-15
   HEMME DH, 1981, J DAIRY RES, V48, P139, DOI 10.1017/S0022029900021555
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   HICKEY MW, 1983, AUST J BIOL SCI, V36, P487
   Iwai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166104
   Jia HX, 2015, CYTA-J FOOD, V13, P464, DOI 10.1080/19476337.2014.1003099
   Jimeno J, 1995, LAIT, V75, P401, DOI 10.1051/lait:19954-530
   Keller A, 2014, GENE, V549, P186, DOI 10.1016/j.gene.2014.07.066
   Kerjean JR, 2000, FOOD RES INT, V33, P281, DOI 10.1016/S0963-9969(00)00048-X
   Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002
   Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502
   Kuntal BK, 2013, GENOMICS, V102, P409, DOI 10.1016/j.ygeno.2013.08.004
   KURTZ FE, 1959, J DAIRY SCI, V42, P1008, DOI 10.3168/jds.S0022-0302(59)90684-8
   Ladoukakis Efthymios, 2014, Front Cell Dev Biol, V2, P70, DOI 10.3389/fcell.2014.00070
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lazzi C, 2004, J APPL MICROBIOL, V96, P481, DOI 10.1111/j.1365-2672.2004.02180.x
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Liu SQ, 2003, INT J FOOD MICROBIOL, V83, P115, DOI 10.1016/S0168-1605(02)00366-5
   LIU WJ, 2015, BMC MICROBIOL, V15
   Mendes-Soares H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1230-3
   Minot SS, 2015, BIORXIV, DOI [10.1101/027607, DOI 10.1101/027607]
   NOEL Y, 1999, TECHNOLOGY CHEESEMAK, P222
   Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462
   Parente E., 2004, CHEESE CHEM PHYS MIC, V1, P123, DOI DOI 10.1016/S1874-558X(04)80065-4
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041
   Parlapani FF, 2013, FOOD MICROBIOL, V33, P85, DOI 10.1016/j.fm.2012.09.001
   Parlapani FF, 2016, LWT-FOOD SCI TECHNOL, V66, P553, DOI 10.1016/j.lwt.2015.11.007
   Parlapani FF, 2015, J SCI FOOD AGR, V95, P2386, DOI 10.1002/jsfa.6957
   Piveteau PG, 1995, LAIT, V75, P331, DOI 10.1051/lait:19954-525
   Polka J, 2015, FOOD MICROBIOL, V46, P342, DOI 10.1016/j.fm.2014.08.023
   Pothakos V, 2015, APPL ENVIRON MICROB, V81, P3529, DOI 10.1128/AEM.03941-14
   PREMI L, 1972, APPL MICROBIOL, V24, P51, DOI 10.1128/AEM.24.1.51-57.1972
   Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252
   Pylro VS, 2016, MICROB ECOL, V72, P443, DOI 10.1007/s00248-016-0785-x
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030
   Rantsiou K, 2011, TRENDS FOOD SCI TECH, V22, pS21, DOI 10.1016/j.tifs.2011.03.002
   Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526
   Rossetti L, 2008, INT J FOOD MICROBIOL, V127, P168, DOI 10.1016/j.ijfoodmicro.2008.06.005
   Rossi F, 2012, INT J DAIRY TECHNOL, V65, P401, DOI 10.1111/j.1471-0307.2012.00844.x
   Roumpeka DD, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00023
   Sattin E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01272
   Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013
   Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209
   Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002
   Stellato G, 2016, APPL ENVIRON MICROB, V82, P4045, DOI 10.1128/AEM.00793-16
   Thierry A, 2011, INT J FOOD MICROBIOL, V149, P19, DOI 10.1016/j.ijfoodmicro.2011.04.026
   VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994
   Wood J., 2016, BIOINFORMATICS REV, V2, P1
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
   Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755
NR 81
TC 1
Z9 1
U1 2
U2 88
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0740-0020
EI 1095-9998
J9 FOOD MICROBIOL
JI Food Microbiol.
PD DEC
PY 2018
VL 76
BP 279
EP 286
DI 10.1016/j.fm.2018.05.009
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
SC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
GA GR6LL
UT WOS:000442762900032
PM 30166151
DA 2020-05-07
ER

PT J
AU Hazim, C
   Ibrahim, RA
   Westercamp, M
   Belete, GA
   Kibret, BA
   Kanter, T
   Yimer, G
   Adem, TS
   Stevenson, KB
   Urrego, M
   Kale, KN
   Omondi, MW
   VanderEnde, D
   Park, BJ
   Parsons, MMB
   Gallagher, KM
AF Hazim, Carmen
   Ibrahim, Rajiha Abubeker
   Westercamp, Matthew
   Belete, Gebrie Alebachew
   Kibret, Berhanu Amare
   Kanter, Theresa
   Yimer, Getnet
   Adem, Thuria Siraj
   Stevenson, Kurt B.
   Urrego, Maritza
   Kale, Kashmira N.
   Omondi, Michael W.
   VanderEnde, Daniel
   Park, Benjamin J.
   Parsons, Michele M. B.
   Gallagher, Kathleen M.
TI Establishment of a Sentinel Laboratory-Based Antimicrobial Resistance
   Surveillance Network in Ethiopia
SO HEALTH SECURITY
LA English
DT Article
DE Surveillance; Antimicrobial resistance; Global health security;
   Laboratory capacity building
AB In 2014, as part of the Global Health Security Agenda, Ethiopia was provided the technical and financial resources needed to prioritize antimicrobial resistance (AMR) in the national public health sphere. Under the direction of a multi-stakeholder working group, AMR surveillance was launched in July 2017 at 4 sentinel sites across the country. The AMR surveillance initiative in Ethiopia represents one of the first systematic efforts to prospectively collect, analyze, and report national-level microbiology results from a network of hospitals and public health laboratories in the country. Baseline readiness assessments were conducted to identify potential challenges to implementation to be addressed through capacity-building efforts. As part of these efforts, the working group leveraged existing resources, initiated laboratory capacity building through mentorship, and established infrastructure and systems for quality assurance, data management, and improved coordination. As a result, AMR surveillance data are being reported and analyzed for use; data from more than 1,700 patients were collected between July 2017 and March 2018. The critical challenges and effective solutions identified through surveillance planning and implementation have provided lessons to help guide successful AMR surveillance in other settings. Ultimately, the surveillance infrastructure, laboratory expertise, and communication frameworks built specifically for AMR surveillance in Ethiopia can be extended for use with other infectious diseases and potential public health emergencies. Thus, building AMR surveillance in Ethiopia has illustrated how laying the foundation for a specific public health initiative can develop capacity for core public health functions with potential benefit.
C1 [Hazim, Carmen; Westercamp, Matthew; Omondi, Michael W.; VanderEnde, Daniel; Park, Benjamin J.] US Ctr Dis Control & Prevent CDC, Int Infect Control Program, Div Healthcare Qual Promot, Atlanta, GA USA.
   [Parsons, Michele M. B.] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Ibrahim, Rajiha Abubeker] Ethiopian Publ Hlth Inst, Clin Bacteriol & Mycol Res Team, Addis Ababa, Ethiopia.
   [Belete, Gebrie Alebachew] Ethiopian Publ Hlth Inst, Bacteriol Parasitol & Zoonosis Directorate, Addis Ababa, Ethiopia.
   [Kibret, Berhanu Amare; Kanter, Theresa; Kale, Kashmira N.; Gallagher, Kathleen M.] CDC, Div Global Hlth Protect, Addis Ababa, Ethiopia.
   [Yimer, Getnet] Ohio State Univ, Global One Hlth Initiat, Addis Ababa, Ethiopia.
   [Adem, Thuria Siraj] Amer Soc Microbiol, Int Affairs, Addis Ababa, Ethiopia.
   [Stevenson, Kurt B.] Ohio State Univ, Coll Med, Dept Internal Med, Med & Epidemiol, Columbus, OH 43210 USA.
   [Urrego, Maritza] ASM, Int Affairs, Washington, DC USA.
RP Hazim, C (reprint author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Int Infect Control Program, Atlanta, GA 30333 USA.
EM chazim@cdc.gov
RI Yimer, Getnet/A-9436-2015
OI Yimer, Getnet/0000-0002-1469-837X
FU Intramural CDC HHS [CC999999]
CR Barbe B, 2017, CLIN MICROBIOL INFEC, V23, P426, DOI 10.1016/j.cmi.2017.05.007
   Centers for Disease Control and Prevention, GLOB HLTH SEC AG ACT
   Drug Administration and Control Authority of Ethiopia, 2009, ANT US RES CONT BAS
   Federal Democratic Republic of Ethiopia Ministry of H, 2010, HLTH SECT DEV PROGR
   Kebede Y, 2016, J INFECT DIS, V213, pS59, DOI 10.1093/infdis/jiv576
   Moges F, 2014, J GLOB ANTIMICROB RE, V2, P148, DOI 10.1016/j.jgar.2014.02.004
   The Review on Antimicrobial Resistance, 2016, TACKLING DRUG RESIST
   Toner E, 2015, HEALTH SECUR, V13, P153, DOI 10.1089/hs.2014.0088
   World Health Organization, 2016, DRAFT RES POL DECL H
NR 9
TC 2
Z9 2
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD DEC
PY 2018
VL 16
SU 1
SI SI
BP S30
EP S36
DI 10.1089/hs.2018.0052
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HB8LD
UT WOS:000451339800007
PM 30480505
OA Bronze, Green Accepted
DA 2020-05-07
ER

PT J
AU Pajusalu, M
   Borlina, CS
   Seager, S
   Ono, S
   Bosak, T
AF Pajusalu, Mihkel
   Borlina, Caue S.
   Seager, Sara
   Ono, Shuhei
   Bosak, Tanja
TI Open-source sensor for measuring oxygen partial pressures below 100
   microbars
SO PLOS ONE
LA English
DT Article
AB The ability to measure partial pressures of oxygen below 100 microbars and nanomolar dissolved oxygen concentrations in in situ laboratory systems benefits many fields including microbiology, geobiology, oceanography, chemistry, and materials science. Here, we present an easily constructible open-source design for a networked luminescence lifetime measurement system for in situ measurements in arbitrary laboratory containers. The system is well suited for measuring oxygen partial pressures in the 0-100 mu bar range, with the maximum potentially usable upper range limit at around 10 mbar, depending on experimental conditions. The sensor has a limited drift and its detectability limit for oxygen is at 0.02 mu bar for short timescale measurements. Each sensor can connect to a Wi-Fi network and send the logged data either over the Internet or to a local server, enabling a large number of parallel unattended experiments. Designs are also provided for attaching the sensor to various commercially available containers used in laboratories. The design files are released under an open source license, which enables other laboratories to build, customize, and use these sensors.
C1 [Pajusalu, Mihkel; Borlina, Caue S.; Seager, Sara; Ono, Shuhei; Bosak, Tanja] MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Pajusalu, M (reprint author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM pajusalu@mit.edu
RI Pajusalu, Mihkel/AAJ-6056-2020
OI Pajusalu, Mihkel/0000-0003-3500-2770
FU "FESD Type I: The Dynamics of Earth System Oxygenation" National Science
   Foundation [1338810]; Simons Foundation Collaboration on the Origins of
   Life [327126]; John Templeton foundation; MIT
FX Funded by "FESD Type I: The Dynamics of Earth System Oxygenation"
   National Science Foundation (https://www.nsf.gov) project #1338810, for
   SO, TB, and MP. "The Alien Earths Initiative: Pursuing Humanity's Quest
   to Understand Inhabited Planets Orbiting Other Stars" project from John
   Templeton foundation (https://www.templeton.org), for SS and MP. Simons
   Foundation Collaboration on the Origins of Life,
   https://www.simonsfoundation.org/life-sciences/origins-of-life/,
   (#327126) for TB. "Mapping Biochemical Space to Search for Life Beyond
   Earth and for Fundamental Terrestrial Applications" The Professor Amar
   G. Bose Research Grant Program, MIT (http://bosefellows.mit.edu/), for
   SS and MP. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR AI Thinker, 2017, ESP0180211 AI THINK
   Arduino, ARD DUE
   Atmel, ATSAM3X8E 32 BIT SAM
   Hecht H, 2002, ENVIRON GEOL, V42, P800, DOI 10.1007/s00254-002-0583-2
   Larndorfer C., 2011, THESIS
   Lehner P., 2011, THESIS
   Lehner P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128125
   Naykki T, 2013, WATER-SUI, V5, P420, DOI 10.3390/w5020420
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Ocean Optics, REDEYE OX SENS PATCH
   Ozderya HY, PCB2BLENDER MOVE YOU
   Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321
   Pyro Science, CONT FIB OPT OX SENS
   Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/B978-0-12-381294-0.00014-6, 10.1016/S0076-6879(11)86014-3]
   Sander R, 2015, ATMOS CHEM PHYS, V15, P4399, DOI 10.5194/acp-15-4399-2015
   Texas Instruments, 2007, OPA380 DAT
   Wolfbeis OS, 2015, BIOESSAYS, V37, P921, DOI 10.1002/bies.201500002
NR 17
TC 3
Z9 3
U1 3
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2018
VL 13
IS 11
AR e0206678
DI 10.1371/journal.pone.0206678
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HA3GQ
UT WOS:000450138500066
PM 30427903
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Ieven, M
   Coenen, S
   Loens, K
   Lammens, C
   Coenjaerts, E
   Vanderstraeten, A
   Henriques-Normark, B
   Crook, D
   Huygen, K
   Butler, CC
   Verheij, TJM
   Little, P
   Zlateva, K
   van Loon, A
   Claas, ECJ
   Goossens, H
AF Ieven, M.
   Coenen, S.
   Loens, K.
   Lammens, C.
   Coenjaerts, E.
   Vanderstraeten, A.
   Henriques-Normark, B.
   Crook, D.
   Huygen, K.
   Butler, C. C.
   Verheij, T. J. M.
   Little, P.
   Zlateva, K.
   van Loon, A.
   Claas, E. C. J.
   Goossens, H.
CA GRACE Consortium
TI Aetiology of lower respiratory tract infection in adults in primary
   care: a prospective study in 11 European countries
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Aetiology; Lower respiratory tract infection; Respiratory
ID COMMUNITY-ACQUIRED PNEUMONIA; HUMAN BOCAVIRUS; SYNCYTIAL VIRUS;
   POLYOMAVIRUSES; RHINOVIRUS; DISEASE; ILLNESS; WU; KI; AMOXICILLIN
AB Objectives: To describe the role of bacteria (including bacterial resistance), viruses (including those recently described) and mixed bacterial-viral infections in adults presenting to primary care with lower respiratory tract infection (LRTI).
   Methods: In all, 3104 adults with LRTI were enrolled, of whom 141 (4.5%) had community-acquired pneumonia (CAP), and 2985 matched controls in a prospective study in 16 primary care networks in Europe, and followed patients up at 28-35 days. We detected Streptococcus pneumoniae and Haemophilus influenzae and assessed susceptibility, atypical bacteria and viruses.
   Results: A potential pathogen was detected in 1844 (59%) (in 350 (11%) bacterial pathogens only, in 1190 (38%) viral pathogens only, and in 304 (10%) both bacterial and viral pathogens). The most common bacterial pathogens isolated were S. pneumoniae (5.5% overall, 9.2% in CAP patients) and H. influenzae (5.4% overall, 14.2% in CAP patients). Less than 1% of S. pneumoniae were highly resistant to penicillin and 12.6% of H. influenzae were beta-lactamase positive. The most common viral pathogens detected were human rhinovirus (20.1%), influenza viruses (9.9%), and human coronavirus (7.4%). Influenza virus, human parainfluenza viruses and human respiratory syncytial virus as well as human rhinovirus, human coronavirus and human metapneumovirus were detected significantly more frequently in LRTI patients than in controls.
   Conclusions: A bacterial pathogen is identified in approximately one in five adult patients with LRTI in primary care, and a viral pathogen in just under half, with mixed infections in one in ten. Penicillin-resistant pneumococci and beta-lactamase producing H. influenzae are uncommon. These new findings support a restrictive approach to antibiotic prescribing for LRTI and the use of first-line, narrow-spectrum agents in primary care. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Ieven, M.; Loens, K.; Lammens, C.; Vanderstraeten, A.; Goossens, H.] Antwerp Univ Hosp, Dept Med Microbiol, Antwerp, Belgium.
   [Ieven, M.; Coenen, S.; Loens, K.; Lammens, C.; Vanderstraeten, A.; Goossens, H.] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Antwerp, Belgium.
   [Coenen, S.] Univ Antwerp, Dept Primary & Interdisciplinary Care ELIZA, Antwerp, Belgium.
   [Coenen, S.] Univ Antwerp, Dept Epidemiol & Social Med ESOC, Antwerp, Belgium.
   [Coenjaerts, E.; van Loon, A.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.
   [Henriques-Normark, B.] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden.
   [Henriques-Normark, B.] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.
   [Crook, D.; Butler, C. C.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Nuffield Dept Med, Oxford, England.
   [Huygen, K.] Sci Inst Publ Hlth, Dept Communicable & Infect Dis, Brussels, Belgium.
   [Verheij, T. J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Little, P.] Univ Southampton, Southampton, Hants, England.
   [Zlateva, K.; Claas, E. C. J.] Leiden Univ, Med Ctr, Leiden, Netherlands.
RP Ieven, M (reprint author), Antwerp Univ Hosp, Dept Med Microbiol, Antwerp, Belgium.
EM greet.ieven@uza.be
RI Coenen, Samuel JA/A-6410-2011
OI Coenen, Samuel JA/0000-0002-1238-8052
FU Research Foundation Flanders (Belgium)FWO [G.0274.08N]; 6th Framework
   Program of the European CommissionEuropean Union (EU)
   [LSHM-CT-2005-518226]; European Science Foundation (ESF)European Science
   Foundation (ESF) [09-RNP-053]
FX GRACE (Genomics to combat Resistance against Antibiotics in CA-LRTI in
   Europe, www.grace-lrti.org) was supported by the Research Foundation
   Flanders (Belgium) (G.0274.08N) and the 6th Framework Program of the
   European Commission, contract no. LSHM-CT-2005-518226). The work
   reported in this publication has been financially supported through the
   European Science Foundation (ESF), in the framework of the Research
   Networking Programme TRACE (http://archives.esf.org/trace; 09-RNP-053).
   The funding sources were not involved in the design, conduct, analysis
   and interpretation of the data, nor in the writing and decision to
   submit the paper.
CR Babakir-Mina M, 2013, APMIS, V121, P746, DOI 10.1111/apm.12091
   Babakir-Mina M, 2011, NEW MICROBIOL, V34, P1
   BUTLER CC, 2009, BRIT MED J, V338
   Chalker VJ, 2011, EUR J CLIN MICROBIOL, V30, P915, DOI 10.1007/s10096-011-1176-3
   Chow BDW, 2008, J CLIN VIROL, V43, P302, DOI 10.1016/j.jcv.2008.07.009
   Creer DD, 2006, THORAX, V61, P75, DOI 10.1136/thx.2004.027441
   de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000
   Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839
   Falsey AR, 2006, J CLIN VIROL, V35, P46, DOI 10.1016/j.jcv.2005.04.004
   Greenberg SB, 2007, SEMIN RESP CRIT CARE, V28, P182, DOI 10.1055/s-2007-976490
   Hernes SS, 2011, EUR J CLIN MICROBIOL, V30, P159, DOI 10.1007/s10096-010-1064-2
   Hicks LA, 2006, J AM GERIATR SOC, V54, P284, DOI 10.1111/j.1532-5415.2005.00529.x
   Huygen K, 2012, EPIDEMIOL INFECT, V2014, P724
   Jain S, 2015, NEW ENGL J MED, V373, P415, DOI 10.1056/NEJMoa1500245
   Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678
   Lieberman D, 2010, CHEST, V138, P811, DOI 10.1378/chest.09-2717
   Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6
   Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11
   Malhotra-Kumar S, 2016, J ANTIMICROB CHEMOTH, V71, P3258, DOI 10.1093/jac/dkw234
   Ghietto LM, 2015, ARCH VIROL, V160, P117, DOI 10.1007/s00705-014-2238-5
   Moore M, 2014, BRIT J GEN PRACT, V64, pE75, DOI 10.3399/bjgp14X677121
   Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008
   Rasmussen JN, 2010, EUROSURVEILLANCE, V15, P2
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07
   Teepe J, 2015, BRIT J GEN PRACT, V65, pE662, DOI 10.3399/bjgp15X686917
   van Vugt SF, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2450
   Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x
   Zlateva KT, 2014, EUR RESPIR J, V44, P169, DOI 10.1183/09031936.00172113
   Zlateva KT, 2011, J VIROL METHODS, V177, P174, DOI 10.1016/j.jviromet.2011.08.005
NR 30
TC 14
Z9 14
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD NOV
PY 2018
VL 24
IS 11
BP 1158
EP 1163
DI 10.1016/j.cmi.2018.02.004
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GY0FE
UT WOS:000448188200010
PM 29447989
OA Bronze, Green Accepted, Green Published
DA 2020-05-07
ER

PT J
AU Kritikos, A
   Neofytos, D
   Khanna, N
   Schreiber, PW
   Boggian, K
   Bille, J
   Schrenzel, J
   Muhlethaler, K
   Zbinden, R
   Bruderer, T
   Goldenberger, D
   Pfyffer, G
   Conen, A
   Van Delden, C
   Zimmerli, S
   Sanglard, D
   Bachmann, D
   Marchetti, O
   Lamoth, E
AF Kritikos, A.
   Neofytos, D.
   Khanna, N.
   Schreiber, P. W.
   Boggian, K.
   Bille, J.
   Schrenzel, J.
   Muhlethaler, K.
   Zbinden, R.
   Bruderer, T.
   Goldenberger, D.
   Pfyffer, G.
   Conen, A.
   Van Delden, C.
   Zimmerli, S.
   Sanglard, D.
   Bachmann, D.
   Marchetti, O.
   Lamoth, E.
CA Fungal Infect Network Switzerland
TI Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off
   values for identification of FKS mutant Candida albicans and Candida
   glabrata: a ten year national survey of the Fungal Infection Network of
   Switzerland (FUNGINOS)
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Anidulafungin; Antifungal susceptibility testing; Candidaemia;
   Caspofungin; FKS hotspot; Micafungin; Minimal inhibitory concentration
ID ESCMID-ASTERISK GUIDELINE; BLOOD-STREAM INFECTIONS; SURVEILLANCE
   PROGRAM; ANTIFUNGAL AGENTS; RESISTANCE; MANAGEMENT; MUTATIONS;
   HOSPITALS; DIAGNOSIS; FUNGEMIA
AB Objectives: Echinocandins represent the first-line treatment of candidaemia. Acquired echinocandin resistance is mainly observed among Candida albicans and Candida glabrata and is associated with FKS hotspot mutations. The commercial Sensititre YeastOne (TM) (SYO) kit is widely used for antifungal susceptibility testing, but interpretive clinical breakpoints are not well defined. We determined echinocandins epidemiological cut-off values (ECV) for C albicans/glabrata tested by SYO and assessed their ability to identify FKS mutants in a national survey of candidaemia.
   Methods: Bloodstream isolates of C. albicans and C. glabrata were collected in 25 Swiss hospitals from 2004 to 2013 and tested by SYO. FKS hotspot sequencing was performed for isolates with an MIC>ECV for any echinocandin.
   Results: In all, 1277 C albicans and 347 C glabrata were included. ECV 97.5% of caspofungin, anidulafungin and micafungin were 0.12, 0.06 and 0.03 mu g/mL for C albicans, and 0.25, 0.12 and 0.03 mu g/mL for C glabrata, respectively. FKS hotspot sequencing was performed for 70 isolates. No mutation was found in the 52 'limit wildtype' isolates (MIC=ECV for at least one echinocandin). Among the 18 'non-wild-type' isolates (MIC>ECV for at least one echinocandin), FKS mutations were recovered in the only two isolates with MIC>ECV for all three echinocandins, but not in those exhibiting a 'non-wild-type' phenotype for only one or two echinocandins.
   Conclusion: This 10-year nationwide survey showed that the rate of echinocandin resistance among C. albicans and C. glabrata remains low in Switzerland despite increased echinocandin use. SYO-ECV could discriminate FKS mutants from wild-type isolates tested by SYO in this population. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Kritikos, A.; Bille, J.; Marchetti, O.; Lamoth, E.] Lausanne Univ Hosp, Dept Med, Infect Dis Serv, Lausanne, Switzerland.
   [Neofytos, D.; Schrenzel, J.; Van Delden, C.] Geneva Univ Hosp, Serv Infect Dis, Geneva, Switzerland.
   [Neofytos, D.; Schrenzel, J.; Van Delden, C.; Zimmerli, S.] Fac Med, Geneva, Switzerland.
   [Khanna, N.] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Biomed, Basel, Switzerland.
   [Khanna, N.] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland.
   [Schreiber, P. W.; Zbinden, R.] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.
   [Boggian, K.] Cantonal Hosp, Div Infect Dis & Hosp Hyg, St Gallen, Switzerland.
   [Bille, J.; Sanglard, D.; Bachmann, D.; Lamoth, E.] Lausanne Univ Hosp, Inst Microbiol, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.
   [Zimmerli, S.] Geneva Univ Hosp, Bacteriol Lab, Geneva, Switzerland.
   [Muhlethaler, K.] Bern Univ Hosp, Dept Infect Dis, Bern, Switzerland.
   [Bruderer, T.] Cantonal Hosp St Gallen, Ctr Lab Med, Dept Bacteriol Mycol & Parasitol, St Gallen, Switzerland.
   [Goldenberger, D.] Univ Hosp Basel, Div Clin Microbiol, Basel, Switzerland.
   [Pfyffer, G.] Canton Hosp Luzern, Dept Med Microbiol, Luzern, Switzerland.
   [Conen, A.] Cantonal Hosp Aarau, Div Infect Dis & Hosp Epidemiol, Aarau, Switzerland.
   [Marchetti, O.] Ensemble Hosp Cote, Dept Med, Morges, Switzerland.
RP Lamoth, E (reprint author), Lausanne Univ Hosp, Inst Microbiol, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.; Lamoth, E (reprint author), Lausanne Univ Hosp, Infect Dis Serv, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.
EM Frederic.Lamoth@chuv.ch
RI Schrenzel, Jacques/P-8525-2017; Calandra, Thierry/D-9017-2015
OI Schrenzel, Jacques/0000-0001-5464-7764; Calandra,
   Thierry/0000-0003-3051-1285; de Kaenel, Isabelle/0000-0002-6124-7846;
   Neofytos, Dionysios/0000-0001-6970-2869; Khanna,
   Nina/0000-0002-2642-419X
FU Santos-Suarez foundation
FX We acknowledge the Santos-Suarez foundation for financial support to F.
   Lamoth laboratory.
CR Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212
   Arendrup MC, 2013, DRUG RESIST UPDATE, V16, P81, DOI 10.1016/j.drup.2014.01.001
   Canton E, 2012, J CLIN MICROBIOL, V50, P3921, DOI 10.1128/JCM.01730-12
   CLSI, 2017, REF METH BROTH DIL A
   Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039
   Espinel-Ingroff A, 2015, ANTIMICROB AGENTS CH, V59, P6725, DOI 10.1128/AAC.01250-15
   European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2017, ANT CLIN BREAKP TABL
   Marcos-Zambrano LJ, 2014, ANTIMICROB AGENTS CH, V58, P4565, DOI 10.1128/AAC.02670-14
   Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637
   MCS Diagnostics, 2012, SENS YEAST IN VITR D
   Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933
   Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016
   Pham CD, 2014, ANTIMICROB AGENTS CH, V58, P4690, DOI 10.1128/AAC.03255-14
   Shields RK, 2015, ANTIMICROB AGENTS CH, V59, P7465, DOI 10.1128/AAC.01973-15
   Ullmann AJ, 2012, CLIN MICROBIOL INFEC, V18, P53, DOI 10.1111/1469-0691.12041
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
NR 16
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD NOV
PY 2018
VL 24
IS 11
AR 1214.e1
DI 10.1016/j.cmi.2018.05.012
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GY0FE
UT WOS:000448188200025
PM 29909005
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Wache, Y
   Do, TL
   Do, TBH
   Do, TY
   Haure, M
   Ho, PH
   Anal, AK
   Le, VVM
   Li, WJ
   Licandro, H
   Lorn, D
   Ly-Chatain, MH
   Ly, S
   Mahakarnchanakul, W
   Mai, DV
   Mith, H
   Nguyen, DH
   Nguyen, TKC
   Nguyen, TMT
   Nguyen, TTT
   Nguyen, TVA
   Pham, HV
   Pham, TA
   Phan, TT
   Tan, R
   Tien, TN
   Tran, T
   Try, S
   Phi, QT
   Valentin, D
   Vo-Van, QB
   Vongkamjan, K
   Vu, DC
   Vu, NT
   Son, CK
AF Wache, Yves
   Do, Thuy-Le
   Thi-Bao-Hoa Do
   Thi-Yen Do
   Haure, Maxime
   Ho, Phu-Ha
   Anal, Anil Kumar
   Van-Viet-Man Le
   Li, Wen-Jun
   Licandro, Helene
   Lorn, Da
   Ly-Chatain, Mai-Huong
   Ly, Sokny
   Mahakarnchanakul, Warapa
   Dinh-Vuong Mai
   Mith, Hasika
   Dzung-Hoang Nguyen
   Thi-Kim-Chi Nguyen
   Thi-Minh-Tu Nguyen
   Thi-Thanh-Thuy Nguyen
   Thi-Viet-Anh Nguyen
   Hai-Vu Pham
   Tuan-Anh Pham
   Thanh-Tam Phan
   Tan, Reasmey
   Tien, Tien-Nam
   Tran, Thierry
   Try, Sophal
   Quyet-Tien Phi
   Valentin, Dominique
   Quoc-Bao Vo-Van
   Vongkamjan, Kitiya
   Duc-Chien Vu
   Nguyen-Thanh Vu
   Son Chu-Ky
TI Prospects for Food Fermentation in South-East Asia, Topics From the
   Tropical Fermentation and Biotechnology Network at the End o the AsiFood
   Erasmus plus Project
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE prospects; food fermentation; South-East Asia; Tropical Fermentation and
   Biotechnology Network; hurdle technology
ID ANTIBACTERIAL ACTIVITY; RICE WINE; SOY-SAUCE; HISTAMINE; DIVERSITY;
   THAILAND; FLAVOR; STARCH; OIL
AB Fermentation has been used for centuries to produce food in South-East Asia and some foods of this region are famous in the whole world. However, in the twenty first century, issues like food safety and quality must be addressed in a world changing from local business to globalization. In Western countries, the answer to these questions has been made through hygienisation, generalization of the use of starters, specialization of agriculture and use of long-distance transportation. This may have resulted in a loss in the taste and typicity of the products, in an extensive use of antibiotics and other chemicals and eventually, in a loss in the confidence of consumers to the products. The challenges awaiting fermentation in South-East Asia are thus to improve safety and quality in a sustainable system producing tasty and typical fermented products and valorising by-products. At the end of the "AsiFood Erasmus+ project" (www.asifood.org ), the goal of this paper is to present and discuss these challenges as addressed by the Tropical Fermentation Network, a group of researchers from universities, research centers and companies in Asia and Europe. This paper presents current actions and prospects on hygienic, environmental, sensorial and nutritional qualities of traditional fermented food including screening of functional bacteria and starters, food safety strategies, research for new antimicrobial compounds, development of more sustainable fermentations and valorisation of by-products. A specificity of this network is also the multidisciplinary approach dealing with microbiology, food, chemical, sensorial, and genetic analyses, biotechnology, food supply chain, consumers and ethnology.
C1 [Wache, Yves; Thi-Yen Do; Haure, Maxime; Ho, Phu-Ha; Licandro, Helene; Lorn, Da; Dinh-Vuong Mai; Thi-Kim-Chi Nguyen; Thi-Minh-Tu Nguyen; Tuan-Anh Pham; Thanh-Tam Phan; Try, Sophal; Son Chu-Ky] Univ Bourgogne Franche, Trop Bioresources 8 Biotechnol Int Joint Lab, AgroSup Dijon, Dijon, France.
   [Wache, Yves; Thi-Yen Do; Haure, Maxime; Ho, Phu-Ha; Licandro, Helene; Lorn, Da; Thi-Kim-Chi Nguyen; Thi-Minh-Tu Nguyen; Tuan-Anh Pham; Thanh-Tam Phan; Try, Sophal; Son Chu-Ky] Hanoi Univ Sci & Technol, Hanoi, Vietnam.
   [Wache, Yves; Haure, Maxime; Licandro, Helene; Lorn, Da; Thi-Kim-Chi Nguyen; Try, Sophal] Univ Bourgogne Franche Comte, AgroSup Dijon, PAM UMR A 02 102, Dijon, France.
   [Wache, Yves; Haure, Maxime; Licandro, Helene; Lorn, Da; Thi-Kim-Chi Nguyen; Hai-Vu Pham; Tran, Thierry; Try, Sophal; Valentin, Dominique] Agreenium, Paris, France.
   [Do, Thuy-Le; Thi-Viet-Anh Nguyen; Duc-Chien Vu; Nguyen-Thanh Vu] Food Ind Res Inst, Hanoi, Vietnam.
   [Thi-Bao-Hoa Do] Natl Inst Nutr, Hanoi, Vietnam.
   [Thi-Yen Do; Ho, Phu-Ha; Thi-Minh-Tu Nguyen; Tuan-Anh Pham; Thanh-Tam Phan; Son Chu-Ky] Hanoi Univ Sci & Technol, Sch Biotechnol & Food Technol, Hanoi, Vietnam.
   [Haure, Maxime] Atelier Fruit, Longvic, France.
   [Anal, Anil Kumar] Asian Inst Technol, Dept Food Agr & Bioresources, Food Engn & Bioproc Technol, Klongluang, Thailand.
   [Van-Viet-Man Le; Dzung-Hoang Nguyen] Ho Chi Minh City Univ Technol, Ho Chi Minh City, Vietnam.
   [Li, Wen-Jun] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.
   [Lorn, Da; Ly, Sokny; Mith, Hasika; Tan, Reasmey; Try, Sophal] Inst Technol Cambodia, Phnom Penh, Cambodia.
   [Ly-Chatain, Mai-Huong] VetoPhage, Lyon, France.
   [Mahakarnchanakul, Warapa] Kasetsart Univ, Fac Agroind, Dept Food Sci & Technol, Bangkok, Thailand.
   [Thi-Thanh-Thuy Nguyen] Vietnam Natl Univ Agr, Fac Food Sci & Technol, Hanoi, Vietnam.
   [Hai-Vu Pham] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, CESAER, Dijon, France.
   [Tien, Tien-Nam] Ho Chi Minh City Univ Food Ind, Ctr Expt & Practice, Ho Chi Minh City, Vietnam.
   [Tran, Thierry] CGIAR Res Program Roots Tubers & Bananas, Int Ctr Trop Agr, Cali, Colombia.
   [Tran, Thierry] Ctr Cooperat Int Rech Agronom Dev, UMR Qualisud, CGIAR Res Program Roots Tubers & Bananas, Montpellier, France.
   [Quyet-Tien Phi] Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam.
   [Valentin, Dominique] Univ Bourgogne Franche Comte, CNRS, INRA, AgroSup Dijon,Ctr Sci Gout & Alimentat, Dijon, France.
   [Quoc-Bao Vo-Van] Hue Univ, Coll Agr & Forestry, Hue, Vietnam.
   [Vongkamjan, Kitiya] Prince Songkla Univ, Dept Food Technol, Hat Yai, Thailand.
RP Wache, Y; Son, CK (reprint author), Univ Bourgogne Franche, Trop Bioresources 8 Biotechnol Int Joint Lab, AgroSup Dijon, Dijon, France.; Wache, Y; Son, CK (reprint author), Hanoi Univ Sci & Technol, Hanoi, Vietnam.; Wache, Y (reprint author), Univ Bourgogne Franche Comte, AgroSup Dijon, PAM UMR A 02 102, Dijon, France.; Wache, Y (reprint author), Agreenium, Paris, France.; Son, CK (reprint author), Hanoi Univ Sci & Technol, Sch Biotechnol & Food Technol, Hanoi, Vietnam.
EM yves.wache@agrosupdijon.fr; son.chuky@hust.edu.vn
RI Nguyen, Thi Thanh Thuy/N-6332-2019; , Van Viet Man Le/AAE-4439-2019;
   Thanh, Vu Nguyen/O-9080-2019; PHAM, Hai Vu/S-8175-2017
OI , Van Viet Man Le/0000-0003-3284-207X; Thanh, Vu
   Nguyen/0000-0002-4911-6771; Tran, Thierry/0000-0002-9557-3340; , Anil
   Kumar/0000-0002-2857-7579; PHAM, Hai Vu/0000-0002-7911-6852; Licandro,
   Helene/0000-0002-8088-7945
FU Universite Bourgogne Franche-Comte/AgroSup Dijon, France - Hanoi
   University of Science and Technology, Vietnam through "Tropical
   Bioresources & Biotechnology International Joint Laboratory";
   French-Speaking Universities Agency (AUF) [PCSI 54410PS202]; EUEuropean
   Union (EU); Vietnamese-French bilateral Lotus/Hoa Sen projects; Regional
   Council of Bourgogne - Franche ComteRegion Bourgogne-Franche-Comte;
   Fonds Europeen de Developpement Regional (FEDER)European Union (EU);
   Vietnam Ministry of Education and Training [B2013.01.07DA, B2014.01.79,
   B2014.01.08DA]; Vietnam Ministry of Science and Technology
   [15/2014/HD-NDT]; Vietnam Ministry of Industry and Trade
   [SXTN.04.15/CNSHCB, SXTN.02.16/CNSHCB, SXTN.05.16/CNSHCB]
FX The "Tropical Fermentation and Biotechnology Network" has been created
   and supported by Universite Bourgogne Franche-Comte/AgroSup Dijon,
   France - Hanoi University of Science and Technology, Vietnam through
   "Tropical Bioresources & Biotechnology International Joint Laboratory",
   by the French-Speaking Universities Agency (AUF) through a Pre-project
   for Interuniversity Scientific Cooperation (PCSI 54410PS202) "Exploring
   Vegetal and Microbial Diversity and Technological Innovation for Food
   Quality and Safety (http://pcsi2013.hust.edu.vn/en/)", and by the
   EU-funded Erasmus+project AsiFood "Universities as key partners for the
   new challenges regarding food safety & quality in ASEAN
   (www.asifood.org). Collaborations and scientific results presented in
   this paper have been supported and funded by the Vietnamese-French
   bilateral Lotus/Hoa Sen projects, by the Regional Council of Bourgogne -
   Franche Comte, the "Fonds Europeen de Developpement Regional (FEDER)",
   by Vietnam Ministry of Education and Training (grants B2013.01.07DA,
   B2014.01.79, and B2014.01.08DA), Vietnam Ministry of Science and
   Technology (grant 15/2014/HD-NDT) and Vietnam Ministry of Industry and
   Trade (grants SXTN.04.15/CNSHCB, SXTN.02.16/CNSHCB, and
   SXTN.05.16/CNSHCB).
CR Cao-Hoang L, 2013, INT J FOOD SCI TECH, V48, P1115, DOI 10.1111/ijfs.12064
   Chavalparit O, 2009, J CLEAN PROD, V17, P105, DOI 10.1016/j.jclepro.2008.03.001
   Nguyen CN, 2014, IND CROP PROD, V56, P160, DOI 10.1016/j.indcrop.2014.02.004
   Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273
   Cousin E, 1944, REV MED FANC EXTERME, V22, P382
   Dung NTP, 2005, INNOV FOOD SCI EMERG, V6, P429, DOI 10.1016/j.ifset.2005.04.007
   Feng YZ, 2015, FOOD CHEM, V187, P44, DOI 10.1016/j.foodchem.2015.03.138
   Feng YZ, 2015, FOOD CHEM, V167, P220, DOI 10.1016/j.foodchem.2014.06.057
   Feng YZ, 2014, FOOD CHEM, V158, P438, DOI 10.1016/j.foodchem.2014.02.147
   Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001
   Gohel Vipul, 2012, Int J Microbiol, V2012, P680232, DOI 10.1155/2012/680232
   Hansupalak N, 2016, J CLEAN PROD, V134, P539, DOI 10.1016/j.jclepro.2015.06.138
   Ho P.-H., 2017, SECURITE SANITAIRE A, P85
   Ho P.-H. H, 2013, P NAT BIOT C HAN
   Hoang V.-Q., 2017, SECURITE SANITAIRE A, P69
   Ilbery B, 2000, AREA, V32, P317, DOI 10.1111/j.1475-4762.2000.tb00144.x
   Kumar A., 2018, FOOD PROCESSING BY P, P1
   La Anh N, 2015, FOOD SCI HUM WELLNES, V4, P147, DOI DOI 10.1016/J.FSHW.2015.08.004
   Lee YC, 2013, J FOOD PROTECT, V76, P860, DOI 10.4315/0362-028X.JFP-12-298
   Lefevre S, 2017, REV FR ALLERGOL, V57, P24, DOI 10.1016/j.reval.2016.10.004
   Ly S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00894
   Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051
   Nguyen HV, 2018, LETT APPL MICROBIOL, V66, P207, DOI 10.1111/lam.12837
   Nguyen HV, 2016, J APPL MICROBIOL, V121, P341, DOI 10.1111/jam.13160
   Pham H. V, 2017, LEGISLATION GOUVERNA, P167
   Pham H. V., 2017, SECURITE SANITAIRE A
   Phan T. T, 2011, J SCI TECHNOL, V49, P416
   Phan T. T, 2011, P 57 INT C MEAT SCI
   Phan T. T, 2007, J SCI TECHNOL TECHNO, V61, P107
   Phan T. T, 2008, J SCI TECHNOL TECHNO, V65, P105
   Ruddle K, 2010, GLOBALIZATION FOOD S
   Salam N, 2017, BIOMED RES INT, DOI 10.1155/2017/1308563
   Sanceda NG, 1999, J AGR FOOD CHEM, V47, P3596, DOI 10.1021/jf9812174
   Sarter S, 2015, QUAL ASSUR SAF CROP, V7, P57, DOI 10.3920/QAS2014.x009
   Son CK, 2016, FOOD BIOPROD PROCESS, V98, P79, DOI 10.1016/j.fbp.2015.10.003
   Sonnino R, 2007, ANTHR FOOD S, VS2, P12
   Do TTL, 2014, INT J FOOD SCI TECH, V49, P1099, DOI 10.1111/ijfs.12405
   Khieu TN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00574
   Tran D. D, 2014, J SCI TECHNOL, V52, P267
   Valentin D, 2018, METHODS CONSUMER RES, V1, P103
   Vongkamjan K, 2017, FOOD MICROBIOL, V66, P11, DOI 10.1016/j.fm.2017.03.014
   Vu N. T., 2016, ETHNIC FERMENTED FOO, P383
   Thanh VN, 2016, INT J FOOD MICROBIOL, V232, P15, DOI 10.1016/j.ijfoodmicro.2016.05.024
   Wache Y, 2017, ETAT LIEUX PLURIDISC, P207
   Waisundara V, 2016, REGULATING SAFETY TR, P149, DOI [10.1016/B978-0-12-800605-4.00008-6, DOI 10.1016/B978-0-12-800605-4.00008-6]
NR 45
TC 4
Z9 4
U1 2
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 15
PY 2018
VL 9
AR 2278
DI 10.3389/fmicb.2018.02278
PG 8
WC Microbiology
SC Microbiology
GA GW9BJ
UT WOS:000447276300001
PM 30374334
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Escalante, MJ
   Ceriani-Cernadas, JM
   D'Apremont, I
   Bancalari, A
   Webb, V
   Genes, L
   Villarroel, L
   Munoz, E
   Tapia, JL
AF Jose Escalante, Maria
   Maria Ceriani-Cernadas, Jose
   D'Apremont, Ivonne
   Bancalari, Aldo
   Webb, Veronica
   Genes, Larisa
   Villarroel, Luis
   Munoz, Elizabeth
   Tapia, Jose L.
CA NEOCOSUR Neonatal Network
TI Late Onset Sepsis in Very Low Birth Weight Infants in the South American
   NEOCOSUR Network
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE very low birth weight; late-onset sepsis; preterm infants; neonatal
   network; central lines
ID BLOOD-STREAM INFECTIONS; NEONATAL SEPSIS; PRETERM INFANTS; MULTICENTER;
   TIME
AB Background: The main aim is to determine the incidence and associated factors of late onset sepsis (LOS) in very low birth weight infants (500-1500g), from the NEOCOSUR Network during years 2001-2013. Secondary objectives are to describe the microbiology of the first and second episode of LOS and to study the association between catheter dwell time and LOS.
   Methods: Demographic information and outcome data are prospectively and routinely collected across the network using predefined diagnostic criteria and online data entry. LOS was confirmed by isolation of the organism in blood or through cerebrospinal fluid in cultures. The participating countries were Argentina, Brazil, Chile, Paraguay, Peru and Uruguay.
   Results: Overall incidence was 22.2% (3066/13,821). Infants who developed LOS were smaller by weight and gestational age; also, they feature less prenatal care and prenatal steroids, and longer hospital stays. A greater number of infants in the LOS group had 1 minute Apgar Scores 3. Multivariate logistic regression analysis showed a positive association between LOS and necrotizing enterocolitis, mechanical ventilation requirements, patent ductus arteriosus, oxygen dependency at 36 weeks and death. The majority of first LOS episode was caused by coagulase-negative staphylococci (44.3%). An increased risk of LOS was observed in relation to catheter dwell time (6% per day of stay of central lines).
   Conclusions: The incidence of LOS was associated with mechanical ventilation, patent ductus arteriosus, necrotizing enterocolitis and death. LOS was an important cause of morbidity and mortality in very low birth weight infants in our network, and coagulase-negative staphylococci was the most frequent causative microorganism.
C1 [Jose Escalante, Maria; D'Apremont, Ivonne; Tapia, Jose L.] Pontificia Univ Catolica Chile, Fac Med, Dept Neonatol, Santiago, Chile.
   [Maria Ceriani-Cernadas, Jose] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina.
   [Bancalari, Aldo] Univ Concepcion, Hosp Guillermo Grant, Dept Pediat, Fac Med, Concepcion, Chile.
   [Webb, Veronica] Univ Peruana Cayetano, Fac Med Alberto Hurtado, Lima, Peru.
   [Genes, Larisa] Univ Nacl Asuncion, Fac Ciencias Med, Hosp Clin, Dept Neonatol, San Lorenzo, Paraguay.
   [Villarroel, Luis] Pontificia Univ Catolica Chile, Dept Salud Publ, Santiago, Chile.
   [Munoz, Elizabeth] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile.
RP Escalante, MJ (reprint author), Pontificia Univ Catolica Chile, Hosp Clin, Marcoleta 367, Santiago 8330024, Chile.
EM mariajose.escalante@gmail.com
CR ANZNN (Australian and New Zealand Neonatal Network), 2015, AUSTR NZ NEON NEON N
   Aziz Khalid, 2005, BMC Pediatr, V5, P22, DOI 10.1186/1471-2431-5-22
   Bentlin MR, 2015, J PEDIAT-BRAZIL, V91, P168, DOI 10.1016/j.jped.2014.07.004
   Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552
   Carrieri MP, 2003, PEDIATR INFECT DIS J, V22, P599, DOI 10.1097/00006454-200307000-00007
   Coggins SA, 2015, CLIN PERINATOL, V42, P133, DOI 10.1016/j.clp.2014.10.012
   Dong Y, 2015, ARCH DIS CHILD-FETAL, V100, pF257, DOI 10.1136/archdischild-2014-306213
   Fehlmann E, 2010, ARCH ARGENT PEDIATR, V108, P393, DOI 10.1590/S0325-00752010000500004
   Fernandez R, 2014, ARCH ARGENT PEDIATR, V112, P405, DOI [10.5546/aap.2014.405, 10.1590/S0325-00752014000500004]
   Ferreira RC, 2014, J PEDIAT-BRAZIL, V90, P293, DOI 10.1016/j.jped.2013.09.006
   GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130
   Gonzalez A, 1996, J PEDIATR-US, V128, P470, DOI 10.1016/S0022-3476(96)70356-6
   Gordon A, 2006, PEDIATR INFECT DIS J, V25, P25, DOI 10.1097/01.inf.0000195628.35980.2e
   Hentges CR, 2014, J PEDIAT-BRAZIL, V90, P50, DOI 10.1016/j.jped.2013.10.002
   Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1
   Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34
   Milstone AM, 2013, PEDIATRICS, V132, pE1609, DOI 10.1542/peds.2013-1645
   Okada Y, 2000, ANN SURG, V231, P276, DOI 10.1097/00000658-200002000-00018
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   Payne NR, 2004, PEDIATRICS, V114, P348, DOI 10.1542/peds.114.2.348
   Resende DS, 2015, BRAZ J INFECT DIS, V19, P52, DOI 10.1016/j.bjid.2014.09.006
   Shah P, CANADIAN NEONATAL NE
   Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357
   Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285
   Tapia Jose L., 2006, J. Pediatr. (Rio J.), V82, P15, DOI 10.2223/JPED.1431
   Unidad Neonatal 5 D Hospital de Cruces, 2011, EURONEONET ANN REP V
NR 28
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD OCT
PY 2018
VL 37
IS 10
BP 1022
EP 1027
DI 10.1097/INF.0000000000001958
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA HF0GQ
UT WOS:000453838400020
PM 29561518
DA 2020-05-07
ER

PT J
AU Piantola, MAF
   Moreno, ACR
   Matielo, HA
   Taschner, NP
   Cavalcante, RCM
   Khan, S
   Ferreira, RDC
AF Floriano Piantola, Marco Aurelio
   Ramos Moreno, Ana Carolina
   Matielo, Heloisa Alonso
   Taschner, Natalia Pasternak
   Marques Cavalcante, Rafael Ciro
   Khan, Samia
   Cafe Ferreira, Rita de Cassia
TI Adopt a Bacterium - an active and collaborative learning experience in
   microbiology based on social media
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Microbiology education; Active learning; Social Media
AB The "Adopt a Bacterium" project is based on the use of social network as a tool in Microbiology undergraduate education, improving student learning and encouraging students to participate in collaborative learning. The approach involves active participation of both students and teachers, emphasizing knowledge exchange, based on widely used social media. Students were organized in groups and asked to adopt a specific bacterial genus and, subsequently, submit posts about "adopted genus". The formative assessment is based on posting information on Facebook (R), and the summative assessment involves presentation of seminars about the adopted theme. To evaluate the project, students filled out three anonymous and voluntary surveys. Most of the students enjoyed the activities and positively evaluated the experience. A large amount of students declared a change in their attitude towards the way they processed information, especially regarding the use of scientific sources. Finally, we evaluated knowledge retention six months after the end of the course and students were able to recall relevant Microbiology concepts. Our results suggest that the "Adopt a Bacterium" project represents a useful strategy in Microbiology learning and may be applied to other academic fields. (C) 2018 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.
C1 [Floriano Piantola, Marco Aurelio; Ramos Moreno, Ana Carolina; Matielo, Heloisa Alonso; Taschner, Natalia Pasternak; Cafe Ferreira, Rita de Cassia] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
   [Marques Cavalcante, Rafael Ciro] Univ Fed Sergipe, Fac Ciencias Farmaceut, Campus Lagarto, Lagarto, SE, Brazil.
   [Khan, Samia] Univ British Columbia, Vancouver, BC, Canada.
RP Ferreira, RDC (reprint author), Univ Sao Paulo, Lab Vaccine Dev, Inst Biomed Sci, Sao Paulo, Brazil.
EM ritacafe@usp.br
OI Taschner, Natalia Pasternak/0000-0001-7559-602X; Khan,
   Samia/0000-0002-7137-3731
CR Botte DAC, 2014, MICROBIOL FOCO, V73, P5
   CAIN J, 2011, AM J PHARM ED, V75
   Fahnert B, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw048
   Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111
   Gil A. C., 2008, METODOS TECNICAS PES
   Jetten MSM, 2016, TRENDS MICROBIOL, V24, P319, DOI 10.1016/j.tim.2016.02.020
   Kinchin IM, 2008, STUD HIGH EDUC, V33, P89, DOI 10.1080/03075070701794858
   Kinchin IM, 2003, J BIOL EDUC, V37, P110, DOI 10.1080/00219266.2003.9655864
   Legaree BA, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv128
   Legaree BA, 2014, J MICROBIOL BIOL EDU, V15, P301, DOI 10.1128/jmbe.v15i2.713
   Masetto Marcos, 2004, Interface (Botucatu), V8, P197
   Merkel SM, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw172
   Novak JD, 1981, TEORIA EDUCACAO, P55
   Rutherford S, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv191
   Severino Antonio Joaquim, 2008, ENSINO PESQUISA DOCE
   Song PF, 2014, J MICROBIOL BIOL EDU, V15, P55, DOI 10.1128/jmbe.v15i1.682
NR 16
TC 0
Z9 0
U1 0
U2 6
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD OCT-DEC
PY 2018
VL 49
IS 4
BP 942
EP 948
DI 10.1016/j.bjm.2018.04.005
PG 7
WC Microbiology
SC Microbiology
GA GX6SM
UT WOS:000447893000034
PM 29728341
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU El-Chakhtoura, J
   Saikaly, PE
   van Loosdrecht, MCM
   Vrouwenvelder, JS
AF El-Chakhtoura, Joline
   Saikaly, Pascal E.
   van Loosdrecht, Mark C. M.
   Vrouwenvelder, Johannes S.
TI Impact of Distribution and Network Flushing on the Drinking Water
   Microbiome
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE 16S rRNA gene pyrosequencing; biofilm; core microbiome; drinking water
   distribution system; microbial ecology; network flushing; residence
   time; water quality
ID BACTERIAL COMMUNITY STRUCTURE; IN-SITU HYBRIDIZATION;
   DISTRIBUTION-SYSTEMS; BULK WATER; SP-NOV.; BIOLOGICAL STABILITY;
   NITRIFYING BACTERIA; UNITED-STATES; GEN. NOV.; DIVERSITY
AB We sampled the tap water of seven unique, full-scale drinking water distribution systems at different locations as well as the corresponding treatment plant effluents to evaluate the impact of distribution and the potential presence of a core drinking water microbiome. The water was also sampled during network flushing to examine its effect on the microbial ecology. While a core microbiome dominated by Gammaproteobacteria was found using 16S rRNA gene pyrosequencing, an increase in biomass was detected in the networks, especially during flushing. Water age did not significantly impact the microbiology. Irrespective of differences in treatment plants, tap water bacterial communities in the distinct networks converged and highly resembled the flushed water communities. Piping biofilm and sediment communities therefore largely determine the final tap water microbial quality, attenuating the impact of water source and treatment strategy and highlighting the fundamental role of local physicochemical conditions and microbial processes within infrastructure micro-niches.
C1 [El-Chakhtoura, Joline; van Loosdrecht, Mark C. M.; Vrouwenvelder, Johannes S.] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Delft, Netherlands.
   [El-Chakhtoura, Joline; Saikaly, Pascal E.; Vrouwenvelder, Johannes S.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Water Desalinat & Reuse Ctr, Jeddah, Saudi Arabia.
RP El-Chakhtoura, J (reprint author), Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Delft, Netherlands.; El-Chakhtoura, J (reprint author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Water Desalinat & Reuse Ctr, Jeddah, Saudi Arabia.
EM J.ElChakhtoura@tudelft.nl
RI van Loosdrecht, Mark/AAA-9997-2019; Saikaly, Pascal/G-7958-2014
OI van Loosdrecht, Mark/0000-0003-0658-4775; El-Chakhtoura,
   Joline/0000-0003-2151-9197; Saikaly, Pascal/0000-0001-7678-3986;
   Vrouwenvelder, Hans/0000-0003-2668-2057
FU Evides Waterbedrijf (Netherlands) funding; King Abdullah University of
   Science and Technology (KAUST) Office of Competitive Research Funds
   (OCRF) [URF/1/1728-01-01]
FX This research was supported by Evides Waterbedrijf (Netherlands) funding
   and King Abdullah University of Science and Technology (KAUST) Office of
   Competitive Research Funds (OCRF) under award no. URF/1/1728-01-01.
CR Abe Y, 2012, WATER RES, V46, P1155, DOI 10.1016/j.watres.2011.12.013
   Al-Mutaz I., 1999, IDA WORLD C DES WAT
   Araya R, 2003, FEMS MICROBIOL ECOL, V43, P111, DOI 10.1111/j.1574-6941.2003.tb01050.x
   ARENS P, 1995, ZBL HYG UMWELTMED, V196, P444
   Bautista-de los Santos QM, 2016, ENVIRON SCI-WAT RES, V2, P631, DOI [10.1039/c6ew00030d, 10.1039/C6EW00030D]
   Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001
   Beer KD, 2015, MMWR-MORBID MORTAL W, V64, P842, DOI 10.1111/ajt.13602
   Colford John M. Jr., 2006, Journal of Water and Health, V4, P71, DOI 10.2166/wh.2006.018
   Cheng W, 2014, ANN MICROBIOL, V64, P875, DOI 10.1007/s13213-013-0712-z
   Deb A. K., 2010, 4036 WAT RES FDN
   DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11
   Douterelo I, 2014, WATER RES, V54, P100, DOI 10.1016/j.watres.2014.01.049
   Douterelo I, 2013, WATER RES, V47, P503, DOI 10.1016/j.watres.2012.09.053
   El-Chakhtoura J, 2015, WATER RES, V74, P180, DOI 10.1016/j.watres.2015.02.015
   Emtiazi F, 2004, WATER RES, V38, P1197, DOI 10.1016/j.watres.2003.10.056
   Ginige MP, 2013, FEMS MICROBIOL ECOL, V85, P553, DOI 10.1111/1574-6941.12137
   Glockner J, 2010, ENVIRON MICROBIOL, V12, P1218, DOI 10.1111/j.1462-2920.2010.02164.x
   Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009
   Harmsen HJM, 1998, INT J SYST BACTERIOL, V48, P1383, DOI 10.1099/00207713-48-4-1383
   He ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep32241
   Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11
   Herlemann DPR, 2009, APPL ENVIRON MICROB, V75, P2841, DOI 10.1128/AEM.02698-08
   Hiras J, 2016, ISME J, V10, P833, DOI 10.1038/ismej.2015.158
   Hoehn RC, 1988, WATER QUAL B, V13, P46
   Holinger EP, 2014, WATER RES, V49, P225, DOI 10.1016/j.watres.2013.11.027
   Ingerson-Mahar M., 2012, MIP MICROBIOLOGY WAT
   Kampfer P, 2009, INT J SYST EVOL MICR, V59, P341, DOI 10.1099/ijs.0.002675-0
   Keevil C.W., 2003, PATHOGENS ENV BIOFIL
   Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002
   Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032
   LEE SH, 1980, J AM WATER WORKS ASS, V72, P636
   Lipponen MTT, 2002, WATER RES, V36, P4319, DOI 10.1016/S0043-1354(02)00169-0
   Liu G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20367
   Liu G, 2014, ENVIRON SCI TECHNOL, V48, P5467, DOI 10.1021/es5009467
   Liu G, 2013, APPL MICROBIOL BIOT, V97, P9265, DOI 10.1007/s00253-013-5217-y
   Magic-Knezev A, 2004, WATER RES, V38, P3971, DOI 10.1016/j.watres.2004.06.017
   Manz W, 1999, MICROB ECOL, V37, P225, DOI 10.1007/s002489900148
   Martiny AC, 2005, APPL ENVIRON MICROB, V71, P8611, DOI 10.1128/AEM.71.12.8611-8617.2005
   McCoy ST, 2014, ENVIRON ENG SCI, V31, P32, DOI 10.1089/ees.2013.0174
   Messner Michael, 2006, Journal of Water and Health, V4, P201, DOI 10.2166/wh.2006.024
   Nescerecka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096354
   O'Sullivan LA, 2002, APPL ENVIRON MICROB, V68, P201, DOI 10.1128/AEM.68.1.201-210.2002
   Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14
   Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t
   Prest EI, 2014, WATER RES, V63, P179, DOI 10.1016/j.watres.2014.06.020
   Rees GN, 2004, ANTON LEEUW INT J G, V86, P339, DOI 10.1007/s10482-004-0498-x
   Regan JM, 2003, WATER RES, V37, P197, DOI 10.1016/S0043-1354(02)00237-3
   Rochex A, 2008, WATER RES, V42, P4915, DOI 10.1016/j.watres.2008.09.015
   Schroeder JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117221
   Sly LI, 1998, INT J SYST BACTERIOL, V48, P731, DOI 10.1099/00207713-48-3-731
   Sorokin DY, 2007, INT J SYST EVOL MICR, V57, P1582, DOI 10.1099/ijs.0.65112-0
   Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P2175, DOI 10.1099/00207713-52-6-2175
   Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x
   Van Der Kooij D, 2000, WATER AIR SOIL POLL, V123, P25, DOI 10.1023/A:1005288720291
   van der Wielen PWJJ, 2010, WATER RES, V44, P4860, DOI 10.1016/j.watres.2010.07.016
   van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09
   van Lieverloo JHM, 2004, WATER RES, V38, P1101, DOI 10.1016/j.watres.2003.11.021
   Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373
   Wang DL, 2010, J ENVIRON SCI-CHINA, V22, P1203, DOI 10.1016/S1001-0742(09)60239-4
   Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u
   YABUUCHI E, 1983, INT J SYST BACTERIOL, V33, P580, DOI 10.1099/00207713-33-3-580
   Yeoh YK, 2016, MOL BIOL EVOL, V33, P915, DOI 10.1093/molbev/msv281
   Youssef NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127499
   Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11
NR 64
TC 6
Z9 6
U1 2
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 19
PY 2018
VL 9
AR 2205
DI 10.3389/fmicb.2018.02205
PG 13
WC Microbiology
SC Microbiology
GA GU1IA
UT WOS:000445011600002
PM 30283424
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Stack, CM
   Gold, HS
   Wright, SB
   Baldini, LM
   Snyder, GM
AF Stack, Conor M.
   Gold, Howard S.
   Wright, Sharon B.
   Baldini, Linda M.
   Snyder, Graham M.
TI Perioperative antimicrobial prophylaxis and prevention of hepatobiliary
   surgical site infections
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID CARE SAFETY NETWORK; PENICILLIN ALLERGY; HOSPITALIZED-PATIENTS;
   IMPROVEMENT-PROGRAM; RISK-FACTORS; IMPACT; ANTIBIOTICS; OUTCOMES;
   SURGERY
AB Objective: To characterize the microbiology of hepatobiliary surgical site infections (SSIs) and to explore the relationship between specific antimicrobial prophylaxis regimens and the development of SSIs.
   Design: Retrospective matched case-control study comparing patient, procedure, and antimicrobial prophylaxis characteristics among patients undergoing a hepatobiliary surgical procedure with and without an SSI.
   Setting: A tertiary referral acute-care facility.
   Methods: Patients undergoing procedures defined as "BILI" (bile duct, liver, or pancreas surgery) using National Healthcare Safety Network (NHSN) definitions, excluding those undergoing concomitant liver transplantation, from January 2013 through June 2016 were included in the study population. The SSIs were identified through routine infection control surveillance using NHSN definitions. All patients who developed an SSI were considered cases. Controls were selected randomly matched 2: 1 with cases based on fiscal quarter of the procedure. Logistic regression modeling was performed to explore variables associated with SSI, including antimicrobial prophylaxis received.
   Results: Among 975 procedures, 80 (8.2%) resulted in an SSI. Most cases involved an organism nonsusceptible to standard prophylaxis regimens, including cefazolin (68.8%), cefazolin plus metronidazole (61.3%), and ampicillin-sulbactam (52.5%). In a multivariate model, antimicrobial coverage against Enterococcus spp (aOR, 0.58; 95% confidence interval [CI], 0.17-2.04; P = .40) and against Pseudomonas spp (aOR, 2.40; 95% CI, 0.56-10.29; P =. 24) were not protective against the development of an SSI. The presence of a documented beta-lactam allergy was significantly associated with the development of an SSI (aOR, 3.54; 95% CI, 1.36-9.19; P =. 009).
   Conclusions: Although SSIs at the study institution were associated with pathogens nonsusceptible to the most commonly used prophylaxis regimens, broader-spectrum coverage was not associated with a reduction in SSIs.
C1 [Stack, Conor M.; Gold, Howard S.; Wright, Sharon B.; Baldini, Linda M.; Snyder, Graham M.] Beth Israel Deaconess Med Ctr, Silverman Inst Hlth Care Qual & Safety, Div Infect Control Hosp Epidemiol, Boston, MA 02215 USA.
   [Stack, Conor M.; Gold, Howard S.; Wright, Sharon B.; Snyder, Graham M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA.
RP Stack, CM (reprint author), Mailstop SL 435,330 Brookline Ave, Boston, MA 02115 USA.
EM cstack1@bidmc.harvard.edu
CR Berenguer CM, 2010, J AM COLL SURGEONS, V210, P737, DOI 10.1016/j.jamcollsurg.2010.01.029
   Blumenthal KG, 2018, CLIN INFECT DIS, V66, P329, DOI 10.1093/cid/cix794
   Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568
   Bull AL, 2017, SURG INFECT, V18, P834, DOI 10.1089/sur.2017.119
   Centers for Disease Control and Prevention, SURG SIT INF SSI EV
   Charneski L, 2011, PHARMACOTHERAPY, V31, P742, DOI 10.1592/phco.31.8.742
   Clinical and Laboratory Standards Institute (CLSI), 2016, PERFORMANCE STANDARD
   Donald GW, 2013, SURGERY, V154, P190, DOI 10.1016/j.surg.2013.04.001
   Fong ZV, 2016, JAMA SURG, V151, P432, DOI 10.1001/jamasurg.2015.4510
   Gavazzi F, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0460-1
   Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929
   Macy E, 2014, J ALLERGY CLIN IMMUN, V133, P790, DOI 10.1016/j.jaci.2013.09.021
   Morikane K, 2017, SURG TODAY, V47, P1208, DOI 10.1007/s00595-017-1503-0
   Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016
   Saeed MJ, 2015, AM J INFECT CONTROL, V43, P617, DOI 10.1016/j.ajic.2015.02.012
   Tan TL, 2016, CLIN ORTHOP RELAT R, V474, P1601, DOI 10.1007/s11999-015-4672-4
   Trinh JV, 2009, INFECT CONT HOSP EP, V30, P440, DOI 10.1086/596612
   Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763
NR 18
TC 0
Z9 0
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD SEP
PY 2018
VL 39
IS 9
BP 1037
EP 1041
DI 10.1017/ice.2018.164
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GT8QY
UT WOS:000444805900003
PM 30064539
DA 2020-05-07
ER

PT J
AU Shugart, A
   Walters, MS
   Weiner, LM
   Lonsway, D
   Kallen, AJ
AF Shugart, Alicia
   Walters, Maroya Spalding
   Weiner, Lindsey M.
   Lonsway, David
   Kallen, Alexander J.
TI Hospital microbiology laboratory practices for Enterobacteriaceae:
   Centers for Disease Control and Prevention National Healthcare Safety
   Network (NHSN) annual survey, 2015 and 2016
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
AB We analyzed clinical microbiology laboratory practices for detection of multidrug-resistant Enterobacteriaceae in US short-stay acute-care hospitals using data from the National Healthcare Safety Network (NHSN) Annual Facility Survey. Half of hospitals reported testing for carbapenemases, and 1% performed routine polymyxin susceptibility testing using reference broth microdilution.
C1 [Shugart, Alicia; Walters, Maroya Spalding; Weiner, Lindsey M.; Lonsway, David; Kallen, Alexander J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA.
RP Shugart, A (reprint author), Ctr Dis Control & Prevent, Roybal Campus,1600 Clifton Rd,MS A31, Atlanta, GA 30329 USA.
EM ashugart@cdc.gov
OI Weiner Lastinger, Lindsey/0000-0002-7327-9108
FU Intramural CDC HHS [CC999999]
CR CLSI. Clinical and Laboratory Standards Institute, 2010, M100S20U CLSI
   Hindler JA, 2013, J CLIN MICROBIOL, V51, P1678, DOI 10.1128/JCM.03385-12
   Revell P, ASMS PUBLIC SCI AFFA
   Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1105, DOI 10.1017/ice.2016.139
NR 4
TC 5
Z9 5
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD SEP
PY 2018
VL 39
IS 9
BP 1115
EP 1117
DI 10.1017/ice.2018.153
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GT8QY
UT WOS:000444805900015
PM 30039775
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Gao, W
   Wu, HL
   Siddiqui, MK
   Baig, AQ
AF Gao, Wei
   Wu, Hualong
   Siddiqui, Muhammad Kamran
   Baig, Abdul Qudair
TI Study of biological networks using graph theory
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Biological mathematics; DNA sequence; Biological networks; Topological
   index
ID FORGOTTEN TOPOLOGICAL INDEX; DNA-SEQUENCES; CELL BIOLOGY;
   REPRESENTATION; ALGORITHM; CODONS; CURVE
AB As an effective modeling, analysis and computational tool, graph theory is widely used in biological mathematics to deal with various biology problems. In the field of microbiology, graph can express the molecular structure, where cell, gene or protein can be denoted as a vertex, and the connect element can be regarded as an edge. In this way, the biological activity characteristic can be measured via topological index computing in the corresponding graphs. In our article, we mainly study the biology features of biological networks in terms of eccentric topological indices computation. By means of graph structure analysis and distance calculating, the exact expression of several important eccentric related indices of hypertree network and X-tree are determined. The conclusions we get in this paper illustrate that the bioengineering has the promising application prospects. (C) 2017 Production and hosting by Elsevier B.V.
C1 [Gao, Wei; Wu, Hualong] Yunnan Normal Univ, Sch Informat Sci & Technol, Kunming 650500, Yunnan, Peoples R China.
   [Siddiqui, Muhammad Kamran] Comsats Inst Informat Technol, Dept Math, Sahiwal 57000, Pakistan.
   [Baig, Abdul Qudair] Comsats Inst Informat Technol, Dept Math, Attock Campus, Attock, Pakistan.
RP Wu, HL (reprint author), Yunnan Normal Univ, Sch Informat Sci & Technol, Kunming 650500, Yunnan, Peoples R China.
EM hualong_wu@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11401519]
FX We thank the reviewers for their constructive comments in improving the
   quality of this paper. This work was supported in part by the National
   Natural Science Foundation of China (11401519).
CR Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022
   Alexander SA, 2013, ACTA BIOTHEOR, V61, P181, DOI 10.1007/s10441-012-9168-y
   Alqallaf AK, 2016, OPTIK, V127, P1929, DOI 10.1016/j.ijleo.2015.11.068
   Aram V, 2012, MATCH-COMMUN MATH CO, V67, P809
   Banerjee A, 2009, DISCRETE APPL MATH, V157, P2425, DOI 10.1016/j.dam.2008.06.033
   Basavanagoud B., 2017, APPL MATH NONLINEAR, V2, P369
   Blazewicz J, 1999, DISCRETE APPL MATH, V98, P1, DOI 10.1016/S0166-218X(99)00109-2
   Blazewicz J, 2009, COMPUT BIOL CHEM, V33, P224, DOI 10.1016/j.compbiolchem.2009.04.005
   Bokhari SH, 2005, BIOINFORMATICS, V21, P889, DOI 10.1093/bioinformatics/bti129
   Chakraborty R, 2016, PHYS CHEM CHEM PHYS, V18, P6526, DOI 10.1039/c5cp07804k
   Chlopkowski M, 2016, RAIRO-OPER RES, V50, P351, DOI 10.1051/ro/2015039
   da Silva ES, 2016, COMPUT BIOL MED, V70, P51, DOI 10.1016/j.compbiomed.2016.01.004
   Eckman BA, 2006, IBM J RES DEV, V50, P545, DOI 10.1147/rd.506.0545
   El-Ghoul M, 2006, CHAOS SOLITON FRACT, V27, P159, DOI 10.1016/j.chaos.2005.03.017
   Farahani MR, 2015, LEONARDO ELECT J PRA, V27, P155
   Gao W, 2017, OPTOELECTRON ADV MAT, V11, P119
   Gao W, 2017, J CHEM-NY, DOI 10.1155/2017/6540754
   Gao W, 2017, SAUDI J BIOL SCI, V24, P132, DOI 10.1016/j.sjbs.2016.09.001
   Gao W, 2016, J CHEM-NY, DOI 10.1155/2016/1053183
   Gao W, 2016, CHAOS SOLITON FRACT, V89, P290, DOI 10.1016/j.chaos.2015.11.035
   Gao W, 2016, ACTA MEDICA MEDITERR, V32, P579
   Gao W, 2016, SAUDI PHARM J, V24, P258, DOI 10.1016/j.jsps.2016.04.012
   Gao W, 2016, J CHEM-NY, DOI 10.1155/2016/3216327
   Gao W, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/418106
   Ghorbani M, 2010, OPTOELECTRON ADV MAT, V4, P2212
   Jafarzadeh N, 2016, STUD U BABES-BOL CHE, V61, P9
   Jafarzadeh N, 2016, MATCH-COMMUN MATH CO, V75, P731
   Jafarzadeh N, 2013, MATH BIOSCI, V241, P217, DOI 10.1016/j.mbs.2012.11.009
   Jafarzadeh N, 2012, MATCH-COMMUN MATH CO, V68, P611
   Khan F. J., 2017, MATRIKS SAINS MATEMA, V1, P25
   Khan H. U., 2017, MATRIKS SAINS MATEMA, V1
   Kletsov A. A., 2015, BIOCHIM BIOPHYS ACTA, V1860, P140
   Kulli V. R., 2016, ANN PURE APPL MATH, V12, P169
   Lesne A, 2006, LETT MATH PHYS, V78, P235, DOI 10.1007/s11005-006-0123-1
   Ma'ayan A, 2008, IET SYST BIOL, V2, P206, DOI 10.1049/iet-syb:20070075
   Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038
   Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084
   Niwa HS, 2016, ICES J MAR SCI, V73, P2181, DOI 10.1093/icesjms/fsw070
   O'Reilly E, 2016, J COMPUT BIOL, V23, P789, DOI 10.1089/cmb.2015.0185
   Pendavingh R, 2003, DISCRETE APPL MATH, V127, P85, DOI 10.1016/S0166-218X(02)00287-1
   Pesek I, 2008, MATCH-COMMUN MATH CO, V60, P301
   Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098
   Rajan RS, 2015, PROCEDIA COMPUT SCI, V57, P738, DOI 10.1016/j.procs.2015.07.466
   Rastgou A, 2017, MICROELECTRON ENG, V169, P9, DOI 10.1016/j.mee.2016.11.012
   Sa-Ardyen P., 2003, Natural Computing, V2, P427, DOI 10.1023/B:NACO.0000006771.95566.34
   Samina Shah K., 2017, MATRIKS SAINS MATEMA, V1, P21
   Shah K., 2017, MATRIKS SAINS MATEMA, V1, P16
   Shoaib M., 2017, MATRIKS SAINS MATEMA, V1
   Wang SY, 2008, SCI CHINA SER A, V51, P437, DOI 10.1007/s11425-007-0123-3
NR 49
TC 76
Z9 76
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1319-562X
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD SEP
PY 2018
VL 25
IS 6
BP 1212
EP 1219
DI 10.1016/j.sjbs.2017.11.022
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA GR9HA
UT WOS:000443059800031
PM 30174525
OA DOAJ Gold, Green Published
HC Y
HP Y
DA 2020-05-07
ER

PT J
AU Tack, ILMM
   Nimmegeers, P
   Akkermans, S
   Logist, F
   Van Impe, JFM
AF Tack, Ignace L. M. M.
   Nimmegeers, Philippe
   Akkermans, Simen
   Logist, Filip
   Van Impe, Jan F. M.
TI A low-complexity metabolic network model for the respiratory and
   fermentative metabolism of Escherichia coli
SO PLOS ONE
LA English
DT Article
ID LACTATE-DEHYDROGENASE; LISTERIA-MONOCYTOGENES; ANAEROBIC FERMENTATION;
   GENOME SEQUENCE; MICROBIAL LAG; GROWTH-RATE; PH; TEMPERATURE; ACID;
   MAINTENANCE
AB Over the last decades, predictive microbiology has made significant advances in the mathematical description of microbial spoiler and pathogen dynamics in or on food products. Recently, the focus of predictive microbiology has shifted from a (semi-) empirical population-level approach towards mechanistic models including information about the intracellular metabolism in order to increase model accuracy and genericness. However, incorporation of this subpopulation-level information increases model complexity and, consequently, the required run time to simulate microbial cell and population dynamics. In this paper, results of metabolic flux balance analyses (FBA) with a genome-scale model are used to calibrate a low-complexity linear model describing the microbial growth and metabolite secretion rates of Escherichia coli as a function of the nutrient and oxygen uptake rate. Hence, the required information about the cellular metabolism (i.e., biomass growth and secretion of cell products) is selected and included in the linear model without incorporating the complete intracellular reaction network. However, the applied FBAs are only representative for microbial dynamics under specific extracellular conditions, viz., a neutral medium without weak acids at a temperature of 37 degrees C. Deviations from these reference conditions lead to metabolic shifts and adjustments of the cellular nutrient uptake or maintenance requirements. This metabolic dependency on extracellular conditions has been taken into account in our low-complex metabolic model. In this way, a novel approach is developed to take the synergistic effects of temperature, pH, and undissociated acids on the cell metabolism into account. Consequently, the developed model is deployable as a tool to describe, predict and control E. coli dynamics in and on food products under various combinations of environmental conditions. To emphasize this point, three specific scenarios are elaborated: (i) aerobic respiration without production of weak acid extracellular metabolites, (ii) anaerobic fermentation with secretion of mixed acid fermentation products into the food environment, and (iii) respiro-fermentative metabolic regimes in between the behaviors at aerobic and anaerobic
C1 [Tack, Ignace L. M. M.; Nimmegeers, Philippe; Akkermans, Simen; Logist, Filip; Van Impe, Jan F. M.] Katholieke Univ Leuven, BioTeC, Dept Chem Engn, Ghent, Belgium.
RP Van Impe, JFM (reprint author), Katholieke Univ Leuven, BioTeC, Dept Chem Engn, Ghent, Belgium.
EM jan.vanimpe@kuleuven.be
RI Logist, Filip/AAG-4210-2020; Nimmegeers, Philippe/AAG-1512-2020
OI Logist, Filip/0000-0001-8621-7531; Nimmegeers,
   Philippe/0000-0002-2086-7694
FU Agency for Innovation by Science and Technology (IWT)Institute for the
   Promotion of Innovation by Science and Technology in Flanders (IWT) [IWT
   SB-111565]; Research Foundation Flanders (FWO)FWO [FWO-G.0930.13, FWO
   KAN2013,1.5.189.13]; KU Leuven Research FundKU Leuven [PFV/10/002];
   Knowledge Platform (SCORES4CHEM) of the KU Leuven Industrial Research
   Fund [KP/09/005]; Belgian Program on Interuniversity Poles of
   AttractionBelgian Federal Science Policy Office; Belgian Federal Science
   Policy Office (IAP Phase VII - 19 DYSCO)Belgian Federal Science Policy
   Office
FX The research of I.L.M.M. Tack is funded by PhD grant IWT SB-111565 of
   the Agency for Innovation by Science and Technology (IWT,
   https://www.vlaio.be/nl). In addition, this work is supported by
   projects FWO-G.0930.13 and FWO KAN2013,1.5.189.13 of the Research
   Foundation Flanders (FWO, https://www.vlaio.be/nl), project PFV/10/002
   (Center of Excellence OPTEC - Optimization in Engineering) of the KU
   Leuven Research Fund
   (https://www.kuleuven.be/english/research/support/if), Knowledge
   Platform KP/09/005 (SCORES4CHEM) of the KU Leuven Industrial Research
   Fund (https://www.kuleuven.be/english/research/iof), and the Belgian
   Program on Interuniversity Poles of Attraction, initiated by the Belgian
   Federal Science Policy Office (IAP Phase VII - 19 DYSCO,
   https://www.belspo.be).
CR ALAM KY, 1989, J BACTERIOL, V171, P6213, DOI 10.1128/jb.171.11.6213-6217.1989
   [Anonymous], 1994, ILJ, V23, DOI DOI 10.1016/0168-1605(94)90157-0
   Baka M, 2013, FOOD CONTROL, V29, P328, DOI 10.1016/j.foodcont.2012.04.022
   Banerjee C, 2016, BIOTECHNOL J, V11, P303, DOI 10.1002/biot.201500284
   Baweja M, 2016, FRONTIER DISCOVERIES, P207, DOI DOI 10.1007/978-81-322-2610-9_13
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Bernaerts K, 2002, INT J FOOD MICROBIOL, V73, P145, DOI 10.1016/S0168-1605(01)00645-6
   Biryukova IV, 2010, RUSS J GENET+, V46, P308, DOI 10.1134/S1022795410030075
   BLACKWOOD AC, 1956, J BACTERIOL, V72, P497, DOI 10.1128/JB.72.4.497-499.1956
   Buchanan RL, 1998, J FOOD PROTECT, V61, P1531, DOI 10.4315/0362-028X-61.11.1531
   Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187
   Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803
   CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x
   Clomburg JM, 2011, BIOTECHNOL BIOENG, V108, P867, DOI 10.1002/bit.22993
   COLE MB, 1990, J APPL BACTERIOL, V69, P63, DOI 10.1111/j.1365-2672.1990.tb02912.x
   Coroller L, 2005, INT J FOOD MICROBIOL, V100, P167, DOI 10.1016/j.ijfoodmicro.2004.10.014
   Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P319, DOI 10.1016/j.ijfoodmicro.2004.11.017
   Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025
   DiezGonzalez F, 1997, MICROBIOL-UK, V143, P1175, DOI 10.1099/00221287-143-4-1175
   Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379
   Eklund T, 1989, MECH ACTION FOOD PRE, P160
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003
   Ferrier R, 2013, APPL ENVIRON MICROB, V79, P5870, DOI 10.1128/AEM.01311-13
   Ginovart M, 2002, J THEOR BIOL, V214, P305, DOI 10.1006/jtbi.2001.2466
   Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11
   HEIJNEN JJ, 1981, BIOTECHNOL BIOENG, V23, P739, DOI 10.1002/bit.260230407
   Higgins TE, 1970, J BACTERIOL, V101, P885, DOI 10.1128/JB.101.3.885-891.1970
   Hinshelwood CN, 1946, CHEM KINETICS BACTER
   Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149
   Ihssen J, 2007, MICROBIOL-SGM, V153, P2052, DOI 10.1099/mic.0.2006/002006-0
   Ingraham JL, 1996, ESCHERICHIA COLI SAL, P1570
   Jiang GRJ, 2001, MICROBIOL-SGM, V147, P2437, DOI 10.1099/00221287-147-9-2437
   Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566
   KAREL SF, 1989, BIOTECHNOL BIOENG, V34, P337, DOI 10.1002/bit.260340308
   Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7
   Leistner L, 2000, INT J FOOD MICROBIOL, V55, P181, DOI 10.1016/S0168-1605(00)00161-6
   MATJAN F, 1989, J BACTERIOL, V171, P342, DOI 10.1128/jb.171.1.342-348.1989
   MONOD J, 1942, RECHERCHES CROISSANC
   Palsson B., 2006, SYSTEMS BIOL PROPERT
   Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004
   Pharkya P, 2003, BIOTECHNOL BIOENG, V84, P887, DOI 10.1002/bit.10857
   PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069
   Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10
   Prats C, 2006, J THEOR BIOL, V241, P939, DOI 10.1016/j.jtbi.2006.01.029
   Presser KA, 1997, APPL ENVIRON MICROB, V63, P2355, DOI 10.1128/AEM.63.6.2355-2360.1997
   Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38
   SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845
   Sanchez AM, 2005, METAB ENG, V7, P229, DOI 10.1016/j.ymben.2005.03.001
   Scheibe TD, 2009, MICROB BIOTECHNOL, V2, P274, DOI 10.1111/j.1751-7915.2009.00087.x
   SCHULZE KL, 1964, ARCH MIKROBIOL, V48, P1, DOI 10.1007/BF00406595
   Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424
   Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043
   Standaert A. R., 2004, 9 IFAC S COMP APPL B, V9, P183
   STEPHANOPOULOS GN, 1998, METABOLIC ENG
   Stling O C, 1993, J APPL BACTERIOL, V75, P18, DOI [10.1111/j.1365-2672.1993.tb03402.x, DOI 10.1111/J.1365-2672.1993.TB03402.X]
   STOKES JL, 1949, J BACTERIOL, V57, P147, DOI 10.1128/JB.57.2.147-158.1949
   Swinnen IAM, 2005, INT J FOOD MICROBIOL, V100, P85, DOI 10.1016/j.ijfoodmicro.2004.10.022
   Tack ILMM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02509
   TARMY EM, 1968, J BIOL CHEM, V243, P2587
   terSteeg PF, 1995, FOOD MICROBIOL, V12, P471, DOI 10.1016/S0740-0020(95)80132-4
   Trinh CT, 2009, APPL ENVIRON MICROB, V75, P6696, DOI 10.1128/AEM.00670-09
   Valero A, 2006, EUR FOOD RES TECHNOL, V224, P91, DOI 10.1007/s00217-006-0293-1
   van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5
   Van Derlinden E, 2009, QUANTIFYING MICROBIA
   VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993
   Varma A, 1993, J THEOR BIOL, V1993, P4
   Verhulst AJ, 2011, FOOD MICROBIOL, V28, P656, DOI 10.1016/j.fm.2010.07.014
   WALLACE RJ, 1986, FEMS MICROBIOL LETT, V37, P317, DOI 10.1016/0378-1097(86)90427-1
   Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005
   Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4&lt;203::AID-BIT1&gt;3.0.CO;2-#]
   ZWIETERING MH, 1992, J FOOD PROTECT, V55, P973, DOI 10.4315/0362-028X-55.12.973
NR 73
TC 0
Z9 0
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2018
VL 13
IS 8
AR e0202565
DI 10.1371/journal.pone.0202565
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR9JD
UT WOS:000443071400062
PM 30157229
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Lei, Y
   Zhang, K
   Guo, MM
   Li, GW
   Li, C
   Li, BB
   Yang, YX
   Chen, YL
   Wang, XL
AF Lei, Yu
   Zhang, Ke
   Guo, Mengmeng
   Li, Guanwei
   Li, Chao
   Li, Bibo
   Yang, Yuxin
   Chen, Yulin
   Wang, Xiaolong
TI Exploring the Spatial-Temporal Microbiota of Compound Stomachs in a
   Pre-weaned Goat Model
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE taxonomic diversity; ruminant; microbial community; rumen microbiology;
   gut microbiota
ID GUT MICROBIOME; HUMAN-MILK; IMPACT; CONTAMINATION; DIVERSITY; COMMUNITY;
   DELIVERY; BREAST; BIRTH
AB Ruminant animals possess a characteristic four-compartment stomach (rumen, reticulum, omasum, and abomasum) that is specialized for pre-intestinal digestion of plant materials. Of these four compartments, the rumen is the largest. The rumen's diverse microbial community has been well studied. However, the current understanding of microbial profiles in the reticulum, omasum and abomasum are lacking. In the present study, fluid samples from the reticulum, omasum, and abomasum of goats at 3, 7, 14, 21, 28, 42, and 56 days after birth, as well as the negative controls (NC) used for microbial DNA extraction, were subjected to 16S rRNA sequencing. By filtering operational taxonomic units (OTUs) in NC, distinct temporal distributions of microbes were observed in the different compartments, we showed that the OTUs in control samples had a large effect to the samples with low microbial density. In addition, Proteobacteria gradually decreased with age from days 3 to 56 in all three compartments, and the relative abundance of Bacteroidetes increased from 24.15% (Day 3) to 52.03% (Day 56) in abomasum. Network analysis revealed that Prevotellaceae_UGG-03 and Rikenellaceae_RC9 were positively correlated with Prevotella_1, lending support to the well understood fact that cellulose is well digested in compound stomachs prior to the rumen. Pathway analysis revealed that gene expression in abomasum at Day 3 were primarily related to Glycolysis/Gluconeogenesis and Pyruvate metabolism, suggesting that colostrum digestion is the dominant function of the abomasum at an early age. These findings combined with other recent rumen microbiota data show that the microbiome landscape represents three distinct stages in ruminant stomachs. The first stage is to gain access to external microorganisms at Day 0-14, the secondary stage is for microbial transition at Day 14-28, and the third stage is for exogenous and endogenous microbial colonization beyond Day 28 of age. Our results provide insight into microbiota dynamics in ruminant stomachs, and will facilitate efforts for the maintenance of gastrointestinal balance and intervention with starter diets in juvenile ruminants during early development.
C1 [Lei, Yu; Zhang, Ke; Guo, Mengmeng; Li, Guanwei; Li, Chao; Li, Bibo; Yang, Yuxin; Chen, Yulin; Wang, Xiaolong] Northwest A&F Univ, Coll Anim Sci & Technol, Xianyang, Peoples R China.
RP Wang, XL (reprint author), Northwest A&F Univ, Coll Anim Sci & Technol, Xianyang, Peoples R China.
EM xiaolongwang@nwafu.edu.cn
FU Key Research Program of Shaanxi Province [2017NY-072]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [31572369, 31772571]; China Agriculture Research System [CARS-39];
   Innovative Talents Promotion Plan in Shaanxi Province
FX The present study was supported by the Key Research Program of Shaanxi
   Province (2017NY-072), the National Natural Science Foundation of China
   (31572369 and 31772571), as well as by China Agriculture Research System
   (CARS-39). XW was supported by the Innovative Talents Promotion Plan in
   Shaanxi Province, and is a Tang Scholar at Northwest A&F University.
CR Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16
   Animut G, 2008, SMALL RUMINANT RES, V77, P127, DOI 10.1016/j.smallrumres.2008.03.012
   Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Davis NM, 2017, BIORXIV, DOI [10.1101/221499, DOI 10.1101/221499]
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001
   Guaraldi F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00094
   Han XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117811
   Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2
   Jonsson H., 2011, FORAGING BEHAV CATTL
   Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982
   Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733
   Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47
   Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3
   Ley RE, 2016, NAT REV GASTRO HEPAT, V13, P69, DOI 10.1038/nrgastro.2016.4
   Lim ES, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0475-7
   Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116
   Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028
   McLean MH, 2014, GUT, V63, P362, DOI [10.1136/gutjnl-2014-308514, 10.1136/gutjnl-2013-306499]
   Morgavi DP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01060
   Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149
   Peng S, 2015, J APPL GENET, V56, P393, DOI 10.1007/s13353-014-0258-1
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Ramayo-Caldas Y, 2016, ISME J, V10, P2973, DOI 10.1038/ismej.2016.77
   Rey M, 2012, J DAIRY SCI, V95, P1500, DOI 10.3168/jds.2011-4902
   Rubino F, 2017, ISME J, V11, P932, DOI 10.1038/ismej.2016.172
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011
   Snijders AM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.221
   Toscano M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1109-0
   Trenkle A., 2001, EXPERIENCE ELECT IDE
   Wang J, 2017, ASIAN AUSTRAL J ANIM, V30, P100, DOI 10.5713/ajas.16.0166
   Wang LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154354
   Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12
   White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352
   Yeoh N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0314-y
NR 45
TC 7
Z9 7
U1 1
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 15
PY 2018
VL 9
AR 1846
DI 10.3389/fmicb.2018.01846
PG 11
WC Microbiology
SC Microbiology
GA GQ3MD
UT WOS:000441567300001
PM 30158908
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Shu, X
   Zang, XY
   Liu, XS
   Yang, J
   Wang, J
AF Shu, Xin
   Zang, Xinyuan
   Liu, Xiaoshuang
   Yang, Jie
   Wang, Jin
TI Predicting MicroRNA Mediated Gene Regulation between Human and Viruses
SO CELLS
LA English
DT Article
DE miRNA; virus; host; Cross-Kingdom; target prediction
ID HERPESVIRUS ENCODES; TARGET; MODULATION
AB MicroRNAs (miRNAs) mediate various biological processes by actively fine-tuning gene expression at the post-transcriptional level. With the identification of numerous human and viral miRNAs, growing evidence has indicated a common role of miRNAs in mediating the interactions between humans and viruses. However, there is only limited information about Cross-Kingdom miRNA target sites from studies. To facilitate an extensive investigation on the interplay among the gene regulatory networks of humans and viruses, we designed a prediction pipeline, mirTarP, that is suitable for miRNA target screening on the genome scale. By applying mirTarP, we constructed the database mirTar, which is a comprehensive miRNA target repository of bidirectional interspecies regulation between viruses and humans. To provide convenient downloading for users from both the molecular biology field and medical field, mirTar classifies viruses according to "ICTV viral category" and the medical "microbiology classification" on the web page. The mirTar database and mirTarP tool are freely available online.
C1 [Yang, Jie; Wang, Jin] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, NAILS, Nanjing 210023, Jiangsu, Peoples R China.
   Nanjing Univ, NAILS, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
RP Yang, J; Wang, J (reprint author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, NAILS, Nanjing 210023, Jiangsu, Peoples R China.
EM cpu_shuxin@126.com; hsinring@foxmail.com; xsliunju@foxmail.com;
   yangjie@nju.edu.cn; jwang@nju.edu.cn
RI Yang, Jie/AAH-7541-2019
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [81250044, 31500674]; NJU-Yangzhou Institute of Optoelectronics
FX This research was funded by National Science Foundation of China
   [81250044, 31500674]; NJU-Yangzhou Institute of Optoelectronics.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Anastasiadou E, 2019, LEUKEMIA, V33, P132, DOI 10.1038/s41375-018-0178-x
   Balasubramaniam M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030110
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207
   Bryan C.R., 2013, INTRINSIC IMMUNITY
   Cheng JC, 2012, CELL MOL LIFE SCI, V69, P2621, DOI 10.1007/s00018-012-0940-6
   Cheng S, 2016, IEEE ACM T COMPUT BI, V13, P1161, DOI 10.1109/TCBB.2015.2510002
   Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178
   Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004
   Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013
   Hancock MH, 2017, MBIO, V8, DOI 10.1128/mBio.00109-17
   Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kim H, 2012, ARCH VIROL, V157, P497, DOI 10.1007/s00705-011-1181-y
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Lagana Alessandro, 2010, J RNAi Gene Silencing, V6, P379
   Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784
   Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Manzano M, 2013, J VIROL, V87, P11821, DOI 10.1128/JVI.01692-13
   Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205
   Qureshi A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau103
   Shao TT, 2015, MOL BIOSYST, V11, P1319, DOI 10.1039/c5mb00095e
   Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07
   Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484
   Skinner CM, 2017, J VIROL, V91, DOI 10.1128/JVI.00530-17
   Witkos TM, 2011, CURR MOL MED, V11, P93
NR 36
TC 0
Z9 0
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG
PY 2018
VL 7
IS 8
AR 100
DI 10.3390/cells7080100
PG 7
WC Cell Biology
SC Cell Biology
GA GS1BH
UT WOS:000443248600016
PM 30096814
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Al-Najar, H
   Ghourab, A
   Eid, R
   Farhouda, H
AF Al-Najar, Husam
   Ghourab, Ayah
   Eid, Reham
   Farhouda, Hanady
TI Medical Wastewater Characterization in the Gaza Strip: Al-Shifa Medical
   Complex as a Case Study
SO HEALTH SCOPE
LA English
DT Article
DE Wastewater; Heavy Metals; Hospital; Effluent
ID EFFLUENTS
AB Al-Shifa medical complex is one of the most famous medical complex in the Gaza Strip. Since 1946 it was expanded many times, nowadays, the total clinical capacity has 564 beds on an area of 42,000 m(2). The main aim of the current research is to characterize the medical wastewater in the Gaza Strip. Currently, wastewater from hospitals is discharged to the public network then to overloaded central wastewater treatment plants, where partially treated effluent is infiltrate to the groundwater and the majority discharged to the sea. Composite samples from different sectors of the complex are collected every two hours for 24 hours and analyzed for physical and chemical characteristics. The pH from different medical sectors showed an acceptable range for disposal to the public network, while the salinity was extremely high and differs from sector to another. The Surgery department recorded the highest wastewater pollution i.e. TSS, BOD, and COD accounted for 3008,1150, and 5350 mg/L, respectively, while the highest TKN (117 mg/L) was from the surgery operation room. Heavy metals such as Cd, Zn, and Pb in the medical wastewater from Al-Shifa medical complex do not constitute a threat to public wastewater sewerage system, mostly below the detection limits. It is highly recommended to further investigate the causes of strong pollution from both the surgery department and surgery room to propose pretreatment before disposal to the public network. Microbiology and infectious diseases and radioactive pollution should be considered in future planned research to gain comprehensive medical waste characteristics in the Gaza Strip.
C1 [Al-Najar, Husam; Ghourab, Ayah; Eid, Reham; Farhouda, Hanady] Islamic Univ Gaza, Dept Civil Engn, Gaza Strip, Palestine.
RP Al-Najar, H (reprint author), Islamic Univ Gaza, Dept Civil Engn, Gaza Strip, Palestine.
EM halnajar@iugaza.edu.ps
RI Al-Najar, Husam/K-5464-2019
CR Al-Khatib M., 2011, Journal of Water Resource and Protection, V3, P341
   Al-Najar H, 2014, J AGR ENV SCI, V3
   Al-Najar H., 2007, RICS RES, V7, P9
   Altin A, 2003, FRESEN ENVIRON BULL, V12, P1098
   Amouei A, 2015, HEALTH SCOPE, V4
   [Anonymous], 2012, STANDARD METHOD EXAM
   Aurelien BD, 2013, CHEMOSPHERE, V93, P2365, DOI 10.1016/j.chemosphere.2013.08.034
   Ekhaise F, 2008, J AGR ENV SCI, V4, P484
   Emmanuel E, 2005, J HAZARD MATER, V117, P1, DOI 10.1016/j.jhazmat.2004.08.032
   Gautam AK, 2007, J ENVIRON MANAGE, V83, P298, DOI 10.1016/j.jenvman.2006.03.009
   Gharbia AS, 2016, J GEOSCI ENV PROT, V4, P89, DOI DOI 10.4236/GEP.2016.42011
   Hamdan Sami M, 2007, International Journal of Environment and Health, V1, P580, DOI 10.1504/IJENVH.2007.018582
   Khalaf A. R., 2006, Journal of Applied Sciences, V6, P2693
   Kumarathilakal P, 2015, 6 INT C STRUCT ENG C
   Mesdaghinia AR, 2009, IRAN J PUBLIC HEALTH, V38, P34
   Metcalf & Eddy Inc, 2003, WASTEWATER ENG TREAT
   Palestinian Environmental Quality Affairs, 2015, GUIDELINES RECOMMEND
   POLPRASERT C, 1996, ORGANIC WASTE RECYCL
   Prayitno I., 2013, INT J ENG SCI, V2, P13
   Qahman Khalid, 2009, Journal of Water Resource and Protection, V1, P249, DOI 10.4236/jwarp.2009.14030
   Shomar B, 2011, ENVIRON GEOCHEM HLTH, V33, P189, DOI 10.1007/s10653-010-9332-8
   Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005
NR 22
TC 0
Z9 0
U1 0
U2 2
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 2251-8959
EI 2251-9513
J9 HEALTH SCOPE
JI Health Scope
PD AUG
PY 2018
VL 7
IS 3
AR e14513
DI 10.5812/jhealthscope.14513
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GS0RK
UT WOS:000443212600005
OA Other Gold
DA 2020-05-07
ER

PT J
AU Garcia-Rubio, R
   Escribano, P
   Gomez, A
   Guinea, J
   Mellado, E
AF Garcia-Rubio, Rocio
   Escribano, Pilar
   Gomez, Ana
   Guinea, Jesus
   Mellado, Emilia
TI Comparison of Two Highly Discriminatory Typing Methods to Analyze
   Aspergillus fumigatus Azole Resistance
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Aspergillus fumigatus; molecular typing; genotypic analysis; STRAf;
   TRESPERG; azole resistance
ID SURVEILLANCE NETWORK TRANSNET; INVASIVE FUNGAL-INFECTIONS; MOLECULAR
   EPIDEMIOLOGY; ITRACONAZOLE RESISTANCE; TRANSPLANT RECIPIENTS;
   CYSTIC-FIBROSIS; 1ST DETECTION; CYP51A GENE; IN-VITRO; PATIENT
AB Aspergillus fumigatus molecular typing has become increasingly more important for detecting outbreaks as well as for local and global epidemiological investigations and surveillance. Over the years, many different molecular methods have been described for genotyping this species. Some outstanding approaches are based on microsatellite markers (STRAf assay, which is the current gold standard), or based on sequencing data (TRESP typing improved in this work with a new marker and was renamed TRESPERG). Both methodologies were used to type a collection of 212 A. fumigatus isolates that included 70 azole resistant strains with diverse resistance mechanisms from different geographic locations. Our results showed that both methods are totally reliable for epidemiological investigations showing similar stratification of the A. fumigatus population. STRAf assay offered higher discriminatory power (D = 0.9993) than the TRESPERG typing method (D = 0.9972), but the latter does not require specific equipment or skilled personnel, allowing for a prompt integration into any clinical microbiology laboratory. Among azole resistant isolates, two groups were differentiated considering their resistance mechanisms: cyp51A single point mutations (G54, M220, or G448), and promoter tandem repeat integrations with or without cyp51A modifications (TR34/L98H, TR46/Y121F/A289T, or TR53). The genotypic differences were assessed to explore the population structure as well as the genetic relationship between strains and their azole resistance profile. Genetic cluster analyses suggested that our A. fumigatus population was formed by 6-7 clusters, depending on the methodology. Also, the azole susceptible and resistance population showed different structure and organization. The combination of both methodologies resolved the population structure in a similar way to what has been described in whole-genome sequencing works.
C1 [Garcia-Rubio, Rocio; Mellado, Emilia] Inst Salud Carlos III, Natl Ctr Microbiol, Mycol Reference Lab, Madrid, Spain.
   [Escribano, Pilar; Gomez, Ana; Guinea, Jesus] Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.
   [Escribano, Pilar; Gomez, Ana; Guinea, Jesus] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.
   [Guinea, Jesus] Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain.
RP Mellado, E (reprint author), Inst Salud Carlos III, Natl Ctr Microbiol, Mycol Reference Lab, Madrid, Spain.
EM emellado@isciii.es
RI Martos, Pilar Escribano/M-2387-2014; Ortega, Jesus Vicente
   Guinea/G-3083-2014
OI Martos, Pilar Escribano/0000-0001-6254-4570; Ortega, Jesus Vicente
   Guinea/0000-0002-7901-8355; Mellado, Emilia/0000-0002-9801-0260
FU Fond de Investigation Sanitaria [FIS PI15_00019]; Plan National de I+D+i
   2013-2016; Instituto de Salud Carlos III, Subdireccion General de Redes
   y Centros de Investigation Cooperativa, de Economia, Industria y
   Competitividad; Spanish Network for Research in Infectious Diseases
   [REIPI RD16/CIII/0004/0003]; European Development Regional Fund ERDF "A
   way to achieve Europe," Operative program Intelligent Growth 2014-2020;
   Fondo de Investigacion Sanitaria [CPI15/00115, CPII15/00006]
FX This work has been supported by Fond de Investigation Sanitaria (FIS
   PI15_00019), and Plan National de I+D+i 2013-2016 and Instituto de Salud
   Carlos III, Subdireccion General de Redes y Centros de Investigation
   Cooperativa, de Economia, Industria y Competitividad, Spanish Network
   for Research in Infectious Diseases (REIPI RD16/CIII/0004/0003),
   co-financed by European Development Regional Fund ERDF "A way to achieve
   Europe," Operative program Intelligent Growth 2014-2020. PE
   (CPI15/00115) and JG (CPII15/00006) are recipients of a Miguel Servet
   contract supported by Fondo de Investigacion Sanitaria.
CR Abdolrasouli A, 2015, MBIO, V6, DOI 10.1128/mBio.00536-15
   Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07
   Ashu EE, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00019-17
   Astvad KMT, 2014, ANTIMICROB AGENTS CH, V58, P5096, DOI 10.1128/AAC.02855-14
   Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07
   Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011
   Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07
   Bart-Delabesse E, 1998, J CLIN MICROBIOL, V36, P2413, DOI 10.1128/JCM.36.9.2413-2418.1998
   Bellete B, 2010, MED MYCOL, V48, P197, DOI 10.3109/13693780902717018
   Burgel PR, 2012, ANTIMICROB AGENTS CH, V56, P869, DOI 10.1128/AAC.05077-11
   Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12
   Chang H, 2016, MYCOSES, V59, P450, DOI 10.1111/myc.12494
   Chen J, 2005, J ANTIMICROB CHEMOTH, V55, P31, DOI 10.1093/jac/dkh507
   Chen Y, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01549-17, 10.1128/aac.01549-17]
   Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871
   Dannaoui E, 2001, J ANTIMICROB CHEMOTH, V47, P333, DOI 10.1093/jac/47.3.333
   de Ruiter MT, 2007, J MICROBIOL METH, V70, P528, DOI 10.1016/j.mimet.2007.06.009
   de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005
   de Valk HA, 2007, J MICROBIOL METH, V69, P268, DOI 10.1016/j.mimet.2007.01.009
   Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003
   Garcia-Rubio R, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00241-18, 10.1128/aac.00241-18]
   Garcia-Rubio R, 2017, DRUGS, V77, P599, DOI 10.1007/s40265-017-0714-4
   Garcia-Rubio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163869
   Guinea J, 2011, J CLIN MICROBIOL, V49, P3498, DOI 10.1128/JCM.01159-11
   Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310
   Hodiamont CJ, 2009, MED MYCOL, V47, P217, DOI 10.1080/13693780802545600
   Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017
   HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Klaassen CHW, 2007, STUD MYCOL, P47, DOI 10.3114/sim.2007.59.06
   Klaassen CHW, 2009, MED MYCOL, V47, pS27, DOI 10.1080/13693780802382244
   Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x
   Klaassen CHW, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P177, DOI 10.1007/978-90-481-2408-4_12
   Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263
   Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310
   Le Pape P, 2016, EMERG INFECT DIS, V22, P156, DOI 10.3201/eid2201.150978
   Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018
   LOUDON KW, 1993, J CLIN MICROBIOL, V31, P1117, DOI 10.1128/JCM.31.5.1117-1121.1993
   Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003
   Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06
   Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004
   Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001
   Mortensen KL, 2011, J CLIN MICROBIOL, V49, P2243, DOI 10.1128/JCM.00213-11
   Natesan SK, 2012, DIAGN MICR INFEC DIS, V74, P272, DOI 10.1016/j.diagmicrobio.2012.06.030
   Neuveglise C, 1996, NUCLEIC ACIDS RES, V24, P1428, DOI 10.1093/nar/24.8.1428
   Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262
   Pelaez T., 2015, New Microbes and New Infections, V6, P33, DOI 10.1016/j.nmni.2015.04.005
   Pelaez T, 2012, J CLIN MICROBIOL, V50, P2531, DOI 10.1128/JCM.00329-12
   Sharma C, 2015, J GLOB ANTIMICROB RE, V3, P69, DOI 10.1016/j.jgar.2015.01.005
   Shen H., 2018, POSTER AT THE 8TH AD, P168
   Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219
   Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09
   van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x
   van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320
   Vermeulen E, 2012, EUROSURVEILLANCE, V17, P11
   Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720
   Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885
   Wang HC, 2018, ENVIRON MICROBIOL, V20, P270, DOI 10.1111/1462-2920.13988
   Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003
NR 59
TC 6
Z9 6
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 20
PY 2018
VL 9
AR 1626
DI 10.3389/fmicb.2018.01626
PG 9
WC Microbiology
SC Microbiology
GA GN7ZP
UT WOS:000439371400003
PM 30079058
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Dahle, H
   Bauer, SL
   Baumberger, T
   Stokke, R
   Pedersen, RB
   Thorseth, IH
   Steen, IH
AF Dahle, Hakon
   Bauer, Sven Le Moine
   Baumberger, Tamara
   Stokke, Runar
   Pedersen, Rolf B.
   Thorseth, Ingunn H.
   Steen, Ida H.
TI Energy Landscapes in Hydrotherma Chimneys Shape Distributions of Primary
   Producers
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE geobiology; geochemistry; microbiology; thermodynamics; modeling;
   ecology; hydrothermal systems
ID MICROBIAL COMMUNITIES; MIDOCEAN RIDGE; VENT CHIMNEYS; SYSTEMS;
   MINERALOGY; DIVERSITY; INSIGHTS; DEPOSITS; GROWTH; RATES
AB Hydrothermal systems are excellent natural laboratories for the study of how chemical energy landscapes shape microbial communities. Yet, only a few attempts have been made to quantify relationships between energy availability and microbial community structure in these systems. Here, we have investigated how microbial communities and chemical energy availabilities vary along cross-sections of two hydrothermal chimneys from the Soria Moria Vent Field and the Bruse Vent Field. Both vent fields are located on the Arctic Mid-Ocean Ridge, north of the Jan Mayen Island and the investigated chimneys were venting fluids with markedly different H2S:CH4 ratios. Energy landscapes were inferred from a stepwise in silico mixing of hydrothermal fluids (HFs) with seawater, where Gibbs energies of relevant redox-reactions were calculated at each step. These calculations formed the basis for simulations of relative abundances of primary producers in microbial communities. The simulations were compared with an analysis of 24 samples from chimney wall transects by sequencing of 16S rRNA gene amplicons using 454 sequencing. Patterns in relative abundances of sulfide oxidizing Epsilonproteobacteria and methane oxidizing Methylococcales and ANME-1, were consistent with simulations. However, even though H-2 was present in HFs from both chimneys, the observed abundances of putative hydrogen oxidizing anaerobic sulfate reducers (Archaeoglobales) and methanogens (Methanococcales) in the inner parts of the Soria Moria Chimney were considerably higher than predicted by simulations. This indicates biogenic production of H-2 in the chimney wall by fermentation, and suggests that biological activity inside the chimneys may modulate energy landscapes significantly. Our results are consistent with the notion that energy landscapes largely shape the distribution of primary producers in hydrothermal systems. Our study demonstrates how a combination of modeling and field observations can be useful in deciphering connections between chemical energy landscapes and metabolic networks within microbial communities.
C1 [Dahle, Hakon; Bauer, Sven Le Moine; Stokke, Runar; Pedersen, Rolf B.; Thorseth, Ingunn H.; Steen, Ida H.] Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway.
   [Dahle, Hakon; Bauer, Sven Le Moine; Stokke, Runar; Steen, Ida H.] Univ Bergen, Dept Biol, Bergen, Norway.
   [Baumberger, Tamara] NOAA, Pacific Marine Environm Lab, Newport, OR USA.
   [Pedersen, Rolf B.; Thorseth, Ingunn H.] Univ Bergen, Dept Earth Sci, Bergen, Norway.
RP Dahle, H (reprint author), Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway.; Dahle, H (reprint author), Univ Bergen, Dept Biol, Bergen, Norway.
EM hakon.dahle@uib.no
RI Baumberger, Tamara/L-8177-2019
OI Baumberger, Tamara/0000-0001-5920-6212
FU Research Council of NorwayResearch Council of Norway [179560]
FX This project was funded by the Research Council of Norway (Grant No.
   179560).
CR Amend JP, 2011, GEOCHIM COSMOCHIM AC, V75, P5736, DOI 10.1016/j.gca.2011.07.041
   BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177
   Baumberger T., 2011, THESIS
   Bayer B, 2016, ISME J, V10, P1051, DOI 10.1038/ismej.2015.200
   Button DK, 2001, APPL ENVIRON MICROB, V67, P1636, DOI 10.1128/AEM.67.4.1636-1645.2001
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Dahle H, 2015, ISME J, V9, P1593, DOI 10.1038/ismej.2014.247
   Dahle H, 2013, ENV MICROBIOL REP, V5, P282, DOI 10.1111/1758-2229.12016
   Dick JM, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-10
   DiPippo JL, 2009, INT J SYST EVOL MICR, V59, P2991, DOI 10.1099/ijs.0.008045-0
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Eecke HCV, 2012, P NATL ACAD SCI USA, V109, P13674, DOI 10.1073/pnas.1206632109
   Flores GE, 2012, GEOBIOLOGY, V10, P333, DOI 10.1111/j.1472-4669.2012.00325.x
   Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x
   Goldfarb M.S., 1983, EC GEOLOGY MONOGRAPH, V5, P184
   Gotz D, 2002, INT J SYST EVOL MICR, V52, P1349, DOI [10.1099/ijs.0.02126-0, 10.1099/00207713-52-4-1349]
   HAYMON RM, 1983, NATURE, V301, P695, DOI 10.1038/301695a0
   Jannasch H.W., 1995, GEOPHYS MONOGR SER, V91, P273, DOI DOI 10.1029/GM091P0273
   JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717
   JOHNSON JW, 1992, COMPUT GEOSCI, V18, P899, DOI 10.1016/0098-3004(92)90029-Q
   KARL DM, 1995, MICR EXTREM UNUSUAL, P35
   Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331
   LaRowe DE, 2014, GEOCHIM COSMOCHIM AC, V124, P72, DOI 10.1016/j.gca.2013.09.005
   Lin TJ, 2016, GEOCHEM GEOPHY GEOSY, V17, P300, DOI 10.1002/2015GC006091
   Lupton J, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001152
   Mccollom TM, 2007, ASTROBIOLOGY, V7, P933, DOI 10.1089/ast.2006.0119
   Miroshnichenko ML, 2006, EXTREMOPHILES, V10, P85, DOI 10.1007/s00792-005-0489-5
   MOTTL MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P1103, DOI 10.1016/0016-7037(78)90107-2
   Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z
   Oksanen J., 2011, VEGAN COMMUNITY ECOL, DOI DOI 10.HTTP://CRAN.R-PROJECT.ORG/PACKAGE=VEGAN
   Page A, 2008, ENVIRON MICROBIOL, V10, P874, DOI 10.1111/j.1462-2920.2007.01505.x
   Pedersen RB, 2010, GEOPHYS MONOGR SER, V188, P67, DOI 10.1029/2008GM000783
   Perner M, 2007, FEMS MICROBIOL ECOL, V61, P97, DOI 10.1111/j.1574-6941.2007.00325.x
   Postec A, 2007, EXTREMOPHILES, V11, P747, DOI 10.1007/s00792-007-0092-z
   Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38
   Reysenbach A.-L., 2002, BIODIVERSITY MICROBI, P345
   Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921
   Roalkvam I, 2011, FEMS MICROBIOL ECOL, V78, P233, DOI 10.1111/j.1574-6941.2011.01153.x
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003
   Shock EL, 2004, GEOPH MONOG SERIES, V144, P153, DOI 10.1029/144GM10
   Stokke R, 2015, ENVIRON MICROBIOL, V17, P4063, DOI 10.1111/1462-2920.12970
   TIVEY MK, 1995, GEOCHIM COSMOCHIM AC, V59, P1933, DOI 10.1016/0016-7037(95)00118-2
   Topcuoglu BD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01240
   Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144
NR 45
TC 3
Z9 3
U1 2
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 16
PY 2018
VL 9
AR 1570
DI 10.3389/fmicb.2018.01570
PG 12
WC Microbiology
SC Microbiology
GA GN0YO
UT WOS:000438707800001
PM 30061874
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Hu, JY
   Lin, L
   Chen, M
   Yan, WL
AF Hu, Jieyun
   Lin, Lu
   Chen, Min
   Yan, Weiling
TI Modeling for Predicting the Time to Detection of Staphylococcal
   Enterotoxin A in Cooked Chicken Product
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE predictive microbiology; Staphylococcus aureus; Staphylococcal
   enterotoxins; time to detection; cooked chicken
ID RESPONSE-SURFACE MODEL; COLI O157-H7 GROWTH; AUREUS ENTEROTOXIN;
   MICROBIAL-GROWTH; NEURAL-NETWORK; TO-DETECTION; PORK; FOOD; TEMPERATURE;
   MEAT
AB Staphylococcal enterotoxins (SEs) produced by Staphylococcus aureus (S. aureus) are the cause of Saphylococcal food poisoning (SFP) outbreaks. Thus, estimation of the time to detection (TTD) of SEs, that is, the time required to reach the SEs detection limit, is essential for food preservation and quantitative risk assessment. This study was conducted to explore an appropriate method to predict the TTD of SEs in cooked chicken product under variable environmental conditions. An S. aureus strain that produces staphylococcal enterotoxin A (SEA) was inoculated into cooked chicken meat. Initial inoculating concentrations (approximately 10(2), 10(3), 10(4) CFU/g) of S. aureus and incubation temperatures (15 +/- 1, 22 +/- 1, 29 +/- 1, and 36 +/- 1 degrees C) were chosen as environmental variables. The counting of S. aureus colonies and the detection of SEA were performed every 3 or 6 h during the incubation. The TTD of SEA was considered a response of S. aureus to environmental variables. Linear polynomial regression was used to model the effects of environmental variables on the TTD of SEA. Result showed that the correlation coefficient (R-2) of the regressed equation is higher than 0.98, which means the obtained equation was reliable. Moreover, the minimum concentration of S. aureus for producing a detectable amount of SEA under various environmental conditions was approximately 6.32 log CFU/g, which was considered the threshold for S. aureus to produce SEA. Hence, the TTD of SEA could be obtained by calculating the time required to reach the threshold by using an established S. aureus growth predictive model. Both established methods were validated through internal and external validation. The results of graphical comparison, RMSE, SEP, A(f), and B-f showed that the accuracy of both methods were acceptable, and linear polynomial regression method showed more accurately.
C1 [Hu, Jieyun; Lin, Lu; Yan, Weiling] Shanghai Food Res Inst, Shanghai, Peoples R China.
   [Chen, Min] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China.
RP Yan, WL (reprint author), Shanghai Food Res Inst, Shanghai, Peoples R China.
EM yanwling@tom.com
FU Development of Application Technology Project [2015-114]
FX This study was supported by the program (2015-114) of the Development of
   Application Technology Project issued by Science and Technology
   Committee of Shanghai Municipal Government.
CR ANUNCIACAO LLC, 1995, INT J FOOD MICROBIOL, V26, P259
   Basti AA, 2004, FOOD MICROBIOL, V21, P431, DOI 10.1016/j.fm.2003.10.006
   Chaves RD, 2017, J FOOD SAFETY, V37, DOI 10.1111/jfs.12342
   Chen J., 2014, SHANGHAI J PREVENTIV, V26, P169
   Cretenet M, 2011, DAIRY SCI TECHNOL, V91, P127, DOI 10.1007/s13594-011-0014-9
   Denayer S, 2017, TOXINS, V9, DOI 10.3390/toxins9120407
   Dong QL, 2007, FOOD MICROBIOL, V24, P624, DOI 10.1016/j.fm.2006.12.003
   European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329
   Fujikawa H, 2006, FOOD MICROBIOL, V23, P260, DOI 10.1016/j.fm.2005.04.005
   Garcia-Gimeno RM, 2005, J FOOD SCI, V70, pM30, DOI 10.1111/j.1365-2621.2005.tb09043.x
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   GIBSON AM, 1987, J APPL BACTERIOL, V62, P479, DOI 10.1111/j.1365-2672.1987.tb02680.x
   Guan ZP, 2017, INT J FOOD PROP, V20, P68, DOI 10.1080/10942912.2015.1136325
   Hervas C, 2001, FOOD SCI TECHNOL INT, V7, P159, DOI 10.1106/6Q2A-8D7R-JHJU-T7F6
   [胡洁云 Hu Jieyun], 2016, [微生物学通报, Microbiology China], V43, P1999
   Lebert I, 2000, INT J FOOD MICROBIOL, V61, P27, DOI 10.1016/S0168-1605(00)00359-7
   Lee YJ, 2015, MEAT SCI, V107, P20, DOI 10.1016/j.meatsci.2015.04.006
   Lin L., 2015, CHINESE J MICROBIOL, V3, P9, DOI [10.3969/j.issn.1005-7021.2015.03.002, DOI 10.3969/J.ISSN.1005-7021.2015.03.002]
   Min KJ, 2013, J FOOD SAFETY, V33, P17, DOI 10.1111/jfs.12018
   Peter A. C., 2005, 5 INT C MUSHR BIOL M
   Rodriguez-Caturla MY, 2012, MEAT SCI, V92, P409, DOI 10.1016/j.meatsci.2012.05.003
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8
   Ross T., 1999, PREDICTIVE FOOD MICR, V196
   Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]
   Schelin J, 2011, VIRULENCE, V2, P580, DOI 10.4161/viru.2.6.18122
   SMITH JL, 1983, J FOOD PROTECT, V46, P545, DOI 10.4315/0362-028X-46.6.545
   Sospedra I, 2013, FOOD RES INT, V54, P1052, DOI 10.1016/j.foodres.2013.03.002
   Tango CN, 2015, J FOOD SCI, V80, pM2911, DOI 10.1111/1750-3841.13143
   Tsutsuura S, 2013, BIOSCI BIOTECH BIOCH, V77, P30, DOI 10.1271/bbb.120391
   Tu L. L., 2012, MATH THEORY APPL, V32, P110
   Valero A, 2009, INT J FOOD MICROBIOL, V133, P186, DOI 10.1016/j.ijfoodmicro.2009.05.023
   Wallin-Carlquist N, 2010, INT J FOOD MICROBIOL, V141, pS69, DOI 10.1016/j.ijfoodmicro.2010.03.028
   [王军 Wang Jun], 2011, [食品科学, Food Science], V32, P268
   Wang T, 2015, THESIS
   Wu XL, 2014, FOOD CONTROL, V42, P63, DOI 10.1016/j.foodcont.2014.01.039
   Ye L. Q., 2012, STRAIT J PREV MED, V18, P53
   Zeaki N, 2014, INT J FOOD MICROBIOL, V182, P44, DOI 10.1016/j.ijfoodmicro.2014.05.010
   Zhao L, 2002, INT J FOOD MICROBIOL, V77, P187, DOI 10.1016/S0168-1605(02)00111-3
   Zhou S. J., 2014, CHIN J FOOD HYG, V26, P496, DOI [10.13590/j.cjfh.2014.05.021, DOI 10.13590/J.CJFH.2014.05.021]
   Zurera-Cosano G, 2006, FOOD CONTROL, V17, P429, DOI 10.1016/j.foodcont.2005.02.003
NR 42
TC 3
Z9 3
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 13
PY 2018
VL 9
AR 1536
DI 10.3389/fmicb.2018.01536
PG 11
WC Microbiology
SC Microbiology
GA GM8VN
UT WOS:000438514800001
PM 30057574
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Timme, RE
   Rand, H
   Leon, MS
   Hoffmann, M
   Strain, E
   Allard, M
   Roberson, D
   Baugher, JD
AF Timme, Ruth E.
   Rand, Hugh
   Leon, Maria Sanchez
   Hoffmann, Maria
   Strain, Errol
   Allard, Marc
   Roberson, Dwayne
   Baugher, Joseph D.
TI GenomeTrakr proficiency testing for foodborne pathogen surveillance: an
   exercise from 2015
SO MICROBIAL GENOMICS
LA English
DT Article
DE molecular epidemiology; proficiency test; whole-genome sequencing;
   outbreak detection; foodborne pathogen; GenomeTrakr
ID LABORATORY PERFORMANCE; MICROBIOLOGY; COLLEGE; REQUIREMENTS; PIPELINE;
   QUALITY; NETWORK; TOOL
AB Pathogen monitoring is becoming more precise as sequencing technologies become more affordable and accessible worldwide. This transition is especially apparent in the field of food safety, which has demonstrated how whole-genome sequencing (WGS) can be used on a global scale to protect public health. GenomeTrakr coordinates the WGS performed by public-health agencies and other partners by providing a public database with real-time cluster analysis for foodborne pathogen surveillance. Because WGS is being used to support enforcement decisions, it is essential to have confidence in the quality of the data being used and the downstream data analyses that guide these decisions. Routine proficiency tests, such as the one described here, have an important role in ensuring the validity of both data and procedures. In 2015, the GenomeTrakr proficiency test distributed eight isolates of common foodborne pathogens to participating laboratories, who were required to follow a specific protocol for performing WGS. Resulting sequence data were evaluated for several metrics, including proper labelling, sequence quality and new single nucleotide polymorphisms (SNPs). Illumina MiSeq sequence data collected for the same set of strains across 21 different laboratories exhibited high reproducibility, while revealing a narrow range of technical and biological variance. The numbers of SNPs reported for sequencing runs of the same isolates across multiple laboratories support the robustness of our cluster analysis pipeline in that each individual isolate cultured and resequenced multiple times in multiple places are all easily identifiable as originating from the same source.
C1 [Timme, Ruth E.; Rand, Hugh; Leon, Maria Sanchez; Hoffmann, Maria; Strain, Errol; Allard, Marc; Roberson, Dwayne; Baugher, Joseph D.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.
RP Timme, RE (reprint author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.
EM ruth.timme@fda.hhs.gov
OI Timme, Ruth/0000-0002-9705-5897; Baugher, Joseph/0000-0003-2466-3047
FU CFSAN at the FDA, USA; United States Department of EnergyUnited States
   Department of Energy (DOE); FDAUnited States Department of Health &
   Human Services
FX This work was supported by the CFSAN at the FDA, USA. This project was
   supported in part by an appointment to the Research Participation
   Program at the Office of Analytics and Outreach and the Office of
   Regulatory Science, CFSAN, FDA, USA, administered by the Oak Ridge
   Institute for Science and Education through an interagency agreement
   between the United States Department of Energy and the FDA.
CR Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16
   Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32
   Andrews S, 2010, FASTQC QUALITY CONTR
   APHL, 2015, NEXT GEN SEQ PUBL HL
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20
   Feldman GL, 2014, GENET MED, V16, P695, DOI 10.1038/gim.2014.14
   Gargis AS, 2016, J CLIN MICROBIOL, V54, P2857, DOI 10.1128/JCM.00949-16
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086
   Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297
   Illumina, 2016, OPT CLUST DENS ILL S
   Katz LS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00375
   Kozyreva VK, 2017, J CLIN MICROBIOL, V55, P2502, DOI 10.1128/JCM.00361-17
   Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lesho E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155770
   Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443
   Lyon E, 2015, GENET MED, V17, P219, DOI 10.1038/gim.2014.93
   Moran-Gilad J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0902-3
   Moura A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.185
   Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544
   Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1
   Pightling AW, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0526-1
   Pirone-Davies C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123639
   Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51
   Stevens EL, 2017, MAKING CASE USING WH
   Swaminathan B, 2001, EMERG INFECT DIS, V7, P382
   Toker Lilah, 2016, F1000Res, V5, P2103
   Tyler AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148676
   Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963
   Weck KE, 2012, GENET MED, V14, P306, DOI 10.1038/gim.2011.11
   Wyres KL, 2014, PATHOGENS, V3, P437, DOI 10.3390/pathogens3020437
   Yachison CA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01044
   Yao K, 2016, GENOME ANNOUNC, V4
NR 36
TC 6
Z9 6
U1 2
U2 3
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 2057-5858
J9 MICROB GENOMICS
JI Microb. Genomics
PD JUL
PY 2018
VL 4
IS 7
AR 000185
DI 10.1099/mgen.0.000185
PG 11
WC Genetics & Heredity; Microbiology
SC Genetics & Heredity; Microbiology
GA GP0UP
UT WOS:000440526300006
PM 29906258
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Pena-Lopez, Y
   Pujol, M
   Campins, M
   Lagunes, L
   Balcells, J
   Rello, J
AF Pena-Lopez, Y.
   Pujol, M.
   Campins, M.
   Lagunes, L.
   Balcells, J.
   Rello, J.
TI Assessing prediction accuracy for outcomes of ventilator-associated
   events and infections in critically ill children: a prospective cohort
   study
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Children Hypoxaemia; Respiratory infections; Ventilation-associated
   tracheobronchitis (VAT); Ventilator-associated condition (VAC);
   Ventilator-associated event (VAE); Ventilator-associated pneumonia (VAP)
ID FOR-DISEASE-CONTROL; CARE SAFETY NETWORK; MECHANICAL VENTILATION;
   SURVEILLANCE; PNEUMONIA; TRACHEOBRONCHITIS; CRITERIA; PICU;
   COMPLICATIONS; DEFINITION
AB Objectives: To assess the prediction accuracy of the 2008 US Centers for Disease Control and Prevention (CDC) definitions for ventilator-associated pneumonia (VAP)/ventilator-associated tracheobronchitis (VAT), 2013 CDC definitions for ventilator-associated events (VAE) and a new VAE algorithm in the paediatric (Ped) population, the Ped-VAE.
   Methods: We performed a prospective 13-month cohort study at a multidisciplinary paediatric intensive care unit (PICU). Primary endpoints were duration of ventilation episode, PICU or hospitalization length of stay from episode and episode mortality. Episodes without VAE (or VAP/VAT) served as comparison groups.
   Results: One hundred eight episodes of ventilation (99 children) with 2554 ventilator-days were assessed. In episodes not meeting 2008 CDC definitions, a median of 6 ventilator-days (PICU stay 11 days) was documented (with eight deaths), not significantly different from episodes not meeting VAE or Ped-VAE definitions. Using 2008 CDC criteria, 11 (10.2%) respiratory infections (eight tracheobronchitis) were identified, seven VAEs using 2013 CDC criteria (6.4%) and 29 (26.8%) using Ped-VAE criteria (relative risk vs. 2008 CDC criteria 2.58; 95% confidence interval 1.36-4.91). In contrast with their comparison groups, episodes meeting 2008 CDC criteria did not significantly predict outcomes, whereas VAEs (only four possible VAPs) were associated with significantly more ventilation and PICU length of stay (12-day/8-day increase) and sevenfold increase in mortality. Ped-VAE did not increase mortality, but it was associated with 4-day increase in ventilation and PICU length of stay, with ten possible VAPs, and atelectasis (9/12) as the main paediatric ventilator-associated condition.
   Conclusions: The 2008 CDC criteria did not predict outcomes, whereas VAE only identified very severe events. The Ped-VAE algorithm had more accuracy predicting outcomes by characterizing lower oxygenation changes and identifying hypoxaemia severity, a major driver of management. (c) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Pena-Lopez, Y.; Pujol, M.; Balcells, J.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, Pediat Crit Care Dept, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.
   [Campins, M.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Prevent Med & Epidemiol, Barcelona, Spain.
   [Lagunes, L.] European Study Grp Infect Critically Ill Patients, Vall dHebron Inst Recerca, Passeig Vall dHebron 129, Barcelona 08035, Spain.
   [Rello, J.] European Study Grp Infect Critically Ill Patients, Vall dHebron Inst Res, Ctr Invest Biomed Red CIBERES, Passeig Vall dHebron 129,AMI-14, Barcelona 08035, Spain.
RP Rello, J (reprint author), European Study Grp Infect Critically Ill Patients, Vall dHebron Inst Res, Ctr Invest Biomed Red CIBERES, Passeig Vall dHebron 129,AMI-14, Barcelona 08035, Spain.
EM jrello@crips.es
RI Rello, Jordi/P-2402-2019
OI Rello, Jordi/0000-0003-0676-6210; BALCELLS, JOAN/0000-0002-8341-6508;
   Pena-Lopez, Yolanda/0000-0001-5381-4858; Lagunes,
   Leonel/0000-0003-2517-8000
FU ESGCIP (European Society of Intensive Care Medicine, Basel,
   Switzerland); Programa Corporativo de Investigacion en Neumonia (Centro
   de Investigacion Biomedica en Red de Enfermedades Respiratorias,
   CIBERES); Programa Corporativo de Investigacion en Neumonia (Fondo
   Europeo Desarrollo Regional, Instituto Salud Carlos III, Madrid)
FX This study was funded in part by grants from ESGCIP (European Society of
   Intensive Care Medicine, Basel, Switzerland) and Programa Corporativo de
   Investigacion en Neumonia (Centro de Investigacion Biomedica en Red de
   Enfermedades Respiratorias, CIBERES; and Fondo Europeo Desarrollo
   Regional, Instituto Salud Carlos III, Madrid). JR has served on the
   speakers' bureau and as a consultant for Cubist, Bayer, Medimmune,
   Pfizer and Aridis. The other authors report no conflicts of interest
   relevant to this article.
CR Beardsley AL, 2015, GLOB PEDIAT HLTH, V2
   Beardsley AL, 2016, PEDIATR CRIT CARE ME, V17, P73, DOI 10.1097/PCC.0000000000000569
   Bouadma L, 2015, CRIT CARE MED, V43, P1798, DOI 10.1097/CCM.0000000000001091
   Cirulis MM, 2016, PEDIATR CRIT CARE ME, V17, P157, DOI 10.1097/PCC.0000000000000590
   Cocoros NM, 2017, INFECT CONT HOSP EP, V38, P327, DOI 10.1017/ice.2016.277
   Cocoros NM, 2016, CRIT CARE MED, V44, P14, DOI 10.1097/CCM.0000000000001372
   Fan YZ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1506-z
   Farias J.A., 2006, Med. Intensiva, V30, P425
   Foglia E, 2007, CLIN MICROBIOL REV, V20, P409, DOI 10.1128/CMR.00041-06
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Iosifidis E, 2016, INFECT CONT HOSP EP, V37, P1162, DOI 10.1017/ice.2016.135
   Klompas M, 2017, CLIN INFECT DIS, V64, P870, DOI 10.1093/cid/ciw870
   Klompas M, 2013, NEW ENGL J MED, V368, P1472, DOI 10.1056/NEJMp1300633
   Lilly CM, 2014, CRIT CARE MED, V42, P2019, DOI 10.1097/CCM.0000000000000396
   MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937
   Magill SS, 2016, CRIT CARE MED, V44, P2154, DOI 10.1097/CCM.0000000000001871
   Magill SS, 2014, CURR OPIN INFECT DIS, V27, P394, DOI 10.1097/QCO.0000000000000083
   Muszynski JA, 2013, PEDIATR CRIT CARE ME, V14, P533, DOI 10.1097/PCC.0b013e31828a897f
   Pena-Lopez Y, 2016, INT J INFECT DIS, V52, P43, DOI 10.1016/j.ijid.2016.09.021
   Phongjitsiri S, 2015, CRIT CARE MED, V43, P2446, DOI 10.1097/CCM.0000000000001261
   Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004
   Principi T, 2011, PEDIATR PULM, V46, P452, DOI 10.1002/ppul.21389
   Rello J, 2014, LANCET RESP MED, V2, P764, DOI 10.1016/S2213-2600(14)70171-7
   Schouten LRA, 2016, CRIT CARE MED, V44, P819, DOI 10.1097/CCM.0000000000001388
   Simpson VS, 2013, CHEST, V144, P32, DOI 10.1378/chest.12-2343
   Tamma PD, 2011, CLIN INFECT DIS, V52, P1324, DOI 10.1093/cid/cir203
   Wheeler DS, 2015, PEDIATR CRIT CARE ME, V16, P565, DOI 10.1097/PCC.0000000000000405
   Willson DF, 2017, PEDIATR CRIT CARE ME, V18, pE24, DOI 10.1097/PCC.0000000000001001
NR 28
TC 8
Z9 8
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUL
PY 2018
VL 24
IS 7
BP 732
EP 737
DI 10.1016/j.cmi.2017.10.004
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GL0FM
UT WOS:000436640800013
PM 29031787
OA Bronze
DA 2020-05-07
ER

PT J
AU Pedersen, RM
   Nielsen, MTK
   Moller, S
   Ethelberg, S
   Skov, MN
   Kolmos, HJ
   Scheutz, F
   Holt, HM
   Rosenvinge, FS
AF Pedersen, R. M.
   Nielsen, M. T. K.
   Moeller, S.
   Ethelberg, S.
   Skov, M. N.
   Kolmos, H. J.
   Scheutz, F.
   Holt, H. M.
   Rosenvinge, F. S.
TI Shiga toxin-producing Escherichia coli: incidence and clinical features
   in a setting with complete screening of patients with suspected
   infective diarrhoea
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Epidemiology; Incidence; Long-term symptoms; Screening; Shiga
   toxin-producing Escherichia coli; Signs and symptoms; STEC; VTEC
ID HEMOLYTIC-UREMIC SYNDROME; ACTIVE SURVEILLANCE NETWORK; VIRULENCE
   FACTORS; OUTBREAK; DISEASE; GERMANY; O157; VTEC
AB Objectives: Shiga toxin-producing Escherichia coli (STEC) causes diarrhoeal disease, bloody diarrhoea, and haemolytic uraemic syndrome. The aim of this study was to describe the incidence of STEC and the clinical features of STEC patients from a well-defined Danish population in which all fecal samples of patients with suspected infective gastroenteritis were analysed for STEC.
   Methods: In this population-based cohort study, all stool samples referred to two clinical microbiology laboratories were screened for STEC by culture and/or PCR. Epidemiological (n=170) and clinical (n=209) characteristics were analysed using data from local and national registries.
   Results: Overall, 75,132 samples from 30,073 patients were screened resulting in 217 unique STECisolates. The epidemiological analysis showed an incidence of 10.1 cases per 100,000 person-years, which was more than twofold higher than the incidence in the rest of Denmark (3.4 cases per 100,000 person-years, p <0.001). Three groups were associated with a higher incidence: age <5 years (n=28, p <0.001), age >= 65 years (n=38, p 0.045), and foreign ethnicity (n=27, p 0.003). In the clinical analysis, patients with STEC harbouring only the Shiga toxin 1 gene (stx(1)-only isolates) showed a lower frequency of acute (n=11, p <0.05) and bloody diarrhoea (n=5, p <0.05) and a higher frequency of gastrointestinal symptoms for >= 3 months (n=8, p <0.05) than the other STEC patients.
   Conclusions: We report a more than twofold higher incidence in the project area compared with the rest of Denmark, indicating that patients remain undiagnosed when selective STEC screening is used. We found an association between patients with stx(1)-only isolates and long-term gastrointestinal symptoms. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Pedersen, R. M.; Kolmos, H. J.] Univ Southern Denmark, Dept Clin Res, Res Unit Clin Microbiol, JB Winslowsvej 21-2, DK-5000 Odense C, Denmark.
   [Pedersen, R. M.; Rosenvinge, F. S.] Lillebaelt Hosp, Dept Clin Microbiol, Vejle, Denmark.
   [Nielsen, M. T. K.; Skov, M. N.; Holt, H. M.; Rosenvinge, F. S.] Odense Univ Hosp, Dept Clin Microbiol, Odense, Denmark.
   [Moeller, S.] Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, Odense, Denmark.
   [Moeller, S.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark.
   [Ethelberg, S.] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark.
   [Scheutz, F.] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Int Collaborating Ctr Reference & Res Escherichia, Copenhagen, Denmark.
RP Pedersen, RM (reprint author), Univ Southern Denmark, Dept Clin Res, Res Unit Clin Microbiol, JB Winslowsvej 21-2, DK-5000 Odense C, Denmark.
EM rmpedersen@health.sdu.dk
RI Moller, Soren/X-8738-2019
OI Moller, Soren/0000-0003-0858-4269; Nielsen, Marc Trunjer
   Kusk/0000-0002-3297-3814; Ethelberg, Steen/0000-0002-9709-356X
CR Aarhus University Hospital, CLIN MICROBIOLOGY
   Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999
   Brandal LT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1017-6
   Busani L, 2006, EPIDEMIOL INFECT, V134, P407, DOI 10.1017/S0950268805004735
   Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073
   DSKM, DIAGN BAKT MAV TARM
   Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576
   European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329
   Haugum K, 2014, J CLIN MICROBIOL, V52, P3156, DOI 10.1128/JCM.00453-14
   Huang JY, 2016, MMWR-MORBID MORTAL W, V65, P368, DOI 10.15585/mmwr.mm6514a2
   Karmali MA, 2017, CLIN INFECT DIS, V64, P371, DOI 10.1093/cid/ciw708
   King LA, 2014, CLIN MICROBIOL INFEC, V20, pO1136, DOI 10.1111/1469-0691.12736
   Kuehne A, 2016, EPIDEMIOL INFECT, V144, P3305, DOI 10.1017/S0950268816001436
   Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704
   Marcon MJ, 2011, J CLIN MICROBIOL, V49, P2390, DOI 10.1128/JCM.00817-11
   Messens W, 2015, EPIDEMIOL INFECT, V143, P1652, DOI 10.1017/S095026881400137X
   Morita-Ishihara T, 2016, EMERG INFECT DIS, V22, P2181, DOI 10.3201/eid2212.160783
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142
   Nielsen EM, 2006, FOODBORNE PATHOG DIS, V3, P81, DOI 10.1089/fpd.2006.3.81
   Olesen B, 2005, SCAND J INFECT DIS, V37, P288, DOI 10.1080/00365540410021090
   R Core Team, 2016, R LANG ENV STAT COMP
   Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920
   Scallan E, 2015, FOODBORNE PATHOG DIS, V12, P492, DOI 10.1089/fpd.2014.1915
   Simonsen J, 2008, EPIDEMIOLOGY, V19, P282, DOI 10.1097/EDE.0b013e3181633c19
   Statens Serum Institut, PUBLIC HLTH
   Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2
   Yukioka H, 1997, Eur J Emerg Med, V4, P165, DOI 10.1097/00063110-199709000-00009
NR 27
TC 4
Z9 4
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2018
VL 24
IS 6
BP 635
EP 639
DI 10.1016/j.cmi.2017.10.002
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GG1KS
UT WOS:000432446500015
PM 29030168
OA Bronze
DA 2020-05-07
ER

PT J
AU Kaplon, J
   Grangier, N
   Pillet, S
   Minoui-Tran, A
   Vabret, A
   Wilhelm, N
   Prieur, N
   Lazrek, M
   Alain, S
   Mekki, Y
   Foulongne, V
   Guinard, J
   Avettand-Fenoel, V
   Schnuriger, A
   Beby-Defaux, A
   Lagathu, G
   Pothier, P
   de Rougemont, A
AF Kaplon, J.
   Grangier, N.
   Pillet, S.
   Minoui-Tran, A.
   Vabret, A.
   Wilhelm, N.
   Prieur, N.
   Lazrek, M.
   Alain, S.
   Mekki, Y.
   Foulongne, V.
   Guinard, J.
   Avettand-Fenoel, V.
   Schnuriger, A.
   Beby-Defaux, A.
   Lagathu, G.
   Pothier, P.
   de Rougemont, A.
TI Predominance of G9P[8] rotavirus strains throughout France, 2014-2017
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE G9P[8]; gastroenteritis; genotype; rotavirus; vaccine
ID MAJOR CAUSE; CHILDREN; EUROPE; G9; GASTROENTERITIS; SURVEILLANCE;
   VACCINATION; GENOTYPES; DIARRHEA; G1
AB Objectives: Group A rotavirus is a major cause of acute gastroenteritis in young children worldwide. A prospective surveillance network has been set up in France to investigate rotavirus infections and to detect the emergence of potentially epidemic strains.
   Methods: From 2014 to 2017, rotavirus-positive stool samples were collected from 2394 children under 5 years old attending the paediatric emergency units of 13 large hospitals. Rotaviruses were genotyped by RT-PCR with regard to their outer capsid proteins VP4 and VP7.
   Results: Genotyping of 2421 rotaviruses showed that after a marked increase in G9P[8] (32.1%) during the 2014-2015 season, G9P[8] became the predominant genotype during the 2015-2016 and 2016-2017 seasons with detection rates of 64.1% and 77.3%, respectively, whereas G1P[8] were detected at low rates of 16.8% and 6.6%, respectively. Phylogenetic analysis of the partial rotavirus VP7 and VP4 coding genes revealed that all of these G9P [8] strains belonged to the lineage III and the P [8]-3 lineage, respectively, and shared the same genetic background (G9-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1) as did most of previously detected G9P[8] strains and particularly the emerging G9P[8] strains from the 2004-2005 season in France.
   Conclusions: G9P[8] rotaviruses have become the predominant circulating genotype for the first time since their emergence a decade ago. In the absence of rotavirus immunization programmes in France, our data give an insight into the natural fluctuation of rotavirus genotypes in a non-vaccinated population and provide a base line for a better interpretation of data in European countries with routine rotavirus vaccination. (c) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Kaplon, J.; Grangier, N.; Pothier, P.; de Rougemont, A.] Univ Hosp Dijon, Lab Biol & Pathol, Natl Reference Ctr Gastroenteritis Viruses, Dijon, France.
   [Kaplon, J.] Univ Bourgogne Franche Comte AgroSup Dijon, UMR PAM A Procedes Alimentaires & Microbiol 02 10, Dijon, France.
   [Kaplon, J.; Grangier, N.; Pillet, S.; Minoui-Tran, A.; Vabret, A.; Wilhelm, N.; Prieur, N.; Lazrek, M.; Alain, S.; Mekki, Y.; Foulongne, V.; Guinard, J.; Avettand-Fenoel, V.; Schnuriger, A.; Beby-Defaux, A.; Lagathu, G.; Pothier, P.; de Rougemont, A.] French Rotavirus Network, Dijon, France.
   [Pillet, S.] Univ Hosp St Etienne, Lab Infect Agents & Hyg, St Etienne, France.
   [Minoui-Tran, A.] Univ Hosp Brest, Lab Clin Virol, Brest, France.
   [Vabret, A.] Univ Hosp Caen, Lab Clin Virol, Caen, France.
   [Wilhelm, N.] Hosp Cahors, Lab Clin Biol, Lot, France.
   [Prieur, N.] Hosp Charleville Mezieres, Lab Clin Biol, Ardennes, France.
   [Lazrek, M.] Univ Hosp Lille, Lab Clin Virol, Lille, France.
   [Alain, S.] Univ Hosp Limoges, Lab Clin Virol, Limoges, France.
   [Mekki, Y.] Univ Hosp Lyon, Lab Clin Virol, Lyon, France.
   [Foulongne, V.] Univ Hosp Montpellier, Lab Clin Virol, Montpellier, France.
   [Guinard, J.] Hosp Orleans, Lab Clin Biol, Orleans, France.
   [Avettand-Fenoel, V.; Schnuriger, A.] Univ Hosp Paris, Lab Clin Virol, Paris, France.
   [Beby-Defaux, A.] Univ Hosp Poitiers, Lab Clin Virol, Poitiers, France.
   [Lagathu, G.] Univ Hosp Rennes, Lab Clin Virol, Rennes, France.
RP Kaplon, J; de Rougemont, A (reprint author), CHU Dijon Bourgogne, Ctr Natl Reference Virus Gastroenterites, Lab Biol & Pathol, 2 Rue Angel Ducoudray,BP 37013, F-21070 Dijon, France.
EM jerome.kaplon@chu-dijon.fr; alexis.de-rougemont@u-bourgogne.fr
RI de ROUGEMONT, Alexis/M-1090-2016; Avettand-Fenoel,
   Veronique/O-6285-2017; Kaplon, Jerome/E-1707-2013
OI de ROUGEMONT, Alexis/0000-0002-3084-9414; Avettand-Fenoel,
   Veronique/0000-0002-7022-2990; Pillet, Sylvie/0000-0002-0882-3162;
   Kaplon, Jerome/0000-0002-8180-4152; VABRET, Astrid/0000-0002-8940-7645
FU EuroRotaNet project
FX The authors declare no competing financial interests in the conduct of
   the study. This study received funding from the EuroRotaNet project
   through a non-restrictive collaborative grant.
CR Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06
   Aupiais C, 2009, J CLIN VIROL, V46, P282, DOI 10.1016/j.jcv.2009.07.021
   Banyai K, 2005, J MED VIROL, V76, P414, DOI 10.1002/jmv.20372
   de Rougemont A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.025
   de Rougemont A, 2009, EUR J CLIN MICROBIOL, V28, P403, DOI 10.1007/s10096-008-0640-1
   de Rougemont A, 2011, PEDIATR INFECT DIS J, V30, P118, DOI 10.1097/INF.0b013e3181ef034e
   Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810
   Iturriza-Gomara M, 2009, J INFECT DIS, V200, pS215, DOI 10.1086/605052
   Martinot A, 2014, ARCH PEDIATRIE, V21, P1389, DOI 10.1016/j.arcped.2014.08.001
   Parez N, 2014, LANCET INFECT DIS, V14, P416, DOI 10.1016/S1473-3099(14)70035-0
   Rahman M, 2005, J CLIN VIROL, V33, P1, DOI 10.1016/j.jcv.2004.09.020
   Rodrigues F, 2007, J CLIN VIROL, V40, P214, DOI 10.1016/j.jcv.2007.08.006
   Sanchez-Fauquier A, 2006, EMERG INFECT DIS, V12, P1536, DOI 10.3201/eid1210.060384
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   Van Damme P, 2007, J INFECT DIS, V195, pS17, DOI 10.1086/516715
NR 16
TC 6
Z9 8
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2018
VL 24
IS 6
DI 10.1016/j.cmi.2017.10.009
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GG1KS
UT WOS:000432446500022
PM 29066401
OA Bronze
DA 2020-05-07
ER

PT J
AU Bauer, SL
   Stensland, A
   Daae, FL
   Sandaa, RA
   Thorseth, IH
   Steen, IH
   Dahle, H
AF Bauer, Sven Le Moine
   Stensland, Anne
   Daae, Frida L.
   Sandaa, Ruth-Anne
   Thorseth, Ingunn H.
   Steen, Ida H.
   Dahle, Hakon
TI Water Masses and Depth Structure Prokaryotic and T4-Like Viral
   Communities Around Hydrothermal Systems of the Nordic Seas
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE marine microbiology; water mass; microbial ecology; hydrothermal plume;
   viral ecology; community profiling
ID EAST GREENLAND CURRENT; NORTH-ATLANTIC SST; BACTERIAL COMMUNITIES;
   MICROBIAL COMMUNITIES; FRAM STRAIT; WINTER CIRCULATION; AMMONIA
   OXIDATION; ICE ANOMALIES; ARCTIC-OCEAN; DIVERSITY
AB The oceanographic features of the Nordic Seas, situated between Iceland and Svalbard, have been extensively studied over the last decades. As well, the Nordic Seas hydrothermal systems situated on the Arctic Mid-Ocean Ridge System have received an increasing interest. However, there is very little knowledge on the microbial communities inhabiting the water column of the Nordic Seas, and nothing is known about the influence of the different water masses and hydrothermal plumes on the microbial community structures. In this study, we aimed at characterizing the impact of hydrothermal plumes on prokaryotic and T4-like viral communities around the island of Jan Mayen. To this end, we used 16S rRNA-gene and g23-gene profiling as well as flow cytometry counts to examine prokaryotic and viral communities in 27 samples obtained from different water masses in this area. While Thaumarchaeota and Marine group II Archaea dominated the waters deeper than 500 m, members of Flavobacteria generally dominated the shallower waters. Furthermore, extensive chemical and physical characteristics of all samples were obtained, including temperature measurements and concentrations of major ions and gases. The effect of these physiochemical variables on the communities was measured by using constrained and unconstrained multivariate analyzes, Mantel tests, network analyzes, phylogenetic analyzes, taxonomic analyzes and temperature-salinity (Theta-S) plots. Our results suggest that hydrothermal activity has little effect on pelagic microbial communities in hydrothermal plumes of the Nordic Seas. However, we provide evidences that observed differences in prokaryotic community structure can largely be attributed to which water mass each sample was taken from. In contrast, depth was the major factor structuring the T4-like viral communities. Our results also show that it is crucial to include water masses when studying the influence of hydrothermal plumes on microbial communities, as it could prevent to falsely associate a change in community structure with the presence of a plume.
C1 [Bauer, Sven Le Moine; Daae, Frida L.; Sandaa, Ruth-Anne; Steen, Ida H.; Dahle, Hakon] Univ Bergen, Dept Biol Sci, Bergen, Norway.
   [Bauer, Sven Le Moine; Stensland, Anne; Thorseth, Ingunn H.; Steen, Ida H.; Dahle, Hakon] Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway.
   [Stensland, Anne; Thorseth, Ingunn H.] Univ Bergen, Dept Earth Sci, Bergen, Norway.
RP Bauer, SL (reprint author), Univ Bergen, Dept Biol Sci, Bergen, Norway.; Bauer, SL (reprint author), Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway.
EM sven.lemoinebauer@gmail.com
FU Research Council of NorwayResearch Council of Norway [179560]
FX This project was funded by the Research Council of Norway (Grant number
   179560). The authors thank Elzbieta Petelenz-Kurdziel from the
   Department of Biology of the University Of Bergen for her time and input
   related to flow-cytometry. As well, we are grateful to Kjetil Vage from
   the Geophysical Institute and Svein Osterhus from UniResearch for the
   discussions and input regarding the circulation of water masses in the
   Nordic Seas.
CR AAGAARD K, 1985, J GEOPHYS RES-OCEANS, V90, P4833, DOI 10.1029/JC090iC03p04833
   AAGAARD K, 1975, J GEOPHYS RES-OC ATM, V80, P3821, DOI 10.1029/JC080i027p03821
   Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x
   Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535
   Anantharaman K, 2016, ISME J, V10, P225, DOI 10.1038/ismej.2015.81
   Anantharaman K, 2014, SCIENCE, V344, P757, DOI 10.1126/science.1252229
   Anderson RE, 2013, FEMS MICROBIOL ECOL, V83, P324, DOI 10.1111/j.1574-6941.2012.01478.x
   Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368
   Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159
   Baker BJ, 2012, ISME J, V6, P2269, DOI 10.1038/ismej.2012.64
   Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11
   Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140
   Blindheim J, 2005, GEOPH MONOG SERIES, V158, P11
   Blindheim J, 2004, ICES J MAR SCI, V61, P846, DOI 10.1016/j.icesjms.2004.05.003
   BLINDHEIM J, 1990, DEEP-SEA RES, V37, P1475, DOI 10.1016/0198-0149(90)90138-L
   BOURKE RH, 1992, J GEOPHYS RES-OCEANS, V97, P7241, DOI 10.1029/92JC00150
   Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399
   Brum JR, 2005, AQUAT MICROB ECOL, V41, P103, DOI 10.3354/ame041103
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9
   Dahle H, 2015, ISME J, V9, P1593, DOI 10.1038/ismej.2014.247
   De Corte D, 2016, ENV MICROBIOL REP, V8, P305, DOI 10.1111/1758-2229.12381
   De Corte D, 2012, ISME J, V6, P1566, DOI 10.1038/ismej.2011.214
   DEANGELIS MA, 1993, GLOBAL BIOGEOCHEM CY, V7, P509, DOI 10.1029/93GB01636
   DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250
   Deser C, 2004, J CLIMATE, V17, P877, DOI 10.1175/1520-0442(2004)017<0877:TEONAS>2.0.CO;2
   Dick GJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00124
   Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x
   Dickson B, 2007, NORSK GEOGR TIDSSKR, V61, P56, DOI 10.1080/00291950701409256
   Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Filee J, 2005, P NATL ACAD SCI USA, V102, P12471, DOI 10.1073/pnas.0503404102
   Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x
   Fofonoff NP, 1983, UNESCO TECHNICAL PAP, V44
   Fogelqvist E, 2003, DEEP-SEA RES PT I, V50, P73, DOI 10.1016/S0967-0637(02)00131-0
   Frindte K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143428
   Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134
   Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23
   Galili T., 2017, DENDEXTEND EXTENDING
   Galili T., 2015, DENDEXTENDRCPP FASTE
   Ghiglione JF, 2008, BIOGEOSCIENCES, V5, P1751, DOI 10.5194/bg-5-1751-2008
   Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107
   Goffredi SK, 2008, ISME J, V2, P204, DOI 10.1038/ismej.2007.103
   Guerrero-Feijoo E, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw224
   Haine TWN, 2015, GLOBAL PLANET CHANGE, V125, P13, DOI 10.1016/j.gloplacha.2014.11.013
   Han D, 2015, DEEP-SEA RES PT II, V120, P52, DOI 10.1016/j.dsr2.2015.01.018
   Havik L, 2017, J GEOPHYS RES-OCEANS, V122, P1974, DOI 10.1002/2016JC012228
   Hernando-Morales V, 2017, ENVIRON MICROBIOL, V19, P1017, DOI 10.1111/1462-2920.13538
   HIRCHE HJ, 1991, POLAR BIOL, V11, P351
   Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712
   Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143
   Ingvaldsen RB, 2004, CONT SHELF RES, V24, P1015, DOI 10.1016/j.csr.2004.02.011
   Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219
   Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109
   KADKO DC, 1990, EARTH PLANET SC LETT, V99, P315, DOI 10.1016/0012-821X(90)90137-M
   KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6
   Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051
   Karstensen J, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002510
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Koszalka I, 2011, DEEP-SEA RES PT I, V58, P468, DOI 10.1016/j.dsr.2011.01.007
   Lam P, 2004, FEMS MICROBIOL ECOL, V47, P191, DOI 10.1016/S0168-6496(03)00256-3
   Lam P, 2008, GEOCHIM COSMOCHIM AC, V72, P2268, DOI 10.1016/j.gca.2008.01.033
   Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716
   Lekunberri I, 2013, FEMS MICROBIOL ECOL, V85, P537, DOI 10.1111/1574-6941.12142
   Lesniewski RA, 2012, ISME J, V6, P2257, DOI 10.1038/ismej.2012.63
   Li JT, 2016, GEOMICROBIOL J, V33, P401, DOI 10.1080/01490451.2015.1048393
   Li M, 2014, ENVIRON MICROBIOL, V16, P60, DOI 10.1111/1462-2920.12182
   LUPTON JE, 1985, NATURE, V316, P621, DOI 10.1038/316621a0
   Magnusdottir G, 2004, J CLIMATE, V17, P857, DOI 10.1175/1520-0442(2004)017<0857:TEONAS>2.0.CO;2
   MANTEL N, 1967, CANCER RES, V27, P209
   Marie D, 1999, APPL ENVIRON MICROB, V65, P45
   Marnela M, 2008, PROG OCEANOGR, V78, P1, DOI 10.1016/j.pocean.2007.06.004
   Maruyama A, 1998, CAH BIOL MAR, V39, P249
   Melle Webjorn, 2004, P137
   Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240
   O'Brien D, 1998, EARTH PLANET SC LETT, V157, P223, DOI 10.1016/S0012-821X(98)00037-5
   Oksanen J., 2017, VEGAN COMMUNITY ECOL
   Ortmann AC, 2005, DEEP-SEA RES PT I, V52, P1515, DOI 10.1016/j.dsr.2005.04.002
   Osterhus S, 1999, J CLIMATE, V12, P3297, DOI 10.1175/1520-0442(1999)012<3297:TAOTNS>2.0.CO;2
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Pagarete A, 2013, APPL ENVIRON MICROB, V79, P6253, DOI 10.1128/AEM.01075-13
   Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023
   Pedersen RB, 2005, EOS T AM GEOPHYS UN, V86, pOS21C
   Pedersen RB, 2010, GEOPHYS MONOGR SER, V188, P67, DOI 10.1029/2008GM000783
   Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124
   Pinhassi J, 2003, MAR ECOL PROG SER, V255, P1, DOI 10.3354/meps255001
   Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/nmeth.1361, 10.1038/NMETH.1361]
   Ray J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034238
   Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262
   Rhines PB, 2003, ASOF NEWSL, V1, P13, DOI DOI 10.1175/1520-0442(2004)017<0877:TE0NAS>2.0.C0;2
   Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000
   Rudels B, 2005, J MARINE SYST, V55, P1, DOI 10.1016/j.jmarsys.2004.06.008
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sandaa RA, 2009, ENVIRON MICROBIOL, V11, P2585, DOI 10.1111/j.1462-2920.2009.01983.x
   Schander C, 2010, MAR BIOL RES, V6, P155, DOI 10.1080/17451000903147450
   Schattenhofer M, 2009, ENVIRON MICROBIOL, V11, P2078, DOI 10.1111/j.1462-2920.2009.01929.x
   Schauer U, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001823
   Schlitzer R., 2016, OCEAN DATA VIEW
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sheik CS, 2015, ISME J, V9, P1434, DOI 10.1038/ismej.2014.228
   Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165
   Soetaert K., 2016, PLOT3D PLOTTING MULT
   Soetaert K., 2016, MARELAC TOOLS AQUATI
   Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697
   Suh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131633
   Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359
   Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004
   SWIFT JH, 1988, J GEOPHYS RES-OCEANS, V93, P3563, DOI 10.1029/JC093iC04p03563
   Sylvan JB, 2012, GEOBIOLOGY, V10, P178, DOI 10.1111/j.1472-4669.2011.00315.x
   Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6
   Takai K, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P251, DOI 10.1007/978-90-481-9204-5_12
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Techtmann SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120605
   Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131
   Thiele S, 2012, APPL ENVIRON MICROB, V78, P8803, DOI 10.1128/AEM.01814-12
   Thordardottir T., 1984, 1984120 ICES CM, V20, P17
   Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109
   Varela MM, 2008, ENVIRON MICROBIOL, V10, P1903, DOI 10.1111/j.1462-2920.2008.01627.x
   Wickham H., 2016, GGPLOT2 CREATE ELEGA
   Wilkins D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3457
   Winter C, 2013, ISME J, V7, P1507, DOI 10.1038/ismej.2013.56
   Wommack KE, 2004, DEEP-SEA RES PT I, V51, P1781, DOI 10.1016/j.dsr.2004.05.011
   Woodgate RA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054092
   Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016
   Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11
   Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x
NR 129
TC 2
Z9 2
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 31
PY 2018
VL 9
AR 1002
DI 10.3389/fmicb.2018.01002
PG 17
WC Microbiology
SC Microbiology
GA GH6ME
UT WOS:000433557600001
PM 29904373
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Kopec-Godlewska, K
   Wojkowska-Mach, J
AF Kopec-Godlewska, K.
   Wojkowska-Mach, J.
CA Polish Neonatology Surveillance Ne
TI Infections following surgical patent ductus arteriosus ligation in
   very-low-birthweight neonates
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article
DE Patent ductus arteriosus; Polish neonatology surveillance network; Very
   low birthweight; Infections
ID INTENSIVE-CARE UNITS; PREMATURE-INFANTS; NECROTIZING ENTEROCOLITIS;
   PRETERM INFANTS; CHORIOAMNIONITIS; MANAGEMENT; OUTCOMES; RISK;
   DIAGNOSIS; MORTALITY
AB Background: Very-low-birthweight (VLBW) neonates (< 1500 g) comprise approximately 1% of liveborn infants in Poland. Patent ductus arteriosus (PDA) is a common complication of prematurity. This study aimed to determine how many VLBW neonates treated in the participating units needed surgical correction of PDA, and to evaluate the incidence of various types of postoperative infections and their microbiology.
   Methods: Observational study in five neonatology departments by the Polish Neonatology Surveillance Network, involving 2039 VLBW newborns of whom 103 (5.1%) required surgical PDA ligation. Continuous infection surveillance was conducted between 2009 and 2013; infections were defined based on Gastmeier's criteria.
   Results: PDA surgery was required significantly more frequently in infants from multiple pregnancies, and where labour was complicated by amnionitis. Surgical PDA correction was performed, on average, at 19 days of life. The incidence of infection was 48.5% (N = 50), and the most common infections were bloodstream infection (26.2%) and pneumonia (22.3%). A correlation was observed between the day on which the procedure was performed and the time of infection: the earlier the neonate underwent PDA surgery, the earlier the infection manifested (P = 0.032). A high CRIB score and chorioamnionitis contributed significantly to the presence of infection.
   Conclusion: The later the PDA surgery was performed, the later the infection occurred. The incidence of infection after correction of PDA among VLBW neonates was comparable with the incidence of infection among all hospitalized VLBW neonates. (C) 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
C1 [Kopec-Godlewska, K.] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Krakow, Poland.
   [Wojkowska-Mach, J.] Jagiellonian Univ, Med Coll, Fac Med, Microbiol Dept, 18 Czysta St, PL-31121 Krakow, Poland.
RP Wojkowska-Mach, J (reprint author), Jagiellonian Univ, Med Coll, Fac Med, Microbiol Dept, 18 Czysta St, PL-31121 Krakow, Poland.
EM mbmach@cyf-kr.edu.pl
RI Wojkowska-Mach, Jadwiga/U-1186-2018
OI Wojkowska-Mach, Jadwiga/0000-0003-0756-1639
CR Ahle M, 2013, PEDIATRICS, V132, pE443, DOI 10.1542/peds.2012-3847
   Avsar MK, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0539-3
   Backes CH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002923
   Bixler GM, 2017, J PEDIATR-US, V189, P105, DOI 10.1016/j.jpeds.2017.05.024
   Central Statistical Office, 2015, UR WEDL WAG NOW PRZ
   Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013
   Fowlie PW, 1996, ARCH DIS CHILD-FETAL, V75, pF49, DOI 10.1136/fn.75.1.F49
   Garcia HJ, 2005, REV INVEST CLIN, V57, P425
   Rodrigo FGM, 2014, PEDIATR NEONATOL, V55, P381, DOI 10.1016/j.pedneo.2013.12.007
   Gastmeier P, 2004, J HOSP INFECT, V57, P126, DOI 10.1016/j.jhin.2003.12.038
   Glass HC, 2011, CARDIOL YOUNG, V21, P562, DOI 10.1017/S1047951111000473
   Gonzalez A, 1996, J PEDIATR-US, V128, P470, DOI 10.1016/S0022-3476(96)70356-6
   Hamilton BE, 2015, NATL VITAL STAT REPO, V64, P12
   Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506
   Huttova M, 2007, NEUROENDOCRINOL LETT, V28, P15
   Jhaveri N, 2010, J PEDIATR-US, V157, P381, DOI 10.1016/j.jpeds.2010.02.062
   Johnson CT, 2014, OBSTET GYN CLIN N AM, V41, P649, DOI 10.1016/j.ogc.2014.08.007
   Karagol BS, 2010, NEUROPEDIATRICS, V41, DOI 10.1055/s-0031-1273713
   Ko YC, 2009, J FORMOS MED ASSOC, V108, P69, DOI 10.1016/S0929-6646(09)60034-6
   Lee SK, 2014, CAN MED ASSOC J, V186, pE485, DOI 10.1503/cmaj.140399
   Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1
   Morikawa N, 2008, PEDIATR SURG INT, V24, P1105, DOI 10.1007/s00383-008-2226-5
   Ofman G, 2016, AM J PERINAT, V33, P339, DOI [10.1055/s-0035-1556758, 10.1055/S-0035-1556758]
   Park HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138114
   Pasquali SK, 2012, PEDIATRICS, V129, pE385, DOI 10.1542/peds.2011-2034
   Raval MV, 2007, J PEDIATR SURG, V42, P69, DOI 10.1016/j.jpedsurg.2006.09.040
   Sankaran K, 2004, J PEDIATR GASTR NUTR, V39, P366, DOI 10.1097/00005176-200410000-00012
   Schneider DJ, 2012, SEMIN PERINATOL, V36, P146, DOI 10.1053/j.semperi.2011.09.025
   Sorensen CM, 2010, DAN MED BULL, V57
   Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003
   Vitale S G, 2014, Minerva Ginecol, V66, P589
   Weisz DE, 2014, J CLIN NEONATOL, V3, P67, DOI 10.4103/2249-4847.134670
   Wojkowska-Mach J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-339
   Wojkowska-Mach J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092865
   Wojkowska-Mach Jadwiga, 2013, Med Wieku Rozwoj, V17, P143
   Wojkowska-Mach J, 2012, PEDIATR INFECT DIS J, V31, P691, DOI 10.1097/INF.0b013e3182567b74
NR 36
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0195-6701
EI 1532-2939
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD MAY
PY 2018
VL 99
IS 1
BP 62
EP 67
DI 10.1016/j.jhin.2017.07.029
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GB9OG
UT WOS:000429402500010
PM 28757329
DA 2020-05-07
ER

PT J
AU Kavuncuoglu, H
   Kavuncuoglu, E
   Karatas, SM
   Benli, B
   Sagdic, O
   Yalcin, H
AF Kavuncuoglu, Hatice
   Kavuncuoglu, Erhan
   Karatas, Seyda Merve
   Benli, Busra
   Sagdic, Osman
   Yalcin, Hasan
TI Prediction of the antimicrobial activity of walnut (Juglans regia L.)
   kernel aqueous extracts using artificial neural network and multiple
   linear regression
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE Prediction; Juglans regia L.; antimicrobial effect; artificial neural
   network; multiple linear regression
ID ANTIBACTERIAL ACTIVITY; OXIDATIVE STABILITY; OIL; ANTIOXIDANTS;
   CULTIVARS; ALGORITHM; AUREUS; GROWTH; ANNS
AB The mathematical model was established to determine the diameter of inhibition zone of the walnut extract on the twelve bacterial species. Type of extraction, concentration, and pathogens were taken as input variables. Two models were used with the aim of designing this system. One of them was developed with artificial neural networks (ANN), and the other was formed with multiple linear regression (MLR). Four common training algorithms were used. Levenberg-Marquardt (LM), Bayesian regulation (BR), scaled conjugate gradient (SCG) and resilient back propagation (RP) were investigated, and the algorithms were compared. Root mean squared error and correlation coefficient were evaluated as performance criteria. When these criteria were analyzed, ANN showed high prediction performance, while MLR showed low prediction performance. As a result, it is seen that when the different input values are provided to the system developed with ANN, the most accurate inhibition zone (IZ) estimates were obtained. The results of this study could offer new perspectives, particularly in the field of microbiology, because these could be applied to other type of extraction, concentrations, and pathogens, without resorting to experiments.
C1 [Kavuncuoglu, Hatice; Benli, Busra; Yalcin, Hasan] Erciyes Univ, Engn Fac, Dept Food Engn, Kayseri, Turkey.
   [Kavuncuoglu, Erhan] Cumhuriyet Univ, Gemerek Vocat Sch, Sivas, Turkey.
   [Karatas, Seyda Merve] Gumushane Univ, Fac Engn & Nat Sci, Dept Food Engn, Gumushane, Turkey.
   [Sagdic, Osman] Yildiz Tech Univ, Fac Chem & Met Engn, Dept Food Engn, Istanbul, Turkey.
RP Kavuncuoglu, H (reprint author), Erciyes Univ, Engn Fac, Dept Food Engn, Kayseri, Turkey.
EM haticetk@erciyes.edu.tr
RI YALCIN, HASAN/AAG-5508-2019
OI YALCIN, HASAN/0000-0002-1038-1877
CR Abbasi MA, 2010, P PAKISTAN ACAD SCI, V47, P137
   Amaral JS, 2003, J AGR FOOD CHEM, V51, P7698, DOI 10.1021/jf030451d
   Artajo LS, 2006, EUR J LIPID SCI TECH, V108, P19, DOI 10.1002/ejlt.200500227
   Astray G, 2016, IND CROP PROD, V92, P290, DOI 10.1016/j.indcrop.2016.08.011
   Atsamnia D, 2017, LWT-FOOD SCI TECHNOL, V82, P287, DOI 10.1016/j.lwt.2017.04.053
   Azadi S, 2016, WASTE MANAGE, V48, P14, DOI 10.1016/j.wasman.2015.09.034
   Azadi S, 2012, THEOR APPL CLIMATOL, V109, P175, DOI 10.1007/s00704-011-0575-9
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Beale M H, 2010, NEURAL NETWORK TOOLB
   Blomhoff R, 2006, BRIT J NUTR, V96, pS52, DOI 10.1017/BJN20061864
   (CDPH) California Department of Public Health, 2010, CAL DEP PUBL HLTH AT
   Cheroutre-Vialette M, 2000, INT J FOOD MICROBIOL, V55, P201, DOI 10.1016/S0168-1605(00)00164-1
   Chun SS, 2005, PROCESS BIOCHEM, V40, P809, DOI 10.1016/j.procbio.2004.02.018
   Colaric M, 2005, J AGR FOOD CHEM, V53, P6390, DOI 10.1021/jf050721n
   Escobar MA, 2008, J AM SOC HORTIC SCI, V133, P852, DOI 10.21273/JASHS.133.6.852
   Esnoz A, 2006, INT J FOOD MICROBIOL, V106, P153, DOI 10.1016/j.ijfoodmicro.2005.06.016
   FDA, 2010, US FOOD DRUG ADM ENF
   FDA, 2009, US FOOD DRUG ADM ENF
   Fernandez-Agullo A, 2013, IND CROP PROD, V42, P126, DOI 10.1016/j.indcrop.2012.05.021
   Flott L.W., 2012, MET FINISH, V110, P33
   Frelka JC, 2015, FOOD MICROBIOL, V48, P133, DOI 10.1016/j.fm.2014.10.015
   Fukuda T, 2003, PHYTOCHEMISTRY, V63, P795, DOI 10.1016/S0031-9422(03)00333-9
   Fukuoka Y, 1998, NEURAL NETWORKS, V11, P1059, DOI 10.1016/S0893-6080(98)00087-2
   Funes E, 2017, J NEAR INFRARED SPEC, V25, P278, DOI 10.1177/0967033517725639
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Goncalves EC, 2005, CHEM ENG PROCESS, V44, P1269, DOI 10.1016/j.cep.2005.04.001
   Huang YQ, 2007, CRIT REV FOOD SCI, V47, P113, DOI 10.1080/10408390600626453
   Jahandideh S, 2009, WASTE MANAGE, V29, P2874, DOI 10.1016/j.wasman.2009.06.027
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Kocadagli O, 2015, APPL SOFT COMPUT, V35, P52, DOI 10.1016/j.asoc.2015.06.003
   Makridakis S, 1995, EVALUATING ACCURACY
   Martinez ML, 2013, LWT-FOOD SCI TECHNOL, V51, P44, DOI 10.1016/j.lwt.2012.10.021
   Marzouk M, 2016, J CLEAN PROD, V112, P4540, DOI 10.1016/j.jclepro.2015.09.015
   Oliveira I, 2008, FOOD CHEM TOXICOL, V46, P2326, DOI 10.1016/j.fct.2008.03.017
   Pereira JA, 2008, FOOD CHEM TOXICOL, V46, P2103, DOI 10.1016/j.fct.2008.02.002
   Sagdic O, 2006, ACTA ALIMENT HUNG, V35, P487, DOI 10.1556/AAlim.35.2006.4.12
   Shu YQ, 2011, ATMOS ENVIRON, V45, P634, DOI 10.1016/j.atmosenv.2010.10.037
   Silva SF, 2015, FOOD CHEM, V179, P35, DOI 10.1016/j.foodchem.2015.01.100
   Srinivasan D, 2001, J ETHNOPHARMACOL, V74, P217, DOI 10.1016/S0378-8741(00)00345-7
   Tina GM, 2012, ENERG CONVERS MANAGE, V64, P533, DOI 10.1016/j.enconman.2012.05.031
   Wang YM, 2015, APPL SOFT COMPUT, V35, P280, DOI 10.1016/j.asoc.2015.05.047
   Yamamura S, 2008, BIOMED PHARMACOTHER, V62, P53, DOI 10.1016/j.biopha.2007.11.004
   Yolmeh M, 2014, MICROB PATHOGENESIS, V67-68, P36, DOI 10.1016/j.micpath.2014.02.003
   Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7
   Zhao X, 2011, ENRGY PROCED, V12, DOI 10.1016/j.egypro.2011.10.102
NR 45
TC 7
Z9 7
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD MAY
PY 2018
VL 148
BP 78
EP 86
DI 10.1016/j.mimet.2018.04.003
PG 9
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GG2GF
UT WOS:000432507500013
PM 29649523
DA 2020-05-07
ER

PT J
AU Cohen, B
   Liu, JF
   Cohen, AR
   Larson, E
AF Cohen, Bevin
   Liu, Jianfang
   Cohen, Adam Ross
   Larson, Elaine
TI Association Between Healthcare-Associated Infection and Exposure to
   Hospital Roommates and Previous Bed Occupants with the Same Organism
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID CLOSTRIDIUM-DIFFICILE; PATIENT-SAFETY; DISINFECTION
AB OBJECTIVE. To quantify the association between having a prior bed occupant or roommate with a positive blood, respiratory, urine, or wound culture and subsequent infection with the same organism.
   DESIGN. Case-control study.
   SETTING. The study included 4 hospitals within an academically affiliated network in New York City, including a community hospital (221 beds), a pediatric acute-care hospital (283 beds), an adult tertiary-/quaternary-care hospital (647 beds), and a pediatric and adult tertiary-/quaternary-care hospital (914 beds).
   PATIENTS. All 761,426 inpatients discharged from 2006 to 2012 were eligible. Cases included all patients who developed a healthcare-associated infection (HAI) with Staphylococcus aureus, Acinetobacter baumannii, Streptococcus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, or Enterococcus faecium. Controls were uninfected patients matched by fiscal quarter, hospital, and length of stay. For each bed occupied during the 3-5-day period prior to infection, microbiology results for assigned roommates and the patient who occupied the bed immediately prior to the case were collected. For controls, the day of infection of the matched case served as the reference point.
   RESULTS. In total, 10,289 HAIs were identified. In a multivariable analysis controlling for both exposures and patient characteristics, the odds of cases having been exposed to a prior bed occupant with the same organism were 5.83 times that of controls (95% confidence interval [CI], 3.62-9.39), and the odds of cases having been exposed to a roommate with the same organism were 4.82 times that of controls (95% CI, 3.67-6.34).
   CONCLUSION. Infected or colonized roommates and prior occupants do pose a risk, which may warrant enhanced terminal and intermittent cleaning measures.
C1 [Cohen, Bevin; Liu, Jianfang; Larson, Elaine] Columbia Univ, Sch Nursing, 630 West 168th St, New York, NY 10032 USA.
   [Cohen, Bevin; Larson, Elaine] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
RP Cohen, B (reprint author), Columbia Univ, Sch Nursing, 630 West 168th St, New York, NY 10032 USA.
EM bac2116@columbia.edu
FU National Institute of Nursing Research at the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Nursing
   Research (NINR) [R01 NR010822]
FX This project was supported by a grant from the National Institute of
   Nursing Research at the National Institutes of Health (grant no. R01
   NR010822).
CR Anderson DJ, 2017, LANCET, V389, P805, DOI [10.1016/S0140-6736(16)31588-4, 10.1016/s0140-6736(16)31588-4]
   Apte M, 2011, CTS-CLIN TRANSL SCI, V4, P338, DOI 10.1111/j.1752-8062.2011.00353.x
   Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22
   Boyce JM, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0111-x
   Cohen B, 2017, CLIN EPIDEMIOL, V9, P297, DOI 10.2147/CLEP.S124382
   Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030
   Freedberg DE, 2016, JAMA INTERN MED, V176, P1801, DOI 10.1001/jamainternmed.2016.6193
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Institute of Medicine, 2001, CROSSING QUALITY CHA
   Jeeva RR, 2014, MED CARE, V52, pS4, DOI 10.1097/MLR.0b013e3182a54581
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801
   Ranji SR, 2007, LOSING QUALITY GAP C, V6
   Russotto V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0120-5
   Scott RD, 2009, DIRECT MED COSTS HEA
   Siani H, 2015, EUR J CLIN MICROBIOL, V34, P1, DOI 10.1007/s10096-014-2205-9
   Stone PW, 2010, MED CARE, V48, P433, DOI 10.1097/MLR.0b013e3181d5fb3f
   Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912
   Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991
NR 19
TC 9
Z9 14
U1 1
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD MAY
PY 2018
VL 39
IS 5
BP 541
EP 546
DI 10.1017/ice.2018.22
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GD2DZ
UT WOS:000430311600005
PM 29486805
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Clifford, RJ
   Chukwuma, U
   Sparks, ME
   Richesson, D
   Neumann, CV
   Waterman, PE
   Moran-Gilad, J
   Julius, MD
   Hinkle, MK
   Lesho, EP
AF Clifford, Robert J.
   Chukwuma, Uzo
   Sparks, Michael E.
   Richesson, Douglas
   Neumann, Charlotte V.
   Waterman, Paige E.
   Moran-Gilad, Jacob
   Julius, Michael D.
   Hinkle, Mary K.
   Lesho, Emil P.
TI Semi-Automated Visualization and ANalysis of Trends: A "SAVANT" for
   Facilitating Antimicrobial Stewardship Using Antistaphylococcal
   Resistance and Consumption as a Prototype
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE antibiotic consumption and resistance; antimicrobial stewardship;
   informatics; Staphylococcus aureus
ID SOFT-TISSUE INFECTIONS; STAPHYLOCOCCUS-AUREUS ENDOCARDITIS; MILITARY
   HEALTH SYSTEM; TIME-SERIES ANALYSIS; ANTIBIOTIC STEWARDSHIP; SKIN;
   VANCOMYCIN; BACTEREMIA; CARBAPENEM; BARRIERS
AB Background. Governments and health care regulators now require hospitals and nursing homes to establish programs to monitor and report antimicrobial consumption and resistance. However, additional resources were not provided. We sought to develop an approach for monitoring antimicrobial resistance and consumption that health care systems can implement with minimal added costs or modifications to existing diagnostic and informatics infrastructure.
   Methods. Using (1) the electronic laboratory information system of a nationwide managed care network, (2) the 3 most widely used commercial microbiology diagnostic platforms, and (3) Staphylococcus aureus, one of the most common causes of infections worldwide, as a prototype, we validated the approach dubbed "SAVANT" for Semi-Automated Visualization and ANalysis of Trends. SAVANT leverages 3 analytical methods (time series analysis, the autoregressive integrated moving average, and generalized linear regression) on either commercial or open source software to report trends in antistaphylococcal use and resistance.
   Results. All laboratory results from January 2010 through December 2015 from an annual average of 9.2 million health care beneficiaries were queried. Inpatient and outpatient prescription rates were calculated for 8 key antistaphylococcal compounds. Trends and relationships of antistaphylococcal consumption and resistance among 81 840 unique S. aureus isolates from >6.5 million cultures were revealed.
   Conclusions. Using existing or freely available resources, SAVANT was successfully implemented across a complex and geographically dispersed 280-hospital network, bridging a critical gap between medical informatics, large-scale data analytics, and mandatory reporting of health care quality metrics.
C1 [Clifford, Robert J.; Sparks, Michael E.; Richesson, Douglas; Julius, Michael D.; Hinkle, Mary K.] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA.
   [Chukwuma, Uzo; Neumann, Charlotte V.] Navy & Marine Corps Public Hlth Ctr, EpiData Ctr Dept, Portsmouth, VA USA.
   [Waterman, Paige E.] Armed Forces Hlth Surveillance Ctr, Global Emerging Infect Surveillance, Silver Spring, MD USA.
   [Moran-Gilad, Jacob] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.
   [Lesho, Emil P.] Rochester Reg Hlth, Infect Dis Unit, Rochester, NY USA.
RP Lesho, EP (reprint author), 1425 Portland Ave, Rochester, NY 14621 USA.
EM carolinelesho@yahoo.com
OI Moran-Gilad, Jacob/0000-0001-9134-050X
FU US Army Medical Command [MedCom 15-042]; Global Emerging Infections
   Surveillance [20160280023]
FX This work was supported by US Army Medical Command grant MedCom 15-042
   and Global Emerging Infections Surveillance grant 20160280023 to E.L.
   The funding source had no role in the study design, collection, analysis
   and interpretation of data, writing of the manuscript, or in the
   decision to submit the paper for publication.
CR Centers for Medicare and Medicaid Services, CMS ISS PROP RUL PRO
   Cleveland R., 1990, J OFF STAT, V6, P3, DOI DOI 10.1016/J.SOILBIO.2009.09.001
   CRABTREE BF, 1990, J CLIN EPIDEMIOL, V43, P241, DOI 10.1016/0895-4356(90)90005-A
   Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747
   David MZ, 2014, CLIN INFECT DIS, V59, P798, DOI 10.1093/cid/ciu410
   Dhand Abhay, 2012, F1000 Med Rep, V4, P4, DOI 10.3410/M4-4
   Ellis MW, 2007, ANTIMICROB AGENTS CH, V51, P3591, DOI 10.1128/AAC.01086-06
   Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012
   Gharbi M, 2015, INT J ANTIMICROB AG, V46, P150, DOI 10.1016/j.ijantimicag.2015.03.005
   Hawser SP, 2011, INT J ANTIMICROB AG, V37, P219, DOI 10.1016/j.ijantimicag.2010.10.029
   Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864
   Holmes NE, 2011, J INFECT DIS, V204, P340, DOI 10.1093/infdis/jir270
   Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03
   Joint Commission on Hospital Accreditation, 2016, Jt Comm Perspect, V36, P3
   Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629
   Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139
   Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x
   Lesho EP, 2015, DIAGN MICR INFEC DIS, V81, P119, DOI 10.1016/j.diagmicrobio.2014.09.017
   Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187
   Morrison SM, 2013, INFECT CONT HOSP EP, V34, P841, DOI 10.1086/671278
   Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389
   Nurjadi D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.021
   Polgreen PM, 2011, INFECT CONT HOSP EP, V32, P723, DOI 10.1086/660858
   President's Council of Advisors on Science and Technology, NAT ACT PLAN COMB AN
   R Core Team, 2015, R LANG ENV STAT COMP
   Ray GT, 2013, DIAGN MICR INFEC DIS, V76, P24, DOI 10.1016/j.diagmicrobio.2013.02.020
   Rybak MJ, 2013, J CLIN MICROBIOL, V51, P2077, DOI 10.1128/JCM.00448-13
   Schwaber MJ, 2004, NAT REV MICROBIOL, V2, P979, DOI 10.1038/nrmicro1047
   Sexton DJ, 2017, CLIN INFECT DIS, V65, P697, DOI 10.1093/cid/cix409
   SOCIETY FOR, 2012, INFECT CONT HOSP EP, V33, P322, DOI DOI 10.1086/665010
   Stenehjem E, 2017, CLIN INFECT DIS, V65, P691, DOI 10.1093/cid/cix407
   Sutter DE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3099
   The Joint Commission, 2016, JT COMM PERSPECT, V36, P8
   The Joint Commission, 2016, JT COMM PERSPECT, V36, P3
   van Hal SJ, 2013, CLIN INFECT DIS, V56, P1779, DOI 10.1093/cid/cit178
   Wang A, 2017, INFECT CONT HOSP EP, V38, P1457, DOI 10.1017/ice.2017.222
   Whitman TJ, 2010, INFECT CONT HOSP EP, V31, P1207, DOI 10.1086/657136
   WHO, 2014, ANT RES GLOB REP SUR
   Willmann M, 2013, ANTIMICROB AGENTS CH, V57, P1797, DOI 10.1128/AAC.02142-12
NR 39
TC 0
Z9 0
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD APR
PY 2018
VL 5
IS 4
DI 10.1093/ofid/ofy066
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GE3XK
UT WOS:000431146000019
PM 30568986
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Corel, E
   Meheust, R
   Watson, AK
   Mclnerney, JO
   Lopez, P
   Bapteste, E
AF Corel, Eduardo
   Meheust, Raphael
   Watson, Andrew K.
   Mclnerney, James O.
   Lopez, Philippe
   Bapteste, Eric
TI Bipartite Network Analysis of Gene Sharings in the Microbial World
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE microbial evolution; bipartite graph; virus; network
ID COMPLETE GENOME SEQUENCE; RHODOSPIRILLUM-RUBRUM; PHYLOGENETIC ANALYSES;
   LATERAL TRANSFER; EVOLUTION; TREE; PROKARYOTES; ALIGNMENT; VIRUSES;
   MOBILE
AB Extensive microbial gene flows affect how we understand virology, microbiology, medical sciences, genetic modification, and evolutionary biology. Phylogenies only provide a narrow view of these gene flows: plasmids and viruses, lacking core genes, cannot be attached to cellular life on phylogenetic trees. Yet viruses and plasmids have a major impact on cellular evolution, affecting both the gene content and the dynamics of microbial communities. Using bipartite graphs that connect up to 149,000 clusters of homologous genes with 8,217 related and unrelated genomes, we can in particular show patterns of gene sharing that do not map neatly with the organismal phylogeny. Homologous genes are recycled by lateral gene transfer, and multiple copies of homologous genes are carried by otherwise completely unrelated (and possibly nested) genomes, that is, viruses, plasmids and prokaryotes. When a homologous gene is present on at least one plasmid or virus and at least one chromosome, a process of "gene externalization," affected by a postprocessed selected functional bias, takes place, especially in Bacteria. Bipartite graphs give us a view of vertical and horizontal gene flow beyond classic taxonomy on a single very large, analytically tractable, graph that goes beyond the cellular Web of Life.
C1 [Corel, Eduardo; Meheust, Raphael; Watson, Andrew K.; Lopez, Philippe; Bapteste, Eric] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech Evolut Paris Seine 7138, CNRS,Inst Biol Paris Seine, Paris, France.
   [Mclnerney, James O.] Univ Manchester, Chair Evolutionary Biol, Manchester, Lancs, England.
RP Bapteste, E (reprint author), Univ Paris 06, Sorbonne Univ, Unite Mixte Rech Evolut Paris Seine 7138, CNRS,Inst Biol Paris Seine, Paris, France.
EM epbapteste@gmail.com
RI /B-5108-2012
OI /0000-0003-1885-2503; Bapteste, Eric/0000-0003-1966-1215; Corel,
   Eduardo/0000-0003-4410-9035; Meheust, Raphael/0000-0002-4847-426X
FU ERCEuropean Research Council (ERC) [615274]
FX This work was supported by the ERC (grant FP7/2007-2013 Grant Agreement
   #615274 to E.B. and E.C.). We thank D. Bhattacharya and H. Le Guyader
   and four anonymous reviewers for reading the manuscript and critical
   comments.
CR Ageevets V, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01856-16
   Ahmad Norazah, 2015, J Genomics, V3, P97, DOI 10.7150/jgen.13910
   Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196
   Aleksandrzak-Piekarczyk T, 2016, GENOME BIOL EVOL, V8, P202, DOI 10.1093/gbe/evv247
   Alzahrani T, 2016, UNDERSTING COMPLE, V73
   Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593
   Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387
   Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140
   Bapteste E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00083
   Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102
   Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821
   Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102
   Beiko RG, 2006, SYST BIOL, V55, P553, DOI 10.1080/10635150600812544
   Benjamini Y, 2001, ANN STAT, V29, P1165
   Biller SJ, 2015, NAT REV MICROBIOL, V13, P13, DOI 10.1038/nrmicro3378
   Brilli M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-551
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024
   Busby B, 2013, ENVIRON MICROBIOL, V15, P307, DOI 10.1111/j.1462-2920.2012.02886.x
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Challacombe J.F., 2012, MOBILE GENET ELEM, V2, P179, DOI DOI 10.4161/mge.21943
   Challacombe JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024882
   Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10
   Cheng S., 2014, FRONT ECOL EVOL, V2, P1
   Corel E, 2016, TRENDS MICROBIOL, V24, P224, DOI 10.1016/j.tim.2015.12.003
   Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105
   Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Dunfield PF, 2003, INT J SYST EVOL MICR, V53, P1231, DOI 10.1099/ijs.0.02481-0
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Fondi M, 2016, GENOME BIOL EVOL, V8, P1388, DOI 10.1093/gbe/evw077
   Fondi M, 2010, ENVIRON MICROBIOL, V12, P3228, DOI 10.1111/j.1462-2920.2010.02295.x
   Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5
   Dias ACF, 2018, MICROB ECOL, V75, P479, DOI 10.1007/s00248-017-1059-y
   Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107
   Hernandez-Lopez A, 2013, GENOME BIOL EVOL, V5, P2305, DOI 10.1093/gbe/evt178
   Hooper SD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r45
   Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.48, 10.1038/NMICROBIOL.2016.48]
   Huo YY, 2012, J BACTERIOL, V194, P197, DOI 10.1128/JB.06343-11
   Hwang TH, 2008, BIOINFORMATICS, V24, P2023, DOI 10.1093/bioinformatics/btn383
   Iranzo J, 2016, J VIROL, V90, P11043, DOI 10.1128/JVI.01622-16
   Iranzo J, 2016, MBIO, V7, DOI 10.1128/mBio.00978-16
   Jachiet PA, 2014, GENOME BIOL EVOL, V6, P2195, DOI 10.1093/gbe/evu168
   Jaffe AL, 2016, ENVIRON MICROBIOL, V18, P5072, DOI 10.1111/1462-2920.13477
   Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801
   Johnson ET, 2014, MOL GENET GENOMICS, V289, P895, DOI 10.1007/s00438-014-0860-2
   Jones-Dias D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00671
   Kappler U, 2001, ARCH MICROBIOL, V175, P102, DOI 10.1007/s002030000241
   Kappler U, 2012, STAND GENOMIC SCI, V7, P44, DOI 10.4056/sigs.3006378
   Karcagi I, 2016, MOL BIOL EVOL, V33, P1257, DOI 10.1093/molbev/msw009
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297
   Koonin EV, 2017, CURR OPIN VIROL, V25, P7, DOI 10.1016/j.coviro.2017.06.008
   Koonin Eugene V, 2016, F1000Res, V5, DOI 10.12688/f1000research.8737.1
   Koonin EV, 2015, J MOL EVOL, V80, P244, DOI 10.1007/s00239-015-9679-7
   Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709
   Krupovic M, 2017, CURR OPIN MICROBIOL, V38, P36, DOI 10.1016/j.mib.2017.04.004
   Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963
   KUHL SA, 1984, J BACTERIOL, V159, P913, DOI 10.1128/JB.159.3.913-918.1984
   Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Larremore DB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003268
   Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023
   MacLeod D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-27
   Manageiro V, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01076-15
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V3
   McInerney JO, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-41
   Meheust R, 2016, P NATL ACAD SCI USA, V113, P3579, DOI 10.1073/pnas.1517551113
   Mukherjee S, 2017, NUCLEIC ACIDS RES, V45, pD446, DOI 10.1093/nar/gkw992
   Munk AC, 2011, STAND GENOMIC SCI, V4, P293, DOI 10.4056/sigs.1804360
   Murata Tsuyoshi, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P50, DOI 10.1109/CSE.2009.81
   Nandasena KG, 2006, APPL ENVIRON MICROB, V72, P7365, DOI 10.1128/AEM.00889-06
   Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805
   Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109
   Otsuka Y, 2016, CURR GENET, V62, P379, DOI 10.1007/s00294-015-0557-z
   Pant A, 2016, J BACTERIOL, V198, P268, DOI 10.1128/JB.00674-15
   Pedrosa FO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002064
   Popa O, 2017, ISME J, V11, P543, DOI 10.1038/ismej.2016.116
   Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110
   Puigbo P, 2010, GENOME BIOL EVOL, V2, P745, DOI 10.1093/gbe/evq062
   Raymond J, 2003, PHILOS T ROY SOC B, V358, P223, DOI 10.1098/rstb.2002.1181
   Reeve W, 2013, STAND GENOMIC SCI, V9, P410, DOI 10.4056/sigs.4568282
   Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490
   Sabat AJ, 2015, J ANTIMICROB CHEMOTH, V70, P2956, DOI 10.1093/jac/dkv210
   Schliep K, 2011, MOL BIOL EVOL, V28, P1393, DOI 10.1093/molbev/msq323
   Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177
   Skalka AM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0005-2014
   Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571
   Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501
   Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x
   Sun C, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0145-1
   Sun LY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01541
   Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292
   Wang YN, 2016, ENZYME MICROB TECH, V92, P31, DOI 10.1016/j.enzmictec.2016.06.015
   Wilson WH, 2017, ISME J, V11, P1736, DOI 10.1038/ismej.2017.61
   Yang SH, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00200, 10.3389/fmicb.2017.00021]
   Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913
   Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-158
   Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306
NR 104
TC 8
Z9 8
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD APR
PY 2018
VL 35
IS 4
BP 899
EP 913
DI 10.1093/molbev/msy001
PG 15
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA GF3WT
UT WOS:000431889000009
PM 29346651
OA Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Crobach, MJT
   in 't holt, AFV
   Knetsch, CW
   van Dorp, SM
   Bras, W
   Harmanus, C
   Kuijper, EJ
   Vos, MC
AF Crobach, M. J. T.
   in 't holt, A. F. Voor
   Knetsch, C. W.
   van Dorp, S. M.
   Bras, W.
   Harmanus, C.
   Kuijper, E. J.
   Vos, M. C.
TI An outbreak of Clostridium difficile infections due to new PCR ribotype
   826: epidemiologic and microbiologic analyses
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Clostridium difficile; Epidemiology Infection control; Outbreak
   Surveillance
AB Objectives: To investigate an unusual outbreak of five patients with a total of eight episodes of a Clostridium difficile infection on a gastrointestinal surgical ward of a Dutch tertiary-care, university-affiliated hospital.
   Methods: Clinical case investigations and laboratory analyses were performed. Laboratory analyses included PCR ribotyping, multiple-locus variable-number tandem repeat analysis typing, toxin typing, antimicrobial susceptibility testing and whole genome sequencing.
   Results: The outbreak was associated with recurrent and severe disease in two of five patients. All episodes were due to a unique ribotype that was not recognized in the collection of an international network of reference laboratories and was assigned PCR ribotype 826. PCR ribotype 826 is a toxin A-,toxin Be and binary toxinepositive ribotype which according to molecular typing belongs to clade 5 and resembles the so-called hypervirulent ribotype 078. The presence of a clonal outbreak was confirmed by whole genome sequencing, yet the source of this newly identified ribotype remained unclear.
   Conclusions: This newly identified C. difficile PCR ribotype 826 is part of clade 5 and might also have increased virulence. The recognition of this outbreak highlights the need for ongoing C. difficile infection surveillance to monitor new circulating ribotypes with assumed increased virulence. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Crobach, M. J. T.; Knetsch, C. W.; van Dorp, S. M.; Harmanus, C.; Kuijper, E. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.
   [in 't holt, A. F. Voor; Bras, W.; Vos, M. C.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.
RP Vos, MC (reprint author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.
EM m.vos@erasmusmc.nl
OI Kuijper, Ed/0000-0001-5726-2405; Knetsch, Wilco/0000-0001-8569-3456;
   Harmanus, Celine/0000-0002-5328-3273
CR Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418
   Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150
   Keessen EC, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-14
   Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954
   Knetsch CW, 2011, MICROBIOL-SGM, V157, P3113, DOI 10.1099/mic.0.051953-0
   Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x
   Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433
   Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4
   van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06
   Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127
NR 10
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2018
VL 24
IS 3
DI 10.1016/j.cmi.2017.08.014
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FX9KG
UT WOS:000426417300022
PM 28830806
OA Other Gold
DA 2020-05-07
ER

PT J
AU Smith, KP
   Kang, AD
   Kirby, JE
AF Smith, Kenneth P.
   Kang, Anthony D.
   Kirby, James E.
TI Automated Interpretation of Blood Culture Gram Stains by Use of a Deep
   Convolutional Neural Network
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Gram stain; blood culture; machine learning; deep learning; automated
   microscopy; analytics; artificial intelligence; big data; neural network
ID MORTALITY; CLASSIFICATION; BACTEREMIA; ACCURACY; THERAPY
AB Microscopic interpretation of stained smears is one of the most operator-dependent and time-intensive activities in the clinical microbiology laboratory. Here, we investigated application of an automated image acquisition and convolutional neural network (CNN)-based approach for automated Gram stain classification. Using an automated microscopy platform, uncoverslipped slides were scanned with a 40 x dry objective, generating images of sufficient resolution for interpretation. We collected 25,488 images from positive blood culture Gram stains prepared during routine clinical workup. These images were used to generate 100,213 crops containing Gram-positive cocci in clusters, Gram-positive cocci in chains/pairs, Gram-negative rods, or background (no cells). These categories were targeted for proof-of-concept development as they are associated with the majority of bloodstream infections. Our CNN model achieved a classification accuracy of 94.9% on a test set of image crops. Receiver operating characteristic (ROC) curve analysis indicated a robust ability to differentiate between categories with an area under the curve of >0.98 for each. After training and validation, we applied the classification algorithm to new images collected from 189 whole slides without human intervention. Sensitivity and specificity were 98.4% and 75.0% for Gram-positive cocci in chains and pairs, 93.2% and 97.2% for Gram-positive cocci in clusters, and 96.3% and 98.1% for Gram-negative rods. Taken together, our data support a proof of concept for a fully automated classification methodology for blood-culture Gram stains. Importantly, the algorithm was highly adept at identifying image crops with organisms and could be used to present prescreened, classified crops to technologists to accelerate smear review. This concept could potentially be extended to all Gram stain interpretive activities in the clinical laboratory.
C1 [Smith, Kenneth P.; Kang, Anthony D.; Kirby, James E.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.
   [Smith, Kenneth P.; Kang, Anthony D.; Kirby, James E.] Harvard Med Sch, Boston, MA 02115 USA.
   [Kang, Anthony D.] US Army Med Dept Ctr & Sch, Ft Sam Houston, TX USA.
RP Kirby, JE (reprint author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.; Kirby, JE (reprint author), Harvard Med Sch, Boston, MA 02115 USA.
EM jekirby@bidmc.harvard.edu
RI Kirby, James/K-4438-2019
OI Smith, Kenneth/0000-0001-5819-0482
FU Harvard Catalyst \ The Harvard Clinical and Translational Science Center
   (National Center for Research Resources, National Institutes of Health)
   [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and
   Translational Science Center (National Center for Advancing
   Translational Sciences, National Institutes of Health) [UL1 TR001102];
   Harvard University; National Institute of Allergy and Infectious
   Diseases of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [F32
   AI124590]
FX This work was conducted with support from Harvard Catalyst vertical bar
   The Harvard Clinical and Translational Science Center (National Center
   for Research Resources and the National Center for Advancing
   Translational Sciences, National Institutes of Health Award UL1
   TR001102) and financial contributions from Harvard University and its
   affiliated academic health care centers. A.D.K. was supported by the
   Long Term Health Education and Training Program of the United States
   Army as an American Society for Microbiology Committee on Postgraduate
   Educational Programs Fellow at Beth Israel Deaconess Medical Center.
   K.P.S. was supported by the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health under award number F32
   AI124590. The content is solely our responsibility and does not
   necessarily represent the official views of the National Institutes of
   Health, United States Army, or Department of Defense.
CR [Anonymous], 2017, TENSORFLOW OPEN SOUR
   [Anonymous], 2017, TENSORFLOW GITHUB RE
   Barenfanger J, 2008, AM J CLIN PATHOL, V130, P870, DOI 10.1309/AJCPVMDQU2ZJDPBL
   Bourbeau PP, 2013, J CLIN MICROBIOL, V51, P1658, DOI 10.1128/JCM.00301-13
   Bridle J. S., 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28
   De Boer PT, 2005, ANN OPER RES, V134, P19, DOI 10.1007/s10479-005-5724-z
   Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056
   Garcia E, 2015, AM J CLIN PATHOL, V144, P432, DOI 10.1309/AJCPN7G0MXMSTXCD
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Jones E, 2001, SCIPY OPEN SOURCE SC
   Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200
   Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286
   Madani A, 2017, FAST ACCURATE CLASSI
   Meyer J, 2015, ARCH PATHOL LAB MED, V139, P1550, DOI 10.5858/arpa.2014-0606-RA
   Nesterov Y., 1983, SOV MATH DOKL, V27, P372
   Rand KH, 2006, AM J CLIN PATHOL, V126, P686, DOI 10.1309/V4KE2FPM5T8V4552
   Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y
   Samuel LP, 2016, J CLIN MICROBIOL, V54, P1442, DOI 10.1128/JCM.03066-15
   Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318
   Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162
   Smith KP, 2017, SLAS TECHNOL, V22, P662, DOI 10.1177/2472630317727721
   Sogaard M, 2007, J CLIN MICROBIOL, V45, P1113, DOI 10.1128/JCM.02523-06
   Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7
   Szegedy C., GOING DEEPER CONVOLU
   Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308
   Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998
   Wang D., 2016, DEEP LEARNING IDENTI
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
NR 30
TC 5
Z9 5
U1 2
U2 20
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2018
VL 56
IS 3
AR UNSP e01521-17
DI 10.1128/JCM.01521-17
PG 12
WC Microbiology
SC Microbiology
GA FX1WJ
UT WOS:000425843200012
PM 29187563
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Galey, MM
   Sanchez, LM
AF Galey, Melissa M.
   Sanchez, Laura M.
TI Spatial Analyses of Specialized Metabolites: The Key to Studying
   Function in Hosts
SO MSYSTEMS
LA English
DT Article
DE chemical communication; imaging mass spectrometry; specialized
   metabolites
ID MOLECULAR NETWORKING; SQUID; COLONIZATION; CARTOGRAPHY; MICROBIOME;
   ZEBRAFISH
AB Microbial communities contribute to a wide variety of biological functions in hosts and have the ability to specifically influence the health of those organisms through production of specialized metabolites. However, the structures or molecular mechanisms related to health or disease in host-microbe interactions represent a knowledge gap. In order to close this gap, we propose that a combinatory approach, pulling from microbiology and analytical chemistry, be considered to investigate these interactions so as to gain a better understanding of the chemistry being produced. We hypothesize that bacteria alter their chemistry in order to survive and induce specific states in their host organisms. Our lab makes use of imaging mass spectrometry and other analytical techniques to study this chemistry in situ, which provides actionable information to test hypotheses.
C1 [Galey, Melissa M.; Sanchez, Laura M.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.
RP Sanchez, LM (reprint author), Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.
EM sanchelm@uic.edu
OI Sanchez, Laura/0000-0001-9223-7977; Galey, Melissa/0000-0002-9886-7416
FU Chicago Biomedical Consortium; Searle Funds at The Chicago Community
   Trust; National Institute of Child Health and Human Development
   (NICHD)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [K12HD055892];
   National Institutes of Health Office of Research on Women's Health
   (ORWH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Office of Research on Women's Health
   (ORWH); UIC Startup funds
FX This publication was funded in part by the Chicago Biomedical Consortium
   with support from the Searle Funds at The Chicago Community Trust, by
   grant K12HD055892 from the National Institute of Child Health and Human
   Development (NICHD) and the National Institutes of Health Office of
   Research on Women's Health (ORWH), and by UIC Startup funds.
CR Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112
   Brooks JF, 2014, P NATL ACAD SCI USA, V111, P17284, DOI 10.1073/pnas.1415957111
   Clark CM, 2017, BIORXIV, DOI [10.1101/215350, DOI 10.1101/215350]
   Cleary JL, 2017, CHEM-US, V2, P334, DOI 10.1016/j.chempr.2017.02.001
   Garg N, 2017, CELL HOST MICROBE, V22, P705, DOI 10.1016/j.chom.2017.10.001
   Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399
   Ismail AS, 2016, CELL HOST MICROBE, V19, P470, DOI 10.1016/j.chom.2016.02.020
   Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3
   Kim YG, 2017, SCIENCE, V356, P312, DOI 10.1126/science.aag2029
   Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957
   Runft DL, 2014, APPL ENVIRON MICROB, V80, P1710, DOI 10.1128/AEM.03580-13
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002
   Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s
NR 15
TC 3
Z9 3
U1 0
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD MAR-APR
PY 2018
VL 3
IS 2
SI SI
AR e00148-17
DI 10.1128/mSystems.00148-17
PG 5
WC Microbiology
SC Microbiology
GA GD8JZ
UT WOS:000430760000004
PM 29556545
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Hynson, NA
   Frank, KL
   Alegado, RA
   Amend, AS
   Arif, M
   Bennett, GM
   Jani, AJ
   Medeiros, MCI
   Mileyko, Y
   Nelson, CE
   Nguyen, NH
   Nigro, OD
   Prisic, S
   Shin, S
   Takagi, D
   Wilson, ST
   Yew, JY
AF Hynson, Nicole A.
   Frank, Kiana L.
   Alegado, Rosanna A.
   Amend, Anthony S.
   Arif, Mohammad
   Bennett, Gordon M.
   Jani, Andrea J.
   Medeiros, Matthew C. I.
   Mileyko, Yuriy
   Nelson, Craig E.
   Nguyen, Nhu H.
   Nigro, Olivia D.
   Prisic, Sladjana
   Shin, Sangwoo
   Takagi, Daisuke
   Wilson, Samuel T.
   Yew, Joanne Y.
TI Synergy among Microbiota and Their Hosts: Leveraging the Hawaiian
   Archipelago and Local Collaborative Networks To Address Pressing
   Questions in Microbiome Research
SO MSYSTEMS
LA English
DT Article
DE ecology; environmental microbiology; evolution; microbiome; paradigm
   shift
ID DIVERSITY
AB Despite increasing acknowledgment that microorganisms underpin the healthy functioning of basically all multicellular life, few cross-disciplinary teams address the diversity and function of microbiota across organisms and ecosystems. Our newly formed consortium of junior faculty spanning fields such as ecology and geo-science to mathematics and molecular biology from the University of Hawai'i at Manoa aims to fill this gap. We are united in our mutual interest in advancing a new paradigm for biology that incorporates our modern understanding of the importance of microorganisms. As our first concerted research effort, we will assess the diversity and function of microbes across an entire watershed on the island of Oahu, Hawai'i. Due to its high ecological diversity across tractable areas of land and sea, Hawai'i provides a model system for the study of complex microbial communities and the processes they mediate. Owing to our diverse expertise, we will leverage this study system to advance the field of biology.
C1 [Hynson, Nicole A.; Amend, Anthony S.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.
   [Frank, Kiana L.; Medeiros, Matthew C. I.; Yew, Joanne Y.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.
   [Alegado, Rosanna A.; Jani, Andrea J.; Nelson, Craig E.; Nigro, Olivia D.; Wilson, Samuel T.] Univ Hawaii Manoa, Dept Oceanog, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA.
   [Arif, Mohammad; Bennett, Gordon M.] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.
   [Mileyko, Yuriy; Takagi, Daisuke] Univ Hawaii Manoa, Dept Math, Honolulu, HI 96822 USA.
   [Alegado, Rosanna A.; Nelson, Craig E.] Univ Hawaii Manoa, Sea Grant Coll Program, Honolulu, HI 96822 USA.
   [Nguyen, Nhu H.] Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA.
   [Prisic, Sladjana] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.
   [Shin, Sangwoo] Univ Hawaii Manoa, Dept Mech Engn, Honolulu, HI 96822 USA.
RP Hynson, NA (reprint author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.
EM nhynson@hawaii.edu
RI Shin, Sangwoo/D-2812-2011; Nelson, Craig/H-3323-2019
OI Shin, Sangwoo/0000-0001-5618-8522; Nelson, Craig/0000-0003-2525-3496;
   Prisic, Sladjana/0000-0003-3137-4358; Wilson, Samuel/0000-0002-7289-0909
FU Office of the Vice Chancellor for Research at the University of Hawai'i
   at Manoa; National Oceanic and Atmospheric Administration (NOAA),
   project R/WR-3 - University of Hawai'i Sea Grant College Program, SOEST,
   under NOAA's National Sea Grant Office, Department of Commerce
   [NA14OAR4170071]; University of Hawai'i Sea Grant College Program
   [UNIHI-SEAGRANT-JC-16-13]
FX We thank the Office of the Vice Chancellor for Research at the
   University of Hawai'i at Manoa for funding. This paper is funded in part
   by a grant/cooperative agreement from the National Oceanic and
   Atmospheric Administration (NOAA), project R/WR-3, which is sponsored by
   the University of Hawai'i Sea Grant College Program, SOEST, under
   institutional grant no. NA14OAR4170071 from NOAA's National Sea Grant
   Office, Department of Commerce.; This is publication number 10279 of the
   School of Ocean and Earth Science and Technology of the University of
   Hawai'i at Manoa and publication UNIHI-SEAGRANT-JC-16-13 of the
   University of Hawai'i Sea Grant College Program.
CR Amend A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004277
   Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459
   Bennett GM, 2015, P NATL ACAD SCI USA, V112, P10169, DOI 10.1073/pnas.1421388112
   Datlof EM, 2017, PEERJ, V5, DOI 10.7717/peerj.3730
   Dayel MJ, 2011, DEV BIOL, V357, P73, DOI 10.1016/j.ydbio.2011.06.003
   Haas AF, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.42, 10.1038/nmicrobiol.2016.42]
   Hynson NA, 2014, FUNGAL ECOL, V12, P1, DOI 10.1016/j.funeco.2014.09.005
   Jani AJ, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0944
   Kuhn T., 2012, STRUCTURE SCI REVOLU
   Medeiros MCI, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-415
   Nigro OD, 2017, MBIO, V8, DOI 10.1128/mBio.02129-16
   Poff KE, 2017, INSECTS, V8, DOI 10.3390/insects8040130
   Prisic S, 2015, MOL MICROBIOL, V97, P263, DOI 10.1111/mmi.13022
   Shin S, 2016, P NATL ACAD SCI USA, V113, P257, DOI 10.1073/pnas.1511484112
   Sogin EM, 2017, ENV MICROBIOL REP, V9, P310, DOI 10.1111/1758-2229.12541
   Takagi D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.038301
   Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300
   Wainwright BJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3532
   Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694
NR 19
TC 0
Z9 0
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD MAR-APR
PY 2018
VL 3
IS 2
SI SI
AR e00159-17
DI 10.1128/mSystems.00159-17
PG 5
WC Microbiology
SC Microbiology
GA GD8JZ
UT WOS:000430760000014
PM 29556540
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Treepong, P
   Kos, VN
   Guyeux, C
   Blanc, DS
   Bertrand, X
   Valot, B
   Hocquet, D
AF Treepong, P.
   Kos, V. N.
   Guyeux, C.
   Blanc, D. S.
   Bertrand, X.
   Valot, B.
   Hocquet, D.
TI Global emergence of the widespread Pseudomonas aeruginosa ST235 clone
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Bacterial resistance; Epidemic; Fluoroquinolones; High-risk clones;
   International clones; Pathogen; Phylogeny
ID STAPHYLOCOCCUS-AUREUS; RESISTANCE GENES; SPREAD; MECHANISMS; VIRULENCE;
   RESISTOME; ALIGNMENT; GENOTYPE; GENOMES
AB Objectives: Despite the non-clonal epidemic population structure of Pseudomonas aeruginosa, several multi-locus sequence types are distributed worldwide and are frequently associated with epidemics where multidrug resistance confounds treatment. ST235 is the most prevalent of these widespread clones. In this study we aimed to understand the origin of ST235 and the molecular basis for its success.
   Methods: The genomes of 79 P. aeruginosa ST235 isolates collected worldwide over a 27-year period were examined. A phylogenetic network was built, using a Bayesian approach to find the Most Recent Common Ancestor, and we identified antibiotic resistance determinants and ST235-specific genes.
   Results: Our data suggested that the ST235 sublineage emerged in Europe around 1984, coinciding with the introduction of fluoroquinolones as an antipseudomonal treatment. The ST235 sublineage seemingly spread from Europe via two independent clones. ST235 isolates then appeared to acquire resistance determinants to aminoglycosides, beta-lactams and carbapenems locally. Additionally, we found that all the ST235 genomes contained the exoU-encoded exotoxin and identified 22 ST235-specific genes clustering in blocks and implicated in transmembrane efflux, DNA processing and bacterial transformation. These unique combinations of genes may have contributed to the poor outcome associated with P. aeruginosa ST235 infections and increased the ability of this international clone to acquire mobile resistance elements.
   Conclusion: Our data suggest that P. aeruginosa ST235 (a) has become prevalent across the globe potentially due to the selective pressure of fluoroquinolones and (b) readily became resistant to aminoglycosides, b-lactams and carbapenems through mutation and acquisition of resistance elements among local populations. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Treepong, P.; Guyeux, C.] Univ Bourgogne Franche Comte, Dept DISC, Inst FEMTO ST, UMR CNRS 6174, Besancon, France.
   [Treepong, P.] Prince Songkla Univ, Fac Technol & Environm, Phuket, Thailand.
   [Kos, V. N.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Waltham, MA USA.
   [Blanc, D. S.] Lausanne Univ Hosp, Serv Hosp Prevent Med, Lausanne, Switzerland.
   [Blanc, D. S.] Lausanne Univ Hosp, Inst Microbiol, Lausanne, Switzerland.
   [Bertrand, X.; Hocquet, D.] Ctr Hosp Reg Univ, Lab Hyg Hosp, 3 Blvd Fleming, F-25030 Besancon, France.
   [Bertrand, X.; Valot, B.; Hocquet, D.] Univ Bourgogne Franche Comte, Chronoenvironm, UMR CNRS 6249, Besancon, France.
   [Hocquet, D.] Ctr Hosp Reg Univ, Ctr Ressources Biol Filiere Microbiol Besancon, Besancon, France.
RP Hocquet, D (reprint author), Ctr Hosp Reg Univ, Lab Hyg Hosp, 3 Blvd Fleming, F-25030 Besancon, France.
EM dhocquet@chu-besancon.fr
RI Hocquet, Didier/AAK-9107-2020
OI Hocquet, Didier/0000-0002-4192-7238; Treepong,
   Panisa/0000-0002-5370-6387; Blanc, Dominique/0000-0002-0324-8437
FU Prince of Songkla University, Thailand
FX PT was supported by a grant from Prince of Songkla University, Thailand.
   The project was partially granted by the Region Franche-Comte (Grant
   'Environnement, Homme, Territoire' of the Reseau franco-suisse). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agnello M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01591
   BALL P, 1990, J ANTIMICROB CHEMOTH, V26, P165, DOI 10.1093/jac/26.suppl_F.165
   Ben Zakour NL, 2016, MBIO, V7, DOI 10.1128/mBio.00347-16
   Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bryant D, 2002, LECT NOTES COMPUT SC, V2452, P375
   Cabot G, 2016, ANTIMICROB AGENTS CH, V60, P7415, DOI 10.1128/AAC.01720-16
   Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008
   Chowdhury PR, 2017, J ANTIMICROB CHEMOTH, V72, P620, DOI 10.1093/jac/dkw471
   Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3
   Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098
   Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033
   He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478
   Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199
   Juan C, 2010, J ANTIMICROB CHEMOTH, V65, P474, DOI 10.1093/jac/dkp491
   Kolmogorov M, 2014, BIOINFORMATICS, V30, P302, DOI 10.1093/bioinformatics/btu280
   Kos VN, 2016, ANTIMICROB AGENTS CH, V60, P3856, DOI 10.1128/AAC.03113-15
   Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14
   Koutsogiannou M, 2013, J CLIN MICROBIOL, V51, P665, DOI 10.1128/JCM.03071-12
   Kugelberg E, 2005, J ANTIMICROB CHEMOTH, V55, P22, DOI 10.1093/jac/dkh505
   Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12
   Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002
   Pena C, 2015, CLIN INFECT DIS, V60, P539, DOI 10.1093/cid/ciu866
   Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x
   Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290
   Valot B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126468
   Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
NR 33
TC 32
Z9 35
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2018
VL 24
IS 3
BP 258
EP 266
DI 10.1016/j.cmi.2017.06.018
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FX9KG
UT WOS:000426417300010
PM 28648860
OA Bronze
DA 2020-05-07
ER

PT J
AU Borujeni, MS
   Ghaderi-Zefrehei, M
   Ghanegolmohammadi, F
   Ansari-Mahyari, S
AF Borujeni, Masoud Salehi
   Ghaderi-Zefrehei, Mostafa
   Ghanegolmohammadi, Farzan
   Ansari-Mahyari, Saeid
TI A Novel LSSVM Based Algorithm to Increase Accuracy of Bacterial Growth
   Modeling
SO IRANIAN JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Bacterial growth curve; Hybrid algorithm; LSSVM; NSGA-II; Modeling
ID LAG TIME DISTRIBUTIONS; LISTERIA-MONOCYTOGENES; MICROBIAL-GROWTH;
   GENETIC ALGORITHM; NEURAL-NETWORK; SYSTEM
AB Background: The recent progress and achievements in the advanced, accurate, and rigorously evaluated algorithms has revolutionized different aspects of the predictive microbiology including bacterial growth.
   Objectives: In this study, attempts were made to develop a more accurate hybrid algorithm for predicting the bacterial growth curve which can also be applicable in predictive microbiology studies.
   Materials and Methods: Sigmoid functions, including Logistic and Gompertz, as well as least square support vector machine (LSSVM) based algorithms were employed to model the bacterial growth of the two important strains comprising Listeria monocytogenes and Escherichia coli. Even though cross-validation is generally used for tuning the parameters in LSSVM, in this study, parameters tuning (i.e.,'c' and 'sigma') of the LSSVM were optimized using non-dominated sorting genetic algorithm-II (NSGA-II), named as NSGA-II-LSSVM. Then, the results of each approach were compared with the mean absolute error (MAE) as well as the mean absolute percentage error (MAPE).
   Results: Applying LSSVM, it was resulted in a precise bacterial growth modeling compared to the sigmoid functions. Moreover, our results have indicated that NSGA-II-LSSVM was more accurate in terms of prediction than LSSVM method.
   Conclusion: Application of the NSGA-II-LSSVM hybrid algorithm to predict precise values of 'c' and 'sigma' parameters in the bacterial growth modeling resulted in a better growth prediction. In fact, the power of NSGA-II for estimating optimal coefficients led to a better disclosure of the predictive potential of the LSSVM.
C1 [Borujeni, Masoud Salehi] Semnan Univ, Elect & Comp Engn Fac, Elect Dept, Semnan, Iran.
   [Ghaderi-Zefrehei, Mostafa] Univ Yasuj, Fac Agr, Dept Anim Sci, Pasdaran Ave, Yasuj 75914, Iran.
   [Ghanegolmohammadi, Farzan] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.
   [Ansari-Mahyari, Saeid] Isfahan Univ Technol, Coll Agr, Dept Anim Sci, Esfahan, Iran.
RP Ghaderi-Zefrehei, M (reprint author), Univ Yasuj, Fac Agr, Dept Anim Sci, Pasdaran Ave, Yasuj 75914, Iran.
EM mghaderi@yu.ac.ir
OI Ghanegolmohammadi, Farzan/0000-0001-5217-0878; Ansari - Mahyari,
   Saeid/0000-0003-1115-5043
CR Augustin JC, 2005, J APPL MICROBIOL, V99, P1019, DOI 10.1111/j.1365-2672.2005.02710.x
   Augustin JC, 2000, APPL ENVIRON MICROB, V66, P1706, DOI 10.1128/AEM.66.4.1706-1710.2000
   Baty F, 2004, INT J FOOD MICROBIOL, V91, P261, DOI 10.1016/j.ijfoodmicro.2003.07.002
   Bernaerts K, 2004, J FOOD PROTECT, V67, P2041, DOI 10.4315/0362-028X-67.9.2041
   Bigdeli N, 2010, ENERG CONVERS MANAGE, V51, P2419, DOI 10.1016/j.enconman.2010.05.006
   Chatterjee T, 2015, BBA-GEN SUBJECTS, V1850, P299, DOI 10.1016/j.bbagen.2014.10.022
   Chen ZY, 2011, EXPERT SYST APPL, V38, P12151, DOI 10.1016/j.eswa.2011.03.025
   Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017
   Dubey R, 2002, PRACTICAL MICROBIOLO, DOI [10.4172/2157-7471.1000385, DOI 10.4172/2157-7471.1000385]
   Esen H, 2009, EXPERT SYST APPL, V36, P10673, DOI 10.1016/j.eswa.2009.02.045
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Gencoglu MT, 2009, EXPERT SYST APPL, V36, P10789, DOI 10.1016/j.eswa.2009.02.021
   Guillier L, 2006, INT J FOOD MICROBIOL, V111, P241, DOI 10.1016/j.ijfoodmicro.2006.05.011
   Hsu C-W, 2016, TECHNICAL REPORT
   Ismail S, 2012, HYDROL EARTH SYST SC, V16, P4417, DOI 10.5194/hess-16-4417-2012
   Khemchandani R, 2009, EXPERT SYST APPL, V36, P132, DOI 10.1016/j.eswa.2007.09.035
   Kikuchi S, 2003, BIOINFORMATICS, V19, P643, DOI 10.1093/bioinformatics/btg027
   Ma SY, 2015, J HAZARD MATER, V283, P591, DOI 10.1016/j.jhazmat.2014.10.011
   Mejlholm O, 2009, J FOOD PROTECT, V72, P2132, DOI 10.4315/0362-028X-72.10.2132
   Membre JM, 1999, LETT APPL MICROBIOL, V28, P216, DOI 10.1046/j.1365-2672.1999.00499.x
   MORE JJ, 1983, SIAM J SCI STAT COMP, V4, P553, DOI 10.1137/0904038
   Pang SN, 2011, INFORM SCIENCES, V181, P2071, DOI 10.1016/j.ins.2011.01.008
   Perni S, 2005, FOOD MICROBIOL, V22, P491, DOI 10.1016/j.fm.2004.11.014
   Polat K, 2008, EXPERT SYST APPL, V34, P482, DOI 10.1016/j.eswa.2006.09.012
   Polat K, 2007, DIGIT SIGNAL PROCESS, V17, P694, DOI 10.1016/j.dsp.2006.10.008
   Pommerville JC, 2009, ALCAMOS FUNDAMENTALS, DOI [10.1007/978-0-387-22458-9_3, DOI 10.1007/978-0-387-22458-9_3]
   Pouillot R, 2011, FOOD MICROBIOL, V28, P720, DOI 10.1016/j.fm.2010.06.002
   Ross T, 2009, INT J FOOD MICROBIOL, V131, P128, DOI 10.1016/j.ijfoodmicro.2009.02.007
   Salehi Borojeni M, 2014, 2 INT C MATH SCI ICM
   Sallehuddin R, 2007, NEURAL NETW WORLD, V17, P573
   Shi ZB, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION AND MULTIMEDIA TECHNOLOGY, PROCEEDINGS, P306, DOI 10.1109/ICIMT.2009.57
   Standaert AR, 2007, RISK ANAL, V27, P241, DOI 10.1111/j.1539-6924.2006.00873.x
   Suykens J. A. K., 2002, LEAST SQUARES SUPPOR
   Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0
   Zhang JL, 2012, COMPUT IND ENG, V63, P695, DOI 10.1016/j.cie.2012.03.016
   Zhang K, 2014, SCI WORLD J, DOI 10.1155/2014/928395
   Zhang W, 2009, 5 INT C NAT COMP, DOI [10.1109/ICNC.2009.26, DOI 10.1109/ICNC.2009.26]
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 38
TC 2
Z9 2
U1 0
U2 3
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 1728-3043
J9 IRAN J BIOTECHNOL
JI Iran. J. Biotechnol.
PD SPR
PY 2018
VL 16
IS 2
BP 105
EP 113
AR e1542
DI 10.21859/ijb.1542
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GJ3SB
UT WOS:000435216800003
PM 30805384
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Albiger, B
   Revez, J
   Leitmeyer, KC
   Struelens, MJ
AF Albiger, Barbara
   Revez, Joana
   Leitmeyer, Katrin Claire
   Struelens, Marc J.
TI Networking of Public Health Microbiology Laboratories Bolsters Europe's
   Defenses against Infectious Diseases
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE public health laboratory networks; public health microbiology; external
   quality assessment; molecular diagnostics; antimicrobial susceptibility
   testing; molecular typing; communicable disease surveillance; emerging
   diseases
ID MYCOBACTERIUM-CHIMERA INFECTION; CARDIAC-SURGERY; TUBERCULOSIS;
   PROFICIENCY; CORONAVIRUS; OUTBREAK
AB In an era of global health threats caused by epidemics of infectious diseases and rising multidrug resistance, microbiology laboratories provide essential scientific evidence for risk assessment, prevention, and control. Microbiology has been at the core of European infectious disease surveillance networks for decades. Since 2010, these networks have been coordinated by the European Centre for Disease Prevention and Control (ECDC). Activities delivered in these networks include harmonization of laboratory diagnostic, antimicrobial susceptibility and molecular typing methods, multicentre method validation, technical capacity mapping, training of laboratory staff, and continuing quality assessment of laboratory testing. Cooperation among the European laboratory networks in the past 7 years has proved successful in strengthening epidemic preparedness by enabling adaptive capabilities for rapid detection of emerging pathogens across Europe. In partnership with food safety authorities, international public health agencies and learned societies, ECDC-supported laboratory networks have also progressed harmonization of routinely used antimicrobial susceptibility and molecular typing methods, thereby significantly advancing the quality, comparability and precision of microbiological information gathered by ECDC for surveillance for zoonotic diseases and multidrug-resistant pathogens in Europe. ECDC continues to act as a catalyst for sustaining continuous practice improvements and strengthening wider access to laboratory capacity across the European Union. Key priorities include optimization and broader use of rapid diagnostics, further integration of whole-genome sequencing in surveillance and electronic linkage of laboratory and public health systems. This article highlights some of the network contributions to public health in Europe and the role that ECDC plays managing these networks.
C1 [Albiger, Barbara] European Ctr Dis Prevent & Control, Sci Advice Coordinat Sect, Off Chief Scientist, Stockholm, Sweden.
   [Revez, Joana; Leitmeyer, Katrin Claire; Struelens, Marc J.] European Ctr Dis Prevent & Control, Microbiol Coordinat Sect, Off Chief Scientist, Stockholm, Sweden.
RP Struelens, MJ (reprint author), European Ctr Dis Prevent & Control, Microbiol Coordinat Sect, Off Chief Scientist, Stockholm, Sweden.
EM marc.struelens@ecdc.europa.eu
CR Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062
   [Anonymous], 2016, INT HLTH REG
   Broberg E, 2014, EUROSURVEILLANCE, V19, P27, DOI 10.2807/1560-7917.ES2014.19.4.20682
   Brown D, 2015, EUROSURVEILLANCE, V20, P21, DOI 10.2807/1560-7917.ES2015.20.2.21008
   Chand M, 2017, CLIN INFECT DIS, V64, P335, DOI 10.1093/cid/ciw754
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   de Beer JL, 2014, INT J TUBERC LUNG D, V18, P594, DOI 10.5588/ijtld.13.0531
   EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2017, EFSA J, V15, P1, DOI [10. 2903/j. efsa. 2017. 4694, DOI 10.2903/J.EFSA.2017.4694]
   Ellerbrok H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005570
   European Center for Disease Prevention and Control, 2016, EU PROT HARM MON ANT
   European Centre for Disease Prevention and Control, 2011, SURV COMM DIS EUR CO
   European Centre for Disease Prevention and Control, 2015, ANT RES SURV EUR ANN
   European Centre for Disease Prevention and Control, 2014, EXT QUAL ASS ASCHEM
   European Centre for Disease Prevention and Control, 2016, ANN EP REP 2016 EB M
   European Centre for Disease Prevention and Control, 2016, ECDC ROADM INT MOL G
   European Centre for Disease Prevention and Control, 2013, CARB PROD BACT EUR I
   European Centre for Disease Prevention and Control, 2015, INV CARD INF MYC CHI
   European Centre for Disease Prevention and Control, 2015, EU PROT CAS DET LAB
   European Centre for Disease Prevention and Control, 2016, LAB STAND OP PROC MU
   European Centre for Disease Prevention and Control, 2016, GON ANT SUSC SURV EU
   European Centre for Disease Prevention and Control, 2017, ECDC STUD PROT GEN B
   European Centre for Disease Prevention and Control, 2017, MULT OUTBR SALM ENT
   European Centre for Disease Prevention and Control, 2015, SEV RESP DIS ASS MID
   European Centre for Disease Prevention and Control, 2017, EUR GASP EXT QUAL AS
   European Centre for Disease Prevention and Control, 2017, EU LAB CAP MON SYST
   European Centre for Disease Prevention and Control, 2012, RESP PLAN CONTR MAN
   European Centre for Disease Prevention and Control, 2016, EXP OP WHOL GEN SEQ
   European Centre for Disease Prevention and Control, 2011, ANT RES SURV EUR ANN
   European Centre for Disease Prevention and Control, 2016, INV CARD INF MYC CHI
   European Commission, 2016, STUD COST BEN AN REF
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Glasner C., 2013, EURP SURVEILL, P18, DOI DOI 10.2807/1560-7917.ES2013.18.28.20525
   Grundmann H, 2017, LANCET INFECT DIS, V17, P153, DOI 10.1016/S1473-3099(16)30257-2
   Haller S, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.17.30215
   Jacobsson S, 2016, J ANTIMICROB CHEMOTH, V71, P3109, DOI 10.1093/jac/dkw279
   Kahlmeter G, 2014, UPSALA J MED SCI, V119, P78, DOI 10.3109/03009734.2014.901446
   Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748
   Mulders MN, 2016, MMWR-MORBID MORTAL W, V65, P438, DOI 10.15585/mmwr.mm6517a3
   Nadon CA, 2013, EUROSURVEILLANCE, V18, P10, DOI 10.2807/1560-7917.ES2013.18.35.20565
   Nikolayevskyy V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152926
   Nisii C, 2017, CLIN MICROBIOL INFEC, V23, P58, DOI 10.1016/j.cmi.2016.07.003
   Palm D, 2012, EUROSURVEILLANCE, V17, P11
   Pas SD, 2016, EXPERT REV MOL DIAGN, V16, P7, DOI 10.1586/14737159.2016.1116943
   Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022
   Pereyaslov D, 2014, EUROSURVEILLANCE, V19, P26, DOI 10.2807/1560-7917.ES2014.19.40.20923
   Sax H, 2015, CLIN INFECT DIS, V61, P67, DOI 10.1093/cid/civ198
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   van Ingen J, 2017, LANCET INFECT DIS, V17, P1033, DOI 10.1016/S1473-3099(17)30324-9
   Wolfel R, 2015, EUROSURVEILLANCE, V20, P31, DOI 10.2807/1560-7917.ES.2015.20.44.30055
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 50
TC 3
Z9 3
U1 2
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD FEB 26
PY 2018
VL 6
AR 46
DI 10.3389/fpubh.2018.00046
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FY6WW
UT WOS:000427004600001
PM 29535998
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Mo, ZX
   Guo, JQ
   She, D
   Zhang, X
   Puthiyakunnon, S
   Chen, XG
   Wu, ZD
   Shin, JW
   Cui, LW
   Li, H
AF Mo, Ze-Xun
   Guo, Jin-Qiang
   She, Dan
   Zhang, Xin
   Puthiyakunnon, Santhosh
   Chen, Xiao-Guang
   Wu, Zhong-Dao
   Shin, Jyh-Wei
   Cui, Li-Wang
   Li, Hua
TI Infection by the nematode Angiostrongylus cantonensis induces
   differential expression of miRNAs in mouse brain
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Angiostrongylus cantonensis; immune response; microRNAs;
   mmu-miR-146a-5p; TNF-alpha
ID TNF-ALPHA; KAPPA-B; INFLAMMATION; ACTIVATION; RESPONSES; RECEPTOR;
   GROWTH; MODEL
AB Background: The parasitic nematode Angiostrongylus cantonensis is the primary pathogen causing eosinophilic meningitis and meningoencephalitis in nonpermissive hosts. The larval parasites are eliminated by the host's immune responses in the central nervous system (CNS) through infiltration of eosinophils and lymphocytes. This study aimed to determine primary alterations of microRNA (miRNA) during A. cantonensis infection in mice.
   Methods: miRNA array was used to analyze the expression of miRNA in uninfected and A. cantonensis-infected mouse brains at 21 days postinfection (dpi). Target genes were predicted by miRDB software, and protein-protein interaction network was analyzed using STRING v9.1. Expression levels of selected miRNAs and cytokine production were verified by quantitative reverse transcription polymerase chain reaction (qRT-PCR).
   Results: Twenty-five mature miRNAs showed differential expression in infected mouse brains, of which 24 were upregulated and one was downregulated compared to the uninfected control. These 25 miRNAs were divided into five clusters, and the first upregulated cluster was selected for further bioinformatics analysis. Target gene prediction and gene ontology (GO) enrichment analysis revealed that the miRNAs were mainly related to the immune response. Furthermore, six target genes of mmu-miR-146a-5p were predicted to interact with tumor necrosis factor alpha (TNF-alpha). The in vitro study suggested that transfected mmu-miR-146a-5p inhibitor upregulated TNF-alpha and its target gene Traf6 in microglia following stimulation with A. cantonensis larval antigen.
   Conclusion: This study suggested a critical role of miRNAs in the host defense during A. cantonensis infection, providing new insights into the molecular mechanisms underlying the interaction between mmu-miR-146a-5p and TNF-alpha in angiostrongyliasis in nonpermissive hosts. Copyright (C) 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
C1 [Mo, Ze-Xun; Guo, Jin-Qiang; She, Dan; Zhang, Xin; Puthiyakunnon, Santhosh; Chen, Xiao-Guang; Li, Hua] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China.
   [Mo, Ze-Xun; Guo, Jin-Qiang; She, Dan; Zhang, Xin; Puthiyakunnon, Santhosh; Chen, Xiao-Guang; Li, Hua] Southern Med Univ, Sch Publ Hlth,Expt Teaching Ctr Prevent Med, Key Lab Trop Dis Res Guangdong Prov, Key Lab Prevent & Control Emerging Infect Dis Gua, Guangzhou, Guangdong, Peoples R China.
   [Wu, Zhong-Dao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510080, Guangdong, Peoples R China.
   [Shin, Jyh-Wei] Natl Cheng Kung Univ, Coll Med, Dept Parasitol, Tainan 701, Taiwan.
   [Cui, Li-Wang] Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.
RP Li, H (reprint author), Southern Med Univ Guangzhou, Guangzhou Ave North 1838, Guangzhou, Guangdong, Peoples R China.
EM lih@smu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471980]; Natural Science Foundation of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2014A030313318]; 973 project of ChinaNational Basic Research Program of
   China [2010CB530000]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81471980), the Natural Science Foundation of
   Guangdong Province (No. 2014A030313318) and the 973 project of China
   (No. 2010CB530000).
CR Ahmad SF, 2015, IMMUNOBIOLOGY, V220, P889, DOI 10.1016/j.imbio.2015.01.008
   Alicata J. E., 1965, Advances in Parasitology, V3, P223
   Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979
   Alto W, 2001, Pac Health Dialog, V8, P176
   Alvarado R, 2015, IMMUNOBIOLOGY, V220, P262, DOI 10.1016/j.imbio.2014.11.008
   Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274
   Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P70
   Feng MJ, 2012, INT IMMUNOPHARMACOL, V13, P347, DOI 10.1016/j.intimp.2012.05.001
   Fiorillo AA, 2015, CELL REP, V12, P1678, DOI 10.1016/j.celrep.2015.07.066
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Gilicze AB, 2014, BIOMED RES INT, DOI 10.1155/2014/870267
   Gosnell William L, 2013, Hawaii J Med Public Health, V72, P49
   Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08
   Jarvi SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123064
   Lan KP, 2004, J HELMINTHOL, V78, P311, DOI 10.1079/JOH2004256
   Li Hua, 2005, Chinese Journal of Parasitology and Parasitic Diseases, V23, P36
   Li J, 2015, LAB INVEST, V95, P1056, DOI 10.1038/labinvest.2015.76
   Liu HY, 2015, EXP NEUROL, V269, P202, DOI 10.1016/j.expneurol.2015.04.011
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397
   Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008
   Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-14
   Sugaya H, 1997, PARASITOL RES, V83, P10, DOI 10.1007/s004360050199
   Talari M, 2015, BIOCHIMIE, V119, P16, DOI 10.1016/j.biochi.2015.10.004
   Thiengo Silvana Carvalho, 2013, Hawaii J Med Public Health, V72, P18
   Tsai HC, 2003, AM J TROP MED HYG, V68, P281, DOI 10.4269/ajtmh.2003.68.281
   Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9
   Wei J, 2013, PARASITOL RES, V112, P207, DOI 10.1007/s00436-012-3127-z
   Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027
   Yu LP, 2014, PARASITOL RES, V113, P91, DOI 10.1007/s00436-013-3630-x
   Zhang Xin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P477
   Zhao J, 2013, PARASITOL RES, V112, P2689, DOI 10.1007/s00436-013-3436-x
   Zhu DH, 2013, J ALLERGY CLIN IMMUN, V132, P426, DOI 10.1016/j.jaci.2013.02.005
NR 33
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD FEB
PY 2018
VL 51
IS 1
BP 94
EP 102
DI 10.1016/j.jmii.2016.02.002
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FX7XI
UT WOS:000426304500012
PM 27156837
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Pindyck, T
   Gupta, K
   Strymish, J
   Itani, KM
   Carter, ME
   Suo, Y
   Bessesen, MT
   Topkoff, J
   Steele, AS
   Baron, AE
   Gundlapalli, AV
   Branch-Elliman, W
AF Pindyck, T.
   Gupta, K.
   Strymish, J.
   Itani, K. M.
   Carter, M. E.
   Suo, Y.
   Bessesen, M. T.
   Topkoff, J.
   Steele, A. S.
   Baron, A. E.
   Gundlapalli, A. V.
   Branch-Elliman, W.
TI Validation of an electronic tool for flagging surgical site infections
   based on clinical practice patterns for triaging surveillance:
   Operational successes and barriers
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Surgical site infection surveillance; SSI surveillance; electronic SSI
   flagging tool; electronic surveillance tool
ID CARE-ASSOCIATED INFECTIONS; NETWORK; COSTS
AB Background: Surveillance is an effective strategy for reducing surgical site infections (SSIs); however, current identification methods are resource-intensive. Therefore, we sought to validate an electronic SSI triaging tool for detection of probable infections and identify operational barriers and challenges.
   Methods: A retrospective cohort study was conducted among all Veterans Affairs Surgical Quality Improvement Program (VASQIP)-reviewed surgeries at 2 Veterans Affairs medical centers from October 1, 2011-September 30, 2014. During the postoperative period, clinical and administrative variables associated with SSI (relevant microbiology order, antibiotic order, radiology order, and administrative codes) were extracted from the electronic medical record and used to score the probability (high, intermediate, and low) that an SSI occurred. VASQIP manual chart review was used as the gold standard of comparison.
   Results: VASQIP manual review identified 118 SSIs out of 3,700 surgeries (3.2%). There were 2,041, 1,428, and 231 surgeries that met criteria for low, intermediate, and high probability for SSI. The tool's area under the curve was 0.86 (95% confidence interval, 0.82-0.89). The sensitivity among low-probability surgeries was 92.4%, and the specificity among high-probability surgeries was 95.1%.
   Conclusions: The electronic SSI tool has the potential to be used for triaging VASQIP surveillance toward the high-probability surgeries and to avoid manual review of surgeries with low probability of SSI. (c) 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Pindyck, T.] Univ Colorado, Dept Family Med, Prevent Med Residency Program, Anschutz Med Campus,13001E 17th Pl, Aurora, CO 80045 USA.
   [Gupta, K.; Strymish, J.; Itani, K. M.; Branch-Elliman, W.] VA Boston Healthcare Syst, Boston, MA USA.
   [Gupta, K.; Itani, K. M.] Boston Univ, Sch Med, Boston, MA 02215 USA.
   [Strymish, J.] Harvard Med Sch, Boston, MA USA.
   [Carter, M. E.; Suo, Y.; Gundlapalli, A. V.] VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA.
   [Carter, M. E.; Suo, Y.; Gundlapalli, A. V.] IDEAS Ctr 20, Salt Lake City, UT USA.
   [Carter, M. E.; Suo, Y.; Gundlapalli, A. V.] Univ Utah, Sch Med, Salt Lake City, UT USA.
   [Bessesen, M. T.; Topkoff, J.] Eastern Colorado VA Healthcare Syst, Denver, CO USA.
   [Bessesen, M. T.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA.
   [Steele, A. S.] US Dept Veteran Affairs, VA St Louis Healthcare Syst, St Louis, MO USA.
   [Baron, A. E.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostatist & Informat, Anschutz Med Campus, Aurora, CO USA.
RP Pindyck, T (reprint author), Univ Colorado, Dept Family Med, Prevent Med Residency Program, Anschutz Med Campus,13001E 17th Pl, Aurora, CO 80045 USA.
EM talia.pindyck@ucdenver.edu
FU Denver VA Medical Center; Health Resources and Services Administration
   of the Department of Veteran Affairs [D33HP25768]; Veterans Integrated
   Service Network-1 Career Development award; American Heart Association
   Institute for Precision Cardiovascular Medicine award [17IG33630052];
   VAUS Department of Veteran Affairs; VA Health Services Research and
   Development Service grant [CIR 13-414]; VA Health Services Research and
   Development Service Merit ReviewUS Department of Veteran Affairs [IIR
   891-01-A1]; National Patient Safety Foundation [XVA 68-023]
FX Supported by operational funding from the Denver VA Medical Center. T.P.
   is supported by a grant from the Health Resources and Services
   Administration of the Department of Veteran Affairs (D33HP25768).
   W.B.-E. is supported by a Veterans Integrated Service Network-1 Career
   Development award and an American Heart Association Institute for
   Precision Cardiovascular Medicine award (17IG33630052). M.T.B. is
   supported by a VA Merit Review award. A.V.G. is supported by a VA Health
   Services Research and Development Service grant (CIR 13-414). K.G. is
   supported by a VA Health Services Research and Development Service Merit
   Review (IIR 891-01-A1) and a National Patient Safety Foundation grant
   (XVA 68-023).
CR Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]
   Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940
   Astagneau P, 2009, J HOSP INFECT, V72, P127, DOI 10.1016/j.jhin.2009.03.005
   Astagneau P, 2001, J HOSP INFECT, V48, P267, DOI 10.1053/jhin.2001.1003
   Bolon MK, 2009, CLIN INFECT DIS, V48, P1223, DOI 10.1086/597584
   Branch-Elliman W, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002340
   Branch-Elliman W, 2014, AM J INFECT CONTROL, V42, P1291, DOI 10.1016/j.ajic.2014.08.013
   Branch-Elliman W, 2014, INFECT CONT HOSP EP, V35, P692, DOI 10.1086/676437
   Dupree JM, 2014, J AM COLL SURGEONS, V218, P1, DOI 10.1016/j.jamcollsurg.2013.09.017
   Hebden JN, 2008, AM J INFECT CONTROL, V36, pS7, DOI 10.1016/j.ajic.2007.10.011
   Hebden JN, 2012, AM J INFECT CONTROL, V40, pS29, DOI 10.1016/j.ajic.2012.03.009
   Henderson WG, 2009, AM J SURG, V198, pS19, DOI 10.1016/j.amjsurg.2009.07.025
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Lewis SS, 2013, INFECT CONT HOSP EP, V34, P1229, DOI 10.1086/673443
   Mittenzwei SE, 2017, INFECT CONT HOSP EP, V38, P1002, DOI 10.1017/ice.2017.104
   Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4
   Schweizer ML, 2014, JAMA SURG, V149, P575, DOI 10.1001/jamasurg.2013.4663
   Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99
   Stamm AM, 2012, AM J INFECT CONTROL, V40, P688, DOI 10.1016/j.ajic.2012.01.033
   Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004
   Szilagyi E, 2009, J HOSP INFECT, V71, P74, DOI 10.1016/j.jhin.2008.07.001
   van Mourik MSM, 2013, CLIN INFECT DIS, V57, P85, DOI 10.1093/cid/cit185
   Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572
   Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763
NR 24
TC 5
Z9 5
U1 1
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD FEB
PY 2018
VL 46
IS 2
BP 186
EP 190
DI 10.1016/j.ajic.2017.08.026
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FU3DA
UT WOS:000423728900012
PM 29031434
DA 2020-05-07
ER

PT J
AU Rozanska, A
   Jarynowski, A
   Kopec-Godlewska, K
   Wojkowska-Mach, J
   Misiewska-Kaczur, A
   Lech, M
   Rozwadowska, M
   Karwacka, M
   Liberda, J
   Domanska, J
AF Rozanska, Anna
   Jarynowski, Andrzej
   Kopec-Godlewska, Katarzyna
   Wojkowska-Mach, Jadwiga
   Misiewska-Kaczur, Agnieszka
   Lech, Marzena
   Rozwadowska, Malgorzata
   Karwacka, Marlena
   Liberda, Joanna
   Domanska, Joanna
CA Polish Soc Hosp Infections Team
TI Does surgical site infection after Caesarean section in Polish hospitals
   reflect high-quality patient care or poor postdischarge surveillance?
   Results from a 3-year multicenter study
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Healthcare associated infections; Obstetric; ASA score; Perioperative
   antibiotic prophylaxis; Incidence study; Duration of surgery
ID DELIVERY; PROPHYLAXIS; EXPERIENCE
AB Background: Caesarean sections (CSs) are associated with a high infection risk. Surgical site infection (SSI) incidence is among the markers of effectiveness of infection prevention efforts. The aim of this study was to analyze risk factors for SSI, incidence, and microbiology in patients who underwent CS.
   Methods: The study was conducted during 2013-2015 using active infection surveillance in 5 Polish hospitals according to the European Centre for Disease Prevention and Control surveillance network known as HAI-Net. For each procedure, the following data were registered: age, American Society of Anesthesiologists score, procedure time, elective or emergency procedure, use of perioperative antibiotic prophylaxis, microbiology, the treatment used, and other information.
   Results: SSI incidence was 0.5% and significant differences were noted among hospitals (between 0.1% and 1.8%), for different American Society of Anesthesiologists scales (between 0.2% and 4.8%) and different values of standardized SSI risk index (between 0.0% and 0.8%). In 3.1% of procedures, with no antibiotic prophylaxis, SSI risk was significantly higher. Deep infections dominated: 61.5% with superficial infections in only approximately 30% of cases and 2.6% of infections were detected postdischarge without readmissions.
   Conclusions: Results showed high incidence of SSI in Poland without perioperative antibiotic prophylaxis, and secondly, ineffective surveillance according to CS status, considering outpatient obstetric care. Without postdischarge surveillance, it is not possible to recognize the epidemiologic situation, and further, to set priorities and needs when it comes to infection prophylaxis, especially because such low incidence may indicate no need for improvement in infection control. (C) 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Rozanska, Anna; Wojkowska-Mach, Jadwiga] Jagiellonian Univ, Med Coll, Dept Microbiol, 18 Czysta St, PL-31121 Krakow, Poland.
   [Jarynowski, Andrzej] Jagiellonian Univ, Smoluchowski Inst Phys, Krakow, Poland.
   [Kopec-Godlewska, Katarzyna] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Krakow, Poland.
   [Misiewska-Kaczur, Agnieszka] Voivodeship Hosp, Bielsko Biala, Poland.
   [Lech, Marzena] SPZZOZ Hosp, Staszow, Poland.
   [Rozwadowska, Malgorzata] Ujastek Obstet & Gynaecol Hosp, Krakow, Poland.
   [Karwacka, Marlena] SPWZOS MSWiA Hosp, Bydgoszcz, Poland.
   [Liberda, Joanna] Henryk Klimontowicz Specialist Hosp, Gorlice, Poland.
   [Domanska, Joanna] Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland.
RP Wojkowska-Mach, J (reprint author), Jagiellonian Univ, Med Coll, Dept Microbiol, 18 Czysta St, PL-31121 Krakow, Poland.
EM mbmach@cyf-kr.edu.pl
RI Domanska, Joanna/J-8501-2013; Wojkowska-Mach, Jadwiga/U-1186-2018
OI Domanska, Joanna/0000-0002-1935-8358; Jarynowski,
   Andrzej/0000-0003-0949-6674; Wojkowska-Mach, Jadwiga/0000-0003-0756-1639
CR [Anonymous], 1985, LANCET, V2, P436
   [Anonymous], 2013, SURV SURG SIT INF EU
   Baker CJ, 2011, PEDIATRICS, V128, P611, DOI 10.1542/peds.2011-1466
   Brusaferro S, 2001, J HOSP INFECT, V47, P288, DOI 10.1053/jhin.2001.0946
   del Monte MCC, 2010, AM J INFECT CONTROL, V38, P467, DOI 10.1016/j.ajic.2009.10.008
   De Nardo P, 2016, J HOSP INFECT, V93, P355, DOI 10.1016/j.jhin.2016.02.021
   Deptula A, 2017, J HOSP INFECT, V96, P145, DOI 10.1016/j.jhin.2016.12.020
   Lima JLDD, 2016, AM J INFECT CONTROL, V44, P273, DOI 10.1016/j.ajic.2015.10.022
   European Center for Disease Prevention and Control, 2012, SURV HEALTHC ASS INF, P43
   European Centre for Disease Prevention and Control, 2016, SURG SIT INF ANN EP
   Ferraro F, 2016, NEW MICROBIOL, V39, P134
   Fukuda H, 2013, AM J INFECT CONTROL, V41, P810, DOI 10.1016/j.ajic.2012.10.004
   Gouvea M, 2015, BRAZ J INFECT DIS, V19, P517, DOI 10.1016/j.bjid.2015.06.004
   Halwani MA, 2016, AM J INFECT CONTROL, V44, P455, DOI 10.1016/j.ajic.2015.10.023
   Hamilton Brady E Ph D, 2015, Natl Vital Stat Rep, V64, P1
   Koek M. B., 2015, Eurosurveillance, V20, P21042
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P193, DOI 10.1111/j.1471-0528.2010.02729.x
   Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870
   Macfarlane AJ, 2016, BJOG-INT J OBSTET GY, V123, P559, DOI 10.1111/1471-0528.13284
   Mousavi S, 2017, J RES PHARM PRACT, V6, P126, DOI 10.4103/jrpp.JRPP_16_164
   Mylonas I, 2015, DTSCH ARZTEBL INT, V112, P489, DOI 10.3238/arztebl.2015.0489
   Prospero E, 2011, EPIDEMIOL INFECT, V139, P1326, DOI 10.1017/S0950268810002505
   Rozanska A, 2016, J HOSP INFECT, V94, P228, DOI 10.1016/j.jhin.2016.08.003
   Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71
   WHO Euro Health for All Database, 2014, EUR HLTH ALL DAT HFA
   Wloch C, 2012, BJOG-INT J OBSTET GY, V119, P1324, DOI 10.1111/j.1471-0528.2012.03452.x
   Wojkowska-Mach J, 2008, GINEKOL POL, V79, P536
   Yokoe DS, 2001, EMERG INFECT DIS, V7, P837
   Yokoe DS, 2014, INFECT CONTROL HO S2, V35, P21
NR 29
TC 3
Z9 3
U1 1
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD JAN
PY 2018
VL 46
IS 1
BP 20
EP 25
DI 10.1016/j.ajic.2017.07.025
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FQ9JS
UT WOS:000418679000007
PM 28967511
DA 2020-05-07
ER

PT J
AU Taylor, SL
   Leong, LEX
   Choo, JM
   Wesselingh, S
   Yang, IA
   Upham, JW
   Reynolds, PN
   Hodge, S
   James, AL
   Jenkins, C
   Peters, MJ
   Baraket, M
   Marks, GB
   Gibson, PG
   Simpson, JL
   Rogers, GB
AF Taylor, Steven L.
   Leong, Lex E. X.
   Choo, Jocelyn M.
   Wesselingh, Steve
   Yang, Ian A.
   Upham, John W.
   Reynolds, Paul N.
   Hodge, Sandra
   James, Alan L.
   Jenkins, Christine
   Peters, Matthew J.
   Baraket, Melissa
   Marks, Guy B.
   Gibson, Peter G.
   Simpson, Jodie L.
   Rogers, Geraint B.
TI Inflammatory phenotypes in patients with severe asthma are associated
   with distinct airway microbiology
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Article
DE Asthma; microbiome; neutrophil; eosinophil
ID INDUCED SPUTUM; HAEMOPHILUS-INFLUENZAE; EXACERBATIONS; DYNAMICS;
   FEATURES; SAMPLES
AB Background: Asthma pathophysiology and treatment responsiveness are predicted by inflammatory phenotype. However, the relationship between airway microbiology and asthma phenotype is poorly understood.
   Objective: We aimed to characterize the airway microbiota in patients with symptomatic stable asthma and relate composition to airway inflammatory phenotype and other phenotypic characteristics.
   Methods: The microbial composition of induced sputum specimens collected from adult patients screened for a multicenter randomized controlled trial was determined by using 16SrRNA gene sequencing. Inflammatory phenotypes were defined by sputum neutrophil and eosinophil cell proportions. Microbiota were defined by using alpha- and beta-diversity measures, and interphenotype differences were identified by using similarity of percentages, network analysis, and taxon fold change. Phenotypic predictors of airway microbiology were identified by using multivariate linear regression.
   Results: Microbiota composition was determined in 167 participants and classified as eosinophilic (n = 84), neutrophilic (n = 14), paucigranulocytic (n = 60), or mixed neutrophilic-eosinophilic (n = 9) asthma phenotypes. Airway microbiology was significantly less diverse (P = .022) and more dissimilar (P = .005) in neutrophilic compared with eosinophilic participants. Sputum neutrophil proportions, but not eosinophil proportions, correlated significantly with these diversity measures (a-diversity: Spearman r = -20.374, P < .001; beta-diversity: r = 0.238, P = .002). Interphenotype differences were characterized by a greater frequency of pathogenic taxa at high relative abundance and reduced Streptococcus, Gemella, and Porphyromonas taxa relative abundance in patients with neutrophilic asthma. Multivariate regression confirmed that sputum neutrophil proportion was the strongest predictor of microbiota composition.
   Conclusions: Neutrophilic asthma is associated with airway microbiology that is significantly different from that seen in patients with other inflammatory phenotypes, particularly eosinophilic asthma. Differences in microbiota composition might influence the response to antimicrobial and steroid therapies and the risk of lung infection.
C1 [Taylor, Steven L.; Leong, Lex E. X.; Choo, Jocelyn M.; Wesselingh, Steve; Rogers, Geraint B.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Taylor, Steven L.; Leong, Lex E. X.; Choo, Jocelyn M.; Wesselingh, Steve; Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, SAHMRI Microbiome Res Lab, Adelaide, SA, Australia.
   [Yang, Ian A.; Upham, John W.] Univ Queensland, Sch Med, St Lucia, Qld, Australia.
   [Yang, Ian A.] Prince Charles Hosp, Dept Thorac Med, Chermside, Australia.
   [Upham, John W.] Princess Alexandra Hosp, Translat Res Inst, Woolloongabba, Qld, Australia.
   [Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA, Australia.
   [Reynolds, Paul N.; Hodge, Sandra] Hanson Inst, Lung Res Lab, Adelaide, SA, Australia.
   [Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Sch Med, Adelaide, SA, Australia.
   [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Nedlands, WA, Australia.
   [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Crawley, Australia.
   [Jenkins, Christine] George Inst Global Hlth, Resp Trials, Newtown, Tas, Australia.
   [Jenkins, Christine; Peters, Matthew J.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia.
   [Peters, Matthew J.] Concord Gen Hosp, Dept Thorac Med, Concord West, NSW, Australia.
   [Baraket, Melissa; Marks, Guy B.] Liverpool Hosp, Resp Med Dept, Liverpool, NSW, Australia.
   [Baraket, Melissa; Marks, Guy B.] Liverpool Hosp, Ingham Inst, Liverpool, NSW, Australia.
   [Marks, Guy B.; Gibson, Peter G.] Woolcock Inst Med Res, Glebe, NSW, Australia.
   [Gibson, Peter G.; Simpson, Jodie L.] Univ Newcastle, Prior Res Ctr Healthy Lungs, Resp & Sleep Med, Callaghan, NSW, Australia.
   [Marks, Guy B.] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.
RP Rogers, GB (reprint author), Flinders Univ S Australia, Sch Med, Univ Dr, Adelaide, SA 5042, Australia.
EM geraint.rogers@sahmri.com
RI Taylor, Steven/AAD-7827-2019; Rogers, Geraint/AAD-1011-2020; Yang, Ian
   A/B-9609-2008; Upham, John/F-4420-2010; Marks, Guy/F-5058-2013; Rogers,
   Geraint/N-1957-2013; gibson, peter/G-6194-2014
OI Taylor, Steven/0000-0003-4357-8243; Yang, Ian A/0000-0001-8338-1993;
   Upham, John/0000-0002-0017-3433; Leong, Lex Ee
   Xiang/0000-0002-5073-2272; Marks, Guy/0000-0002-8976-8053; Rogers,
   Geraint/0000-0003-4054-1947; Peters, Matthew/0000-0002-9649-8741;
   gibson, peter/0000-0001-5865-489X
FU Australian National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [569246]; John Hunter
   Hospital Charitable Trust
FX Supported by the Australian National Health and Medical Research Council
   (NHMRC); grant no. 569246) and a grant from the John Hunter Hospital
   Charitable Trust.
CR Anderson M. J., 2001, AUSTRAL ECOL, V26, P2
   Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x
   [Anonymous], 1987, AM REV RESPIR DIS, V136, P225
   Bacci E, 2002, MEDIAT INFLAMM, V11, P293, DOI 10.1080/09629350210000015692
   Brooks CR, 2013, RESPIROLOGY, V18, P857, DOI 10.1111/resp.12079
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cuthbertson L, 2016, ISME J, V10, P1081, DOI 10.1038/ismej.2015.198
   Daniels TWV, 2013, J CYST FIBROS, V12, P22, DOI 10.1016/j.jcf.2012.05.008
   Denner DR, 2016, J ALLERGY CLIN IMMUN, V137, P1398, DOI 10.1016/j.jaci.2015.10.017
   Durack J, 2017, J ALLERGY CLIN IMMUN, V140, P63, DOI 10.1016/j.jaci.2016.08.055
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Essilfie AT, 2012, THORAX, V67, P588, DOI 10.1136/thoraxjnl-2011-200160
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031
   Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645
   Hancox RJ, 2012, RESPIROLOGY, V17, P461, DOI 10.1111/j.1440-1843.2011.02113.x
   Hofstra JJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1081-y
   Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044
   Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14
   Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8
   Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x
   JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   McKeever T, 2013, CHEST, V144, P1788, DOI 10.1378/chest.13-0871
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257
   Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9
   Pelaia G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/879783
   Pettigrew MM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1670-4
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rogers GB, 2015, ISME J, V9, P217, DOI 10.1038/ismej.2014.124
   Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9
   Rogers GB, 2013, TRENDS MICROBIOL, V21, P271, DOI 10.1016/j.tim.2013.03.004
   Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09
   Rossall MRW, 2014, RESP MED, V108, P1566, DOI 10.1016/j.rmed.2014.08.004
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x
   Simpson JL, 2016, CHEST, V149, P704, DOI 10.1016/j.chest.2015.12.018
   Simpson JL, 2016, EUR RESPIR J, V47, P792, DOI 10.1183/13993003.00405-2015
   Simpson JL, 2014, EUR RESPIR J, V43, P1067, DOI 10.1183/09031936.00105013
   Suarez-Cuartin G, 2016, ARCH BRONCONEUMOL, V52, P76, DOI 10.1016/j.arbres.2015.03.007
   Tarabichi Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0133-2
   Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
   Zhang QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152724
   Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109
NR 49
TC 54
Z9 55
U1 4
U2 16
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
EI 1097-6825
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD JAN
PY 2018
VL 141
IS 1
BP 94
EP +
DI 10.1016/j.jaci.2017.03.044
PG 25
WC Allergy; Immunology
SC Allergy; Immunology
GA FR8GH
UT WOS:000419312200015
PM 28479329
OA Other Gold, Green Published
HC Y
HP N
DA 2020-05-07
ER

PT J
AU Bloem, A
   Rollero, S
   Seguinot, P
   Crepin, L
   Perez, M
   Picou, C
   Camarasa, C
AF Bloem, Audrey
   Rollero, Stephanie
   Seguinot, Pauline
   Crepin, Lucie
   Perez, Marc
   Picou, Christian
   Camarasa, Carole
TI Workflow Based on the Combination of Isotopic Tracer Experiments to
   Investigate Microbial Metabolism of Multiple Nutrient Sources
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 131; Quantitative analysis; metabolism; multiple
   nutrient source; isotopic tracer experiment; fermentation; GC-MS; ionic
   liquid chromatography
ID SACCHAROMYCES-CEREVISIAE; FLUX ANALYSIS; NETWORK
AB Studies in the field of microbiology rely on the implementation of a wide range of methodologies. In particular, the development of appropriate methods substantially contributes to providing extensive knowledge of the metabolism of microorganisms growing in chemically defined media containing unique nitrogen and carbon sources. In contrast, the management through metabolism of multiple nutrient sources, despite their broad presence in natural or industrial environments, remains virtually unexplored. This situation is mainly due to the lack of suitable methodologies, which hinders investigations.
   We report an experimental strategy to quantitatively and comprehensively explore how metabolism operates when a nutrient is provided as a mixture of different molecules, i.e., a complex resource. Here, we describe its application for assessing the partitioning of multiple nitrogen sources through the yeast metabolic network. The workflow combines information obtained during stable isotope tracer experiments using selected C-13- or N-15-labeled substrates. It first consists of parallel and reproducible fermentations in the same medium, which includes a mixture of N-containing molecules; however, a selected nitrogen source is labeled each time. A combination of analytical procedures (HPLC, GC-MS) is implemented to assess the labeling patterns of targeted compounds and to quantify the consumption and recovery of substrates in other metabolites. An integrated analysis of the complete dataset provides an overview of the fate of consumed substrates within cells. This approach requires an accurate protocol for the collection of samples-facilitated by a robot-assisted system for online monitoring of fermentations-and the achievement of numerous time-consuming analyses. Despite these constraints, it allowed understanding, for the first time, the partitioning of multiple nitrogen sources throughout the yeast metabolic network. We elucidated the redistribution of nitrogen from more abundant sources toward other N-compounds and determined the metabolic origins of volatile molecules and proteinogenic amino acids.
C1 [Bloem, Audrey; Seguinot, Pauline; Perez, Marc; Picou, Christian; Camarasa, Carole] Univ Montpellier, SupAgroM, INRA, UMR SPO, Montpellier, France.
   [Rollero, Stephanie] Stellenbosch Univ, IWBT, Stellenbosch, South Africa.
   [Crepin, Lucie] Toulouse White Biotechnol, PILI, Toulouse, France.
RP Camarasa, C (reprint author), Univ Montpellier, SupAgroM, INRA, UMR SPO, Montpellier, France.
EM carole.camarasa@inra.fr
RI ; Rollero, Stephanie/M-2006-2017
OI Seguinot, Pauline/0000-0001-7452-0736; Rollero,
   Stephanie/0000-0002-7598-4492
FU Ministere de l'Education Nationale, de la Recherche et de la Technologie
FX We thank Jean-Roch Mouret, Sylvie Dequin and Jean-Marie Sabalyrolles for
   contributing to the conception of the robotic-assisted fermentation
   system and Martine Pradal, Nicolas Bouvier and Pascale Brial for their
   technical support. Funding for this project was provided by the
   Ministere de l'Education Nationale, de la Recherche et de la
   Technologie.
CR BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4
   Cooper T, 1982, MOL BIOL YEAST SACCH, V1, P39, DOI DOI 10.1101/087969180.11B.39
   Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036
   Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503
   Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001
   Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07
   Jones EW, 1982, MOL BIOL YEAST SACCH, P182
   Kruger NJ, 2009, BIOCHIMIE, V91, P697, DOI 10.1016/j.biochi.2009.01.004
   Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127
   Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021
   Perpete P, 2005, J AM SOC BREW CHEM, V63, P23, DOI 10.1094/ASBCJ-63-0023
   Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002
   Rantanen A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-266
   Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187
   Zamboni N, 2011, CURR OPIN BIOTECH, V22, P103, DOI 10.1016/j.copbio.2010.08.009
NR 17
TC 3
Z9 3
U1 0
U2 11
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JAN
PY 2018
IS 131
AR e56393
DI 10.3791/56393
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX5CM
UT WOS:000426095700035
PM 29443074
OA Green Published
DA 2020-05-07
ER

PT J
AU Brinkworth, AJ
   Wildung, MR
   Carabeo, RA
AF Brinkworth, Amanda J.
   Wildung, Mark R.
   Carabeo, Rey A.
TI Genomewide Transcriptional Responses of Iron-Starved Chlamydia
   trachomatis Reveal Prioritization of Metabolic Precursor Synthesis over
   Protein Translation
SO MSYSTEMS
LA English
DT Article
DE Chiarnydio; microbiology; global regulatory networks; intracellular
   bacteria; iron reduction; stress response; stringent response; systems;
   transcriptional regulation; translational control
ID OBLIGATE INTRACELLULAR PATHOGEN; INTERFERON-MEDIATED INHIBITION;
   STRINGENT RESPONSE; IN-VITRO; EXPRESSION PROFILES; DEVELOPMENTAL CYCLE;
   ESCHERICHIA-COLI; RIBONUCLEIC-ACID; EPITHELIAL-CELLS; GENE-EXPRESSION
AB Iron is essential for growth and development of Chlarnydia. Its longterm starvation in cultured mammalian cells leads to production of aberrant noninfectious chlamydial forms, also known as persistence. Immediate transcriptional responses to iron limitation have not been characterized, leaving a knowledge gap of how Chlamydia regulates its response to changes in iron availability. We used the fast-chelating agent 2,2'-bipyridyl (BPDL) to homogeneously starve Chlamydia trachomatis serovar L2 of iron, starting at 6 or 12 h postinfection. Immediate transcriptional responses were monitored after only 3 or 6 h of BPDL treatment, well before formation of aberrant Chlamydia. The first genomewide transcriptional response of C. trachornatis to iron starvation was subsequently determined utilizing RNA sequencing. Only 7% and 8% of the genome were differentially expressed in response to iron starvation at the early and middle stages of development, respectively. Biological pathway analysis revealed an overarching theme. Synthesis of macromolecular precursors (deoxynucleotides, amino acids, charged tRNAs, and acetyl coenzyme A [acetyl-Con was upregulated, while energy-expensive processes (ABC transport and translation) were downregulated. A large fraction of differentially downregulated genes are involved in translation, including those encoding ribosome assembly and initiation and termination factors, which could be analogous to the translation downregulation triggered by stress in other prokaryotes during stringent responses. Additionally, transcriptional upregulation of DNA repair, oxidative stress, and tryptophan salvage genes reveals a possible coordination of responses to multiple antimicrobial and immunological insults. These responses of replicative-phase Chlarnydia to iron starvation indicate a prioritization of survival over replication, enabling the pathogen to "stock the pantry" with ingredients needed for rapid growth once optimal iron levels are restored.
   IMPORTANCE By utilizing an experimental approach that monitors the immediate global response of Chlarnydia trachomatis to iron starvation, clues to long-standing issues in Chlamydia biology are revealed, including how Chlamydia adapts to this stress. We determined that this pathogen initiates a transcriptional program that prioritizes replenishment of nutrient stores over replication, possibly in preparation for rapid growth once optimal iron levels are restored. Transcription of genes for biosynthesis of metabolic precursors was generally upregulated, while those involved in multiple steps of translation were downregulated. We also observed an increase in transcription of genes involved in DNA repair and neutralizing oxidative stress, indicating that Chlamydia employs an "all-or-nothing" strategy. Its small genome limits its ability to tailor a specific response to a particular stress. Therefore, the "all-or nothing" strategy may be the most efficient way of surviving within the host, where the pathogen likely encounters multiple simultaneous immunological and nutritional insults.
C1 [Brinkworth, Amanda J.; Wildung, Mark R.; Carabeo, Rey A.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.
   [Wildung, Mark R.] Washington State Univ, Coll Vet Med, Lab Biotechnol & Bioanal, Pullman, WA 99164 USA.
RP Carabeo, RA (reprint author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.
EM rcarabeo@vetmed.wsu.edu
OI CARABEO, REY/0000-0002-5708-5493; Brinkworth, Amanda/0000-0003-3340-8494
FU School of Molecular Biosciences, College of Veterinary Medicine,
   Washington State University; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [2R01A1065545-06A1]; NIH training grantUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
FX This work was funded by startup funds for R.A.C. from the School of
   Molecular Biosciences, College of Veterinary Medicine, Washington State
   University; by NIH grant 2R01A1065545-06A1 awarded to R.A.C.; and by NIH
   training grant for A.J.B.
CR AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002
   Adams NE, 2014, MBIO, V5, DOI 10.1128/mBio.01378-14
   Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2
   Akers JC, 2006, J BACTERIOL, V188, P4236, DOI 10.1128/JB.01660-05
   Al-Younes HM, 2006, J MED MICROBIOL, V55, P879, DOI 10.1099/jmm.0.46445-0
   Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x
   Amirshahi A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-150
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734
   BEATTY WL, 1995, INFECT IMMUN, V63, P199, DOI 10.1128/IAI.63.1.199-205.1995
   BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998
   Belland RJ, 2003, P NATL ACAD SCI USA, V100, P15971, DOI 10.1073/pnas.2535394100
   Boradia VM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5730
   Braun PR, 2008, J BACTERIOL, V190, P1822, DOI 10.1128/JB.01240-07
   BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209
   Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11
   BYRD TF, 1989, J CLIN INVEST, V83, P1457, DOI 10.1172/JCI114038
   BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986
   Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI 10.1172/JCI200317993
   Carlson JH, 2006, MOL MICROBIOL, V59, P1678, DOI 10.1111/j.1365-2958.2006.05045.x
   CASHEL M, 1969, J BIOL CHEM, V244, P3133
   Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164
   Caza M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00080
   Centers for Disease Control and Prevention (CDC), 2016, SEX TRANSM DIS SURV
   Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088
   de Barsy M, 2016, ISME J, V10, P2129, DOI 10.1038/ismej.2016.23
   Dill BD, 2009, MICROBIOL-SGM, V155, P210, DOI 10.1099/mic.0.022731-0
   Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200
   HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564
   Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028
   Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836
   Jain V, 2006, J MICROBIOL, V44, P1
   Kane CD, 1999, INFECT IMMUN, V67, P1666
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   KARAYIANNIS P, 1981, J CLIN MICROBIOL, V13, P427, DOI 10.1128/JCM.13.3.427-432.1981
   KAZAR J, 1971, INFECT IMMUN, V3, P825, DOI 10.1128/IAI.3.6.825-832.1971
   Kelver ME, 1996, AM J REPROD IMMUNOL, V36, P243
   KIM I, 1993, AM J CLIN NUTR, V58, P705
   Kjaer HO, 2000, SEX TRANSM INFECT, V76, P169
   Klitgaard K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-698
   Kunkle CA, 2003, J BACTERIOL, V185, P6826, DOI 10.1128/JB.185.23.6826-6840.2003
   Larue RW, 2007, INFECT IMMUN, V75, P2374, DOI 10.1128/IAI.01465-06
   Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07
   Lewis ME, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00071
   Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892
   Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459
   Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083
   MATSUMOTO A, 1970, J BACTERIOL, V101, P278, DOI 10.1128/JB.101.1.278-285.1970
   McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138
   Miethke M, 2006, J BACTERIOL, V188, P8655, DOI 10.1128/JB.01049-06
   Miller JD, 2009, MICROBIOL-SGM, V155, P2884, DOI 10.1099/mic.0.030247-0
   Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585
   Mpiga P, 2006, MICROBIOL RES, V161, P9, DOI 10.1016/j.micres.2005.04.004
   Mukhopadhyay S, 2006, INFECT IMMUN, V74, P3853, DOI 10.1128/IAI.02104-05
   Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152
   Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235
   Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617
   Ouellette SP, 2006, MOL MICROBIOL, V62, P1387, DOI 10.1111/j.1365-2958.2006.05465.x
   Ouellette SP, 2016, INFECT IMMUN, V84, P2703, DOI 10.1128/IAI.00377-16
   Ouellette SP, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00112
   Pan X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-64
   Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854
   Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030
   Pokorzynski ND, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00394
   Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x
   Price MJ, 2016, J INFECT DIS, V214, P617, DOI 10.1093/infdis/jiw178
   Raulston JE, 2007, FEMS IMMUNOL MED MIC, V51, P569, DOI 10.1111/j.1574-695X.2007.00336.x
   Raulston JE, 1997, INFECT IMMUN, V65, P4539, DOI 10.1128/IAI.65.11.4539-4547.1997
   Reveneau N, 2005, ANTIMICROB AGENTS CH, V49, P1787, DOI 10.1128/AAC.49.5.1787-1793.2005
   ROSENKRANZ HS, 1973, J BACTERIOL, V115, P682, DOI 10.1128/JB.115.2.682-690.1973
   Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003
   Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949
   Smith R, 2002, NIST CRITICALLY SELE
   Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234
   Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200
   Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754
   Stoner BP, 2015, CLIN INFECT DIS, V61, pS865, DOI 10.1093/cid/civ756
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Taylor Lacey D, 2014, Subcell Biochem, V80, P255, DOI 10.1007/978-94-017-8881-6_13
   Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019
   Thompson CC, 2012, P NATL ACAD SCI USA, V109, P10546, DOI 10.1073/pnas.1201398109
   Thompson CC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00020
   Timms P, 2009, J MICROBIOL IMMUNOL, V42, P27
   Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x
   Vardhan H, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/342032
   Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101
   Wood H, 2003, MOL MICROBIOL, V49, P1347, DOI 10.1046/j.1365-2958.2003.03638.x
   Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394
   Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x
NR 90
TC 7
Z9 7
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD JAN-FEB
PY 2018
VL 3
IS 1
AR e00184-17
DI 10.1128/mSystems.00184-17
PG 22
WC Microbiology
SC Microbiology
GA FX6DS
UT WOS:000426173900008
PM 29468197
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Namakchian, M
   Kassler, K
   Sticht, H
   Hensel, M
   Deiwick, J
AF Namakchian, Mahsa
   Kassler, Kristin
   Sticht, Heinrich
   Hensel, Michael
   Deiwick, Joerg
TI Structure-based functional analysis of effector protein SifA in living
   cells reveals motifs important for Salmonella intracellular
   proliferation
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE Type III secretion system; Effector protein; RhoA interaction;
   Salmonella-induced filaments; Intracellular lifestyle
ID III SECRETION SYSTEM; NUCLEOTIDE EXCHANGE FACTOR; ENDOSOMAL SYSTEM;
   CELLULAR MICROBIOLOGY; BACTERIAL PATHOGENS; EPITHELIAL-CELLS; ENTERICA;
   TYPHIMURIUM; VIRULENCE; VACUOLE
AB The facultative intracellular pathogen Salmonella enterica survives and replicates inside the Salmonella-containing vacuole (SCV) of mammalian host cells. SifA is a key effector protein translocated by a type III secretion system and involved in formation of Salmonella-induced filaments (SIF), extensive tubular endosomal compartments. Recruitment of LAMP1 (lysosomal-associated membrane protein 1)-positive membranes to SIF ensures integrity and dynamics of the membrane network. The binding of SifA to the host protein SKIP (SifA and kinesin interacting protein) was proposed as crucial for this function. Due to structural mimicry SifA has further been proposed to interact with G-proteins. We conducted a mutational study of SifA to identify domains and amino acid residues specifically relevant for intracellular replication and SIF formation. Mutations were designed based on the available structural data of SifA and its interface with SKIP, or modeled for SifA as putative guanine nucleotide exchange factor. We developed a live cell imaging-based approach for volume quantification of the SIF network that allowed determination of subtle changes in SIF network and performed a comprehensive analysis of mutant forms of SifA by this approach. We found that the SifA catalytic loop of WxxxE effectors is as important for SIF formation and intracellular proliferation as the SKIP interaction motif, or the CAAX motif for membrane anchoring of SifA.
C1 [Namakchian, Mahsa; Hensel, Michael; Deiwick, Joerg] Univ Osnabruck, Abt Mikrobiol, Osnabruck, Germany.
   [Kassler, Kristin; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany.
RP Hensel, M; Deiwick, J (reprint author), Univ Osnabruck, Abt Mikrobiol, Fachbereich Biol Chem, Barbarastr 11, D-49076 Osnabruck, Germany.
EM Michael.Hensel@biologie.uni-osnabrueck.de;
   Deiwick@biologie.uni-osnabrueck.de
OI Sticht, Heinrich/0000-0001-5644-045X; Hensel,
   Michael/0000-0001-6604-6253
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [HE1964/18-2, SPP 1580, SFB 944, SFB 796]; Niedersachsisches Ministerium
   fur Wissenschaft and Kultur
FX We are grateful to Monika Nietschke and Ursula Krehe for technical
   support, and Dr. Xu Xin for initial experimental work of this project.
   This work was supported by the Deutsche Forschungsgemeinschaft grant
   HE1964/18-2 within Priority Program SPP 1580 and SFB 944, Z project, and
   the Niedersachsisches Ministerium fur Wissenschaft and Kultur. HS
   acknowledges support by the Deutsche Forschungsgemeinschaft (SFB 796,
   project A2).
CR Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x
   Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235
   Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225
   Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200
   Brown NF, 2006, MICROBIOL-SGM, V152, P2323, DOI 10.1099/mic.0.28995-0
   Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002
   Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329
   Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09
   Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975
   Dumont A, 2010, TRAFFIC, V11, P899, DOI 10.1111/j.1600-0854.2010.01069.x
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544
   Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092
   Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003
   Helaine S, 2013, CURR OPIN MICROBIOL, V16, P184, DOI 10.1016/j.mib.2012.12.004
   Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103
   Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578
   Huang ZW, 2010, VIRULENCE, V1, P93, DOI 10.4161/viru.1.2.10617
   Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647
   Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105
   Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009
   Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077
   Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953
   Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z
   Kuhle V, 2004, TRAFFIC, V5, P356, DOI 10.1111/j.1398-9219.2004.00179.x
   LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420
   Liss V, 2017, CELL HOST MICROBE, V21, P390, DOI 10.1016/j.chom.2017.02.005
   Liss V, 2015, CELL MICROBIOL, V17, P639, DOI 10.1111/cmi.12441
   Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732
   McEwan DG, 2015, CELL HOST MICROBE, V17, P58, DOI 10.1016/j.chom.2014.11.011
   McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037
   Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394
   Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539
   OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333
   Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012
   Orchard RC, 2012, CELL MICROBIOL, V14, P10, DOI 10.1111/j.1462-5822.2011.01703.x
   Popp J, 2015, INFECT IMMUN, V83, P4466, DOI 10.1128/IAI.00624-15
   Rajashekar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115423
   Rajashekar R, 2011, EUR J CELL BIOL, V90, P897, DOI 10.1016/j.ejcb.2011.05.008
   Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x
   Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200
   Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007
   Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501
   Schroeder N, 2011, TRENDS MICROBIOL, V19, P268, DOI 10.1016/j.tim.2011.01.006
   Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593
   Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x
   Vorwerk S, 2015, MOL CELL PROTEOMICS, V14, P81, DOI 10.1074/mcp.M114.041145
   Weber S, 2014, MBIO, V5, DOI 10.1128/mBio.00839-13
   Zhang YY, 2013, NANOSCALE, V5, P9296, DOI 10.1039/c3nr01550e
   Zhao WD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12979
NR 50
TC 1
Z9 2
U1 2
U2 5
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1438-4221
EI 1618-0607
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD JAN
PY 2018
VL 308
IS 1
BP 84
EP 96
DI 10.1016/j.ijmm.2017.09.004
PG 13
WC Microbiology; Virology
SC Microbiology; Virology
GA GB3OZ
UT WOS:000428968600011
PM 28939436
DA 2020-05-07
ER

PT J
AU Pan, W
   Kang, YB
AF Pan, Wei
   Kang, Yongbo
TI Role of the microbiota in cancer growth and necrosis: the challenges and
   opportunities of bacteriotherapy for cancer and its complications
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE cancer; complication; immunotherapy; metabolism; microorganism
ID INTESTINAL INFLAMMATION; GUT MICROBIOTA; PROTEIN AVRA; TUMORIGENESIS;
   METABOLITES; SALMONELLA; OBESITY; IMPACT
AB Possessing a selective growth advantage by influencing proliferation barrier, immune system, metabolism, and cell proliferation and death in tissues, is a critical event in cancer formation, progression, and suppression, indicating that specific microbes and microbiotas may enhance or dwindle cancer susceptibility. A host's microbiota may affect not only immune responses in developing tumor environment by inducing proinflammatory or immunosuppressive events but also response to cancer diagnosis, treatment, and relevant complications. As gifts to both cancer biology and microbiology, increased interrogating technologies have shed light on host-microbiota interactions and their roles in human health and disease. The interacting network of cancer, host, and microbial genotypes is identified in this review to assess how microorganism may play an important role in carcinogenesis, developing novel therapeutic and diagnostic strategies for cancer and its complications. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Pan, Wei] Kunming Univ Sci & Technol, Fac Foreign Languages & Cultures, Kunming, Yunnan, Peoples R China.
   [Kang, Yongbo] Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan, Peoples R China.
   [Kang, Yongbo] Kunming Univ Sci & Technol, Genet & Pharmacogen Lab, Kunming, Yunnan, Peoples R China.
RP Kang, YB (reprint author), Kunming Univ Sci & Technol, Kunming 650500, Yunnan, Peoples R China.
EM 657151276@qq.com
CR Abreu MT, 2014, GASTROENTEROLOGY, V146
   Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051
   Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Faber F, 2014, IMMUNOL LETT, V162, P48, DOI 10.1016/j.imlet.2014.04.014
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Gedye C, 2015, INTERN MED J, V45, P696, DOI 10.1111/imj.12653
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Guerra L, 2011, FEBS J, V278, P4577, DOI 10.1111/j.1742-4658.2011.08125.x
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408
   Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109
   Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20
   Lu R, 2012, AM J PHYSIOL-GASTR L, V303, pG1113, DOI 10.1152/ajpgi.00453.2011
   Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530
   Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14
   Patterson AD, 2014, CELL METAB, V20, P761, DOI 10.1016/j.cmet.2014.07.002
   Rivera-Chavez F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003267
   Roberts AB, 2013, MOL PHARMACOL, V84, P208, DOI 10.1124/mol.113.085852
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI [10.1002/path.5047, 10.1038/nrc3610]
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129
   Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 36
TC 0
Z9 0
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD JAN
PY 2018
VL 29
IS 1
BP 20
EP 23
DI 10.1097/MRM.0000000000000120
PG 4
WC Microbiology
SC Microbiology
GA FR9ZA
UT WOS:000419432200004
DA 2020-05-07
ER

PT J
AU Haenni, M
   Chatre, P
   Dupieux-Chabert, C
   Metayer, V
   Bes, M
   Madec, JY
   Laurent, F
AF Haenni, Marisa
   Chatre, Pierre
   Dupieux-Chabert, Celine
   Metayer, Veronique
   Bes, Michele
   Madec, Jean-Yves
   Laurent, Frederic
TI Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in
   Horses, Cats, and Dogs Over a 5-Year Period in France
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE MRSA; mecA; clone; horses; cats; dogs; veterinary microbiology
ID COMPANION ANIMALS; MRSA; STRAINS; PSEUDINTERMEDIUS; PREVALENCE;
   COMMUNITY; ST398; ASSAY; UK
AB Methicillin-resistant Staphylococcus aureus (MRSA) has been reported as a worldwide pathogen in humans and animals including companion animals, i.e., cats, dogs, and horses. France lacked a comprehensive nationwide study describing the molecular features of MRSA circulating among companion animals over a large period of time. Here is reported the characterization of 130 non-duplicate clinical MRSA isolates collected from those three animal species from 2010 to 2015 through the French national Resapath network. Characterization of isolates was performed using phenotypic (antimicrobial susceptibility tests) and molecular (DNA arrays, spatyping) methods. A horse-specific epidemiology was observed in France with the large dissemination of a unique clone, the CC398 clone harboring a Staphylococcal chromosomal cassette mec (SCCmec) type IV and spa-type t011. It was even the unique clone collected in 2015 whereas the clone CC8 USA500 (SCCmec type IV), classically described in horses, was present until 2014. Contrarily, cats and dogs were mainly infected by human-related MRSA isolates, i.e., clones usually reported in human infections, thus mirroring the human epidemiology in hospitals in France. Isolates belonging to the CC398 clone (SCCmec type IV or V) were also identified in 21.4% of dogs' and 26.5% of cats' MRSA isolates. In order to differentiate human-related from CC398 MRSA, tetracycline-resistance [or tet(M) detection] could be useful since this resistance is scarce in human-related strains but constant in CC398 MRSA isolates. In all, our data give a nationwide epidemiological picture of MRSA in companion animals over a 5-year period in France, adding further epidemiological information on the contribution of those animal species to a major public health issue. Considering the wide dissemination of CC398 MRSA isolates and the fact that 11/64 (17.2%) of them presented the Immune Evasion Cluster which enhances CC398 capacities to colonize humans, a specific attention should be paid in the coming years to determine the risk associated to the transmission in people in frequent contacts with companion animals. Our data also show that the prevalence of MRSA has likely decreased in cats, dogs, and horses between 2012 and 2015 in France. This trend should be monitored in the years to come.
C1 [Haenni, Marisa; Chatre, Pierre; Metayer, Veronique; Madec, Jean-Yves] Claude Bernard Univ Lyon 1, Unite Antibioresistance & Virulence Bacteriennes, French Agcy Food Environm & Occupat Hlth Safety, Lyon, France.
   [Dupieux-Chabert, Celine; Bes, Michele; Laurent, Frederic] Hosp Civils Lyon, French Natl Reference Ctr Staphylococci, Inst Infect Agents, Bacteriol Dept, Lyon, France.
   [Dupieux-Chabert, Celine; Bes, Michele; Laurent, Frederic] Claude Bernard Univ Lyon 1, Ecole Normale Super Lyon, UMR5308, INSERM U1111,CNRS,Int Ctr Infectiol Res, Lyon, France.
   [Laurent, Frederic] Inst Pharmaceut & Biol Sci Lyon, Lyon, France.
RP Haenni, M (reprint author), Claude Bernard Univ Lyon 1, Unite Antibioresistance & Virulence Bacteriennes, French Agcy Food Environm & Occupat Hlth Safety, Lyon, France.
EM marisa.haenni@anses.fr
RI Haenni, Marisa/AAF-5545-2020
OI Dupieux, Celine/0000-0001-7388-4087; laurent,
   frederic/0000-0003-0609-9091
FU French Agency for Food, Environmental and Occupational Health Safety
   (ANSES), Sante Publique France; Institut National de la Sante Et de la
   Recherche Medicale (INSERM)Institut National de la Sante et de la
   Recherche Medicale (Inserm)
FX This work was supported by the French Agency for Food, Environmental and
   Occupational Health Safety (ANSES), Sante Publique France and the
   Institut National de la Sante Et de la Recherche Medicale (INSERM).
CR Abdelbary MMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088083
   Aires-De-Sousa M, 2017, CLIN MICROBIOL INFEC, V23, P373, DOI 10.1016/j.cmi.2016.11.002
   Ballhausen B, 2017, VET MICROBIOL, V200, P39, DOI 10.1016/j.vetmic.2016.05.006
   Bergstrom K, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-11
   Bierowiec K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156052
   Blaiotta G, 2010, J CLIN MICROBIOL, V48, P192, DOI 10.1128/JCM.00542-09
   Couto N, 2016, J ANTIMICROB CHEMOTH, V71, P1479, DOI 10.1093/jac/dkw029
   Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845
   Cuny C, 2016, ONE HEALTH, V2, P11, DOI 10.1016/j.onehlt.2015.11.004
   Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031
   Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8
   Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215
   Guerin F, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-016-0924-z
   Haenni M, 2015, J ANTIMICROB CHEMOTH, V70, P3401, DOI 10.1093/jac/dkv278
   Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P326, DOI 10.1093/jac/dkr499
   Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13
   Hau SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142832
   Koop G, 2016, VET REC, V178, P471, DOI 10.1136/vr.i2531
   Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004
   Larsen J, 2015, EUROSURVEILLANCE, V20, P5, DOI 10.2807/1560-7917.ES.2015.20.37.30021
   Larsen J, 2016, ANTIMICROB AGENTS CH, V60, P4401, DOI 10.1128/AAC.00426-16
   Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476
   Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P330, DOI 10.1093/jac/dkr497
   Maes N, 2002, J CLIN MICROBIOL, V40, P1514, DOI 10.1128/JCM.40.4.1514-1517.2002
   Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936
   Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394
   Mutters NT, 2016, DIAGN MICR INFEC DIS, V86, P417, DOI 10.1016/j.diagmicrobio.2016.08.016
   Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11
   Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645
   Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10
   Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471
   van Balen J, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-31
   Van den Eede A, 2013, VET MICROBIOL, V163, P313, DOI 10.1016/j.vetmic.2012.12.038
   Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021
   van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009
   van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006
   Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656
   Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08
   Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039
   Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481
   Weese JS, 2005, JAVMA-J AM VET MED A, V226, P580, DOI 10.2460/javma.2005.226.580
   Wipf JRK, 2016, SCHWEIZ ARCH TIERH, V158, P443, DOI 10.17236/sat00070
NR 42
TC 8
Z9 8
U1 1
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 13
PY 2017
VL 8
AR 2493
DI 10.3389/fmicb.2017.02493
PG 8
WC Microbiology
SC Microbiology
GA FP7ES
UT WOS:000417791900001
PM 29326664
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Khatami, A
   Khan, F
   Macartney, KK
AF Khatami, Ameneh
   Khan, Fouzia
   Macartney, Kristine K.
TI Enteric Fever in Children in Western Sydney, Australia, 2003-2015
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE enteric fever; typhoid; paratyphoid; Salmonella; children
ID TRAVELERS VISITING FRIENDS; GEOSENTINEL SURVEILLANCE NETWORK;
   TYPHOID-FEVER; RELATIVES ABROAD; UNITED-STATES; RESISTANCE; ILLNESS
AB Background: Enteric fever is a vaccine-preventable disease with cases in Australia predominantly acquired overseas. The aim of this study was to define the burden of enteric fever in children presenting to a pediatric hospital in Western Sydney between 2003 and 2015.
   Methods: Cases between January 2003 and December 2013 were ascertained through medical records using International Classification of Disease-coded discharge diagnoses, cross-referenced with microbiology laboratory data for all isolates of Salmonella enterica serovar typhi and S. enterica serovar paratyphi. Prospective cases from January 2014 to April 2015 were additionally captured through records maintained by the infectious diseases team.
   Results: Seventy-one cases of enteric fever were identified in 12.3 years with an average of 4 cases per year between 2003 and 2008 and 7 cases per year between 2009 and 2014. Two were visitors to Australia, 8 were recent migrants, and 59 were Australian residents returning from overseas travel. Two children had no history of overseas travel. Countries of travel predominantly included the Indian subcontinent (60/69) and Southeast Asia (7/69). Of 30 children with information available on pretravel medical consultation, 1 was offered and received typhoid vaccine. Ninety-four percent of children (67) required admission for 1-28 days (median: 5 days). Three children required readmission, with 1 case of presumed relapse. Ninety percent (64) were diagnosed by blood or stool culture with S. enterica serovar typhi the predominant organism (54/64).
   Conclusions: In Australia, hospitalizations for pediatric enteric fever appear to be increasing; predominantly occurring in Australian-resident children. Greater awareness and education are required for parents and clinicians regarding travel health risks and prevention strategies.
C1 [Khatami, Ameneh; Macartney, Kristine K.] Childrens Hosp Westmead, Dept Infect Dis & Microbiol, Sydney, NSW, Australia.
   [Khatami, Ameneh; Macartney, Kristine K.] Univ Sydney, Div Child & Adolescent Hlth, Sydney, NSW, Australia.
   [Khan, Fouzia] Childrens Hosp Westmead, Dept Gen Med, Sydney, NSW, Australia.
   [Macartney, Kristine K.] Natl Ctr Immunisat Res & Surveillance, Sydney, NSW, Australia.
   [Khatami, Ameneh] NYU, Langone Med Ctr, Dept Pediat Infect Dis, Med Sci Bldg,Level 2,550 First Ave, New York, NY 10003 USA.
RP Khatami, A (reprint author), NYU, Langone Med Ctr, Dept Pediat Infect Dis, Lab 223, Med Sci Bldg,Level 2,550 First Ave, New York, NY 10003 USA.
EM ameneh.khatami@gmail.com
CR Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013
   [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49
   Australian Bureau of Statistics, 2016, MIGR AUSTR 2014
   Australian Bureau of Statistics, AUSTR DEM STAT
   Australian Technical Advisory Group on Immunisation, 2015, AUSTR IMM HDB
   Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856
   Bell SM, 2014, ANTIBIOTIC SUSCEPTIB
   Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUSC
   Commons RJ, 2012, MED J AUSTRALIA, V196, P332, DOI 10.5694/mja12.10082
   Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
   Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541
   Department of Health, NAT NOT DIS SURV SYS
   Effa EE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006083.pub2
   Gunaratnam Praveena, 2014, N S W Public Health Bull, V24, P171, DOI 10.1071/NB13005
   Gunaratnam Praveena, 2013, N S W Public Health Bull, V24, P87, DOI 10.1071/NB12125
   Gupta SK, 2008, CLIN INFECT DIS, V46, P1656, DOI 10.1086/587894
   Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111
   Hagmann S, 2010, PEDIATRICS, V125, pE1072, DOI 10.1542/peds.2009-1951
   Hagmann S, 2009, J TRAVEL MED, V16, P407, DOI 10.1111/j.1708-8305.2009.00357.x
   Han P, 2012, PEDIATR INFECT DIS J, V31, P915, DOI 10.1097/INF.0b013e318259efbe
   Hendel-Paterson B, 2011, TRAVEL MED INFECT DI, V9, P192, DOI 10.1016/j.tmaid.2010.09.007
   Hume S, 2009, EUR J CLIN MICROBIOL, V28, P963, DOI 10.1007/s10096-009-0732-6
   Humphries RM, 2012, CLIN INFECT DIS, V55, P1107, DOI 10.1093/cid/cis600
   Lane RJ, 2015, INTERN MED J, V45, P148, DOI 10.1111/imj.12644
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701
   Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229
   Mahon BE, 2014, VACCINE, V32, P3577, DOI 10.1016/j.vaccine.2014.04.055
   Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201
   Parry CM, 2004, T ROY SOC TROP MED H, V98, P413, DOI 10.1016/j.trstmh.2003.10.014
   Steinberg EB, 2004, CLIN INFECT DIS, V39, P186, DOI 10.1086/421945
   Van Herck K, 2004, J TRAVEL MED, V11, P3, DOI 10.2310/7060.2004.13609
   Western Sydney Regional Organisation of Councils, 2011, COMM PROF GREAT W SY
   World Tourism Organization, 2016, AUSTR COUNTR SPEC BA
   World Tourism Organization, 2016, UNTWO TOUR HIGHL 201
NR 35
TC 4
Z9 4
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD DEC
PY 2017
VL 36
IS 12
BP 1124
EP 1128
DI 10.1097/INF.0000000000001606
PG 5
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA FN8BW
UT WOS:000416244700020
PM 28445250
DA 2020-05-07
ER

PT J
AU Santos-Beneit, F
   Gu, JY
   Stimming, U
   Errington, J
AF Santos-Beneit, Fernando
   Gu, Jing-Ying
   Stimming, Ulrich
   Errington, Jeff
TI ylmD and ylmE genes are dispensable for growth, cross-wall formation and
   sporulation in Streptomyces venezuelae
SO HELIYON
LA English
DT Article
DE Microbiology; Cell biology
ID ESCHERICHIA-COLI; REGULATORS; DIVIVA
AB Streptomycetes are Gram-positive filamentous soil bacteria that grow by tip extension and branching, forming a network of multinucleoid hyphae. These bacteria also have an elaborate process of morphological differentiation, which involves the formation of an aerial mycelium that eventually undergoes extensive septation into chains of uninucleoid cells that further metamorphose into spores. The tubulin-like FtsZ protein is essential for this septation process. Most of the conserved cell division genes (including ftsZ) have been inactivated in Streptomyces without the anticipated lethality, based on studies of many other bacteria. However, there are still some genes of the Streptomyces division and cell wall (dcw) cluster that remain uncharacterized, the most notable example being the two conserved genes immediately adjacent to ftsZ (i.e. ylmDE). Here, for the first time, we made a ylmDE mutant in Streptomyces venezuelae and analysed it using epifluorescence microscopy, scanning electron microscopy (SEM) and atomic force microscopy (AFM). The mutant showed no significant effects on growth, cross-wall formation and sporulation in comparison to the wild type strain, which suggests that the ylmDE genes do not have an essential role in the Streptomyces cell division cycle (at least under the conditions of this study).
C1 [Santos-Beneit, Fernando; Errington, Jeff] Newcastle Univ, Med Sch, Ctr Bacterial Cell Biol, Newcastle Upon Tyne, Tyne & Wear, England.
   [Gu, Jing-Ying; Stimming, Ulrich] Newcastle Univ, Sch Chem, Newcastle Upon Tyne, Tyne & Wear, England.
RP Santos-Beneit, F (reprint author), Newcastle Univ, Med Sch, Ctr Bacterial Cell Biol, Newcastle Upon Tyne, Tyne & Wear, England.
EM fernando.santos-beneit@ncl.ac.uk
RI Errington, Jeff/G-1832-2011; Santos-Beneit, Fernando/B-4678-2019
OI Errington, Jeff/0000-0002-6977-9388; 
FU Wellcome TrustWellcome Trust [098374]
FX This work was supported by grant 098374 from the Wellcome Trust to JE.
CR Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198
   Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x
   Bush MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00684-13
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Eland LE, 2016, METHOD MICROBIOL, V43, P69, DOI 10.1016/bs.mim.2016.10.002
   Fadda D, 2003, J BACTERIOL, V185, P6209, DOI 10.1128/JB.185.20.6209-6214.2003
   Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x
   Flardh K, 2000, MOL MICROBIOL, V38, P737, DOI 10.1046/j.1365-2958.2000.02177.x
   Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   HIGGENS CE, 1974, J ANTIBIOT, V27, P298, DOI 10.7164/antibiotics.27.298
   MACNEIL DJ, 1992, GENE, V115, P119, DOI 10.1016/0378-1119(92)90549-5
   Marbouty M, 2009, MOL MICROBIOL, V74, P409, DOI 10.1111/j.1365-2958.2009.06873.x
   McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x
   MCCORMICK JR, 1994, MOL MICROBIOL, V14, P243, DOI 10.1111/j.1365-2958.1994.tb01285.x
   Santos-Beneit F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01596-z
   Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x
   Schlimpert S, 2016, JOVE-J VIS EXP, DOI 10.3791/53863
NR 18
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD NOV
PY 2017
VL 3
IS 11
AR e00459
DI 10.1016/j.heliyon.2017.e00459
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF5SM
UT WOS:000432028000016
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Baker, KS
   Campos, J
   Pichel, M
   Della Gaspera, A
   Duarte-Martinez, F
   Campos-Chacon, E
   Bolanos-Acuna, HM
   Guzman-Verri, C
   Mather, AE
   Velasco, SD
   Rojas, MLZ
   Forbester, JL
   Connor, TR
   Keddy, KH
   Smith, AM
   de Delgado, EAL
   Angiolillo, G
   Cuaical, N
   Fernandez, J
   Aguayo, C
   Aguilar, MM
   Valenzuela, C
   Medrano, AJM
   Sirok, A
   Gustafson, NW
   Guevara, PLD
   Montano, LA
   Perez, E
   Thomson, NR
AF Baker, K. S.
   Campos, J.
   Pichel, M.
   Della Gaspera, A.
   Duarte-Martinez, F.
   Campos-Chacon, E.
   Bolanos-Acuna, H. M.
   Guzman-Verri, C.
   Mather, A. E.
   Diaz Velasco, S.
   Zamudio Rojas, M. L.
   Forbester, J. L.
   Connor, T. R.
   Keddy, K. H.
   Smith, A. M.
   Lopez de Delgado, E. A.
   Angiolillo, G.
   Cuaical, N.
   Fernandez, J.
   Aguayo, C.
   Morales Aguilar, M.
   Valenzuela, C.
   Morales Medrano, A. J.
   Sirok, A.
   Weiler Gustafson, N.
   Diaz Guevara, P. L.
   Montano, L. A.
   Perez, E.
   Thomson, N. R.
TI Whole genome sequencing of Shigella sonnei through PulseNet Latin
   America and Caribbean: advancing global surveillance of foodborne
   illnesses
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Shigellosis; Antimicrobial resistance; Diarrhoeal disease; Epidemiology;
   South America; Central America; Genomics
ID PREDICTS ANTIMICROBIAL RESISTANCE; COMMUNITY; CHILDREN; DIARRHEA;
   DISSEMINATION; TRANSMISSION; COUNTRIES
AB Objectives: Shigella sonnei is a globally important diarrhoeal pathogen tracked through the surveillance network PulseNet Latin America and Caribbean (PNLA&C), which participates in PulseNet International. PNLA&C laboratories use common molecular techniques to track pathogens causing foodborne illness. We aimed to demonstrate the possibility and advantages of transitioning to whole genome sequencing (WGS) for surveillance within existing networks across a continent where S. sonnei is endemic.
   Methods: We applied WGS to representative archive isolates of S. sonnei (n - 323) from laboratories in nine PNLA&C countries to generate a regional phylogenomic reference for S. sonnei and put this in the global context. We used this reference to contextualise 16 S. sonnei from three Argentinian outbreaks, using locally generated sequence data. Assembled genome sequences were used to predict antimicrobial resistance (AMR) phenotypes and identify AMR determinants.
   Results: S. sonnei isolates clustered in five Latin American sublineages in the global phylogeny, with many (46%, 149 of 323) belonging to previously undescribed sublineages. Predicted multidrug resistance was common (77%, 249 of 323), and clinically relevant differences in AMR were found among sublineages. The regional overview showed that Argentinian outbreak isolates belonged to distinct sublineages and had different epidemiologic origins.
   Conclusions: Latin America contains novel genetic diversity of S. sonnei that is relevant on a global scale and commonly exhibits multidrug resistance. Retrospective passive surveillance with WGS has utility for informing treatment, identifying regionally epidemic sublineages and providing a framework for interpretation of prospective, locally sequenced outbreaks. Crown Copyright (C) 2017 Published by Elsevier on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Baker, K. S.] Univ Liverpool, Dept Funct & Comparat Genom, Liverpool, Merseyside, England.
   [Baker, K. S.; Mather, A. E.; Forbester, J. L.; Thomson, N. R.] Wellcome Trust Sanger Inst, Pathogen Variat Programme, Hinxton CB10 1SA, England.
   [Campos, J.; Pichel, M.; Della Gaspera, A.] ANLIS, Inst Nacl Enfermedades Infecciosas, Buenos Aires, DF, Argentina.
   [Duarte-Martinez, F.; Campos-Chacon, E.; Bolanos-Acuna, H. M.] Inst Costarricense Invest & Ensenanza Nutr & Salu, Cartago, Costa Rica.
   [Guzman-Verri, C.] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica.
   [Guzman-Verri, C.] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica.
   [Mather, A. E.] Univ Cambridge, Dept Vet Med, Cambridge, England.
   [Diaz Velasco, S.; Zamudio Rojas, M. L.] Natl Inst Heath, Lima, Peru.
   [Connor, T. R.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg, Cardiff, S Glam, Wales.
   [Keddy, K. H.; Smith, A. M.] Univ Witwatersrand, Natl Inst Communicable Dis, Ctr Enter Dis, Johannesburg, South Africa.
   [Keddy, K. H.; Smith, A. M.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.
   [Lopez de Delgado, E. A.; Angiolillo, G.; Cuaical, N.] Natl Inst Hyg Rafael Rangel, Dept Bacteriol, Ciudad Univ, Los Chaguaramos, Venezuela.
   [Fernandez, J.; Aguayo, C.] Inst Publ Hlth Chile, Mol Genet Lab, Santiago, Chile.
   [Morales Aguilar, M.; Valenzuela, C.; Morales Medrano, A. J.] Natl Hlth Lab Guatemala, Dept Foodborne Dis, Lab Nacl Salud, Barcenas, Guatemala.
   [Sirok, A.] Minist Salud Publ, Dept Lab Salud Publ, Bacteriol Lab, Montevideo, Uruguay.
   [Weiler Gustafson, N.] Lab Cent Salud Publ, Dept Bacteriol, Asuncion, Paraguay.
   [Diaz Guevara, P. L.; Montano, L. A.] Inst Nacl Salud, Grp Microbiol, Bogota, Colombia.
   [Perez, E.] WHO, Pan Amer Hlth Org, Dept Hlth Emergencies, Washington, DC USA.
   [Thomson, N. R.] London Sch Hyg & Trop Med, London, England.
RP Thomson, NR (reprint author), Wellcome Trust Sanger Inst, Pathogen Variat Programme, Hinxton CB10 1SA, England.; Baker, KS (reprint author), Univ Liverpool, Dept Funct & Comparat Genom, Liverpool L69 7ZB, Merseyside, England.
EM kbaker@liverpool.ac.uk; nrt@sanger.ac.uk
RI Thomson, Nicholas R/P-5988-2014; Baker, Kate/P-2087-2016
OI Thomson, Nicholas R/0000-0002-4432-8505; Campos,
   Josefina/0000-0003-1409-0441; Baker, Kate/0000-0001-5850-1949;
   Guzman-Verri, Caterina/0000-0003-1036-920X; Connor,
   Thomas/0000-0003-2394-6504
FU Wellcome TrustWellcome Trust [098051]; Biotechnology and Biological
   Sciences Research CouncilBiotechnology and Biological Sciences Research
   Council (BBSRC) [BB/M014088/1]; Biotechnology and Biological Sciences
   Research CouncilBiotechnology and Biological Sciences Research Council
   (BBSRC); Wellcome TrustWellcome Trust
FX Supported in part by the Wellcome Trust (grant 098051). AEM is supported
   by Biotechnology and Biological Sciences Research Council grant
   BB/M014088/1. KSB is a Wellcome Trust Clinical Research Fellow
   (106690/A/14/Z). AEM reports grants from Biotechnology and Biological
   Sciences Research Council during the conduct of study. KSB reports
   grants from the Wellcome Trust during the conduct of study. All other
   authors report no conflicts of interest relevant to this article.
CR Achi R, 1996, J INFECTION, V32, P211, DOI 10.1016/S0163-4453(96)80021-1
   Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093
   Azmi IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102533
   Baker KS, 2016, EMERG INFECT DIS, V22, P1545, DOI [10.3201/eid2209.151953, 10.3201/eid2209.1511953]
   Baker KS, 2015, LANCET INFECT DIS, V15, P913, DOI 10.1016/S1473-3099(15)00002-X
   Sousa MAB, 2013, MEM I OSWALDO CRUZ, V108, P30, DOI 10.1590/S0074-02762013000100005
   Campos J, 2012, FOOD RES INT, V45, P1030, DOI 10.1016/j.foodres.2011.10.020
   Connor TR, 2015, ELIFE, V4, DOI 10.7554/eLife.07335
   Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196
   Dallman TJ, 2016, J MED MICROBIOL, V65, P882, DOI 10.1099/jmm.0.000296
   Deng XY, 2016, ANNU REV FOOD SCI T, V7, P353, DOI 10.1146/annurev-food-041715-033259
   Fulla N, 2005, AM J TROP MED HYG, V72, P851, DOI 10.4269/ajtmh.2005.72.851
   The HC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002055
   Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110
   Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369
   Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
   Miranda A, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00077
   Njamkepo E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.27, 10.1038/nmicrobiol.2016.27]
   Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000083
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5
   Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P36, DOI 10.1089/fpd.2006.3.36
   Thompson CN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003708
   Tyson GH, 2015, J ANTIMICROB CHEMOTH, V70, P2763, DOI 10.1093/jac/dkv186
   Woodward D L, 2000, Can J Infect Dis, V11, P181
   World Health Organization, 2015, WHO EST GLOB BURD FO
   Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
   Zhao S, 2016, APPL ENVIRON MICROB, V82, P459, DOI 10.1128/AEM.02873-15
NR 32
TC 10
Z9 11
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD NOV
PY 2017
VL 23
IS 11
BP 845
EP 853
DI 10.1016/j.cmi.2017.03.021
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FK8EC
UT WOS:000413739600014
PM 28389276
OA Green Accepted, Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Hensel, Z
AF Hensel, Zach
TI A plasmid-based Escherichia coli gene expression system with
   cell-to-cell variation below the extrinsic noise limit
SO PLOS ONE
LA English
DT Article
ID PROPAGATION; CONSTRUCTION; SIMULATION; MOLECULES; NETWORKS; BINDING;
   DESIGN; IMAGE
AB Experiments in synthetic biology and microbiology can benefit from protein expression systems with low cell(to(cell variability (noise) and expression levels precisely tunable across a useful dynamic range. Despite advances in understanding the molecular biology of microbial gene regulation, many experiments employ protein(expression systems exhibiting high noise and nearly all(or(none responses to induction. I present an expression system that incorporates elements known to reduce gene expression noise: negative autoregulation and bicistronic transcription. I show by stochastic simulation that while negative autoregulation can produce a more gradual response to induction, bicistronic expression of a repressor and gene of interest can be necessary to reduce noise below the extrinsic limit. I synthesized a plasmid(based system incorporating these principles and studied its properties in Escherichia coli cells, using flow cytometry and fluorescence microscopy to characterize induction dose(response, induction/repression kinetics and gene expression noise. By varying ribosome binding site strengths, expression levels from 55-10,740 molecules/cell were achieved with noise below the extrinsic limit. Individual strains are inducible across a dynamic range greater than 20(fold. Experimental comparison of different regulatory networks confirmed that bicistronic autoregulation reduces noise, and revealed unexpectedly high noise for a conventional expression system with a constitutively expressed transcriptional repressor. I suggest a hybrid, low(noise expression system to increase the dynamic range.
C1 [Hensel, Zach] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.
   [Hensel, Zach] Okinawa Inst Sci & Technol, Deans Res Unit, Okinawa, Japan.
RP Hensel, Z (reprint author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.; Hensel, Z (reprint author), Okinawa Inst Sci & Technol, Deans Res Unit, Okinawa, Japan.
EM zach.hensel@itqb.unl.pt
RI Hensel, Zach/G-2941-2015
OI Hensel, Zach/0000-0002-4348-6229
FU Microbiologia Molecular, Estrutural e Celular
   [LISBOA-01-0145-FEDER-007660]; national funds through FCT - Fundacao
   para a Ciencia e a Tecnologia; Research Unit at the Okinawa Institute of
   Science and Technology (OIST); FEDER funds through COMPETE - Programa
   Operacional Competitividade e Internacionalizacao (POCI)
FX This work was financially supported by: Project
   LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e
   Celular) funded by FEDER funds through COMPETE2020 - Programa
   Operacional Competitividade e Internacionalizacao (POCI), by national
   funds through FCT - Fundacao para a Ciencia e a Tecnologia, and by the
   Dean's Research Unit at the Okinawa Institute of Science and Technology
   (OIST). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; This
   work was financially supported by: Project LISBOA-01-0145-FEDER-007660
   (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds
   through COMPETE2020-Programa Operacional Competitividade e
   Internacionalizacao (POCI), by national funds through FCT-Fundacao para
   a Ciencia e a Tecnologia, and by the Dean's Research Unit at the Okinawa
   Institute of Science and Technology (GIST). Experiments were done at
   GIST; data analysis, simulations, additional experiments and paper
   writing were done at the Instituto de Tecnologia Quimica e Biologica
   Antonio Xavier. I thank Dr. Eder Zavala (University of Exeter) for his
   insightful comments on the manuscript.
CR Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194
   Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651
   Binder D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160711
   CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978
   Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0
   Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810
   Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Gillespie DT, 1996, PHYS REV E, V54, P2084, DOI 10.1103/PhysRevE.54.2084
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x
   Hensel Z, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001591
   Hensel Z, 2012, NAT STRUCT MOL BIOL, V19, P797, DOI 10.1038/nsmb.2336
   Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927
   Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102
   Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800
   Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191
   Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765
   Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e
   Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171
   Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203
   Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106
   Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202
   Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257
   Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090
   POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849
   Ray JCJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002672
   Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172
   Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31
   Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881
   Sneppen K, 2010, MBIO, V1, DOI 10.1128/mBio.00177-10
   Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
NR 36
TC 2
Z9 2
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 30
PY 2017
VL 12
IS 10
AR e0187259
DI 10.1371/journal.pone.0187259
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL0OH
UT WOS:000413910200043
PM 29084263
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU de Vos, MGJ
   Zagorski, M
   McNally, A
   Bollenbach, T
AF de Vos, Marjon G. J.
   Zagorski, Marcin
   McNally, Alan
   Bollenbach, Tobias
TI Interaction networks, ecological stability, and collective antibiotic
   tolerance in polymicrobial infections
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE microbiology; systems biology; antibiotics; infection
ID URINARY-TRACT-INFECTIONS; ESCHERICHIA-COLI; BACTERIAL COMMUNITY;
   HUMAN-DISEASE; MECHANISMS; COMPETITION; RESISTANCE; MICROBIOME;
   DIVERSITY; DYNAMICS
AB Polymicrobial infections constitute small ecosystems that accommodate several bacterial species. Commonly, these bacteria are investigated in isolation. However, it is unknown to what extent the isolates interact and whether their interactions alter bacterial growth and ecosystem resilience in the presence and absence of antibiotics. We quantified the complete ecological interaction network for 72 bacterial isolates collected from 23 individuals diagnosed with polymicrobial urinary tract infections and found that most interactions cluster based on evolutionary relatedness. Statistical network analysis revealed that competitive and cooperative reciprocal interactions are enriched in the global network, while cooperative interactions are depleted in the individual host community networks. A population dynamics model parameterized by our measurements suggests that interactions restrict community stability, explaining the observed species diversity of these communities. We further show that the clinical isolates frequently protect each other from clinically relevant antibiotics. Together, these results highlight that ecological interactions are crucial for the growth and survival of bacteria in polymicrobial infection communities and affect their assembly and resilience.
C1 [de Vos, Marjon G. J.] Wageningen Univ, Lab Genet, NL-6708 PB Wageningen, Netherlands.
   [de Vos, Marjon G. J.; Zagorski, Marcin; Bollenbach, Tobias] IST Austria, A-3400 Klosterneuburg, Austria.
   [McNally, Alan] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
   [Bollenbach, Tobias] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany.
RP Bollenbach, T (reprint author), IST Austria, A-3400 Klosterneuburg, Austria.; Bollenbach, T (reprint author), Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany.
EM t.bollenbach@uni-koeln.de
RI Bollenbach, Tobias/AAK-3206-2020
OI Bollenbach, Tobias/0000-0003-4398-476X; McNally,
   Alan/0000-0002-3099-630X; Zagorski, Marcin/0000-0001-7896-7762; de Vos,
   Marjon GJ/0000-0003-0601-908X
FU Marie Curie Career Integration GrantEuropean Union (EU) [303507];
   Austrian Science FundAustrian Science Fund (FWF) [P 27201-B22]; Human
   Frontier Science ProgramHuman Frontier Science Program [RGP0042/2013];
   Netherlands Organization for Scientific Research (Now) Earth and Life
   Sciences (ALW) VENI [863.14.015]
FX We thank Otto Cordero, Kevin Foster, Eric Kelsic, Marta Lukacisinova,
   and Martin Lukacisin for critical comments on the manuscript, and the
   T.B. group and the Genetics group for fruitful discussions. This work
   was supported in part by Marie Curie Career Integration Grant 303507,
   Austrian Science Fund Standalone Grant P 27201-B22, Human Frontier
   Science Program Grant RGP0042/2013, and Netherlands Organization for
   Scientific Research (Now) Earth and Life Sciences (ALW) VENI Project
   863.14.015.
CR Abrudan MI, 2015, P NATL ACAD SCI USA, V112, P11054, DOI 10.1073/pnas.1504076112
   Aguirre-von-Wobeser E, 2014, ENVIRON MICROBIOL, V16, P1366, DOI 10.1111/1462-2920.12305
   Alteri CJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004601
   Andersen SB, 2015, P NATL ACAD SCI USA, V112, P10756, DOI 10.1073/pnas.1508324112
   ARNDT WF, 1961, P SOC EXP BIOL MED, V108, P166, DOI 10.3181/00379727-108-26881
   Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076
   Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x
   Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10
   Boscia J A, 1987, Infect Dis Clin North Am, V1, P893
   Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076
   Brogden KA, 2004, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027
   Burns JH, 2011, P NATL ACAD SCI USA, V108, P5302, DOI 10.1073/pnas.1013003108
   Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753
   Chen SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005497
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486
   Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602
   Croxall G, 2011, J MED MICROBIOL, V60, P102, DOI 10.1099/jmm.0.020602-0
   Czaran T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006655
   Darwin C., 1859, ORIGINS SPECIES MEAN
   Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432
   Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005
   Fourcade C, 2015, EUR J CLIN MICROBIOL, V34, P1667, DOI 10.1007/s10096-015-2403-0
   FREDRICKSON AG, 1981, SCIENCE, V213, P972, DOI 10.1126/science.7268409
   FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983
   GLECKMAN R, 1981, PHARMACOTHERAPY, V1, P14
   Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113
   GORDON DM, 1992, MOL MICROBIOL, V6, P555, DOI 10.1111/j.1365-2958.1992.tb01500.x
   Guo XK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005079
   Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259
   HITCHINGS GH, 1973, J INFECT DIS, V128, pS433, DOI 10.1093/infdis/128.Supplement_3.S433
   Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258
   Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485
   Khanum N, 2012, ASIAN J CHEM, V24, P1851
   Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105
   Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011
   Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524
   Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354
   Lemonnier M, 2008, P R SOC B, V275, P3, DOI 10.1098/rspb.2007.1234
   Logan M, 2017, BIORXIV
   Macleod SM, 2007, J MED MICROBIOL, V56, P1549, DOI 10.1099/jmm.0.47395-0
   Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016
   Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803
   MAY RM, 1973, STABILITY COMPLEXITY
   MCOSKER CC, 1994, J ANTIMICROB CHEMOTH, V33, P23, DOI 10.1093/jac/33.suppl_A.23
   Meredith HR, 2015, NAT CHEM BIOL, V11, P182, DOI 10.1038/nchembio.1754
   Merton Boothe D, 2015, NITROFURANS
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209, DOI 10.1016/S0040-1625(99)00022-0
   Momeni B, 2017, ELIFE, V6, DOI 10.7554/eLife.25051
   Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101
   Perez-Gutierrez RA, 2013, ISME J, V7, P487, DOI 10.1038/ismej.2012.119
   Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11
   Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764
   Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9
   Schmiemann G, 2010, DTSCH ARZTEBL INT, V107, P361, DOI 10.3238/arztebl.2010.0361
   Short FL, 2014, TRENDS MICROBIOL, V22, P508, DOI 10.1016/j.tim.2014.05.007
   Stacy A, 2016, NAT REV MICROBIOL, V14, P93, DOI 10.1038/nrmicro.2015.8
   Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2
   Vega NM, 2014, CURR OPIN MICROBIOL, V21, P28, DOI 10.1016/j.mib.2014.09.003
   Vega NM, 2013, P NATL ACAD SCI USA, V110, P14420, DOI 10.1073/pnas.1308085110
   Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184
   Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45
   Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66
   Yurtsev EA, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.39
   Yurtsev EA, 2016, P NATL ACAD SCI USA, V113, P6236, DOI 10.1073/pnas.1523317113
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
NR 68
TC 28
Z9 28
U1 3
U2 58
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 3
PY 2017
VL 114
IS 40
BP 10666
EP 10671
DI 10.1073/pnas.1713372114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI6TX
UT WOS:000412130500061
PM 28923953
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Rodriguez-Dominguez, M
   Gonzalez-Alba, JM
   Puerta, T
   Martinez-Garcia, L
   Menendez, B
   Canton, R
   del Romero, J
   Galan, JC
AF Rodriguez-Dominguez, M.
   Gonzalez-Alba, J. M.
   Puerta, T.
   Martinez-Garcia, L.
   Menendez, B.
   Canton, R.
   del Romero, J.
   Galan, J. C.
TI Spread of a new Chlamydia trachomatis variant from men who have sex with
   men to the heterosexual population after replacement and recombination
   in ompA and pmpH genes
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Chlamydia trachomatis; Molecular epidemiology; OmpA; Recombination;
   Spread
ID EVOLUTION; STRAINS; GENOTYPES
AB Objectives: Sexually transmitted infections are frequently related to outbreaks in high-risk populations due to the dense sexual networks. We wanted to determine the dissemination of a Chlamydia trachomatis variant characterized by the pmpH-recombinant gene between L and G genotypes, which was previously described in a high-risk population.
   Methods: A total of 449 samples were analysed in two periods ranging from 2009 to 2015 for detection of the pmpH-recombinant gene. For those samples yielding positive amplification, a sampling was selected for phylogenetic reconstructions based on sequencing of five chromosomal genes.
   Results: Globally this variant was found in 113 of the 449 samples (25%). During the first years (2009-13), this variant was found almost exclusively in rectal samples (30/112 samples) of men who have sex with men and in only one non-rectal sample (1/63). In 2014, this variant was also found in urethral and pharyngeal samples (1/24 and 1/7, respectively). However, in 2015, an epidemiological change was observed as the proportion of this variant had increased in rectal samples (20/51; 39%) and non-rectal samples, including cervical samples (51/142; 36.4%). The molecular characterization revealed the replacement of the ompA gene belonging to subtype G in samples recovered from 2009 to 2013 by the ompA gene belonging to subtype J after 2013.
   Conclusions: Our data would support the evidence that subtype J could be a 'subtype bridge' between different sexual networks, as subtype J has been found in men who have sex with men and heterosexual populations in similar proportions. This work reveals the necessity of implementing molecular surveillance in extra-rectal samples to help us understand the gaps in transmission. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Rodriguez-Dominguez, M.; Gonzalez-Alba, J. M.; Martinez-Garcia, L.; Canton, R.; Galan, J. C.] Hosp Univ Ramon & Cajal, Serv Microbiol, Carretera Colmenar,Km 9-1, Madrid 28034, Spain.
   [Rodriguez-Dominguez, M.; Gonzalez-Alba, J. M.; Martinez-Garcia, L.; Canton, R.; Galan, J. C.] Inst Ramon & Cajal Invest Sanitaria, Madrid, Spain.
   [Rodriguez-Dominguez, M.; Gonzalez-Alba, J. M.; Galan, J. C.] CIBER Epidemiol & Salud Publ, Madrid, Spain.
   [Puerta, T.; Menendez, B.; del Romero, J.] Ctr Sanitario Sandoval, Madrid, Spain.
   [Puerta, T.; Menendez, B.; del Romero, J.] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain.
   [Martinez-Garcia, L.; Canton, R.] Red Espanola Invest Patol Infecciosa, Madrid, Spain.
   [Menendez, B.] Ctr Sandoval, Lab Microbiol, Madrid, Spain.
   [Galan, J. C.] Unidad Resistencia Antibiot & Virulencia Bacteria, Madrid, Spain.
RP Galan, JC (reprint author), Hosp Univ Ramon & Cajal, Serv Microbiol, Carretera Colmenar,Km 9-1, Madrid 28034, Spain.
EM juancarlos.galan@salud.madrid.org
FU Instituto de Salud Carlos III (Plan Estatal de I+D+i) [PI16-01242];
   CIBER [CB06/02/0053]; European Development Regional Fund
FX This study was supported by the Instituto de Salud Carlos III (Plan
   Estatal de I+D+i 2013-2016), Grant PI16-01242 and CIBER (CB06/02/0053)
   actions, and co-financed by the European Development Regional Fund 'A
   way to achieve Europe'. This project was also included within the
   Subprograma de Inmigracion y Salud belonging to the DAPET programme into
   CIBERESP (Biomedical Research in Network in Epidemiology and Public
   Health). We thank Mary Harper for corrections to the English.
CR Batteiger BE, 2014, EMERG INFECT DIS, V20, P1841, DOI 10.3201/2011.140604
   Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869
   Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS SURV
   Clarke IN, 2011, ANN NY ACAD SCI, V1230, pE11, DOI 10.1111/j.1749-6632.2011.06194.x
   European Centre for Disease Prevention and Control, 2015, SEX TRANSM INF EUR 2
   Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706
   Gravningen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034452
   Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214
   Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15
   Hooppaw AJ, 2016, INFECT IMMUN, V84, P612, DOI 10.1128/IAI.01186-15
   Jeffrey BM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-142
   Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09
   Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198
   Korhonen S, 2012, SEX TRANSM INFECT, V88, P465, DOI 10.1136/sextrans-2011-050458
   Labiran C, 2016, SEX TRANSM INFECT, V92, P299, DOI 10.1136/sextrans-2015-052261
   Maticic M, 2015, EURO SURVEILL, V21
   Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029
   Qin XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159658
   Rodriguez-Dominguez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126145
   Seth-Smith HMB, 2013, CURR OPIN INFECT DIS, V26, P90, DOI 10.1097/QCO.0b013e32835c2159
   Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11
   Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11
   van Rooijen MS, 2015, SEX TRANSM INFECT, V91, P157, DOI 10.1136/sextrans-2014-051633
NR 23
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2017
VL 23
IS 10
BP 761
EP 766
DI 10.1016/j.cmi.2017.03.009
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FI3OF
UT WOS:000411873200016
PM 28323193
OA Bronze
DA 2020-05-07
ER

PT J
AU Saeed, DK
   Hasan, R
   Naim, M
   Zafar, A
   Khan, E
   Jabeen, K
   Irfan, S
   Ahmed, I
   Zeeshan, M
   Wajidali, Z
   Farooqi, J
   Shakoor, S
   Chagla, A
   Rao, J
AF Saeed, Dania Khalid
   Hasan, Rumina
   Naim, Mahwish
   Zafar, Afia
   Khan, Erum
   Jabeen, Kausar
   Irfan, Seema
   Ahmed, Imran
   Zeeshan, Mohammad
   Wajidali, Zabin
   Farooqi, Joveria
   Shakoor, Sadia
   Chagla, Abdul
   Rao, Jason
TI Readiness for antimicrobial resistance (AMR) surveillance in Pakistan; a
   model for laboratory strengthening
SO ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
LA English
DT Article
DE Antimicrobial susceptibility testing; Laboratory capacity; Surveillance
   for antimicrobial resistance
ID PROFICIENCY TESTING PROGRAM
AB Background: Limited capacity of laboratories for antimicrobial susceptibility testing (AST) presents a critical diagnostic bottleneck in resource limited countries. This paper aims to identify such gaps and to explore whether laboratory networks could contribute towards improving AST in low resource settings.
   Methods: A self-assessment tool to assess antimicrobial susceptibility testing capacity was administered as a pre-workshop activity to participants from 30 microbiology laboratories in 3 cities in Pakistan. Data from public and private laboratories was analyzed and capacity of each scored in percentage terms. Laboratories from Karachi were invited to join a support network. A cohort of five laboratories that consented were provided additional training and updates sessions over a period of 15 months. Impact of training activities in these laboratories was evaluated using a point scoring (0-11) tool.
   Results: Results of self-assessment component identified a number of areas that required strengthening (scores of <= 60%). These included; readiness for AMR surveillance; 38 and 46%, quality assurance; 49 and 55%, and detection of specific organisms; 56 and 60% for public and private laboratories respectively. No significant difference was detected in AST capacity between public and private laboratories [ANOVA; p > 0.05]. Scoring tool used to assess impact of training within the longitudinal cohort showed an increase from a baseline of 1-5.5 (August 2015) to improved post training scores of 7-11 (October 2016) for the 5 laboratories included. Moreover, statistical analysis using paired t-Test Analysis, assuming unequal variance, indicated that the increase in scored noted represents a statistically significant improvement in the components evaluated [p < 0.05].
   Conclusion: Strengthening of laboratory capacity for AMR surveillance is important. Our data shows that close mentoring and support can help enhance capacity for antimicrobial sensitivity testing in resource limited settings. Our study further presents a model wherein laboratory networks can be successfully established and used towards improving diagnostic capacity in such settings.
C1 [Saeed, Dania Khalid; Hasan, Rumina; Zafar, Afia; Khan, Erum; Jabeen, Kausar; Irfan, Seema; Ahmed, Imran; Zeeshan, Mohammad; Wajidali, Zabin; Farooqi, Joveria; Shakoor, Sadia] Aga Khan Univ Hosp, Dept Pathol & Lab Med, Stadium Rd,POB 3500, Karachi 74800, Pakistan.
   [Naim, Mahwish] Baqai Med Univ, Baqai Inst Hlth Sci, Karachi, Pakistan.
   [Chagla, Abdul; Rao, Jason] Hlth Secur Partners, Washington, DC 20009 USA.
RP Hasan, R (reprint author), Aga Khan Univ Hosp, Dept Pathol & Lab Med, Stadium Rd,POB 3500, Karachi 74800, Pakistan.
EM rumina.hasan@aku.edu
RI Farooqi, Joveria/R-4494-2019
OI Jabeen, Kauser/0000-0003-2497-7847
FU Health Security Partners (HSP)-USA, as part of their collaboration with
   the Department of Pathology and Laboratory Medicine, Aga Khan University
FX This study was supported by the Health Security Partners (HSP)-USA, as
   part of their collaboration with the Department of Pathology and
   Laboratory Medicine, Aga Khan University, for laboratory capacity
   building and strengthening for antimicrobial resistance surveillance. We
   declare that there were no competing interest by the funding agency in
   determining or influencing the study at any point.
CR [Anonymous], 2014, OUT POCK HLTH EXP PR
   [Anonymous], 2003, QUEST ASS NAT NETW
   Chaitram JM, 2003, J CLIN MICROBIOL, V41, P2372, DOI 10.1128/JCM.41.6.2372-2377.2003
   Dacombe R, 2016, ANAL APPROACHES LAB
   Dar OA, 2016, LANCET
   Denning DW, 2017, EMERG INFECT DIS, V23, P177, DOI 10.3201/eid2302.152042
   Gandra S, 2016, FUTURE MICROBIOL
   Garcia A, 2014, J CLIN MICROBIOL, V52, P773, DOI 10.1128/JCM.03097-13
   Ghanchi NK, 2014, AM J INFECT CONTROL, V42, P1022, DOI 10.1016/j.ajic.2014.06.006
   Hsieh K, 2013, PUBLIC HEALTH REP, V128, P63, DOI 10.1177/00333549131280S210
   Johnson AP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0080
   London School of Hygiene and Tropical Medicine, 2016, ROADM PART GLOB ANT
   Masanza MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-S1-S8
   McGowan JE, 2004, NAT REV MICROBIOL, V2, P251, DOI 10.1038/nrmicro845
   Ndihokubwayo JB, 2013, AFRICAN HLTH MONITOR, V16, P27
   Nishtar S., 2006, POK HLTH POL FOR HEA, P3
   Nyasulu PS, 2014, ADV MICROBIOL
   Okeke IN, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i3.497
   Peterson LR, 2001, CLIN INFECT DIS
   Slotved HC, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0049-6
   Solomon S, 2015, OVERCOMING GLOBAL AN, P34
   Stevenson KB, 2003, DIAGN MICR INFEC DIS, V47, P303, DOI 10.1016/S0732-8893(03)00092-0
   Struwe J, 2008, WIEN KLIN WOCHENSCHR, V120, P268, DOI 10.1007/s00508-008-0977-6
   WHO, 2001, WHO GLOB STRAT CONT
   WHO, 2015, GLOB ANT RES SURV SY
   WHO, 2013, GUID EST LAB BAS SUR
   WHO (World Health Organization), 2015, SER RED BLOOD CELL F, P1
   World Bank, 2014, HLTH EXP TOT GDP
   World Health Organization (WHO), 2016, JOINT EXT EV IHR COR
NR 29
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2047-2994
J9 ANTIMICROB RESIST IN
JI Antimicrob. Resist. Infect. Control
PD SEP 29
PY 2017
VL 6
AR 101
DI 10.1186/s13756-017-0260-6
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Microbiology; Pharmacology & Pharmacy
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Microbiology; Pharmacology & Pharmacy
GA FI5YY
UT WOS:000412065700001
PM 29021895
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Adams, RI
   Lymperopoulou, DS
   Misztal, PK
   Pessotti, RD
   Behie, SW
   Tian, YL
   Goldstein, AH
   Lindow, SE
   Nazaroff, WW
   Taylor, JW
   Traxler, MF
   Bruns, TD
AF Adams, Rachel I.
   Lymperopoulou, Despoina S.
   Misztal, Pawel K.
   Pessotti, Rita De Cassia
   Behie, Scott W.
   Tian, Yilin
   Goldstein, Allen H.
   Lindow, Steven E.
   Nazaroff, William W.
   Taylor, John W.
   Traxler, Matt F.
   Bruns, Thomas D.
TI Microbes and associated soluble and volatile chemicals on periodically
   wet household surfaces
SO MICROBIOME
LA English
DT Article
DE Bathroom tiles; Built environment; Chemical ecology; Emissions; Indoors;
   Metabolites; Microbiota; Stainless steel coupons; Volatile organic
   compounds
ID HUMAN SKIN SURFACE; 16S RIBOSOMAL-RNA; ORGANIC-COMPOUNDS; INDOOR
   ENVIRONMENTS; BUILDING CHARACTERISTICS; BACTERIA; DATABASE; FUNGI; AIR;
   DIVERSITY
AB Background: Microorganisms influence the chemical milieu of their environment, and chemical metabolites can affect ecological processes. In built environments, where people spend the majority of their time, very little is known about how surface-borne microorganisms influence the chemistry of the indoor spaces. Here, we applied multidisciplinary approaches to investigate aspects of chemical microbiology in a house.
   Methods: We characterized the microbial and chemical composition of two common and frequently wet surfaces in a residential setting: kitchen sink and bathroom shower. Microbial communities were studied using culture-dependent and independent techniques, including targeting RNA for amplicon sequencing. Volatile and soluble chemicals from paired samples were analyzed using state-of-the-art techniques to explore the links between the observed microbiota and chemical exudates.
   Results: Microbial analysis revealed a rich biological presence on the surfaces exposed in kitchen sinks and bathroom shower stalls. Microbial composition, matched for DNA and RNA targets, varied by surface type and sampling period. Bacteria were found to have an average of 25x more gene copies than fungi. Biomass estimates based on qPCR were well correlated with measured total volatile organic compound (VOC) emissions. Abundant VOCs included products associated with fatty acid production. Molecular networking revealed a diversity of surface-borne compounds that likely originate from microbes and from household products.
   Conclusions: Microbes played a role in structuring the chemical profiles on and emitted from kitchen sinks and shower stalls. Microbial VOCs (mVOCs) were predominately associated with the processing of fatty acids. The mVOC composition may be more stable than that of microbial communities, which can show temporal and spatial variation in their responses to changing environmental conditions. The mVOC output from microbial metabolism on kitchen sinks and bathroom showers should be apparent through careful measurement, even against a broader background of VOCs in homes, some of which may originate from microbes in other locations within the home. A deeper understanding of the chemical interactions between microbes on household surfaces will require experimentation under relevant environmental conditions, with a finer temporal resolution, to build on the observational study results presented here.
C1 [Adams, Rachel I.; Lymperopoulou, Despoina S.; Pessotti, Rita De Cassia; Behie, Scott W.; Lindow, Steven E.; Taylor, John W.; Traxler, Matt F.; Bruns, Thomas D.] Univ Calif Berkeley, Plant & Microbial Biol, Berkeley, CA 94720 USA.
   [Misztal, Pawel K.; Goldstein, Allen H.] Univ Calif Berkeley, Environm Sci Policy & Management, Berkeley, CA 94720 USA.
   [Tian, Yilin; Goldstein, Allen H.; Nazaroff, William W.] Univ Calif Berkeley, Civil & Environm Engn, Berkeley, CA USA.
RP Adams, RI (reprint author), Univ Calif Berkeley, Plant & Microbial Biol, Berkeley, CA 94720 USA.
EM adamsri@berkeley.edu
RI Goldstein, Allen H/A-6857-2011; Nazaroff, William W/C-4106-2008;
   Misztal, Pawel K/B-8371-2009
OI Goldstein, Allen H/0000-0003-4014-4896; Nazaroff, William
   W/0000-0001-5645-3357; Misztal, Pawel K/0000-0003-1060-1750; Traxler,
   Matthew/0000-0001-8430-595X; Adams, Rachel/0000-0003-4499-5743
FU Alfred P. Sloan FoundationAlfred P. Sloan Foundation
FX The funding was provided by the Alfred P. Sloan Foundation to the
   Berkeley Indoor Microbial Ecology Research Consortium (BIMERC).
CR Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x
   Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0112-7
   Adams RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078866
   Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783
   Andersson K, 1997, INDOOR AIR, V7, P78, DOI 10.1111/j.1600-0668.1997.t01-2-00002.x
   Araki A, 2010, SCI TOTAL ENVIRON, V408, P2208, DOI 10.1016/j.scitotenv.2010.02.012
   Aurass P, 2017, MICROBIOL RESOUR ANN, V5, DOI 10.1128/genomeA.00487-17
   Back J, 2010, ATMOS ENVIRON, V44, P3651, DOI 10.1016/j.atmosenv.2010.06.042
   Baron JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102679
   Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Carini P, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.242
   Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003
   Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536
   DOWNING DT, 1969, J INVEST DERMATOL, V53, P322, DOI 10.1038/jid.1969.157
   Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171
   Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036
   Graham JL, 2010, ENVIRON SCI TECHNOL, V44, P7361, DOI 10.1021/es1008938
   Gray CM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001291
   Guo H, 2009, INDOOR AIR, V19, P206, DOI 10.1111/j.1600-0668.2008.00580.x
   Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997
   Holzinger R, 2015, ATMOS MEAS TECH, V8, P3903, DOI 10.5194/amt-8-3903-2015
   Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x
   James AG, 2004, WORLD J MICROB BIOT, V20, P787, DOI 10.1007/s11274-004-5843-8
   Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25
   Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004
   Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743
   Kesselmeier J, 2000, ATMOS ENVIRON, V34, P4063, DOI 10.1016/S1352-2310(00)00186-2
   Khan Z, 2011, MED MYCOL, V49, P439, DOI 10.3109/13693786.2010.530696
   Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x
   Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770
   Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]
   Kuske M, 2005, BUILD ENVIRON, V40, P824, DOI 10.1016/j.buildenv.2004.08.012
   Lane D, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0
   Langer S, 2016, ATMOS ENVIRON, V128, P82, DOI 10.1016/j.atmosenv.2015.12.060
   Langer S, 2013, BUILD ENVIRON, V69, P44, DOI 10.1016/j.buildenv.2013.07.013
   Leff JW, 2008, SOIL BIOL BIOCHEM, V40, P1629, DOI 10.1016/j.soilbio.2008.01.018
   Lemfack MC, 2014, NUCLEIC ACIDS RES, V42, pD744, DOI 10.1093/nar/gkt1250
   Leung MHY, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0165-2
   Lymperopoulou DS, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0223-9
   Lymperopoulou DS, 2016, APPL ENVIRON MICROB, V82, P3822, DOI 10.1128/AEM.00610-16
   Magan N, 2000, J STORED PROD RES, V36, P319, DOI 10.1016/S0022-474X(99)00057-0
   Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7
   Martinez E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13823
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Moen B, 2016, CAN J MICROBIOL, V62, P148, DOI 10.1139/cjm-2015-0562
   Muller A, 2013, FUNGAL GENET BIOL, V54, P25, DOI 10.1016/j.fgb.2013.02.005
   National Academies of Sciences Engineering and Medicine, 2017, MICR BUILT ENV RES A
   Nazaroff WW, 2015, INDOOR AIR, V25, P357, DOI 10.1111/ina.12219
   Offermann FJ., 2009, CEC5002009085 PIER C
   Oksanen J., 2012, R PACKAGE VERSION, V2, P1
   Park JH, 2013, SCIENCE, V341, P643, DOI 10.1126/science.1235053
   Prussin AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0144-z
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   R-project, 2014, R LANG ENV STAT COMP
   Ramirez KS, 2010, BIOGEOCHEMISTRY, V99, P97, DOI 10.1007/s10533-009-9393-x
   Raw GJ, 2004, J EXPO ANAL ENV EPID, V14, pS85, DOI 10.1038/sj.jea.7500363
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Sahlberg B, 2013, SCI TOTAL ENVIRON, V444, P433, DOI 10.1016/j.scitotenv.2012.10.114
   Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schmidt R, 2015, ISME J, V9, P2329, DOI 10.1038/ismej.2015.42
   Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h
   SCOTT E, 1982, J HYG-CAMBRIDGE, V89, P279, DOI 10.1017/S0022172400070819
   Singer BC, 2007, ATMOS ENVIRON, V41, P3251, DOI 10.1016/j.atmosenv.2006.07.056
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009
   Speirs J. P., 1995, International Journal of Environmental Health Research, V5, P109, DOI 10.1080/09603129509356839
   Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721
   Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004
   Tang XC, 2015, ENVIRON SCI TECH LET, V2, P303, DOI 10.1021/acs.estlett.5b00256
   Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   Weschler CJ, 2016, INDOOR AIR, V26, P6, DOI 10.1111/ina.12185
   Weschler CJ, 2011, INDOOR AIR, V21, P205, DOI 10.1111/j.1600-0668.2011.00713.x
   Wessen B, 1996, ANALYST, V121, P1203, DOI 10.1039/an9962101203
   Wickham H, 2016, GGPLOT2 ELEGANT GRAP
   Wieslander G, 2007, INDOOR AIR, V17, P19, DOI 10.1111/j.1600-0668.2006.00441.x
   Yamamoto N, 2010, INDOOR AIR, V20, P85, DOI 10.1111/j.1600-0668.2009.00622.x
   Yano T, 2013, MICROBES ENVIRON, V28, P87, DOI 10.1264/jsme2.ME12146
   Ye W, 2014, BUILD ENVIRON, V79, P168, DOI 10.1016/j.buildenv.2014.05.009
   Zupancic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148166
NR 86
TC 17
Z9 17
U1 2
U2 46
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD SEP 26
PY 2017
VL 5
AR 128
DI 10.1186/s40168-017-0347-6
PG 16
WC Microbiology
SC Microbiology
GA FI1HC
UT WOS:000411682700001
PM 28950891
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Zielinski, B
   Plichta, A
   Misztal, K
   Spurek, P
   Brzychczy-Wloch, M
   Ochonska, D
AF Zielinski, Bartosz
   Plichta, Anna
   Misztal, Krzysztof
   Spurek, Przemyslaw
   Brzychczy-Wloch, Monika
   Ochonska, Dorota
TI Deep learning approach to bacterial colony classification
SO PLOS ONE
LA English
DT Article
ID AUTOMATIC IDENTIFICATION
AB In microbiology it is diagnostically useful to recognize various genera and species of bacteria. It can be achieved using computer-aided methods, which make the recognition processes more automatic and thus significantly reduce the time necessary for the classification. Moreover, in case of diagnostic uncertainty (the misleading similarity in shape or structure of bacterial cells), such methods can minimize the risk of incorrect recognition. In this article, we apply the state of the art method for texture analysis to classify genera and species of bacteria. This method uses deep Convolutional Neural Networks to obtain image descriptors, which are then encoded and classified with Support Vector Machine or Random Forest. To evaluate this approach and to make it comparable with other approaches, we provide a new dataset of images. DIBaS dataset (Digital Image of Bacterial Species) contains 660 images with 33 different genera and species of bacteria.
C1 [Zielinski, Bartosz; Misztal, Krzysztof; Spurek, Przemyslaw] Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland.
   [Plichta, Anna] Cracow Univ Technol, Dept Comp Sci, 24 Warszawska St, PL-31422 Krakow, Poland.
   [Brzychczy-Wloch, Monika] Jagiellonian Univ, Med Coll, Chair Microbiol, Dept Bacteriol Microbial Ecol & Parasitol, 18 Czysta St, PL-31121 Krakow, Poland.
   [Ochonska, Dorota] Jagiellonian Univ, Med Coll, Fac Med, Chair Microbiol,Dept Infect Epidemiol, 18 Czysta St, PL-31121 Krakow, Poland.
RP Misztal, K (reprint author), Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland.
EM krzysztof.misztal@uj.edu.pl
OI Misztal, Krzysztof/0000-0003-2480-3505
FU National Science Centre (Poland) [2015/19/D/ST6/01215,
   2015/19/D/ST6/01472, 2012/07/N/ST6/02192]; PL-Grid infrastructure
FX The work of B. Zielinski was supported by the National Science Centre
   (Poland) under grant agreement no 2015/19/D/ST6/01215; 2016-2019. The
   work of P. Spurek was supported by the National Science Centre (Poland)
   under grant agreement no. 2015/19/D/ST6/01472; 2016-2019. The work of K.
   Misztal was supported by the National Science Centre (Poland) under
   grant agreement no. 2012/07/N/ST6/02192; 2012-2017. This research was
   supported in part by PL-Grid infrastructure.; The work of B. Zielinski
   was supported by the National Science Centre (Poland) under grant
   agreement no 2015/19/D/ST6/01215; 2016-2019.; The work of P. Spurek was
   supported by the National Science Centre (Poland) under grant agreement
   no. 2015/19/D/ST6/01472; 2016-2019.; The work of K. Misztal was
   supported by the National Science Centre (Poland) under grant agreement
   no. 2012/07/N/ST6/02192; 2012-2017.; This research was supported in part
   by PL-Grid infrastructure.
CR Ahmed WM, 2013, IEEE J BIOMED HEALTH, V17, P232, DOI 10.1109/TITB.2012.2222654
   Ates H, 2009, 2009 24TH INTERNATIONAL SYMPOSIUM ON COMPUTER AND INFORMATION SCIENCES, P18, DOI 10.1109/ISCIS.2009.5291926
   Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246
   Bosch A, 2006, LECT NOTES COMPUT SC, V3954, P517
   Chatfield K, 2014, ARXIV140535312014
   Cimpoi M, 2016, INT J COMPUT VISION, V118, P65, DOI 10.1007/s11263-015-0872-3
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018
   De Bruyne K, 2011, SYST APPL MICROBIOL, V34, P20, DOI 10.1016/j.syapm.2010.11.003
   Forero MG, 2006, J MICROSC-OXFORD, V223, P120, DOI 10.1111/j.1365-2818.2006.01610.x
   Hiremath P., 2009, P IEEE INT C SIGN IM, P209
   Holmberg M, 1998, BIOTECHNOL TECH, V12, P319, DOI 10.1023/A:1008862617082
   Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386
   Liu B, 2016, BIOINFORMATICS, V32, P362, DOI 10.1093/bioinformatics/btv604
   Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691
   Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709
   Liu J, 2001, MICROB ECOL, V41, P173, DOI 10.1007/s002480000004
   Lowe DG, 1999, P INT C COMP VIS, P1150, DOI DOI 10.1109/ICCV.1999.790410
   Perner P., 2001, MED DATA LVSIS, V2199, P219
   Perronnin F., 2007, P IEEE COMP SOC C CO, P1, DOI DOI 10.1109/CVPR.2007.383266
   Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y
   Simonyan K, 2014, ARXIV140915562014
   Snoek J., 2012, ADV NEURAL INFORM PR, V25, P2951, DOI DOI 10.1094/PDIS-11-11-0999-PDN
   Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604
   Trattner S, 2004, IEEE T MED IMAGING, V23, P807, DOI 10.1109/TMI.2004.827481
NR 24
TC 8
Z9 9
U1 4
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 14
PY 2017
VL 12
IS 9
AR e0184554
DI 10.1371/journal.pone.0184554
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH0VR
UT WOS:000410859200061
PM 28910352
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Gross, AE
   Johannes, RS
   Gupta, V
   Tabak, YP
   Srinivasan, A
   Bleasdale, SC
AF Gross, Alan E.
   Johannes, Richard S.
   Gupta, Vikas
   Tabak, Ying P.
   Srinivasan, Arjun
   Bleasdale, Susan C.
TI The Effect of a Piperacillin/Tazobactam Shortage on Antimicrobial
   Prescribing and Clostridium difficile Risk in 88 US Medical Centers
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Clostridium difficile; drug shortage; piperacillin/tazobactam
ID BLOOD-STREAM INFECTION; DRUG SHORTAGES; KLEBSIELLA-PNEUMONIAE;
   HOSPITALIZED-PATIENTS; TOXIN PRODUCTION; UNITED-STATES; ANTIBIOTICS;
   TAZOBACTAM; DIARRHEA; SURVEILLANCE
AB Background. Anti-infective shortages are a pervasive problem in the United States. The objective of this study was to identify any associations between changes in prescribing of antibiotics that have a high risk for CDI during a piperacillin/tazobactam (PIP/TAZO) shortage and hospital-onset Clostridium difficile infection (HO-CDI) risk in 88 US medical centers.
   Methods. We analyzed electronically captured microbiology and antibiotic use data from a network of US hospitals from July 2014 through June 2016. The primary outcome was HO-CDI rate and the secondary outcome was changes in antibiotic usage. We fit a Poisson model to estimate the risk of HO-CDI associated with PIP/TAZO shortage that were associated with increased high-risk antibiotic use while controlling for hospital characteristics.
   Results. A total of 88 hospitals experienced PIP/TAZO shortage and 72 of them experienced a shift toward increased use of high-risk antibiotics during the shortage period. The adjusted relative risk (RR) of HO-CDI for hospitals experiencing a PIP/TAZO shortage was 1.03 (95% confidence interval [CI], .85-1.26; P = .73). The adjusted RR of HO-CDI for hospitals that both experienced a shortage and also showed a shift toward increased use of high-risk antibiotics was 1.30 (95% CI, 1.03-1.64; P < .05).
   Conclusions. Hospitals that experienced a PIP/TAZO shortage and responded to that shortage by shifting antibiotic usage toward antibiotics traditionally known to place patients at greater risk for CDI experienced greater HO-CDI rates; this highlights an important adverse effect of the PIP/TAZO shortage and the importance of antibiotic stewardship when mitigating drug shortages.
C1 [Gross, Alan E.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA.
   [Gross, Alan E.] Univ Illinois Hosp & Hlth Sci Syst, Hosp Pharm Serv, Chicago, IL USA.
   [Johannes, Richard S.; Gupta, Vikas; Tabak, Ying P.] Dickinson & Co, Becton, Franklin Lakes, NJ USA.
   [Johannes, Richard S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA USA.
   [Srinivasan, Arjun] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA.
   [Bleasdale, Susan C.] Univ Illinois, Div Infect Dis, Internal Med, Chicago, IL USA.
RP Gross, AE (reprint author), Univ Illinois, Coll Pharm, 833 S Wood St, Chicago, IL 60612 USA.
EM aegross@uic.edu
RI Tabak, Ying/AAB-2387-2020
OI Gross, Alan/0000-0001-9352-8389
CR Alston WK, 2004, J ANTIMICROB CHEMOTH, V53, P549, DOI 10.1093/jac/dkh127
   Baines SD, 2005, J ANTIMICROB CHEMOTH, V55, P974, DOI 10.1093/jac/dki120
   Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6
   Brossette SE, 2006, AM J CLIN PATHOL, V125, P34, DOI 10.1309/502AUPR8VE67MBDE
   Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12
   Buchler AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0607-z
   Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC
   Daikos GL, 2010, J ANTIMICROB CHEMOTH, V65, P784, DOI 10.1093/jac/dkq005
   DOWELL ME, 1992, AM J MED, V93, P481, DOI 10.1016/0002-9343(92)90574-U
   Dubberke ER, 2015, ANTIMICROB AGENTS CH, V59, P4533, DOI 10.1128/AAC.00642-15
   Garneau JR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-29
   Griffith MM, 2012, PHARMACOTHERAPY, V32, P665, DOI 10.1002/j.1875-9114.2012.01158.x
   Griffith MM, 2012, INFECT CONT HOSP EP, V33, P745, DOI 10.1086/666332
   Griffith MM, 2012, CLIN INFECT DIS, V54, P684, DOI 10.1093/cid/cir954
   Hauck C, 2016, CLIN MICROBIOL INFEC, V22, P513, DOI 10.1016/j.cmi.2016.01.023
   Kundrapu S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1514-2
   Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]
   Mendez MN, 2006, PHARMACOTHERAPY, V26, P61, DOI 10.1592/phco.2006.26.1.61
   Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005
   Quadri F, 2015, CLIN INFECT DIS, V60, P1737, DOI 10.1093/cid/civ201
   Ridgway JP, 2016, AM J INFECT CONTROL, V44, P567, DOI 10.1016/j.ajic.2015.12.044
   Routsi C, 2013, INTENS CARE MED, V39, P1253, DOI 10.1007/s00134-013-2914-z
   Sader HS, 2015, INT J ANTIMICROB AG, V46, P53, DOI 10.1016/j.ijantimicag.2015.02.022
   Settle CD, 1998, ALIMENT PHARM THER, V12, P1217
   Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477
   Tabak YP, 2013, INFECT CONT HOSP EP, V34, P588, DOI 10.1086/670621
   Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254
   Tumbarello M, 2014, ANTIMICROB AGENTS CH, V58, P3514, DOI 10.1128/AAC.02373-13
   Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258
   Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V54, P168, DOI 10.1093/jac/dkh285
NR 30
TC 16
Z9 16
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2017
VL 65
IS 4
BP 613
EP 618
DI 10.1093/cid/cix379
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC2MB
UT WOS:000406670800013
PM 28444166
OA Bronze
DA 2020-05-07
ER

PT J
AU Huang, YP
   Lin, TL
   Lin, TH
   Wu, HS
AF Huang, Yuan-Pin
   Lin, Tsuey-Li
   Lin, Ting-Han
   Wu, Ho-Sheng
TI Molecular and epidemiological study of enterovirus D68 in Taiwan
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE enterovirus D68; epidemiology; phylogeny
ID RESPIRATORY-TRACT INFECTION; SURVEILLANCE; EMERGENCE; ILLNESS; CHINA
AB Background/purpose: As an immunofluorescence assay for enterovirus D68 (EVD68) is not available in the enteroviruses surveillance network in Taiwan, EV-D68 may be the actual pathogen of untypeable enterovirus-suspected isolates.
   Methods: The untypeable isolates collected from 2007 through 2014 were identified by nucleic acid amplification-based methods and sequencing of the VP1 region to analyze the phylogeny and epidemiology of EV-D68 in Taiwan.
   Results: Twenty-nine EV-D68 isolates were sequenced, including 15 Cluster 3 and 14 Cluster 1 viruses. Approximately 41% of the patients were children under 5 years of age and their infections peaked in August. The ratio of male to female patients was 1.5 and 3.67 for Cluster 3 and Cluster 1, respectively. Fever and respiratory symptoms were commonly reported in EV-D68infected patients. The results of phylogenetic analyses showed that EV-D68 isolates between 2007 and 2014 belonged to different clusters and existed for years, indicating that endemic circulation of EV-D68 existed in Taiwan.
   Conclusion: This study showed that EV-D68 has been endemic in Taiwan for some years despite a small number of positive cases. The continuous monitoring and efforts towards the improvement of diagnostic techniques are required to complete the surveillance system. This study provided the genetic and epidemiological information which could contribute to understanding the etiology and epidemiology of EV-D68. Copyright (C) 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
C1 [Huang, Yuan-Pin; Lin, Tsuey-Li; Lin, Ting-Han; Wu, Ho-Sheng] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, 161 Kun Yang St, Taipei 11561, Taiwan.
   [Wu, Ho-Sheng] Taipei Med Univ, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan.
RP Wu, HS (reprint author), Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, 161 Kun Yang St, Taipei 11561, Taiwan.
EM wuhs@cdc.gov.tw
FU Taiwan CDC [DOH100-DC2019, DOH101-DC-2401, DOH102-DC-2601, MOHW103CDC-,
   C-315-000601]; National Research Program for Genomic MedicineNational
   Science Council of Taiwan [98-0324-01-F-20, 99-0324-01-F-12]
FX The authors would like to thank all principal investigators, physicians,
   and colleagues of Taiwan CDC Collaborating Laboratories of Virology.
   This study was supported financially by research grants from Taiwan CDC
   (DOH100-DC2019, DOH101-DC-2401, DOH102-DC-2601, and MOHW103CDC-
   C-315-000601) and National Research Program for Genomic Medicine
   (98-0324-01-F-20 and 99-0324-01-F-12). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The findings and conclusions in this
   study are those of the authors and do not necessarily represent the
   views of Taiwan CDC.
CR Centers for Disease Control and Prevention, ENT D68
   Huang YP, 2016, J MICROBIOL IMMUNOL, V49, P321, DOI 10.1016/j.jmii.2014.06.013
   Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277
   Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x
   Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13
   Imamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074221
   Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301
   Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010
   Khetsuriani N, 2006, MMWR SURVEILL SUMM, V55, P1
   Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1
   Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005
   Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190
   Lu QB, 2014, J MED MICROBIOL, V63, P408, DOI 10.1099/jmm.0.068247-0
   MCPHEE F, 1994, VIRUS RES, V34, P139, DOI 10.1016/0168-1702(94)90096-5
   Meijer A, 2014, EURO SURVEILL, V19
   Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021
   Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798
   Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06
   Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0
   Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866
   Picornaviridae, ENT D
   Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821
   Renois F, 2013, J CLIN MICROBIOL, V51, P640, DOI 10.1128/JCM.02640-12
   SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Todd AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-103
   Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0
   Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006
   Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321
   Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376
NR 30
TC 21
Z9 21
U1 0
U2 2
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD AUG
PY 2017
VL 50
IS 4
BP 411
EP 417
DI 10.1016/j.jmii.2015.07.015
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FI0QO
UT WOS:000411634300002
PM 26458357
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Shaw, GTW
   Liu, AC
   Weng, CY
   Chou, CY
   Wang, DY
AF Shaw, Grace Tzun-Wen
   Liu, An-Chi
   Weng, Chieh-Yin
   Chou, Chu-Yang
   Wang, Daryi
TI Inferring microbial interactions in thermophilic and mesophilic
   anaerobic digestion of hog waste
SO PLOS ONE
LA English
DT Article
ID NON-ACETICLASTIC METHANOGENESIS; INTESTINAL BACTERIAL COMMUNITY; ACETATE
   OXIDATION; BIOGAS; NETWORKS; DYNAMICS; PATHWAY; ECOLOGY; METHANE;
   DIVERSITY
AB Anaerobic digestion (AnD) is a microbiological process that converts organic waste materials into biogas. Because of its high methane content, biogas is a combustible energy source and serves as an important environmental technology commonly used in the management of animal waste generated on large animal farms. Much work has been done on hardware design and process engineering for the generation of biogas. However, little is known about the complexity of the microbiology in this process. In particular, how microbes interact in the digester and eventually breakdown and convert organic matter into biogas is still regarded as a "black box." We used 16S rRNA sequencing as a tool to study the microbial community in laboratory hog waste digesters under tightly controlled conditions, and systematically unraveled the distinct interaction networks of two microbial communities from mesophilic (MAnD) and thermophilic anaerobic digestion (TAnD). Under thermophilic conditions, the well-known association between hydrogen-producing bacteria, e.g., Ruminococcaceae and Prevotellaceae, and hydrotrophic methanogens, Methanomicrobiaceae, was reverse engineered by their interactive topological niches. The inferred interaction network provides a sketch enabling the determination of microbial interactive relationships that conventional strategy of finding differential taxa was hard to achieve. This research is still in its infancy, but it can help to depict the dynamics of microbial ecosystems and to lay the groundwork for understanding how microorganisms cohabit in the anaerobic digester.
C1 [Shaw, Grace Tzun-Wen; Weng, Chieh-Yin; Wang, Daryi] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.
   [Liu, An-Chi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan.
   [Liu, An-Chi; Chou, Chu-Yang] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei, Taiwan.
RP Wang, DY (reprint author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.
EM dywang@gate.sinica.edu.tw
FU Sustainability Science Research Project, Academia Sinica
FX This work was supported by Sustainability Science Research Project,
   Academia Sinica. The funder had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093
   Angly FE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-11
   Bastian M, 2009, P INT AAAI C WEBL SO, DOI [DOI 10.1136/QSHC.2004.010033, 10.1136/qshc.2004.010033]
   Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219
   Borjesson P, 2008, TRENDS BIOTECHNOL, V26, P7, DOI 10.1016/j.tibtech.2007.09.007
   Campanaro S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0441-1
   [承磊 Cheng Lei], 2016, [微生物学通报, Microbiology China], V43, P1143
   Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013
   Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602
   Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1
   Deng Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-113
   Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Etchebehere C, 2016, APPL MICROBIOL BIOT, V100, P3371, DOI 10.1007/s00253-016-7325-y
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451
   Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13
   Gao RuiFang, 2012, African Journal of Biotechnology, V11, P6494
   Gause G. F., 1934, STRUGGLE EXISTENCE
   Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288
   Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x
   Hofbauer J, 1998, EVOLUTIONARY GAMES P
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06
   Klocke M, 2007, SYST APPL MICROBIOL, V30, P139, DOI 10.1016/j.syapm.2006.03.007
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Kuever J, 2014, FAMILY SYNTROPHOBACT, P289
   Leclerc M, 2004, ENVIRON MICROBIOL, V6, P809, DOI 10.1111/j.1462-2920.2004.00616.x
   Leven L, 2007, FEMS MICROBIOL ECOL, V59, P683, DOI 10.1111/j.1574-6941.2006.00263.x
   Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110
   Li YF, 2015, APPL MICROBIOL BIOT, V99, P969, DOI 10.1007/s00253-014-6036-5
   Liu AC, 2015, J BIOTECHNOL, V194, P124, DOI 10.1016/j.jbiotec.2014.11.026
   Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   McHugh S, 2004, FEMS MICROBIOL ECOL, V48, P369, DOI 10.1016/j.femsec.2004.02.012
   McMahon KD, 2001, WATER RES, V35, P1817, DOI 10.1016/S0043-1354(00)00438-3
   Moset V, 2015, MICROB BIOTECHNOL, V8, P787, DOI 10.1111/1751-7915.12271
   Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Oren A., 2014, FAMILY METHANOMICROB, P231
   PETERSEN SP, 1991, FEMS MICROBIOL ECOL, V86, P149, DOI 10.1111/j.1574-6968.1991.tb04804.x
   Pihur V, 2008, BIOINFORMATICS, V24, P561, DOI 10.1093/bioinformatics/btm640
   Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004
   Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012
   Saengkerdsub S, 2007, LETT APPL MICROBIOL, V45, P629, DOI 10.1111/j.1472-765X.2007.02243.x
   Sahlstrom L, 2003, BIORESOURCE TECHNOL, V87, P161, DOI 10.1016/S0960-8524(02)00168-2
   Sasaki D, 2011, J BIOSCI BIOENG, V111, P41, DOI 10.1016/j.jbiosc.2010.08.011
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365
   Shankar V, 2015, ISME J, V9, P1899, DOI 10.1038/ismej.2014.258
   Shaw GTW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1359-0
   Shih JC, 2015, DEV ANAEROBIC DIGEST, P339
   Sivagurunathan P, 2016, RSC ADV
   Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388
   Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872
   Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148
   Tang YQ, 2011, APPL MICROBIOL BIOT, V91, P1447, DOI 10.1007/s00253-011-3479-9
   Tour JM, 2010, NAT MATER, V9, P871, DOI 10.1038/nmat2887
   Trosvik P, 2008, ISME J, V2, P707, DOI 10.1038/ismej.2008.36
   Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96
   Tuan NN, 2014, MICROBIOL RES, V169, P717, DOI 10.1016/j.micres.2014.02.003
   Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263
   Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x
   Wold H., 1985, ENCY STAT SCI
   WOOD HG, 1986, TRENDS BIOCHEM SCI, V11, P14, DOI 10.1016/0968-0004(86)90223-9
   Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15
   Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093445
   Yadvika, 2004, BIORESOURCE TECHNOL, V95, P1, DOI 10.1016/j.biortech.2004.02.010
   Yang ZM, 2015, BIORESOURCE TECHNOL, V190, P132, DOI 10.1016/j.biortech.2015.04.057
   Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347
   Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185
   Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10
   Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11
   Zhu CG, 2011, MICROBIOL RES, V166, P27, DOI 10.1016/j.micres.2010.01.004
   ZINDER SH, 1984, ARCH MICROBIOL, V138, P263, DOI 10.1007/BF00402133
NR 75
TC 7
Z9 7
U1 2
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2017
VL 12
IS 7
AR e0181395
DI 10.1371/journal.pone.0181395
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC2BU
UT WOS:000406643100034
PM 28732056
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Edlund, A
   Garg, N
   Mohimani, H
   Gurevich, A
   He, XS
   Shi, WY
   Dorrestein, PC
   McLean, JS
AF Edlund, Anna
   Garg, Neha
   Mohimani, Hosein
   Gurevich, Alexey
   He, Xuesong
   Shi, Wenyuan
   Dorrestein, Pieter C.
   McLean, Jeffrey S.
TI Metabolic Fingerprints from the Human Oral Microbiome Reveal a Vast
   Knowledge Gap of Secreted Small Peptidic Molecules
SO MSYSTEMS
LA English
DT Article
DE Lactobacillus; Streptococcus; Veillonella; biofilms; oral microbiology;
   peptidic small molecules
ID NATURAL-PRODUCTS; ENDOGENOUS MELATONIN; STREPTOCOCCUS-MUTANS; PLANT
   METABOLOMICS; PH; PLAQUE; DIVERSITY; DISCOVERY; STANDARDS; EVOLUTION
AB Recent research indicates that the human microbiota play key roles in maintaining health by providing essential nutrients, providing immune education, and preventing pathogen expansion. Processes underlying the transition from a healthy human microbiome to a disease-associated microbiome are poorly understood, partially because of the potential influences from a wide diversity of bacterium-derived compounds that are illy defined. Here, we present the analysis of peptidic small molecules (SMs) secreted from bacteria and viewed from a temporal perspective. Through comparative analysis of mass spectral profiles from a collection of cultured oral isolates and an established in vitro multispecies oral community, we found that the production of SMs both delineates a temporal expression pattern and allows discrimination between bacterial isolates at the species level. Importantly, the majority of the identified molecules were of unknown identity, and only similar to 2.2% could be annotated and classified. The catalogue of bacterially produced SMs we obtained in this study reveals an undiscovered molecular world for which compound isolation and ecosystem testing will facilitate a better understanding of their roles in human health and disease.
   IMPORTANCE Metabolomics is the ultimate tool for studies of microbial functions under any specific set of environmental conditions (D. S. Wishart, Nat Rev Drug Discov 45:473-484, 2016, https://doi.org/10.1038/nrd. 2016.32). This is a great advance over studying genes alone, which only inform about metabolic potential. Approximately 25,000 compounds have been chemically characterized thus far; however, the richness of metabolites such as SMs has been estimated to be as high as 1 x 10(30) in the biosphere (K. Garber, Nat Biotechnol 33:228-231, 2015, https://doi. org/10.1038/nbt.3161). Our classical, one-at-a-time activity-guided approach to compound identification continues to find the same known compounds and is also incredibly tedious, which represents a major bottleneck for global SM identification. These challenges have prompted new developments of databases and analysis tools that provide putative classifications of SMs by mass spectral alignments to already characterized tandem mass spectrometry spectra and databases containing structural information (e.g., Pub-Chem and AntiMarin). In this study, we assessed secreted peptidic SMs (PSMs) from 27 oral bacterial isolates and a complex oral in vitro biofilm community of >100 species by using the Global Natural Products Social molecular Networking and the DEREPLICATOR infrastructures, which are methodologies that allow automated and putative annotation of PSMs. These approaches enabled the identification of an untapped resource of PSMs from oral bacteria showing species-unique patterns of secretion with putative matches to known bioactive compounds.
C1 [Edlund, Anna] J Craig Venter Inst, Genom Med Grp, La Jolla, CA USA.
   [Garg, Neha; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA 92093 USA.
   [Mohimani, Hosein] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.
   [Gurevich, Alexey] St Petersburg State Univ, Inst Translat Biomed, Ctr Algorithm Biotechnol, St Petersburg, Russia.
   [He, Xuesong; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.
   [McLean, Jeffrey S.] Univ Washington, Sch Dent, Dept Periodont, Seattle, WA 98195 USA.
RP Edlund, A (reprint author), J Craig Venter Inst, Genom Med Grp, La Jolla, CA USA.
EM aedlund@jcvi.org
RI Garg, Neha/L-3120-2018; Gurevich, Alexey/Q-6888-2016
OI Garg, Neha/0000-0002-2760-7123; Gurevich, Alexey/0000-0002-5855-3519;
   Edlund, Anna/0000-0002-3394-4804
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; National Institute of Dental and
   Craniofacial Research (NIDCR)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [R00DE024543]; NIDCRUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Dental & Craniofacial
   Research (NIDCR) [K99DE024543]; NIGMSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM095373,
   1R01DE023810, 1R01DE020102, 1R01DE026186]; National Institute of General
   Medical Sciences (NIGMS)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [2 P41 GM103484-06A1]
FX This research was funded by NIH, National Institute of Dental and
   Craniofacial Research (NIDCR) R00DE024543 (A.E.), NIDCR K99DE024543
   (A.E.), NIGMS R01GM095373 (J.S.M.), 1R01DE023810 (W.S., X.H., and J.M.),
   1R01DE020102 (W.S., X.H., and J.S.M.), 1R01DE026186 (W.S., X.H., and
   J.S.M.), and the National Institute of General Medical Sciences (NIGMS)
   2 P41 GM103484-06A1 (H.M.).
CR Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005
   Ali L, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0722-7
   Arneberg P, 1997, CARIES RES, V31, P451, DOI 10.1159/000262437
   Belizario JE, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01050, 10.1186/1476-069X-6-20, 10.3389/fmicb.2015.1050]
   Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004
   Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112
   Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937
   de Carvalho MP, 2012, CURR MED CHEM, V19, P3564
   Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998
   Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766
   Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032
   Edlund A, 2015, ISME J, V9, P2605, DOI 10.1038/ismej.2015.72
   Edlund A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-25
   Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x
   Garg N, 2017, NAT PROD REP, V34, P194, DOI 10.1039/c6np00063k
   Garg N, 2015, INT J MASS SPECTROM, V377, P719, DOI 10.1016/j.ijms.2014.06.005
   Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06
   Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5
   HARPER DS, 1983, J DENT RES, V62, P526, DOI 10.1177/00220345830620050101
   He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112
   Holden MTG, 1999, MOL MICROBIOL, V33, P1254, DOI 10.1046/j.1365-2958.1999.01577.x
   Horsman ME, 2017, NAT CHEM BIOL, V13, P6, DOI 10.1038/nchembio.2265
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06
   Jenkins H, 2005, PLANT PHYSIOL, V138, P67, DOI 10.1104/pp.104.058875
   Jenkins H, 2004, NAT BIOTECHNOL, V22, P1601, DOI 10.1038/nbt1041
   Jiao J, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.02067, 10.3389/fpls.2016.01387]
   Joyner PM, 2010, ORG BIOMOL CHEM, V8, P5486, DOI 10.1039/c0ob00579g
   Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x
   Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684
   Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07
   Li XY, 2017, NAT METHODS, V14, P23, DOI [10.1038/NMETH.4110, 10.1038/nmeth.4110]
   Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691
   McLean JS, 2008, ISME J, V2, P121, DOI 10.1038/ismej.2007.107
   Mcwilliams BD, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0003-2013
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004
   Mohimani H, 2017, NAT CHEM BIOL, V13, P30, DOI [10.1038/nchembio.2219, 10.1038/NCHEMBIO.2219]
   Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108
   Poeggeler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010206
   Quackenbush J, 2004, NAT BIOTECHNOL, V22, P613, DOI 10.1038/nbt0504-613
   Reiter RJ, 1998, ANN NY ACAD SCI, V854, P410, DOI 10.1111/j.1749-6632.1998.tb09920.x
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Rubtsov DV, 2007, J MAGN RESON, V188, P367, DOI 10.1016/j.jmr.2007.08.008
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801
   Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256
   TERLECKYJ B, 1975, INFECT IMMUN, V11, P656, DOI 10.1128/IAI.11.4.656-664.1975
   Tian Y, 2010, MOL ORAL MICROBIOL, V25, P357, DOI 10.1111/j.2041-1014.2010.00585.x
   Tilden AR, 1997, J PINEAL RES, V22, P102, DOI 10.1111/j.1600-079X.1997.tb00310.x
   Utter DR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00564
   VANHOUTE J, 1991, J DENT RES, V70, P1503, DOI 10.1177/00220345910700120601
   Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   Welch JLM, 2016, P NATL ACAD SCI USA, V113, pE791, DOI 10.1073/pnas.1522149113
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001
   Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang LS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0296-x
   Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111
NR 65
TC 8
Z9 9
U1 1
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD JUL-AUG
PY 2017
VL 2
IS 4
AR UNSP e00058-17
DI 10.1128/mSystems.00058-17
PG 16
WC Microbiology
SC Microbiology
GA FE4PZ
UT WOS:000408197100010
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Griffiths, E
   Dooley, D
   Graham, M
   Van Domselaar, G
   Brinkman, FSL
   Hsiao, WWL
AF Griffiths, Emma
   Dooley, Damion
   Graham, Morag
   Van Domselaar, Gary
   Brinkman, Fiona S. L.
   Hsiao, William W. L.
TI Context Is Everything: Harmonization of Critical Food Microbiology
   Descriptors and Metadata for Improved Food Safety and Surveillance
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE genomic epidemiology; foodborne pathogen surveillance; outbreak
   investigations; ontology; contextual metadata
ID MINIMUM INFORMATION; ONTOLOGY; EPIDEMIOLOGY; SALMONELLA; DISEASE;
   IDENTIFICATION; SYSTEM; CHAIN
AB Globalization of food networks increases opportunities for the spread of foodborne pathogens beyond borders and jurisdictions. High resolution whole-genome sequencing (WGS) subtyping of pathogens promises to vastly improve our ability to track and control foodborne disease, but to do so it must be combined with epidemiological, clinical, laboratory and other health care data (called "contextual data") to be meaningfully interpreted for regulatory and health interventions, outbreak investigation, and risk assessment. However, current multi-jurisdictional pathogen surveillance and investigation efforts are complicated by time-consuming data re-entry, curation and integration of contextual information owing to a lack of interoperable standards and inconsistent reporting. A solution to these challenges is the use of 'ontologies' hierarchies of well-defined and standardized vocabularies interconnected by logical relationships. Terms are specified by universal IDs enabling integration into highly regulated areas and multi-sector sharing (e.g., food and water microbiology with the veterinary sector). Institution-specific terms can be mapped to a given standard at different levels of granularity, maximizing comparability of contextual information according to jurisdictional policies. Fit-for-purpose ontologies provide contextual information with the auditability required for food safety laboratory accreditation. Our research efforts include the development of a Genomic Epidemiology Ontology (GenEpiO), and Food Ontology (FoodOn) that harmonize important laboratory, clinical and epidemiological data fields, as well as existing food resources. These efforts are supported by a global consortium of researchers and stakeholders worldwide. Since foodborne diseases do not respect international borders, uptake of such vocabularies will be crucial for multi-jurisdictional interpretation of WGS results and data sharing.
C1 [Griffiths, Emma; Brinkman, Fiona S. L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Vancouver, BC, Canada.
   [Dooley, Damion; Hsiao, William W. L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Graham, Morag; Van Domselaar, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Graham, Morag; Van Domselaar, Gary] Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.
   [Hsiao, William W. L.] British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada.
RP Hsiao, WWL (reprint author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.; Hsiao, WWL (reprint author), British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada.
EM william.hsiao@bccdc.ca
FU Genome Canada Bioinformatics and Computational Biology (BCB) [172PHM];
   Genome BC; federal Genomics Research and Development Initiative (GRDI)
   interdepartmental Food and Water Safety project; Genome Canada BCBGenome
   Canada [254EPI]; AllerGen NCE, Inc.; Government of Canada's Networks of
   Centres of Excellence (NCE) program
FX This work was funded by Genome Canada Bioinformatics and Computational
   Biology (BCB) 2012 Grant #172PHM with co-funding from Genome BC and the
   federal Genomics Research and Development Initiative (GRDI)
   interdepartmental Food and Water Safety project. FoodON is funded by
   Genome Canada BCB 2015 Grant #254EPI, with some additional support from
   AllerGen NCE, Inc., of the Government of Canada's Networks of Centres of
   Excellence (NCE) program.
CR Ammon A, 2010, INT J FOOD MICROBIOL, V139, pS43, DOI 10.1016/j.ijfoodmicro.2010.03.002
   Arp R., 2015, BUILD ONT BAS FORM
   Ashton PM, 2016, PEERJ, V4, DOI 10.7717/peerj.1752
   Aziz N, 2015, ARCH PATHOL LAB MED, V139, P481, DOI 10.5858/arpa.2014-0250-CP
   Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027
   Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7
   Buttigieg PL, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0097-6
   Clark CG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3340
   Danan C, 2011, EPIDEMIOL INFECT, V139, P736, DOI 10.1017/S0950268810001469
   Day M, 2017, J ANTIMICROB CHEMOTH, V72, P145, DOI 10.1093/jac/dkw371
   Dugan VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099979
   Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44
   Evans P., 2015, P INF M PHO AZ
   Ferreira JD, 2013, J EPIDEMIOL COMMUN H, V67, P385, DOI 10.1136/jech-2012-201142
   Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960
   Field D, 2006, OMICS, V10, P84, DOI 10.1089/omi.2006.10.84
   Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4
   Flynn D., 2014, FOOD SAF NEWS
   Food and Agriculture Organization of the United Nations [FAO], 2005, FOOD SAF RISK AN OVE
   Glasset B, 2016, EUROSURVEILLANCE, V21, P18, DOI 10.2807/1560-7917.ES.2016.21.48.30413
   Global Microbial Identifier, 2013, 6 ANN M GLO MICR IDE
   Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4
   Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031
   Griffiths E., 2016, P ICBO C CORVALIS OR
   Hoornstra E, 2001, FOOD CONTROL, V12, P229, DOI 10.1016/S0956-7135(01)00019-6
   Ireland JD, 2010, EUR J CLIN NUTR, V64, pS44, DOI 10.1038/ejcn.2010.209
   Ison J, 2013, BIOINFORMATICS, V29, P1325, DOI 10.1093/bioinformatics/btt113
   Kanagarajah S., 2017, FOOD MICROBI INPRESS
   Kanengoni AT, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx010
   Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382
   Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1
   Lambert D, 2017, J AOAC INT, V100, P721, DOI 10.5740/jaoacint.16-0269
   Lammerding AM, 2000, INT J FOOD MICROBIOL, V58, P147, DOI 10.1016/S0168-1605(00)00269-5
   Leebens-Mack J, 2006, OMICS, V10, P231, DOI 10.1089/omi.2006.10.231
   Lynch T, 2016, CLIN MICROBIOL REV, V29, P881, DOI 10.1128/CMR.00001-16
   Mattingly CJ, 2012, ENVIRON SCI TECHNOL, V46, P3046, DOI 10.1021/es2033857
   McMahon Christiana, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P199
   Minor T, 2015, RISK ANAL, V35, P1125, DOI 10.1111/risa.12316
   Moura A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.185
   Njamkepo E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.27, 10.1038/nmicrobiol.2016.27]
   Paszkiewicz KH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00157
   Pesquita C, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-4
   Pisani E, 2010, B WORLD HEALTH ORGAN, V88, P462, DOI 10.2471/BLT.09.074393
   Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972
   Sharma M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01741
   Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46
   Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346
   Tagini F, 2017, EUR J CLIN MICROBIOL, V36, P1173, DOI 10.1007/s10096-017-2905-z
   United Nations, 2016, BIOD 2030 AG SUST DE
   van Panhuis WG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1144
   Waldram A, 2018, FOOD MICROBIOL, V71, P39, DOI 10.1016/j.fm.2017.02.012
   Wielinga PR, 2017, FOOD MICROBIOL FOOD, P13, DOI 10.1007/978-3-319-43751-4_2
   World Health Organization, 2008, FOODBORNE DIS OUTBRE
   Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823
   Zaidi MB, 2008, EMERG INFECT DIS, V14, P429, DOI 10.3201/eid1403.071057
NR 55
TC 11
Z9 11
U1 1
U2 20
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 26
PY 2017
VL 8
AR 1068
DI 10.3389/fmicb.2017.01068
PG 11
WC Microbiology
SC Microbiology
GA EY5GM
UT WOS:000404005200001
PM 28694792
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Wang, J
   Koseki, S
   Chung, MJ
   Oh, DH
AF Wang, Jun
   Koseki, Shige
   Chung, Mi-Ja
   Oh, Deog-Hwan
TI A Novel Approach to Predict the Growth of Staphylococcus aureus on Rice
   Cake
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Staphylococcus aureus; predictive microbiology; rice cake; growth model;
   probability model
ID ESCHERICHIA-COLI; RELATIVE-HUMIDITY; BACTERIAL-GROWTH; SODIUM-CHLORIDE;
   NEURAL-NETWORKS; RISK-ASSESSMENT; LACTIC-ACID; TEMPERATURE; PH;
   INTERFACE
AB This study aimed to investigate the growth kinetics of Staphylococcus aureus on rice cake and to determine the shelf life based on the probability model of the increase in S. aureus contamination on rice cake. Secondary models were developed based on the growth parameters derived from the Baranyi model at constant temperatures (15, 25, 35, and 45 0). External validation was then conducted using additional data under experimental conditions not used in development of the models to verify the performance and reliability of the developed model through different goodness-of-fit indices. Furthermore, the growth of S. aureus on rice cake under dynamic temperature was obtained with the root mean square error (RMSE) of 0.218 and the 90.9% acceptable prediction rate. In addition, probability models of the 1-, 2-, 3-, and 4-log increases of S. aureus on rice cake were also developed from the data, which could provide the probability and the time to a certain log increase. The results of validation demonstrated that the developed predictive model and the obtained growth parameters could be used for evaluating the growth behavior of S. aureus on rice cake under different conditions, and qualified to supply sufficient information for microbiological risk assessment studies of S. aureus on rice cake in Korea.
C1 [Wang, Jun] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Peoples R China.
   [Koseki, Shige] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan.
   [Chung, Mi-Ja] Gwangju Univ, Coll Hlth Welf & Educ, Dept Food Sci & Nutr, Gwangju, South Korea.
   [Oh, Deog-Hwan] Kangwon Natl Univ, Inst Biosci & Biotechnol, Dept Food Sci & Biotechnol, Chunchon, South Korea.
RP Oh, DH (reprint author), Kangwon Natl Univ, Inst Biosci & Biotechnol, Dept Food Sci & Biotechnol, Chunchon, South Korea.
EM deoghwa@kangwon.ac.kr
RI Wang, Jun/H-4803-2011; Koseki, Shige/J-8317-2012
OI Wang, Jun/0000-0001-7676-0493; Koseki, Shige/0000-0001-7046-5354
FU Korea Food & Drug AdministrationMinistry of Food & Drug Safety (MFDS)
   [10162KFDA995]
FX This research was supported by a grant (10162KFDA995) from the Korea
   Food & Drug Administration.
CR Agresti A., 2007, INTRO CATEGORICAL DA
   BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0
   CDC, 2016, SURV FOODB DIS OUTBR
   Dabrowski W. M., 2004, TOXINS IN FOOD, P187
   Ding T, 2016, FOOD CONTROL, V59, P636, DOI 10.1016/j.foodcont.2015.06.049
   FDA, 2003, COMPR REV FOOD SCI F, V2, P33, DOI [10.1111/j.1541-4337.2003.tb00049.x, DOI 10.1111/J.1541-4337.2003.TB00049.X]
   Food and Drug Administration, 2012, STAPH AUR BAD BUG BO, P80
   Fujikawa H, 2005, APPL ENVIRON MICROB, V71, P7920, DOI 10.1128/AEM.71.12.7920-7926.2005
   Fujikawa H, 2006, FOOD MICROBIOL, V23, P260, DOI 10.1016/j.fm.2005.04.005
   Fujikawa H, 2004, FOOD MICROBIOL, V21, P501, DOI 10.1016/j.fm.2004.01.007
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Heidinger JC, 2009, J FOOD PROTECT, V72, P1641, DOI 10.4315/0362-028X-72.8.1641
   Hervas-Martinez C, 2006, J FOOD SCI, V71, pM31, DOI 10.1111/j.1365-2621.2006.tb08904.x
   Hwang CA, 2011, J FOOD PROTECT, V74, P622, DOI 10.4315/0362-028X.JFP-10-325
   *ICMSF, 1980, MICR EC FOODS, V1
   Koseki S, 2009, APPL ENVIRON MICROB, V75, P1885, DOI 10.1128/AEM.02283-08
   Le Marc Y, 2005, INT J FOOD MICROBIOL, V100, P3, DOI 10.1016/j.ijfoodmicro.2004.10.003
   Lee KA, 2011, FOOD SCI BIOTECHNOL, V20, P1069, DOI 10.1007/s10068-011-0145-z
   Lee WC, 2001, J FOOD PROTECT, V64, P899, DOI 10.4315/0362-028X-64.6.899
   LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049
   Li J, 2016, APPL ENVIRON MICROB, V82, P1828, DOI 10.1128/AEM.03080-15
   MCKELLAR RC, 2004, MODELING MICROBIAL R
   McMeekin T, 2013, FOOD CONTROL, V29, P290, DOI 10.1016/j.foodcont.2012.06.001
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Oh SK, 2007, J FOOD PROTECT, V70, P1153, DOI 10.4315/0362-028X-70.5.1153
   Olmez HK, 2005, INT J FOOD MICROBIOL, V98, P135, DOI 10.1016/j.ijfoodmicro.2004.05.018
   Oscar TP, 2002, INT J FOOD MICROBIOL, V76, P177, DOI 10.1016/S0168-1605(02)00025-9
   Oscar TR, 2005, J FOOD SCI, V70, pM129, DOI 10.1111/j.1365-2621.2005.tb07103.x
   Park H O, 2001, J FOOD HYG SAF, V16, P280
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773
   RATKOWSKY DA, 1995, LETT APPL MICROBIOL, V20, P29, DOI 10.1111/j.1472-765X.1995.tb00400.x
   RATKOWSKY DA, 1982, J BACTERIOL, V149, P1
   Riva M, 2000, CEREAL CHEM, V77, P433, DOI 10.1094/CCHEM.2000.77.4.433
   Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8
   ROSS T, 1999, PREDICTIVE FOOD MICR
   SUTHERLAND JP, 1994, INT J FOOD MICROBIOL, V21, P217, DOI 10.1016/0168-1605(94)90029-9
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
   Wang J, 2012, J FOOD SAFETY, V32, P296, DOI 10.1111/j.1745-4565.2012.00380.x
   Wang J, 2012, FOOD SCI BIOTECHNOL, V21, P859, DOI 10.1007/s10068-012-0111-4
   Wu Y, 2009, FOOD RES INT, V42, P221, DOI 10.1016/j.foodres.2008.11.001
   Yoon SK, 2011, FOOD SCI BIOTECHNOL, V20, P23, DOI 10.1007/s10068-011-0004-y
   Zhao X, 2014, J MICROBIOL BIOTECHN, V24, P297, DOI 10.4014/jmb.1310.10013
NR 42
TC 3
Z9 3
U1 2
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 22
PY 2017
VL 8
AR 1140
DI 10.3382/fmicb.2017.01140
PG 10
WC Microbiology
SC Microbiology
GA EY3LN
UT WOS:000403872900001
PM 28690596
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Lin, KY
   Cheng, A
   Chang, YC
   Hung, MC
   Wang, JT
   Sheng, WH
   Hseuh, PR
   Chen, YC
   Chang, SC
AF Lin, Kuan-Yin
   Cheng, Aristine
   Chang, Yu-Ching
   Hung, Mei-Chuan
   Wang, Jann-Tay
   Sheng, Wang-Huei
   Hseuh, Po-Ren
   Chen, Yee-Chun
   Chang, Shan-Chwen
TI Central line-associated bloodstream infections among critically-ill
   patients in the era of bundle care
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Bloodstream infection; Central line; Intensive care unit; Mortality;
   Risk factor
ID DEVICE-ASSOCIATED MODULE; CONTROL CONSORTIUM INICC; GRAM-NEGATIVE
   BACTERIA; RISK-FACTORS; SURVEILLANCE DEFINITION; 8 CITIES; UNITS;
   EPIDEMIOLOGY; RATES; IMPACT
AB Background/Purpose: Patients admitted to intensive care units (ICUs) are at high risk for central line-associated bloodstream infections (CLABSIs). Bundle care has been documented to reduce CLABSI rates in Western countries, however, few reports were from Asian countries and the differences in the epidemiology or outcomes of critically-ill patients with CLABSIs after implementation of bundle care remain unknown. We aimed to evaluate the incidence, microbiological characteristics, and factors associated with mortality in critically-ill patients after implementation of bundle care.
   Methods: Prospective surveillance was performed on patients admitted to ICUs at the National Taiwan University Hospital, Taipei, Taiwan from January 2012 to June 2013. The demographic, microbiological, and clinical data of patients who developed CLABSI according to the National Healthcare Safety Network definition were reviewed. A total of 181 episodes of CLABSI were assessed in 156 patients over 46,020 central-catheter days.
   Results: The incidence of CLABSI was 3.93 per 1000 central-catheter days. The predominant causative microorganisms isolated from CLABSI episodes were Gram-negative bacteria (39.2%), followed by Gram-positive bacteria (33.2%) and Candida spp. (27.6%). Median time from insertion of a central catheter to occurrence of CLABSI was 8 days. In multivariate analysis, the independent factors associated with mortality were higher Pitt bacteremia score [odds ratio (OR) 1.41; 95% confidence interval (CI) 1.18-1.68] and longer interval between onset of CLABSIs and catheter removal (OR 1.10; 95% CI 1.02-1.20), respectively.
   Conclusion: In institutions with a high proportion of CLABSI caused by Gram-negative bacteria, severity of bacteremia and delay in catheter removal were significant factors associated with mortality. Copyright (C) 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
C1 [Lin, Kuan-Yin] Ctr Drug Evaluat, Taipei, Taiwan.
   [Cheng, Aristine] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan.
   [Chang, Yu-Ching; Hung, Mei-Chuan] Natl Taiwan Univ Hosp, Infect Control Ctr, Taipei, Taiwan.
   [Wang, Jann-Tay; Sheng, Wang-Huei; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 100, Taiwan.
   [Wang, Jann-Tay; Sheng, Wang-Huei; Hseuh, Po-Ren; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.
   [Wang, Jann-Tay; Sheng, Wang-Huei; Hseuh, Po-Ren; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan.
RP Sheng, WH (reprint author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 100, Taiwan.
EM whsheng@ntu.edu.tw
OI CHEN, YEE-CHUN/0000-0002-1816-9010; CHANG,
   SHAN-CHWEN/0000-0001-6505-4139; Cheng, Aristine/0000-0002-1182-7375;
   SHENG, WANG-HUEI/0000-0002-5605-7853; WANG,
   JANN-TAY/0000-0002-0924-3469; Lin, Kuan-Yin/0000-0001-6877-5345
CR AL-Rawajfah OM, 2012, AM J INFECT CONTROL, V40, P227, DOI 10.1016/j.ajic.2011.03.014
   Aslakson RA, 2011, INFECT CONT HOSP EP, V32, P121, DOI 10.1086/657941
   Bouza E, 2013, J HOSP INFECT, V85, P316, DOI 10.1016/j.jhin.2013.08.008
   Center for Disease Control Statistics of Communicable Diseases and Surveillance Reports on Taiwan Area, 2012, STAT COMM DIS SURV R
   Centers for Disease Control and Prevention (CDC), 2013, NAT HEALTHC SAF NETW
   Chang TY, 2010, J MICROBIOL IMMUNOL, V43, P233, DOI 10.1016/S1684-1182(10)60037-0
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002
   Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002
   Exline MC, 2013, CRIT CARE, V17, DOI 10.1186/cc12551
   Fagan RP, 2013, INFECT CONT HOSP EP, V34, P893, DOI 10.1086/671724
   Fysaraki M, 2013, INT J MED SCI, V10, P1632, DOI 10.7150/ijms.6710
   Garnacho-Montero J, 2008, INTENS CARE MED, V34, P2185, DOI 10.1007/s00134-008-1204-7
   Hebert C, 2010, CURR OPIN INFECT DIS, V23, P340, DOI 10.1097/QCO.0b013e32833ae214
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Jaggi N, 2013, INT J INFECT DIS, V17, pE1218, DOI 10.1016/j.ijid.2013.07.007
   Jensen US, 2011, CLIN MICROBIOL INFEC, V17, P1148, DOI 10.1111/j.1469-0691.2011.03587.x
   Jeong IS, 2013, AM J INFECT CONTROL, V41, P710, DOI 10.1016/j.ajic.2012.10.010
   Katherason SG, 2010, TROP BIOMED, V27, P308
   Khalid I, 2013, AM J INFECT CONTROL, V41, P1209, DOI 10.1016/j.ajic.2013.05.028
   Leblebicioglu H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-10
   Marcos M, 2011, J ANTIMICROB CHEMOTH, V66, P2119, DOI 10.1093/jac/dkr231
   Marra AR, 2007, J CLIN GASTROENTEROL, V41, P19, DOI 10.1097/01.mcg.0000212606.13348.f7
   Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
   O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003
   Oostdijk EAN, 2011, CRIT CARE MED, V39, P961, DOI 10.1097/CCM.0b013e318208ee26
   Peng SL, 2013, J CRIT CARE, V28, P277, DOI 10.1016/j.jcrc.2012.09.007
   Picardi M, 2012, ANN ONCOL, V23, P2122, DOI 10.1093/annonc/mdr588
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115
   Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309
   Rattanaumpawan P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-167
   Rodriguez-Creixems M, 2013, CLIN MICROBIOL INFEC, V19, P845, DOI 10.1111/1469-0691.12050
   Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020
   Sagana R, 2013, CRIT CARE CLIN, V29, P1, DOI 10.1016/j.ccc.2012.10.003
   Silvestri L, 2007, J HOSP INFECT, V65, P187, DOI 10.1016/j.jhin.2006.10.014
   Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243
   Steinberg JP, 2013, INFECT CONT HOSP EP, V34, P171, DOI 10.1086/669082
   Vandijck DM, 2008, INT J ANTIMICROB AG, V31, P161, DOI 10.1016/j.ijantimicag.2007.10.015
   Wu Chi-Jung, 2006, Journal of Microbiology Immunology and Infection, V39, P135
   Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763
NR 40
TC 17
Z9 17
U1 0
U2 1
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD JUN
PY 2017
VL 50
IS 3
BP 339
EP 348
DI 10.1016/j.jmii.2015.07.001
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FB4KN
UT WOS:000406110600011
PM 26316008
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Totaro, M
   Valentini, P
   Casini, B
   Miccoli, M
   Costa, AL
   Baggiani, A
AF Totaro, M.
   Valentini, P.
   Casini, B.
   Miccoli, M.
   Costa, A. L.
   Baggiani, A.
TI Experimental comparison of point-of-use filters for drinking water
   ultrafiltration
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article
DE Point-of-use filters; Pseudomonas; Brevundimonas; Water quality
ID BREVUNDIMONAS-DIMINUTA; PREVENTING EXPOSURE; LEGIONELLA; CONTAMINATION;
   INFECTIONS; STAGNATION; PATHOGENS; MICROBES; RECOVERY; BACTERIA
AB Background: Waterborne pathogens such as Pseudomonas spp. and Legionella spp. may persist in hospital water networks despite chemical disinfection. Point-of-use filtration represents a physical control measure that can be applied in high-risk areas to contain the exposure to such pathogens. New technologies have enabled an extension of filters' lifetimes and have made available faucet hollow-fibre filters for water ultrafiltration.
   Aim: To compare point-of-use filters applied to cold water within their period of validity.
   Methods: Faucet hollow-fibre filters (filter A), shower hollow-fibre filters (filter B) and faucet membrane filters (filter C) were contaminated in two different sets of tests with standard bacterial strains (Pseudomonas aeruginosa DSM 939 and Brevundimonas diminuta ATCC 19146) and installed at points-of-use. Every day, from each faucet, 100 L of water was flushed. Before and after flushing, 250 mL of water was collected and analysed for microbiology.
   Findings: There was a high capacity of microbial retention from filter C; filter B released only low Brevundimonas spp. counts; filter A showed poor retention of both microorganisms.
   Conclusion: Hollow-fibre filters did not show good micro-organism retention. All point-of-use filters require an appropriate maintenance of structural parameters to ensure their efficiency. (C) 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
C1 [Totaro, M.; Valentini, P.; Casini, B.; Costa, A. L.; Baggiani, A.] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.
   [Miccoli, M.] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.
RP Baggiani, A (reprint author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.
EM angelo.baggiani@med.unipi.it
CR [Anonymous], 2009, 109931 ENISO
   [Anonymous], 2011, GUID DRINK WAT QUAL
   Baggiani A, 2015, ANN IG MED PREV COMU, V27, P718, DOI 10.7416/ai.2015.2064
   Baron JL, 2014, AM J INFECT CONTROL, V42, P1193, DOI 10.1016/j.ajic.2014.08.002
   Casini B, 2014, INFECT CONT HOSP EP, V35, P293, DOI 10.1086/675280
   Cristina ML, 2014, INFECT CONT HOSP EP, V35, P122, DOI 10.1086/674863
   Donofrio RS, 2010, J IND MICROBIOL BIOT, V37, P407, DOI 10.1007/s10295-010-0689-6
   Hill VR, 2007, APPL ENVIRON MICROB, V73, P4218, DOI 10.1128/AEM.02713-06
   Hosein IK, 2005, J HOSP INFECT, V61, P100, DOI 10.1016/j.jhin.2005.02.008
   Jiang X, 2015, J BIOMED MAT RES B
   Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032
   Lindquist ED, 2014, AM J TROP MED HYG, V91, P190, DOI 10.4269/ajtmh.13-0568
   Lipphaus P, 2014, ENVIRON TECHNOL, V35, P620, DOI 10.1080/09593330.2013.839748
   Marchesi I, 2011, J HOSP INFECT, V77, P47, DOI 10.1016/j.jhin.2010.09.012
   Sax H, 2015, CLIN INFECT DIS, V61, P67, DOI 10.1093/cid/civ198
   SEGERS P, 1994, INT J SYST BACTERIOL, V44, P499, DOI 10.1099/00207713-44-3-499
   Sheffer PJ, 2005, AM J INFECT CONTROL, V33, pS20, DOI 10.1016/j.ajic.2005.03.012
   Smith CM, 2009, APPL ENVIRON MICROB, V75, P5284, DOI 10.1128/AEM.00456-09
   Trautmann M, 2008, AM J INFECT CONTROL, V36, P421, DOI 10.1016/j.ajic.2007.09.012
   UK Department of Health, 2006, 0401 DOH B
   US Environmental Protection Agency, 2005, EPA600R05104
   Wang H, 2013, WATER RES, V47, P5760, DOI 10.1016/j.watres.2013.06.052
   Warris A, 2010, J HOSP INFECT, V76, P56, DOI 10.1016/j.jhin.2010.03.014
   WHO, 2007, LEGIONELLA PREVENTIO
   Zhou ZY, 2014, CLIN MICROBIOL INFEC, V20, P310, DOI 10.1111/1469-0691.12299
NR 25
TC 7
Z9 7
U1 3
U2 25
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0195-6701
EI 1532-2939
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD JUN
PY 2017
VL 96
IS 2
BP 172
EP 176
DI 10.1016/j.jhin.2016.11.017
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EU4YS
UT WOS:000401038700015
PM 28073586
DA 2020-05-07
ER

PT J
AU Martinez-Bonet, M
   Gonzalez-Serna, A
   Clemente, MI
   Moron-Lopez, S
   Diaz, L
   Navarro, M
   Puertas, MC
   Leal, M
   Ruiz-Mateos, E
   Martinez-Picado, J
   Munoz-Fernandez, MA
AF Martinez-Bonet, M.
   Gonzalez-Serna, A.
   Clemente, M. I.
   Moron-Lopez, S.
   Diaz, L.
   Navarro, M.
   Puertas, M. C.
   Leal, M.
   Ruiz-Mateos, E.
   Martinez-Picado, J.
   Munoz-Fernandez, M. A.
TI Relationship between CCR5((WT/Delta 32)) heterozygosity and HIV-1
   reservoir size in adolescents and young adults with perinatally acquired
   HIV-1 infection
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Adolescents; CCR5((WT/Delta 32)); Human immunodeficiency virus-1;
   Reservoir size; Young adults
ID SUPPRESSIVE ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; DISEASE
   PROGRESSION; CELLS; CCR5; AGE; INDIVIDUALS; ACTIVATION; INFANTS; CD4(+)
AB Background: Several host factors contribute to human immunodeficiency virus (HIV) disease progression in the absence of combination antiretroviral therapy (cART). Among them, the CC-chemokine receptor 5 (CCR5) is known to be the main co-receptor used by HIV-1 to enter target cells during the early stages of an HIV-1 infection.
   Objective: We evaluated the association of CCR5((WT/Delta 32)) heterozygosity with HIV-1 reservoir size, lymphocyte differentiation, activation and immunosenescence in adolescents and young adults with perinatally acquired HIV infection receiving cART.
   Methods: CCR5 genotype was analysed in 242 patients with vertically transmitted HIV-1 infection from Paediatric Spanish AIDS Research Network Cohort (coRISpe). Proviral HIV-1 DNA was quantified by digital-droplet PCR, and T-cell phenotype was evaluated by flow cytometry in a subset of 24 patients (ten with CCR5((Delta 32/WT)) genotype and 14 with CCR5((WT/WT)) genotype).
   Results: Twenty-three patients were heterozygous for the Delta 32 genotype but none was homozygous for the mutated CCR5 allele. We observed no difference in the HIV-1 reservoir size (455 and 578 copies of HIV-1 DNA per million CD4(+) T cells in individuals with CCR5((WT/WT)) and CCR5((Delta 32/WT)) genotypes, respectively; p 0.75) or in the immune activation markers between both genotype groups. However, we found that total HIV-1 DNA in CD4(+) T cells correlated with the percentage of memory CD4(+) T cells: a direct correlation in CCR5((WT/Delta 32)) patients but an inverse correlation in those with the CCR5((WT/WT)) genotype.
   Conclusions: This finding suggests a differential distribution of the viral reservoir compartment in CCR5((WT/Delta 32)) patients with perinatal HIV infection, which is a characteristic that may affect the design of strategies for reservoir elimination. M. Martinez-Bonet, Clin Microbiol Infect 2017;23:318 (C) 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Martinez-Bonet, M.; Gonzalez-Serna, A.; Clemente, M. I.; Diaz, L.; Munoz-Fernandez, M. A.] IiSGM, Hosp Gen Univ Gregorio Maranon, Sect Immunol, Lab Immuno Mol Biol, Madrid, Spain.
   [Martinez-Bonet, M.; Clemente, M. I.; Diaz, L.; Munoz-Fernandez, M. A.] Spanish HIV HGM BioBank, Madrid, Spain.
   [Martinez-Bonet, M.; Clemente, M. I.; Diaz, L.; Munoz-Fernandez, M. A.] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
   [Gonzalez-Serna, A.; Leal, M.; Ruiz-Mateos, E.] Univ Seville, Lab Immunovirol, Clin Unit Infect Dis Microbiol & Prevent Med, Inst Biomed Seville,IBiS,Virgen Rocio Univ Hosp,C, Seville, Spain.
   [Moron-Lopez, S.; Puertas, M. C.; Martinez-Picado, J.] Univ Autonoma Barcelona, AIDS Res Inst IrsiCaixa, Inst Invest Ciencies Salut Germans Trias i Pujol, Badalona, Spain.
   [Navarro, M.] Hosp Gen Univ Gregorio Maranon, Dept Infect Dis Sect, Paediat Serv, Madrid, Spain.
   [Martinez-Picado, J.] Univ Vic Univ Cent Catalunya UVic UCC, Barcelona, Spain.
   [Martinez-Picado, J.] ICREA, Barcelona, Spain.
RP Munoz-Fernandez, MA (reprint author), IrsiCaixa Fdn, Inst Invest Sanitaria Gregorio Maranon, Hosp Gen Univ Gregorio Maranon, Hosp Germans Trias i Pujol,Lab Inmunobiol Mol,Spa, Madrid, Spain.; Martinez-Picado, J (reprint author), Ctra Canyet S-N, Barcelona 08916, Spain.
EM jmpicado@irsicaixa.es; mmunoz.hgugm@gmail.com
RI Gonzalez-Serna, Alejandro/M-2076-2014; Ruiz-Mateos,
   Ezequiel/P-9741-2019; Moron-Lopez, Sara/AAA-8246-2020; Gonzalez-Serna,
   Alejandro/A-3565-2016; Martinez-Picado, Javier/G-5507-2012; Puertas,
   Maria/G-3251-2016
OI Gonzalez-Serna, Alejandro/0000-0002-0239-8417; Ruiz-Mateos,
   Ezequiel/0000-0001-6747-7813; Moron-Lopez, Sara/0000-0003-0800-9205;
   Gonzalez-Serna, Alejandro/0000-0002-5397-0006; Martinez-Picado,
   Javier/0000-0002-4916-2129; Puertas, Maria/0000-0002-6750-2318; Martinez
   Bonet, Marta/0000-0003-0715-403X; Munoz-Fernandez/0000-0002-0813-4500
FU Spanish Institute de Salud Carlos IIIInstituto de Salud Carlos III;
   CERCA programme from Generalitat de Catalunya; Institute de Salud Carlos
   III (Subdireccion General de Evaluacion); Fondo Europeo de Desarrollo
   Regional (FEDER)European Union (EU) [RETIC PT13/0010/0028]; Fondo de
   Investigacion Sanitaria (FIS)Instituto de Salud Carlos III [PI13/02016,
   PI12/0014, CD14/00320, CPII014/00025, PI12/02283]; Comunidad de
   MadridComunidad de MadridInstituto de Salud Carlos III
   [RD12/2010/BMD-2332]; Accion Estrategica en Salud, Plan Nacional de
   Investigacion Cientifica, Desarrollo e Innovacion Tecnologica
   [RD12/0017/0037]; CYTED [214RT0482]; VI National RDi Plan; Iniciativa
   Ingenio; Consolider Program; CIBER Actions; Institute de Salud Carlos
   IIIInstituto de Salud Carlos III; Spanish Secretariat of Research
   [RD12/0017, SAF2013-49042-R]; Foundation for AIDS Research (amfAR);
   Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA'
   [RD12/0017/0002]; Agencia de Gestio d'Ajuts Universitaris i de Recerca
   from Generalitat de CatalunyaGeneralitat de Catalunya [2013FI_B 00275]
FX We particularly acknowledge the Spanish HIV HGM BioBank supported by the
   Spanish Institute de Salud Carlos III, which is integrated with the
   Spanish AIDS Research Network. We thank V. Urrea (AIDS Research
   Institute IrsiCaixa, Badalona) for statistical support. IrsiCaixa is
   supported by the CERCA programme from Generalitat de Catalunya.; Work by
   the group of MAMF was supported by Institute de Salud Carlos III
   (Subdireccion General de Evaluacion) and Fondo Europeo de Desarrollo
   Regional (FEDER), RETIC PT13/0010/0028, Fondo de Investigacion Sanitaria
   (FIS) (grants PI13/02016, PI12/0014 and CD14/00320 to AGS), Comunidad de
   Madrid (grant RD12/2010/BMD-2332]. This work was (partially) funded by
   the RD12/0017/0037 project as part of the Accion Estrategica en Salud,
   Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion
   Tecnologica 2008-2011 (HGUGM) and by CYTED 214RT0482. CIBER-BBN is an
   initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa
   Ingenio 2010, Consolider Program, CIBER Actions and financed by the
   Institute de Salud Carlos III with assistance from the European Regional
   Development Fund. This project was also supported by the Spanish
   Secretariat of Research (grant Red Tematica de Investigacion Cooperativa
   en SIDA [RD12/0017] and CPII014/00025 and PI12/02283 from Fondo de
   Investigacion Sanitaria (FIS) to E.R.-M.); Work by the JM-P group is
   supported by the Spanish Secretariat of Research (grant
   SAF2013-49042-R), the Foundation for AIDS Research (amfAR), and the
   Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA'
   (RD12/0017/0002). S.M-L. was supported by Agencia de Gestio d'Ajuts
   Universitaris i de Recerca from Generalitat de Catalunya (2013FI_B
   00275).
CR ALDHOUS MC, 1994, J CLIN IMMUNOL, V14, P289, DOI 10.1007/BF01540982
   Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269
   Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925
   Briz V, 2012, PEDIATR INFECT DIS J, V31, P1048, DOI 10.1097/INF.0b013e3182684d8e
   Bunders MJ, 2012, BLOOD, V120, P4383, DOI 10.1182/blood-2012-06-437566
   Cavarelli M, 2009, DIS MARKERS, V27, P121, DOI [10.1155/2009/685608, 10.3233/DMA-2009-0656]
   De Martino M, 1998, PEDIATR RES, V43, P752, DOI 10.1203/00006450-199806000-00007
   Ferrando-Martinez S, 2010, IMMUNOL LETT, V127, P157, DOI 10.1016/j.imlet.2009.10.001
   Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27
   Henrich TJ, 2016, J INFECT DIS, V213, P766, DOI 10.1093/infdis/jiv504
   Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240
   Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311
   JAPOUR AJ, 1994, J CLIN MICROBIOL, V32, P2291, DOI 10.1128/JCM.32.9.2291-2294.1994
   Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456
   Mendez-Lagares G, 2013, CLIN MICROBIOL INFEC, V19, P558, DOI 10.1111/j.1469-0691.2012.03934.x
   Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338
   Misrahi M, 1998, JAMA-J AM MED ASSOC, V279, P277, DOI 10.1001/jama.279.4.277
   Neogi U, 2012, JAIDS-J ACQ IMM DEF, V59, P347, DOI 10.1097/QAI.0b013e3182405c7b
   Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999
   Persaud D, 2007, AIDS RES HUM RETROV, V23, P381, DOI 10.1089/aid.2006.0175
   Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560
   Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638
   Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211
   Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
   Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003
   Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003
   Vallejo A, 2006, VIRAL IMMUNOL, V19, P759, DOI 10.1089/vim.2006.19.759
   Wang C, 2014, J INFECT DIS, V210, P1838, DOI 10.1093/infdis/jiu338
   Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665
NR 29
TC 3
Z9 3
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAY
PY 2017
VL 23
IS 5
BP 318
EP 324
DI 10.1016/j.cmi.2016.12.020
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EZ1KM
UT WOS:000404469900010
PM 28042001
OA Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Santos, DW
   Camargo, LP
   Goncalves, SS
   Ogawa, MM
   Tomimori, J
   Enokihara, MM
   Medina-Pestana, JO
   Colombo, AL
AF Santos, D. W.
   Camargo, L. P.
   Goncalves, S. S.
   Ogawa, M. M.
   Tomimori, J.
   Enokihara, M. M.
   Medina-Pestana, J. O.
   Colombo, A. L.
TI Melanized fungal infections in kidney transplant recipients:
   contributions to optimize clinical management
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Chromoblastomycosis; Kidney transplantation; Melanized fungi;
   Phaeohyphomycosis; Exophiala spp.
ID SURVEILLANCE NETWORK TRANSNET; DEMATIACEOUS FUNGI; SURGICAL EXCISION;
   HUMAN-DISEASE; PHEOHYPHOMYCOSIS; CHROMOBLASTOMYCOSIS; CHROMOMYCOSIS;
   PATIENT
AB Objectives: This is a retrospective and observational study addressing clinical and therapeutic aspects of melanized fungal infections in kidney transplant recipients.
   Methods: We retrospectively reviewed medical records of all patients admitted between January 1996 and December 2013 in a single institution who developed infections by melanized fungi.
   Results: We reported on 56 patients aged between 30 and 74 years with phaeohyphomycosis or chromoblastomycosis (0.54 cases per 100 kidney transplants). The median time to diagnosis post-transplant was 31.2 months. Thirty-four (60.8%) infections were reported in deceased donor recipients. Fifty-one cases of phaeohyphomycosis were restricted to subcutaneous tissues, followed by two cases with pneumonia and one with brain involvement. Most dermatological lesions were represented by cysts (23/51; 45.1%) or nodules (9/51; 17.9%). Exophiala spp. (34.2%) followed by Alternaria spp. (7.9%) were the most frequent pathogens. Graft loss and death occurred in two patients and one patient, respectively. Regarding episodes of subcutaneous phaeohyphomycosis, a complete surgical excision without antifungal therapy was possible in 21 of 51 (41.2%) patients. Long periods of itraconazole were required to treat the other 30 (58.8%) episodes of subcutaneous disease. All four cases of chromoblastomycosis were treated only with antifungal therapy.
   Conclusions: Melanized fungal infections should be considered in the differential diagnosis of all chronic skin lesions in transplant recipients. It is suggested that the impact of these infections on graft function and mortality is low. The reduction in immunosuppression should be limited to severely ill patients. (C) 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Santos, D. W.; Goncalves, S. S.; Colombo, A. L.] Univ Fed Sao Paulo, Div Infect Dis, Special Mycol Lab LEMI, Sao Paulo, SP, Brazil.
   [Santos, D. W.; Medina-Pestana, J. O.] Hosp Rim, Div Infect Dis, Sao Paulo, SP, Brazil.
   [Camargo, L. P.; Colombo, A. L.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, SP, Brazil.
   [Ogawa, M. M.; Tomimori, J.; Enokihara, M. M.] Univ Fed Sao Paulo, Dept Dermatol, Sao Paulo, SP, Brazil.
RP Colombo, AL (reprint author), Univ Fed Sao Paulo, Lab Especial Micol, Disciplina Infectol, Rua Botucatu 740, BR-04023062 Sao Paulo, SP, Brazil.
EM arnaldolcolombo@gmail.com
RI Ogawa, Marilia/N-2287-2017; Colombo, Arnaldo Lopes/V-4417-2019
OI Ogawa, Marilia/0000-0002-8073-923X; Camargo, Luis Fernando
   Aranha/0000-0002-3888-8661; MEDINA-PESTANA, JOSE/0000-0002-0750-7360;
   Colombo, Arnaldo Lopes/0000-0003-0793-8491; Medina Pestana,
   Jose/0000-0003-3912-2980
FU Ethical Committee of the UNIFESP [0524/08]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [307510/2015-8]
FX We are grateful to the team of infectious diseases and dermatology
   responsible for solid organ transplant of Federal University of Sao
   Paulo (UNIFESP) and to Dr Jose Osmar Medina-Pestana of Division of
   Nephrology (UNIFESP). This project was approved by the Ethical Committee
   of the UNIFESP No. 0524/08. This study was partially supported by CNPq,
   Grant 307510/2015-8.
CR AJELLO L, 1974, MYCOLOGIA, V66, P490, DOI 10.2307/3758492
   Ben-Ami R, 2009, CLIN INFECT DIS, V48, P1033, DOI 10.1086/597400
   Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425
   Chowdhary A, 2014, CLIN MICROBIOL INFEC, V20, P47, DOI 10.1111/1469-0691.12515
   Chowdhary A, 2008, MED MYCOL, V46, P163, DOI 10.1080/13693780701630420
   Crawford SJ, 2015, TRANSPL INFECT DIS, V17, P915, DOI 10.1111/tid.12464
   de Monbrison F, 2004, BRIT J DERMATOL, V150, P597, DOI 10.1111/j.1365-2133.2003.05794.x
   De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660
   Dupont C, 2010, TRANSPL INFECT DIS, V12, P180, DOI 10.1111/j.1399-3062.2009.00477.x
   Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928
   Franco A, 1996, NEPHROL DIAL TRANSPL, V11, P715, DOI 10.1093/oxfordjournals.ndt.a027370
   Garcia-Diaz Julia B, 2002, Semin Respir Infect, V17, P303, DOI 10.1053/srin.2002.36448
   Koo S, 2010, MED MYCOL, V48, P769, DOI 10.3109/13693780903471081
   Machet L, 1996, DERMATOLOGY, V193, P342, DOI 10.1159/000246287
   McCarty TP, 2015, MED MYCOL, V53, P440, DOI 10.1093/mmy/myv018
   MORALES LA, 1985, NEPHRON, V40, P238, DOI 10.1159/000183468
   Ogawa MM, 2009, J AM ACAD DERMATOL, V61, P977, DOI 10.1016/j.jaad.2009.03.037
   Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262
   Queiroz-Telles F, 2017, CLIN MICROBIOL REV, V30, P233, DOI 10.1128/CMR.00032-16
   Revankar SG, 2006, INFECT DIS CLIN N AM, V20, P609, DOI 10.1016/j.idc.2006.06.004
   Revankar SG, 2010, CLIN MICROBIOL REV, V23, P884, DOI 10.1128/CMR.00019-10
   Rossmann SN, 1996, CLIN INFECT DIS, V22, P73, DOI 10.1093/clinids/22.1.73
   Salama AD, 1997, TRANSPLANTATION, V63, P160, DOI 10.1097/00007890-199701150-00030
   Schieffelin JS, 2014, TRANSPL INFECT DIS, V16, P270, DOI 10.1111/tid.12197
   Severo CB, 2012, MEM I OSWALDO CRUZ, V107, P854, DOI 10.1590/S0074-02762012000700003
   Shoham S, 2008, TRANSPL INFECT DIS, V10, P442, DOI 10.1111/j.1399-3062.2008.00327.x
   Singh N, 1997, CLIN INFECT DIS, V24, P369, DOI 10.1093/clinids/24.3.369
   Sutton Deanna A., 1999, Revista Iberoamericana de Micologia, V16, P171
   WACKYM PA, 1985, ARCH INTERN MED, V145, P1036, DOI 10.1001/archinte.145.6.1036
   YOUNG NA, 1973, AM J CLIN PATHOL, V59, P810
NR 30
TC 11
Z9 11
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAY
PY 2017
VL 23
IS 5
AR 333.e9
DI 10.1016/j.cmi.2016.12.024
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EZ1KM
UT WOS:000404469900014
PM 28062320
OA Bronze
DA 2020-05-07
ER

PT J
AU Debroas, D
   Domaizon, I
   Humbert, JF
   Jardillier, L
   Lepere, C
   Oudart, A
   Taib, N
AF Debroas, Didier
   Domaizon, Isabelle
   Humbert, Jean-Francois
   Jardillier, Ludwig
   Lepere, Cecile
   Oudart, Anne
   Taib, Najwa
TI Overview of freshwater microbial eukaryotes diversity: a first analysis
   of publicly available metabarcoding data
SO FEMS MICROBIOLOGY ECOLOGY
LA English
DT Article
DE microbial eukaryotes; metabarcoding; freshwater; bioinformatics
ID MOLECULAR DIVERSITY; PHYLOGENETIC DIVERSITY; PROTIST COMMUNITIES;
   GENETIC DIVERSITY; RARE; LAKE; BACTERIAL; ECOLOGY; DNA; PICOEUKARYOTES
AB Although they are widespread, diverse and involved in biogeochemical cycles, microbial eukaryotes attract less attention than their prokaryotic counterparts in environmental microbiology. In this study, we used publicly available 18S barcoding data to define biases that may limit such analyses and to gain an overview of the planktonic microbial eukaryotic diversity in freshwater ecosystems. The richness of the microbial eukaryotes was estimated to 100 798 operational taxonomic units (OTUs) delineating 1267 clusters or phylogenetic units (PUs, i.e. monophyletic groups of OTUs that are phylogenetically close). By summing the richness found in aquatic environments, we can predict the microbial eukaryotic richness to be around 200 000- 250 000 species. The molecular diversity of protists in freshwater environments is generally higher than that of the morphospecies and cultivated species catalogued in public databases. Amoebozoa, Viridiplantae, Ichthyosporea, and Cryptophyta are the most phylogenetically diverse taxa, and characterisation of these groups is still needed. A network analysis showed that Fungi, Stramenopiles and Viridiplantae play central role in lake ecosystems. Finally, this work provides guidance for compiling metabarcoding data and identifies missing data that should be obtained to increase our knowledge on microbial eukaryote diversity.
C1 [Debroas, Didier; Lepere, Cecile; Oudart, Anne; Taib, Najwa] Univ Clermont Auvergne, CNRS, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France.
   [Domaizon, Isabelle] INRA, UMR 42, Ctr Alpin Rech Reseaux Troph & Ecosyst Limn, F-74200 Thonon Les Bains, France.
   [Humbert, Jean-Francois] INRA, UMR BIOEMCO, Site ENS,46 Rue Ulm, F-75005 Paris, France.
   [Jardillier, Ludwig] Univ Paris Sud, CNRS UMR 8079, Unite Ecol Systemat & Evolut, F-91405 Orsay, France.
RP Debroas, D (reprint author), Univ Clermont Auvergne, CNRS, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France.
EM didier.debroas@uca.fr
RI Jardillier, Ludwig E/H-8486-2015; Domaizon, Isabelle/A-2517-2011
OI Jardillier, Ludwig E/0000-0003-4982-5807; Domaizon,
   Isabelle/0000-0001-9785-3082; Humbert, Jean-Francois/0000-0002-1519-5651
FU SENDEFO project - French ANR (National Research Agency)
   Contaminants-Ecosystems-HealthFrench National Research Agency (ANR)
FX This work was partly supported by the SENDEFO project funded by the
   French ANR (National Research Agency) Contaminants-Ecosystems-Health
   (CES-2009).
CR Adl SM, 2007, SYSTEMATIC BIOL, V56, P684, DOI 10.1080/10635150701494127
   Archmiller AA, 2015, MOL ECOL, V24, P4042, DOI 10.1111/mec.13264
   Artigas J, 2014, SCI TOTAL ENVIRON, V468, P326, DOI 10.1016/j.scitotenv.2013.08.074
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x
   Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219
   Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298
   Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39
   Bricheux G, 2013, MICROBIOLOGYOPEN, V2, P402, DOI 10.1002/mbo3.80
   BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826
   Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101
   Charvet S, 2014, FEMS MICROBIOL ECOL, V88, P550, DOI 10.1111/1574-6941.12324
   Charvet S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00422
   Chen MJ, 2008, MICROB ECOL, V56, P572, DOI 10.1007/s00248-008-9377-8
   Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602
   de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605
   Debroas D, 2015, MOL ECOL, V24, P1236, DOI 10.1111/mec.13116
   del Campo J, 2015, ENVIRON MICROBIOL, V17, P3195, DOI 10.1111/1462-2920.12759
   del Campo J, 2014, TRENDS ECOL EVOL, V29, P252, DOI 10.1016/j.tree.2014.03.006
   Deng Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-113
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2
   Duarte S, 2015, FUNGAL DIVERS, V70, P127, DOI 10.1007/s13225-014-0300-y
   Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5
   Gaedke U, 2004, AQUAT MICROB ECOL, V34, P247, DOI 10.3354/ame034247
   Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16
   Grattepanche JD, 2014, TRENDS MICROBIOL, V22, P432, DOI 10.1016/j.tim.2014.04.006
   Grossart HP, 2016, FUNGAL ECOL, V19, P28, DOI 10.1016/j.funeco.2015.06.004
   Gutierrez MH, 2011, MAR BIOL, V158, P205, DOI 10.1007/s00227-010-1552-z
   Hugoni M, 2013, P NATL ACAD SCI USA, V110, P6004, DOI 10.1073/pnas.1216863110
   Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x
   Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222
   Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984
   Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166
   Kammerlander B, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv010
   Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166
   Korajkic A, 2015, WATER RES, V69, P30, DOI 10.1016/j.watres.2014.11.003
   Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09
   Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324
   Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005
   Legendre P., 1998, NUMERICAL ECOLOGY
   Lepere C, 2008, APPL ENVIRON MICROB, V74, P2940, DOI 10.1128/AEM.01156-07
   Lepere C, 2013, FEMS MICROBIOL ECOL, V85, P85, DOI 10.1111/1574-6941.12100
   Lepere C, 2010, ISME J, V4, P1509, DOI 10.1038/ismej.2010.83
   Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073
   Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010
   Lynch MDJ, 2015, NAT REV MICROBIOL, V13, P217, DOI 10.1038/nrmicro3400
   Lynch MDJ, 2012, ISME J, V6, P2067, DOI 10.1038/ismej.2012.50
   Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065
   Mangot JF, 2011, HYDROBIOLOGIA, V659, P37, DOI 10.1007/s10750-010-0268-x
   Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341
   Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002
   Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004
   Massana R, 2014, ISME J, V8, P854, DOI 10.1038/ismej.2013.204
   Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903
   Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x
   Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x
   Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606
   Niquil N, 2011, HYDROBIOLOGIA, V659, P65, DOI 10.1007/s10750-010-0308-6
   Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x
   Nowack ECM, 2010, PHILOS T R SOC B, V365, P699, DOI 10.1098/rstb.2009.0188
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419
   Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948
   Pfister G, 2002, LIMNOLOGICA, V32, P147, DOI 10.1016/S0075-9511(02)80005-6
   Pommier T, 2009, BIOINFORMATICS, V25, P736, DOI 10.1093/bioinformatics/btp051
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864
   Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x
   Santoferrara LF, 2014, ENVIRON MICROBIOL, V16, P2752, DOI 10.1111/1462-2920.12380
   Schloss PD, 2016, MBIO, V7, DOI 10.1128/mBio.00201-16
   Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844
   SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225
   Simon M, 2015, ENVIRON MICROBIOL, V17, P3610, DOI 10.1111/1462-2920.12591
   Simon M, 2015, ISME J, V9, P1941, DOI [10.1038/ISMEJ.2015.6, 10.1038/ismej.2015.6]
   Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103
   Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12
   Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004
   Stoeck T, 2014, ENVIRON MICROBIOL, V16, P430, DOI 10.1111/1462-2920.12194
   Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390
   Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950
   Vick-Majors TJ, 2014, ISME J, V8, P778, DOI 10.1038/ismej.2013.190
   Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656
NR 86
TC 33
Z9 33
U1 6
U2 36
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0168-6496
EI 1574-6941
J9 FEMS MICROBIOL ECOL
JI FEMS Microbiol. Ecol.
PD APR
PY 2017
VL 93
IS 4
AR fix023
DI 10.1093/femsec/fix023
PG 14
WC Microbiology
SC Microbiology
GA FA6WU
UT WOS:000405586200009
PM 28334157
OA Bronze
DA 2020-05-07
ER

PT J
AU Vercammen, D
   Telen, D
   Nimmegeers, P
   Janssens, A
   Akkermans, S
   Fernandez, EN
   Logist, F
   Van Impe, J
AF Vercammen, D.
   Telen, D.
   Nimmegeers, P.
   Janssens, A.
   Akkermans, S.
   Fernandez, E. Noriega
   Logist, F.
   Van Impe, J.
TI Application of a dynamic metabolic flux algorithm during a
   temperature-induced lag phase
SO FOOD AND BIOPRODUCTS PROCESSING
LA English
DT Article
DE Dynamic metabolic flux analysis; B-spline parameterization; Experimental
   validation; Predictive microbiology; Dynamic optimization; Lag phase
ID ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; BALANCE ANALYSIS; SYSTEMS
   BIOLOGY; GROWTH-RATE; MICROBIOLOGY; GENERATION; NETWORKS; DURATION;
   MODELS
AB In predictive microbiology, the (induced) lag-phase is a phenomenon of specific interest, as it has a large impact on the assessment of safety and quality of food products. This lag phase has been studied mostly on a macroscopic level. However, a quest for more mechanistically based predictive models has started, for example, through the integration of a metabolic reaction network into widely used macroscopic model structures. This multi-scale modeling approach is called dynamic metabolic flux analysis (dMFA). In this contribution, a recently developed algorithm for dMFA is used to estimate the metabolic fluxes in Escherichia coli K12 during an experimentally induced lag phase through a sudden shift in temperature. To study this phenomenon, controlled bioreactor experiments were performed: on the one hand at a fixed and optimal temperature for growth (37 degrees C), and on the other hand starting at 20 degrees C, with a sudden temperature shift to 37 degrees C during the exponential growth, inducing an intermediate lag phase. The evolution of biomass and metabolite concentrations was monitored during these experiments. After dMFA analysis of the gathered measurements, some interesting patterns in metabolic activity during the different growth phases are revealed. The described case study is a first practical test case to assess the capabilities of the recently developed dMFA methodology in an experimental predictive microbiology setting. (C) 2016 Published by Elsevier B.V. on behalf of Institution of Chemical Engineers.
C1 [Vercammen, D.; Telen, D.; Nimmegeers, P.; Janssens, A.; Akkermans, S.; Fernandez, E. Noriega; Logist, F.; Van Impe, J.] Katholieke Univ Leuven, Dept Chem Engn, BioTeC & OPTEC, Gebroeders Smetstr 1, B-9000 Ghent, Belgium.
RP Van Impe, J (reprint author), Katholieke Univ Leuven, Dept Chem Engn, BioTeC & OPTEC, Gebroeders Smetstr 1, B-9000 Ghent, Belgium.
EM jan.vanimpe@kuleuven.be
RI Logist, Filip/AAG-4210-2020; Nimmegeers, Philippe/AAG-1512-2020
OI Logist, Filip/0000-0001-8621-7531; Nimmegeers,
   Philippe/0000-0002-2086-7694
FU OPTEC [PFV/10/002]; FWOFWO [KAN2013 1.5.189.13, FWO-G.0930.13]; DYSCO
   [BelSPO: IAP VII/19]; KU LeuvenKU Leuven [2015/134]
FX The research was supported by PFV/10/002 (OPTEC), FWO KAN2013
   1.5.189.13, FWO-G.0930.13 and BelSPO: IAP VII/19 (DYSCO). DT holds PDM
   grant 2015/134 from KU Leuven.
CR Andersson J., 2012, RECENT ADV ALGORITHM, V87, P297, DOI DOI 10.1007/978-3-642-30023-3_
   Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003
   Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P973, DOI 10.1016/j.copbio.2013.03.018
   Baert K, 2007, INT J FOOD MICROBIOL, V118, P139, DOI 10.1016/j.ijfoodmicro.2007.07.006
   Berthoumieux S, 2011, BIOINFORMATICS, V27, pI186, DOI 10.1093/bioinformatics/btr225
   Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012
   Biegler LT, 2010, NONLINEAR PROGRAMMIN
   Brul S, 2007, WOODHEAD PUBL FOOD S, P250, DOI 10.1533/9781845692940.2.250
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Chang L, 2016, J PROCESS CONTR, V42, P137, DOI 10.1016/j.jprocont.2016.04.012
   de Boor C, 2001, PRACTICAL GUIDE SPLI
   Delignette-Muller ML, 2005, INT J FOOD MICROBIOL, V100, P77, DOI 10.1016/j.ijfoodmicro.2004.10.021
   Dierckx P, 1993, CURVE SURFACE FITTIN
   Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002
   Francois K, 2006, INT J FOOD MICROBIOL, V108, P326, DOI 10.1016/j.ijfoodmicro.2005.11.017
   Kayser A, 2005, MICROBIOL-SGM, V151, P693, DOI 10.1099/mic.0.27481-0
   Kuhl P, 2011, COMPUT CHEM ENG, V35, P71, DOI 10.1016/j.compchemeng.2010.07.012
   Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9
   Martinez V.S., 2015, METAB ENG COMMUN, V2, P46, DOI DOI 10.1016/j.meteno.2015.06.001
   McMeekin TA, 1997, EMERG INFECT DIS, V3, P541, DOI 10.3201/eid0304.970419
   McMeekin T, 2008, INT J FOOD MICROBIOL, V128, P2, DOI 10.1016/j.ijfoodmicro.2008.06.026
   Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P295, DOI 10.1016/S0168-1605(02)00378-1
   Metris A, 2012, INT J FOOD MICROBIOL, V152, P123, DOI 10.1016/j.ijfoodmicro.2011.06.016
   Munoz-Cuevas M, 2010, APPL ENVIRON MICROB, V76, P2908, DOI 10.1128/AEM.02572-09
   Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006
   Swinnen IAM, 2005, INT J FOOD MICROBIOL, V100, P85, DOI 10.1016/j.ijfoodmicro.2004.10.022
   Swinnen IAM, 2004, INT J FOOD MICROBIOL, V94, P137, DOI 10.1016/j.ijfoodmicro.2004.01.006
   Van Impe JF, 2013, FOOD CONTROL, V29, P336, DOI 10.1016/j.foodcont.2012.06.019
   Vercammen D, 2016, J PROCESS CONTR, V37, P1, DOI 10.1016/j.jprocont.2015.08.014
   Vercammen D., 2014, P 24 EUR S COMP AID, P289
   Vercammen D, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0132-0
   von Stockar U, 1999, BBA-BIOENERGETICS, V1412, P191, DOI 10.1016/S0005-2728(99)00065-1
   Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y
   Whiting RC, 2002, INT J FOOD MICROBIOL, V73, P291, DOI 10.1016/S0168-1605(01)00662-6
   Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187
NR 35
TC 2
Z9 2
U1 0
U2 14
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0960-3085
EI 1744-3571
J9 FOOD BIOPROD PROCESS
JI Food Bioprod. Process.
PD MAR
PY 2017
VL 102
BP 1
EP 19
DI 10.1016/j.fbp.2016.10.003
PG 19
WC Biotechnology & Applied Microbiology; Engineering, Chemical; Food
   Science & Technology
SC Biotechnology & Applied Microbiology; Engineering; Food Science &
   Technology
GA EP4SZ
UT WOS:000397371500001
DA 2020-05-07
ER

PT J
AU Nunez, EGF
   Barchi, AC
   Ito, S
   Escaramboni, B
   Herculano, RD
   Mayer, CRM
   Neto, PD
AF Fernandez Nunez, Eutimio Gustavo
   Barchi, Augusto Cesar
   Ito, Shuri
   Escaramboni, Bruna
   Herculano, Rondinelli Donizetti
   Malacrida Mayer, Cassia Roberta
   Neto, Pedro de Oliva
TI Artificial intelligence approach for high level production of amylase
   using Rhizopus microsporus var. oligosporus and different
   agro-industrial wastes
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE enzymes; experimental design; industrial microbiology; mathematical
   modelling; waste treatment and waste minimization; solid state
   fermentation
ID SOLID-STATE FERMENTATION; OPTIMIZATION; DESIGN
AB BACKGROUND: Culture medium is a key element to be defined when biotechnologies are chosen for agro-industrial wastes reutilization. This work aimed at definition of culture medium composition using four agro-industrial wastes (wheat bran, type II wheat flour, soybean meal and sugarcane bagasse) in solid-state fermentation (SSF) of Rhizopus oligosporus, for high-level production of amylases through approaches based on artificial intelligence (AI) or response surface methodologies (RSM). First, substrates were individually assessed. Then, I-optimal mixture experimental designs were performed to determine the influence of two sets of ternary agro-industrial waste mixtures on amylase and specific amylase activities.
   RESULTS: The best individual substrate for amylases production was wheat bran (392.5 U g(-1)). As a rule, no significant interactions among substrates affecting amylase activities were observed for ternary systems and the approaches under consideration. A significant exception was the amylolytic activity for mixtures composed of wheat bran (91% w/w) and soybean meal (9% w/w). This finding was confirmed analytically by a combination of artificial neural network (ANN) and genetic algorithm (GA). The AI approach improved modelling quality with respect to RSM for production of fungal amylases in SSF.
   CONCLUSION: The I-optimal design in conjunction with ANN-GA is suggested to optimize accurately culture medium to maximize amylase production by SSF. (C) 2016 Society of Chemical Industry
C1 [Fernandez Nunez, Eutimio Gustavo; Barchi, Augusto Cesar; Ito, Shuri] Univ Estadual Paulista, Dept Ciencias Biol, Grp Engn Bioproc, Campus Assis,Ave Dom Antonio 2100, BR-19806900 Assis, SP, Brazil.
   [Escaramboni, Bruna; Neto, Pedro de Oliva] Univ Estadual Paulista, Dept Ciencias Biol, Lab Biotecnol Ind, Campus Assis,Ave Dom Antonio 2100, BR-19806900 Assis, SP, Brazil.
   [Herculano, Rondinelli Donizetti] Univ Estadual Paulista, Dept Ciencias Biol, Lab Fis Biofis & Biomat, Campus Assis,Ave Dom Antonio 2100, BR-19806900 Assis, SP, Brazil.
   [Malacrida Mayer, Cassia Roberta] Univ Estadual Paulista, Dept Ciencias Biol, Lab Quim Alimentos & Nanobiotecnol, Campus Assis,Ave Dom Antonio 2100, BR-19806900 Assis, SP, Brazil.
RP Nunez, EGF (reprint author), Univ Estadual Julio de Mesquita Filho, Dept Ciencias Biol, Campus Assis Ave Dom Antonio 2100, BR-19806900 Assis, SP, Brazil.
EM eutimiocu@yahoo.com
RI Herculano, Rondinelli Donizetti R.D./D-2249-2012; Malacrida,
   Cassia/L-4011-2019; Escaramboni, Bruna/R-9461-2016; Oliva-Neto,
   Pedro/O-2844-2017; Malacrida, Cassia/G-5917-2014; Nunez, Eutimio Gustavo
   Fernandez/I-3064-2013
OI Herculano, Rondinelli Donizetti R.D./0000-0001-7236-0847; Malacrida,
   Cassia/0000-0003-0069-6581; Escaramboni, Bruna/0000-0002-2285-3624;
   Oliva-Neto, Pedro/0000-0001-9378-9036; Malacrida,
   Cassia/0000-0003-0069-6581; Nunez, Eutimio Gustavo
   Fernandez/0000-0002-2800-392X
FU Fundacao para o Desenvolvimento da Unesp (Fundunesp)
   [0312/001/14-Prope/CDC]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) for Scientific Initiation Scholarship [14/06447-0]
FX The authors would like to thank Fundacao para o Desenvolvimento da Unesp
   (Fundunesp) for Scientific Grant (0312/001/14-Prope/CDC) and Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for Scientific
   Initiation Scholarship (14/06447-0), as well as PhD student Edson
   Marcelino Alves for his valuable technical support. Corresponding author
   gratefully acknowledges his wife, Relma, and daughters, Giovanna and
   Paola for the inspiration to write this paper.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Castro R. J. S., 2013, IND CROP PROD, V49, P813, DOI DOI 10.1016/j.indcrop.2013.07.002
   Chiranjeevi PV, 2014, BIORESOURCES, V9, P2459
   Cornell J.A., 2002, EXPT MIXTURES DESIGN
   de Freitas AC, 2014, CHEM PAP, V68, P442, DOI 10.2478/s11696-013-0466-x
   Escaramboni B, 2014, Brazilian Patent, Patent No. [BR 10-2014-031591-8, 1020140315918]
   Fernandez-Nunez EG, 2013, ASIAN J BIOTECHNOL, V5, P1
   Freshney RI, 2010, CULTURE ANIMAL CELLS
   Johnson RT, 2011, QUAL ENG, V23, P287, DOI 10.1080/08982112.2011.576203
   Kosseva MR, 2013, FOOD SCI TECH-INT SE, P77, DOI 10.1016/B978-0-12-391921-2.00005-6
   LEVINSON HS, 1950, J GEN PHYSIOL, V33, P601, DOI 10.1085/jgp.33.5.601
   Liu XS, 2014, STATISTICAL POWER ANALYSIS FOR THE SOCIAL AND BEHAVIORAL SCIENCES: BASIC AND ADVANCED TECHNIQUES, P347
   Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI 10.1002/btpr.67
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Mitchell DA, 2006, SOLID-STATE FERMENTATION BIOREACTORS: FUNDAMENTALS OF DESIGN AND OPERATION, P1, DOI 10.1007/3-540-31286-2_1
   Moreira GA, 2007, BIOCHEM ENG J, V35, P48, DOI 10.1016/j.bej.2006.12.025
   Pandey AK, 2011, BIOAUGMENTATION BIOS, P85
   Prakasham RS, 2009, INT J HYDROGEN ENERG, V34, P6143, DOI 10.1016/j.ijhydene.2009.06.016
   Pruckler M, 2014, LWT-FOOD SCI TECHNOL, V56, P211, DOI 10.1016/j.lwt.2013.12.004
   Singh SK, 2008, CURRENT DEV SOLID ST, P181
   de Castro RJS, 2014, BIOCATAL AGRIC BIOTE, V3, P236, DOI 10.1016/j.bcab.2014.06.001
   Ugwuanyi J.O, 2009, BIOTECHNOLOGY AGROIN, P77
   Ustok FI, 2007, J BIOTECHNOL, V127, P322, DOI 10.1016/j.jbiotec.2006.07.010
   Vijayaraghavan P., 2011, Research Journal of Microbiology, V6, P366, DOI 10.3923/jm.2011.366.375
   Zenebon O, 2008, METODOS FISICO QUIMI
NR 25
TC 4
Z9 4
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2017
VL 92
IS 3
BP 684
EP 692
DI 10.1002/jctb.5054
PG 9
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA EP5DZ
UT WOS:000397400500026
DA 2020-05-07
ER

PT J
AU Bouza, E
   Martinez-Alarcon, J
   Maseda, E
   Palomar, M
   Zaragoza, R
   Perez-Granda, MJ
   Munoz, P
   Burillo, A
AF Bouza, Emilio
   Martinez-Alarcon, Jose
   Maseda, Emilio
   Palomar, Mercedes
   Zaragoza, Rafael
   Perez-Granda, Maria Jesus
   Munoz, Patricia
   Burillo, Almudena
CA Diag Etiolog Neumonia Asoc Ventila
TI Quality of the aetiological diagnosis of ventilator-associated pneumonia
   in Spain in the opinion of intensive care specialists and
   microbiologists
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Ventilator-associated pneumonia; diagnosis; Intensive care;
   Microbiological techniques; Health surveys
ID HOSPITAL-ACQUIRED PNEUMONIA; CLINICAL-PRACTICE GUIDELINES;
   CRITICALLY-ILL PATIENTS; REQUIRING MECHANICAL VENTILATION; ENDOTRACHEAL
   ASPIRATE; RANDOMIZED-TRIAL; MANAGEMENT; IMPLEMENTATION; ASPERGILLOSIS;
   SURVEILLANCE
AB Introduction: Current guidelines for the microbiological diagnosis of ventilator-associated pneumonia (VAP) are imprecise. Based on data provided by intensive care specialists (ICS) and microbiologists, this study defines the clinical practices and microbiological techniques currently used for an aetiological diagnosis of VAP and pinpoints deficiencies.
   Methods: Eighty hospitals in the national health network with intensive care and microbiology departments were sent two questionnaires, one for each department, in order to collect data on VAP diagnosis for the previous year.
   Results: Out of the 80 hospitals,35 (43.8%) hospitals participated. These included 673 ICU beds, 32,020 ICU admissions, 173,820 ICU days stay, and generated 27,048 lower respiratory tract specimens in the year. A third of the hospitals (35%) had a microbiology department available 24/7. Most samples (83%) were tracheal aspirates. Gram stain results were immediately reported in around half (47%) of the hospitals. Quantification was made in 75% of hospitals. Molecular techniques and direct susceptibility testing were performed in 12% and one institution, respectively. Mean turnaround time for a microbiological report was 1.7 (SD; 0.7), and 2.2 (SD; 0.6) days for a negative and positive result, respectively. Telephone/inperson information was offered by 65% of the hospitals. Most (89%) ICS considered microbiological information as very useful. No written procedures were available in half the ICUs.
   Conclusions: Both ICS and microbiologists agreed that present guidelines for the diagnosis of VAP could be much improved, and that a new set of consensus guidelines is urgently required. A need for guidelines to be more effectively implemented was also identified in order to improve outcomes in patients with VAP.(C) 2016 Elsevier Espafia, S.L.U. and Sociedad Espafiola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Bouza, Emilio; Martinez-Alarcon, Jose; Munoz, Patricia; Burillo, Almudena] Univ Gen Hosp Gregorio Maranon, Dept Clin Microbiol & infectious Diseases, Madrid, Spain.
   [Perez-Granda, Maria Jesus] Univ Gen Hosp Gregorio Maranon, Dept Anesthesia, Madrid, Spain.
   [Bouza, Emilio; Perez-Granda, Maria Jesus] Hlth Res Inst Gregorio Maranon, Madrid, Spain.
   [Maseda, Emilio] Hosp Gen Univ La Paz, Dept Anesthesia, Madrid, Spain.
   [Palomar, Mercedes] Hosp Arnau Vilanova, Intensive Care Dept, Lerida, Spain.
   [Zaragoza, Rafael] Univ Hosp Doctor Peset, Intensive Care Dept, Valencia, Spain.
   [Bouza, Emilio; Munoz, Patricia; Burillo, Almudena] Univ Complutense Madrid, Sch Med, Dept Med, Valencia, Spain.
   [Bouza, Emilio; Palomar, Mercedes; Perez-Granda, Maria Jesus; Munoz, Patricia] CIBER Respiratory Diseas, Valencia, Spain.
   [Martinez-Alarcon, Jose] Hosp Nuestra Senora Prado, Dept Microbiol, Present Affiliat Jose Martinez Alarcon, Toledo, Spain.
RP Burillo, A (reprint author), Univ Gen Hosp Gregorio Maranon, Dept Clin Microbiol & infectious Diseases, Madrid, Spain.
EM almudena.burillo@gmail.com
RI Bouza, Emilio/D-8661-2014; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015;
   Munoz, Patricia/E-9431-2017
OI Bouza, Emilio/0000-0001-6967-9267; GRANDA, MARIA JESUS mjpg
   PEREZ/0000-0002-0613-2122; Munoz, Patricia/0000-0001-5706-5583; Maseda,
   Emilio/0000-0003-2898-7073; Burillo, Almudena/0000-0003-2545-4204
CR Lerma FA, 2015, MED INTENSIVA, V39, P149, DOI 10.1016/j.medin.2014.02.004
   [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST
   Baron EJ, 1996, J CLIN MICROBIOL, V34, P496, DOI 10.1128/JCM.34.3.496-500.1996
   Berton DC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006482.pub4
   Boots RJ, 2005, ANAESTH INTENS CARE, V33, P87, DOI 10.1177/0310057X0503300115
   Boots RJ, 2008, RESPIROLOGY, V13, P87, DOI 10.1111/j.1440-1843.2007.01211.x
   Bouza E, 2003, CRIT CARE MED, V31, P1964, DOI [10.1097/01.ccm.0000084807.15352.93, 10.1097/01.CCM.0000084807.15352.93]
   Bouza E, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.008
   Browne E, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000066
   Correa RD, 2014, J BRAS PNEUMOL, V40, P643, DOI 10.1590/S1806-37132014000600008
   Delclaux C, 1997, AM J RESP CRIT CARE, V156, P1092, DOI 10.1164/ajrccm.156.4.9701065
   Dellit TH, 2008, INFECT CONT HOSP EP, V29, P525, DOI 10.1086/588160
   Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004
   Fangio P, 2002, ANN FR ANESTH, V21, P184, DOI 10.1016/S0750-7658(02)00584-1
   Garnacho-Montero J, 2006, CRIT CARE, V10, DOI 10.1186/cc4860
   Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904
   Ioanas M, 2003, EUR RESPIR J, V22, P876, DOI 10.1183/09031936.03.00045903
   Jung B, 2009, INTENS CARE MED, V35, P101, DOI 10.1007/s00134-008-1248-8
   Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353
   Khuri SF, 2008, ANN SURG, V248, P329, DOI 10.1097/SLA.0b013e3181823485
   Koulenti D, 2009, CRIT CARE MED, V37, P2360, DOI 10.1097/CCM.0b013e3181a037ac
   Bassi GL, 2010, CURR OPIN INFECT DIS, V23, P171, DOI 10.1097/QCO.0b013e328337241a
   Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162
   Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008
   Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012
   Muscedere JG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.004
   Papazian L, 1996, ANESTHESIOLOGY, V84, P280, DOI 10.1097/00000542-199602000-00005
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115
   Rello J, 2004, CRIT CARE MED, V32, P2183, DOI 10.1097/01.CCM.0000145997.10438.28
   Rello J, 2002, CHEST, V122, P656, DOI 10.1378/chest.122.2.656
   Rello J, 2011, J CRIT CARE, V26, P3, DOI 10.1016/j.jcrc.2010.04.001
   Sanders KM, 2008, J CRIT CARE, V23, P58, DOI 10.1016/j.jcrc.2008.01.009
   Shorr AF, 2005, CRIT CARE MED, V33, P46, DOI 10.1097/01.CCM.0000149852.32599.31
   Sinuff T, 2013, CRIT CARE MED, V41, P15, DOI 10.1097/CCM.0b013e318265e874
   STANECK J L, 1985, Diagnostic Microbiology and Infectious Disease, V3, p51S, DOI 10.1016/0732-8893(85)90053-7
   Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7
   Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9
   Vandewoude KH, 2006, CRIT CARE, V10, DOI 10.1186/cc4823
   Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06
   York MK, 2010, CLIN MICROBIOLOGY PR
   Yu VL, 2011, LANCET INFECT DIS, V11, P248, DOI 10.1016/S1473-3099(11)70005-6
NR 41
TC 1
Z9 2
U1 1
U2 6
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD MAR
PY 2017
VL 35
IS 3
BP 153
EP 164
DI 10.1016/j.eimc.2016.08.009
PG 12
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EO6JY
UT WOS:000396799500005
PM 27743679
DA 2020-05-07
ER

PT J
AU Vincent, MS
   Canestrari, MJ
   Leone, P
   Stathopulos, J
   Ize, B
   Zoued, A
   Cambillau, C
   Kellenberger, C
   Roussel, A
   Cascales, E
AF Vincent, Maxence S.
   Canestrari, Mickael J.
   Leone, Philippe
   Stathopulos, Julien
   Ize, Berengere
   Zoued, Abdelrahim
   Cambillau, Christian
   Kellenberger, Christine
   Roussel, Alain
   Cascales, Eric
TI Characterization of the Porphyromonas gingivalis Type IX Secretion
   Trans-envelope PorKLMNP Core Complex
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE bacterial pathogenesis; membrane protein; microbiology; protein
   assembly; protein complex; protein purification; protein secretion;
   secretion
ID ENTEROAGGREGATIVE ESCHERICHIA-COLI; TRANSMEMBRANE PROTEIN TOPOLOGY;
   BACTERIAL GLIDING MOTILITY; GRAM-NEGATIVE BACTERIA; C-TERMINAL DOMAIN;
   VI SECRETION; TANNERELLA-FORSYTHIA; 2-COMPONENT SYSTEM; SIGNAL PEPTIDES;
   IV SECRETION
AB The transport of proteins at the cell surface of Bacteroidetes depends on a secretory apparatus known as type IX secretion system (T9SS). This machine is responsible for the cell surface exposition of various proteins, such as adhesins, required for gliding motility in Flavobacterium, S-layer components in Tannerella forsythia, and tooth tissue-degrading enzymes in the oral pathogen Porphyromonas gingivalis. Although a number of subunits of the T9SS have been identified, we lack details on the architecture of this secretion apparatus. Here we provide evidence that five of the genes encoding the core complex of the T9SS are co-transcribed and that the gene products are distributed in the cell envelope. Protein-protein interaction studies then revealed that these proteins oligomerize and interact through a dense network of contacts.
C1 [Vincent, Maxence S.; Canestrari, Mickael J.; Ize, Berengere; Zoued, Abdelrahim; Cascales, Eric] Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UMR 7255,CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.
   [Leone, Philippe; Stathopulos, Julien; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain] CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France.
   [Leone, Philippe; Stathopulos, Julien; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR 7257, Campus Luminy,Case 932, F-13288 Marseille 09, France.
RP Cascales, E (reprint author), Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UMR 7255,CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.
EM cascales@imm.cnrs.fr
RI CASCALES, ERIC/G-7420-2011
OI CASCALES, ERIC/0000-0003-0611-9179; Vincent, Maxence
   S./0000-0001-8431-7504; Zoued, Abdelrahim/0000-0002-6973-1755
FU CNRSCentre National de la Recherche Scientifique (CNRS); Aix-Marseille
   Universite; Agence Nationale de la RechercheFrench National Research
   Agency (ANR) [ANR-15-CE11-0019-01]; French Ministere de la
   RechercheMinistry of Research, France; Fondation pour la Recherche
   MedicaleFondation pour la Recherche Medicale [FDT20140931060]
FX This work was supported by the CNRS, the Aix-Marseille Universite, and a
   grant from the Agence Nationale de la Recherche (ANR-15-CE11-0019-01).
   The authors declare that they have no conflicts of interest with the
   contents of this article.; Supported by a doctoral fellowship from the
   French Ministere de la Recherche.; Supported by an end-of-thesis
   fellowship from the Fondation pour la Recherche Medicale
   (FDT20140931060).
CR Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080
   Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08
   Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9
   Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002
   Boisvert H, 2014, P NATL ACAD SCI USA, V111, P5355, DOI 10.1073/pnas.1402740111
   Boisvert H, 2010, INFECT IMMUN, V78, P3616, DOI 10.1128/IAI.00187-10
   Braun TF, 2005, J BACTERIOL, V187, P2628, DOI 10.1128/JB.187.8.2628-2637.2005
   Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x
   Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101
   Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x
   Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456
   Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667
   Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386
   FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973
   Flaugnatti N, 2016, MOL MICROBIOL, V99, P1099, DOI 10.1111/mmi.13292
   Glew MD, 2014, J PROTEOMICS, V110, P72, DOI 10.1016/j.jprot.2014.07.033
   Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223
   Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200
   Gorasia DG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005820
   Goulas T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11969
   Hasegawa Y, 2016, J DENT RES, V95, P1291, DOI 10.1177/0022034516655083
   Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052
   Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703
   Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Kharade SS, 2015, J BACTERIOL, V197, P147, DOI 10.1128/JB.02085-14
   Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8
   McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12
   Nakane D, 2013, P NATL ACAD SCI USA, V110, P11145, DOI 10.1073/pnas.1219753110
   Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255
   Narita Y, 2014, MICROBIOL-SGM, V160, P2295, DOI 10.1099/mic.0.080192-0
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036
   Rhodes RG, 2011, J BACTERIOL, V193, P599, DOI 10.1128/JB.01203-10
   Rocas IN, 2001, ORAL SURG ORAL MED O, V91, P468, DOI 10.1067/moe.2001.114379
   Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824
   Sakamoto M, 2005, J PERIODONTAL RES, V40, P277, DOI 10.1111/j.1600-0765.2005.00793.x
   Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028
   Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107
   Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372
   Shrivastava A, 2015, CURR OPIN MICROBIOL, V28, P93, DOI 10.1016/j.mib.2015.07.018
   Shrivastava A, 2015, CURR BIOL, V25, P338, DOI 10.1016/j.cub.2014.11.045
   Shrivastava A, 2013, J BACTERIOL, V195, P3201, DOI 10.1128/JB.00333-13
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Stoffel W., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108
   Taguchi Y, 2016, INFECT IMMUN, V84, P230, DOI 10.1128/IAI.01308-15
   Tomek MB, 2014, MOL ORAL MICROBIOL, V29, P307, DOI 10.1111/omi.12062
   Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107
   van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008
   Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b
   Vincent MS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00096
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
   Zoued A, 2016, NATURE, V531, P59, DOI 10.1038/nature17182
NR 60
TC 17
Z9 17
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 24
PY 2017
VL 292
IS 8
BP 3252
EP 3261
DI 10.1074/jbc.M116.765081
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EM8CM
UT WOS:000395538800017
PM 28057754
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Huang, ZA
   Chen, X
   Zhu, ZX
   Liu, HS
   Yan, GY
   You, ZH
   Wen, ZK
AF Huang, Zhi-An
   Chen, Xing
   Zhu, Zexuan
   Liu, Hongsheng
   Yan, Gui-Ying
   You, Zhu-Hong
   Wen, Zhenkun
TI PBHMDA: Path-Based Human Microbe-Disease Association Prediction
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE microbes; diseases; path-based measure; computational prediction model;
   association network
ID GUT MICROBIOTA; INTESTINAL MICROBIOTA; HEALTHY-CHILDREN; INNATE
   IMMUNITY; LIVER; OBESITY; ASTHMA; METABOLISM; MODULATION; MUTUALISM
AB With the advance of sequencing technology and microbiology, the microorganismshave been found to be closely related to various important human diseases. The increasing identification of human microbe-disease associations offers important in sights into the underlying disease mechanism understanding from the perspective of humanmicrobes, which are greatly helpful for investigating pathogenesis, promoting early diagnosis and improving precision medicine. However, the current knowledge in this domain is still limited and far from complete. Here, we present the computational modelof Path-Based Human Microbe-Disease Association prediction (PBHMDA) based on the integration of known microbe-disease associations and the Gaussian interactionprofile kernel similarity for microbes and diseases. A special depth-first search algorithm was implemented to traverse all possible paths between microbes and diseases for inferring the most possible disease-related microbes. As a result, PBHMDA obtained a reliable prediction performance with AUCs (The area under ROC curve) of 0.9169 and 0.8767 in the frameworks of both global and local leave-one-out cross validations,respectively. Based on 5-fold cross validation, average AUCs of 0.9082 +/- 0.0061 further demonstrated the efficiency of the proposed model. For the case studies of liver cirrhosis, type 1 diabetes, and asthma, 9, 7, and 9 out of predicted microbes in the top 10 have been confirmed by previously published experimental literatures,respectively. We have publicly released the prioritized microbe-disease associations,which may help to select the most potential pairs for further guiding the experimental confirmation. In conclusion, PBHMDA may have potential to boost the discovery of novelmicrobe-disease associations and aid future research efforts toward microbe involvement in human disease mechanism. The code and data of PBHMDA is freely available at http://www.escience.cn/system/file?fileId=85214.
C1 [Huang, Zhi-An; Zhu, Zexuan; Wen, Zhenkun] Shenzhen Univ, Coll Comp Sci & Software Engn, Shenzhen, Peoples R China.
   [Chen, Xing] China Univ Min & Technol, Sch Informat & Control Engn, Xuzhou, Peoples R China.
   [Liu, Hongsheng] Liaoning Univ, Sch Life Sci, Shenyang, Peoples R China.
   [Liu, Hongsheng] Res Ctr Comp Simulating & Informat Proc Biomacrom, Shenyang, Peoples R China.
   [Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China.
   [You, Zhu-Hong] Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Urumqi, Peoples R China.
RP Zhu, ZX (reprint author), Shenzhen Univ, Coll Comp Sci & Software Engn, Shenzhen, Peoples R China.; Chen, X (reprint author), China Univ Min & Technol, Sch Informat & Control Engn, Xuzhou, Peoples R China.
EM xingchen@amss.ac.cn; zhuzx@szu.edu.cn
RI Chen, Xing/G-6844-2016; You, Zhu-Hong/AAI-6862-2020
OI Chen, Xing/0000-0001-9028-5342; You, Zhu-Hong/0000-0003-1266-2696
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11301517, 11631014, 61471246, 31570160, 11371355,
   61572506, 61572328]; Guangdong Foundation of Outstanding Young Teachers
   in Higher Education Institutions [Yq2013141]; Guangdong Special Support
   Program of Top-notch Young Professionals [2014TQ01X273]; Innovation Team
   Project from the Education Department of Liaoning Province [LT2015011];
   Pioneer Hundred Talents Program of Chinese Academy of Sciences; China-UK
   Visual Information Processing Lab
FX DXC was supported by National Natural Science Foundation of China under
   Grant No. 11301517 and 11631014. ZZ was supported by the National
   Natural Science Foundation of China under Grant No. 61471246, Guangdong
   Foundation of Outstanding Young Teachers in Higher Education
   Institutions under Grant No. Yq2013141, and Guangdong Special Support
   Program of Top-notch Young Professionals under Grant No. 2014TQ01X273.
   HL was supported by National Natural Science Foundation of China under
   Grant No. 31570160 and Innovation Team Project from the Education
   Department of Liaoning Province under Grant No. LT2015011. GY was
   supported by National Natural Science Foundation of China under Grant
   No. 11371355 and 11631014. ZY was supported by National Natural Science
   Foundation of China under Grant No. 61572506 and Pioneer Hundred Talents
   Program of Chinese Academy of Sciences. ZW was supported by National
   Nature Science Foundation of China under Grant No. 61572328 and research
   funding of China-UK Visual Information Processing Lab.
CR Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C
   Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060
   Chen X, 2016, ONCOTARGET, V7, P45948, DOI 10.18632/oncotarget.10008
   Chen X, 2016, ONCOTARGET, V7, P57919, DOI 10.18632/oncotarget.11141
   Chen X, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004975
   Chen X, 2016, MOL BIOSYST, V12, P624, DOI 10.1039/c5mb00697j
   Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep13877
   Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11338
   Chen X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05501
   Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426
   Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Ciaccio CE, 2014, J ALLERGY CLIN IMMUN, V133, pAB70, DOI 10.1016/j.jaci.2013.12.274
   Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
   Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032
   Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019
   Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92
   Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Holodniy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014764
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064
   Kim Wonyong, 2013, Journal of Bacteriology and Virology, V43, P270, DOI 10.4167/jbv.2013.43.4.270
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751
   Liu JJ, 2012, CURR MICROBIOL, V65, P7, DOI 10.1007/s00284-012-0105-8
   Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788
   Ma J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4889
   Ma W, 2017, BRIEF BIOINFORM, V18, P85, DOI 10.1093/bib/bbw005
   Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013
   Mason MR, 2015, ISME J, V9, P268, DOI 10.1038/ismej.2014.114
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Minino AM, 2011, NCHS DATA BRIEF, V115, P1
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46
   Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080
   Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605
   Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109710
   Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034
   Qi CJ, 2016, CHINESE MED J-PEKING, V129, P1298, DOI 10.4103/0366-6999.182841
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qiu RH, 2016, CHEST, V149, p14A, DOI 10.1016/j.chest.2016.02.016
   Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI [10.1002/path.5047, 10.1038/nrc3610]
   Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691
   Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974
   Soyucen E, 2014, PEDIATR INT, V56, P336, DOI 10.1111/ped.12243
   Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400
   Tejesvi MV, 2016, EUR J CLIN MICROBIOL, V35, P363, DOI 10.1007/s10096-015-2548-x
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   VADILLO M, 1994, CLIN INFECT DIS, V18, P938, DOI 10.1093/clinids/18.6.938
   Vael Carl, 2008, BMC Pulm Med, V8, P19, DOI 10.1186/1471-2466-8-19
   van Best N, 2015, HEPATOL INT, V9, P406, DOI 10.1007/s12072-015-9640-2
   Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047
   Vollberg CM, 1997, SOUTHERN MED J, V90, P1040, DOI 10.1097/00007611-199710000-00014
   Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118
   Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015
   Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018
   Yu J, 2010, ALLERGY ASTHMA IMMUN, V2, P199, DOI 10.4168/aair.2010.2.3.199
   Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106
NR 70
TC 31
Z9 31
U1 1
U2 24
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 22
PY 2017
VL 8
AR 233
DI 10.3389/fmicb.2017.00233
PG 10
WC Microbiology
SC Microbiology
GA EL3TU
UT WOS:000394543000001
PM 28275370
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Dias, SP
   Brouwer, MC
   Bijlsma, MW
   van der Ende, A
   van de Beek, D
AF Dias, S. P.
   Brouwer, M. C.
   Bijlsma, M. W.
   van der Ende, A.
   van de Beek, D.
TI Sex-based differences in adults with community-acquired bacterial
   meningitis: a prospective cohort study
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Bacterial meningitis; Dexamethasone; Gender differences; Infectious
   diseases; Sex differences
ID SURVEILLANCE NETWORK FOODNET; LISTERIA-MONOCYTOGENES; CLINICAL-FEATURES;
   IMMUNE-RESPONSES; RISK; DIAGNOSIS; DEXAMETHASONE; MANAGEMENT; INFECTION;
   HORMONES
AB Objectives: To investigate sex-based differences in clinical features, causative pathogens, outcome and treatment of adult community-acquired meningitis.
   Methods: From January 2006 to July 2014, we prospectively investigated sex-based differences in clinical features, causative pathogens, outcome and treatment of adult community-acquired meningitis in a nationwide cohort study in the Netherlands. Sex was analysed along with known predictors of unfavourable outcome using logistic regression.
   Results: We evaluated 1412 episodes of meningitis, 707 (50%) in men. Men more often presented with a history of remote head injury (41/667 (6%) versus 14/658 (2%) women, p 0.0002) or alcoholism (61/652 (9%) versus 21/660 (3%) women, p <0.0001). Neck stiffness was less common in men (453/651 (70%) versus 524/671 (78%) women, p 0.0004). Despite greater illness severity, women were less likely to receive treatment in an intensive care unit (odds ratio (OR) 0.72, 95% CI 0.58-0.89, p 0.003) or mechanical ventilation (OR 0.67, 95% CI 0.54-0.85, p 0.001). Women exhibited higher serum inflammatory parameters than men (median C-reactive protein 211 versus 171, p 0.0001; median erythrocyte sedimentation rate 48 versus 33, p <0.0001). Corticosteroids improved prognosis in both sexes, but absolute risk reduction was higher in women (20% versus 15%, p 0.001), although we found no significant interaction between sex and dexamethasone (p 0.38). In the multivariable analysis, male sex was an independent predictor of unfavourable outcome (OR 1.34, 95% CI 1.03-1.75, p 0.03) and death (OR 1.47, 95% CI 1.04-2.07, p 0.03).
   Conclusions: Our findings show sex-based differences in adults with community-acquired bacterial meningitis. Male sex is an independent risk factor for adverse outcome. It is possible that sex-based differences in immune reaction could determine a distinct response to corticosteroids. (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Dias, S. P.; Brouwer, M. C.; Bijlsma, M. W.; van de Beek, D.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam Neurosci, Amsterdam, Netherlands.
   [Dias, S. P.] Ctr Hosp Lisboa Cent, Dept Neurol, Lisbon, Portugal.
   [van der Ende, A.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands.
   [van der Ende, A.] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands.
RP van de Beek, D (reprint author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol,Amsterdam Neurosci, POB 22660, NL-1100 DD Amsterdam, Netherlands.
EM d.vandebeek@amc.uva.nl
RI van de Beek, Diederik/Y-2713-2019
OI van de Beek, Diederik/0000-0002-4571-044X
FU European Research Council(ERC)European Research Council (ERC) [281156,
   DvdB]; National Institute of Public Health and the Environment; European
   Union's seventh Framework programmeEuropean Union (EU) [279185,
   EUCLIDS]; Academic Medical Centre ( AMC Fellowship, DvdB); Netherlands
   Organization for Health Research and DevelopmentNetherlands Organization
   for Health Research and Development [016.116.358,DvdB, 2012
   916.13.078,MCB]
FX We are indebted to many physicians in the Netherlands for their
   cooperation and we acknowledge the ESCMID Study Group for Infectious
   Diseases of the Brain ( ESGIB) for this collaboration. This study was
   supported by grants from the European Research Council ( ERC Starting
   Grant # 281156, DvdB), National Institute of Public Health and the
   Environment, the European Union's seventh Framework programme (# 279185,
   EUCLIDS), Academic Medical Centre ( AMC Fellowship, DvdB), Netherlands
   Organization for Health Research and Development ( Vidi grant #
   016.116.358, DvdB; Veni Grant 2012 # 916.13.078, MCB). Some of the
   results were presented at the 26th European Congress of Clinical
   Microbiology and Infectious Diseases.
CR Arslan F, 2015, EUR J CLIN MICROBIOL, V34, P1213, DOI 10.1007/s10096-015-2346-5
   Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2
   Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297
   Brouwer MC, 2006, CLIN INFECT DIS, V43, P1233, DOI 10.1086/508462
   Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5
   Brouwer MC, 2014, ACTA NEUROPATHOL, V127, P553, DOI 10.1007/s00401-013-1216-4
   Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09
   Cardozo DM, 2008, J MED MICROBIOL, V57, P185, DOI 10.1099/jmm.0.47470-0
   Chaudhuri A, 2008, EUR J NEUROL, V15, P649, DOI 10.1111/j.1468-1331.2008.02193.x
   Costerus JM, 2016, CLIN MICROBIOL INFEC, V22, P428, DOI 10.1016/j.cmi.2015.12.026
   Costerus JM, 2016, NEUROLOGY, V86, P860, DOI 10.1212/WNL.0000000000002315
   de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334
   Dharmarajan L, 2016, J MENINGITIS, V1
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547
   Fischer J, 2015, INFECTION, V43, P399, DOI 10.1007/s15010-015-0791-9
   Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394
   Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112
   Goulet V, 2012, CLIN INFECT DIS, V54, P652, DOI 10.1093/cid/cir902
   Heckenberg SGB, 2012, CLIN MICROBIOL INFEC, V18, P849, DOI 10.1111/j.1469-0691.2011.03668.x
   Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023
   JENNETT B, 1975, LANCET, V1, P480
   Klein Sabra L, 2012, Handb Exp Pharmacol, P499, DOI 10.1007/978-3-642-30726-3_22
   Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9
   Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0
   Koopmans MM, 2013, CLIN INFECT DIS, V57, P247, DOI 10.1093/cid/cit250
   Mook P, 2011, EMERG INFECT DIS, V17, P38, DOI 10.3201/eid1701.101174
   Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11
   Mylonakis E, 1998, MEDICINE, V77, P313, DOI 10.1097/00005792-199809000-00002
   Prins MH, 2007, GENDER MED, V4, pS106, DOI 10.1016/S1550-8579(07)80051-9
   Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001
   Schmand B, 2010, J INFECTION, V61, P330, DOI 10.1016/j.jinf.2010.07.006
   Shiferaw B, 2012, CLIN INFECT DIS, V54, pS453, DOI 10.1093/cid/cis247
   Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268
   SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   Valentin A, 2003, CRIT CARE MED, V31, P1901, DOI 10.1097/01.CCM.0000069347.78151.50
   van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116
   van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845
   van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5
   van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6
   van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X
   van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573
   Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216
   Zanger P, 2012, CLIN INFECT DIS, V55, P1625, DOI 10.1093/cid/cis778
NR 44
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD FEB
PY 2017
VL 23
IS 2
AR e9-121.e15
DI 10.1016/j.cmi.2016.10.026
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EP0IL
UT WOS:000397070500018
PM 27816734
OA Bronze
DA 2020-05-07
ER

PT J
AU Lachapelle, V
   Letellier, A
   Fravalo, P
   Brassard, J
   L'Homme, Y
AF Lachapelle, Virginie
   Letellier, Ann
   Fravalo, Philippe
   Brassard, Julie
   L'Homme, Yvan
TI Dynamics of Virus Distribution in a Defined Swine Production Network
   Using Enteric Viruses as Molecular Markers
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE astrovirus; environmental microbiology; indicators; network; rotavirus;
   swine
ID GROUP-A ROTAVIRUS; INTERSPECIES TRANSMISSION EVENTS; FULL GENOME
   CHARACTERIZATION; POLYMERASE-CHAIN-REACTION; PORCINE-LIKE HUMAN;
   ZOONOTIC TRANSMISSION; MULTIPLE REASSORTMENT; GENETIC DIVERSITY;
   SOUTH-KOREA; STRAINS
AB Modern swine production systems represent complex and dynamic networks involving numerous stakeholders. For instance, livestock transporters carry live animals between fattening sites, abattoirs, and other premises on a daily basis. This interconnected system may increase the risk of microbial spread within and between networks, although little information is available in that regard. In the present study, a swine network composed of 10 finishing farms, one abattoir, and three types of stakeholders (veterinarians, livestock transporters, and nutritional technicians) in Quebec, Canada, was selected to investigate specific vectors and reservoirs of enteric viruses. Environmental samples were collected from the premises over a 12-month period. Samples were screened using targeted reverse transcription-PCR and sequencing of two selected viral markers, group A rotaviruses (RVA) and porcine astroviruses (PoAstV), both prevalent and genetically heterogeneous swine enteric viruses. The results revealed frequent contamination of farm sites (21.4 to 100%), livestock transporter vehicles (30.6 to 68.8%) and, most importantly, the abattoir yard (46.7 to 94.1%), depending on the sample types. Although high levels of strain diversity for both viruses were found, identical PoAstV and RVA strains were detected in specific samples from farms, the abattoir yard, and the livestock transporter vehicle, suggesting interconnections between these premises and transporters. Overall, the results from this study underscore the potential role of abattoirs and livestock transport as a reservoir and transmission route for enteric viruses within and between animal production networks, respectively.
   IMPORTANCE Using rotaviruses and astroviruses as markers of enteric contamination in a swine network has revealed the potential role of abattoirs and livestock transporters as a reservoir and vectors of enteric pathogens. The results from this study highlight the importance of tightening biosecurity measures. For instance, implementing sanitary vacancy between animal batches and emphasizing washing, disinfection, and drying procedures on farms and for transportation vehicles, as well as giving limited access and circulation of vehicles throughout the production premises, are some examples of measures that should be applied properly. The results also emphasize the need to closely monitor the dynamics of enteric contamination in the swine industry in order to better understand and potentially prevent the spread of infectious diseases. This is especially relevant when a virulent and economically damaging agent is involved, as seen with the recent introduction of the porcine epidemic diarrhea virus in the country.
C1 [Lachapelle, Virginie; Letellier, Ann; Fravalo, Philippe; Brassard, Julie; L'Homme, Yvan] Univ Montreal, Fac Vet Med, NSERC Ind Res Chair Meat Safety, St Hyacinthe, PQ, Canada.
   [Brassard, Julie] Agr & Agri Food Canada, St Hyacinthe Res & Dev Ctr, St Hyacinthe, PQ, Canada.
   [L'Homme, Yvan] Canadian Food Inspect Agcy, St Hyacinthe Lab, St Hyacinthe, PQ, Canada.
RP Lachapelle, V (reprint author), Univ Montreal, Fac Vet Med, NSERC Ind Res Chair Meat Safety, St Hyacinthe, PQ, Canada.
EM virginie.lachapelle.1@umontreal.ca
FU Canadian swine cluster of research [1002]; Science Division of the
   Canadian Food Inspection Agency; Swine and Poultry Infectious Diseases
   Research Center (CRIPA)
FX This project was supported by the Canadian swine cluster of research
   (Project 1002), the Science Division of the Canadian Food Inspection
   Agency, and the Swine and Poultry Infectious Diseases Research Center
   (CRIPA).
CR Brassard J, 2011, INT J FOOD MICROBIOL, V144, P565, DOI 10.1016/j.ijfoodmicro.2010.11.015
   Brnic D, 2014, VET J, V202, P390, DOI 10.1016/j.tvjl.2014.08.015
   Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008
   Chandler-Bostock R, 2015, VET MICROBIOL, V180, P205, DOI 10.1016/j.vetmic.2015.09.009
   Chitambar SD, 2009, J MED MICROBIOL, V58, P1611, DOI 10.1099/jmm.0.012856-0
   Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08
   De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024
   De Busser EV, 2013, VET J, V196, P20, DOI 10.1016/j.tvjl.2013.01.002
   Dee SA, 2004, CAN J VET RES, V68, P128
   Doan YH, 2013, J CLIN MICROBIOL, V51, P182, DOI 10.1128/JCM.02062-12
   Dorjee S, 2013, PREV VET MED, V112, P118, DOI 10.1016/j.prevetmed.2013.06.008
   Dorjee S, 2013, ZOONOSES PUBLIC HLTH, V60, P383, DOI 10.1111/zph.12010
   Doro R, 2015, EXPERT REV ANTI-INFE, V13, P1337, DOI 10.1586/14787210.2015.1089171
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   Ghosh S, 2012, VET MICROBIOL, V158, P410, DOI 10.1016/j.vetmic.2012.02.037
   Ghosh S, 2012, INFECT GENET EVOL, V12, P471, DOI 10.1016/j.meegid.2011.12.012
   GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990
   Ha TPM, 2009, J CLIN MICROBIOL, V47, P3329, DOI 10.1128/JCM.01583-08
   Holzknecht BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115331
   Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13
   Hundesa A, 2009, J VIROL METHODS, V158, P130, DOI 10.1016/j.jviromet.2009.02.006
   Hwang KP, 2012, J MED MICROBIOL, V61, P990, DOI 10.1099/jmm.0.042499-0
   Jimenez-Clavero MA, 2003, APPL ENVIRON MICROB, V69, P6311, DOI 10.1128/AEM.69.10.6311-6315.2003
   Jones TH, 2012, J FOOD PROTECT, V75, P1492, DOI 10.4315/0362-028X.JFP-11-547
   Kingsley DH, 2007, J VIROL METHODS, V141, P58, DOI 10.1016/j.jviromet.2006.11.027
   Komoto S, 2013, J GEN VIROL, V94, P1568, DOI 10.1099/vir.0.051011-0
   Lachapelle V, 2014, ARCH VIROL, V159, P1771, DOI 10.1007/s00705-013-1951-9
   Lamhoujeb S, 2010, ARCH VIROL, V155, P1127, DOI 10.1007/s00705-010-0700-6
   Laurin MA, 2011, ARCH VIROL, V156, P2095, DOI 10.1007/s00705-011-1088-7
   Li D, 2011, J ENVIRON SCI-CHINA, V23, P1691, DOI 10.1016/S1001-0742(10)60623-7
   Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628
   Luo ZY, 2011, VET MICROBIOL, V149, P316, DOI 10.1016/j.vetmic.2010.11.026
   Machnowska P, 2014, VET MICROBIOL, V168, P60, DOI 10.1016/j.vetmic.2013.10.018
   Martel-Paradis O, 2013, VET MICROBIOL, V162, P94, DOI 10.1016/j.vetmic.2012.08.028
   Martella V, 2006, VIROLOGY, V344, P509, DOI 10.1016/j.virol.2005.08.029
   Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028
   Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   Matthijnssens J, 2011, INFECT GENET EVOL, V11, P1396, DOI 10.1016/j.meegid.2011.05.007
   Monini M, 2015, ARCH VIROL, V160, P2547, DOI 10.1007/s00705-015-2538-4
   Mukherjee A, 2013, J MED VIROL, V85, P537, DOI 10.1002/jmv.23483
   Mukherjee A, 2009, ARCH VIROL, V154, P733, DOI 10.1007/s00705-009-0363-3
   Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009
   Papp H, 2013, INFECT GENET EVOL, V19, P71, DOI 10.1016/j.meegid.2013.06.013
   Park SI, 2011, VET MICROBIOL, V152, P55, DOI 10.1016/j.vetmic.2011.04.015
   Paul P, 1999, DIS SWINE, P255
   Anh PH, 2014, VET MICROBIOL, V170, P258, DOI 10.1016/j.vetmic.2014.02.030
   Poljak Z, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-59
   Rusinol M, 2014, WATER RES, V59, P119, DOI 10.1016/j.watres.2014.04.013
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Theuns S, 2016, VIRUS RES, V213, P172, DOI 10.1016/j.virusres.2015.12.004
   Nguyen TH, 2016, COMP IMMUNOL MICROB, V46, P53, DOI 10.1016/j.cimid.2016.04.003
   Than VT, 2013, ARCH VIROL, V158, P2385, DOI 10.1007/s00705-013-1720-9
   Than VT, 2013, J MED VIROL, V85, P171, DOI 10.1002/jmv.23436
   Zeller M, 2012, INFECT GENET EVOL, V12, P1492, DOI 10.1016/j.meegid.2012.03.002
NR 56
TC 4
Z9 4
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD FEB
PY 2017
VL 83
IS 4
AR UNSP e03187
DI 10.1128/AEM.03187-16
PG 15
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA EJ8NI
UT WOS:000393482200023
PM 27940545
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Lau, JSY
   Kiss, C
   Roberts, E
   Horne, K
   Korman, TM
   Woolley, I
AF Lau, Jillian S. Y.
   Kiss, Christopher
   Roberts, Erika
   Horne, Kylie
   Korman, Tony M.
   Woolley, Ian
TI Surveillance of life-long antibiotics: a review of antibiotic
   prescribing practices in an Australian Healthcare Network
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Article
DE Antibiotics; Resistance; Infection; Suppression; Pharmacy
ID PROSTHETIC JOINT INFECTIONS; GUIDELINES; EXACERBATIONS; EPIDEMIOLOGY;
   PROPHYLAXIS; PREVENTION; DIAGNOSIS; DISEASE; AGENT; COPD
AB Background: The rise of antimicrobial use in the twentieth century has significantly reduced morbidity due to infection, however it has also brought with it the rise of increasing resistance. Some patients are on prolonged, if not "lifelong" course of antibiotics. The reasons for this are varied, and include non-infectious indications. We aimed to study the characteristics of this potential source of antibiotic resistance, by exploring the antibiotic dispensing practices and describing the population of patients on long-term antibiotic therapy.
   Methods: A retrospective cross-sectional study of antibiotic dispensing records was performed at a large university hospital-based healthcare network in Melbourne, Australia. Outpatient prescriptions were extracted from the hospital pharmacy database over a 6 month period in 2014. Medical records of these patients were reviewed to determine the indication for prescription, including microbiology, the intended duration, and the prescribing unit. A descriptive analysis was performed on this data.
   Results: 66,127 dispensing episodes were reviewed. 202 patients were found to have been prescribed 1 or more antibiotics with an intended duration of 1 year or longer. 69/202 (34%) of these patients were prescribed prolonged antibiotics for primary prophylaxis in the setting of immunosuppression. 43/202 (21%) patients were prescribed long-term suppressive antibiotics for infections of thought incurable (e.g. vascular graft infections), and 34/43 (79%) were prescribed by Infectious Diseases doctors. 66/202 (33%) patients with cystic fibrosis were prescribed prolonged courses of macrolides or fluoroquinolones, by respiratory physicians. There was great heterogeneity noted in indications for prolonged antibiotic courses, as well as antibiotic agents utilised.
   Conclusion: Our study found that that continuous antibiotic therapy represented only a small proportion of overall antibiotic prescribing at our health network. Prolonged courses of antibiotics were used mainly to suppress infections thought incurable, but also as primary and secondary prophylaxis and as anti-inflammatory agents. More research is needed to understand the impact of long-term antibiotic consumption on both patients and microbial ecology.
C1 [Lau, Jillian S. Y.; Kiss, Christopher; Horne, Kylie; Korman, Tony M.; Woolley, Ian] Monash Univ, Monash Hlth, Monash Infect Dis, Clayton, Vic, Australia.
   [Roberts, Erika] Monash Hlth, Monash Hlth Pharm, Clayton, Vic, Australia.
RP Woolley, I (reprint author), Monash Univ, Monash Hlth, Monash Infect Dis, Clayton, Vic, Australia.
EM ian.woolley@monash.edu
RI Lau, Jillian/Y-2787-2019; Korman, Tony M/I-3099-2013
OI Korman, Tony M/0000-0002-6155-8353; Woolley, Ian
   John/0000-0003-2928-1291; Lau, Jillian/0000-0002-6797-4307
CR Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623
   COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050
   Dason S, 2011, CUAJ-CAN UROL ASSOC, V5, P316, DOI 10.5489/cuaj.11214
   Dawson MH, 1943, ANN INTERN MED, V19, P707, DOI 10.7326/0003-4819-19-5-707
   Enzler MJ, 2011, MAYO CLIN PROC, V86, P686, DOI 10.4065/mcp.2011.0012
   Goto N, 2011, TRANSPL INFECT DIS, V13, P551, DOI 10.1111/j.1399-3062.2011.00691.x
   James GDR, 2013, PRIM CARE RESP J, V22, P271, DOI 10.4104/pcrj.2013.00061
   Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377
   Martin SI, 2009, AM J TRANSPLANT, V9, pS227, DOI 10.1111/j.1600-6143.2009.02914.x
   MOZWECZ H, 1990, DIGEST DIS SCI, V35, P902, DOI 10.1007/BF01536806
   Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11
   Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC
   Shapiro S, 2013, J ANTIBIOT, V66, P371, DOI 10.1038/ja.2013.27
   Smith MT, 2012, AUST FAM PHYSICIAN, V41, P31
   Southern KW, 2003, COCHRANE DB SYST REV, V31
   Spagnolo P, 2013, EUR RESPIR J, V42, P239, DOI 10.1183/09031936.00136712
   Spelman D, 2008, INTERN MED J, V38, P349, DOI 10.1111/j.1445-5994.2007.01579.x
   Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
NR 19
TC 6
Z9 6
U1 0
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD JAN 18
PY 2017
VL 16
AR 3
DI 10.1186/s12941-017-0180-6
PG 4
WC Microbiology
SC Microbiology
GA EI2VV
UT WOS:000392347400001
PM 28100229
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Sun, T
   Liu, SL
   Zhou, YB
   Yao, ZW
   Zhang, DF
   Cao, SG
   Wei, ZL
   Tan, B
   Li, Y
   Lian, Z
   Wang, S
AF Sun, Teng
   Liu, Shanglong
   Zhou, Yanbing
   Yao, Zengwu
   Zhang, Dongfeng
   Cao, Shougen
   Wei, Zhiliang
   Tan, Bin
   Li, Yi
   Lian, Zheng
   Wang, Song
TI Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma
   sequence' mouse colorectal cancer model induced by 1,
   2-Dimethylhydrazine
SO ONCOTARGET
LA English
DT Article
DE colorectal cancer; microbiology; animal model
ID ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; COMPLETE GENOME SEQUENCE;
   FUSOBACTERIUM-NUCLEATUM; COLON CARCINOGENESIS; GENE-MUTATIONS;
   TUMORIGENESIS; HEALTH; CELLS; INFLAMMATION; COLITIS
AB The molecular biological mechanisms underlying the evolutionary biologic changes leading to carcinogenesis remain unclear. The main objective of our study was to explore the evolution of the microbiota community and molecules related with CRC in the dynamic transition from normal colon epithelium to premalignant adenoma with the aid of an 'adenoma-carcinoma sequence' mouse CRC model induced by DMH. We generated a modified mouse CRC model induced by DMH for DNA sequences, and characterized the molecular networks. Data from 454 pyrosequencing of the V3- V5 region of the 16S rDNA gene and immunohistochemical detection of APC, P53, K-RAS and BRAF genes were assessed with Principal coordinates, UniFrac, and Kruskal-Wallis rank sum test. The inflammatory group showed enrichment of Bacteroidetes and Porphyromonadaceae (P < 0.01). OTUs affiliated with Firmicutes were enriched in the hyperproliferative group (P < 0.01). Rikenellaceae and Ruminococcaceae showed an increasing trend during the CRC process while the opposite pattern was observed for Prevotellaceae and Enterobacteriaceae. OTUs related to Alistipes finegoldii were significantly increased during CRC development, P53, K-RAS and BRAF, were gradually increased (P < 0.05). Conversely, expression of APC was decreased during the course of development of CRC. Our results demonstrate that the biological evolutionary shift of gut microbiota, characterized by a gradual decrease in 'driver' bacteria and an increase in DNA damage-causing bacteria, is accompanied by tumor development in the CRC model. The synergistic actions of microbiota dysbiosis and effects of bacterial metabolites on related molecular events are proposed to contribute to the progression of CRC tumorigenesis.
C1 [Liu, Shanglong; Zhou, Yanbing; Cao, Shougen; Wei, Zhiliang; Tan, Bin; Li, Yi] Affiliated Hosp Qingdao Univ, Dept Gen Surg, Qingdao, Peoples R China.
   [Sun, Teng] Qingdao Municipal Hosp, Dept Gen Surg, Qingdao, Peoples R China.
   [Yao, Zengwu] Yantai Yuhuangding Hosp, Dept Gen Surg, Yantai, Peoples R China.
   [Zhang, Dongfeng] Qingdao Univ, Coll Med, Qingdao, Peoples R China.
   [Lian, Zheng] Zhucheng Peoples Hosp, Dept Gen Surg, Weifang, Peoples R China.
   [Wang, Song] Linzi Dist Peoples Hosp, Dept Gen Surg, Zibo, Peoples R China.
RP Zhou, YB (reprint author), Affiliated Hosp Qingdao Univ, Dept Gen Surg, Qingdao, Peoples R China.
EM zhouyanbing999@aliyun.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81270449]; Shandong Provincial Natural Science
   Foundation, ChinaNatural Science Foundation of Shandong Province
   [ZR2012HM046]; Qingdao Minsheng Science and Technology Foundation,
   Shandong, China [14-2-3-5-nsh]; Qingdao Science and Technology Plan
   Project [13-1-4-220-jch]
FX This study was funded by the National Natural Science Foundation of
   China (Grant Number: 81270449), Shandong Provincial Natural Science
   Foundation, China (Grant Number: ZR2012HM046), Qingdao Minsheng Science
   and Technology Foundation, Shandong, China (Grant Number: 14-2-3-5-nsh),
   and the Qingdao Science and Technology Plan Project (Grant Number:
   13-1-4-220-jch).
CR Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981
   BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   CHANG WWL, 1986, AM J PATHOL, V124, P420
   CHANG WWL, 1982, VIRCHOWS ARCH B, V41, P17, DOI 10.1007/BF02890268
   CHANG WWL, 1978, J NATL CANCER I, V60, P1405, DOI 10.1093/jnci/60.6.1405
   Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   Dalton-Griffin Lucy, 2009, Journal of Biology (London), V8, P67, DOI 10.1186/jbiol168
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x
   Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0
   Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611
   Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Hahnke S, 2015, J BIOTECHNOL, V193, P34, DOI 10.1016/j.jbiotec.2014.11.010
   Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352
   Jobin C, 2012, NAT REV GASTRO HEPAT, V9, P694, DOI 10.1038/nrgastro.2012.220
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Krych L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062578
   Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937
   Liang XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04985
   Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588
   Mavromatis K, 2013, STAND GENOMIC SCI, V8, P26, DOI 10.4056/sigs.3527032
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787
   Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568
   Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080
   Newbury S, 2010, GUIDELINES STANDARDS
   Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Scheppach W, 2001, BRIT J NUTR, V85, pS23, DOI 10.1079/BJN2000259
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08
   Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280
   Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076
   VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z
   Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849
NR 53
TC 14
Z9 15
U1 1
U2 8
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JAN 3
PY 2017
VL 8
IS 1
BP 444
EP 457
DI 10.18632/oncotarget.13443
PG 14
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EH1DH
UT WOS:000391503300037
PM 27880935
OA Bronze, Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Farag, TH
   Koplan, JP
   Breiman, RF
   Madhi, SA
   Heaton, PM
   Mundel, T
   Ordi, J
   Bassat, Q
   Menendez, C
   Dowell, SF
AF Farag, Tamer H.
   Koplan, Jeffrey P.
   Breiman, Robert F.
   Madhi, Shabir A.
   Heaton, Penny M.
   Mundel, Trevor
   Ordi, Jaume
   Bassat, Quique
   Menendez, Clara
   Dowell, Scott F.
TI Precisely Tracking Childhood Death
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Little is known about the specific causes of neonatal and under-five childhood death in high-mortality geographic regions due to a lack of primary data and dependence on inaccurate tools, such as verbal autopsy. To meet the ambitious new Sustainable Development Goal 3.2 to eliminate preventable child mortality in every country, better approaches are needed to precisely determine specific causes of death so that prevention and treatment interventions can be strengthened and focused. Minimally invasive tissue sampling (MITS) is a technique that uses needle-based postmortem sampling, followed by advanced histopathology and microbiology to definitely determine cause of death. The Bill & Melinda Gates Foundation is supporting a new surveillance system called the Child Health and Mortality Prevention Surveillance network, which will determine cause of death using MITS in combination with other information, and yield cause-specific population-based mortality rates, eventually in up to 12-15 sites in sub-Saharan Africa and south Asia. However, the Gates Foundation funding alone is not enough. We call on governments, other funders, and international stakeholders to expand the use of pathology-based cause of death determination to provide the information needed to end preventable childhood mortality.
C1 [Farag, Tamer H.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Heaton, Penny M.; Dowell, Scott F.] Bill & Melinda Gates Fdn, Vaccine Dev & Surveillance, Seattle, WA USA.
   [Mundel, Trevor] Bill & Melinda Gates Fdn, Global Hlth, Seattle, WA USA.
   [Koplan, Jeffrey P.; Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA.
   [Koplan, Jeffrey P.] Int Assoc Natl Publ Hlth Inst, Atlanta, GA USA.
   [Madhi, Shabir A.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.
   [Ordi, Jaume; Bassat, Quique; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Ordi, Jaume] Univ Barcelona, Hosp Clin, Dept Pathol, Barcelona, Spain.
   [Bassat, Quique; Menendez, Clara] CISM, Maputo, Mozambique.
   [Bassat, Quique] ICREA, Barcelona, Spain.
   [Farag, Tamer H.] Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
   [Koplan, Jeffrey P.; Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA.
   [Ordi, Jaume; Menendez, Clara] Barcelona Ctr Int Hlth Res CRESIB, Inst Salud Global Barcelona, Barcelona, Spain.
RP Farag, TH (reprint author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
EM faragt@uw.edu; jkoplan@emory.edu; rfbreiman@emory.edu;
   shabirm@nicd.ac.za; penny.heaton@gatesfoundation.org;
   trevor.mundel@gatesfoundation.org; jordi@clinic.cat;
   quique.bassat@isglobal.org; clara.menendez@isglobal.org;
   scott.dowell@gatesfoundation.org
RI Bassat, Quique/P-2341-2016; Ordi, Jaume/X-4524-2018; Menendez,
   Clara/Q-3446-2016; Murphy, Georgina/AAG-4805-2020
OI Bassat, Quique/0000-0003-0875-7596; Ordi, Jaume/0000-0002-4820-7954;
   Menendez, Clara/0000-0002-2641-6907; Murphy,
   Georgina/0000-0001-5978-483X
CR AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2
   Bassat Q, 2013, LANCET GLOB HEALTH, V1, pE125, DOI 10.1016/S2214-109X(13)70037-8
   Blokker BM, 2016, EUR RADIOL, V26, P1159, DOI 10.1007/s00330-015-3908-8
   Castillo P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002171
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a
   Fligner CL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-25
   Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8
   Maixenchs M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002172
   Munguambe K, 2015, 9 EUR C TROP MED INT
   Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
   United Nations, 2017, SUST DEV GOALS 17 GO
   Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6
   [World Health Organization UNICEF The World Bank], 2009, STAT WORLDS VACC IMM
   You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8
NR 15
TC 16
Z9 16
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 3
EP 5
DI 10.4269/ajtmh.16-0302
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900002
PM 28719334
OA Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Shea, S
   Kubota, KA
   Maguire, H
   Gladbach, S
   Woron, A
   Atkinson-Dunn, R
   Couturier, MR
   Miller, MB
   Gilligan, PH
AF Shea, Shari
   Kubota, Kristy A.
   Maguire, Hugh
   Gladbach, Stephen
   Woron, Amy
   Atkinson-Dunn, Robyn
   Couturier, Marc Roger
   Miller, Melissa B.
   Gilligan, Peter H.
TI Clinical Microbiology Laboratories' Adoption of Culture-Independent
   Diagnostic Tests Is a Threat to Foodborne-Disease Surveillance in the
   United States
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Campylobacter jejuni; PulseNet; STEC; Salmonella; Shigella; culture
   independent; food-borne pathogens
ID REAL-TIME PCR; ESCHERICHIA-COLI INFECTIONS; CAMPYLOBACTER SPP.; NETWORK;
   FOOD; PULSENET; ALBERTA; CANADA; STOOL; SITES
AB In November 2015, the Centers for Disease Control and Prevention (CDC) sent a letter to state and territorial epidemiologists, state and territorial public health laboratory directors, and state and territorial health officials. In this letter, culture-independent diagnostic tests (CIDTs) for detection of enteric pathogens were characterized as "a serious and current threat to public health surveillance, particularly for Shiga toxin-producing Escherichia coli (STEC) and Salmonella." The document says CDC and its public health partners are approaching this issue, in part, by "reviewing regulatory authority in public health agencies to require culture isolates or specimen submission if CIDTs are used." Large-scale foodborne outbreaks are a continuing threat to public health, and tracking these outbreaks is an important tool in shortening them and developing strategies to prevent them. It is clear that the use of CIDTs for enteric pathogen detection, including both antigen detection and multiplex nucleic acid amplification techniques, is becoming more widespread. Furthermore, some clinical microbiology laboratories will resist the mandate to require submission of culture isolates, since it will likely not improve patient outcomes but may add significant costs. Specimen submission would be less expensive and time-consuming for clinical laboratories; however, this approach would be burdensome for public health laboratories, since those laboratories would need to perform culture isolation prior to typing. Shari Shea and Kristy Kubota from the Association of Public Health Laboratories, along with state public health laboratory officials from Colorado, Missouri, Tennessee, and Utah, will explain the public health laboratories' perspective on why having access to isolates of enteric pathogens is essential for public health surveillance, detection, and tracking of outbreaks and offer potential workable solutions which will allow them to do this. Marc Couturier of ARUP Laboratories and Melissa Miller of the University of North Carolina will explain the advantages of CIDTs for enteric pathogens and discuss practical solutions for clinical microbiology laboratories to address these public health needs.
C1 [Shea, Shari; Kubota, Kristy A.] Assoc Publ Hlth Labs, Silver Spring, MD 20910 USA.
   [Maguire, Hugh] Colorado Dept Publ Hlth & Environm, Denver, CO USA.
   [Gladbach, Stephen] Missouri State Publ Hlth Lab, Jefferson City, MO USA.
   [Woron, Amy] Tennessee Dept Hlth, Lab Serv Nashville, Nashville, TN USA.
   [Atkinson-Dunn, Robyn] Utah Publ Hlth Lab, Salt Lake City, UT USA.
   [Couturier, Marc Roger] ARUP Labs, Salt Lake City, UT 84108 USA.
   [Couturier, Marc Roger] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.
   [Miller, Melissa B.] UNC HealthCare, Clin Microbiol Immunol Labs, Chapel Hill, NC USA.
   [Miller, Melissa B.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA.
RP Shea, S (reprint author), Assoc Publ Hlth Labs, Silver Spring, MD 20910 USA.; Couturier, MR (reprint author), ARUP Labs, Salt Lake City, UT 84108 USA.; Couturier, MR (reprint author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.
EM shari.shea@aphl.org; marc.couturier@aruplab.com
FU BioGX (Birmingham, Alabama); Luminex Molecular Diagnostics; Cepheid
FX M.R.C. has received research support from BioGX (Birmingham, Alabama).
   M.B.M. has received research funding from Luminex Molecular Diagnostics
   and Cepheid.
CR Association of Public Health Laboratories, 2012, CULTURE INDEPENDENT
   Association of Public Health Laboratories, 2012, APHL POSITION STATEM
   Association of Public Health Laboratories, 2016, STATE LEGAL REQUIREM
   Association of Public Health Laboratories, 2016, SUBMISSION OF ENTERI
   Atkinson R, 2013, J CLIN MICROBIOL, V51, P2479, DOI 10.1128/JCM.00253-13
   Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15
   Centers for Disease Control and Prevention, 2016, MULTISTATE OUTBREAK
   Centers for Disease Control and Prevention, 2016, PULSENET 20 YEARS OF
   Chapin K., 2015, APHL WEBINAR THE UPD
   Chui L, 2013, DIAGN MICR INFEC DIS, V77, P8, DOI 10.1016/j.diagmicrobio.2013.05.015
   Chui L, 2011, J CLIN MICROBIOL, V49, P4307, DOI 10.1128/JCM.05211-11
   Fitzgerald C, 2016, J CLIN MICROBIOL, V54, P1209, DOI 10.1128/JCM.01925-15
   Ford A., 2016, CAP TODAY
   Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9
   Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1
   Huang JY, 2016, MMWR-MORBID MORTAL W, V65, P368, DOI 10.15585/mmwr.mm6514a2
   Hurd S, 2012, CLIN INFECT DIS, V54, pS440, DOI 10.1093/cid/cis245
   Jones TF, 2012, EMERG INFECT DIS, V18, P513, DOI 10.3201/eid1803.111914
   M'ikanatha NM, 2012, EMERG INFECT DIS, V18, P484, DOI 10.3201/eid1803.111266
   McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16
   Qin X, 2015, J CLIN MICROBIOL, V53, P2148, DOI 10.1128/JCM.00115-15
   Rex D., 2016, NEJM JOURNAL WATCH
   Riddle MS, 2016, AM J GASTROENTEROL, V111, P602, DOI 10.1038/ajg.2016.126
   Scharff RL, 2016, AM J PREV MED, V50, pS66, DOI 10.1016/j.amepre.2015.09.018
   Stigi KA, 2012, EMERG INFECT DIS, V18, P477, DOI 10.3201/eid1803.111358
   U.S. Food and Drug Administration, 2016, JACK AND THE GREEN S
   U.S. Health and Human Services, 2016, PROACTIVE EFFORTS BY
   Vallieres E, 2013, J CLIN MICROBIOL, V51, P481, DOI 10.1128/JCM.02219-12
   Van Lint P, 2016, DIAGN MICR INFEC DIS, V85, P255, DOI 10.1016/j.diagmicrobio.2016.03.017
NR 29
TC 18
Z9 18
U1 0
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2017
VL 55
IS 1
BP 10
EP 19
DI 10.1128/JCM.01624-16
PG 10
WC Microbiology
SC Microbiology
GA EH7QC
UT WOS:000391966600004
PM 27795338
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Shamsudin, SN
   Rahiman, MHF
   Taib, MN
   Ahmad, AH
   Razak, WRWA
AF Shamsudin, S. N.
   Rahiman, M. H. F.
   Taib, M. N.
   Ahmad, A. H.
   Razak, W. R. W. A.
TI ESCHERICHIA COLI GROWTH MODELING USING NEURAL NETWORK
SO JOURNAL OF FUNDAMENTAL AND APPLIED SCIENCES
LA English
DT Article
DE neural network; NARX; prediction; Escherichia coli; pH; optical density
ID MICROBIAL-GROWTH; PREDICTIVE MICROBIOLOGY; WATER ACTIVITY; PH;
   TEMPERATURE; DYNAMICS; OIL
AB The assessment of water microbial quality is normally performed by verification of Escherichia coli where the growth is in nonlinearity. NARX is computational tools that have extensive utilization in solving nonlinear time series problems. It is well known as one of the technique that has the ability to predict with efficient and good performance. Using NARX, a highly accurate model was developed to predict the growth of Escherichia coli (E. coli) based on pH water parameter. The multiparameter portable sensor and spectrophotometer data were used to build and train the neural network. The selection of neural network structure for pH and optical density modelling was optimized and also the training and validation were analyzed. The result exhibited that NARX modeling was able to predict the growth of E. coli based on pH water parameter with overall regression is 0.99956.
C1 [Shamsudin, S. N.; Rahiman, M. H. F.; Taib, M. N.] Univ Teknol MARA, Fac Elect Engn, Shah Alam 40450, Selangor, Malaysia.
   [Ahmad, A. H.; Razak, W. R. W. A.] Univ Teknol MARA, Fac Sci Appl, Shah Alam 40450, Selangor, Malaysia.
RP Rahiman, MHF (reprint author), Univ Teknol MARA, Fac Elect Engn, Shah Alam 40450, Selangor, Malaysia.
EM hezrif@ieee.org
RI Zoolfakar, Ahmad Sabirin/D-7579-2015
FU Research Management Institute (RMI); UniversitiTeknologi MARA; MyPhD
FX The financial support by Research Management Institute (RMI),
   UniversitiTeknologi MARA and MyPhD are gratefully acknowledged. Faculty
   of Applied Sciences (FSG), Faculty of Civil (FKA), Faculty of Electrical
   Engineering (FKE) UniversitiTeknologi MARA and PICO/PICON members are
   also acknowledged for their technical support in conducting the field
   experiment.
CR Abdollahzadeh E, 2017, FOOD CONTROL, V73, P954, DOI 10.1016/j.foodcont.2016.10.014
   Alonso V, 2017, J APPL MICROBIOL, V122, P1048, DOI 10.1111/jam.13395
   Bakobie N, 2015, INT RES J PUBLIC ENV, V2, P197
   Balamurugan S, 2015, LETT APPL MICROBIOL, V60, P341, DOI 10.1111/lam.12375
   Choi SW, 2017, KSCE J CIV ENG, P1
   Esnoz A, 2006, INT J FOOD MICROBIOL, V106, P153, DOI 10.1016/j.ijfoodmicro.2005.06.016
   Esser DS, 2015, APPL MICROBIOL BIOT, V99, P8831, DOI 10.1007/s00253-015-6877-6
   Geeraerd AH, 2004, INT J FOOD MICROBIOL, V91, P229, DOI 10.1016/S0168-1605(03)00388-X
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Hamzah A, 2011, SAINS MALAYS, V40, P93
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Khan MJ, 2017, PAKISTAN J PATHOLOGY, V28, P28
   Low Samuel Xin Zher, 2013, Electron Physician, V5, P576, DOI 10.14661/2013.576-581
   MENEZES JMP, 2006, [No title captured], P28
   Oladunjoye AO, 2017, LWT-FOOD SCI TECHNOL, V76, P9, DOI 10.1016/j.lwt.2016.10.042
   Oscar TP, 2017, INT J FOOD SCI TECH, V52, P214, DOI 10.1111/ijfs.13242
   Peleg M, 2011, CRIT REV FOOD SCI, V51, P917, DOI 10.1080/10408398.2011.570463
   Sampson RW, 2006, WATER RESOUR MANAG, V20, P151, DOI 10.1007/s11269-006-5528-1
   Shamsudin SN, 2016, 2016 7TH IEEE CONTROL AND SYSTEM GRADUATE RESEARCH COLLOQUIUM (ICSGRC), P131, DOI 10.1109/ICSGRC.2016.7813315
   Sivasankar P, 2017, BIORESOURCE TECHNOL, V224, P498, DOI 10.1016/j.biortech.2016.10.091
   Soller JA, 2014, WATER RES, V66, P254, DOI 10.1016/j.watres.2014.08.026
   Uejio CK, 2017, HYDROGEOL J, V25, P969, DOI 10.1007/s10040-016-1521-9
   WHITING RC, 1995, CRIT REV FOOD SCI, V35, P467, DOI 10.1080/10408399509527711
   Yassin I M, 2016, INT J ADV SCI ENG IN, V6, P630
   Yassin I M, 2017, INT J ADV SCI ENG IN, V7, P215
   Zabidi A, 2017, INT J ADV SCI ENG IN, V7, P373
NR 26
TC 0
Z9 0
U1 0
U2 0
PU UNIV EL OUED, FAC SCIENCE & TECHNOLOGY
PI EL OUED
PA PO BOX 789, EL OUED, 39000, ALGERIA
SN 1112-9867
J9 J FUNDAM APPL SCI
JI J. Fundam. Appl. Sci.
PY 2017
VL 9
SU 4
SI SI
BP 759
EP 771
DI 10.4314/jfas.v9i4s.42
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM1PP
UT WOS:000414750700044
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Noaman, AY
   Nadeem, F
   Ragab, AHM
   Jamjoom, A
   Al-Abdullah, N
   Nasir, M
   Ali, AG
AF Noaman, Amin Y.
   Nadeem, Farrukh
   Ragab, Abdul Hamid M.
   Jamjoom, Arwa
   Al-Abdullah, Nabeela
   Nasir, Mahreen
   Ali, Anser G.
TI Improving Prediction Accuracy of "Central Line-Associated Blood Stream
   Infections" Using Data Mining Models
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SURGICAL SITE INFECTIONS; ANTIBIOTIC-RESISTANCE; NOSOCOMIAL INFECTIONS;
   SYSTEM; MICROBIOLOGY; SURVEILLANCE; PREVENTION
AB Prediction of nosocomial infections among patients is an important part of clinical surveillance programs to enable the related personnel to take preventive actions in advance. Designing a clinical surveillance program with capability of predicting nosocomial infections is a challenging task due to several reasons, including high dimensionality of medical data, heterogenous data representation, and special knowledge required to extract patterns for prediction. In this paper, we present details of six data mining methods implemented using cross industry standard process for data mining to predict central line-associated blood stream infections. For our study, we selected datasets of healthcare-associated infections from US National Healthcare Safety Network and consumer survey data from Hospital Consumer Assessment of Healthcare Providers and Systems. Our experiments show that central line-associated blood stream infections (CLABSIs) can be successfully predicted using AdaBoost method with an accuracy up to 89.7%. This will help in implementing effective clinical surveillance programs for infection control, as well as improving the accuracy detection of CLABSIs. Also, this reduces patients' hospital stay cost and maintains patients' safety.
C1 [Noaman, Amin Y.; Jamjoom, Arwa] King Abdulaziz Univ, Fac Comp & Informat Technol, Dept Comp Sci, Jeddah, Saudi Arabia.
   [Nadeem, Farrukh; Ragab, Abdul Hamid M.; Ali, Anser G.] King Abdulaziz Univ, Fac Comp & Informat Technol, Dept Informat Syst, Jeddah, Saudi Arabia.
   [Al-Abdullah, Nabeela] King Abdulaziz Univ, Fac Nursing, Clin Epidemiol & Infect Control, Jeddah, Saudi Arabia.
   [Nasir, Mahreen] Univ Hail, Dept Comp Sci & Software Engn, Hail, Saudi Arabia.
RP Ragab, AHM (reprint author), King Abdulaziz Univ, Fac Comp & Informat Technol, Dept Informat Syst, Jeddah, Saudi Arabia.
EM aragab@kau.edu.sa
RI Jamjoom, Arwa A/H-3663-2018; Al-Abdullah, Nabeela/AAC-5656-2019
OI Al-Abdullah, Nabeela/0000-0002-3605-8090
FU National Plan for Science, Technology and Innovation (MAARIFAH), King
   Abdulaziz City for Science and Technology, Saudi Arabia [12-INF2752-03]
FX This project was funded by the National Plan for Science, Technology and
   Innovation (MAARIFAH), King Abdulaziz City for Science and Technology,
   Saudi Arabia, Award no. 12-INF2752-03. The authors also thankfully
   acknowledge Science and Technology Unit, King Abdulaziz University, for
   technical support.
CR Aktar F, 2016, BIOMED RES INT, DOI 10.1155/2016/7240864
   [Anonymous], 2017, LOGISTIC REGRESSION
   [Anonymous], 2017, GENERATIVE DISCRIMIN
   [Anonymous], 2017, HOSP COMP
   Azari Ali, 2012, INT J KNOWLEDGE DISC, V3, P44
   Belciug S, 2009, ANN UNIV CRAIOVA-MAT, V36, P79
   Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006
   Boots R, 2016, NEUROCRIT CARE, V25, P167, DOI 10.1007/s12028-016-0314-2
   Brossette SE, 1998, J AM MED INFORM ASSN, V5, P373, DOI 10.1136/jamia.1998.0050373
   Brossette SE, 2008, CLIN LAB MED, V28, P119, DOI 10.1016/j.cll.2007.10.007
   Chang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023137
   Dao TK, 2008, AM J INFECT CONTROL, V36, pS18, DOI 10.1016/j.ajic.2007.05.010
   Esmaeili M., 2011, INT J COMPUTER APPL, V34
   Faria R, 2016, LECT NOTES ARTIF INT, V9693, P159, DOI 10.1007/978-3-319-39384-1_14
   Ferreira A., 2017, BOOSTING ALGORITHMS
   Fukuda H, 2016, INFECT CONT HOSP EP, V37, P260, DOI 10.1017/ice.2015.302
   Gerontini M., 2011, P 24 INT S COMP BAS, P1
   Gomez-Vallejo HJ, 2016, DECIS SUPPORT SYST, V84, P104, DOI 10.1016/j.dss.2016.02.005
   Gordini N., 2014, SOFT COMPUTING INTEL
   Grundmann H, 2014, UPSALA J MED SCI, V119, P87, DOI 10.3109/03009734.2014.904458
   Ha JF, 2010, OCHSNER J, V10, P38
   Hofmann Markus, 2013, RAPIDMINER DATA MINI
   Huang B.-C., 2014, P 7 BIOM ENG INT C B
   Jabbar H., 2015, COMPUTER SCI COMMUNI
   Lamma E., 2002, P 15 IEEE S COMP BAS
   Lo YS, 2010, INT CONF COMP SCI, P449, DOI 10.1109/ICCSIT.2010.5563823
   Louppe G., 2014, THESIS
   Ltifi H., 2012, INT J ADV RES ARTIFI, V1
   Ma Lili, 2003, AMIA Annu Symp Proc, P410
   McGregor C., 2011, P 13 C ART INT MED A, P3546
   Neves J., 2016, APPL BUSINESS INTELL, P24
   Obenshain MK, 2004, INFECT CONT HOSP EP, V25, P690, DOI 10.1086/502460
   Osborne Jason W., 2007, BEST PRACTICES QUANT
   Pechenizkiy M, 2005, LECT NOTES ARTIF INT, V3782, P360
   Pedroso-Fernandez Y, 2016, AM J INFECT CONTROL, V44, P450, DOI 10.1016/j.ajic.2015.10.024
   Peronnet E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152388
   Public Health Ontario, 2014, SURVEILLANCE HLTH CA, V7
   Ramchoun H, 2016, INT J INTERACT MULTI, V4, P26, DOI 10.9781/ijimai.2016.415
   Riedmiller M., 2017, MACHINE LEARNING MUL
   Saman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061097
   Santos RS, 2013, COMPUT METH PROG BIO, V109, P269, DOI 10.1016/j.cmpb.2012.10.010
   School of Information System, 2017, PHAS CROSS IND STAND
   Sharma A, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT (INDIACOM), P377, DOI 10.1109/IndiaCom.2014.6828163
   Shearer C., 2000, J DATA WAREHOUSING, V5
   Silva E., 2016, APPL BUSINESS INTELL, P188
   Somasundaram R.S., 2011, INT J COMPUTER APPL, V21
   Suleyman G, 2016, INFECT DIS CLIN N AM, V30, P1023, DOI 10.1016/j.idc.2016.07.008
   Tomar D., 2013, INT J BIOSCI BIOTECH, V5, P241, DOI DOI 10.14257/IJBSBT.2013.5.5.25
   Tsalik EL, 2016, ANN AM THORAC SOC, V13, P401, DOI 10.1513/AnnalsATS.201504-205OC
   Tseng YJ, 2010, P 10 INT C INF TECHN, P1
   Tu RH, 2016, SURG ENDOSC, V30, P3026, DOI 10.1007/s00464-015-4594-y
   Uhel F, 2017, AM J RESP CRIT CARE, V196, P315, DOI 10.1164/rccm.201606-1143OC
   Ulas M. A., 2011, THESIS
   Wang L., 2005, SUPPORT VECTOR MACHI
   Wisniewski MF, 2003, J AM MED INFORM ASSN, V10, P454, DOI 10.1197/jamia.M1299
   Wolkewitz M, 2017, J HOSP INFECT, V96, P81, DOI 10.1016/j.jhin.2017.01.017
   Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2
   Yang D, 2016, BIOMED REP, V5, P501, DOI 10.3892/br.2016.752
   Zareapoor M, 2015, PROCEDIA COMPUT SCI, V48, P679, DOI 10.1016/j.procs.2015.04.201
NR 59
TC 2
Z9 2
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2017
AR 3292849
DI 10.1155/2017/3292849
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA FI1XJ
UT WOS:000411729400001
PM 29085836
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Pulcini, C
   Mohrs, S
   Beovic, B
   Gyssens, I
   Theuretzbacher, U
   Cars, O
AF Pulcini, Celine
   Mohrs, Simone
   Beovic, Bojana
   Gyssens, Inge
   Theuretzbacher, Ursula
   Cars, Otto
CA ESGAP
   ReAct Working Grp Old Antibiotics
TI Forgotten antibiotics: a follow-up inventory study in Europe, the USA,
   Canada and Australia
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Bacterial resistance; Drug approval; Drug marketing; Antibiotic
   stewardship
ID ANTIMICROBIAL RESISTANCE; OLD ANTIBIOTICS
AB The objective of this study was to update a 2011 survey, conducted on behalf of the ESCMID Study Group for Antibiotic Policies (ESGAP), studying the availability of old but clinically useful antibiotics in North America, Europe and Australia. This follow-up survey was performed in 2015 in 40 countries among specialists from the pharmaceutical, infectious diseases and microbiology sectors in North America, Europe and Australia in order to assess the availability through usual marketing processes of 36 systemic antibiotics (addition of 3 antibiotics compared with the 2011 survey) selected for their ability to treat infections caused by resistant bacteria and their unique value for specific criteria. The questionnaire was sent by e-mail to national contacts belonging to ESGAP and ReAct networks. In all, 39 of the 40 countries participated in this survey. The number of available antibiotics differed considerably from one drug to another as well as from one country to another (e.g. 7 antibiotics available in Estonia, 24 in France). Overall, 25/36 selected antibiotics were marketed in 20/39 countries or less. From 2011 to 2015 (data available for both periods in 37 countries for 33 antibiotics), the number of available selected antibiotics increased in 13 countries and decreased in 17. In conclusion, despite the ongoing bacterial resistance crisis, the situation regarding the availability of 'forgotten antibiotics' has worsened since 2011. Urgent measures are needed to ensure better availability of these antibiotics on a global scale as a conservation measure to ensure sustainable and responsible use of antibiotics. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
C1 [Pulcini, Celine] Univ Lorraine, Ctr Hosp Reg Univ CHRU Nancy, Fac Med, Serv Malad Infect & Trop, Rue Morvan, F-54511 Nancy, France.
   [Mohrs, Simone; Cars, Otto] Uppsala Univ, Dept Med Sci, ReAct Act Antibiot Resistance, Uppsala, Sweden.
   [Beovic, Bojana] Univ Med Ctr Ljubljana, Ljubljana, Slovenia.
   [Gyssens, Inge] Radboud Univ Nijmegen, Med Ctr, Dept Med, Nijmegen, Netherlands.
   [Gyssens, Inge] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands.
   [Gyssens, Inge] Hasselt Univ, Hasselt, Belgium.
   [Theuretzbacher, Ursula] Ctr Antiinfect Agents, Vienna, Austria.
RP Pulcini, C (reprint author), Univ Lorraine, Ctr Hosp Reg Univ CHRU Nancy, Fac Med, Serv Malad Infect & Trop, Rue Morvan, F-54511 Nancy, France.
EM celine.pulcini@univ-lorraine.fr
RI Gyssens, Inge C.J./L-4343-2015; Zarb, Peter/Q-5765-2016
OI Zarb, Peter/0000-0003-4437-5069; Harxhi, Arjan/0000-0001-8518-7377;
   Mohrs, Simone/0000-0002-8790-4832
CR [Anonymous], 2016, TACKL DRUG RES INF G
   Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5
   Cassir N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00551
   European Commission, 2015, EXPL NOT JOINT PROC
   Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710
   Muller AE, 2015, CLIN MICROBIOL INFEC, V21, P881, DOI 10.1016/j.cmi.2015.06.007
   Pulcini C, 2012, CLIN INFECT DIS, V54, P268, DOI 10.1093/cid/cir838
   WHO, 2015, GLOB ACT PLAN ANT RE
NR 8
TC 22
Z9 22
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JAN
PY 2017
VL 49
IS 1
BP 98
EP 101
DI 10.1016/j.ijantimicag.2016.09.029
PG 4
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA EO1AG
UT WOS:000396429300014
PM 27887966
DA 2020-05-07
ER

PT J
AU Oscar, TP
AF Oscar, T. P.
TI Neural Network Model for Thermal Inactivation of Salmonella Typhimurium
   to Elimination in Ground Chicken: Acquisition of Data by Whole Sample
   Enrichment, Miniature Most-Probable-Number Method
SO JOURNAL OF FOOD PROTECTION
LA English
DT Article
DE Ground chicken; Neural network model; Predictive microbiology;
   Salmonella Typhimurium; Thermal inactivation; Whole sample enrichment;
   miniature most-probable-number method
ID LISTERIA-MONOCYTOGENES; MEAT; SEROTYPES; POULTRY; CINNAMALDEHYDE;
   CARVACROL; SURVIVAL; PATTIES; GROWTH; THIGH
AB Predictive models are valuable tools for assessing food safety. Existing thermal inactivation models for Salmonella and ground chicken do not provide predictions above 71 degrees C, which is below the recommended final cooked temperature of 73.9 degrees C for chicken. They also do not predict when all Salmonella are eliminated without extrapolating beyond the data used to develop them. Thus, a study was undertaken to develop a model for thermal inactivation of Salmonella to elimination in ground chicken at temperatures above those of existing models. Ground chicken thigh portions (0.76 cm(3)) in microcentrifuge tubes were inoculated with 4.45 +/- 0.25 log most probable number (MPN) of a single strain of Salmonella Typhimurium (chicken isolate). They were cooked at 50 to 100 degrees C in 2 or 2.5 degrees C increments in a heating block that simulated two-sided pan frying. A whole sample enrichment, miniature MPN (WSE-mMPN) method was used for enumeration. The lower limit of detection was one Salmonella cell per portion. MPN data were used to develop a multiple-layer feedforward neural network model. Model performance was evaluated using the acceptable prediction zone (APZ) method. The proportion of residuals in an APZ (pAPZ) from -1 log (fail-safe) to 0.5 log (fail-dangerous) was 0.911 (379 of 416) for dependent data and 0.910 (162 of 178) for independent data for interpolation. A pAPZ >= 0.7 indicated that model predictions had acceptable bias and accuracy. There were no local prediction problems because pAPZ for individual thermal inactivation curves ranged from 0.813 to 1.000. Independent data for interpolation satisfied the test data criteria of the APZ method. Thus, the model was successfully validated. Predicted times for a 1-log reduction ranged from 9.6 min at 56 degrees C to 0.71 min at 100 degrees C. Predicted times for elimination ranged from 8.6 min at 60 degrees C to 1.4 min at 100 degrees C. The model will be a valuable new tool for predicting and managing this important risk to public health.
C1 [Oscar, T. P.] Univ Maryland Eastern Shore, Residue Chem & Predict Microbiol Res Unit, Ctr Food Sci & Technol, USDA,ARS, Room 2111, Princess Anne, MD 21853 USA.
RP Oscar, TP (reprint author), Univ Maryland Eastern Shore, Residue Chem & Predict Microbiol Res Unit, Ctr Food Sci & Technol, USDA,ARS, Room 2111, Princess Anne, MD 21853 USA.
EM thomas.oscar@ars.usda.gov
CR [Anonymous], 1996, NATIONWIDE RAW GROUN
   BUCHANAN RL, 1993, TRENDS FOOD SCI TECH, V4, P6, DOI 10.1016/S0924-2244(05)80004-4
   Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11
   Ikediala JN, 1996, J FOOD SCI, V61, P796, DOI 10.1111/j.1365-2621.1996.tb12205.x
   Juneja VK, 2013, INT J FOOD MICROBIOL, V165, P184, DOI 10.1016/j.ijfoodmicro.2013.04.025
   Juneja VK, 2012, J FOOD PROTECT, V75, P289, DOI 10.4315/0362-028X.JFP-11-307
   Juneja VK, 2001, INT J FOOD MICROBIOL, V70, P37, DOI 10.1016/S0168-1605(01)00518-9
   Kosa KM, 2015, J FOOD PROTECT, V78, P180, DOI 10.4315/0362-028X.JFP-14-231
   Mackey BM, 2006, INT J FOOD MICROBIOL, V107, P295, DOI 10.1016/j.ijfoodmicro.2005.10.008
   Murphy RY, 2004, J FOOD PROTECT, V67, P1403, DOI 10.4315/0362-028X-67.7.1403
   Murphy RY, 2004, POULTRY SCI, V83, P1218, DOI 10.1093/ps/83.7.1218
   Murphy RY, 2001, POULTRY SCI, V80, P515, DOI 10.1093/ps/80.4.515
   Murphy RY, 1999, J FOOD PROTECT, V62, P980, DOI 10.4315/0362-028X-62.9.980
   Osaili TM, 2013, INT J FOOD MICROBIOL, V166, P15, DOI 10.1016/j.ijfoodmicro.2013.06.009
   Oscar TP, 2015, J FOOD PROTECT, V78, P1819, DOI 10.4315/0362-028X.JFP-15-093
   Oscar TP, 2014, J FOOD PROTECT, V77, P1086, DOI 10.4315/0362-028X.JFP-13-505
   Oscar TP, 2005, J FOOD PROTECT, V68, P2606, DOI 10.4315/0362-028X-68.12.2606
   Oscar TR, 2005, J FOOD SCI, V70, pM129, DOI 10.1111/j.1365-2621.2005.tb07103.x
   Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101
   THOMAS CJ, 1981, APPL ENVIRON MICROB, V42, P130, DOI 10.1128/AEM.42.1.130-134.1981
   THOMAS HAROLD A., 1942, JOUR AMER WATER WORKS ASSOC, V34, P572
   WHITING RC, 1994, FOOD TECHNOL-CHICAGO, V48, P113
NR 22
TC 4
Z9 4
U1 0
U2 1
PU INT ASSOC FOOD PROTECTION
PI DES MOINES
PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA
SN 0362-028X
EI 1944-9097
J9 J FOOD PROTECT
JI J. Food Prot.
PD JAN
PY 2017
VL 80
IS 1
BP 104
EP 112
DI 10.4315/0362-028X.JFP-16-199
PG 9
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA EI4SP
UT WOS:000392483900014
PM 28221884
DA 2020-05-07
ER

PT J
AU King, ZA
   O'Brien, EJ
   Feist, AM
   Palsson, BO
AF King, Zachary A.
   O'Brien, Edward J.
   Feist, Adam M.
   Palsson, Bernhard O.
TI Literature mining supports a next-generation modeling approach to
   predict cellular byproduct secretion
SO METABOLIC ENGINEERING
LA English
DT Article
DE Constraint-based modeling; Genome-scale model; ME-model; Literature
   mining; Escherichia coli
ID METABOLICALLY ENGINEERED STRAINS; SUCCINIC ACID PRODUCTION; GENOME-SCALE
   MODELS; ESCHERICHIA-COLI; FUNCTIONAL REPLACEMENT; PYRUVATE-CARBOXYLASE;
   MALIC ENZYME; OMIC DATA; EXPRESSION; GROWTH
AB The metabolic byproducts secreted by growing cells can be easily measured and provide a window into the state of a cell; they have been essential to the development of microbiology, cancer biology, and biotechnology. Progress in computational modeling of cells has made it possible to predict metabolic byproduct secretion with bottom-up reconstructions of metabolic networks. However, owing to a lack of data, it has not been possible to validate these predictions across a wide range of strains and conditions. Through literature mining, we were able to generate a database of Escherichia coli strains and their experimentally measured byproduct secretions. We simulated these strains in six historical genome-scale models of E. coli, and we report that the predictive power of the models has increased as they have expanded in size and scope. The latest genome-scale model of metabolism correctly predicts byproduct secretion for 35/89 (39%) of designs. The next-generation genome-scale model of metabolism and gene expression (ME-model) correctly predicts byproduct secretion for 40/89 (45%) of designs, and we show that ME-model predictions could be further improved through kinetic parameterization. We analyze the failure modes of these simulations and discuss opportunities to improve prediction of byproduct secretion.
C1 [King, Zachary A.; O'Brien, Edward J.; Feist, Adam M.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr 0412, La Jolla, CA 92093 USA.
   [Palsson, Bernhard O.] Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr 0412, La Jolla, CA 92093 USA.
   [Feist, Adam M.; Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Bldg 220, DIC-2800 Lyngby, Denmark.
RP Palsson, BO (reprint author), Univ Calif San Diego, Dept Bioengn, PFBH, Room 417,9500 Gilman Dr 0412, La Jolla, CA 92093 USA.
EM palsson@ucsd.edu
RI King, Zachary/V-3402-2019
OI King, Zachary/0000-0003-1238-1499
FU National Science Foundation Graduate Research FellowshipNational Science
   Foundation (NSF) [DGE-1144086]; Novo Nordisk Foundation through the
   Center for Biosustainability at the Technical University of Denmark
   [NNF16CC0021858]; NNF Center for Biosustainability [Network
   Reconstruction in Silico Biology]
FX We would like to thank Gabriela I. Guzman and Joshua A. Lerman for their
   guidance and suggestions during the course of this project. Funding for
   this work was provided by the National Science Foundation Graduate
   Research Fellowship [DGE-1144086 to Z.A.K.] and by the Novo Nordisk
   Foundation through the Center for Biosustainability at the Technical
   University of Denmark [NNF16CC0021858].
CR Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450
   Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6
   Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289
   Basan M., 2015, NATURE
   Blankschien MD, 2010, METAB ENG, V12, P409, DOI 10.1016/j.ymben.2010.06.002
   Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643
   Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803
   Carneiro Sonia, 2011, Microb Inform Exp, V1, P14, DOI 10.1186/2042-5783-1-14
   Chubukov V, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.9
   CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x
   Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333
   Donnelly MI, 1998, APPL BIOCHEM BIOTECH, V70-2, P187, DOI 10.1007/BF02920135
   Ebrahim A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13091
   Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74
   Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003
   Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542
   Golabgir A, 2016, BIOTECHNOL ADV, V34, P621, DOI 10.1016/j.biotechadv.2016.02.011
   Guzman GI, 2015, P NATL ACAD SCI USA, V112, P929, DOI 10.1073/pnas.1414218112
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hayden EC, 2015, NATURE, V520, P141, DOI 10.1038/520141a
   Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149
   INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987
   Kartal O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.76
   King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049
   King ZA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004321
   King ZA, 2015, CURR OPIN BIOTECH, V35, P23, DOI 10.1016/j.copbio.2014.12.016
   Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73
   Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365
   Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7880, DOI 10.1128/AEM.71.12.7880-7887.2005
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928
   Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737
   Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47
   Ma J., 2013, APPL MICROBIOL BIOTE
   Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998
   McMurry J., 2016, NAVIGATING PHENOTYPE
   Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82
   Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65
   O'Brien EJ, 2015, CURR OPIN BIOTECH, V34, P125, DOI 10.1016/j.copbio.2014.12.017
   O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52
   Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Palsson B., 2006, SYSTEMS BIOL PROPERT
   Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002
   Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54
   Sanchez AM, 2005, METAB ENG, V7, P229, DOI 10.1016/j.ymben.2005.03.001
   Sanchez AM, 2005, BIOTECHNOL PROGR, V21, P358, DOI 10.1021/bp049676e
   Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162
   Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006
   Stols L, 1997, APPL ENVIRON MICROB, V63, P2695, DOI 10.1128/AEM.63.7.2695-2701.1997
   Stols L, 1997, APPL BIOCHEM BIOTECH, V63-5, P153, DOI 10.1007/BF02920421
   Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11
   VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993
   Vemuri GN, 2002, APPL ENVIRON MICROB, V68, P1715, DOI 10.1128/AEM.68.4.1715-1727.2002
   Winkler James D., 2015, Metabolic Engineering Communications, V2, P30, DOI 10.1016/j.meteno.2015.06.003
   Wu SG, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004838
   Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]
   Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024
   Zhang X, 2007, APPL MICROBIOL BIOT, V77, P355, DOI 10.1007/s00253-007-1170-y
   Zhang XL, 2010, APPL ENVIRON MICROB, V76, P2397, DOI 10.1128/AEM.02902-09
   Zhao Q, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0968-2
   Zhou SD, 2003, APPL ENVIRON MICROB, V69, P2237, DOI 10.1128/AEM.69.4.2237-2244.2003
NR 64
TC 14
Z9 14
U1 1
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7176
EI 1096-7184
J9 METAB ENG
JI Metab. Eng.
PD JAN
PY 2017
VL 39
BP 220
EP 227
DI 10.1016/j.ymben.2016.12.004
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EI5VU
UT WOS:000392565200023
PM 27986597
OA Bronze
DA 2020-05-07
ER

PT J
AU Kirkpatrick, CL
   Lesouhaitier, O
   Malone, JG
   An, SQ
   Caly, DL
AF Kirkpatrick, Clare L.
   Lesouhaitier, Olivier
   Malone, Jacob G.
   An, Shi-Qi
   Caly, Delphine L.
TI Interaction and signalling networks: a report from the fourth 'Young
   Microbiologists Symposium on Microbe Signalling, Organisation and
   Pathogenesis'
SO MICROBIOLOGY-SGM
LA English
DT Article
DE gene regulation; signalling; secretion; host-pathogen interactions;
   microbe-microbe interactions
ID PSEUDOMONAS-AERUGINOSA; HD-GYP; CONTRIBUTES; RESISTANCE; MECHANISM;
   VIRULENCE; PROTEINS; MOTILITY; BIOFILM
AB At the end of June, over 120 microbiologists from 18 countries gathered in Dundee, Scotland for the fourth edition of the Young Microbiologists Symposium on 'Microbe Signalling, Organisation and Pathogenesis'. The aim of the symposium was to give early career microbiologists the opportunity to present their work in a convivial environment and to interact with senior world-renowned scientists in exciting fields of microbiology research. The meeting was supported by the Microbiology Society, the Society of Applied Microbiology and the American Society for Microbiology with further sponsorship from the European Molecular Biology Organisation and the Royal Society of Edinburgh. In this report, we highlight some themes that emerged from the many interesting talks and poster presentations, as well as some of the other activities that were on offer at this energetic meeting.
C1 [Kirkpatrick, Clare L.] Univ Geneva, Univ Med Ctr, Dept Microbiol & Mol Med, Inst Genet & Genom Geneva iGE3,Fac Med, Geneva, Switzerland.
   [Lesouhaitier, Olivier] Univ Rouen, Normandy Univ, Lab Microbiol Signals & Microenvironm, Evreux, France.
   [Malone, Jacob G.] John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England.
   [Malone, Jacob G.] Univ East Anglia, Norwich, Norfolk, England.
   [An, Shi-Qi] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee, Scotland.
   [Caly, Delphine L.] Univ Lille, EA 7394, ICV, Lille, France.
RP Caly, DL (reprint author), Univ Lille, EA 7394, ICV, Lille, France.
EM delphine.caly@polytech-lille.fr
RI Kirkpatrick, Clare/M-1890-2018
OI Kirkpatrick, Clare/0000-0001-8564-8559; Malone,
   Jacob/0000-0003-1959-6820; An, Shi-qi/0000-0002-2593-9642
FU American Society for Microbiology; European Molecular Biology
   OrganizationEuropean Molecular Biology Organization (EMBO); Federation
   of European Microbiological Societies; Microbiology Society; Society for
   Applied Microbiology; Royal Society of Edinburgh; Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BBS/E/J/000C0655]
FX We are deeply grateful to the participants who agreed for their work to
   be described in this report and we apologize to those whose work could
   not be mentioned due to space constraints. We also would like to thank
   all the speakers and participants for contributing to the success of
   this meeting. The organizers are extremely grateful to Erin Stanbridge,
   Kushal Rugjee, Birte Hollmann, Anne Six, the members of the Division of
   Molecular Microbiology in University of Dundee and Debbie Ree from the
   Dundee and Angus Convention Bureau for their help and support with the
   organization of the meeting. We also thank the American Society for
   Microbiology, the European Molecular Biology Organization, the
   Federation of European Microbiological Societies, the Microbiology
   Society, the Society for Applied Microbiology and the Royal Society of
   Edinburgh and all our other sponsors for their financial support.
CR Ahlstrand T, 2017, VIRULENCE, V8, P115, DOI 10.1080/21505594.2016.1216294
   Ahmad I, 2013, MOL MICROBIOL, V90, P1216, DOI 10.1111/mmi.12428
   Barnwal RP, 2016, NUCLEIC ACIDS RES, V44, P9426, DOI 10.1093/nar/gkw584
   Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447
   Caly DL, 2014, J BACTERIOL, V196, P3527, DOI 10.1128/JB.02029-14
   Caly DL, 2012, MOL MICROBIOL, V86, P501, DOI 10.1111/mmi.12016
   Cianfanelli FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005735
   Connolly JPR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005359
   Connolly JP, 2015, ISME J, V9, P1039, DOI 10.1038/ismej.2014.242
   Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217
   Gawthorne JA, 2016, APPL ENVIRON MICROB, V82, P2700, DOI 10.1128/AEM.03418-15
   Kirkpatrick CL, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.8, 10.1038/NMICROBIOL.2016.8]
   Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108
   Le Guyon S, 2015, ENVIRON MICROBIOL, V17, P1310, DOI 10.1111/1462-2920.12580
   Lee C, 2015, ENVIRON MICROBIOL, V17, P4511, DOI 10.1111/1462-2920.12915
   Mars RAT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005046
   Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623
   Paino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070509
   Paino A, 2012, CYTOKINE, V60, P565, DOI 10.1016/j.cyto.2012.07.024
   Planamente S, 2016, EMBO J, V28
   Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106
   Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107
   Ryan RP, 2009, MOL MICROBIOL, V73, P760, DOI 10.1111/j.1365-2958.2009.06822.x
   Stacy A, 2016, NAT REV MICROBIOL, V14, P93, DOI 10.1038/nrmicro.2015.8
   Stano P, 2012, BIOSYSTEMS, V109, P24, DOI 10.1016/j.biosystems.2012.01.002
   Turner KH, 2015, P NATL ACAD SCI USA, V112, P4110, DOI 10.1073/pnas.1419677112
NR 26
TC 1
Z9 1
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD JAN
PY 2017
VL 163
IS 1
BP 4
EP 8
DI 10.1099/mic.0.000401
PG 5
WC Microbiology
SC Microbiology
GA EN6ED
UT WOS:000396096400002
PM 27902434
OA Green Accepted, Bronze
DA 2020-05-07
ER

PT J
AU Katz, Y
   Springer, M
AF Katz, Yarden
   Springer, Michael
TI Probabilistic adaptation in changing microbial environments
SO PEERJ
LA English
DT Article
DE Systems biology; Microbiology; Microbiota; Gut microbiome; Bayesian
   inference; Microbial adaptation; Bet-hedging; Cellular circuits;
   Evolution; Epigenetics
ID SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; YEAST; GLUCOSE; GROWTH;
   MEMORY; EVOLUTION; GALACTOSE; NETWORKS; BEHAVIOR
AB Microbes growing in animal host environments face fluctuations that have elements of both randomness and predictability. IIn the mammalian gut, fluctuations in nutrient levels and other physiological parameters are structured by the host's behavior, diet, health and microbiota composition. Microbial cells that can anticipate environmental fluctuations by exploiting this structure would likely gain a fitness advantage (by adapting their internal state in advance). We propose that the problem of adaptive growth in structured changing environments, such as the gut, can be viewed as probabilistic inference. We analyze environments that are "meta-changing": where there are changes in the way the environment fluctuates, governed by a mechanism unobservable to cells. We develop a dynamic Bayesian model of these environments and show that a real-time inference algorithm (particle filtering) for this model can be used as a microbial growth strategy implementable in molecular circuits. The growth strategy suggested by our model outperforms heuristic strategies, and points to a class of algorithms that could support real-time probabilistic inference in natural or synthetic cellular circuits.
C1 [Katz, Yarden; Springer, Michael] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
   [Katz, Yarden] Harvard Univ, Berkman Klein Ctr Internet & Soc, Cambridge, MA 02138 USA.
RP Katz, Y (reprint author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Katz, Y (reprint author), Harvard Univ, Berkman Klein Ctr Internet & Soc, Cambridge, MA 02138 USA.
EM yarden@hms.harvard.edu
CR Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020
   Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167
   Borschinger B, 2011, P AUSTR LANG TECHN A, P10
   Bowsher CG, 2014, CURR OPIN BIOTECH, V28, P149, DOI 10.1016/j.copbio.2014.04.010
   Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731
   Brown AJP, 2014, TRENDS MICROBIOL, V22, P614, DOI 10.1016/j.tim.2014.07.001
   Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195
   Cappe O, 2007, P IEEE, V95, P899, DOI 10.1109/JPROC.2007.893250
   Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x
   David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Drager A, 2009, BIOINFORMATICS, V25, P1455, DOI 10.1093/bioinformatics/btp170
   Escalante-Chong R, 2015, P NATL ACAD SCI USA, V112, P1636, DOI 10.1073/pnas.1418058112
   Fox E, 2011, IEEE T SIGNAL PROCES, V59, P1569, DOI 10.1109/TSP.2010.2102756
   Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458
   GANCEDO JM, 1992, EUR J BIOCHEM, V206, P297, DOI 10.1111/j.1432-1033.1992.tb16928.x
   Gelman A., 1995, BAYESIAN DATA ANAL
   GHAHRAMANI Z, 1998, NEURAL COMPUT, V12, P963, DOI DOI 10.1162/089976600300015619
   Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106
   Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147
   Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024
   Jaynes ET, 2003, PROBABILITY THEORY L
   Johnson MJ, 2013, J MACH LEARN RES, V14, P673
   Jordan MI, 2004, STAT SCI, V19, P140, DOI 10.1214/088342304000000026
   Kobayashi TJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228104
   Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034
   Lambert G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004556
   Levins R, 1968, EVOLUTION CHANGING E
   LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056
   Marr D, 1982, VISION COMPUTATIONAL
   Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112
   Murphy K.P., 2002, THESIS
   Napp NE, 2013, ADV NEURAL INFORM PR, V26, P2247
   New AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001764
   Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566
   Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153
   Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035
   Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006
   Sarkka S., 2013, BAYESIAN FILTERING S
   Sivak DA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003826
   Stockwell SR, 2015, MOL BIOSYST, V11, P28, DOI 10.1039/c4mb00448e
   Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456
   Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048
   Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002
   Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830
   Wang J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002041
   Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5
   Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700
   Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011
NR 49
TC 5
Z9 5
U1 0
U2 20
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD DEC 14
PY 2016
VL 4
AR e2716
DI 10.7717/peerj.2716
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EF0ZK
UT WOS:000390054600002
PM 27994963
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Durante-Mangoni, E
   Andini, R
   Signoriello, S
   Cavezza, G
   Murino, P
   Buono, S
   De Cristofaro, M
   Taglialatela, C
   Bassetti, M
   Malacarne, P
   Petrosillo, N
   Corcione, A
   Viscoli, C
   Utili, R
   Gallo, C
AF Durante-Mangoni, E.
   Andini, R.
   Signoriello, S.
   Cavezza, G.
   Murino, P.
   Buono, S.
   De Cristofaro, M.
   Taglialatela, C.
   Bassetti, M.
   Malacarne, P.
   Petrosillo, N.
   Corcione, A.
   Viscoli, C.
   Utili, R.
   Gallo, C.
TI Acute kidney injury during colistin therapy: a prospective study in
   patients with extensively-drug resistant Acinetobacter baumannii
   infections
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Acinetobacter baumannii; Colistin; Extensively-drug-resistant;
   Nephrotoxicity; Nosocomial infection; Risk factors
ID INTRAVENOUS COLISTIN; RISK-FACTORS; NEPHROTOXICITY; PNEUMONIA; OUTCOMES;
   SODIUM; COHORT; MODEL
AB The study aimed to prospectively assess incidence and risk factors for colistin-associated nephrotoxicity. This is a secondary analysis of a multicentre, randomized clinical trial, comparing efficacy and safety of colistin versus the combination of colistin plus rifampicin in severe infections due to extensively drug-resistant (XDR) Acinetobacter baumannii. The primary end point was acute kidney injury (AKI) during colistin treatment, assessed using the AKI Network Criteria, and considering death as a competing risk. A total of 166 adult patients without baseline kidney disease on renal replacement therapy were studied. All had life-threatening infections due to colistin-susceptible XDR A. baumannii. Patients received colistin intravenously at the same initial dose (2 million international units (MIU) every 8 h) with predefined dose adjustments according to the actual renal function. Serum creatinine was measured at baseline and at days 4, 7, 11, 14 and 21 (or last day of therapy when discontinued earlier). Outcomes assessed were 'time to any kidney injury' (AKI stages 1-3) and 'time to severe kidney injury' (considering only AKI stages 2e3 as events). When evaluating overall mortality, AKI occurrence was modelled as a time-dependent variable. AKI was observed in 84 patients (50.6%, stage 1 in 40.4%), with an incidence rate of 5/100 person-days (95% CI 4-6.2). Risk estimates of AKI at 7 and 14 days were 30.6% and 58.8%. Age and previous chronic kidney disease were significantly associated with any AKI in multivariable analysis. Neither 'any' nor 'severe AKI' were associated with on-treatment mortality (p 0.32 and p 0.54, respectively). AKI occurs in one-third to one-half of colistin-treated patients and is more likely in elderly patients and in patients with kidney disease. As no impact of colistin-associated AKI on mortality was found, this adverse event should not represent a reason for withholding colistin therapy, whenever indicated. (C) 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Durante-Mangoni, E.; Andini, R.; Cavezza, G.; Utili, R.] Univ Naples SUN, Dept Cardiothorac Sci, Internal Med, Naples, Italy.
   [Durante-Mangoni, E.; Andini, R.; Cavezza, G.; Utili, R.] Monaldi Hosp, AORN Osped Colli, Naples, Italy.
   [Signoriello, S.; Gallo, C.] Univ Naples SUN, Dept Med & Publ Hlth, Med Stat, Naples, Italy.
   [Murino, P.; Buono, S.; Corcione, A.] Monaldi Hosp, AORN Osped Colli, Anaesthesia & Intens Care Unit, Naples, Italy.
   [De Cristofaro, M.; Taglialatela, C.] AORN Cardarelli, Anaesthesia & Intens Care Unit, Naples, Italy.
   [Bassetti, M.] S Maria Misericordia Univ Hosp, Div Infect Dis, Udine, Italy.
   [Malacarne, P.] AOU Pisana, Emergency Dept, Intens Care Unit, Pisa, Italy.
   [Petrosillo, N.] Natl Inst Infect Dis L Spallanzani, Infect Dis Div 2, Rome, Italy.
   [Viscoli, C.] San Martino Univ Hosp, Div Infect Dis, Genoa, Italy.
   [Viscoli, C.] Univ Genoa, Genoa, Italy.
RP Utili, R (reprint author), Osped Monaldi, Med Interna SUN, Via Leonardo Bianchi Snc, I-80131 Naples, Italy.
EM riccardo.utili@unina2.it
RI Bassetti, Matteo/L-3081-2019; Gallo, Ciro/AAA-9241-2019
OI Gallo, Ciro/0000-0002-7939-3104; Durante-Mangoni,
   Emanuele/0000-0002-5381-3537; Bassetti, Matteo/0000-0002-0145-9740
FU Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) [Bando per
   la Ricerca Indipendente sui Farmaci] [FARM7X9F8K]; EU AIDA grant
   [HealthF3-2011-278348]
FX This work was funded by the Italian Medicines Agency (Agenzia Italiana
   del Farmaco, AIFA) [Bando per la Ricerca Indipendente sui Farmaci 2007,
   contract number FARM7X9F8K]. EDM was funded in part by the EU AIDA grant
   (HealthF3-2011-278348). The remaining authors have disclosed that they
   do not have any conflicts of interest.
CR Balkan II, 2014, SCAND J INFECT DIS, V46, P678, DOI 10.3109/00365548.2014.926021
   Couet W, 2012, CLIN MICROBIOL INFEC, V18, P30, DOI 10.1111/j.1469-0691.2011.03667.x
   DeRyke CA, 2010, ANTIMICROB AGENTS CH, V54, P4503, DOI 10.1128/AAC.01707-09
   Doshi NM, 2011, PHARMACOTHERAPY, V31, P1257, DOI 10.1592/phco.31.12.1257
   Durante-Mangoni E, 2014, FUTURE MICROBIOL, V9, P773, DOI [10.2217/fmb.14.34, 10.2217/FMB.14.34]
   Durante-Mangoni E, 2013, CLIN INFECT DIS, V57, P349, DOI 10.1093/cid/cit253
   Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI [10.2217/FMB.11.23, 10.2217/fmb.11.23]
   Falagas ME, 2005, INT J ANTIMICROB AG, V26, P504, DOI 10.1016/j.ijantimicag.2005.09.004
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   Florescu DF, 2012, CLIN INFECT DIS, V54, P670, DOI 10.1093/cid/cir934
   Gauthier TP, 2012, ANTIMICROB AGENTS CH, V56, P2392, DOI 10.1128/AAC.00028-12
   Hartzell JD, 2009, CLIN INFECT DIS, V48, P1724, DOI 10.1086/599225
   Kim J, 2009, INT J ANTIMICROB AG, V34, P434, DOI 10.1016/j.ijantimicag.2009.06.028
   Ko HJ, 2011, NEPHRON CLIN PRACT, V117, pC284, DOI 10.1159/000320746
   Kwon KH, 2015, INT J ANTIMICROB AG, V45, P605, DOI 10.1016/j.ijantimicag.2015.01.011
   Lee YJ, 2015, CRIT CARE MED, V43, P1187, DOI 10.1097/CCM.0000000000000931
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1
   Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160
   Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
   Omrani AS, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0062-8
   Ozkan G, 2013, ANTIMICROB AGENTS CH, V57, P3463, DOI 10.1128/AAC.00343-13
   Phe K, 2014, ANTIMICROB AGENTS CH, V58, P6946, DOI 10.1128/AAC.03776-14
   Pike Matthew, 2014, J Pharm Pract, V27, P554, DOI 10.1177/0897190014546116
   Pogue JM, 2011, CLIN INFECT DIS, V53, P879, DOI 10.1093/cid/cir611
   Rattanaumpawan P, 2011, J INFECTION, V62, P187, DOI 10.1016/j.jinf.2010.11.013
   Santamaria C, 2009, SCAND J INFECT DIS, V41, P767, DOI 10.1080/00365540903147001
   Sorli L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-380
   Temocin F, 2015, JPN J INFECT DIS, V68, P318, DOI 10.7883/yoken.JJID.2014.223
   Tuon FF, 2014, INT J ANTIMICROB AG, V43, P349, DOI 10.1016/j.ijantimicag.2013.12.002
   Yahav D, 2012, CLIN MICROBIOL INFEC, V18, P18, DOI 10.1111/j.1469-0691.2011.03734.x
NR 30
TC 9
Z9 10
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD DEC
PY 2016
VL 22
IS 12
BP 984
EP 989
DI 10.1016/j.cmi.2016.08.004
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EF6DK
UT WOS:000390420800006
PM 27545697
DA 2020-05-07
ER

PT J
AU Petretto, A
   Carbotti, G
   Inglese, E
   Lavarello, C
   Pistillo, MP
   Rigo, V
   Croce, M
   Longo, L
   Martini, S
   Vacca, P
   Ferrini, S
   Fabbi, M
AF Petretto, Andrea
   Carbotti, Grazia
   Inglese, Elvira
   Lavarello, Chiara
   Pistillo, Maria Pia
   Rigo, Valentina
   Croce, Michela
   Longo, Luca
   Martini, Stefania
   Vacca, Paola
   Ferrini, Silvano
   Fabbi, Marina
TI Proteomic analysis uncovers common effects of IFN-gamma and IL-27 on the
   HLA class I antigen presentation machinery in human cancer cells
SO ONCOTARGET
LA English
DT Article
DE IL-27; IFN-gamma; proteomic analysis; HLA class I; cancer cells;
   Immunology and Microbiology Section; Immune response Immunity
ID BINDING-PROTEIN 1; CD4(+) T-CELLS; OVARIAN CARCINOMAS; DENDRITIC CELLS;
   MYELOID CELLS; IL-12 FAMILY; INTERLEUKIN-27; EXPRESSION; MACROPHAGES;
   ACTIVATION
AB IL-27, a member of the IL-12-family of cytokines, has shown anti-tumor activity in several pre-clinical models due to anti-proliferative, anti-angiogenic and immune-enhancing effects. On the other hand, IL-27 demonstrated immune regulatory activities and inhibition of auto-immunity in mouse models. Also, we reported that IL-27, similar to IFN-gamma, induces the expression of IL-18BP, IDO and PD-L1 immune regulatory molecules in human cancer cells. Here, a proteomic analysis reveals that IL-27 and IFN-gamma display a broad overlap of functions on human ovarian cancer cells. Indeed, among 990 proteins modulated by either cytokine treatment in SKOV3 cells, 814 showed a concordant modulation by both cytokines, while a smaller number (176) were differentially modulated. The most up-regulated proteins were common to both IFN-gamma and IL-27. In addition, functional analysis of IL-27-regulated protein networks highlighted pathways of interferon signaling and regulation, antigen presentation, protection from natural killer cell-mediated cytotoxicity, regulation of protein polyubiquitination and proteasome, aminoacid catabolism and regulation of viral protein levels.
   Importantly, we found that IL-27 induced HLA class I molecule expression in human cancer cells of different histotypes, including tumor cells showing very low expression. IL-27 failed only in a cancer cell line bearing a homozygous deletion in the B2M gene. Altogether, these data point out to a broad set of activities shared by IL-27 and IFN-gamma, which are dependent on the common activation of the STAT1 pathway. These data add further explanation to the anti-tumor activity of IL-27 and also to its dual role in immune regulation.
C1 [Petretto, Andrea; Inglese, Elvira; Lavarello, Chiara] Ist Giannina Gaslini, Core Facil, Prote Lab, Genoa, Italy.
   [Carbotti, Grazia; Rigo, Valentina; Croce, Michela; Longo, Luca; Martini, Stefania; Vacca, Paola; Ferrini, Silvano; Fabbi, Marina] IRCCS AOU San Martino IST Ist Nazl Ric Sul Canc, Dept Integrated Oncol Therapies, Genoa, Italy.
   [Pistillo, Maria Pia] IRCCS AOU San Martino IST Ist Nazl Ric Sul Canc, Tumor Epigenet Unit, Genoa, Italy.
   [Vacca, Paola] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy.
RP Ferrini, S; Fabbi, M (reprint author), IRCCS AOU San Martino IST Ist Nazl Ric Sul Canc, Dept Integrated Oncol Therapies, Genoa, Italy.
EM silvanodomenico.ferrini@hsanmartino.it; marina.fabbi@hsanmartino.it
RI Carbotti, Grazia/AAB-2726-2020; Petretto, Andrea/AAA-7342-2020;
   Pistillo, Maria Pia/V-1118-2019; Croce, Michela/AAA-8966-2020;
   Lavarello, Chiara/AAA-8261-2019; Longo, Luca/K-6156-2018; Vacca,
   Paola/K-2603-2016
OI Pistillo, Maria Pia/0000-0002-1154-4121; Croce,
   Michela/0000-0003-4683-4951; Lavarello, Chiara/0000-0002-5543-5285;
   Longo, Luca/0000-0002-5153-4243; Stefania, Martini/0000-0002-4579-4540;
   Petretto, Andrea/0000-0001-7811-8517; Vacca, Paola/0000-0002-0757-0108;
   Fabbi, Marina/0000-0002-4203-2022
FU AIRC (Associazione Italiana per la Ricerca sul Cancro)Associazione
   Italiana per la Ricerca sul Cancro (AIRC) [IG13518]; Italian Ministry of
   HealthMinistry of Health, Italy [GR-2013-02356568]; Italian
   Neuroblastoma Foundation; FIRC (Fondazione Italiana per la Ricerca sul
   Cancro)Associazione Italiana per la Ricerca sul Cancro (AIRC) [16497,
   16533]
FX Financial support: AIRC (Associazione Italiana per la Ricerca sul
   Cancro, IG13518), Italian Ministry of Health (GR-2013-02356568; 5 x 1000
   Funds).; Michela Croce and Luca Longo are supported by Italian
   Neuroblastoma Foundation.; Grazia Carbotti and Valentina Rigo are
   recipient of FIRC (Fondazione Italiana per la Ricerca sul Cancro)
   triennial fellowships 16497 and 16533, respectively.
CR Airoldi I, 2015, ONCOTARGET, V6, P3694, DOI 10.18632/oncotarget.2797
   Alama A, 1996, GYNECOL ONCOL, V62, P82, DOI 10.1006/gyno.1996.0194
   Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614
   Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912
   Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541
   Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375
   Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988
   Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P1359, DOI 10.1007/s00262-012-1321-6
   Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023
   Canale S, 2011, LEUKEMIA, V25, P1815, DOI 10.1038/leu.2011.158
   Carbotti G, 2015, ONCOTARGET, V6, P43267, DOI 10.18632/oncotarget.6530
   Carbotti G, 2013, CLIN CANCER RES, V19, P4611, DOI 10.1158/1078-0432.CCR-13-0568
   Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328
   Cocco C, 2010, CLIN CANCER RES, V16, P4188, DOI 10.1158/1078-0432.CCR-10-0173
   Corrias MV, 2001, TISSUE ANTIGENS, V57, P110, DOI 10.1034/j.1399-0039.2001.057002110.x
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Di Carlo E, 2014, ONCOTARGET, V5, P10332, DOI 10.18632/oncotarget.1425
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026
   Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578
   Feng XM, 2008, BIOCHEM BIOPH RES CO, V367, P553, DOI 10.1016/j.bbrc.2007.12.154
   Garrido F, 2016, INT J CANCER, V138, P271, DOI 10.1002/ijc.29375
   Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270
   Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568
   Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433
   Hause L, 2007, ANTIVIR RES, V76, P159, DOI 10.1016/j.antiviral.2007.06.013
   Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024
   Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c
   Kocher T, 2012, NAT PROTOC, V7, P882, DOI 10.1038/nprot.2012.036
   Li MS, 2015, IMMUNOTHERAPY-UK, V7, P191, DOI 10.2217/imt.14.95
   Lipnik K, 2010, MOL MED, V16, P177, DOI 10.2119/molmed.2009.00172
   Liu ZZ, 2013, EUR J IMMUNOL, V43, P468, DOI 10.1002/eji.201242930
   Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100
   Meunier E, 2016, CELL MICROBIOL, V18, P168, DOI 10.1111/cmi.12546
   Morandi F, 2014, J IMMUNOL, V192, P2634, DOI 10.4049/jimmunol.1302656
   Moretta L, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00087
   Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686
   Norell H, 2006, CANCER RES, V66, P6387, DOI 10.1158/0008-5472.CAN-06-0029
   Ostler N, 2014, MOL CELL BIOL, V34, P196, DOI 10.1128/MCB.00664-13
   Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200
   Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2
   Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157
   Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087
   Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170
   Scholtalbers J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0240-5
   Sekar D, 2012, EUR J IMMUNOL, V42, P1585, DOI 10.1002/eji.201142093
   Senecal V, 2016, GLIA, V64, P553, DOI 10.1002/glia.22948
   Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317
   Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6
   Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366
   Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524
   Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814
   Wittmann M, 2009, J ALLERGY CLIN IMMUN, V124, P81, DOI 10.1016/j.jaci.2009.04.026
   Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527
   Zhu X, 2016, GYNECOLOGIC ONCOLOGY
   Zorzoli A, 2012, CLIN CANCER RES, V18, P1630, DOI 10.1158/1078-0432.CCR-11-2432
NR 57
TC 9
Z9 9
U1 0
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD NOV 8
PY 2016
VL 7
IS 45
BP 72518
EP 72536
DI 10.18632/oncotarget.12235
PG 19
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EB5WT
UT WOS:000387452100011
PM 27683036
OA Green Published, Other Gold, Bronze
DA 2020-05-07
ER

PT J
AU Fajardo, TJ
   AlShaikhahmed, K
   Roy, P
AF Fajardo, Teodoro Jr
   AlShaikhahmed, Kinda
   Roy, Polly
TI Generation of infectious RNA complexes in Orbiviruses: RNA-RNA
   interactions of genomic segments
SO ONCOTARGET
LA English
DT Article
DE dsRNA virus; RNA-RNA interactions; orbivirus genome assembly; segmented
   genome sorting and packaging; reverse genetics; Immunology and
   Microbiology Section; Immune response; Immunity
ID HORSE SICKNESS VIRUS; INFLUENZA-A VIRUS; EPIZOOTIC HEMORRHAGIC-DISEASE;
   DEER ODOCOILEUS-VIRGINIANUS; REVERSE GENETICS SYSTEM; BLUETONGUE VIRUS;
   PRIMARY REPLICATION; SYNTHETIC RNA; DSRNA VIRUS; RECOVERY
AB Viruses with segmented RNA genomes must package the correct number of segments for synthesis of infectious virus particles. Recent studies suggest that the members of the Reoviridae family with segmented double-stranded RNA genomes achieve this challenging task by forming RNA networks of segments prior to their recruitment into the assembling capsid albeit direct evidence is still lacking. Here, we investigated the capability of virus recovery by preformed complexes of ten RNA segments of Epizootic Haemorrhagic Disease Virus ( EHDV), a Reoviridae member, by transcribing exact T7 cDNA copies of genomic RNA segments in a single in vitro reaction followed by transfection of mammalian cells. The data obtained was further confirmed by RNA complexes generated from Bluetongue virus, another family member. Formation of RNA complexes was demonstrated by sucrose gradient ultracentrifugation, and RNA-RNA interactions inherent to the formation of the RNA complexes were demonstrated by electrophoretic mobility shift assay. Further, we showed that disruption of RNA complex formation inhibits virus recovery, confirming that recruitment of complete RNA networks is essential for packaging and consequently, virus recovery. This efficient reverse genetics system will allow further understanding of evolutionary relationships of Reoviridae members and may also contribute to development of antiviral molecules.
C1 [Fajardo, Teodoro Jr; AlShaikhahmed, Kinda; Roy, Polly] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London, England.
   [AlShaikhahmed, Kinda] Univ Oxford, Nuffield Dept Med, Oxford, England.
RP Roy, P (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London, England.
EM polly.roy@lshtm.ac.uk
OI Roy, Polly/0000-0001-6535-6911
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AJ045000];
   Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/J014877]; National
   Institutes of Health (NIH, USA)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; Biotechnology
   and Biological Sciences Research Council (BBSRC, UK)Biotechnology and
   Biological Sciences Research Council (BBSRC); Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/J014877/1, BB/J021342/1]
FX National Institutes of Health (NIH, USA); Biotechnology and Biological
   Sciences Research Council (BBSRC, UK). Funding for open access charge:
   National Institutes of Health (R01AJ045000); Biotechnology and
   Biological Sciences Research Council (BB/J014877).
CR Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08
   Boyce M, 2007, J VIROL, V81, P2179, DOI 10.1128/JVI.01819-06
   Boyce M, 2016, J GEN VIROL, V97, P1145, DOI 10.1099/jgv.0.000400
   Burkhardt C, 2014, J GEN VIROL, V95, P2240, DOI 10.1099/vir.0.066647-0
   Fajardo T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005321
   Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985
   Gavazzi C, 2013, P NATL ACAD SCI USA, V110, P16604, DOI 10.1073/pnas.1314419110
   Gavazzi C, 2013, NUCLEIC ACIDS RES, V41, P1241, DOI 10.1093/nar/gks1181
   Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694
   Huiskonen JT, 2006, STRUCTURE, V14, P1039, DOI 10.1016/j.str.2006.03.018
   Kaname Y, 2013, J GEN VIROL, V94, P2259, DOI 10.1099/vir.0.055905-0
   Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663
   Liu HR, 2015, SCIENCE, V349, P1347, DOI 10.1126/science.aaa4938
   Lourenco S, 2011, P NATL ACAD SCI USA, V108, P13746, DOI 10.1073/pnas.1108667108
   Lulla V, 2016, J VIROL, V90, P7405, DOI 10.1128/JVI.00548-16
   Matsuo E, 2015, FEBS OPEN BIO, V5, P445, DOI 10.1016/j.fob.2015.05.006
   Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12
   Matsuo E, 2010, FEBS LETT, V584, P3386, DOI 10.1016/j.febslet.2010.06.030
   MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7
   Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008
   Pretorius JM, 2015, VIROLOGY, V486, P71, DOI 10.1016/j.virol.2015.09.004
   ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051
   Ruder MG, 2012, J WILDLIFE DIS, V48, P676, DOI 10.7589/0090-3558-48.3.676
   SHOPE RE, 1960, J EXP MED, V111, P155, DOI 10.1084/jem.111.2.155
   Standfast H.A., 1985, Progress in Clinical and Biological Research, V178, P177
   Sung PY, 2014, NUCLEIC ACIDS RES, V42, P13824, DOI 10.1093/nar/gku1171
   VANDIJK AA, 1988, J GEN VIROL, V69, P573, DOI 10.1099/0022-1317-69-3-573
   Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003
   WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6
   Yang T, 2015, J GEN VIROL
   Zhang X, 2015, NATURE, V527, P531, DOI 10.1038/nature15767
NR 31
TC 3
Z9 3
U1 0
U2 2
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD NOV 8
PY 2016
VL 7
IS 45
BP 72559
EP 72570
DI 10.18632/oncotarget.12496
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EB5WT
UT WOS:000387452100014
PM 27736800
OA Other Gold, Bronze, Green Accepted, Green Published
DA 2020-05-07
ER

PT J
AU Dorries, M
   Wohlbrand, L
   Rabus, R
AF Doerries, Marvin
   Woehlbrand, Lars
   Rabus, Ralf
TI Differential proteomic analysis of the metabolic network of the marine
   sulfate-reducer Desulfobacterium autotrophicum HRM2
SO PROTEOMICS
LA English
DT Article
DE Desulfobacterium autotrophicum HRM2; Energy metabolism; Metabolic
   reconstruction; Microbiology; Proteogenomics; Sulfate-reducing bacteria
ID CARBON-MONOXIDE DEHYDROGENASE; VULGARIS HILDENBOROUGH; PROTEIN
   IDENTIFICATION; ENERGY-CONSERVATION; ELECTRON-TRANSFER; GENOME SEQUENCE;
   ORGANIC-CARBON; TOLUOLICA TOL2; BACTERIA; COMPLEX
AB The marine sulfate-reducing bacterium Desulfobacterium autotrophicum HRM2 belongs to the deltaproteobacterial family Desulfobacteraceae and stands out for its capacity of facultative chemolithoautotrophic growth (next to heterotrophy). Here, proteomics-driven metabolic reconstruction was based on a combination of 2D-DIGE, shotgun proteomics, and analysis of the membrane protein enriched fraction applied to eight different substrate adaptation conditions (seven aliphatic compounds plus H-2/CO2). In total, 1344 different proteins were identified (similar to 27% of the 4947 genome-predicted), from which a complex metabolic network was reconstructed consisting of 136 proteins (124 detected; similar to 91%). Peripheral degradation routes for organic substrates feed directly or via the methylmalonyl-CoA pathway into the Wood-Ljungdahl pathway (WLP) for terminal oxidation to CO2. Chemolithoautotrophic growth apparently involves the periplasmic [Ni/Fe/Se]-containing hydrogenase HysAB (H-2 oxidation), the reductively operating WLP (CO2 fixation), and classical gluconeogenesis. Diverse soluble proteins (e.g., Hdr, Etf) probably establish a fine balanced cytoplasmic electron transfer network connecting individual catabolic reactions with the membrane menaquinone pool. In addition, multiple membrane protein complexes (Nqr, Qmo, Qrc, Rnf1, Rnf2, and Tmc) provide ample routes for interacting with the reducing equivalent pool and delivering electrons to dissimilatory sulfate reduction (both localized in the cytoplasm). Overall, this study contributes to the molecular understanding of the habitat-relevant Desulfobacteraceae.
C1 [Doerries, Marvin; Woehlbrand, Lars; Rabus, Ralf] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Gen & Mol Microbiol, Carl von Ossietzky St 9-11, D-26111 Oldenburg, Germany.
   [Rabus, Ralf] Max Planck Inst Marine Microbiol, Dept Microbiol, Bremen, Germany.
RP Rabus, R (reprint author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Gen & Mol Microbiol, Carl von Ossietzky St 9-11, D-26111 Oldenburg, Germany.
EM rabus@icbm.de
CR Amann J, 2010, J MOL MICROB BIOTECH, V18, P74, DOI 10.1159/000277655
   Barquera B, 2014, J BIOENERG BIOMEMBR, V46, P289, DOI 10.1007/s10863-014-9565-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRYSCH K, 1987, ARCH MICROBIOL, V148, P264, DOI 10.1007/BF00456703
   Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002
   CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N
   Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069
   Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08
   DEVEREUX R, 1989, J BACTERIOL, V171, P6689, DOI 10.1128/jb.171.12.6689-6695.1989
   Dorries M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3236-7
   Fenchel T.M., 1977, Advances in Microbial Ecology, V1, P1
   Gade D, 2003, J MOL MICROB BIOTECH, V5, P240, DOI 10.1159/000071076
   Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557
   Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959
   Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07
   JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0
   LANGE S, 1989, ARCH MICROBIOL, V151, P77
   Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011
   Pereira PM, 2006, BIOCHEMISTRY-US, V45, P10359, DOI 10.1021/bi0610294
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Price MN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00577
   Rabus R, 2000, PROKARYOTES EVOLVING, P659
   Rabus R, 2015, ADV MICROB PHYSIOL, V66, P55, DOI 10.1016/bs.ampbs.2015.05.002
   ROSSI M, 1993, J BACTERIOL, V175, P4699, DOI 10.1128/JB.175.15.4699-4711.1993
   Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944
   Santos AA, 2015, SCIENCE, V350, P1541, DOI 10.1126/science.aad3558
   SCHAUDER R, 1986, ARCH MICROBIOL, V145, P162, DOI 10.1007/BF00446775
   SCHAUDER R, 1989, ARCH MICROBIOL, V151, P84
   Steuber J, 2001, BBA-BIOENERGETICS, V1505, P45, DOI 10.1016/S0005-2728(00)00276-0
   Strittmatter AW, 2009, ENVIRON MICROBIOL, V11, P1038, DOI 10.1111/j.1462-2920.2008.01825.x
   Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631
   Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931
   Venceslau SS, 2011, FEBS LETT, V585, P2177, DOI 10.1016/j.febslet.2011.05.054
   Venceslau SS, 2010, J BIOL CHEM, V285, P22772, DOI 10.1074/jbc.M110.124305
   Weidenhaupt M, 1996, ARCH MICROBIOL, V165, P169, DOI 10.1007/s002030050312
   WIDDEL F, 1981, ARCH MICROBIOL, V129, P395, DOI 10.1007/BF00406470
   WIDDEL F, 1992, PROKARYOTES, P3352
   Wohlbrand L, 2007, PROTEOMICS, V7, P2222, DOI 10.1002/pmic.200600987
   Wohlbrand L, 2016, PROTEOMICS, V16, P973, DOI 10.1002/pmic.201500360
   Wohlbrand L, 2013, PROTEOMICS, V13, P2700, DOI 10.1002/pmic.201300175
   Wohlbrand L, 2013, ENVIRON MICROBIOL, V15, P1334, DOI 10.1111/j.1462-2920.2012.02885.x
   Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105
   Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513
   Zech H, 2011, PROTEOMICS, V11, P3380, DOI 10.1002/pmic.201100071
NR 44
TC 4
Z9 4
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD NOV
PY 2016
VL 16
IS 22
SI SI
BP 2878
EP 2893
DI 10.1002/pmic.201600041
PG 16
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ED9US
UT WOS:000389219200008
PM 27701823
DA 2020-05-07
ER

PT J
AU Park, R
   O'Brien, TF
   Huang, SS
   Baker, MA
   Yokoe, DS
   Kulldorff, M
   Barrett, C
   Swift, J
   Stelling, J
AF Park, Rachel
   O'Brien, Thomas F.
   Huang, Susan S.
   Baker, Meghan A.
   Yokoe, Deborah S.
   Kulldorff, Martin
   Barrett, Craig
   Swift, Jamie
   Stelling, John
CA Ctr Dis Control Prevention
TI Statistical detection of geographic clusters of resistant Escherichia
   coli in a regional network with WHONET and SaTScan
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Article
DE Geographic clustering; outbreak detection; antimicrobial resistance;
   Escherichia coli; Escherichia coli ST131; WHONET; SaTScan
ID CARE-ASSOCIATED INFECTIONS; ANTIMICROBIAL RESISTANCE; SHIGELLA SPP.;
   UNITED-STATES; DISSEMINATION; PREVALENCE; OUTBREAKS; CTX-M-15; ST131
AB Background: While antimicrobial resistance threatens the prevention, treatment, and control of infectious diseases, systematic analysis of routine microbiology laboratory test results worldwide can alert new threats and promote timely response. This study explores statistical algorithms for recognizing geographic clustering of multi-resistant microbes within a healthcare network and monitoring the dissemination of new strains over time.Methods:Escherichia coli antimicrobial susceptibility data from a three-year period stored in WHONET were analyzed across ten facilities in a healthcare network utilizing SaTScan's spatial multinomial model with two models for defining geographic proximity. We explored geographic clustering of multi-resistance phenotypes within the network and changes in clustering over time.Results: Geographic clustering identified from both latitude/longitude and non-parametric facility groupings geographic models were similar, while the latter was offers greater flexibility and generalizability. Iterative application of the clustering algorithms suggested the possible recognition of the initial appearance of invasive E. coli ST131 in the clinical database of a single hospital and subsequent dissemination to others.Conclusion: Systematic analysis of routine antimicrobial resistance susceptibility test results supports the recognition of geographic clustering of microbial phenotypic subpopulations with WHONET and SaTScan, and iterative application of these algorithms can detect the initial appearance in and dissemination across a region prompting early investigation, response, and containment measures.
C1 [Park, Rachel; O'Brien, Thomas F.; Baker, Meghan A.; Yokoe, Deborah S.; Kulldorff, Martin; Stelling, John] Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.
   [Park, Rachel] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Park, Rachel] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.
   [O'Brien, Thomas F.; Kulldorff, Martin; Stelling, John] Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
   [Huang, Susan S.] Univ Calif Irvine, Sch Med, Div Infect Dis, Orange, CA 92668 USA.
   [Huang, Susan S.] Univ Calif Irvine, Hlth Policy Res Inst, Orange, CA 92668 USA.
   [Baker, Meghan A.; Kulldorff, Martin] Harvard Pilgrim Hlth Care, Boston, MA USA.
   [Baker, Meghan A.; Kulldorff, Martin] Harvard Med Sch, Dept Populat Med, Boston, MA USA.
   [Barrett, Craig] Premier Inc, Safety Solut, Charlotte, NC USA.
   [Swift, Jamie] Mt States Hlth Alliance, Dept Infect Prevent, Johnson City, TN USA.
   [Kulldorff, Martin] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacovigilance, 75 Francis St, Boston, MA 02115 USA.
RP Stelling, J (reprint author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.; Stelling, J (reprint author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
EM jstelling@whonet.org
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RR025040]; Centers
   for Disease Control and Prevention (CDC) Epicenters Program
   [U54CK000172]
FX This paper was funded by grants from the National Institutes of Health
   (grant number RR025040) and the Centers for Disease Control and
   Prevention (CDC) Epicenters Program (Cooperative Agreement Number
   U54CK000172). Its contents are solely the responsibility of the authors
   and do not necessarily represent the official views of the Centers for
   Disease Control and Prevention.
CR Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4
   [Anonymous], 2015, THESIS
   Baker MA, 2015, IDWEEK 2015 OCT 8
   Chen LF, 2014, ANTIMICROB AGENTS CH, V58, P1200, DOI 10.1128/AAC.01099-13
   Clinical and Laboratory Standards Institute, 2015, M100S25 CLIN LAB STA
   Farrington C P, 1993, Commun Dis Rep CDR Rev, V3, pR78
   Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238
   Huttner A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-31
   Hutwagner L, 2003, J URBAN HEALTH, V80, pI89
   [Imperial College London Wellcome Trust], 2015, MAPP INF DIS EP
   Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932
   Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951
   Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995
   Kulldorff M., 2015, SATSCAN USER GUIDE V
   Kulldorff M., 2015, SATSCAN SOFTWARE SPA
   Lishman H, 2014, THESIS
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801
   Peirano G, 2010, ANTIMICROB AGENTS CH, V54, P1327, DOI 10.1128/AAC.01338-09
   Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111
   Stelling J, 2010, EPIDEMIOL INFECT, V138, P873, DOI 10.1017/S0950268809990884
   Stelling J, 2016, MOL MICROBIOLOGY DIA, P692, DOI [DOI 10.1128/9781555819071.CH48, 10.1128/9781555819071.ch48.]
   Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463
   Vinas MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002521
   *WHO, 2001, WHOCDSCSRDRS20012
   World Health Organization, 2015, WHO HOM PAG WHONET S
   World Health Organization, 2015, WHOHSEPEDAIP20142
   World Health Organization, 2015, WHO GLOB ACT PLAN AN
   Zarb P, 2012, EURO SURVILLANCE, V17
NR 28
TC 5
Z9 6
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD NOV
PY 2016
VL 14
IS 11
BP 1097
EP 1107
DI 10.1080/14787210.2016.1220303
PG 11
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA EA1ID
UT WOS:000386344800011
PM 27530311
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Bhat, J
   Sosna, J
   Fritsch, J
   Quabius, ES
   Schutze, S
   Zeissig, S
   Ammerpohl, O
   Adam, D
   Kabelitz, D
AF Bhat, Jaydeep
   Sosna, Justyna
   Fritsch, Juergen
   Quabius, Elgar Susanne
   Schuetze, Stefan
   Zeissig, Sebastian
   Ammerpohl, Ole
   Adam, Dieter
   Kabelitz, Dieter
TI Expression of non-secreted IL-4 is associated with HDAC
   inhibitor-induced cell death, histone acetylation and c-Jun regulation
   in human gamma/delta T-cells
SO ONCOTARGET
LA English
DT Article
DE IL-4; apoptosis; necroptosis; HDAC inhibitors; valproic acid; Immunology
   and Microbiology Section; Immune response; Immunity
ID VALPROIC ACID; DEACETYLASE INHIBITORS; TUMOR-CELLS; INDUCED NECROPTOSIS;
   CLINICAL-TRIAL; APOPTOSIS; ACTIVATION; RECEPTOR; CANCER; DIFFERENTIATION
AB Previously, the expression of a non-secreted IL-4 variant (IL-4 delta(13)) has been described in association with apoptosis and age-dependent Th2 T-cell polarization. Signaling pathways involved in this process have so far not been studied. Here we report the induction of IL-4 delta(13) expression in human gamma delta T-cells upon treatment with a sublethal dose of histone deacetylase (HDACi) inhibitor valproic acid (VPA). Induction of IL-4 delta(13) was associated with increased cytoplasmic IL-4Ra and decreased IL-4 expression, while mRNA for mature IL-4 was concomitantly down-regulated. Importantly, only the simultaneous combination of apoptosis and necroptosis inhibitors prevented IL-4 delta(13) expression and completely abrogated VPA-induced global histone H3K9 acetylation mark. Further, our work reveals a novel involvement of transcription factor c-Jun in the signaling network of IL-4, HDAC1, caspase-3 and mixed lineage kinase domain-like protein (MLKL). This study provides novel insights into the effects of epigenetic modulator VPA on human gamma delta T-cell differentiation.
C1 [Bhat, Jaydeep; Sosna, Justyna; Fritsch, Juergen; Quabius, Elgar Susanne; Schuetze, Stefan; Adam, Dieter; Kabelitz, Dieter] Univ Kiel, Inst Immunol, Kiel, Germany.
   [Quabius, Elgar Susanne] Univ Kiel, Dept Otorhinolaryngol Head & Neck Surg, Kiel, Germany.
   [Zeissig, Sebastian] Univ Kiel, Dept Internal Med 1, Kiel, Germany.
   [Ammerpohl, Ole] Univ Kiel, Univ Med Ctr Schleswig Holstein Kiel, Inst Human Genet, Kiel, Germany.
   [Sosna, Justyna] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.
   [Zeissig, Sebastian] Tech Univ Dresden, Univ Med Ctr Dresden, Dept Med 1, Dresden, Germany.
   [Zeissig, Sebastian] Tech Univ Dresden, CRTD, Dresden, Germany.
RP Kabelitz, D (reprint author), Univ Kiel, Inst Immunol, Kiel, Germany.
EM dietrich.kabelitz@uksh.de
RI Kabelitz, Dieter/A-2757-2010; Sosna, Justyna/I-5682-2019; Zeissig,
   Sebastian/B-6297-2012; Bhat, Jaydeep/Q-2795-2015; Fritsch,
   Juergen/M-7727-2016; Ammerpohl, Ole/G-2691-2010; Fritsch,
   Jurgen/Z-1146-2018; Adam, Dieter/E-9763-2010
OI Zeissig, Sebastian/0000-0001-5124-0897; Bhat,
   Jaydeep/0000-0002-5123-3125; Fritsch, Juergen/0000-0001-6909-6096;
   Fritsch, Jurgen/0000-0001-6909-6096; Adam, Dieter/0000-0002-5668-5032
FU Deutsche Forschungsgemeinschaft through the Cluster of Excellence
   "Inflammation-at-Interfaces"German Research Foundation (DFG) [EXC306-PN,
   EXC306-PM]; Kreitz Foundation (Kiel, Germany)
FX This work was supported by the Deutsche Forschungsgemeinschaft through
   the Cluster of Excellence "Inflammation-at-Interfaces" (EXC306-PN and
   EXC306-PM). Jaydeep Bhat acknowledges financial support from the Kreitz
   Foundation (Kiel, Germany).
CR Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851
   Avallone A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-875
   Behrens A, 2001, P NATL ACAD SCI USA, V98, P1769, DOI 10.1073/pnas.98.4.1769
   Bhat J, 2015, CELL IMMUNOL, V296, P50, DOI 10.1016/j.cellimm.2015.01.019
   Bhat J, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1006088
   Bollino D, 2015, J NEUROCHEM, V133, P174, DOI 10.1111/jnc.13029
   Caccamo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041940
   Chateauvieux S, 2010, J BIOMEDICINE BIOTEC, V2010
   Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212
   Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324
   Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6
   Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14
   Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58
   Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500
   Grabarska A D-GM, 2014, HEAD NECK ONCOL, V6, P7
   Greenblatt DY, 2008, ANN SURG, V247, P1036, DOI 10.1097/SLA.0b013e3181758d0e
   Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799
   Hebel K, 2014, J IMMUNOL, V192, P5160, DOI 10.4049/jimmunol.1302539
   Kabelitz D, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23304
   Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Koyanagi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-223
   Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584
   Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111
   Ledru E, 2003, BLOOD, V101, P3102, DOI 10.1182/blood-2002-08-2499
   Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743
   Lv J, 2012, J BIOL CHEM, V287, P28656, DOI 10.1074/jbc.M112.356584
   Mao YJ, 2016, CELL MOL IMMUNOL, V13, P217, DOI 10.1038/cmi.2015.07
   Munster P, 2009, CLIN CANCER RES, V15, P2488, DOI 10.1158/1078-0432.CCR-08-1930
   Ness-Schwickerath KJ, 2010, J IMMUNOL, V184, P7268, DOI 10.4049/jimmunol.1000600
   Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197
   Peters C, 2014, CELL MOL LIFE SCI, V71, P1943, DOI 10.1007/s00018-013-1467-1
   Philipp S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0103-0
   Quabius ES, 2012, J BIOMED MATER RES B, V100B, P1283, DOI 10.1002/jbm.b.32693
   Schwartz C, 2007, INT J ONCOL, V30, P573
   Sharma S, 2008, TRANSL ONCOL, V1, P141, DOI 10.1593/tlo.08136
   Sosna J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-76
   SPINOZZI F, 1995, IMMUNOLOGY, V86, P379
   Stein GM, 2000, CYTOMETRY, V41, P261, DOI 10.1002/1097-0320(20001201)41:4<261::AID-CYTO4>3.0.CO;2-S
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Su JM, 2011, CLIN CANCER RES, V17, P589, DOI 10.1158/1078-0432.CCR-10-0738
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Th'ng JPH, 2001, BIOCHEM CELL BIOL, V79, P305, DOI 10.1139/bcb-79-3-305
   Trinka E, 2014, CNS DRUGS, V28, P623, DOI 10.1007/s40263-014-0167-1
   Valapour M, 2002, J ALLERGY CLIN IMMUN, V109, P238, DOI 10.1067/mai.2002.121145
   Vasiliev AM, 2003, J PROTEOME RES, V2, P273, DOI 10.1021/pr025586y
   Wesch D, 2001, CELL IMMUNOL, V212, P110, DOI 10.1006/cimm.2001.1850
   West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738
   Yagi Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-149
   Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200
   Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200
NR 51
TC 6
Z9 6
U1 0
U2 5
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD OCT 4
PY 2016
VL 7
IS 40
BP 64743
EP 64756
DI 10.18632/oncotarget.11462
PG 14
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EB3QQ
UT WOS:000387281000016
PM 27556516
OA Bronze, Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Sala-Comorera, L
   Vilaro, C
   Galofre, B
   Blanch, AR
   Garcia-Aljaro, C
AF Sala-Comorera, Laura
   Vilaro, Caries
   Galofre, Belen
   Blanch, Anicet R.
   Garcia-Aljaro, Cristina
TI Use of matrix-assisted laser desorption/ionization-time of flight
   (MALDI-TOF) mass spectrometry for bacterial monitoring in routine
   analysis at a drinking water treatment plant
SO INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
LA English
DT Article; Proceedings Paper
CT 7th International Water and Health Seminar
CY JUN 29-JUL 01, 2015
CL Cannes, FRANCE
DE MALDI-TOF; Drinking water; PhenePlate system; Environmental strains;
   Routine analysis; Identification
ID DESORPTION IONIZATION-TIME; CLINICAL MICROBIOLOGY; DISTRIBUTION-SYSTEMS;
   IDENTIFICATION; POPULATIONS; MS; PERSISTENCE; DIVERSITY; DNA;
   DEREPLICATION
AB The study of bacterial communities throughout a drinking water treatment plant could provide a basic understanding of the effects of water processing that could then be used to improve the management of such plants. However, it is necessary to develop new analytical techniques that are sufficiently efficient, robust and fast for their effective and useful application in routine analysis. The aim of this study is therefore to assess the performance of matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), as compared to the PhenePlate (TM) system, for routine analysis in a drinking water treatment plant. To this end we studied a total of 277 colonies isolated in different seasons and from different points throughout the water treatment process, including: raw water, sand filtration, ultrafiltration, reverse osmosis and chlorination. The colonies were analysed using MALDI-TOF MS by direct deposition of the cells on the plate. The colonies were also biochemically fingerprinted using the PhenePlate (TM) system, clustered according to their similarity and a representative strain was selected for 16S rRNA gene sequencing and API (R) gallery-based identification. The use of MALDI-TOF MS was reliable compared to the PhenePlate (TM) system and has the advantage of being faster and relatively cheap. Bacteria typing by MALDI-TOF MS is therefore a promising method to replace conventional routine phenotypic methods for the identification of bacteria in drinking water laboratories, thanks to its robustness. The major limiting factor for MALDI-TOF MS is the lack of a suitable mass spectra database; although each laboratory can develop its own library. This methodology will provide a tracking tool for companies to use in risk management and the detection of possible failures in both the water treatment processes and the distribution network, as well as offering characterization of the intrinsic microbial populations. (C) 2016 Elsevier GmbH. All rights reserved.
C1 [Sala-Comorera, Laura; Blanch, Anicet R.; Garcia-Aljaro, Cristina] Univ Barcelona, Fac Biol, Dept Microbiol, Av Diagonal 643, E-08028 Barcelona, Spain.
   [Vilaro, Caries; Galofre, Belen] EMGCIA, Aigues Barcelona, C Gen Batet 1-7, Barcelona 08028, Spain.
RP Garcia-Aljaro, C (reprint author), Univ Barcelona, Fac Biol, Dept Microbiol, Av Diagonal 643, E-08028 Barcelona, Spain.
EM crgarcia@ub.edu
RI Blanch, Anicet R./B-7573-2012; Garcia-Aljaro, Cristina/F-3893-2016
OI Blanch, Anicet R./0000-0002-7632-6758; Garcia-Aljaro,
   Cristina/0000-0003-4863-3547
CR Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11
   [Anonymous], 1999, WATER QUALITY ENUMER
   [Anonymous], 1998, OFFIC J EUR COMM L, V330, P32
   Ansaruzzaman M, 1996, J DIARRHOEAL DIS RES, V14, P248
   Ansaruzzaman M, 2007, J MED MICROBIOL, V56, P217, DOI 10.1099/jmm.0.46473-0
   Barberis C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106303
   Benagli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048441
   Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x
   Bosshard PP, 2006, J CLIN MICROBIOL, V44, P1359, DOI 10.1128/JCM.44.4.1359-1366.2006
   Calderaro A, 2014, INT J MOL SCI, V15, P16012, DOI 10.3390/ijms150916012
   Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017
   Casanovas-Massana A, 2013, INT J HYG ENVIR HEAL, V216, P132, DOI 10.1016/j.ijheh.2012.04.002
   Casanovas-Massana A, 2012, INT J FOOD MICROBIOL, V153, P38, DOI 10.1016/j.ijfoodmicro.2011.10.012
   Casanovas-Massana A, 2010, J MICROBIOL METH, V81, P1, DOI 10.1016/j.mimet.2009.12.013
   Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12
   Croci L, 2007, J APPL MICROBIOL, V102, P229, DOI 10.1111/j.1365-2672.2006.03046.x
   Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x
   Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2
   Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006
   Emami K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038515
   Franca L., 2014, ENV MICROBIOL
   Ghyselinck J, 2013, SYST APPL MICROBIOL, V36, P116, DOI 10.1016/j.syapm.2012.11.007
   Ghyselinck J, 2011, J MICROBIOL METH, V86, P327, DOI 10.1016/j.mimet.2011.06.004
   Hausdorf L, 2013, FOOD MICROBIOL, V34, P406, DOI 10.1016/j.fm.2012.10.008
   Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200
   Inger K., 1985, J MICROBIOL METH, V3, P159
   KUHN I, 1993, J MICROBIOL METH, V17, P255, DOI 10.1016/0167-7012(93)90054-L
   KUHN I, 1991, APPL ENVIRON MICROB, V57, P3171
   KUHN I, 1995, J CLIN MICROBIOL, V33, P2812
   Kuhn I, 1997, APPL ENVIRON MICROB, V63, P2708
   Munoz R, 2011, SYST APPL MICROBIOL, V34, P69, DOI 10.1016/j.syapm.2010.11.012
   Ng HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106514
   O'Hara CM, 2003, J CLIN MICROBIOL, V41, P5654, DOI 10.1128/JCM.41.12.5654-5659.2003
   Park JY, 2011, VET MICROBIOL, V147, P142, DOI 10.1016/j.vetmic.2010.06.020
   Penna VTC, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-13
   Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t
   Poitelon JB, 2010, J IND MICROBIOL BIOT, V37, P117, DOI 10.1007/s10295-009-0653-5
   Poitelon JB, 2009, WATER RES, V43, P4197, DOI 10.1016/j.watres.2009.07.020
   Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008
   Ribas F, 2000, J APPL MICROBIOL, V88, P704, DOI 10.1046/j.1365-2672.2000.01021.x
   Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584
   Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791
   Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10
   Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI 10.2217/FMB.10.127
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7
   STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846
   Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81
   Uhlik O, 2011, APPL ENVIRON MICROB, V77, P6858, DOI 10.1128/AEM.05465-11
   Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0
   Vila J, 2012, J CLIN MICROBIOL, V50, P1745, DOI 10.1128/JCM.05821-11
   Vilanova X, 2005, J GEN APPL MICROBIOL, V51, P361, DOI 10.2323/jgam.51.361
   Vilanova X, 2004, J APPL MICROBIOL, V96, P279, DOI 10.1046/j.1365-2672.2003.02149.x
   Welker M, 2011, PROTEOMICS, V11, P3143, DOI 10.1002/pmic.201100049
   Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013
NR 55
TC 9
Z9 9
U1 1
U2 16
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1438-4639
EI 1618-131X
J9 INT J HYG ENVIR HEAL
JI Int. J. Hyg. Environ. Health.
PD OCT
PY 2016
VL 219
IS 7
BP 577
EP 584
DI 10.1016/j.ijheh.2016.01.001
PN A
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EB6VX
UT WOS:000387524800002
PM 26809219
DA 2020-05-07
ER

PT J
AU Bale, J
   Meunier, D
   Weill, FX
   dePinna, E
   Peters, T
   Nair, S
AF Bale, Janet
   Meunier, Daniele
   Weill, Francois-Xavier
   dePinna, Elizabeth
   Peters, Tansy
   Nair, Satheesh
TI Characterization of new Salmonella serovars by whole-genome sequencing
   and traditional typing techniques
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID ENTERICA; IDENTIFICATION
AB Serotyping forms the basis of all national and international surveillance networks for Salmonella. Public health microbiology is currently being transformed by high-throughput DNA sequencing, which opens the door to serovar determination using this powerful technique. Twenty-nine Salmonella isolates referred to the Public Health England between 1994 and 2004 for serovar identification were selected for this study, and they all presented with novel antigenic formulae. Results from a combination of traditional phenotypic and molecular assays were compared. Twenty-two isolates (76 %) were subsequently independently confirmed as new types; of these, 18 (82 %) were grouped as Salmonellaenterica subspecies I, and four (18 %) were S. enterica subspecies II. In general, it is shown that there is concordance between the DNA sequence type and traditional phenotypic serotype, but it would be necessary to analyse a larger data set to confirm this. Traditional multilocus sequence typing (MLST) by Sanger sequencing also correlates to in silico whole-genome sequencing MLST. This permits the continuation of traditional serovar nomenclature alongside sequence type methods and enhances the ability to infer true phylogenetic relationships between isolates.
C1 [Bale, Janet; Meunier, Daniele; dePinna, Elizabeth; Peters, Tansy; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London NW9 5EQ, England.
   [Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, WHO Collaborating Ctr Reference & Res Salmonella, Paris, France.
RP Bale, J (reprint author), Publ Hlth England, Salmonella Reference Serv, London NW9 5EQ, England.
EM janet.bale@phe.gov.uk
OI Nair, Satheesh/0000-0002-7297-1485; Meunier,
   Daniele/0000-0003-4678-8094; Weill, Francois-Xavier/0000-0001-9941-5799
CR Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776
   Andino A, 2015, ScientificWorldJournal, V2015, P520179, DOI 10.1155/2015/520179
   Ashton P.M., 2015, PLOS CURR, V7
   Ashton PM, 2016, PEERJ, V4, DOI 10.7717/peerj.1752
   BARROW GI, 1993, COWAN STEELS MANUAL
   Biolog Inc., US Patent, Patent No. [5,627,045, 5627045]
   Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x
   BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0
   Grimont P.A., 2007, WHO COLLABORATING CT
   Hopkins KL, 2011, DIAGN MICR INFEC DIS, V70, P278, DOI 10.1016/j.diagmicrobio.2011.01.015
   Hopkins KL, 2009, DIAGN MICR INFEC DIS, V64, P452, DOI 10.1016/j.diagmicrobio.2009.03.022
   Issenhuth-Jeanjean S, 2014, RES MICROBIOL, V165, P526, DOI 10.1016/j.resmic.2014.07.004
   KAUFFMANN F, 1966, BACTERIOLOGY ENTEROB
   Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8
   Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991
   Luheshi L., 2015, PATHOGEN GENOMICS PR
   McQuiston JR, 2004, J CLIN MICROBIOL, V42, P1923, DOI 10.1128/JCM.42.5.1923-1932.2004
   Mortimer CKB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-31
   Nair S, 2014, J MED MICROBIOL, V63, P831, DOI 10.1099/jmm.0.072702-0
   Paulsen I. T., 2014, METHODS MICROBIOLOGY
   Public Health England, 2013, SUMM SALM SURV 2013
   Ranieri ML, 2013, J CLIN MICROBIOL, V51, P1786, DOI 10.1128/JCM.03201-12
   Shi CL, 2015, CRIT REV MICROBIOL, V41, P309, DOI 10.3109/1040841X.2013.837862
   SHIPP CR, 1980, J CLIN PATHOL, V33, P595, DOI 10.1136/jcp.33.6.595
   Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11
   Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15
NR 26
TC 13
Z9 14
U1 0
U2 9
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD OCT
PY 2016
VL 65
BP 1074
EP 1078
DI 10.1099/jmm.0.000325
PN 10
PG 5
WC Microbiology
SC Microbiology
GA EA5IN
UT WOS:000386653000003
PM 27481354
OA Bronze
DA 2020-05-07
ER

PT J
AU Veloo, ACM
   de Vries, ED
   Jean-Pierre, H
   Justesen, US
   Morris, T
   Urban, E
   Wybo, I
   van Winkelhoff, AJ
AF Veloo, A. C. M.
   de Vries, E. D.
   Jean-Pierre, H.
   Justesen, U. S.
   Morris, T.
   Urban, E.
   Wybo, I.
   van Winkelhoff, A. J.
CA ENRIA Workgrp
TI The optimization and validation of the Biotyper MALDI-TOF MS database
   for the identification of Gram-positive anaerobic cocci
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Database; European Network for the Rapid; Identification of Anaerobes;
   Gram-positive anaerobic cocci; Identification; Matrix-assisted laser
   desorption-ionization time-of-flight mass spectrometry; Optimization
ID FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; HUMAN CLINICAL
   SPECIMENS; SPECIES IDENTIFICATION; BACTERIA; BACTEROIDES; REVOLUTION
AB Gram-positive anaerobic cocci (GPAC) account for 24%-31% of the anaerobic bacteria isolated from human clinical specimens. At present, GPAC are under-represented in the Biotyper MALDI-TOF MS database. Profiles of new species have yet to be added. We present the optimization of the matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) database for the identification of GPAC. Main spectral profiles (MSPs) were created for 108 clinical GPAC isolates. Identity was confirmed using 16S rRNA gene sequencing. Species identification was considered to be reliable if the sequence similarity with its closest relative was >= 98.7%. The optimized database was validated using 140 clinical isolates. The 16S rRNA sequencing identity was compared with the MALDI-TOF MS result. MSPs were added from 17 species that were not yet represented in the MALDI-TOF MS database or were under-represented (fewer than five MSPs). This resulted in an increase from 53.6% (75/140) to 82.1% (115/140) of GPAC isolates that could be identified at the species level using MALDI-TOF MS. An improved log score was obtained for 51.4% (72/140) of the strains. For strains with a sequence similarity <98.7% with their closest relative (n = 5) or with an inconclusive sequence identity (n = 4), no identification was obtained by MALDI-TOFMS or in the latter case an identity with one of its relatives. For some species the MSP of the type strain was not part of the confined cluster of the corresponding clinical isolates. Also, not all species formed a homogeneous cluster. It emphasizes the necessity of adding sufficient MSPs of human clinical isolates. A.C.M. Veloo, CMI 2016; 22: 793 (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Veloo, A. C. M.; de Vries, E. D.; van Winkelhoff, A. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Jean-Pierre, H.] Ctr Hosp Univ Montpellier, Hop Arnaud Villeneuve, Lab Bacteriol, Montpellier, France.
   [Jean-Pierre, H.] Univ Montpellier I, Equipe Pathogenes Hydr Sante Environm, ECOSYM UMR5119, UMR Hydrosci 5569,UFR Pharm, Montpellier, France.
   [Justesen, U. S.] Odense Univ Hosp, Dept Clin Microbiol, Odense, Denmark.
   [Morris, T.] Publ Hlth Wales Microbiol, UK Anaerobe Reference Unit, Cardiff, S Glam, Wales.
   [Urban, E.] Univ Szeged, Inst Clin Microbiol, Szeged, Hungary.
   [Wybo, I.] Univ Ziekenhuis Brussel, Dept Microbiol & Infect Control, Brussels, Belgium.
   [van Winkelhoff, A. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Dent & Oral Hyg, Groningen, Netherlands.
RP Veloo, ACM (reprint author), Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM a.c.m.veloo@umcg.nl
RI Justesen, Ulrik/AAM-2536-2020
OI Justesen, Ulrik Stenz/0000-0002-6130-1902; Wybo,
   Ingrid/0000-0002-6217-1695
FU Bruker Daltoniks, Bremen, Germany
FX A.C.M. Veloo reports non-financial and technical support from Bruker
   Daltoniks, Bremen, Germany, during the conduct of the study. No external
   funding has been received.
CR Barreau M, 2013, ANAEROBE, V22, P123, DOI 10.1016/j.anaerobe.2013.04.011
   Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   BROOK I, 1988, J CLIN MICROBIOL, V26, P1181, DOI 10.1128/JCM.26.6.1181-1188.1988
   Culebras E, 2012, ANAEROBE, V18, P163, DOI 10.1016/j.anaerobe.2011.09.005
   Fedorko DP, 2012, EUR J CLIN MICROBIOL, V31, P2257, DOI 10.1007/s10096-012-1563-4
   Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81
   Nagy E, 2009, CLIN MICROBIOL INFEC, V15, P796, DOI 10.1111/j.1469-0691.2009.02788.x
   Schmitt BH, 2013, J CLIN MICROBIOL, V51, P782, DOI 10.1128/JCM.02420-12
   Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   Stackebrandt E, 2005, CURR MICROBIOL, V50, P71, DOI 10.1007/s00284-004-4395-3
   Stackebrandt E., 2006, MICROBIOLOGY TODAY, V33, P152, DOI DOI 10.1038/MSB.2013.22
   Veloo ACM, 2015, ANAEROBE, V33, P71, DOI 10.1016/j.anaerobe.2015.02.002
   Veloo ACM, 2014, CLIN MICROBIOL INFEC, V20, pO1091, DOI 10.1111/1469-0691.12644
   Veloo ACM, 2011, SYST APPL MICROBIOL, V34, P58, DOI 10.1016/j.syapm.2010.11.005
   Veloo ACM, 2015, ANAEROBE
   Wildeboer-Veloo ACM, 2007, CLIN MICROBIOL INFEC, V13, P985, DOI 10.1111/j.1469-0691.2007.01803.x
   Wybo I, 2012, J CLIN MICROBIOL, V50, P1415, DOI 10.1128/JCM.06326-11
NR 19
TC 13
Z9 13
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD SEP
PY 2016
VL 22
IS 9
BP 793
EP 798
DI 10.1016/j.cmi.2016.06.016
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EC4QL
UT WOS:000388118300011
PM 27404365
OA Green Published, Green Accepted, Bronze
DA 2020-05-07
ER

PT J
AU Huang, HI
   Chang, YY
   Lin, JY
   Kuo, RL
   Liu, HP
   Shih, SR
   Wu, CC
AF Huang, Hsing-I
   Chang, Ying-Ying
   Lin, Jhao-Yin
   Kuo, Rei-Lin
   Liu, Hao-Ping
   Shih, Shin-Ru
   Wu, Chih-Ching
TI Interactome analysis of the EV71 5 ' untranslated region in
   differentiated neuronal cells SH-SY5Y and regulatory role of FBP3 in
   viral replication
SO PROTEOMICS
LA English
DT Article
DE Differentiated neuronal cells; EV71; FBP3; Internal ribosomal entry
   site; Microbiology
ID ENTEROVIRUS 71 INFECTION; ELEMENT-BINDING PROTEIN-1; RIBOSOMAL ENTRY
   SITE; TRANSLATION INITIATION; VIRUS-REPLICATION; MOUTH-DISEASE; RNA;
   IDENTIFICATION; CANCER; MICROTUBULE
AB Enterovirus 71 (EV71), a single-stranded RNA virus, is one of the most serious neurotropic pathogens in the Asia-Pacific region. Through interactions with host proteins, the 5' untranslated region (5'UTR) of EV71 is important for viral replication. To gain a protein profile that interact with the EV71 5'UTR in neuronal cells, we performed a biotinylated RNA-protein pull-down assay in conjunction with LC-MS/MS analysis. A total of 109 proteins were detected and subjected to Database for Annotation, Visualization and Integrated Discovery (DAVID) analyses. These proteins were found to be highly correlated with biological processes including RNA processing/splicing, epidermal cell differentiation, and protein folding. Aprotein-protein interaction network was constructed using the STRING online database to illustrate the interactions of those proteins that are mainly involved in RNA processing/splicing or protein folding. Moreover, we confirmed that the far-upstream element binding protein 3 (FBP3) was able to bind to the EV71 5'UTR. The redistribution of FBP3 in subcellular compartments was observed after EV71 infection, and the decreased expression of FBP3 in host neuronal cells markedly inhibited viral replication. Our results reveal various host proteins that potentially interact with the EV71 5'UTR in neuronal cells, and we found that FBP3 could serve as a positive regulator in host cells.
C1 [Huang, Hsing-I; Kuo, Rei-Lin; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.
   [Huang, Hsing-I; Kuo, Rei-Lin; Shih, Shin-Ru; Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan.
   [Huang, Hsing-I; Chang, Ying-Ying; Lin, Jhao-Yin; Kuo, Rei-Lin; Shih, Shin-Ru; Wu, Chih-Ching] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan.
   [Huang, Hsing-I; Kuo, Rei-Lin] Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan.
   [Liu, Hao-Ping] Natl Chung Hsing Univ, Dept Vet Med, Taichung, Taiwan.
   [Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Med Technol, Clin Virol Lab, Linkou, Taiwan.
   [Wu, Chih-Ching] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan.
   [Wu, Chih-Ching] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Linkou, Taiwan.
RP Huang, HI (reprint author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Huang, HI; Wu, CC (reprint author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan.; Huang, HI; Wu, CC (reprint author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan.; Huang, HI (reprint author), Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan.; Wu, CC (reprint author), Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan.; Wu, CC (reprint author), Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Linkou, Taiwan.
EM luckywu@mail.cgu.edu.tw
RI Liu, Hao-Ping/AAJ-3038-2020
OI Liu, Hao-Ping/0000-0001-5915-5128; Wu, Chih-Ching/0000-0002-7264-9672
FU Ministry of Science and Technology (MOST), Taiwan
   [102-2320-B-182-029-MY3, 103-2325-B-182-007, 103-2632-B-182-001]; Chang
   Gung Memorial Hospital (CGMH), Taiwan [CLRPD190016, CMRPD2B0053,
   BMRPC77]; MOSTMinistry of Science and Technology (MOST) Korea
   [104-2320-B-182-024-MY3]; CGMH, Taiwan [CMRPD1C0601-3, CMRPD1E0431-4,
   BMRPB33]
FX We thank the Proteomics Core Laboratory, Chang Gung University, Taiwan
   for the technical assistance. This work was supported by grants to
   Chih-Ching Wu from the Ministry of Science and Technology (MOST), Taiwan
   (102-2320-B-182-029-MY3, 103-2325-B-182-007, and 103-2632-B-182-001) and
   Chang Gung Memorial Hospital (CGMH), Taiwan (CLRPD190016, CMRPD2B0053,
   and BMRPC77), and grants to Hsing-I Huang from the MOST
   (104-2320-B-182-024-MY3) and CGMH, Taiwan (CMRPD1C0601-3, CMRPD1E0431-4,
   and BMRPB33).
CR Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08
   Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110
   CROEN KD, 1988, P NATL ACAD SCI USA, V85, P9773, DOI 10.1073/pnas.85.24.9773
   DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679
   Dechtawewat T, 2015, VIROL J, V12, DOI 10.1186/s12985-014-0219-7
   Ertel KJ, 2010, J VIROL, V84, P4229, DOI 10.1128/JVI.02198-09
   Havin L, 1998, GENE DEV, V12, P1593, DOI 10.1101/gad.12.11.1593
   Hsu CW, 2014, J PROTEOME RES, V13, P4796, DOI 10.1021/pr500038k
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682
   Jagdeo JM, 2015, J VIROL, V89, P7064, DOI 10.1128/JVI.02977-14
   Knowles RB, 1996, J NEUROSCI, V16, P7812
   Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862
   Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945
   LENK R, 1979, CELL, V16, P289, DOI 10.1016/0092-8674(79)90006-0
   Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0
   Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08
   Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901
   Lin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094040
   Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11
   Liu PJ, 2015, MOL CELL PROTEOMICS, V14, P917, DOI 10.1074/mcp.M114.045914
   Lloyd RE, 2015, VIROLOGY, V479, P457, DOI 10.1016/j.virol.2015.03.001
   Luo Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087491
   Markus A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004885
   Martinez-Salas E, 2013, INT J MOL SCI, V14, P21705, DOI 10.3390/ijms141121705
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761
   Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07
   Pilipenko EV, 1999, J VIROL, V73, P3190, DOI 10.1128/JVI.73.4.3190-3196.1999
   Pilipenko EV, 2000, GENE DEV, V14, P2028
   Preitner N, 2014, CELL, V158, P368, DOI 10.1016/j.cell.2014.05.042
   Rothe F, 2006, BIOCHEM BIOPH RES CO, V343, P57, DOI 10.1016/j.bbrc.2006.02.112
   Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104
   Soues S, 2003, EXP CELL RES, V288, P363, DOI 10.1016/S0014-4827(03)00248-9
   Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0
   Walter BL, 2002, J VIROL, V76, P12008, DOI 10.1128/JVI.76.23.12008-12022.2002
   Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149
   Weber A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-369
   Wu CC, 2015, PROTEOMICS, V15, P3394, DOI 10.1002/pmic.201500157
   Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006
   Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000
   Yu CJ, 2011, J PROTEOME RES, V10, P3778, DOI 10.1021/pr2004133
   Yu P, 2014, VIRUS RES, V189, P121, DOI 10.1016/j.virusres.2014.05.006
NR 45
TC 7
Z9 8
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD SEP
PY 2016
VL 16
IS 17
BP 2351
EP 2362
DI 10.1002/pmic.201600098
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DW4KJ
UT WOS:000383611400006
PM 27291656
DA 2020-05-07
ER

PT J
AU Millon, L
   Herbrecht, R
   Grenouillet, F
   Morio, F
   Alanio, A
   Letscher-Bru, V
   Cassaing, S
   Chouaki, T
   Kauffmann-Lacroix, C
   Poirier, P
   Toubas, D
   Augereau, O
   Rocchi, S
   Garcia-Hermoso, D
   Bretagne, S
AF Millon, L.
   Herbrecht, R.
   Grenouillet, F.
   Morio, F.
   Alanio, A.
   Letscher-Bru, V.
   Cassaing, S.
   Chouaki, T.
   Kauffmann-Lacroix, C.
   Poirier, P.
   Toubas, D.
   Augereau, O.
   Rocchi, S.
   Garcia-Hermoso, D.
   Bretagne, S.
CA French Mycosis Study Grp
TI Early diagnosis and monitoring of mucormycosis by detection of
   circulating DNA in serum: retrospective analysis of 44 cases collected
   through the French Surveillance Network of Invasive Fungal Infections
   (RESSIF)
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Diagnosis; monitoring; Mucorales; mucormycosis; quantitative PCR
ID AMPHOTERICIN-B; EUROPEAN ORGANIZATION; MOLD INFECTIONS; THERAPY;
   ASPERGILLOSIS; VORICONAZOLE; DEFINITIONS; DISEASES; PATIENT; LOAD
AB The main objective of this study was to assess the diagnostic performance of a set of three Mucorales quantitative PCR assays in a retrospective multicentre study. Mucormycosis cases were recorded thanks to the French prospective surveillance programme (RESSIF network). The day of sampling of the first histological or mycological positive specimen was defined as day 0 (D0). Detection of circulating DNA was performed on frozen serum samples collected from D-30 to D30, using quantitative PCR assays targeting Rhizomucor, Lichtheimia, Mucor/Rhizopus. Forty-four patients diagnosed with probable (n = 19) or proven (n = 25) mucormycosis were included. Thirty-six of the 44 patients (81%) had at least one PCR-positive serum. The first PCR-positive sample was observed 9 days (range 0-28 days) before diagnosis was made using mycological criteria and at least 2 days (range 0-24 days) before imaging. The identifications provided with the quantitative PCR assays were all concordant with culture and/or PCR-based identification of the causal species. Survival rate at D84 was significantly higher for patients with an initially positive PCR that became negative after treatment initiation than for patients whose PCR remained positive (48% and 4%, respectively; p < 10(-6)). The median time for complete negativity of PCR was 7 days (range 3-19 days) after initiation of L-AmB treatment. Despite some limitations due to the retrospective design of the study, we showed that Mucorales quantitative PCR could not only confirm the mucormycosis diagnosis when other mycological arguments were present but could also anticipate this diagnosis. Quantification of DNA loads may also be a useful adjunct to treatment monitoring. (C) 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Millon, L.; Grenouillet, F.] Ctr Hosp Reg Univ, Lab Parasitol Mycol, Besancon, France.
   [Millon, L.; Grenouillet, F.; Rocchi, S.] Univ Bourgogne Franche Comte, Lab Chronoenvironm UMR6249, CNRS, Besancon, France.
   [Herbrecht, R.] Hop Univ Strasbourg, Dept Oncol & Hematol, Strasbourg, France.
   [Morio, F.] Ctr Hosp Univ Nantes, Lab Parasitol Mycol, Nantes, France.
   [Morio, F.] Nantes Atlantique Univ, Dept Parasitol & Mycol Med, Univ Nantes, EA1155,IICiMed,Fac Pharm, Nantes, France.
   [Alanio, A.; Bretagne, S.] Ctr Hosp Univ APHP St Louis Paris, Paris, France.
   [Alanio, A.; Garcia-Hermoso, D.; Bretagne, S.] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycoses Invas & Antifong, Paris, France.
   [Alanio, A.; Garcia-Hermoso, D.; Bretagne, S.] Inst Pasteur, CNRS, URA3012, Paris, France.
   [Alanio, A.; Bretagne, S.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.
   [Letscher-Bru, V.] Hop Univ Strasbourg, Lab Mycol Med, Plateau Tech Microbiol, Strasbourg, France.
   [Letscher-Bru, V.] Univ Strasbourg, Inst Parasitol & Pathol Tropicale, EA7292, Federat Med Translat, Strasbourg, France.
   [Cassaing, S.] Ctr Hosp Univ Toulouse, Lab Parasitol Mycol, Toulouse, France.
   [Chouaki, T.] Ctr Hosp Univ Amiens, Amiens, France.
   [Chouaki, T.] Univ Picardie Jules Verne, Ctr Univ Rech Sante, CAP Sante FED 4231, EA 4666, Amiens, France.
   [Kauffmann-Lacroix, C.] Ctr Hosp Univ Poitiers, Poitiers, France.
   [Poirier, P.] Ctr Hosp Univ Gabriel Montpied, Lab Parasitol Mycol, Clermont Ferrand, France.
   [Toubas, D.] Ctr Hosp Univ Reims, Lab Parasitol Mycol, Reims, France.
   [Toubas, D.] Univ Reims, Unite MEDyC, CNRS, UMR7369, Reims, France.
   [Augereau, O.] Ctr Hosp Reg Orleans, Orleans, France.
RP Millon, L (reprint author), Univ Hosp, Dept Parasitol Mycol, Bd Fleming, F-25030 Besancon, France.
EM lmillon@chu-besancon.fr
RI Millon, laurence/AAK-5980-2020; DESOUBEAUX, Guillaume/J-5026-2015;
   Grenouillet, Frederic/R-5176-2016; Bouteille, Bernard/M-4547-2018;
   Bouteille, Bernard/T-6519-2019; BRETAGNE, Stephane/H-6655-2019; Morio,
   Florent/B-6159-2008; Alanio, Alexandre/N-8472-2016
OI DESOUBEAUX, Guillaume/0000-0001-7945-9890; Grenouillet,
   Frederic/0000-0001-6001-3135; Bouteille, Bernard/0000-0001-9661-0302;
   BRETAGNE, Stephane/0000-0001-6870-3800; Morio,
   Florent/0000-0002-5859-6105; Alanio, Alexandre/0000-0001-9726-3082;
   Cassaing, Sophie/0000-0003-0055-0136; Rocchi,
   steffi/0000-0001-9262-1127; Poirier, Philippe/0000-0001-9173-2634;
   Bergeron, Anne/0000-0003-2156-254X; Herbrecht, Raoul/0000-0002-9381-4876
FU French Ministry of Health [2014-A00580-47]; PfizerPfizer; Renishaw
   Diagnostics; MSD
FX This work was supported by a grant from French Ministry of Health
   (Projet Hospitalier de Recherche Clinique; national-ModiMucor
   2014-A00580-47). LM has received support for travel to meetings from
   Pfizer, MSD and Gilead. RH received honoraria from Astellas, Basilea,
   Gilead, MSD, Pfizer and Schering-Plough and a research grant from
   Pfizer. SB received project funding from Renishaw Diagnostics, was
   sponsored by Pfizer and MSD to attend international meetings, and
   provided consultancy for Gilead.
CR Bialek R, 2005, J CLIN PATHOL, V58, P1180, DOI 10.1136/jcp.2004.024703
   Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004
   De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660
   Garcia-Hermoso D, 2009, J CLIN MICROBIOL, V47, P3862, DOI 10.1128/JCM.02094-08
   Georgiadou SP, 2011, CLIN INFECT DIS, V52, P1144, DOI 10.1093/cid/cir122
   Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10
   Hasan B, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.06.016
   Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191
   Herbrecht R, 2015, CLIN INFECT DIS, V60, P713, DOI 10.1093/cid/ciu911
   Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08
   Ibrahim AS, 2012, CLIN INFECT DIS, V54, pS16, DOI 10.1093/cid/cir865
   Kobayashi M, 2004, RESPIROLOGY, V9, P397, DOI 10.1111/j.1440-1843.2004.00582.x
   Kontoyiannis DP, 2012, CLIN INFECT DIS, V54, pS79, DOI 10.1093/cid/cir886
   Lanternier F, 2012, CLIN INFECT DIS, V54, pS35, DOI 10.1093/cid/cir880
   Millon L, 2005, J CLIN MICROBIOL, V43, P5097, DOI 10.1128/JCM.43.10.5097-5101.2005
   Millon L, 2011, J CLIN MICROBIOL, V49, P1058, DOI 10.1128/JCM.01904-10
   Millon L, 2013, CLIN INFECT DIS, V56, pE95, DOI 10.1093/cid/cit094
   Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332
   Park BJ, 2011, EMERG INFECT DIS, V17, P1855, DOI 10.3201/eid1710.110087
   Perkhofer S, 2009, ANTIMICROB AGENTS CH, V53, P1645, DOI 10.1128/AAC.01530-08
   Petrikkos G, 2012, CLIN INFECT DIS, V54, pS23, DOI 10.1093/cid/cir866
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Shigemura T, 2014, INT J INFECT DIS, V29, P200, DOI 10.1016/j.ijid.2014.10.019
   Shigemura T, 2014, INT J HEMATOL, V100, P206, DOI 10.1007/s12185-014-1597-8
   Skiada A, 2011, CLIN MICROBIOL INFEC, V17, P1859, DOI 10.1111/j.1469-0691.2010.03456.x
   Skiada A, 2013, HAEMATOLOGICA, V98, P492, DOI 10.3324/haematol.2012.065110
   WHITE TJ, 1990, PCR PROTOCOLS GUIDE
NR 27
TC 63
Z9 63
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD SEP
PY 2016
VL 22
IS 9
AR 810.e1
DI 10.1016/j.cmi.2015.12.006
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EC4QL
UT WOS:000388118300013
PM 26706615
OA Bronze
DA 2020-05-07
ER

PT J
AU Muyldermans, G
   Ducoffre, G
   Leroy, M
   Dupont, Y
   Quolin, S
AF Muyldermans, Gaetan
   Ducoffre, Genevieve
   Leroy, Mathias
   Dupont, Yves
   Quolin, Sophie
CA Participating Sentinel Labs
TI Surveillance of Infectious Diseases by the Sentinel Laboratory Network
   in Belgium: 30 Years of Continuous Improvement
SO PLOS ONE
LA English
DT Article
ID EPIDEMIOLOGIC SURVEILLANCE
AB In 1983 the sentinel laboratory network was established because of the need to describe the epidemiological evolution of infectious diseases. During the study period of 30 years (1983-2013), microbiology laboratories reported on weekly basis the laboratory diagnosed cases for a selection of infectious diseases. This resulted in a large longitudinal laboratory based database allowing to provide trends over time and distribution by person and place. During this period, adaptations to data collection were made due to changes in diagnostic methods and public health priorities, introduction and application of digital revolution, and multiple reorganizations of the laboratories. Since the surveillance network is dynamic, it necessitates a continuous evaluation to ensure that, over time, it continues to be representative of the general epidemiological trends in the country. Secondly the aim is to examine the robustness and stability of this surveillance system. Here we demonstrated that the flexibility of the data collection methodology by the sentinel laboratory network is unique and that adaptations do not affect the capacity of the system to follow trends. Therefore, the surveillance by this network is representative of the current epidemiological situation in Belgium. To our knowledge, no such surveillance network with such a long-term follow-up and demonstrated stability for multiple infectious diseases in the general population was earlier described. Furthermore, expected trends due to the implementation of vaccination or other events were accurately detected. The collected data obtained from this network allows interesting comparisons with other national and international information sources.
C1 [Muyldermans, Gaetan; Ducoffre, Genevieve; Leroy, Mathias; Dupont, Yves; Quolin, Sophie; Participating Sentinel Labs] WIV ISP, OD Publ Hlth & Surveillance, Unit Epidemiol Infect Dis, Brussels, Belgium.
RP Muyldermans, G (reprint author), WIV ISP, OD Publ Hlth & Surveillance, Unit Epidemiol Infect Dis, Brussels, Belgium.
EM gaetan.muyldermans@wiv-isp.be
RI Muyldermans, Gaetan/AAE-7235-2020
OI KABAMBA MUKADI, Benoit/0000-0003-0284-5210; Melin,
   Pierrette/0000-0002-2159-5774
FU Flemish region; Walloon-Brussels federation; Flemish Community; Brussels
   Capital; French-speaking Community
FX The sentinel laboratory network was funded by the Flemish region and the
   Walloon-Brussels federation.; The Flemish Community, Brussels Capital
   and the French-speaking Community for their financial support.
CR Berger N, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0145-9
   Bernard A, 2002, INT J TOXICOL, V21, P333, DOI 10.1080/10915810290096540
   Dufour B, 2000, VET RES, V31, P169, DOI 10.1051/vetres:2000116
   European Centre for Disease Prevention and Control (ECDC), 2014, ANN EP REP SEX TRANS
   European Centre for Disease Prevention and Control (ECDC), 2013, ANN EP REP REP 2011
   Hanquet G, 2011, VACCINE, V29, P4698, DOI 10.1016/j.vaccine.2011.04.098
   Institute of Public Health (Belgium), SURV SEX TRANSM INF
   Institute of Public Health (Belgium), ANN REP NAT REF CTR
   Muyldermans G, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-8
   STROOBANT A, 1986, INT J EPIDEMIOL, V15, P386, DOI 10.1093/ije/15.3.386
   Vandenbergh H., 2004, BROCH SEM DIAGN SURV
   Vellinga A, 2002, EMERG INFECT DIS, V8, P19, DOI 10.3201/eid0801.010129
   Voldstedlund M, 2014, EURO SURVEILL, V19
   WALCKIERS D, 1991, GENITOURIN MED, V67, P374
   WALCKIERS D, 1991, EPIDEMIOL INFECT, V106, P297, DOI 10.1017/S0950268800048445
NR 15
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2016
VL 11
IS 8
AR e0160429
DI 10.1371/journal.pone.0160429
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV4DZ
UT WOS:000382876700004
PM 27571203
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU de Rougemont, A
   Kaplon, J
   Fremy, C
   Legrand-Guillien, MC
   Minoui-Tran, A
   Payan, C
   Vabret, A
   Mendes-Martins, L
   Chouchane, M
   Maudinas, R
   Huet, F
   Dubos, F
   Hober, D
   Lazrek, M
   Bouquignaud, C
   Decoster, A
   Alain, S
   Languepin, J
   Gillet, Y
   Lina, B
   Mekki, Y
   Morfin-Sherpa, F
   Guigon, A
   Guinard, J
   Foulongne, V
   Rodiere, M
   Avettand-Fenoel, V
   Bonacorsi, S
   Garbarg-Chenon, A
   Gendrel, D
   Lebon, P
   Lorrot, M
   Mariani, P
   Meritet, JF
   Schnuriger, A
   Agius, G
   Beby-Defaux, A
   Oriot, D
   Colimon, R
   Lagathu, G
   Mory, O
   Pillet, S
   Pozzetto, B
   Stephan, JL
   Aho, S
   Pothier, P
AF de Rougemont, A.
   Kaplon, J.
   Fremy, C.
   Legrand-Guillien, M. -C.
   Minoui-Tran, A.
   Payan, C.
   Vabret, A.
   Mendes-Martins, L.
   Chouchane, M.
   Maudinas, R.
   Huet, F.
   Dubos, F.
   Hober, D.
   Lazrek, M.
   Bouquignaud, C.
   Decoster, A.
   Alain, S.
   Languepin, J.
   Gillet, Y.
   Lina, B.
   Mekki, Y.
   Morfin-Sherpa, F.
   Guigon, A.
   Guinard, J.
   Foulongne, V.
   Rodiere, M.
   Avettand-Fenoel, V.
   Bonacorsi, S.
   Garbarg-Chenon, A.
   Gendrel, D.
   Lebon, P.
   Lorrot, M.
   Mariani, P.
   Meritet, J. -F.
   Schnuriger, A.
   Agius, G.
   Beby-Defaux, A.
   Oriot, D.
   Colimon, R.
   Lagathu, G.
   Mory, O.
   Pillet, S.
   Pozzetto, B.
   Stephan, J. -L.
   Aho, S.
   Pothier, P.
CA French Natl Rotavirus Network
TI Clinical severity and molecular characteristics of circulating and
   emerging rotaviruses in young children attending hospital emergency
   departments in France
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Acute gastroenteritis; Diarrhoea; Emerging rotavirus; Genotyping;
   Rotavirus; Severity
ID GROUP-A ROTAVIRUS; GENOME CHARACTERIZATION; UNITED-STATES; STRAINS;
   SEROTYPE; DISEASE; GASTROENTERITIS; SURVEILLANCE; DIVERSITY; VACCINE
AB Group A rotavirus (RVA) is the leading cause of acute gastroenteritis in young children worldwide. A prospective surveillance network has been set up to investigate the virological and clinical features of RVA infections and to detect the emergence of potentially epidemic strains in France. From 2009 to 2014, RVA-positive stool samples were collected from 4800 children <5 years old attending the paediatric emergency units of 16 large hospitals. Rotaviruses were then genotyped by RT-PCR with regard to their outer capsid proteins VP4 and VP7. Genotyping of 4708 RVA showed that G1P[8] strains (62.2%) were predominant. The incidence of G9P[8] (11.5%), G3P[8] (10.4%) and G2P[4] (6.6%) strains varied considerably, whereas G4P[8] (2.7%) strains were circulating mostly locally. Of note, G12P[8] (1.6%) strains emerged during the seasons 2011-12 and 2012-13 with 4.1% and 3.0% prevalence, respectively. Overall, 40 possible zoonotic reassortants, such as G6 (33.3%) and G8 (15.4%) strains, were detected, and were mostly associated with P[6] (67.5%). Analysis of clinical records of 624 hospitalized children and severity scores from 282 of them showed no difference in clinical manifestations or severity in relation to the genotype. The relative stability of RVA genotypes currently co-circulating and the large predominance of P[8] type strains may ensure vaccine effectiveness in France. The surveillance will continue to monitor the emergence of new reassortants that might not respond to current vaccines, all the more so as all genotypes can cause severe infections in infants. A. de Rougemont, (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [de Rougemont, A.; Kaplon, J.; Fremy, C.; Pothier, P.] CHU Dijon, Lab Virol, Ctr Natl Reference Virus Enteriques, 2 Rue Angelique Ducoudray,BP 37013, F-21070 Dijon, France.
   [de Rougemont, A.; Huet, F.; Pothier, P.] Univ Bourgogne, UFR Sci Sante, Dijon, France.
   [Legrand-Guillien, M. -C.; Minoui-Tran, A.; Payan, C.] Ctr Hosp Univ Brest, Brest, France.
   [Vabret, A.] Ctr Hosp Univ Caen, Caen, France.
   [Mendes-Martins, L.] Ctr Hosp Charleville Mezieres, Charleville Mezieres, France.
   [Chouchane, M.; Maudinas, R.; Huet, F.] Ctr Hosp Univ Dijon, Dijon, France.
   [Dubos, F.; Hober, D.; Lazrek, M.] Ctr Hosp Reg Univ Lille, Lille, France.
   [Bouquignaud, C.; Decoster, A.] Inst Catholique Lille, Grp Hop, Lille, France.
   [Alain, S.; Languepin, J.] Ctr Hosp Univ Limoges, Limoges, France.
   [Gillet, Y.; Lina, B.; Mekki, Y.; Morfin-Sherpa, F.] Hosp Civils Lyon, Lyon, France.
   [Guigon, A.; Guinard, J.] Ctr Hosp Univ Orleans, Orleans, France.
   [Foulongne, V.; Rodiere, M.] Ctr Hosp Univ Montpellier, Montpellier, France.
   [Avettand-Fenoel, V.; Bonacorsi, S.; Garbarg-Chenon, A.; Gendrel, D.; Lebon, P.; Lorrot, M.; Mariani, P.; Meritet, J. -F.; Schnuriger, A.] AP HP, Paris, France.
   [Agius, G.; Beby-Defaux, A.; Oriot, D.] Ctr Hosp Univ Poitiers, Poitiers, France.
   [Colimon, R.; Lagathu, G.] Ctr Hosp Univ Rennes, Rennes, France.
   [Mory, O.; Pillet, S.; Pozzetto, B.; Stephan, J. -L.] Ctr Hosp Univ St Etienne, St Etienne, France.
   [Aho, S.] Ctr Hosp Univ Dijon, Serv Hygiene Hosp, Dijon, France.
RP de Rougemont, A (reprint author), CHU Dijon, Lab Virol, Ctr Natl Reference Virus Enteriques, 2 Rue Angelique Ducoudray,BP 37013, F-21070 Dijon, France.
EM alexis.de-rougemont@u-bourgogne.fr
RI Avettand-Fenoel, Veronique/O-6285-2017; de ROUGEMONT,
   Alexis/M-1090-2016; gillet, yves/C-6307-2012; Garbarg- Chenon,
   antoine/B-3397-2010; lina, bruno/N-3663-2019; Kaplon, Jerome/E-1707-2013
OI Avettand-Fenoel, Veronique/0000-0002-7022-2990; de ROUGEMONT,
   Alexis/0000-0002-3084-9414; gillet, yves/0000-0003-1791-1639; Garbarg-
   Chenon, antoine/0000-0003-2940-6672; lina, bruno/0000-0002-8959-2123;
   POZZETTO, Bruno/0000-0002-2603-8467; Kaplon, Jerome/0000-0002-8180-4152;
   VABRET, Astrid/0000-0002-8940-7645; Ludwig Serge, Aho
   Glele/0000-0001-7590-8644; Pillet, Sylvie/0000-0002-0882-3162
FU EuroRotaNet project; SPMSD
FX The authors declare no competing financial interests in the conduct of
   the study. This work received funding from the EuroRotaNet project and
   SPMSD through a non-restrictive collaborative grant.
CR Albano F, 2007, EUR J PEDIATR, V166, P241, DOI 10.1007/s00431-006-0237-6
   Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06
   Aupiais C, 2009, J CLIN VIROL, V46, P282, DOI 10.1016/j.jcv.2009.07.021
   Cascio A, 2001, CLIN INFECT DIS, V32, P1126, DOI 10.1086/319744
   Ciarlet M, 1997, J VIROL, V71, P8213, DOI 10.1128/JVI.71.11.8213-8220.1997
   Cilla G, 2013, EPIDEMIOL INFECT, V141, P868, DOI 10.1017/S0950268812001306
   Clark HF, 2004, J CLIN MICROBIOL, V42, P1434, DOI 10.1128/JCM.42.4.1434-1438.2004
   Cunliffe NA, 2000, VIROLOGY, V274, P309, DOI 10.1006/viro.2000.0456
   de Rougemont A, 2009, EUR J CLIN MICROBIOL, V28, P403, DOI 10.1007/s10096-008-0640-1
   de Rougemont A, 2011, PEDIATR INFECT DIS J, V30, P118, DOI 10.1097/INF.0b013e3181ef034e
   Delogu R, 2013, J CLIN MICROBIOL, V51, P1583, DOI 10.1128/JCM.00396-13
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810
   Iturriza-Gomara M, 2009, J INFECT DIS, V200, pS215, DOI 10.1086/605052
   Kirkwood CD, 2009, VACCINE, V27, pF102, DOI 10.1016/j.vaccine.2009.08.070
   Koopmans M, 1999, ACTA PAEDIATR, V88, P14, DOI 10.1111/j.1651-2227.1999.tb14320.x
   Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849
   Lewis KDC, 2012, VACCINE, V30, pA159, DOI 10.1016/j.vaccine.2011.07.126
   Linhares AC, 2006, CLIN INFECT DIS, V43, P312, DOI 10.1086/505493
   Martinot A, 2014, ARCH PEDIATRIE, V21, P1389, DOI 10.1016/j.arcped.2014.08.001
   Matthijnssens J, 2014, CLIN MICROBIOL INFEC, V20, pO702, DOI 10.1111/1469-0691.12612
   Matthijnssens J, 2011, INFECT GENET EVOL, V11, P1396, DOI 10.1016/j.meegid.2011.05.007
   Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI 10.2217/FMB.09.96
   Melliez H, 2005, MED MALADIES INFECT, V35, P492, DOI 10.1016/j.medmal.2005.08.007
   Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008
   Nyaga MM, 2014, VIRUS GENES, V49, P196, DOI 10.1007/s11262-014-1091-7
   Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003
   RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5
   Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   Wu FT, 2014, INFECT GENET EVOL, V28, P530, DOI 10.1016/j.meegid.2014.09.033
NR 35
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD AUG
PY 2016
VL 22
IS 8
AR UNSP 737.e9
DI 10.1016/j.cmi.2016.05.025
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EH9FX
UT WOS:000392078200011
PM 27287887
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Christiansen, AJ
   Dieterich, LC
   Ohs, I
   Bachmann, SB
   Bianchi, R
   Proulx, ST
   Hollmen, M
   Aebischer, D
   Detmar, M
AF Christiansen, Ailsa J.
   Dieterich, Lothar C.
   Ohs, Isabel
   Bachmann, Samia B.
   Bianchi, Roberta
   Proulx, Steven T.
   Hollmen, Maija
   Aebischer, David
   Detmar, Michael
TI Lymphatic endothelial cells attenuate inflammation via suppression of
   dendritic cell maturation
SO ONCOTARGET
LA English
DT Article
DE Inflammation; Lymphangiogenesis; VEGF-C; Immunology and Microbiology
   Section; Immune response; Immunity
ID REGULATORY T-CELLS; GROWTH-FACTOR-BETA; VEGF-C; SKIN INFLAMMATION;
   PROSTACYCLIN SYNTHESIS; TISSUE INFLAMMATION; MICE LACKING; MOUSE SKIN;
   TNF-ALPHA; LYMPHANGIOGENESIS
AB Vascular endothelial growth factor-C (VEGF-C)-induced lymphangiogenesis and increased tissue drainage have been reported to inhibit acute and chronic inflammation, and an activated lymphatic endothelium might mediate peripheral tolerance. Using transgenic mice overexpressing VEGF-C in the skin, we found that under inflammatory conditions, VEGF-C-mediated expansion of the cutaneous lymphatic network establishes an immune-inhibitory microenvironment characterised by increased regulatory T (Treg) cells, immature CD11c+CD11b+ dendritic cells (DCs) and CD8+ cells exhibiting decreased effector function. Strikingly, lymphatic endothelial cell (LEC)-conditioned media (CM) potently suppress DC maturation with reduced expression of MHCII, CD40, and IL-6, and increased IL-10 and CCL2 expression. We identify an imbalance in prostaglandin synthase expression after LEC activation, favoring anti-inflammatory prostacyclin synthesis. Importantly, blockade of LEC prostaglandin synthesis partially restores DC maturity. LECs also produce TGF-beta 1, contributing to the immune-inhibitory microenvironment. This study identifies novel mechanisms by which the lymphatic endothelium modulates cellular immune responses to limit inflammation.
C1 [Christiansen, Ailsa J.; Dieterich, Lothar C.; Ohs, Isabel; Bachmann, Samia B.; Bianchi, Roberta; Proulx, Steven T.; Hollmen, Maija; Aebischer, David; Detmar, Michael] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.
RP Detmar, M (reprint author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.
EM michael.detmar@pharma.ethz.ch
RI Hollmen, Maija/B-5831-2017
OI Hollmen, Maija/0000-0002-3250-7653; Dieterich,
   Lothar/0000-0001-7908-5710; Proulx, Steven/0000-0003-2154-8502
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310030B_147087]; European Research Council grant LYVICAM; Leducq
   Foundation Transatlantic Network of Excellence grant Lymph Vessels in
   Obesity and Cardiovascular DiseaseLeducq Foundation [11CVD03]; NH&MRC
   Early Career FellowshipNational Health and Medical Research Council of
   Australia [GNT 1013705]; ETH Zurich fellowship
FX We thank Jeannette Scholl, Sun-Young Yoon, Carlos Ochoa, Peter Camenzind
   and Catharina Seidel for technical assistance. This work was supported
   by Swiss National Science Foundation grant 310030B_147087, European
   Research Council grant LYVICAM and Leducq Foundation Transatlantic
   Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular
   Disease 11CVD03 (to M.D.) AJC was supported by an NH&MRC Early Career
   Fellowship, CJ Martin GNT 1013705 and by an ETH Zurich fellowship.
CR Aebischer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099297
   Aebischer D, 2014, ANGIOGENESIS, V17, P383, DOI 10.1007/s10456-013-9404-3
   ALDAZ CM, 1985, CANCER RES, V45, P2753
   Alitalo AK, 2013, CANCER RES, V73, P4212, DOI 10.1158/0008-5472.CAN-12-4539
   Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629
   Bonham C A, 1996, Transpl Immunol, V4, P186, DOI 10.1016/S0966-3274(96)80015-3
   Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660
   Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152
   Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849
   Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465
   D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189
   Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233
   Dieterich LC, 2014, ANGIOGENESIS, V17, P359, DOI 10.1007/s10456-013-9406-1
   Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149
   Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8
   Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166
   Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096
   Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463
   Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076
   Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704
   Groux H, 1997, NATURE, V389, P737
   Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761
   Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004
   Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5
   Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758
   Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492
   Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356
   Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559
   Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213
   Jordan JT, 2008, CANCER IMMUNOL IMMUN, V57, P123, DOI 10.1007/s00262-007-0336-x
   Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599
   Jurisic G, 2013, INFLAMM BOWEL DIS, V19, P1983, DOI 10.1097/MIB.0b013e31829292f7
   Kajiya K, 2009, J INVEST DERMATOL, V129, P1292, DOI 10.1038/jid.2008.351
   Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200
   Karaman S, 2015, MOL METAB, V4, P93, DOI 10.1016/j.molmet.2014.11.006
   Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776
   Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721
   Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607
   Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109
   Krause P, 2009, BLOOD, V113, P2451, DOI 10.1182/blood-2008-05-157123
   Kumar GK, 2011, EUR J PHARMACOL, V662, P63, DOI 10.1016/j.ejphar.2011.04.037
   LEWIS JG, 1987, CARCINOGENESIS, V8, P889, DOI 10.1093/carcin/8.7.889
   Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1
   Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013
   Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034
   Lund Amanda W, 2012, CELLREPORTS, P1
   Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276
   Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com
   Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200
   Nagao K, 2003, AM J RESP CELL MOL, V29, P314, DOI 10.1165/rcmb.2003-0035OC
   Naraba H, 1998, J IMMUNOL, V160, P2974
   Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014
   Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167
   Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271
   Rouhani SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7771
   Rouhani SJ, 2014, J CLIN CELL IMMUNOL, P5, DOI [10.4172/2155-9899.1000242, DOI 10.4172/2155-9899.1000242]
   Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095
   Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173
   STANLEY PL, 1991, SKIN PHARMACOL, V4, P262, DOI 10.1159/000210960
   Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7
   Takahashi Y, 2002, BRIT J PHARMACOL, V137, P315, DOI 10.1038/sj.bjp.0704872
   Teige I, 2009, J INVEST DERMATOL, V129, P1437, DOI 10.1038/jid.2008.375
   Tewalt EF, 2012, BLOOD, V120, P4772, DOI 10.1182/blood-2012-04-427013
   Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100
   Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447
   Vitiello PF, 2004, IMMUNOL LETT, V91, P239, DOI 10.1016/j.imlet.2003.12.009
   Wang YF, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-32
   Yamaguchi Y, 1997, STEM CELLS, V15, P144, DOI 10.1002/stem.150144
   Zhang YB, 2014, IMMUNITY, V40, P501, DOI 10.1016/j.immuni.2014.01.013
   Zhou Q, 2011, ARTHRITIS RHEUM-US, V63, P2318, DOI 10.1002/art.30421
   Zhou WS, 2007, J IMMUNOL, V178, P702, DOI 10.4049/jimmunol.178.2.702
NR 73
TC 20
Z9 20
U1 1
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JUN 28
PY 2016
VL 7
IS 26
BP 39421
EP 39435
DI 10.18632/oncotarget.9820
PG 15
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DP6NV
UT WOS:000378614700036
PM 27270646
OA Green Published, Other Gold, Bronze
DA 2020-05-07
ER

PT J
AU Fernandez-Ricaud, L
   Kourtchenko, O
   Zackrisson, M
   Warringer, J
   Blomberg, A
AF Fernandez-Ricaud, Luciano
   Kourtchenko, Olga
   Zackrisson, Martin
   Warringer, Jonas
   Blomberg, Anders
TI PRECOG: a tool for automated extraction and visualization of fitness
   components in microbial growth phenomics
SO BMC BIOINFORMATICS
LA English
DT Article
DE Phenomics; Yeast; growth; Data pre-processing; Fitness components;
   Automation; Data presentation
ID HIGH-THROUGHPUT; GENE-EXPRESSION; GENOME DATABASE; YEAST; RESOLUTION;
   PROPHECY
AB Background: Phenomics is a field in functional genomics that records variation in organismal phenotypes in the genetic, epigenetic or environmental context at a massive scale. For microbes, the key phenotype is the growth in population size because it contains information that is directly linked to fitness. Due to technical innovations and extensive automation our capacity to record complex and dynamic microbial growth data is rapidly outpacing our capacity to dissect and visualize this data and extract the fitness components it contains, hampering progress in all fields of microbiology.
   Results: To automate visualization, analysis and exploration of complex and highly resolved microbial growth data as well as standardized extraction of the fitness components it contains, we developed the software PRECOG (PREsentation and Characterization Of Growth-data). PRECOG allows the user to quality control, interact with and evaluate microbial growth data with ease, speed and accuracy, also in cases of non-standard growth dynamics. Quality indices filter high-from low-quality growth experiments, reducing false positives. The pre-processing filters in PRECOG are computationally inexpensive and yet functionally comparable to more complex neural network procedures. We provide examples where data calibration, project design and feature extraction methodologies have a clear impact on the estimated growth traits, emphasising the need for proper standardization in data analysis.
   Conclusions: PRECOG is a tool that streamlines growth data pre-processing, phenotypic trait extraction, visualization, distribution and the creation of vast and informative phenomics databases.
C1 [Fernandez-Ricaud, Luciano; Blomberg, Anders] Univ Gothenburg, Lundberg Lab, Dept Marine Sci, Med Gatan 9c, S-41390 Gothenburg, Sweden.
   [Kourtchenko, Olga] Univ Gothenburg, Dept Marine Sci, POB 461, SE-40530 Gothenburg, Sweden.
   [Zackrisson, Martin; Warringer, Jonas] Univ Gothenburg, Lundberg Lab, Dept Cell & Mol Biol, Med Gatan 9c, S-41390 Gothenburg, Sweden.
   [Warringer, Jonas] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, POB 5003, N-1432 As, Norway.
RP Blomberg, A (reprint author), Univ Gothenburg, Lundberg Lab, Dept Marine Sci, Med Gatan 9c, S-41390 Gothenburg, Sweden.
EM anders.blomberg@marine.gu.se
OI Blomberg, Anders/0000-0002-1260-3920
FU Swedish Research Council FORMASSwedish Research CouncilSwedish Research
   Council Formas [216-2013-549]; national Bioinformatics in Life Sciences
   (BILS)
FX We thank Peter Dahl for excellent technical help with establishing the
   calibration functions. Financial support from the Swedish Research
   Council FORMAS (216-2013-549) to AB, and from the national
   Bioinformatics in Life Sciences (BILS) to LFR, is acknowledged.
CR Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362
   Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534
   Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886
   Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013
   Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046
   Cerutti S, 1996, COMPUT METH PROG BIO, V51, P51, DOI 10.1016/0169-2607(96)01762-2
   Costanzo MC, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap001
   Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823
   de la Cruz N, 2005, NUCLEIC ACIDS RES, V33, pD485, DOI 10.1093/nar/gki050
   Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033
   Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871
   Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917
   Fernandez- Ricaud L, 2005, NUCLEIC ACIDS RES, V33, pD369, DOI 10.1093/nar/gki126
   Fernandez-Ricaud L, 2007, NUCLEIC ACIDS RES, V35, pD463, DOI 10.1093/nar/gkl1029
   Freeman A, 2010, INTRO VISUAL C 2010
   Gribbon P, 2005, J BIOMOL SCREEN, V10, P99, DOI 10.1177/1087057104271957
   Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187
   Harrison PW, 2012, SEMIN CELL DEV BIOL, V23, P222, DOI 10.1016/j.semcdb.2011.12.004
   Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1007/s10462-004-4304-y
   Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882
   Holowachuk SA, 2003, J MICROBIOL METH, V55, P441, DOI 10.1016/S0167-7012(03)00190-8
   Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897
   Huber R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-22
   Jasnos L, 2005, ANAL BIOCHEM, V344, P138, DOI 10.1016/j.ab.2005.04.034
   Jung PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119807
   Kensy F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-68
   King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620
   Lawless C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-287
   LEE YH, 1985, IEEE T ACOUST SPEECH, V33, P672
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Liu Y, 2009, GEOPHYSICS, V74, pV17, DOI 10.1190/1.3043446
   Liu ZQ, 1997, ULTRASONICS, V35, P325, DOI 10.1016/S0041-624X(97)00009-7
   Montes JM, 2007, TRENDS PLANT SCI, V12, P433, DOI 10.1016/j.tplants.2007.08.006
   Nachtomy O, 2007, STUD HIST PHI PART C, V38, P238, DOI 10.1016/j.shpsc.2006.12.014
   Nathan A, 2006, WINDOWS PRESENTATION
   Novak M, 2009, ANTON LEEUW INT J G, V96, P267, DOI 10.1007/s10482-009-9342-7
   Olsen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-141
   PITAS I, 1992, P IEEE, V80, P1893, DOI 10.1109/5.192071
   Pitas I, 1990, NONLINEAR DIGITAL FI, DOI New York
   Pylvanainen I., 2005, PARAMETRIC APPROACH
   Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102
   Sakurai T, 2005, NUCLEIC ACIDS RES, V33, pD647, DOI 10.1093/nar/gki014
   Schilling CH, 1999, BIOTECHNOL PROGR, V15, P288, DOI 10.1021/bp9900357
   Sells C, 2007, PROGRAMMING WPF BUIL
   Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793
   Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304
   Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013
   Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005
   Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/NMETH.1431, 10.1038/nmeth.1431]
   Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100
   Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931
   Warringer J, 2014, PHENOMICS, P172
   Warringer Jonas, 2008, BMC Chemical Biology, V8, P3, DOI 10.1186/1472-6769-8-3
   Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239
   Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]
   Zackrisson M, 2016, G3 GENES GE IN PRESS, pG3
   Zhao H, 2015, NUCLEIC ACIDS RES, V43, pD1018, DOI 10.1093/nar/gku894
NR 57
TC 11
Z9 11
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD JUN 23
PY 2016
VL 17
AR 249
DI 10.1186/s12859-016-1134-2
PG 15
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA DP9VU
UT WOS:000378846600001
PM 27334112
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Huang, YP
   Hsieh, JY
   Wu, HS
   Yang, JY
AF Huang, Yuan-Pin
   Hsieh, Juo-Yu
   Wu, Ho-Sheng
   Yang, Jyh-Yuan
TI Molecular and epidemiological study of human parechovirus infections in
   Taiwan, 2007-2012
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE epidemiology; parechovirus; phylogenetic analysis
ID STOOL SAMPLES; HUMAN ENTEROVIRUSES; CLINICAL SPECIMENS; IDENTIFICATION;
   PCR; CHILDREN; SURVEILLANCE; ASSOCIATION; PREVALENCE; SEROTYPE
AB Background/Purpose: As routine diagnostic assays for human parechoviruses (HPeVs) have not been included in the enteroviruses surveillance network in Taiwan, HPeVs may be the actual pathogens of hundreds of untypeable enteroviruses-suspected isolates.
   Methods: In this study, these untypeable isolates collected from 2007 through 2012 were examined by reverse transcription-polymerase chain reaction (RT-PCR)-based methods to survey the epidemiology of HPeVs in Taiwan.
   Results: Thirty-eight HPeV isolates were identified from 575 untypeable isolates, including 23 HPeV type1 (HPeV1), 13 HPeV3, and two HPeV6. Most of the patients were Taiwanese children under 5 years of age and their infections were generally prevalent in summer and autumn, with the highest peak occurring in September. The ratio of male to female patients was 1.56 and 2.25 for HPeV1 and HPeV3, respectively. Fever and respiratory symptoms were reported in significantly more patients infected with HPeV1. The results of phylogenetic analyses showed that HPeV isolates between 2007 and 2012 belonged to different lineages, indicating that endemic circulation of HPeV existed in Taiwan.
   Conclusion: This study showed that HPeVs have been endemic in Taiwan for some years despite a low positive rate. The detection tests of HPeVs are needed to correct a diagnostic deficit in the surveillance system. The epidemiological and genetic information obtained from the present study would contribute to the understanding of the etiology and epidemiology of HPeVs. Copyright (C) 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
C1 [Huang, Yuan-Pin; Hsieh, Juo-Yu; Wu, Ho-Sheng; Yang, Jyh-Yuan] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, 161 Kun Yang St, Taipei 11561, Taiwan.
   [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.
RP Yang, JY (reprint author), Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, 161 Kun Yang St, Taipei 11561, Taiwan.
EM jyyang@cdc.gov.tw
FU Taiwan CDC [DOH100-DC-2019, DOH101-DC-2401, DOH102-DC-2601]; National
   Research Program for Genomic MedicineNational Science Council of Taiwan
   [98-0324-01-F-20, 99-0324-01-F-12]
FX The authors would like to thank all principal investigators, physicians,
   and colleagues of the Taiwan CDC Collaborating Laboratories of Virology.
   This study was supported financially by research grants from the Taiwan
   CDC (DOH100-DC-2019, DOH101-DC-2401 and DOH102-DC-2601) and the National
   Research Program for Genomic Medicine (98-0324-01-F-20 and
   99-0324-01-F-12). The findings and conclusions in this study are those
   of the authors and do not necessarily represent the views of the Taiwan
   Centers for Disease Control.
CR Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08
   Benschop KSM, 2008, J GEN VIROL, V89, P1030, DOI 10.1099/vir.0.83498-0
   Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647
   Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905
   Ghazi F, 2012, INT J INFECT DIS, V16, pE673, DOI 10.1016/j.ijid.2012.05.1020
   Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068321
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Harvala H, 2009, J INFECT DIS, V199, P1753, DOI 10.1086/599094
   Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009
   Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277
   Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0
   Ito M, 2010, J CLIN MICROBIOL, V48, P2683, DOI 10.1128/JCM.00086-10
   Kolehmainen P, 2012, J CLIN VIROL, V54, P156, DOI 10.1016/j.jcv.2012.02.006
   Lin TL, 2008, J CLIN MICROBIOL, V46, P785, DOI 10.1128/JCM.01114-07
   Mizuta K, 2012, EMERG INFECT DIS, V18, P1787, DOI 10.3201/eid1811.111570
   Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08
   Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06
   Nix WA, 2010, J CLIN VIROL, V48, P202, DOI 10.1016/j.jcv.2010.04.007
   Oberste MS, 1998, VIRUS RES, V56, P217, DOI 10.1016/S0168-1702(98)00080-X
   Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0
   Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999
   Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006
   van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08
   Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896
   Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321
NR 29
TC 11
Z9 11
U1 0
U2 1
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD JUN
PY 2016
VL 49
IS 3
BP 321
EP 328
DI 10.1016/j.jmii.2014.06.013
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DO8XK
UT WOS:000378068600002
PM 25174670
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Whelton, E
   Lynch, C
   O'Reilly, B
   Corcoran, GD
   Cryan, B
   Keane, SM
   Sleator, RD
   Lucey, B
AF Whelton, E.
   Lynch, C.
   O'Reilly, B.
   Corcoran, G. D.
   Cryan, B.
   Keane, S. M.
   Sleator, R. D.
   Lucey, B.
TI Vancomycin-resistant enterococci carriage in an acute Irish hospital
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article
DE Enterococci; Vancomycin; Vancomycin resistant-enterococci
ID ELEMENT IS16; FAECIUM; INFECTION; EPIDEMIOLOGY; PREVALENCE; BACTEREMIA;
   EMERGENCE; STRAINS; TOOL
AB Background: Ireland has been shown to have the highest rate of vancomycin-resistant enterococci (VRE) in cases of bacteraemia in Europe, according to a report in 2014 from the European Antimicrobial Resistance Surveillance System Network.
   Aim: To investigate the prevalence of VRE gut colonization in a cohort of patients in 2014 at Cork University Hospital (CUH) by performing a cross-sectional study using faecal samples submitted to the microbiology laboratory for routine investigation from both hospital inpatients and community-based patients.
   Methods: Faeces were examined for VRE colonization using selective cultivation, antimicrobial susceptibility testing, and speciation using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. All VRE isolates were evaluated by molecular means for resistance determinants, type, and Insertion Sequence 16 as an indicator of Clonal Complex 17 (CC17).
   Findings: From the 350 specimens investigated, 67 (19.1%) specimens were positive for VRE [95% confidence interval (CI): 15.0-23.2]. The prevalence of VRE colonization among CUH patients tested in this study (N = 194) was 31.4% (95% CI: 24.7-38.1). By contrast, the general practitioner patient samples (N = 29) showed a prevalence of 0%, whereas 22.2% of samples from other hospitals (N = 27) were positive for VRE. All isolates were Enterococcus faecium (VREfm) and were indicated to contain CC17, though with considerable heterogeneity among the isolates.
   Conclusion: This high prevalence goes some way towards providing an explanation for the current high rates of VRE bacteraemia in Ireland, as well as highlighting the benefits of screening and enhanced infection control practices by all hospitals to control the high rates of VRE observed. (C) 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
C1 [Whelton, E.; Corcoran, G. D.; Cryan, B.] Cork Univ Hosp, Dept Med Microbiol, Cork, Ireland.
   [Lynch, C.; Keane, S. M.; Sleator, R. D.; Lucey, B.] Cork Inst Technol, Dept Biol Sci, Cork, Ireland.
   [O'Reilly, B.] Cork Univ Hosp, Dept Pathol, Cork, Ireland.
RP Lucey, B (reprint author), Cork Inst Technol, Dept Biol Sci, Cork, Ireland.
EM Brigid.lucey@cit.ie
OI Lucey, Brigid/0000-0002-0872-202X
FU Health Service Executive and Cork Institute of Technology
FX This study was funded by the Health Service Executive and Cork Institute
   of Technology.
CR Boyce JM, 1997, INFECT DIS CLIN N AM, V11, P367, DOI 10.1016/S0891-5520(05)70361-5
   Chabros L, 2014, TRANSPL P, V46, P2583, DOI 10.1016/j.transproceed.2014.08.025
   Clinical and Laboratory Standards Institute, 2014, M2 A11 PERF STAND AN
   Coque TM, 2005, ANTIMICROB AGENTS CH, V49, P2693, DOI 10.1128/AAC.49.7.2693-2700.2005
   De Angelis G, 2014, J ANTIMICROB CHEMOTH, V69, P1185, DOI 10.1093/jac/dkt525
   de Niederhausern S, 2011, CURR MICROBIOL, V62, P1363, DOI 10.1007/s00284-011-9868-6
   European Centre for Disease Prevention and Control, 2014, SURV REP ANT RES SUR
   Gambarotto K, 2000, J CLIN MICROBIOL, V38, P620, DOI 10.1128/JCM.38.2.620-624.2000
   Ghanem G, 2007, INFECT CONT HOSP EP, V28, P1054, DOI 10.1086/519932
   Howden BP, 2013, MBIO, V4, DOI 10.1128/mBio.00412-13
   Lancaster A D, 1994, Asepsis, V16, P19
   Lester CH, 2008, J ANTIMICROB CHEMOTH, V62, P1203, DOI 10.1093/jac/dkn360
   Mascini EM, 2005, CLIN MICROBIOL INFEC, V11, P43, DOI 10.1111/j.1469-0691.2005.01164.x
   Pavel AB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-9
   Peter Asha, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1738
   Pourshafie MR, 2008, TROP MED INT HEALTH, V13, P722, DOI 10.1111/j.1365-3156.2008.02065.x
   Ryan L, 2015, J ANTIMICROB CHEMOTH, V70, P2718, DOI 10.1093/jac/dkv185
   Salgado CD, 2008, AM J INFECT CONTROL, V36
   Top J, 2008, J CLIN MICROBIOL, V46, P214, DOI 10.1128/JCM.01351-07
   van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239
   Vijaya D, 2014, J CLIN DIAGN RES, V8, pDD03, DOI [10.7860/JCDR/2014/8588.4898, 10.7860/JCDR2014/8588.4898]
   Werner G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-80
   Yang KS, 2007, ANN ACAD MED SINGAP, V36, P379
   Zirakzadeh A, 2006, MAYO CLIN PROC, V81, P529, DOI 10.4065/81.4.529
NR 24
TC 9
Z9 10
U1 0
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0195-6701
EI 1532-2939
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD JUN
PY 2016
VL 93
IS 2
BP 175
EP 180
DI 10.1016/j.jhin.2016.03.005
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DM9KT
UT WOS:000376685600015
PM 27112046
DA 2020-05-07
ER

PT J
AU Zhou, H
   Zhang, J
   Eyers, F
   Xiang, Y
   Herbert, C
   Tay, HL
   Foster, PS
   Yang, M
AF Zhou, Hong
   Zhang, Jie
   Eyers, Fiona
   Xiang, Yang
   Herbert, Cristan
   Tay, Hock L.
   Foster, Paul S.
   Yang, Ming
TI Identification of the microRNA networks contributing to macrophage
   differentiation and function
SO ONCOTARGET
LA English
DT Article
DE microRNA; macrophage; differentiation; transcriptional regulation;
   Immunology and Microbiology Section; Immune response; Immunity
ID COLONY-STIMULATING FACTOR-1; ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B;
   MONOCYTE/MACROPHAGE DIFFERENTIATION; INFLAMMATORY RESPONSES; TARGETED
   DISRUPTION; HEMATOPOIETIC-CELLS; NEGATIVE REGULATOR; GENE-EXPRESSION;
   DENDRITIC CELLS
AB Limited evidence is available about the specific miRNA networks that regulate differentiation of specific immune cells. In this study, we characterized miRNA expression and associated alterations in expression with putative mRNA targets that are critical during differentiation of macrophages. In an effort to map the dynamic changes in the bone marrow (BM), we profiled whole BM cultures during differentiation into macrophages. We identified 112 miRNAs with expression patterns that were differentially regulated 5-fold or more during BMDM development. With TargetScan and MeSH databases, we identified 1267 transcripts involved in 30 canonical pathways linked to macrophage biology as potentially regulated by these specific 112 miRNAs. Furthermore, by employing miRanda and Ingenuity Pathways Analysis (IPA) analysis systems, we identified 18 miRNAs that are temporally linked to the expression of CSF1R, CD36, MSR1 and SCARB1; 7 miRNAs linked to the regulation of the transcription factors RUNX1 and PU.1, and 14 miRNAs target the nuclear receptor PPAR alpha and PPAR gamma. This novel information provides an important reference resource for further study of the functional links between miRNAs and their target mRNAs for the regulation of differentiation and function of macrophages.
C1 [Zhou, Hong; Zhang, Jie] Jilin Univ, Hosp 2, Dept Resp Med, Changchun 130023, Jilin, Peoples R China.
   [Zhou, Hong; Eyers, Fiona; Tay, Hock L.; Foster, Paul S.; Yang, Ming] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.
   [Zhou, Hong; Eyers, Fiona; Tay, Hock L.; Foster, Paul S.; Yang, Ming] Hunter Med Res Inst, Callaghan, NSW, Australia.
   [Xiang, Yang] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China.
   [Herbert, Cristan] UNSW Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia.
RP Foster, PS; Yang, M (reprint author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.; Foster, PS; Yang, M (reprint author), Hunter Med Res Inst, Callaghan, NSW, Australia.
EM Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia; Australian Research
   CouncilAustralian Research Council; Cooperative Research Centre for
   Asthma and AirwaysAustralian GovernmentDepartment of Industry,
   Innovation and ScienceCooperative Research Centres (CRC) Programme;
   Medical Research CouncilMedical Research Council UK (MRC) [MR/K006584/1]
FX The authors are supported by the National Health and Medical Research
   Council of Australia, the Australian Research Council, the Cooperative
   Research Centre for Asthma and Airways.
CR Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bastos KRB, 2004, MICROBES INFECT, V6, P630, DOI 10.1016/j.micinf.2004.02.012
   Bocher Virginie, 2002, Journal de la Societe de Biologie, V196, P47
   Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111
   DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456
   DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439
   Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798
   Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686
   Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141
   Ginhoux F, 2014, NAT IMMUNOL, V15, P1005, DOI 10.1038/ni.3011
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031
   Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233
   Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712
   HAMILTON JA, 1993, IMMUNOL TODAY, V14, P18, DOI 10.1016/0167-5699(93)90319-G
   Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890
   Hu ZB, 2011, BLOOD, V117, P6498, DOI 10.1182/blood-2010-10-312512
   Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7
   Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012
   Li JJ, 2015, J ALLERGY CLIN IMMUN, V136, P462, DOI 10.1016/j.jaci.2014.11.044
   LOPEZ AF, 1992, IMMUNOL TODAY, V13, P495, DOI 10.1016/0167-5699(92)90025-3
   Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107
   McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403
   Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721
   Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8
   Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002
   Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458
   Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178
   SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170
   Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030
   Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5
   Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110
   Valledor AF, 2004, BIOCHEM PHARMACOL, V67, P201, DOI 10.1016/j.bcp.2003.10.016
   Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405
   WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Xiang Y, 2016, J IMMUNOL, V196, P3421, DOI 10.4049/jimmunol.1502081
   Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098139
   Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203
   Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097537
   ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085
   Zhang X, 2008, CURR PROTOC IMMUNOL
NR 52
TC 3
Z9 4
U1 0
U2 15
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAY 17
PY 2016
VL 7
IS 20
BP 28806
EP 28820
DI 10.18632/oncotarget.8933
PG 15
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DO4HO
UT WOS:000377742600005
PM 27119502
OA Other Gold, Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Xie, GX
   Wang, XN
   Liu, P
   Wei, RM
   Chen, WL
   Rajani, C
   Hernandez, BY
   Alegado, R
   Dong, B
   Li, DF
   Jia, W
AF Xie, Guoxiang
   Wang, Xiaoning
   Liu, Ping
   Wei, Runmin
   Chen, Wenlian
   Rajani, Cynthia
   Hernandez, Brenda Y.
   Alegado, Rosanna
   Dong, Bing
   Li, Defa
   Jia, Wei
TI Distinctly altered gut microbiota in the progression of liver disease
SO ONCOTARGET
LA English
DT Article
DE gut microbiota; lipopolysaccharides; liver disease; pathogenesis;
   Immunology and Microbiology Section; Immune response; Immunity
ID INTESTINAL MICROBIOME; OBESITY; INFLAMMATION; FIBROSIS; IMPACT; MODEL;
   MICE
AB Recent studies underscore important roles of intestinal microbiota and the bacterial lipopolysaccharides (LPS) production in the pathogenesis of liver disease. However, how gut microbiota alters in response to the development of steatosis and subsequent progression to nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) remains unclear. We aimed to study the gut microbial changes over liver disease progression using a streptozotocin-high fat diet (STZ-HFD) induced NASH-HCC C57BL/6J mouse model that is highly relevant to human liver disease. The fecal microbiota at various liver pathological stages was analyzed by 16S rDNA gene pyrosequencing. Both UniFrac analysis and partial least squares-discriminant analysis showed significant structural alterations in gut microbiota during the development of liver disease. Co-abundance network analysis highlighted relationships between genera. Spearman correlation analysis revealed that the bacterial species, Atopobium spp., Bacteroides spp., Bacteroides vulgatus, Bacteroides acidifaciens, Bacteroides uniformis, Clostridium cocleatum, Clostridium xylanolyticum and Desulfovibrio spp., markedly increased in model mice, were positively correlated with LPS levels and pathophysiological features. Taken together, the results showed that the gut microbiota was altered significantly in the progression of liver disease. The connection between the gut microbial ecology and the liver pathology may represent potential targets for the prevention and treatment of chronic liver disease and HCC.
C1 [Xie, Guoxiang; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai 200030, Peoples R China.
   [Xie, Guoxiang; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai 200030, Peoples R China.
   [Xie, Guoxiang; Wei, Runmin; Chen, Wenlian; Rajani, Cynthia; Hernandez, Brenda Y.; Jia, Wei] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.
   [Wang, Xiaoning; Liu, Ping; Jia, Wei] Shanghai Univ Tradit Chinese Med, E Inst Shanghai Municipal Educ Comm, Shanghai, Peoples R China.
   [Wang, Xiaoning; Liu, Ping] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Liver Dis, Minist Educ,Key Lab Liver & Kidney Dis, Shanghai, Peoples R China.
   [Alegado, Rosanna] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.
   [Dong, Bing; Li, Defa] China Agr Univ, Natl Key Lab Anim Nutr, Beijing 100094, Peoples R China.
RP Jia, W (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai 200030, Peoples R China.; Jia, W (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai 200030, Peoples R China.; Jia, W (reprint author), Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.; Jia, W (reprint author), Shanghai Univ Tradit Chinese Med, E Inst Shanghai Municipal Educ Comm, Shanghai, Peoples R China.
EM wjia@cc.hawaii.edu
RI Wei, Runmin/J-6128-2019; Xie, Guoxiang/F-3022-2016; Wang,
   Xiaoning/A-2645-2013
OI Wei, Runmin/0000-0001-7707-0160; Xie, Guoxiang/0000-0002-0951-4150;
   Wang, Xiaoning/0000-0002-9806-9537; Jia, Wei/0000-0002-3739-8994;
   Alegado, Rosanna/0000-0003-3615-5613
FU National Institutes of Health GrantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [1U01CA188387-01A1]
FX This study was financially supported by the National Institutes of
   Health Grant 1U01CA188387-01A1.
CR Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373
   Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105
   BJORNSON HS, 1984, REV INFECT DIS, V6, pS30
   Boursier J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004559
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chang CJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8489
   Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   DeAngelis RA, 2005, HEPATOLOGY, V42, P1148, DOI 10.1002/hep.20879
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107
   DOWD SE, 2008, BMC MICROBIOL, V8
   Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153
   Foster James A, 2008, Interdiscip Perspect Infect Dis, V2008, P839501, DOI 10.1155/2008/839501
   Fox JG, 2010, GUT, V59, P88, DOI 10.1136/gut.2009.183749
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1
   Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203
   Hartmann P, 2015, ALCOHOL CLIN EXP RES, V39, P763, DOI 10.1111/acer.12704
   Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505
   Jiang JT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-4
   Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Manos MM, 2008, HEPATOLOGY, V47, P1150, DOI 10.1002/hep.22181
   Mazagova M, 2015, FASEB J, V29, P1043, DOI 10.1096/fj.14-259515
   Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848
   Minemura M, 2015, WORLD J GASTROENTERO, V21, P1691, DOI 10.3748/wjg.v21.i6.1691
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Rajpal Deepak K., 2013, Science Progress, V96, P224, DOI 10.3184/003685013X13691404141587
   Rao RK, 2013, CURR NUTR FOOD SCI, V9, P99, DOI 10.2174/1573401311309020004
   Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Sipka S, 2014, INT ARCH ALLERGY IMM, V165, P1, DOI 10.1159/000366100
   Son G, 2010, GASTROENTEROL RES PR, V2010
   Stein LY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00629
   Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162
   Tacer KF, 2011, J LIPIDS, DOI 10.1155/2011/783976
   Valenti L, 2009, SEMIN IMMUNOPATHOL, V31, P359, DOI 10.1007/s00281-009-0152-9
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655
   Yin XC, 2013, SYST APPL MICROBIOL, V36, P188, DOI 10.1016/j.syapm.2012.12.009
   Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112
NR 50
TC 64
Z9 66
U1 1
U2 15
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD APR 12
PY 2016
VL 7
IS 15
BP 19355
EP 19366
DI 10.18632/oncotarget.8466
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DL7ES
UT WOS:000375804000023
PM 27036035
OA Other Gold, Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Chiou, CS
   Izumiya, H
   Kawamura, M
   Liao, YS
   Su, YS
   Wu, HH
   Chen, WC
   Lo, YC
AF Chiou, C. -S.
   Izumiya, H.
   Kawamura, M.
   Liao, Y. -S.
   Su, Y. -S.
   Wu, H. -H.
   Chen, W. -C.
   Lo, Y. -C.
TI The worldwide spread of ciprofloxacin-resistant Shigella sonnei among
   HIV-infected men who have sex with men, Taiwan
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Bacillary; ciprofloxacin resistance; dysentery; HIV infections;
   homosexuality; male; molecular epidemiology; Shigella sonnei
ID TANDEM-REPEAT ANALYSIS; PHYLOGENETIC ANALYSIS; UNITED-STATES;
   TRANSMISSION; SUSCEPTIBILITY; POLYMORPHISMS; EPIDEMIOLOGY; AZITHROMYCIN;
   STRAINS; PLASMID
AB Ciprofloxacin-resistant shigellosis outbreaks among men who have sex with men (MSM) have not been reported in Asia. During 3 March to 6 May 2015, the Notifiable Disease Surveillance System detected nine non-imported Shigella sonnei infections among human immunodeficiency virus (HIV) -infected Taiwanese MSM. We conducted a molecular epidemiological investigation using a 1 : 5 matched case-control study and laboratory characterizations for the isolates. Of the nine patients, four reported engagement in oral-anal sex before illness onset. Shigellosis was associated with a syphilis report within 12 months (adjusted odds ratio (aOR) 8.6; 95% CI 1.05-70.3) and no HIV outpatient follow-up within 12 months (aOR 22.3; 95% CI 2.5-201). Shigella sonnei isolates from the nine patients were all ciprofloxacin-resistant and the resistance was associated with S83L and D87G mutations in gyrA and S80I mutation in parC. The nine outbreak isolates were discriminated into two closely related pulsed-field gel electrophoresis (PFGE) genotypes and seven 8-locus multilocus variable-number tandem repeat analysis (MLVA8) types that suggest multiple sources of infections for the outbreak and possible under-recognition of infection among Taiwanese MSM. The outbreak isolates were characterized to be variants of the intercontinentally transmitted SS18.1 clone, which falls into the globally prevalent phylogenetic sub-lineage IIIb. Inter-database pattern similarity searching indicated that the two PFGE genotypes had emerged in the USA and Japan. The epidemiological characteristics of this outbreak suggest roles of risky sexual behaviours or networks in S. sonnei transmission. We urge enhanced surveillance and risk-reduction interventions regionally against the interplay of HIV and shigellosis among MSM. (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Chiou, C. -S.; Liao, Y. -S.; Su, Y. -S.; Wu, H. -H.; Chen, W. -C.; Lo, Y. -C.] Taiwan Ctr Dis Control, Taipei, Taiwan.
   [Izumiya, H.] Natl Inst Infect Dis, Tokyo, Japan.
   [Kawamura, M.] Tokyo Metropolitan Inst Publ Hlth, 3-24-1 Hyakunincho, Tokyo 1690073, Japan.
RP Lo, YC (reprint author), Taiwan Ctr Dis Control, Off Prevent Med, 6 Linsen South Rd, Taipei 100, Taiwan.
EM loyichun@cdc.gov.tw
OI Chen, Wan-Chin/0000-0002-2278-6193
CR Aragon TJ, 2007, CLIN INFECT DIS, V44, P327, DOI 10.1086/510593
   Bowen A, 2015, MMWR-MORBID MORTAL W, V64, P318
   Chang YH, 2014, J MICROBIOL IMMUNOL, V47, P533, DOI 10.1016/j.jmii.2013.11.003
   Chen YC, 2015, JAIDS-J ACQ IMM DEF, V68, P432, DOI 10.1097/QAI.0000000000000477
   Chiou CS, 2006, J CLIN MICROBIOL, V44, P3928, DOI 10.1128/JCM.01069-06
   Chiou CS, 2009, J CLIN MICROBIOL, V47, P1149, DOI 10.1128/JCM.01607-08
   Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI
   Daskalakis DC, 2007, CLIN INFECT DIS, V44, P335, DOI 10.1086/510591
   De Lappe N, 2015, EMERG INFECT DIS, V21, P894, DOI 10.3201/eid2105.141184
   Filliol-Toutain I, 2011, EMERG INFECT DIS, V17, P1910, DOI 10.3201/eid1710.101486
   Gaudreau C, 2014, EMERG INFECT DIS, V20, P854, DOI 10.3201/eid2005.130966
   Gaudreau C, 2011, EMERG INFECT DIS, V17, P1747, DOI 10.3201/eid1709.102034
   Gilbart VL, 2015, SEX TRANSM INFECT, V91, P598, DOI 10.1136/sextrans-2015-052014
   Gilbart VL, 2013, LANCET, V381, P1358, DOI 10.1016/S0140-6736(13)60882-X
   Heiman KE, 2014, MMWR-MORBID MORTAL W, V63, P132
   Hoffmann C, 2013, INFECTION, V41, P999, DOI 10.1007/s15010-013-0501-4
   Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369
   Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P639, DOI 10.1128/AAC.01051-08
   La Jeon Y, 2012, ANN LAB MED, V32, P366, DOI 10.3343/alm.2012.32.5.366
   Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666
   Liang SY, 2007, J CLIN MICROBIOL, V45, P3574, DOI 10.1128/JCM.00675-07
   Lo YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139687
   Lo YC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003222
   Mazi W, 2015, J CLIN MICROBIOL, V53, P2389, DOI 10.1128/JCM.00874-15
   Okame M, 2012, JPN J INFECT DIS, V65, P277, DOI 10.7883/yoken.65.277
   Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59
   Sangal V, 2013, J CLIN MICROBIOL, V51, P303, DOI 10.1128/JCM.02238-12
   SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75, DOI 10.1128/IAI.34.1.75-83.1981
   Simms I, 2015, EURO SURVEILL, V20
   Wei HL, 2007, DIAGN MICR INFEC DIS, V58, P469, DOI 10.1016/j.diagmicrobio.2007.03.006
NR 30
TC 13
Z9 13
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2016
VL 22
IS 4
AR 383.e11
DI 10.1016/j.cmi.2015.12.021
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DL1NW
UT WOS:000375399900021
PM 26806133
OA Bronze
DA 2020-05-07
ER

PT J
AU Tuomela, S
   Rautio, S
   Ahlfors, H
   Oling, V
   Salo, V
   Ullah, U
   Chen, Z
   Hamalisto, S
   Tripathi, SK
   Aijo, T
   Rasool, O
   Soueidan, H
   Wessels, L
   Stockinger, B
   Lahdesmaki, H
   Lahesmaa, R
AF Tuomela, Soile
   Rautio, Sini
   Ahlfors, Helena
   Oling, Viveka
   Salo, Verna
   Ullah, Ubaid
   Chen, Zhi
   Hamalisto, Saara
   Tripathi, Subhash K.
   Aijo, Tarmo
   Rasool, Omid
   Soueidan, Hayssam
   Wessels, Lodewyk
   Stockinger, Brigitta
   Lahdesmaki, Harri
   Lahesmaa, Riitta
TI Comparative analysis of human and mouse transcriptomes of Th17 cell
   priming
SO ONCOTARGET
LA English
DT Article
DE Th17 cell priming; RNA-seq; comparative analysis of human and mouse;
   lncRNA; disease-associated SNPs; Immunology and Microbiology Section;
   Immune response; Immunity
ID LONG NONCODING RNAS; SET ENRICHMENT ANALYSIS; GENE-EXPRESSION;
   REGULATORY NETWORK; HUMAN-DISEASE; DIFFERENTIATION; EVOLUTION;
   CONSERVATION; PROFILES; MODELS
AB Uncontrolled Th17 cell activity is associated with cancer and autoimmune and inflammatory diseases. To validate the potential relevance of mouse models of targeting the Th17 pathway in human diseases we used RNA sequencing to compare the expression of coding and non-coding transcripts during the priming of Th17 cell differentiation in both human and mouse. In addition to already known targets, several transcripts not previously linked to Th17 cell polarization were found in both species. Moreover, a considerable number of human-specific long non-coding RNAs were identified that responded to cytokines stimulating Th17 cell differentiation. We integrated our transcriptomics data with known disease-associated polymorphisms and show that conserved regulation pinpoints genes that are relevant to Th17 cell-mediated human diseases and that can be modelled in mouse. Substantial differences observed in non-coding transcriptomes between the two species as well as increased overlap between Th17 cell-specific gene expression and disease-associated polymorphisms underline the need of parallel analysis of human and mouse models. Comprehensive analysis of genes regulated during Th17 cell priming and their classification to conserved and non-conserved between human and mouse facilitates translational research, pointing out which candidate targets identified in human are worth studying by using in vivo mouse models.
C1 [Tuomela, Soile; Oling, Viveka; Salo, Verna; Ullah, Ubaid; Chen, Zhi; Hamalisto, Saara; Tripathi, Subhash K.; Rasool, Omid; Lahdesmaki, Harri; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, Turku, Finland.
   [Tuomela, Soile; Oling, Viveka; Salo, Verna; Ullah, Ubaid; Chen, Zhi; Hamalisto, Saara; Tripathi, Subhash K.; Rasool, Omid; Lahdesmaki, Harri; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland.
   [Rautio, Sini; Aijo, Tarmo; Lahdesmaki, Harri] Aalto Univ, Dept Comp Sci, Espoo, Finland.
   [Ahlfors, Helena; Stockinger, Brigitta] MRC Natl Inst Med Res, Div Mol Immunol, London, England.
   [Soueidan, Hayssam; Wessels, Lodewyk] Netherlands Canc Inst, Div Mol Carcinogenesis, Computat Canc Biol, Amsterdam, Netherlands.
RP Lahesmaa, R (reprint author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Lahesmaa, R (reprint author), Abo Akad Univ, Turku, Finland.
EM riitta.lahesmaa@btk.fi
OI Ullah, Ubaid/0000-0002-2539-2296; Rautio, Sini/0000-0001-5215-4456;
   Ahlfors, Helena/0000-0002-8183-0895; Chen, Zhi/0000-0002-4658-7463;
   Stockinger, Brigitta/0000-0001-8781-336X; /0000-0003-2372-3167
FU Seventh Framework Programme of the European CommissionEuropean Union
   (EU) [FP7-SYBILLA-201106, FP7-NANOMMUNE-214281, FP7-DIABIMMUNE-202063,
   FP7-PEVNET-261441, FP7-NANOSOLUTIONS-309329]; Academy of Finland the
   Centre of Excellence in Molecular Systems Immunology and Physiology
   Research [250114, 77773, 203725, 207490, 116639, 115939, 123864,
   126063]; Sigrid Juselius FoundationSigrid Juselius Foundation; Juvenile
   Diabetes Research Foundation (JDRF)Juvenile Diabetes Research
   Foundation; Turku University Hospital Research Fund; Emil Aaltonen
   Foundation; Biocenter Finland
FX This work was supported by the Seventh Framework Programme of the
   European Commission (FP7-SYBILLA-201106, FP7-NANOMMUNE-214281,
   FP7-DIABIMMUNE-202063, FP7-PEVNET-261441, and FP7-NANOSOLUTIONS-309329),
   the Academy of Finland the Centre of Excellence in Molecular Systems
   Immunology and Physiology Research, 2012-2017, grant 250114, and grants
   77773, 203725, 207490, 116639, 115939, 123864, 126063, the Sigrid
   Juselius Foundation, the Juvenile Diabetes Research Foundation (JDRF),
   Turku University Hospital Research Fund, the Emil Aaltonen Foundation,
   and Biocenter Finland.
CR Aboukhalil R, 2013, BMC BIOINFORMATICS, V14
   Aijo T, 2012, BMC GENOMICS, V13
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002
   Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323
   Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276
   Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016
   den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006
   Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586
   Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144
   Hrdlickova B, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0088-0
   Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Liu Q, 2010, BIOINFORMATICS, V26, P770, DOI 10.1093/bioinformatics/btq022
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010
   Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653
   Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598
   Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093
   Rice J, 2012, NATURE, V484, pS9, DOI 10.1038/nature11102
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rowel E, 2008, CURR OPIN IMMUNOL, V20, P272, DOI 10.1016/j.coi.2008.03.012
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110
   Spurlock CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7932
   Stegle O, 2010, J COMPUT BIOL, V17, P355, DOI 10.1089/cmb.2009.0175
   Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528
   Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020
   van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245
   Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003
   Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981
   Zhang H, 2013, J ALLERGY CLIN IMMUN, V132, P1005, DOI 10.1016/j.jaci.2013.05.033
NR 36
TC 8
Z9 8
U1 0
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAR 22
PY 2016
VL 7
IS 12
BP 13416
EP 13428
DI 10.18632/oncotarget.7963
PG 13
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DL5OT
UT WOS:000375687200012
PM 26967054
OA Bronze, Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Moran, MA
   Kujawinski, EB
   Stubbins, A
   Fatland, R
   Aluwihare, LI
   Buchan, A
   Crump, BC
   Dorrestein, PC
   Dyhrman, ST
   Hess, NJ
   Howe, B
   Longnecker, K
   Medeiros, PM
   Niggemann, J
   Obernosterer, I
   Repeta, DJ
   Waldbauer, JR
AF Moran, Mary Ann
   Kujawinski, Elizabeth B.
   Stubbins, Aron
   Fatland, Rob
   Aluwihare, Lihini I.
   Buchan, Alison
   Crump, Byron C.
   Dorrestein, Pieter C.
   Dyhrman, Sonya T.
   Hess, Nancy J.
   Howe, Bill
   Longnecker, Krista
   Medeiros, Patricia M.
   Niggemann, Jutta
   Obernosterer, Ingrid
   Repeta, Daniel J.
   Waldbauer, Jacob R.
TI Deciphering ocean carbon in a changing world
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE dissolved organic matter; marine microbes; cyberinfrastructure
ID DISSOLVED ORGANIC-MATTER; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY;
   MOLECULAR NETWORKING; MICROBIAL-PRODUCTION; COMMUNITY STRUCTURE;
   MARINE-BACTERIA; VIRAL LYSIS; AMINO-ACIDS; MAJOR ROLE
AB Dissolved organic matter (DOM) in the oceans is one of the largest pools of reduced carbon on Earth, comparable in size to the atmospheric CO2 reservoir. A vast number of compounds are present in DOM, and they play important roles in all major element cycles, contribute to the storage of atmospheric CO2 in the ocean, support marine ecosystems, and facilitate interactions between organisms. At the heart of the DOM cycle lie molecular-level relationships between the individual compounds in DOM and the members of the ocean microbiome that produce and consume them. In the past, these connections have eluded clear definition because of the sheer numerical complexity of both DOM molecules and microorganisms. Emerging tools in analytical chemistry, microbiology, and informatics are breaking down the barriers to a fuller appreciation of these connections. Here we highlight questions being addressed using recent methodological and technological developments in those fields and consider how these advances are transforming our understanding of some of the most important reactions of the marine carbon cycle.
C1 [Moran, Mary Ann; Medeiros, Patricia M.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.
   [Kujawinski, Elizabeth B.; Longnecker, Krista; Repeta, Daniel J.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.
   [Stubbins, Aron] Univ Georgia, Dept Marine Sci, Skidaway Inst Oceanog, Savannah, GA 31411 USA.
   [Fatland, Rob] Univ Washington, Dept Informat Technol, Seattle, WA 98105 USA.
   [Aluwihare, Lihini I.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA.
   [Buchan, Alison] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.
   [Crump, Byron C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.
   [Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92037 USA.
   [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA.
   [Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Biochem, La Jolla, CA 92037 USA.
   [Dyhrman, Sonya T.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA.
   [Dyhrman, Sonya T.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.
   [Hess, Nancy J.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA.
   [Howe, Bill] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.
   [Niggemann, Jutta] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Res Grp Marine Geochem, D-26129 Oldenburg, Germany.
   [Obernosterer, Ingrid] Univ Paris 06, Sorbonne Univ, CNRS, Observ Oceanol,Lab Oceanog Microbienne, F-66650 Banyuls Sur Mer, France.
   [Waldbauer, Jacob R.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.
RP Moran, MA (reprint author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.; Kujawinski, EB (reprint author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.; Stubbins, A (reprint author), Univ Georgia, Dept Marine Sci, Skidaway Inst Oceanog, Savannah, GA 31411 USA.; Fatland, R (reprint author), Univ Washington, Dept Informat Technol, Seattle, WA 98105 USA.
EM mmoran@uga.edu; ekujawinski@whoi.edu; aron.stubbins@skio.uga.edu;
   rob5@uw.edu
RI Obernosterer, Ingrid/A-5434-2011; Stubbins, Aron/M-8801-2014
OI Obernosterer, Ingrid/0000-0002-2530-8111; Stubbins,
   Aron/0000-0002-3994-1946; Crump, Byron/0000-0001-7062-1273; Moran, Mary
   Ann/0000-0002-0702-8167; Buchan, Alison/0000-0001-7420-985X; Hess,
   Nancy/0000-0002-8930-9500
FU Gordon and Betty Moore FoundationGordon and Betty Moore Foundation;
   Microsoft Research Corporation; National Science FoundationNational
   Science Foundation (NSF) [OCE1356010, OCE1154320, OCE1356890]; Gordon
   and Betty Moore FoundationGordon and Betty Moore Foundation [3304]
FX We thank Jack Cook for graphics expertise. Formative discussions for
   this perspective occurred at a workshop entitled "Linking Marine
   Microbes and the Molecules of Dissolved Organic Matter," held in New
   York City in November 2014. The workshop was supported by the Gordon and
   Betty Moore Foundation and Microsoft Research Corporation. Additional
   support was provided by National Science Foundation Grants OCE1356010,
   OCE1154320, and OCE1356890, and by Gordon and Betty Moore Foundation
   Grant 3304.
CR Alcolombri U, 2015, SCIENCE, V348, P1466, DOI 10.1126/science.aab1586
   Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0
   Amaral-Zettler Linda, 2010, P223
   Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488
   Ankrah NYD, 2014, ISME J, V8, P1089, DOI 10.1038/ismej.2013.216
   Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501
   Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731
   Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955
   Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747
   Beaupre SR, 2010, DEEP-SEA RES PT II, V57, P1494, DOI 10.1016/j.dsr2.2010.02.017
   Becker JW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00111
   Beier S, 2015, ENVIRON MICROBIOL, V17, P3466, DOI 10.1111/1462-2920.12434
   Bertrand EM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00375
   Bittar TB, 2015, LIMNOL OCEANOGR, V60, P1172, DOI 10.1002/lno.10090
   Bjorkman KM, 2005, AQUAT MICROB ECOL, V39, P193, DOI 10.3354/ame039193
   Bouslimani A, 2014, NAT PROD REP, V31, P718, DOI 10.1039/c4np00044g
   Cade-Menun BJ, 2005, MAR CHEM, V97, P293, DOI 10.1016/j.marchem.2005.05.005
   Carini P, 2013, ISME J, V7, P592, DOI 10.1038/ismej.2012.122
   Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073
   Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019
   CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0
   Chen CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118300
   Chen Y, 2010, APPL ENVIRON MICROB, V76, P4102, DOI 10.1128/AEM.00469-10
   CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0
   Church MJ, 2002, LIMNOL OCEANOGR, V47, P1, DOI 10.4319/lo.2002.47.1.0001
   Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465
   Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034
   Cottrell MT, 1999, APPL ENVIRON MICROB, V65, P2553
   da Silva RR, 2015, P NATL ACAD SCI USA, V112, P12549, DOI 10.1073/pnas.1516878112
   DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157
   DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250
   Denger K, 2014, NATURE, V507, P114, DOI 10.1038/nature12947
   Denger K, 2009, J BACTERIOL, V191, P5648, DOI 10.1128/JB.00569-09
   DIAZ MR, 1992, FEMS MICROBIOL LETT, V96, P61, DOI 10.1111/j.1574-6968.1992.tb05394.x
   Dittmar T, 2006, MAR CHEM, V102, P208, DOI 10.1016/j.marchem.2006.04.003
   Dittmar T, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P369, DOI 10.1016/B978-0-12-405940-5.00007-8
   Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440
   Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611
   Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112
   Duncan KR, 2015, CHEM BIOL, V22, P460, DOI 10.1016/j.chembiol.2015.03.010
   Durham BP, 2015, P NATL ACAD SCI USA, V112, P453, DOI 10.1073/pnas.1413137112
   Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768
   Dyhrman ST, 2009, NAT GEOSCI, V2, P696, DOI 10.1038/NGEO639
   Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228
   Engel A, 2014, J PLANKTON RES, V36, P641, DOI 10.1093/plankt/fbt125
   Feingersch R, 2012, ISME J, V6, P827, DOI 10.1038/ismej.2011.149
   FERGUSON RL, 1984, LIMNOL OCEANOGR, V29, P258, DOI 10.4319/lo.1984.29.2.0258
   Ferrera I, 2015, CURR OPIN MICROBIOL, V25, P33, DOI 10.1016/j.mib.2015.03.007
   Fiore CL, 2015, ENVIRON MICROBIOL, V17, P3949, DOI 10.1111/1462-2920.12899
   Follett CL, 2014, P NATL ACAD SCI USA, V111, P16706, DOI 10.1073/pnas.1407445111
   Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544
   Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144
   Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013
   Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110
   Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96
   Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057
   Gledhill M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00069
   Glibert PM, 2004, MAR ECOL PROG SER, V280, P73, DOI 10.3354/meps280073
   Green NW, 2014, MAR CHEM, V161, P14, DOI 10.1016/j.marchem.2014.01.012
   Haaber J, 2009, ISME J, V3, P430, DOI 10.1038/ismej.2008.125
   Hansell DA, 1998, GLOBAL BIOGEOCHEM CY, V12, P443, DOI 10.1029/98GB01928
   Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757
   Hansman RL, 2009, P NATL ACAD SCI USA, V106, P6513, DOI 10.1073/pnas.0810871106
   Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004
   Hertkorn N, 2006, GEOCHIM COSMOCHIM AC, V70, P2990, DOI 10.1016/j.gca.2006.03.021
   Hertkorn N, 2013, BIOGEOSCIENCES, V10, P1583, DOI 10.5194/bg-10-1583-2013
   Hertkorn N, 2008, ANAL CHEM, V80, P8908, DOI 10.1021/ac800464g
   HODSON RE, 1981, MAR BIOL, V61, P89, DOI 10.1007/BF00386648
   HOLLIBAUGH JT, 1983, LIMNOL OCEANOGR, V28, P1104, DOI 10.4319/lo.1983.28.6.1104
   Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657
   Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103
   Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386
   Johnson CH, 2015, ANAL CHEM, V87, P147, DOI 10.1021/ac5040693
   Johnson WM, 2016, ISME J, V10, P2304, DOI 10.1038/ismej.2016.6
   Jorgensen L, 2011, MAR CHEM, V126, P139, DOI 10.1016/j.marchem.2011.05.002
   Kaiser K, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007141
   Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234
   KEIL RG, 1993, LIMNOL OCEANOGR, V38, P1256, DOI 10.4319/lo.1993.38.6.1256
   Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p
   Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309
   Koch BP, 2008, MAR CHEM, V111, P233, DOI 10.1016/j.marchem.2008.05.008
   Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027
   Kujawinski EB, 2002, ANAL CHEM, V74, P413, DOI 10.1021/ac0108313
   Lau WWY, 2006, ENVIRON MICROBIOL, V8, P1688, DOI 10.1111/j.1462-2920.2006.01092.x
   Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077
   Lechtenfeld OJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7711
   Levine NM, 2012, ENVIRON MICROBIOL, V14, P1210, DOI 10.1111/j.1462-2920.2012.02700.x
   Lidbury I, 2015, ENVIRON MICROBIOL, V17, P5048, DOI 10.1111/1462-2920.12943
   Lidbury I, 2014, P NATL ACAD SCI USA, V111, P2710, DOI 10.1073/pnas.1317834111
   Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073
   Liu Q, 2015, BIOGEOCHEMISTRY, V123, P117, DOI 10.1007/s10533-014-0056-1
   Lonborg C, 2013, BIOGEOCHEMISTRY, V116, P231, DOI 10.1007/s10533-013-9853-1
   Marshall KT, 2013, ISME J, V7, P452, DOI 10.1038/ismej.2012.78
   Martinez A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00340
   Mayer J, 2010, MICROBIOL-SGM, V156, P1556, DOI 10.1099/mic.0.037580-0
   McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107
   Medeiros PM, 2015, GEOPHYS RES LETT, V42, P863, DOI 10.1002/2014GL062663
   Metcalf WW, 2012, SCIENCE, V337, P1104, DOI 10.1126/science.1219875
   MOPPER K, 1992, ENVIRON SCI TECHNOL, V26, P133, DOI 10.1021/es00025a014
   Mopper K, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P389, DOI 10.1016/B978-0-12-405940-5.00008-X
   Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170
   Moran XAG, 2013, MAR ECOL PROG SER, V489, P75, DOI 10.3354/meps10428
   Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12
   Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4
   Nagata T, 2000, MICROBIAL ECOLOGY OC, P121
   Osterholz H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8422
   Paul C, 2009, MAR ECOL PROG SER, V389, P61, DOI 10.3354/meps08162
   Pedler BE, 2014, P NATL ACAD SCI USA, V111, P7202, DOI 10.1073/pnas.1401887111
   Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x
   Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745
   Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198
   Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x
   Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001
   Reed DC, 2014, P NATL ACAD SCI USA, V111, P1879, DOI 10.1073/pnas.1313713111
   Repeta DJ, 2006, LIMNOL OCEANOGR, V51, P1045, DOI 10.4319/lo.2006.51.2.1045
   Rinta-Kanto JM, 2011, ENVIRON MICROBIOL, V13, P453, DOI 10.1111/j.1462-2920.2010.02350.x
   Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x
   Saito MA, 2014, SCIENCE, V345, P1173, DOI 10.1126/science.1256450
   Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109
   Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088
   Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10
   Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI 10.1038/NCHEM.1002
   SHERR EB, 1988, NATURE, V335, P348, DOI 10.1038/335348a0
   SHERR EB, 1994, MICROBIAL ECOL, V28, P223, DOI 10.1007/BF00166812
   Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189
   Sosa OA, 2015, ISME J, V9, P2725, DOI 10.1038/ismej.2015.68
   Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83
   Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572
   Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929
   Stubbins A, 2012, BIOGEOSCIENCES, V9, P1661, DOI 10.5194/bg-9-1661-2012
   Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102
   Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359
   Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750
   Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690
   Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344
   Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x
   Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60
   Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776
   van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201
   Van Mooy BAS, 2015, SCIENCE, V348, P783, DOI 10.1126/science.aaa8181
   Varaljay VA, 2015, ISME J, V9, P1677, DOI 10.1038/ismej.2015.23
   Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109
   Weinbauer MG, 2011, MICROBIAL CARBON PUM, P54, DOI DOI 10.1126/SCIENCE.OPMS.SB0001
   Weitz JS, 2015, ISME J, V9, P1352, DOI 10.1038/ismej.2014.220
   WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0
   Wilson MC, 2013, CHEM BIOL, V20, P636, DOI 10.1016/j.chembiol.2013.04.011
   Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530
   Zark M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500531
   Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112
   Ziolkowski LA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043963
NR 150
TC 87
Z9 88
U1 7
U2 124
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 22
PY 2016
VL 113
IS 12
BP 3143
EP 3151
DI 10.1073/pnas.1514645113
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0QH
UT WOS:000372488200031
PM 26951682
OA Green Published, Bronze
HC Y
HP N
DA 2020-05-07
ER

PT J
AU Wang, TH
   Johansson, P
   Abos, B
   Holt, A
   Tafalla, C
   Jiang, YS
   Wang, A
   Xu, QQ
   Qi, ZT
   Huang, WS
   Costa, MM
   Diaz-Rosales, P
   Holland, JW
   Secombes, CJ
AF Wang, Tiehui
   Johansson, Petronella
   Abos, Beatriz
   Holt, Amy
   Tafalla, Carolina
   Jiang, Youshen
   Wang, Alex
   Xu, Qiaoqing
   Qi, Zhitao
   Huang, Wenshu
   Costa, Maria M.
   Diaz-Rosales, Patricia
   Holland, Jason W.
   Secombes, Christopher J.
TI First in-depth analysis of the novel Th2-type cytokines in salmonid fish
   reveals distinct patterns of expression and modulation but overlapping
   bioactivities
SO ONCOTARGET
LA English
DT Article
DE rainbow trout Oncorhynchus mykiss; IL-4/13A and 13B; expression;
   bioactivity; type-2 immunity; Immunology and Microbiology Section;
   Immune response; Immunity
ID TROUT ONCORHYNCHUS-MYKISS; PROLIFERATIVE KIDNEY-DISEASE; RAINBOW-TROUT;
   DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; CELL-LINE; T-CELL; IL-13
   RECEPTORS; IFN-GAMMA; IDENTIFICATION
AB IL-4 and IL-13 are closely related canonical type-2 cytokines in mammals and have overlapping bioactivities via shared receptors. They are frequently activated together as part of the same immune response and are the signature cytokines produced by T-helper (Th)2 cells and type-2 innate lymphoid cells (ILC2), mediating immunity against extracellular pathogens. Little is known about the origin of type-2 responses, and whether they were an essential component of the early adaptive immune system that gave a fitness advantage by limiting collateral damage caused by metazoan parasites. Two evolutionary related type-2 cytokines, IL-4/13A and IL-4/13B, have been identified recently in several teleost fish that likely arose by duplication of an ancestral IL-4/13 gene as a consequence of a whole genome duplication event that occurred at the base of this lineage. However, studies of their comparative expression levels are largely missing and bioactivity analysis has been limited to IL-4/13A in zebrafish. Through interrogation of the recently released salmonid genomes, species in which an additional whole genome duplication event has occurred, four genomic IL-4/13 loci have been identified leading to the cloning of three active genes, IL-4/13A, IL-4/13B1 and IL-4/13B2, in both rainbow trout and Atlantic salmon. Comparative expression analysis by real-time PCR in rainbow trout revealed that the IL-4/13A expression is broad and high constitutively but less responsive to pathogen-associated molecular patterns (PAMPs) and pathogen challenge. In contrast, the expression of IL-4/13B1 and IL-4/13B2 is low constitutively but is highly induced by viral haemorrhagic septicaemia virus (VHSH) infection and during proliferative kidney disease (PKD) in vivo, and by formalin-killed bacteria, PAMPs, the T cell mitogen PHA, and the T-cell cytokines IL-2 and IL-21 in vitro. Moreover, bioactive recombinant cytokines of both IL-4/13A and B were produced and found to have shared but also distinct bioactivities. Both cytokines rapidly induce the gene expression of antimicrobial peptides and acute phase proteins, providing an effector mechanism of fish type-2 cytokines in immunity. They are anti-inflammatory via up-regulation of IL-10 and down-regulation of IL-1 beta and IFN-gamma. They modulate the expression of cellular markers of T cells, macrophages and B cells, the receptors of IFN-gamma, the IL-6 cytokine family and their own potential receptors, suggesting multiple target cells and important roles of fish type-2 cytokines in the piscine cytokine network. Furthermore both cytokines increased the number of IgM secreting B cells but had no effects on the proliferation of IgM(+) B cells in vitro. Taken as a whole, fish IL-4/13A may provide a basal level of type-2 immunity whilst IL-4/13B, when activated, provides an enhanced type-2 immunity, which may have an important role in specific cell-mediated immunity. To our knowledge this is the first in-depth analysis of the expression, modulation and bioactivities of type-2 cytokines in the same fish species, and in any early vertebrate. It contributes to a broader understanding of the evolution of type-2 immunity in vertebrates, and establishes a framework for further studies and manipulation of type-2 cytokines in fish.
C1 [Wang, Tiehui; Johansson, Petronella; Holt, Amy; Jiang, Youshen; Wang, Alex; Xu, Qiaoqing; Qi, Zhitao; Huang, Wenshu; Costa, Maria M.; Diaz-Rosales, Patricia; Holland, Jason W.; Secombes, Christopher J.] Univ Aberdeen, Sch Biol Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland.
   [Abos, Beatriz; Tafalla, Carolina] INIA, CISA, Valdeolmos, Madrid, Spain.
   [Jiang, Youshen] Shanghai Ocean Univ, Coll Fishery & Life Sci, Shanghai, Peoples R China.
   [Xu, Qiaoqing] Yangtze Univ, Sch Anim Sci, Jingzhou, Hubei Province, Peoples R China.
   [Qi, Zhitao] Yancheng Inst Technol, Chem & Biol Engn Coll, Cent Lab Biol, Yancheng, Jiangsu, Peoples R China.
   [Huang, Wenshu] Jimei Univ, Coll Fisheries, Xiamen, Fujian Province, Peoples R China.
   [Costa, Maria M.] CSIC, Inst Invest Marinas, Vigo, Spain.
RP Wang, TH; Secombes, CJ (reprint author), Univ Aberdeen, Sch Biol Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland.
EM t.h.wang@abdn.ac.uk; c.secombes@abdn.ac.uk
RI Diaz-Rosales, Patricia/H-9679-2013; Costa, Maria M/M-2485-2017; Tafalla,
   Carolina/J-8074-2014
OI Diaz-Rosales, Patricia/0000-0001-6965-3702; Wang,
   Tiehui/0000-0002-1148-8959; Tafalla, Carolina/0000-0002-0860-2976
FU MASTS pooling initiative (Marine Alliance for Science and Technology for
   Scotland); Scottish Funding Council [HR09011]; National Scholarship
   Council of China; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31302221]; Consejo Superior de
   Investigaciones CientificasConsejo Superior de Investigaciones
   Cientificas (CSIC); Xunta de GaliciaXunta de Galicia; European
   Commission (EC) Marie Curie Intra European Fellowship; Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/K009125/1]; ECEuropean Commission
   Joint Research CentreEuropean Community (EC) [222719, 311993]; European
   Research CouncilEuropean Research Council (ERC) [280469]
FX T. W. received funding from the MASTS pooling initiative (The Marine
   Alliance for Science and Technology for Scotland). MASTS is funded by
   the Scottish Funding Council (grant reference HR09011) and contributing
   institutions. Y.J., W.H. and Q.X. were supported financially by the
   National Scholarship Council of China. Z.Q. was supported by grants from
   the National Natural Science Foundation of China (31302221) and the
   overseas training plan for young and middle-aged teachers and principals
   of colleges and universities in Jiangsu Province, China. M.M.C. was
   funded by an Angeles Alvarino postdoctoral contract from the Consejo
   Superior de Investigaciones Cientificas and the Xunta de Galicia.
   P.D.-R. was funded by a European Commission (EC) Marie Curie Intra
   European Fellowship (FP7). J.W.H. was funded by the Biotechnology and
   Biological Sciences Research Council (BB/K009125/1). This work was also
   supported financially by the EC, under contract Nos. 222719 (LIFECYCLE)
   and 311993 (TargetFish), and by the European Research Council Starting
   Grant 2011 (contract No. 280469).
CR Abos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082737
   Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189
   Bao K, 2015, CYTOKINE, V75, P25, DOI 10.1016/j.cyto.2015.05.008
   Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657
   Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553
   BROWN KD, 1989, J IMMUNOL, V142, P679
   Buechel HM, 2015, CYTOKINE, V72, P204, DOI 10.1016/j.cyto.2014.12.005
   Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29
   Campbell S, 2009, DIS AQUAT ORGAN, V86, P205, DOI 10.3354/dao02127
   Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Chettri JK, 2014, J FISH DIS, V37, P771, DOI 10.1111/jfd.12169
   CLIFTONHADLEY RS, 1987, J FISH DIS, V10, P335, DOI 10.1111/j.1365-2761.1987.tb01081.x
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   Costa MM, 2012, IMMUNOGENETICS, V64, P229, DOI 10.1007/s00251-011-0581-1
   Costa MM, 2011, MOL IMMUNOL, V48, P1903, DOI 10.1016/j.molimm.2011.05.027
   DELUCA D, 1983, EUR J IMMUNOL, V13, P546, DOI 10.1002/eji.1830130706
   Diaz-Rosales P, 2009, FISH SHELLFISH IMMUN, V27, P414, DOI 10.1016/j.fsi.2009.06.008
   Dijkstra JM, 2014, NATURE, V511, pE7, DOI 10.1038/nature13446
   Fukuoka A, 2013, INT IMMUNOL, V25, P373, DOI 10.1093/intimm/dxs160
   Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246
   Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153
   Gao Q, 2009, DEV COMP IMMUNOL, V33, P920, DOI 10.1016/j.dci.2009.03.001
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1592598900, DOI 10.1385/1-59259-890-0:571]
   Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063
   Gibbs BF, 1996, EUR J IMMUNOL, V26, P2493, DOI 10.1002/eji.1830261033
   Gorgoglione B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-55
   Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014
   Harun NO, 2011, VACCINE, V29, P4388, DOI 10.1016/j.vaccine.2011.04.003
   Harun NO, 2011, FISH SHELLFISH IMMUN, V31, P107, DOI 10.1016/j.fsi.2011.04.010
   Hong S, 2001, VET IMMUNOL IMMUNOP, V81, P1, DOI 10.1016/S0165-2427(01)00328-2
   Hong S, 2013, J IMMUNOL, V191, P5959, DOI 10.4049/jimmunol.1301584
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   Husain M, 2012, DEV COMP IMMUNOL, V38, P431, DOI 10.1016/j.dci.2012.07.010
   Hwang HJ, 2015, METABOLISM, V64, P1175, DOI 10.1016/j.metabol.2015.06.001
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   Jiang YS, 2015, MOL IMMUNOL, V66, P216, DOI 10.1016/j.molimm.2015.03.014
   Johansson P, 2016, DEV COMP IMMUNOL, V54, P55, DOI 10.1016/j.dci.2015.08.005
   Johansson P, 2012, DEV COMP IMMUNOL, V37, P402, DOI 10.1016/j.dci.2012.02.012
   Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2
   Kokkinos PA, 2005, FISH SHELLFISH IMMUN, V18, P371, DOI 10.1016/j.fsi.2004.09.004
   LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030
   LE HV, 1991, BIOCHEMISTRY-US, V30, P9576, DOI 10.1021/bi00104a003
   LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606
   Li JH, 2007, MOL IMMUNOL, V44, P2078, DOI 10.1016/j.molimm.2006.09.010
   Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617
   Lin AF, 2009, J IMMUNOL, V183, P7398, DOI 10.4049/jimmunol.0803955
   Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156
   LOWENTHAL JW, 1988, J IMMUNOL, V140, P456
   Lupardus PJ, 2010, STRUCTURE, V18, P332, DOI 10.1016/j.str.2010.01.003
   Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881
   Maehr T, 2014, MOL IMMUNOL, V62, P186, DOI 10.1016/j.molimm.2014.06.021
   McCormick SM, 2015, CYTOKINE, V75, P38, DOI 10.1016/j.cyto.2015.05.023
   McLeod JJA, 2015, CYTOKINE, V75, P57, DOI 10.1016/j.cyto.2015.05.019
   Monte MM, 2012, FISH SHELLFISH IMMUN, V33, P365, DOI 10.1016/j.fsi.2012.05.023
   Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636
   MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654
   Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013
   Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X
   Ohta Y, 2004, J IMMUNOL, V173, P4553, DOI 10.4049/jimmunol.173.7.4553
   Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x
   Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064
   Redpath SA, 2015, CYTOKINE, V75, P51, DOI 10.1016/j.cyto.2015.02.026
   Salonius K, 2005, DEV BIOLOGICALS, V121, P189
   Schirmer K, 1998, TOXICOLOGY, V127, P143, DOI 10.1016/S0300-483X(98)00031-6
   Secombes CJ, 2015, IMMUNOBIOLOGY OF THE SHARK, P123
   Secombes CJ, 2006, DANIO RERIO PARTIAL
   Serafini N, 2015, MUCOSAL IMMUNOLOGY
   Severinson E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00628
   Shea-Donohue T, 2015, CYTOKINE, V75, P62, DOI 10.1016/j.cyto.2015.06.007
   Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x
   Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026
   Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tsarbopoulos A, 2000, J MASS SPECTROM, V35, P446, DOI 10.1002/(SICI)1096-9888(200003)35:3<446::AID-JMS956>3.0.CO;2-O
   van der Velden VHJ, 1998, CYTOKINE, V10, P803, DOI 10.1006/cyto.1998.0365
   Wang T, 2003, IMMUNOGENETICS, V55, P615, DOI 10.1007/s00251-003-0622-5
   Wang TH, 2001, FISH SHELLFISH IMMUN, V11, P233, DOI 10.1006/fsim.2000.0310
   Wang TH, 2008, J IMMUNOL, V181, P3310, DOI 10.4049/jimmunol.181.5.3310
   Wang T, 2008, MOL IMMUNOL, V45, P1449, DOI 10.1016/j.molimm.2007.08.016
   Wang TH, 2015, CYTOKINE, V75, P8, DOI 10.1016/j.cyto.2015.04.012
   Wang TH, 2015, IMMUNOGENETICS, V67, P395, DOI 10.1007/s00251-015-0838-1
   Wang TH, 2014, DEV COMP IMMUNOL, V46, P194, DOI 10.1016/j.dci.2014.04.008
   Wang TH, 2014, EUR J IMMUNOL, V44, P1541, DOI 10.1002/eji.201344273
   Wang TH, 2013, MOL IMMUNOL, V53, P398, DOI 10.1016/j.molimm.2012.09.008
   Wang TH, 2011, FISH SHELLFISH IMMUN, V31, P673, DOI 10.1016/j.fsi.2011.05.016
   Wang TH, 2011, IMMUNOGENETICS, V63, P235, DOI 10.1007/s00251-010-0508-2
   Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203
   Wang TH, 2010, MOL IMMUNOL, V47, P2563, DOI 10.1016/j.molimm.2010.06.015
   Wang TH, 2010, FISH SHELLFISH IMMUN, V29, P705, DOI 10.1016/j.fsi.2010.06.016
   Wangkahart E, 2016, DEV COMP IMMUNOL, V57, P75, DOI 10.1016/j.dci.2015.12.017
   WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065
   Yamaguchi T, 2013, FISH SHELLFISH IMMUN, V34, P433, DOI 10.1016/j.fsi.2012.11.005
   Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913
   Zhang YA, 2009, J IMMUNOL, V183, P83, DOI 10.4049/jimmunol.0900605
   Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9
   Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010
   Zhu LY, 2012, J IMMUNOL, V188, P5571, DOI 10.4049/jimmunol.1102259
NR 102
TC 52
Z9 55
U1 1
U2 17
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAR 8
PY 2016
VL 7
IS 10
BP 10917
EP 10946
DI 10.18632/oncotarget.7295
PG 30
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DL5LK
UT WOS:000375678300019
PM 26870894
OA Green Published, Other Gold, Bronze
DA 2020-05-07
ER

PT J
AU Li, Y
   Li, JJ
   Tian, ZH
   Xu, Y
   Zhang, JH
   Liu, W
   Tan, HR
AF Li, Yue
   Li, Jingjing
   Tian, Zhenhua
   Xu, Yu
   Zhang, Jihui
   Liu, Wen
   Tan, Huarong
TI Coordinative Modulation of Chlorothricin Biosynthesis by Binding of the
   Glycosylated Intermediates and End Product to a Responsive Regulator
   ChlF1
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE antibiotics; DNA-protein interaction; gene regulation; glycosylation;
   microbiology; chlorothricin; signaling molecule; TetR family regulator;
   Streptomyces antibioticus
ID GAMMA-BUTYROLACTONE RECEPTORS; ANTIBIOTIC BIOSYNTHESIS; POLYOXIN
   BIOSYNTHESIS; STREPTOMYCES-CACAOI; TETR FAMILY; GENE; ACTINOMADURA;
   THIOESTERASE; POLYKETIDE; MECHANISM
AB Chlorothricin, isolated from Streptomyces antibioticus, is a parent member of spirotetronate family of antibiotics that have long been appreciated for their remarkable biological activities. ChlF1 plays bifunctional roles in chlorothricin biosynthesis by binding to its target genes (chlJ, chlF1, chlG, and chlK). The dissociation constants of ChlF1 to these genes are approximate to 102-140 nm. A consensus sequence, 5-GTAANNATTTAC-3, was found in these binding sites. ChlF1 represses the transcription of chlF1, chlG, and chlK but activates chlJ, which encodes a key enzyme acyl-CoA carboxyl transferase involved in the chlorothricin biosynthesis. We demonstrate that the end product chlorothricin and likewise its biosynthetic intermediates (demethylsalicycloyl chlorothricin and deschloro-chlorothricin) can act as signaling molecules to modulate the binding of ChlF1 to its target genes. Intriguingly, a correlation between the antibacterial activity and binding ability of signaling molecules to the regulator ChlF1 is clearly observed. These features of the signaling molecules are associated with the glycosylation of spirotetronate macrolide aglycone. The findings provide new insights into the TetR family regulators responding to special structure of signaling molecules, and we reveal the regulatory mini-network mediated by ChlF1 in chlorothricin biosynthesis for the first time.
C1 [Li, Yue; Li, Jingjing; Zhang, Jihui; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.
   [Li, Yue; Li, Jingjing] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Tian, Zhenhua; Xu, Yu; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China.
RP Tan, HR (reprint author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.; Liu, W (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China.
EM wliu@mail.sioc.ac.cn; tanhr@im.ac.cn
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2015CB150600, 2013CB734001]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31270110, 31370097]
FX This work was supported by Ministry of Science and Technology of China
   Grants 2015CB150600 and 2013CB734001 and National Natural Science
   Foundation of China Grants 31270110 and 31370097.
CR Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016
   Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13
   Cuthbertson L, 2013, CHEM BIOL, V20, P232, DOI 10.1016/j.chembiol.2012.11.011
   Ding W, 2010, CHEM BIOL, V17, P495, DOI 10.1016/j.chembiol.2010.04.009
   Hu ZH, 2003, MICROBIOL-SGM, V149, P2213, DOI 10.1099/mic.0.26015-0
   Igarashi Y, 2012, J ANTIBIOT, V65, P355, DOI 10.1038/ja.2012.30
   Jimenez JI, 2011, ENVIRON MICROBIOL, V13, P1718, DOI 10.1111/j.1462-2920.2011.02471.x
   Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380
   Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Kotowska M, 2009, APPL ENVIRON MICROB, V75, P887, DOI 10.1128/AEM.01371-08
   Lacoske MH, 2015, J NAT PROD, V78, P562, DOI 10.1021/np500757w
   Li R, 2010, MOL MICROBIOL, V75, P349, DOI 10.1111/j.1365-2958.2009.06968.x
   Li R, 2009, MICROBIOL-SGM, V155, P1819, DOI 10.1099/mic.0.028639-0
   Li SM, 2013, ORG LETT, V15, P1374, DOI 10.1021/ol400342e
   Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12
   Liu TG, 2006, CHEM BIOL, V13, P945, DOI 10.1016/j.chembiol.2006.07.006
   MORIMOTO M, 1982, J ANTIBIOT, V35, P1033, DOI 10.7164/antibiotics.35.1033
   Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005
   Sambrook J., 2001, MOL CLONING LAB MANU
   SCHINDLER PW, 1975, EUR J BIOCHEM, V51, P579, DOI 10.1111/j.1432-1033.1975.tb03959.x
   Shao ZH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0264-y
   Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x
   Tian ZH, 2015, NAT CHEM BIOL, V11, P259, DOI [10.1038/NCHEMBIO.1769, 10.1038/nchembio.1769]
   van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a
   WAITZ JA, 1981, J ANTIBIOT, V34, P1101, DOI 10.7164/antibiotics.34.1101
   Wang JL, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-35
   Wang J, 2011, MOL MICROBIOL, V82, P236, DOI 10.1111/j.1365-2958.2011.07811.x
   Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106
   Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081
   Xu Y, 2012, MBIO, V3, DOI 10.1128/mBio.00191-12
   Zianni Michael, 2006, J Biomol Tech, V17, P103
   Zou ZZ, 2014, MOL MICROBIOL, V94, P490, DOI 10.1111/mmi.12752
NR 34
TC 16
Z9 17
U1 1
U2 16
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 4
PY 2016
VL 291
IS 10
BP 5406
EP 5417
DI 10.1074/jbc.M115.695874
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DF8WF
UT WOS:000371640600048
PM 26750095
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Galm, U
   Sparks, TC
AF Galm, Ute
   Sparks, Thomas C.
TI Natural product derived insecticides: discovery and development of
   spinetoram
SO JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Article
DE Saccharopolyspora spinosa; Spinosyn; Spinetoram; Natural products;
   Insecticide
ID SACCHAROPOLYSPORA-SPINOSA; NEURAL-NETWORKS; BIOSYNTHESIS;
   IDENTIFICATION; RHAMNOSE; GENES
AB This review highlights the importance of natural product research and industrial microbiology for product development in the agricultural industry, based on examples from Dow AgroSciences. It provides an overview of the discovery and development of spinetoram, a semi synthetic insecticide derived by a combination of a genetic block in a specific O-methylation of the rhamnose moiety of spinosad coupled with neural network-based QSAR and synthetic chemistry. It also emphasizes the key role that new technologies and multidisciplinary approaches play in the development of current spinetoram production strains.
C1 [Galm, Ute; Sparks, Thomas C.] Dow AgroSci LLC, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.
RP Galm, U (reprint author), Dow AgroSci LLC, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.
EM uggalm@dow.com
FU Dow AgroSciences LLC
FX The authors thank Drs. Nigel Mouncey and Tom Ramseier for useful
   discussions and support in compiling this overview, and Drs. Babu Raman
   and Nadaraj Palaniappan for providing some of the data. The research
   presented herein was supported by Dow AgroSciences LLC. (R) Trademark of
   The Dow Chemical Company ("DOW") or an affiliated company of Dow.
CR ANDREA TA, 1991, J MED CHEM, V34, P2824, DOI 10.1021/jm00113a022
   BOECK LD, 1996, Patent No. 5496931
   Crouse GD, 2001, PEST MANAG SCI, V57, P177, DOI 10.1002/1526-4998(200102)57:2<177::AID-PS281>3.0.CO;2-Z
   Gaisser S, 2002, CHEM COMMUN, P618, DOI 10.1039/b200536k
   Gaisser S, 2009, ORG BIOMOL CHEM, V7, P1705, DOI 10.1039/b900233b
   Geng CX, 2013, ADV INSECT PHYSIOL, V44, P101, DOI 10.1016/B978-0-12-394389-7.00003-X
   Gerwick BC, 2014, PEST MANAG SCI, V70, P1169, DOI 10.1002/ps.3744
   Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383
   Hahn DR, 2006, J IND MICROBIOL BIOT, V33, P94, DOI 10.1007/s10295-005-0016-9
   Hahn DR, 2002, Genes for enzymes of biosynthesis of insecticidal butenyl spinosyn of Saccharopolyspora and their use in the development of new insecticides, Patent No. [WO2002079477A2, 2002079477]
   Han L, 2011, Patent No. [WO2011143291A1, 2011143291]
   Kim HJ, 2007, J AM CHEM SOC, V129, P14582, DOI 10.1021/ja076580i
   Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981
   Kim HJ, 2010, J AM CHEM SOC, V132, P2901, DOI 10.1021/ja910223x
   KIRST HA, 1991, TETRAHEDRON LETT, V32, P4839, DOI 10.1016/S0040-4039(00)93474-9
   Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5
   Madduri K, 2001, J IND MICROBIOL BIOT, V27, P399, DOI 10.1038/sj.jim.7000180
   Madduri K, 2001, J BACTERIOL, V183, P5632, DOI 10.1128/JB.183.19.5632-5638.2001
   MERTZ FP, 1990, INT J SYST BACTERIOL, V40, P34, DOI 10.1099/00207713-40-1-34
   Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428
   Sheehan LS, 2006, J NAT PROD, V69, P1702, DOI 10.1021/np0602517
   Sparks TC, 2000, PESTIC BIOCHEM PHYS, V67, P187, DOI 10.1006/pest.2000.2490
   Sparks TC, 2008, J COMPUT AID MOL DES, V22, P393, DOI 10.1007/s10822-008-9205-8
   Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1
   ZUPAN J, 2000, NEURAL NETWORKS CHEM
NR 25
TC 19
Z9 23
U1 5
U2 46
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1367-5435
EI 1476-5535
J9 J IND MICROBIOL BIOT
JI J. Ind. Microbiol. Biotechnol.
PD MAR
PY 2016
VL 43
IS 2-3
SI SI
BP 185
EP 193
DI 10.1007/s10295-015-1710-x
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DH1IQ
UT WOS:000372538000009
PM 26582335
DA 2020-05-07
ER

PT J
AU Lynch, T
   Gregson, D
   Church, DL
AF Lynch, T.
   Gregson, D.
   Church, D. L.
TI Species-Level Identification of Actinomyces Isolates Causing Invasive
   Infections: Multiyear Comparison of Vitek MS (Matrix-Assisted Laser
   Desorption Ionization-Time of Flight Mass Spectrometry) to Partial
   Sequencing of the 16S rRNA Gene
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID ANAEROBIC-BACTERIA; SP-NOV; ABSCESS; NAESLUNDII; DIVERSITY; TOOLS; SILVA
AB Actinomyces species are uncommon but important causes of invasive infections. The ability of our regional clinical microbiology laboratory to report species-level identification of Actinomyces relied on molecular identification by partial sequencing of the 16S ribosomal gene prior to the implementation of the Vitek MS (matrix-assisted laser desorption ionization-time of flight mass spectrometry [MALDI-TOF MS]) system. We compared the use of the Vitek MS to that of 16S rRNA gene sequencing for reliable species-level identification of invasive infections caused by Actinomyces spp. because limited data had been published for this important genera. A total of 115 cases of Actinomyces spp., either alone or as part of a polymicrobial infection, were diagnosed between 2011 and 2014. Actinomyces spp. were considered the principal pathogen in bloodstream infections (n = 17, 15%), in skin and soft tissue abscesses (n = 25, 22%), and in pulmonary (n = 26, 23%), bone (n = 27, 23%), intraabdominal (n = 16, 14%), and central nervous system (n = 4, 3%) infections. Compared to sequencing and identification from the SmartGene Integrated Database Network System (IDNS), Vitek MS identified 47/115 (41%) isolates to the correct species and 10 (9%) isolates to the correct genus. However, the Vitek MS was unable to provide identification for 43 (37%) isolates while 15 (13%) had discordant results. Phylogenetic analyses of the 16S rRNA sequences demonstrate high diversity in recovered Actinomyces spp. and provide additional information to compare/confirm discordant identifications between MALDI-TOF and 16S rRNA gene sequences. This study highlights the diversity of clinically relevant Actinomyces spp. and provides an important typing comparison. Based on our analysis, 16S rRNA gene sequencing should be used to rapidly identify Actinomyces spp. until MALDI-TOF databases are optimized.
C1 [Lynch, T.; Gregson, D.; Church, D. L.] Univ Calgary, CLS, Div Microbiol, Calgary, AB, Canada.
   [Lynch, T.; Gregson, D.; Church, D. L.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.
   [Gregson, D.; Church, D. L.] Univ Calgary, Dept Med, Calgary, AB, Canada.
RP Lynch, T (reprint author), Univ Calgary, CLS, Div Microbiol, Calgary, AB, Canada.; Lynch, T (reprint author), Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.
EM tarah.lynch@ahs.ca
FU Calgary Laboratory Services (CLS)
FX Calgary Laboratory Services (CLS) provided funding to Tarah Lynch, Dan
   Gregson, and Deirdre L. Church.
CR Attar KH, 2007, BREAST J, V13, P501, DOI 10.1111/j.1524-4741.2007.00472.x
   Bing AU, 2015, J CLIN MICROBIOL, V53, P3247, DOI 10.1128/JCM.01030-15
   Bose M, 2014, J CLIN DIAGN RES, V8, pYD3, DOI 10.7860/JCDR/2014/8286.4591
   Boyanova L, 2015, FUTURE MICROBIOL, V10, P613, DOI [10.2217/fmb.14.130, 10.2217/FMB.14.130]
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013
   Clancy U, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-207548
   Clinical and Laboratory Standards Institute, 2008, MM18A CLSI
   Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10
   Dubourg Gregory, 2015, J Med Case Rep, V9, P223, DOI 10.1186/s13256-015-0704-7
   Fujita Y, 2012, J MED MICROBIOL, V61, P1156, DOI 10.1099/jmm.0.040394-0
   Garner O, 2014, CLIN MICROBIOL INFEC, V20, P335, DOI 10.1111/1469-0691.12317
   Gliga S, 2014, CAN RESPIR J, V21, pE75, DOI 10.1155/2014/841480
   GRICE GC, 1983, BRIT J VENER DIS, V59, P317
   Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88
   Hagiya H, 2014, INTERNAL MED, V53, P67, DOI 10.2169/internalmedicine.53.0403
   Hall V, 2008, ANAEROBE, V14, P1, DOI 10.1016/j.anaerobe.2007.12.001
   Henssge U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021430
   Henssge U, 2009, INT J SYST EVOL MICR, V59, P509, DOI 10.1099/ijs.0.000950-0
   JOHNSON JL, 1990, INT J SYST BACTERIOL, V40, P273, DOI 10.1099/00207713-40-3-273
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166
   Kononen E, 2015, CLIN MICROBIOL REV, V28, P419, DOI 10.1128/CMR.00100-14
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lee EHL, 2011, J CLIN MICROBIOL, V49, P1745, DOI 10.1128/JCM.02166-10
   MILLER PH, 1995, J CLIN MICROBIOL, V33, P329, DOI 10.1128/JCM.33.2.329-330.1995
   Nielsen H. L., 2015, New Microbes and New Infections, V7, P21, DOI 10.1016/j.nmni.2015.05.001
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rambaut A, 2008, FIGTREE V1 3 1
   Simmon KE, 2008, J CLIN MICROBIOL, V46, P1596, DOI 10.1128/JCM.02469-07
   Simmon KE, 2006, J CLIN MICROBIOL, V44, P4400, DOI 10.1128/JCM.01364-06
   Stingu CS, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26110
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thompson H, 2015, APPL ENVIRON MICROB, V81, P8307, DOI 10.1128/AEM.02156-15
   Van Hoecke F, 2013, J CLIN MICROBIOL, V51, P4252, DOI 10.1128/JCM.02142-13
   Wong VK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6099
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
NR 38
TC 6
Z9 6
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2016
VL 54
IS 3
BP 712
EP 717
DI 10.1128/JCM.02872-15
PG 6
WC Microbiology
SC Microbiology
GA DF2EC
UT WOS:000371152200030
PM 26739153
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Quinn, RA
   Navas-Molina, JA
   Hyde, ER
   Song, SJ
   Vazquez-Baeza, Y
   Humphrey, G
   Gaffney, J
   Minich, JJ
   Melnik, AV
   Herschend, J
   DeReus, J
   Durant, A
   Dutton, RJ
   Khosroheidari, M
   Green, C
   da Silva, R
   Dorrestein, PC
   Knight, R
AF Quinn, Robert A.
   Navas-Molina, Jose A.
   Hyde, Embriette R.
   Song, Se Jin
   Vazquez-Baeza, Yoshiki
   Humphrey, Greg
   Gaffney, James
   Minich, Jeremiah J.
   Melnik, Alexey V.
   Herschend, Jakob
   DeReus, Jeff
   Durant, Austin
   Dutton, Rachel J.
   Khosroheidari, Mahdieh
   Green, Clifford
   da Silva, Ricardo
   Dorrestein, Pieter C.
   Knight, Rob
TI From Sample to Multi-Omics Conclusions in under 48 Hours
SO MSYSTEMS
LA English
DT Article
DE 16S rRNA; microbiome; fermented food; metabolome; molecular networking;
   rapid response
ID MOLECULAR NETWORKING; REAL-TIME; METABOLOMICS; METABOLISM
AB Multi-omics methods have greatly advanced our understanding of the biological organism and its microbial associates. However, they are not routinely used in clinical or industrial applications, due to the length of time required to generate and analyze omics data. Here, we applied a novel integrated omics pipeline for the analysis of human and environmental samples in under 48 h. Human subjects that ferment their own foods provided swab samples from skin, feces, oral cavity, fermented foods, and household surfaces to assess the impact of home food fermentation on their microbial and chemical ecology. These samples were analyzed with 16S rRNA gene sequencing, inferred gene function profiles, and liquid chromatography-tandem mass spectrometry (LC-MS/MS) metabolomics through the Qiita, PICRUSt, and GNPS pipelines, respectively. The human sample microbiomes clustered with the corresponding sample types in the American Gut Project (http://www.americangut.org), and the fermented food samples produced a separate cluster. The microbial communities of the household surfaces were primarily sourced from the fermented foods, and their consumption was associated with increased gut microbial diversity. Untargeted metabolomics revealed that human skin and fermented food samples had separate chemical ecologies and that stool was more similar to fermented foods than to other sample types. Metabolites from the fermented foods, including plant products such as procyanidin and pheophytin, were present in the skin and stool samples of the individuals consuming the foods. Some food metabolites were modified during digestion, and others were detected in stool intact. This study represents a first-of-its-kind analysis of multi-omics data that achieved time intervals matching those of classic microbiological culturing.
   IMPORTANCE Polymicrobial infections are difficult to diagnose due to the challenge in comprehensively cultivating the microbes present. Omics methods, such as 16S rRNA sequencing, metagenomics, and metabolomics, can provide a more complete picture of a microbial community and its metabolite production, without the biases and selectivity of microbial culture. However, these advanced methods have not been applied to clinical or industrial microbiology or other areas where complex microbial dysbioses require immediate intervention. The reason for this is the length of time required to generate and analyze omics data. Here, we describe the development and application of a pipeline for multi-omics data analysis in time frames matching those of the culture-based approaches often used for these applications. This study applied multi-omics methods effectively in clinically relevant time frames and sets a precedent toward their implementation in clinical medicine and industrial microbiology.
C1 [Quinn, Robert A.; Melnik, Alexey V.; Herschend, Jakob; da Silva, Ricardo; Dorrestein, Pieter C.; Knight, Rob] Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA.
   [Navas-Molina, Jose A.; Hyde, Embriette R.; Song, Se Jin; Humphrey, Greg; Gaffney, James; Minich, Jeremiah J.; DeReus, Jeff; Dorrestein, Pieter C.; Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA.
   [Navas-Molina, Jose A.; Vazquez-Baeza, Yoshiki; Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA.
   [Durant, Austin] Fermenters Club San Diego, San Diego, CA 92105 USA.
   [Dutton, Rachel J.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.
   [Khosroheidari, Mahdieh; Green, Clifford] Univ Calif San Diego, Inst Genom Med Genom Ctr, La Jolla, CA 92093 USA.
   [Dorrestein, Pieter C.; Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, San Diego, CA 92093 USA.
   [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA.
   [Song, Se Jin] Univ Colorado, Boulder, CO 80309 USA.
RP Quinn, RA; Dorrestein, PC; Knight, R (reprint author), Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA.
EM rquinn@ucsd.edu; pdorrestein@ucsd.edu; robknight@ucsd.edu
RI da Silva, Ricardo Roberto/F-8354-2019
OI da Silva, Ricardo Roberto/0000-0001-6378-0479; Song, Se
   Jin/0000-0003-0750-5709
FU Sloan FoundationAlfred P. Sloan Foundation; National Science Foundation
   (NSF)National Science Foundation (NSF) [ACI-1053575, 1341698]; Sao Paulo
   Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [FAPESP-2015/03348-3]
FX This work, including the efforts of Robert Andrew Quinn, Alexey V.
   Melnik, Jakob Herschend, and Pieter C. Dorrestein, was funded by Sloan
   Foundation. This work, including the efforts of Robert Andrew Quinn,
   Jose Antonio Navas-Molina, Embriette Hyde, Se Jin Song, Yoshiki
   Vasquez-Baeza, Greg Humphrey, James Gaffney, Jeremiah J. Minich, Alexey
   V. Melnik, Jakob Herschend, Jeff DeReus, Austin Durant, Mahdieh
   Khosroheidari, Clifford Green, Ricardo da Silva, Pieter C. Dorrestein,
   and Rob Knight, was funded by National Science Foundation (NSF)
   (ACI-1053575). This work, including the efforts of Pieter C. Dorrestein,
   Rob Knight, Robert Andrew Quinn, Jose Antonio Navas-Molina, Embriette
   Hyde, Se Jin Song, Yoshiki Vasquez-Baeza, Greg Humphrey, James Gaffney,
   Jeremiah J. Minich, Alexey V. Melnik, Jakob Herschend, Jeff DeReus,
   Austin Durant, Mahdieh Khosroheidari, Clifford Green, and Ricardo da
   Silva, was funded by National Science Foundation (NSF) (1341698). This
   work, including the efforts of Ricardo da Silva, was funded by Sao Paulo
   Research Foundation (FAPESP-2015/03348-3).
CR Balog J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005623
   Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   da Silva RR, 2015, P NATL ACAD SCI USA, V112, P12549, DOI 10.1073/pnas.1516878112
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3
   Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451
   Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14
   Greninger AL, 2015, GENOME MED, V7
   Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872
   Hsu CC, 2013, ANAL CHEM, V85, P7014, DOI 10.1021/ac401613x
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235
   Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052
   McGovern P.E., 2003, ANCIENT WINE SEARCH
   Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Prasain JK, 2003, J AGR FOOD CHEM, V51, P4213, DOI 10.1021/jf030174a
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Rossen NG, 2015, WORLD J GASTROENTERO, V21, P5359, DOI 10.3748/wjg.v21.i17.5359
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000
   Sprague SJ, 2007, NEW PHYTOL, V176, P211, DOI 10.1111/j.1469-8137.2007.02156.x
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16
   Vinaixa M, 2016, TRAC-TREND ANAL CHEM, V78, P23, DOI 10.1016/j.trac.2015.09.005
   Vlieg JETV, 2011, CURR OPIN BIOTECH, V22, P211, DOI 10.1016/j.copbio.2010.12.004
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109
   Wolfe BE, 2015, CELL, V161, P49, DOI 10.1016/j.cell.2015.02.034
   Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s
NR 44
TC 30
Z9 32
U1 2
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD MAR-APR
PY 2016
VL 1
IS 2
AR UNSP e00038-16
DI 10.1128/mSystems.00038-16
PG 13
WC Microbiology
SC Microbiology
GA FE4NS
UT WOS:000408191200008
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Bordron, P
   Latorre, M
   Cortes, MP
   Gonzalez, M
   Thiele, S
   Siegel, A
   Maass, A
   Eveillard, D
AF Bordron, Philippe
   Latorre, Mauricio
   Cortes, Maria-Paz
   Gonzalez, Mauricio
   Thiele, Sven
   Siegel, Anne
   Maass, Alejandro
   Eveillard, Damien
TI Putative bacterial interactions from metagenomic knowledge with an
   integrative systems ecology approach
SO MICROBIOLOGYOPEN
LA English
DT Article
DE Environmental microbiology; in silico analysis; metabolic pathways;
   molecular microbial ecology
ID DRAFT GENOME SEQUENCE; NETWORKS; RECONSTRUCTION; ASSIMILATION;
   METABOLISM; PHYSIOLOGY; REDUCTION; EVOLUTION; PATHWAYS; DATABASE
AB Following the trend of studies that investigate microbial ecosystems using different metagenomic techniques, we propose a new integrative systems ecology approach that aims to decipher functional roles within a consortium through the integration of genomic and metabolic knowledge at genome scale. For the sake of application, using public genomes of five bacterial strains involved in copper bioleaching: Acidiphilium cryptum, Acidithiobacillus ferrooxidans, Acidithiobacillus thiooxidans, Leptospirillum ferriphilum, and Sulfobacillus thermosulfidooxidans, we first reconstructed a global metabolic network. Next, using a parsimony assumption, we deciphered sets of genes, called Sets from Genome Segments (SGS), that (1) are close on their respective genomes, (2) take an active part in metabolic pathways and (3) whose associated metabolic reactions are also closely connected within metabolic networks. Overall, this SGS paradigm depicts genomic functional units that emphasize respective roles of bacterial strains to catalyze metabolic pathways and environmental processes. Our analysis suggested that only few functional metabolic genes are horizontally transferred within the consortium and that no single bacterial strain can accomplish by itself the whole copper bioleaching. The use of SGS pinpoints a functional compartmentalization among the investigated species and exhibits putative bacterial interactions necessary for promoting these pathways.
C1 [Bordron, Philippe; Latorre, Mauricio; Cortes, Maria-Paz; Maass, Alejandro] Univ Chile, Ctr Math Modeling, Math, Beauchef 851,Piso 6,Of 613, Santiago, Chile.
   [Bordron, Philippe; Latorre, Mauricio; Cortes, Maria-Paz; Gonzalez, Mauricio; Maass, Alejandro] Univ Chile, Ctr Genome Regulat Fondap 15090007, Santiago, Chile.
   [Latorre, Mauricio; Gonzalez, Mauricio] Univ Chile, Lab Bioinformat & Expres Gen INTA, Santiago, Chile.
   [Thiele, Sven] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.
   [Siegel, Anne] CNRS, IRISA, UMR 6074, Rennes, France.
   [Siegel, Anne] Ctr Rennes Bretagne Atlantique, INRIA, Dyliss Team, Rennes, France.
   [Maass, Alejandro] Univ Chile, Dept Engn Math, Santiago, Chile.
   [Eveillard, Damien] Univ Nantes, LINA, UMR CNRS 6241, EMN, Nantes, France.
RP Bordron, P (reprint author), Univ Chile, Ctr Math Modeling, Math, Beauchef 851,Piso 6,Of 613, Santiago, Chile.
EM phbordron@dim.uchile.cl
RI Maass, Alejandro/D-5848-2012; Gonzalez, Mauricio/I-2772-2013; eveillard,
   damien/A-1635-2012
OI Maass, Alejandro/0000-0002-7038-4527; Thiele, Sven/0000-0002-5812-6963;
   eveillard, damien/0000-0002-8162-7360; Siegel, Anne/0000-0001-6542-1568
FU grants Fondap [15090007]; Basal programComision Nacional de
   Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL
   [PFB-03 CMM]; IntegrativeBioChile INRIA Assoc. Team [ANR-10-BLANC-0218];
   CIRIC-INRIA Chile (line Natural Resources)
FX This work was supported by grants Fondap 15090007, Basal program PFB-03
   CMM, IntegrativeBioChile INRIA Assoc. Team, ANR-10-BLANC-0218 and
   CIRIC-INRIA Chile (line Natural Resources).
CR Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X
   Barreto M, 2003, HYDROMETALLURGY, V71, P97, DOI 10.1016/S0304-386X(03)00145-2
   Bordron P, 2011, IET SYST BIOL, V5, P261, DOI 10.1049/iet-syb.2010.0070
   Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105
   Boyer F, 2005, BIOINFORMATICS, V21, P4209, DOI 10.1093/bioinformatics/bti711
   Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86
   Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014
   Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109
   Christian N, 2009, MOL BIOSYST, V5, P1889, DOI [10.1039/b915913b, 10.1039/B915913b]
   Croes D, 2005, NUCLEIC ACIDS RES, V33, pW326, DOI 10.1093/nar/gki437
   de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605
   DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158
   DROBNER E, 1990, NATURE, V346, P742, DOI 10.1038/346742a0
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288
   Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59
   Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043
   Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177
   Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471
   Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018
   Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004
   Larhlimi A, 2011, BIOSYSTEMS, V106, P1, DOI 10.1016/j.biosystems.2011.06.002
   Latorre M, 2016, BIORESOURCE TECHNOL, V200, P29, DOI 10.1016/j.biortech.2015.09.110
   Levican G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-581
   Liberal R, 2013, BIOINFORMATICS, V29, P154, DOI 10.1093/bioinformatics/btt236
   Magnuson TS, 2010, BIOMETALS, V23, P1129, DOI 10.1007/s10534-010-9360-y
   Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757
   McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18
   Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312
   Mi S, 2011, J MICROBIOL, V49, P890, DOI 10.1007/s12275-011-1099-9
   Nunez PA, 2013, GENOME BIOL EVOL, V5, P2242, DOI 10.1093/gbe/evt174
   Orphan VJ, 2009, CURR OPIN MICROBIOL, V12, P231, DOI 10.1016/j.mib.2009.04.003
   Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109
   Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394
   Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6
   Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53
   Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8
   Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417
   Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22
   Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020
   Travisany D, 2012, J BACTERIOL, V194, P6327, DOI 10.1128/JB.01622-12
   Tzamali E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-167
   Valdes J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-51
   Valdes J, 2010, HYDROMETALLURGY, V104, P471, DOI 10.1016/j.hydromet.2010.03.028
   Valdes J, 2011, J BACTERIOL, V193, P7003, DOI 10.1128/JB.06281-11
   Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597
   Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307
   Yin HQ, 2008, SYST APPL MICROBIOL, V31, P302, DOI 10.1016/j.syapm.2008.05.003
   Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263
   Zaneveld JRR, 2011, TRENDS MICROBIOL, V19, P472, DOI 10.1016/j.tim.2011.07.006
   Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112
   Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763
   Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307
NR 56
TC 6
Z9 6
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-8827
J9 MICROBIOLOGYOPEN
JI MicrobiologyOpen
PD FEB
PY 2016
VL 5
IS 1
BP 106
EP 117
DI 10.1002/mbo3.315
PG 12
WC Microbiology
SC Microbiology
GA DF3QI
UT WOS:000371259500009
PM 26677108
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Mayer, CL
   Haley, VB
   Giardina, R
   Hazamy, PA
   Tsivitis, M
   Knab, R
   Lutterloh, E
AF Mayer, Christen L.
   Haley, Valerie B.
   Giardina, Rosalie
   Hazamy, Peggy A.
   Tsivitis, Marie
   Knab, Robin
   Lutterloh, Emily
TI Lessons learned from initial reporting of carbapenem-resistant
   Enterobacteriaceae in New York State hospitals, 2013-2014
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Carbapenem-resistant Enterobacteriaceae; National Healthcare Safety
   Network; Hospital-acquired infection; Data validation
AB Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an urgent concern in health care in the United States because of high attributable mortality and versatile resistance mechanisms. CRE reporting was mandated in New York State (NYS) hospitals in July 2013.
   Methods: Infection preventionists from the NYS Department of Health audited hospital-reported CRE data by comparing laboratory records with cases reported to the National Healthcare Safety Network (NHSN). Information regarding microbiology laboratory testing methodologies was obtained through a survey in October 2013.
   Results: There were 1,151 CRE laboratory reports audited, with 13.6% determined not to have been reported to the NHSN when they should have been and 4.6% determined to be reported in error. There were a variety of errors, including lapses in surveillance and misinterpretation of the surveillance definition.
   Conclusion: Educational initiatives that include microbiology laboratory staff, improvements in the use of laboratory information systems to communicate with infection prevention, and updated NHSN definitions should improve the accuracy and consistency of CRE reporting in NYS. Copyright (c) 2016 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Mayer, Christen L.; Haley, Valerie B.; Giardina, Rosalie; Hazamy, Peggy A.; Tsivitis, Marie; Knab, Robin; Lutterloh, Emily] New York State Dept Hlth, Bur Healthcare Associated Infect, Albany, NY USA.
   [Mayer, Christen L.; Haley, Valerie B.; Lutterloh, Emily] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Haley, VB (reprint author), Corning Tower Room 523,Empire State Plaza, Albany, NY 12237 USA.
EM Valerie.haley@health.ny.gov
FU Epidemiology and Laboratory Capacity for Infectious Diseases from the
   Centers for Disease Control and Prevention [15-0610-04, 15-0775-01]
FX This work was funded in part by Epidemiology and Laboratory Capacity for
   Infectious Diseases (grant nos. 15-0610-04 and 15-0775-01) from the
   Centers for Disease Control and Prevention.
CR Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922
   CDC, MULT RES ORG CLOSTR
   Centers for Disease Control and Prevention, 2013, NHSN PAT SAF MAN
   Centers for Diseases Control. National Center for Emerging and Zoonotic Infectious Diseases. DHQP, GUID CONTR CARB RES
   CSTE Infectious Disease Committee, 2015, POS STAT ST IN PRESS
   Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165
   Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135
   Pfeiffer CD, 2014, INFECT CONT HOSP EP, V35, P356, DOI 10.1086/675605
   Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07
NR 9
TC 1
Z9 1
U1 0
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD FEB 1
PY 2016
VL 44
IS 2
BP 131
EP 133
DI 10.1016/j.ajic.2015.09.001
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DB8NF
UT WOS:000368772700004
PM 26601706
DA 2020-05-07
ER

PT J
AU Betiku, E
   Emeko, HA
   Solomon, BO
AF Betiku, Eriola
   Emeko, Harrison A.
   Solomon, Bamidele O.
TI Fermentation parameter optimization of microbial oxalic acid production
   from cashew apple juice
SO HELIYON
LA English
DT Article
DE Biochemical engineering; Applied microbiology; Food science;
   Mathematical modelling; Optimization
ID RESPONSE-SURFACE METHODOLOGY; ARTIFICIAL NEURAL-NETWORK;
   ASPERGILLUS-NIGER; CITRIC-ACID; STARCH HYDROLYZATE; SUBSTRATE;
   BIOSYNTHESIS; REAGENT; DESIGN; MUTANT
AB The potential of cashew apple juice (CAJ) as a carbon source for oxalic acid (OA) production via fermentation process was investigated in this study. The effects and interactions of CAJ concentration, time, pH, NaNO3 concentration and methanol concentration on OA production were determined in a central composite design (CCD) and the process was modelled and optimized using response surface methodology (RSM). The results showed that OA fermentation can be described significantly (p < 0.05) by a quadratic model giving regression coefficient (R-2) of 0.9964. NaNO3 concentration was the most significant positive variable while methanol was not a significant variable. A maximum OA concentration of 122.68 g/1 could be obtained using the optimum levels of CAJ of 150.0 g/1, pH of 5.4, time of 7.31 days, NaNO3 of 2 g/1 and methanol of 1% volume. The production of OA was found to increase from 106.75 to 122.68 g/1 using the statistically design optimization. This study revealed that CAJ could serve as an inexpensive and abundant feedstock for fermentative OA production, the resulting model could be used in the design of a typical pilot plant for a scale up production.
C1 [Betiku, Eriola; Emeko, Harrison A.; Solomon, Bamidele O.] Obafemi Awolowo Univ, Dept Chem Engn, Biochem Engn Lab, Ife 220005, Osun State, Nigeria.
RP Betiku, E (reprint author), Obafemi Awolowo Univ, Dept Chem Engn, Biochem Engn Lab, Ife 220005, Osun State, Nigeria.
EM ebetiku@oauife.edu.ng
RI Betiku, Eriola/B-6238-2015
OI Betiku, Eriola/0000-0003-4521-1277
CR Aghaie E, 2009, CHEM ENG J, V147, P245, DOI 10.1016/j.cej.2008.07.008
   Andre A, 2010, IND CROP PROD, V31, P407, DOI 10.1016/j.indcrop.2009.12.011
   AOAC, 1995, OFFICIAL METHODS ANA
   Betiku E, 2014, J NIGER SOC CHEM ENG, V29, P15
   Betiku E, 2015, RENEW ENERG, V74, P87, DOI 10.1016/j.renene.2014.07.054
   Betiku E, 2013, BIOMASS BIOENERG, V55, P350, DOI 10.1016/j.biombioe.2013.02.034
   Bohlmann JT, 1998, BIOPROCESS ENG, V19, P337
   Box G. E. P., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.1080/00401706.1960.10489912]
   Chen HL, 2010, BIORESOURCES, V5, P1581
   Dhillon GS, 2011, FOOD CHEM, V128, P864, DOI 10.1016/j.foodchem.2011.03.107
   Emeko HA, 2015, BIORESOURCES, V10, P2067, DOI 10.15376/biores.10.2.2067-2082
   Fontes CPML, 2009, BIOPROC BIOSYST ENG, V32, P493, DOI 10.1007/s00449-008-0269-6
   Hodgkinson A., 1977, OXALIC ACID BIOL MED
   Honorato TL, 2007, WORLD J MICROB BIOT, V23, P1409, DOI 10.1007/s11274-007-9381-z
   Huang H, 2013, POSTHARVEST BIOL TEC, V84, P22, DOI 10.1016/j.postharvbio.2013.04.002
   Jiang ZL, 1996, ANAL CHIM ACTA, V320, P139
   JOGLEKAR AM, 1987, CEREAL FOOD WORLD, V32, P857
   KUBICEK CP, 1988, APPL ENVIRON MICROB, V54, P633, DOI 10.1128/AEM.54.3.633-637.1988
   LAYOKUN SK, 1986, J FOOD SCI, V51, P237, DOI 10.1111/j.1365-2621.1986.tb10882.x
   Magnuson JK, 2004, ADV FUNGAL BIOTECHNO, P307, DOI [10.1007/978-1-4419-8859-1, DOI 10.1007/978-1-4419-8859-1]
   Mandal SK, 2005, PROCESS BIOCHEM, V40, P1605, DOI 10.1016/j.procbio.2004.06.013
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Musial I, 2011, APPL CLAY SCI, V52, P277, DOI 10.1016/j.clay.2011.03.004
   Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x
   Osho A, 1995, NAHRUNG, V39, P521, DOI 10.1002/food.19950390518
   Oyeniran O. O., 2013, IFE J TECHNOLOGY, V22, P21
   Papagora C, 2013, FOOD BIOPROD PROCESS, V91, P413, DOI 10.1016/j.fbp.2013.02.008
   Podgorski W, 2003, CHEM PAP, V57, P408
   Rocha MVP, 2006, WORLD J MICROB BIOT, V22, P1295, DOI 10.1007/s11274-006-9175-8
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ruijter GJG, 1999, MICROBIOL-SGM, V145, P2569, DOI 10.1099/00221287-145-9-2569
   Rymowicz W, 2003, BIOTECHNOL LETT, V25, P955, DOI 10.1023/A:1024082130677
   Rymowicz W., 2004, EJPAU SERIES BIOTECH, V2
   Saqib AAN, 2011, BIOMASS BIOENERG, V35, P4748, DOI 10.1016/j.biombioe.2011.09.013
   SCHIERHOLT J, 1977, PROCESS BIOCHEM, V12, P20
   Shanmugaprakash M, 2014, INT J BIOL MACROMOL, V64, P443, DOI 10.1016/j.ijbiomac.2013.12.033
   Son SM, 2000, J AGR FOOD CHEM, V48, P2071, DOI 10.1021/jf991397x
   STRASSER H, 1994, FEMS MICROBIOL LETT, V119, P365, DOI 10.1111/j.1574-6968.1994.tb06914.x
   Zheng XL, 2006, FOOD CHEM, V96, P519, DOI 10.1016/j.foodchem.2005.02.049
NR 39
TC 10
Z9 10
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD FEB
PY 2016
VL 2
IS 2
AR e00082
DI 10.1016/j.heliyon.2016.e00082
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA VC1XR
UT WOS:000432004600001
PM 27441258
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Steen, IH
   Dahle, H
   Stokke, R
   Roalkvam, I
   Daae, FL
   Rapp, HT
   Pedersen, RB
   Thorseth, IH
AF Steen, Ida H.
   Dahle, Hakon
   Stokke, Runar
   Roalkvam, Irene
   Daae, Frida-Lise
   Rapp, Hans Tore
   Pedersen, Rolf B.
   Thorseth, Ingunn H.
TI Novel Barite Chimneys at the Loki's Castle Vent Field Shed Light on Key
   Factors Shaping Microbial Communities and Functions in Hydrothermal
   Systems
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE hydrothermal systems; barite chimney; Epsilonproteobacteria; Loki's
   Castle Vent Field; chemolithoautotroph; low-temperature venting
ID IN-SITU HYBRIDIZATION; ARCTIC MIDOCEAN RIDGE; LITHOTROPHIC SULFUR
   OXIDATION; PARACOCCUS-PANTOTROPHUS GB17; SP-NOV.; OXIDIZING BACTERIA;
   ANAEROBIC OXIDATION; EMENDED DESCRIPTION; SEA-FLOOR; DIVERSITY
AB In order to fully understand the cycling of elements in hydrothermal systems it is critical to understand intra-field variations in geochemical and microbiological processes in both focused, high-temperature and diffuse, low-temperature areas. To reveal important causes and effects of this variation, we performed an extensive chemical and microbiological characterization of a low-temperature venting area in the Loki's Castle Vent Field (LCVF). This area, located at the flank of the large sulfide mound, is characterized by numerous chimney-like barite (BaSO4) structures (<= 1 m high) covered with white cotton-like microbial mats. Results from geochemical analyses, microscopy (FISH, SEM), 16S rRNA gene amplicon-sequencing and metatranscriptomics were compared to results from previous analyses of biofilms growing on black smoker chimneys at LCVF. Based on our results, we constructed a conceptual model involving the geochemistry and microbiology in the LCVF. The model suggests that CH4 and H2S are important electron donors for microorganisms in both high-temperature and low-temperature areas, whereas the utilization of H-2 seems restricted to high-temperature areas. This further implies that sub-seafloor processes can affect energy-landscapes, elemental cycling, and the metabolic activity of primary producers on the seafloor. In the cotton like microbial mats on top of the active barite chimneys, a unique network of single cells of Epsilonproteobacteria interconnected by threads of extracellular polymeric substances (EPS) was seen, differing significantly from the long filamentous Sulfurovum filaments observed in biofilms on the black smokers. This network also induced nucleation of barite crystals and is suggested to play an essential role in the formation of the microbial mats and the chimneys. Furthermore, it illustrates variations in how different genera of Epsilonproteobacteria colonize and position cells in different vent fluid mixing zones within a vent field. This may be related to niche-specific physical characteristics. Altogether, the model provides a reference for future studies and illustrates the importance of systematic comparative studies of spatially closely connected niches in order to fully understand the geomicrobiology of hydrothermal systems.
C1 [Steen, Ida H.; Dahle, Hakon; Stokke, Runar; Roalkvam, Irene; Daae, Frida-Lise; Rapp, Hans Tore; Pedersen, Rolf B.; Thorseth, Ingunn H.] Univ Bergen, Ctr Geobiol, Bergen, Norway.
   [Steen, Ida H.; Dahle, Hakon; Stokke, Runar; Roalkvam, Irene; Daae, Frida-Lise; Rapp, Hans Tore] Univ Bergen, Dept Biol, Bergen, Norway.
   [Pedersen, Rolf B.; Thorseth, Ingunn H.] Univ Bergen, Dept Earth Sci, Bergen, Norway.
RP Steen, IH (reprint author), Univ Bergen, Ctr Geobiol, Bergen, Norway.
EM ida.steen@uib.no
FU Norwegian Research Council through the Center for Geobiology [179560];
   ARGUS Remote Systems
FX This work was supported by the Norwegian Research Council through the
   Center for Geobiology (Project:179560). We acknowledge the crew on the
   R/V G.O. Sars and the ROV pilots from the ARGUS Remote Systems for
   support during the cruise to the LCVE in 2009 and 2010.
CR Ahn YB, 2009, APPL ENVIRON MICROB, V75, P4248, DOI 10.1128/AEM.00203-09
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amend JP, 2011, GEOCHIM COSMOCHIM AC, V75, P5736, DOI 10.1016/j.gca.2011.07.041
   ARIELI B, 1994, J BIOL CHEM, V269, P5705
   Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414
   Christensen H, 1999, APPL ENVIRON MICROB, V65, P1753
   Dahle H, 2015, ISME J, V9, P1593, DOI 10.1038/ismej.2014.247
   Dahle H, 2013, ENV MICROBIOL REP, V5, P282, DOI 10.1111/1758-2229.12016
   Eickmann B, 2014, GEOBIOLOGY, V12, P308, DOI 10.1111/gbi.12086
   Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000
   Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x
   Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403
   Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109
   Hansen M, 2015, ISME J, V9, P696, DOI 10.1038/ismej.2014.173
   Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77
   Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109
   Kato S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00089
   Kleindienst S, 2014, ISME J, V8, P2029, DOI 10.1038/ismej.2014.51
   Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130
   Kongsrud JA, 2012, POLAR BIOL, V35, P161, DOI 10.1007/s00300-011-1048-4
   Labrenz M, 2013, INT J SYST EVOL MICR, V63, P4141, DOI 10.1099/ijs.0.048827-0
   LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955
   Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334
   Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006
   Lloyd KG, 2011, ENVIRON MICROBIOL, V13, P2548, DOI 10.1111/j.1462-2920.2011.02526.x
   Losekann T, 2008, ENVIRON MICROBIOL, V10, P3237, DOI 10.1111/j.1462-2920.2008.01712.x
   Makita H, 2012, ARCH MICROBIOL, V194, P785, DOI 10.1007/s00203-012-0814-1
   McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Mino S, 2014, INT J SYST EVOL MICR, V64, P3195, DOI 10.1099/ijs.0.065094-0
   MORIKAWA K, 1981, J BIOCHEM-TOKYO, V89, P693, DOI 10.1093/oxfordjournals.jbchem.a133247
   Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x
   Nakamura K, 2014, PROG EARTH PLANET SC, V1, DOI 10.1186/2197-4284-1-5
   Oksanen J., 2011, VEGAN COMMUNITY ECOL, DOI DOI 10.HTTP://CRAN.R-PROJECT.ORG/PACKAGE=VEGAN
   Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10
   Oshiki M, 2013, APPL ENVIRON MICROB, V79, P4087, DOI 10.1128/AEM.00743-13
   Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124
   Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38
   Rabus R, 2014, ARCH PHYSIOL BIOCHEM, V120, P173, DOI 10.3109/13813455.2014.951658
   Roalkvam I, 2011, FEMS MICROBIOL ECOL, V78, P233, DOI 10.1111/j.1574-6941.2011.01153.x
   Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53
   Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12
   Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001
   RUBY EG, 1981, APPL ENVIRON MICROB, V42, P317, DOI 10.1128/AEM.42.2.317-324.1981
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837
   Schweinitzer T, 2010, ARCH MICROBIOL, V192, P507, DOI 10.1007/s00203-010-0575-7
   Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165
   Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07
   Sievert SM, 2007, ENVIRON MICROBIOL, V9, P271, DOI 10.1111/j.1462-2920.2006.01156.x
   Sievert SM, 2012, OCEANOGRAPHY, V25, P218, DOI 10.5670/oceanog.2012.21
   Spieck E, 2011, METHOD ENZYMOL, V486, P109, DOI [10.1016/B978-0-12-381294-0.00005-5, 10.1016/S0076-6879(11)86005-2]
   Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128
   Stokke R, 2015, ENVIRON MICROBIOL, V17, P4063, DOI 10.1111/1462-2920.12970
   Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647
   Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004
   Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005
   Takai K, 2004, INT J SYST EVOL MICR, V54, P2325, DOI 10.1099/ijs.0.63284-0
   Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999
   Thornburg CC, 2010, J NAT PROD, V73, P489, DOI 10.1021/np900662k
   Watsuji TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046282
   Watsuji T, 2010, MICROBES ENVIRON, V25, P288, DOI 10.1264/jsme2.ME10135
   Yamamoto M, 2010, ENVIRON MICROBIOL, V12, P1144, DOI 10.1111/j.1462-2920.2010.02155.x
NR 63
TC 12
Z9 13
U1 0
U2 37
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 7
PY 2016
VL 6
AR 1510
DI 10.3389/fmicb.2015.01510
PG 13
WC Microbiology
SC Microbiology
GA DA4RO
UT WOS:000367788200002
PM 26779165
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Salhi, A
   Essack, M
   Radovanovic, A
   Marchand, B
   Bougouffa, S
   Antunes, A
   Simoes, MF
   Lafi, FF
   Motwalli, OA
   Bokhari, A
   Malas, T
   Al Amoudi, S
   Othum, G
   Allam, I
   Mineta, K
   Gao, X
   Hoehndorf, R
   Archer, JAC
   Gojobori, T
   Bajic, VB
AF Salhi, Adil
   Essack, Magbubah
   Radovanovic, Aleksandar
   Marchand, Benoit
   Bougouffa, Salim
   Antunes, Andre
   Simoes, Marta Filipa
   Lafi, Feras F.
   Motwalli, Olaa A.
   Bokhari, Ameerah
   Malas, Tariq
   Al Amoudi, Soha
   Othum, Ghofran
   Allam, Intikhab
   Mineta, Katsuhiko
   Gao, Xin
   Hoehndorf, Robert
   Archer, John A. C.
   Gojobori, Takashi
   Bajic, Vladimir B.
TI DESM: portal for microbial knowledge exploration systems
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; METHANOGENIC ARCHAEA; GLYOXYLATE CYCLE;
   ISOCITRATE LYASE; DRAGON DATABASE; IDENTIFICATION; ANNOTATION;
   DIVERSITY; BACTERIAL
AB Microorganisms produce an enormous variety of chemical compounds. It is of general interest for microbiology and biotechnology researchers to have means to explore information about molecular and genetic basis of functioning of different microorganisms and their ability for bioproduction. To enable such exploration, we compiled 45 topic-specific knowledgebases (KBs) accessible through DESM portal (www.cbrc.kaust.edu.sa/desm). The KBs contain information derived through text-mining of PubMed information and complemented by information data-mined from various other resources (e.g. ChEBI, Entrez Gene, GO, KOBAS, KEGG, UniPathways, BioGrid). All PubMed records were indexed using 4 538 278 concepts from 29 dictionaries, with 1 638 986 records utilized in KBs. Concepts used are normalized whenever possible. Most of the KBs focus on a particular type of microbial activity, such as production of biocatalysts or nutraceuticals. Others are focused on specific categories of microorganisms, e.g. streptomyces or cyanobacteria. KBs are all structured in a uniform manner and have a standardized user interface. Information exploration is enabled through various searches. Users can explore statistically most significant concepts or pairs of concepts, generate hypotheses, create interactive networks of associated concepts and export results. We believe DESM will be a useful complement to the existing resources to benefit microbiology and biotechnology research.
C1 [Salhi, Adil; Essack, Magbubah; Radovanovic, Aleksandar; Bougouffa, Salim; Antunes, Andre; Simoes, Marta Filipa; Motwalli, Olaa A.; Malas, Tariq; Al Amoudi, Soha; Othum, Ghofran; Allam, Intikhab; Mineta, Katsuhiko; Gao, Xin; Hoehndorf, Robert; Archer, John A. C.; Gojobori, Takashi; Bajic, Vladimir B.] KAUST, CBRC, Thuwal 239556900, Saudi Arabia.
   [Marchand, Benoit] NYU, Abu Dhabi, U Arab Emirates.
   [Lafi, Feras F.; Bokhari, Ameerah] KAUST, CDA, Thuwal 239556900, Saudi Arabia.
   [Lafi, Feras F.; Bokhari, Ameerah; Gojobori, Takashi] KAUST, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia.
   [Mineta, Katsuhiko; Gao, Xin; Hoehndorf, Robert; Archer, John A. C.; Bajic, Vladimir B.] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal 239556900, Saudi Arabia.
RP Bajic, VB (reprint author), KAUST, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal 239556900, Saudi Arabia.
EM vladimir.bajic@kaust.edu.sa
RI Bougouffa, Salim/AAG-8976-2020; Hoehndorf, Robert/A-9943-2011; Simoes,
   Marta Filipa/M-4917-2013; Hoehndorf, Robert/H-6127-2019; Lafi,
   Feras/M-5946-2019; Mineta, Katsuhiko/A-5455-2012; Antunes,
   Andre/A-8711-2012; Essack, Magbubah/R-2773-2019; Gao, Xin/D-5487-2013;
   Bajic, Vladimir/D-2810-2009; Lafi, Feras/P-4776-2016; Archer,
   John/D-5200-2012; Essack, Magbubah/G-5008-2013
OI Bougouffa, Salim/0000-0001-9218-6452; Hoehndorf,
   Robert/0000-0001-8149-5890; Simoes, Marta Filipa/0000-0002-8767-9487;
   Hoehndorf, Robert/0000-0001-8149-5890; Lafi, Feras/0000-0001-6468-4104;
   Mineta, Katsuhiko/0000-0002-4727-045X; Antunes,
   Andre/0000-0001-7668-9842; Gao, Xin/0000-0002-7108-3574; Bajic,
   Vladimir/0000-0001-5435-4750; Lafi, Feras/0000-0001-6468-4104; Al
   Amoudi, Soha/0000-0003-1028-7634; Essack, Magbubah/0000-0003-2709-5356
FU King Abdullah University of Science and Technology (KAUST) in Saudi
   Arabia; King Abdullah University of Science and Technology (KAUST)King
   Abdullah University of Science & Technology
FX Competitive research funding from King Abdullah University of Science
   and Technology (KAUST) in Saudi Arabia. Funding for open access charge:
   King Abdullah University of Science and Technology (KAUST).
CR Amato P, 2009, APPL ENVIRON MICROB, V75, P711, DOI 10.1128/AEM.02193-08
   Bang C, 2015, FEMS MICROBIOL REV, V39, P631, DOI 10.1093/femsre/fuv010
   Bekhuis Tanja, 2006, Biomed Digit Libr, V3, P2, DOI 10.1186/1742-5581-3-2
   Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179
   Bougouffa S., 2014, DATABASE J BIOL DATA, V2014
   Bouma G., 2009, P BIENN GSCL C, V2009, P31
   Bourdichon F, 2012, INT J FOOD MICROBIOL, V154, P87, DOI 10.1016/j.ijfoodmicro.2011.12.030
   CARON DA, 1994, MICROBIAL ECOL, V28, P295, DOI 10.1007/BF00166820
   Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   Dawe AS, 2012, REPROD TOXICOL, V33, P99, DOI 10.1016/j.reprotox.2011.12.007
   de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011
   Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0
   Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003
   Eme L, 2015, CURR BIOL, V25, pR227, DOI 10.1016/j.cub.2014.12.044
   Essack M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-219
   Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9
   Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146
   He JZ, 2015, FOLIA MICROBIOL, V60, P69, DOI 10.1007/s12223-014-0342-2
   Horz HP, 2015, ANAEROBE, V35, P10, DOI 10.1016/j.anaerobe.2015.02.008
   Idnurm A, 2002, EUKARYOT CELL, V1, P719, DOI 10.1128/EC.1.5.719-724.2002
   Kanehisa Minoru, 2013, Methods Mol Biol, V939, P263, DOI 10.1007/978-1-62703-107-3_17
   Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051
   Karp PD, 2015, METABOLITES, V5, P291, DOI 10.3390/metabo5020291
   Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593
   Kibbler CC, 2003, J HOSP INFECT, V54, P18, DOI 10.1016/S0195-6701(03)00085-9
   Kulik EM, 2001, FEMS MICROBIOL LETT, V196, P129, DOI 10.1111/j.1574-6968.2001.tb10553.x
   Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983
   Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101
   Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975
   Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594
   Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237
   Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849
   McLaughlin MJ, 2014, PM&R, V6, P544, DOI 10.1016/j.pmrj.2014.04.006
   Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078
   Morgat A, 2012, NUCLEIC ACIDS RES, V40, pD761, DOI 10.1093/nar/gkr1023
   Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   Park I, 2012, ASIAN AUSTRAL J ANIM, V25, P852, DOI 10.5713/ajas.2011.11501
   Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241
   Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388
   Sagar S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-11
   Sagar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-622
   Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104
   Sasaya T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00409
   Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Vidali M, 2001, PURE APPL CHEM, V73, P1163, DOI 10.1351/pac200173071163
   Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x
   WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982
   Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483
   Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30
NR 52
TC 8
Z9 8
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 4
PY 2016
VL 44
IS D1
BP D624
EP D633
DI 10.1093/nar/gkv1147
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DF3QY
UT WOS:000371261700088
PM 26546514
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT S
AU Salfa, MC
   Suligoi, B
AF Salfa, Maria Cristina
   Suligoi, Barbara
CA Italian STI Lab Based Surveillance
BE Donelli, G
TI Prevalence of Chlamydia trachomatis, Trichomonas vaginalis and Neisseria
   gonorrhoeae Based on Data Collected by a Network of Clinical
   Microbiology Laboratories, in Italy
SO ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 2
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Prevalence; Microbiology laboratories; Chlamydia trachomatis;
   Trichomonas vaginalis; Neisseria gonorrhoeae; Risk factors
ID SEXUALLY-TRANSMITTED INFECTIONS; RISK-FACTORS; WOMEN; EPIDEMIOLOGY;
   BRAZIL
AB Bacterial and protozoal sexually transmitted infections (STIs), such as Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae, may cause acute symptoms, chronic infections and severe long-term complications. The complications of these infections in women include pelvic inflammatory disease, chronic pelvic pain, tubal infertility, ectopic pregnancy, and infertility. Moreover, infection during pregnancy is associated with premature rupture of the membranes, low birth weight and miscarriage.
   In Italy, Chlamydia trachomatis and Trichomonas vaginalis infections are not subject to mandatory reporting; while gonorrhoea is subject to mandatory reporting.
   To extend surveillance to STIs that are widespread yet often asymptomatic and to improve the knowledge on the epidemiology of these infections in Italy, in 2009 the "Centro Operativo AIDS of the Istituto Superiore di Sanita", in collaboration with the Association of Italian Clinical Microbiologists (AMCLI, Associazione Microbiologi Clinici Italiani), launched the sentinel STIs surveillance system based on a network of 13 clinical microbiology laboratories.
   The main objective of the surveillance was to assess the prevalence and risk factors associated with Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoea infections among individuals attending microbiology laboratories in Italy.
C1 [Salfa, Maria Cristina; Suligoi, Barbara] Ist Super Sanita, Ctr Operat AIDS, Dipartimento Malattie Infett Parassitarie & Immun, Rome, Italy.
RP Salfa, MC (reprint author), Ist Super Sanita, Ctr Operat AIDS, Dipartimento Malattie Infett Parassitarie & Immun, Rome, Italy.
EM mariacristina.salfa@iss.it; barbara.suligoi@iss.it
RI SULIGOI, BARBARA/O-6490-2019; Tagliaferro, Luigi/X-1818-2019; SULIGOI,
   BARBARA/C-6494-2016
OI Tagliaferro, Luigi/0000-0002-4411-0717
CR Adams EJ, 2004, SEX TRANSM INFECT, V80, P354, DOI 10.1136/sti.2003.005454
   Barbosa MJ, 2010, REV SOC BRAS MED TRO, V43, P500, DOI 10.1590/S0037-86822010000500005
   Desai S, 2011, SEX HEALTH, V8, P120, DOI 10.1071/SH10036
   European Centre for Disease Prevention and Control (ECDC), 2014, SEX TRANSM INF EUR 1
   Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415
   Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6
   Geelen TH, 2013, SEX TRANSM INFECT, V89, P532, DOI 10.1136/sextrans-2012-051010
   Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752
   Grama DF, 2013, T ROY SOC TROP MED H, V107, P584, DOI 10.1093/trstmh/trt063
   GRECO D, 1990, GENITOURIN MED, V66, P383
   Grio R, 2004, Minerva Ginecol, V56, P401
   Kucinskiene Vesta, 2006, Medicina (Kaunas), V42, P885
   Mitchell HD, 2014, EPIDEMIOL INFECT, V142, P1678, DOI 10.1017/S0950268813002902
   Navarro Christine, 2002, Can J Infect Dis, V13, P195
   Piperaki ET, 2010, J CLIN PATHOL, V63, P249, DOI 10.1136/jcp.2009.070920
   Poole DN, 2013, SEX TRANSM INFECT, V89, P418, DOI 10.1136/sextrans-2013-051075
   Rao GG, 2008, SEX TRANSM INFECT, V84, P117, DOI 10.1136/sti.2007.026914
   Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753
   Salfa MC, 2011, EPIDEMIOL BIOSTAT PU, V8, P295
   Salfa MC, 2015, NOT I SUPER SANITA, V28, P3
   Samarawickrema N, 2014, INT J STD AIDS
   Stevens-Simon Catherine, 2005, J Pediatr Adolesc Gynecol, V18, P231, DOI 10.1016/j.jpag.2005.05.002
   Sutton M, 2007, CID, V45
   Sviben M, 2015, SEX TRANSM INFECT, V91, P360, DOI 10.1136/sextrans-2014-051771
   Uddin RNN, 2011, SEX HEALTH, V8, P65, DOI 10.1071/SH09147
   Verteramo R, 2008, J OBSTET GYNAECOL RE, V34, P233, DOI 10.1111/j.1447-0756.2007.00692.x
   Wangnapi RA, 2015, SEX TRANSM INFECT, V91, P194, DOI 10.1136/sextrans-2014-051670
   Wilson JS, 2002, HUM REPROD UPDATE, V8, P385, DOI 10.1093/humupd/8.4.385
   World Health Organization, 2012, GLOB INC PREV CUR SE
NR 29
TC 6
Z9 6
U1 1
U2 1
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-3-319-27935-0; 978-3-319-27934-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2016
VL 901
BP 47
EP 57
DI 10.1007/5584_2015_5015
D2 10.1007/978-3-319-27935-0
PG 11
WC Biology; Public, Environmental & Occupational Health; Infectious
   Diseases; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Public, Environmental &
   Occupational Health; Infectious Diseases; Research & Experimental
   Medicine
GA BL0JT
UT WOS:000446015100005
PM 26691509
DA 2020-05-07
ER

PT S
AU Kauffmann-Lacroix, C
   Costa, D
   Imbert, C
AF Kauffmann-Lacroix, Catherine
   Costa, Damien
   Imbert, Christine
BE Imbert, C
TI Fungi, Water Supply and Biofilms
SO FUNGAL BIOFILMS AND RELATED INFECTIONS - ADVANCES IN MICROBIOLOGY,
   INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 3
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID DENTAL UNIT WATERLINES; FILAMENTOUS FUNGI; DRINKING-WATER; HOSPITAL
   WATER; TAP-WATER; MYCOLOGICAL CONTAMINATION; INVASIVE ASPERGILLOSIS;
   SPECIES IDENTIFICATION; HEMODIALYSIS UNITS; DIALYSIS WATER
AB Even though it has been studied for many years, water-related infectious risk still exists in both care and community environments due to the possible presence of numerous microorganisms such as bacteria, fungi and protists. People can be exposed directly to these microorganisms either through aerosols and water, after ingestion, inhalation, skin contact and entry through mucosal membranes, or indirectly usually due to pre-treatment of some medical devices. Species belonging to genera such as Aspergillus, Penicillium, Pseudallesheria, Fusarium, Cuninghamella, Mucor and in some particular cases Candida have been isolated in water from health facilities and their presence is particularly related to the unavoidable formation of a polymicrobial biofilm in waterlines. Fungi isolation methods are based on water filtration combined with conventional microbiology cultures and/or molecular approaches; unfortunately, these are still poorly standardized. Moreover, due to inappropriate culture media and inadequate sampling volumes, the current standardized methods used for bacterial research are not suitable for fungal search. In order to prevent water-related fungal risk, health facilities have implemented measures such as ultraviolet radiation to treat the input network, continuous chemical treatment, chemical or thermal shock treatments, or microfiltration at points of use. This article aims to provide an overviewof fungal colonization ofwater (especially in hospitals), involvement of biofilms that develop in waterlines and application of preventive strategies.
C1 [Kauffmann-Lacroix, Catherine] UBM, CHU Poitiers, Lab Parasitol & Mycol Med, 2 Rue Miletrie, F-86021 Poitiers, France.
   [Costa, Damien; Imbert, Christine] UBM, CHU Poitiers, Lab Parasitol & Mycol Med, 2 Rue Miletrie,BP577, F-86021 Poitiers, France.
   [Costa, Damien; Imbert, Christine] Univ Poitiers, UFR Med Pharm, Lab Ecol Biol Interact EBI, Equipe Microbiol Eau,CNRS,UMR 7267, Bat D1,6 Rue Miletrie,TSA 51115, F-86073 Poitiers, France.
RP Kauffmann-Lacroix, C (reprint author), UBM, CHU Poitiers, Lab Parasitol & Mycol Med, 2 Rue Miletrie, F-86021 Poitiers, France.
EM c.lacroix@chu-poitiers.fr
RI costa, damien/AAL-4465-2020
CR Anaissie EJ, 2001, CLIN INFECT DIS, V33, P1546, DOI 10.1086/322967
   Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530
   Anaissie EJ, 2002, CLIN INFECT DIS, V34, P780, DOI 10.1086/338958
   Ao JH, 2014, MYCOPATHOLOGIA, V177, P51, DOI 10.1007/s11046-013-9697-1
   Arvanitidou M, 2000, J HOSP INFECT, V45, P225, DOI 10.1053/jhin.2000.0763
   Arvanitidou M, 1999, LETT APPL MICROBIOL, V29, P81, DOI 10.1046/j.1365-2672.1999.00583.x
   Balajee SA, 2007, STUD MYCOL, P39, DOI 10.3114/sim.2007.59.05
   Barbot V, 2012, FEMS IMMUNOL MED MIC, V65, P196, DOI 10.1111/j.1574-695X.2012.00971.x
   Barbot V, 2011, FEMS MICROBIOL LETT, V324, P17, DOI 10.1111/j.1574-6968.2011.02379.x
   Bolasco P, 2012, BLOOD PURIFICAT, V34, P238, DOI 10.1159/000343127
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   Coleman DC, 2014, WOODH PUBL SER BIOM, V62, P166, DOI 10.1533/9780857096692.2.166
   Costa Damien, 2013, European Journal of Water Quality, V44, P113, DOI 10.1051/wqual/2014004
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   delaCamara R, 1996, BONE MARROW TRANSPL, V18, P1189
   Egli A, 2012, TRANSPLANTATION, V94, P403, DOI 10.1097/TP.0b013e31825992f0
   Etienne KA, 2011, J HOSP INFECT, V79, P344, DOI 10.1016/j.jhin.2011.06.012
   Figel IC, 2013, MYCOPATHOLOGIA, V175, P413, DOI 10.1007/s11046-013-9633-4
   Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9
   Gangneux JP, 2002, PRESSE MED, V31, P841
   Goncalves AB, 2006, INT J HYG ENVIR HEAL, V209, P257, DOI 10.1016/j.ijheh.2005.12.001
   Gottlich E, 2002, INT J HYG ENVIR HEAL, V205, P269, DOI 10.1078/1438-4639-00158
   Hageskal G, 2007, J APPL MICROBIOL, V102, P774, DOI 10.1111/j.1365-2672.2006.03119.x
   Hageskal G, 2006, APPL ENVIRON MICROB, V72, P7586, DOI 10.1128/AEM.01628-06
   Heinrichs G, 2013, MYCOPATHOLOGIA, V175, P399, DOI 10.1007/s11046-013-9619-2
   HINZELIN F, 1985, ENVIRON TECHNOL LETT, V6, P101, DOI 10.1080/09593338509384324
   Kadaifciler DG, 2013, BRAZ J MICROBIOL, V44, P977, DOI 10.1590/S1517-83822013000300049
   Kauffmann-Lacroix C, 2008, PRESSE MED, V37, P751, DOI 10.1016/j.lpm.2007.09.015
   Kumar S, 2010, J HOSP INFECT, V74, P99, DOI 10.1016/j.jhin.2009.03.027
   Kwon-Chung KJ, 2009, TRENDS MICROBIOL, V17, P481, DOI 10.1016/j.tim.2009.08.004
   Lisboa Guacyra M, 2014, Acta odontol. latinoam., V27, P110, DOI 10.1590/S1852-48342014000300002
   Locatelli F, 2010, J AM SOC NEPHROL, V21, P1798, DOI 10.1681/ASN.2010030280
   Mesquita-Rocha S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-289
   Ministeres des solidarites dlsedlf DGS/ DHOS, 2005, EAU EST SANT GUID TE
   Nucci M, 2002, CLIN INFECT DIS, V34, P1475, DOI 10.1086/340344
   O'Donnell MJ, 2011, FUTURE MICROBIOL, V6, P1209, DOI [10.2217/fmb.11.104, 10.2217/FMB.11.104]
   Oliveira BR, 2013, WATER RES, V47, P6338, DOI 10.1016/j.watres.2013.08.004
   Panagopoulou P, 2007, INFECT CONT HOSP EP, V28, P60, DOI 10.1086/508832
   Pires-Goncalves RH, 2008, LETT APPL MICROBIOL, V46, P542, DOI 10.1111/j.1472-765X.2008.02349.x
   Proia LA, 2004, CLIN INFECT DIS, V39, P373, DOI 10.1086/422320
   Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521
   Rao CY, 2009, INFECT CONT HOSP EP, V30, P840, DOI 10.1086/605324
   Roe AD, 2010, MOL ECOL RESOUR, V10, P946, DOI 10.1111/j.1755-0998.2010.02844.x
   Sammon NB, 2010, INT J ENV RES PUB HE, V7, P1597, DOI 10.3390/ijerph7041597
   Samson RA, 2014, STUD MYCOL, V78, P1
   Schelenz S, 2015, LANCET INFECT DIS, V15, P461, DOI 10.1016/S1473-3099(15)70006-X
   Schiavano GF, 2014, J HOSP INFECT, V86, P194, DOI 10.1016/j.jhin.2013.11.010
   Simoes LC, 2015, BIOFOULING, V31, P349, DOI 10.1080/08927014.2015.1042873
   Siqueira VM, 2011, INT J ENV RES PUB HE, V8, P456, DOI 10.3390/ijerph8020456
   Squier, 2000, Curr Infect Dis Rep, V2, P490, DOI 10.1007/s11908-000-0049-1
   Szymanska J, 2005, ANN AGR ENV MED, V12, P157
   Szymanska J, 2005, ANN AGR ENV MED, V12, P153
   Szymanska J, 2003, ANN AGR ENV MED, V10, P151
   Tintelnot K, 2008, MYCOSES, V51, P11, DOI 10.1111/j.1439-0507.2008.01579.x
   Unal A, 2011, THER APHER DIAL, V15, P115, DOI 10.1111/j.1744-9987.2010.00852.x
   VandenBergh MFQ, 1999, DIAGN MICR INFEC DIS, V34, P221, DOI 10.1016/S0732-8893(99)00026-7
   Vanessa B, 2012, WATER RES, V46, P5707, DOI 10.1016/j.watres.2012.07.054
   Varo SD, 2007, REV SOC BRAS MED TRO, V40, P326, DOI 10.1590/S0037-86822007000300015
   Warris A, 2010, J HOSP INFECT, V76, P56, DOI 10.1016/j.jhin.2010.03.014
   Warris A, 2002, CLIN INFECT DIS, V34, P1159, DOI 10.1086/339754
   Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003
   Warris A, 2001, J HOSP INFECT, V47, P143, DOI 10.1053/jhin.2000.0876
   Warris Adilia, 2001, Revista Iberoamericana de Micologia, V18, P156
   Williams H N, 1995, Quintessence Int, V26, P331
NR 64
TC 3
Z9 3
U1 1
U2 7
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-3-319-42360-9; 978-3-319-42359-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2016
VL 931
BP 49
EP 61
DI 10.1007/5584_2016_8
D2 10.1007/978-3-319-42360-9
PG 13
WC Biology; Public, Environmental & Occupational Health; Infectious
   Diseases; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Public, Environmental &
   Occupational Health; Infectious Diseases; Research & Experimental
   Medicine
GA BL2HE
UT WOS:000448957400005
PM 27167410
DA 2020-05-07
ER

PT J
AU Carbotti, G
   Barisione, G
   Airoldi, I
   Mezzanzanica, D
   Bagnoli, M
   Ferrero, S
   Petretto, A
   Fabbi, M
   Ferrini, S
AF Carbotti, Grazia
   Barisione, Gaia
   Airoldi, Irma
   Mezzanzanica, Delia
   Bagnoli, Marina
   Ferrero, Simone
   Petretto, Andrea
   Fabbi, Marina
   Ferrini, Silvano
TI IL-27 induces the expression of IDO and PD-L1 in human cancer cells
SO ONCOTARGET
LA English
DT Article
DE IL-27; IDO; PD-L1; STAT; Immunology and Microbiology Section; Immune
   response; Immunity
ID OVARIAN-CANCER; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE SUPPRESSION;
   IFN-GAMMA; T-CELLS; INTERFERON-GAMMA; IL-12 FAMILY; TUMOR-CELLS;
   INTERLEUKIN-27; ANTITUMOR
AB IL-27 is a member of the IL-12 family that is produced by macrophages and dendritic cells. IL-27 inhibits the growth and invasiveness of different cancers and therefore represents a potential anti-tumor agent. By contrast, it may exert immune-regulatory properties in different biological systems. We reported that IL-27 induces the expression of the IL-18 inhibitor IL-18BP, in human Epithelial Ovarian Cancer (EOC) cells, thus potentially limiting the immune response. Here, we tested whether IL-27 may modulate other immune-regulatory molecules involved in EOC progression, including Indoleamine 2,3-dioxygenase (IDO) and Programmed Death-Ligand (PDL) 1. IDO and PD-L1 were not constitutively expressed by EOC cells in vitro, but IL-27 increased their expression through STAT1 and STAT3 tyrosine phosphorylation. Differently, cells isolated from EOC ascites showed constitutive activation of STAT1 and STAT3 and IDO expression. These findings, together with the expression of IL-27 in scattered leukocytes in EOC ascites and tissues, suggest a potential role of IL-27 in immune-regulatory networks of EOC. In addition, IL-27 induced IDO or PD-L1 expression in monocytes and in human PC3 prostate and A549 lung cancer cells. A current paradigm in tumor immunology is that tumor cells may escape from immune control due to "adaptive resistance" mediated by T cell-secreted IFN-gamma, which induces PD-L1 and IDO expression in tumor cells. Our present data indicate that also IL-27 has similar activities and suggest that the therapeutic use of IL-27 as anti-cancer agent may have dual effects, in some tumors.
C1 [Carbotti, Grazia; Barisione, Gaia; Fabbi, Marina; Ferrini, Silvano] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Dept Integrated Oncol Therapies, Genoa, Italy.
   [Airoldi, Irma] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy.
   [Mezzanzanica, Delia; Bagnoli, Marina] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.
   [Ferrero, Simone] Univ Genoa, IRCCS AOU San Martino IST Ist Nazl Ric Canc, Dept Surg, Unit Obstet & Gynaecol, Genoa, Italy.
   [Ferrero, Simone] Univ Genoa, DINOGMI, Genoa, Italy.
   [Petretto, Andrea] Ist Giannina Gaslini, Core Facil, I-16148 Genoa, Italy.
RP Ferrini, S (reprint author), IRCCS AOU San Martino IST Ist Nazl Ric Canc, Dept Integrated Oncol Therapies, Genoa, Italy.
EM marina.fabbi@hsanmartino.it; silvanodomenico.ferrini@hsanmartino.it
RI Bagnoli, Marina/K-4773-2018; Fabbi, Marina/K-3917-2016; airoldi,
   irma/I-6169-2017; Ferrero, Simone/A-9493-2012; Petretto,
   Andrea/AAA-7342-2020; Carbotti, Grazia/AAB-2726-2020; Mezzanzanica,
   Delia/C-2607-2017
OI airoldi, irma/0000-0002-4352-8396; Ferrero, Simone/0000-0003-2225-5568;
   Mezzanzanica, Delia/0000-0002-9664-6871; Petretto,
   Andrea/0000-0001-7811-8517; BARISIONE, GAIA/0000-0001-6290-7503;
   Carbotti, Grazia/0000-0003-4504-1925; Ferrini,
   Silvano/0000-0001-7254-2616; Fabbi, Marina/0000-0002-4203-2022; Bagnoli,
   Marina/0000-0001-7655-4630
FU AIRC (Associazione Italiana per la Ricerca sul Cancro)Associazione
   Italiana per la Ricerca sul Cancro (AIRC) [IG5509, IG13018, IG13518];
   Italian Ministry of HealthMinistry of Health, Italy; Compagnia di San
   PaoloCompagnia di San Paolo; FIRC (Fondazione Italiana per la Ricerca
   sul Cancro)Associazione Italiana per la Ricerca sul Cancro (AIRC)
   [16497]
FX Financial support: AIRC (Associazione Italiana per la Ricerca sul
   Cancro, IG5509, IG13018 and IG13518), Italian Ministry of Health (5 x
   1000 Funds 2011 and 2012) and Compagnia di San Paolo.; Grazia Carbotti
   is recipient of FIRC (Fondazione Italiana per la Ricerca sul Cancro)
   triennial fellowship 16497.
CR Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101
   Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199
   Airoldi I, 2015, ONCOTARGET, V6, P3694, DOI 10.18632/oncotarget.2797
   Anglesio MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072162
   Aparicio-Siegmund S, 2015, CYTOKINE GROWTH F R, V26, P579, DOI 10.1016/j.cytogfr.2015.07.008
   Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541
   Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752
   Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375
   Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694
   Canale S, 2011, LEUKEMIA, V25, P1815, DOI 10.1038/leu.2011.158
   Carbotti G, 2013, CLIN CANCER RES, V19, P4611, DOI 10.1158/1078-0432.CCR-13-0568
   Chiba Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076159
   Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848
   Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247
   Cocco C, 2010, CLIN CANCER RES, V16, P4188, DOI 10.1158/1078-0432.CCR-10-0173
   Croce M, 2015, J IMMUNOL RES, DOI 10.1155/2015/696578
   Di Carlo E, 2014, ONCOTARGET, V5, P10332, DOI 10.18632/oncotarget.1425
   Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126
   Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208
   Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550
   Eggermont A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27560
   Fabbi M, 2015, J LEUKOCYTE BIOL, V97, P665, DOI 10.1189/jlb.5RU0714-360RR
   Fang WF, 2014, ONCOTARGET, V5, P12189, DOI 10.18632/oncotarget.2608
   FERRINI S, 1985, INT J CANCER, V36, P337
   Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104
   Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433
   Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024
   Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084
   Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272
   Inaba T, 2009, GYNECOL ONCOL, V115, P185, DOI 10.1016/j.ygyno.2009.07.015
   Ino K, 2011, CURR OPIN OBSTET GYN, V23, P13, DOI 10.1097/GCO.0b013e3283409c79
   Kharma B, 2014, CANCER RES, V74, P6519, DOI 10.1158/0008-5472.CAN-14-0847
   Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274
   Lavoue V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-147
   LEUNG BS, 1992, CANCER LETT, V66, P77, DOI 10.1016/0304-3835(92)90283-2
   Li MS, 2015, IMMUNOTHERAPY-UK, V7, P191, DOI 10.2217/imt.14.95
   Litzenburger UM, 2014, ONCOTARGET, V5, P1038, DOI 10.18632/oncotarget.1637
   Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100
   Maine CJ, 2014, CANCER IMMUNOL IMMUN, V63, P215, DOI 10.1007/s00262-013-1503-x
   Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295
   Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105
   Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695
   Munn DH, 2011, CURR MED CHEM, V18, P2240, DOI 0929-8673/11 $58.00+.00
   Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x
   Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8
   Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001
   Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087
   Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239
   Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2
   Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]
   Qian F, 2009, CANCER RES, V69, P5498, DOI 10.1158/0008-5472.CAN-08-2106
   Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170
   Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102
   Sekar D, 2012, EUR J IMMUNOL, V42, P1585, DOI 10.1002/eji.201142093
   Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317
   Sotero-Esteva WD, 2000, J INTERF CYTOK RES, V20, P623, DOI 10.1089/107999000414790
   Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504
   Swarbrick A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25409
   Tanizaki Y, 2014, CANCER SCI, V105, P966, DOI 10.1111/cas.12445
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6
   Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954
   Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934
   Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366
   Webb JR, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27668
   Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527
   Yu JP, 2014, J IMMUNOL, V193, P2574, DOI 10.4049/jimmunol.1400833
   Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164
   Zorzoli A, 2012, CLIN CANCER RES, V18, P1630, DOI 10.1158/1078-0432.CCR-11-2432
NR 69
TC 44
Z9 44
U1 3
U2 18
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD DEC 22
PY 2015
VL 6
IS 41
BP 43267
EP 43280
DI 10.18632/oncotarget.6530
PG 14
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DD4QU
UT WOS:000369908400011
PM 26657115
OA Green Published, Bronze, Other Gold
DA 2020-05-07
ER

PT J
AU Sastry, S
   Clarke, LG
   Alrowais, H
   Querry, AM
   Shutt, KA
   Doi, Y
AF Sastry, Sangeeta
   Clarke, Lloyd G.
   Alrowais, Hind
   Querry, Ashley M.
   Shutt, Kathleen A.
   Doi, Yohei
TI Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID URINARY-TRACT-INFECTIONS; EPIDEMIOLOGY; SURVEILLANCE; ANTIBIOTICS;
   PREVALENCE; BACTERIA; CYSTITIS; OUTCOMES; ADULTS; BLOOD
AB Fosfomycin is recommended as one of the first-line agents for treatment of urinary tract infections (UTIs) in the latest guidelines endorsed by the Infectious Diseases Society of America (IDSA) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). We evaluated the use of fosfomycin among inpatients at a tertiary care hospital between 2009 and 2013. UTI cases were defined using physician diagnosis and the National Healthcare Safety Network (NHSN) surveillance definitions. The number of patients treated with fosfomycin increased from none in 2009 to 391 in 2013. Among 537 patients who received fosfomycin for any indication during this period, UTI was the most common indication (74%), followed by asymptomatic bacteriuria (10%). All except 19 patients received a single dose of fosfomycin. Escherichia coli was the most common organism involved (52%). For 119 patients with UTIs, after exclusion of those with negative urine culture results, negative urinalysis results, receipt of additional agents, or indeterminate clinical outcomes, the clinical success rate at 48 h was 74.8%. Of 89 patients who met the criteria for NHSN-defined UTIs, 89.9% had successful outcomes. Recurrent infections occurred in 4.3% of cases, and mild adverse events were observed in 2.0%. All 100 randomly selected extended-spectrum beta-lactamase (ESBL)-producing E. coli clinical isolates from this period were susceptible to fosfomycin. In conclusion, the use of fosfomycin has increased substantially since implementation of the updated guidelines at this hospital. Fosfomycin was used mainly for the treatment of physician-diagnosed UTIs, and the clinical outcomes were generally favorable. Fosfomycin maintained activity against E. coli despite the increased use of the agent.
C1 [Sastry, Sangeeta; Alrowais, Hind; Shutt, Kathleen A.; Doi, Yohei] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15260 USA.
   [Clarke, Lloyd G.] Univ Pittsburgh, Med Ctr, Dept Pharm & Therapeut, Antibiot Management Program, Pittsburgh, PA USA.
   [Querry, Ashley M.] Univ Pittsburgh, Med Ctr, Dept Infect Control & Hosp Epidemiol, Pittsburgh, PA USA.
RP Doi, Y (reprint author), Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15260 USA.
EM yod4@pitt.edu
OI Doi, Yohei/0000-0002-9620-2525; Shutt, Kathleen/0000-0003-3376-6152
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI104895,
   R21AI107302]; Merck Co.Merck & Company
FX The efforts of Y.D. were supported by research grants from the National
   Institutes of Health (grants R01AI104895 and R21AI107302).; Y.D. has
   served on an advisory board for Shionogi Inc., has consulted for Melinta
   Therapeutics, and received research funding from Merck & Co. for a study
   unrelated to this work. All other authors declare no potential conflicts
   of interest.
CR Castaneda-Garcia A, 2013, ANTIBIOTICS-BASEL, V2, P217, DOI 10.3390/antibiotics2020217
   Centers for Disease Control and Prevention, 2015, UR TRACT INF CATH AS
   Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUSC
   Endimiani A, 2010, ANTIMICROB AGENTS CH, V54, P526, DOI 10.1128/AAC.01235-09
   Falagas ME, 2010, J ANTIMICROB CHEMOTH, V65, P1862, DOI 10.1093/jac/dkq237
   FOXMAN B, 2002, AM J MED, V113, P5, DOI DOI 10.1016/S0002-9343(02)01054-9
   Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190
   Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007
   Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI 10.1093/cid/ciq257
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Ho PL, 2013, J MED MICROBIOL, V62, P1707, DOI 10.1099/jmm.0.062653-0
   Johnson JR, 2013, ANTIMICROB AGENTS CH, V57, P4856, DOI 10.1128/AAC.00650-13
   Karageorgopoulos DE, 2012, J ANTIMICROB CHEMOTH, V67, P255, DOI 10.1093/jac/dkr466
   Karlowsky JA, 2014, ANTIMICROB AGENTS CH, V58, P1252, DOI 10.1128/AAC.02399-13
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007
   MORONI M, 1987, EUR UROL, V13, P101
   Neuner EA, 2012, ANTIMICROB AGENTS CH, V56, P5744, DOI 10.1128/AAC.00402-12
   Pontikis K, 2014, INT J ANTIMICROB AG, V43, P52, DOI 10.1016/j.ijantimicag.2013.09.010
   Qiao LD, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004157
   RODRIGUEZ A, 1977, CHEMOTHERAPY, V23, P247, DOI 10.1159/000222055
   Sanchez GV, 2012, ANTIMICROB AGENTS CH, V56, P2181, DOI 10.1128/AAC.06060-11
   Sorlozano A, 2014, AM J INFECT CONTROL, V42, P1033, DOI 10.1016/j.ajic.2014.06.013
   van Duin D, 2015, J ANTIMICROB CHEMOTH, V70, P1203, DOI 10.1093/jac/dku495
   Wachino J, 2010, ANTIMICROB AGENTS CH, V54, P3061, DOI 10.1128/AAC.01834-09
NR 25
TC 19
Z9 22
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD DEC
PY 2015
VL 59
IS 12
BP 7355
EP 7361
DI 10.1128/AAC.01071-15
PG 7
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA DB2KO
UT WOS:000368337300024
PM 26369978
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Vidal, E
   Cervera, C
   Cordero, E
   Arminanzas, C
   Carratala, J
   Cisneros, JM
   Farinas, MC
   Lopez-Medrano, F
   Moreno, A
   Munoz, P
   Origuen, J
   Sabe, N
   Valerio, M
   Torre-Cisneros, J
AF Vidal, Elisa
   Cervera, Carlos
   Cordero, Elisa
   Arminanzas, Carlos
   Carratala, Jordi
   Miguel Cisneros, Jose
   Farinas, M. Carmen
   Lopez-Medrano, Francisco
   Moreno, Asuncion
   Munoz, Patricia
   Origueen, Julia
   Sabe, Nuria
   Valerio, Maricela
   Torre-Cisneros, Julian
CA Study Grp Infect Transplant Recipi
   Spanish Soc Infect Dis Clinical Mi
   Spanish Network Res Infect Dis REI
TI Executive summary. Management of urinary tract infection in solid organ
   transplant recipients: Consensus statement of the Group for the Study of
   Infection in Transplant Recipients (GESITRA) of the Spanish Society of
   Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish
   Network for Research in Infectious Diseases (REIPI)
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Urinary infection; Transplantation; Consensus; Prophylaxis; Treatment
AB Urinary tract infections (UTI) are one of the most common infections in solid organ transplant (SOT) recipients. A systematic review was performed to assess the management of UTI in SOT recipients.
   Recommendations are provided on the management of asymptomatic bacteriuria, and prophylaxis and treatment of UTI in SOT recipients. The diagnostic-therapeutic management of recurrent UTI and the role of infection in kidney graft rejection or dysfunction are reviewed. Finally, recommendations on antimicrobials and immunosuppressant interactions are also included. (C) 2015 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Vidal, Elisa; Torre-Cisneros, Julian] Univ Cordoba, Unidad Clin Gest Enfermedades Infecciosas, Inst Maimonides Invest Biomed Cordoba, Hosp Univ Reina Sofia, Cordoba, Spain.
   [Cervera, Carlos; Moreno, Asuncion] Univ Barcelona, Serv Enfermedades Infecciosas, Hosp Clin Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain.
   [Cordero, Elisa] Univ Seville, Unidad Clin Gest Enfermedades Infecciosas Microbi, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Seville, Spain.
   [Arminanzas, Carlos; Farinas, M. Carmen] Univ Cantabria, Unidad Enfermedades Infecciosas, Hosp Univ Marques de Valdecilla, IDIVAL, E-39005 Santander, Spain.
   [Carratala, Jordi; Sabe, Nuria] Univ Barcelona, Serv Enfermedades Infecciosas, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain.
   [Lopez-Medrano, Francisco; Origueen, Julia] Univ Complutense, Unidad Enfermedades Infecciosas, Hosp Univ Octubre 12, Inst Invest Biomed Octubre 12,Dept Med, E-28040 Madrid, Spain.
   [Munoz, Patricia; Valerio, Maricela] Hosp Gen Univ Gregorio Maranon, Dept Microbiol Clin & Enfermedades Infecciosas, Madrid, Spain.
RP Vidal, E (reprint author), Univ Cordoba, Unidad Clin Gest Enfermedades Infecciosas, Inst Maimonides Invest Biomed Cordoba, Hosp Univ Reina Sofia, Cordoba, Spain.
EM vidal.elisa@gmail.com
RI Carratala, Jordi/AAC-2639-2020; Cordero, Elisa/C-7797-2015; Munoz,
   Patricia/E-9431-2017; Carratala, Jordi/B-8410-2011; Cervera,
   Carlos/U-4538-2018
OI Carratala, Jordi/0000-0003-3209-2563; Cordero,
   Elisa/0000-0001-7766-7266; Munoz, Patricia/0000-0001-5706-5583;
   Carratala, Jordi/0000-0003-3209-2563; Cervera,
   Carlos/0000-0002-0161-1749; Origuen, Julia/0000-0002-6507-0363;
   Cisneros, Jose Miguel/0000-0001-5001-672X; Sabe,
   Nuria/0000-0003-1697-4347
FU AstellasAstellas Pharmaceuticals; Astra-ZenecaAstraZeneca; MSD;
   NovartisNovartis; PfizerPfizer
FX JMC has received a conference grant from Astellas, Astra-Zeneca, MSD,
   Novartis, and Pfizer. All other authors have no conflict of interest to
   declare.
CR Vidal E, 2015, ENFERM INFEC MICR CL, V33
NR 1
TC 3
Z9 3
U1 0
U2 2
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD DEC
PY 2015
VL 33
IS 10
BP 680
EP 687
DI 10.1016/j.eimc.2015.03.020
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CZ9LD
UT WOS:000367418200010
PM 25976750
DA 2020-05-07
ER

PT J
AU Crisp, JG
   Takhar, SS
   Moran, GJ
   Krishnadasan, A
   Dowd, SE
   Finegold, SM
   Summanen, PH
   Talan, DA
AF Crisp, Jonathan G.
   Takhar, Sukhjit S.
   Moran, Gregory J.
   Krishnadasan, Anusha
   Dowd, Scot E.
   Finegold, Sydney M.
   Summanen, Paula H.
   Talan, David A.
CA EMERGEncy ID Net Study Grp
TI Inability of Polymerase Chain Reaction, Pyrosequencing, and Culture of
   Infected and Uninfected Site Skin Biopsy Specimens to Identify the Cause
   of Cellulitis
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE cellulitis; culture; polymerase chain reaction; PCR; pyrosequencing
ID RESISTANT STAPHYLOCOCCUS-AUREUS; FINE-NEEDLE-ASPIRATION; SOFT-TISSUE
   INFECTIONS; ANTIBACTERIAL PROPERTIES; EMERGENCY-DEPARTMENT; DIAGNOSIS;
   ERYSIPELAS; MANAGEMENT; ADULTS; PCR
AB Background. The cause of cellulitis is unclear. Streptococcus pyogenes, and to a lesser extent, Staphylococcus aureus, are presumed pathogens.
   Methods. We conducted a study of adults with acute cellulitis without drainage presenting to a US emergency department research network. Skin biopsy specimens were taken from the infected site and a comparable uninfected site on the opposite side of the body. Microbiology was evaluated using quantitative polymerase chain reaction (PCR), pyrosequencing, and standard culture techniques. To determine the cause, the prevalence and quantity of bacterial species at the infected and uninfected sites were compared.
   Results. Among 50 subjects with biopsy specimens from infected and uninfected sites, culture rarely identified a bacterium. Among 49 subjects with paired specimens from infected and uninfected sites tested with PCR, methicillin- susceptible S. aureus was identified in 20 (41%) and 17 (34%), respectively. Pyrosequencing identified abundant atypical bacteria in addition to streptococci and staphylococci. Among 49 subjects with paired specimens tested by pyrosequencing, S. aureus was identified from 11 (22%) and 15 (31%) and streptococci from 15 (31%) and 20 (41%) of the specimens, respectively. Methicillin-resistant S. aureus was not found by culture or PCR, and S. pyogenes was not identified by any technique.
   Conclusions. The bacterial cause of cellulitis cannot be determined by comparing the prevalence and quantity of pathogens from infected and uninfected skin biopsy specimens using current molecular techniques. Methicillin-susceptible S. aureus was detected but not methicillin-resistant S. aureus or S. pyogenes from cellulitis tissue specimens. For now, optimal treatment will need to be guided by clinical trials. Noninfectious causes should also be explored.
C1 [Crisp, Jonathan G.; Moran, Gregory J.; Krishnadasan, Anusha; Talan, David A.] Olive View UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA USA.
   [Moran, Gregory J.; Talan, David A.] Olive View UCLA Med Ctr, Dept Med, Div Infect Dis, Los Angeles, CA USA.
   [Finegold, Sydney M.; Summanen, Paula H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis,VA Greater Angeles Healthcare Syst, Los Angeles, CA 90095 USA.
   [Takhar, Sukhjit S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Emergency Med,Div Infect Dis, Boston, MA 02115 USA.
   [Takhar, Sukhjit S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Infect Dis, Boston, MA 02115 USA.
   [Dowd, Scot E.] MR DNA, Shallowater, TX USA.
RP Talan, DA (reprint author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.
EM dtalan@ucla.edu
RI Dowd, Scot/M-5386-2017
OI Dowd, Scot/0000-0002-6296-1427; Chiang, William/0000-0003-3562-8896;
   Rothman, Richard/0000-0002-1017-9505
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01/CI000353-0]
FX This work was supported by the Centers for Disease Control and
   Prevention (cooperative agreement U01/CI000353-0).
CR Al Masalma M, 2009, CLIN INFECT DIS, V48, P1169, DOI 10.1086/597578
   Arakaki RY, 2014, JAMA DERMATOL, V150, P1056, DOI 10.1001/jamadermatol.2014.1085
   BARON EJ, 1995, CLIN INFECT DIS, V20, pS174, DOI 10.1093/clinids/20.Supplement_2.S174
   Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17
   Berg JO, 2006, WOUND REPAIR REGEN, V14, P581, DOI 10.1111/j.1743-6109.2006.00157.x
   BERNARD P, 1989, ARCH DERMATOL, V125, P779, DOI 10.1001/archderm.125.6.779
   BROOK I, 1995, ARCH SURG-CHICAGO, V130, P786
   BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801
   CHARTIER C, 1990, INT J DERMATOL, V29, P459, DOI 10.1111/j.1365-4362.1990.tb04833.x
   Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483
   DiGiulio DB, 2009, CLIN INFECT DIS, V48, P1179, DOI 10.1086/597579
   Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326
   DUVANEL T, 1989, ARCH INTERN MED, V149, P293, DOI 10.1001/archinte.149.2.293
   EPPERLY TD, 1986, J FAM PRACTICE, V23, P337
   Eriksson B, 1996, CLIN INFECT DIS, V23, P1091, DOI 10.1093/clinids/23.5.1091
   Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008
   FLEISHER G, 1981, ANN EMERG MED, V10, P356, DOI 10.1016/S0196-0644(81)80236-3
   FLEISHER G, 1980, ANN EMERG MED, V9, P246, DOI 10.1016/S0196-0644(80)80380-5
   GINSBERG MB, 1981, SOUTHERN MED J, V74, P530, DOI 10.1097/00007611-198105000-00006
   GOLDGEIER MH, 1983, CUTIS, V31, P649
   Gunderson CG, 2012, J INFECTION, V64, P148, DOI 10.1016/j.jinf.2011.11.004
   Harbinson J E, 1927, Cal West Med, V26, P485
   Hein I, 2001, APPL ENVIRON MICROB, V67, P3122, DOI 10.1128/AEM.67.7.3122-3126.2001
   Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766
   HOOK EW, 1986, ARCH INTERN MED, V146, P295, DOI 10.1001/archinte.146.2.295
   HOWE PM, 1987, PEDIATR INFECT DIS J, V6, P685, DOI 10.1097/00006454-198707000-00014
   Jeng A, 2010, MEDICINE, V89, P217, DOI 10.1097/MD.0b013e3181e8d635
   JOUSIMIESSOMER HR, 2002, WADSWORTH KTL ANAERO
   Khawcharoenporn T, 2010, AM J MED, V123, P942, DOI 10.1016/j.amjmed.2010.05.020
   KIELHOFNER MA, 1988, ARCH INTERN MED, V148, P2451, DOI 10.1001/archinte.148.11.2451
   Lebre C, 1996, ARCH DERMATOL, V132, P842, DOI 10.1001/archderm.132.7.842
   LEE PC, 1985, J CLIN MICROBIOL, V22, P80, DOI 10.1128/JCM.22.1.80-83.1985
   Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106
   LILES DK, 1985, CUTIS, V36, P63
   LUTOMSKI DM, 1988, J FAM PRACTICE, V26, P45
   Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173
   MILLER MA, 1985, ARCH DERMATOL, V121, P1157, DOI 10.1001/archderm.121.9.1157
   Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356
   NEWELL PM, 1988, J CLIN MICROBIOL, V26, P401, DOI 10.1128/JCM.26.3.401-404.1988
   Pallin DJ, 2013, CLIN INFECT DIS, V56, P1754, DOI 10.1093/cid/cit122
   Robb JJ, 1935, BRIT MED J, V1935, P466, DOI 10.1136/bmj.1.3870.466
   SACHS MK, 1990, ARCH INTERN MED, V150, P1907, DOI 10.1001/archinte.150.9.1907
   SIGURDSSON AF, 1989, SCAND J INFECT DIS, V21, P537, DOI 10.3109/00365548909037882
   Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004
   Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]
   Talan DA, 1999, CLIN INFECT DIS, V28, P401, DOI 10.1086/517199
   Terp S, 2014, CLIN INFECT DIS, V58, pE129, DOI 10.1093/cid/ciu039
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001
   UMAN SJ, 1975, ARCH INTERN MED, V135, P959, DOI 10.1001/archinte.135.7.959
   Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997
NR 51
TC 21
Z9 23
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 1
PY 2015
VL 61
IS 11
BP 1679
EP 1687
DI 10.1093/cid/civ655
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CY5RF
UT WOS:000366464200008
PM 26240200
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Pak, TR
   Kasarskis, A
AF Pak, Theodore R.
   Kasarskis, Andrew
TI How Next-Generation Sequencing and Multiscale Data Analysis Will
   Transform Infectious Disease Management
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE whole genome sequencing; hospital-acquired infections;
   healthcare-associated infections; electronic medical records; multiscale
   analysis
ID ELECTRONIC MEDICAL-RECORDS; ANTIMICROBIAL STEWARDSHIP; DIFFICILE
   INFECTION; HEALTH RECORDS; INFRASTRUCTURE; INNOVATION; PHENOTYPE;
   OUTBREAK; NETWORK; BIOLOGY
AB Recent reviews have examined the extent to which routine next-generation sequencing (NGS) on clinical specimens will improve the capabilities of clinical microbiology laboratories in the short term, but do not explore integrating NGS with clinical data from electronic medical records (EMRs), immune profiling data, and other rich datasets to create multiscale predictive models. This review introduces a range of "omics" and patient data sources relevant to managing infections and proposes 3 potentially disruptive applications for these data in the clinical workflow. The combined threats of healthcare-associated infections and multidrug-resistant organisms may be addressed by multiscale analysis of NGS and EMR data that is ideally updated and refined over time within each healthcare organization. Such data and analysis should form the cornerstone of future learning health systems for infectious disease.
C1 [Kasarskis, Andrew] Icahn Sch Med Mt Sinai, Icahn Inst, New York, NY 10029 USA.
   [Kasarskis, Andrew] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
RP Kasarskis, A (reprint author), Icahn Sch Med Mt Sinai, Icahn Inst, One Gustave L Levy Pl,Box 1498, New York, NY 10029 USA.
EM andrew.kasarskis@mssm.edu
OI Pak, Theodore/0000-0002-1676-2523
FU Icahn Institute for Genomics and Multiscale Biology at Mount Sinai
FX Both authors were supported by the Icahn Institute for Genomics and
   Multiscale Biology at Mount Sinai.
CR Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706
   Committee on the Learning Healthcare System in America Institute of Medicine, 2014, BEST CARE LOWER COST
   Cusumano-Towner M, 2013, J AM MED INFORM ASSN, V20, P427, DOI 10.1136/amiajnl-2012-001401
   DeLisle S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070944
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226
   Doern CD, 2013, CLIN LAB MED, V33, P705, DOI 10.1016/j.cll.2013.03.004
   Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064
   Felsen UR, 2014, AIDS CARE, V26, P1318, DOI 10.1080/09540121.2014.911813
   Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237
   Gordon NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13
   Gottesman O, 2013, CLIN PHARMACOL THER, V94, P214, DOI 10.1038/clpt.2013.72
   Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72
   Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108
   Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044
   Klompas M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002626
   Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824
   Kohane IS, 2012, NEW ENGL J MED, V367, P2538, DOI 10.1056/NEJMe1213371
   Kohane IS, 2012, J AM MED INFORM ASSN, V19, P181, DOI 10.1136/amiajnl-2011-000492
   Kullar R, 2013, CLIN INFECT DIS, V57, P1005, DOI 10.1093/cid/cit318
   Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772
   Leibovici L, 1997, J INTERN MED, V242, P395, DOI 10.1046/j.1365-2796.1997.00232.x
   Lengauer T, 2006, NAT REV MICROBIOL, V4, P790, DOI 10.1038/nrmicro1477
   Liao KP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1885
   Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087
   Mandl KD, 2014, J AM MED INFORM ASSN, V21, P615, DOI 10.1136/amiajnl-2014-002727
   McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109
   McKellar MR, 2014, CLIN INFECT DIS, V59, pS104, DOI 10.1093/cid/ciu530
   Mejias A, 2014, J INFECTION, V68, pS94, DOI 10.1016/j.jinf.2013.09.018
   Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912
   Norton B, 2015, ANTIVIR THER, V20, P457, DOI 10.3851/IMP2910
   Pathak J, 2013, J AM MED INFORM ASSN, V20, pE206, DOI 10.1136/amiajnl-2013-002428
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027631
   Ram D, 2015, J VIROL METHODS, V212, P12, DOI 10.1016/j.jviromet.2014.11.003
   Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920
   Rea S, 2012, J BIOMED INFORM, V45, P763, DOI 10.1016/j.jbi.2012.01.009
   Reis BY, AMIA ANN S P 2003
   Scott RD, 2009, DIRECT MED COSTS HEA
   Silva JC, 2013, ARTIF INTELL MED, V59, P169, DOI 10.1016/j.artmed.2013.09.001
   Wagner B, 2014, INFECT CONT HOSP EP, V35, P1209, DOI 10.1086/678057
   Wiens J, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu045
   Wiens J, 2014, J AM MED INFORM ASSN, V21, P699, DOI 10.1136/amiajnl-2013-002162
   Zazzi M, 2011, HIV MED, V12, P211, DOI 10.1111/j.1468-1293.2010.00871.x
   Zazzi M, 2012, INTERVIROLOGY, V55, P123, DOI 10.1159/000332008
NR 47
TC 26
Z9 26
U1 0
U2 17
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 1
PY 2015
VL 61
IS 11
BP 1695
EP 1702
DI 10.1093/cid/civ670
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CY5RF
UT WOS:000366464200010
PM 26251049
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Hu, Y
   Mathema, B
   Zhao, Q
   Chen, L
   Lu, W
   Wang, W
   Kreiswirth, B
   Xu, B
AF Hu, Y.
   Mathema, B.
   Zhao, Q.
   Chen, L.
   Lu, W.
   Wang, W.
   Kreiswirth, B.
   Xu, B.
TI Acquisition of second-line drug resistance and extensive drug resistance
   during recent transmission of Mycobacterium tuberculosis in rural China
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Beijing family; Mycobacterium tuberculosis; rural China; second-line
   drug resistance transmission; transmission network
ID MULTIDRUG-RESISTANT; COST-EFFECTIVENESS; EPIDEMIOLOGY; POPULATION;
   STRAINS; PROPOSAL
AB Multidrug-resistant tuberculosis (MDR-TB) is prevalent in countries with a high TB burden, like China. As little is known about the emergence and spread of second-line drug (SLD) -resistant TB, we investigate the emergence and transmission of SLD-resistant Mycobacterium tuberculosis in rural China. In a multi-centre population-based study, we described the bacterial population structure and the transmission characteristics of SLD-resistant TB using Spoligotyping in combination with genotyping based on 24-locus MIRU-VNTR (mycobacterial interspersed repetitive unit-variable-number tandem repeat) plus four highly variable loci for the Beijing family, in four rural Chinese regions with diverse geographic and socio-demographic characteristics. Transmission networks among genotypically clustered patients were constructed using social network analysis. Of 1332 M. tuberculosis patient isolates recovered, the Beijing family represented 74.8% of all isolates and an association with MDR and simultaneous resistance between first-line drugs and SLDs. The genotyping analysis revealed that 189 isolates shared MIRU-VNTR patterns in 78 clusters with clustering rate and recent transmission rate of 14.2% and 8.3%, respectively. Fifty-three SLD-resistant isolates were observed in 31 clusters, 30 of which contained the strains with different drug susceptibility profiles and genetic mutations. In conjunction with molecular data, socio-network analysis indicated a key role of Central Township in the transmission across a highly interconnected network where SLD resistance accumulation occurred during transmission. SLD-resistant M. tuberculosis has been spreading in rural China with Beijing family being the dominant strains. Primary transmission of SLD-resistant strains in the population highlights the importance of routine drug susceptibility testing and effective anti-tuberculosis regimens for drug-resistant TB. Clinical Microbiology and Infection (C) 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Hu, Y.; Zhao, Q.; Wang, W.; Xu, B.] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200032, Peoples R China.
   [Hu, Y.; Zhao, Q.; Wang, W.; Xu, B.] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200032, Peoples R China.
   [Mathema, B.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Mathema, B.; Chen, L.; Kreiswirth, B.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, TB Ctr, Newark, NJ 07102 USA.
   [Lu, W.] Jiangsu Prov Ctr Dis Prevent & Control, Dept Chron Infect Dis, Nanjing, Jiangsu, Peoples R China.
RP Xu, B (reprint author), Fudan Univ, Sch Publ Hlth, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.
EM bxu@shmu.edu.cn
FU National Institutes of Health (NIH)/NIAIDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [5R01AI075463]; National Natural Science Foundation of China
   (NSFC)National Natural Science Foundation of China [30771843, 81373063]
FX This work was supported by a grant from the National Institutes of
   Health (NIH)/NIAID (R01) (PI, Biao Xu, No. 5R01AI075463) and as well as
   grants from National Natural Science Foundation of China (NSFC) (PI,
   Biao Xu, No. 30771843; PI, Yi Hu, No. 81373063). The content of the
   paper is solely the responsibility of the authors and does not
   necessarily represent the official view of NIH and NSFC.
CR Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13
   Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2
   Arentz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076533
   Banerjee R, 2008, EXPERT REV ANTI-INFE, V6, P713, DOI 10.1586/14787210.6.5.713
   Bartu V, 2010, J INT MED RES, V38, P1156, DOI 10.1177/147323001003800345
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
   Dharmadhikari AS, 2013, J INFECT DIS, V207, P1, DOI 10.1093/infdis/jis634
   Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09
   Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000
   Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411
   Fok A, 2008, INT J TUBERC LUNG D, V12, P480
   Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2
   Gonzalez-Angulo Y, 2013, AM J INFECT CONTROL, V41, P717, DOI 10.1016/j.ajic.2012.10.003
   Jain A, 2008, J BIOSCIENCES, V33, P605, DOI 10.1007/s12038-008-0078-8
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997
   Leung ECC, 2013, EUR RESPIR J, V41, P901, DOI 10.1183/09031936.00071212
   Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954
   Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06
   Upshur R, 2009, B WORLD HEALTH ORGAN, V87, P481, DOI 10.2471/BLT.08.051698
   VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991
   Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC
   Yuan XL, 2012, J CLIN MICROBIOL, V50, P2404, DOI 10.1128/JCM.06860-11
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789
   Zhao YD, 2012, INFECT GENET EVOL, V12, P718, DOI 10.1016/j.meegid.2011.09.022
   Zhou A, 2011, INT J TUBERC LUNG D, V15, P517, DOI 10.5588/ijtld.10.0495
NR 26
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD DEC
PY 2015
VL 21
IS 12
AR UNSP 1093.e9
DI 10.1016/j.cmi.2015.08.023
PG 10
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CY7JZ
UT WOS:000366585900013
PM 26348262
OA Bronze
DA 2020-05-07
ER

PT J
AU Tsai, HC
   Huang, LM
   Chang, LY
   Lee, PI
   Chen, JM
   Shao, PL
   Hsueh, PR
   Sheng, WH
   Chang, YC
   Lu, CY
AF Tsai, Hsing-Chen
   Huang, Li-Min
   Chang, Luan-Yin
   Lee, Ping-Ing
   Chen, Jong-Ming
   Shao, Pei-Lan
   Hsueh, Po-Ren
   Sheng, Wang-Huei
   Chang, Yu-Ching
   Lu, Chun-Yi
TI Central venous catheter-associated bloodstream infections in pediatric
   hematology-oncology patients and effectiveness of antimicrobial lock
   therapy
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE antimicrobial lock therapy; bloodstream infection; central catheter;
   hematology-oncology; pediatric
ID ANTIBIOTIC LOCK; HICKMAN CATHETERS; CANCER-PATIENTS; ACCESS DEVICES;
   CHILDREN; CHLORHEXIDINE; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION;
   LEUKEMIA
AB Background: Central line-associated bloodstream infection (CLABSI) is a serious complication in hematology-oncology patients. This study aimed to analyze the prevalence of CLABSI and the effectiveness of antimicrobial lock therapy (ALT) in pediatric patients.
   Methods: BSIs of all pediatric hematology-oncology patients admitted to a children's hospital between January 2009 and December 2013 were reviewed. The United States National Healthcare Safety Network and Infectious Diseases Society of America guidelines were used to define CLABSI and catheter-related BSI (CRBSI). The incidence, laboratory and microbiology characteristics, poor outcome, and effectiveness of ALT were analyzed.
   Results: There were 246 cases of CLABSI in 146 patients (mean age, 10.0 years), including 66 (26.8%) cases of CRBSI. The incidence of CLABSI was 4.49/1000 catheter-days, and the infection was responsible for 32.9% of the complications these patients developed and 9.3% of contributable mortality. Patients with acute myeloid leukemia had the highest infection density (5.36/1000 patient-days). Enterobacteriaceae (40.2%) and coagulase-negative staphylococci (CoNS; 20.7%) were the predominant pathogens. In multivariate analysis, older age, male sex, elevated C-reactive protein, acute lymphoblastic leukemia, and candidemia were associated with poor outcome. The success rate of ALT was 58.6% (17/29) for the treatment of CoNS and 78.3% (29/37) for Enterobacteriaceae infections. Patients with candidemia (n = 18) had the highest mortality (33.4%) and catheter removal rate (66.7%). Chlorhexidine as the disinfectant decreased the 1-year CLABSI rate from 13.7/1000 to 8.4/1000 catheterdays (p = 0.02).
   Conclusion: CoNS and Enterobacteriaceae are the predominant pathogens in CLABSI among pediatric hematology-oncology patients. ALT is effective and showed no significant side effect. New disinfection practice and infection control measures can decrease CLABSI. Copyright (C) 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Tsai, Hsing-Chen; Huang, Li-Min; Chang, Luan-Yin; Lee, Ping-Ing; Shao, Pei-Lan; Lu, Chun-Yi] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Div Pediat Infect Dis,Dept Pediat, Taipei 10764, Taiwan.
   [Chen, Jong-Ming; Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan.
   [Sheng, Wang-Huei] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei 10764, Taiwan.
   [Chang, Yu-Ching] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Nursing, Taipei 10764, Taiwan.
   [Tsai, Hsing-Chen] New Taipei City Hosp, Dept Pediat, New Taipei City, Taiwan.
RP Lu, CY (reprint author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Div Pediat Infect Dis,Dept Pediat, Taipei 10764, Taiwan.
EM cylu@ntu.edu.tw
OI HUANG, LI-MIN/0000-0002-9291-260X; LEE, PING-ING/0000-0002-7299-2825;
   Shao, Pei-Lan/0000-0003-3334-1330; HSUEH, PO-REN/0000-0002-7502-9225;
   SHENG, WANG-HUEI/0000-0002-5605-7853; CHANG,
   LUAN-YIN/0000-0003-2632-1956; LU, CHUN-YI/0000-0002-5240-2808
CR Abbas AAH, 2004, PEDIATR BLOOD CANCER, V42, P325, DOI 10.1002/pbc.10450
   Adler A, 2006, J HOSP INFECT, V62, P358, DOI 10.1016/j.jhin.2005.08.019
   Allen RC, 2008, PEDIATR BLOOD CANCER, V51, P53, DOI 10.1002/pbc.21497
   Astagneau P, 1999, INFECT CONT HOSP EP, V20, P494, DOI 10.1086/501658
   Bailey E, 2002, J ANTIMICROB CHEMOTH, V50, P615, DOI 10.1093/jac/dkf183
   Bartram JL, 2011, ARCH DIS CHILD, V96, P1082, DOI 10.1136/adc.2009.173856
   Berrueco R, 2013, J PEDIAT HEMATOL ONC, V35, pE194, DOI 10.1097/MPH.0b013e318290c24f
   Celebi S, 2013, PEDIATR HEMAT ONCOL, V30, P187, DOI 10.3109/08880018.2013.772683
   Chen PY, 2014, J MICROBIOL IMMUNOL, V47, P95, DOI 10.1016/j.jmii.2012.08.025
   De Sio L, 2004, PEDIATR INFECT DIS J, V23, P963, DOI 10.1097/01.inf.0000141740.82420.e6
   Flynn PM, 2003, J CLIN ONCOL, V21, P3520, DOI 10.1200/JCO.2003.03.012
   GROEGER JS, 1993, ANN INTERN MED, V119, P1168, DOI 10.7326/0003-4819-119-12-199312150-00003
   Handrup MM, 2010, PEDIATR BLOOD CANCER, V55, P309, DOI 10.1002/pbc.22530
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   JOHNSON DC, 1994, PEDIATR INFECT DIS J, V13, P930, DOI 10.1097/00006454-199410000-00015
   Kao HF, 2014, SUPPORT CARE CANCER, V22, P1189, DOI 10.1007/s00520-013-2071-5
   Kliegman R.M., 2011, NELSON TXB PEDIAT
   Lebeaux D, 2012, MEDICINE, V91, P309, DOI 10.1097/MD.0b013e318275ffe1
   Lee MY, 2007, J ANTIMICROB CHEMOTH, V60, P782, DOI 10.1093/jac/dkm295
   Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
   Mouw E, 2008, J PEDIATR SURG, V43, P1025, DOI 10.1016/j.jpedsurg.2008.02.026
   O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257
   O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262
   Rinke ML, 2013, PEDIATR BLOOD CANCER, V60, P1882, DOI 10.1002/pbc.24677
   Ruschulte H, 2009, ANN HEMATOL, V88, P267, DOI 10.1007/s00277-008-0568-7
   SEVERIEN C, 1991, AM J DIS CHILD, V145, P1433, DOI 10.1001/archpedi.1991.02160120101028
   Smith TL, 2002, INFECT CONT HOSP EP, V23, P239, DOI 10.1086/502042
   Wolf J, 2013, PEDIATR INFECT DIS J, V32, P905, DOI 10.1097/INF.0b013e3182996b6e
   Wolosker N, 2004, EJSO-EUR J SURG ONC, V30, P771, DOI 10.1016/j.ejso.2004.05.019
   Wu PP, 2012, J MICROBIOL IMMUNOL, V45, P370, DOI 10.1016/j.jmii.2011.12.016
   WURZEL CL, 1988, AM J DIS CHILD, V142, P536, DOI 10.1001/archpedi.1988.02150050074036
NR 31
TC 12
Z9 13
U1 0
U2 5
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD DEC
PY 2015
VL 48
IS 6
BP 639
EP 646
DI 10.1016/j.jmii.2014.07.008
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CY6QR
UT WOS:000366534400009
PM 25311403
OA Other Gold
DA 2020-05-07
ER

PT J
AU Dahlstrom, KM
   Giglio, KM
   Collins, AJ
   Sondermann, H
   O'Toole, GA
AF Dahlstrom, Kurt M.
   Giglio, Krista M.
   Collins, Alan J.
   Sondermann, Holger
   O'Toole, George A.
TI Contribution of Physical Interactions to Signaling Specificity between a
   Diguanylate Cyclase and Its Effector
SO MBIO
LA English
DT Article
ID CYCLIC-DI-GMP; PSEUDOMONAS-AERUGINOSA PA14; BIOFILM FORMATION;
   EXTRACELLULAR-MATRIX; FLUORESCENS WCS365; RESPONSE REGULATOR; CELL
   CYCLE; PROTEIN; ATTACHMENT; MOTILITY
AB Cyclic diguanylate (c-di-GMP) is a bacterial second messenger that controls multiple cellular processes. c-di-GMP networks have up to dozens of diguanylate cyclases (DGCs) that synthesize c-di-GMP along with many c-di-GMP-responsive target proteins that can bind and respond to this signal. For such networks to have order, a mechanism(s) likely exists that allow DGCs to specifically signal their targets, and it has been suggested that physical interactions might provide such specificity. Our results show a DGC from Pseudomonas fluorescens physically interacting with its target protein at a conserved interface, and this interface can be predictive of DGC-target protein interactions. Furthermore, we demonstrate that physical interaction is necessary for the DGC to maximally signal its target. If such "local signaling" is a theme for even a fraction of the DGCs used by bacteria, it becomes possible to posit a model whereby physical interaction allows a DGC to directly signal its target protein, which in turn may help curtail undesired cross talk with other members of the network.
   IMPORTANCE An important question in microbiology is how bacteria make decisions using a signaling network made up of proteins that make, break, and bind the second messenger c-di-GMP, which is responsible for controlling many cellular behaviors. Previous work has shown that a given DGC enzyme will signal for specific cellular outputs, despite making the same diffusible molecule as its sibling DGCs in the unpartitioned space of the bacterial cell. Understanding how one DGC differentiates its output from the dozens of other such enzymes in the cell is synonymous with understanding a large component of the bacterial decision-making machinery. We present evidence for a helix on a DGC used to physically associate with its target protein, which is necessary to achieve maximal signaling.
C1 [Dahlstrom, Kurt M.; Collins, Alan J.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.
   [Giglio, Krista M.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.
RP O'Toole, GA (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.
EM georgeo@dartmouth.edu
OI Collins, Alan/0000-0003-4960-5716
FU Fleming Fellowship; NSFNational Science Foundation (NSF) [MCB-9984521];
   National Science FoundationNational Science Foundation (NSF); National
   Institutes of Health/National Institute of General Medical Sciences
   under NSFUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [DMR-1332208]; National Institute of General
   Medical Sciences, National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [GM 103485]; 
   [R01-AI097307];  [T32-GM08704]
FX This work was supported by grant R01-AI097307 (H.S./G.A.O.), by a
   Fleming Fellowship (K.M.G.), and by grant T32-GM08704 (K.M.D.) and by
   the NSF grant MCB-9984521 (G.A.O.). Part of this work is based upon
   research conducted at the Cornell High Energy Synchrotron Source
   (CHESS), which is supported by the National Science Foundation and the
   National Institutes of Health/National Institute of General Medical
   Sciences under NSF award DMR-1332208, using the Macromolecular
   Diffraction at CHESS (MacCHESS) facility, which is supported by award GM
   103485 from the National Institute of General Medical Sciences, National
   Institutes of Health.
CR Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744
   Ballok AE, 2012, J BACTERIOL, V194, P5315, DOI 10.1128/JB.00984-12
   Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x
   Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x
   Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004
   Chatterjee D, 2014, ELIFE, V3, DOI 10.7554/eLife.03650
   Cooley RB, 2015, J BACTERIOL
   Davis NJ, 2013, GENE DEV, V27, P2049, DOI 10.1101/gad.222679.113
   Guzzo CR, 2013, J MOL BIOL, V425, P2174, DOI 10.1016/j.jmb.2013.03.021
   Ha DG, 2014, APPL ENVIRON MICROB, V80, P3384, DOI 10.1128/AEM.00299-14
   Hinsa SM, 2006, MICROBIOL-SGM, V152, P1375, DOI 10.1099/mic.0.28696-0
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120
   Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13
   Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10
   Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588
   Newell PD, 2011, J BACTERIOL, V193, P4685, DOI 10.1128/JB.05483-11
   Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587
   Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x
   Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220
   Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040
   Srivastava D, 2013, MOL MICROBIOL, V90, P1262, DOI 10.1111/mmi.12432
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Townsley L, 2015, ENV MICROBIOL
   Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X
NR 33
TC 29
Z9 29
U1 1
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD NOV-DEC
PY 2015
VL 6
IS 6
AR e01978-15
DI 10.1128/mBio.01978-15
PG 11
WC Microbiology
SC Microbiology
GA DA0YY
UT WOS:000367524700061
PM 26670387
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Hemme, CL
   Tu, QC
   Shi, Z
   Qin, YJ
   Gao, WM
   Deng, Y
   Van Nostrand, JD
   Wu, LY
   He, ZL
   Chain, PSG
   Tringe, SG
   Fields, MW
   Rubin, EM
   Tiedje, JM
   Hazen, TC
   Arkin, AP
   Zhou, JZ
AF Hemme, Christopher L.
   Tu, Qichao
   Shi, Zhou
   Qin, Yujia
   Gao, Weimin
   Deng, Ye
   Van Nostrand, Joy D.
   Wu, Liyou
   He, Zhili
   Chain, Patrick S. G.
   Tringe, Susannah G.
   Fields, Matthew W.
   Rubin, Edward M.
   Tiedje, James M.
   Hazen, Terry C.
   Arkin, Adam P.
   Zhou, Jizhong
TI Comparative metagenomics reveals impact of contaminants on groundwater
   microbiomes
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE metagenomics; bioremediation; groundwater microbiology
ID IN-SITU BIOREMEDIATION; COMMUNITY STRUCTURE; ANALYSIS SYSTEM;
   GENE-TRANSFER; HIGH-NITRATE; URANIUM; SUBSURFACE; GENOMES; AQUIFER;
   WATER
AB To understand patterns of geochemical cycling in pristine versus contaminated groundwater ecosystems, pristine shallow groundwater (FW301) and contaminated groundwater (FW106) samples from the Oak Ridge Integrated Field Research Center (OR-IFRC) were sequenced and compared to each other to determine phylogenetic and metabolic difference between the communities. Proteobacteria (e.g., Burkholderia, Pseudomonas) are the most abundant lineages in the pristine community, though a significant proportion (>55%) of the community is composed of poorly characterized low abundance (individually <1%) lineages. The phylogenetic diversity of the pristine community contributed to a broader diversity of metabolic networks than the contaminated community. In addition, the pristine community encodes redundant and mostly complete geochemical cycles distributed over multiple lineages and appears capable of a wide range of metabolic activities. In contrast, many geochemical cycles in the contaminated community appear truncated or minimized due to decreased biodiversity and dominance by Rhodanobacter populations capable of surviving the combination of stresses at the site. These results indicate that the pristine site contains more robust and encodes more functional redundancy than the stressed community, which contributes to more efficient nutrient cycling and adaptability than the stressed community.
C1 [Hemme, Christopher L.; Tu, Qichao; Shi, Zhou; Qin, Yujia; Deng, Ye; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Inst Environm Genom, Norman, OK 73019 USA.
   [Gao, Weimin] Arizona State Univ, Biodesign Inst, Tempe, AZ USA.
   [Deng, Ye] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, CAS Key Lab Environm Biotechnol, Beijing, Peoples R China.
   [Chain, Patrick S. G.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.
   [Tringe, Susannah G.; Rubin, Edward M.] US DOE, Joint Genome Inst, Walnut Creek, CA USA.
   [Fields, Matthew W.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.
   [Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.
   [Hazen, Terry C.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA.
   [Hazen, Terry C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA.
   [Hazen, Terry C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.
   [Hazen, Terry C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.
   [Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Bioengn, Berkeley, CA 94720 USA.
   [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.
   [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.
RP Zhou, JZ (reprint author), Univ Oklahoma, Dept Microbiol & Plant Biol, Inst Environm Genom, Norman, OK 73019 USA.
EM hemmecl@uri.edu; jzhou@ou.edu
RI Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Tringe, Susannah
   Green/T-9431-2019; He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Fields,
   Matthew W W./O-5442-2018; Hazen, Terry C/C-1076-2012; Chain,
   Patrick/O-4140-2019; Arkin, Adam P/A-6751-2008; Gao, Weimin/J-1795-2014;
   Arkin, Adam/M-9941-2019
OI Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450;
   Tringe, Susannah Green/0000-0001-6479-8427; He,
   Zhili/0000-0001-8225-7333; Fields, Matthew W W./0000-0001-9053-1849;
   Hazen, Terry C/0000-0002-2536-9993; Chain, Patrick/0000-0003-3949-3634;
   Arkin, Adam P/0000-0002-4999-2931; Gao, Weimin/0000-0002-6758-9775;
   Arkin, Adam/0000-0002-4999-2931; Tu, Qichao/0000-0002-3245-7545
FU Office of Science, Office of Biological and Environmental Research, of
   the U. S. Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC02-05CH11231]; U.S. Department of EnergyUnited States Department
   of Energy (DOE) [DE-FG02-07ER64398]; Office of Science of the U.S.
   Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC02-05CH11231]; Office of the Vice President for Research; College
   of Arts and Sciences; Department of Microbiology and Plant Biology at
   the University of Oklahoma
FX This work conducted by ENIGMA- Ecosystems and Networks Integrated with
   Genes and Molecular Assemblies was supported by the Office of Science,
   Office of Biological and Environmental Research, of the U. S. Department
   of Energy under Contract No. DE-AC02-05CH11231, U.S. Department of
   Energy Grant DE-FG02-07ER64398. The work conducted by the U.S.
   Department of Energy joint Genome Institute is supported by the Office
   of Science of the U.S. Department of Energy under Contract No.
   DE-AC02-05CH11231. We also wish to acknowledge financial support
   provided by the Office of the Vice President for Research, the College
   of Arts and Sciences, and the Department of Microbiology and Plant
   Biology at the University of Oklahoma.
CR Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683
   Brisson VL, 2012, ISME J, V6, P1702, DOI 10.1038/ismej.2012.15
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Cardenas E, 2008, APPL ENVIRON MICROB, V74, P3718, DOI 10.1128/AEM.02308-07
   Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808
   Chapelle FH, 2007, GROUND WATER, V45, P272, DOI 10.1111/j.1745-6584.2007.00284.x
   Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669
   Coombs JM, 2004, APPL ENVIRON MICROB, V70, P1698, DOI 10.1128/AEM.70.3.1698-1707.2004
   DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Fields MW, 2006, ENVIRON SCI TECHNOL, V40, P2601, DOI 10.1021/es051748q
   Foster SSD, 2003, PHILOS T R SOC B, V358, P1957, DOI 10.1098/rstb.2003.1380
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Gleick PH, 2000, WORLDS WATER 2000 20
   Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154
   Inskeep WP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00067
   Kim YJ, 2009, ENVIRON GEOL, V58, P1301, DOI 10.1007/s00254-008-1633-1
   Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009
   Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35
   LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044
   Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887
   Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393
   Martinez RJ, 2006, APPL ENVIRON MICROB, V72, P3111, DOI 10.1128/AEM.72.5.3111-3118.2006
   Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Moreels D, 2008, ENVIRON SCI POLLUT R, V15, P481, DOI 10.1007/s11356-008-0034-z
   North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004
   Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041
   Schreiber ME, 1999, GROUND WATER MONIT R, V19, P95, DOI 10.1111/j.1745-6592.1999.tb00192.x
   Shelobolina ES, 2003, SOIL SEDIMENT CONTAM, V12, P865, DOI [10.1080/714037720, 10.1080/10588330390254928]
   Smith RJ, 2012, ENVIRON MICROBIOL, V14, P240, DOI 10.1111/j.1462-2920.2011.02614.x
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340
   Van Nostrand JD, 2011, APPL ENVIRON MICROB, V77, P3860, DOI 10.1128/AEM.01981-10
   Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x
   Wada Y, 2014, EARTH SYST DYNAM, V5, P15, DOI 10.5194/esd-5-15-2014
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Watson D, 2004, OAK RIDGE FIELD RES
   Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996
NR 43
TC 30
Z9 31
U1 0
U2 43
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 31
PY 2015
VL 6
AR 1205
DI 10.3389/fmicb.2015.01205
PG 12
WC Microbiology
SC Microbiology
GA CV4NA
UT WOS:000364242600002
PM 26583008
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Lopez, P
   Halary, S
   Bapteste, E
AF Lopez, Philippe
   Halary, Sebastien
   Bapteste, Eric
TI Highly divergent ancient gene families in metagenomic samples are
   compatible with additional divisions of life
SO BIOLOGY DIRECT
LA English
DT Article
DE Microbiology; Metagenomics; Comparative analysis; Networks;
   Environmental diversity
ID TARGETED RECOVERY; DIVERSITY; LEVEL; LINEAGES; INSIGHTS; REVEALS;
   VIRUSES; GENOMES; ARCHAEA; DOMAIN
AB Background: Microbial genetic diversity is often investigated via the comparison of relatively similar 16S molecules through multiple alignments between reference sequences and novel environmental samples using phylogenetic trees, direct BLAST matches, or phylotypes counts. However, are we missing novel lineages in the microbial dark universe by relying on standard phylogenetic and BLAST methods? If so, how can we probe that universe using alternative approaches? We performed a novel type of multi-marker analysis of genetic diversity exploiting the topology of inclusive sequence similarity networks.
   Results: Our protocol identified 86 ancient gene families, well distributed and rarely transferred across the 3 domains of life, and retrieved their environmental homologs among 10 million predicted ORFs from human gut samples and other metagenomic projects. Numerous highly divergent environmental homologs were observed in gut samples, although the most divergent genes were over-represented in non-gut environments. In our networks, most divergent environmental genes grouped exclusively with uncultured relatives, in maximal cliques. Sequences within these groups were under strong purifying selection and presented a range of genetic variation comparable to that of a prokaryotic domain.
   Conclusions: Many genes families included environmental homologs that were highly divergent from cultured homologs: in 79 gene families (including 18 ribosomal proteins), Bacteria and Archaea were less divergent than some groups of environmental sequences were to any cultured or viral homologs. Moreover, some groups of environmental homologs branched very deeply in phylogenetic trees of life, when they were not too divergent to be aligned. These results underline how limited our understanding of the most diverse elements of the microbial world remains, and encourage a deeper exploration of natural communities and their genetic resources, hinting at the possibility that still unknown yet major divisions of life have yet to be discovered.
C1 [Lopez, Philippe; Bapteste, Eric] Univ Paris 06, Inst Biol Paris Seine, UMR CNRS Evolut Paris Seine 7138, Team Adaptat Integrat Reticulat Evolut, F-75005 Paris, France.
   [Halary, Sebastien] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada.
RP Lopez, P (reprint author), Univ Paris 06, Inst Biol Paris Seine, UMR CNRS Evolut Paris Seine 7138, Team Adaptat Integrat Reticulat Evolut, 7 Quai St Bernard, F-75005 Paris, France.
EM philippe.lopez@upmc.fr
OI Bapteste, Eric/0000-0003-1966-1215
FU European Research CouncilEuropean Research Council (ERC) [615274];
   Genome Canada/Genome Quebec research grant (Genorem)
FX This work was supported by the European Research Council FP7 [2007-2013
   Grant Agreement no615274] to E.B, and S.H. was supported by a Genome
   Canada/Genome Quebec research grant (Genorem) awarded to M. St-Arnaud
   and M. Hijri. We thank R.M. Burian, D. Bhattacharya and J.W. Leigh for
   critical reading.
CR Alvarez-Ponce D, 2013, P NATL ACAD SCI USA, V110, pE1594, DOI 10.1073/pnas.1211371110
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188
   Beauregard-Racine J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-39
   Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005
   Chouari R, 2003, APPL ENVIRON MICROB, V69, P7354, DOI 10.1128/AEM.69.12.7354-7363.2003
   Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061
   Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599
   Derakshani M, 2001, APPL ENVIRON MICROB, V67, P623, DOI 10.1128/AEM.67.2.623-631.2001
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0
   GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haggerty LS, 2014, MOL BIOL EVOL, V31, P501, DOI 10.1093/molbev/mst228
   Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998
   Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018
   Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023
   Lapointe FJ, 2010, TRENDS MICROBIOL, V18, P341, DOI 10.1016/j.tim.2010.03.009
   Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09
   Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108
   Leskovec J., 2008, P 17 INT C WORLD WID, P695, DOI DOI 10.1145/1367497.1367591
   Lopez-Garcia P, 2001, ENVIRON MICROBIOL, V3, P72, DOI 10.1046/j.1462-2920.2001.00162.x
   Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372
   Lynch MDJ, 2012, ISME J, V6, P2067, DOI 10.1038/ismej.2012.50
   Makino K, 2004, LECT NOTES COMPUT SC, V3111, P260
   Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Moreira D, 2006, MICROBIOL-SGM, V152, P505, DOI 10.1099/mic.0.28254-0
   Murray AE, 2007, PHILOS T R SOC B, V362, P2259, DOI 10.1098/rstb.2006.1944
   Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78
   Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759
   Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352
   Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Williams TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021080
   WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088
   Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033
   Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011
   Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151
   Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
NR 53
TC 8
Z9 9
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6150
J9 BIOL DIRECT
JI Biol. Direct
PD OCT 26
PY 2015
VL 10
AR 64
DI 10.1186/s13062-015-0092-3
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CU4MY
UT WOS:000363505100001
PM 26502935
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Chen, L
   Xu, JM
   Feng, YZ
   Wang, JT
   Yu, YJ
   Brookes, PC
AF Chen, Lin
   Xu, Jianming
   Feng, Youzhi
   Wang, Juntao
   Yu, Yongjie
   Brookes, Philip C.
TI Responses of soil microeukaryotic communities to short-term
   fumigation-incubation revealed by MiSeq amplicon sequencing
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE fumigation; fungi; protist; enzymes; network analysis
ID MICROBIAL BIOMASS; FUNGAL COMMUNITIES; CHLOROFORM FUMIGATION; EXTRACTION
   METHOD; DIVERSITY; BACTERIAL; FERTILIZATION; PATTERNS; MOISTURE;
   NITROGEN
AB In soil microbiology, there is a "paradox' of soil organic carbon (SOC) mineralization, which is that even though chloroform fumigation destroys majority of the soil microbial biomass, SOC mineralization continues at the same rate as in the non-fumigated soil during the incubation period. Soil microeukaryotes as important SOC decomposers, however, their community level responses to chloroform fumigation are not well understood. Using the 18S rRNA gene amplicon sequencing, we analyzed the composition, diversity, and C-metabolic functions of a grassland soil and an arable soil microeukaryotic community in response to fumigation followed by a 30-day incubation. The grassland and arable soil microeukaryotic communities were dominated by the fungal Ascomycota (80.5-93.1% of the fungal sequences), followed by the protistan Cercozoa and Apicomplexa. In the arable soil fungal community, the predominance of the class Sordariomycetes was replaced by the class Eurotiomycetes after fumigation at days 7 and 30 of the incubation. Fumigation changed the microeukaryotic u-diversity in the grassland soil at days 0 and 7, and (3-diversity in the arable soil at days 7 and 30. Network analysis indicated that after fumigation fungi were important groups closely related to other taxa. Most phylotypes (especially Sordariomycetes, Dothideomycetes, Coccidia, and uncultured Chytridiomycota) were inhibited, and only a few were positively stimulated by fumigation. Despite the inhibited Sordariomycetes, the fumigated communities mainly consisted of Eurotiomycetes and Sordariomycetes (21.9 and 36.5% relative frequency, respectively), which are able to produce hydrolytic enzymes associated with SOC mineralization. Our study suggests that fumigation not only decreases biomass size, but modulates the composition and diversity of the soil microeukaryotic communities, which are capable of driving SOC mineralization by release of hydrolytic enzymes during short-term fumigation incubation.
C1 [Chen, Lin; Xu, Jianming; Brookes, Philip C.] Zhejiang Univ, Inst Soil & Water Resources & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.
   [Feng, Youzhi] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.
   [Wang, Juntao] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.
   [Yu, Yongjie] Nanjing Univ Informat Sci & Technol, Coll Appl Meteorol, Nanjing, Jiangsu, Peoples R China.
RP Brookes, PC (reprint author), Zhejiang Univ, Inst Soil & Water Resources & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.
EM philipbrookes@zju.edu.cn
RI Wang, Juntao/O-4423-2015; Xu, Jianming/C-8752-2016
OI Wang, Juntao/0000-0002-1822-2176; 
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [41371246]; National Basic Research Program (973
   Program) of ChinaNational Basic Research Program of China [2014CB441003]
FX This work was supported by the National Natural Science Foundation of
   China (41371246) and the National Basic Research Program (973 Program)
   of China (2014CB441003). The authors thank our lab colleagues for soil
   sampling and analysis, and two reviewers for insightful comments and
   constructive suggestions which improved this manuscript.
CR Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI 10.1046/j.1462-2920.2003.00522.x
   Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6
   Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119
   Bastian M, 2009, INT AAAI C WEBL SOC
   Blagodatskaya EV, 1998, SOIL BIOL BIOCHEM, V30, P1269, DOI 10.1016/S0038-0717(98)00050-9
   BRAY JR, 1957, ECOL MONOGR, V27, P326
   Brookes P. C., 2009, SOIL BIOL BIOCHEM, V41, P440, DOI [10.1016/1 .soilbio.006 . 09.002, DOI 10.1016/1]
   BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3
   BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Chen L, 2015, APPL SOIL ECOL, V86, P62, DOI 10.1016/j.apsoil.2014.09.011
   Chen L, 2014, J SOIL SEDIMENT, V14, P1829, DOI 10.1007/s11368-014-0924-2
   Chen MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040659
   de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6
   Dickens HE, 1999, SOIL BIOL BIOCHEM, V31, P2049, DOI 10.1016/S0038-0717(99)00128-5
   Dominguez-Mendoza CA, 2014, SOIL BIOL BIOCHEM, V73, P122, DOI 10.1016/j.soilbio.2014.02.012
   Domonell A, 2013, PEDOBIOLOGIA, V56, P1, DOI 10.1016/j.pedobi.2012.07.001
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Fan FL, 2012, SOIL BIOL BIOCHEM, V55, P70, DOI 10.1016/j.soilbio.2012.06.008
   Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x
   Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144
   Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184
   Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143
   JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P209, DOI 10.1016/0038-0717(76)90005-5
   Jing ZB, 2014, ECOL ENG, V70, P169, DOI 10.1016/j.ecoleng.2014.05.011
   Karst J, 2013, MYCOLOGIA, V105, P61, DOI 10.3852/12-042
   Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021
   Kis-Papo T, 2001, MYCOL RES, V105, P749, DOI 10.1017/S0953756201004129
   Klaubauf S, 2010, FUNGAL DIVERS, V44, P65, DOI 10.1007/s13225-010-0053-1
   Lara E, 2007, FEMS MICROBIOL ECOL, V62, P365, DOI 10.1111/j.1574-6941.2007.00387.x
   Lentendu G, 2014, MOL ECOL, V23, P3341, DOI 10.1111/mec.12819
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Lu R K., 2000, ANAL METHODS SOIL AG
   Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237
   Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338
   Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3
   Moon-van der Staay SY, 2006, FEMS MICROBIOL ECOL, V57, P420, DOI 10.1111/j.1574-6941.2006.00130.x
   Morris S. J., 2007, SOIL MICROBIOLOGY EC, P195, DOI DOI 10.1016/B978-0-08-047514-1.50012-3
   Nai C, 2013, FUNGAL GENET BIOL, V56, P54, DOI 10.1016/j.fgb.2013.04.001
   Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0
   Nelson D. W., 1982, METHODS SOIL ANAL, V2, P539, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C29
   Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x
   Paterson E, 2009, SOIL BIOL BIOCHEM, V41, P1352, DOI 10.1016/j.soilbio.2009.02.012
   Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381
   Renella G, 2002, SOIL BIOL BIOCHEM, V34, P51, DOI 10.1016/S0038-0717(01)00152-3
   Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940
   Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348
   Shen CC, 2014, ECOLOGY, V95, P3190, DOI 10.1890/14-0310.1
   Shi Y, 2015, APPL ENVIRON MICROB, V81, P492, DOI 10.1128/AEM.03229-14
   Sterflinger K, 2012, FUNGAL ECOL, V5, P453, DOI 10.1016/j.funeco.2011.12.007
   Stres B, 2006, SOIL BIOL, V8, P1
   Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80
   Sugiyama Shu-ichi, 2008, Grassland Science, V54, P117, DOI 10.1111/j.1744-697X.2008.00113.x
   Tabatabai MA, 1994, METHODS SOIL ANAL 2, P775, DOI DOI 10.2136/SSSABOOKSER5.2.C37
   Tu QC, 2015, APPL ENVIRON MICROB, V81, P2445, DOI 10.1128/AEM.04040-14
   Tzeneva VA, 2009, RES MICROBIOL, V160, P89, DOI 10.1016/j.resmic.2008.12.001
   VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6
   Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051
   Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7
   WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3
   Wu J, 1996, SOIL BIOL BIOCHEM, V28, P511, DOI 10.1016/0038-0717(95)00193-X
   Zelles L, 1997, SOIL BIOL BIOCHEM, V29, P1325, DOI 10.1016/S0038-0717(97)00062-X
NR 64
TC 10
Z9 11
U1 0
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 20
PY 2015
VL 6
AR 1149
DI 10.3389/fmicb.2015.01149
PG 13
WC Microbiology
SC Microbiology
GA CV0XF
UT WOS:000363976400002
PM 26539178
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Agrawal, S
   Ganguly, S
   Hajian, P
   Cao, JN
   Agrawal, A
AF Agrawal, Sudhanshu
   Ganguly, Sreerupa
   Hajian, Pega
   Cao, Jia-Ning
   Agrawal, Anshu
TI PDGF upregulates CLEC-2 to induce T regulatory cells
SO ONCOTARGET
LA English
DT Article
DE Clec-2; dendritic cell; platelets; T regulatory cells; PDGF; podoplanin;
   Immunology and Microbiology Section; Immune response; Immunity
ID TOLEROGENIC DENDRITIC CELLS; LECTIN-LIKE RECEPTORS; PLATELET ACTIVATION;
   TH17 CELLS; PODOPLANIN; ANGIOGENESIS; MECHANISM; NETWORKS; CD4(+);
   GROWTH
AB The effect of platelet derived growth factor (PDGF) on immune cells is not elucidated. Here, we demonstrate PDGF inhibited the maturation of human DCs and induced IL-10 secretion. Culture of PDGF-DCs with T cells induced the polarization of T cells towards FoxP3 expressing T regulatory cells that secreted IL-10. Gene expression studies revealed that PDGF induced the expression of C-type lectin like receptor member 2, (CLEC-2) receptor on DCs. Furthermore, DCs transfected with CLEC-2 induced T regulatory cells in DC-T cell co-culture. CLEC-2 is naturally expressed on platelets. Therefore, to confirm whether CLEC-2 is responsible for inducing the T regulatory cells, T cells were cultured with either CLEC-2 expressing platelets or soluble CLEC-2. Both conditions resulted in the induction of regulatory T cells. The generation of T regulatory cells was probably due to the binding of CLEC-2 with its ligand podoplanin on T cells, since crosslinking of podoplanin on the T cells also resulted in the induction of T regulatory cells. These data demonstrate that PDGF upregulates the expression of CLEC-2 on cells to induce T regulatory cells.
C1 [Agrawal, Sudhanshu; Ganguly, Sreerupa; Hajian, Pega; Cao, Jia-Ning; Agrawal, Anshu] Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA.
RP Agrawal, A (reprint author), Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA.
EM aagrawal@uci.edu
FU National Center for Research ResourcesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR); National Center for Advancing
   Translational Sciences, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1 TR000153];  [AG045216]
FX We are grateful to Dr. Steve Watson for providing the CLEC-2 plasmid and
   ICTS for the blood. The project described was supported by AG045216 to
   AA and National Center for Research Resources and the National Center
   for Advancing Translational Sciences, National Institutes of Health,
   through Grant UL1 TR000153. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   NIH.
CR Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814
   Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022
   Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912
   Agrawal A, 2012, AGING-US, V4, P648, DOI 10.18632/aging.100490
   Agrawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013418
   Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035
   Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x
   Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889
   Chong AS, 2014, IMMUNOL REV, V258, P80, DOI 10.1111/imr.12147
   Colonna M, 2000, EUR J IMMUNOL, V30, P697
   Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003
   Fujio K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00028
   Fujita N, 2012, J BIOCHEM, V152, P407, DOI 10.1093/jb/mvs108
   Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200
   Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501
   Hilkens CMU, 2010, INT REV IMMUNOL, V29, P156, DOI 10.3109/08830180903281193
   Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486
   Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228
   Jain RK, 2003, J CLIN INVEST, V112, P1134, DOI 10.1172/JCI200320087
   Kato Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05924
   Kramer PA, 2014, JOVE-J VIS EXP, DOI 10.3791/51301
   Liu X, 2005, MULT SCLER J, V11, P381, DOI 10.1191/1352458505ms1180oa
   Lowe KL, 2015, EUR J IMMUNOL, V45, P2484, DOI 10.1002/eji.201445314
   Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI 10.1016/S0065-2776(10)08004_1
   Martin E, 2007, ARTHRITIS RHEUM, V56, P2255, DOI 10.1002/art.22655
   Miyamoto Y, 2013, MOL IMMUNOL, V54, P199, DOI 10.1016/j.molimm.2012.11.013
   Motta JM, 2014, HUM IMMUNOL, V75, P641, DOI 10.1016/j.humimm.2014.04.013
   Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641
   Nagae M, 2014, STRUCTURE, V22, P1711, DOI 10.1016/j.str.2014.09.009
   Peters A, 2015, J CLIN INVEST, V125, P129, DOI 10.1172/JCI74685
   Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015
   Pyz E, 2006, ANN MED, V38, P242, DOI 10.1080/07853890600608985
   Sierko E, 2004, SEMIN THROMB HEMOST, V30, P95
   Smigiel KS, 2014, IMMUNOL REV, V259, P40, DOI 10.1111/imr.12170
   Sobanov Y, 2001, EUR J IMMUNOL, V31, P3493, DOI 10.1002/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9
   Sridharan A, 2011, AGE, V33, P363, DOI 10.1007/s11357-010-9191-3
   Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468
   Steinman RM, 2010, EUR J IMMUNOL, V40, P2085, DOI 10.1002/eji.201040733
   Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994
   Suzuki-Inoue K, 2011, J THROMB HAEMOST, V9, P44, DOI 10.1111/j.1538-7836.2011.04335.x
   Thomson AW, 2008, ANN RHEUM DIS, V67, P90, DOI 10.1136/ard.2008.099176
   Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015
   Trabanelli S, 2011, CURR MED CHEM, V18, P2234, DOI 0929-8673/11 $58.00+.00
   Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257
   Tsirakis G, 2012, HEMATOL ONCOL, V30, P131, DOI 10.1002/hon.1014
NR 45
TC 15
Z9 15
U1 0
U2 1
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD OCT 6
PY 2015
VL 6
IS 30
BP 28621
EP 28632
DI 10.18632/oncotarget.5765
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA CU0CL
UT WOS:000363183200019
PM 26416420
OA Green Published, Bronze, Other Gold
DA 2020-05-07
ER

PT J
AU Hossain, L
   Karimi, F
   Wigand, RT
AF Hossain, Liaquat
   Karimi, Faezeh
   Wigand, Rolf T.
TI Dynamics of a Global Zoonotic Research Network Over 33 Years (1980-2012)
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE animal diseases; capacity building; civil defense; communication;
   education; public health professional
ID INFECTIOUS-DISEASES; CENTRALITY
AB Objective: The increasing rate of outbreaks in humans of zoonotic diseases requires detailed examination of the education, research, and practice of animal health and its connection to human health. This study investigated the collaboration network of different fields engaged in conducting zoonotic research from a transdisciplinary perspective.
   Methods: Examination of the dynamics of this network for a 33-year period from 1980 to 2012 is presented through the development of a large scientometric database from Scopus. In our analyses we compared several properties of these networks, including density, clustering coefficient, giant component, and centrality measures over time. We also elicited patterns in different fields of study collaborating with various other fields for zoonotic research.
   Results: We discovered that the strongest collaborations across disciplines are formed among the fields of medicine; biochemistry, genetics, and molecular biology; immunology and microbiology; veterinary; agricultural and biological sciences; and social sciences. Furthermore, the affiliation network is growing overall in terms of collaborative research among different fields of study such that more than two-thirds of all possible collaboration links among disciplines have already been formed.
   Conclusions: Our findings indicate that zoonotic research scientists in different fields (human or animal health, social science, earth and environmental sciences, engineering) have been actively collaborating with each other over the past 11 years.
C1 [Hossain, Liaquat] Univ Hong Kong, Fac Educ, Div Informat & Technol Studies, Pokfulam, Hong Kong, Peoples R China.
   [Karimi, Faezeh] Univ Sydney, Fac Engn & Informat Technol, Complex Syst Res & Project Management Program, Sydney, NSW 2006, Australia.
   [Wigand, Rolf T.] Univ Arkansas, Dept Informat Sci, Little Rock, AR 72204 USA.
RP Hossain, L (reprint author), Univ Hong Kong, Fac Educ, Div Informat & Technol Studies, Pokfulam, Hong Kong, Peoples R China.
EM lhossain@hku.hk
RI ; /E-7946-2010
OI Karimi, Faezeh/0000-0002-3343-4054; /0000-0002-7616-9182
CR Abbasi A, 2011, LECT NOTES COMPUT SC, V6882, P256, DOI 10.1007/978-3-642-23863-5_26
   Abbasi A, 2011, SCIENTOMETRICS, V89, P687, DOI 10.1007/s11192-011-0463-1
   [Anonymous], 1959, World Health Organ Tech Rep Ser, V58, P1
   Bliziotis IA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-16
   Borgatti S. P., 2002, UCINET WINDOWS SOFTW
   Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008
   Easley David A., 2010, NETWORKS CROWDS MARK
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Garg KC, 2009, HEALTH INFO LIBR J, V26, P22, DOI 10.1111/j.1471-1842.2008.00779.x
   Patra SK, 2007, LIBR INFORM SCI RES, V29, P124, DOI 10.1016/j.lisr.2006.08.010
   Ramos JM, 2008, INT J TUBERC LUNG D, V12, P1461
   Ramos JM, 2009, EUR J CLIN MICROBIOL, V28, P713, DOI 10.1007/s10096-008-0691-3
   Ramos JM, 2004, EUR J CLIN MICROBIOL, V23, P180, DOI 10.1007/s10096-003-1074-4
   Romo-Fernandez LM, 2013, SCIENTOMETRICS, V97, P743, DOI 10.1007/s11192-013-1009-5
   Scott J., 2000, SOCIAL NETWORK ANAL
   Takahashi-Omoe H., 2012, INSIGHT CONTROL INFE
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Universities and Colleges Admissions Services and Higher Education Statistics Agency, JOINT AC COD SYST JA
   Uthman OA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-19
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2009, PRO INT CONF SCI INF, V2, P886
   *WHO, ZOON HUM AN EC INT
   World Health Organization, DIS OUTBR NEWS DONS
NR 23
TC 1
Z9 1
U1 0
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD OCT
PY 2015
VL 9
IS 5
BP 496
EP 503
DI 10.1017/dmp.2015.58
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF0NK
UT WOS:000371035600008
PM 26212618
DA 2020-05-07
ER

PT J
AU Beermann, S
   Allerberger, F
   Wirtz, A
   Burger, R
   Hamouda, O
AF Beermann, Sandra
   Allerberger, Franz
   Wirtz, Angela
   Burger, Reinhard
   Hamouda, Osamah
TI Public health microbiology in Germany: 20 years of national reference
   centers and consultant laboratories
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE Germany Public health microbiology laboratories; National reference
   centers (NRCs); consultant laboratories (CLs); National networks
ID DISEASE OUTBREAK; INFECTIONS; DIAGNOSTICS; VACCINE
AB In 1995, in agreement with the German Federal Ministry of Health, the Robert Koch Institute established a public health microbiology system consisting of national reference centers (NRCs) and consultant laboratories (CLs). The goal was to improve the efficiency of infection protection by advising the authorities on possible measures and to supplement infectious disease surveillance by monitoring selected pathogens that have high public health relevance. Currently, there are 19 NRCs and 40 CLs, each appointed for three years. In 2009, an additional system of national networks of NRCs and CLs was set up in order to enhance effectiveness and cooperation within the national reference laboratory system. The aim of these networks was to advance exchange in diagnostic methods and prevention concepts among reference laboratories and to develop geographic coverage of services. In the last two decades, the German public health laboratory reference system coped with all major infectious disease challenges. The European Union and the European Centre for Disease Prevention and Control (ECDC) are considering implementing a European public health microbiology reference laboratory system. The German reference laboratory system should be well prepared to participate actively in this upcoming endeavor. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Beermann, Sandra; Hamouda, Osamah] Robert Koch Inst, Dept Infect Dis Epidemiol, D-13353 Berlin, Germany.
   [Allerberger, Franz] Austrian Agcy Hlth & Food Safety, A-1220 Vienna, Austria.
   [Wirtz, Angela] Minist Social Affairs, Dept Publ Hlth, D-65187 Wiesbaden, Germany.
   [Burger, Reinhard] Robert Koch Inst, D-13353 Berlin, Germany.
RP Hamouda, O (reprint author), Robert Koch Inst, Dept Infect Dis Epidemiol, Seestr 10, D-13353 Berlin, Germany.
EM HamoudaO@rki.de
OI Allerberger, Franz/0000-0002-0045-8164
CR Allerberger F, 2013, BUNDESGESUNDHEITSBLA, V56, P22, DOI 10.1007/s00103-012-1579-z
   Beyrer K, 2007, EPIDEMIOL INFECT, V135, P802, DOI 10.1017/S0950268806007473
   European Centre for Disease Prevention and Control, 2010, COR FUNCT MICR REF L
   Fork R.R., 1995, Z ARZTL FORTBILD JEN, V89, P203
   Frank C, 2011, EUROSURVEILLANCE, V2011, P16
   Gilsdorf A., 2011, EUROSURVEILLANCE, V5, P16
   Kalies H, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-45
   Marcus U., 2013, EUROSURVEILLANCE, V11, P18
   Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254
   Petersen LR, 2000, EMERG INFECT DIS, V6, P576, DOI 10.3201/eid0606.000605
   Reuss A, 2014, EMERG INFECT DIS, V20, P620, DOI 10.3201/eid2004.131375
   Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057
   Sanchini A., 2014, EUROSURVEILLANCE, V19, P1
   Schmidt-Chanasit J., 2010, EUROSURVEILLANCE, V7, P15
   Schwab F, 2014, INFECTION, V42, P73, DOI 10.1007/s15010-013-0516-x
   Schweiger B, 2013, BUNDESGESUNDHEITSBLA, V56, P28, DOI 10.1007/s00103-012-1580-6
   van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848
   Witze A, 2014, NATURE, V512, P360, DOI [10.1038/512360a, 10.1038/516300a]
NR 18
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1438-4221
EI 1618-0607
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD OCT
PY 2015
VL 305
IS 7
BP 595
EP 600
DI 10.1016/j.ijmm.2015.08.007
PG 6
WC Microbiology; Virology
SC Microbiology; Virology
GA CV4QB
UT WOS:000364250500002
PM 26321004
OA Green Published
DA 2020-05-07
ER

PT J
AU de Barsy, M
   Bertelli, C
   Jacquier, N
   Kebbi-Beghdadi, C
   Greub, G
AF de Barsy, Marie
   Bertelli, Claire
   Jacquier, Nicolas
   Kebbi-Beghdadi, Carole
   Greub, Gilbert
TI ESCCAR international congress on Rickettsia and other intracellular
   bacteria
SO MICROBES AND INFECTION
LA English
DT Article
DE Intracellular bacteria; Rickettsia; Chlamydia; Chlamydia-related;
   Coxiella; Anaplasma
ID CHRONIC Q-FEVER; FRENCH-GUIANA; CHLAMYDIA-TRACHOMATIS; COMPARATIVE
   GENOMICS; CLINICAL-SAMPLES; BARTONELLA SPP.; SCRUB TYPHUS;
   IDENTIFICATION; HOST; EPIDEMIOLOGY
AB The European Society for the study of Chlamydia, Coxiella, Anaplasma and Rickettsia (ESCCAR) held his triennial international meeting in Lausanne. This meeting gathered 165 scientists from 28 countries and all 5 continents, allowing efficient networking and major scientific exchanges.
   Topics covered include molecular and cellular microbiology, genomics, as well as epidemiology, veterinary and human medicine. Several breakthroughs have been revealed at the meeting, such as (i) the presence of CRISPR (the "prokaryotic immune system") in chlamydiae, (ii) an Anaplasma effector involved in host chromatin remodelling, (iii) the polarity of the type Ill secretion system of chlamydiae during the entry process revealed by cryo-electron tomography.
   Moreover, the ESCCAR meeting was a unique opportunity to be exposed to cutting-edge science and to listen to comprehensive talks on current hot topics. (C) 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.
   Univ Lausanne, CH-1011 Lausanne, Switzerland.
RP Greub, G (reprint author), Univ Hosp Ctr, Inst Microbiol, CRIB, Bugnon 48, CH-1011 Lausanne, Switzerland.
EM gilbert.greub@chuv.ch
RI Bertelli, Claire/H-9609-2015; Greub, Gilbert/K-5804-2017; GREUB,
   Gilbert/S-4677-2019
OI Bertelli, Claire/0000-0003-0550-8981; Greub,
   Gilbert/0000-0001-9529-3317; GREUB, Gilbert/0000-0001-9529-3317;
   Jacquier, Nicolas/0000-0002-1974-8161
CR Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269
   Aeberhard L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004883
   Bachmann NL, 2015, J CLIN MICROBIOL, V53, P1573, DOI 10.1128/JCM.03534-14
   Ball SG, 2015, BBA-BIOENERGETICS, V1847, P495, DOI 10.1016/j.bbabio.2015.02.007
   Barten DG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-413
   Bertelli C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00101
   Biswas S, 2008, INT J ANTIMICROB AG, V32, P207, DOI 10.1016/j.ijantimicag.2008.03.017
   Carrasco SE, 2014, VECTOR-BORNE ZOONOT, V14, P831, DOI 10.1089/vbz.2014.1612
   Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171
   Croxatto A, 2014, TICKS TICK-BORNE DIS, V5, P359, DOI 10.1016/j.ttbdis.2013.11.009
   de Barsy M, 2013, MICROBES INFECT, V15, P1033, DOI 10.1016/j.micinf.2013.09.010
   de Barsy M, 2013, BRIEF FUNCT GENOMICS, V12, P341, DOI 10.1093/bfgp/elt012
   Deng HK, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-15
   Derne B, 2015, ACTA TROP, V143, P121, DOI 10.1016/j.actatropica.2014.10.012
   Dieme C, 2015, P NATL ACAD SCI USA, V112, P8088, DOI 10.1073/pnas.1413835112
   Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041
   Dugat T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-973
   Eldin C, 2015, AM J TROP MED HYG, V92, P979, DOI 10.4269/ajtmh.14-0751
   Eldin C, 2014, AM J TROP MED HYG, V91, P771, DOI 10.4269/ajtmh.14-0282
   Facchinelli F, 2013, TRENDS PLANT SCI, V18, P673, DOI 10.1016/j.tplants.2013.09.006
   Flores-Ramirez G, 2014, PROTEOMICS, V14, P1868, DOI 10.1002/pmic.201300338
   Gorvel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099420
   Graves S, 2006, ANN NY ACAD SCI, V1078, P74, DOI 10.1196/annals.1374.008
   Hammac GK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-193
   Huang B, 2010, CELL MICROBIOL, V12, P1292, DOI 10.1111/j.1462-5822.2010.01468.x
   IChrouf F, 2014, J CLIN MICROBIOL, V52, P268
   Jacquier N, 2015, FEMS MICROBIOL REV, V39, P262, DOI 10.1093/femsre/fuv001
   Johnston KL, 2014, INT J PARASITOL-DRUG, V4, P278, DOI 10.1016/j.ijpddr.2014.09.001
   Kebbi-Beghdadi C, 2015, PATHOG DIS, P73
   Kehoe SP, 2014, EMERG INFECT DIS, V20, P2133, DOI 10.3201/eid2012.140578
   Keller CA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003064
   Kernif T, 2012, TICKS TICK-BORNE DIS, V3, P379, DOI 10.1016/j.ttbdis.2012.10.012
   Letaief A, 2006, ANN NY ACAD SCI, V1078, P34, DOI 10.1196/annals.1374.004
   Magouras I., 2015, TRANSBOUND EMERG DIS
   Mahamat A, 2013, EMERG INFECT DIS, V19, P1102, DOI 10.3201/eid1907.130044
   Marwaha S, 2014, ANTIMICROB AGENTS CH, V58, P2968, DOI 10.1128/AAC.02015-13
   Maurer FP, 2013, J CLIN MICROBIOL, V51, P169, DOI 10.1128/JCM.01955-12
   McDonough JA, 2013, MBIO, V4, DOI 10.1128/mBio.00606-12
   McGready R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003327
   Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718
   Million M, 2015, J INFECTION, V71, pS2, DOI 10.1016/j.jinf.2015.04.024
   Minnick MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002919
   Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325
   Moniuszko A, 2014, TICKS TICK-BORNE DIS, V5, P415, DOI 10.1016/j.ttbdis.2014.01.010
   Nans A, 2014, CELL MICROBIOL, V16, P1457, DOI 10.1111/cmi.12310
   Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286
   Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405
   Niemi S, 2011, MICROBES INFECT, V13, P824, DOI 10.1016/j.micinf.2011.04.012
   Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112
   Omsland A, 2014, FEMS MICROBIOL REV, V38, P779, DOI 10.1111/1574-6976.12059
   Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035
   Patel P, 2014, MICROBES INFECT, V16, P690, DOI 10.1016/j.micinf.2014.07.003
   Pierle SA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-669
   Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197
   Raoult D, 2012, J INFECTION, V65, P102, DOI 10.1016/j.jinf.2012.04.006
   Rennoll-Bankert KE, 2015, CELL MICROBIOL
   Schoffelen T, 2014, CLIN MICROBIOL INFEC, V20, P642, DOI 10.1111/1469-0691.12423
   Sentausa E, 2013, GENOME ANNOUNC, P1
   Seth-Smith HMB, 2013, NAT PROTOC, V8, P2404, DOI 10.1038/nprot.2013.147
   Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112
   Siamer S, 2015, CURR OPIN MICROBIOL, V23, P80, DOI 10.1016/j.mib.2014.11.007
   Stekhoven DJ, 2014, J PROTEOMICS, V99, P123, DOI 10.1016/j.jprot.2014.01.015
   Taylor-Brown A, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu009
   Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624
   Thomas V, 2011, ENVIRON MICROBIOL, V13, P1454, DOI 10.1111/j.1462-2920.2011.02446.x
   Thwaites T, 2014, J BIOL CHEM, V289, P30426, DOI 10.1074/jbc.M114.604876
   Wang YB, 2014, PATHOG DIS, V72, P19, DOI 10.1111/2049-632X.12175
   Wang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059195
   Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258
   Yssouf A, 2014, COMP IMMUNOL MICROB, V37, P153, DOI 10.1016/j.cimid.2014.05.002
NR 70
TC 1
Z9 1
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD OCT
PY 2015
VL 17
IS 10
BP 680
EP 688
DI 10.1016/j.micinf.2015.07.002
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CU8VM
UT WOS:000363822200003
PM 26297854
DA 2020-05-07
ER

PT J
AU Smit, PW
   Lindholm, L
   Lyytikainen, O
   Jalava, J
   Patari-Sampo, A
   Vuopio, J
AF Smit, P. W.
   Lindholm, L.
   Lyytikainen, O.
   Jalava, J.
   Patari-Sampo, A.
   Vuopio, J.
TI Epidemiology and emm types of invasive group A streptococcal infections
   in Finland, 2008-2013
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
ID SUPERANTIGEN PROFILES; PYOGENES DISEASE; RESISTANCE; EUROPE
AB Invasive Streptococcus pyogenes (group A streptococcus, GAS) infections are a major global cause of morbidity and mortality. We analysed the surveillance data on invasive GAS and the microbiological characteristics of corresponding isolates to assess the incidence and emm type distribution of invasive GAS infections in Finland. Cases defined as patients with isolations of blood and cerebrospinal fluid S. pyogenes are mandatorily notified to the National Infectious Disease Registry and sent to the national reference laboratory for emm typing. Antimicrobial data were collected through the network including all clinical microbiology laboratories. Pulsed-field gel electrophoresis (PFGE) analysis was performed to assess clonality. In total, 1165 cases of invasive GAS were reported in Finland during 2008-2013; the median age was 52 years (range, 0-100) and 54 % were male. The overall day 7 case fatality rate was 5.1 % (59 cases). The average annual incidence was 3.6 cases per 100,000 population. A total of 1122 invasive GAS isolates (96 %) were analysed by emm typing; 72 different emm types were identified, of which emm28 (297 isolates, 26 %), emm89 (193 isolates, 12 %) and emm1 (132 isolates, 12 %) were the most common types. During 2008-2013, an increase of erythromycin resistance (1.9 % to 8.7 %) and clindamycin (0.9 % to 9.2 %) was observed. This resistance increase was in parallel with the introduction of a novel clone emm33 into Finland. The overall incidence of invasive GAS infections remained stable over the study period in Finland. We identified clonal spread of macrolide-resistant invasive emm33 GAS type, highlighting the importance of molecular surveillance.
C1 [Smit, P. W.] European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden.
   [Smit, P. W.] Natl Inst Hlth & Welf, Dept Infect Dis, Helsinki, Finland.
   [Lindholm, L.; Jalava, J.; Vuopio, J.] Natl Inst Hlth & Welf, Bacterial Infect Unit, Dept Infect, Turku, Finland.
   [Lyytikainen, O.] Natl Inst Hlth & Welf, Infect Dis Control Unit, Dept Infect, Helsinki, Finland.
   [Patari-Sampo, A.] Helsinki Univ Hosp, Div Clin Microbiol, HUSLAB, Helsinki, Finland.
   [Vuopio, J.] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland.
RP Smit, PW (reprint author), European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden.
EM pieterwsmit@gmail.com
FU Academy of FinlandAcademy of Finland [255636]
FX The authors would like to thank Androulla Efstratiou and Aftab Jasir for
   critically reading the manuscript, the Finnish Study Group for
   Antimicrobial Resistance (FiRe), and Tuula Rantasalo and Toni Huovinen
   for the excellent technical assistance. This study was supported, in
   part, by the Academy of Finland (255636).
CR Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660
   Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896
   Darenberg J, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.14.20443
   Deresinski S., 2014, CLIN INFECT DIS, V59, piii, DOI DOI 10.1093/CID/CIU351
   Douthwaite S, 2005, MOL MICROBIOL, V58, P613, DOI 10.1111/j.1365-2958.2005.04863.x
   Gunell M, 2014, ANTIMICROBIAL RESIST
   Guy R, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.12.20749
   Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08
   Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08
   Meehan M, 2013, EUROSURVEILLANCE, P18
   Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09
   Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111
   Olafsdottir LB, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.17.20784
   Pesola AK, 2015, EURO SURVEILL, V20
   Rantala S, 2012, EUR J CLIN MICROBIOL, V31, P859, DOI 10.1007/s10096-011-1385-9
   Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701
   Siljander T, 2010, EUR J CLIN MICROBIOL, V29, P1229, DOI 10.1007/s10096-010-0989-9
   Siljander T, 2008, CLIN INFECT DIS, V46, P855, DOI 10.1086/527388
   Siljander T, 2009, J CLIN MICROBIOL, V47, P477, DOI 10.1128/JCM.01663-08
   Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1
   Syrogiannopoulos GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071558
   Turner CE, 2015, MBIO, V6, DOI 10.1128/mBio.00622-15
   Vahakuopus S, 2012, EUR J CLIN MICROBIOL, V31, P1251, DOI 10.1007/s10096-011-1436-2
   Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13
NR 24
TC 19
Z9 19
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD OCT
PY 2015
VL 34
IS 10
BP 2131
EP 2136
DI 10.1007/s10096-015-2462-2
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CR1FX
UT WOS:000361071400028
PM 26292935
DA 2020-05-07
ER

PT J
AU Moreira, DD
   Pescher, P
   Laurent, C
   Lenormand, P
   Spath, GF
   Murta, SMF
AF Moreira, Douglas de Souza
   Pescher, Pascale
   Laurent, Christine
   Lenormand, Pascal
   Spaeth, Gerald F.
   Murta, Silvane M. F.
TI Phosphoproteomic analysis of wild-type and antimony-resistant Leishmania
   braziliensis lines by 2D-DIGE technology
SO PROTEOMICS
LA English
DT Article
DE Antimony resistance; 2D-DIGE; L. braziliensis; Microbiology;
   Phosphoproteomic analysis; SbIII
ID PROTOZOAN PARASITE LEISHMANIA; TRYPAREDOXIN PEROXIDASE;
   TRYPANOSOMA-CRUZI; DRUG-RESISTANCE; MOLECULAR CHARACTERIZATION;
   PROTEIN-PHOSPHORYLATION; PROTEOMIC ANALYSIS; INFANTUM-CHAGASI;
   GENE-EXPRESSION; DONOVANI
AB Protein phosphorylation is one of the most studied post-translational modifications that is involved in different cellular events in Leishmania. In this study, we performed a comparative phosphoproteomics analysis of potassium antimonyl tartrate (SbIII)-resistant and -susceptible lines of Leishmania braziliensis using a 2D-DIGE approach followed by MS. In order to investigate the differential phosphoprotein abundance associated with the drug-induced stress response and SbIII-resistance mechanisms, we compared nontreated and SbIII-treated samples of each line. Pair wise comparisons revealed a total of 116 spots that showed a statistically significant difference in phosphoprotein abundance, including 11 and 34 spots specifically correlated with drug treatment and resistance, respectively. We identified 48 different proteins distributed into seven biological process categories. The category "protein folding/chaperones and stress response" is mainly implicated in response to SbIII treatment, while the categories "antioxidant/detoxification," "metabolic process," "RNA/DNA processing," and "protein biosynthesis" aremodulated in the case of antimony resistance. Multiple sequence alignments were performed to validate the conservation of phosphorylated residues in nine proteins identified here. Western blot assays were carried out to validate the quantitative phosphoproteome analysis. The results revealed differential expression level of three phosphoproteins in the lines analyzed. This novel study allowed us to profile the L. braziliensis phosphoproteome, identifying several potential candidates for biochemical or signaling networks associated with antimony resistance phenotype in this parasite.
C1 [Moreira, Douglas de Souza; Murta, Silvane M. F.] Ctr Pesquisas Rene Rachou CPqRR Fiocruz, Lab Parasitol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
   [Pescher, Pascale; Spaeth, Gerald F.] Inst Pasteur, Unite Parasitol Mol & Signalisat, CNRS URA2581, Paris, France.
   [Laurent, Christine; Lenormand, Pascal] Inst Pasteur, Dept Struct Biol & Chem, Pasteur Genopole Ile de France, Plate Forme Proteom, Paris, France.
RP Murta, SMF (reprint author), Ctr Pesquisas Rene Rachou CPqRR Fiocruz, Lab Parasitol Celular & Mol, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM silvane@cpqrr.fiocruz.br
OI Spaeth, Gerald/0000-0002-0256-2029
FU Institut Pasteur/FIOCRUZ funding; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [CNPq/Universal 475782/2012-7];
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [CBB-PPM 00536/11, 00196/13];
   UNICEF/UNDP/World Bank/WHO (TDR)World Health Organization; P3D-Programa
   de Descoberta e Desenvolvimento de Drogas [PROEP/CNPq/FIOCRUZ
   401988/2012-0]; CNPq (National Council for the Development of Research
   of Brazil)National Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq) [140435/2013-1]
FX The authors wish to thank Dr. Fernanda Nogueira, and MSc. Nayara
   Tessarolo for kindly providing the polyclonal antibodies anti-cTcTXNPx,
   and anti-LbKMP-11, respectively. The authors thank the Program for
   Technological Development in Tools for Health-PDTIS-FIOCRUZ for use of
   its facilities. This investigation received financial support from the
   following agencies: Institut Pasteur/FIOCRUZ funding, Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq/Universal
   475782/2012-7), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG - CBB-PPM 00536/11 and 00196/13), UNICEF/UNDP/World Bank/WHO
   (TDR) and P3D-Programa de Descoberta e Desenvolvimento de Drogas
   (PROEP/CNPq/FIOCRUZ 401988/2012-0). S.M.F. Murta is research fellows
   supported by CNPq (National Council for the Development of Research of
   Brazil) and D.S. Moreira by CNPq (140435/2013-1).
CR Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0
   Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1768-1797.2006, 10.1128/AAC.50.5.1788-1797.2006]
   BERMAN JD, 1985, ANTIMICROB AGENTS CH, V27, P916, DOI 10.1128/AAC.27.6.916
   BERMAN JD, 1987, BIOCHEM PHARMACOL, V36, P197, DOI 10.1016/0006-2952(87)90689-7
   BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7
   Biyani N, 2011, MOL BIOCHEM PARASIT, V179, P91, DOI 10.1016/j.molbiopara.2011.06.004
   Brotherton MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081899
   CHRISTEN RD, 1994, CANCER METAST REV, V13, P175, DOI 10.1007/BF00689635
   Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007
   Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6
   Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI [10.1128/CMR.19.1.111-126.2006, 10.4103/0974-777X.62887]
   Cuervo P, 2010, J PROTEOMICS, V73, P845, DOI 10.1016/j.jprot.2009.12.012
   Daneshvar H, 2012, J PROTEOMICS, V75, P1463, DOI 10.1016/j.jprot.2011.11.018
   Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200
   DUNCAN R, 1984, J BIOL CHEM, V259, P1882
   El Fadili K, 2009, EXP PARASITOL, V123, P51, DOI 10.1016/j.exppara.2009.05.013
   Folgueira C, 2007, FEMS MICROBIOL REV, V31, P359, DOI 10.1111/j.1574-6976.2007.00069.x
   Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001
   GLOVER CVC, 1982, P NATL ACAD SCI-BIOL, V79, P1781, DOI 10.1073/pnas.79.6.1781
   Pelaez RG, 2012, BIOMEDICA, V32, P418, DOI [10.1590/S0120-41572012000300012, 10.7705/biomedica.v32i3.392]
   Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6
   Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162
   Hem S, 2010, PROTEOMICS, V10, P3868, DOI 10.1002/pmic.201000305
   Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2
   Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040
   Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007
   Jayanarayan KG, 2002, PARASITOL RES, V88, P754, DOI 10.1007/s00436-002-0632-5
   Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740
   KRISHNAN HB, 1987, BIOCHEM BIOPH RES CO, V148, P762, DOI 10.1016/0006-291X(87)90941-7
   Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x
   Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069
   Liarte DB, 2010, PARASITOL RES, V107, P205, DOI 10.1007/s00436-010-1852-8
   Lin YC, 2005, MOL BIOCHEM PARASIT, V142, P66, DOI 10.1016/j.molbiopara.2005.03.009
   Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896
   Luis L, 2013, BIOMED RES INT, DOI 10.1155/2013/843748
   MAHER PA, 1989, J CELL BIOL, V108, P2029, DOI 10.1083/jcb.108.6.2029
   Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3
   Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014
   Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006
   McKean PG, 2001, J CELL SCI, V114, P2723
   Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104
   Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697
   Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107
   Moreira DS, 2013, INT J PARASITOL-DRUG, V3, P143, DOI 10.1016/j.ijpddr.2013.08.001
   Nakayasu ES, 2009, PROTEOMICS, V9, P3489, DOI 10.1002/pmic.200800874
   Nare B, 2009, CURR GENET, V55, P287, DOI 10.1007/s00294-009-0244-z
   Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200
   Nogueira F, 2009, PARASITOL RES, V104, P835, DOI 10.1007/s00436-008-1264-1
   Ouellette M, 2002, INT J PARASITOL, V32, P385, DOI 10.1016/S0020-7519(01)00346-0
   Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127
   Pescher P, 2011, CELL MICROBIOL, V13, P978, DOI 10.1111/j.1462-5822.2011.01593.x
   Ponte-Sucre A., 2003, KINETOPLASTID BIOL D, V28, P2, DOI DOI 10.1186/1475-9292-2-14
   Raggiaschi R, 2005, BIOSCIENCE REP, V25, P33, DOI 10.1007/s10540-005-2846-0
   Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043
   Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001
   Shaw JJ, 2006, MEM I OSWALDO CRUZ, V101, P577, DOI 10.1590/S0074-02762006000500017
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.3.CO;2-M
   Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200
   Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x
   Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017
   Thakur CP, 2004, INDIAN J MED RES, V120, P166
   Tsigankov P, 2014, MOL CELL PROTEOMICS, V13, P1787, DOI 10.1074/mcp.M114.037705
   Tsigankov P, 2013, J PROTEOME RES, V12, P3405, DOI 10.1021/pr4002492
   Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021
   Vergnes B, 2007, MOL CELL PROTEOMICS, V6, P88, DOI 10.1074/mcp.M600319-MCP200
   Walker J, 2006, MOL BIOCHEM PARASIT, V145, P254, DOI 10.1016/j.molbiopara.2005.10.008
   Walker J, 2012, MOL BIOCHEM PARASIT, V183, P166, DOI 10.1016/j.molbiopara.2012.03.002
   WANDOSELL F, 1987, J BIOL CHEM, V262, P8268
   Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200
   Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07
   Wyllie S, 2010, MOL BIOCHEM PARASIT, V173, P162, DOI 10.1016/j.molbiopara.2010.05.015
   Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492
   Zilberstein D, 2015, METHODS MOL BIOL, V1201, P261, DOI 10.1007/978-1-4939-1438-8_16
NR 75
TC 13
Z9 13
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD SEP
PY 2015
VL 15
IS 17
BP 2999
EP 3019
DI 10.1002/pmic.201400611
PG 21
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CQ9WM
UT WOS:000360965900013
PM 25959087
DA 2020-05-07
ER

PT J
AU Hare, NJ
   Chan, B
   Chan, E
   Kaufman, KL
   Britton, WJ
   Saunders, BM
AF Hare, Nathan J.
   Chan, Brian
   Chan, Edwina
   Kaufman, Kimberley L.
   Britton, Warwick J.
   Saunders, Bernadette M.
TI Microparticles released from Mycobacterium tuberculosis-infected human
   macrophages contain increased levels of the type I interferon inducible
   proteins including ISG15
SO PROTEOMICS
LA English
DT Article
DE Macrophage; Microbiology; Microparticle; Mycobacterium tuberculosis
ID PHAGOSOME MATURATION; MICROVESICLES; LYMPHOCYTES; CONJUGATION;
   RESISTANCE; INDUCTION; INFLUENZA; VESICLES; IMMUNITY; GAMMA
AB Microparticles (MPs) are small membranous particles (100-1000 nm) released under normal steady-state conditions and are thought to provide a communication network between host cells. Previous studies demonstrated that Mycobacterium tuberculosis (M. tb) infection of macrophages increased the release of MPs, and these MPs induced a proinflammatory response from un-infected macrophages in vitro and in vivo following their transfer into uninfected mice. To determine how M. tb infection modulates the protein composition of the MPs, and if this contributes to their proinflammatory properties, we compared the proteomes of MPs derived from M. tb-infected (TBinf-MP) and uninfected human THP-1 monocytic cells. MP proteins were analyzed by GeLC-MS/MS with spectral counting revealing 68 proteins with statistically significant differential abundances. The 42 proteins increased in abundance in TBinf-MPs included proteins associated with immune function (7), lysosomal/endosomal maturation (4), vesicular formation (12), nucleosome proteins (4), and antigen processing (9). Prominent among these were the type I interferon inducible proteins, ISG15, IFIT1, IFIT2, and IFIT3. Exposure of uninfected THP-1 cells to TBinf-MPs induced increased gene expression of isg15, ifit1, ifit2, and ifit3 and the release of proinflammatory cytokines. These proteins may regulate the proinflammatory potential of the MPs and provide candidate biomarkers for M. tb infection.
C1 [Hare, Nathan J.; Chan, Brian; Chan, Edwina; Britton, Warwick J.; Saunders, Bernadette M.] Univ Sydney, Sydney Med Sch, Disciplines Med Infect Dis & Immunol, TB Res Program, Newtown, NSW, Australia.
   [Kaufman, Kimberley L.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Saunders, Bernadette M.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia.
RP Hare, NJ (reprint author), Centenary Inst, TB Res Program, Locked Bag 6, Newtown, NSW 2042, Australia.
EM N.hare@centenary.org.au
RI Kaufman, Kimberley/K-8776-2019; Kaufman, Kimberley/G-2632-2011
OI Kaufman, Kimberley/0000-0002-7239-039X; Kaufman,
   Kimberley/0000-0002-7239-039X; Saunders, Bernadette/0000-0003-0540-4445
FU NHMRC Centre for Research Excellence in Tuberculosis ControlNational
   Health and Medical Research Council of Australia [APP1043225];
   NHMRCNational Health and Medical Research Council of Australia
   [APP570771]
FX This work was funded in part by the NHMRC Centre for Research Excellence
   in Tuberculosis Control (APP1043225) (www.tbcre.org.au) and NHMRC
   project grant (APP570771). Mass spectrometry analysis was conducted at
   the Sydney University Proteomics Research Unit (SUPRU), The University
   of Sydney, and at the Bioanalytical Mass Spectrometry Facility (BMSF) at
   the University of New South Wales. We thank Dr. Valery Combes, Prof
   Georges Grau, and Dr. Ben Crossett for helpful discussions.
CR Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630
   Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026
   Dauphinee SM, 2014, GENES IMMUN, V15, P282, DOI 10.1038/gene.2014.17
   DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211
   Deshpande NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022170
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132
   Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.3.CO;2-W
   Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793
   Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006
   Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701
   Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   KNIGHT E, 1991, J IMMUNOL, V146, P2280
   Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407
   Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104
   Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200
   Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428
   Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828
   Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839
   Pham TV, 2012, BIOINFORMATICS, V28, pI596, DOI 10.1093/bioinformatics/bts394
   Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1
   Puiffe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054589
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787
   Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800
   Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143
   Taki S, 2002, CYTOKINE GROWTH F R, V13, P379, DOI 10.1016/S1359-6101(02)00023-0
   Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07
   Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326
   Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x
   Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
   Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801
   Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102
NR 42
TC 12
Z9 12
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD SEP
PY 2015
VL 15
IS 17
BP 3020
EP 3029
DI 10.1002/pmic.201400610
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CQ9WM
UT WOS:000360965900014
PM 26036210
DA 2020-05-07
ER

PT J
AU Moehring, RW
   Hazen, KC
   Hawkins, MR
   Drew, RH
   Sexton, DJ
   Anderson, DJ
AF Moehring, Rebekah W.
   Hazen, Kevin C.
   Hawkins, Myra R.
   Drew, Richard H.
   Sexton, Daniel J.
   Anderson, Deverick J.
TI Challenges in Preparation of Cumulative Antibiogram Reports for
   Community Hospitals
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID ANTIMICROBIAL SUSCEPTIBILITY DATA; LABORATORY STANDARDS INSTITUTE;
   UNITED-STATES; GUIDELINES
AB Knowledge of local antimicrobial resistance is critical for management of infectious diseases. Community hospitals' compliance with Clinical and Laboratory Standards Institute (CLSI) guidance for creation of cumulative antibiograms is uncertain. This descriptive cohort study of antibiogram reporting practices included community hospitals enrolled in the Duke Infection Control Outreach Network. Cumulative antibiograms from 2012 were reviewed for criteria on reporting practices and compliance with CLSI guidelines. Microbiology personnel were sent a voluntary, electronic survey on antibiogram preparation practices. Data were compiled using descriptive statistics. Thirty-two of 37 (86%) hospitals provided antibiograms; 26 of 37 (70%) also provided survey responses. Twelve (38%) antibiograms specified methods used for compiling data and exclusion of duplicates. Eight (25%) reported only species with >30 isolates. Of the 24 that did not follow the 30-isolate rule, 3 (13%) included footnotes to indicate impaired statistical validity. Twenty (63%) reported at least 1 pathogen-drug combination not recommended for primary or supplemental testing per CLSI. Thirteen (41%) separately reported methicillin-resistant and -susceptible Staphylococcus aureus. Complete compliance with CLSI guidelines was observed in only 3 (9%) antibiograms. Survey respondents' self-assessment of full or partial compliance with CLSI guidelines was 50% and 15%, respectively; 33% reported uncertainty with CLSI guidelines. Full adherence to CLSI guidelines for hospital antibiograms was uncommon. Uncertainty about CLSI guidelines was common. Alternate strategies, such as regional antibiograms using pooled data and educational outreach efforts, are needed to provide reliable and appropriate susceptibility estimates for community hospitals.
C1 [Moehring, Rebekah W.; Drew, Richard H.; Sexton, Daniel J.; Anderson, Deverick J.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.
   [Moehring, Rebekah W.; Hawkins, Myra R.; Drew, Richard H.; Sexton, Daniel J.; Anderson, Deverick J.] Duke Infect Control Outreach Network, Durham, NC USA.
   [Moehring, Rebekah W.; Hawkins, Myra R.; Drew, Richard H.; Sexton, Daniel J.; Anderson, Deverick J.] Duke Antimicrobial Stewardship Outreach Network, Durham, NC USA.
   [Moehring, Rebekah W.] Durham Vet Affairs Med Ctr, Dept Med, Div Infect Dis, Durham, NC USA.
   [Hazen, Kevin C.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
   [Drew, Richard H.] Campbell Univ, Coll Pharm & Hlth Sci, Buies Creek, NC 27506 USA.
RP Moehring, RW (reprint author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.
EM rebekah.moehring@duke.edu
OI Anderson, Deverick/0000-0001-6882-5496
FU Duke Endowment; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K23 AI095357];
   AHRQUnited States Department of Health & Human ServicesAgency for
   Healthcare Research & Quality [K08 HS023866-01]; bioMerieux, Inc.;
   CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA
FX This study was funded by a grant from The Duke Endowment to D.J.S. and
   R.W.M. D.J.A. was supported by NIH K23 AI095357. R.W.M. was supported by
   AHRQ K08 HS023866-01.; Rebekah W. Moehring has no direct conflicts. She
   has received royalties from UpToDate, Inc. Kevin C. Hazen has no direct
   conflicts. He has received research support from bioMerieux, Inc. Myra
   R. Hawkins has no conflicts. Richard H. Drew has no direct conflicts. He
   has received royalties from UpToDate, Inc.; development royalties from
   CustomID; and speaker honoraria from both Vemco Medical Education and
   the American Society for Microbiology. Daniel J. Sexton has no direct
   conflicts. He has received research support from CDC and royalties from
   UpToDate, Inc. Deverick J. Anderson has no direct conflicts. He has
   received royalties from UpToDate, Inc.
CR Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940
   Boehme MS, 2010, PUBLIC HEALTH REP, V125, P63, DOI 10.1177/00333549101250S208
   Centers for Disease Control and Prevention, 2013, CENT DIS CONTR PREV
   Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI
   Clinical and Laboratory Standards Institute, 2009, M39A3 CLSI
   Ernst EJ, 2004, DIAGN MICR INFEC DIS, V49, P141, DOI 10.1016/j.diagmicrobio.2004.03.007
   Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864
   Lautenbach E, 2006, INFECT CONT HOSP EP, V27, P409, DOI 10.1086/503342
   National Committee for Clinical Laboratory Standards, 2002, M39A NCCLS
   Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093
   Standiford HC, 2012, INFECT CONT HOSP EP, V33, P338, DOI 10.1086/664909
   Xu R, 2012, AM J HEALTH-SYST PH, V69, P598, DOI 10.2146/ajhp110332
   Zapantis A, 2005, J CLIN MICROBIOL, V43, P2629, DOI 10.1128/JCM.43.6.2629-2634.2005
NR 13
TC 15
Z9 16
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 2015
VL 53
IS 9
BP 2977
EP 2982
DI 10.1128/JCM.01077-15
PG 6
WC Microbiology
SC Microbiology
GA CW6TE
UT WOS:000365129900027
PM 26179303
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Pezzoli, L
   Keramarou, M
   Ladbury, G
   Jaramillo-Gutierrez, G
   Williams, CJ
   Le Menach, A
AF Pezzoli, L.
   Keramarou, M.
   Ladbury, G.
   Jaramillo-Gutierrez, G.
   Williams, C. J.
   Le Menach, A.
TI Time, place, and people: composition of the EPIET Alumni Network and its
   contribution to the European public health resource in 2013
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Alumni association; epidemiologists; evaluation; microbiologists; public
   health
ID EPIDEMIC INTELLIGENCE SERVICE; MEDICAL-EDUCATION; CORE COMPETENCES;
   EPIDEMIOLOGISTS; CURRICULUM
AB The EPIET Alumni Network (EAN) is an association of professionals who have completed field epidemiology or public health microbiology training programmes in the European Union. In 2013, we conducted a survey of EAN members to investigate this network's role within European public health. We distributed an online questionnaire to members registered at the time, collecting data on demographics, professional background, and attitudes towards EAN. Out of 362 registered members, 189 (52%) responded; 97% were from Europe; 65% were female. Their mean age was 39 years. The highest academic qualification was PhD for 44% and Master's degree for 55%. The majority (60%) worked in public health institutes. They were especially satisfied with having access to job offers and professional networking via EAN, but requested more learning opportunities and knowledge-sharing between members. EAN is a unique platform where highly skilled professionals can connect to control infectious diseases locally and internationally. Having a network of professionals that know each other, speak the same language', and can easily access each other's expertise, represents an important resource for European and global public health, which should be nurtured by encouraging more collaborations devoted to professional development.
C1 [Pezzoli, L.; Keramarou, M.; Ladbury, G.; Jaramillo-Gutierrez, G.; Williams, C. J.; Le Menach, A.] EPIET Alumni Network EAN, St Maurice, France.
   [Keramarou, M.] Univ Crete, Sch Med, Iraklion, Greece.
   [Ladbury, G.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
   [Jaramillo-Gutierrez, G.] London Sch Hyg & Trop Med, London WC1, England.
   [Williams, C. J.] Publ Hlth Wales, Cardiff, S Glam, Wales.
RP Pezzoli, L (reprint author), EPIET Alumni Network, London, England.
EM Lorenzo.Pezz@gmail.com
RI Pezzoli, Lorenzo/AAA-9894-2019
OI Williams, Christopher/0000-0002-5092-4987
CR Bahner DP, 2012, MED TEACH, V34, P439, DOI 10.3109/0142159X.2012.668245
   Bhatnagar T, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-36
   Bondy SJ, 2008, CAN J PUBLIC HEALTH, V99, P246, DOI 10.1007/BF03403748
   Bosman A, 2009, EUROSURVEILLANCE, V14
   Bremer V, 2009, EUROSURVEILLANCE, V14
   Cardenas VM, 2002, AM J PUBLIC HEALTH, V92, P196, DOI 10.2105/AJPH.92.2.196
   Cartledge P, 2013, MED TEACH, V35, P847, DOI 10.3109/0142159X.2013.804909
   ESCAIDE Scientific Committee, 2009, EUROSURVEILLANCE, V14
   Forgie SE, 2013, MED TEACH, V35, P8, DOI 10.3109/0142159X.2012.746448
   Giesecke Johan, 1996, Euro Surveill, V1, P30
   King LJ, 2008, PUBLIC HEALTH REP, V123, P264, DOI 10.1177/003335490812300306
   Krause G, 2009, EUROSURVEILLANCE, V14
   McCarthy M, 2013, EUR J PUBLIC HEALTH, V23, P43, DOI 10.1093/eurpub/ckt155
   Moren A, 1998, REV EPIDEMIOL SANTE, V46, P533
   Moser M, 2008, PUBLIC HEALTH REP, V123, P59, DOI 10.1177/00333549081230S113
   Paccaud F, 2013, INT J PUBLIC HEALTH, V58, P799, DOI [10.1007/s00038-013-0481-2, 10.1007/s00038-013-0508-8]
   Pell G, 2005, MED EDUC, V39, P970, DOI 10.1111/j.1365-2929.2005.02237.x
   Pezzoli L, 2010, EPIDEMIOL INFECT, V138, P45, DOI 10.1017/S0950268809002866
   Ragan P, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S108
   Rahu M, 2013, INT J EPIDEMIOL, V42, P870, DOI 10.1093/ije/dyt054
   Subramanian RE, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-45
   THACKER SB, 1992, PUBLIC HEALTH REP, V107, P718
   Thacker SB, 2001, AM J EPIDEMIOL, V154, P985, DOI 10.1093/aje/154.11.985
   The Lancet, 2014, LANCET, V384, P1321, DOI DOI 10.1016/S0140-6736(14)61697-425306562
   Traicoff DA, 2008, PUBLIC HEALTH REP, V123, P28, DOI 10.1177/00333549081230S109
   WATSON R, 2013, BMJ-BRIT MED J, V347, P78498, DOI DOI 10.1136/BMJ.F6057
   White F, 2013, MED PRINCIPLES PRACT
NR 27
TC 0
Z9 0
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD SEP
PY 2015
VL 143
IS 12
BP 2539
EP 2546
DI 10.1017/S0950268814003392
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CO0ME
UT WOS:000358844800008
PM 25521307
DA 2020-05-07
ER

PT J
AU Sanchez-Alberola, N
   Campoy, S
   Emerson, D
   Barbe, J
   Erill, I
AF Sanchez-Alberola, Neus
   Campoy, Susana
   Emerson, David
   Barbe, Jordi
   Erill, Ivan
TI An SOS Regulon under Control of a Noncanonical LexA-Binding Motif in the
   Betaproteobacteria
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; COMPARATIVE GENOMICS;
   OXIDIZING BACTERIA; TERMINAL DOMAIN; DNA-DAMAGE; RECA GENE;
   PROTEOBACTERIA; TRANSCRIPTION; PROTEIN
AB The SOS response is a transcriptional regulatory network governed by the LexA repressor that activates in response to DNA damage. In the Betaproteobacteria, LexA is known to target a palindromic sequence with the consensus sequence CTGT-N-8-ACAG. We report the characterization of a LexA regulon in the iron-oxidizing betaproteobacterium Sideroxydans lithotrophicus. In silico and in vitro analyses show that LexA targets six genes by recognizing a binding motif with the consensus sequence GAACGaaCGTTC, which is strongly reminiscent of the Bacillus subtilis LexA-binding motif. We confirm that the closely related Gallionella capsiferriformans shares the same LexA-binding motif, and in silico analyses indicate that this motif is also conserved in the Nitrosomonadales and the Methylophilales. Phylogenetic analysis of LexA and the alpha subunit of DNA polymerase III (DnaE) reveal that the organisms harboring this noncanonical LexA form a compact taxonomic cluster within the Betaproteobacteria. However, their lexA gene is unrelated to the standard Betaproteobacteria lexA, and there is evidence of its spread through lateral gene transfer. In contrast to other reported cases of noncanonical LexA-binding motifs, the regulon of S. lithotrophicus is comparable in size and function to that of many other Betaproteobacteria, suggesting that a convergent SOS regulon has reevolved under the control of a new LexA protein. Analysis of the DNA-binding domain of S. lithotrophicus LexA reveals little sequence similarity with that of other LexA proteins targeting similar binding motifs, suggesting that network structure may limit site evolution or that structural constrains make the B. subtilis-type motif an optimal interface for multiple LexA sequences.
   IMPORTANCE
   Understanding the evolution of transcriptional systems enables us to address important questions in microbiology, such as the emergence and transfer potential of different regulatory systems to regulate virulence or mediate responses to stress. The results reported here constitute the first characterization of a noncanonical LexA protein regulating a standard SOS regulon. This is significant because it illustrates how a complex transcriptional program can be put under the control of a novel transcriptional regulator. Our results also reveal a substantial degree of plasticity in the LexA recognition domain, raising intriguing questions about the space of protein-DNA interfaces and the specific evolutionary constrains faced by these elements.
C1 [Sanchez-Alberola, Neus; Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.
   [Sanchez-Alberola, Neus; Erill, Ivan] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.
   [Emerson, David] Bigelow Lab Ocean Sci, East Boothbay, ME USA.
RP Erill, I (reprint author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.
EM erill@umbc.edu
RI Barbe, Jordi/G-5212-2015; campoy, susana/E-4346-2010; Campoy,
   Susana/C-7335-2008; Erill, Ivan/H-9405-2015
OI Barbe, Jordi/0000-0003-4408-013X; campoy, susana/0000-0003-1369-0197;
   Campoy, Susana/0000-0003-1369-0197; Erill, Ivan/0000-0002-7280-7191
FU UMBC Special Research Assistantship/Initiative Support (SRAIS); U.S.
   National Science FoundationNational Science Foundation (NSF)
   [MCB-1158056]; Spanish Ministry of Science and InnovationSpanish
   Government [BFU2011-23478]; Generalitat de CatalunyaGeneralitat de
   Catalunya [2014SGR572]; Fundacio Cellex fellowshipFoundation CELLEX
FX This study was supported by UMBC Special Research
   Assistantship/Initiative Support (SRAIS) and U.S. National Science
   Foundation (MCB-1158056) awards to I.E. and by Spanish Ministry of
   Science and Innovation (BFU2011-23478) and Generalitat de Catalunya
   (2014SGR572) awards to J.B. N.S.-A. was funded by a Fundacio Cellex
   fellowship.
CR Abella M, 2004, MOL MICROBIOL, V54, P212, DOI 10.1111/j.1365-2958.2004.04260.x
   Abella M, 2007, J BACTERIOL, V189, P8855, DOI 10.1128/JB.01213-07
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anzaldi LJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-124
   Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005
   Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198
   BERTRANDBURGGRAF E, 1987, J MOL BIOL, V193, P293, DOI 10.1016/0022-2836(87)90220-8
   Bhargava N, 2010, BIOINFORMATION, V5, P49, DOI 10.6026/97320630005049
   Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7
   Boutry C, 2013, J BACTERIOL, V195, P696, DOI 10.1128/JB.01605-12
   BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204
   Cambray G, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-6
   Campoy S, 2005, J BACTERIOL, V187, P5367, DOI 10.1128/JB.187.15.5367-5375.2005
   Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Cornish JP, 2014, BIOINFORMATICS, V30, P1193, DOI 10.1093/bioinformatics/btt753
   Cornish JP, 2012, EVOL BIOINFORM, V8, P449, DOI 10.4137/EBO.S9205
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Cune J, 2005, J BACTERIOL, V187, P5841, DOI 10.1128/JB.187.16.5841-5845.2005
   Cune J, 2002, J BACTERIOL, V184, P6073
   da Rocha RP, 2008, J BACTERIOL, V190, P1209, DOI 10.1128/JB.01419-07
   de Henestrosa ARF, 2003, J BACTERIOL, V185, P4471, DOI 10.1128/JB.185.15.4471-4482.2003
   de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299
   Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667
   Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254
   Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208
   Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412
   Erill I, 2004, NUCLEIC ACIDS RES, V32, P6617, DOI 10.1093/nar/gkh996
   Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303
   Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x
   FAVRE D, 1990, NUCLEIC ACIDS RES, V18, P4243, DOI 10.1093/nar/18.14.4243
   Fonseca LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076419
   Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939
   Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0
   Henestrosa de AR F, 2000, MOL MICROBIOL, V35, P1560, DOI DOI 10.1046/J.1365-2958.2000.01826.X
   Jara M, 2003, J BACTERIOL, V185, P2493, DOI 10.1128/JB.185.8.2493-2502.2003
   Jochmann N, 2009, MICROBIOL-SGM, V155, P1459, DOI 10.1099/mic.0.025841-0
   Kilic S, 2014, NUCLEIC ACIDS RES, V42, pD156, DOI 10.1093/nar/gkt1123
   Klucar L, 2010, NUCLEIC ACIDS RES, V38, pD366, DOI 10.1093/nar/gkp911
   Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028
   LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D
   LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X
   Mazon G, 2006, MICROBIOL-SGM, V152, P1109, DOI 10.1099/mic.0.28376-0
   Mazon G, 2004, MOL GENET GENOMICS, V271, P40, DOI 10.1007/s00438-003-0952-x
   Mazon G, 2006, ANTON LEEUW INT J G, V90, P123, DOI 10.1007/s10482-006-9066-x
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   OERTELBUCHHEIT P, 1990, MOL GEN GENET, V223, P40, DOI 10.1007/BF00315795
   OTTLEBEN G, 1991, J BIOMOL STRUCT DYN, V9, P447, DOI 10.1080/07391102.1991.10507928
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Podgornaia AI, SCIENCE, V347, P673
   Podgornaia AI, 2013, STRUCTURE, V21, P1636, DOI 10.1016/j.str.2013.07.005
   Pougach K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5868
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Quinones M, 2006, J BIOL CHEM, V281, P39407, DOI 10.1074/jbc.M609694200
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Rowland MA, 2014, P NATL ACAD SCI USA, V111, P5550, DOI 10.1073/pnas.1317178111
   Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501
   Sanchez-Alberola N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-58
   SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7
   Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540
   Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040
   Smollett KL, 2012, J BIOL CHEM, V287, P22004, DOI 10.1074/jbc.M112.357715
   Tapias A, 2002, NUCLEIC ACIDS RES, V30, P1539, DOI 10.1093/nar/30.7.1539
   THLIVERIS AT, 1992, P NATL ACAD SCI USA, V89, P4500, DOI 10.1073/pnas.89.10.4500
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Ulrich RL, 2013, APPL ENVIRON MICROB, V79, P5830, DOI 10.1128/AEM.00538-13
   van der Veen S, 2010, MICROBIOL-SGM, V156, P374, DOI 10.1099/mic.0.035196-0
   Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605
   Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131
   Walter BM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-88
   Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200
NR 73
TC 6
Z9 7
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD AUG
PY 2015
VL 197
IS 16
BP 2622
EP 2630
DI 10.1128/JB.00035-15
PG 9
WC Microbiology
SC Microbiology
GA CM9UA
UT WOS:000358053300001
PM 25986903
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Pardos de la Gandara, M
   Garay, JAR
   Mwangi, M
   Tobin, JN
   Tsang, A
   Khalida, C
   D'Orazio, B
   Kost, RG
   Leinberger-Jabari, A
   Coffran, C
   Evering, TH
   Coller, BS
   Balachandra, S
   Urban, T
   Parola, C
   Salvato, S
   Jenks, N
   Wu, DR
   Burgess, R
   Chung, M
   de Lencastre, H
   Tomasz, A
AF Pardos de la Gandara, Maria
   Garay, Juan Antonio Raygoza
   Mwangi, Michael
   Tobin, Jonathan N.
   Tsang, Amanda
   Khalida, Chamanara
   D'Orazio, Brianna
   Kost, Rhonda G.
   Leinberger-Jabari, Andrea
   Coffran, Cameron
   Evering, Teresa H.
   Coller, Barry S.
   Balachandra, Shirish
   Urban, Tracie
   Parola, Claude
   Salvato, Scott
   Jenks, Nancy
   Wu, Daren
   Burgess, Rhonda
   Chung, Marilyn
   de Lencastre, Herminia
   Tomasz, Alexander
TI Molecular Types of Methicillin-Resistant Staphylococcus aureus and
   Methicillin-Sensitive S. aureus Strains Causing Skin and Soft Tissue
   Infections and Nasal Colonization, Identified in Community Health
   Centers in New York City
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR STRATEGY; MEC ELEMENT;
   SEQUENCE; USA300; HOSPITALS; VIRULENCE; CLONES; EPIDEMIOLOGY; EVOLUTION
AB In November 2011, The Rockefeller University Center for Clinical and Translational Science (CCTS), the Laboratory of Microbiology and Infectious Diseases, and Clinical Directors Network (CDN) launched a research and learning collaborative project with six community health centers in the New York City metropolitan area to determine the nature (clonal type) of community-acquired Staphylococcus aureus strains causing skin and soft tissue infections (SSTIs). Between November 2011 and March 2013, wound and nasal samples from 129 patients with active SSTIs suspicious for S. aureus were collected and characterized by molecular typing techniques. In 63 of 129 patients, the skin wounds were infected by S. aureus: methicillin-resistant S. aureus (MRSA) was recovered from 39 wounds and methicillin-sensitive S. aureus (MSSA) was recovered from 24. Most-46 of the 63-wound isolates belonged to the CC8/Panton-Valentine leukocidin-positive (PVL+) group of S. aureus clone USA300: 34 of these strains were MRSA and 12 were MSSA. Of the 63 patients with S. aureus infections, 30 were also colonized by S. aureus in the nares: 16 of the colonizing isolates were MRSA, and 14 were MSSA, and the majority of the colonizing isolates belonged to the USA300 clonal group. In most cases (70%), the colonizing isolate belonged to the same clonal type as the strain involved with the infection. In three of the patients, the identity of invasive and colonizing MRSA isolates was further documented by whole-genome sequencing.
C1 [Pardos de la Gandara, Maria; Chung, Marilyn; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10021 USA.
   [Garay, Juan Antonio Raygoza; Mwangi, Michael] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   [Tobin, Jonathan N.; Tsang, Amanda; Khalida, Chamanara; D'Orazio, Brianna] CDN, New York, NY USA.
   [Tobin, Jonathan N.; Kost, Rhonda G.; Leinberger-Jabari, Andrea; Coffran, Cameron; Evering, Teresa H.; Coller, Barry S.] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA.
   [Balachandra, Shirish; Urban, Tracie; Parola, Claude; Salvato, Scott] Urban Hlth Ctr, Bronx, NY USA.
   [Jenks, Nancy] Hudson River Hlth Care, New York, NY USA.
   [Wu, Daren] Open Door Family Med Ctr, New York, NY USA.
   [Burgess, Rhonda] Manhattan Physicians Group, New York, NY USA.
   [de Lencastre, Herminia] Inst Tecnol Quim Biol ITQB UNL, Mol Genet Lab, Oeiras, Portugal.
RP Tomasz, A (reprint author), Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
EM tomasz@rockefeller.edu
RI Pardos de la Gandara, Maria/G-9933-2017; Tobin, Jonathan/R-2413-2019
OI Pardos de la Gandara, Maria/0000-0002-3273-6392; /0000-0001-6816-8932;
   Leinberger-Jabari, Andrea/0000-0003-2014-9032; Tomasz,
   Alexander/0000-0003-1520-1983
FU NIH-NCATSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [8 UL1 TR000043]; CTSA Administrative
   Supplement Award; U.S. Public Health ServiceUnited States Public Health
   Service [2 RO1 AI457838-15]; AHRQ grant [1 P30-HS-021667]; PCORI
   grantPatient-Centered Outcomes Research Institute - PCORI
   [CER-1402-10800]
FX This work was supported by NIH-NCATS grant 8 UL1 TR000043 to B. S.
   Coller (principal investigator [PI]) and by a 2011 CTSA Administrative
   Supplement Award to J. N. Tobin (PI). Additional support was provided by
   U.S. Public Health Service award 2 RO1 AI457838-15 to A. Tomasz (PI),
   AHRQ grant 1 P30-HS-021667 to J. N. Tobin (PI), and PCORI grant
   CER-1402-10800 to J. N. Tobin (PI).
CR Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006
   Balachandra S, 2015, MICROB DRUG RESIST, V21, P237, DOI 10.1089/mdr.2014.0283
   BARRETT FF, 1968, NEW ENGL J MED, V279, P441, DOI 10.1056/NEJM196808292790901
   Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088
   Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V282, P1123
   Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189
   Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI
   Conceicao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077812
   De Sousa MA, 2000, MICROB DRUG RESIST, V6, P253, DOI 10.1089/mdr.2000.6.253
   DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1
   Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7
   Dordel J, 2014, MBIO, V5, DOI 10.1128/mBio.01000-13
   Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000
   Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003
   Fritz SA, 2014, JAMA PEDIATR, V168, P1030, DOI 10.1001/jamapediatrics.2014.1218
   Golding George R, 2008, Can J Infect Dis Med Microbiol, V19, P273
   Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99
   Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101
   Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461
   Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003
   Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07
   Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112
   Miller LG, 2007, CLIN INFECT DIS, V44, P471, DOI 10.1086/511033
   Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X
   Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002
   Oliveira DC, 2008, J ANTIMICROB CHEMOTH, V61, P959, DOI 10.1093/jac/dkn021
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610
   Roberts RB, 2000, MICROB DRUG RESIST, V6, P245, DOI 10.1089/mdr.2000.6.245
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241
   Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x
   Tobin JN, 2014, N AM PRIM CAR RES GR
   TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124
   UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E
   Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111
NR 39
TC 17
Z9 17
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD AUG
PY 2015
VL 53
IS 8
BP 2648
EP 2658
DI 10.1128/JCM.00591-15
PG 11
WC Microbiology
SC Microbiology
GA CN2YV
UT WOS:000358290200034
PM 26063853
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Bordenstein, SR
   Theis, KR
AF Bordenstein, Seth R.
   Theis, Kevin R.
TI Host Biology in Light of the Microbiome: Ten Principles of Holobionts
   and Hologenomes
SO PLOS BIOLOGY
LA English
DT Article
ID HYBRID INVIABILITY GENE; GUT MICROBIOTA; RHIZOSPHERE MICROBIOME;
   INTESTINAL MICROBIOTA; CLOSTRIDIUM-DIFFICILE; BACTERIAL COMMUNITIES;
   ADAPTIVE EVOLUTION; NICHE CONSTRUCTION; ANIMAL DEVELOPMENT; SOIL
   MICROBES
AB Groundbreaking research on the universality and diversity of microorganisms is now challenging the life sciences to upgrade fundamental theories that once seemed untouchable. To fully appreciate the change that the field is now undergoing, one has to place the epochs and foundational principles of Darwin, Mendel, and the modern synthesis in light of the current advances that are enabling a new vision for the central importance of microbiology. Animals and plants are no longer heralded as autonomous entities but rather as biomolecular networks composed of the host plus its associated microbes, i.e., "holobionts." As such, their collective genomes forge a "hologenome," and models of animal and plant biology that do not account for these intergenomic associations are incomplete. Here, we integrate these concepts into historical and contemporary visions of biology and summarize a predictive and refutable framework for their evaluation. Specifically, we present ten principles that clarify and append what these concepts are and are not, explain how they both support and extend existing theory in the life sciences, and discuss their potential ramifications for the multifaceted approaches of zoology and botany. We anticipate that the conceptual and evidence-based foundation provided in this essay will serve as a roadmap for hypothesis-driven, experimentally validated research on holobionts and their hologenomes, thereby catalyzing the continued fusion of biology's subdisciplines. At a time when symbiotic microbes are recognized as fundamental to all aspects of animal and plant biology, the holobiont and hologenome concepts afford a holistic view of biological complexity that is consistent with the generally reductionist approaches of biology.
C1 [Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.
   [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.
   [Theis, Kevin R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
RP Bordenstein, SR (reprint author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM s.bordenstein@vanderbilt.edu
FU National Science FoundationNational Science Foundation (NSF) [DEB
   1046149, IOS 1456778, IOS 0920505]; BEACON Center for the Study of
   Evolution in Action (National Science Foundation)National Science
   Foundation (NSF) [DBI 0939454]
FX This publication was made possible by National Science Foundation
   (http://www.nsf.gov) grants DEB 1046149 and IOS 1456778 to SRB, and IOS
   0920505 to KRT. KRT was supported, in part, by the BEACON Center for the
   Study of Evolution in Action (National Science Foundation Cooperative
   Agreement DBI 0939454). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allen-Vercoe E, 2013, CURR OPIN MICROBIOL, V16, P625, DOI 10.1016/j.mib.2013.09.008
   Archie EA, 2011, ANIM BEHAV, V82, P425, DOI 10.1016/j.anbehav.2011.05.029
   Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x
   Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110
   Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107
   Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001
   Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x
   Berg JJ, 2014, PLOS GENET, V10, P25
   Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3
   Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366
   Bolnick DI, 2014, MOL ECOL, V23, P4831, DOI 10.1111/mec.12846
   Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543
   Borer ET, 2013, BASIC APPL ECOL, V14, P533, DOI 10.1016/j.baae.2013.08.009
   Bosch TCG, 2011, ZOOLOGY, V114, P185, DOI 10.1016/j.zool.2011.04.001
   Bouchard F, 2013, VIENNA SER THEOR BIO, P243
   Brandvain Y, 2011, GENETICS, V189, P397, DOI 10.1534/genetics.111.130906
   BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0
   Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262
   Brown JM, 2015, ANNU REV MED, V66, P343, DOI 10.1146/annurev-med-060513-093205
   Brucker RM, 2013, ZOOLOGY, V116, P260, DOI 10.1016/j.zool.2013.08.003
   Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659
   Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011
   Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x
   Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758
   Cabello AE, 2005, J EXP MAR BIOL ECOL, V327, P157, DOI 10.1016/j.jembe.2005.06.009
   Chandler JA, 2011, PLOS GENET, V7, P18
   Chaston J, 2012, BIOL BULL-US, V223, P21, DOI 10.1086/BBLv223n1p21
   Chaston JM, 2013, CELL MICROBIOL, V15, P1545, DOI 10.1111/cmi.12134
   Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037
   Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346
   Darwin CH, 1859, ORIGIN SPECIES
   Dheilly NM, 2014, PLOS PATHOG, V10, P4
   Dobzhansky T, 1937, GENETICS ORIGIN SPEC
   Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x
   Douglas AE, 2014, COLD SPRING HARBOR P, V6, P13
   Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822
   Drown DM, 2013, EVOL ECOL RES, V15, P43
   Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992
   Easson CG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00532
   Ebert D, 2013, ANNU REV ECOL EVOL S, V44, P623, DOI 10.1146/annurev-ecolsys-032513-100555
   EHRMAN L, 1971, J HERED, V62, P67, DOI 10.1093/oxfordjournals.jhered.a108145
   EHRMAN L, 1968, MOL GEN GENET, V103, P218, DOI 10.1007/BF00273689
   Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412
   Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307
   Fisher R. A., 1930, GENETICAL THEORY NAT
   Fitzpatrick BM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00046
   Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104
   Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18
   Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314
   Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631
   Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x
   Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427
   Gilbert SF, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00282
   Gilbert SF, 2012, Q REV BIOL, V87, P325, DOI 10.1086/668166
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Gordon J, 2013, MICROBE, V8, P152, DOI DOI 10.1128/MICR0BE.8.152.1
   Greenblum S, 2013, CURR OPIN BIOTECH, V24, P810, DOI 10.1016/j.copbio.2013.04.001
   Haber M, 2013, VIENNA SER THEOR BIO, P195
   Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009
   Haldane J. B. S., 1932, CAUSES EVOLUTION
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71
   Hermesh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037334
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695
   Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337
   Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x
   Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Huxley JS, 1942, EVOLUTION MODERN SYN
   Inglis TJJ, 2007, J MED MICROBIOL, V56, P1419, DOI 10.1099/jmm.0.47179-0
   Ispolatov I, 2009, EVOLUTION, V63, P3076, DOI 10.1111/j.1558-5646.2009.00800.x
   Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325
   Jefferson R, 1994, HOLOGENOME AGR ENV D
   Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007
   Kaltenpoth M, 2014, P NATL ACAD SCI USA, V111, P6359, DOI 10.1073/pnas.1400457111
   Kembel SW, 2014, P NATL ACAD SCI USA, V111, P13715, DOI 10.1073/pnas.1216057111
   Klassen JL, 2014, CURR OPIN INSECT SCI, V4, P15, DOI 10.1016/j.cois.2014.08.004
   Koonin EV, 2009, CELL CYCLE, V8, P799, DOI 10.4161/cc.8.6.8187
   Koonin EV, 2009, BIOL DIRECT, V4, P14
   Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112
   Kussmann M, 2014, PHYS DAILY LIFE APPL, P121
   Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111
   Laland K, 2014, NATURE, V514, P161, DOI 10.1038/514161a
   Le Sage V, 2013, VIRUSES-BASEL, V5, P2019, DOI 10.3390/v5082019
   LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003
   Lewis Z, 2015, CURR OPIN INSECT SCI, V9, P86, DOI 10.1016/j.cois.2015.03.003
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978
   Liu YS, 2011, ITAL J ZOOL, V78, P410, DOI 10.1080/11250003.2011.562554
   Lloyd EA, 2007, CAMBR COMPANION PHIL, P44
   Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9
   Ma WJ, 2014, SEX DEV, V8, P59, DOI 10.1159/000357024
   Manor O, 2014, CELL METAB, V20, P742, DOI 10.1016/j.cmet.2014.07.021
   Margulis L., 1971, ORIGIN EUKARYOTIC CE
   Margulis L., 1991, SYMBIOSIS SOURCE EVO, P1
   Margulis Lynn, 1993, SYMBIOSIS CELL EVOLU
   Margulis Lynn, 1991, SYMBIOSIS SOURCE EVO
   Matthews B, 2014, ECOL MONOGR, V84, P245, DOI 10.1890/13-0953.1
   Mayr E, 1997, P NATL ACAD SCI USA, V94, P2091, DOI 10.1073/pnas.94.6.2091
   Mayr E, 1942, SYSTEMATICS ORIGIN S
   McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a
   McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783
   McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110
   McFall-Ngai M, 2012, SEMIN IMMUNOL, V24, P3, DOI 10.1016/j.smim.2011.11.006
   McFall-Ngai MJ, 2014, ANNU REV MICROBIOL, V68, P177, DOI 10.1146/annurev-micro-091313-103654
   McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522
   McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191
   Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214
   MINDELL DP, 1992, BIOSYSTEMS, V27, P53, DOI 10.1016/0303-2647(92)90046-2
   Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111
   Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104
   Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12
   Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170
   Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Obbard DJ, 2009, PLOS GENET, V5, P13
   Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546
   Odling-Smee J, 2013, Q REV BIOL, V88, P3, DOI 10.1086/669266
   Palkovacs EP, 2010, F1000 BIOL REPORTS, V2
   Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110
   Pillai P, 2014, ECOL LETT, V17, P1437, DOI 10.1111/ele.12349
   Possemiers S, 2011, FITOTERAPIA, V82, P53, DOI 10.1016/j.fitote.2010.07.012
   Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157
   Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718
   Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679
   Queller DC, 2009, PHILOS T R SOC B, V364, P3143, DOI 10.1098/rstb.2009.0095
   Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804
   Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001
   Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007
   Rosenberg E., 2013, HOLOGENOME CONCEPT H
   Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635
   Rosenberg E, 2010, ENV MICROBIOL REP, V2, P500, DOI 10.1111/j.1758-2229.2010.00177.x
   Rosenberg E, 2009, ENVIRON MICROBIOL, V11, P2959, DOI 10.1111/j.1462-2920.2009.01995.x
   Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164
   Salem H, 2013, ENVIRON MICROBIOL, V15, P1956, DOI 10.1111/1462-2920.12001
   Sanders JG, 2014, MOL ECOL, V23, P1268, DOI 10.1111/mec.12611
   Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116
   Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644
   Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336
   Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x
   Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011
   Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107
   Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x
   Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540
   Stilling RM, 2014, FRONTIERS CELLULAR I, V4, P17
   Theis KR, 2013, P NATL ACAD SCI USA, V110, P19832, DOI 10.1073/pnas.1306477110
   Thompson J. N., 2013, RELENTLESS EVOLUTION
   Thompson J.N., 2005, INTERSPEC INTERACT
   Traw MB, 2010, CURR OPIN PLANT BIOL, V13, P466, DOI 10.1016/j.pbi.2010.04.009
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.05224
   Underhill DM, 2014, NAT REV IMMUNOL, V14, P405, DOI 10.1038/nri3684
   van Baalen M, 2013, VIENNA SER THEOR BIO, P117
   van Baarlen P, 2013, CURR OPIN MICROBIOL, V16, P270, DOI 10.1016/j.mib.2013.07.001
   Van Leuven JT, 2014, CELL, V158, P1270, DOI 10.1016/j.cell.2014.07.047
   Vavre F, 2014, CURR OPIN INSECT SCI, V4, P29, DOI 10.1016/j.cois.2014.08.003
   Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031
   Wade MJ, 2010, NATURE, V463, pE8, DOI 10.1038/nature08809
   Wagner MR, 2014, ECOL LETT, V17, P717, DOI 10.1111/ele.12276
   Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7440
   Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x
   WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9
   WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576
   Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004
   Wright S, 1931, GENETICS, V16, P0097
   Yeoman CJ, 2011, ENTROPY-SWITZ, V13, P570, DOI 10.3390/e13030570
   Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x
NR 173
TC 345
Z9 352
U1 7
U2 268
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD AUG
PY 2015
VL 13
IS 8
AR e1002226
DI 10.1371/journal.pbio.1002226
PG 23
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA CQ5BN
UT WOS:000360618400014
PM 26284777
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2020-05-07
ER

PT J
AU van Mourik, MSM
   Moons, KGM
   Murphy, MV
   Bonten, MJM
   Klompas, M
AF van Mourik, Maaike S. M.
   Moons, Karel G. M.
   Murphy, Michael V.
   Bonten, Marc J. M.
   Klompas, Michael
CA MICU Registry
   Ctr Dis Control Prevention CDC
TI Severity of Disease Estimation and Risk-Adjustment for Comparison of
   Outcomes in Mechanically Ventilated Patients Using Electronic Routine
   Care Data
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID SURGICAL-SITE INFECTION; ACUTE PHYSIOLOGY SCORE; CASE-MIX ADJUSTMENT;
   INTENSIVE-CARE; HOSPITAL MORTALITY; MODEL MPM0-III; SAFETY NETWORK;
   APACHE-III; PERFORMANCE; RATES
AB BACKGROUND. Valid comparison between hospitals for benchmarking or pay-for-performance incentives requires accurate correction for underlying disease severity (case-mix). However, existing models are either very simplistic or require extensive manual data collection.
   OBJECTIVE. To develop a disease severity prediction model based solely on data routinely available in electronic health records for risk-adjustment in mechanically ventilated patients.
   DESIGN. Retrospective cohort study.
   PARTICIPANTS. Mechanically ventilated patients from a single tertiary medical center (2006-2012).
   METHODS. Predictors were extracted from electronic data repositories (demographic characteristics, laboratory tests, medications, microbiology results, procedure codes, and comorbidities) and assessed for feasibility and generalizability of data collection. Models for in-hospital mortality of increasing complexity were built using logistic regression. Estimated disease severity from these models was linked to rates of ventilator-associated events.
   RESULTS. A total of 20,028 patients were initiated on mechanical ventilation, of whom 3,027 deceased in hospital. For models of incremental complexity, area under the receiver operating characteristic curve ranged from 0.83 to 0.88. A simple model including demographic characteristics, type of intensive care unit, time to intubation, blood culture sampling, 8 common laboratory tests, and surgical status achieved an area under the receiver operating characteristic curve of 0.87 (95% CI, 0.86-0.88) with adequate calibration. The estimated disease severity was associated with occurrence of ventilator-associated events.
   CONCLUSIONS. Accurate estimation of disease severity in ventilated patients using electronic, routine care data was feasible using simple models. These estimates may be useful for risk-adjustment in ventilated patients. Additional research is necessary to validate and refine these models.
C1 [van Mourik, Maaike S. M.; Murphy, Michael V.; Klompas, Michael] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA.
   [van Mourik, Maaike S. M.; Murphy, Michael V.; Klompas, Michael] Harvard Pilgrim Hlth Care Inst, Boston, MA USA.
   [van Mourik, Maaike S. M.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.
   [Moons, Karel G. M.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Klompas, Michael; MICU Registry] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
RP van Mourik, MSM (reprint author), Dept Med Microbiol, HP G04-614,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.
EM M.S.M.vanMourik-2@umcutrecht.nl
RI Klompas, Michael/Z-2415-2019
FU Netherlands Organization for Scientific ResearchNetherlands Organization
   for Scientific Research (NWO) [9120.8004, 918.10.615]; Centers for
   Disease Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [1U54CK000172]
FX Netherlands Organization for Scientific Research (project 9120.8004 and
   918.10.615 to K.G.M.M.); Centers for Disease Control and Prevention
   (grant 1U54CK000172 to M.K.).
CR Afessa B, 2005, INTENS CARE MED, V31, P1537, DOI 10.1007/s00134-005-2751-9
   Bosman RJ, 1998, INTENS CARE MED, V24, P953, DOI 10.1007/s001340050695
   Breslow MJ, 2012, CHEST, V141, P245, DOI 10.1378/chest.11-0330
   Centers for Disease Control and Prevention (CDC), 2013, NAT HEALTHC SAF NETW
   Centers for Medicare and Medicaid Services, HOSP ACQ COND
   Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC
   Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004
   Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002
   Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004
   Graham PL, 2004, CHEST, V125, P1458, DOI 10.1378/chest.125.4.1458
   Harrell F. E., 2001, REGRESSION MODELING
   Harris AD, 2008, INFECT CONT HOSP EP, V29, P693, DOI 10.1086/590471
   Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7
   Healthcare Cost and Utilization Project, COM SOFTW VERS 3 7
   Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F
   Higgins TL, 2009, CRIT CARE MED, V37, P1619, DOI 10.1097/CCM.0b013e31819ded31
   Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592
   Johnson AEW, 2013, CRIT CARE MED, V41, P1711, DOI 10.1097/CCM.0b013e31828a24fe
   Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164
   Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0
   Kritsotakis EI, 2008, INFECT CONT HOSP EP, V29, P685, DOI 10.1086/588704
   Kuzniewicz MW, 2008, CHEST, V133, P1319, DOI 10.1378/chest.07-3061
   Liu V, 2013, CRIT CARE MED, V41, P41, DOI 10.1097/CCM.0b013e318267636e
   Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db
   Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5
   Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016
   Panzer RJ, 2013, JAMA-J AM MED ASSOC, V310, P1971, DOI 10.1001/jama.2013.282047
   Partners Healthcare, RES AT DAT REG RDR
   Polderman KH, 1999, LANCET, V353, P380, DOI 10.1016/S0140-6736(05)74953-9
   Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913
   Render ML, 2008, CRIT CARE MED, V36, P1031, DOI 10.1097/CCM.0b013e318169f290
   Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184
   Rubin D. B, 1987, MULTIPLE IMPUTATION
   Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9
   Surveillance for ventilator-associated events, SURV VENT ASS EV
   van Buuren S, 2011, J STAT SOFTW, V45, P1
   van Dishoeck AM, 2013, BRIT J SURG, V100, P628, DOI 10.1002/bjs.9039
   Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0
NR 38
TC 6
Z9 6
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD JUL
PY 2015
VL 36
IS 7
BP 807
EP 815
DI 10.1017/ice.2015.75
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CK8UE
UT WOS:000356513400008
PM 25881675
OA Green Published
DA 2020-05-07
ER

PT J
AU Gan, J
   Wang, C
   Jin, YL
   Guo, Y
   Xu, F
   Zhu, Q
   Ding, L
   Shang, H
   Wang, JW
   Wei, F
   Cai, QL
   Robertson, ES
AF Gan, Jin
   Wang, Chong
   Jin, Yanling
   Guo, Yi
   Xu, Feng
   Zhu, Qing
   Ding, Ling
   Shang, Hong
   Wang, Junwen
   Wei, Fang
   Cai, Qiliang
   Robertson, Erle S.
TI Proteomic profiling identifies the SIM-associated complex of
   KSHV-encoded LANA
SO PROTEOMICS
LA English
DT Article
DE KSHV; LANA; Microbiology; SUMO-interacting motif
ID SARCOMA-ASSOCIATED HERPESVIRUS; PROTEIN-INTERACTION NETWORK;
   KAPOSIS-SARCOMA; NUCLEAR ANTIGEN; TRANSCRIPTIONAL ACTIVITY; SUMO
   MODIFICATION; BINDING PROTEIN; DNA-SEQUENCES; SUMOYLATION; LATENCY
AB The Kaposi's sarcoma-associated herpesvirus (KSHV) encoded latent nuclear antigen latency-associated nuclear antigen (LANA) plays an essential role in viral episomemaintenance. LANA also contributes to DNA replication and tumorigenesis during latency. Recent studies suggested that LANA was involved in regulation of SUMOylation, which results in chromatin silencing. To examine the pleiotropic effects of LANA protein on host cell gene expression, we utilized MS analysis to identify cellular proteins associated with the small ubiquitin related modifier (SUMO) interacting motif of LANA (LANA(SIM)). In addition to the six bands identified as substantially associated with LANA(SIM), 151 proteins were positively identified by MS/MS analysis. Compared with previous proteomic analysis of the N- and C-truncated mutants of LANA (LANA(NC)), our results revealed that a complex of specific proteins with relatively high SUMOylation and SIM motifs is associated with LANA(SIM). Intriguingly, consistent with our previous report that identified KAP1 as a key component, the in vitro SUMO-2-modified isoform has a substantially higher affinity with LANA(SIM) than the SUMO-1-modified isoform. Moreover, via cluster and pathway analysis, we proposed a hypothetical model for the LANA(SIM) regulatory circuit involving aberrant SUMOylation of cell cycle (particular mitotic), DNA unwinding and replication, and pre-mRNA/mRNA processing related proteins. This study provides a SUMOylated and non-SUMOylated proteome profile of LANA(SIM)-associated complex and facilitates our understanding that viral-mediated gene regulation through SUMOylation is important for Kaposi's sarcoma-associated herpesvirus persistence and pathogenesis.
C1 [Gan, Jin; Wang, Chong; Zhu, Qing; Ding, Ling; Cai, Qiliang] Fudan Univ, Shanghai Med Coll, Sch Basic Med, MOE & MOH Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
   [Jin, Yanling; Wei, Fang] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, ShengYushou Ctr Cell Biol & Immunol, Shanghai 200030, Peoples R China.
   [Guo, Yi; Shang, Hong] China Med Univ, Affiliated Hosp 1, Minist Hlth, Key Lab AIDS Immunol,Dept Gynecol, Shenyang 110001, Peoples R China.
   [Xu, Feng; Wang, Junwen] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
   [Xu, Feng; Wang, Junwen] Univ Hong Kong, Ctr Genome Sci, Hong Kong, Hong Kong, Peoples R China.
   [Robertson, Erle S.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Robertson, Erle S.] Univ Penn, Perelman Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA.
RP Cai, QL (reprint author), Fudan Univ, Shanghai Med Coll, Sch Basic Med, MOE & MOH Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
EM fangwei@sjtu.edu.cn; qiliang@fudan.edu.cn; erle@upenn.edu
RI Wang, Junwen/D-3700-2011
OI Wang, Junwen/0000-0002-4432-4707; Gan, Jin/0000-0002-8785-3035
FU Shanghai Municipal EducationShanghai Municipal Education Commission
   (SHMEC) [13zz011]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81471930, 81402542]; National Key
   Basic Research Program of ChinaNational Basic Research Program of China
   [2012CB519001]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01CA919972,
   R01DE017338, R01CA171979, P01CA174439]
FX This work was supported by the Key Program of the Shanghai Municipal
   Education (13zz011), the National Natural Science Foundation of China
   (81471930, 81402542), and the National Key Basic Research Program of
   China (2012CB519001). F.W. is a scholar of Pujiang Talents in Shanghai.
   Q.C. is a scholar of New Century Excellent Talents in University of
   China. Public health grants from the NIH (R01CA919972, R01DE017338,
   R01CA171979, and P01CA174439) to E.S.R. also supported this work.
CR Ballestas ME, 2011, FUTURE MICROBIOL, V6, P1399, DOI [10.2217/FMB.11.137, 10.2217/fmb.11.137]
   Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200
   Cai QL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003750
   Cai QL, 2010, ADV VIRUS RES, V78, P87, DOI 10.1016/S0065-3527(10)78003-9
   Campbell M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00031
   Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015
   Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311
   Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011
   Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2
   Kaul R, 2007, VIROLOGY, V364, P317, DOI 10.1016/j.virol.2007.03.010
   Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980
   Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000
   Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102
   Lan K, 2005, J VIROL, V79, P7453, DOI 10.1128/JVI.79.12.7453-7465.2005
   Li X, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000781
   Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200
   Mattoscio Domenico, 2013, World J Virol, V2, P79, DOI 10.5501/wjv.v2.i2.79
   Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888
   Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115
   Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674
   Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646
   Rodriguez JA, 2014, SEMIN CANCER BIOL, V27, P11, DOI 10.1016/j.semcancer.2014.03.005
   Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004
   Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200
   Shamay M, 2012, J VIROL, V86, P5179, DOI 10.1128/JVI.00169-12
   Si H, 2006, J VIROL, V80, P9017, DOI 10.1128/JVI.00297-06
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun R, 2014, J VIROL, V88, P7331, DOI 10.1128/JVI.00596-14
   Verma SC, 2007, CURR TOP MICROBIOL, V312, P101
   Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53
   Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110
   Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383
NR 36
TC 9
Z9 9
U1 1
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD JUN
PY 2015
VL 15
IS 12
SI SI
BP 2023
EP 2037
DI 10.1002/pmic.201400624
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CK6NN
UT WOS:000356344900008
PM 25894481
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Lin, WH
   Tseng, CC
   Wu, AB
   Yang, DC
   Cheng, SW
   Wang, MC
   Wu, JJ
AF Lin, Wei-Hung
   Tseng, Chin-Chung
   Wu, An-Bang
   Yang, Deng-Chi
   Cheng, Shian-Wen
   Wang, Ming-Cheng
   Wu, Jiunn-Jong
TI Clinical and microbiological characteristics of peritoneal
   dialysis-related peritonitis caused by Klebsiella pneumoniae in southern
   Taiwan
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Hypermucoviscosity; Klebsiella pneumoniae; Peritoneal dialysis;
   Peritonitis; Virulence factor
ID GRAM-NEGATIVE PERITONITIS; PYOGENIC LIVER-ABSCESS; NETWORK 9
   PERITONITIS; INFECTIONS RECOMMENDATIONS; CAPSULAR SEROTYPES; VIRULENCE;
   COMPLICATIONS; BACTEREMIA; OUTCOMES; GENE
AB Background/Purpose(s): Gram-negative peritonitis is a frequent and serious complication of peritoneal dialysis (PD). No previous reports have focused on Klebsiella pneumoniae infection. The aim of this study was to investigate the host and bacterial factors associated with K. pneumoniae PD-related peritonitis.
   Methods: We retrospectively studied K. pneumoniae PD-peritonitis cases treated at a university hospital in southern Taiwan during 1990-2011, and analyzed the clinical features and outcomes and bacterial characteristics of serotypes, hypermucoviscosity (HV), and virulence-associated genes such as wabG, uge, and rmpA in K. pneumoniae PD-related peritonitis. Fifty-four isolates of K. pneumoniae-related community-acquired urinary tract infection (UTI) and 76 morphologically different nonpathogenic K. pneumoniae isolates from healthy adults were used as controls.
   Results: K. pneumoniae was the second most common monomicrobial pathogen causing Gramnegative PD-related peritonitis (n = 13, 2.7%), and the most common pathogen involved in polymicrobial peritonitis (16/43, 37.2%) and associated with high catheter removal rate (7/16, 43.8%). Compared with Escherichia coli peritonitis cases, patients with monomicrobial K. pneumoniae peritonitis also had insignificantly higher incidence of sepsis/bacteremia [n = 5 (38%), p = 0.11] and a higher mortality rate [n = 3 (23%), p = 0.36]. The prevalence of K1/K2 (n = 1, 7.7%) serotypes was low, but there was a higher prevalence of serotype K20 (n = 3, 23.1%) in K. pneumoniae isolates derived from monomicrobial PD-related peritonitis compared with control groups. HV phenotype (p < 0.001) and rmpA genotype (p = 0.007) were absent in the peritonitis group.
   Conclusion: This is the first study focused on clinical and microbiological characteristics of K. pneumoniae PD-related peritonitis. K. pneumoniae was a common Gram-negative pathogen causing monomicrobial and polymicrobial PD-related peritonitis in southern Taiwan. The bacterial characteristics with low percentage of capsular serotype K1/K2, no significant HV, and absence of rmpA suggest a different pathogenesis in K. pneumoniae PD-related peritonitis compared with that in UTI and liver abscess. Copyright (C) 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Lin, Wei-Hung; Tseng, Chin-Chung; Wu, An-Bang; Yang, Deng-Chi; Wang, Ming-Cheng] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan.
   [Lin, Wei-Hung; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan.
   [Cheng, Shian-Wen; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.
   [Wang, Ming-Cheng] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan.
   [Wu, Jiunn-Jong] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan.
RP Wu, JJ (reprint author), Natl Cheng Kung Univ, Coll Med, Infect Dis & Signaling Res Ctr, Dept Med Lab Sci & Biotechnol, 1 Univ Rd, Tainan 70101, Taiwan.
EM wangmc@mail.ncku.edu.tw; jjwu@mail.ncku.edu.tw
RI Tseng, Chin-Chung/K-5476-2019
OI Tseng, Chin-Chung/0000-0002-8445-5269
FU National Science Council (Taipei, Taiwan)National Science Council of
   Taiwan [NSC101-2320-B-006-020-MY3]; National Cheng Kung University
   Hospital, Tainan, Taiwan [NCKUH-10205016]
FX We are very grateful to Robert M. Jonas for helpful comments on the
   manuscript. This work was supported in part by grant
   NSC101-2320-B-006-020-MY3 from the National Science Council (Taipei,
   Taiwan) and by grant NCKUH-10205016 from the National Cheng Kung
   University Hospital, Tainan, Taiwan.
CR BERNARDINI J, 1991, CLIN NEPHROL, V36, P29
   Bunke CM, 1997, KIDNEY INT, V52, P524, DOI 10.1038/ki.1997.363
   BUNKE M, 1995, AM J KIDNEY DIS, V25, P769, DOI 10.1016/0272-6386(95)90553-7
   Chaudhary K, 2011, CLIN J AM SOC NEPHRO, V6, P447, DOI 10.2215/CJN.07920910
   Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968
   Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262
   Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857
   FOX L, 1992, ADV PERIT D, V8, P346
   Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420
   Golper TA, 1996, AM J KIDNEY DIS, V28, P428, DOI 10.1016/S0272-6386(96)90502-8
   Gupta B, 1996, AM J KIDNEY DIS, V28, P415, DOI 10.1016/S0272-6386(96)90500-4
   Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003
   Jain AK, 2006, KIDNEY INT, V69, P1107, DOI 10.1038/sj.ki.5000257
   Jarvis EM, 2010, KIDNEY INT, V78, P408, DOI 10.1038/ki.2010.149
   KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995
   Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025
   Ku YH, 2008, J MICROBIOL IMMUNOL, V41, P311
   Lee HC, 2006, J INTERN MED, V259, P606, DOI 10.1111/j.1365-2796.2006.01641.x
   Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049
   Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003
   Lin WH, 2010, INFECTION, V38, P459, DOI 10.1007/s15010-010-0049-5
   Lin YC, 2012, INTERNAL MED, V51, P1841, DOI 10.2169/internalmedicine.51.7485
   Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619
   NAGAPPAN R, 1992, AM J KIDNEY DIS, V20, P492, DOI 10.1016/S0272-6386(12)70262-7
   NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989
   Piraino B, 2005, PERITON DIALYSIS INT, V25, P107
   Regue M, 2004, INFECT IMMUN, V72, P54, DOI 10.1128/IAI.72.1.54-61.2004
   Sandhu A, 2012, PERITON DIALYSIS INT, V32, P229, DOI 10.3747/pdi.2011.00108
   SIMOONSSMIT AM, 1986, J MED MICROBIOL, V21, P133, DOI 10.1099/00222615-21-2-133
   Szeto CC, 2006, KIDNEY INT, V69, P1245, DOI 10.1038/sj.ki.5000037
   TRANAEUS A, 1989, PERITON DIALYSIS INT, V9, P179
   Troidle L, 1998, AM J KIDNEY DIS, V32, P623, DOI 10.1016/S0272-6386(98)70026-5
   Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021
   Valdes-Sotomayor J, 2003, PERITON DIALYSIS INT, V23, P450
   Vas S, 2000, AM J KIDNEY DIS, V36, P1057
   VAS SI, 1984, T AM SOC ART INT ORG, V30, P682
   Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06
   Yu WL, 2006, CLIN INFECT DIS, V42, P1351, DOI 10.1086/503420
   Zelenitsky S, 2000, AM J KIDNEY DIS, V36, P1009, DOI 10.1053/ajkd.2000.19103
NR 39
TC 10
Z9 12
U1 0
U2 5
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD JUN
PY 2015
VL 48
IS 3
BP 276
EP 283
DI 10.1016/j.jmii.2013.10.002
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CK1GB
UT WOS:000355954200006
PM 24291619
OA Bronze
DA 2020-05-07
ER

PT J
AU Kidd, S
   Halliday, C
   Ellis, D
AF Kidd, Sarah
   Halliday, Catriona
   Ellis, David
TI The role of clinical mycology reference laboratories
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
AB Mycology reference laboratories fulfil a critical role in clinical microbiology. Staff with extensive training and expertise in mycology: (1) perform testing (e. g. fungal identification, susceptibility testing, fungal antigen detection, fungal DNA detection) using methodologies conforming to internationally accepted standards; (2) provide education and training in mycology; (3) provide scientific advice; (4) collaborate with regulatory bodies to deliver quality assurance programs; and (5) participate in research including monitoring emerging fungal trends and outbreaks. It is critically important that reference laboratories be resourced adequately for these functions and we believe there is scope to form an officially recognised network of mycology centres in Australia.
C1 [Kidd, Sarah] SA Pathol, Natl Mycol Reference Ctr, Adelaide, SA 5000, Australia.
   [Halliday, Catriona] Westmead Hosp, Ctr Infect Dis, Clin Mycol Reference Lab, Westmead, NSW 2145, Australia.
   [Halliday, Catriona] Westmead Hosp, Microbiol Lab Serv, Pathol West, Westmead, NSW 2145, Australia.
   [Ellis, David] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.
RP Kidd, S (reprint author), SA Pathol, Natl Mycol Reference Ctr, Adelaide, SA 5000, Australia.
EM sarah.kidd@health.sa.gov.au; Catriona.Halliday@health.nsw.gov.au;
   dellis@adelaide.edu.au
RI Kidd, Sarah E/N-1362-2013
OI Kidd, Sarah E/0000-0002-5957-4178
CR European Centre for Disease Prevention and Control, 2010, COR FUNCT MICR REF L
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
NR 2
TC 0
Z9 0
U1 0
U2 1
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2015
VL 36
IS 2
BP 64
EP 66
DI 10.1071/MA15022
PG 3
WC Microbiology
SC Microbiology
GA CJ9WR
UT WOS:000355854500007
DA 2020-05-07
ER

PT J
AU Fernandez-Rodriguez, A
   Cohen, MC
   Lucena, J
   Van de Voorde, W
   Angelini, A
   Ziyade, N
   Saegeman, V
AF Fernandez-Rodriguez, A.
   Cohen, M. C.
   Lucena, J.
   Van de Voorde, W.
   Angelini, A.
   Ziyade, N.
   Saegeman, V.
TI How to optimise the yield of forensic and clinical post-mortem
   microbiology with an adequate sampling: a proposal for standardisation
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
ID INFECTIOUS-DISEASES; DIAGNOSIS; DEATH
AB Post-mortem microbiology (PMM) is an important tool in forensic pathology, helping to determine the cause and manner of death, especially in difficult scenarios such as sudden unexpected death (SD). Currently, there is a lack of standardization of PMM sampling throughout Europe. We present recommendations elaborated by a panel of European experts aimed to standardize microbiological sampling in the most frequent forensic and clinical post-mortem situations. A network of forensic microbiologists, pathologists and physicians from Spain, England, Belgium, Italy and Turkey shaped a flexible protocol providing minimal requirements for PMM sampling at four practical scenarios: SD, bioterrorism, tissue and cell transplantation (TCT) and paleomicrobiology. Biosafety recommendations were also included. SD was categorized into four subgroups according to the age of the deceased and circumstances at autopsy: (1) included SD in infancy and childhood (0-16 years); (2) corresponded to SD in the young (17-35 years); (3) comprised SD at any age with clinical symptoms; and (4) included traumatic/iatrogenic SD. For each subgroup, a minimum set of samples and general recommendations for microbiological analyses were established. Sampling recommendations for main bioterrorism scenarios were provided. In the TCT setting, the Belgian sampling protocol was presented as an example. Finally, regarding paleomicrobiology, the sampling selection for different types of human remains was reviewed. This proposal for standardization in the sampling constitutes the first step towards a consensus in PMM procedures. In addition, the protocol flexibility to adapt the sampling to the clinical scenario and specific forensic findings adds a cost-benefit value.
C1 [Fernandez-Rodriguez, A.] Inst Nacl Toxicol & Ciencias Forenses, Forens Microbiol Lab, Madrid, Spain.
   [Cohen, M. C.] Sheffield Childrens NHS FT, Dept Histopathol, Sheffield, S Yorkshire, England.
   [Lucena, J.] Inst Legal Med, Forens Pathol Serv, Seville, Spain.
   [Van de Voorde, W.] KU Leuven Univ Leuven, Univ Hosp Leuven, Dept Forens Med, B-3000 Leuven, Belgium.
   [Angelini, A.] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.
   [Ziyade, N.] Council Forens Med, Postmortem Microbiol Lab, Istanbul, Turkey.
   [Saegeman, V.] KU Leuven Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium.
RP Fernandez-Rodriguez, A (reprint author), Inst Nacl Toxicol & Ciencias Forenses, Forens Microbiol Lab, Madrid, Spain.
EM amparo.fernandezrodriguez@justicia.es
RI Cohen, Marta/X-2014-2019; LUCENA, JOAQUIN S/A-8415-2011; Cohen,
   Marta/A-9937-2016
OI Cohen, Marta/0000-0001-5534-444X; LUCENA, JOAQUIN S/0000-0002-6271-2113;
   Cohen, Marta/0000-0001-5534-444X
FU European Twinning Project [TR/2008/IB/KH/01]
FX In memoriam of M<SUP>a</SUP> Jose Burguete dagger, a skilled
   microbiology technician at the Instituto Nacional de Toxicologia y
   Ciencias Forenses. The authors also want to thank Dr. Pedro Manuel
   Garamendi for all his support for forensic microbiology all along the
   European Twinning Project TR/2008/IB/KH/01.
CR Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101
   Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278
   Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554
   Budowle B, 2005, INT J LEGAL MED, V119, P317, DOI 10.1007/s00414-005-0535-y
   Caplan MJ, 2001, CUMITECH, V35
   CDC NIH, 2007, BIOSAFETY MICROBIOLO
   CLSI, 2005, M29A3 CLSI
   De La Fuente C, 2013, ARCHAEOMETRY, V55, DOI 10.1111/j.1475-4754.2012.00707.x
   Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063
   EASTLUND T, 2004, ADV TISSUE BANKING, V7, P51, DOI DOI 10.1142/9789812796646_0003
   Fernandez-Rodriguez A, 2005, FORENSIC SCI INT, V147, P13, DOI 10.1016/j.forsciint.2004.02.030
   Fernandez-Rodriguez A, 2013, ENFERM INFEC MICR CL, V31, P685, DOI 10.1016/j.eimc.2012.09.019
   LASSEN C, 1994, INT J LEGAL MED, V107, P152, DOI 10.1007/BF01225603
   Lehman D. C., 2014, Clinical Microbiology Newsletter, V36, P49, DOI 10.1016/j.clinmicnews.2014.03.001
   Leles D, 2008, MEM I OSWALDO CRUZ, V103, P106, DOI 10.1590/S0074-02762008005000004
   Morentin B, 2012, FORENSIC SCI INT, V220, P80, DOI 10.1016/j.forsciint.2012.01.030
   Morris JA, 2007, CURR DIAGN PATHOL, V13, P65, DOI DOI 10.1016/J.CDIP.2006.07.005
   Nolte KB, 2010, AM J FOREN MED PATH, V31, P308, DOI 10.1097/PAF.0b013e3181c187b5
   Papagrigorakis MJ, 2006, INT J INFECT DIS, V10, P206, DOI 10.1016/j.ijid.2005.09.001
   Pirnay JP, 2012, CELL TISSUE BANK, V13, P287, DOI 10.1007/s10561-011-9256-2
   Pratk Al-Adnani M, 2010, ARCH DIS CHILD, V95, P371
   Rambaud C, 2012, ESCMID SFM MANUAL MI, P255
   Riedel S, 2014, J CLIN MICROBIOL, V52, P1028, DOI 10.1128/JCM.03102-13
   Roberts FJ, 1998, EUR J CLIN MICROBIOL, V17, P821, DOI 10.1007/s100960050200
   Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108
   Sharma BR, 2005, AM J INFECT DIS, V1, P25, DOI 10.3844/ajidsp.2005.25.33
   Snyder JW, 2010, CLIN MICROBIOLOGY PR, V3
   Tran TNN, 2011, BIOTECHNIQUES, V50, P370, DOI 10.2144/000113689
   Veronick SMS, 2007, J MICROBIOL METH, V70, P374, DOI 10.1016/j.mimet.2007.05.014
NR 30
TC 9
Z9 10
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD MAY
PY 2015
VL 34
IS 5
BP 1045
EP 1057
DI 10.1007/s10096-015-2317-x
PG 13
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CG7GK
UT WOS:000353470600025
PM 25680317
DA 2020-05-07
ER

PT J
AU Zhang, SK
   Yin, YL
   Jones, MB
   Zhang, ZZ
   Kaiser, BLD
   Dinsmore, BA
   Fitzgerald, C
   Fields, PI
   Deng, XY
AF Zhang, Shaokang
   Yin, Yanlong
   Jones, Marcus B.
   Zhang, Zhenzhen
   Kaiser, Brooke L. Deatherage
   Dinsmore, Blake A.
   Fitzgerald, Collette
   Fields, Patricia I.
   Deng, Xiangyu
TI Salmonella Serotype Determination Utilizing High-Throughput Genome
   Sequencing Data
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID ANTIGEN GENE-CLUSTER; O-ANTIGENS; ANTIMICROBIAL RESISTANCE;
   ESCHERICHIA-COLI; EPIDEMIOLOGY; SURVEILLANCE; OUTBREAK; TYPHIMURIUM;
   SEROVAR
AB Serotyping forms the basis of national and international surveillance networks for Salmonella, one of the most prevalent food-borne pathogens worldwide (1-3). Public health microbiology is currently being transformed by whole-genome sequencing (WGS), which opens the door to serotype determination using WGS data. SeqSero (www.denglab.info/SeqSero) is a novel Web-based tool for determining Salmonella serotypes using high-throughput genome sequencing data. SeqSero is based on curated databases of Salmonella serotype determinants (rfb gene cluster, fliC and fljB alleles) and is predicted to determine serotype rapidly and accurately for nearly the full spectrum of Salmonella serotypes (more than 2,300 serotypes), from both raw sequencing reads and genome assemblies. The performance of SeqSero was evaluated by testing (i) raw reads from genomes of 308 Salmonella isolates of known serotype; (ii) raw reads from genomes of 3,306 Salmonella isolates sequenced and made publicly available by GenomeTrakr, a U.S. national monitoring network operated by the Food and Drug Administration; and (iii) 354 other publicly available draft or complete Salmonella genomes. We also demonstrated Salmonella serotype determination from raw sequencing reads of fecal metagenomes from mice orally infected with this pathogen. SeqSero can help to maintain the well-established utility of Salmonella serotyping when integrated into a platform of WGS-based pathogen subtyping and characterization.
C1 [Zhang, Shaokang; Deng, Xiangyu] Univ Georgia, Dept Food Sci & Technol, Ctr Food Safety, Griffin, GA 30223 USA.
   [Yin, Yanlong] IIT, Dept Comp Sci, Chicago, IL 60616 USA.
   [Jones, Marcus B.] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA.
   [Zhang, Zhenzhen] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.
   [Kaiser, Brooke L. Deatherage] Pacific NW Natl Lab, Div Biol Sci, Richard, WA USA.
   [Dinsmore, Blake A.; Fitzgerald, Collette; Fields, Patricia I.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA.
RP Deng, XY (reprint author), Univ Georgia, Dept Food Sci & Technol, Ctr Food Safety, Griffin, GA 30223 USA.
EM xdeng@uga.edu
RI Zhang, Shaokang/J-3764-2019
FU Board of Advisors, Center for Food Safety, University of Georgia;
   University of Georgia
FX This work was supported in part by contributions from the Board of
   Advisors, Center for Food Safety, University of Georgia, and by
   University of Georgia startup funds to X.D.
CR Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776
   Brenner FW, 1998, IDENTIFICATION AND S
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095
   EISENSTEIN TK, 1975, INFECT IMMUN, V12, P364, DOI 10.1128/IAI.12.2.364-377.1975
   Fitzgerald C, 2003, APPL ENVIRON MICROB, V69, P6099, DOI 10.1128/AEM.69.10.6099-6105.2003
   Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07
   Grimont PAD, 2007, ANTIGENIC FORMULAE O
   Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002
   Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842
   Hong YQ, 2012, MOL MICROBIOL, V84, P620, DOI 10.1111/j.1365-2958.2012.08048.x
   JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x
   Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13
   Kaiser BLD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067155
   Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824
   Kupferschmidt K, 2011, SCIENCE, V333, P1818, DOI 10.1126/science.333.6051.1818
   Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034
   Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231
   McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10
   McQuiston JR, 2004, J CLIN MICROBIOL, V42, P1923, DOI 10.1128/JCM.42.5.1923-1932.2004
   Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001
   Ottesen AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073079
   Ran L, 2011, FOODBORNE PATHOG DIS, V8, P921, DOI 10.1089/fpd.2010.0827
   Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009
   Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101
   Shi C, 2013, CRIT REV MICROBIOL
   SMITH NH, 1991, P NATL ACAD SCI USA, V88, P956, DOI 10.1073/pnas.88.3.956
   SMITH NH, 1990, J BACTERIOL, V172, P603, DOI 10.1128/jb.172.2.603-609.1990
   VANEGAS RA, 1995, J BACTERIOL, V177, P3863, DOI 10.1128/jb.177.13.3863-3864.1995
   Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11
   Weinberger M, 2005, CURR OPIN INFECT DIS, V18, P513, DOI 10.1097/01.qco.0000186851.33844.b2
   Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
NR 35
TC 127
Z9 129
U1 1
U2 26
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAY
PY 2015
VL 53
IS 5
BP 1685
EP 1692
DI 10.1128/JCM.00323-15
PG 8
WC Microbiology
SC Microbiology
GA CG1MK
UT WOS:000353036500030
PM 25762776
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Forestier, E
   Paccalin, M
   Roubaud-Baudron, C
   Fraisse, T
   Gavazzi, G
   Gaillat, J
AF Forestier, E.
   Paccalin, M.
   Roubaud-Baudron, C.
   Fraisse, T.
   Gavazzi, G.
   Gaillat, J.
TI Subcutaneously administered antibiotics: a national survey of current
   practice from the French Infectious Diseases (SPILF) and Geriatric
   Medicine (SFGG) society networks
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Antibiotics; ceftriaxone; ertapenem; subcutaneous; teicoplanin
AB A national survey was performed to explore antibiotic prescription by the subcutaneous (sc) route among French infectious diseases and geriatric practitioners. Among the participating physicians, 367 (96.1%) declared administering sc antibiotics at some point. Ceftriaxone was prescribed sc by all but one, and ertapenem, teicoplanin, aminoglycosides and amoxicillin by 33.2%, 39.2%, 35.1% and 15.3%, respectively. The sc route was resorted to mainly in case of unavailable oral, intravenous or intramuscular routes, especially during palliative care. Pain, skin necrosis and lack of efficacy were the main adverse effects, reported by 70.8%, 12.8% and 19.9% of practitioners, respectively. Further studies are needed to precise the indications, modalities and tolerance of sc antibiotic use. Clinical Microbiology and Infection (C) 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Forestier, E.] Ctr Hosp, Serv Malad Infect, BP 1125, F-73011 Chambery, France.
   [Paccalin, M.] Ctr Hosp Univ, Serv Geriatrie, Poitiers, France.
   [Roubaud-Baudron, C.] Ctr Hosp Univ, Pole Gerontol Clin, Bordeaux, France.
   [Fraisse, T.] Ctr Hosp, Serv Geriatrie, Ales, France.
   [Gavazzi, G.] CHU Grenoble, Serv Geriatrie, Grenoble, France.
   [Gaillat, J.] Ctr Hosp, Serv Malad Infect, Annecy, France.
RP Forestier, E (reprint author), Ctr Hosp, Serv Malad Infect, BP 1125, F-73011 Chambery, France.
EM emmanuel.forestier@ch-chambery.fr
CR Barbot A, 2003, INTENS CARE MED, V29, P1528, DOI 10.1007/s00134-003-1859-z
   BORNER K, 1985, CHEMOTHERAPY, V31, P237, DOI 10.1159/000238342
   BRICAIRE F, 1988, PATHOL BIOL, V36, P702
   Carpentier E, 2013, ARCH PEDIATRIE, V20, P775, DOI 10.1016/j.arcped.2013.04.019
   Ferry T, 2012, J INFECTION, V65, P579, DOI 10.1016/j.jinf.2012.09.004
   Fonzo-Christe C, 2005, PALLIATIVE MED, V19, P208, DOI 10.1191/0269216304pm1006oa
   Forestier E, 2012, MED MALADIES INFECT, V42, P440, DOI 10.1016/j.medmal.2012.07.005
   Frasca D, 2010, ANTIMICROB AGENTS CH, V54, P924, DOI 10.1128/AAC.00836-09
   Gauthier D, 2014, MED MALADIES INFECT, V44, P275, DOI 10.1016/j.medmal.2014.03.007
   Harb G, 2010, CURR MED RES OPIN, V26, P279, DOI 10.1185/03007990903432900
   Remington R, 2007, J AM GERIATR SOC, V55, P2051, DOI 10.1111/j.1532-5415.2007.01437.x
   Robelet A, 2009, PRESSE MED, V38, P366, DOI 10.1016/j.lpm.2008.07.018
NR 12
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2015
VL 21
IS 4
DI 10.1016/j.cmi.2014.11.017
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA V47CA
UT WOS:000209928700014
PM 25658521
OA Bronze
DA 2020-05-07
ER

PT J
AU Perez-Lago, L
   Lirola, MM
   Herranz, M
   Comas, I
   Bouza, E
   Garcia-de-Viedma, D
AF Perez-Lago, L.
   Martinez Lirola, M.
   Herranz, M.
   Comas, I.
   Bouza, E.
   Garcia-de-Viedma, D.
TI Fast and low-cost decentralized surveillance of transmission of
   tuberculosis based on strain-specific PCRs tailored from whole genome
   sequencing data: a pilot study
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Allele-specific PCR; transmission; TRAP; tuberculosis; whole genome
   sequencing
ID MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; CLINICAL
   MICROBIOLOGY; IMMIGRANTS; IMPACT; ASSAY
AB Molecular epidemiology has transformed our knowledge of how tuberculosis (TB) is transmitted. Whole genome sequencing (WGS) has reached unprecedented levels of accuracy. However, it has increased technical requirements and costs, and analysis of data delays results. Our objective was to find a way to reconcile speed and ease of implementation with the high resolution of WGS. The targeted regional allele-specific oligonucleotide PCR (TRAP) assay presented here is based on allele-specific PCR targeting strain-specific single nucleotide polymorphisms, identified from WGS, and makes it possible to track actively transmitted Mycobacterium tuberculosis strains. A TRAP assay was optimized to track the most actively transmitted strains in a population in Almeria, Southeast Spain, with high rates of TB. TRAP was transferred to the local laboratory where transmission was occurring. It performed well from cultured isolates and directly from sputa, enabling new secondary cases of infection from the actively transmitted strains to be detected. TRAP constitutes a fast, simple and low-cost tool that could modify surveillance of TB transmission. This pilot study could help to define a new model to survey TB transmission based on a decentralized multinodal network of local laboratories applying fast and low-cost TRAPs, which are developed by central reference centres, tailored to the specific demands of transmission at each local node. Clinical Microbiology and Infection (C) 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Perez-Lago, L.; Herranz, M.; Bouza, E.; Garcia-de-Viedma, D.] Hosp Gen Univ Gregorio Maranon, Serv Microbiol Clin & Enfermedades Infecciosas, Madrid 28007, Spain.
   [Perez-Lago, L.; Herranz, M.; Bouza, E.; Garcia-de-Viedma, D.] Univ Complutense Madrid, Fac Med, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.
   [Bouza, E.] Univ Complutense Madrid, Fac Med, Dept Med, Madrid, Spain.
   [Garcia-de-Viedma, D.] UPM, UCM, CEI Campus Moncloa, Madrid, Spain.
   [Martinez Lirola, M.] Complejo Hosp Torrecardenas, Almeria, Spain.
   [Comas, I.] Univ Valencia, FISABIO Salud Publ, Unidad Mixta Infecc & Salud, Valencia, Spain.
   [Perez-Lago, L.; Herranz, M.; Bouza, E.; Garcia-de-Viedma, D.] CIBERES, CIBER Enfermedades Resp, Madrid, Spain.
   [Comas, I.] CIBERES, Madrid, Spain.
RP Garcia-de-Viedma, D (reprint author), Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Serv Microbiol & Enfermedades Infecciosas, C Dr Esquerdo 46, Madrid 28007, Spain.
EM dgviedma2@gmail.com
RI Comas, Inaki/AAA-1155-2019; Bouza, Emilio/D-8661-2014; Perez-Lago,
   Laura/AAB-4206-2020; Comas, Inaki/F-1185-2011; de Viedma, Dario
   Garcia/D-6914-2018
OI Comas, Inaki/0000-0001-5504-9408; Bouza, Emilio/0000-0001-6967-9267;
   Perez-Lago, Laura/0000-0001-5249-7619; Comas, Inaki/0000-0001-5504-9408;
   de Viedma, Dario Garcia/0000-0003-3647-7110; Martinez-Lirola, Miguel
   Jose/0000-0003-3282-1367
FU Fondo de Investigaciones Sanitarias (FIS)Instituto de Salud Carlos III;
   FEDER fundsEuropean Union (EU); Fondo de Investigaciones Sanitarias
   (ISCIII, Plan Nacional I+D+I) [13/01207, 12/02080]; Ramon y Cajal
   Spanish research grant [RYC2012-10627]; MINECO research grant
   [SAF2013-43521-R]
FX This work was supported by Fondo de Investigaciones Sanitarias (FIS;
   ISCIII, Plan Nacional I+D+I 2008-2011 and 2013-2016: Refs 13/01207,
   12/02080) and cofinanced by FEDER funds. L. Perez-Lago holds a contract
   from CIBERES (Ref CP13/27/01). Ramon y Cajal Spanish research grant
   RYC2012-10627 and MINECO research grant SAF2013-43521-R (to I.C.). All
   authors report no conflicts of interest relevant to this article.
CR Alonso M, 2011, CLIN MICROBIOL INFEC, V17, P349, DOI 10.1111/j.1469-0691.2010.03234.x
   Alonso M, 2012, J CLIN MICROBIOL, V50, P1755, DOI 10.1128/JCM.00132-12
   Bertelli C, 2013, CLIN MICROBIOL INFEC, V19, P803, DOI 10.1111/1469-0691.12217
   Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   Crudu V, 2012, J CLIN MICROBIOL, V50, P1264, DOI 10.1128/JCM.05903-11
   Davis JL, 2014, AM J RESP CRIT CARE, V189, P1551, DOI 10.1164/rccm.201311-1974OC
   Diel R, 2004, J CLIN MICROBIOL, V42, P2952, DOI 10.1128/JCM.42.7.2952-2960.2004
   Fournier PE, 2013, NAT REV MICROBIOL, V11, P574, DOI 10.1038/nrmicro3068
   Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Martinez-Lirola M, 2008, CLIN INFECT DIS, V47, P8, DOI 10.1086/588785
   Mokrousov I, 2014, J CLIN MICROBIOL, V52, P1691, DOI 10.1128/JCM.03193-13
   MOONAN PK, 2004, INT J HEALTH GEOGR, V3, P23, DOI DOI 10.1186/1476-072X-3-23
   Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005
   Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06
   Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439
   Rodriguez NA, 2009, CLIN MICROBIOL INFEC, V15, P435, DOI 10.1111/j.1469-0691.2008.02670.x
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387
   Soolingen DV, 2014, LANCET RESP MED, V2, P251
   Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253
   Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06
   Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3
NR 25
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2015
VL 21
IS 3
DI 10.1016/j.cmi.2014.10.003
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CZ8XV
UT WOS:000367383300009
PM 25614157
OA Bronze
DA 2020-05-07
ER

PT J
AU Paterson, GK
   Harrison, EM
   Murray, GGR
   Welch, JJ
   Warland, JH
   Holden, MTG
   Morgan, FJE
   Ba, XL
   Koop, G
   Harris, SR
   Maskell, DJ
   Peacock, SJ
   Herrtage, ME
   Parkhill, J
   Holmes, MA
AF Paterson, Gavin K.
   Harrison, Ewan M.
   Murray, Gemma G. R.
   Welch, John J.
   Warland, James H.
   Holden, Matthew T. G.
   Morgan, Fiona J. E.
   Ba, Xiaoliang
   Koop, Gerrit
   Harris, Simon R.
   Maskell, Duncan J.
   Peacock, Sharon J.
   Herrtage, Michael E.
   Parkhill, Julian
   Holmes, Mark A.
TI Capturing the cloud of diversity reveals complexity and heterogeneity of
   MRSA carriage, infection and transmission
SO NATURE COMMUNICATIONS
LA English
DT Article
ID RESISTANT STAPHYLOCOCCUS-AUREUS; INSERTIONAL INACTIVATION;
   BAYESIAN-INFERENCE; AGR DYSFUNCTION; EVOLUTION; CULTURE; SITES;
   SEQUENCE; SAMPLES; PROTEIN
AB Genome sequencing is revolutionizing clinical microbiology and our understanding of infectious diseases. Previous studies have largely relied on the sequencing of a single isolate from each individual. However, it is not clear what degree of bacterial diversity exists within, and is transmitted between individuals. Understanding this 'cloud of diversity' is key to accurate identification of transmission pathways. Here, we report the deep sequencing of methicillin-resistant Staphylococcus aureus among staff and animal patients involved in a transmission network at a veterinary hospital. We demonstrate considerable within-host diversity and that within-host diversity may rise and fall over time. Isolates from invasive disease contained multiple mutations in the same genes, including inactivation of a global regulator of virulence and changes in phage copy number. This study highlights the need for sequencing of multiple isolates from individuals to gain an accurate picture of transmission networks and to further understand the basis of pathogenesis.
C1 [Paterson, Gavin K.; Harrison, Ewan M.; Warland, James H.; Morgan, Fiona J. E.; Ba, Xiaoliang; Maskell, Duncan J.; Herrtage, Michael E.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England.
   [Murray, Gemma G. R.; Welch, John J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England.
   [Holden, Matthew T. G.; Harris, Simon R.; Peacock, Sharon J.; Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton CB10 15A, England.
   [Koop, Gerrit] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands.
   [Peacock, Sharon J.] Univ Cambridge, Dept Clin Med, Cambridge CB2 0QQ, England.
RP Holmes, MA (reprint author), Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England.
EM mah1@cam.ac.uk
RI Paterson, Gavin/V-6725-2019; Murray, Gemma/L-2719-2015; Murray,
   Gemma/Z-2813-2019; Parkhill, Julian/G-4703-2011; Holden, Matthew
   TG/K-6449-2014; Harrison, Ewan/I-5003-2013
OI Paterson, Gavin/0000-0002-1880-0095; Murray, Gemma/0000-0002-9531-1711;
   Murray, Gemma/0000-0002-9531-1711; Parkhill, Julian/0000-0002-7069-5958;
   Holden, Matthew TG/0000-0002-4958-2166; Ba,
   Xiaoliang/0000-0002-3882-3585; Holmes, Mark/0000-0002-5454-1625;
   Harrison, Ewan/0000-0003-2720-0507
FU Medical Research CouncilMedical Research Council UK (MRC) [G1001787/1];
   NIHR Cambridge Biomedical Research CentreNational Institute for Health
   Research (NIHR); Wellcome TrustWellcome Trust [098051]; MRC
   studentshipMedical Research Council UK (MRC); Medical Research
   CouncilMedical Research Council UK (MRC) [G1001787]
FX Thanks to Dr Alex O'Neill, University of Leeds and Dr Matthew Ellington,
   Public Health England for provision of RN4220 and RN4200mutS. We thank
   the core sequencing and informatics team at the Wellcome Trust Sanger
   Institute for sequencing of the isolates described in this study. This
   work was supported by a Medical Research Council Partnership grant
   (G1001787/1) held between the Department of Veterinary Medicine,
   University of Cambridge (M.A.H.), the School of Clinical Medicine,
   University of Cambridge (S.J.P.), the Moredun Research Institute and the
   Wellcome Trust Sanger Institute (J.P. and S.J.P). S.J.P. receives
   support from the NIHR Cambridge Biomedical Research Centre. M.T.G.H.,
   S.R.H. and J.P. were funded by Wellcome Trust grant no. 098051. G.G.R.M.
   was funded by an MRC studentship.
CR Afroz S, 2008, JPN J INFECT DIS, V61, P393
   [Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1
   Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638
   Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7
   Butterfield JM, 2011, ANTIMICROB AGENTS CH, V55, P5433, DOI 10.1128/AAC.00407-11
   Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557
   Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121
   Didelot X, 2013, P NATL ACAD SCI USA, V110, P13880, DOI 10.1073/pnas.1304681110
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226
   Doughty EL, 2014, PEERJ, V2, DOI 10.7717/peerj.585
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Eyre DW, 2012, J CLIN MICROBIOL, V50, P142, DOI 10.1128/JCM.05177-11
   Forbes KJ, 2009, J CLIN MICROBIOL, V47, P111, DOI 10.1128/JCM.01731-08
   Fowler VG, 2004, J INFECT DIS, V190, P1140
   Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106
   Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319
   Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2
   Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13
   Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13
   Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112
   Hombach M, 2010, J CLIN MICROBIOL, V48, P3882, DOI 10.1128/JCM.00670-10
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263
   Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003
   Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305
   Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824
   Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910
   Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421
   Lauderdale TLY, 2010, EUR J CLIN MICROBIOL, V29, P1553, DOI 10.1007/s10096-010-1042-8
   Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012
   Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231
   Lynn F, 2005, J CLIN MICROBIOL, V43, P368, DOI 10.1128/JCM.43.1.368-375.2005
   Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   O'Neill AJ, 2002, J ANTIMICROB CHEMOTH, V50, P161, DOI 10.1093/jac/dkf118
   Park SY, 2013, INFECTION, V41, P111, DOI 10.1007/s15010-012-0348-0
   Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329
   Paulander W, 2012, MBIO, V3, DOI 10.1128/mBio.00459-12
   Pollitt EJG, 2014, INFECT IMMUN, V82, P1045, DOI 10.1128/IAI.01216-13
   Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270
   Reuter S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/jamainternmed.2013.7734
   RICHARDSON JF, 1993, J HOSP INFECT, V25, P45, DOI 10.1016/0195-6701(93)90007-M
   Rosenthal A, 2006, J CLIN MICROBIOL, V44, P4234, DOI 10.1128/JCM.00860-06
   SAKO T, 1983, NUCLEIC ACIDS RES, V11, P7679, DOI 10.1093/nar/11.22.7679
   Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10
   Seth-Smith HMB, 2013, NAT PROTOC, V8, P2404, DOI 10.1038/nprot.2013.147
   Smith JA, 2010, J INFECT DIS, V202, P1770, DOI 10.1086/657317
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191
   Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0
   van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006
   Vincze S, 2013, APPL ENVIRON MICROB, V79, P655, DOI 10.1128/AEM.02704-12
   Votintseva AA, 2014, J CLIN MICROBIOL, V52, P1192, DOI 10.1128/JCM.03254-13
   WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549
   Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13
   Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 61
TC 56
Z9 56
U1 0
U2 35
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR
PY 2015
VL 6
AR 6560
DI 10.1038/ncomms7560
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG1NM
UT WOS:000353039800003
PM 25814293
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Beneteau, A
   Levy, C
   Foucaud, P
   Bechet, S
   Cohen, R
   Raymond, J
   Dommergues, MA
AF Beneteau, Anne
   Levy, Corinne
   Foucaud, Pierre
   Bechet, Stephane
   Cohen, Robert
   Raymond, Josette
   Dommergues, Marie-Aliette
TI Childhood Meningitis Caused by Streptococcus bovis Group: Clinical and
   Biologic Data During a 12-Year Period in France
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE S. bovis infection; meningitis; neonates; national survey
ID GALLOLYTICUS SUBSP PASTEURIANUS; NEONATAL BACTERIAL-MENINGITIS;
   INFECTION; INFANTS; SEPSIS
AB Background: Bacterial meningitis (BM) is a major cause of morbidity and mortality in children. Sporadic cases of Streptococcus bovis have been described in neonates and infants. To assess the epidemiologic, clinical and biologic characteristics of this meningitis, we used the French Surveillance Network for BM in children.
   Methods: Two hundred and twenty-seven pediatric wards working with 168 microbiology departments throughout France were asked to report all cases of BM in patients <18 years. Diagnosis was based on a combination of fever, meningeal signs and a positive cerebrospinal fluid (CSF) culture and/or a positive polymerase chain reaction in the CSF and/or positive blood culture associated with pleiocytosis.
   Results: Among 4806 cases of BM recorded in 12 years (2001-2012), 23 cases were caused by S. bovis (0.5%). All were infants. Among them, 15 cases (65.2%) occurred in the neonatal period. The majority occurred in premature infants (73.9%). In 21 cases, the diagnosis was based on a positive CSF culture. Blood culture was positive in 17 children. When S. bovis subtype was identified, it was type 2 (Streptococcus gallolyticus pasteurianus) in 80% of cases. All infants received antibiotic therapy with parenteral penicillin and/or third-generation cephalosporin combined with an aminoglycoside. The duration of treatment ranged from 10 to 25 days. Of the 23 patients, 17 (73.9%) had a second lumbar puncture and in all those cases, the CSF was sterile. No deaths or neurologic complications were reported.
   Conclusion: BM due to S. bovis is rare and primarily affects infants, particularly premature infants. Antibiotic treatment is effective with low morbidity and mortality.
C1 [Beneteau, Anne; Foucaud, Pierre; Dommergues, Marie-Aliette] Ctr Hosp Versailles, Dept Paediat, F-78150 Le Chesnay, France.
   [Levy, Corinne; Bechet, Stephane; Cohen, Robert] Assoc Clin & Therapeut Infantile Val Marne, ACTIV, St Maur Les Fosses, France.
   [Levy, Corinne; Foucaud, Pierre; Cohen, Robert; Raymond, Josette; Dommergues, Marie-Aliette] Ctr Hosp Intercommunal Creteil, Pediat Infect Dis Grp, GPIP, Creteil, France.
   [Levy, Corinne; Cohen, Robert] Ctr Hosp Intercommunal Creteil, CRC, Creteil, France.
   [Cohen, Robert] Ctr Hosp Intercommunal Creteil, Dept Pediat, Creteil, France.
   [Raymond, Josette] Hop Cochin, Dept Microbiol, F-75674 Paris, France.
RP Dommergues, MA (reprint author), Ctr Hosp Versailles, Dept Paediat, 177 Rue Versailles, F-78150 Le Chesnay, France.
EM madommergues@orange.fr
FU Pediatric Infectious Diseases Group of the French Pediatrics Society
   (GPIP); Association Clinique et Therapeutique Infantile du Val de Marne
   (ACTIV)
FX Financial support was provided by the Pediatric Infectious Diseases
   Group of the French Pediatrics Society (GPIP) and Association Clinique
   et Therapeutique Infantile du Val de Marne (ACTIV).
CR Al-Arishi Haider, 2002, Int J Infect Dis, V6, P323, DOI 10.1016/S1201-9712(02)90171-2
   Ben Hamouda H, 2013, ARCH PEDIATRIE, V20, P938, DOI [10.1016/j.arcped.2013.05.005, 10.1016/j.arcped.2013]
   Boleij A, 2013, LANCET INFECT DIS, V13, P719, DOI 10.1016/S1473-3099(13)70107-5
   Cheung M, 2000, PEDIATR INFECT DIS J, V19, P891, DOI 10.1097/00006454-200009000-00019
   Clark TR, 2012, CLIN PEDIATR, V51, P521, DOI 10.1177/0009922812440843
   Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7
   Gavin PJ, 2003, J CLIN MICROBIOL, V41, P3433, DOI 10.1128/JCM.41.7.3433-3435.2003
   Gerber JS, 2006, PEDIATR INFECT DIS J, V25, P1069, DOI 10.1097/01.inf.0000240334.91713.48
   Grant RJ, 2000, J CLIN MICROBIOL, V38, P462
   Khan A, 2009, J PAEDIATR CHILD H, V45, P474, DOI 10.1111/j.1440-1754.2009.01541.x
   Klatte JM, 2012, J CLIN MICROBIOL, V50, P57, DOI 10.1128/JCM.05635-11
   Koh TH, 2002, SCAND J INFECT DIS, V34, P63, DOI 10.1080/00365540110076958
   Levy C, 2014, ARCH PEDIATRIE, V21, P736, DOI 10.1016/j.arcped.2014.04.025
   Levy C, 2009, MED MALADIES INFECT, V39, P419, DOI 10.1016/j.medmal.2009.03.006
   Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69
   Onoyama S, 2009, J MED MICROBIOL, V58, P1252, DOI 10.1099/jmm.0.006551-0
   Thatrimontrichai A, 2012, SE ASIAN J TROP MED, V43, P145
   WISWELL TE, 1995, PEDIATRICS, V95, P803
NR 18
TC 9
Z9 10
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD FEB
PY 2015
VL 34
IS 2
BP 136
EP 139
DI 10.1097/INF.0000000000000513
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA CB8VE
UT WOS:000349908800007
PM 25144798
DA 2020-05-07
ER

PT J
AU Hui, S
   Silverman, JM
   Chen, SS
   Erickson, DW
   Basan, M
   Wang, JL
   Hwa, T
   Williamson, JR
AF Hui, Sheng
   Silverman, Josh M.
   Chen, Stephen S.
   Erickson, David W.
   Basan, Markus
   Wang, Jilong
   Hwa, Terence
   Williamson, James R.
TI Quantitative proteomic analysis reveals a simple strategy of global
   resource allocation in bacteria
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE growth physiology; metabolic network; microbiology; quantitative
   proteomics; systems biology
ID ESCHERICHIA-COLI; MASS-SPECTROMETRY; ABSOLUTE QUANTIFICATION;
   PROTEIN-SYNTHESIS; GROWTH-RATE; GENE-EXPRESSION; BALANCED GROWTH;
   IN-VIVO; E. COIL; ABUNDANCE
AB A central aim of cell biology was to understand the strategy of gene expression in response to the environment. Here, we study gene expression response to metabolic challenges in exponentially growing Escherichia coli using mass spectrometry. Despite enormous complexity in the details of the underlying regulatory network, we find that the proteome partitions into several coarse-grained sectors, with each sector's total mass abundance exhibiting positive or negative linear relations with the growth rate. The growth rate-dependent components of the proteome fractions comprise about half of the proteome by mass, and their mutual dependencies can be characterized by a simple flux model involving only two effective parameters. The success and apparent generality of this model arises from tight coordination between proteome partition and metabolism, suggesting a principle for resource allocation in proteome economy of the cell. This strategy of global gene regulation should serve as a basis for future studies on gene expression and constructing synthetic biological circuits. Coarse graining may be an effective approach to derive predictive phenomenological models for other 'omics' studies.
C1 [Hui, Sheng; Erickson, David W.; Basan, Markus; Wang, Jilong; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.
   [Silverman, Josh M.; Chen, Stephen S.; Williamson, James R.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
   [Silverman, Josh M.; Chen, Stephen S.; Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, La Jolla, CA 92037 USA.
   [Hwa, Terence] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.
RP Hwa, T (reprint author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.
EM hwa@ucsd.edu; jrwill@scripps.edu
RI Williamson, James/B-2891-2009; Erickson, David W/A-6628-2008; Hwa,
   Terry/J-4012-2013
OI Williamson, James/0000-0002-8772-468X; Hwa, Terry/0000-0003-1837-6842;
   Hui, Sheng/0000-0002-4226-6806; Chen, Stephen/0000-0003-2154-2143
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R37-GM053357, R01-GM095903]; NSF
   through the Center for Theoretical Biological PhysicsNational Science
   Foundation (NSF) [PHY0822283]; Simons Foundation [330378]; China
   Scholarship CouncilChina Scholarship Council; ARCS Foundation; PRIDE
   Team, EBI
FX We benefited from helpful discussions with numerous colleagues through
   the course of this work, including Hirotada Mori, Kenji Nakahigashi,
   Steen Pedersen, Alexander Schmidt, Matthew Scott, Yang Shen, John Yates,
   and members of the Hwa and Williamson labs. We particularly thank Sherry
   Niessen, Elizabeth Valentine, and Catherine Wong who helped with mass
   spectrometry, and Jessica Lynn Figueroa for artistic contributions to
   the figures. This work is supported by the NIH to JRW (R37-GM053357) and
   to TH (R01-GM095903), by the NSF through the Center for Theoretical
   Biological Physics (PHY0822283), and by the Simons Foundation (330378).
   JW acknowledges support of a scholarship from the China Scholarship
   Council. JMS acknowledges the support of a fellowship from the ARCS
   Foundation. The data deposition to the ProteomeXchange Consortium was
   supported by PRIDE Team, EBI.
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257
   ANDREWS KJ, 1976, J MOL EVOL, V8, P317, DOI 10.1007/BF01739257
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   BENNETT PM, 1974, J MOL BIOL, V90, P541, DOI 10.1016/0022-2836(74)90234-4
   Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774
   Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200
   Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779
   Bremer H, 2009, ECOSAL ESCHERICHIA C, P1
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54
   CAYLEY S, 1989, J BACTERIOL, V171, P3597, DOI 10.1128/jb.171.7.3597-3602.1989
   Chubukov V, 2014, APPL ENVIRON MICROB, V12, P327
   Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842
   DENNIS PP, 1974, J MOL BIOL, V84, P407, DOI 10.1016/0022-2836(74)90449-5
   DENNIS PP, 1976, J MOL BIOL, V108, P535, DOI 10.1016/S0022-2836(76)80135-0
   Deris JB, 2013, SCIENCE, V342, P1068, DOI 10.1126/science.1237435
   DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995
   Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Goelzer A, 2011, BBA-GEN SUBJECTS, V1810, P978, DOI 10.1016/j.bbagen.2011.05.014
   Han XM, 2008, CURR OPIN CHEM BIOL, V12, P483, DOI 10.1016/j.cbpa.2008.07.024
   Hayek FA, 1945, AM ECON REV, V35, P519
   Hinshelwood CN, 1944, BIOL REV CAMB PHILOS, V19, P150, DOI 10.1111/j.1469-185X.1944.tb00309.x
   Hofmeyr JHS, 2000, FEBS LETT, V476, P47, DOI 10.1016/S0014-5793(00)01668-9
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200
   Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102
   KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607
   Klumpp S, 2013, P NATL ACAD SCI USA, V110, P16754, DOI 10.1073/pnas.1310377110
   Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001
   KOCH AL, 1971, J MOL BIOL, V55, P549, DOI 10.1016/0022-2836(71)90336-6
   Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x
   Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315
   Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250
   Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033
   Lovell MC, 2004, EC CALCULUS
   Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270
   Maaloe O, 1979, BIOL REGUL DEV, V1, P1
   Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mankiw NG, 2011, PRINCIPLES EC
   Mather WH, 2013, BIOPHYS J, V104, P2564, DOI 10.1016/j.bpj.2013.04.049
   Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82
   Muntel J, 2014, MOL CELL PROTEOMICS, V13, P1008, DOI 10.1074/mcp.M113.032631
   O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52
   Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736
   PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4
   Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107
   Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820
   Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588
   Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
   Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999
   VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994
   Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839
   Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59
   Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]
   Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46
   You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446
   Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545
NR 69
TC 104
Z9 107
U1 1
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD FEB
PY 2015
VL 11
IS 2
DI 10.15252/msb.20145697
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CC7JN
UT WOS:000350543600003
PM 25678603
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Liu, Y
   Xie, DF
   Han, L
   Bai, H
   Li, F
   Wang, SQ
   Bo, XC
AF Liu, Yang
   Xie, Dafei
   Han, Lu
   Bai, Hui
   Li, Fei
   Wang, Shengqi
   Bo, Xiaochen
TI EHFPI: a database and analysis resource of essential host factors for
   pathogenic infection
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID VIRUS; MANAGEMENT
AB High-throughput screening and computational technology has greatly changed the face of microbiology in better understanding pathogen-host interactions. Genome-wide RNA interference (RNAi) screens have given rise to a new class of host genes designated as Essential Host Factors (EHFs), whose knockdown effects significantly influence pathogenic infections. Therefore, we present the first release of a manually-curated bioinformatics database and analysis resource EHFPI (Essential Host Factors for Pathogenic Infection, http://biotech.bmi.ac.cn/ehfpi). EHFPI captures detailed article, screen, pathogen and phenotype annotation information for a total of 4634 EHF genes of 25 clinically important pathogenic species. Notably, EHFPI also provides six powerful and data-integrative analysis tools, i.e. EHF Overlap Analysis, EHF-pathogen Network Analysis, Gene Enrichment Analysis, Pathogen Interacting Proteins (PIPs) Analysis, Drug Target Analysis and GWAS Candidate Gene Analysis, which advance the comprehensive understanding of the biological roles of EHF genes, as in diverse perspectives of protein-protein interaction network, drug targets and diseases/traits. The EHFPI web interface provides appropriate tools that allow efficient query of EHF data and visualization of custom-made analysis results. EHFPI data and tools shall keep available without charge and serve the microbiology, biomedicine and pharmaceutics research communities, to finally facilitate the development of diagnostics, prophylactics and therapeutics for human pathogens.
C1 [Liu, Yang; Xie, Dafei; Han, Lu; Bai, Hui; Li, Fei; Wang, Shengqi; Bo, Xiaochen] Beijing Inst Radiat Med, Dept Biotechnol, Beijing 100850, Peoples R China.
   [Bai, Hui] 451 Hosp Chinese Peoples Liberat Army, Xian 710054, Peoples R China.
RP Bo, XC (reprint author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing 100850, Peoples R China.
EM huibai13@hotmail.com; lifei@bmi.ac.cn; boxc@bmi.ac.cn
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [81102419, 81230089]; National Key Technologies R &
   D Program for New DrugsNational Key Technology R&D Program
   [2012ZX09301-003]; Program of International S T Cooperation
   [2014DFB30020]; National Major Science and Technology Special Projects
   for New Drugs [2013ZX09304102]; National Science & Technology Pillar
   Program of China [2012BAI29B07]; Nonprofit Research Program of Zhejiang
   Province [2012C33062, 2013C33113]
FX National Nature Science Foundation of China [81102419, 81230089];
   National Key Technologies R & D Program for New Drugs [2012ZX09301-003];
   Program of International S & T Cooperation [2014DFB30020]; National
   Major Science and Technology Special Projects for New Drugs
   [2013ZX09304102]; National Science & Technology Pillar Program of China
   [2012BAI29B07]; Nonprofit Research Program of Zhejiang Province
   [2012C33062, 2013C33113]. Funding for open access charge: National
   Nature Science Foundation of China [81102419, 81230089].
CR Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x
   Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739
   CONTI G, 1995, RES VIROLOGY, V146, P141, DOI 10.1016/0923-2516(96)81083-1
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   Fecteau ME, 2011, J VET INTERN MED, V25, P1152, DOI 10.1111/j.1939-1676.2011.0768.x
   Fecteau ME, 2014, VET J, V202, P195, DOI 10.1016/j.tvjl.2014.06.023
   Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953
   Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066
   Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Imanishi T, 2009, NUCLEIC ACIDS RES, V37, pW17, DOI 10.1093/nar/gkp355
   Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760
   Kasprzyk A., 2011, DATABASE, V2011, DOI DOI 10.1093/DATABASE/BAR049
   Kent SJ, 2012, AIDS RES HUM RETROV, V28, P761, DOI [10.1089/aid.2012.0017, 10.1089/AID.2012.0017]
   Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118
   Min JY, 2010, NAT BIOTECHNOL, V28, P239, DOI 10.1038/nbt0310-239
   MOELLING K, 1990, FEBS LETT, V261, P373, DOI 10.1016/0014-5793(90)80595-A
   Nasheri N, 2013, CHEM BIOL, V20, P570, DOI 10.1016/j.chembiol.2013.03.014
   Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794
   Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892
   Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735
   Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170
   Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018
   Su WC, 2013, P NATL ACAD SCI USA, V110, P17516, DOI 10.1073/pnas.1312374110
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229
   Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276
   Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004
NR 32
TC 8
Z9 9
U1 1
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 28
PY 2015
VL 43
IS D1
BP D946
EP D955
DI 10.1093/nar/gku1086
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CC2YF
UT WOS:000350210400139
PM 25414353
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Wodke, JAH
   Alibes, A
   Cozzuto, L
   Hermoso, A
   Yus, E
   Lluch-Senar, M
   Serrano, L
   Roma, G
AF Wodke, Judith A. H.
   Alibes, Andreu
   Cozzuto, Luca
   Hermoso, Antonio
   Yus, Eva
   Lluch-Senar, Maria
   Serrano, Luis
   Roma, Guglielmo
TI MyMpn: a database for the systems biology model organism Mycoplasma
   pneumoniae
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID GENOME-REDUCED BACTERIUM; METABOLISM; PROTEIN; INFORMATION; INTEGRATION;
   RESOURCE; SEQUENCE; GROWTH; PPLO; RNA
AB MyMpn ( ext-link-type="uri" xlink:href="http://mympn.crg.eu" xlink:type="simple">http://mympn.crg.eu) is an online resource devoted to studying the human pathogen Mycoplasma pneumoniae, a minimal bacterium causing lower respiratory tract infections. Due to its small size, its ability to grow in vitro, and the amount of data produced over the past decades, M. pneumoniae is an interesting model organisms for the development of systems biology approaches for unicellular organisms. Our database hosts a wealth of omics-scale datasets generated by hundreds of experimental and computational analyses. These include data obtained from gene expression profiling experiments, gene essentiality studies, protein abundance profiling, protein complex analysis, metabolic reactions and network modeling, cell growth experiments, comparative genomics and 3D tomography. In addition, the intuitive web interface provides access to several visualization and analysis tools as well as to different data search options. The availability and-even more relevant-the accessibility of properly structured and organized data are of up-most importance when aiming to understand the biology of an organism on a global scale. Therefore, MyMpn constitutes a unique and valuable new resource for the large systems biology and microbiology community.
C1 [Wodke, Judith A. H.; Yus, Eva; Lluch-Senar, Maria; Serrano, Luis] Ctr Genom Regulat, EMBL CRG Syst Biol Res Unit, Barcelona 08003, Spain.
   [Wodke, Judith A. H.; Alibes, Andreu; Cozzuto, Luca; Hermoso, Antonio; Yus, Eva; Lluch-Senar, Maria; Serrano, Luis; Roma, Guglielmo] Univ Pompeu Fabra, Barcelona 08003, Spain.
   [Wodke, Judith A. H.] Humboldt Univ, D-10115 Berlin, Germany.
   [Alibes, Andreu; Cozzuto, Luca; Hermoso, Antonio; Roma, Guglielmo] Ctr Genom Regulat CRG, CRG Bioinformat Facil, Barcelona 08003, Spain.
   [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain.
RP Roma, G (reprint author), Univ Pompeu Fabra, Dr Aiguader 88, Barcelona 08003, Spain.
EM luis.serrano@crg.eu; guglielmo.roma@crg.eu
RI Senar, Maria Lluch/K-7848-2018; Cozzuto, Luca/K-5385-2015;
   Serrano-Macin, Luis Felipe/M-1157-2015; Alibes, Andreu/A-5790-2008;
   Pulido, Toni Hermoso/K-3701-2015; Serrano, Luis/B-3355-2013
OI Senar, Maria Lluch/0000-0001-7568-4353; Cozzuto,
   Luca/0000-0003-3194-8892; Serrano-Macin, Luis
   Felipe/0000-0003-0648-1012; Alibes, Andreu/0000-0002-0055-3014; Pulido,
   Toni Hermoso/0000-0003-2016-6465; Serrano, Luis/0000-0002-5276-1392
FU European Union through the European Research Council (ERC) ['Celldoctor'
   GA 232913]; Spanish Ministerio de Economia y Competitividad Plan
   Nacional [BIO2007-61762]; Fundacion Marcelino Botin; laCaixa-CRG
   Fellowship, Fundacio laCaixa; Spanish Ministry of Economy and
   Competitiveness [PTA2010-4446-I, PTA2011-6729-I]; ERCEuropean Research
   Council (ERC); ICREAICREA
FX European Union through the European Research Council (ERC) ['Celldoctor'
   GA 232913]; Spanish Ministerio de Economia y Competitividad Plan
   Nacional [BIO2007-61762]; Fundacion Marcelino Botin [to L.S.].
   laCaixa-CRG Fellowship, Fundacio laCaixa [to J.W.]; Spanish Ministry of
   Economy and Competitiveness No [PTA2010-4446-I to A.H.; PTA2011-6729-I
   to L.C.]. Funding for open access charge: ERC [to L.S.].
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140
   CHANOCK RM, 1962, P NATL ACAD SCI USA, V48, P41, DOI 10.1073/pnas.48.1.41
   CHANOCK RM, 1962, P SOC EXP BIOL MED, V110, P884, DOI 10.3181/00379727-110-27681
   Chiner E, 2003, An Med Interna, V20, P597
   Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278
   Donlin M.J., 2009, CURRENT PROTOCOLS BI
   Florez LA, 2010, BIOINFORMATICS, V26, P2997, DOI 10.1093/bioinformatics/btq585
   Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620
   Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951
   Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001
   Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027
   Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111
   Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343
   Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92
   Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191
   Maier T, 2013, MOL BIOSYST, V9, P1743, DOI 10.1039/c3mb70113a
   Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38
   MANOLUKAS JT, 1988, J GEN MICROBIOL, V134, P791
   Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002
   Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889
   POLLACK J D, 1973, Journal of Infectious Diseases, V127, pS32
   RAZIN S, 1963, J GEN MICROBIOL, V33, P477, DOI 10.1099/00221287-33-3-477
   Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998
   Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200
   Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049
   Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010
   Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602
   van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4
   Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004
   Wodke JAH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.6
   Yus E, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.16
   Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263
NR 36
TC 15
Z9 15
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 28
PY 2015
VL 43
IS D1
BP D618
EP D623
DI 10.1093/nar/gku1105
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CC2YF
UT WOS:000350210400092
PM 25378328
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-05-07
ER

PT J
AU Kempf, M
   Varon, E
   Lepoutre, A
   Gravet, A
   Baraduc, R
   Brun, M
   Chardon, H
   Cremniter, J
   Croize, J
   Dalmay, F
   Demachy, MC
   Fosse, T
   Grelaud, C
   Hadou, T
   Hamdad, F
   Koeck, JL
   Luce, S
   Mermond, S
   Patry, I
   Pechinot, A
   Raymond, J
   Ros, A
   Segonds, C
   Soullie, B
   Tande, D
   Vergnaudl, M
   Vernet-Garnier, V
   Wallet, F
   Gutmann, L
   Ploy, MC
   Lanottel, P
AF Kempf, M.
   Varon, E.
   Lepoutre, A.
   Gravet, A.
   Baraduc, R.
   Brun, M.
   Chardon, H.
   Cremniter, J.
   Croize, J.
   Dalmay, F.
   Demachy, M. -C.
   Fosse, T.
   Grelaud, C.
   Hadou, T.
   Hamdad, F.
   Koeck, J. -L.
   Luce, S.
   Mermond, S.
   Patry, I.
   Pechinot, A.
   Raymond, J.
   Ros, A.
   Segonds, C.
   Soullie, B.
   Tande, D.
   Vergnaudl, M.
   Vernet-Garnier, V.
   Wallet, F.
   Gutmann, L.
   Ploy, M. -C.
   Lanottel, P.
TI Decline in antibiotic resistance and changes in the serotype
   distribution of Streptococcus pneumoniae isolates from children with
   acute otitis media; a 2001-2011 survey by the French Pneumococcal
   Network
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Epidemiology; French regional observatories; pneumococcal vaccine;
   Streptococcus pneumoniae
ID CONJUGATE VACCINE; IMPLEMENTATION; EUROPE
AB Streptococcus pneumoniae is an important cause of acute otitis media (AOM). The aim of this study was to evaluate trends in antibiotic resistance and circulating serotypes of pneumococci isolated from middle ear fluid of French children with AOM during the period 2001-2011, before and after the introduction of the PCV-7 (2003) and PCV-I3 (2010) vaccines. Between 2001 and 2011 the French pneumococcal surveillance network analysed the antibiotic susceptibility of 6683 S. pneumoniae isolated from children with AOM, of which 1569 were serotyped. We observed a significant overall increase in antibiotic susceptibility. Respective resistance (1+R) rates in 2001 and 2011 were 76.9% and 57.3% for penicillin, 43.0% and 29.8% for amoxicillin, and 28.6% and 13.0% for cefotaxime. We also found a marked reduction in vaccine serotypes after PCV-7 implementation, from 63.0% in 2001 to 13.2% in 2011, while the incidence of the additional six serotypes included in PCV-13 increased during the same period, with a particularly high proportion of 19A isolates. The proportion of some non-PCV-13 serotypes also increased between 2001 and 2011, especially 15A and 23A. Before PCV-7 implementation, most (70.8%) penicillin non-susceptible pneumococci belonged to PCV-7 serotypes, whereas in 2011, 56.8% of penicillin non-susceptible pneumococci belonged to serotype 19A. Between 2001 and 2011, antibiotic resistance among pneumococci responsible for AOM in France fell markedly, and PCV-7 serotypes were replaced by non-PCV-7 serotypes, especially 19A. We are continuing to assess the impact of PCV-I3, introduced in France in 2010, on pneumococcal serotype circulation and antibiotic resistance. Clinical Microbiology and Infection (C) 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Kempf, M.; Lepoutre, A.; Gravet, A.; Baraduc, R.; Brun, M.; Chardon, H.; Cremniter, J.; Croize, J.; Demachy, M. -C.; Fosse, T.; Grelaud, C.; Hadou, T.; Hamdad, F.; Koeck, J. -L.; Mermond, S.; Patry, I.; Pechinot, A.; Raymond, J.; Ros, A.; Segonds, C.; Soullie, B.; Tande, D.; Vergnaudl, M.; Vernet-Garnier, V.; Wallet, F.; Ploy, M. -C.; Lanottel, P.] CHU Limoges, French Pneumococcal Surveillance Network Observ R, Limoges, France.
   [Varon, E.; Gutmann, L.] HEGP, AP HP, CNRP, Paris, France.
   [Lepoutre, A.] Inst Veille Sanitaire InVS, St Maurice, France.
   [Dalmay, F.; Luce, S.] CHU Limoges, UFRCB, Limoges, France.
RP Lanottel, P (reprint author), CHRU Tours, Serv Bacteriol Virol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France.
EM philippe.lanotte@univ-tours.fr
RI Vernet-Garnier, Veronique/P-5729-2016; Ploy, Marie-Cecile/O-7501-2016
CR Alonso M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054333
   Azanowsky JM, 2008, EUROSURVEILLANCE, P13
   Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80
   Cohen R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-52
   Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84
   Couloigner V, 2012, PEDIATR INFECT DIS J, V31, P154, DOI 10.1097/INF.0b013e3182357c8d
   Critchley IA, 2003, J ANTIMICROB CHEMOTH, V51, P639, DOI 10.1093/jac/dkg130
   Fenoll A, 2011, BMC INFECT DIS, V11, p[1997, 239]
   Fenoll A, 2007, J ANTIMICROB CHEMOTH, V60, P323, DOI 10.1093/jac/dkm209
   Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0
   Hau I, 2014, PEDIATR DRUGS, V16, P1, DOI 10.1007/s40272-013-0044-2
   Kempf M, 2011, MICROB DRUG RESIST, V17, P31, DOI 10.1089/mdr.2010.0031
   McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908
   McEllistrem MC, 2003, J INFECT DIS, V188, P1679, DOI 10.1086/379665
   Olarte L, 2014, PEDIAT INFECT DIS J
   Onwubiko C, 2007, FEMS IMMUNOL MED MIC, V50, P119, DOI 10.1111/j.1574-695X.2007.00245.x
   Rodgers GL, 2009, VACCINE, V27, P3802, DOI 10.1016/j.vaccine.2009.04.021
   Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091
   van de Sande-Bruinsman Grundmann H, 2008, EMERG INFECT DIS, V14, P1722
NR 19
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JAN
PY 2015
VL 21
IS 1
BP 35
EP 42
DI 10.1016/j.cmi.2014.08.009
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CI2MA
UT WOS:000354580500007
PM 25636925
OA Bronze
DA 2020-05-07
ER

PT J
AU Auger, C
   Appanna, VD
AF Auger, Christopher
   Appanna, Vasu D.
TI A novel ATP-generating machinery to counter nitrosative stress is
   mediated by substrate-level phosphorylation
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Metabolon; Reactive nitrogen species; Phosphotransfer; Metabolism;
   Microbiology
ID TRICARBOXYLIC-ACID CYCLE; NITRIC-OXIDE; ALPHA-KETOGLUTARATE;
   CARBONIC-ANHYDRASE; GLYCOLYTIC-ENZYMES; PYRUVATE; KINASE; DEHYDROGENASE;
   METABOLON; ELECTROPHORESIS
AB Background: It is well-known that elevated amounts of nitric oxide and other reactive nitrogen species (RNS) impact negatively on the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. These perturbations severely compromise O-2-dependent energy production. While bacteria are known to adapt to RNS, a key tool employed by macrophages to combat infections, the exact mechanisms are unknown.
   Methods: The bacterium was cultured in a defined mineral medium and cell-free extracts obtained at the same growth phase were utilized for various biochemical studies Blue native polyacrylamide gel electrophoresis followed by in-gel activity assays, high performance liquid chromatography and co-immunoprecipitaton are applied to investigate the effects of RNS on the model microbe Pseudomonas fluorescens.
   Results: Citrate is channeled away from the tricarboxylic acid cycle using a novel metabolon consisting of citrate lyase (CL), phosphoenolpyruvate carboxylase (PEPC) and pyruvate phosphate dikinase (PPDK). This metabolic engine comprising three disparate enzymes appears to transiently assemble as a supercomplex aimed at ATP synthesis. The up-regulation in the activities of adenylate kinase (AK) and nucleoside diphosphate kinase (NDPK) ensured the efficacy of this ATP-making machine.
   Conclusion: Microbes may escape the effects of nitrosative stress by re-engineering metabolic networks in order to generate and store ATP anaerobically when the electron transport chain is defective.
   General significance: The molecular configuration described herein provides further understanding of how metabolism plays a key role in the adaptation to nitrosative stress and reveals novel targets that will inform the development of antimicrobial agents to counter RNS-resistant pathogens. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Auger, Christopher; Appanna, Vasu D.] Laurentian Univ, Fac Engn Sci, Sudbury, ON P3E 2C6, Canada.
RP Appanna, VD (reprint author), Laurentian Univ, Fac Engn Sci, Sudbury, ON P3E 2C6, Canada.
EM vappanna@laurentian.ca
RI Auger, Christopher/AAF-5757-2019
OI Appanna, Vasu/0000-0002-0138-5665
FU Laurentian University; NSERC post-graduate scholarshipNatural Sciences
   and Engineering Research Council of Canada
FX This work was supported by Laurentian University. Christopher Auger is a
   recipient of the NSERC post-graduate scholarship at the doctoral level.
CR ANDERSON S, 1992, FEBS LETT, V308, P94, DOI 10.1016/0014-5793(92)81059-U
   Araiza-Olivera D, 2013, FEBS J, V280, P3887, DOI 10.1111/febs.12387
   Auger C, 2012, ELECTROPHORESIS, V33, P1095, DOI 10.1002/elps.201100517
   Auger C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028469
   Bartholomae M., 2013, FEBS J
   Bielen AAM, 2010, FEMS MICROBIOL LETT, V307, P48, DOI 10.1111/j.1574-6968.2010.01957.x
   Bignucolo A, 2013, J BIOTECHNOL, V167, P309, DOI 10.1016/j.jbiotec.2013.07.002
   Bonora M, 2012, PURINERG SIGNAL, V8, P343, DOI 10.1007/s11302-012-9305-8
   Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963
   Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198
   Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI 10.1139/w07-110
   Chastain CJ, 2011, J EXP BOT, V62, P3083, DOI 10.1093/jxb/err058
   Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200
   Deamer D., 2010, PERSPECT BIOL, V2, DOI DOI 10.1101/CSHPERSPECT.A004929
   Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200
   Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200
   Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426
   Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164
   Gupta KJ, 2012, J EXP BOT, V63, P1773, DOI 10.1093/jxb/ers053
   Hernandez-Domiguez EE, 2012, PLANT SCI, V187, P39, DOI 10.1016/j.plantsci.2012.01.009
   Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953
   Kumar P, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq002
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laver JR, 2010, FASEB J, V24, P286, DOI 10.1096/fj.08-128330
   Lemire J, 2010, FEMS MICROBIOL LETT, V309, P170, DOI 10.1111/j.1574-6968.2010.02034.x
   Lemire J, 2010, ENVIRON MICROBIOL, V12, P1384, DOI 10.1111/j.1462-2920.2010.02200.x
   Mailloux RJ, 2008, ELECTROPHORESIS, V29, P1484, DOI 10.1002/elps.200700697
   Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09
   McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443
   Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247
   Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004
   Reithmeier RAF, 2001, BLOOD CELL MOL DIS, V27, P85, DOI 10.1006/bcmd.2000.0353
   Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004
   Rogstam A, 2007, J BACTERIOL, V189, P3063, DOI 10.1128/JB.01782-06
   Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shepherd M, 2010, J BIOL CHEM, V285, P12747, DOI 10.1074/jbc.M109.084509
   Singh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007344
   Slamovits CH, 2006, EUKARYOT CELL, V5, P148, DOI 10.1128/EC.5.1.148-154.2006
   Sowah D, 2011, AM J PHYSIOL-CELL PH, V301, pC336, DOI 10.1152/ajpcell.00005.2011
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803
   Wang SB, 2013, TRENDS CARDIOVAS MED, V23, P14, DOI 10.1016/j.tcm.2012.08.005
   Williamson MP, 2010, BIOCHEM SOC T, V38, P875, DOI 10.1042/BST0380875
   Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714
   Yang ES, 2002, FREE RADICAL BIO MED, V33, P927, DOI 10.1016/S0891-5849(02)00981-4
NR 48
TC 13
Z9 13
U1 1
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JAN
PY 2015
VL 1850
IS 1
BP 43
EP 50
DI 10.1016/j.bbagen.2014.09.028
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW5PG
UT WOS:000346326100005
PM 25304769
DA 2020-05-07
ER

PT J
AU Karwautz, C
   Lueders, T
AF Karwautz, Clemens
   Lueders, Tillmann
TI Impact of Hydraulic Well Restoration on Native Bacterial Communities in
   Drinking Water Wells
SO MICROBES AND ENVIRONMENTS
LA English
DT Article
DE biofilms; drinking water; high pressure jetting; groundwater;
   pyrosequencing
ID DISTRIBUTION-SYSTEM; BULK WATER; MICROBIAL DIVERSITY; BIOFILMS;
   IDENTIFICATION; POPULATIONS; NETWORKS; GERMANY
AB The microbial monitoring of drinking water production systems is essential to assure water quality and minimize possible risks. However, the comparative impact of microbes from the surrounding aquifer and of those established within drinking water wells on water parameters remains poorly understood. High pressure jetting is a routine method to impede well clogging by fine sediments and also biofilms. In the present study, bacterial communities were investigated in a drinking water production system before, during, and after hydraulic purging. Variations were observed in bacterial communities between different wells of the same production system before maintenance, despite them having practically identical water chemistries. This may have reflected the distinct usage practices of the different wells, and also local aquifer heterogeneity. Hydraulic jetting of one well preferentially purged a subset of the dominating taxa, including lineages related to Diaphorobacter, Nitrospira, Sphingobium, Ralstonia, Alkanindiges, Janthinobacterium, and Pseudomonas spp, suggesting their tendency for growth in well-associated biofilms. Lineages of potential drinking water concern (i.e. Legionellaceae, Pseudomonadaceae, and Acinetobacter spp.) reacted distinctly to hydraulic jetting. Bacterial diversity was markedly reduced in drinking water 2 weeks after the cleaning procedure. The results of the present study provide a better understanding of drinking water wells as a microbial habitat, as well as their role in the microbiology of drinking water systems.
C1 [Karwautz, Clemens; Lueders, Tillmann] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Groundwater Ecol, D-85764 Neuherberg, Germany.
RP Lueders, T (reprint author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Groundwater Ecol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM tillmann.lueders@helmholtz-muenchen.de
RI Lueders, Tillmann/B-1486-2013
OI Lueders, Tillmann/0000-0002-9361-5009; Karwautz,
   Clemens/0000-0002-5323-1123
FU Helmholtz Zentrum MunchenHelmholtz Association
FX This study was carried out within the framework of a 'Biofilm
   Initiative' funded by the Helmholtz Zentrum Munchen. K. Hormann
   (Institute of Groundwater Ecology) is acknowledged for expert technical
   assistance. The authors are grateful to the Wasserverband Baldham headed
   by Dr. Ortner and Mr. Seebauer for their kind permission to access their
   drinking water production system and the jetting event. The
   Wasserverband Baldham is a public water supply association within the
   municipality of Vaterstetten, east of Munich.
CR Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003
   Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007
   Boe-Hansen R, 2002, WATER RES, V36, P4477, DOI 10.1016/S0043-1354(02)00191-4
   Brielmann H, 2009, FEMS MICROBIOL ECOL, V68, P273, DOI 10.1111/j.1574-6941.2009.00674.x
   de Vet WWJM, 2009, WATER RES, V43, P182, DOI 10.1016/j.watres.2008.09.038
   Dibbern D, 2014, SOIL BIOL BIOCHEM, V69, P187, DOI 10.1016/j.soilbio.2013.10.040
   EC Council Directive, 1998, OFFICIAL J EUROPEA L, V330, P32
   Giao MS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-57
   Harter T., 2003, FARM WATER QUALITY P
   Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11
   Hubbell Stephen P., 2001, V32, pi
   HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366
   Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12
   Hwang CC, 2012, MICROBES ENVIRON, V27, P9, DOI 10.1264/jsme2.ME11132
   Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1
   Jousset A, 2011, ISME J, V5, P1108, DOI 10.1038/ismej.2011.9
   Kahlisch L, 2012, MICROB ECOL, V63, P383, DOI 10.1007/s00248-011-9918-4
   Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08
   KATZNELSON R, 1989, FEMS MICROBIOL ECOL, V62, P231, DOI 10.1111/j.1574-6968.1989.tb03697.x
   Khardenavis AA, 2007, APPL MICROBIOL BIOT, V77, P403, DOI 10.1007/s00253-007-1176-5
   Lane D, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0
   Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002
   Liu G, 2013, WATER RES, V47, P3523, DOI 10.1016/j.watres.2013.03.058
   Loy A, 2005, APPL ENVIRON MICROB, V71, P3624, DOI 10.1128/AEM.71.7.3624-3632.2005
   Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x
   Martiny AC, 2005, APPL ENVIRON MICROB, V71, P8611, DOI 10.1128/AEM.71.12.8611-8617.2005
   Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7
   Oksanen J, 2013, PACKAGE VEGAN COMMUN
   Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467
   Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t
   R Development CoreTeam, 2013, R LANG ENV STAT COMP
   Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008
   Ross N, 2001, WATER RES, V35, P2029, DOI 10.1016/S0043-1354(00)00476-0
   Sand W, 2006, RES MICROBIOL, V157, P49, DOI 10.1016/j.resmic.2005.07.012
   Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310
   Schmeisser C, 2003, APPL ENVIRON MICROB, V69, P7298, DOI 10.1128/AEM.69.12.7298-7309.2003
   Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838
   Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81
   Ultee A, 2004, J APPL MICROBIOL, V96, P560, DOI 10.1111/j.1365-2672.2004.02174.x
   Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82
   Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x
   Wullings BA, 2011, APPL ENVIRON MICROB, V77, P634, DOI 10.1128/AEM.01215-10
   Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813
   Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340
   Zektser I.S., 2004, IHP SERIES GROUNDWAT
   Zhang ML, 2012, MICROBES ENVIRON, V27, P443, DOI 10.1264/jsme2.ME12035
NR 46
TC 11
Z9 11
U1 2
U2 28
PU JAPANESE SOC MICROBIAL ECOLOGY, DEPT BIORESOURCE SCIENCE
PI IBARAKI
PA C/O DR. HIROYUKI OHTA, SEC, IBARAKI UNIV COLLEGE OF AGRICULT, AMI-MACHI,
   IBARAKI, JAPAN
SN 1342-6311
J9 MICROBES ENVIRON
JI Microbes Environ.
PD DEC 19
PY 2014
VL 29
IS 4
BP 363
EP 369
DI 10.1264/jsme2.ME14035
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA AX1WQ
UT WOS:000346734500005
PM 25273229
OA Green Published
DA 2020-05-07
ER

PT J
AU Levy, C
   Varon, E
   Picard, C
   Bechet, S
   Martinot, A
   Bonacorsi, S
   Cohen, R
AF Levy, Corinne
   Varon, Emmanuelle
   Picard, Capucine
   Bechet, Stephane
   Martinot, Alain
   Bonacorsi, Stephane
   Cohen, Robert
TI Trends of Pneumococcal Meningitis in Children After Introduction of the
   13-Valent Pneumococcal Conjugate Vaccine in France
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE pneumococcal conjugate vaccines; pneumococcal meningitis; children
ID UNITED-STATES; BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; 7-VALENT;
   DISEASE; EPIDEMIOLOGY; INFECTIONS; POPULATION; SEROTYPES
AB Background: Streptococcus pneumoniae remains an important cause of bacterial meningitis in children younger than 2 years. Here, we analyzed data from an active surveillance network established 12 years ago by the Pediatric Infectious Disease Group and the Pediatric Clinical and Therapeutical Association to analyze the impact of pneumococcal conjugate vaccine (PCV7 implemented in 2002 and PCV13 in 2010) on pneumococcal meningitis (PM).
   Methods: Two hundred twenty-seven pediatric wards working with 168 microbiology departments throughout France were asked to report all cases of PM.
   Results: From 2001 to 2012, among 4808 bacterial meningitis cases, 1406 cases of PM (29.2%) were reported. After PCV13 implementation, from 2009 to 2012, the number of cases significantly decreased by 27.4% (P = 0.041, Cuzick trend test). For children younger than 2 years, the decrease was 28.2% (P = 0.039, Cuzick trend test). In the same period, the decrease was 66.7% in cases due to 6 additional PCV13 types, and the number of cases due to nonvaccine types remained stable. In 2012, the non-PCV13 serotype represented 67.6% of cases and were mainly represented by 12F (15%), 24F (15%), 22F (7%) and 15B/C (7%). For 88.6% of cases, initial antibiotic treatment was vancomycin with a third-generation cephalosporin. Overall mortality was 10.6%, most deaths (86.4%) occurred before day 15.
   Conclusions: Two years after the PCV13 implementation, we found an impact on PM cases particularly for children younger than 2 years.
C1 [Levy, Corinne; Martinot, Alain; Cohen, Robert] Pediat Infect Dis Grp, GPIP, Paris, France.
   [Levy, Corinne; Bechet, Stephane; Cohen, Robert] ACTIV, Pediat Clin & Therapeut Assoc Val de Marne, F-94100 St Maur Des Fosses, France.
   [Levy, Corinne; Cohen, Robert] Ctr Hosp Intercommunal, CRC, Creteil, France.
   [Varon, Emmanuelle] Hop Europeen Georges Pompidou, AP HP, Microbiol Lab, Natl Reference Ctr Pneumococci, Paris, France.
   [Picard, Capucine] INSERM, U980, Necker Branch, Lab Human Genet Infect Dis, F-75654 Paris 13, France.
   [Picard, Capucine] Univ Paris 05, Sorbonne Paris Cite, Malades Hosp, Paris, France.
   [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Study Primary Immunodeficiencies, Paris, France.
   [Martinot, Alain] CHRU Lille, UDSL, Lille Univ Hosp, Pediat Emergency Unit, F-59037 Lille, France.
   [Martinot, Alain] CHRU Lille, UDSL, Lille Univ Hosp, F-59037 Lille, France.
   [Bonacorsi, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.
   [Cohen, Robert] Ctr Hosp Intercommunal, Serv Neonatol, Unite Court Sejour, Creteil, France.
RP Cohen, R (reprint author), ACTIV, 27 Rue Inkermann, F-94100 St Maur Des Fosses, France.
EM corinne.levy@activ-france.fr; robert.cohen@wanadoo.fr
RI Martinot, Alain/M-6780-2016; Picard, Capucine/H-3914-2017
OI Martinot, Alain/0000-0002-2146-8273; Picard,
   Capucine/0000-0001-8788-5056
FU PfizerPfizer; Pediatric Infectious Diseases Group (GPIP) of the French
   Pediatrics Society (SFP); Association Clinique et Therapeutique
   Infantile du Val de Marne (ACTIV); NovartisNovartis;
   SanofiSanofi-Aventis; GSKGlaxoSmithKline
FX Financial support was provided, in part, by Pfizer and by the Pediatric
   Infectious Diseases Group (GPIP) of the French Pediatrics Society (SFP)
   and Association Clinique et Therapeutique Infantile du Val de Marne
   (ACTIV). Grants for GPIP/ACTIV from Pfizer, Novartis, Sanofi and GSK
   during the conduct of the study. Dr L. C. reports personal fees from
   Pfizer and Novartis outside the submitted work. Dr V. E. reports
   personal fees and nonfinancial support from Pfizer, personal fees from
   GSK, outside the submitted work. Dr C. R. reports personal fees from
   Pfizer, GSK, Sanofi and Novartis outside the submitted work. The authors
   have no other funding or conflicts of interest to disclose.
CR BeCSd G, 2009, ARCH PEDIATR, V15, pS97
   Ben-Shimol S, 2012, VACCINE, V30, P6600, DOI 10.1016/j.vaccine.2012.08.012
   Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y
   Bingen E, 2005, CLIN INFECT DIS, V41, P1059, DOI 10.1086/432944
   Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494
   Doit C, 1997, ANTIMICROB AGENTS CH, V41, P2050, DOI 10.1128/AAC.41.9.2050
   Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517
   Gaudelus J, 2009, MED ENFANCE, P151
   Prieto RG, 2009, VACCINE, V27, P2669, DOI 10.1016/j.vaccine.2009.02.063
   Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38
   Haddy RI, 2005, PEDIATR INFECT DIS J, V24, P320, DOI 10.1097/01.inf.0000157090.40719.9b
   Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102
   Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836
   Htar MTT, 2013, ADV THER, V30, P748, DOI 10.1007/s12325-013-0051-2
   Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b
   Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702
   Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443
   Ladhani SN, 2013, EMERG INFECT DIS, V19, P61, DOI 10.3201/eid1901.120741
   Ladhani SN, 2013, CLIN INFECT DIS
   Levy C, 2014, ARCH PEDIATRIE, V21, P736, DOI 10.1016/j.arcped.2014.04.025
   Levy C, 2009, MED MALADIES INFECT, V39, P419, DOI 10.1016/j.medmal.2009.03.006
   Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69
   Martinot A, 2013, ARCH PEDIATRIE, V20, P837, DOI 10.1016/j.arcped.2013.05.016
   Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112
   Pickering L, 2003, RED BOOK 2003 REPORT, P293
   Richter SS, 2013, EMERG INFECT DIS, V19, P1074, DOI 10.3201/eid1907.121830
   Saez-Llorens XM, 2008, PRINCIPLES PRACTICE, V3, P284
   Self WH, 2013, ACAD EMERG MED, V20, P957, DOI 10.1111/acem.12203
   Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032
   Stockmann C, 2013, PEDIATRICS, V132, P421, DOI 10.1542/peds.2013-0621
   Tacon CL, 2012, EMERG MED INT, DOI 10.1155/2012/320309
   Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384
   Tsai CJ, 2008, CLIN INFECT DIS, V46, P1664, DOI 10.1086/587897
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
NR 34
TC 42
Z9 42
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD DEC
PY 2014
VL 33
IS 12
BP 1216
EP 1221
DI 10.1097/INF.0000000000000451
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA AU2ND
UT WOS:000345454300005
PM 25037044
DA 2020-05-07
ER

PT J
AU Westwood, J
   Burnett, M
   Spratt, D
   Ball, M
   Wilson, DJ
   Wellsteed, S
   Cleary, D
   Green, A
   Hutley, E
   Cichowska, A
   Hopkins, S
   Wilcox, M
   Kessel, A
   Zoubiane, G
   Bethke, L
   Crook, DW
   Walker, J
   Sutton, M
   Marsh, P
   Moore, G
   Wilson, P
   Holmes, A
   Hoffman, P
   Smith, C
   Oppenheim, B
   Parkhill, J
   Woodford, N
   Robotham, J
   Kidgell, C
   Anyim, M
   Gilkes, G
   Field, D
   Quick, J
   Pickering, T
   Kirkup, BC
   Gilbert, J
AF Westwood, Jack
   Burnett, Matthew
   Spratt, David
   Ball, Michael
   Wilson, Daniel J.
   Wellsteed, Sally
   Cleary, David
   Green, Andy
   Hutley, Emma
   Cichowska, Anna
   Hopkins, Susan
   Wilcox, Mark
   Kessel, Anthony
   Zoubiane, Ghada
   Bethke, Lara
   Crook, Derrick W.
   Walker, Jimmy
   Sutton, Mark
   Marsh, Philip
   Moore, Ginny
   Wilson, Peter
   Holmes, Alison
   Hoffman, Peter
   Smith, Chris
   Oppenheim, Beryl
   Parkhill, Julian
   Woodford, Neil
   Robotham, Julie
   Kidgell, Claire
   Anyim, Martin
   Gilkes, Gabriella
   Field, Dawn
   Quick, Josh
   Pickering, Tony
   Kirkup, Benjamin C.
   Gilbert, Jack
TI The hospital microbiome project: meeting report for the UK science and
   innovation network UK-USA workshop 'beating the superbugs: hospital
   microbiome studies for tackling antimicrobial resistance', October 14th
   2013
SO STANDARDS IN GENOMIC SCIENCES
LA English
DT Article
DE Antibiotic resistance; Nosocomial infections; Hospital microbiome;
   Superbugs
AB The UK Science and Innovation Network UK-USA workshop 'Beating the Superbugs: Hospital Microbiome Studies for tackling Antimicrobial Resistance' was held on October 14th 2013 at the UK Department of Health, London. The workshop was designed to promote US-UK collaboration on hospital microbiome studies to add a new facet to our collective understanding of antimicrobial resistance. The assembled researchers debated the importance of the hospital microbial community in transmission of disease and as a reservoir for antimicrobial resistance genes, and discussed methodologies, hypotheses, and priorities. A number of complementary approaches were explored, although the importance of the built environment microbiome in disease transmission was not universally accepted. Current whole genome epidemiological methods are being pioneered in the UK and the benefits of moving to community analysis are not necessarily obvious to the pioneers; however, rapid progress in other areas of microbiology suggest to some researchers that hospital microbiome studies will be exceptionally fruitful even in the short term. Collaborative studies will recombine different strengths to tackle the international problems of antimicrobial resistance and hospital and healthcare associated infections.
C1 [Westwood, Jack] British Consulate Gen, Chicago, IL 60611 USA.
   [Burnett, Matthew; Smith, Chris] Univ Cambridge, Dept Pathol, Cambridge, England.
   [Spratt, David] UCL Eastman Dent Inst, Dept Microbial Dis, London, England.
   [Ball, Michael] Biotechnol & Biol Sci Res Council, Swindon, Wilts, England.
   [Wilson, Daniel J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford, England.
   [Wellsteed, Sally] Richmond House, Dept Hlth, London, England.
   [Cleary, David] Def Sci & Technol Lab, Porton Down, Wilts, England.
   [Green, Andy; Hutley, Emma] Royal Ctr Def Med, Birmingham, W Midlands, England.
   [Cichowska, Anna; Hopkins, Susan; Kessel, Anthony] Publ Hlth England, London, England.
   [Wilcox, Mark] Univ Leeds, Leeds, W Yorkshire, England.
   [Wilcox, Mark] Leeds Teaching Hosp, Leeds, W Yorkshire, England.
   [Zoubiane, Ghada] MRC, London, England.
   [Bethke, Lara] Wellcome Trust Res Labs, London, England.
   [Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England.
   [Walker, Jimmy; Moore, Ginny] Publ Hlth England, Biosafety Unit, Salisbury, Wilts, England.
   [Sutton, Mark; Marsh, Philip] HPA Microbiol Serv, Salisbury, Wilts, England.
   [Wilson, Peter] UCLH NHS Fdn Trust, Clin Microbiol & Virol, London, England.
   [Holmes, Alison] Imperial Coll, London, England.
   [Hoffman, Peter; Woodford, Neil] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, London, England.
   [Smith, Chris] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England.
   [Oppenheim, Beryl] Queen Elizabeth Hosp, Birmingham, W Midlands, England.
   [Parkhill, Julian] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England.
   [Robotham, Julie] Publ Hlth England, Modeling & Econ Unit, Stat Modeling & Econ Dept, London, England.
   [Kidgell, Claire] Univ Southampton, Natl Inst Hlth Res, Evaluat Trials & Studies Coordinating Ctr NETSCC, Southampton, Hants, England.
   [Anyim, Martin] NIHR Invent Innovat Programme, London, England.
   [Gilkes, Gabriella] Human Micro Biome Project, Eden Project, St Austell PL24 2SG, Cornwall, England.
   [Field, Dawn] NERC Ctr Ecol & Hydrol, Oxford, England.
   [Quick, Josh] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Pickering, Tony] Univ South Manchester, North West Lung Res Ctr, Wythenshawe Hosp, Manchester, Lancs, England.
   [Kirkup, Benjamin C.] Walter Reed Army Inst Res, Dept Wound Infect, Bethesda, MD USA.
   [Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.
   [Gilbert, Jack] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA.
RP Gilbert, J (reprint author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.
EM gilbertjack@uchicago.edu
RI Gilbert, Jack/AAF-3270-2019; Parkhill, Julian/G-4703-2011; Cleary,
   David/K-7083-2019; Wilson, Daniel J/AAE-8975-2019
OI Parkhill, Julian/0000-0002-7069-5958; Cleary, David/0000-0003-4533-0700;
   Wilson, Daniel J/0000-0002-0940-3311; Robotham,
   Julie/0000-0003-2515-4084; Hopkins, Susan/0000-0001-5179-5702; Bethke,
   Lara/0000-0002-1316-4704
FU UK Science and Innovation Network; British Consulate-General Chicago;
   Foreign and Commonwealth Office; APSF; U.S. Dept. of EnergyUnited States
   Department of Energy (DOE) [DE-AC02-06CH11357]; Medical Research
   CouncilMedical Research Council UK (MRC) [G0800777]
FX We acknowledge the UK Science and Innovation Network, British
   Consulate-General Chicago and Foreign and Commonwealth Office, as well
   as APSF for funding this workshop. This work was supported in part by
   the U.S. Dept. of Energy under Contract DE-AC02-06CH11357. The opinions
   and assertions contained herein are the private views of the authors and
   are not to be construed as official or as reflecting true views of the
   Department of Army or the Department of Defense.
CR [Anonymous], 2002, ESTIMATING HLTH CARE
   Belmont PJ, 2010, MIL MED, V175, P469, DOI 10.7205/MILMED-D-10-00041
   Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953
   Bokulich NA, 2013, J CLIN MICROBIOL, V51, P2617, DOI 10.1128/JCM.00898-13
   Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535
   Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021
   Davies S., 2013, ANN REPORT CHIEF MED
   Fischer H, 2014, GUIDE US MILITARY CA
   Fluit AC, 2013, J ANTIMICROB CHEMOTH, V68, P1707, DOI 10.1093/jac/dkt121
   Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771
   Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703
   Keen EF, 2012, INFECT CONT HOSP EP, V33, P905, DOI 10.1086/667382
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235
   Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413
   Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112
   Rhoads DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/ijms13032535
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Rosenthal M, 2014, PATHOGENS, V3, P1, DOI 10.3390/pathogens3010001
   Ruimy R, 2012, NEW FRONTIERS OF MOLECULAR EPIDEMIOLOGY OF INFECTIOUS DISEASES, P219, DOI 10.1007/978-94-007-2114-2_10
   Scott RD, 2009, DIRECT MED COSTS HEA
   Shogan BD, 2013, STAND GENOMIC SCI, V8, P571, DOI 10.4056/sigs.4187859
   Smith D, 2013, STAND GENOMIC SCI, V8, P112, DOI 10.4056/sigs.3717348
   Spanu T, 2012, ANTIMICROB AGENTS CH, V56, P4516, DOI 10.1128/AAC.00234-12
   Spellberg B, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-3
   Sutter DE, 2011, INFECT CONT HOSP EP, V32, P854, DOI 10.1086/661284
   TULLUS K, 1988, J ANTIMICROB CHEMOTH, V22, P563, DOI 10.1093/jac/22.4.563
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Tuttle MS, 2011, J CLIN MICROBIOL, V49, P3812, DOI 10.1128/JCM.00847-11
   Vento TJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-68
NR 31
TC 2
Z9 2
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1944-3277
J9 STAND GENOMIC SCI
JI Stand. Genomic Sci.
PD DEC
PY 2014
VL 9
IS 1
AR 12
DI 10.1186/1944-3277-9-12
PG 12
WC Genetics & Heredity; Microbiology
SC Genetics & Heredity; Microbiology
GA V45LA
UT WOS:000209816900012
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Jackrel, ME
   Tariq, A
   Yee, K
   Weitzman, R
   Shorter, J
AF Jackrel, Meredith E.
   Tariq, Amber
   Yee, Keolamau
   Weitzman, Rachel
   Shorter, James
TI Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Microbiology; Issue 93; Protein-misfolding disorders; yeast
   proteinopathy models; Hsp104; proteotoxicity; amyloid; disaggregation
ID ALPHA-SYNUCLEIN; DIVERSE; TOXICITY; DISORDERS; NETWORK
AB Many protein-misfolding disorders can be modeled in the budding yeast Saccharomyces cerevisiae. Proteins such as TDP-43 and FUS, implicated in amyotrophic lateral sclerosis, and alpha-synuclein, implicated in Parkinson's disease, are toxic and form cytoplasmic aggregates in yeast. These features recapitulate protein pathologies observed in patients with these disorders. Thus, yeast are an ideal platform for isolating toxicity suppressors from libraries of protein variants. We are interested in applying protein disaggregases to eliminate misfolded toxic protein conformers. Specifically, we are engineering Hsp104, a hexameric AAA+ protein from yeast that is uniquely capable of solubilizing both disordered aggregates and amyloid and returning the proteins to their native conformations. While Hsp104 is highly conserved in eukaryotes and eubacteria, it has no known metazoan homologue. Hsp104 has only limited ability to eliminate disordered aggregates and amyloid fibers implicated in human disease. Thus, we aim to engineer Hsp104 variants to reverse the protein misfolding implicated in neurodegenerative disorders. We have developed methods to screen large libraries of Hsp104 variants for suppression of proteotoxicity in yeast. As yeast are prone to spontaneous nonspecific suppression of toxicity, a two-step screening process has been developed to eliminate false positives. Using these methods, we have identified a series of potentiated Hsp104 variants that potently suppress the toxicity and aggregation of TDP-43, FUS, and alpha-synuclein. Here, we describe this optimized protocol, which could be adapted to screen libraries constructed using any protein backbone for suppression of toxicity of any protein that is toxic in yeast.
C1 [Jackrel, Meredith E.; Tariq, Amber; Yee, Keolamau; Weitzman, Rachel; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.
RP Shorter, J (reprint author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.
EM jshorter@mail.med.upenn.edu
OI Shorter, James/0000-0001-5269-8533; Jackrel,
   Meredith/0000-0003-4406-9504
FU American Heart Association Post-Doctoral FellowshipAmerican Heart
   Association; NIH Director's New Innovator AwardUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [DP2OD002177]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21NS067354,
   R21HD074510, R01GM099836]; Muscular Dystrophy Association Research
   AwardMuscular Dystrophy Association [MDA277268]; Packard Center for ALS
   Research at Johns Hopkins UniversityJohns Hopkins University; Ellison
   Medical Foundation New Scholar in Aging AwardLawrence Ellison
   Foundation; Target ALS
FX We thank Sue Lindquist, Aaron Gitler, and Martin Duennwald for kindly
   sharing reagents. Our studies were supported by: an American Heart
   Association Post-Doctoral Fellowship (M.E.J); NIH Director's New
   Innovator Award DP2OD002177, NIH grants R21NS067354, R21HD074510, and
   R01GM099836, a Muscular Dystrophy Association Research Award
   (MDA277268), Packard Center for ALS Research at Johns Hopkins
   University, Target ALS, and an Ellison Medical Foundation New Scholar in
   Aging Award (J.S.).
CR Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502
   Armakola M, 2011, METHODS, V53, P238, DOI 10.1016/j.ymeth.2010.11.006
   BOEKE JD, 1987, METHOD ENZYMOL, V154, P164
   Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462
   DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038
   Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320
   Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113
   Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13
   Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300
   Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047
   Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105
   Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052
   Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853
   Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23
   Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573
   Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439
   Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658
   Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760
   Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267
   Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614
   Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321
   Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668
   Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]
   Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0
NR 24
TC 10
Z9 11
U1 0
U2 1
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD NOV
PY 2014
IS 93
AR e52089
DI 10.3791/52089
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB0JH
UT WOS:000349311400047
PM 25407485
OA Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Liu, J
   Guan, X
   Schaffner, DW
AF Liu, Jing
   Guan, Xiao
   Schaffner, Donald W.
TI PREDICTION OF THE GROWTH BEHAVIOR OF AEROMONAS HYDROPHILA USING A NOVEL
   MODELING APPROACH: SUPPORT VECTOR MACHINE
SO JOURNAL OF FOOD SAFETY
LA English
DT Article
ID ARTIFICIAL NEURAL NETWORKS; ESCHERICHIA-COLI O157-H7; RESPONSE-SURFACE
   MODELS; COOKED MEAT-PRODUCTS; LISTERIA-MONOCYTOGENES; MICROBIAL-GROWTH;
   TEMPERATURE; PH; PERFORMANCE; SURVIVAL
AB A new technique called support vector machine (SVM), which is used to predict the microbial growth, is presented in this paper. Experimental data on temperature, pH and NaCl from a previously published paper were modeled as inputs, and the kinetic growth parameters, including generation time (GT) and lag phase duration (LPD), were used as outputs of the SVM model. The results derived from SVM model, published artificial neural network (ANN) model and a traditional statistical model were compared using several evaluation criteria: accuracy factor (A(f)), bias factor (B-f), mean relative percentage residual, mean absolute relative residual, root mean square residual, internal validation (Q(2)) and external validation (Q(ext)(2)). Graphical plots were also used for model comparison. The results show that SVM outperforms ANN and statistical model on predicting microbial GT and LPD, especially when predicting data not used for model development. Sensitivity analyses of the three environmental factors show that the most influential on LPD of Aeromonas hydrophila is temperature, followed by pH and NaCl, and the most influential on GT is pH, followed by temperature and then NaCl.
   Practical ApplicationsAeromonas hydrophila is a foodborne microorganism, which has been isolated from seafood, red meat, poultry, vegetables and water. Predictive microbiology describes microbial behavior using mathematical models to predict the microbiological safety and quality of a food. A nonlinear modeling technique, termed support vector machine (SVM), is proposed to predict lag phase duration and generation time of A.hydrophila. Statistical criteria show that SVM has a better predictive performance for the generation time and lag phase duration than neural network and traditional statistical models. Sensitivity analyses of the SVM can reveal which condition is the most influential factor on the lag phase duration and generation time, respectively. Therefore, SVM could become an alternative to other modeling approaches, all of which are faster than traditional microbiological experiments.
C1 [Liu, Jing] State Key Lab Dairy Biotechnol, Shanghai 201103, Peoples R China.
   [Guan, Xiao] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai, Peoples R China.
   [Schaffner, Donald W.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA.
   [Liu, Jing] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China.
RP Liu, J (reprint author), State Key Lab Dairy Biotechnol, Shanghai 201103, Peoples R China.
EM jingliu@shmtu.edu.cn
RI Schaffner, Don/AAA-1264-2020
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31101348]; Shanghai Natural Science
   FoundationNatural Science Foundation of Shanghai [14ZR1419200]
FX The authors are grateful for the financial supports from the National
   Natural Science Foundation of China (Grant No.31101348) and Shanghai
   Natural Science Foundation (Grant No. 14ZR1419200). Jing Liu thanks Dr.
   Schaffner and the Shanghai Municipal Education Commission for providing
   her study at Rutgers University.
CR Amina M, 2012, EXPERT SYST APPL, V39, P1435, DOI 10.1016/j.eswa.2011.08.028
   BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0
   Devlieghere F, 2001, FOOD MICROBIOL, V18, P53, DOI 10.1006/fmic.2000.0378
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HUDSON JA, 1992, J FOOD PROTECT, V55, P968, DOI 10.4315/0362-028X-55.12.968
   Hunter A, 2000, COMPUT METH PROG BIO, V62, P11, DOI 10.1016/S0169-2607(99)00046-2
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   MCCLURE PJ, 1994, INT J FOOD MICROBIOL, V23, P359, DOI 10.1016/0168-1605(94)90163-5
   PALUMBO SA, 1992, J FOOD PROTECT, V55, P260, DOI 10.4315/0362-028X-55.4.260
   PALUMBO SA, 1985, J FOOD SCI, V50, P1417, DOI 10.1111/j.1365-2621.1985.tb10490.x
   PALUMBO SA, 1985, APPL ENVIRON MICROB, V50, P1027, DOI 10.1128/AEM.50.4.1027-1030.1985
   Panagou EZ, 2009, EXPERT SYST APPL, V36, P121, DOI 10.1016/j.eswa.2007.09.022
   RATKOWSKY DA, 1982, J BACTERIOL, V149, P1
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ross T, 2009, INT J FOOD MICROBIOL, V131, P128, DOI 10.1016/j.ijfoodmicro.2009.02.007
   Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007
   Uykan Z, 2000, IEEE T NEURAL NETWOR, V11, P851, DOI 10.1109/72.857766
   Valero A, 2007, J FOOD SCI, V72, pM16, DOI 10.1111/j.1750-3841.2006.00208.x
   Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640
   Wu Q, 2011, EXPERT SYST APPL, V38, P12028, DOI 10.1016/j.eswa.2011.01.054
   Zurera-Cosano G, 2004, J FOOD PROTECT, V67, P1138, DOI 10.4315/0362-028X-67.6.1138
NR 25
TC 0
Z9 0
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0149-6085
EI 1745-4565
J9 J FOOD SAFETY
JI J. Food Saf.
PD NOV
PY 2014
VL 34
IS 4
BP 292
EP 299
DI 10.1111/jfs.12125
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA AT3YD
UT WOS:000344870600004
DA 2020-05-07
ER

PT J
AU Leung, MHY
   Wilkins, D
   Li, EKT
   Kong, FKF
   Lee, PKH
AF Leung, Marcus H. Y.
   Wilkins, David
   Li, Ellen K. T.
   Kong, Fred K. F.
   Lee, Patrick K. H.
TI Indoor-Air Microbiome in an Urban Subway Network: Diversity and Dynamics
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID AIRBORNE BACTERIAL COMMUNITIES; ATMOSPHERIC SURFACE-LAYER; TEMPORAL
   VARIABILITY; METRO STATIONS; POPULATIONS; ENVIRONMENT; SYSTEM; FUNGI;
   EXPOSURE; PATTERN
AB Subway systems are indispensable for urban societies, but microbiological characteristics of subway aerosols are relatively unknown. Previous studies investigating microbial compositions in subways employed methodologies that underestimated the diversity of microbial exposure for commuters, with little focus on factors governing subway air microbiology, which may have public health implications. Here, a culture-independent approach unraveling the bacterial diversity within the urban subway network in Hong Kong is presented. Aerosol samples from multiple subway lines and outdoor locations were collected. Targeting the 16S rRNA gene V4 region, extensive taxonomic diversity was found, with the most common bacterial genera in the subway environment among those associated with skin. Overall, subway lines harbored different phylogenetic communities based on alpha- and beta- diversity comparisons, and closer inspection suggests that each community within a line is dependent on architectural characteristics, nearby outdoor microbiomes, and connectedness with other lines. Microbial diversities and assemblages also varied depending on the day sampled, as well as the time of day, and changes in microbial communities between peak and nonpeak commuting hours were attributed largely to increases in skin-associated genera in peak samples. Microbial diversities within the subway were influenced by temperature and relative humidity, while carbon dioxide levels showed a positive correlation with abundances of commuter-associated genera. This Hong Kong data set and communities from previous studies conducted in the United States formed distinct community clusters, indicating that additional work is required to unravel the mechanisms that shape subway microbiomes around the globe.
C1 [Leung, Marcus H. Y.; Wilkins, David; Li, Ellen K. T.; Kong, Fred K. F.; Lee, Patrick K. H.] City Univ Hong Kong, Sch Energy & Environm, Hong Kong, Hong Kong, Peoples R China.
RP Lee, PKH (reprint author), City Univ Hong Kong, Sch Energy & Environm, Hong Kong, Hong Kong, Peoples R China.
EM patrick.kh.lee@cityu.edu.hk
RI Lee, Patrick K H/L-1844-2016
OI Lee, Patrick K H/0000-0003-0911-5317; Leung, Marcus/0000-0002-6342-8181
FU Research Grants Council of Hong KongHong Kong Research Grants Council
   [124412]
FX This research was supported by the Research Grants Council of Hong Kong
   through project 124412. We thank Wai Shan Chow, Catherine Chung, Ka Yan
   Ng, Yuet Ying Wong, and Flora Yeh for sampling assistance and Zhi Ning
   and Fenhuan Yang for their support with instruments. Wethank Wei Chi
   Wang and the members of Health GeneTech Corporation for sample
   processing and sequence analysis.
CR Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283
   Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28
   Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107
   Awad AHA, 2002, J OCCUP HEALTH, V44, P112, DOI 10.1539/joh.44.112
   Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0
   Birenzvige A, 2003, AEROSOL SCI TECH, V37, P210, DOI 10.1080/02786820300941
   Bogomolova E, 2009, INT BIODETER BIODEGR, V63, P156, DOI 10.1016/j.ibiod.2008.05.008
   Bonetta S, 2010, ENVIRON MONIT ASSESS, V161, P473, DOI 10.1007/s10661-009-0761-8
   Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005
   Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   CHAO A, 1984, SCAND J STAT, V11, P265
   Cho JH, 2006, INT J HYG ENVIR HEAL, V209, P249, DOI 10.1016/j.ijheh.2005.10.001
   Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075
   Dong SF, 2010, ENVIRON MONIT ASSESS, V170, P331, DOI 10.1007/s10661-009-1236-7
   Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032
   Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133
   Dybwad M, 2014, APPL ENVIRON MICROB, V80, P257, DOI 10.1128/AEM.02849-13
   Dybwad M, 2012, APPL ENVIRON MICROB, V78, P1917, DOI 10.1128/AEM.07212-11
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3
   Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106
   Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07
   Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036
   Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132
   Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12
   Gilleberg SB, 1998, INT BIODETER BIODEGR, V41, P149, DOI 10.1016/S0964-8305(98)00005-5
   Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Hwang SH, 2010, ATMOS ENVIRON, V44, P1658, DOI 10.1016/j.atmosenv.2010.01.047
   Kawasaki T, 2013, J OCCUP HEALTH, V55, P495, DOI 10.1539/joh.13-0055-FS
   Kawasaki Tamami, 2010, J Occup Health, V52, P186, DOI 10.1539/joh.O9022
   Ke MT, 2002, BUILD ENVIRON, V37, P1139, DOI 10.1016/S0360-1323(01)00105-6
   Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093
   Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211
   Kettleson E, 2013, INDOOR AIR, V23, P387, DOI 10.1111/ina.12035
   KIM K, 2010, IND HLTH, V49, P242
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165
   Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650
   LIGHTHART B, 1995, APPL ENVIRON MICROB, V61, P1492, DOI 10.1128/AEM.61.4.1492-1496.1995
   Lighthart B, 1999, ATMOS ENVIRON, V33, P611, DOI 10.1016/S1352-2310(98)00215-5
   Ling ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06
   Maron PA, 2005, ATMOS ENVIRON, V39, P3687, DOI 10.1016/j.atmosenv.2005.03.002
   Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047
   Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110
   Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x
   Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56
   Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13
   Seino K, 2005, ATMOS ENVIRON, V39, P337, DOI 10.1016/j.atmosenv.2004.09.030
   Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus
   Vaz-Moreira I, 2013, FEMS MICROBIOL ECOL, V83, P361, DOI 10.1111/1574-6941.12002
   Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283
   Woo AC, 2013, ATMOS ENVIRON, V74, P291, DOI 10.1016/j.atmosenv.2013.03.047
   Zeng YH, 2007, J MICROBIOL, V45, P205
   Zhou F, 2013, INT J ENV RES PUB HE, V10, P2412, DOI 10.3390/ijerph10062412
   Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2
NR 62
TC 66
Z9 67
U1 2
U2 80
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD NOV
PY 2014
VL 80
IS 21
BP 6760
EP 6770
DI 10.1128/AEM.02244-14
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA AS3FA
UT WOS:000344160900021
PM 25172855
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Coffin, SE
   Klieger, SB
   Duggan, C
   Huskins, WC
   Milstone, AM
   Potter-Bynoe, G
   Raphael, B
   Sandora, TJ
   Song, XY
   Zerr, DM
   Lee, GM
AF Coffin, Susan E.
   Klieger, Sarah B.
   Duggan, Christopher
   Huskins, W. Charles
   Milstone, Aaron M.
   Potter-Bynoe, Gail
   Raphael, Bram
   Sandora, Thomas J.
   Song, Xiaoyan
   Zerr, Danielle M.
   Lee, Grace M.
CA Pediat Prevention EpiCtr
TI Central Line-Associated Bloodstream Infections in Neonates with
   Gastrointestinal Conditions: Developing a Candidate Definition for
   Mucosal Barrier Injury Bloodstream Infections
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID CARE SAFETY NETWORK; BIRTH-WEIGHT INFANTS; BACTERIAL TRANSLOCATION;
   RISK-FACTORS; PATHOGENS; SEPSIS; RATES
AB OBJECTIVE. To develop a candidate definition for central line-associated bloodstream infection (CLABSI) in neonates with presumed mucosal barrier injury due to gastrointestinal (MBI-GI) conditions and to evaluate epidemiology and microbiology of MBI-GI CLABSI in infants.
   DESIGN. Multicenter retrospective cohort study.
   SETTING. Neonatal intensive care units from 14 US children's hospitals and pediatric facilities.
   METHODS. A multidisciplinary focus group developed a candidate MBI-GI CLABSI definition based on presence of an MBI-GI condition, parenteral nutrition (PN) exposure, and an eligible enteric organism. CLABSI surveillance data from participating hospitals were supplemented by chart review to identify MBI-GI conditions and PN exposure.
   RESULTS. During 2009-2012, 410 CLABSIs occurred in 376 infants. MBI-GI conditions and PN exposure occurred in 149 (40%) and 324 (86%) of these 376 neonates, respectively. The distribution of pathogens was similar among neonates with versus without MBI-GI conditions and PN exposure. Fifty-nine (16%) of the 376 initial CLABSI episodes met the candidate MBI-GI CLABSI definition. Subsequent versus initial CLABSIs were more likely to be caused by an enteric organism (22 of 34 [65%] vs 151 of 376 [40%]; P = .009) and to meet the candidate MBI-GI CLABSI definition (19 of 34 [56%] vs 59 of 376 [16%]; P < .01).
   CONCLUSIONS. While MBI-GI conditions and PN exposure were common, only 16% of initial CLABSIs met the candidate definition of MBI-GI CLABSI. The high proportion of MBI-GI CLABSIs among subsequent infections suggests that infants with MBI-GI CLABSI should be a population targeted for further surveillance and interventional research.
C1 [Coffin, Susan E.; Klieger, Sarah B.] Childrens Hosp Philadelphia, Div Infect Dis, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA.
   [Coffin, Susan E.; Klieger, Sarah B.] Childrens Hosp Philadelphia, Dept Infect Prevent, Philadelphia, PA 19104 USA.
   [Coffin, Susan E.] Perelman Sch Med, Philadelphia, PA USA.
   [Duggan, Christopher; Raphael, Bram] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA.
   [Duggan, Christopher; Raphael, Bram; Sandora, Thomas J.; Lee, Grace M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.
   [Huskins, W. Charles] Mayo Clin, Div Pediat Infect Dis, Rochester, MN USA.
   [Milstone, Aaron M.] Johns Hopkins Univ, Sch Med, Div Pediat Infect Dis, Baltimore, MD USA.
   [Potter-Bynoe, Gail; Sandora, Thomas J.; Lee, Grace M.] Boston Childrens Hosp, Boston, MA USA.
   [Sandora, Thomas J.; Lee, Grace M.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA.
   [Song, Xiaoyan] Childrens Natl Med Ctr, Div Infect Dis, Washington, DC 20010 USA.
   [Song, Xiaoyan] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA.
   [Zerr, Danielle M.] Univ Washington, Div Infect Dis, Seattle, WA 98195 USA.
   [Zerr, Danielle M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Lee, Grace M.] Harvard Pilgrim Healthcare Inst, Boston, MA USA.
RP Coffin, SE (reprint author), Childrens Hosp Philadelphia, Div Infect Dis, 3535 Market St,Suite 1579, Philadelphia, PA 19104 USA.
EM coffin@email.chop.edu
OI Logan, Latania/0000-0002-3883-2043; Milstone, Aaron/0000-0001-8498-8682;
   Kociolek, Larry/0000-0002-8756-3417
FU Centers for Disease Control and Prevention Epicenters ProgramUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA [U54-CK000163];  [K24HD058795]
FX Financial support. This work was supported in part by the Centers for
   Disease Control and Prevention Epicenters Program (U54-CK000163). C.D.
   was supported in part by K24HD058795.
CR Advani S, 2011, CLIN INFECT DIS, V52, P1108, DOI 10.1093/cid/cir145
   Beekmann SE, 2012, INFECT CONT HOSP EP, V33, P875, DOI 10.1086/667379
   Bizzarro MJ, 2010, INFECT CONT HOSP EP, V31, P241, DOI 10.1086/650448
   Blanchard AC, 2013, INFECT CONT HOSP EP, V34, P1167, DOI 10.1086/673464
   Centers for Disease Control and Prevention (CDC), 2012, 17 CDC NHSN SURV DEF
   Cole CR, 2012, J PEDIATR-US, V160, P54, DOI 10.1016/j.jpeds.2011.06.034
   Cole CR, 2010, J PEDIATR-US, V156, P941, DOI 10.1016/j.jpeds.2009.12.008
   COWAN ME, 1986, J HOSP INFECT, V7, P91, DOI 10.1016/0195-6701(86)90033-2
   DiGiorgio MJ, 2012, INFECT CONT HOSP EP, V33, P865, DOI 10.1086/667380
   Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002
   Fraser TG, 2011, CLIN INFECT DIS, V52, P1446, DOI 10.1093/cid/cir200
   Graham PL, 2006, PEDIATR INFECT DIS J, V25, P113, DOI 10.1097/01.inf.0000199310.52875.10
   Hocevar SN, 2012, INFECT CONT HOSP EP, V33, P1200, DOI 10.1086/668425
   Hull MA, 2011, JPEN-PARENTER ENTER, V35, P181, DOI 10.1177/0148607110381406
   Lukenbill J, 2013, BIOL BLOOD MARROW TR, V19, P720, DOI 10.1016/j.bbmt.2013.01.022
   MacFie J, 2006, BRIT J SURG, V93, P87, DOI 10.1002/bjs.5184
   MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223
   Milisavljevic V, 2013, BMC PEDIATR, V13, P1, DOI [10.1371/journal.pbio.0050177, DOI 10.1371/JOURNAL.PBIO.0050177]
   Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382
   Niedner MF, 2011, INFECT CONT HOSP EP, V32, P1200, DOI 10.1086/662621
   O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29
   Polin RA, 2012, PEDIATRICS, V129, pE1085, DOI 10.1542/peds.2012-0145
   Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873
   See I, 2013, INFECT CONT HOSP EP, V34, P769, DOI 10.1086/671281
   Sexton DJ, 2010, INFECT CONT HOSP EP, V31, P1286, DOI 10.1086/657583
   Squires RH, 2012, J PEDIATR-US, V161, P723, DOI 10.1016/j.jpeds.2012.03.062
   Steinberg JP, 2013, INFECT CONT HOSP EP, V34, P171, DOI 10.1086/669082
   Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580
   Wheeler DS, 2011, PEDIATRICS, V128, pE995, DOI 10.1542/peds.2010-2601
   Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007
NR 30
TC 6
Z9 6
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD NOV
PY 2014
VL 35
IS 11
BP 1391
EP 1399
DI 10.1086/678410
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AS5NF
UT WOS:000344316700010
PM 25333434
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Rosenman, MB
   Szucs, KA
   Finnell, SME
   Khokhar, S
   Egg, J
   Lemmon, L
   Shepherd, DC
   Fried, J
   Li, XC
   Kho, AN
AF Rosenman, Marc B.
   Szucs, Kinga A.
   Finnell, S. Maria E.
   Khokhar, Shahid
   Egg, James
   Lemmon, Larry
   Shepherd, David C.
   Fried, Jeff
   Li, Xiaochun
   Kho, Abel N.
TI Nascent Regional System for Alerting Infection Preventionists about
   Patients with Multidrug-Resistant Gram-Negative Bacteria: Implementation
   and Initial Results
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID KLEBSIELLA-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; CARE;
   HOSPITALS; SURVEILLANCE; COMMUNITY; NETWORK; IMPACT; MRSA
AB OBJECTIVE. To build and to begin evaluating a regional automated system to notify infection preventionists (IPs) when a patient with a history of gram-negative rod multidrug-resistant organism (GNRMDRO) is admitted to an emergency department (ED) or inpatient setting.
   DESIGN. Observational, retrospective study.
   SETTING. Twenty-seven hospitals, mostly in the Indianapolis metropolitan area, in a health information exchange (HIE).
   PATIENTS. During testing of the new system: 80,180 patients with microbiology cultures between October 1, 2013, and December 31, 2013; 573 had a GNRMDRO.
   METHODS/INTERVENTION. A Health Level Seven (HL7) data feed from the HIE was obtained, corrected, enhanced, and used for decision support (secure e-mail notification to the IPs). Retrospective analysis of patients with microbiology data (October 1, 2013, through December 31, 2013) and subsequent healthcare encounters (through February 6, 2014).
   RESULTS. The 573 patients (median age, 66 years; 68% women) had extended-spectrum 0-lactamase producing Enterobacteriaceae (78%), carbapenem-resistant Enterobacteriaceae (7%), Pseudomonas aeruginosa (9%), Acinetobacter baumannii (3%), or other GNR (3%). Body sources were urine (68%), sputum/trachea/bronchoalveolar lavage (13%), wound/skin (6%), blood (6%), or other/unidentified (7%). Between October 1, 2013, and February 6, 2014, 252 (44%) of 573 had an ED or inpatient encounter after the GNRMDRO culture, 47 (19% of 252) at an institution different from where the culture was drawn. During the first 7 weeks of actual alerts (January 29, 2014, through March 19, 2014), alerts were generated regarding 67 patients (19 of 67 admitted elsewhere from where the culture was drawn).
   CONCLUSIONS. It proved challenging but ultimately feasible to create a regional microbiology-based alert system. Even in a few months, we observed substantial crossover between institutions. This system, if it contributes to timely isolation, may help reduce the spread of GNRMDROs.
C1 [Rosenman, Marc B.; Szucs, Kinga A.; Finnell, S. Maria E.; Li, Xiaochun] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Rosenman, Marc B.; Finnell, S. Maria E.; Khokhar, Shahid; Egg, James; Lemmon, Larry; Kho, Abel N.] Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA.
   [Shepherd, David C.] Shepherd Internal Med, Indianapolis, IN USA.
   [Li, Xiaochun] Indiana Univ, Sch Publ Hlth, Indianapolis, IN 46202 USA.
   [Kho, Abel N.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Rosenman, MB (reprint author), Indiana Univ, Dept Pediat, Childrens Hlth Serv Res, 410 West 10th St,Suite 1000, Indianapolis, IN 46202 USA.
EM mrosenma@iu.edu
FU Agency for Healthcare Research and Quality (AHRQ), US Department of
   Health and Human Services [5R18HS020014]
FX This project was funded under grant 5R18HS020014 from the Agency for
   Healthcare Research and Quality (AHRQ), US Department of Health and
   Human Services. The findings and conclusions in this document are those
   of the authors, who are responsible for its content, and do not
   necessarily represent the views of AHRQ. No statement in this report
   should be construed as an official position of AHRQ or of the US
   Department of Health and Human Services.
CR Birgand G, 2013, AM J INFECT CONTROL, V41, P443, DOI 10.1016/j.ajic.2012.05.015
   Caini S, 2013, EURO SURVEILL, V18
   Carbonnel A, 2013, J ANTIMICROB CHEMOTH, V68, P954, DOI 10.1093/jac/dks464
   Centers for Disease Control and Prevention, 2013, NEW CARB RES ENT WAR
   Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101
   Datta S, 2012, INDIAN J MED RES, V135, P907
   Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942
   Duffy J, 2011, PUBLIC HEALTH REP, V126, P176, DOI 10.1177/003335491112600208
   Huang S, 2010, INFECT CONT HOSP EP, V31, P1160, DOI 10.1086/656747
   Kallen AJ, 2010, INFECT CONT HOSP EP, V31, pS51, DOI 10.1086/655996
   Khan E, 2010, J PAK MED ASSOC, V60, P186
   Kho Abel, 2008, AMIA Annu Symp Proc, P1222
   Kho AN, 2007, STUD HEALTH TECHNOL, V129, P213
   Kho AN, 2008, J AM MED INFORM ASSN, V15, P212, DOI 10.1197/jamia.M2577
   Kho AN, 2013, CLIN INFECT DIS, V57, P254, DOI 10.1093/cid/cit229
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9
   Lee BY, 2012, HEALTH AFFAIR, V31, P2295, DOI 10.1377/hlthaff.2011.0992
   Lee BY, 2011, INFECT CONT HOSP EP, V32, P562, DOI 10.1086/660014
   Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954
   Lowe C, 2012, AM J INFECT CONTROL, V40, P836, DOI 10.1016/j.ajic.2011.11.008
   McDonald CJ, 2005, HEALTH AFFAIR, V24, P1214, DOI 10.1377/hlthaff.24.5.1214
   Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412
   Rosenman MB, 2014, ADV PREVENTION CONTR
   Sittig DF, 2012, MED CARE, V50, pS49, DOI 10.1097/MLR.0b013e318259c02b
   Smith DL, 2005, P NATL ACAD SCI USA, V102, P3153, DOI 10.1073/pnas.0409523102
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
NR 26
TC 3
Z9 3
U1 0
U2 9
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD OCT
PY 2014
VL 35
SU 3
BP S40
EP S47
DI 10.1086/677833
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AP2XP
UT WOS:000341939700007
PM 25222897
OA Bronze
DA 2020-05-07
ER

PT J
AU Luge, T
   Kube, M
   Freiwald, A
   Meierhofer, D
   Seemuller, E
   Sauer, S
AF Luge, Toni
   Kube, Michael
   Freiwald, Anja
   Meierhofer, David
   Seemueller, Erich
   Sauer, Sascha
TI Transcriptomics assisted proteomic analysis of Nicotiana occidentalis
   infected by Candidatus Phytoplasma mali strain AT
SO PROTEOMICS
LA English
DT Article
DE Apple proliferation; Microbiology; Plant bacteria interaction;
   Proteogenomics; Proteomics informed by transcriptomics; RNA-Seq
ID PROLIFERATION; PROTEINS; PLANTS
AB Phytoplasmas are pathogenic bacteria within the class of Mollicutes, which are associated with more than 1000 plant diseases. In this study, we applied quantitative mass spectrometry to analyse affected pathways of the model plant tobacco (Nicotiana occidentalis) upon Candidatus Phytoplasma mali strain AT infection. Using tissue obtained from leaf midribs, 1466 plant-assigned proteins were identified. For 1019 of these proteins, we could reproducibly quantify the expression changes of infected versus noninfected plants, of which 157 proteins were up-and 173 proteins were downregulated. Differential expression took place in a number of pathways, among others strong downregulation of porphyrin and chlorophyll metabolism and upregulation of alpha-linolenic acid metabolism, which was consistent with observed increased levels of jasmonic acid, a key signal molecule of plant defence. Our data shed light on the molecular networks that are involved in defence of plants against phytoplasma infection and provide a resource for further studies.
C1 [Luge, Toni; Freiwald, Anja; Meierhofer, David; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany.
   [Kube, Michael] Humboldt Univ, Div Phytomed, Dept Crop & Anim Sci, D-10099 Berlin, Germany.
   [Seemueller, Erich] Julius Kuhn Inst Fed Res Ctr Cultivated Plants, Inst Plant Protect Fruit Crops & Viticulture, Dossenheim, Germany.
RP Sauer, S (reprint author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 63-73, D-14195 Berlin, Germany.
EM sauer@molgen.mpg.de
RI Meierhofer, David/V-4711-2019
OI Meierhofer, David/0000-0002-0170-868X
FU German Ministry for Education and Research (BMBF)Federal Ministry of
   Education & Research (BMBF) [0315082, 01EA1303]; European UnionEuropean
   Union (EU) [262055]; German Research FoundationGerman Research
   Foundation (DFG) [KU 2679/2-1, BU 890/21-1]; Max Planck SocietyMax
   Planck SocietyFoundation CELLEX
FX Our work is supported by the German Ministry for Education and Research
   (BMBF, grant number 0315082, 01EA1303 to S.S.), the European Union
   (FP7/2007-2013, under grant agreement no 262055 (ESGI) to S. S.), the
   German Research Foundation (through projects KU 2679/2-1 and BU
   890/21-1) and the Max Planck Society. This study is part of the Ph.D.
   thesis of T.
CR Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/NCLIMATE1990, 10.1038/nclimate1990]
   Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008
   Clough T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S6
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Contaldo N, 2012, PHYTOPATHOL MEDITERR, V51, P607
   Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D
   Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/NMETH.2227, 10.1038/nmeth.2227]
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X
   Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106
   Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625
   Ji XL, 2009, PROTEOMICS, V9, P5328, DOI 10.1002/pmic.200900012
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Kube M, 2012, SCI WORLD J, DOI 10.1100/2012/185942
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lauer U, 2000, J BACTERIOL, V182, P1415, DOI 10.1128/JB.182.5.1415-1418.2000
   Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Margaria P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-38
   Margaria P, 2011, PROTEOMICS, V11, P212, DOI 10.1002/pmic.201000409
   MARWITZ R, 1974, Phytopathologische Zeitschrift, V81, P85
   Mayer CJ, 2008, J CHEM ECOL, V34, P1045, DOI 10.1007/s10886-008-9516-1
   Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t
   Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37
   R Core Team, 2018, R LANG ENV STAT COMP, DOI [10.1007/978-3-540-74686-7., DOI 10.1007/978-3-540-74686-7]
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Schneider Bernd, 1995, P369, DOI 10.1016/B978-012583805-4/50040-6
   Schroder C, 2013, PROTEOM CLIN APPL, V7, P802, DOI 10.1002/prca.201300048
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Siewert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094391
   Strauss E, 2009, SCIENCE, V325, P388, DOI 10.1126/science.325_388
   Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108
   Taheri F, 2011, MOL BIOSYST, V7, P3028, DOI 10.1039/c1mb05268c
   Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n
NR 40
TC 25
Z9 25
U1 0
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD AUG
PY 2014
VL 14
IS 16
BP 1882
EP 1889
DI 10.1002/pmic.201300551
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AN2NH
UT WOS:000340422000004
PM 24920314
DA 2020-05-07
ER

PT J
AU Thaden, JT
   Lewis, SS
   Hazen, KC
   Huslage, K
   Fowler, VG
   Moehring, RW
   Chen, LF
   Jones, CD
   Moore, ZS
   Sexton, DJ
   Anderson, DJ
AF Thaden, Joshua T.
   Lewis, Sarah S.
   Hazen, Kevin C.
   Huslage, Kirk
   Fowler, Vance G., Jr.
   Moehring, Rebekah W.
   Chen, Luke F.
   Jones, Constance D.
   Moore, Zack S.
   Sexton, Daniel J.
   Anderson, Deverick J.
TI Rising Rates of Carbapenem-Resistant Enterobacteriaceae in Community
   Hospitals: A Mixed-Methods Review of Epidemiology and Microbiology
   Practices in a Network of Community Hospitals in the Southeastern United
   States
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID KLEBSIELLA-PNEUMONIAE CARBAPENEMASE; BETA-LACTAMASE; INFECTIONS;
   PREVENTION; IMPACT
AB OBJECTIVE. Describe the epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) and examine the effect of lower carbapenem breakpoints on CRE detection.
   DESIGN. Retrospective cohort.
   SETTING. Inpatient care at community hospitals.
   PATIENTS. All patients with CRE-positive cultures were included.
   METHODS. CRE isolated from 25 community hospitals were prospectively entered into a centralized database from January 2008 through December 2012. Microbiology laboratory practices were assessed using questionnaires.
   RESULTS. A total of 305 CRE isolates were detected at 16 hospitals (64%). Patients with CRE had symptomatic infection in 180 cases (59%) and asymptomatic colonization in the remainder (125 cases; 41%). Klebsiella pneumoniae (277 isolates; 91%) was the most prevalent species. The majority of cases were healthcare associated (288 cases; 94%). The rate of CRE detection increased more than fivefold from 2008 (0.26 cases per 100,000 patient-days) to 2012 (1.4 cases per 100,000 patient-days; incidence rate ratio (IRR), 5.3 [95% confidence interval (CI), 1.22-22.7]; P = .01). Only 5 hospitals (20%) had adopted the 2010 Clinical and Laboratory Standards Institute (CLSI) carbapenem breakpoints. The 5 hospitals that adopted the lower carbapenem breakpoints were more likely to detect CRE after implementation of breakpoints than before (4.1 vs 0.5 cases per 100,000 patient-days; P < .001; IRR, 8.1 [95% CI, 2.7-24.6]). Hospitals that implemented the lower carbapenem breakpoints were more likely to detect CRE than were hospitals that did not (3.3 vs 1.1 cases per 100,000 patient-days; P = .01).
   CONCLUSIONS. The rate of CRE detection increased fivefold in community hospitals in the southeastern United States from 2008 to 2012. Despite this, our estimates are likely underestimates of the true rate of CRE detection, given the low adoption of the carbapenem breakpoints recommended in the 2010 CLSI guidelines.
C1 [Thaden, Joshua T.; Lewis, Sarah S.; Fowler, Vance G., Jr.; Moehring, Rebekah W.; Chen, Luke F.; Sexton, Daniel J.; Anderson, Deverick J.] Duke Univ, Div Infect Dis, Durham, NC 27710 USA.
   [Lewis, Sarah S.; Moehring, Rebekah W.; Chen, Luke F.; Sexton, Daniel J.; Anderson, Deverick J.] Duke Infect Control Outreach Network, Durham, NC USA.
   [Hazen, Kevin C.] Duke Univ, Duke Clin Microbiol Lab, Durham, NC 27710 USA.
   [Huslage, Kirk] Univ N Carolina, Statewide Program Infect Control & Epidemiol, Chapel Hill, NC USA.
   [Moehring, Rebekah W.] Durham Vet Affairs Med Ctr, Durham, NC USA.
   [Jones, Constance D.; Moore, Zack S.] North Carolina Div Publ Hlth, Raleigh, NC USA.
RP Thaden, JT (reprint author), Duke Univ, Med Ctr, Div Infect Dis, 315 Trent Dr, Durham, NC 27710 USA.
EM joshua.thaden@duke.edu
OI Anderson, Deverick/0000-0001-6882-5496
FU  [K23-AI095357];  [K24-AI093969];  [UM1-AI0468]
FX D.J.A. was supported by K23-AI095357. V.G.F. was supported by
   K24-AI093969 and UM1-AI0468.
CR Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940
   Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07
   Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x
   Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922
   Centers for Disease Control and Prevention, 2012, 2012 CRE TOOLK GUID
   [CLSI] Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI
   Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08
   Freeman JT, 2009, CLIN INFECT DIS, V49, pE30, DOI 10.1086/600046
   Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202
   Lewis SS, 2013, PROGRAM ABSTRACTS ID
   Lin MY, 2013, CLIN INFECT DIS, V57, P1246, DOI 10.1093/cid/cit500
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655
   Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412
   Wise R, 2011, J ANTIMICROB CHEMOTH, V66, P1939, DOI 10.1093/jac/dkr261
   Woodford N, 2010, J CLIN MICROBIOL, V48, P2999, DOI 10.1128/JCM.00341-10
NR 15
TC 62
Z9 64
U1 1
U2 12
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD AUG
PY 2014
VL 35
IS 8
BP 978
EP 983
DI 10.1086/677157
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AL3RQ
UT WOS:000339046900006
PM 25026612
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Zarecki, R
   Oberhardt, MA
   Reshef, L
   Gophna, U
   Ruppin, E
AF Zarecki, Raphy
   Oberhardt, Matthew A.
   Reshef, Leah
   Gophna, Uri
   Ruppin, Eytan
TI A Novel Nutritional Predictor Links Microbial Fastidiousness with
   Lowered Ubiquity, Growth Rate, and Cooperativeness
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI METABOLISM; GENOME; NETWORK; RECONSTRUCTION;
   METAGENOMICS; CULTIVATION; SEQUENCE
AB Understanding microbial nutritional requirements is a key challenge in microbiology. Here we leverage the recent availability of thousands of automatically generated genome-scale metabolic models to develop a predictor of microbial minimal medium requirements, which we apply to thousands of species to study the relationship between their nutritional requirements and their ecological and genomic traits. We first show that nutritional requirements are more similar among species that co-habit many ecological niches. We then reveal three fundamental characteristics of microbial fastidiousness (i.e., complex and specific nutritional requirements): (1) more fastidious microorganisms tend to be more ecologically limited; (2) fastidiousness is positively associated with smaller genomes and smaller metabolic networks; and (3) more fastidious species grow more slowly and have less ability to cooperate with other species than more metabolically versatile organisms. These associations reflect the adaptation of fastidious microorganisms to unique niches with few cohabitating species. They also explain how non-fastidious species inhabit many ecological niches with high abundance rates. Taken together, these results advance our understanding microbial nutrition on a large scale, by presenting new nutrition-related associations that govern the distribution of microorganisms in nature.
C1 [Zarecki, Raphy; Oberhardt, Matthew A.; Ruppin, Eytan] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.
   [Zarecki, Raphy; Oberhardt, Matthew A.; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
   [Oberhardt, Matthew A.; Reshef, Leah; Gophna, Uri] Tel Aviv Univ, Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.
RP Zarecki, R (reprint author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.
EM ruppin@post.tau.ac.il
RI Ruppin, Eytan/R-9698-2017
OI Ruppin, Eytan/0000-0002-7862-3940; Gophna, Uri/0000-0001-5129-5652
FU Whitaker Foundation; Dan David Fellowship; European Union FP7 INFECT
   project; ERA-Net Plant project; I-CORE Program of the Planning and
   Budgeting Committee; Israel Science FoundationIsrael Science Foundation
   [41/11]; McDonnell foundation; German-Israeli Project Cooperation
FX MAO: Whitaker Foundation (Whitaker International Scholars Program:
   http://www.whitaker.org/) and the Dan David Fellowship
   (http://www.dandavidprize.org/about/about-the-prize); ER: European Union
   FP7 INFECT project, theERA-Net Plant project, and the I-CORE Program of
   the Planning and Budgeting Committee and The Israel Science Foundation
   (grant No 41/11). UG: McDonnell foundation, and the German-Israeli
   Project Cooperation (DIP). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alam MT, 2011, FEBS LETT, V585, P2389, DOI 10.1016/j.febslet.2011.06.014
   Baldrian P, 2011, FEMS MICROBIOL ECOL, V78, P1, DOI 10.1111/j.1574-6941.2011.01184.x
   Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105
   Borenstein E, 2009, J COMPUT BIOL, V16, P191, DOI 10.1089/cmb.2008.06TT
   Brooks J. Paul, 2012, Advances in Bioinformatics, V2012, P323472, DOI 10.1155/2012/323472
   Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880
   Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109
   Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15
   Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498
   Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Doern GV, 2000, CLIN INFECT DIS, V30, P166, DOI 10.1086/313586
   Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597
   Henry CS, 2011, BBA-GEN SUBJECTS, V1810, P967, DOI 10.1016/j.bbagen.2011.03.010
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69
   Hongoh Y, 2011, METHODS MOL BIOL, V733, P25, DOI 10.1007/978-1-61779-089-8_2
   Martinez-Gomez K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-46
   McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18
   Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240
   Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07
   Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116
   Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77
   Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033
   Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169
   Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805
   Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001
   Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917
   Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088
   Schut F, 1997, AQUAT MICROB ECOL, V12, P177, DOI 10.3354/ame012177
   Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56
   Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285
   Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x
   Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808
   Zakrzewski P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051511
   Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0
NR 38
TC 11
Z9 11
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD JUL
PY 2014
VL 10
IS 7
AR e1003726
DI 10.1371/journal.pcbi.1003726
PG 12
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA AM5IO
UT WOS:000339890900039
PM 25033033
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Besmer, MD
   Weissbrodt, DG
   Kratochvil, BE
   Sigrist, JA
   Weyland, MS
   Hammes, F
AF Besmer, Michael D.
   Weissbrodt, David G.
   Kratochvil, Bradley E.
   Sigrist, Juerg A.
   Weyland, Mathias S.
   Hammes, Frederik
TI The feasibility of automated online flow cytometry for in-situ
   monitoring of microbial dynamics in aquatic ecosystems
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE flow cytometry (FCM); bacteria; drinking water; monitoring; sensors;
   automation; online; staining
ID DRINKING-WATER TREATMENT; ENVIRONMENTAL MICROBIOLOGY;
   ELECTRICAL-CONDUCTIVITY; DISTRIBUTION-SYSTEM; COMMUNITY DYNAMICS;
   ORGANIC-CARBON; KARST SPRINGS; FRESH-WATER; BACTERIA; QUANTIFICATION
AB Fluorescent staining coupled with flow cytometry (FCM) is often used for the monitoring, quantification and characterization of bacteria in engineered and environmental aquatic ecosystems including seawater, freshwater, drinking water, wastewater, and industrial bioreactors. However, infrequent grab sampling hampers accurate characterization and subsequent understanding of microbial dynamics in all of these ecosystems. A logic technological progression is high throughput and full automation of the sampling, staining, measurement, and data analysis steps. Here we assess the feasibility and applicability of automated FCM by means of actual data sets produced with prototype instrumentation. As proof-of-concept we demonstrate examples of microbial dynamics in (i) flowing tap water from a municipal drinking water supply network and (ii) river water from a small creek subject to two rainfall events. In both cases, automated measurements were done at 15-min intervals during 12-14 consecutive days, yielding more than 1000 individual data points for each ecosystem. The extensive data sets derived from the automated measurements allowed for the establishment of baseline data for each ecosystem, as well as for the recognition of daily variations and specific events that would most likely be missed (or miss-characterized) by infrequent sampling. In addition, the online FCM data from the river water was combined and correlated with online measurements of abiotic parameters, showing considerable potential for a better understanding of cause-and-effect relationships in aquatic ecosystems. Although several challenges remain, the successful operation of an automated online FCM system and the basic interpretation of the resulting data sets represent a breakthrough toward the eventual establishment of fully automated online microbiological monitoring technologies.
C1 [Besmer, Michael D.; Weissbrodt, David G.; Kratochvil, Bradley E.; Sigrist, Juerg A.; Weyland, Mathias S.; Hammes, Frederik] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, CH-8600 Dubendorf, Switzerland.
   [Besmer, Michael D.] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Dept Environm Syst Sci, Zurich, Switzerland.
   [Weissbrodt, David G.] Swiss Fed Inst Technol, Inst Environm Engn, Chair Proc Engn Urban Water Management, Zurich, Switzerland.
RP Hammes, F (reprint author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, Drinking Water Microbiol Grp, Uberlandstr 133, CH-8600 Dubendorf, Switzerland.
EM frederik.hammes@eawag.ch
RI Weissbrodt, David Gregory/A-2101-2017
OI Weissbrodt, David Gregory/0000-0002-6313-1652
FU Canton Basel-Landschaft, Switzerland
FX The authors acknowledge the financial support from the Canton
   Basel-Landschaft, Switzerland in the framework of the project "Regionale
   Wasserversorgung Basel-Landschaft 21" as well as internal Eawag
   Discretionary Funding. The authors thank Beat Schwarzenbach from Empa
   Dubendorf for providing rainfall data from the NABEL project (FOEN and
   EMPA). The authors thank Dr. Francesco Pomati for advice on data
   analysis.
CR Abu-Absi NR, 2003, CYTOM PART A, V51A, P87, DOI 10.1002/cyto.a.10016
   [Anonymous], 2011, GUID DRINK WAT QUAL
   Arnoldini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080117
   Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6
   Broger T, 2011, J BIOTECHNOL, V154, P240, DOI 10.1016/j.jbiotec.2011.05.003
   Brognaux A, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-100
   Butscher C, 2011, GROUND WATER, V49, P66, DOI 10.1111/j.1745-6584.2010.00687.x
   Czechowska K, 2008, CURR OPIN MICROBIOL, V11, P205, DOI 10.1016/j.mib.2008.04.006
   Day A, 2007, HEATMAP PLUS HEATMAP
   Dubelaar GBJ, 1999, CYTOMETRY, V37, P247, DOI 10.1002/(SICI)1097-0320(19991201)37:4<247::AID-CYTO1>3.3.CO;2-0
   Foladori P, 2010, WATER RES, V44, P3807, DOI 10.1016/j.watres.2010.04.027
   Gregori G, 2001, APPL ENVIRON MICROB, V67, P4662, DOI 10.1128/AEM.67.10.4662-4670.2001
   Guadayol O, 2009, MAR ECOL PROG SER, V381, P139, DOI 10.3354/meps07939
   Gunther S, 2012, ENVIRON SCI TECHNOL, V46, P84, DOI 10.1021/es2010682
   Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009
   Hammes F, 2012, CYTOM PART A, V81A, P508, DOI 10.1002/cyto.a.22048
   Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3
   Hayashi M, 2012, J HYDROL, V450, P93, DOI 10.1016/j.jhydrol.2012.05.020
   Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12
   Koch C, 2013, CYTOM PART A, V83A, P561, DOI 10.1002/cyto.a.22286
   Koch C, 2013, ENVIRON SCI TECHNOL, V47, P1753, DOI 10.1021/es3041048
   KRISHNAMURTI K, 1951, NATURE, V168, P170, DOI 10.1038/168170b0
   Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032
   Legendre L, 2001, CYTOMETRY, V44, P164, DOI 10.1002/1097-0320(20010701)44:3<164::AID-CYTO1108>3.0.CO;2-6
   Lehtola MJ, 2006, WATER RES, V40, P2151, DOI 10.1016/j.watres.2006.04.010
   LINDBERG W, 1993, CYTOMETRY, V14, P230, DOI 10.1002/cyto.990140217
   Oksanen J, 2009, VEGAN COMMUNITY ECOL
   OMANN GM, 1985, CYTOMETRY, V6, P69, DOI 10.1002/cyto.990060113
   Ploner A., 2011, HEATPLUS HEATMAPS RO
   Pomati F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071677
   Porter J, 1997, FEMS MICROBIOL ECOL, V24, P93, DOI 10.1016/S0168-6496(97)00038-X
   Prest EI, 2013, WATER RES, V47, P7131, DOI 10.1016/j.watres.2013.07.051
   Pronk M, 2006, HYDROGEOL J, V14, P473, DOI 10.1007/s10040-005-0454-5
   R development Core Team, 2008, R LANG ENV STAT COMP
   Read S, 2011, APPL MICROBIOL BIOT, V90, P861, DOI 10.1007/s00253-011-3223-5
   Sheikh QI, 2012, SIGNIFICANCE OF FAECAL INDICATORS IN WATER: A GLOBAL PERSPECTIVE, P131, DOI 10.1039/9781849735421-00131
   Signor RS, 2006, WATER SCI TECHNOL, V54, P261, DOI 10.2166/wst.2006.478
   SLMB, 2012, 3331 SLMB FED OFF PU
   Smeets PWMH, 2010, WATER SCI TECHNOL, V61, P1561, DOI 10.2166/wst.2010.839
   Stadler H, 2008, WATER SCI TECHNOL, V58, P899, DOI 10.2166/wst.2008.442
   Stadler H, 2010, WATER SCI TECHNOL, V62, P1898, DOI 10.2166/wst.2010.500
   SUNDH I, 1992, HYDROBIOLOGIA, V229, P93, DOI 10.1007/BF00006993
   Thyssen M, 2008, J PLANKTON RES, V30, P333, DOI 10.1093/plankt/fbn005
   van den Hoven T., 2009, TECHNEAU SAFE DRINKI
   Vital M, 2012, WATER RES, V46, P4665, DOI 10.1016/j.watres.2012.06.010
   Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1016/S0168-6445(00)00033-4
   Vogt T, 2010, ADV WATER RESOUR, V33, P1296, DOI 10.1016/j.advwatres.2010.02.007
   Wang Y, 2007, ENVIRON SCI TECHNOL, V41, P7080, DOI 10.1021/es0707198
   Weissbrodt DG, 2014, FEMS MICROBIOL ECOL, V88, P579, DOI 10.1111/1574-6941.12326
   Zhao R, 1999, BIOTECHNOL BIOENG, V62, P609, DOI 10.1002/(SICI)1097-0290(19990305)62:5<609::AID-BIT13>3.0.CO;2-C
NR 50
TC 65
Z9 66
U1 3
U2 61
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 2
PY 2014
VL 5
AR 265
DI 10.3389/fmicb.2014.00265
PG 12
WC Microbiology
SC Microbiology
GA AJ2WY
UT WOS:000337526700003
PM 24917858
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Yang, XL
   Smith, AA
   Williams, MS
   Pal, U
AF Yang, Xiuli
   Smith, Alexis A.
   Williams, Mark S.
   Pal, Utpal
TI A Dityrosine Network Mediated by Dual Oxidase and Peroxidase Influences
   the Persistence of Lyme Disease Pathogens within the Vector
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Host-Pathogen Interactions; Infectious Diseases; Innate Immunity;
   Microbiology; NADPH Oxidase; Nitric-oxide Synthase; Peroxidase; Protein
   Cross-linking
ID IXODES-SCAPULARIS TICKS; INNATE IMMUNE-RESPONSE; BORRELIA-BURGDORFERI;
   CAENORHABDITIS-ELEGANS; NITRIC-OXIDE; EXTRACELLULAR-MATRIX; ANNOTATED
   CATALOG; ANOPHELES-GAMBIAE; CROSS-LINKING; IMD PATHWAYS
AB Background: How tick immune components influence persistence of pathogens remains unknown. Results: Impairment of dityrosine network formed by a dual oxidase and a peroxidase activates specific immune genes and reduces pathogen survival. Conclusion: A dityrosine network influences persistence of Lyme disease pathogens. Significance: Knowledge of a Duox system in protein cross-linking may offer new strategies to disrupt pathogen life cycle. Ixodes scapularis ticks transmit a wide array of human and animal pathogens including Borrelia burgdorferi; however, how tick immune components influence the persistence of invading pathogens remains unknown. As originally demonstrated in Caenorhabditis elegans and later in Anopheles gambiae, we show here that an acellular gut barrier, resulting from the tyrosine cross-linking of the extracellular matrix, also exists in I. scapularis ticks. This dityrosine network (DTN) is dependent upon a dual oxidase (Duox), which is a member of the NADPH oxidase family. The Ixodes genome encodes for a single Duox and at least 16 potential peroxidase proteins, one of which, annotated as ISCW017368, together with Duox has been found to be indispensible for DTN formation. This barrier influences pathogen survival in the gut, as an impaired DTN in Doux knockdown or in specific peroxidase knockdown ticks, results in reduced levels of B. burgdorferi persistence within ticks. Absence of a complete DTN formation in knockdown ticks leads to the activation of specific tick innate immune pathway genes that potentially resulted in the reduction of spirochete levels. Together, these results highlighted the evolution of the DTN in a diverse set of arthropod vectors, including ticks, and its role in protecting invading pathogens like B. burgdorferi. Further understanding of the molecular basis of tick innate immune responses, vector-pathogen interaction, and their contributions in microbial persistence may help the development of new targets for disrupting the pathogen life cycle.
C1 [Yang, Xiuli; Smith, Alexis A.; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.
   [Yang, Xiuli; Smith, Alexis A.; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.
   [Williams, Mark S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
RP Pal, U (reprint author), Univ Maryland, Dept Vet Med, Bldg 795,Rm 1341, College Pk, MD 20742 USA.
EM upal@umd.edu
RI Pal, Utpal/I-5265-2015
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI080615]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant R01AI080615 (to U. P.).
CR Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552
   Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003
   Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09
   de Silva AM, 2009, FRONT BIOSCI-LANDMRK, V14, P3051, DOI 10.2741/3434
   Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052
   Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767
   Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132
   Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002
   Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje
   Ghigo D, 2006, NITRIC OXIDE-BIOL CH, V15, P148, DOI 10.1016/j.niox.2006.01.002
   Govind S, 2004, PLOS BIOL, V2, P1065, DOI 10.1371/journal.pbio.0020276
   Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311
   Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121
   Hynes WL, 2005, MED VET ENTOMOL, V19, P339, DOI 10.1111/j.1365-2915.2005.00579.x
   Kariu T., 2011, J VIS EXP, V48, P2544
   Kariu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078376
   Kopacek P, 2010, ADV EXP MED BIOL, V708, P137
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994
   Meitzler JL, 2010, J BIOL CHEM, V285, P40991, DOI 10.1074/jbc.M110.170902
   Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581
   MODOLELL M, 1994, IMMUNOL LETT, V40, P139, DOI 10.1016/0165-2478(94)90185-6
   Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x
   Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957
   MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253
   Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027
   Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2
   Pal U., 2010, BORRELIA MOL BIOL HO, P279
   PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352
   Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714
   Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005
   Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2
   Sonenshine D.E., 1993, BIOL TICKS
   Sonenshine DE, 2005, EXP APPL ACAROL, V36, P207, DOI 10.1007/s10493-005-2564-0
   Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7
   Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207
   Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006
   Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06
   Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200
   Tyson KR, 2009, ADV INSECT PHYSIOL, V37, P243, DOI 10.1016/S0065-2806(09)37005-8
   Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302
   van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x
   Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326
   Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x
   ZHU Z, 1991, PARASITOL RES, V77, P635, DOI 10.1007/BF00931028
NR 45
TC 16
Z9 16
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 2
PY 2014
VL 289
IS 18
BP 12813
EP 12822
DI 10.1074/jbc.M113.538272
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AG7ER
UT WOS:000335581400050
PM 24662290
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Martiny, D
   Cremagnani, P
   Gaillard, A
   Deyi, VYM
   Mascart, G
   Ebraert, A
   Attalibi, S
   Dediste, A
   Vandenberg, O
AF Martiny, D.
   Cremagnani, P.
   Gaillard, A.
   Deyi, V. Y. Miendje
   Mascart, G.
   Ebraert, A.
   Attalibi, S.
   Dediste, A.
   Vandenberg, O.
TI Feasibility of matrix-assisted laser desorption/ionisation
   time-of-flight mass spectrometry (MALDI-TOF MS) networking in university
   hospitals in Brussels
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
ID DESORPTION-IONIZATION-TIME; ROUTINE IDENTIFICATION; CLINICAL
   MICROBIOLOGY; BACTERIA; SYSTEM; IMPACT; MANAGEMENT; REVOLUTION;
   ORGANISMS
AB The mutualisation of analytical platforms might be used to address rising healthcare costs. Our study aimed to evaluate the feasibility of networking a unique matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) system for common use in several university hospitals in Brussels, Belgium. During a one-month period, 1,055 successive bacterial isolates from the Brugmann University Hospital were identified on-site using conventional techniques; these same isolates were also identified using a MALDI-TOF MS system at the Porte de Hal Laboratory by sending target plates and identification projects via transportation and the INFECTIO_MALDI software (Infopartner, Nancy, France), respectively. The occurrence of transmission problems (< 2 %) and human errors (< 1 %) suggested that the system was sufficiently robust to be implemented in a network. With a median time-to-identification of 5 h and 11 min (78 min, min-max: 154-547), MALDI-TOF MS networking always provided a faster identification result than conventional techniques, except when chromogenic culture media and oxidase tests were used (p < 0.0001). However, the limited clinical benefits of the chromogenic culture media do not support their extra cost. Our financial analysis also suggested that MALDI-TOF MS networking could lead to substantial annual cost savings. MALDI-TOF MS networking presents many advantages, and few conventional techniques (optochin and oxidase tests) are required to ensure the same quality in patient care from the distant laboratory. Nevertheless, such networking should not be considered unless there is a reorganisation of workflow, efficient communication between teams, qualified technologists and a reliable IT department and helpdesk to manage potential connectivity problems.
C1 [Martiny, D.; Gaillard, A.; Deyi, V. Y. Miendje; Mascart, G.; Ebraert, A.; Attalibi, S.; Dediste, A.; Vandenberg, O.] Iris Brussels Publ Hosp Network, Dept Microbiol, Iris Lab, Brussels, Belgium.
   [Cremagnani, P.] Iris Brussels Publ Hosp Network, Dept Financial, Iris Lab, Brussels, Belgium.
   [Vandenberg, O.] Univ Libre Brussels, Sch Publ Hlth, Infect Dis Epidemiol Unit, Brussels, Belgium.
RP Martiny, D (reprint author), Iris Brussels Publ Hosp Network, Dept Microbiol, Iris Lab, Brussels, Belgium.
EM delphine_martiny@stpierre-bru.be
CR Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10
   Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x
   Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09
   Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204
   Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x
   Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10
   Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x
   Emonet S, 2011, EXPERT REV ANTI-INFE, V9, P707, DOI [10.1586/eri.11.84, 10.1586/ERI.11.84]
   Fagg KL, 1999, CLIN CHIM ACTA, V290, P73, DOI 10.1016/S0009-8981(99)00178-3
   Francis Diane, 2002, Clin Leadersh Manag Rev, V16, P293
   Humphreys H, 2010, EUR J CLIN MICROBIOL, V29, P617, DOI 10.1007/s10096-010-0906-2
   Ikryannikova LN, 2013, CLIN MICROBIOL INFEC, V19, P1066, DOI 10.1111/1469-0691.12113
   Martiny D, 2012, EUR J CLIN MICROBIOL, V31, P2269, DOI 10.1007/s10096-012-1566-1
   Martiny D, 2011, CLIN MICROBIOL INFEC, V17, P1001, DOI 10.1111/j.1469-0691.2010.03328.x
   Martiny D, 2013, CLIN MICROBIOL INFEC
   Martiny D, 2012, J CLIN MICROBIOL, V50, P1313, DOI 10.1128/JCM.05971-11
   Mellmann A, 2009, J CLIN MICROBIOL, V47, P3732, DOI 10.1128/JCM.00921-09
   Raoult D, 2004, NAT REV MICROBIOL, V2, P151, DOI 10.1038/nrmicro820
   Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10
   Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12
   TeKippe EM, 2013, J CLIN MICROBIOL, V51, P1421, DOI 10.1128/JCM.02680-12
   Van Herendael BH, 2012, EUR J CLIN MICROBIOL, V31, P841, DOI 10.1007/s10096-011-1383-y
   Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589
NR 25
TC 8
Z9 8
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD MAY
PY 2014
VL 33
IS 5
BP 745
EP 754
DI 10.1007/s10096-013-2006-6
PG 10
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA AF8AV
UT WOS:000334938300008
PM 24197439
DA 2020-05-07
ER

PT J
AU Laabei, M
   Recker, M
   Rudkin, JK
   Aldeljawi, M
   Gulay, Z
   Sloan, TJ
   Williams, P
   Endres, JL
   Bayles, KW
   Fey, PD
   Yajjala, VK
   Widhelm, T
   Hawkins, E
   Lewis, K
   Parfett, S
   Scowen, L
   Peacock, SJ
   Holden, M
   Wilson, D
   Read, TD
   van den Elsen, J
   Priest, NK
   Feil, EJ
   Hurst, LD
   Josefsson, E
   Massey, RC
AF Laabei, Maisem
   Recker, Mario
   Rudkin, Justine K.
   Aldeljawi, Mona
   Gulay, Zeynep
   Sloan, Tim J.
   Williams, Paul
   Endres, Jennifer L.
   Bayles, Kenneth W.
   Fey, Paul D.
   Yajjala, Vijaya Kumar
   Widhelm, Todd
   Hawkins, Erica
   Lewis, Katie
   Parfett, Sara
   Scowen, Lucy
   Peacock, Sharon J.
   Holden, Matthew
   Wilson, Daniel
   Read, Timothy D.
   van den Elsen, Jean
   Priest, Nicholas K.
   Feil, Edward J.
   Hurst, Laurence D.
   Josefsson, Elisabet
   Massey, Ruth C.
TI Predicting the virulence of MRSA from its genome sequence
SO GENOME RESEARCH
LA English
DT Article
ID RESISTANT STAPHYLOCOCCUS-AUREUS; IDENTIFICATION; EXPRESSION; EVOLUTION;
   GENE; BIOSYNTHESIS; MICROBIOLOGY; EMERGENCE; GENOTYPE; BIOLOGY
AB Microbial virulence is a complex and often multifactorial phenotype, intricately linked to a pathogen's evolutionary trajectory. Toxicity, the ability to destroy host cell membranes, and adhesion, the ability to adhere to human tissues, are the major virulence factors of many bacterial pathogens, including Staphylococcus aureus. Here, we assayed the toxicity and adhesiveness of 90 MRSA (methicillin resistant S. aureus) isolates and found that while there was remarkably little variation in adhesion, toxicity varied by over an order of magnitude between isolates, suggesting different evolutionary selection pressures acting on these two traits. We performed a genome-wide association study (GWAS) and identified a large number of loci, as well as a putative network of epistatically interacting loci, that significantly associated with toxicity. Despite this apparent complexity in toxicity regulation, a predictive model based on a set of significant single nucleotide polymorphisms (SNPs) and insertion and deletions events (indels) showed a high degree of accuracy in predicting an isolate's toxicity solely from the genetic signature at these sites. Our results thus highlight the potential of using sequence data to determine clinically relevant parameters and have further implications for understanding the microbial virulence of this opportunistic pathogen.
C1 [Laabei, Maisem; Rudkin, Justine K.; Aldeljawi, Mona; Hawkins, Erica; Lewis, Katie; Parfett, Sara; Scowen, Lucy; van den Elsen, Jean; Priest, Nicholas K.; Feil, Edward J.; Hurst, Laurence D.; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
   [Recker, Mario] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England.
   [Gulay, Zeynep] Dokuz Eylul Univ, Sch Med, Dept Clin Microbiol, TR-35210 Konak, Turkey.
   [Sloan, Tim J.; Williams, Paul] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England.
   [Endres, Jennifer L.; Bayles, Kenneth W.; Fey, Paul D.; Yajjala, Vijaya Kumar; Widhelm, Todd] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.
   [Holden, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Wilson, Daniel] Univ Oxford, Nuffield Dept Med, Oxford 0X3 7BN, England.
   [Read, Timothy D.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.
   [Josefsson, Elisabet] Univ Gothenburg, Dept Rheumatol & Inflammat Res, S-40530 Gothenburg, Sweden.
RP Massey, RC (reprint author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
EM r.c.massey@bath.ac.uk
RI van den Elsen, Jean/D-9274-2011; Holden, Matthew TG/K-6449-2014; Rudkin,
   Justine/AAA-4390-2020; Williams, Paul/P-5224-2019; Wilson, Daniel
   J/AAE-8975-2019; Hurst, Laurence D/F-9215-2010
OI Holden, Matthew TG/0000-0002-4958-2166; Rudkin,
   Justine/0000-0002-3044-0459; Williams, Paul/0000-0002-1920-5036; Wilson,
   Daniel J/0000-0002-0940-3311; Hurst, Laurence D/0000-0002-1002-1054;
   Priest, Nicholas/0000-0002-8253-2697; Massey, Ruth/0000-0002-8154-4039;
   van den Elsen, Jean/0000-0002-0367-1956; Laabei,
   Maisem/0000-0002-8425-3704; Recker, Mario/0000-0001-9489-1315; Sloan,
   Tim/0000-0003-3668-7775
FU EC-FP7European Union (EU) [245500]; BBSRCBiotechnology and Biological
   Sciences Research Council (BBSRC); Royal Society University
   FellowshipRoyal Society of London; Medical Research CouncilMedical
   Research Council UK (MRC) [G1000803, G9219778, G1000362]; National
   Institute for Health ResearchNational Institute for Health Research
   (NIHR) [435]
FX The authors acknowledge financial support via the EC-FP7 program no.
   245500 and the BBSRC. M.R. has a Royal Society University Fellowship.
CR Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06
   Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x
   Beltrao P, 2012, ADV EXP MED BIOL, V751, P139, DOI 10.1007/978-1-4614-3567-9_7
   Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272
   Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Castillo-Ramirez S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r126
   Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129
   Collins J, 2008, J CLIN MICROBIOL, V46, P2112, DOI 10.1128/JCM.00156-08
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226
   Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964
   Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124
   Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747
   Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12
   FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591
   Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2
   Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112
   Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09
   Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001
   Hurdle JG, 2004, ANTIMICROB AGENTS CH, V48, P4366, DOI 10.1128/AAC.48.11.4366-4376.2004
   Jelier R, 2011, NAT GENET, V43, P1270, DOI 10.1038/ng.1007
   Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018
   Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055
   Josefsson E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002206
   Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344
   Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824
   Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910
   Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355
   Kyburz A, 2010, BIOMOL NMR ASSIGN, V4, P235, DOI 10.1007/s12104-010-9249-2
   Laabei M, 2012, PEDIATR INFECT DIS J, V31, pE73, DOI 10.1097/INF.0b013e3182493b21
   Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692
   Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109
   McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000
   Mijts BN, 2005, CHEM BIOL, V12, P453, DOI 10.1016/j.chembiol.2005.02.010
   Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442
   Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640
   Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997
   Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309
   Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230
   Priest NK, 2012, NAT REV MICROBIOL, V10, P791, DOI 10.1038/nrmicro2880
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Qian ZL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-74
   Rudkin JK, 2012, J INFECT DIS, V205, P798, DOI 10.1093/infdis/jir845
   Ruzin A, 2001, MOL MICROBIOL, V41, P365, DOI 10.1046/j.1365-2958.2001.02488.x
   Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110
   Sherry NL, 2013, J CLIN MICROBIOL, V51, P1396, DOI 10.1128/JCM.03332-12
   Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034
   Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3
   Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109
NR 56
TC 81
Z9 85
U1 1
U2 50
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD MAY
PY 2014
VL 24
IS 5
BP 839
EP 849
DI 10.1101/gr.165415.113
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA AG4CA
UT WOS:000335365600013
PM 24717264
OA Green Published, Bronze, Other Gold
DA 2020-05-07
ER

PT J
AU Pfeiffer, CD
   Cunningham, MC
   Poissant, T
   Furuno, JP
   Townes, JM
   Leitz, A
   Thomas, A
   Buser, GL
   Arao, RF
   Beldavs, ZG
AF Pfeiffer, Christopher D.
   Cunningham, Margaret C.
   Poissant, Tasha
   Furuno, Jon P.
   Townes, John M.
   Leitz, Andrew
   Thomas, Ann
   Buser, Genevieve L.
   Arao, Robert F.
   Beldavs, Zintars G.
TI Establishment of a Statewide Network for Carbapenem-Resistant
   Enterobacteriaceae Prevention in a Low-Incidence Region
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID TERM-CARE FACILITIES; KLEBSIELLA-PNEUMONIAE; INFECTION PREVENTION;
   SPREAD; EMERGENCE
AB Objective.To establish a statewide network to detect, control, and prevent the spread of carbapenem-resistant Enterobacteriaceae (CRE) in a region with a low incidence of CRE infection.Design.Implementation of the Drug Resistant Organism Prevention and Coordinated Regional Epidemiology (DROP-CRE) Network.Setting and participants.Oregon infection prevention and microbiology laboratory personnel, including 48 microbiology laboratories, 62 acute care facilities, and 140 long-term care facilities.Methods.The DROP-CRE working group, comprising representatives from academic institutions and public health, convened an interdisciplinary advisory committee to assist with planning and implementation of CRE epidemiology and control efforts. The working group established a statewide CRE definition and surveillance plan; increased the state laboratory capacity to perform the modified Hodge test and polymerase chain reaction for carbapenemases in real time; and administered surveys that assessed the needs and capabilities of Oregon infection prevention and laboratory personnel. Results of these inquiries informed CRE education and the response plan.Results.Of 60 CRE reported from November 2010 through April 2013, only 3 were identified as carbapenemase producers; the cases were not linked, and no secondary transmission was found. Microbiology laboratories, acute care facilities, and long-term care facilities reported lacking carbapenemase testing capability, reliable interfacility communication, and CRE awareness, respectively. Survey findings informed the creation of the Oregon CRE Toolkit, a state-specific CRE guide booklet.Conclusions.A regional epidemiology surveillance and response network has been implemented in Oregon in advance of widespread CRE transmission. Prospective surveillance will determine whether this collaborative approach will be successful at forestalling the emergence of this important healthcare-associated pathogen.
C1 [Pfeiffer, Christopher D.; Townes, John M.] Portland VA Med Ctr, Dept Hosp & Specialty Med, Portland, OR 97239 USA.
   [Pfeiffer, Christopher D.; Leitz, Andrew] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA.
   [Cunningham, Margaret C.; Poissant, Tasha; Thomas, Ann; Buser, Genevieve L.; Arao, Robert F.; Beldavs, Zintars G.] Oregon Hlth Author, Oregon Publ Hlth Div, Portland, OR USA.
   [Furuno, Jon P.] Oregon Hlth & Sci Univ, Oregon State Univ, Coll Pharm, Portland, OR 97201 USA.
RP Pfeiffer, CD (reprint author), Portland VA Med Ctr, POB 1034 P3 ID, Portland, OR 97239 USA.
EM pfeiffec@ohsu.edu
OI Poissant, Tasha/0000-0003-4407-272X
FU Centers for Disease Control and Prevention Epidemiology and Laboratory
   Capacity Program through the Affordable Care ActUnited States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
FX Financial support. This work was funded by a cooperative agreement with
   Centers for Disease Control and Prevention Epidemiology and Laboratory
   Capacity Program through the Affordable Care Act.
CR Barnes SL, 2011, INFECT CONT HOSP EP, V32, P1073, DOI 10.1086/662375
   Centers for Disease Control and Prevention, LONG TERM CAR ASS TO
   Centers or Disease Control and Prevention, GUID CONTR CARB RES
   CLSI: Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLSI
   Council of State and Territorial Epidemiologists, 2013, COMM POSS HEALTHC AS
   Gamage B, 2012, AM J INFECT CONTROL, V40, P150, DOI 10.1016/j.ajic.2011.03.026
   Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655
   Oregon Health Authority, GUID CONTR CARB RES
   Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412
   Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048
   Roup BJ, 2006, AM J INFECT CONTROL, V34, P122, DOI 10.1016/j.ajic.2005.12.010
   Roup BJ, 2011, AM J INFECT CONTROL, V39, P292, DOI 10.1016/j.ajic.2010.09.004
   Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025
   Smith DL, 2004, P NATL ACAD SCI USA, V101, P3709, DOI 10.1073/pnas.0400456101
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   The Joint Commission, 2013, IC8IC9 JOINT COMM RE, pIC
   Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482
   Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001
NR 19
TC 13
Z9 13
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD APR 1
PY 2014
VL 35
IS 4
SI SI
BP 356
EP 361
DI 10.1086/675605
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AC2DP
UT WOS:000332308400005
PM 24602939
DA 2020-05-07
ER

PT J
AU Drees, M
   Pineles, L
   Harris, AD
   Morgan, DJ
AF Drees, Marci
   Pineles, Lisa
   Harris, Anthony D.
   Morgan, Daniel J.
TI Variation in Definitions and Isolation Procedures for
   Multidrug-Resistant Gram-Negative Bacteria: A Survey of the Society for
   Healthcare Epidemiology of America Research Network
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID COLONIZATION; INFECTIONS; SETTINGS
AB Objective.To assess definitions, experience, and infection control practices for multidrug-resistant gram-negative bacteria (MDR-GNB), including Enterobacteriaceae, Acinetobacter, and Pseudomonas species, in acute care hospitals.Design.Cross-sectional survey.Participants.US and international members of the Society for Healthcare Epidemiology of America (SHEA) Research Network.Methods.Online survey that included definitions, infection control procedures, and microbiology capability related to MDR-GNB and other MDR bacteria.Results.From November 2012 through February 2013, 66 of 170 SHEA Research Network members responded (39% response rate), representing 26 states and 15 countries. More than 80% of facilities reported experience with each MDR-GNB isolate, and 78% had encountered GNB resistant to all antibiotics except colistin (62% Acinetobacter, 59% Pseudomonas, and 52% Enterobacteriaceae species). Participants varied regarding their definitions of multidrug resistant, with 14 unique definitions for Acinetobacter, 18 for Pseudomonas, and 22 for Enterobacteriaceae species. Substantial variation also existed in isolation practices. Although isolation was commonly used for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and carbapenem-resistant Enterobacteriaceae (CRE), approximately 20% of facilities did not isolate for MDR Pseudomonas or Acinetobacter. The majority of those that isolated MDR organisms also removed isolation using a wide variety of criteria.Conclusion.Facilities vary significantly in their approach to preventing MDR-GNB transmission. Although practices for MRSA and VRE are relatively standardized, emerging pathogens CRE and other MDR-GNB have highly varied definitions and management. This confusion makes communication difficult, and varied use of isolation may contribute to emergence of these organisms. Public health agencies need to promote standard definitions and management to enable broader initiatives to limit emergence of MDR-GNB.
C1 [Drees, Marci] Christiana Care Hlth Syst, Dept Med, Wilmington, DE USA.
   [Drees, Marci] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA.
   [Pineles, Lisa; Harris, Anthony D.; Morgan, Daniel J.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Morgan, Daniel J.] Vet Affairs Maryland Healthcare Syst, Baltimore, MD USA.
RP Drees, M (reprint author), Christiana Care Hlth Syst, 4755 Ogletown Stanton Rd,Suite 2E70,POB 6001, Newark, DE 19718 USA.
EM mdrees@christianacare.org
OI Pineles, Lisa/0000-0002-2377-5971
FU Society for Healthcare Epidemiology of America (SHEA); SHEA Research
   Network; Agency for Healthcare Research on Quality [K08 HS18111]
FX We thank the Society for Healthcare Epidemiology of America (SHEA) and
   the SHEA Research Network for their support of this study and for their
   participation.; Financial support. This study was supported financially
   by the Society for Healthcare Epidemiology of America (SHEA). D.J.M. was
   supported by grant K08 HS18111 from the Agency for Healthcare Research
   on Quality.
CR Baden LR, 2001, CLIN INFECT DIS, V33, P1654, DOI 10.1086/323762
   Centers for Disease Control and Prevention, 2012 CRE TOOLK GUID
   Clinical and Laboratory Standards Institute (CLSI), 2010, M100S23 CLSI
   Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359
   Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169
   Lledo W., 2009, Morbidity and Mortality Weekly Report, V58, P256
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   Morgan DJ, 2012, CLIN INFECT DIS, V55, P923, DOI 10.1093/cid/cis556
   Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741
   Nicasio AM, 2008, PHARMACOTHERAPY, V28, P235, DOI 10.1592/phco.28.2.235
   Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013
   Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006
NR 14
TC 23
Z9 23
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD APR 1
PY 2014
VL 35
IS 4
SI SI
BP 362
EP 366
DI 10.1086/675600
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AC2DP
UT WOS:000332308400006
PM 24602940
DA 2020-05-07
ER

PT J
AU Marcoux, PR
   Dupoy, M
   Cuer, A
   Kodja, JL
   Lefebvre, A
   Licari, F
   Louvet, R
   Narassiguin, A
   Mallard, F
AF Marcoux, Pierre R.
   Dupoy, Mathieu
   Cuer, Antoine
   Kodja, Joe-Loic
   Lefebvre, Arthur
   Licari, Florian
   Louvet, Robin
   Narassiguin, Anil
   Mallard, Frederic
TI Optical forward-scattering for identification of bacteria within
   microcolonies
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Bacteria; Identification; Forward-scattering; Label-free; Microcolonies;
   Non-invasive technique
ID RESISTANT STAPHYLOCOCCUS-AUREUS; FAST COMPUTATION; LIGHT; PATTERNS;
   COLONIES
AB The development of methods for the rapid identification of pathogenic bacteria is a major step towards accelerated clinical diagnosis of infectious diseases and efficient food and water safety control. Methods for identification of bacterial colonies on gelified nutrient broth have the potential to bring an attractive solution, combining simple optical instrumentation, no need for sample preparation or labelling, in a non-destructive process. Here, we studied the possibility of discriminating different bacterial species at a very early stage of growth (6 h of incubation at 37 degrees C), on thin layers of agar media (1 mm of Tryptic Soy Agar), using light forward-scattering and learning algorithms (Bayes Network, Continuous Naive Bayes, Sequential Minimal Optimisation). A first database of more than 1,000 scatterograms acquired on 7 gram-negative strains yielded a recognition rate of nearly 80 %, after only 6 h of incubation. We investigated also the prospect of identifying different strains from a same species through forward scattering. We discriminated, thus, four strains of Escherichia coli with a recognition rate reaching 82 %. Finally, we show the discrimination of two species of coagulase-negative Staphylococci (S. haemolyticus and S. cohnii), on a commercial selective pre-poured medium used in clinical diagnosis (ChromID MRSA, bioMerieux), without opening lids during the scatterogram acquisition. This shows the potential of this method-non-invasive, preventing cross-contaminations and requiring minimal dish handling-to provide early clinically-relevant information in the context of fully automated microbiology labs.
C1 [Marcoux, Pierre R.; Dupoy, Mathieu] CEA LETI, MINATEC, Dept Technol Biol & Healthcare, F-38054 Grenoble, France.
   [Cuer, Antoine; Kodja, Joe-Loic; Lefebvre, Arthur; Licari, Florian; Louvet, Robin; Narassiguin, Anil] Ecole Cent Lyon, F-69134 Ecully, France.
   [Mallard, Frederic] BioMerieux SA, Sample Prep & Proc Lab, Innovat & Syst Technol Res, F-38000 Grenoble, France.
RP Marcoux, PR (reprint author), CEA LETI, MINATEC, Dept Technol Biol & Healthcare, 17 Ave Martyrs, F-38054 Grenoble, France.
EM pierre.marcoux@cea.fr
RI Marcoux, Pierre/A-5877-2009
OI Marcoux, Pierre/0000-0003-3855-9662; MALLARD,
   Frederic/0000-0002-9706-403X
CR Bae E, 2011, BIOTECHNOL BIOENG, V108, P637, DOI 10.1002/bit.22980
   Bae EW, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/015802
   Bae E, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2830655
   Banada PP, 2007, BIOSENS BIOELECTRON, V22, P1664, DOI 10.1016/j.bios.2006.07.028
   Banada PP, 2009, BIOSENS BIOELECTRON, V24, P1685, DOI 10.1016/j.bios.2008.08.053
   Bayraktar B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203987
   Buzalewicz I, 2011, OPT EXPRESS, V19, P21768, DOI 10.1364/OE.19.021768
   Citti G, 2013, ZERNIKE POLYNOMIALS
   COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110
   Forbes BA, 2007, BAILEY SCOTTS DIAGNO, P324
   Fox A, 2006, J CLIN MICROBIOL, V44, P2677, DOI 10.1128/JCM.00971-06
   Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361
   Gazin M, 2012, EUR J CLIN MICROBIOL, V31, P1765, DOI 10.1007/s10096-011-1499-0
   Goodacre R, 2003, VIB SPECTROSC, V32, P33, DOI 10.1016/S0924-2031(03)00045-6
   Gu J, 2002, PATTERN RECOGN, V35, P2905, DOI 10.1016/S0031-3203(01)00194-7
   Haavig DL, 2002, US Patent, Patent No. [US2002/0186372A1, 20020186372A1]
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278
   Huang WE, 2010, ADV APPL MICROBIOL, V70, P153, DOI 10.1016/S0065-2164(10)70005-8
   Hwang SK, 2006, PATTERN RECOGN, V39, P2065, DOI 10.1016/j.patcog.2006.03.004
   LANGLEY P, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P223
   Lesne A, 2011, SHANNON ENTROPY RIGO
   Martins A, 2007, MICROBIOL IMMUNOL, V51, P787, DOI 10.1111/j.1348-0421.2007.tb03968.x
   Morris K, 2012, J HOSP INFECT, V81, P20, DOI 10.1016/j.jhin.2012.02.003
   Platt J., 1998, ADV KERNEL METHODS S
   Rakotomalala R., 2005, ACTES EGC 2005 RNTI, V2, P697
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Singh C, 2010, PATTERN RECOGN, V43, P2497, DOI 10.1016/j.patcog.2010.02.005
   Van Hoecke F, 2011, EUR J CLIN MICROBIOL, V30, P1595, DOI 10.1007/s10096-011-1265-3
   Vinh DC, 2006, J CLIN MICROBIOL, V44, P4623, DOI 10.1128/JCM.01764-06
   Wee CY, 2006, PATTERN RECOGN, V39, P2036, DOI 10.1016/j.patcog.2006.05.027
   Willemse-Erix DFM, 2009, J CLIN MICROBIOL, V47, P652, DOI 10.1128/JCM.01900-08
   Witten IH, 2011, MOR KAUF D, P1
NR 33
TC 9
Z9 9
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2014
VL 98
IS 5
BP 2243
EP 2254
DI 10.1007/s00253-013-5495-4
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AB9JB
UT WOS:000332107700029
PM 24413976
DA 2020-05-07
ER

PT J
AU Schwaber, MJ
   Carmeli, Y
AF Schwaber, Mitchell J.
   Carmeli, Yehuda
TI An Ongoing National Intervention to Contain the Spread of
   Carbapenem-Resistant Enterobacteriaceae
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE carbapenem-resistant Enterobacteriaceae; Klebsiella pneumoniae;
   outbreak; intervention
ID KLEBSIELLA-PNEUMONIAE; OXA-48-PRODUCING ENTEROBACTERIACEAE; ISRAELI
   HOSPITALS; UNITED-STATES; OUTBREAK; PREDICTORS; CARRIAGE; STRAIN
AB In 2007, the Israel Ministry of Health initiated a nationwide intervention aimed at containing the spread of carbapenem-resistant Enterobacteriaceae (CRE), primarily manifested by the rapid dissemination of a single clone of Klebsiella pneumoniae. Data were gathered from acute and long-term care facilities, and ward-based mandatory guidelines for carrier isolation, patient and staff cohorting, and active surveillance were issued. Guidelines were issued to the microbiology laboratories delineating procedures for identifying CRE and carbapenemase production. A protocol for ruling out continued carriage in known carriers was established. Compliance with national guidelines was overseen via site visits at healthcare facilities, routine reporting of carrier census and isolation status, and the establishment of a network of communications to facilitate reporting on identified carriage, contact tracing and screening, and outbreak investigations. During the intervention, nosocomial CRE acquisition in acute care declined from a monthly high of 55.5 to an annual low of 4.8 cases per 100 000 patient-days (P < .001).
C1 [Schwaber, Mitchell J.; Carmeli, Yehuda] Natl Ctr Infect Control, IL-6423906 Tel Aviv, Israel.
RP Schwaber, MJ (reprint author), Natl Ctr Infect Control, 6 Weizmann St, IL-6423906 Tel Aviv, Israel.
EM mitchells@tlvmc.gov.il
RI Schwaber, Mitchell/AAI-2486-2019
CR Adler A, 2013, J CLIN MICROBIOL, V51, P2926, DOI 10.1128/JCM.01049-13
   Adler A, 2011, J ANTIMICROB CHEMOTH, V66, P2763, DOI 10.1093/jac/dkr382
   Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x
   Ben-David D, 2012, 52 INT C ANT AG CHEM
   Ben-David D, 2011, INFECT CONT HOSP EP, V32, P845, DOI 10.1086/661279
   Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528
   Borer A, 2011, INFECT CONT HOSP EP, V32, P1158, DOI 10.1086/662620
   Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922
   Ciobotaro P, 2011, AM J INFECT CONTROL, V39, P671, DOI 10.1016/j.ajic.2011.05.004
   Cohen MJ, 2011, INFECT CONT HOSP EP, V32, P673, DOI 10.1086/660358
   European Antimicrobial Resistance Surveillance System, ANN REP 2007
   Feldman N, 2013, CLIN MICROBIOL INFEC, V19, pE190, DOI 10.1111/1469-0691.12099
   Feldman N, 2009, 49 INT C ANT AG CHEM
   Gefen-Halevi S, 2013, J CLIN MICROBIOL, V51, P1642, DOI 10.1128/JCM.00381-13
   Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2
   Navon-Venezia S, 2009, ANTIMICROB AGENTS CH, V53, P818, DOI 10.1128/AAC.00987-08
   Schechner V, 2011, INFECT CONT HOSP EP, V32, P497, DOI 10.1086/659762
   Schechner V, 2009, J CLIN MICROBIOL, V47, P3261, DOI 10.1128/JCM.02368-08
   Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07
   Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025
   Wiener-Well Y, 2010, J HOSP INFECT, V74, P344, DOI 10.1016/j.jhin.2009.07.022
NR 22
TC 121
Z9 127
U1 0
U2 22
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2014
VL 58
IS 5
BP 697
EP 703
DI 10.1093/cid/cit795
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AB5RR
UT WOS:000331846700020
PM 24304707
DA 2020-05-07
ER

PT J
AU Petrus, MLC
   van Veluw, GJ
   Wosten, HAB
   Claessen, D
AF Petrus, Marloes L. C.
   van Veluw, G. Jerre
   Woesten, Han A. B.
   Claessen, Dennis
TI Sorting of Streptomyces Cell Pellets Using a Complex Object Parametric
   Analyzer and Sorter
SO Jove-Journal of Visualized Experiments
LA English
DT Article
DE Microbiology; Issue 84; Streptomyces; flow cytometry; pellets;
   morphology; fluorescence; COPAS; biotechnology; high-throughput
   analysis; sorting; heterogeneity
ID FLOW-CYTOMETRY
AB Streptomycetes are filamentous soil bacteria that are used in industry for the production of enzymes and antibiotics. When grown in bioreactors, these organisms form networks of interconnected hyphae, known as pellets, which are heterogeneous in size. Here we describe a method to analyze and sort mycelial pellets using a Complex Object Parametric Analyzer and Sorter (COPAS). Detailed instructions are given for the use of the instrument and the basic statistical analysis of the data. We furthermore describe how pellets can be sorted according to user-defined settings, which enables downstream processing such as the analysis of the RNA or protein content. Using this methodology the mechanism underlying heterogeneous growth can be tackled. This will be instrumental for improving streptomycetes as a cell factory, considering the fact that productivity correlates with pellet size.
C1 [Petrus, Marloes L. C.; Claessen, Dennis] Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands.
   [van Veluw, G. Jerre; Woesten, Han A. B.] Univ Utrecht, Kluyver Ctr Genom Ind Fermentat, NL-3508 TC Utrecht, Netherlands.
RP Claessen, D (reprint author), Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands.
EM d.claessen@biology.leidenuniv.nl
RI Claessen, Dennis/J-1903-2014
OI Claessen, Dennis/0000-0002-0789-2633
CR Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028
   Bell PJL, 1998, APPL ENVIRON MICROB, V64, P1669
   BETZ JW, 1984, CYTOMETRY, V5, P145, DOI 10.1002/cyto.990050208
   Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961
   Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779
   Davey Hazel M., 2003, Current Issues in Molecular Biology, V5, P9
   de Bekker C, 2011, APPL ENVIRON MICROB, V77, P1263, DOI 10.1128/AEM.02134-10
   Hopwood D. A., 2007, STREPTOMYCES NATURE
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Pulak Rock, 2006, V351, P275
   REICHL U, 1992, BIOTECHNOL BIOENG, V39, P164, DOI 10.1002/bit.260390207
   van Veluw GJ, 2013, STUD MYCOL, P47, DOI 10.3114/sim0008
   van Veluw GJ, 2012, APPL MICROBIOL BIOT, V96, P1301, DOI 10.1007/s00253-012-4490-5
   van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a
   Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002
   Vinck A, 2005, MOL MICROBIOL, V58, P693, DOI 10.1111/j.1365-2958.2005.04869.x
NR 16
TC 6
Z9 7
U1 0
U2 4
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2014
IS 84
AR e51178
DI 10.3791/51178
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA0JL
UT WOS:000348604100048
PM 24561666
OA Green Published, Bronze
DA 2020-05-07
ER

PT S
AU Jorge, P
   Pereira, MO
   Lourenco, A
AF Jorge, Paula
   Pereira, Maria Olivia
   Lourenco, Analia
BE SaezRodriguez, J
   Rocha, MP
   FdezRiverola, F
   Santana, JFD
TI Networking the Way towards Antimicrobial Combination Therapies
SO 8TH INTERNATIONAL CONFERENCE ON PRACTICAL APPLICATIONS OF COMPUTATIONAL
   BIOLOGY & BIOINFORMATICS (PACBB 2014)
SE Advances in Intelligent Systems and Computing
LA English
DT Proceedings Paper
CT 8th International Conference on Practical Applications of Computational
   Biology & Bioinformatics (PACBB)
CY JUN 04-06, 2014
CL Univ Salamanca, Salamanca, SPAIN
SP Telefonica Digital, Indra, Ingn Software Avanzado S A, IBM, IEEE Syst Man & Cybernet Soc Spain, Asociac Espanola Para Inteligencia Artificial, Associacao Portuguesa Para Inteligencia Artificial, Ctr Natl Rech Scientifique, Unive Salamanca, Bioinformat Intelligent Syst & Educ Technol Res Grp, Univ Vigo, Next Generat Comp Syst Grp
HO Univ Salamanca
DE Antimicrobial peptides; drug synergism; interaction network; Pseudomonas
   aeruginosa infections
ID DRUG-INTERACTIONS; INFECTIONS
AB The exploration of new antimicrobial combinations is a pressing concern for Clinical Microbiology due to the growing number of resistant strains emerging in healthcare settings and in the general community. Researchers are screening agents with alternative modes of action and interest is rising for the potential of antimicrobial peptides (AMPs). This work presents the first ever network reconstruction of AMP combinations reported in the literature fighting Pseudomonas aeruginosa infections. The network, containing 193 combinations of AMPs with 39 AMPs and 154 traditional antibiotics, is expected to help in the design of new studies, notably by unveiling different mechanisms of action and helping in the prediction of new combinations and synergisms. The challenges faced in the attempted text-mining approaches and other considerations regarding the manual curation of the data are pointed out, reflecting about the future automation of this type of reconstruction as means to widen the scope of analysis.
C1 [Jorge, Paula; Pereira, Maria Olivia; Lourenco, Analia] Univ Minho, Ctr Biol Engn, P-4710057 Braga, Portugal.
   [Lourenco, Analia] Univ Vigo, ESEI Escuela Super Ingn Informat, Orense 32004, Spain.
RP Jorge, P (reprint author), Univ Minho, Ctr Biol Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM paulajorge@ceb.uminho.pt; mopereira@deb.uminho.pt; analia@ceb.uminho.pt
RI Lourenco, Analia/Y-9447-2019; Lourenco, Analia/G-8879-2013; Jorge,
   Paula/L-6576-2018; Pereira, Maria Olivia/O-4859-2015
OI Lourenco, Analia/0000-0001-8401-5362; Lourenco,
   Analia/0000-0001-8401-5362; Jorge, Paula/0000-0002-0094-7830; Pereira,
   Maria Olivia/0000-0002-4307-3985
CR Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147
   Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007
   Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007
   Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210
   Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1
   Percha B, 2013, TRENDS PHARMACOL SCI, V34, P178, DOI 10.1016/j.tips.2013.01.006
   Saiman L, 2007, PAEDIATR RESPIR REV, V8, P249, DOI 10.1016/j.prrv.2007.04.006
   Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441
   Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0
   Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133
NR 11
TC 3
Z9 3
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2194-5357
BN 978-3-319-07581-5; 978-3-319-07580-8
J9 ADV INTELL SYST
PY 2014
VL 294
BP 201
EP 206
DI 10.1007/978-3-319-07581-5_24
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA BC2RI
UT WOS:000351276700024
DA 2020-05-07
ER

PT J
AU Harron, K
   Goldstein, H
   Wade, A
   Muller-Pebody, B
   Parslow, R
   Gilbert, R
AF Harron, Katie
   Goldstein, Harvey
   Wade, Angie
   Muller-Pebody, Berit
   Parslow, Roger
   Gilbert, Ruth
TI Linkage, Evaluation and Analysis of National Electronic Healthcare Data:
   Application to Providing Enhanced Blood-Stream Infection Surveillance in
   Paediatric Intensive Care
SO PLOS ONE
LA English
DT Article
ID RECORD LINKAGE
AB Background: Linkage of risk-factor data for blood-stream infection (BSI) in paediatric intensive care (PICU) with bacteraemia surveillance data to monitor risk-adjusted infection rates in PICU is complicated by a lack of unique identifiers and under-ascertainment in the national surveillance system. We linked, evaluated and performed preliminary analyses on these data to provide a practical guide on the steps required to handle linkage of such complex data sources.
   Methods: Data on PICU admissions in England and Wales for 2003-2010 were extracted from the Paediatric Intensive Care Audit Network. Records of all positive isolates from blood cultures taken for children <16 years and captured by the national voluntary laboratory surveillance system for 2003-2010 were extracted from the Public Health England database, LabBase2. "Gold-standard" datasets with unique identifiers were obtained directly from three laboratories, containing microbiology reports that were eligible for submission to LabBase2 (defined as "clinically significant" by laboratory microbiologists). Reports in the gold-standard datasets were compared to those in LabBase2 to estimate ascertainment in LabBase2. Linkage evaluated by comparing results from two classification methods (highest-weight classification of match weights and prior-informed imputation using match probabilities) with linked records in the gold-standard data. BSI rate was estimated as the proportion of admissions associated with at least one BSI.
   Results: Reporting gaps were identified in 548/2596 lab-months of LabBase2. Ascertainment of clinically significant BSI in the remaining months was approximately 80-95%. Prior-informed imputation provided the least biased estimate of BSI rate (5.8% of admissions). Adjusting for ascertainment, the estimated BSI rate was 6.1-7.3%.
   Conclusion: Linkage of PICU admission data with national BSI surveillance provides the opportunity for enhanced surveillance but analyses based on these data need to take account of biases due to ascertainment and linkage error. This study provides a generalisable guide for linkage, evaluation and analysis of complex electronic healthcare data.
C1 [Harron, Katie; Goldstein, Harvey; Wade, Angie; Gilbert, Ruth] UCL, Inst Child Hlth, London, England.
   [Goldstein, Harvey] Univ Bristol, Grad Sch Educ, Bristol, Avon, England.
   [Muller-Pebody, Berit] Publ Hlth England, Healthcare Associated Infect & Antimicrobial Resi, London, England.
   [Parslow, Roger] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England.
RP Harron, K (reprint author), UCL, Inst Child Hlth, London, England.
EM Katie.harron.10@ucl.ac.uk
OI Gilbert, Ruth/0000-0001-9347-2709; Muller-Pebody,
   Berit/0000-0002-8874-480X; Parslow, Roger/0000-0002-3945-5294;
   Goldstein, Harvey/0000-0003-3878-4122; Harron, Katie/0000-0002-3418-2856
FU National Institute for Health Research Health Technology Assessment
   (NIHR HTA) programmeNational Institute for Health Research (NIHR)
   [08/13/47]; National Clinical Audit and Patient Outcomes Programme via
   Healthcare Quality Improvement Partnership (HQIP); Health Commission
   Wales Specialised Services; NHS Lothian / National Service Division NHS
   Scotland; Royal Belfast Hospital for Sick Children; Our Lady's
   Children's Hospital, Crumlin; Children's University Hospital, Temple
   Street; Harley Street Clinic, London
FX This work was supported by funding from the National Institute for
   Health Research Health Technology Assessment (NIHR HTA) programme
   [project number 08/13/47]. The views and opinions expressed therein are
   those of the authors and do not necessarily reflect those of the HTA
   programme, NIHR, NHS or the Department of Health. PICANet is funded by
   the National Clinical Audit and Patient Outcomes Programme via
   Healthcare Quality Improvement Partnership (HQIP), Health Commission
   Wales Specialised Services, NHS Lothian / National Service Division NHS
   Scotland, the Royal Belfast Hospital for Sick Children, Our Lady's
   Children's Hospital, Crumlin, Children's University Hospital, Temple
   Street and The Harley Street Clinic, London. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alvarez LG, 2011, J HOSP INFECT, V79, P231, DOI 10.1016/j.jhin.2011.06.016
   Bohensky MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-346
   Charlton CMJ, 2012, STATJR SOFTWARE
   Clark DE, 2004, INJURY PREV, V10, P186, DOI 10.1136/ip.2003.004580
   DuVall SL, 2010, J BIOMED INFORM, V43, P24, DOI 10.1016/j.jbi.2009.08.004
   Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256
   FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061
   Ford JB, 2006, PAEDIATR PERINAT EP, V20, P329, DOI 10.1111/j.1365-3016.2006.00715.x
   Goldstein H, 2012, STAT MED, V31, P3481, DOI 10.1002/sim.5508
   Harron K, 2013, INTENS CARE MED, V39, P1080, DOI 10.1007/s00134-013-2841-z
   Harron K, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech-2012-201376
   JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510
   Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x
   Lariscy JT, 2011, J AGING HEALTH, V23, P1263, DOI 10.1177/0898264311421369
   Nosocomial Infection National Surveillance Service, 2007, SURV HOSP ACQ BACT E, P1997
   Pearson A, 2009, J ANTIMICROB CHEMOTH, V64, P11, DOI 10.1093/jac/dkp260
   Rubin D. B, 1987, MULTIPLE IMPUTATION
   Schmidlin K, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-1
   Universities of Leeds and Leicester, 2012, PAED INT CAR AUD NET
   Urrea M, 2003, PEDIATR INFECT DIS J, V22, P490, DOI 10.1097/00006454-200306000-00002
   Wilson J, 2011, CLIN MICROBIOL INFEC, V17, P451, DOI 10.1111/j.1469-0691.2010.03262.x
   Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481
NR 22
TC 23
Z9 24
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2013
VL 8
IS 12
AR e85278
DI 10.1371/journal.pone.0085278
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276IX
UT WOS:000328745100200
PM 24376874
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Kalra, L
   Camacho, F
   Whitener, CJ
   Du, P
   Miller, M
   Zalonis, C
   Julian, KG
AF Kalra, Lalit
   Camacho, Fabian
   Whitener, Cynthia J.
   Du, Ping
   Miller, Margaret
   Zalonis, Crystal
   Julian, Kathleen G.
TI Risk of methicillin-resistant Staphylococcus aureus surgical site
   infection in patients with nasal MRSA colonization
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Cohort studies; Nasal mucosa; Microbiology; Staphylococcal infections;
   Etiology; Prevention and control; Surgical wound infection
ID UNITED-STATES; PREVENTION; GUIDELINE; HOSPITALS
AB Background: Patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) are at increased risk for invasive infection compared with noncolonized patients; however, the magnitude of risk for MRSA surgical site infection (SSI) is unclear. To aid in planning of infection prevention strategies, we sought to assess the incidence of MRSA SSI in MRSA carriers.
   Methods: We conducted a retrospective cohort study at our tertiary care center of inpatients who underwent MRSA polymerase chain reaction (PCR) screen of the nares within 30 days before a National Healthcare Safety Network principal procedure between April 2008 and July 2010.
   Results: The rate of MRSA SSI was 1.86% in the MRSA PCR-positive group (n=431) and 0.20% in the MRSA PCR-negative group (n=9432). Multivariate analysis identified MRSA PCR-positive status as an independent risk factor for MRSA SSI (odds ratio, 9.20; 95% confidence interval, 3.81-20.47; P<.0001); other risk factors included duration of surgery >= 137 minutes, American Society of Anesthesiologists score >= 3, and abdominal surgery.
   Conclusions: Surgical patients with a positive nasal MRSA PCR screen had a 9-fold greater odds of developing a subsequent MRSA SSI compared with patients with a negative nasal MRSA PCR screen. The incidence of MRSA SSI in PCR-positive patients was low (1.86%), however, and identifying subsets of patients at greatest risk for SSI may help target decolonization and other interventions. Copyright (C) 2013 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Kalra, Lalit; Whitener, Cynthia J.; Du, Ping; Zalonis, Crystal; Julian, Kathleen G.] Penn State Hershey Med Ctr, Div Infect Dis, Hershey, PA USA.
   [Camacho, Fabian; Du, Ping] Penn State Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA USA.
   [Miller, Margaret] Penn State Hershey Med Ctr, Infect Prevent Dept, Hershey, PA USA.
RP Julian, KG (reprint author), 500 Univ Dr,Mail Code H036, Hershey, PA 17033 USA.
EM kjulian@hmc.psu.edu
CR Akins PT, 2010, J NEUROSURG, V112, P354, DOI 10.3171/2009.5.JNS081589
   Anderson DJ, 2008, INFECT CONT HOSP EP, V29, pS51, DOI 10.1086/591064
   Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939
   Chlebicki MP, 2013, AM J INFECT CONTROL, V41, P167, DOI 10.1016/j.ajic.2012.02.014
   Cordova KB, 2010, DERMATOL SURG, V36, P1537, DOI 10.1111/j.1524-4725.2010.01678.x
   Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494
   Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362
   Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687
   Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474
   Kim DH, 2010, J BONE JOINT SURG AM, V92A, P1820, DOI 10.2106/JBJS.I.01050
   Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016
   Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213
   Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756
   RAGHUNATHAN T, 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186
   Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296
   Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034
   Scott R.D, DIRECT MED COSTS HEA
   Talbot T, 2009, PRINCIPLES PRACTICE, P3891
   Templ M, 2011, COMPUT STAT DATA AN, V55, P2793, DOI 10.1016/j.csda.2011.04.012
   Weigelt JA, 2010, AM J INFECT CONTROL, V38, P112, DOI 10.1016/j.ajic.2009.06.010
NR 22
TC 34
Z9 37
U1 0
U2 10
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD DEC
PY 2013
VL 41
IS 12
BP 1253
EP 1257
DI 10.1016/j.ajic.2013.05.021
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 259QA
UT WOS:000327540200022
PM 23973424
DA 2020-05-07
ER

PT J
AU Wu, XP
   Wang, SY
   Yu, Y
   Zhang, JY
   Sun, ZY
   Yan, Y
   Zhou, JY
AF Wu, Xiaopeng
   Wang, Sanying
   Yu, Yang
   Zhang, Jinyang
   Sun, Zeyu
   Yan, Yan
   Zhou, Jiyong
TI Subcellular proteomic analysis of human host cells infected with H3N2
   swine influenza virus
SO PROTEOMICS
LA English
DT Article
DE 2DE; A549 cells; Interaction; Microbiology; Subcellular proteomics;
   Swine influenza
ID RESPIRATORY SYNCYTIAL VIRUS; STRIKING DIFFERENCES; ANTIVIRAL FUNCTION;
   CELLULAR-PROTEINS; REVEALS CHANGES; MESSENGER-RNA; UP-REGULATION; NS1
   PROTEIN; NUCLEAR; INTERFERON
AB Cross-species transmissions of swine influenza viruses (SIVs) raise great public health concerns. In this study, subcellular proteomic profiles of human A549 cells inoculated with H3N2 subtype SIV were used to characterize dynamic cellular responses to infection. By 2DE and MS, 27 differentially expressed (13 upregulated, 14 downregulated) cytoplasmic proteins and 20 differentially expressed (13 upregulated, 7 downregulated) nuclear proteins were identified. Gene ontology analysis suggested that these differentially expressed proteins were mainly involved in cell death, stress response, lipid metabolism, cell signaling, and RNA PTMs. Moreover, 25 corresponding genes of the differentially expressed proteins were quantitated by real time RT-PCR to examine the transcriptional profiles between mock- and virus-infected A549 cells. Western blot analysis confirmed that changes in abundance of identified cellular proteins heterogeneous nuclear ribonucleoprotein (hnRNP) U, hnRNP C, ALDH1A1, tryptophanyl-tRNA synthetase, IFI35, and HSPB1 in H3N2 SIV-infected cells were consistent with results of 2DE analysis. By confocal microscopy, nucleus-to-cytoplasm translocation of hnRNP C and colocalization between the viral nonstructural protein 1 and hnRNP C as well as N-myc (and STAT) interactor were observed upon infection. Ingenuity Pathway Analysis revealed that cellular proteins altered during infection were grouped mainly into NFB and interferon signaling networks. Collectively, these identified subcellular constituents provide an important framework for understanding host/SIV interactions and underlying mechanisms of SIV cross-species infection and pathogenesis.
C1 [Wu, Xiaopeng; Wang, Sanying; Yu, Yang; Zhang, Jinyang; Yan, Yan; Zhou, Jiyong] Zhejiang Univ, Key Lab Anim Virol, Minist Agr, Hangzhou 310058, Zhejiang, Peoples R China.
   [Wu, Xiaopeng; Wang, Sanying; Yu, Yang; Zhang, Jinyang; Yan, Yan; Zhou, Jiyong] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China.
   [Sun, Zeyu] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst, Hangzhou 310058, Zhejiang, Peoples R China.
   [Zhou, Jiyong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China.
RP Zhou, JY (reprint author), Zhejiang Univ, Key Lab Anim Virol, Minist Agr, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
EM jyzhou@zju.edu.cn
RI Zhang, Jinyang/S-9625-2019
OI Zhang, Jinyang/0000-0001-7533-998X
FU National Key Technology RD of China [2010BAD04B01, 2010BAD04B02]
FX This work was supported by grants from National Key Technology R&D of
   China (Grant Nos. 2010BAD04B01, 2010BAD04B02). We thank Jianwen Hu
   (Shanghai Applied Protein Technology Co. Ltd, China) for help with
   MALDI-TOF/TOF MS.
CR Alfonso P, 2004, PROTEOMICS, V4, P2037, DOI 10.1002/pmic.200300742
   Arrigo AP, 2011, METHODS MOL BIOL, V787, P105, DOI 10.1007/978-1-61779-295-3_9
   Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06
   Billharz R, 2009, J VIROL, V83, P10557, DOI 10.1128/JVI.00330-09
   Brasier AR, 2004, J VIROL, V78, P11461, DOI 10.1128/JVI.78.21.11461-11476.2004
   Chan RB, 2010, CHEM PHYS LIPIDS, V163, P449, DOI 10.1016/j.chemphyslip.2010.03.002
   Christian KJ, 2008, MOL PHARMACOL, V73, P1558, DOI 10.1124/mol.107.042507
   Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10
   Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1
   Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002
   Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g
   Emmott E, 2010, MOL CELL PROTEOMICS, V9, P1920, DOI 10.1074/mcp.M900345-MCP200
   Fillmore RA, 2009, INT J CANCER, V125, P556, DOI 10.1002/ijc.24276
   GORLACH M, 1994, J BIOL CHEM, V269, P23074
   Grills C., 2011, PLOS ONE, V6
   Gupta AK, 1998, J VIROL, V72, P8532, DOI 10.1128/JVI.72.11.8532-8540.1998
   Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002
   Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240
   Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0
   Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208
   Kalinec F, 2009, BRIT J PHARMACOL, V158, P1820, DOI 10.1111/j.1476-5381.2009.00473.x
   Kamal AM, 2001, CLIN EXP ALLERGY, V31, P1116, DOI 10.1046/j.1365-2222.2001.01137.x
   KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x
   Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004
   KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P
   Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200
   Lee JH, 2010, VIROLOGY, V397, P89, DOI 10.1016/j.virol.2009.10.041
   Lee ND, 1999, J INTERF CYTOK RES, V19, P1245, DOI 10.1089/107999099312902
   Lemon SM, 2005, BIOSECUR BIOTERROR, V3, P70, DOI 10.1089/bsp.2005.3.70
   Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x
   Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757
   Ma WJ, 2011, J VIROL, V85, P11626, DOI 10.1128/JVI.05705-11
   Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109
   Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06
   Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06
   Mincberg M, 2011, VIROLOGY, V412, P233, DOI 10.1016/j.virol.2010.12.035
   Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501
   Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529
   Munday DC, 2010, PROTEOMICS, V10, P4320, DOI 10.1002/pmic.201000228
   Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859
   Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200
   Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165
   Ohman T, 2009, J IMMUNOL, V182, P5682, DOI 10.4049/jimmunol.0803093
   Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8
   Piccoli C, 2006, BBA-BIOENERGETICS, V1757, P1429, DOI 10.1016/j.bbabio.2006.05.018
   Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10
   Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018
   Shetty S, 2005, MOL CELL BIOCHEM, V272, P107, DOI 10.1007/s11010-005-7644-2
   Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944
   Spahn A, 2008, NEUROCHEM RES, V33, P1859, DOI 10.1007/s11064-008-9658-0
   Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07
   Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   Vester D, 2010, J PROTEOMICS, V73, P1656, DOI 10.1016/j.jprot.2010.04.006
   Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893
   Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004
   Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63
   Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032
   Xiao TL, 2009, J TOXICOL ENV HEAL A, V72, P577, DOI 10.1080/15287390802706371
   Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6
   Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002
   Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200
   Zhou XJ, 2000, J BIOL CHEM, V275, P21364, DOI 10.1074/jbc.M003177200
NR 65
TC 13
Z9 13
U1 2
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD NOV
PY 2013
VL 13
IS 22
BP 3309
EP 3326
DI 10.1002/pmic.201300180
PG 18
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 265VG
UT WOS:000327979600010
PM 24115376
DA 2020-05-07
ER

PT J
AU Battaglioli, T
   Rintiswati, N
   Martin, A
   Palupi, KR
   Bernaerts, G
   Dwihardiani, B
   Ahmad, RA
   Matthys, F
   Mahendradhata, Y
   Van der Stuyft, P
AF Battaglioli, T.
   Rintiswati, N.
   Martin, A.
   Palupi, K. R.
   Bernaerts, G.
   Dwihardiani, B.
   Ahmad, R. A.
   Matthys, F.
   Mahendradhata, Y.
   Van der Stuyft, P.
TI Comparative performance of Thin Layer Agar and Lowenstein-Jensen culture
   for diagnosis of tuberculosis
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Culture; rapid detection; sensitivity; Thin Layer Agar; tuberculosis
ID MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; MICROCOLONY DETECTION;
   MICROSCOPIC OBSERVATION; RIFAMPICIN RESISTANCE; MIDDLEBROOK 7H11;
   SPUTUM; ASSAY; PREVALENCE
AB Sputum smear microscopy for the diagnosis of tuberculosis (TB) is cheap and simple but its sensitivity is low. Culture on Lowenstein-Jensen (LJ) is more sensitive but it takes a long time to yield results. Thin-Layer Agar (TLA) culture was suggested as an equally sensitive and faster alternative. We evaluated the performance of TLA for diagnosing TB in Jogjakarta, Indonesia. People with suspected TB presenting from July 2010 to July 2011 to two chest clinics of the National TB Control Programme network of Jogjakarta were eligible for inclusion. A sputum sample was sent to the Gadjah Mada University microbiology laboratory for concentration, smearing, Ziehl-Neelsen staining and culture on LJ and TLA. Sensitivity of cultures was evaluated against a composite reference standard (any positive culture). Time to detection of Mycobacteria was recorded. Out of 1414 samples, 164 (12%) were smear positive, 99 (7%) were scanty and 1151 (81%) were negative. On TLA and LJ respectively, 168 (12%) and 149 (11%) samples were positive, 72 (5%) and 32 (2%) were contaminated (=0.64; 95% CI 0.59-0.69, p<0.01). Using the reference standard, 196 (14%) TB cases were identified. The sensitivity of TLA was 0.86 (95% CI 0.80-0.90), significantly higher (p0.03) than for LJ (0.76; 95% CI 0.69-0.81). The median time to detection in days was significantly shorter (p<0.01) for TLA (12; 95% CI 11-13) than for LJ (44; 95% CI 43-45). TLA is a rapid and sensitive method for the diagnosis of TB. Implementation studies to evaluate the cost-effectiveness and impact of its introduction into programmatic settings are urgently needed.
C1 [Battaglioli, T.; Matthys, F.; Van der Stuyft, P.] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Rintiswati, N.; Palupi, K. R.] Gadjah Mada Univ, Dept Microbiol, Fac Med, Yogyakarta, Indonesia.
   [Martin, A.; Bernaerts, G.] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
   [Dwihardiani, B.; Ahmad, R. A.; Mahendradhata, Y.] Gadjah Mada Univ, Ctr Trop Med, Fac Med, Yogyakarta, Indonesia.
   [Van der Stuyft, P.] Univ Ghent, Fac Med, Dept Publ Hlth, B-9000 Ghent, Belgium.
RP Battaglioli, T (reprint author), Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, Nationalestr 155, B-2000 Antwerp, Belgium.
EM tbattaglioli@itg.be
OI Mahendradhata, Yodi/0000-0002-4522-1785
FU Belgian government FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen)
FX This work received financial support from the Belgian government FWO
   (Fonds Wetenschappelijk Onderzoek - Vlaanderen). Thank you to the staff
   of the participating health facilities and to Alonso Soto for his
   comments on the manuscript. We dedicate this work to the memory of our
   dear colleague Francine Matthys.
CR da Silva PEA, 2007, BRAZ J MICROBIOL, V38, P421, DOI 10.1590/S1517-83822007000300007
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847
   Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000
   Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012
   Dean A.G., 2010, OPENEPI OPEN SOURCE
   Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064
   Gil-Setas A, 2004, CLIN MICROBIOL INFEC, V10, P224, DOI 10.1111/j.1198-743X.2004.00733.x
   IDIGORAS P, 1995, EUR J CLIN MICROBIOL, V14, P6, DOI 10.1007/BF02112611
   International Union Against Tuberculosis and Lung Disease, 2000, TECHN GUID SPUT EX T
   Irfan Seema, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1187
   Kent PTK, 1985, PUBLIC HLTH MYCOBACT
   Leung E, 2012, INT J TUBERC LUNG D, V16, P16, DOI 10.5588/ijtld.10.0065
   Mahendradhata Y, 2008, T ROY SOC TROP MED H, V102, P1003, DOI 10.1016/j.trstmh.2008.04.042
   Martin A, PROCEDURE MANUAL THI
   Martin A, 2008, J ANTIMICROB CHEMOTH, V62, P56, DOI 10.1093/jac/dkn139
   Martin A, 2009, J CLIN MICROBIOL, V47, P2632, DOI 10.1128/JCM.00264-09
   Martin A, 2009, J MICROBIOL METH, V78, P107, DOI 10.1016/j.mimet.2009.05.001
   McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860
   Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138
   Mejía Gloria Isabel, 2004, Biomédica, V24, P52
   Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1
   Ministry of Health Republic of Indonesia, 2010, GUID CULT ID SENS TE
   Nahid P, 2012, J INFECT DIS, V205, pS159, DOI 10.1093/infdis/jis194
   Robledo JA, 2006, INT J TUBERC LUNG D, V10, P613
   Satti L, 2010, INT J TUBERC LUNG D, V14, P1354
   SOEMANTRI S, 2005, TUBERCULOSIS PREVALE
   Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8
   Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816
   WELCH DF, 1993, J CLIN MICROBIOL, V31, P2178, DOI 10.1128/JCM.31.8.2178-2184.1993
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 1998, LAB SERV TUB CONTR
NR 32
TC 9
Z9 9
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD NOV
PY 2013
VL 19
IS 11
BP E502
EP E508
DI 10.1111/1469-0691.12265
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 233JK
UT WOS:000325564400004
PM 23738759
OA Bronze
DA 2020-05-07
ER

PT J
AU Lopez-Medrano, F
   Cordero, E
   Gavalda, J
   Cruzado, JM
   Marcos, MA
   Perez-Romero, P
   Sabe, N
   Gomez-Bravo, MA
   Delgado, JF
   Cabral, E
   Carratala, J
AF Lopez-Medrano, Francisco
   Cordero, Elisa
   Gavalda, Joan
   Cruzado, Josep M.
   Angeles Marcos, M.
   Perez-Romero, Pilar
   Sabe, Nuria
   Angel Gomez-Bravo, Miguel
   Francisco Delgado, Juan
   Cabral, Evelyn
   Carratala, Jordi
CA Spanish Soc Infect Dis Clinical Mi
   Spanish Network Res Infect Dis REI
TI Executive summary. Management of influenza infection in solid-organ
   transplant recipients: Consensus statement of the Group for the Study of
   Infection in Transplant Recipients (GESITRA) of the Spanish Society of
   Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish
   Network for Research in Infectious Diseases (REIPI)
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Influenza; Consensus; Transplantation; Vaccination; Treatment;
   Prophylaxis
AB Solid organ transplant (SOT) recipients are at greater risk than the general population for complications and mortality from influenza infection. We have conducted a systematic review to assess the management and prevention of influenza infection in SOT recipients.
   Recommendations are provided about the procurement of organs from donors with influenza infection. We highlight the importance of the possibility of influenza infection in any SOT recipient presenting upper or lower respiratory symptoms, including pneumonia. The importance of early antiviral treatment of SOT recipients with suspected or confirmed influenza infection and the necessity of annual influenza vaccination are emphasized. The microbiological techniques for diagnosis of influenza infection are reviewed. Guidelines for the use of antiviral prophylaxis are provided. Recommendations for household contacts of SOT recipients with influenza infection and health care workers are also included. Antiviral dose adjustment guidelines are presented for cases of impaired renal function and for pediatric populations. (C) 2013 Elsevier Espana, S.L. All rights reserved.
C1 [Lopez-Medrano, Francisco] Univ Complutense, Dept Med, Inst Invest Biomed Octubre I 12 12, Hosp Univ Octubre 12,Unidad Enfermedades Infeccio, E-28040 Madrid, Spain.
   [Cordero, Elisa; Perez-Romero, Pilar] Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Unidad Clin Gest Enfermedades Infecciosas Microbi, Seville, Spain.
   [Gavalda, Joan; Cabral, Evelyn] Hosp Univ Vall dHebron, Serv Enfermedades Infecciosas, Barcelona, Spain.
   [Cruzado, Josep M.] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Hosp Univ Bellvitge, Serv Nefrol, Barcelona, Spain.
   [Angeles Marcos, M.] Univ Barcelona, Dept Microbiol, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Sabe, Nuria; Carratala, Jordi] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Hosp Univ Bellvitge, Serv Enfermedades Infecciosas, Barcelona, Spain.
   [Angel Gomez-Bravo, Miguel] Hosp Univ Virgen Rocio, Unidad Cirugia Hepatobiliopancreat, Seville, Spain.
   [Francisco Delgado, Juan] Hosp Univ 12 Octubre, Serv Cardiol, Unidad Insuficiencia Cardiaca & Trasplante Corazo, Madrid, Spain.
RP Lopez-Medrano, F (reprint author), Univ Complutense, Dept Med, Inst Invest Biomed Octubre I 12 12, Hosp Univ Octubre 12,Unidad Enfermedades Infeccio, E-28040 Madrid, Spain.
EM flmedrano@yahoo.es
RI Delgado, Juan F./G-1066-2017; Cordero, Elisa/C-7797-2015; Carratala,
   Jordi/B-8410-2011; Carratala, Jordi/AAC-2639-2020
OI Delgado, Juan F./0000-0002-5401-8324; Cordero,
   Elisa/0000-0001-7766-7266; Carratala, Jordi/0000-0003-3209-2563;
   Carratala, Jordi/0000-0003-3209-2563; Sabe, Nuria/0000-0003-1697-4347;
   Gavalda, Joan/0000-0002-9829-3141; GOMEZ BRAVO, MIGUEL
   ANGEL/0000-0002-5155-3508; Lopez-Medrano, Francisco/0000-0001-5333-7529
FU Spanish Society of Transplantation (SET); National Transplant
   Organization (ONT) of the Ministry of Health of Spain; Spanish Society
   of Nephrology (SEN); Section of Heart Failure and Heart Transplantation
   of the Spanish Society of Cardiology (SEC); Spanish Society of Liver
   Transplantation (SETH)
FX This document has been reviewed and is supported by the Spanish Society
   of Transplantation (SET), the National Transplant Organization (ONT) of
   the Ministry of Health of Spain, the Spanish Society of Nephrology
   (SEN), the Section of Heart Failure and Heart Transplantation of the
   Spanish Society of Cardiology (SEC) and the Spanish Society of Liver
   Transplantation (SETH).
CR Lopez-Medrano F, 2013, ENFERM INFECC MICROB, V31, p526e1
NR 1
TC 3
Z9 3
U1 0
U2 8
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD OCT
PY 2013
VL 31
IS 8
BP 528
EP 534
DI 10.1016/j.eimc.2013.01.014
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 244UR
UT WOS:000326416200008
PM 23528340
DA 2020-05-07
ER

PT J
AU Boyce, JM
   Nadeau, J
   Dumigan, D
   Miller, D
   Dubowsky, C
   Reilly, L
   Hannon, CV
AF Boyce, John M.
   Nadeau, Jacqueline
   Dumigan, Diane
   Miller, Debra
   Dubowsky, Cindy
   Reilly, Lenore
   Hannon, Carla V.
TI Obtaining Blood Cultures by Venipuncture versus from Central Lines:
   Impact on Blood Culture Contamination Rates and Potential Effect on
   Central Line-Associated Bloodstream Infection Reporting
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID DRAWN
AB OBJECTIVE. Reduce the frequency of contaminated blood cultures that meet National Healthcare Safety Network definitions for a central line-associated bloodstream infection (CLABSI).
   DESIGN. An observational study.
   SETTING. A 500-bed university-affiliated hospital.
   METHODS. A new blood culture policy discouraged drawing blood samples from central lines. Phlebotomists were reeducated regarding aseptic technique when obtaining blood samples by venipuncture. The intravenous therapy team was taught how to draw blood samples by venipuncture and served as a backup when phlebotomists were unable to obtain blood samples. A 2-nurse protocol and a special supply kit for obtaining blood samples from catheters were developed. Rates of blood culture contamination were monitored by the microbiology laboratory.
   RESULTS. The proportion of blood samples obtained for culture from central lines decreased from 10.9% during January-June 2010 to 0.4% during July-December 2012 (P<.001). The proportion of blood cultures that were contaminated decreased from 84 (1.6%) of 5,274 during January-June 2010 to 21 (0.5%) of 4,245 during January-June 2012 (P<.001). Based on estimated excess hospital costs of $3,000 per contaminated blood culture, the reduction in blood culture contaminants yielded an estimated annualized savings of $378,000 in 2012 when compared to 2010. In mid-2010, 3 (30%) of 10 reported CLABSIs were suspected to represent blood culture contamination compared with none of 6 CLABSIs reported from mid-November 2010 through June 2012 (P = 0.25).
   CONCLUSIONS. Multiple interventions resulted in a reduction in blood culture contamination rates and substantial cost savings to the hospital, and they may have reduced the number of reportable CLABSIs.
C1 [Boyce, John M.; Dumigan, Diane] Yale New Haven Med Ctr, Hosp Epidemiol & Infect Control, New Haven, CT 06510 USA.
   [Boyce, John M.] Yale Univ, Sch Med, New Haven, CT USA.
   [Nadeau, Jacqueline] Yale New Haven Med Ctr, Clin Microbiol Lab, New Haven, CT 06510 USA.
   [Miller, Debra; Reilly, Lenore; Hannon, Carla V.] Yale New Haven Med Ctr, Dept Nursing, New Haven, CT 06510 USA.
   [Dubowsky, Cindy] Yale New Haven Med Ctr, Lab Support Serv, New Haven, CT 06510 USA.
RP Boyce, JM (reprint author), Yale New Haven Med Ctr, Hosp Epidemiol & Infect Control, 20 York St, New Haven, CT 06510 USA.
EM John.Boyce@ynhh.org
CR Alahmadi YM, 2011, J HOSP INFECT, V77, P233, DOI 10.1016/j.jhin.2010.09.033
   BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365
   Beekmann SE, 2012, INFECT CONT HOSP EP, V33, P875, DOI 10.1086/667379
   Bekeris LG, 2005, ARCH PATHOL LAB MED, V129, P1222
   Centers for Disease Control and Prevention, 2010, NATL HEALTHCARE SAFE, V5, P1
   Dumigan DG, 2012, 22 EUR SOC CLIN MICR
   Dwivedi S, 2009, J CLIN MICROBIOL, V47, P2950, DOI 10.1128/JCM.00292-09
   Eskira S, 2006, CLIN MICROBIOL INFEC, V12, P818, DOI 10.1111/j.1469-0691.2006.01446.x
   Gander RM, 2009, J CLIN MICROBIOL, V47, P1021, DOI 10.1128/JCM.02162-08
   Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05
   Johns Hopkins Hospital, 2012, VASC ACC DEV VAD POL
   Mathew A, 2009, J INFUS MURS, V32, P212, DOI 10.1097/NAN.0b013e3181aac20c
   Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115
   Schifman RB, 1998, ARCH PATHOL LAB MED, V122, P216
   Sexton DJ, 2010, INFECT CONT HOSP EP, V31, P1286, DOI 10.1086/657583
   Sherertz RJ, 2011, EUR J CLIN MICROBIOL, V30, P1571, DOI 10.1007/s10096-011-1262-6
   Shuman EK, 2010, INFECT CONT HOSP EP, V31, P551, DOI 10.1086/652157
   Snyder SR, 2012, CLIN BIOCHEM, V45, P999, DOI 10.1016/j.clinbiochem.2012.06.007
   Souvenir D, 1998, J CLIN MICROBIOL, V36, P1923, DOI 10.1128/JCM.36.7.1923-1926.1998
   Suwanpimolkul G, 2008, J INFECTION, V56, P354, DOI 10.1016/j.jinf.2008.03.001
   Teplick R, 2011, CRIT CARE MED, V39, P392, DOI 10.1097/CCM.0b013e318205c35e
   Weinbaum FI, 1997, J CLIN MICROBIOL, V35, P563, DOI 10.1128/JCM.35.3.563-565.1997
   Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003
   Zwang O, 2006, J HOSP MED, V1, P272, DOI 10.1002/jhm.115
NR 25
TC 23
Z9 23
U1 1
U2 12
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD OCT 1
PY 2013
VL 34
IS 10
BP 1042
EP 1047
DI 10.1086/673142
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 213LH
UT WOS:000324058200002
PM 24018920
DA 2020-05-07
ER

PT J
AU Ziv, N
   Brandt, NJ
   Gresham, D
AF Ziv, Naomi
   Brandt, Nathan J.
   Gresham, David
TI The Use of Chemostats in Microbial Systems Biology
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Environmental Sciences; Issue 80; Saccharomyces cerevisiae; Molecular
   Biology; Computational Biology; Systems Biology; Cell Biology; Genetics;
   Environmental Microbiology; Biochemistry; Chemostat; growth-rate; steady
   state; nutrient limitation; adaptive evolution
AB Cells regulate their rate of growth in response to signals from the external world. As the cell grows, diverse cellular processes must be coordinated including macromolecular synthesis, metabolism and ultimately, commitment to the cell division cycle. The chemostat, a method of experimentally controlling cell growth rate, provides a powerful means of systematically studying how growth rate impacts cellular processes - including gene expression and metabolism - and the regulatory networks that control the rate of cell growth. When maintained for hundreds of generations chemostats can be used to study adaptive evolution of microbes in environmental conditions that limit cell growth. We describe the principle of chemostat cultures, demonstrate their operation and provide examples of their various applications. Following a period of disuse after their introduction in the middle of the twentieth century, the convergence of genome- scale methodologies with a renewed interest in the regulation of cell growth and the molecular basis of adaptive evolution is stimulating a renaissance in the use of chemostats in biological research.
C1 [Ziv, Naomi; Brandt, Nathan J.; Gresham, David] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA.
RP Gresham, D (reprint author), NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA.
EM dgresham@nyu.edu
OI Ziv, Naomi/0000-0003-1299-5335
FU start up funds form New York University
FX This work was supported by start up funds form New York University. We
   thank Maitreya Dunham and Matt Brauer who initially developed the use of
   Sixfors bioreactors as chemostats.
CR Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597
   Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200
   Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779
   Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54
   Cipollina C, 2008, MICROBIOL-SGM, V154, P337, DOI 10.1099/mic.0.2007/011767-0
   COHEN EP, 1961, J EXP MED, V113, P467, DOI 10.1084/jem.113.2.467
   Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2
   Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918
   Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799
   Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358
   Gresham D, 2011, GENETICS, V187, P299, DOI 10.1534/genetics.110.120766
   Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107
   Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303
   Hall MN, 2004, CELL GROWTH CONTROL
   INGRAHAM JL, 1983, GROWTH BACTERIAL CEL
   Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280
   KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607
   Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083
   Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325
   MAALOE O, 1966, CONTROL MACROMOLECUL
   MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390
   NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715
   Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107
   Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103
   Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.E04-04-0306
   Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499
   Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294
   Wenger JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002202
NR 28
TC 24
Z9 24
U1 1
U2 17
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD OCT
PY 2013
IS 80
AR e50168
DI 10.3791/50168
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36RP
UT WOS:000209228800001
PM 24145466
OA Green Published
DA 2020-05-07
ER

PT J
AU Zech, H
   Hensler, M
   Kossmehl, S
   Druppel, K
   Wohlbrand, L
   Trautwein, K
   Hulsch, R
   Maschmann, U
   Colby, T
   Schmidt, J
   Reinhardt, R
   Schmidt-Hohagen, K
   Schomburg, D
   Rabus, R
AF Zech, Hajo
   Hensler, Michael
   Kossmehl, Sebastian
   Drueppel, Katharina
   Woehlbrand, Lars
   Trautwein, Kathleen
   Hulsch, Reiner
   Maschmann, Uwe
   Colby, Thomas
   Schmidt, Juergen
   Reinhardt, Richard
   Schmidt-Hohagen, Kerstin
   Schomburg, Dietmar
   Rabus, Ralf
TI Adaptation of Phaeobacter inhibens DSM 17395 to growth with complex
   nutrients
SO PROTEOMICS
LA English
DT Article
DE Growth balance; Metabolomics; Metabolic network; Microbiology;
   Phaeobacter inhibens; Rich media
ID AROMATOLEUM-AROMATICUM EBN1; MARINE ROSEOBACTER LINEAGE;
   ESCHERICHIA-COLI K-12; GEL-ELECTROPHORESIS; FATTY-ACID; 2-DIMENSIONAL
   ELECTROPHORESIS; METABOLIC-REGULATION; PHYTOPLANKTON BLOOM; AQUATIC
   ECOSYSTEMS; BACILLUS-SUBTILIS
AB Phaeobacter inhibensDSM 17395, a member of the Roseobacter clade, was studied for its adaptive strategies to complex and excess nutrient supply, here mimicked by cultivation with Marine Broth (MB). During growth in process-controlled fermenters, P. inhibens DSM 17395 grew faster (3.6-fold higher (max)) and reached higher optical densities (2.2-fold) with MB medium, as compared to the reference condition of glucose-containing mineral medium. Apparently, in the presence of MB medium, metabolism was tuned to maximize growth rate at the expense of efficiency. Comprehensive proteomic analysis of cells harvested at 1/2 ODmax identified 1783 (2D DIGE, membrane and extracellular protein-enriched fractions, shotgun) different proteins (50.5% coverage), 315 (based on 2D DIGE) of which displayed differential abundance profiles. Moreover, 145 different metabolites (intra- and extracellular combined) were identified, almost all of which (140) showed abundance changes. During growth with MB medium, P. inhibens DSM 17395 specifically formed the various proteins required for utilization of phospholipids and several amino acids, as well as for gluconeogenesis. Metabolic tuning on amino acid utilization is also reflected by massive discharge of urea to dispose the cell of excess ammonia. Apparently, P. inhibens DSM 17395 modulated its metabolism to simultaneously utilize diverse substrates from the complex nutrient supply.
C1 [Zech, Hajo; Kossmehl, Sebastian; Drueppel, Katharina; Woehlbrand, Lars; Trautwein, Kathleen; Hulsch, Reiner; Maschmann, Uwe; Rabus, Ralf] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany.
   [Hensler, Michael; Schmidt-Hohagen, Kerstin; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany.
   [Colby, Thomas; Schmidt, Juergen] Max Planck Inst Plant Breeding Res, Cologne, Germany.
   [Reinhardt, Richard] Max Planck Genome Ctr Cologne, Cologne, Germany.
   [Rabus, Ralf] Max Planck Inst Marine Microbiol, Bremen, Germany.
RP Rabus, R (reprint author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Carl von Ossietzky Str 9-11, D-26111 Oldenburg, Germany.
EM rabus@icbm.de
OI Schomburg, Dietmar/0000-0002-3354-822X; Reinhardt,
   Richard/0000-0001-9376-2132
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB TRR
   51]
FX The authors are grateful to C. Versteegen (Oldenburg) for DOC and
   elemental analysis, A. Harzen (Koln) for expert technical advice, C.
   Feenders (Oldenburg) for plotting comprehensive 2D DIGE data, and the
   students N. Bergen, F. Vocke, and M. Trinkler (Oldenburg) for
   experimental assistance. This study was supported by the Deutsche
   Forschungsgemeinschaft (SFB TRR 51).
CR ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5
   Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000
   Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI [10.1128/JB.186.15.5062-5077.2004, 10.1128/jb.186.15.5062-5077.2004]
   AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257
   AZIZAN A, 1994, J BACTERIOL, V176, P6653, DOI 10.1128/JB.176.21.6653-6662.1994
   BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043
   Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005
   Burman JD, 2004, FEBS LETT, V576, P442, DOI 10.1016/j.febslet.2004.09.058
   Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014
   CHASIN LA, 1968, J BIOL CHEM, V243, P5165
   Christie-Oleza JA, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013110
   Christie-Oleza JA, 2010, MAR DRUGS, V8, P2223, DOI 10.3390/md8082223
   del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503
   DiRusso CC, 1999, PROG LIPID RES, V38, P129, DOI 10.1016/S0163-7827(98)00022-8
   Dixon DP, 2006, PLANT SCI, V171, P360, DOI 10.1016/j.plantsci.2006.04.008
   Doherty NS, 1998, ELECTROPHORESIS, V19, P355, DOI 10.1002/elps.1150190234
   Fisher A. B., 2009, PHOSPHOLIPASES DEGRA
   Furch T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-209
   FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207
   Gade D, 2005, PROTEOMICS, V5, P3672, DOI 10.1002/pmic.200401200
   Gade D, 2003, J MOL MICROB BIOTECH, V5, P240, DOI 10.1159/000071076
   Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405
   Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932
   Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V
   Gram L, 2002, APPL ENVIRON MICROB, V68, P4111, DOI 10.1128/AEM.68.8.4111-4116.2002
   Gray LR, 2011, BIOCHEMISTRY-US, V50, P8656, DOI 10.1021/bi200887a
   Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255
   Hanegraaf PPF, 2001, J THEOR BIOL, V212, P237, DOI 10.1006/jtbi.2001.2369
   HEINZLE E, 1991, BIOTECHNOLOGY, V4, P27
   Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c
   Hopkinson CS, 1998, BIOGEOCHEMISTRY, V43, P211, DOI 10.1023/A:1006016030299
   Hosie AHF, 2001, RES MICROBIOL, V152, P259, DOI 10.1016/S0923-2508(01)01197-4
   Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08
   KENEALY WR, 1982, J BACTERIOL, V150, P1357, DOI 10.1128/JB.150.3.1357-1365.1982
   Koyanagi T, 2004, J BACTERIOL, V186, P343, DOI 10.1128/JB.186.2.343-350.2004
   Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/O10-141, 10.1139/o10-141]
   Kudela RM, 2010, PROG OCEANOGR, V85, P122, DOI 10.1016/j.pocean.2010.02.008
   Lendenmann U, 1996, APPL ENVIRON MICROB, V62, P1493, DOI 10.1128/AEM.62.5.1493-1499.1996
   MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993
   Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0
   MASSEY LK, 1976, BACTERIOL REV, V40, P42, DOI 10.1128/MMBR.40.1.42-54.1976
   Moloney CL, 2005, ICES J MAR SCI, V62, P493, DOI 10.1016/j.icesjms.2004.11.009
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993
   MUYZER G, 1997, MOL MICROBIAL ECOLOG, P1
   Myklestad SM, 2000, HANDB ENVIRON CHEM, V5, P111
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Ostrowski M, 2004, PROTEOMICS, V4, P1779, DOI 10.1002/pmic.200300695
   PARK SJ, 1995, J BACTERIOL, V177, P6652, DOI 10.1128/jb.177.22.6652-6656.1995
   Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6
   Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45
   Quintero MJ, 2000, J BACTERIOL, V182, P1008, DOI 10.1128/JB.182.4.1008-1015.2000
   Rink B, 2007, AQUAT MICROB ECOL, V48, P47, DOI 10.3354/ame048047
   ROELS JA, 1983, ENERGETICS KINETICS
   Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537
   Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775
   Sawers R. G, 2009, AMINO ACID DEGRADATI
   Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001
   SCHUTTE H, 1985, APPL MICROBIOL BIOT, V22, P306, DOI 10.1007/BF00582413
   SENIOR PJ, 1971, BIOCHEM J, V125, P55, DOI 10.1042/bj1250055
   Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659
   Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175
   Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799
   Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344
   Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107
   Thole S, 2012, ISME J, V6, P2229, DOI 10.1038/ismej.2012.62
   Trautwein K, 2012, J BACTERIOL, V194, P2165, DOI 10.1128/JB.06519-11
   Trautwein K, 2012, J BACTERIOL, V194, P518, DOI 10.1128/JB.05072-11
   Tsoy O, 2009, J BACTERIOL, V191, P7157, DOI 10.1128/JB.00838-09
   Vandecandelaere I, 2009, INT J SYST EVOL MICR, V59, P1209, DOI 10.1099/ijs.0.002642-0
   VANDERAAR PC, 1989, J MICROBIOL METH, V9, P281, DOI 10.1016/0167-7012(89)90070-5
   VERDONI N, 1992, APPL ENVIRON MICROB, V58, P3150, DOI 10.1128/AEM.58.9.3150-3156.1992
   Voigt B, 2006, PROTEOMICS, V6, P268, DOI 10.1002/pmic.200500091
   Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115
   WESTERHOFF HV, 1983, P NATL ACAD SCI-BIOL, V80, P305, DOI 10.1073/pnas.80.1.305
   Widdel F, 2010, HDB HYDROCARBON LIPI, P729, DOI [10.1007/978-3-540-77587-4_57, DOI 10.1007/978-3-540-77587-4_57]
   Wohlbrand L, 2007, PROTEOMICS, V7, P2222, DOI 10.1002/pmic.200600987
   Wollast R, 1998, SEA, V10, P213
   Yang KC, 2009, J BACTERIOL, V191, P4667, DOI 10.1128/JB.00235-09
   YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625
   Yoon JH, 2007, INT J SYST EVOL MICR, V57, P856, DOI 10.1099/ijs.0.64779-0
   Zech H, 2011, PROTEOMICS, V11, P3380, DOI 10.1002/pmic.201100071
   Zech H, 2009, PROTEOMICS, V9, P3677, DOI 10.1002/pmic.200900120
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
NR 85
TC 29
Z9 30
U1 2
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD OCT
PY 2013
VL 13
IS 18-19
SI SI
BP 2851
EP 2868
DI 10.1002/pmic.201200513
PG 18
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 252MS
UT WOS:000327010000012
PM 23613352
DA 2020-05-07
ER

PT J
AU Donnenberg, MS
   Narayanan, S
AF Donnenberg, Michael S.
   Narayanan, Shivakumar
TI How to Diagnose a Foodborne Illness
SO INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
LA English
DT Article
DE Outbreaks; Diagnosis; Foodborne illness; Food poisoning; Microbiology;
   Stool culture; Pulsed-field gel electrophoresis; Stool antigen detection
ID FIELD GEL-ELECTROPHORESIS; SURVEILLANCE NETWORK FOODNET;
   ESCHERICHIA-COLI O157H7; UNITED-STATES; ENTAMOEBA-HISTOLYTICA;
   CLOSTRIDIUM-PERFRINGENS; FECAL LEUKOCYTES; STOOL CULTURES; OUTBREAK;
   DIARRHEA
AB Timely diagnosis of foodborne infection can be critical not only for the patient, but also for the larger community because of the potential to interrupt further spread. This article presents the diagnostic approach to patients with foodborne illness, discussing epidemiologic clues of various foodborne pathogens and their distinguishing clinical features of diagnostic importance. Also discussed are situations whereby stool cultures should be ordered; other helpful stool tests; nonculture methods of identifying organisms and their applicability in clinical settings; the role of pulsed-field gel electrophoresis in typing organisms; and large-scale sharing of data to aid in identification of large outbreaks.
C1 [Donnenberg, Michael S.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
   [Donnenberg, Michael S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Donnenberg, Michael S.] Univ Maryland, Sch Med, Med Scientist Training Program, Baltimore, MD 21201 USA.
   [Narayanan, Shivakumar] Univ Maryland, Med Ctr, Inst Human Virol, Div Infect Dis,Dept Med, Baltimore, MD 21201 USA.
RP Donnenberg, MS (reprint author), Univ Maryland, Sch Med, Hlth Sci Facil 2, 20 Penn St,S243, Baltimore, MD 21201 USA.
EM mdonnenb@umaryland.edu
OI Narayanan, Shivakumar/0000-0003-3440-0259; Donnenberg,
   Michael/0000-0002-8818-3184
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI 32074, U19 AI 090873, R03 AI 097953]
FX Public Health Service awards R01 AI 32074, U19 AI 090873, R03 AI 097953
   from the National Institute of Allergy and Infectious Diseases (M.S.
   Donnenberg); None (S. Narayanan).
CR American Medical Association, 2004, MMWR Recomm Rep, V53, P1
   Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20
   Bauer TH, 2001, JAMA-J AM MED ASSOC, V285, P313, DOI 10.1001/jama.285.3.313
   BELONGIA EA, 1993, JAMA-J AM MED ASSOC, V269, P883, DOI 10.1001/jama.269.7.883
   Bennett RW, 2005, J FOOD PROTECT, V68, P1264, DOI 10.4315/0362-028X-68.6.1264
   Bessede E, 2011, J CLIN MICROBIOL, V49, P941, DOI 10.1128/JCM.01489-10
   BIRKHEAD G, 1988, J CLIN MICROBIOL, V26, P471, DOI 10.1128/JCM.26.3.471-474.1988
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8
   Buzby J. C., 1996, AER741 USDA, P93
   Carpenter LR, 2008, J INFECT DIS, V197, P1709, DOI 10.1086/588142
   CDC, 2012, FOODNET SURV REP 201
   Chitkara YK, 1996, ARCH INTERN MED, V156, P1445, DOI 10.1001/archinte.156.13.1445
   Choi SW, 1996, J CLIN MICROBIOL, V34, P928, DOI 10.1128/JCM.34.4.928-932.1996
   Cronquist AB, 2012, CLIN INFECT DIS, V54, pS432, DOI 10.1093/cid/cis267
   Cunningham SA, 2010, J CLIN MICROBIOL, V48, P2929, DOI 10.1128/JCM.00339-10
   Dalton CB, 1999, EPIDEMIOL INFECT, V123, P9, DOI 10.1017/S0950268899002526
   Devasia RA, 2005, MICROB DRUG RESIST, V11, P371, DOI 10.1089/mdr.2005.11.371
   DEWITT TG, 1985, PEDIATRICS, V76, P551
   Eberhard ML, 1997, ARCH PATHOL LAB MED, V121, P792
   Fitzgerald C, 2011, 111 GEN M AM SOC MIC
   FOLEY SL, 2007, INFEC DIS S, P485
   Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997
   Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1
   GUERRANT RL, 1985, AM J MED, V78, P91, DOI 10.1016/0002-9343(85)90370-5
   Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514
   GUERRANT RL, 1981, J INFECT DIS, V143, P83, DOI 10.1093/infdis/143.1.83
   Haque R, 2000, J CLIN MICROBIOL, V38, P3235, DOI 10.1128/JCM.38.9.3235-3239.2000
   HARRIS JC, 1972, ANN INTERN MED, V76, P697, DOI 10.7326/0003-4819-76-5-697
   Hines J, 1996, CLIN INFECT DIS, V23, P1292, DOI 10.1093/clinids/23.6.1292
   JAY JM, 2000, MODERN FOOD MICROBIO
   Jones TF, 2004, CLIN INFECT DIS, V39, P1454, DOI 10.1086/425319
   Kendall ME, 2012, CLIN INFECT DIS, V54, pS480, DOI 10.1093/cid/cis052
   Kolavic SA, 1997, JAMA-J AM MED ASSOC, V278, P396, DOI 10.1001/jama.278.5.396
   KOPLAN JP, 1980, LANCET, V2, P413
   KORZENIOWSKI OM, 1979, AM J TROP MED HYG, V28, P1031, DOI 10.4269/ajtmh.1979.28.1031
   LEE LA, 1991, J INFECT DIS, V163, P660, DOI 10.1093/infdis/163.3.660
   Lew J F, 1990, MMWR Recomm Rep, V39, P1
   Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7
   Morris AJ, 1996, J CLIN MICROBIOL, V34, P1776, DOI 10.1128/JCM.34.7.1776-1778.1996
   MORRIS GK, 1976, J CLIN MICROBIOL, V3, P486
   Murphree R, 2012, CLIN INFECT DIS, V54, pS498, DOI 10.1093/cid/cis232
   Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555
   NEILL MA, 1991, ANN INTERN MED, V114, P195, DOI 10.7326/0003-4819-114-3-195
   Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450
   Pillai DR, 1999, CLIN INFECT DIS, V29, P1315, DOI 10.1086/313433
   Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739
   Roy S, 2005, J CLIN MICROBIOL, V43, P2168, DOI 10.1128/JCM.43.5.2168-2172.2005
   Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]
   SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5
   SERENY B, 1955, Acta Microbiol Acad Sci Hung, V2, P293
   SIEGEL DL, 1990, JAMA-J AM MED ASSOC, V263, P979, DOI 10.1001/jama.263.7.979
   Silletti RP, 1996, J CLIN MICROBIOL, V34, P1161, DOI 10.1128/JCM.34.5.1161-1165.1996
   Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002
   Stapp JR, 2000, J CLIN MICROBIOL, V38, P3404, DOI 10.1128/JCM.38.9.3404-3406.2000
   Swaminathan B, 2001, EMERG INFECT DIS, V7, P382
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389
   Wessels E, 2012, 22 EUR C CLIN MICR I, P503
   Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601
NR 60
TC 4
Z9 5
U1 0
U2 13
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0891-5520
EI 1557-9824
J9 INFECT DIS CLIN N AM
JI Infect. Dis. Clin. North Am.
PD SEP
PY 2013
VL 27
IS 3
BP 535
EP +
DI 10.1016/j.idc.2013.05.001
PG 21
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 228MN
UT WOS:000325191000004
PM 24011829
DA 2020-05-07
ER

PT J
AU Zilberberg, MD
   Shorr, AF
AF Zilberberg, Marya D.
   Shorr, Andrew F.
TI Secular Trends in Gram-Negative Resistance among Urinary Tract Infection
   Hospitalizations in the United States, 2000-2009
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID INTENSIVE-CARE-UNIT; SINGLE-CENTER EXPERIENCE; NOSOCOMIAL INFECTIONS;
   ANTIMICROBIAL THERAPY; ANTIBIOTIC-TREATMENT; ORAL-THERAPY; PNEUMONIA;
   PYELONEPHRITIS; MORTALITY; PATHOGENS
AB Objective.Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge of both its general microbiology and the epidemiology of drug-resistant organisms. We sought to determine secular trends in UTI hospitalizations that involve gram-negative (GN) multidrug-resistant Pseudomonas aeruginosa (MDR-PA), extended-spectrum -lactamase (ESBL)--producing Escherichia coli (EC) and Klebsiella pneumoniae (KP), and carbapenem-resistant Enterobacteriaceae (CRE).Design.Survey.Patients.Patients with UTI in US hospitals between 2000 and 2009.Methods.We first derived the total number of UTI hospitalizations in the United States from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database years 2000--2009. Based on a literature review, we then determined what proportion of all UTIs arise due to each of the organisms of interest, irrespective of resistance pattern. Finally, we assessed the prevalence of resistance within each pathogen based on the Eurofins Surveillance Network database 2000--2009. Susceptibility patterns served as phenotypic surrogates for resistance.Results.Between 2000 and 2009, the frequency of UTI hospitalizations increased by approximately 50%, from 53 to 77 cases per 1,000 hospitalizations. Infections due to all GN bacteria followed a similar trajectory, whereas those caused by resistant GN pathogens increased by approximately 50% (MDR-PA) to approximately 300% (ESBL). CRE emerged and reached 0.5 cases per 1,000 hospitalizations in this 10-year period.Conclusions.The epidemiology and microbiology of GN UTI hospitalizations has shifted over the past decade. The proportion of all hospitalizations involving this infection has climbed. Resistant GN bacteria are becoming more prevalent and are implicated in an increasing proportion of UTIs among hospitalized patients.
C1 [Zilberberg, Marya D.] EviMed Res Grp, Goshen, MA USA.
   [Zilberberg, Marya D.] Univ Massachusetts, Amherst, MA 01003 USA.
   [Shorr, Andrew F.] Washington Hosp Ctr, Washington, DC 20010 USA.
RP Zilberberg, MD (reprint author), POB 303, Goshen, MA 01032 USA.
EM evimedgroup@gmail.com
FU Cubist Pharmaceuticals
FX This study was funded by a grant from Cubist Pharmaceuticals. The funder
   had the opportunity to review the manuscript, but their comments were
   not binding. Only the listed authors participated in the design,
   execution, and reporting of the study.
CR AlvarezLerma F, 1996, INTENS CARE MED, V22, P387, DOI 10.1007/BF01712153
   [Anonymous], 2012, HCUP NAT INP SAMPL
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011
   Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC
   Gandhi T, 2009, INFECT CONT HOSP EP, V30, P193, DOI 10.1086/593951
   Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10
   Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803
   HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988
   HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1
   Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262
   Klein E, 2007, EMERG INFECT DIS
   Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462
   Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868
   Lewis J, 2007, SIGHT SOUND, V17, P51
   Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07
   Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523
   Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07
   Moland ES, 2006, J CLIN MICROBIOL, V44, P3318, DOI 10.1128/JCM.00756-06
   Naber KG, 2009, ANTIMICROB AGENTS CH, V53, P3782, DOI 10.1128/AAC.00837-08
   Peterson J, 2007, CLIN THER, V29, P2215, DOI 10.1016/j.clinthera.2007.10.008
   Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013
   Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7
   Wells WG, 2004, J ANTIMICROB CHEMOTH, V53, P67, DOI 10.1093/jac/dkh208
   Zilberberg MD, 2008, CHEST, V134, P963, DOI 10.1378/chest.08-0842
NR 27
TC 71
Z9 74
U1 0
U2 12
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD SEP 1
PY 2013
VL 34
IS 9
BP 940
EP 946
DI 10.1086/671740
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 195LD
UT WOS:000322702900008
PM 23917908
DA 2020-05-07
ER

PT J
AU Gonnerman, MC
   Benedict, MN
   Feist, AM
   Metcalf, WW
   Price, ND
AF Gonnerman, Matthew C.
   Benedict, Matthew N.
   Feist, Adam M.
   Metcalf, William W.
   Price, Nathan D.
TI Genomically and biochemically accurate metabolic reconstruction of
   Methanosarcina barkeri Fusaro, iMG746
SO BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Metabolic flux analysis; Metabolic network; Modeling; Microbiology;
   Systems biology
ID THERMODYNAMIC ANALYSIS; REDUCTIVE DECHLORINATION; AMMONIA ASSIMILATION;
   GENOME; GROWTH; METHANOGENESIS; BIOSYNTHESIS; REVEALS; PATHWAY;
   1,2-DICHLOROETHANE
AB Methanosarcina barkeri is an Archaeon that produces methane anaerobically as the primary byproduct of its metabolism. M. barkeri can utilize several substrates for ATP and biomass production including methanol, acetate, methyl amines, and a combination of hydrogen and carbon dioxide. In 2006, a metabolic reconstruction of M. barkeri, iAF692, was generated based on a draft genome annotation. The iAF692 reconstruction enabled the first genome-Scale simulations for Archaea. Since the publication of the first metabolic reconstruction of M. barkeri, additional genomic, biochemical, and phenotypic data have clarified several metabolic pathways. We have used this newly available data to improve the M. barkeri metabolic reconstruction. Modeling simulations using the updated model, iMG746, have led to increased accuracy in predicting gene knockout phenotypes and simulations of batch growth behavior. We used the model to examine knockout lethality data and make predictions about metabolic regulation under different growth conditions. Thus, the updated metabolic reconstruction of M. barkeri metabolism is a useful tool for predicting cellular behavior, studying the methanogenic lifestyle, guiding experimental studies, and making predictions relevant to metabolic engineering applications.
C1 [Gonnerman, Matthew C.; Benedict, Matthew N.; Price, Nathan D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Feist, Adam M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.
   [Metcalf, William W.; Price, Nathan D.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Price, Nathan D.] Inst Syst Biol, Seattle, WA 98109 USA.
RP Price, ND (reprint author), Inst Syst Biol, 401 Terry Ave North, Seattle, WA 98109 USA.
EM nprice@systemsbiology.org
OI Price, Nathan/0000-0002-4157-0267
FU Energy Biosciences Institute [EBIOO0J08]
FX M. G. and M. B. participated in the reconstruction of the iMG746 model.
   M. G. performed validation studies on the model. M. G. and A. F.
   provided detailed information on the reactions in the supplemental. W.
   M. provided biological analysis on the simulated predictions of the
   model. W. M. and N. P. conceived the project and N. P. coordinated
   research efforts among all the authors. All authors participated in the
   writing and have read and approved the final paper. The authors
   gratefully acknowledge a critical reading of this paper by Julie Bletz.
   This work was funded by the Energy Biosciences Institute (grant number
   EBIOO0J08).
CR Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Benedict MN, 2012, J BACTERIOL, V194, P855, DOI 10.1128/JB.06040-11
   BOCK AK, 1995, J BACTERIOL, V177, P2002, DOI 10.1128/jb.177.8.2002-2007.1995
   Boek A.-K., 1994, ARCH MICROBIOL
   Bomar M., 1985, FEMS MICROBIOL ECOL
   Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x
   Buchenau B, 2006, J BACTERIOL, V188, P8666, DOI 10.1128/JB.01349-06
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875
   Chatwell L, 2006, J MOL BIOL, V359, P1334, DOI 10.1016/j.jmb.2006.04.045
   DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.bi.59.070190.002035
   EISENREICH W, 1992, J BIOL CHEM, V267, P17574
   Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046
   Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949
   Ferguson T, 2009, J BIOL CHEM, V284, P2285, DOI 10.1074/jbc.M807392200
   Finley SD, 2009, BIOTECHNOL BIOENG, V103, P532, DOI 10.1002/bit.22285
   Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003
   Graham DE, 2009, BIOCHEM J, V424, P467, DOI 10.1042/BJ20090999
   Grochowski LL, 2007, BIOCHEMISTRY-US, V46, P6658, DOI 10.1021/bi700052a
   Grochowski LL, 2009, BIOCHEMISTRY-US, V48, P4181, DOI 10.1021/bi802341p
   Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720
   HOLLIGER C, 1992, J BACTERIOL, V174, P4427, DOI 10.1128/JB.174.13.4427-4434.1992
   Holliger C, 1990, BIODEGRADATION, V1, P253, DOI 10.1007/BF00119762
   Hutten T. J., 1980, A VANLEEUWENHOEK
   Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784
   Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200
   KANDLER O, 1977, ARCH MICROBIOL, V113, P57, DOI 10.1007/BF00428580
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   KENEALY WR, 1982, J BACTERIOL, V150, P1357, DOI 10.1128/JB.150.3.1357-1365.1982
   Kezmarsky ND, 2005, BBA-GEN SUBJECTS, V1722, P175, DOI 10.1016/j.bbagen.2004.12.003
   Kohler PRA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00259
   Koschorreck M, 2010, FEMS MICROBIOL ECOL, V73, P385, DOI 10.1111/j.1574-6941.2010.00886.x
   Kulkarni G, 2009, P NATL ACAD SCI USA, V106, P15915, DOI 10.1073/pnas.0905914106
   Liu JS, 2001, BIOTECHNOL BIOENG, V75, P170, DOI 10.1002/bit.1176
   Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   MAZUMDER TK, 1986, APPL ENVIRON MICROB, V52, P617, DOI 10.1128/AEM.52.4.617-622.1986
   Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499
   Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77
   RAEMAKERSFRANKEN PC, 1991, ANTON LEEUW INT J G, V59, P243, DOI 10.1007/BF00583677
   Rajoka M. I., 1998, BIORESOURCE TECHNOL
   Ranalli G., 1986, FEMS MICROBIOL ECOL
   Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769
   Rodgers J. E., 1991, MICROBIAL PRODUCTION
   Sasaki K, 2010, APPL MICROBIOL BIOT, V86, P1573, DOI 10.1007/s00253-010-2469-7
   Seth-Smith H, 2007, NAT REV MICROBIOL, V5, P248, DOI 10.1038/nrmicro1644
   SILVEIRA RG, 1991, J FERMENT BIOENG, V71, P28, DOI 10.1016/0922-338X(91)90299-V
   Smith M. R., 1978, APPL ENV MICROBIOL
   SOWERS KR, 1984, CURR MICROBIOL, V11, P227, DOI 10.1007/BF01567165
   Storbeck S, 2010, ARCHAEA, DOI 10.1155/2010/175050
   Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931
   Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203
   VANDERMEIJDEN P, 1984, J BACTERIOL, V160, P629, DOI 10.1128/JB.160.2.629-635.1984
   WEIMER PJ, 1978, ARCH MICROBIOL, V119, P49, DOI 10.1007/BF00407927
   Welander PV, 2008, J BACTERIOL, V190, P1928, DOI 10.1128/JB.01424-07
   Welander PV, 2005, P NATL ACAD SCI USA, V102, P10664, DOI 10.1073/pnas.0502623102
   WHITE RH, 1988, BIOCHEMISTRY-US, V27, P4415, DOI 10.1021/bi00412a031
   Yokooji Y, 2009, J BIOL CHEM, V284, P28137, DOI 10.1074/jbc.M109.009696
NR 63
TC 21
Z9 22
U1 2
U2 41
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-6768
EI 1860-7314
J9 BIOTECHNOL J
JI Biotechnol. J.
PD SEP
PY 2013
VL 8
IS 9
SI SI
BP 1070
EP U129
DI 10.1002/biot.201200266
PG 11
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 260JD
UT WOS:000327590100011
PM 23420771
DA 2020-05-07
ER

PT J
AU Rath, CM
   Yang, JY
   Alexandrov, T
   Dorrestein, PC
AF Rath, Christopher M.
   Yang, Jane Y.
   Alexandrov, Theodore
   Dorrestein, Pieter C.
TI Data-Independent Microbial Metabolomics with Ambient Ionization Mass
   Spectrometry
SO JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
LA English
DT Article
DE Ambient mass spectrometry; Data-independent MS/MS; FTICR-MS; MALDI-TOF
   IMS; Metabolomics; Microbiology; MS/MS molecular networking; NanoDESI
ID DESORPTION ELECTROSPRAY-IONIZATION; BACILLUS-SUBTILIS;
   PSEUDOMONAS-AERUGINOSA; DRUG DISCOVERY; VIRULENCE; EXCHANGE;
   MICROORGANISMS; PROTEOMICS; NETWORKS; BACTERIA
AB Atmospheric ionization methods are ideally suited for prolonged MS/MS analysis. Data-independent MS/MS is a complementary technique for analysis of biological samples as compared to data-dependent analysis. Here, we pair data-independent MS/MS with the ambient ionization method nanospray desorption electrospray ionization (nanoDESI) for untargeted analysis of bacterial metabolites. Proof-of-principle data and analysis are illustrated by sampling Bacillus subtilis and Pseudomonas aeruginosa directly from Petri dishes. We found that this technique enables facile comparisons between strains via MS and MS/MS plots which can be translated to chemically informative molecular maps through MS/MS networking. The development of novel techniques to characterize microbial metabolites allows rapid and efficient analysis of metabolic exchange factors. This is motivated by our desire to develop novel techniques to explore the role of interspecies interactions in the environment, health, and disease. This is a contribution to honor Professor Catherine C. Fenselau in receiving the prestigious ASMS Award for a Distinguished Contribution in Mass Spectrometry for her pioneering work on microbial mass spectrometry.
C1 [Rath, Christopher M.; Alexandrov, Theodore; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Yang, Jane Y.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Alexandrov, Theodore] Univ Bremen, Ctr Ind Math, D-28359 Bremen, Germany.
RP Dorrestein, PC (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
EM pdorrestein@ucsd.edu
OI Alexandrov, Theodore/0000-0001-9464-6125
FU Bruker Therapeutic Discovery Mass Spectrometry Center; NIH GMUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [S10RR029121]; European UnionEuropean Union (EU)
   [305259]
FX This work was made possible by the Keck Foundation and NIH AI095125.
   Instrumentation used in this study is supported by Bruker Therapeutic
   Discovery Mass Spectrometry Center and NIH GM S10RR029121. T.A. and
   P.C.D. acknowledge financial support from the European Union 7th
   Framework Program (grants 305259). Dr. Eoin Fahy is thanked for
   additional assistance with Perl scripts.
CR Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j
   Demirev PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/annurev.anchem.1.031207.112838
   Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761
   Geiger T, 2010, MOL CELL PROTEOMICS, V9, P2252, DOI 10.1074/mcp.M110.001537
   Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717
   Harris GA, 2011, ANAL CHEM, V83, P4508, DOI 10.1021/ac200918u
   Hatsis P, 2008, RAPID COMMUN MASS SP, V22, P735, DOI 10.1002/rcm.3416
   HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Korfmacher WA, 2005, DRUG DISCOV TODAY, V10, P1357, DOI 10.1016/S1359-6446(05)03620-2
   Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90
   Li T.Y., 2000, P NATL ACAD SCI USA, V14, P2393
   Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107
   Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r
   Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309
   Panchaud A, 2009, ANAL CHEM, V81, P6481, DOI 10.1021/ac900888s
   Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550
   Purvine S, 2003, PROTEOMICS, V3, P847, DOI 10.1002/pmic.200300362
   RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262
   Rath CM, 2012, ANAL CHEM, V84, P9259, DOI 10.1021/ac302039u
   Rath CM, 2012, CURR OPIN MICROBIOL, V15, P147, DOI 10.1016/j.mib.2011.12.009
   Rath CM, 2011, ACS CHEM BIOL, V6, P1244, DOI 10.1021/cb200244t
   Roach PJ, 2010, ANALYST, V135, P2233, DOI 10.1039/c0an00312c
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Song YS, 2007, CHEM COMMUN, P61, DOI 10.1039/b615724f
   Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120
   Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404
   Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705
   Vestal ML, 2011, J AM SOC MASS SPECTR, V22, P953, DOI 10.1007/s13361-011-0108-x
   Wang J, 2004, LETT APPL MICROBIOL, V39, P98, DOI 10.1111/j.1472-765X.2004.01547.x
   Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109
   Yang JY, 2012, J BACTERIOL, V194, P6023, DOI 10.1128/JB.00823-12
   Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252
   YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1
   Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08
NR 36
TC 16
Z9 16
U1 1
U2 81
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1044-0305
EI 1879-1123
J9 J AM SOC MASS SPECTR
JI J. Am. Soc. Mass Spectrom.
PD AUG
PY 2013
VL 24
IS 8
BP 1167
EP 1176
DI 10.1007/s13361-013-0608-y
PG 10
WC Biochemical Research Methods; Chemistry, Analytical; Chemistry,
   Physical; Spectroscopy
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA 184VZ
UT WOS:000321923100003
PM 23568029
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Muller, M
   Cassonnet, P
   Favre, M
   Jacob, Y
   Demeret, C
AF Muller, Mandy
   Cassonnet, Patricia
   Favre, Michel
   Jacob, Yves
   Demeret, Caroline
TI A Comparative Approach to Characterize the Landscape of Host-Pathogen
   Protein-Protein Interactions
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology; Issue 77; Genetics; Microbiology; Biochemistry; Molecular
   Biology; Cellular Biology; Biomedical Engineering; Infection; Cancer
   Biology; Virology; Medicine; Host-Pathogen Interactions; Host-Pathogen
   Interactions; Protein-protein interaction; High-throughput screening;
   Luminescence; Yeast two-hybrid; HT-GPCA; Network; protein; yeast; cell;
   culture
AB Significant efforts were gathered to generate large-scale comprehensive protein-protein interaction network maps. This is instrumental to understand the pathogen-host relationships and was essentially performed by genetic screenings in yeast two-hybrid systems. The recent improvement of protein-protein interaction detection by a Gaussia luciferase-based fragment complementation assay now offers the opportunity to develop integrative comparative interactomic approaches necessary to rigorously compare interaction profiles of proteins from different pathogen strain variants against a common set of cellular factors.
   This paper specifically focuses on the utility of combining two orthogonal methods to generate protein-protein interaction datasets: yeast two-hybrid (Y2H) and a new assay, high-throughput Gaussia princeps protein complementation assay (HT-GPCA) performed in mammalian cells.
   A large-scale identification of cellular partners of a pathogen protein is performed by mating-based yeast two-hybrid screenings of cDNA libraries using multiple pathogen strain variants. A subset of interacting partners selected on a high-confidence statistical scoring is further validated in mammalian cells for pair-wise interactions with the whole set of pathogen variants proteins using HT-GPCA. This combination of two complementary methods improves the robustness of the interaction dataset, and allows the performance of a stringent comparative interaction analysis. Such comparative interactomics constitute a reliable and powerful strategy to decipher any pathogen-host interplays.
C1 [Muller, Mandy; Cassonnet, Patricia; Favre, Michel; Jacob, Yves; Demeret, Caroline] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain GPCH, Paris, France.
   [Muller, Mandy] Univ Sorbonne Paris Cite, Paris, France.
   [Jacob, Yves] Harvard Univ, Sch Med, Dana Farber Canc Inst, CCSB,Dept Canc Biol, Cambridge, MA 02138 USA.
RP Demeret, C (reprint author), Inst Pasteur, Unite Genet Papillomavirus & Canc Humain GPCH, Paris, France.
EM caroline.demeret@pasteur.fr
RI Muller, Mandy/AAD-1126-2019
OI Muller, Mandy/0000-0002-0056-3589; Demeret, caroline/0000-0002-1103-6805
FU Institut Pasteur; Ligue nationale contre le CancerLigue nationale contre
   le cancer [R05/75-129, RS07/75-75]; Association pour la Recherche sur le
   CancerFondation ARC pour la Recherche sur le CancerAustralian Research
   Council [ARC A09/1/5031, 4867]; Agence Nationale de la RechercheFrench
   National Research Agency (ANR) [ANR07 MIME 009 02, ANR09 MIEN 026 01];
   M.E.N.R.T fellowship
FX This work was supported in part by funding from the Institut Pasteur and
   by grants from the Ligue nationale contre le Cancer (grants R05/75-129
   and RS07/75-75), the Association pour la Recherche sur le Cancer (grants
   ARC A09/1/5031 and 4867), and the Agence Nationale de la Recherche
   (ANR07 MIME 009 02 and ANR09 MIEN 026 01). M.M was a recipient of a
   M.E.N.R.T fellowship.
CR Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]
   Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104
   Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773
   Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002
   de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66
   Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761
   Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029
   Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Simonis N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-26
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Venkatesan K, 2009, NAT METHODS, V6, P83, DOI [10.1038/nmeth.1280, 10.1038/NMETH.1280]
NR 15
TC 2
Z9 2
U1 0
U2 4
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUL
PY 2013
IS 77
AR e50404
DI 10.3791/50404
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36RG
UT WOS:000209227900017
PM 23893119
OA Green Published
DA 2020-05-07
ER

PT J
AU Konwar, KM
   Hanson, NW
   Page, AP
   Hallam, SJ
AF Konwar, Kishori M.
   Hanson, Niels W.
   Page, Antoine P.
   Hallam, Steven J.
TI MetaPathways: a modular pipeline for constructing pathway/genome
   databases from environmental sequence information
SO BMC BIOINFORMATICS
LA English
DT Article
DE Environmental pathway/Genome Database (ePGDB); Metagenome; Pathway
   tools; PathoLogic; MetaCyc; Microbial community; Metabolism; Metabolic
   interaction networks
ID DATA-MANAGEMENT; RAST SERVER; DATA SETS; RESOURCE; GENES; IMG/M; KEGG
AB Background: A central challenge to understanding the ecological and biogeochemical roles of microorganisms in natural and human engineered ecosystems is the reconstruction of metabolic interaction networks from environmental sequence information. The dominant paradigm in metabolic reconstruction is to assign functional annotations using BLAST. Functional annotations are then projected onto symbolic representations of metabolism in the form of KEGG pathways or SEED subsystems.
   Results: Here we present MetaPathways, an open source pipeline for pathway inference that uses the PathoLogic algorithm to map functional annotations onto the MetaCyc collection of reactions and pathways, and construct environmental Pathway/Genome Databases (ePGDBs) compatible with the editing and navigation features of Pathway Tools. The pipeline accepts assembled or unassembled nucleotide sequences, performs quality assessment and control, predicts and annotates noncoding genes and open reading frames, and produces inputs to PathoLogic. In addition to constructing ePGDBs, MetaPathways uses MLTreeMap to build phylogenetic trees for selected taxonomic anchor and functional gene markers, converts General Feature Format (GFF) files into concatenated GenBank files for ePGDB construction based on third-party annotations, and generates useful file formats including Sequin files for direct GenBank submission and gene feature tables summarizing annotations, MLTreeMap trees, and ePGDB pathway coverage summaries for statistical comparisons.
   Conclusions: MetaPathways provides users with a modular annotation and analysis pipeline for predicting metabolic interaction networks from environmental sequence information using an alternative to KEGG pathways and SEED subsystems mapping. It is extensible to genomic and transcriptomic datasets from a wide range of sequencing platforms, and generates useful data products for microbial community structure and function analysis. The MetaPathways software package, installation instructions, and example data can be obtained from http://hallam.microbiology.ubc.ca/MetaPathways.
C1 [Konwar, Kishori M.; Page, Antoine P.; Hallam, Steven J.] Univ British Columbia, Dept Microbiol Immunol, Vancouver, BC V6T1Z3, Canada.
   [Hanson, Niels W.; Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC, Canada.
RP Hallam, SJ (reprint author), Univ British Columbia, Dept Microbiol Immunol, Vancouver, BC V6T1Z3, Canada.
EM shallam@mail.ubc.ca
OI Hanson, Niels William/0000-0003-3081-0736
FU Tula Foundation; Centre for Microbial Diversity and Evolution (CMDE) at
   UBC; Genome CanadaGenome Canada; Genome British Columbia; Natural
   Science and Engineering Research Council (NSERC) of CanadaNatural
   Sciences and Engineering Research Council of Canada; Canadian Foundation
   for Innovation (CFI)Canada Foundation for Innovation; Canadian Institute
   for Advanced Research (CIFAR)Canadian Institute for Advanced Research
   (CIFAR)
FX This work was carried out under the auspices of Genome Canada, Genome
   British Columbia, the Natural Science and Engineering Research Council
   (NSERC) of Canada, the Canadian Foundation for Innovation (CFI) and the
   Canadian Institute for Advanced Research (CIFAR). The Western Canadian
   Research Grid (WestGrid) provided access to high-performance computing
   resources. KMK was supported by the Tula Foundation funded Centre for
   Microbial Diversity and Evolution (CMDE) at UBC. We would like to thank
   Charles Howes and Simon Eng for technical support, Peter Karp and the
   SRI International staff for invaluable comments related to design ethos
   and implementation of MetaPathways, and Dr. Julia Foght at the
   University of Alberta for providing genomic sequence information from a
   Naptha-degrading enrichment culture used in pipeline performance
   evaluation.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961
   Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014
   Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847
   Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15
   DeLong EF, 2002, ENVIRON MICROBIOL, V4, P9, DOI 10.1046/j.1462-2920.2002.t01-12-00257.x
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213
   Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544
   Gentzsch W, 2001, FIRST IEEE/ACM INTERNATIONAL SYMPOSIUM ON CLUSTER COMPUTING AND THE GRID, PROCEEDINGS, P35, DOI 10.1109/CCGRID.2001.923173
   Goll J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029044
   Henry CS, 2011, BBA-GEN SUBJECTS, V1810, P967, DOI 10.1016/j.bbagen.2011.03.010
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Kalyanaraman A, 2003, NUCLEIC ACIDS RES, V31, P2963, DOI 10.1093/nar/gkg379
   Kalyanaraman A, 2011, BIOINFORMATICS, V27, P3072, DOI 10.1093/bioinformatics/btr523
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56
   Karp PD, 2011, STAND GENOMIC SCI, V5, P424, DOI 10.4056/sigs.1794338
   Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225
   Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08
   Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]
   Larsen Peter E, 2011, Microb Inform Exp, V1, P4, DOI 10.1186/2042-5783-1-4
   Latendresse M, 2012, BIOINFORMATICS, V28, P388, DOI 10.1093/bioinformatics/btr681
   Latendresse M, 2012, METHODS MOL BIOL, V804, P197, DOI 10.1007/978-1-61779-361-5_11
   Latendresse M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq006
   Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955
   Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975
   Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698
   Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334
   Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864
   Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137
   Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2
   Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075
   Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461
   Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22
   Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667
   Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778
   Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465
   Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016
NR 53
TC 53
Z9 53
U1 0
U2 43
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD JUN 21
PY 2013
VL 14
AR 202
DI 10.1186/1471-2105-14-202
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 172YH
UT WOS:000321042700001
PM 23800136
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Goossens, MC
   Catry, B
   Verhaegen, J
AF Goossens, M. C.
   Catry, B.
   Verhaegen, J.
TI Antimicrobial resistance to benzylpenicillin in invasive pneumococcal
   disease in Belgium, 2003-2010: the effect of altering clinical
   breakpoints
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Antibiotic resistance; clinical microbiology; Streptococcus pneumoniae
   (pneumococcus); surveillance system
ID STREPTOCOCCUS-PNEUMONIAE
AB The Belgian data (2003-2010) for the European Antimicrobial Resistance Surveillance Network (EARS-Net) showed a significant decreasing trend in the proportion of penicillin non-susceptible Streptococcus pneumoniae (9.4% to <1%) from blood and CSF isolates. We found that 75% of this decrease was explained by a change in Clinical and Laboratory Standards Institute (CLSI) breakpoints as the trend disappeared if only the new breakpoints were applied. Applying only European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints also resulted in a relatively stable proportion of penicillin non-susceptibility (average 5%), but this proportion was 7-13 times higher than with the new CLSI breakpoints. When the new CLSI breakpoints alone are used, fewer than 1% of bacteraemia isolates were penicillin non-susceptible during the entire period, but the proportion of non-susceptible meningitis isolates rose from 6.3% in 2003 to 15.9% between 2003 and 2010. Changing breakpoints should lead to retrospective analysis of historical data to minimize wrongly interpreting resistance trends.
C1 [Goossens, M. C.; Catry, B.] Healthcare Associated Infect & Antimicrobial Resi, Sci Inst Publ Hlth, B-1050 Brussels, Belgium.
   [Verhaegen, J.] Univ Hosp, Belgian Natl Reference Lab Pneumococci, Louvain, Belgium.
RP Goossens, MC (reprint author), Healthcare Associated Infect & Antimicrobial Resi, Sci Inst Publ Hlth, Rue Juliette Wytsmanstraat 14, B-1050 Brussels, Belgium.
EM Mat.goossens@wiv-isp.be
OI Catry, Boudewijn/0000-0002-8700-7138
CR *CLSI, 2005, M100S15 CLSI
   Drlica K, 2011, ANTIBIOTIC RESISTANC, P55
   European Centre for Disease Prevention and Control (ECDC), 2010, ANT RES SURV EUR 201
   Karlsson D, 2011, EPIDEMIOL INFECT, V139, P1351, DOI 10.1017/S0950268810002773
   MARSHALL KJ, 1993, J CLIN MICROBIOL, V31, P1246, DOI 10.1128/JCM.31.5.1246-1250.1993
   Masiero G, 2010, INT J PUBLIC HEALTH, V55, P469, DOI 10.1007/s00038-010-0167-y
   Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021
   Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P1353
   Van Kerkhoven D, 2003, J ANTIMICROB CHEMOTH, V51, P691, DOI 10.1093/jac/dkg116
   Weinstein MP, 2009, CLIN INFECT DIS, V48, P1596, DOI 10.1086/598975
NR 10
TC 9
Z9 9
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAR
PY 2013
VL 141
IS 3
BP 490
EP 495
DI 10.1017/S0950268812001057
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 095ZX
UT WOS:000315374600006
PM 22677465
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU De Jesus, M
   Ahlawat, S
   Mantis, NJ
AF De Jesus, Magdia
   Ahlawat, Sarita
   Mantis, Nicholas J.
TI Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine
   Peyer's Patches
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Infection; Issue 73; Infectious Diseases; Immunology; Microbiology;
   Medicine; Cellular Biology; Surgery; Bacterial Infections and Mycoses;
   Immune System Diseases; Digestive System Diseases; Peyer's patch;
   intestine; Mucosal; lymphoid tissue; lymphocyte; Dendritic; flow
   cytometry; cryosectioning; oral gavage; immunostaining; isolation; cell
   culture; animal model
ID SUBEPITHELIAL DOME; T-CELL; MUCOSAL; HOMEOSTASIS
AB Peyer's patches (PPs) are integral components of the gut-associated lymphoid tissues (GALT) and play a central role in intestinal immunosurveillance and homeostasis. Particulate antigens and microbes in the intestinal lumen are continuously sampled by PP M cells in the follicle-associated epithelium (FAE) and transported to an underlying network of dendritic cells (DCs), macrophages, and lymphocytes. In this article, we describe protocols in which murine PPs are (i) dissociated into single cell suspensions and subjected to flow cytometry and (ii) prepared for cryosectioning and immunostaining. For flow cytometry, PPs are mechanically dissociated and then filtered through 70 mu m membranes to generate single cell suspensions free of epithelial cells and large debris. Starting with 20-25 PPs (from four mice), this quick and reproducible method yields a population of >2.5 x 10(6) cells with >90% cell viability. For cryosectioning, freshly isolated PPs are immersed in Optimal Cutting Temperature (OCT) medium, snap-frozen in liquid nitrogen, and then sectioned using a cryomicrotome. Tissue sections (5-12 mu m) are air-dried, fixed with acetone or methanol, and then subjected to immunolabeling.
C1 [De Jesus, Magdia; Ahlawat, Sarita; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Albany, NY 12237 USA.
RP Mantis, NJ (reprint author), New York State Dept Hlth, Div Infect Dis, Albany, NY 12237 USA.
EM nmantis@wadsworth.org
OI Mantis, Nicholas/0000-0002-5083-8640
FU Life Sciences Research Foundation, Howard Hughes Medical Institute
   (HHMI) Fellowship; Wadsworth Center-Health Research Inc. intramural
   postdoctoral fellowship; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HD061916, GM082978]
FX MDJ is supported by the Life Sciences Research Foundation, Howard Hughes
   Medical Institute (HHMI) Fellowship. SA is supported by a Wadsworth
   Center-Health Research Inc. intramural postdoctoral fellowship. This
   work was supported in part by NIH grants HD061916 and GM082978.
CR Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793
   Fukuda S, 2011, JOVE-J VIS EXP, DOI 10.3791/3225
   Geem D, 2012, JOVE-J VIS EXP, DOI 10.3791/4040
   Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381
   Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634
   Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237
   Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039
   Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051
   Lopez-Guerrero DV, 2010, J VIROL, V84, P1856, DOI 10.1128/JVI.02640-08
   Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41
   Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004
   Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134
   Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003
   Suzuki K, 2010, ADV IMMUNOL, V107, P153, DOI [10.1016/B978-0-12-381300-8.00006-X, 10.1016/S0065-277600)07003-3]
NR 14
TC 15
Z9 16
U1 0
U2 11
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAR
PY 2013
IS 73
AR UNSP e50167
DI 10.3791/50167
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QW
UT WOS:000209226900023
PM 23525039
OA Green Published
DA 2020-05-07
ER

PT J
AU Monteferrante, CG
   MacKichan, C
   Marchadier, E
   Prejean, MV
   Carballido-Lopez, R
   van Dijl, JM
AF Monteferrante, Carmine G.
   MacKichan, Calum
   Marchadier, Elodie
   Prejean, Maria-Victoria
   Carballido-Lopez, Rut
   van Dijl, Jan Maarten
TI Mapping the twin-arginine protein translocation network of Bacillus
   subtilis
SO PROTEOMICS
LA English
DT Article
DE CsbC; HemAT; Microbiology; PhoD; WprA; YwbN
ID SIGNAL PEPTIDE; ESCHERICHIA-COLI; DNA-REPLICATION; FOLDED PROTEINS;
   EXPORT PATHWAY; TATA SUBUNIT; SECRETION; LOCALIZATION; SYSTEM; REVEALS
AB Bacteria employ twin-arginine translocation (Tat) pathways for the transport of folded proteins to extracytoplasmic destinations. In recent years, most studies on bacterial Tat pathways addressed the membrane-bound TatA(B)C subunits of the Tat translocase, and the specific interactions between this translocase and its substrate proteins. In contrast, relatively few studies investigated possible coactors in the TatA(B)C-dependent protein translocation process. The present studies were aimed at identifying interaction partners of the Tat pathway of Bacillus subtilis, which is a paradigm for studies on protein secretion by Gram-positive bacteria. Specifically, 36 interaction partners of the TatA and TatC subunits were identified by rigorous application of the yeast two-hybrid (Y2H) approach. Our Y2H analyses revealed that the three TatA isoforms of B. subtilis can form homo- and heterodimers. Subsequently, the secretion of the Tat substrates YwbN and PhoD was tested in mutant strains lacking genes for the TatAC interaction partners identified in our genome-wide Y2H screens. Our results show that the cell wall-bound protease WprA is important for YwbN secretion, and that the HemAT and CsbC proteins are required for PhoD secretion under phosphate starvation conditions. Taken together, our findings imply that the Bacillus Tat pathway is embedded in an intricate proteinprotein interaction network.
C1 [Monteferrante, Carmine G.; Prejean, Maria-Victoria; van Dijl, Jan Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands.
   [MacKichan, Calum; Marchadier, Elodie; Carballido-Lopez, Rut] INRA, Micalis UMR1319, Jouy En Josas, France.
RP van Dijl, JM (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.
EM j.m.van.dijl01@umcg.nl
RI MARCHADIER, Elodie/AAC-8416-2019; LOPEZ, RUT CARBALLIDO/G-2283-2015; van
   Dijl, Jan Maarten/G-1205-2013
OI MARCHADIER, Elodie/0000-0001-5618-6471; LOPEZ, RUT
   CARBALLIDO/0000-0001-9383-8811; 
FU CEU [PITN-GA-2008-215524 (TranSys), LSHG-CT-2006-037469, 244093]; French
   National Research AgencyFrench National Research Agency (ANR)
   [ANR-08-JCJC-0024-01]; Fondation pour la Recherche MedicaleFondation
   pour la Recherche Medicale [FDT20111223619]; Research Council for Earth
   and Life Sciences of the Netherlands Organization for Scientific
   Research through the transnational project BACELL [SysMO2]
FX The authors thank Marcus Miethke for providing FeuA-specific antibodies,
   Jeanine de Keyzer, and Arnold Driessen for PhoB-specific antibodies,
   Jorg Muller for PhoD- and TatAd-specific antibodies, and Colin Harwood
   for WprA-specific antibodies. C.G.M., C.M, E.M., R.C.-L., and J.M.v.D
   were in parts supported by the CEU through projects PITN-GA-2008-215524
   (TranSys), LSHG-CT-2006-037469 and 244093, the French National Research
   Agency (ANR-08-JCJC-0024-01 to R.C.-L.), the Fondation pour la Recherche
   Medicale (grant FDT20111223619 to C.M.) and the Research Council for
   Earth and Life Sciences of the Netherlands Organization for Scientific
   Research through the transnational project BACELL SysMO2 (to J.M.v.D.).
CR Akbar S, 1999, MICROBIOL-UK, V145, P1069, DOI 10.1099/13500872-145-5-1069
   Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8
   Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801
   Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355
   BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139
   Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x
   Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200
   Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x
   Bolhuis A, 1999, J BIOL CHEM, V274, P15865, DOI 10.1074/jbc.274.22.15865
   Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6
   BRON S, 1972, MUTAT RES, V15, P395, DOI 10.1016/0027-5107(72)90004-8
   Cannistraro VJ, 2011, J BACTERIOL, V193, P3220, DOI 10.1128/JB.01255-10
   Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017
   Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982
   Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11
   Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004
   Eijlander RT, 2009, J BACTERIOL, V191, P196, DOI 10.1128/JB.01264-08
   Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202
   Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001
   Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570
   James P, 1996, GENETICS, V144, P1425
   Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001
   Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200
   Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200
   Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x
   Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100
   Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08
   Krishnappa L, 2012, APPL ENVIRON MICROB, V78, P7801, DOI 10.1128/AEM.02023-12
   Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786
   KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995
   Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]
   Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0
   Marchadier E, 2011, PROTEOMICS, V11, P2981, DOI 10.1002/pmic.201000791
   Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512
   Meissner D, 2007, APPL MICROBIOL BIOT, V76, P633, DOI 10.1007/s00253-007-0934-8
   Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190
   Monteferrante CG, 2012, APPL ENVIRON MICROB, V78, P4999, DOI 10.1128/AEM.01108-12
   Muller J. P., 1997, MICROBIOLOGY, V14, P3947
   Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848
   Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799
   ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417
   Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002
   Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814
   Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200
   Ridder ANJA, 2009, J BACTERIOL, V191, P4410, DOI 10.1128/JB.00215-09
   Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591
   Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004
   Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000
   van der Ploeg R, 2012, APPL ENVIRON MICROB, V78, P7733, DOI 10.1128/AEM.02093-12
   van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824
   van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140
   Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x
   Zweers JC, 2009, APPL ENVIRON MICROB, V75, P7356, DOI 10.1128/AEM.01560-09
NR 57
TC 10
Z9 10
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD MAR
PY 2013
VL 13
IS 5
BP 800
EP 811
DI 10.1002/pmic.201200416
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 104CK
UT WOS:000315967000009
PM 23180473
DA 2020-05-07
ER

PT J
AU Steinberg, JP
   Robichaux, C
   Tejedor, SC
   Reyes, MD
   Jacob, JT
AF Steinberg, James P.
   Robichaux, Chad
   Tejedor, Sheri Chernetsky
   Reyes, Mary Dent
   Jacob, Jesse T.
TI Distribution of Pathogens in Central Line-Associated Bloodstream
   Infections among Patients with and without Neutropenia following
   Chemotherapy: Evidence for a Proposed Modification to the Current
   Surveillance Definition
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID BACTERIAL TRANSLOCATION; GASTROINTESTINAL TRACTS; PREVENTION;
   BACTEREMIA; RATES
AB OBJECTIVE. Many bloodstream infections (BSIs) occurring in patients with febrile neutropenia following cytotoxic chemotherapy are due to translocation of intestinal microbiota. However, these infections meet the National Healthcare Safety Network (NHSN) definition of central line-associated BSIs (CLABSIs). We sought to determine the differences in the microbiology of NHSN-defined CLABSIs in patients with and without neutropenia and, using these data, to propose a modification of the CLABSI definition.
   DESIGN. Retrospective review.
   SETTING. Two large university hospitals over 18 months.
   METHODS. All hospital-acquired BSIs occurring in patients with central venous catheters in place were classified using the NHSN CLABSI definition. Patients with postchemotherapy neutropenia (500 neutrophils/mm(3) or lower) at the time of blood culture were considered neutropenic. Pathogens overrepresented in the neutropenic group were identified to inform development of a modified CLABSI definition.
   RESULTS. Organisms that were more commonly observed in the neutropenic group compared with the nonneutropenic group included Escherichia coli (22.7% vs 2.5%; P < .001) but not other Enterobacteriaceae, Enterococcus faecium (18.2% vs 6.1%; P = .002), and streptococci (18.2% vs 0%; P < .001). Application of a modified CLABSI definition (removing BSI with enterococci, streptococci, or E. coli) excluded 33 of 66 neutropenic CLABSIs and decreased the CLABSI rate in one study hospital with large transplant and oncology populations from 2.12 to 1.79 cases per 1,000 line-days.
   CONCLUSIONS. Common gastrointestinal organisms were more common in the neutropenia group, suggesting that many BSIs meeting the NHSN criteria for CLABSI in the setting of neutropenia may represent translocation of gut organisms. These findings support modification of the NHSN CLABSI definition. Infect Control Hosp Epidemiol 2013; 34(2): 171-175
C1 [Steinberg, James P.; Reyes, Mary Dent; Jacob, Jesse T.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Robichaux, Chad] Emory Healthcare, Atlanta, GA USA.
   [Tejedor, Sheri Chernetsky] Emory Univ, Sch Med, Dept Med, Div Hosp Med, Atlanta, GA USA.
RP Steinberg, JP (reprint author), Med Off Tower,5th Floor,550 Peachtree St NE, Atlanta, GA 30308 USA.
EM jstei02@emory.edu
RI Jacob, Jesse/A-8836-2009; jacob, jesse/P-5664-2019
OI jacob, jesse/0000-0001-9811-6260
FU Baxter Healthcare
FX The data set used for this study was developed for an
   investigator-initiated study funded by Baxter Healthcare.
CR BERG RD, 1983, CURR MICROBIOL, V8, P285, DOI 10.1007/BF01577729
   Cairo J, 2011, CLIN MICROBIOL INFEC, V17, P1711, DOI 10.1111/j.1469-0691.2011.03504.x
   Fatica C, 2011, PRESENTED AT 21ST AN
   Fraser TG, 2011, CLIN INFECT DIS, V52, P1446, DOI 10.1093/cid/cir200
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059
   MONTGOMERIE JZ, 1970, LANCET, V2, P787
   O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003
   PENN RL, 1985, INFECT IMMUN, V47, P793, DOI 10.1128/IAI.47.3.793-798.1985
   Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243
   STEFFEN EK, 1988, J INFECT DIS, V157, P1032, DOI 10.1093/infdis/157.5.1032
   TANCREDE CH, 1985, J INFECT DIS, V152, P99, DOI 10.1093/infdis/152.1.99
   Thoeni RF, 2006, RADIOLOGY, V240, P623, DOI 10.1148/radiol.2403050818
   Wiest R, 2003, BEST PRACT RES CL GA, V17, P397, DOI 10.1016/S1521-6918(03)00024-6
NR 16
TC 35
Z9 36
U1 0
U2 14
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD FEB
PY 2013
VL 34
IS 2
BP 171
EP 175
DI 10.1086/669082
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 068KS
UT WOS:000313366200010
PM 23295563
DA 2020-05-07
ER

PT J
AU Schulz, S
   Brankatschk, R
   Dumig, A
   Kogel-Knabner, I
   Schloter, M
   Zeyer, J
AF Schulz, S.
   Brankatschk, R.
   Duemig, A.
   Koegel-Knabner, I.
   Schloter, M.
   Zeyer, J.
TI The role of microorganisms at different stages of ecosystem development
   for soil formation
SO BIOGEOSCIENCES
LA English
DT Article
ID AMMONIA-OXIDIZING BACTERIA; DAMMA GLACIER FOREFIELD; ALPINA L. HEYWOOD;
   MICROBIAL COMMUNITIES; PRIMARY SUCCESSION; ARCTIC GLACIER; NUTRIENT
   LIMITATION; CRYPTOGAMIC CRUSTS; SEEDLING EMERGENCE; COLORADO PLATEAU
AB Soil formation is the result of a complex network of biological as well as chemical and physical processes. The role of soil microbes is of high interest, since they are responsible for most biological transformations and drive the development of stable and labile pools of carbon (C), nitrogen (N) and other nutrients, which facilitate the subsequent establishment of plant communities. Forefields of receding glaciers provide unique chronosequences of different soil development stages and are ideal ecosystems to study the interaction of bacteria, fungi and archaea with their abiotic environment. In this review we give insights into the role of microbes for soil development. The results presented are based on studies performed within the Collaborative Research Program DFG SFB/TRR 38 (http://www.tu-cottbus.de/ecosystem) and are supplemented by data from other studies. The review focusses on the microbiology of major steps of soil formation. Special attention is given to the development of nutrient cycles on the formation of biological soil crusts (BSCs) and on the establishment of plant-microbe interactions.
C1 [Schulz, S.; Schloter, M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Environm Genom, D-85764 Neuherberg, Germany.
   [Brankatschk, R.; Zeyer, J.] ETH, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland.
   [Duemig, A.; Koegel-Knabner, I.] Tech Univ Munich, Lehrstuhl Bodenkunde, D-85350 Freising Weihenstephan, Germany.
   [Koegel-Knabner, I.] Tech Univ Munich, Inst Adv Study, D-85748 Garching, Germany.
RP Schloter, M (reprint author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Environm Genom, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM schloter@helmholtz-muenchen.de
RI Kogel-Knabner, Ingrid/A-7905-2008
OI Kogel-Knabner, Ingrid/0000-0002-7216-8326; Schulz,
   Stefanie/0000-0001-5520-8106
FU Deutsche Forschungsgemeinschaft (DFG, Bonn)German Research Foundation
   (DFG) [SFB/TRR 38]; Brandenburg Ministry of Science, Research and
   Culture (MWFK, Potsdam)
FX This study is part of the Transregional Collaborative Research Centre 38
   (SFB/TRR 38), which is financially supported by the Deutsche
   Forschungsgemeinschaft (DFG, Bonn) and the Brandenburg Ministry of
   Science, Research and Culture (MWFK, Potsdam). Moreover, we thank Anita
   Zumsteg for providing Fig. 1. Finally, we thank the anonymous reviewers
   for their helpful comments to improve the manuscript.
CR Aneja MK, 2006, MICROB ECOL, V52, P127, DOI 10.1007/s00248-006-9006-3
   Bardgett RD, 2004, SOIL BIOL BIOCHEM, V36, P555, DOI 10.1016/j.soilbio.2003.11.002
   Belnap J, 2001, ECOL STU AN, V150, P281
   Belnap J., 2001, BIOL SOIL CRUSTS STR
   Bernasconi SM, 2008, MINERAL MAG, V72, P19, DOI 10.1180/minmag.2008.072.1.19
   Bernasconi SM, 2011, VADOSE ZONE J, V10, P867, DOI 10.2136/vzj2010.0129
   BILLINGS WD, 1987, ARCTIC ALPINE RES, V19, P357, DOI 10.2307/1551400
   Binder C. R., 2009, BUNDESAMT UMWELT BAF, V28, P1
   Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8
   Borin S, 2010, ENVIRON MICROBIOL, V12, P293, DOI 10.1111/j.1462-2920.2009.02059.x
   Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184
   Bratteler M, 2006, J EVOLUTION BIOL, V19, P1149, DOI 10.1111/j.1420-9101.2006.01090.x
   Breen K, 2008, ARCT ANTARCT ALP RES, V40, P287, DOI 10.1657/1523-0430(06-098)[BREEN]2.0.CO;2
   Briones AM, 2003, PLANT SOIL, V250, P335, DOI 10.1023/A:1022897621223
   Budel B, 2004, GEOBIOLOGY, V2, P261, DOI 10.1111/j.1472-4677.2004.00040.x
   Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003
   CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039
   Cocking EC, 2003, PLANT SOIL, V252, P169, DOI 10.1023/A:1024106605806
   Deiglmayr K, 2006, ENVIRON MICROBIOL, V8, P1600, DOI 10.1111/j.1462-2920.2006.01051.x
   Dickson LG, 2000, ARCT ANTARCT ALP RES, V32, P40, DOI 10.2307/1552408
   Dijkstra P, 2006, SOIL BIOL BIOCHEM, V38, P3257, DOI 10.1016/j.soilbio.2006.04.005
   Doran JW, 2002, AGR ECOSYST ENVIRON, V88, P119, DOI 10.1016/S0167-8809(01)00246-8
   Duc L, 2009, MICROB ECOL, V57, P179, DOI 10.1007/s00248-008-9408-5
   Dumig A, 2012, GEOCHIM COSMOCHIM AC, V85, P1, DOI 10.1016/j.gca.2012.01.046
   Dumig A, 2011, GEODERMA, V163, P83, DOI 10.1016/j.geoderma.2011.04.006
   Edwards IP, 2006, MICROB ECOL, V52, P679, DOI 10.1007/s00248-006-9097-x
   Egli M, 2011, GEODERMA, V164, P11, DOI 10.1016/j.geoderma.2011.05.001
   Escudero A, 2007, J ARID ENVIRON, V70, P18, DOI 10.1016/j.jaridenv.2006.12.019
   Esperschutz J, 2011, BIOGEOSCIENCES, V8, P3283, DOI 10.5194/bg-8-3283-2011
   Fahnestock J. T., 1998, J GEOPHYS RES, V102, P925
   Frey B, 2010, APPL ENVIRON MICROB, V76, P4788, DOI 10.1128/AEM.00657-10
   Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x
   Goransson H, 2011, SOIL BIOL BIOCHEM, V43, P1333, DOI 10.1016/j.soilbio.2011.03.006
   Gold WG, 1998, ARCTIC ALPINE RES, V30, P108, DOI 10.2307/1552125
   Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108
   Guelland K, 2013, BIOGEOCHEMISTRY, V113, P545, DOI 10.1007/s10533-012-9785-1
   Guelland K, 2013, SOIL BIOL BIOCHEM, V57, P237, DOI 10.1016/j.soilbio.2012.07.002
   Hammerli A, 2007, EUR J SOIL SCI, V58, P1437, DOI 10.1111/j.1365-2389.2007.00948.x
   Harper KT, 2001, J ARID ENVIRON, V47, P347, DOI 10.1006/jare.2000.0713
   Harris C, 2009, EARTH-SCI REV, V92, P117, DOI 10.1016/j.earscirev.2008.12.002
   Harrison R.B., 2008, ENCY ECOLOGY, P3291
   Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z
   Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3
   Hodkinson ID, 2003, J ECOL, V91, P651, DOI 10.1046/j.1365-2745.2003.00786.x
   Joerin UE, 2006, HOLOCENE, V16, P697, DOI 10.1191/0959683606hl964rp
   Johnson SL, 2007, ENVIRON MICROBIOL, V9, P680, DOI 10.1111/j.1462-2920.2006.01187.x
   Kastovska K, 2007, POLAR BIOL, V30, P277, DOI 10.1007/s00300-006-0181-y
   Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001
   Kobierska F, 2011, APPL GEOCHEM, V26, pS60, DOI 10.1016/j.apgeochem.2011.03.029
   Korner C, 2004, AMBIO, P11
   Korner C, 1999, ALPINE PLANT LIFE
   Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485
   LANDOLT E, 1992, UNSERE ALPENFLORA
   Lapanje A, 2012, MICROB ECOL, V63, P865, DOI 10.1007/s00248-011-9976-7
   Lazzaro A., 2009, EUROP J SOIL SC, V15, P291
   Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983
   Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393
   Lombard N, 2011, FEMS MICROBIOL ECOL, V78, P31, DOI 10.1111/j.1574-6941.2011.01140.x
   Mavris C, 2011, GEODERMA, V165, P106, DOI 10.1016/j.geoderma.2011.07.010
   Mavris C, 2010, GEODERMA, V155, P359, DOI 10.1016/j.geoderma.2009.12.019
   Merbach W, 1999, J PLANT NUTR SOIL SC, V162, P373, DOI 10.1002/(SICI)1522-2624(199908)162:4<373::AID-JPLN373>3.0.CO;2-#
   Miniaci C, 2007, BIOL FERT SOILS, V44, P289, DOI 10.1007/s00374-007-0203-0
   Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010
   Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x
   Noll M, 2008, SOIL BIOL BIOCHEM, V40, P2611, DOI 10.1016/j.soilbio.2008.07.012
   Nordin A, 2004, ECOLOGY, V85, P955, DOI 10.1890/03-0084
   NYIRI A, 2010, 12010 MSCW
   Ollivier J, 2011, FEMS MICROBIOL ECOL, V78, P3, DOI 10.1111/j.1574-6941.2011.01165.x
   Paterson E, 2000, J EXP BOT, V51, P1449, DOI 10.1093/jexbot/51.349.1449
   PAUL EA, 1996, SOIL MICROBIOLOGY BI
   Paul F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020816
   Paul F, 2007, GLOBAL PLANET CHANGE, V56, P111, DOI 10.1016/j.gloplacha.2006.07.007
   Pluess AR, 2005, OECOLOGIA, V144, P55, DOI 10.1007/s00442-005-0047-y
   Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831
   Ragot S, 2013, GEODERMA, V202, P30, DOI 10.1016/j.geoderma.2013.03.006
   Rajendhran J, 2008, BIOTECHNOL ADV, V26, P576, DOI 10.1016/j.biotechadv.2008.08.002
   Reynolds R, 2001, P NATL ACAD SCI USA, V98, P7123, DOI 10.1073/pnas.121094298
   ROGERS SL, 1994, BIOL FERT SOILS, V18, P209, DOI 10.1007/BF00647668
   Sawstrom C, 2002, POLAR BIOL, V25, P591, DOI 10.1007/s00300-002-0388-5
   Schaaf W, 2011, J PLANT NUTR SOIL SC, V174, P229, DOI 10.1002/jpln.201000158
   Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x
   Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002
   Schmalenberger A, 2010, FEMS MICROBIOL ECOL, V71, P208, DOI 10.1111/j.1574-6941.2009.00799.x
   Sharma S, 2012, J MICROBIOL METH, V91, P62, DOI 10.1016/j.mimet.2012.07.016
   Sigler WV, 2002, MICROBIAL ECOL, V43, P397, DOI 10.1007/s00248-001-0045-5
   Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10
   Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008
   Smittenberg RH, 2012, GLOBAL CHANGE BIOL, V18, P1941, DOI 10.1111/j.1365-2486.2012.02654.x
   Stibal M, 2008, ENVIRON MICROBIOL, V10, P2172, DOI 10.1111/j.1462-2920.2008.01620.x
   Styriakova I, 2012, MINER PETROL, V105, P135, DOI 10.1007/s00710-012-0201-2
   Tackenberg O, 2008, J VEG SCI, V19, P109, DOI 10.3170/2007-8-18338
   Tamburini F, 2010, EUR J SOIL SCI, V61, P1025, DOI 10.1111/j.1365-2389.2010.01290.x
   Towe S, 2010, MICROB ECOL, V60, P762, DOI 10.1007/s00248-010-9695-5
   Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7
   Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105
   Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004
   Tscherko D, 2003, EUR J SOIL SCI, V54, P685, DOI 10.1046/j.1351-0754.2003.0570.x
   van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004
   Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475
   Ward BB, 1997, J CHEM ECOL, V23, P2583, DOI 10.1023/B:JOEC.0000006668.48855.b7
   Yeager CM, 2004, APPL ENVIRON MICROB, V70, P973, DOI 10.1128/AEM.70.2.973-983.2004
   Yoshitake S, 2010, NEW PHYTOL, V186, P451, DOI 10.1111/j.1469-8137.2010.03180.x
   Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3
   Zumsteg A, 2012, MICROB ECOL, V63, P552, DOI 10.1007/s00248-011-9991-8
NR 104
TC 85
Z9 92
U1 2
U2 175
PU COPERNICUS GESELLSCHAFT MBH
PI GOTTINGEN
PA BAHNHOFSALLEE 1E, GOTTINGEN, 37081, GERMANY
SN 1726-4170
EI 1726-4189
J9 BIOGEOSCIENCES
JI Biogeosciences
PY 2013
VL 10
IS 6
BP 3983
EP 3996
DI 10.5194/bg-10-3983-2013
PG 14
WC Ecology; Geosciences, Multidisciplinary
SC Environmental Sciences & Ecology; Geology
GA 173ZQ
UT WOS:000321122700035
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Sanchez, AL
   Canales, M
   Enriquez, L
   Bottazzi, ME
   Zelaya, AA
   Espinoza, VE
   Fontecha, GA
AF Sanchez, Ana Lourdes
   Canales, Maritza
   Enriquez, Lourdes
   Bottazzi, Maria Elena
   Zelaya, Ada Argentina
   Espinoza, Vilma Esther
   Fontecha, Gustavo Adolfo
TI A research capacity strengthening project for infectious diseases in
   Honduras: experience and lessons learned
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE research capacity strengthening; infectious disease; global health;
   Millennium Development Goals; Honduras
ID SCIENCE-CITATION-INDEX; HEALTH RESEARCH; BIBLIOMETRIC ANALYSIS; RESEARCH
   UNIVERSITIES; LATIN-AMERICA; COSTA-RICA; PUBLICATIONS; CHALLENGES;
   COUNTRIES
AB Background: In Honduras, research capacity strengthening (RCS) has not received sufficient attention, but an increase in research competencies would enable local scientists to advance knowledge and contribute to national priorities, including the Millennium Development Goals (MDGs).
   Objective: This project aimed at strengthening research capacity in infectious diseases in Honduras, focusing on the School of Microbiology of the National Autonomous University of Honduras (UNAH). The primary objective was the creation of a research-based graduate program for the continued training of researchers. Parallel objectives included institutional strengthening and the facilitation of partnerships and networks.
   Methods: Based on a multi-stakeholder consultation, an RCS workplan was designed and undertaken from 2007 to 2012. Due to unexpected adverse circumstances, the first 2 years were heavily dedicated to implementing the project's flagship, an MSc program in infectious and zoonotic diseases (MEIZ). In addition, infrastructure improvements and demand-driven continuing education opportunities were facilitated; biosafety and research ethics knowledge and practices were enhanced, and networks fostering collaborative work were created or expanded.
   Results: The project coincided with the peak of UNAH's radical administrative reform and an unprecedented constitutional crisis. Challenges notwithstanding, in September 2009, MEIZ admitted the first cohort of students, all of whom undertook MDG-related projects graduating successfully by 2012. Importantly, MEIZ has been helpful in expanding the School of Microbiology's traditional etiology-based, disciplinary model to infectious disease teaching and research. By fulfilling its objectives, the project contributed to a stronger research culture upholding safety and ethical values at the university.
   Conclusions: The resources and strategic vision afforded by the project enhanced UNAH's overall research capacity and its potential contribution to the MDGs. Furthermore, increased research activity and the ensuing improvement in performance indicators at the prime Honduran research institution invoke the need for a national research system in Honduras.
C1 [Sanchez, Ana Lourdes] Brock Univ, Dept Community Hlth Sci, St Catharines, ON L2S 3A1, Canada.
   [Canales, Maritza; Enriquez, Lourdes; Zelaya, Ada Argentina; Espinoza, Vilma Esther; Fontecha, Gustavo Adolfo] Univ Nacl Autonoma Honduras, Escuela Microbiol, Tegucigalpa, Honduras.
   [Canales, Maritza; Enriquez, Lourdes; Fontecha, Gustavo Adolfo] UNAH, Inst Invest Microbiol, Tegucigalpa, Honduras.
   [Bottazzi, Maria Elena] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Bottazzi, Maria Elena] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Zelaya, Ada Argentina] UNAH, Ctr Nacl Capacitac Bioseguridad, Tegucigalpa, Honduras.
RP Sanchez, AL (reprint author), Brock Univ, Dept Community Hlth Sci, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.
EM ana.sanchez@brocku.ca
RI Fontecha, Gustavo/J-5466-2013
OI Fontecha, Gustavo/0000-0001-9756-4520
FU Global Health Research Initiative (GHRI); Canadian Institutes of Health
   ResearchCanadian Institutes of Health Research (CIHR); Canadian
   International Development Agency; Health Canada; International
   Development Research Centre; Public Health Agency of Canada (IDRC
   Project) [103460-050]
FX This work was carried out with support from the Global Health Research
   Initiative (GHRI), a collaborative research funding partnership of the
   Canadian Institutes of Health Research, the Canadian International
   Development Agency, Health Canada, the International Development
   Research Centre and the Public Health Agency of Canada (IDRC Project
   Number: 103460-050).
CR Acevedo A, 2011, ECONOMIA Y ADMINISTR, V12, P81
   Altbach PG, 2013, STUD HIGH EDUC, V38, P316, DOI 10.1080/03075079.2013.773222
   Anholt RM, 2012, ZOONOSES PUBLIC HLTH, V59, P229, DOI 10.1111/j.1863-2378.2011.01449.x
   AUCC, HIGHLIGHTING THE IMP
   Balan J, 2012, SOC RES, V79, P741
   BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175
   Bates I, 2006, PLOS MED, V3, P1224, DOI 10.1371/journal.pmed.0030299
   Becerra F, 2010, LANCET, V375, P120, DOI 10.1016/S0140-6736(10)60045-1
   Bradley M, 2007, NORTH SOUTH RESEARCH
   Brooks A, 2010, HUM RESOUR DEV INT, V13, P83, DOI 10.1080/13678861003589065
   Buchanan D, 2005, INT J MANAG REV, V7, P189, DOI 10.1111/j.1468-2370.2005.00111.x
   Corbett CF, 2013, MED CARE, V51, pS23, DOI 10.1097/MLR.0b013e31827dc3c9
   Costello A, 2000, BRIT MED J, V321, P827, DOI 10.1136/bmj.321.7264.827
   Datta A, 2012, WORKING PAPER 344
   Earl S., 2001, OUTCOME MAPPING BUIL
   ESSENCE, 2011, PLANNING MONITORING
   Gadsby EW, 2011, INT J HEALTH PLAN M, V26, P89, DOI 10.1002/hpm.1031
   Global Forum for Health Research, 2002, THE 10 90 REPORT ON
   Jacob M, 2013, STUD HIGH EDUC, V38, P331, DOI 10.1080/03075079.2013.773789
   Johnson C, 2010, GLOB PUBLIC HEALTH, V5, P1, DOI 10.1080/17441690902830982
   Lansang MA, 2004, B WORLD HEALTH ORGAN, V82, P764
   Lin N., 1999, CONNECTIONS, V22, P28, DOI DOI 10.1108/14691930410550381
   Lomonte B, 2002, REV BIOL TROP, V50, P951
   Lomonte B, 2000, DESARROLLO CIENTIFIC, P81
   Minja H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001351
   Moloney A, 2009, LANCET, V374, P1053
   Molyneux D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-106
   Monge-Najera J, 2012, REV BIOL TROP, V60, P1649
   Moreno E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001055
   Nuyens Y., 2005, NO DEVELOPMENT WITHO
   Ontario Prevention Clearinghouse, 2002, ONTARIO HEALTH PROMO, V308, P1
   Osei-Atweneboana MY, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001602
   PAHO, 2012, HONDURAS HEALTH IN T, P144
   (RICYT) LRdIdCyT-IeI, LRDIDCYT IEI UPDATED
   Rosales J, 2012, BREAKING THE BARRIER
   Ruhl JM, 2010, J DEMOCR, V21, P93
   Sanchez A, 2011, APPL BIOSAFETY, V16, P240
   Sanchez AL, 2013, LANCET GLOB HEALTH, V1, pE75, DOI 10.1016/S2214-109X(13)70033-0
   Sancho R, 2006, INTERCIENCIA, V31, P284
   Sanyal B, 2006, RESEARCH CAPACITY IN
   SCImago, SJR SCIMAGO JOURNAL
   Stephen C, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5188
   Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17
   Survey U Agency C Fund W Department U, ENCY EARTH
   Taylor-Robinson MM, 2013, J THEOR POLIT, V25, P105, DOI 10.1177/0951629812453216
   Tomlinson M, 2006, INFANT MENT HEALTH J, V27, P532, DOI 10.1002/imhj.20105
   Ubels J, 2010, CAPACITY DEV MARKET
   UNDP, 2012, HUMAN DEVELOPMENT RE
   UNDP, 2013, THE 2013 HUMAN DEVEL
   Vasquez EE, 2013, GLOB PUBLIC HEALTH, V8, pS104, DOI 10.1080/17441692.2013.786117
   VELHO L, 2004, SCI TECHNOLOGY SOC, V9, P171
   Wagner CS, 2001, SCIENCE AND TECHNOLO
   Whitworth J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000299
   Word Bank, HONDURAS OVERVIEW
   Yarzabal L, 2001, HIGHER EDUCATION AND
NR 55
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2013
VL 6
BP 1
EP 11
DI 10.3402/gha.v6i0.21643
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 197AV
UT WOS:000322820400001
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Babu, M
   Kagan, O
   Guo, HB
   Greenblatt, J
   Emili, A
AF Babu, Mohan
   Kagan, Olga
   Guo, Hongbo
   Greenblatt, Jack
   Emili, Andrew
TI Identification of Protein Complexes in Escherichia coli using Sequential
   Peptide Affinity Purification in Combination with Tandem Mass
   Spectrometry
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Genetics; Issue 69; Molecular Biology; Medicine; Biochemistry;
   Microbiology; affinity purification; Escherichia coli; gram-negative
   bacteria; cytosolic proteins; SPA-tagging; homologous recombination;
   mass spectrometry; protein interaction; protein complex
AB Since most cellular processes are mediated by macromolecular assemblies, the systematic identification of protein-protein interactions (PPI) and the identification of the subunit composition of multi-protein complexes can provide insight into gene function and enhance understanding of biological systems(1, 2). Physical interactions can be mapped with high confidence vialarge-scale isolation and characterization of endogenous protein complexes under near-physiological conditions based on affinity purification of chromosomally-tagged proteins in combination with mass spectrometry (APMS). This approach has been successfully applied in evolutionarily diverse organisms, including yeast, flies, worms, mammalian cells, and bacteria(1-6). In particular, we have generated a carboxy-terminal Sequential Peptide Affinity (SPA) dual tagging system for affinity-purifying native protein complexes from cultured gram-negative Escherichia coli, using genetically-tractable host laboratory strains that are well-suited for genome-wide investigations of the fundamental biology and conserved processes of prokaryotes(1, 2, 7). Our SPA-tagging system is analogous to the tandem affinity purification method developed originally for yeast(8, 9,) and consists of a calmodulin binding peptide (CBP) followed by the cleavage site for the highly specific tobacco etch virus (TEV) protease and three copies of the FLAG epitope (3X FLAG), allowing for two consecutive rounds of affinity enrichment. After cassette amplification, sequence-specific linear PCR products encoding the SPA-tag and a selectable marker are integrated and expressed in frame as carboxy-terminal fusions in a DY330 background that is induced to transiently express a highly efficient heterologous bacteriophage lambda recombination system(10.) Subsequent dual-step purification using calmodulin and anti-FLAG affinity beads enables the highly selective and efficient recovery of even low abundance protein complexes from largescale cultures. Tandem mass spectrometry is then used to identify the stably co-purifying proteins with high sensitivity (low nanogram detection limits).
   Here, we describe detailed step-by-step procedures we commonly use for systematic protein tagging, purification and mass spectrometrybased analysis of soluble protein complexes from E. coli, which can be scaled up and potentially tailored to other bacterial species, including certain opportunistic pathogens that are amenable to recombineering. The resulting physical interactions can often reveal interesting unexpected components and connections suggesting novel mechanistic links. Integration of the PPI data with alternate molecular association data such as genetic (gene-gene) interactions and genomic-context (GC) predictions can facilitate elucidation of the global molecular organization of multiprotein complexes within biological pathways. The networks generated for E. coli can be used to gain insight into the functional architecture of orthologous gene products in other microbes for which functional annotations are currently lacking.
C1 [Babu, Mohan; Kagan, Olga; Guo, Hongbo; Greenblatt, Jack; Emili, Andrew] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 1A1, Canada.
   [Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada.
   [Greenblatt, Jack; Emili, Andrew] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A1, Canada.
RP Emili, A (reprint author), Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 1A1, Canada.
EM andrew.emili@utoronto.ca
RI Mohan, Babu P./I-7362-2019
FU Canadian Foundation for Innovation, Genome CanadaGenome CanadaCanada
   Foundation for Innovation; Ontario Genomics Institute; Ontario Ministry
   of Innovation; Canadian Institutes of Health ResearchCanadian Institutes
   of Health Research (CIHR)
FX This work was supported by funds from the Canadian Foundation for
   Innovation, Genome Canada, the Ontario Genomics Institute, the Ontario
   Ministry of Innovation, and the Canadian Institutes of Health Research
   grant to J.G. and A.E. The Red-expressing E. coli strain DY330 was a
   kind gift from Donald L. Court (National Cancer Institute, Frederick,
   MD).
CR Babu Mohan, 2009, Methods Mol Biol, V564, P373, DOI 10.1007/978-1-60761-157-8_22
   Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239
   de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10
   Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096
   Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200
   Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670
   Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201
   Polanowska J, 2004, BIOTECHNIQUES, V36, P778, DOI 10.2144/04365BM05
   Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183
   Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732
   Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272
   Vlasblom J, 2006, BIOINFORMATICS, V22, P2178, DOI 10.1093/bioinformatics/btl356
   Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597
   Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x
NR 14
TC 3
Z9 3
U1 1
U2 8
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD NOV
PY 2012
IS 69
AR e4057
DI 10.3791/4057
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QM
UT WOS:000209226000009
PM 23168686
OA Green Published
DA 2020-05-07
ER

PT J
AU Gagarinova, A
   Babu, M
   Greenblatt, J
   Emili, A
AF Gagarinova, Alla
   Babu, Mohan
   Greenblatt, Jack
   Emili, Andrew
TI Mapping Bacterial Functional Networks and Pathways in Escherichia Coli
   using Synthetic Genetic Arrays
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Genetics; Issue 69; Molecular Biology; Medicine; Biochemistry;
   Microbiology; Aggravating; alleviating; conjugation; double mutant;
   Escherichia coli; genetic interaction; Gram-negative bacteria;
   homologous recombination; network; synthetic lethality or sickness;
   suppression
ID PROTEIN COMPLEXES; HIGH-THROUGHPUT; MAP; ORGANIZATION; FITNESS; SYSTEM
AB Phenotypes are determined by a complex series of physical (e.g. protein-protein) and functional (e.g. gene-gene or genetic) interactions (GI) (1). While physical interactions can indicate which bacterial proteins are associated as complexes, they do not necessarily reveal pathway-level functional relationships(1). GI screens, in which the growth of double mutants bearing two deleted or inactivated genes is measured and compared to the corresponding single mutants, can illuminate epistatic dependencies between loci and hence provide a means to query and discover novel functional relationships(2). Large-scale GI maps have been reported for eukaryotic organisms like yeast(3-7), but GI information remains sparse for prokaryotes(8), which hinders the functional annotation of bacterial genomes. To this end, we and others have developed high-throughput quantitative bacterial GI screening methods(9, 10).
   Here, we present the key steps required to perform quantitative E. coli Synthetic Genetic Array (eSGA) screening procedure on a genomescale(9), using natural bacterial conjugation and homologous recombination to systemically generate and measure the fitness of large numbers of double mutants in a colony array format. Briefly, a robot is used to transfer, through conjugation, chloramphenicol (Cm)-marked mutant alleles from engineered Hfr (High frequency of recombination) 'donor strains' into an ordered array of kanamycin (Kan)-marked F-recipient strains. Typically, we use loss-of-function single mutants bearing non-essential gene deletions (e.g. the 'Keio' collection(11)) and essential gene hypomorphic mutations (i.e. alleles conferring reduced protein expression, stability, or activity(9, 12, 13)) to query the functional associations of non-essential and essential genes, respectively. After conjugation and ensuing genetic exchange mediated by homologous recombination, the resulting double mutants are selected on solid medium containing both antibiotics. After outgrowth, the plates are digitally imaged and colony sizes are quantitatively scored using an in-house automated image processing system(14). GIs are revealed when the growth rate of a double mutant is either significantly better or worse than expected(9). Aggravating (or negative) GIs often result between loss-of-function mutations in pairs of genes from compensatory pathways that impinge on the same essential process(2). Here, the loss of a single gene is buffered, such that either single mutant is viable. However, the loss of both pathways is deleterious and results in synthetic lethality or sickness (i.e. slow growth). Conversely, alleviating (or positive) interactions can occur between genes in the same pathway or protein complex(2) as the deletion of either gene alone is often sufficient to perturb the normal function of the pathway or complex such that additional perturbations do not reduce activity, and hence growth, further. Overall, systematically identifying and analyzing GI networks can provide unbiased, global maps of the functional relationships between large numbers of genes, from which pathway-level information missed by other approaches can be inferred9.
C1 [Gagarinova, Alla; Greenblatt, Jack; Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada.
   [Babu, Mohan; Greenblatt, Jack; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr, Toronto, ON M5S 1A1, Canada.
   [Babu, Mohan] Univ Regina, Dept Biochem, Res & Innovat Ctr, Regina, SK S4S 0A2, Canada.
RP Emili, A (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada.
EM andrew.emili@utoronto.ca
RI Mohan, Babu P./I-7362-2019
FU Genome CanadaGenome Canada; Ontario Genomics Institute; Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR); Vanier Canada Graduate Scholarship
FX This work was supported by funds from Genome Canada, the Ontario
   Genomics Institute, and the Canadian Institutes of Health Research
   grants to J.G. and A.E. AG is a recipient of Vanier Canada Graduate
   Scholarship.
CR ANDERSON RP, 1977, ANNU REV MICROBIOL, V31, P473, DOI 10.1146/annurev.mi.31.100177.002353
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377
   Babu M, 2011, METHODS MOL BIOL, V765, P125, DOI 10.1007/978-1-61779-197-0_9
   Babu Mohan, 2009, Methods Mol Biol, V564, P373, DOI 10.1007/978-1-60761-157-8_22
   Babu M, 2009, MOL BIOSYST, V5, P1439, DOI [10.1039/b907407d, 10.1039/B907407d]
   Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065
   Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085
   Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234
   Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239
   Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239
   Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649
   Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001
   Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640
   Dewey CN, 2011, BRIEF BIOINFORM, V12, P401, DOI 10.1093/bib/bbr040
   Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039
   Gagarinova A, 2012, MOL BIOSYST, V8, P1626, DOI 10.1039/c2mb25040c
   Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096
   Le Meur N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r135
   Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052
   Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609
   Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031
   St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948
   Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317
   Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810
   Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240
   Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038
   van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]
   Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012
   Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101
   Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597
   Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x
NR 34
TC 1
Z9 1
U1 0
U2 11
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD NOV
PY 2012
IS 69
AR e4056
DI 10.3791/4056
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QM
UT WOS:000209226000008
PM 23168417
OA Green Published
DA 2020-05-07
ER

PT J
AU Caly, DL
   Coulthurst, SJ
   Geoghegan, JA
   Malone, JG
   Ryan, RP
AF Caly, Delphine L.
   Coulthurst, Sarah J.
   Geoghegan, Joan A.
   Malone, Jacob G.
   Ryan, Robert P.
TI Socializing, networking and development: a report from the second 'Young
   Microbiologists Symposium on Microbe Signalling, Organization and
   Pathogenesis'
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID BIFIDOBACTERIUM-BREVE UCC2003; REGULATES BIOFILM FORMATION; VI SECRETION
   SYSTEMS; PSEUDOMONAS-AERUGINOSA; BURKHOLDERIA-CENOCEPACIA;
   XANTHOMONAS-CAMPESTRIS; SWARMING MOTILITY; OUTER-MEMBRANE; NITRIC-OXIDE;
   HD-GYP
AB In mid-June, the second Young Microbiologists Symposium took place under the broad title of Microbe signalling, organization and pathogenesis on the picturesque campus of University College Cork, Ireland. The symposium attracted 150 microbiologists from 15 different countries. The key feature of this meeting was that it was specifically aimed at providing a platform for junior scientists to present their work to a broad audience. The meeting was principally supported by Science Foundation Ireland with further backing from the Society for General Microbiology, the American Society for Microbiology and the European Molecular Biology Organization. Sessions focused on microbial gene expression, biogenesis, pathogenicity and host interaction. In this MicroMeeting report, we highlight some of the most significant advances and exciting developments reported during various talks and poster presentations given by the young and talented microbiologists.
C1 [Caly, Delphine L.; Ryan, Robert P.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BioSci Inst, Cork, Ireland.
   [Coulthurst, Sarah J.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland.
   [Geoghegan, Joan A.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland.
   [Malone, Jacob G.] Univ E Anglia, John Innes Ctr, Norwich NR4 7UH, Norfolk, England.
RP Ryan, RP (reprint author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BioSci Inst, Cork, Ireland.
EM r.ryan@ucc.ie
OI Coulthurst, Sarah/0000-0002-0808-1875; Ryan, Rober/0000-0002-7353-0913;
   Malone, Jacob/0000-0003-1959-6820
FU Science Foundation IrelandScience Foundation Ireland [11/CW/B2095];
   American Society for Microbiology; European Molecular Biology
   OrganizationEuropean Molecular Biology Organization (EMBO); Society for
   General Microbiology; Science Foundation IrelandScience Foundation
   Ireland; Wellcome TrustWellcome Trust [WT093314MA]; Royal Society of
   Edinburgh/Scottish Government Personal Research Fellowship;
   BBSRCBiotechnology and Biological Sciences Research Council (BBSRC);
   John Innes Foundation (Institute Strategic Program Grant)
   [BB/J004553/1]; University of East Anglia; Biotechnology and Biological
   Sciences Research CouncilBiotechnology and Biological Sciences Research
   Council (BBSRC) [BBS/E/J/000C0655]
FX We would like to thank all the speakers and participants for
   contributing to the success of this meeting. We are also grateful to the
   participants who contributed to this report by providing comments and
   figures. A special thank you must also go to Heather McLaughlin, Yvonne
   McCarthy, Kate Twomey, Aileen O'Connell, Max Dow and An Shi-Qi for their
   help and support leading up to and during the meeting. We also thank
   Science Foundation Ireland for the conference/workshop grant
   (11/CW/B2095 to R. P. R.), the American Society for Microbiology, the
   European Molecular Biology Organization and the Society for General
   Microbiology for their financial support. The authors' research is
   supported as follows: D. L. C. and R. P. R. are supported by grants from
   Science Foundation Ireland (to R. P. R.) and the Wellcome Trust
   (WT093314MA) through a project grant (to R. P. R.), S. J. C. by a Royal
   Society of Edinburgh/Scottish Government Personal Research Fellowship
   and J. G. M. by the BBSRC and the John Innes Foundation (Institute
   Strategic Program Grant BB/J004553/1) and through start-up funding from
   the University of East Anglia.
CR Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0
   Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11
   Brown MT, 2011, CURR OPIN MICROBIOL, V14, P734, DOI 10.1016/j.mib.2011.09.009
   Bush M, 2010, MOL MICROBIOL, V77, P1278, DOI 10.1111/j.1365-2958.2010.07290.x
   Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209
   Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128
   D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107
   Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x
   Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017
   Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611
   Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1
   Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007
   Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107
   Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454
   Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12
   Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09
   Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07
   Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09
   Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15
   Malone JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002760
   McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x
   Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07
   Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108
   Motherway MO, 2009, MICROB BIOTECHNOL, V2, P321, DOI 10.1111/j.1751-7915.2008.00071.x
   Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505
   Ramsay Joshua P, 2012, Commun Integr Biol, V5, P96
   Ramsay JP, 2011, P NATL ACAD SCI USA, V108, P14932, DOI 10.1073/pnas.1109169108
   Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007
   Roberts MAJ, 2012, P NATL ACAD SCI USA, V109, P6698, DOI 10.1073/pnas.1114000109
   Ryan RP, 2012, MOL MICROBIOL, V86, P557, DOI 10.1111/mmi.12000
   Ryan RP, 2011, TRENDS MICROBIOL, V19, P145, DOI 10.1016/j.tim.2010.12.003
   Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107
   Ryan RP, 2009, MOL MICROBIOL, V73, P760, DOI 10.1111/j.1365-2958.2009.06822.x
   Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103
   Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068
   Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756
   Shioya K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023948
   Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103
   Thompson SR, 2006, P NATL ACAD SCI USA, V103, P8209, DOI 10.1073/pnas.0600919103
   Twomey KB, 2012, ISME J, V6, P939, DOI 10.1038/ismej.2011.167
   Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001
   Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108
   Youle M, 2012, NAT REV MICROBIOL, V10, P583, DOI 10.1038/nrmicro2837
NR 49
TC 3
Z9 3
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD NOV
PY 2012
VL 86
IS 3
BP 501
EP 512
DI 10.1111/mmi.12016
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 025ZW
UT WOS:000310238200001
PM 22934780
DA 2020-05-07
ER

PT J
AU Aziz, RK
   Devoid, S
   Disz, T
   Edwards, RA
   Henry, CS
   Olsen, GJ
   Olson, R
   Overbeek, R
   Parrello, B
   Pusch, GD
   Stevens, RL
   Vonstein, V
   Xia, FF
AF Aziz, Ramy K.
   Devoid, Scott
   Disz, Terrence
   Edwards, Robert A.
   Henry, Christopher S.
   Olsen, Gary J.
   Olson, Robert
   Overbeek, Ross
   Parrello, Bruce
   Pusch, Gordon D.
   Stevens, Rick L.
   Vonstein, Veronika
   Xia, Fangfang
TI SEED Servers: High-Performance Access to the SEED Genomes, Annotations,
   and Metabolic Models
SO PLOS ONE
LA English
DT Article
ID DATABASES; CONSERVATION; ORGANIZATION; GENERATION; EVOLUTION; BACTERIAL;
   ORIGINS; UNIPROT
AB The remarkable advance in sequencing technology and the rising interest in medical and environmental microbiology, biotechnology, and synthetic biology resulted in a deluge of published microbial genomes. Yet, genome annotation, comparison, and modeling remain a major bottleneck to the translation of sequence information into biological knowledge, hence computational analysis tools are continuously being developed for rapid genome annotation and interpretation. Among the earliest, most comprehensive resources for prokaryotic genome analysis, the SEED project, initiated in 2003 as an integration of genomic data and analysis tools, now contains >5,000 complete genomes, a constantly updated set of curated annotations embodied in a large and growing collection of encoded subsystems, a derived set of protein families, and hundreds of genome-scale metabolic models. Until recently, however, maintaining current copies of the SEED code and data at remote locations has been a pressing issue. To allow high-performance remote access to the SEED database, we developed the SEED Servers (http://www.theseed.org/servers): four network-based servers intended to expose the data in the underlying relational database, support basic annotation services, offer programmatic access to the capabilities of the RAST annotation server, and provide access to a growing collection of metabolic models that support flux balance analysis. The SEED servers offer open access to regularly updated data, the ability to annotate prokaryotic genomes, the ability to create metabolic reconstructions and detailed models of metabolism, and access to hundreds of existing metabolic models. This work offers and supports a framework upon which other groups can build independent research efforts. Large integrations of genomic data represent one of the major intellectual resources driving research in biology, and programmatic access to the SEED data will provide significant utility to a broad collection of potential users.
C1 [Aziz, Ramy K.; Devoid, Scott; Disz, Terrence; Henry, Christopher S.; Olson, Robert; Stevens, Rick L.; Xia, Fangfang] Univ Chicago, Computat Inst, Chicago, IL 60637 USA.
   [Devoid, Scott; Disz, Terrence; Edwards, Robert A.; Henry, Christopher S.; Olson, Robert; Xia, Fangfang] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA.
   [Aziz, Ramy K.; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA.
   [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt.
   [Olsen, Gary J.] Univ Illinois, Dept Microbiol, Urbana, IL USA.
RP Aziz, RK (reprint author), Univ Calif San Diego, Syst Biol Res Grp, La Jolla, CA 92093 USA.
EM ramy.aziz@gmail.com; Ross@thefig.info
RI Edwards, Rob/Q-1691-2019; Aziz, Ramy/B-2918-2009
OI Edwards, Rob/0000-0001-8383-8949; Aziz, Ramy/0000-0002-4448-7100
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN266200400042C, HHSN272200900040C]; U.S. Department
   of EnergyUnited States Department of Energy (DOE) [DE-AC02-06CH11357,
   DE-SC0004921]; U.S. Department of Energy University Knowledgebase
   programUnited States Department of Energy (DOE); National Science
   Foundation Division of Biological InfrastructureNational Science
   Foundation (NSF) [NSF DBI-0850356]; National Science Foundation Division
   of Environmental BiologyNational Science Foundation (NSF) [NSF
   DEB-1046413]; Argonne, a U.S. Department of Energy Office of Science
   laboratoryUnited States Department of Energy (DOE) [DE-AC02-06CH11357,
   DE-SC0004921]
FX This work was supported in part with Federal funds from the National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health, Department of Health and Human Services, under Contract No.
   HHSN266200400042C and Contract No. HHSN272200900040C; by the U.S.
   Department of Energy under Contract DE-AC02-06CH11357, Award
   DE-SC0004921, and the U.S. Department of Energy University Knowledgebase
   program; and by the National Science Foundation Division of Biological
   Infrastructure (NSF DBI-0850356 to RAE) and Division of Environmental
   Biology (NSF DEB-1046413 to RAE). The funders played no role in the
   decision to submit this article or its preparation.; RKA is a volunteer
   member of the editorial board of PLOS ONE, and as such had no access to
   the peer review or acceptance process for this manuscript. Other than
   that, the authors have declared that no competing interests exist. The
   submitted manuscript has been created in part by UChicago Argonne, LLC,
   Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S.
   Department of Energy Office of Science laboratory, is operated under
   Contract No. DE-AC02-06CH11357 and Award DE-SC0004921. The U.S.
   Government retains for itself, and others acting on its behalf, a
   paid-up nonexclusive, irrevocable worldwide license in said article to
   reproduce, prepare derivative works, distribute copies to the public,
   and perform publicly and display publicly, by or on behalf of the
   Government. This does not alter the authors' adherence to all the PLOS
   ONE policies on sharing data and materials.
CR Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831
   Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713
   Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163
   Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123
   Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6
   Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139
   Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048
   Disz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-319
   Edwards RA, BIOINFORMAT IN PRESS
   Henry CS, 2011, BBA-GEN SUBJECTS, V1810, P967, DOI 10.1016/j.bbagen.2011.03.010
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69
   Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784
   Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006
   Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698
   Moreno-Hagelsieb Gabriel, 2008, V453, P181, DOI 10.1007/978-1-60327-429-6_8
   Muro EM, 2011, NUCLEIC ACIDS RES, V39, P1732, DOI 10.1093/nar/gkq1067
   Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Overbeek R, 2004, COMMUN ACM, V47, P46, DOI 10.1145/1029496.1029525
   Overbeek R, 1999, In Silico Biol, V1, P93
   Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896
   Overbeek R, 2000, GENOME BIOL, V1
   Overbeek R, 2007, CHEM REV, V107, P3431, DOI 10.1021/cr068308h
   Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100
   Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920
   Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002
   Shea April, 2012, Methods Mol Biol, V881, P331, DOI 10.1007/978-1-61779-827-6_12
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857
   Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R
   Zhang W, 2008, CURR BIOINFORM, V3, P178, DOI 10.2174/157489308785909232
NR 43
TC 86
Z9 87
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 24
PY 2012
VL 7
IS 10
AR e48053
DI 10.1371/journal.pone.0048053
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 026VC
UT WOS:000310310200144
PM 23110173
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Nespolo, NM
   Martineli, TM
   Rossi, OD
AF Nespolo, Natalia Maramarque
   Martineli, Thais Mioto
   Rossi, Oswaldo Durival, Jr.
TI MICROBIOLOGICAL QUALITY OF SALMON (Salmo salar) SOLD IN CITIES OF THE
   STATE OF SAO PAULO, BRAZIL
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE fish; salmon; microbiology; pathogenic bacteria
ID AEROMONAS; IDENTIFICATION; SEAFOOD; REGION; AGAR; FISH
AB The present paper evaluated the microbiology of salmon by quantifying mesophilic heterotrophic microorganisms, total and thermotolerant coliforms, and the presence of Vibrio parahaemolyticus, Staphylococcus aureus, Salmonella sp., Escherichia coli and Aeromonas sp. in the meat. This study can provide technical support for the suggestion of a new regulation of a Brazilian legislation through specific microbiological standards concerning the consumption of raw fish. A number of 31 (16 cooled and 15 frozen) samples of salmon were collected in the retail market network of a few cities in the State of Sao Paulo, Brazil. Results presented populations of mesophilic heterotrophic microorganisms ranging from 1.0 x 10 and 3.9 x 10(6) CFU/g, total and thermotolerant coliforms in 32.25% and 19.35% of the samples, respectively, and Aeromonas sp. in 41.95% of the samples with a populational variation ranging from 2.0 x 10(2) to 8.0 x 10(3) CFU/g. Staphylococcus aureus was found in one sample whereas Vibrio parahaemolyticus, Salmonella sp. and Escherichia coli were not found. These results demonstrated the presence of potencially pathogenic microorganisms in fresh fish consumed in Brazil, highlighting the necessity of control measures to avoid public health problems related to the consumption of raw fish.
C1 [Nespolo, Natalia Maramarque; Martineli, Thais Mioto] Univ Estadual Paulista, Programa Posgrad Med Vet Prevent, BR-14884900 Jaboticabal, SP, Brazil.
   [Nespolo, Natalia Maramarque; Rossi, Oswaldo Durival, Jr.] Univ Estadual Paulista, Dept Vet Prevent Med, BR-14884900 Jaboticabal, SP, Brazil.
RP Nespolo, NM (reprint author), Univ Estadual Paulista, Dept Vet Prevent Med, Via Acesso Prof Paulo Donato Castellane S-N, BR-14884900 Jaboticabal, SP, Brazil.
EM natinespolo@yahoo.com.br
RI Nespolo, Natalia Maramarque/N-1817-2013
OI Nespolo, Natalia Maramarque/0000-0003-4836-0374
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX Thanks to CNPq for a Master's scholarship and FAPESP for financial
   support.
CR Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003
   Albuquerque WF, 2006, HIG ALIMENT, V20, P58
   *APHA, 2001, COMP METH MICR EX FO, V4
   Aquino J.S., 1996, AM B CEPPA, V14, P1
   Azevedo V.M., 2003, REVNET DTA SAO PAULO, V3, P114
   Basti AA, 2006, FOOD CONTROL, V17, P183, DOI 10.1016/j.foodcont.2004.10.001
   BEIGUELMAN B, 2002, [No title captured]
   Cunha Neto Adelino da, 2002, Food Sci. Technol (Campinas), V22, P263, DOI 10.1590/S0101-20612002000300012
   Fang TJ, 2003, INT J FOOD MICROBIOL, V80, P241, DOI 10.1016/S0168-1605(02)00172-1
   FURUWATARI C, 1994, MED SCI RES, V22, P617
   Germano P. M. L., 1998, Higiene Alimentar, V12, P30
   Hamada-Sato N, 2005, FOOD CONTROL, V16, P301, DOI 10.1016/j.foodcont.2004.02.001
   HAVELAAR AH, 1988, LETT APPL MICROBIOL, V7, P169, DOI 10.1111/j.1472-765X.1988.tb01271.x
   Herrera FC, 2006, J APPL MICROBIOL, V100, P527, DOI 10.1111/j.1365-2672.2005.02848.x
   Hozbor MC, 2006, LWT-FOOD SCI TECHNOL, V39, P99, DOI 10.1016/j.lwt.2004.12.008
   Huss HH, 2000, FOOD CONTROL, V11, P149, DOI 10.1016/S0956-7135(99)00087-0
   Lourenco LFH, 2006, HIG ALIMENT, V20, P90
   Mac Faddin J.F., 1976, BIOCH TESTS IDENTIFI
   MAJEED KN, 1990, J APPL BACTERIOL, V69, P332, DOI 10.1111/j.1365-2672.1990.tb01524.x
   Martins F.O., 2006, THESIS USP SAO PAULO
   Meldrum RJ, 2006, INT J FOOD MICROBIOL, V108, P397, DOI 10.1016/j.ijfoodmicro.2006.01.003
   Moraes FP, 2006, REV ELECT FARMACIA, V3, P109
   Muratori M.C.S., 2004, HIG ALIMENT, V18, P50
   Normanno G, 2006, INT J FOOD MICROBIOL, V106, P219, DOI 10.1016/j.ijfoodmicro.2005.05.020
   PALUMBO SA, 1985, APPL ENVIRON MICROB, V50, P1027, DOI 10.1128/AEM.50.4.1027-1030.1985
   Pereira Christiane Soares, 2004, Food Sci. Technol (Campinas), V24, P562, DOI 10.1590/S0101-20612004000400014
   Pereira MA, 2006, BRAZ J MICROBIOL, V37, P159, DOI 10.1590/S1517-83822006000200012
   Popoff M., 1984, BERGEYS MANUAL SYSTE, V1, P545
   Rodrigues DP, 2007, HIG ALIMENT, V21, P94
   SAAD SMI, 1995, REV MICROBIOL, V26, P22
   SAS Institute, 2005, US GUID STAT
   Soares C.M., 2005, HIG ALIMENT, V19, P59
   Soares C.M., 2004, HIG ALIMENT, V18, P88
   Souza ATS., 2003, BIOLOGICO, V65, P11
   Taulo S, 2008, INT J FOOD MICROBIOL, V125, P111, DOI 10.1016/j.ijfoodmicro.2008.02.025
   Ullmann D, 2005, J VET MED B, V52, P82, DOI 10.1111/j.1439-0450.2005.00820.x
   Vernocchi P, 2007, FOOD CONTROL, V18, P1575, DOI 10.1016/j.foodcont.2006.12.009
NR 37
TC 5
Z9 5
U1 0
U2 17
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD OCT-DEC
PY 2012
VL 43
IS 4
BP 1393
EP 1400
DI 10.1590/S1517-83822012000400021
PG 8
WC Microbiology
SC Microbiology
GA 094TJ
UT WOS:000315286400021
PM 24031968
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Wu, PP
   Liu, CE
   Chang, CY
   Huang, HC
   Syu, SS
   Wang, CH
   Huang, YC
AF Wu, Pin-Pin
   Liu, Chun-Eng
   Chang, Chih-Yen
   Huang, Hsiao-Chun
   Syu, Siou-Siou
   Wang, Chu-Hsien
   Huang, Yi-Chen
TI Decreasing catheter-related bloodstream infections in the intensive care
   unit: Interventions in a medical center in central Taiwan
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Catheter-related bloodstream infection; Chlorhexidine gluconate; CRBSI;
   Maximal sterile barrier precautions
ID STERILE BARRIER PRECAUTIONS; CENTRAL VENOUS CATHETERS; PREVENTION; RISK
AB Background: A high catheter-related bloodstream infection (CRBSI) rate, in comparison with that in the National Healthcare Safety Network report, is an important concern in our hospital. Therefore, evidence-based interventions have been introduced to reduce the rate of CRBSI.
   Methods: A surveillance study conducted from March 2008 to May 2010 to observe the reduction of infection rate after interventions in two intensive care units (ICUs). The major intervention, introduced in November 2009, was the standardization of the process of central venous catheter (CVC) implantation, including hand hygiene and maximal sterile barrier precautions.
   Results: The utilization ratios of CVC changed little during the study. The median CRBSI infection rates decreased from 1.95 (mean 1.58) infections per 1000 catheter-days at baseline to 0 (mean 1.06) after interventions (p = 0.310 by the Wilcoxon signed ranks test). The rate of CRBSI in one ICU showed 0 infections per 1000 catheter-days, which was sustained for 6 months after interventions.
   Conclusion: The reduction of infection rates could be possible by standardizing the CVC implantation procedure. However, more interventions, such as cleaning the skin with chlorhexidine, avoiding the femoral site when possible, and removing unnecessary catheters, should also be considered to reduce the rate of CRBSI. Copyright (C) 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Wu, Pin-Pin; Liu, Chun-Eng; Chang, Chih-Yen] Changhua Christian Hosp, Dept Internal Med, Div Infect Dis, Changhua 500, Taiwan.
   [Liu, Chun-Eng; Huang, Hsiao-Chun; Syu, Siou-Siou] Changhua Christian Hosp, Ctr Infect Prevent & Control, Changhua 500, Taiwan.
   [Wang, Chu-Hsien] Changhua Christian Hosp, Dept Internal Med, Div Crit Care Med, Changhua 500, Taiwan.
   [Huang, Yi-Chen] Changhua Christian Hosp, Dept Nursing, Changhua 500, Taiwan.
RP Liu, CE (reprint author), Changhua Christian Hosp, Dept Internal Med, Div Infect Dis, 135 Nanxiao St, Changhua 500, Changhua County, Taiwan.
EM chuneng@cch.org.tw
CR [Anonymous], 2010, RISK ASS INF PREV CO
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Centers for Disease Control, 2009, ANN REP NOS INF
   Deshpande KS, 2005, CRIT CARE MED, V33, P13, DOI 10.1097/01.CCM.0000149838.47048.60
   Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001
   Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Lee DH, 2008, INFECT CONT HOSP EP, V29, P947, DOI 10.1086/590356
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Mannino David M, 2002, MMWR Surveill Summ, V51, P1
   Pronovost P., 2008, AM J INFECT CONTROL, V36, pe1, DOI DOI 10.1016/S0196-6553(08)00811-0
   Pronovost Peter, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.008
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115
   Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309
   RAAD II, 1994, INFECT CONT HOSP EP, V15, P231
   Raad II, 2008, INFECT CONT HOSP EP, V29, P951, DOI 10.1086/591939
   TROTTIER SJ, 1995, CRIT CARE MED, V23, P52, DOI 10.1097/00003246-199501000-00011
NR 17
TC 9
Z9 10
U1 0
U2 9
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD OCT
PY 2012
VL 45
IS 5
BP 370
EP 376
DI 10.1016/j.jmii.2011.12.016
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 032LB
UT WOS:000310719000007
PM 22578645
OA Bronze
DA 2020-05-07
ER

PT J
AU Federle, MJ
   Morrison, DA
AF Federle, Michael J.
   Morrison, Donald A.
TI One if by land, two if by sea: signalling to the ranks with CSP and XIP
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID DNA-BINDING SITES; STREPTOCOCCUS-MUTANS; GENETIC-TRANSFORMATION;
   RESPONSE REGULATOR; COMPETENCE; BACTERIOCIN; PEPTIDE; IDENTIFICATION;
   PHEROMONE
AB In many streptococci, quorum sensing utilizes secreted, linear peptides that engage cognate receptors to coordinate gene expression among members of a local population. Streptococcus mutans employs the secreted peptides CSP and XIP to stimulate production of antimicrobial bacteriocins and to induce development of competence for genetic transformation. Recent progress in the field reveals that these pathways not only monitor the presence of signal emitters but also sense environmental factors. Both kinds of information are integrated by regulatory networks that then generate multiple outcomes, even among parallel cells growing in identical conditions. In this issue of Molecular Microbiology, Son and co-workers investigate how two medium types shape cellular responses to CSP and XIP pheromones in individuals across a population. Their findings characterize restrictive properties of media differing in peptidic fragment content and reveal unusual signalling properties that contribute to bimodal responses of gene expression.
C1 [Federle, Michael J.] Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA.
   [Morrison, Donald A.] Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA.
RP Federle, MJ (reprint author), Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA.
EM mjfederle@gmail.com
RI Federle, Michael J./E-5522-2017
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [NIH AI091779]; NSFNational Science
   Foundation (NSF) [MCB1020863]
FX Some of this work was supported by Grants NIH AI091779 from the NIAID
   (to M.J.F.) and MCB1020863 from the NSF (to D.A.M.).
CR Ahn SJ, 2005, J BACTERIOL, V187, P3028, DOI 10.1128/JB.187.9.3028-3038.2005
   Cassone M., 2012, AM SOC MICR GEN M SA
   Desai K, 2012, J BACTERIOL, V194, P3774, DOI 10.1128/JB.00337-12
   Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x
   Dufour D, 2011, J BACTERIOL, V193, P6552, DOI 10.1128/JB.05968-11
   HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x
   Hossain MS, 2012, J BACTERIOL, V194, P5886, DOI 10.1128/JB.01381-12
   Hung DCI, 2011, J BACTERIOL, V193, P3642, DOI 10.1128/JB.00155-11
   Khan R, 2012, J BACTERIOL, V194, P3781, DOI 10.1128/JB.00624-12
   Kreth J, 2007, MICROBIOL-SGM, V153, P1799, DOI 10.1099/mic.0.2007/005975-0
   Lemme A, 2011, J BACTERIOL, V193, P1863, DOI 10.1128/JB.01363-10
   Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001
   Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x
   Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x
   Petersen FC, 2000, ORAL MICROBIOL IMMUN, V15, P329, DOI 10.1034/j.1399-302x.2000.150511.x
   Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x
   Son MJ, 2012, MOL MICROBIOL, V86, P258, DOI 10.1111/j.1365-2958.2012.08187.x
   Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11
   van der Ploeg JR, 2005, J BACTERIOL, V187, P3980, DOI 10.1128/JB.187.12.3980-3989.2005
   Ween O, 1999, MOL MICROBIOL, V33, P817, DOI 10.1046/j.1365-2958.1999.01528.x
   Wenderska IB, 2012, FEMS MICROBIOL LETT, V336, P104, DOI 10.1111/j.1574-6968.2012.02660.x
NR 21
TC 18
Z9 18
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD OCT
PY 2012
VL 86
IS 2
BP 241
EP 245
DI 10.1111/mmi.12029
PG 5
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 019RH
UT WOS:000309756500001
PM 22958130
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Spratt, BG
AF Spratt, Brian G.
TI The 2011 Garrod Lecture: From penicillin-binding proteins to molecular
   epidemiology
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE penicillin resistance; mosaic genes; multilocus sequence typing; whole
   genome sequencing; sexual networks
ID BETA-LACTAM ANTIBIOTICS; STREPTOCOCCUS-PNEUMONIAE;
   NEISSERIA-GONORRHOEAE; ESCHERICHIA-COLI; INVASIVE DISEASE;
   IDENTIFICATION; RESISTANCE; EVOLUTION; CLUSTERS; STRAINS
AB In this review, based on my Garrod Lecture to the British Society for Antimicrobial Chemotherapy, I have given a brief outline of my career over the past 40 years, starting with research in the 1970s into the properties and functions of penicillin-binding proteins (PBPs), leading to the identification of the high molecular mass PBPs as the physiological targets of penicillin, and subsequent studies showing the emergence of low-affinity PBPs in penicillin-resistant clinical isolates by inter-species recombination and the generation of mosaic PBP genes. The studies of clinical isolates of gonococci, meningococci and pneumococci with PBP-mediated resistance to penicillin led to new interests in molecular epidemiology and the population and evolutionary biology of bacterial pathogens. The development (with colleagues) of multilocus sequence typing provided a method for the unambiguous characterization of bacterial strains that has proved to be very widely used, but the recent remarkable (and ongoing) developments in DNA sequencing technologies have provided the prospect of being able routinely to use whole genome sequences to characterize pathogen isolates. These developments will soon have major implications for diagnostic microbiology, outbreak investigations and our ability to follow the spread of strains of community-acquired and nosocomial pathogens at local, national and international levels. However, there are major barriers to be overcome, particularly with respect to how the avalanche of genome sequence data will be stored so that its transformative potential for molecular epidemiology and international public health are fully realized.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.
RP Spratt, BG (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Hosp Campus,Norfolk Pl, London W2 1PG, England.
EM b.spratt@imperial.ac.uk
FU Wellcome TrustWellcome Trust [WT089472]; National Institute for Health
   ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10336]
FX This work was funded by a Wellcome Trust Principal Research Fellowship
   (WT089472).
CR Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832
   Bilek N, 2007, J CLIN MICROBIOL, V45, P3564, DOI 10.1128/JCM.01453-07
   Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3
   Blumberg P M, 1974, Methods Enzymol, V34, P401
   BROWN DFJ, 1980, FEBS LETT, V122, P275, DOI 10.1016/0014-5793(80)80455-8
   Chan MS, 2001, BIOINFORMATICS, V17, P1077, DOI 10.1093/bioinformatics/17.11.1077
   Choudhury B, 2006, LANCET, V368, P139, DOI 10.1016/S0140-6736(06)69003-X
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   DOUGHERTY TJ, 1980, ANTIMICROB AGENTS CH, V18, P730, DOI 10.1128/AAC.18.5.730
   DOWSON CG, 1989, MOL MICROBIOL, V3, P95, DOI 10.1111/j.1365-2958.1989.tb00108.x
   Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049
   Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215
   HAKENBECK R, 1980, ANTIMICROB AGENTS CH, V17, P364, DOI 10.1128/AAC.17.3.364
   Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917
   Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395
   HEDGE PJ, 1985, NATURE, V318, P478, DOI 10.1038/318478a0
   Kolader ME, 2006, J CLIN MICROBIOL, V44, P2689, DOI 10.1128/JCM.02311-05
   Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012
   Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831
   Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047
   Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751
   OROURKE M, 1995, MOL MICROBIOL, V17, P865, DOI 10.1111/j.1365-2958.1995.mmi_17050865.x
   SELANDER RK, 1987, MICROB PATHOGENESIS, V3, P1, DOI 10.1016/0882-4010(87)90032-5
   SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384
   SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0
   SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0
   SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999
   SPRATT BG, 1977, J BACTERIOL, V131, P293, DOI 10.1128/JB.131.1.293-305.1977
   SPRATT BG, 1978, NATURE, V274, P713, DOI 10.1038/274713a0
   SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988
   Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30
   ZIGHELBOIM S, 1980, ANTIMICROB AGENTS CH, V17, P434, DOI 10.1128/AAC.17.3.434
NR 37
TC 9
Z9 10
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD JUL
PY 2012
VL 67
IS 7
BP 1578
EP 1588
DI 10.1093/jac/dks109
PG 11
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 956JT
UT WOS:000305086600002
PM 22457311
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Watrous, J
   Roach, P
   Alexandrov, T
   Heath, BS
   Yang, JY
   Kersten, RD
   van der Voort, M
   Pogliano, K
   Gross, H
   Raaijmakers, JM
   Moore, BS
   Laskin, J
   Bandeira, N
   Dorrestein, PC
AF Watrous, Jeramie
   Roach, Patrick
   Alexandrov, Theodore
   Heath, Brandi S.
   Yang, Jane Y.
   Kersten, Roland D.
   van der Voort, Menno
   Pogliano, Kit
   Gross, Harald
   Raaijmakers, Jos M.
   Moore, Bradley S.
   Laskin, Julia
   Bandeira, Nuno
   Dorrestein, Pieter C.
TI Mass spectral molecular networking of living microbial colonies
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ambient mass spectrometry; microbial ecology; natural products
ID DESORPTION ELECTROSPRAY-IONIZATION; ASSISTED LASER
   DESORPTION/IONIZATION; BACILLUS-SUBTILIS; METABOLIC EXCHANGE; AMBIENT
   CONDITIONS; NATURAL-PRODUCTS; ASSEMBLY-LINE; SPECTROMETRY;
   IDENTIFICATION; ANTIBIOTICS
AB Integrating the governing chemistry with the genomics and phenotypes of microbial colonies has been a "holy grail" in microbiology. This work describes a highly sensitive, broadly applicable, and cost-effective approach that allows metabolic profiling of live microbial colonies directly from a Petri dish without any sample preparation. Nanospray desorption electrospray ionization mass spectrometry (MS), combined with alignment of MS data and molecular networking, enabled monitoring of metabolite production from live microbial colonies from diverse bacterial genera, including Bacillus subtilis, Streptomyces coelicolor, Mycobacterium smegmatis, and Pseudomonas aeruginosa. This work demonstrates that, by using these tools to visualize small molecular changes within bacterial interactions, insights can be gained into bacterial developmental processes as a result of the improved organization of MS/MS data. To validate this experimental platform, metabolic profiling was performed on Pseudomonas sp. SH-C52, which protects sugar beet plants from infections by specific soil-borne fungi [R. Mendes et al. (2011) Science 332: 1097-1100]. The antifungal effect of strain SHC52 was attributed to thanamycin, a predicted lipopeptide encoded by a nonribosomal peptide synthetase gene cluster. Our technology, in combination with our recently developed peptidogenomics strategy, enabled the detection and partial characterization of thanamycin and showed that it is a monochlorinated lipopeptide that belongs to the syringomycin family of antifungal agents. In conclusion, the platform presented here provides a significant advancement in our ability to understand the spatiotemporal dynamics of metabolite production in live microbial colonies and communities.
C1 [Roach, Patrick; Heath, Brandi S.; Laskin, Julia] Pacific NW Natl Lab, Chem & Mat Sci Div, Richland, WA 99352 USA.
   [Watrous, Jeramie; Yang, Jane Y.; Kersten, Roland D.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.
   [Watrous, Jeramie; Yang, Jane Y.; Kersten, Roland D.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Watrous, Jeramie; Alexandrov, Theodore; Yang, Jane Y.; Moore, Bradley S.; Bandeira, Nuno; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Alexandrov, Theodore] Univ Bremen, Ctr Ind Math, D-28334 Bremen, Germany.
   [Kersten, Roland D.; Moore, Bradley S.; Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.
   [van der Voort, Menno; Raaijmakers, Jos M.] Wageningen Univ, Phytopathol Lab, NL-PB6708 Wageningen, Netherlands.
   [Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.
   [Gross, Harald] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany.
   [Bandeira, Nuno] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.
   [Bandeira, Nuno] Univ Calif San Diego, Ctr Computat Mass Spectrometry, Natl Ctr Res Resources, La Jolla, CA 92093 USA.
RP Laskin, J (reprint author), Pacific NW Natl Lab, Chem & Mat Sci Div, Richland, WA 99352 USA.
EM julia.laskin@pnnl.gov; bandeira@ucsd.edu; pdorrestein@ucsd.edu
RI Raaijmakers, Jos M/D-1574-2014; Laskin, Julia/H-9974-2012
OI Raaijmakers, Jos M/0000-0003-1608-6614; Laskin,
   Julia/0000-0002-4533-9644; Moore, Bradley/0000-0002-4652-1253; Pogliano,
   Kit/0000-0002-7868-3345; Alexandrov, Theodore/0000-0001-9464-6125
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [GM094802,
   AI095125, 1-P41-RR024851, GM085770]; German Research Foundation,
   Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
   [DFG-FOR854 GR2673/2-1]; Chemical Imaging Program at Pacific Northwest
   National Laboratory (PNNL); US Department of Energy (DOE) Science
   Undergraduate Laboratory Internship (SULI) program at PNNL; Dutch
   Science Organization Ecology Regarding Gene-Modified Organisms
   [838.06.101]; Netherlands Genomics Initiative (NGI) ECOLINC and PreSeed;
   DOE's Office of Biological and Environmental ResearchUnited States
   Department of Energy (DOE); National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [GM094802, AI095125, 1-P41-RR024851, GM085770];
   German Research Foundation, Deutsche Forschungsgemeinschaft (DFG)German
   Research Foundation (DFG) [DFG-FOR854 GR2673/2-1]; Chemical Imaging
   Program at Pacific Northwest National Laboratory (PNNL); US Department
   of Energy (DOE) Science Undergraduate Laboratory Internship (SULI)
   program at PNNL; Dutch Science Organization Ecology Regarding
   Gene-Modified Organisms [838.06.101]; Netherlands Genomics Initiative
   (NGI) ECOLINC and PreSeed; DOE's Office of Biological and Environmental
   ResearchUnited States Department of Energy (DOE)
FX The authors thank Peter Tonge (Stony Brook University) for providing the
   Mycobacterium smegamatis strain. Work in this area in the P. C. D.
   laboratory for the development of real-time MS was supported by National
   Institutes of Health (NIH) Grant GM094802; work on interspecies
   interaction was supported by NIH Grant AI095125 and Johnson & Johnson;
   work in this area in the N.B. laboratory was supported by NIH Grant
   1-P41-RR024851; and work in this area in the K. P. laboratory is
   supported by NIH grant AI095125. This work was also supported in part by
   NIH Grant GM085770 (to B. S. M.); the German Research Foundation,
   Deutsche Forschungsgemeinschaft (DFG), Grant DFG-FOR854 GR2673/2-1 (to
   H. G.); the Chemical Imaging Program at Pacific Northwest National
   Laboratory (PNNL) (P. R. and J.L.); the US Department of Energy (DOE)
   Science Undergraduate Laboratory Internship (SULI) program at PNNL (B.
   S. H.); Dutch Science Organization Ecology Regarding Gene-Modified
   Organisms Grant838.06.101 (to M.v.d.V. and J.M.R.); and Netherlands
   Genomics Initiative (NGI) ECOLINC and PreSeed (M.v.d.V. and J.M.R.). A
   part of the research described in this paper was performed at the W. R.
   Wiley Environmental Molecular Sciences Laboratory, a national scientific
   user facility sponsored by the DOE's Office of Biological and
   Environmental Research and located at PNNL, which is operated by
   Battelle for the DOE.
CR Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104
   Blom EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027160
   Bowen BP, 2010, J AM SOC MASS SPECTR, V21, P1471, DOI 10.1016/j.jasms.2010.04.003
   Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104
   CLEJAN S, 1986, J BACTERIOL, V168, P334, DOI 10.1128/jb.168.1.334-340.1986
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j
   CORLEY DG, 1994, J NAT PRODUCTS, V57, P1484, DOI 10.1021/np50113a002
   Davies J, 2012, ACS CHEM BIOL, V7, P252, DOI 10.1021/cb200337h
   Davies J, 2011, CURR OPIN CHEM BIOL, V15, P5, DOI 10.1016/j.cbpa.2010.11.001
   Dennis E, 2005, FUNCTIONAL LIPIDOMIC, P1
   Dockstader K, 2011, PHYSIOL GENOMICS, V43, P1294, DOI 10.1152/physiolgenomics.00067.2011
   Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004
   Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097
   Frank AM, 2008, J PROTEOME RES, V7, P113, DOI 10.1021/pr070361e
   Gidden J, 2009, INT J MASS SPECTROM, V283, P178, DOI 10.1016/j.ijms.2009.03.005
   Gupta N, 2011, J AM SOC MASS SPECTR, V22, P1111, DOI 10.1007/s13361-011-0139-3
   Harper JD, 2008, ANAL CHEM, V80, P9097, DOI 10.1021/ac801641a
   Harris GA, 2008, ANALYST, V133, P1297, DOI 10.1039/b806810k
   Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777
   Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527
   Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684
   Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107
   Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466
   Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980
   Nyadong L, 2009, ANAL BIOANAL CHEM, V394, P245, DOI 10.1007/s00216-009-2674-3
   Oman TJ, 2011, NAT CHEM BIOL, V7, P78, DOI 10.1038/NCHEMBIO.509
   Peng IX, 2007, RAPID COMMUN MASS SP, V21, P2541, DOI 10.1002/rcm.3154
   Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739
   Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699
   Ratcliff WC, 2011, SCIENCE, V332, P547, DOI 10.1126/science.1205970
   Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885
   Roach PJ, 2010, ANALYST, V135, P2233, DOI 10.1039/c0an00312c
   Romero D, 2011, CHEM REV, V111, P5492, DOI 10.1021/cr2000509
   Rosana M, 2011, ANAL BIOANAL CHEM, V398, P265
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shiea J, 2005, RAPID COMMUN MASS SP, V19, P3701, DOI 10.1002/rcm.2243
   Singh GM, 2007, CHEM BIOL, V14, P31, DOI 10.1016/j.chembiol.2006.11.005
   Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Song YS, 2007, CHEM COMMUN, P61, DOI 10.1039/b615724f
   STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P859, DOI 10.1016/1044-0305(94)87009-8
   Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x
   Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404
   Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102
   Watrous J, 2010, ANAL CHEM, V82, P1598, DOI 10.1021/ac9027388
   Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252
   Zhang JI, 2011, INT J MASS SPECTROM, V301, P37, DOI 10.1016/j.ijms.2010.06.014
   Zhu L, 2009, CHEM COMMUN, P559, DOI 10.1039/b818541g
NR 49
TC 414
Z9 418
U1 13
U2 278
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 26
PY 2012
VL 109
IS 26
BP E1743
EP E1752
DI 10.1073/pnas.1203689109
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 972QE
UT WOS:000306291400011
PM 22586093
OA Green Published, Bronze
HC Y
HP N
DA 2020-05-07
ER

PT J
AU Deng, Y
   Jiang, YH
   Yang, YF
   He, ZL
   Luo, F
   Zhou, JZ
AF Deng, Ye
   Jiang, Yi-Huei
   Yang, Yunfeng
   He, Zhili
   Luo, Feng
   Zhou, Jizhong
TI Molecular ecological network analyses
SO BMC BIOINFORMATICS
LA English
DT Article
DE Ecological network; Random Matrix Theory; Microbial community;
   Microbiological ecology; Network interaction; Environmental changes
ID SINGULAR-VALUE DECOMPOSITION; COMMUNITY STRUCTURE; COMPLEX NETWORKS;
   MICROBIAL COMMUNITIES; MUTUALISTIC NETWORKS; BIOLOGICAL NETWORKS;
   EXPRESSION; ARCHITECTURE; MODULARITY; CONNECTIVITY
AB Background: Understanding the interaction among different species within a community and their responses to environmental changes is a central goal in ecology. However, defining the network structure in a microbial community is very challenging due to their extremely high diversity and as-yet uncultivated status. Although recent advance of metagenomic technologies, such as high throughout sequencing and functional gene arrays, provide revolutionary tools for analyzing microbial community structure, it is still difficult to examine network interactions in a microbial community based on high-throughput metagenomics data.
   Results: Here, we describe a novel mathematical and bioinformatics framework to construct ecological association networks named molecular ecological networks (MENs) through Random Matrix Theory (RMT)-based methods. Compared to other network construction methods, this approach is remarkable in that the network is automatically defined and robust to noise, thus providing excellent solutions to several common issues associated with high-throughput metagenomics data. We applied it to determine the network structure of microbial communities subjected to long-term experimental warming based on pyrosequencing data of 16 S rRNA genes. We showed that the constructed MENs under both warming and unwarming conditions exhibited topological features of scale free, small world and modularity, which were consistent with previously described molecular ecological networks. Eigengene analysis indicated that the eigengenes represented the module profiles relatively well. In consistency with many other studies, several major environmental traits including temperature and soil pH were found to be important in determining network interactions in the microbial communities examined. To facilitate its application by the scientific community, all these methods and statistical tools have been integrated into a comprehensive Molecular Ecological Network Analysis Pipeline (MENAP), which is open-accessible now (http://ieg2.ou.edu/MENA).
   Conclusions: The RMT-based molecular ecological network analysis provides powerful tools to elucidate network interactions in microbial communities and their responses to environmental changes, which are fundamentally important for research in microbial ecology and environmental microbiology.
C1 [Deng, Ye; Jiang, Yi-Huei; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.
   [Deng, Ye; Jiang, Yi-Huei; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.
   [Yang, Yunfeng; Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.
   [Deng, Ye] Glomics Inc, Norman, OK 73072 USA.
   [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.
   [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC 29634 USA.
RP Zhou, JZ (reprint author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.
EM jzhou@ou.edu
RI Deng, Ye/X-4358-2019; 吴, 昊/AAB-1620-2020; He, Zhili/C-2879-2012; Yang,
   Yunfeng/H-9853-2013
OI Deng, Ye/0000-0002-7584-0632; He, Zhili/0000-0001-8225-7333; Yang,
   Yunfeng/0000-0001-8274-6196
FU US Department of Energy, Office of Science, Office of Biological and
   Environmental Research, Genomics: GTL Foundational Science (as part of
   ENIGMA, a Scientific Focus Area)United States Department of Energy (DOE)
   [DE-SC0004613, DE-AC02-05CH11231]; US Department of Energy, Office of
   Science, Office of Biological and Environmental Research, Genomics: GTL
   Foundational ScienceUnited States Department of Energy (DOE)
   [DE-SC0004601]; United States Department of Agriculture through NSF-USDA
   [2007-35319-18305]; Oklahoma Bioenergy Center (OBC) of State of
   Oklahoma; State Key Joint Laboratory of Environment Simulation and
   Pollution Control at Tsinghua University [11Z03ESPCT]
FX This work has been supported, through contract DE-SC0004613 and contract
   DE-AC02-05CH11231 (as part of ENIGMA, a Scientific Focus Area) and
   contract DE-SC0004601, by the US Department of Energy, Office of
   Science, Office of Biological and Environmental Research, Genomics: GTL
   Foundational Science, the United States Department of Agriculture
   (Project 2007-35319-18305) through NSF-USDA Microbial Observatories
   Program, the Oklahoma Bioenergy Center (OBC) of State of Oklahoma, and
   State Key Joint Laboratory of Environment Simulation and Pollution
   Control (Grant 11Z03ESPCT) at Tsinghua University.
CR Akutsu T, 1999, Pac Symp Biocomput, P17
   Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072
   Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Bandyopadhyay JN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026109
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299
   Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100
   Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818
   Bascompte J, 2007, BASIC APPL ECOL, V8, P485, DOI 10.1016/j.baae.2007.06.003
   Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950
   BOHIGAS O, 1984, J PHYS LETT-PARIS, V45, P1015, DOI 10.1051/jphyslet:0198400450210101500
   BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631
   Brandes U., 2005, NETWORK ANAL METHODO
   Butte A J, 2000, Pac Symp Biocomput, P418
   Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197
   Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I02]
   Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40
   Carter DA, 2004, BIOL PSYCHIAT, V55, P785, DOI 10.1016/j.biopsych.2003.07.005
   Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109
   Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527
   Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2
   Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699
   Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102
   Dunne JA, 2006, SFI S SCI C, P27
   Epstein SS, 2009, NATURE, V457, P1083, DOI 10.1038/4571083a
   Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961
   Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058
   Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001
   Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900
   Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505
   Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799
   Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288
   Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001
   Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489
   Handelsman J, 2007, COMMITTEE METAGENOMI, P1
   He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2
   He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x
   Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103
   Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471
   Krackhardt D, 1994, GRAPH THEORETICAL DI
   Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701
   Liang S, 1998, Pac Symp Biocomput, P18
   Luo F, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031924
   Luo F, 2006, PHYS LETT A, V357, P420, DOI 10.1016/j.physleta.2006.04.076
   Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299
   Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724
   MANTEL N, 1967, CANCER RES, V27, P209
   Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103
   May R. M., 2001, STABILITY COMPLEXITY
   MAY RM, 1973, STABILITY COMPLEXITY
   MEHTA M, 1990, RANDOM MATRICES
   Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460
   Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190
   Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000
   Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133
   Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207
   Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103
   Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104
   Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014
   Pim S, 1982, FOOD WEBS
   Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471
   Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956
   Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804
   Seba P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198104
   Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321
   Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   West D, 1996, INTRO GRAPH THEORY
   WIGNER EP, 1967, SIAM REV, V9, P1, DOI 10.1137/1009001
   Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131
   Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199
   Zhang B, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1128
   Zhong JX, 1999, PHYS REV E, V59, P4071, DOI 10.1103/PhysRevE.59.4071
   Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105
   Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10
   Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11
   Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11
   Zhou XH, 2002, P NATL ACAD SCI USA, V99, P12783, DOI 10.1073/pnas.192159399
NR 100
TC 358
Z9 377
U1 51
U2 354
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAY 30
PY 2012
VL 13
AR 113
DI 10.1186/1471-2105-13-113
PG 20
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 996FM
UT WOS:000308070200001
PM 22646978
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2020-05-07
ER

PT J
AU Denoncin, K
   Schwalm, J
   Vertommen, D
   Silhavy, TJ
   Collet, JF
AF Denoncin, Katleen
   Schwalm, Jaclyn
   Vertommen, Didier
   Silhavy, Thomas J.
   Collet, Jean-Francois
TI Dissecting the Escherichia coli periplasmic chaperone network using
   differential proteomics
SO PROTEOMICS
LA English
DT Article
DE beta-Barrel; Chaperone; Microbiology; Outer membrane; Periplasm
ID FATTY-ACID OXIDATION; PROLIFERATOR-ACTIVATED RECEPTOR; RAT-LIVER
   MITOCHONDRIA; COMPLEX-I DEFICIENCY; HUMAN MUSCLE MITOCHONDRIA;
   RESPIRATORY-CHAIN; BETA-OXIDATION; ENERGY-METABOLISM; LEIGH-SYNDROME;
   COENZYME-A
AB beta-Barrel proteins, or outer membrane proteins (OMPs), perform many essential functions in Gram-negative bacteria, but questions remain about the mechanism by which they are assembled into the outer membrane (OM). In Escherichia coli, beta-barrels are escorted across the periplasm by chaperones, most notably SurA and Skp. However, the contributions of these two chaperones to the assembly of the OM proteome remained unclear. We used differential proteomics to determine how the elimination of Skp and SurA affects the assembly of many OMPs. We have shown that removal of Skp has no impact on the levels of the 63 identified OM proteins. However, depletion of SurA in the skp strain has a marked impact on the OM proteome, diminishing the levels of almost all beta-barrel proteins. Our results are consistent with a model in which SurA plays a primary chaperone role in E. coli. Furthermore, they suggest that while no OMPs prefer the Skp chaperone pathway in wild-type cells, most can use Skp efficiently when SurA is absent. Our data, which provide a unique glimpse into the protein content of the nonviable surA skp mutant, clarify the roles of the periplasmic chaperones in E. coli.
C1 [Denoncin, Katleen; Collet, Jean-Francois] Catholic Univ Louvain, WELBIO Walloon Excellence Life Sci & Biotechnol, B-1200 Brussels, Belgium.
   [Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, WELBIO, B-1200 Brussels, Belgium.
   [Schwalm, Jaclyn; Silhavy, Thomas J.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.
RP Collet, JF (reprint author), Catholic Univ Louvain, de Duve Inst, WELBIO, 75-39 Ave Hippocrate, B-1200 Brussels, Belgium.
EM jfcollet@uclouvain.be
RI Collet, Jean Francois/F-2105-2010
OI Vertommen, Didier/0000-0001-7648-8282; Silhavy,
   Thomas/0000-0001-7672-5153; Collet, Jean-Francois/0000-0001-8069-7036
FU Interuniversity Attraction Pole Programme-Belgian Science PolicyBelgian
   Federal Science Policy Office [P6/05]; FRS-FNRSFonds de la Recherche
   Scientifique - FNRS; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM07388]; NIGMSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [34821]
FX We thank Genevieve Connerotte and Steve Calberson for technical
   assistance and Pauline Leverrier for critical reading of the manuscript.
   We also thank Bonnie Bassler, Ammar Zafar, and Julia van Kessel for use
   of their qRT-PCR machine and their assistance with the procedure and
   data analysis, and Natividad Ruiz for strains (NR744 and 745) and
   helpful discussion. DV is Collaborateur Logistique and JFC is Chercheur
   Qualifie of the FRS-FNRS. KD is a research fellow of the FRIA. This work
   was supported by the Interuniversity Attraction Pole Programme-Belgian
   Science Policy to JFC (network P6/05), and by grants from the FRS-FNRS
   to JFC. JS is supported by the Genetics and Molecular Biology Training
   Grant from the NIH GM07388 and TJS is supported by NIGMS grant 34821.
CR BENNETT MJ, 1994, J INHERIT METAB DIS, V17, P283, DOI 10.1007/BF00711808
   BENNETT MJ, 1993, J INHERIT METAB DIS, V16, P560, DOI 10.1007/BF00711681
   BENNETT MJ, 1994, CLIN CHEM, V40, P1879
   BOYER B, 1990, BIOCHEM J, V271, P523, DOI 10.1042/bj2710523
   BREMER J, 1972, BIOCHIM BIOPHYS ACTA, V280, P515, DOI 10.1016/0005-2760(72)90131-2
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Budde SMS, 2003, J INHERIT METAB DIS, V26, P813, DOI 10.1023/B:BOLI.0000010003.14113.af
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com
   Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9
   Dong X, 2004, AM J PHYSIOL-HEART C, V287, pH1417, DOI 10.1152/ajpheart.01233.2003
   Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8
   Enns GM, 2000, J PEDIATR-US, V136, P251, DOI 10.1016/S0022-3476(00)70111-9
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Goodwin GW, 1998, AM J PHYSIOL-HEART C, V274, pH1239
   Hagenfeldt L, 1998, J INHERIT METAB DIS, V21, P613, DOI 10.1023/A:1005431424744
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044
   Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004
   LATIPAA PM, 1986, BIOCHIM BIOPHYS ACTA, V875, P293, DOI 10.1016/0005-2760(86)90179-7
   Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mutomba MC, 2000, FEBS LETT, V478, P19, DOI 10.1016/S0014-5793(00)01817-2
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Petersen A, 2007, CURR EYE RES, V32, P871, DOI 10.1080/02713680701642327
   Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40
   POPOV KM, 1992, BIOCHIM BIOPHYS ACTA, V1119, P69, DOI 10.1016/0167-4838(92)90236-7
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637
   REQUERO MA, 1995, BIOCHEMISTRY-US, V34, P10400, DOI 10.1021/bi00033a011
   Rittie L, 2005, METH MOLEC MED, V117, P83
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104
   Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200
   Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124
   SUMEGI B, 1984, J BIOL CHEM, V259, P5040
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Ventura FV, 2007, BIOCHEM BIOPH RES CO, V352, P873, DOI 10.1016/j.bbrc.2006.11.109
   Ventura FV, 2005, MOL GENET METAB, V86, P344, DOI 10.1016/j.ymgme.2005.07.030
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200
   Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0
   WOJTCZAK L, 1976, J BIOENERG BIOMEMBR, V8, P293
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Wu MX, 2009, FREE RADICAL BIO MED, V46, P62, DOI 10.1016/j.freeradbiomed.2008.09.021
   Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222
NR 74
TC 37
Z9 37
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAY
PY 2012
VL 12
IS 9
BP 1391
EP 1401
DI 10.1002/pmic.201100633
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 943AG
UT WOS:000304092200011
PM 22589188
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Sauer, M
   Mattanovich, D
AF Sauer, Michael
   Mattanovich, Diethard
TI Construction of microbial cell factories for industrial bioprocesses
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE industrial microbiology; metabolic engineering; strain improvement;
   systems biology; synthetic biology; metabolic modelling
ID SACCHAROMYCES-CEREVISIAE; METABOLIC FLUX; SYSTEMS BIOLOGY;
   GENE-EXPRESSION; ACID PRODUCTION; MICROORGANISMS; PROTEIN; STRATEGIES;
   FRAMEWORK; ALCOHOLS
AB The development of industrial microbial processes is gaining unprecedented momentum. Increased concern for environmental issues and the prospect of declining petroleum resources has shifted the industrial focus increasingly to microorganisms as biocatalysts. At the same time systems biology and synthetic biology supply industry and academia with new tools to design optimal microbial cell factories.
   Among the tools are systems biology approaches allowing the modelling of cellular networks for rational strain design, single cell analyses methods for gaining insight into population hetereogeneity, and an exciting combination of tools from structural biology and synthetic biology, permitting the catalysis of new (unnatural) enzymatic reactions or the production of new (unnatural) chemicals.
   This perspective article outlines recent advances and new developments within the field of microbial cell factory design. (C) 2012 Society of Chemical Industry
C1 [Sauer, Michael] BOKU Univ Nat Resources & Life Sci, Dept Biotechnol, A-1190 Vienna, Austria.
   Austrian Ctr Ind Biotechnol ACIB GmbH, A-1190 Vienna, Austria.
RP Sauer, M (reprint author), BOKU Univ Nat Resources & Life Sci, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.
EM michael.sauer@boku.ac.at
RI Sauer, Michael/A-4735-2009
OI Sauer, Michael/0000-0003-0510-2447; Mattanovich,
   Diethard/0000-0002-0907-4167
FU Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry
   of Traffic, Innovation and Technology (bmvit); Styrian Business
   Promotion Agency SFG; Standortagentur Tirol; ZIT - Technology Agency of
   the City of Vienna through the COMET
FX This work has been supported by the Federal Ministry of Economy, Family
   and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation and
   Technology (bmvit), the Styrian Business Promotion Agency SFG, the
   Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna
   through the COMET-Funding Program managed by the Austrian Research
   Promotion Agency FFG.
CR Abbott DA, 2009, APPL ENVIRON MICROB, V75, P2320, DOI 10.1128/AEM.00009-09
   Askenazi M, 2003, NAT BIOTECHNOL, V21, P150, DOI 10.1038/nbt781
   Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450
   BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876
   Becker J, 2007, J BIOTECHNOL, V132, P99, DOI 10.1016/j.jbiotec.2007.05.026
   Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003
   Becker J, 2009, APPL ENVIRON MICROB, V75, P7866, DOI 10.1128/AEM.01942-09
   Becker JVW, 2003, FEMS YEAST RES, V4, P79, DOI 10.1016/S1567-1356(03)00157-0
   Beekwilder J, 2006, APPL ENVIRON MICROB, V72, P5670, DOI 10.1128/AEM.00609-06
   Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005
   Blank LM, 2010, APPL MICROBIOL BIOT, V86, P1243, DOI 10.1007/s00253-010-2506-6
   Borland LM, 2008, ANNU REV ANAL CHEM, V1, P191, DOI 10.1146/annurev.anchem.1.031207.113100
   Branduardi P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001092
   Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803
   Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599
   Chen Z, 2010, TRENDS BIOTECHNOL, V28, P534, DOI 10.1016/j.tibtech.2010.07.004
   Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42
   Dong D, 2011, NUCLEIC ACIDS RES, V39, P403, DOI 10.1093/nar/gkq844
   Du J, 2011, J IND MICROBIOL BIOT, V38, P873, DOI 10.1007/s10295-011-0970-3
   Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557
   Greller LD, 2002, TRENDS BIOTECHNOL, V20, P445, DOI 10.1016/S0167-7799(02)02051-6
   Hong KK, 2011, P NATL ACAD SCI USA, V108, P12179, DOI 10.1073/pnas.1103219108
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Katz M, 2008, US Patent Application, Patent No. [0286844 A1, 0286844]
   Khersonsky O, 2010, J MOL BIOL, V396, P1025, DOI 10.1016/j.jmb.2009.12.031
   Kim HU, 2008, MOL BIOSYST, V4, P113, DOI 10.1039/b712395g
   Kohlstedt M, 2010, APPL MICROBIOL BIOT, V88, P1065, DOI 10.1007/s00253-010-2854-2
   Kortmann H, 2011, ADV BIOCHEM ENG BIOT, V124, P99, DOI 10.1007/10_2010_96
   Lee SY, 2009, DRUG DISCOV TODAY, V14, P78, DOI 10.1016/j.drudis.2008.08.004
   Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006
   Mainguet SE, 2010, BIOTECHNOL J, V5, P1297, DOI 10.1002/biot.201000276
   Mattanovich D, 2004, J BIOTECHNOL, V113, P121, DOI 10.1016/j.jbiotec.2004.04.035
   McArthur GH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/459760
   Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004
   Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005
   Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004
   Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10
   Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001
   Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003
   Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004
   Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1
   Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023
   Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640
   Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879
   Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006
   Sauer Michael, 2008, Recent Pat Biotechnol, V2, P191, DOI 10.2174/187220808786240999
   Sauer U, 2001, Adv Biochem Eng Biotechnol, V73, P129
   Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109
   Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9
   Schmid A, 2010, CURR OPIN BIOTECH, V21, P12, DOI 10.1016/j.copbio.2010.01.007
   Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108
   STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U
   Stephanopoulos Gregory, 1994, Current Opinion in Biotechnology, V5, P196, DOI 10.1016/S0958-1669(05)80036-9
   Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105
   SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x
   Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200
   Valli M, 2006, APPL ENVIRON MICROB, V72, P5492, DOI 10.1128/AEM.00683-06
   van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x
   Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002
   Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08
   Zeng An-Ping, 2002, Adv Biochem Eng Biotechnol, V74, P239
   Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106
   Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0
NR 63
TC 24
Z9 24
U1 3
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD APR
PY 2012
VL 87
IS 4
BP 445
EP 450
DI 10.1002/jctb.3711
PG 6
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 906KB
UT WOS:000301342900001
DA 2020-05-07
ER

PT J
AU Boehm, A
   Vogel, J
AF Boehm, Alex
   Vogel, Joerg
TI The csgD mRNA as a hub for signal integration via multiple small RNAs
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID SMALL REGULATORY RNAS; DEPENDENT SMALL RNA; ESCHERICHIA-COLI; BIOFILM
   FORMATION; GENES; HFQ; EXPRESSION; MOTILITY; NETWORK; TARGETS
AB The transcription factor CsgD governing the production of curli fimbriae and cellulose is a key player in the complex regulatory circuit that decides whether Escherichia coli form biofilms. The csgD gene itself is tightly controlled at the level of transcription by a large array of DNA-binding proteins, but what happens after transcription is less understood. In this issue of Molecular Microbiology, Jorgensen (2012), Mika (2012) and Thomason (2012) report on small RNAs (McaS, RprA and GcvB) that together with the RNA-chaperone Hfq regulate the mRNAs of csgD and other biofilm genes, and illustrate the burgeoning concept that the 5' region of bacterial mRNA serves as a hub for sRNA-mediated signal integration at the post-transcriptional level.
C1 [Boehm, Alex; Vogel, Joerg] Inst Mol Infect Biol, D-97080 Wurzburg, Germany.
RP Vogel, J (reprint author), Inst Mol Infect Biol, Josef Schneider Str 2,Bau D15, D-97080 Wurzburg, Germany.
EM alexander.boehm@uni-wuerzburg.de; joerg.vogel@uni-wuerzburg.de
RI Vogel, Jorg/D-5574-2011
OI Vogel, Jorg/0000-0003-2220-1404
CR Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6
   Beisel CL, 2012, EMBO J, V31, P1961, DOI 10.1038/emboj.2012.52
   Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x
   Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8
   Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x
   Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609
   Frohlich KS, 2012, NUCLEIC ACIDS RES, V40, P3623, DOI 10.1093/nar/gkr1156
   Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009
   Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x
   Holmqvist E, 2010, EMBO J, V29, P1840, DOI 10.1038/emboj.2010.73
   Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x
   Le Guyon S, 2012, RNA BIOL IN PRESS, V9
   Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230
   Majdalani N, 2001, MOL MICROBIOL, V39, P1382, DOI 10.1046/j.1365-2958.2001.02329.x
   Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179
   Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103
   Mika F, 2012, MOL MICROBIOL, V84, P51, DOI 10.1111/j.1365-2958.2012.08002.x
   Modi SR, 2011, P NATL ACAD SCI USA, V108, P15522, DOI 10.1073/pnas.1104318108
   Ogasawara H, 2011, J BACTERIOL, V193, P2587, DOI 10.1128/JB.01468-10
   Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x
   Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x
   Papenfort K, 2009, MOL MICROBIOL, V74, P139, DOI 10.1111/j.1365-2958.2009.06857.x
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x
   Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163
   Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x
   Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x
   Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867
   Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x
NR 31
TC 34
Z9 34
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD APR
PY 2012
VL 84
IS 1
BP 1
EP 5
DI 10.1111/j.1365-2958.2012.08033.x
PG 5
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 915HA
UT WOS:000302013500001
PM 22414234
DA 2020-05-07
ER

PT J
AU Baldazzi, V
   Ropers, D
   Geiselmann, J
   Kahn, D
   de Jong, H
AF Baldazzi, Valentina
   Ropers, Delphine
   Geiselmann, Johannes
   Kahn, Daniel
   de Jong, Hidde
TI Importance of metabolic coupling for the dynamics of gene expression
   following a diauxic shift in Escherichia coli
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Systems biology; Modeling and identification; Microbiology; Hybrid
   models
ID CARBON STARVATION RESPONSE; TOMATO FRUIT-DEVELOPMENT; QUALITATIVE
   SIMULATION; REGULATORY NETWORKS; CATABOLITE REPRESSION;
   SIGNAL-TRANSDUCTION; PROTEIN EXPRESSION; MOLECULAR-BIOLOGY; BOOLEAN
   MODELS; TRANSCRIPTION
AB Gene regulatory networks consist of direct interactions, but also include indirect interactions mediated by metabolism. We investigate to which extent these indirect interactions arising from metabolic coupling influence the dynamics of the system. To this end, we build a qualitative model of the gene regulatory network controlling carbon assimilation in Escherichia coli, and use this model to study the changes in gene expression following a diauxic shift from glucose to acetate. In particular, we compare the relative variation in the steady-state concentrations of enzymes and transcription regulators during growth on glucose and acetate, as well as the dynamic response of gene expression to the exhaustion of glucose and the subsequent assimilation of acetate. We find significant differences between the dynamics of the system in the absence and presence of metabolic coupling. This shows that interactions arising from metabolic coupling cannot be ignored when studying the dynamics of gene regulatory networks. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Baldazzi, Valentina] INRA, Plantes & Syst Culture Hort, Site Agroparc, F-84941 Avignon 9, France.
   [Ropers, Delphine; Geiselmann, Johannes; de Jong, Hidde] INRIA Grenoble Rhone Alpes, F-38334 Saint Ismier, France.
   [Geiselmann, Johannes] Univ Grenoble 1, Fac Med Pharm, CNRS, Lab Adaptat & Pathogenie Microorganismes,UMR 5163, La Tronche, France.
   [Kahn, Daniel] Univ Lyon 1, CNRS, INRA, Lab Biometrie & Biol Evolut,UMR 5558, F-69622 Villeurbanne, France.
RP Baldazzi, V (reprint author), INRA, Plantes & Syst Culture Hort, Site Agroparc, F-84941 Avignon 9, France.
EM valentina.baldazzi@avignon.inra.fr
RI Kahn, Daniel/B-9393-2013
OI Kahn, Daniel/0000-0001-8093-0854; Geiselmann,
   Johannes/0000-0002-1329-7558; Baldazzi, Valentina/0000-0001-9734-9759
FU European CommissionEuropean Commission Joint Research Centre
   [FP6-2005-NEST-PATH-COM/043235]; Agence Nationale de la RechercheFrench
   National Research Agency (ANR) [ANR-06-BY0S-0003]
FX This work was supported by the European Commission under project EC-MOAN
   (FP6-2005-NEST-PATH-COM/043235) and the Agence Nationale de la Recherche
   under project MetaGenoReg (ANR-06-BY0S-0003).
CR Baldazzi V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000812
   Batt G, 2008, AUTOMATICA, V44, P982, DOI 10.1016/j.automatica.2007.08.004
   Bettenbrock K, 2006, J BIOL CHEM, V281, P2578, DOI 10.1074/jbc.M508090200
   BOLOURI H, 2008, COMPUTATIONAL MODELI
   Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X
   Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021
   Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288
   Chaves M, 2006, IEE P SYST BIOL, V153, P154, DOI 10.1049/ip-syb:20050079
   Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352
   Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456
   Davidich M, 2008, J THEOR BIOL, V255, P269, DOI 10.1016/j.jtbi.2008.07.020
   De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208
   De Jong H, 2004, B MATH BIOL, V66, P261, DOI 10.1016/j.bulm.2003.08.009
   De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010
   de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851
   de Jong H, 2006, BRIEF BIOINFORM, V7, P354, DOI 10.1093/bib/bbl034
   Faure A, 2009, MOL BIOSYST, V5, P1569, DOI [10.1039/b907562n, 10.1039/B907562n]
   GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7
   Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53
   Hardiman T, 2007, J BIOTECHNOL, V132, P359, DOI 10.1016/j.jbiotec.2007.08.029
   Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004
   Heinrich R., 1996, REGULATION CELLULAR
   Ironi L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S14
   ISHIZUKA H, 1993, MOL MICROBIOL, V10, P341, DOI 10.1111/j.1365-2958.1993.tb01960.x
   Kao KC, 2005, J BIOL CHEM, V280, P36079, DOI 10.1074/jbc.M508202200
   Kappler K, 2003, SIGNAL PROCESS, V83, P789, DOI 10.1016/S0165-1684(02)00479-6
   Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503
   Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143
   Khalil H, 2001, NONLINEAR SYSTEMS
   Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114
   Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10
   Kremling A, 2007, BIOTECHNOL BIOENG, V96, P815, DOI 10.1002/bit.21065
   Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409
   Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312
   Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200
   Mandel MJ, 2005, J BACTERIOL, V187, P434, DOI 10.1128/JB.187.2.434-442.2005
   Monteiro PT, 2008, BIOINFORMATICS, V24, pI227, DOI 10.1093/bioinformatics/btn275
   Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q
   Naldi A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000912
   Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07
   Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200
   Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463
   Oyarzuon D, 2011, P 18 IFAC WORLD C MI, P14838
   Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6
   Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103
   Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040
   Radulescu O, 2006, J R SOC INTERFACE, V3, P185, DOI 10.1098/rsif.2005.0092
   REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0
   Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005
   Ropers D, 2011, IEEE ACM T COMPUT BI, V8, P166, DOI 10.1109/TCBB.2009.49
   Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87
   Saier Jr M.H., 1996, ESCHERICHIA COLI SAL, V1, P1325
   Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122
   Sarkar D, 2008, ARCH MICROBIOL, V190, P559, DOI 10.1007/s00203-008-0406-2
   Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010
   Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141
   Silva-Rocha R, 2011, ENVIRON MICROBIOL, V13, P2389, DOI 10.1111/j.1462-2920.2011.02455.x
   SNOUSSI EH, 1989, DYNAMICS STABILITY S, V4, P189
   Thouvenot B, 2004, BIOCHEM J, V383, P371, DOI 10.1042/BJ20040792
   Venturi V, 2003, MOL MICROBIOL, V49, P1, DOI 10.1046/j.1365-2958.2003.03547.x
   Viretta AU, 2004, BIOTECHNOL PROGR, V20, P670, DOI 10.1021/bp034323l
   Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98
   Zgurskaya HI, 1997, MOL MICROBIOL, V24, P643, DOI 10.1046/j.1365-2958.1997.3961742.x
NR 63
TC 9
Z9 9
U1 0
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD FEB 21
PY 2012
VL 295
BP 100
EP 115
DI 10.1016/j.jtbi.2011.11.010
PG 16
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 880LL
UT WOS:000299408500010
PM 22138386
DA 2020-05-07
ER

PT J
AU Jaeger, L
   Calkins, ER
AF Jaeger, Luc
   Calkins, Erin R.
TI Downward causation by information control in micro-organisms
SO INTERFACE FOCUS
LA English
DT Article
DE RNA world; RNA evolution; information selection; molecular complexity;
   convergence; convergent evolution
ID TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; FUNCTIONAL CONSERVATION;
   REPROGRAMMING BACTERIA; SYSTEMS BIOLOGY; SMALL MOLECULES; EVOLUTION;
   NETWORK; YEAST; PROTEIN
AB The concepts of functional equivalence classes and information control in living systems are useful to characterize downward (or top-down) causation by feedback information control in synthetic biology. Herein, we re-analyse published experiments of microbiology and synthetic biology that demonstrate the existence of several classes of functional equivalence in microbial organisms. Classes of functional equivalence from the bacterial operating system, which processes and controls the information encoded in the genome, can readily be interpreted as strong evidence, if not demonstration, of top-down causation (TDC) by information control. The proposed biological framework reveals how this type of causality is put in action in the cellular operating system. Considerations on TDC by information control and adaptive selection can be useful for synthetic biology by delineating the irreducible set of properties that characterizes living systems. Through a 'retro-synthetic' biology approach, these considerations could contribute to identifying the constraints behind the emergence of molecular complexity during the evolution of an ancient RNA/peptide world into a modern DNA/RNA/protein world. In conclusion, we propose TDCs by information control and adaptive selection as the two types of downward causality absolutely necessary for life.
C1 [Jaeger, Luc; Calkins, Erin R.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.
   [Jaeger, Luc] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.
RP Jaeger, L (reprint author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.
EM jaeger@chem.ucsb.edu
FU Centre for Theology and the Natural Sciences, Berkeley, CA
FX We warmly thank George Ellis and Bill Stoeger for their input on a
   preliminary version of this paper. This work was funded through a STARS
   grant from the Centre for Theology and the Natural Sciences, Berkeley,
   CA (www.ctns.org). L.J. wishes to dedicate this paper to St Thomas
   Aquinas and Roger Bacon.
CR Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024
   Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106
   Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1
   Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011
   Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971
   Auletta G, 2008, J R SOC INTERFACE, V5, P1159, DOI 10.1098/rsif.2008.0018
   Baick JW, 2004, J MICROBIOL, V42, P111
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Bard J, 2010, BIOESSAYS, V32, P559, DOI 10.1002/bies.200900166
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003
   CLAYTON P, 2006, REEMERGENCE EMERGENC
   Coffman JA, 2011, HBK PHILOS SCI, V10, P287
   Coffman JA, 2011, INFORMATION, V2, P102, DOI 10.3390/info2010102
   Conway Morris S., 1998, CRUCIBLE CREATION BU
   Danchin A, 2009, FEMS MICROBIOL REV, V33, P3, DOI 10.1111/j.1574-6976.2008.00137.x
   Danchin Antoine, 2009, Syst Synth Biol, V3, P125, DOI 10.1007/s11693-009-9036-5
   Danchin A, 2009, BIOGERONTOLOGY, V10, P503, DOI 10.1007/s10522-008-9171-5
   DAVIS TN, 1989, P NATL ACAD SCI USA, V86, P7909, DOI 10.1073/pnas.86.20.7909
   de Lorenzo V, 2010, BIOESSAYS, V32, P267, DOI 10.1002/bies.200900194
   dos Santos VAPM, 2010, CURR OPIN BIOTECH, V21, P498, DOI 10.1016/j.copbio.2010.08.001
   EIGEN M, 1991, BIOCHEMISTRY-US, V30, P11005, DOI 10.1021/bi00110a001
   Ellington AD, 2009, INT J BIOCHEM CELL B, V41, P254, DOI 10.1016/j.biocel.2008.08.015
   Ellis GFR, 2009, UNDERST COMPLEX SYST, P63, DOI 10.1007/978-3-642-03205-9_4
   ELLIS GFR, 2008, T ROY SOC S AFR, V63, P69
   Facchin S, 2003, FEBS LETT, V549, P63, DOI 10.1016/S0014-5793(03)00770-1
   FONTANA W, 1994, P NATL ACAD SCI USA, V91, P757, DOI 10.1073/pnas.91.2.757
   Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090
   Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921
   Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x
   Gallivan JP, 2007, CURR OPIN CHEM BIOL, V11, P612, DOI 10.1016/j.cbpa.2007.10.004
   Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721
   Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719
   Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371
   Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812
   Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20
   Gould SJ, 1989, WONDERFUL LIFE BURGE
   Harmer R, 2010, CHAOS, V20, DOI 10.1063/1.3491100
   Jester BC, 2003, P NATL ACAD SCI USA, V100, P14351, DOI 10.1073/pnas.2036253100
   Jewett MC, 2010, CURR OPIN BIOTECH, V21, P697, DOI 10.1016/j.copbio.2010.06.008
   JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0
   Kaiser J, 2007, SCIENCE, V316, P1557, DOI 10.1126/science.316.5831.1557
   Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190
   Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102
   Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434
   Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775
   Klutstein M, 2008, GENETICS, V178, P2389, DOI 10.1534/genetics.108.086777
   Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622
   Leander BS, 2008, J EUKARYOT MICROBIOL, V55, P59, DOI 10.1111/j.1550-7408.2008.00308.x
   Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494
   Luisi PL, 1998, ORIGINS LIFE EVOL B, V28, P613, DOI 10.1023/A:1006517315105
   Luisi PL, 2006, EMERGENCE OF LIFE: FROM CHEMICAL ORIGINS TO SYNTHETIC BIOLOGY, P1
   Luisi PL, 2002, ANAT RECORD, V268, P208, DOI 10.1002/ar.10155
   Maida Y, 2011, BIOL CHEM, V392, P299, DOI 10.1515/BC.2011.035
   Merino E, 2008, CURR OPIN MICROBIOL, V11, P78, DOI 10.1016/j.mib.2008.02.005
   MURPHY N, 2007, EVOLUTION EMERGENCE
   Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817
   Neumann J., 1958, COMPUTER BRAIN
   Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220
   Pereto Juli, 2007, Biology Theory, V2, P128, DOI 10.1162/biot.2007.2.2.128
   Perez-Castineira JR, 2002, P NATL ACAD SCI USA, V99, P15914, DOI 10.1073/pnas.242625399
   Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209
   Randau L, 2008, NATURE, V453, P120, DOI 10.1038/nature06833
   Rauch T, 2005, MOL MICROBIOL, V57, P357, DOI 10.1111/j.1365-2958.2005.04690.x
   Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656
   Schrum JP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002212
   Serganov A, 2009, CURR OPIN STRUC BIOL, V19, P251, DOI 10.1016/j.sbi.2009.02.002
   Shams-Eldin H, 2008, J BACTERIOL, V190, P2217, DOI 10.1128/JB.01778-07
   Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229
   Silvestre DAMM, 2008, J THEOR BIOL, V254, P804, DOI 10.1016/j.jtbi.2008.07.023
   Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369
   Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103
   Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721
   SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0
   Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176
   Terada T, 2002, NAT STRUCT BIOL, V9, P257, DOI 10.1038/nsb777
   Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480
   Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103
   Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308
   Vogan AA, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-1
   Wegscheid B, 2006, EMBO REP, V7, P411, DOI 10.1038/sj.embor.7400641
   Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101
   Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999
   Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507
   Young E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/130781
   Zhong HM, 2006, J BACTERIOL, V188, P909, DOI 10.1128/JB.188.3.909-918.2006
NR 87
TC 19
Z9 19
U1 0
U2 5
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2012
VL 2
IS 1
BP 26
EP 41
DI 10.1098/rsfs.2011.0045
PG 16
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 866KU
UT WOS:000298380400005
PM 23386958
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Barona-Gomez, F
   Cruz-Morales, P
   Noda-Garcia, L
AF Barona-Gomez, Francisco
   Cruz-Morales, Pablo
   Noda-Garcia, Lianet
TI What can genome-scale metabolic network reconstructions do for
   prokaryotic systematics?
SO ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR
   MICROBIOLOGY
LA English
DT Article
DE Genome-scale metabolic network reconstruction; Chemotaxons; Cardiolipin;
   Menaquinones; Natural products; Streptomyces; Actinobacteria
ID STREPTOMYCES-COELICOLOR A3(2); BIOSYNTHETIC-PATHWAY; MENAQUINONE;
   CORYNEBACTERIUM; MICROMONOSPORA; MICROORGANISMS; GENES
AB It has recently been proposed that in addition to Nomenclature, Classification and Identification, Comprehending Microbial Diversity may be considered as the fourth tenet of microbial systematics [Staley JT (2010) The Bulletin of BISMiS, 1(1): 1-5]. As this fourth goal implies a fundamental understanding of microbial speciation, this perspective article argues that translation of bacterial genome sequences into metabolic features may contribute to the development of modern polyphasic taxonomic approaches. Genome-scale metabolic network reconstructions (GSMRs), which are the result of computationally predicted and experimentally confirmed stoichiometric matrices incorporating all enzyme and metabolite components encoded by a genome sequence, provide a platform that can illustrate bacterial speciation. As the topology and the composition of GSMRs are expected to be the result of adaptive evolution, the features of these networks may provide the prokaryotic taxonomist with novel tools for reaching the fourth tenet of microbial systematics. Through selected examples from the Actinobacteria, which have been inferred from GSMRs and experimentally confirmed after phenotypic characterisation, it will be shown that this level of information can be incorporated into modern polyphasic taxonomic approaches. In conclusion, three specific examples are illustrated to show how GSMRs will revolutionize prokaryotic systematics, as has previously occurred in many other fields of microbiology.
C1 [Barona-Gomez, Francisco; Cruz-Morales, Pablo; Noda-Garcia, Lianet] CINVESTAV IPN, Lab Nacl Genom Biodiversidad Langebio, Evolut Metab Divers Lab, Irapuato 36822, Mexico.
RP Barona-Gomez, F (reprint author), CINVESTAV IPN, Lab Nacl Genom Biodiversidad Langebio, Evolut Metab Divers Lab, Km 9-6 Libramiento Norte,Carretera Irapuato Leon, Irapuato 36822, Mexico.
EM fbarona@langebio.cinvestav.mx
OI , Francisco/0000-0003-1492-9497; Cruz-Morales, Pablo/0000-0002-6751-8897
FU Conacyt, MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [82319]
FX This work was supported by Conacyt, Mexico (grant No. 82319).
CR Arakawa C, 2011, ANTIMICROB AGENTS CH, V55, P913, DOI 10.1128/AAC.01362-10
   Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705
   COLLINS MD, 1985, J APPL BACTERIOL, V58, P77, DOI 10.1111/j.1365-2672.1985.tb01431.x
   COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221
   Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42
   Dairi T, 2011, NAT PROD REP, V28, P1054, DOI 10.1039/c0np00047g
   Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949
   Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018
   Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26
   Kieldsen KR, 2009, BIOTECHNOL BIOENG, V102, P583, DOI 10.1002/bit.22067
   KINDBERG C, 1987, J NUTR, V117, P1032
   Koch C, 1996, INT J SYST BACTERIOL, V46, P383, DOI 10.1099/00207713-46-2-383
   Marineo S, 2008, CURR MICROBIOL, V56, P6, DOI 10.1007/s00284-007-9014-7
   Nampoothiri KM, 2002, APPL MICROBIOL BIOT, V58, P89, DOI 10.1007/s00253-001-0861-z
   Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j
   Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9
   Sandoval-Calderon M, 2009, J BIOL CHEM, V284, P17383, DOI 10.1074/jbc.M109.006072
   Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s
   Seyedsayamdost MR, 2011, J AM CHEM SOC, V133, P11434, DOI 10.1021/ja203577e
   Staley J, 2010, B BISMIS, V1, P1
   Tauch A, 2008, J BIOTECHNOL, V136, P22, DOI 10.1016/j.jbiotec.2008.03.004
   Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0
   Trujillo ME, 2005, INT J SYST EVOL MICR, V55, P877, DOI 10.1099/ijs.0.63361-0
   Wagner A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-231
   Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044
NR 27
TC 10
Z9 10
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0003-6072
EI 1572-9699
J9 ANTON LEEUW INT J G
JI Antonie Van Leeuwenhoek
PD JAN
PY 2012
VL 101
IS 1
SI SI
BP 35
EP 43
DI 10.1007/s10482-011-9655-1
PG 9
WC Microbiology
SC Microbiology
GA 858OV
UT WOS:000297811500005
PM 22016333
DA 2020-05-07
ER

PT J
AU Gilbert, JA
   Bao, YM
   Wang, H
   Sansone, SA
   Edmunds, SC
   Morrison, N
   Meyer, F
   Schriml, LM
   Davies, N
   Sterk, P
   Wilkening, J
   Garrity, GM
   Field, D
   Robbins, R
   Smith, DP
   Mizrachi, I
   Moreau, C
AF Gilbert, Jack A.
   Bao, Yiming
   Wang, Hui
   Sansone, Susanna-Assunta
   Edmunds, Scott C.
   Morrison, Norman
   Meyer, Folker
   Schriml, Lynn M.
   Davies, Neil
   Sterk, Peter
   Wilkening, Jared
   Garrity, George M.
   Field, Dawn
   Robbins, Robert
   Smith, Daniel P.
   Mizrachi, Ilene
   Moreau, Corrie
TI Report of the 13th Genomic Standards Consortium Meeting, Shenzhen,
   China, March 4-7, 2012
SO STANDARDS IN GENOMIC SCIENCES
LA English
DT Article
DE Genomic Standards Consortium; microbiome; microbial metagenomics; fungal
   genomics; viral genomics; Genomic Observatories Network
ID MINIMUM INFORMATION; MICROBIOME; EARTH
AB This report details the outcome of the 13th Meeting of the Genomic Standards Consortium. The three-day conference was held at the Kingkey Palace Hotel, Shenzhen, China, on March 5-7, 2012, and was hosted by the Beijing Genomics Institute. The meeting, titled From Genomes to Interactions to Communities to Models, highlighted the role of data standards associated with genomic, metagenomic, and amplicon sequence data and the contextual information associated with the sample. To this end the meeting focused on genomic projects for animals, plants, fungi, and viruses; metagenomic studies in host-microbe interactions; and the dynamics of microbial communities. In addition, the meeting hosted a Genomic Observatories Network session, a Genomic Standards Consortium biodiversity working group session, and a Microbiology of the Built Environment session sponsored by the Alfred P. Sloan Foundation.
C1 [Gilbert, Jack A.; Meyer, Folker; Wilkening, Jared; Smith, Daniel P.] Argonne Natl Lab, Argonne, IL 60439 USA.
   [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA.
   [Bao, Yiming] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA.
   [Wang, Hui; Field, Dawn] Ctr Ecol & Hydrol, Wallingford, Oxon, England.
   [Sansone, Susanna-Assunta; Sterk, Peter] Univ Oxford, E Res Ctr, Oxford, England.
   [Edmunds, Scott C.] BGI Hong Kong Ltd, GigaSci, Hong Kong, Hong Kong, Peoples R China.
   [Morrison, Norman] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.
   [Schriml, Lynn M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Garrity, George M.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
   [Robbins, Robert] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Mizrachi, Ilene] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA.
   [Moreau, Corrie] Field Museum, Chicago, IL 60605 USA.
RP Gilbert, JA (reprint author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.
EM gilbertjack@anl.gov
RI Wang, Hui/E-6764-2012; Garrity, George/F-7551-2013; Gilbert,
   Jack/AAF-3270-2019; Edmunds, Scott/H-2735-2019; Smith,
   Daniel/L-6827-2019; Garrity, George M/I-8452-2019; Davies,
   Neil/E-5863-2012
OI Garrity, George/0000-0002-4465-7034; Edmunds, Scott/0000-0001-6444-1436;
   Smith, Daniel/0000-0002-2479-2044; Garrity, George
   M/0000-0002-4465-7034; Davies, Neil/0000-0001-8085-5014; Sterk,
   Peter/0000-0003-1668-7778; Morrison, Norman/0000-0003-1604-1512; Moreau,
   Corrie/0000-0003-1139-5792; Schriml, Lynn/0000-0001-8910-9851; Meyer,
   Folker/0000-0003-1112-2284; Sansone, Susanna-Assunta/0000-0001-5306-5690
FU US Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]; US National Science Foundation through the research
   coordination network award [RCN4GSC, DBI-0840989]; Eppendorf; MoBio;
   BGI; Lucigen; Hua Yue Enterprise Holdings Ltd.; Gordon and Betty Moore
   FoundationGordon and Betty Moore Foundation; Natural Environment
   Research CouncilNERC Natural Environment Research Council [CEH010021]
FX This work was supported in part by the US Department of Energy under
   Contract DE-AC02-06CH11357 and in part by the US National Science
   Foundation through the research coordination network award RCN4GSC,
   DBI-0840989. We thank Eppendorf, MoBio, BGI, Lucigen, and Hua Yue
   Enterprise Holdings Ltd. for their sponsorship of the meeting. We also
   thank the Gordon and Betty Moore Foundation for support and the U.S.
   Department of Energy for supporting the attendance of Greg Caporaso,
   Daniel Smith, Andreas Wilkening, Austin Davis-Richardson, and Patrick
   Chain through a young investigators travel award.
CR Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Davies N, 2012, NATURE, V481, P145, DOI 10.1038/481145a
   Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360
   Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088
   Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598
   Garrity GM, 2008, OMICS, V12, P157, DOI 10.1089/omi.2008.A2B2
   Gilbert Jack A, 2010, Stand Genomic Sci, V3, P235, DOI 10.4056/sigs.1333437
   Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]
   Hirschman L, 2008, OMICS, V12, P129, DOI 10.1089/omi.2008.0016
   Knight R, 2012, NAT BIOTECH IN PRESS
   Kottmann R, 2008, OMICS, V12, P115, DOI 10.1089/omi.2008.0A10
   Krishna SS, 2010, ACTA CRYSTALLOGR F, V66, P1143, DOI 10.1107/S1744309110035736
   Rocca-Serra P, 2010, BIOINFORMATICS, V26, P2354, DOI 10.1093/bioinformatics/btq415
   Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643
   Sansone SA, 2012, NAT GENET, V44, P121, DOI 10.1038/ng.1054
   Van Brabant B, 2008, OMICS, V12, P123, DOI 10.1089/omi.2008.0020
   Yilmaz P, 2011, ISME J, V5, P1565, DOI 10.1038/ismej.2011.39
   Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823
NR 19
TC 2
Z9 2
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1944-3277
J9 STAND GENOMIC SCI
JI Stand. Genomic Sci.
PY 2012
VL 6
IS 2
BP 276
EP 286
DI 10.4056/sigs.2876184
PG 11
WC Genetics & Heredity; Microbiology
SC Genetics & Heredity; Microbiology
GA 978QC
UT WOS:000306759300013
PM 22768370
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Thurmer, A
   Voigt, B
   Angelov, A
   Albrecht, D
   Hecker, M
   Liebl, W
AF Thuermer, Andrea
   Voigt, Birgit
   Angelov, Angel
   Albrecht, Dirk
   Hecker, Michael
   Liebl, Wolfgang
TI Proteomic analysis of the extremely thermoacidophilic archaeon
   Picrophilus torridus at pH and temperature values close to its growth
   limit
SO PROTEOMICS
LA English
DT Article
DE Acid habitation; Heat shock proteins; Microbiology; Stress;
   Two-dimensional gel electrophoresis
ID 2-DIMENSIONAL GEL-ELECTROPHORESIS; HEAT-SHOCK RESPONSE;
   ESCHERICHIA-COLI; BACILLUS-LICHENIFORMIS; ACID RESISTANCE;
   STRESS-RESPONSE; SULFOLOBUS-SOLFATARICUS; LACTOCOCCUS-LACTIS; REGULATORY
   NETWORK; GENOME SEQUENCE
AB The thermoacidophilic archaeon Picrophilus torridus belongs to the Thermoplasmatales order and is the most acidophilic organism known to date, growing under extremely acidic conditions around pH 0 (pH(opt) 1) and simultaneously at high temperatures up to 65 degrees C. Some genome features that may be responsible for survival under these harsh conditions have been concluded from the analysis of its 1.55 megabase genome sequence. A proteomic map was generated for P. torridus cells grown to the mid-exponential phase. The soluble fraction of the cells was separated by isoelectric focusing in the pH ranges 4-7 and 3-10, followed by a two dimension (2D) on SDS-PAGE gels. A total of 717 Coomassie collodial-stained protein spots from both pH ranges (pH 4-7 and 3-10) were excised and subjected to LC-MS/MS, leading to the identification of 665 soluble protein spots. Most of the enzymes of the central carbon metabolism were identified on the 2D gels, corroborating biochemically the metabolic pathways predicted from the P. torridus genome sequence. The 2D master gels elaborated in this study represent useful tools for physiological studies of this thermoacidophilic organism. Based on quantitative 2D gel electrophoresis, a proteome study was performed to find pH-or temperature-dependent differences in the proteome composition under changing growth conditions. The proteome expression patterns at two different temperatures (50 and 70 degrees C) and two different pH conditions (pH 0.5 and 1.8) were compared. Several proteins were up-regulated under most stress stimuli tested, pointing to general roles in coping with stress.
C1 [Angelov, Angel; Liebl, Wolfgang] Tech Univ Munich, Dept Microbiol, D-85350 Freising Weihenstephan, Germany.
   [Voigt, Birgit; Albrecht, Dirk; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany.
   [Thuermer, Andrea; Angelov, Angel; Liebl, Wolfgang] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany.
RP Liebl, W (reprint author), Tech Univ Munich, Dept Microbiol, Emil Ramann Str 4, D-85350 Freising Weihenstephan, Germany.
EM wliebl@wzw.tum.de
RI Liebl, Wolfgang/D-3766-2014; Angelov, Angel/H-3357-2012
OI Liebl, Wolfgang/0000-0002-8421-2478; Angelov, Angel/0000-0002-9228-0817
FU German Federal Ministry of Education and Research (BMBF)Federal Ministry
   of Education & Research (BMBF)
FX Financial support by the German Federal Ministry of Education and
   Research (BMBF) in the framework of the GenoMik programme is gratefully
   acknowledged.
CR Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28
   Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200
   Barry RC, 2006, ELECTROPHORESIS, V27, P2970, DOI 10.1002/elps.200500851
   Bernhardt J, 1999, ELECTROPHORESIS, V20, P2225, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2225::AID-ELPS2225>3.0.CO;2-8
   Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0
   BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082
   Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M
   Chhabra SR, 2006, J BACTERIOL, V188, P1817, DOI 10.1128/JB.188.5.1817-1828.2006
   Ciaramella M, 2005, TRENDS MICROBIOL, V13, P49, DOI 10.1016/j.tim.2004.12.001
   Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361
   De Angelis M, 2001, MICROBIOL-SGM, V147, P1863, DOI 10.1099/00221287-147-7-1863
   Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021
   Futterer O, 2004, P NATL ACAD SCI USA, V101, P9091, DOI 10.1073/pnas.0401356101
   Gorg A, 1999, ELECTROPHORESIS, V20, P712
   Guillot A, 2003, PROTEOMICS, V3, P337, DOI 10.1002/pmic.200390047
   Haas W, 2005, J BACTERIOL, V187, P8205, DOI 10.1128/JB.187.23.8205-8210.2005
   Hiller K, 2006, BIOINFORMATICS, V22, P2441, DOI 10.1093/bioinformatics/btl409
   HUBER H, 2004, PROKARYOTES EVOLVING
   Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511
   Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0
   Link AJ, 1997, ELECTROPHORESIS, V18, P1314, DOI 10.1002/elps.1150180808
   Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807
   Majumder A, 2011, PROTEOMICS, V11, P3470, DOI 10.1002/pmic.201100115
   Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x
   Palmfeldt J, 2004, PROTEOMICS, V4, P3881, DOI 10.1002/pmic.200400858
   Pessione E, 2005, PROTEOMICS, V5, P687, DOI 10.1002/pmic.200401116
   Reher M, 2010, J BACTERIOL, V192, P964, DOI 10.1128/JB.01281-09
   Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004
   Rosen R, 2002, MASS SPECTROM REV, V21, P244, DOI 10.1002/mas.10031
   Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069
   Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x
   SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995
   Selig M, 1997, ARCH MICROBIOL, V167, P217, DOI 10.1007/BF03356097
   Tachdjian S, 2006, J BACTERIOL, V188, P4553, DOI 10.1128/JB.00080-06
   Tam LT, 2006, PROTEOMICS, V6, P4565, DOI 10.1002/pmic.200600100
   van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P67, DOI 10.1007/s007920050044
   VanBogelen RA, 1997, ELECTROPHORESIS, V18, P1243, DOI 10.1002/elps.1150180805
   Voigt B, 2006, PROTEOMICS, V6, P268, DOI 10.1002/pmic.200500091
   Voigt B, 2004, PROTEOMICS, V4, P1465, DOI 10.1002/pmic.200300684
   Wasinger VC, 1997, ELECTROPHORESIS, V18, P1373, DOI 10.1002/elps.1150180812
   Wecke T, 2006, J BACTERIOL, V188, P7500, DOI 10.1128/JB.01110-06
   WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6
   Wu R, 2009, MOL CELL PROTEOMICS, V8, P2321, DOI 10.1074/mcp.M800483-MCP200
   Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200
NR 44
TC 9
Z9 9
U1 0
U2 21
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD DEC
PY 2011
VL 11
IS 23
BP 4559
EP 4568
DI 10.1002/pmic.201000829
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 855RS
UT WOS:000297582600011
PM 22114103
DA 2020-05-07
ER

PT J
AU Gerlt, JA
   Allen, KN
   Almo, SC
   Armstrong, RN
   Babbitt, PC
   Cronan, JE
   Dunaway-Mariano, D
   Imker, HJ
   Jacobson, MP
   Minor, W
   Poulter, CD
   Raushel, FM
   Sali, A
   Shoichet, BK
   Sweedler, JV
AF Gerlt, John A.
   Allen, Karen N.
   Almo, Steven C.
   Armstrong, Richard N.
   Babbitt, Patricia C.
   Cronan, John E.
   Dunaway-Mariano, Debra
   Imker, Heidi J.
   Jacobson, Matthew P.
   Minor, Wladek
   Poulter, C. Dale
   Raushel, Frank M.
   Sali, Andrej
   Shoichet, Brian K.
   Sweedler, Jonathan V.
TI The Enzyme Function Initiative
SO BIOCHEMISTRY
LA English
DT Article
ID PROTEIN-STRUCTURE; DIVERGENT EVOLUTION; CATALYTIC DIVERSITY; ENOLASE
   SUPERFAMILY; HAD SUPERFAMILY; PREDICTION; MECHANISM; DISCOVERY;
   EFFICIENT; NETWORKS
AB The Enzyme Function Initiative (EFI) was recently established to address the challenge of assigning reliable functions to enzymes discovered in bacterial genome projects; in this Current Topic, we review the structure and operations of the EFI. The EFI includes the Superfamily/Genome, Protein, Structure, Computation, and Data/Dissemination Cores that provide the infrastructure for reliably predicting the in vitro functions of unknown enzymes. The initial targets for functional assignment are selected from five functionally diverse superfamilies (amidohydrolase, enolase, glutathione transferase, haloalkanoic acid dehalogenase, and isoprenoid synthase), with five superfamily specific Bridging Projects experimentally testing the predicted in vitro enzymatic activities. The EFI also includes the Microbiology Core that evaluates the in vivo context of in vitro enzymatic functions and confirms the functional predictions of the EFI. The deliverables of the EFI to the scientific community include (1) development of a large-scale, multidisciplinary sequence/structure-based strategy for functional assignment of unknown enzymes discovered in genome projects (target selection, protein production, structure determination, computation, experimental enzymology, microbiology, and structure-based annotation), (2) dissemination of the strategy to the community via publications, collaborations, workshops, and symposia, (3) computational and bioinformatic tools for using the strategy, (4) provision of experimental protocols and/or reagents for enzyme production and characterization, and (5) dissemination of data via the EFI's Website, http://enzymefunction.org. The realization of multidisciplinary strategies for functional assignment will begin to define the full metabolic diversity that exists in nature and will impact basic biochemical and evolutionary understanding, as well as a wide range of applications of central importance to industrial, medicinal, and pharmaceutical efforts.
C1 [Gerlt, John A.; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   [Gerlt, John A.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Gerlt, John A.; Cronan, John E.; Imker, Heidi J.; Sweedler, Jonathan V.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Allen, Karen N.] Boston Univ, Dept Chem, Boston, MA 02215 USA.
   [Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.
   [Armstrong, Richard N.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA.
   [Babbitt, Patricia C.; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA.
   [Babbitt, Patricia C.; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA.
   [Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.
   [Dunaway-Mariano, Debra; Sweedler, Jonathan V.] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.
   [Jacobson, Matthew P.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.
   [Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
   [Poulter, C. Dale] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.
   [Raushel, Frank M.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.
RP Gerlt, JA (reprint author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
EM j-gerlt@uiuc.edu
RI Allen, Karen N./J-7045-2019; Minor, Wladek/F-3096-2014; Imker,
   Heidi/F-5641-2012; Cronan, John/V-6626-2019; Jacobson, Matthew
   P/Y-5161-2018; Raushel, Frank/B-7125-2015; Sweedler, Jonathan
   V/A-9405-2009
OI Allen, Karen N./0000-0001-7296-0551; Jacobson, Matthew
   P/0000-0001-6262-655X; Raushel, Frank/0000-0002-5918-3089; Sweedler,
   Jonathan V/0000-0003-3107-9922; Imker, Heidi/0000-0003-4748-7453; Minor,
   Wladek/0000-0001-7075-7090
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [5U54GM093342-02, P41 RR-01081, R01GM60595]; National Science
   FoundationNational Science Foundation (NSF) [DBI 0234768, DBI 0640476]
FX This research was supported by National Institutes of Health (NIH) Grant
   5U54GM093342-02. Molecular graphics images were produced using the UCSF
   Chimera package from the Resource for Biocomputing, Visualization, and
   Informatics at the University of California, San Francisco (supported by
   NIH Grant P41 RR-01081).; "The SFLD was developed by the NIH National
   Center for Research Resources for Biocomputing, Visualization, and
   Informatics (supported by NIH Grant P41 RR-01081) as well as NIH Grant
   R01GM60595 and National Science Foundation Grants DBI 0234768 and DBI
   0640476 (to P.C.B.).
CR Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008
   Armstrong RN, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P295
   Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x
   Armstrong RN, 1998, CURR OPIN CHEM BIOL, V2, P618, DOI 10.1016/S1367-5931(98)80093-8
   Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541
   Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v
   Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345
   Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413
   Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289
   Brown SD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r8
   Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Cummings JA, 2010, BIOCHEMISTRY-US, V49, P611, DOI 10.1021/bi901935y
   Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746
   Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471250953.bi0506s15, 10.1002/cpbi.3, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]
   Gerlt J. A., 2011, J BIOL CHEM IN PRESS, V286
   Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034
   Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209
   Gerlt JA, 2007, STRUCTURE, V15, P1353, DOI 10.1016/j.str.2007.10.003
   Hall RS, 2010, J AM CHEM SOC, V132, P1762, DOI 10.1021/ja909817d
   Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981
   Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f
   Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f
   Kalyanaraman C, 2008, STRUCTURE, V16, P1668, DOI 10.1016/j.str.2008.08.015
   Kalyanaraman C, 2010, BIOCHEMISTRY-US, V49, P4003, DOI 10.1021/bi100445g
   Kamat SS, 2011, J AM CHEM SOC, V133, P2080, DOI 10.1021/ja110157u
   Kolb P, 2009, CURR OPIN BIOTECH, V20, P429, DOI 10.1016/j.copbio.2009.08.003
   Ladner JE, 2004, BIOCHEMISTRY-US, V43, P352, DOI 10.1021/bi035832z
   Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810
   Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m
   Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105
   Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l
   Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091
   Rakus JF, 2009, BIOCHEMISTRY-US, V48, P11546, DOI 10.1021/bi901731c
   Sakai A, 2006, BIOCHEMISTRY-US, V45, P4455, DOI 10.1021/bi060230b
   Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605
   Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3
   Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11
   Stourman NV, 2011, BIOCHEMISTRY-US, V50, P1274, DOI 10.1021/bi101861a
   Thompson LC, 2007, BIOCHEMISTRY-US, V46, P6710, DOI 10.1021/bi700356u
   Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786
   Thulasiram HV, 2006, J AM CHEM SOC, V128, P15819, DOI 10.1021/ja065573b
   Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825
   Wallner B, 2005, PROTEIN SCI, V14, P1315, DOI 10.1110/ps.041253405
   Webb E. C., 1992, ENZYME NOMENCLATURE
   Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f
NR 53
TC 111
Z9 112
U1 0
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD NOV 22
PY 2011
VL 50
IS 46
BP 9950
EP 9962
DI 10.1021/bi201312u
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 846JO
UT WOS:000296893700003
PM 21999478
OA Green Accepted
DA 2020-05-07
ER

PT J
AU Navid, A
AF Navid, Ali
TI Applications of system-level models of metabolism for analysis of
   bacterial physiology and identification of new drug targets
SO BRIEFINGS IN FUNCTIONAL GENOMICS
LA English
DT Article
DE flux balance analysis; systems biology; drug target identification;
   bacterial metabolism; constraint-based modeling
ID GENOME-SCALE RECONSTRUCTION; HAEMOPHILUS-INFLUENZAE RD; FLUX-BALANCE
   ANALYSIS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; OPTIMIZATION
   FRAMEWORK; NETWORK RECONSTRUCTION; BIOMASS COMPOSITION; OVERPRODUCTION;
   CAPABILITIES
AB For nearly all of the 20th century, biologists gained considerable insights into the fundamental principles of cellular dynamics by examining select modules of biochemical processes. This form of analysis provides detailed information about the workings of the examined pathways. However, any attempt to alter the normal function of bacteria (perhaps for industrial or medicinal goals) requires a detailed global understanding of cellular mechanisms. The reductionist mode of analysis cannot provide the required information for developing the needed perspective on the complex interactions of biochemical pathways. Thankfully, the increasing availability of microbial genomic, transcriptomic, proteomic and other high-throughput data permits system-level analyses of microbiology. During the past two decades, systems biologists have developed constraint-based genome-scale models (GSM) of metabolism for a variety of pathogens. These models are important tools for assessing the metabolic capabilities of various genotypes. Simultaneously, new computational methods have been developed that use these network reconstructions to answer an array of important immunological questions. The objective of this article is to briefly review some of the uses of GSMs for studying bacterial metabolism under different conditions and to discuss how the calculated solutions can be used for rational design of drugs.
C1 Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA 94551 USA.
RP Navid, A (reprint author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA 94551 USA.
EM navid1@llnl.gov
RI Navid, Ali/A-1336-2013
OI Navid, Ali/0000-0003-2560-6984
FU US Department of Energy by Lawrence Livermore National LaboratoryUnited
   States Department of Energy (DOE) [DE-AC52-07NA27344]; Lawrence
   Livermore National LaboratoryUnited States Department of Energy (DOE)
   [10-ERD-054 (LLNL-JRNL-483102)]
FX This work performed under the auspices of the US Department of Energy by
   Lawrence Livermore National Laboratory under Contract
   DE-AC52-07NA27344.; The Laboratory Directed Research and Development
   Program at Lawrence Livermore National Laboratory under project tracking
   code 10-ERD-054 (LLNL-JRNL-483102).
CR AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868
   Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289
   Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731
   Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068
   Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003
   Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083
   Baart GJE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r136
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8
   Becker SA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-14
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082
   Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89
   Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68
   Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705
   Borodina I, 2008, J BIOL CHEM, V283, P25186, DOI 10.1074/jbc.M803105200
   Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI 10.1093/nar/gkm900
   Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06
   Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15
   Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24
   Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007
   Cvijovic M, 2010, NUCLEIC ACIDS RES, V38, pW144, DOI 10.1093/nar/gkq404
   DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139
   Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104
   Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x
   Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528
   Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949
   Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542
   Forth T, 2010, BIOINFORMATICS, V26, P2352, DOI 10.1093/bioinformatics/btq425
   Ghim CM, 2005, J THEOR BIOL, V237, P401, DOI 10.1016/j.jtbi.2005.04.025
   Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76
   Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Henry CS, 2009, J PHYS CONF SER, V180, DOI 10.1088/1742-6596/180/1/012025
   Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69
   Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26
   Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043
   Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104
   Kim TY, 2010, METAB ENG, V12, P105, DOI 10.1016/j.ymben.2009.05.004
   KORCSMAROS T, 2007, ARXIV PREPRINT
   Le Fevre F, 2009, BIOINFORMATICS, V25, P1987, DOI 10.1093/bioinformatics/btp268
   Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08
   Lee DY, 2003, BIOINFORMATICS, V19, P2144, DOI 10.1093/bioinformatics/btg271
   Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354
   Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196
   Lee S, 2000, COMPUT CHEM ENG, V24, P711, DOI 10.1016/S0098-1354(00)00323-9
   Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7880, DOI 10.1128/AEM.71.12.7880-7887.2005
   Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   MAJEWSKI RA, 1990, BIOTECHNOL BIOENG, V35, P732, DOI 10.1002/bit.260350711
   Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08
   Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834
   Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a
   Navid A, 2009, MOL BIOSYST, V5, P368, DOI 10.1039/b818710j
   Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07
   Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10
   Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200
   Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9
   Pabinger S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-20
   Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104
   Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003
   Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004
   Pharkya P, 2003, BIOTECHNOL BIOENG, V84, P887, DOI 10.1002/bit.10857
   Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60
   Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J
   Pramanik J, 1998, BIOTECHNOL BIOENG, V60, P230, DOI 10.1002/(SICI)1097-0290(19981020)60:2<230::AID-BIT10>3.0.CO;2-Q
   Quadri Luis E. N., 2007, Infectious Disorders - Drug Targets, V7, P230, DOI 10.2174/187152607782110040
   Raghunathan A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-118
   Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38
   Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046
   Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54
   Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003
   Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769
   Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213
   Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088
   Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002
   Schwarz R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-313
   Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399
   Service RF, 2004, SCIENCE, V303, P1796, DOI 10.1126/science.303.5665.1796
   Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487
   Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202
   Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x
   Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285
   Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005
   Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203
   Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312
   Vanee N, 2010, CHEM BIODIVERS, V7, P1026, DOI 10.1002/cbdv.200900323
   VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994
   VARMA A, 1993, BIOTECHNOL BIOENG, V42, P59, DOI 10.1002/bit.260420109
   VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994
   Wang QZ, 2006, APPL MICROBIOL BIOT, V73, P887, DOI 10.1007/s00253-006-0535-y
NR 95
TC 7
Z9 7
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2041-2649
EI 2041-2657
J9 BRIEF FUNCT GENOMICS
JI Brief. Funct. Genomics
PD NOV
PY 2011
VL 10
IS 6
SI SI
BP 354
EP 364
DI 10.1093/bfgp/elr034
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 866NF
UT WOS:000298387100005
PM 22199377
OA Bronze
DA 2020-05-07
ER

PT J
AU Modi, SR
   Camacho, DM
   Kohanski, MA
   Walker, GC
   Collins, JJ
AF Modi, Sheetal R.
   Camacho, Diogo M.
   Kohanski, Michael A.
   Walker, Graham C.
   Collins, James J.
TI Functional characterization of bacterial sRNAs using a network biology
   approach
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE microbiology; network inference; sRNA regulation
ID ESCHERICHIA-COLI; EXPRESSION; GENES; GCVB; RESISTANCE; REGULATORS;
   MICRORNAS; REPRESSES; PROTEIN; HFQ
AB Small RNAs (sRNAs) are important components of posttranscriptional regulation. These molecules are prevalent in bacterial and eukaryotic organisms, and involved in a variety of responses to environmental stresses. The functional characterization of sRNAs is challenging and requires highly focused and extensive experimental procedures. Here, using a network biology approach and a compendium of gene expression profiles, we predict functional roles and regulatory interactions for sRNAs in Escherichia coli. We experimentally validate predictions for three sRNAs in our inferred network: IsrA, GlmZ, and GcvB. Specifically, we validate a predicted role for IsrA and GlmZ in the SOS response, and we expand on current knowledge of the GcvB sRNA, demonstrating its broad role in the regulation of amino acid metabolism and transport. We also show, using the inferred network coupled with experiments, that GcvB and Lrp, a transcription factor, repress each other in a mutually inhibitory network. This work shows that a network-based approach can be used to identify the cellular function of sRNAs and characterize the relationship between sRNAs and transcription factors.
C1 [Modi, Sheetal R.; Camacho, Diogo M.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.
   [Modi, Sheetal R.; Camacho, Diogo M.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA.
   [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA.
   [Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA.
   [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
RP Collins, JJ (reprint author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.
EM jcollins@bu.edu
OI Camacho, Diogo/0000-0002-1971-3524; /0000-0001-7243-8261
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [DP1 OD003644,
   CA21615, GM31030]; Howard Hughes Medical InstituteHoward Hughes Medical
   Institute
FX We thank Susan Gottesman and Gisela Storz for insightful discussions and
   comments on our work, as well as detailed information on Hfq-dependent
   small RNAs in Escherichia coli; and Jorg Vogel for the pXG-0, pXG-1,
   pXG-10, and pSK-015 plasmids. This work was supported by the National
   Institutes of Health Director's Pioneer Award Program Grant DP1 OD003644
   and The Howard Hughes Medical Institute, and National Institutes of
   Health Grants CA21615 and GM31030 (to. G.C.W.). G.C.W. is an American
   Cancer Society Professor.
CR Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241
   Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027
   Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BRENT R, 1980, P NATL ACAD SCI-BIOL, V77, P1932, DOI 10.1073/pnas.77.4.1932
   CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8
   CUI YH, 1995, J BACTERIOL, V177, P4872, DOI 10.1128/jb.177.17.4872-4880.1995
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135
   Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008
   Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131
   Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900
   Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016
   Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841
   Heil G, 2002, MICROBIOL-SGM, V148, P2203, DOI 10.1099/00221287-148-7-2203
   Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09
   Hu M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004495
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055
   Jin Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-165
   Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102
   Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009
   Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203
   Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x
   Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599
   Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005
   Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702
   Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1
   Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004
   Pulvermacher SC, 2008, FEMS MICROBIOL LETT, V281, P42, DOI 10.1111/j.1574-6968.2008.01068.x
   Pulvermacher SC, 2009, J BACTERIOL, V191, P238, DOI 10.1128/JB.00915-08
   Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106
   Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264
   Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064
   Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040
   Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x
   Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043
   Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061
NR 49
TC 61
Z9 63
U1 1
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 13
PY 2011
VL 108
IS 37
BP 15522
EP 15527
DI 10.1073/pnas.1104318108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 819DF
UT WOS:000294804900100
PM 21876160
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Molina, IB
   Mendoza, LO
   Palma, MA
AF Berenice Molina, Ida
   Otilia Mendoza, Lourdes
   Aparicia Palma, Maria
TI Congenital Rubella Syndrome Surveillance in Honduras
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID AMERICA
AB Introduction. Congenital rubella syndrome (CRS) surveillance was established in Honduras to determine the scope of the problem and assess the impact of vaccination.
   Methods. Implementation of the surveillance system required the drafting of national CRS epidemiological surveillance guidelines, the development of a laboratory diagnostic method, and training of physicians, nurses, and microbiologists in the Honduran hospital network and social security system on CRS surveillance guidelines.
   Results. Honduras' experience with the surveillance of other vaccine-preventable diseases facilitated the implementation of hospital-based CRS surveillance. The surveillance system operates in 23 of the 25 public hospitals that offer services to children and at 2 social security hospitals; the private sector has not been integrated into this system. Clinical and technical staff, including representatives from various disciplines such as pediatrics, neonatology, general medicine, epidemiology, nursing, and microbiology, participate in the hospital network, as well as follow up on cases in accordance with the standardized guidelines, depending on their areas of expertise.
   Conclusions. Implementation of the CRS surveillance system requires technical guidelines, laboratory diagnostic capacity, and trained multidisciplinary human resources for its systematization and operation.
C1 [Berenice Molina, Ida; Otilia Mendoza, Lourdes; Aparicia Palma, Maria] Natl Biol Ctr, Minist Hlth, Expanded Program Immunizat, Tegucigalpa, Honduras.
RP Molina, IB (reprint author), Ctr Nacl Biol, Secretaria Salud, Programa Ampliado Inmunizac, Calle Almeria, Tegucigalpa Mdc, Honduras.
EM paihonduras@yahoo.com
FU PAHO/WHO, Immunization UnitWorld Health Organization
FX This work was supported by PAHO/WHO, Immunization Unit.
CR Andrus JK, 2004, REV PANAM SALUD PUBL, V15, P145
   AYES MD, 1993, B ESTADISTICA INFORM
   AYES MD, 1990, B ESTADISTICA INFORM
   AYES MD, 1991, B ESTADISTICA INFORM
   AYES MD, 1992, B ESTADISTICA INFORM
   Castillo-Solorzano C, 2003, J INFECT DIS, V187, pS146, DOI 10.1086/368034
   DIAZ MG, 1994, B ESTADISTICA INFORM
   DIAZ MG, 1995, B ESTADISTICA INFORM
   DIAZ MG, 1996, B INFORM ESTADISTICA
   Division of Vaccines and Immunization, 1997, 12 M TECHN ADV GROUP
   MOLINA IB, 2004, PLAN ACCION NACL ELI
   MOLINA IB, 2001, MANUAL NORMAS PROCED
   MOLINA IB, 1997, LINEAMIENTOS IMPLEME
   MOLINA IB, 2003, SITUACION PROGRAMA A
   MOLINA IB, 1996, PROPUESTA INTRO VACU
   *ORG MUND SAL, 2000, LUCH RUB SINDR RUB C
   *PAN AM HLTH ORG, 2003, REV PANAM SALUD PUBL, V14, P359
   *PAN AM HLTH ORG, 2005, SCI PUBL PAN AM HLTH, V606
   *PAN AM HLTH ORG, 2003, 55 SESS REG COMM
   *PAN AM HLTH ORG, 2003, B INF PAI PROGR AMPL
   *PAN AM HLTH ORG, 2001, GRUP TECN AS ENF PRE
   SABILLON MD, 1999, LINEAMIENTOS PROCESA
NR 22
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2011
VL 204
SU 2
BP S637
EP S641
DI 10.1093/infdis/jir482
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 828OO
UT WOS:000295511800013
PM 21954259
OA Bronze
DA 2020-05-07
ER

PT J
AU Marchadier, E
   Carballido-Lopez, R
   Brinster, S
   Fabret, C
   Mervelet, P
   Bessieres, P
   Noirot-Gros, MF
   Fromion, V
   Noirot, P
AF Marchadier, Elodie
   Carballido-Lopez, Rut
   Brinster, Sophie
   Fabret, Celine
   Mervelet, Peggy
   Bessieres, Philippe
   Noirot-Gros, Marie-Francoise
   Fromion, Vincent
   Noirot, Philippe
TI An expanded protein-protein interaction network in Bacillus subtilis
   reveals a group of hubs: Exploration by an integrative approach
SO PROTEOMICS
LA English
DT Article
DE Cell division; Data integration; DNA replication; Interactome;
   Microbiology; Stress responses; Transcriptome
ID ESCHERICHIA-COLI; DNA-REPLICATION; INTERACTION MAP; CELL-DIVISION;
   YEAST; GENOME; IDENTIFICATION; LOCALIZATION; ORGANIZATION; EXPRESSION
AB We have generated a protein-protein interaction network in Bacillus subtilis focused on several essential cellular processes such as cell division, cell responses to various stresses, the bacterial cytoskeleton, DNA replication and chromosome maintenance by careful application of the yeast two-hybrid approach. This network, composed of 793 interactions linking 287 proteins with an average connectivity of five interactions per protein, represents a valuable resource for future functional analyses. A striking feature of the network is a group of highly connected hubs (GoH) linking many different cellular processes. Most of the proteins of the GoH have unknown functions and are associated to the membrane. By the integration of available knowledge, in particular of transcriptome data sets, the GoH was decomposed into subgroups of party hubs corresponding to protein complexes or regulatory pathways expressed under different conditions. At a global level, the GoH might function as a very robust group of date hubs having partially redundant functions to integrate information from the different cellular pathways. Our analyses also provide a rational way to study the highly redundant functions of the GoH by a genetic approach.
C1 [Marchadier, Elodie; Carballido-Lopez, Rut; Mervelet, Peggy; Noirot-Gros, Marie-Francoise; Noirot, Philippe] INRA, UMR1319 Micalis, F-78350 Jouy En Josas, France.
   [Marchadier, Elodie; Bessieres, Philippe; Fromion, Vincent] INRA, UR1077 Math Informat & Genome, F-78350 Jouy En Josas, France.
   [Brinster, Sophie] INSERM, U1016, Inst Cochin, Paris, France.
   [Fabret, Celine] CNRS, IGM UMR 8621, F-91405 Orsay, France.
RP Noirot, P (reprint author), INRA, UMR1319 Micalis, F-78350 Jouy En Josas, France.
EM vincent.fromion@jouy.inra.fr; philippe.noirot@jouy.inra.fr
RI MARCHADIER, Elodie/AAC-8416-2019; LOPEZ, RUT CARBALLIDO/G-2283-2015;
   noirot-gros, marie-francoise/C-5051-2011
OI MARCHADIER, Elodie/0000-0001-5618-6471; LOPEZ, RUT
   CARBALLIDO/0000-0001-9383-8811; 
FU INRA-AgroBI; European CommissionEuropean Commission Joint Research
   Centre [LSHG-CT-2006-037469]
FX We are grateful to Richard Daniel, Ling J. Wu, Jeff Errington, Slade
   Jensen, Lyndal Thompson, Liz Harry and Etienne Dervyn for the
   construction of some of the baits and preys related to cell division and
   for stimulating discussions about the experiments. We also thank Sylvie
   Huet, Anne Goelzer, Christelle Hennequet-Antier and Leslie
   Aichaoui-Deneve for constructive discussions about statistics and
   computational approaches. This work was financially supported in part by
   an INRA-AgroBI grant to V. F. and P.N., and in part by the BaSysBio
   project (LSHG-CT-2006-037469) funded by the European Commission.
CR Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0
   Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239
   Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017
   Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06
   Dervyn E, 2004, MOL MICROBIOL, V51, P1629, DOI 10.1111/j.1365-2958.2003.03951.x
   Duigou S, 2005, MOL MICROBIOL, V57, P678, DOI 10.1111/j.1365-2958.2005.04725.x
   Fink G. R., 1991, GUIDE YEAST GENETICS
   Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776
   Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009
   Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x
   Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555
   Harwood C. R., 1990, MOL BIOL METHODS BAC
   Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3
   Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47
   James P, 1996, GENETICS, V144, P1425
   Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602
   Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627
   Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138
   Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105
   Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005
   Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2
   Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100
   Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343
   Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786
   LENTH RV, 1989, TECHNOMETRICS, V31, P469, DOI 10.2307/1269997
   Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264
   Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512
   Noirot P, 2004, CURR OPIN MICROBIOL, V7, P505, DOI 10.1016/j.mib.2004.08.005
   Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799
   Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103
   ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417
   Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130
   Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Soufo CD, 2008, DEV CELL, V15, P935, DOI 10.1016/j.devcel.2008.09.010
   Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187
   UNO T, 2004, P IEEE ICDM 04 WORKS
   Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n
   Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684
NR 43
TC 32
Z9 32
U1 1
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD AUG
PY 2011
VL 11
IS 15
SI SI
BP 2981
EP 2991
DI 10.1002/pmic.201000791
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 799FC
UT WOS:000293269100006
PM 21630458
DA 2020-05-07
ER

PT J
AU Zhou, JZ
   Deng, Y
   Luo, F
   He, ZL
   Yang, YF
AF Zhou, Jizhong
   Deng, Ye
   Luo, Feng
   He, Zhili
   Yang, Yunfeng
TI Phylogenetic Molecular Ecological Network of Soil Microbial Communities
   in Response to Elevated CO2
SO MBIO
LA English
DT Article
ID RANDOM-MATRIX THEORY; FOOD-WEB STRUCTURE; FUNCTIONAL-ORGANIZATION;
   BIOLOGICAL NETWORKS; CURRENT KNOWLEDGE; GUT MICROBIOME; BIODIVERSITY;
   CARBON; NITROGEN; DIVERSITY
AB Understanding the interactions among different species and their responses to environmental changes, such as elevated atmospheric concentrations of CO2, is a central goal in ecology but is poorly understood in microbial ecology. Here we describe a novel random matrix theory (RMT)-based conceptual framework to discern phylogenetic molecular ecological networks using metagenomic sequencing data of 16S rRNA genes from grassland soil microbial communities, which were sampled from a long-term free-air CO2 enrichment experimental facility at the Cedar Creek Ecosystem Science Reserve in Minnesota. Our experimental results demonstrated that an RMT-based network approach is very useful in delineating phylogenetic molecular ecological networks of microbial communities based on high-throughput metagenomic sequencing data. The structure of the identified networks under ambient and elevated CO2 levels was substantially different in terms of overall network topology, network composition, node overlap, module preservation, module-based higher-order organization, topological roles of individual nodes, and network hubs, suggesting that the network interactions among different phylogenetic groups/populations were markedly changed. Also, the changes in network structure were significantly correlated with soil carbon and nitrogen contents, indicating the potential importance of network interactions in ecosystem functioning. In addition, based on network topology, microbial populations potentially most important to community structure and ecosystem functioning can be discerned. The novel approach described in this study is important not only for research on biodiversity, microbial ecology, and systems microbiology but also for microbial community studies in human health, global change, and environmental management.
   IMPORTANCE The interactions among different microbial populations in a community play critical roles in determining ecosystem functioning, but very little is known about the network interactions in a microbial community, owing to the lack of appropriate experimental data and computational analytic tools. High-throughput metagenomic technologies can rapidly produce a massive amount of data, but one of the greatest difficulties is deciding how to extract, analyze, synthesize, and transform such a vast amount of information into biological knowledge. This study provides a novel conceptual framework to identify microbial interactions and key populations based on high-throughput metagenomic sequencing data. This study is among the first to document that the network interactions among different phylogenetic populations in soil microbial communities were substantially changed by a global change such as an elevated CO2 level. The framework developed will allow microbiologists to address research questions which could not be approached previously, and hence, it could represent a new direction in microbial ecology research.
C1 [Zhou, Jizhong; Yang, Yunfeng] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.
   [Zhou, Jizhong; Deng, Ye; He, Zhili] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.
   [Zhou, Jizhong; Deng, Ye; He, Zhili] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.
   [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA USA.
   [Deng, Ye] Glomics Inc, Norman, OK USA.
   [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA.
RP Zhou, JZ (reprint author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.
EM jzhou@ou.edu
RI He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Deng, Ye/X-4358-2019; Yang,
   Yunfeng/H-9853-2013
OI He, Zhili/0000-0001-8225-7333; Deng, Ye/0000-0002-7584-0632; Yang,
   Yunfeng/0000-0001-8274-6196
FU U.S. Department of Energy, Office of Science, Office of Biological and
   Environmental Research, Genomics, as part of ENIGMA, a Scientific Focus
   AreaUnited States Department of Energy (DOE) [DE-SC0004601,
   DE-AC02-05CH11231]; United States Department of Agriculture through
   NSF-USDA [2007-35319-18305]; Oklahoma Bioenergy Center of the State of
   Oklahoma; State Key Joint Laboratory of Environment Simulation and
   Pollution Control at Tsinghua University [11Z03ESPCT]; U.S. Department
   of Energy, Office of Science, Office of Biological and Environmental
   Research, GenomicsUnited States Department of Energy (DOE)
   [DE-SC0004601]
FX This work has been supported, through contracts DE-SC0004601,
   DE-AC02-05CH11231 (as part of ENIGMA, a Scientific Focus Area), and
   DE-SC0004601, by the U.S. Department of Energy, Office of Science,
   Office of Biological and Environmental Research, Genomics: GTL
   Foundational Science, the United States Department of Agriculture
   (project 2007-35319-18305) through the NSF-USDA Microbial Observatories
   Program, the Oklahoma Bioenergy Center of the State of Oklahoma, and the
   State Key Joint Laboratory of Environment Simulation and Pollution
   Control (grant 11Z03ESPCT) at Tsinghua University.
CR Adair EC, 2009, ECOSYSTEMS, V12, P1037, DOI 10.1007/s10021-009-9278-9
   Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x
   Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269
   Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Bascompte J, 2007, BASIC APPL ECOL, V8, P485, DOI 10.1016/j.baae.2007.06.003
   Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950
   Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891
   Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104
   Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830
   Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24
   Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699
   Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102
   Dunne JA, 2006, SFI S SCI C, P27
   France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729
   Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222
   Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058
   Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592
   Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489
   He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x
   Heath J, 2005, SCIENCE, V309, P1711, DOI 10.1126/science.1110700
   Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591
   Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922
   Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117
   Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x
   Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54
   Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088
   Luo F, 2006, PHYS LETT A, V357, P420, DOI 10.1016/j.physleta.2006.04.076
   Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299
   Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724
   Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103
   MAY RM, 1973, STABILITY COMPLEXITY
   Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207
   Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104
   Omenn GS, 2006, SCIENCE, V314, P1696, DOI 10.1126/science.1135003
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486
   Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062
   Symstad AJ, 2003, BIOSCIENCE, V53, P89, DOI 10.1641/0006-3568(2003)053[0089:LTALSP]2.0.CO;2
   Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742
   Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Xiaosu D., 2001, CLIMATE CHANGE 2001
   Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10
NR 50
TC 247
Z9 267
U1 30
U2 234
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2011
VL 2
IS 4
AR e00122-11
DI 10.1128/mBio.00122-11
PG 8
WC Microbiology
SC Microbiology
GA 845SX
UT WOS:000296844000009
PM 21791581
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2020-05-07
ER

PT J
AU Liang, CG
   Liebeke, M
   Schwarz, R
   Zuhlke, D
   Fuchs, S
   Menschner, L
   Engelmann, S
   Wolz, C
   Jaglitz, S
   Bernhardt, J
   Hecker, M
   Lalk, M
   Dandekar, T
AF Liang, Chunguang
   Liebeke, Manuel
   Schwarz, Roland
   Zuehlke, Daniela
   Fuchs, Stephan
   Menschner, Leonhard
   Engelmann, Susanne
   Wolz, Christiane
   Jaglitz, Sarah
   Bernhardt, Joerg
   Hecker, Michael
   Lalk, Michael
   Dandekar, Thomas
TI Staphylococcus aureus physiological growth limitations: Insights from
   flux calculations built on proteomics and external metabolite data
SO PROTEOMICS
LA English
DT Article
DE Correlation; Flux balance analysis; Metabolism; Microbiology; Protein
   expression; Staphylococci
ID ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; PATHWAY ANALYSIS;
   GENE-EXPRESSION; GENOME; RECONSTRUCTION; VIRULENCE; NETWORK; DEFINITION
AB Comparing proteomics and metabolomics allows insights into Staphylococcus aureus physiological growth. We update genome and proteome information and deliver strain-specific metabolic models for three S. aureus strains (COL, N315, and Newman). We find a number of differences in metabolism and enzymes. Growth experiments (glucose or combined with oxygen limitation) were conducted to measure external metabolites. Fluxes of the central metabolism were calculated from these data with low error. In exponential phase, glycolysis is active and amino acids are used for growth. In later phases, dehydroquinate synthetase is suppressed and acetate metabolism starts. There are strain-specific differences for these phases. A time series of 2-D gel protein expression data on COL strain delivered a second data set (glucose limitation) on which fluxes were calculated. The comparison with the metabolite-predicted fluxes shows, in general, good correlation. Outliers point to different regulated enzymes for S. aureus COL under these limitations. In exponential growth, there is lower activity for some enzymes in upper glycolysis and pentose phosphate pathway and stronger activity for some in lower glycolysis. In transition phase, aspartate kinase is expressed to meet amino acid requirements and in later phases there is high expression of glyceraldehyde-3-phosphate dehydrogenase and lysine synthetase. Central metabolite fluxes and protein expression of their enzymes correlate in S. aureus.
C1 [Liang, Chunguang; Schwarz, Roland; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97074 Wurzburg, Germany.
   [Liebeke, Manuel; Jaglitz, Sarah; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Greifswald, Germany.
   [Zuehlke, Daniela; Fuchs, Stephan; Menschner, Leonhard; Engelmann, Susanne; Bernhardt, Joerg; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany.
   [Wolz, Christiane] Clin Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany.
   [Dandekar, Thomas] EMBL, Heidelberg, Germany.
RP Dandekar, T (reprint author), Univ Wurzburg, Dept Bioinformat, Bioctr, Hubland, D-97074 Wurzburg, Germany.
EM dandekar@biozentrum.uni-wuerzburg.de
RI Lalk, Michael/C-1618-2010; Dandekar, Thomas/A-4431-2017; Liebeke,
   Manuel/F-3559-2012
OI Lalk, Michael/0000-0002-9230-0267; Dandekar, Thomas/0000-0003-1886-7625;
   Liebeke, Manuel/0000-0002-2339-1409; Wolz,
   Christiane/0000-0003-3909-5281; Menschner, Leonhard/0000-0003-1508-5679;
   Schwarz, Roland/0000-0001-9155-4268
FU Deutsche Forschungsgemeinschaft (German Research Foundation)German
   Research Foundation (DFG) [TR 34-A5, SFB 630-C6, Da 208/10-1, Da
   208/11-1]; BMBFFederal Ministry of Education & Research (BMBF); Land
   Bavaria
FX This work was supported by Deutsche Forschungsgemeinschaft (German
   Research Foundation: TR 34-A5, SFB 630-C6, Da 208/10-1, Da 208/11-1),
   BMBF (SARA) and Land Bavaria.
CR Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M
   Dandekar T, 2003, BIOSYSTEMS, V70, P255, DOI 10.1016/S0303-2647(03)00067-4
   Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103
   Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07
   Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001
   Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06
   Hecker M, 2010, INT J MED MICROBIOL, V300, P76, DOI 10.1016/j.ijmm.2009.10.006
   Hecker M, 2009, RES MICROBIOL, V160, P245, DOI 10.1016/j.resmic.2009.03.008
   Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663
   Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10
   Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18
   Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3
   Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002
   Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08
   Liang CG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-461
   Liebeke M, 2009, APPL MICROBIOL BIOT, V83, P161, DOI 10.1007/s00253-009-1965-0
   Michalik S, 2009, PROTEOMICS, V9, P4468, DOI 10.1002/pmic.200900168
   Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5
   Nocedal J, 1999, NUMERICAL OPTIMIZATI
   Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010
   Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073
   Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786
   Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351
   Schwarz R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-313
   SHAFER WM, 1979, INFECT IMMUN, V25, P902, DOI 10.1128/IAI.25.3.902-911.1979
   Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004
   Szymanski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007441
   Vijayendran C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r72
NR 31
TC 15
Z9 15
U1 0
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD MAY
PY 2011
VL 11
IS 10
BP 1915
EP 1935
DI 10.1002/pmic.201000151
PG 21
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 762NM
UT WOS:000290486200006
PM 21472852
DA 2020-05-07
ER

PT J
AU Ge, RG
   Sun, XS
   Xiao, CL
   Yin, XF
   Shan, WR
   Chen, Z
   He, QY
AF Ge, Ruiguang
   Sun, Xuesong
   Xiao, Chuanle
   Yin, Xingfeng
   Shan, Weiran
   Chen, Zhuo
   He, Qing-Yu
TI Phosphoproteome analysis of the pathogenic bacterium Helicobacter pylori
   reveals over-representation of tyrosine phosphorylation and multiply
   phosphorylated proteins
SO PROTEOMICS
LA English
DT Article
DE Helicobacter pylori; Membrane; Microbiology; Phosphoproteome; Tyrosine
   phosphorylation
ID MASS-SPECTROMETRY; SER/THR/TYR PHOSPHOPROTEOME; VACUOLATING CYTOTOXIN;
   BACILLUS-SUBTILIS; CAGA PROTEIN; IV SECRETION; IN-VIVO; IDENTIFICATION;
   CELLS; EXPRESSION
AB Increasing evidence shows that protein phosphorylation on serine (Ser), threonine (Thr) and tyrosine (Tyr) residues is a major regulatory post-translational modification in the bacteria. To reveal the phosphorylation state in the Gram-negative pathogenic bacterium Helicobacter pylori, we carried out a global and site-specific phosphoproteomic analysis based on TiO(2)-phosphopeptide enrichment and high-accuracy LC-MS/MS determination. Eighty-two phosphopeptides from 67 proteins were identified with 126 phosphorylation sites, among which 79 class I sites were determined to have a distribution of 42.8:38.7:18.5% for the Ser/Thr/Tyr phosphorylation, respectively. The H. pylori phosphoproteome is characterized by comparably big size, high ratio of Tyr phosphorylation, high abundance of multiple phosphorylation sites in individual phosphopeptides and over-representation of membrane proteins. An interaction network covering 28 phosphoproteins was constructed with a total of 163 proteins centering on the major H. pylori virulence factor VacA, indicating that protein phosphorylation in H. pylori may be delicately controlled to regulate many aspects of the metabolic pathways and bacterial virulence.
C1 [Ge, Ruiguang; Shan, Weiran; Chen, Zhuo] Sun Yat Sen Univ, Coll Life Sci, Lab Integrat Biosci, Guangzhou 510275, Guangdong, Peoples R China.
   [Sun, Xuesong; Xiao, Chuanle; Yin, Xingfeng; He, Qing-Yu] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China.
   [Sun, Xuesong; Xiao, Chuanle; Yin, Xingfeng; He, Qing-Yu] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China.
RP Ge, RG (reprint author), Sun Yat Sen Univ, Coll Life Sci, Lab Integrat Biosci, Guangzhou 510275, Guangdong, Peoples R China.
EM gerg@mail.sysu.edu.cn; tqyhe@jnu.edu.cn
RI He, Qing-Yu/H-7078-2014
OI He, Qing-Yu/0000-0003-0503-9492
FU Chang-Jiang Scholars ProgramProgram for Changjiang Scholars & Innovative
   Research Team in University (PCSIRT); National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [20871057, 20801061]; Guangdong Natural Science FoundationNational
   Natural Science Foundation of Guangdong Province [8451027501001233];
   Talents Start-up Foundation of Jinan University [JNU 51208047]; SRF for
   ROCS, SEMScientific Research Foundation for the Returned Overseas
   Chinese Scholars; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
FX This work was partially supported by the 2007 Chang-Jiang Scholars
   Program (to Q.-Y. H.), National Natural Science Foundation of China
   (20871057, to Q.-Y. H.; 20801061, to R. G.), Guangdong Natural Science
   Foundation (8451027501001233, to R. G.), Talents Start-up Foundation of
   Jinan University (JNU 51208047, to X. S.), SRF for ROCS, SEM (to R. G.)
   and the Fundamental Research Funds for the Central Universities (to R.
   G., X. S. and Q.-Y. H.).
CR Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x
   Bayle D, 1998, J BACTERIOL, V180, P317, DOI 10.1128/JB.180.2.317-329.1998
   Blaser MJ, 1997, J CLIN INVEST, V100, P759, DOI 10.1172/JCI119588
   Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200
   Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101
   Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Costa AC, 2009, HELICOBACTER, V14, P15, DOI 10.1111/j.1523-5378.2009.00702.x
   Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095
   Cover TL, 1996, MOL MICROBIOL, V20, P241, DOI 10.1111/j.1365-2958.1996.tb02612.x
   Cozzone AJ, 2009, TRENDS MICROBIOL, V17, P536, DOI 10.1016/j.tim.2009.09.005
   DAI ZH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P97, DOI 10.1016/0925-4439(93)90096-J
   Endo A, 2007, BIOSCI BIOTECH BIOCH, V71, P1073, DOI 10.1271/bbb.60640
   Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602
   Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160
   Ge RG, 2007, J BIOL INORG CHEM, V12, P831, DOI 10.1007/s00775-007-0237-7
   Ge RG, 2009, SCI CHINA SER B, V52, P2055, DOI 10.1007/s11426-009-0144-6
   Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250
   Grangeasse C, 1999, FEMS MICROBIOL LETT, V176, P327, DOI 10.1016/S0378-1097(99)00252-9
   Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004
   Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200
   Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433
   Ilver D, 2004, CELL MICROBIOL, V6, P167, DOI 10.1046/j.1462-5822.2003.00349.x
   Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462
   Jers C, 2008, EXPERT REV PROTEOMIC, V5, P619, DOI 10.1586/14789450.5.4.619
   Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627
   Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7
   Kumar CMS, 2009, J BACTERIOL, V191, P6525, DOI 10.1128/JB.00652-09
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Lin MH, 2009, MOL CELL PROTEOMICS, V8, P2613, DOI 10.1074/mcp.M900276-MCP200
   Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200
   Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200
   Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3
   MARSHALL BJ, 1984, LANCET, V1, P1311
   Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956
   Miller ML, 2009, PROTEOMICS, V9, P116, DOI 10.1002/pmic.200800285
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Paradela A, 2008, J PROTEOME RES, V7, P1809, DOI 10.1021/pr7006544
   Parker JL, 2010, PROTEOMICS, V10, P2486, DOI 10.1002/pmic.201000090
   Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v
   Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615
   Ravichandran A, 2009, PROTEOMICS, V9, P2764, DOI 10.1002/pmic.200800655
   Rosen R, 2004, PROTEOMICS, V4, P3068, DOI 10.1002/pmic.200400890
   Salama NR, 2001, INFECT IMMUN, V69, P730, DOI 10.1128/IAI.69.2.730-736.2001
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559
   Selbach M, 2004, PROTEOMICS, V4, P2961, DOI 10.1002/pmic.200400915
   SHERMAN M, 1994, J BIOL CHEM, V269, P31479
   Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1
   Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069
   SUERBAUM S, 1994, MOL MICROBIOL, V14, P959, DOI 10.1111/j.1365-2958.1994.tb01331.x
   Sun Xuesong, 2008, Metal-Based Drugs, P289490, DOI 10.1155/2008/289490
   Sun XS, 2010, J PROTEOME RES, V9, P275, DOI 10.1021/pr900612v
   TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653
   Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483
   Villen J, 2008, PROTEOMICS, V8, P4444, DOI 10.1002/pmic.200800283
   Voisin S, 2007, PROTEOMICS, V7, P4338, DOI 10.1002/pmic.200700483
   Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016
   Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w
NR 59
TC 42
Z9 43
U1 1
U2 26
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD APR
PY 2011
VL 11
IS 8
BP 1449
EP 1461
DI 10.1002/pmic.201000649
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 750EV
UT WOS:000289528800007
PM 21360674
DA 2020-05-07
ER

PT J
AU Hall, EK
   Maixner, F
   Franklin, O
   Daims, H
   Richter, A
   Battin, T
AF Hall, E. K.
   Maixner, F.
   Franklin, O.
   Daims, H.
   Richter, A.
   Battin, T.
TI Linking Microbial and Ecosystem Ecology Using Ecological Stoichiometry:
   A Synthesis of Conceptual and Empirical Approaches
SO ECOSYSTEMS
LA English
DT Article
DE biogeochemistry; ecological stoichiometry; community structure;
   ecosystem processes; homeostasis; nutrient ratios; Raman; NanoSIMS; XRMA
ID IN-SITU HYBRIDIZATION; N-P STOICHIOMETRY; SINGLE-CELL ANALYSIS; 16S
   RIBOSOMAL-RNA; GROWTH-RATE; BACTERIOPLANKTON COMMUNITIES;
   PSEUDOMONAS-FLUORESCENS; BACTERIAL COMMUNITIES; RAMAN-SPECTROSCOPY;
   MASS-SPECTROMETRY
AB Currently, one of the biggest challenges in microbial and ecosystem ecology is to develop conceptual models that organize the growing body of information on environmental microbiology into a clear mechanistic framework with a direct link to ecosystem processes. Doing so will enable development of testable hypotheses to better direct future research and increase understanding of key constraints on biogeochemical networks. Although the understanding of phenotypic and genotypic diversity of microorganisms in the environment is rapidly accumulating, how controls on microbial physiology ultimately affect biogeochemical fluxes remains poorly understood. We propose that insight into constraints on biogeochemical cycles can be achieved by a more rigorous evaluation of microbial community biomass composition within the context of ecological stoichiometry. Multiple recent studies have pointed to microbial biomass stoichiometry as an important determinant of when microorganisms retain or recycle mineral nutrients. We identify the relevant cellular components that most likely drive changes in microbial biomass stoichiometry by defining a conceptual model rooted in ecological stoichiometry. More importantly, we show how X-ray microanalysis (XRMA), nanoscale secondary ion mass spectroscopy (NanoSIMS), Raman microspectroscopy, and in situ hybridization techniques (for example, FISH) can be applied in concert to allow for direct empirical evaluation of the proposed conceptual framework. This approach links an important piece of the ecological literature, ecological stoichiometry, with the molecular front of the microbial revolution, in an attempt to provide new insight into how microbial physiology could constrain ecosystem processes.
C1 [Hall, E. K.; Battin, T.] Univ Vienna, Dept Limnol, A-1090 Vienna, Austria.
   [Maixner, F.; Daims, H.] Univ Vienna, Dept Microbial Ecol, A-1090 Vienna, Austria.
   [Franklin, O.] IIASA Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria.
   [Richter, A.] Univ Vienna, Vienna Ecol Ctr, Dept Chem Ecol, A-1090 Vienna, Austria.
RP Hall, EK (reprint author), Univ Vienna, Dept Limnol, Althanstr 14, A-1090 Vienna, Austria.
EM ed.hall@univie.ac.at
RI BAttin, Tom/H-7971-2012; Richter, Andreas/D-8483-2012; Daims,
   Holger/I-8410-2012; Hall, Ed/C-6013-2014
OI Richter, Andreas/0000-0003-3282-4808; Daims, Holger/0000-0002-4195-0913;
   Valeeva, Aygul V./0000-0002-9968-9586; Franklin,
   Oskar/0000-0002-0376-4140; Maixner, Frank/0000-0003-2846-8994
FU Austrian Science Foundation (FWF)Austrian Science Fund (FWF)
   [S10005-B17, S10008-BI7, S10002-B17]; National Science
   FoundationNational Science Foundation (NSF) [DEB 9977047]
FX This work is a contribution from the Research Network MICDIF and was
   supported by the Austrian Science Foundation (FWF) specifically
   S10005-B17 for TB, S10008-BI7 for OF, and no. S10002-B17 for HD. The
   current version of this manuscript was greatly improved by feedback from
   Jim Cotner, Sarah Hobbie, Jim Hood, Josh Schimel, Maren Striebel, the
   Battin working group and two anonymous reviewers. Data from the lake
   survey were produced from research funded by a National Science
   Foundation IRCEB grant (DEB 9977047) awarded to Jim Cotner.
CR AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995
   AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257
   Baudouin-Cornu P, 2004, J BIOL CHEM, V279, P5421, DOI 10.1074/jbc.M306415200
   Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052
   Behrens S, 2008, APPL ENVIRON MICROB, V74, P3143, DOI 10.1128/AEM.00191-08
   Binder BJ, 1998, APPL ENVIRON MICROB, V64, P3346
   Cherif M, 2009, P ROY SOC B-BIOL SCI, V276, P487, DOI 10.1098/rspb.2008.0560
   Chrzanowski TH, 1996, AQUAT MICROB ECOL, V10, P115, DOI 10.3354/ame010115
   Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0
   Cotner JB, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00132
   Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718
   Danger M, 2007, FUNCT ECOL, V21, P202, DOI 10.1111/j.1365-2435.2006.01222.x
   Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x
   De Gelder J, 2008, ANAL CHEM, V80, P2155, DOI 10.1021/ac702185d
   Dodds WK, 2004, OECOLOGIA, V140, P458, DOI 10.1007/s00442-004-1599-y
   ELSER JJ, 1995, MICROBIAL ECOL, V29, P145, DOI 10.1007/BF00167161
   Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897
   Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x
   Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013
   Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x
   Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015
   Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213
   FRANKLIN O, AM NAT IN PRESS
   Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103
   GOLDMAN JC, 1987, LIMNOL OCEANOGR, V32, P1239, DOI 10.4319/lo.1987.32.6.1239
   Hall EK, 2011, ISME J, V5, P196, DOI 10.1038/ismej.2010.115
   Hall EK, 2010, FUNCT ECOL, V24, P898, DOI 10.1111/j.1365-2435.2010.01707.x
   Hall EK, 2009, LIMNOL OCEANOGR, V54, P880, DOI 10.4319/lo.2009.54.3.0880
   Huang WE, 2007, MICROB ECOL, V53, P414, DOI 10.1007/s00248-006-9138-5
   Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x
   Hullar MAJ, 2006, APPL ENVIRON MICROB, V72, P713, DOI 10.1128/AEM.72.1.713-722.2006
   Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x
   LECHENE C, 2006, J BIOL, V5
   Li T, 2008, ENVIRON MICROBIOL, V10, P580, DOI 10.1111/j.1462-2920.2007.01478.x
   Makino W, 2004, AQUAT MICROB ECOL, V34, P33, DOI 10.3354/ame034033
   Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x
   Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792
   Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6
   Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341
   Nichols DS, 1997, FEMS MICROBIOL LETT, V152, P349, DOI 10.1016/S0378-1097(97)00224-3
   NICHOLS DS, 1993, ANTARCT SCI, V5, P149, DOI 10.1017/S0954102093000215
   NORLAND S, 1995, APPL ENVIRON MICROB, V61, P1357, DOI 10.1128/AEM.61.4.1357-1362.1995
   Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853
   Pernthaler A, 2004, APPL ENVIRON MICROB, V70, P5426, DOI 10.1128/AEM.70.9.5426-5433.2004
   Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367
   Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643
   Ratcliff WC, 2008, FEMS MICROBIOL ECOL, V65, P391, DOI 10.1111/j.1574-6941.2008.00544.x
   REDFIELD AC, 1958, AM SCI, V46, P205
   Schuster KC, 2000, J MICROBIOL METH, V42, P29, DOI 10.1016/S0167-7012(00)00169-X
   Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487
   Sterner R. W., 2002, ECOLOGICAL STOICHIOM
   STERNER RW, 1990, AM NAT, V136, P209, DOI 10.1086/285092
   Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527
   Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985
   TEZUKA Y, 1990, MICROBIAL ECOL, V19, P227, DOI 10.1007/BF02017167
   Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659
   Vrede K, 2002, APPL ENVIRON MICROB, V68, P2965, DOI 10.1128/AEM.68.6.2965-2971.2002
   Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249
   Wackett LP, 2004, APPL ENVIRON MICROB, V70, P647, DOI 10.1128/AEM.70.2.647-655.2004
   Wagner M, 1998, FEMS MICROBIOL LETT, V160, P159, DOI 10.1016/S0378-1097(97)00570-3
   Wagner M, 2003, CURR OPIN MICROBIOL, V6, P302, DOI 10.1016/S1369-5274(03)00054-7
   Wagner M, 2009, ANNU REV MICROBIOL, V63, P411, DOI 10.1146/annurev.micro.091208.073233
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003
   Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141
NR 65
TC 54
Z9 62
U1 7
U2 162
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1432-9840
EI 1435-0629
J9 ECOSYSTEMS
JI Ecosystems
PD MAR
PY 2011
VL 14
IS 2
BP 261
EP 273
DI 10.1007/s10021-010-9408-4
PG 13
WC Ecology
SC Environmental Sciences & Ecology
GA 732GF
UT WOS:000288172300007
OA Other Gold
DA 2020-05-07
ER

PT J
AU Gaschignard, J
   Levy, C
   Romain, O
   Cohen, R
   Bingen, E
   Aujard, Y
   Boileau, P
AF Gaschignard, Jean
   Levy, Corinne
   Romain, Olivier
   Cohen, Robert
   Bingen, Edouard
   Aujard, Yannick
   Boileau, Pascal
TI Neonatal Bacterial Meningitis 444 Cases in 7 Years
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE neonatal; bacterial; meningitis; mortality; group B streptococci;
   Escherichia coli
ID CHILDREN; INFANCY; ENGLAND; SEPSIS; WALES
AB Background: Neonatal bacterial meningitis remains a severe infectious disease with mortality rates varying between 10% and 15%. The clinical and bacteriologic features of neonatal meningitis collected from January 2001 to December 2007 in a French national survey are presented here.
   Methods: Cases of neonatal meningitis were prospectively collected by a network of 252 pediatric wards covering 61% of French pediatric wards, associated with 168 microbiology laboratories. Neonatal meningitis was classified as early-onset (d0-d4) and late-onset (d5-d28). Statistical analyses were performed according to gestational age and weight at birth.
   Results: A total of 444 cases of neonatal bacterial meningitis were reported by 114 pediatric wards. Five cases were excluded from analysis. Group B streptococci (GBS) and Escherichia coli accounted respectively for 59% and 28% of the cases, followed by Gram-negative bacilli other than E. coli (4%), other streptococci (4%), Neisseria meningitidis (3%), and Listeria monocytogenes (1.5%). GBS was the most common pathogen both in early-onset (77% vs. 18% for E. coli) and in late-onset meningitis (50% vs. 33% for E. coli). Among preterm infants, E. coli was more commonly isolated (45% vs. 32% for GBS), especially in very preterm infants (54%). GBS was more often involved in seizures than E. coli (41% vs. 25%). The overall mortality rate was 13% but reached 25% in preterm or small for gestational age infants, regardless of the etiology.
   Conclusions: GBS was the dominant cause of neonatal bacterial meningitis, with 77% of early-onset and 50% of late-onset cases. E. coli was the most common bacteria in preterm infants.
C1 [Gaschignard, Jean; Romain, Olivier; Boileau, Pascal] Univ Paris 11, Serv Pediat & Reanimat Neonatales, Hop Antoine Beclere, F-92140 Clamart, France.
   [Levy, Corinne; Romain, Olivier; Cohen, Robert; Bingen, Edouard; Aujard, Yannick] Grp Pathol Infect Pediat GPIP, Paris, France.
   [Levy, Corinne; Romain, Olivier; Cohen, Robert; Aujard, Yannick] Assoc Clin Therapeut Infantile Val Marne ACTIV, St Maur Des Fosses, France.
   [Bingen, Edouard] Univ Paris 07, Microbiol Serv, Hop Robert Debre, Paris, France.
RP Boileau, P (reprint author), Univ Paris 11, Serv Pediat & Reanimat Neonatales, Hop Antoine Beclere, 157 Rue Porte Trivaux, F-92140 Clamart, France.
EM pascal.boileau@abc.aphp.fr
RI romain, olivier/AAF-1985-2019; Boileau, Pascal/H-7508-2015
OI romain, olivier/0000-0002-2172-1865; Boileau,
   Pascal/0000-0001-9755-6467; gaschignard, jean/0000-0002-9141-4115
FU GPIP; ACTIV for the French national survey of bacterial meningitis of
   the child
FX Supported by GPIP and ACTIV for the French national survey of bacterial
   meningitis of the child.
CR ANAES, 2001, PREV ANT RISQ INF BA
   Bedford H, 2001, BRIT MED J, V323, P533, DOI 10.1136/bmj.323.7312.533
   Bingen E, 2005, CLIN INFECT DIS, V41, P1059, DOI 10.1086/432944
   Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499
   Georget-Bouquinet E, 2008, ARCH PEDIATRIE, V15, pS126, DOI 10.1016/S0929-693X(08)75495-2
   Heath PT, 2003, ARCH DIS CHILD-FETAL, V88, P173
   Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85
   KLEIN JO, 1995, INFECT DIS FETUS NEW, P835
   Levy C, 2008, ARCH PEDIATRIE, V15, pS99, DOI 10.1016/S0929-693X(08)75491-5
   Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61
   Persson E, 2002, ACTA PAEDIATR, V91, P1087, DOI 10.1080/080352502760311593
   Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103
   Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179
   Stoll BJ, 2004, PEDIATRICS, V113, P1181, DOI 10.1542/peds.113.5.1181
   WISWELL TE, 1995, PEDIATRICS, V95, P803
NR 15
TC 91
Z9 103
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD MAR
PY 2011
VL 30
IS 3
BP 212
EP 217
DI 10.1097/INF.0b013e3181fab1e7
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA 719SV
UT WOS:000287230300009
PM 21416693
DA 2020-05-07
ER

PT J
AU Cheng, VCC
   Wong, LMW
   Tai, JWM
   Chan, JFW
   To, KKW
   Li, IWS
   Hung, IFN
   Chan, KH
   Ho, PL
   Yuen, KY
AF Cheng, Vincent C. C.
   Wong, Lisa M. W.
   Tai, Josepha W. M.
   Chan, Jasper F. W.
   To, Kelvin K. W.
   Li, Iris W. S.
   Hung, Ivan F. N.
   Chan, K. H.
   Ho, P. L.
   Yuen, K. Y.
TI Prevention of Nosocomial Transmission of Norovirus by Strategic
   Infection Control Measures
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID NORWALK-LIKE VIRUSES; TERM-CARE FACILITY; HAND HYGIENE; HEALTH-CARE;
   HONG-KONG; ACUTE GASTROENTERITIS; FELINE CALICIVIRUS; RISK-FACTORS;
   OUTBREAK; SPREAD
AB BACKGROUND. Nosocomial outbreaks of norovirus infection pose a great challenge to the infection control team.
   METHODS. Between November 1, 2009, and February 28, 2010, strategic infection control measures were implemented in a hospital network. In addition to timely staff education and promotion of directly observed hand hygiene, reverse-transcription polymerase chain reaction for norovirus was performed as an added test by the microbiology laboratory for all fecal specimens irrespective of the request for testing. Laboratory-confirmed cases were followed up by the infection control team for timely intervention. The incidence of hospital-acquired norovirus infection per 1,000 potentially infectious patient-days was compared with the corresponding period in the preceding 12 months, and the incidence in the other 6 hospital networks in Hong Kong was chosen as the concurrent control. Phylogenetic analysis of norovirus isolates was performed.
   RESULTS. Of the 988 patients who were tested, 242 (25%) were positive for norovirus; 114 (47%) of those 242 patients had norovirus detected by our added test. Compared with the corresponding period in the preceding 12 months, the incidence of hospital-acquired norovirus infection decreased from 131 to 16 cases per 1,000 potentially infectious patient-days (P<.001), although the number of hospital-acquired infections was low in both the study period (n=8) and the historical control periods (n=11). The incidence of hospital-acquired norovirus infection in our hospital network (0.03 cases per 1,000 patient-days) was significantly lower than that of the concurrent control (0.06 cases per 1,000 patient-days) (P=.015). Forty-three (93%) of 46 norovirus isolates sequenced belonged to the genogroup II.4 variant.
   CONCLUSIONS. Strategic infection control measures with an added test may be useful in controlling nosocomial transmission of norovirus.
C1 [Yuen, K. Y.] Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Cheng, Vincent C. C.; Wong, Lisa M. W.; Tai, Josepha W. M.] Queen Mary Hosp, Infect Control Unit, Hong Kong, Hong Kong, Peoples R China.
   [Hung, Ivan F. N.] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.
RP Yuen, KY (reprint author), Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, Dept Microbiol, Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
EM kyyuen@hkucc.hku.hk
RI 何栢良, Pak-Leung HO/C-4310-2009; Chan, Jasper F. W./D-8007-2013
OI 何栢良, Pak-Leung HO/0000-0002-8811-1308; Chan, Jasper F.
   W./0000-0001-6336-6657; Hung, Ivan Fan Ngai/0000-0002-1556-2538; Yuen,
   Kwok-yung/0000-0002-2083-1552; To, Kelvin/0000-0002-1921-5824
FU Suen Chi Sun Charitable Foundation; Research Fund for the Control of
   Infectious Diseases (RFCID)
FX We thank Dr P. Y. Leung of the Hospital Authority for facilitating this
   study. This work was partly funded by Suen Chi Sun Charitable Foundation
   and Research Fund for the Control of Infectious Diseases (RFCID).
CR Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09
   Billgren M, 2002, J INFECTION, V44, P26, DOI 10.1053/jinf.2001.0946
   Caceres VM, 1998, INFECT CONT HOSP EP, V19, P162, DOI 10.1086/647788
   Chan KH, 2008, J CLIN MICROBIOL, V46, P2195, DOI 10.1128/JCM.00315-08
   Cheng VCC, 2007, J HOSP INFECT, V67, P336, DOI 10.1016/j.jhin.2007.09.010
   Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009
   Cheng VCC, 2009, J HOSP INFECT, V72, P370, DOI 10.1016/j.jhin.2009.04.021
   Doultree JC, 1999, J HOSP INFECT, V41, P51, DOI 10.1016/S0195-6701(99)90037-3
   Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9
   Gehrke C, 2004, J HOSP INFECT, V56, P49, DOI 10.1016/j.jhin.2003.08.019
   Hansen S, 2007, J HOSP INFECT, V65, P348, DOI 10.1016/j.jhin.2006.12.018
   Ho ECM, 2007, J CLIN MICROBIOL, V45, P2205, DOI 10.1128/JCM.02489-06
   *HONG KONG OBS, 2010, CLIM HONG KONG
   Iijima Y, 2008, JPN J INFECT DIS, V61, P419
   Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666
   Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003
   Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004
   Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9
   Lopman BA, 2005, J HOSP INFECT, V60, P135, DOI 10.1016/j.jhin.2004.10.021
   Marx A, 1999, INFECT CONT HOSP EP, V20, P306, DOI 10.1086/501622
   Pittet D, 2009, INFECT CONT HOSP EP, V30, P611, DOI 10.1086/600379
   Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127
   Tai JWM, 2009, INFECTION, V37, P320, DOI 10.1007/s15010-009-8245-x
   Tsang OTY, 2008, J HOSP INFECT, V69, P135, DOI 10.1016/j.jhin.2008.03.015
   Turcios-Ruiz RM, 2008, J PEDIATR-US, V153, P339, DOI 10.1016/j.jpeds.2008.04.015
   Weber DJ, 2005, INFECT CONT HOSP EP, V26, P841, DOI 10.1086/502504
   Wu HM, 2005, INFECT CONT HOSP EP, V26, P802, DOI 10.1086/502497
NR 27
TC 28
Z9 28
U1 0
U2 7
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD MAR
PY 2011
VL 32
IS 3
BP 229
EP 237
DI 10.1086/658330
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 790UH
UT WOS:000292614200005
PM 21460507
OA Green Published
DA 2020-05-07
ER

PT J
AU Raes, J
   Letunic, I
   Yamada, T
   Jensen, LJ
   Bork, P
AF Raes, Jeroen
   Letunic, Ivica
   Yamada, Takuji
   Jensen, Lars Juhl
   Bork, Peer
TI Toward molecular trait-based ecology through integration of
   biogeochemical, geographical and metagenomic data
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE ecosystems biology; environmental genomics; metagenomics; microbiology;
   molecular trait-based ecology
ID OCEAN SAMPLING EXPEDITION; MICROBIAL BIOGEOGRAPHY; DIVERSITY; GENOMES;
   LIFE; PROCHLOROCOCCUS; MICROORGANISMS; COMMUNITIES; PREDICTION; NETWORKS
AB Using metagenomic 'parts lists' to infer global patterns on microbial ecology remains a significant challenge. To deduce important ecological indicators such as environmental adaptation, molecular trait dispersal, diversity variation and primary production from the gene pool of an ecosystem, we integrated 25 ocean metagenomes with geographical, meteorological and geophysicochemical data. We find that climatic factors (temperature, sunlight) are the major determinants of the biomolecular repertoire of each sample and the main limiting factor on functional trait dispersal (absence of biogeographic provincialism). Molecular functional richness and diversity show a distinct latitudinal gradient peaking at 20 degrees N and correlate with primary production. The latter can also be predicted from the molecular functional composition of an environmental sample. Together, our results show that the functional community composition derived from metagenomes is an important quantitative readout for molecular trait-based biogeography and ecology. Molecular Systems Biology 7: 473; published online 15 March 2011; doi:10.1038/msb.2011.6
C1 [Raes, Jeroen; Letunic, Ivica; Yamada, Takuji; Jensen, Lars Juhl; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.
   [Raes, Jeroen] Vrije Univ Brussel VIB, Mol & Cellular Interact Dept, B-1050 Brussels, Belgium.
   [Jensen, Lars Juhl] NNF Ctr Prot Res, Copenhagen, Denmark.
   [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany.
RP Bork, P (reprint author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.
EM bork@embl.de
RI Bork, Peer/F-1813-2013; Letunic, Ivica/K-1102-2019; raes,
   jeroen/D-7835-2018
OI Bork, Peer/0000-0002-2627-833X; Letunic, Ivica/0000-0003-3560-4288;
   raes, jeroen/0000-0002-1337-041X; Jensen, Lars Juhl/0000-0001-7885-715X
FU European UnionEuropean Union (EU) [HEALTH-F4-2007-201052]
FX We thank Chris Creevey and the other Bork laboratory members for their
   valuable input, as well as four anonymous reviewers for their
   constructive remarks. This research is supported by the European Union
   FP7 Program Contract no. HEALTH-F4-2007-201052.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159
   Baas Becking L. G. M., 1934, GEOBIOLOGIE INLEIDIN
   Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08
   Boyer TP, 2006, WORLD OCEAN DATABASE, V60
   CHAO A, 1984, SCAND J STAT, V11, P265
   Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061
   Colinvaux P. A., 1973, INTRO ECOLOGY
   DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200
   Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237
   Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710
   Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388
   Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105
   Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236
   Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106
   Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x
   Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07
   Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475
   GRIESER J, 2002, LOCAL CLIMATE ESTIMA
   Harrington ED, 2007, P NATL ACAD SCI USA, V104, P13913, DOI 10.1073/pnas.0702636104
   Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321
   Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247
   Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384
   Krebs C. J, 2001, ECOLOGY EXPT ANAL DI
   Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35
   Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106
   Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529
   Lindeman RL, 1942, ECOLOGY, V23, P1, DOI 10.2307/1930867
   Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145
   Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088
   Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104
   Magurran A., 1988, ECOLOGICAL DIVERSITY
   Mahenthiralingam E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000017
   Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341
   McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002
   Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0
   Monterey G., 1997, SEASONAL VARIABILITY
   OKSANEN J, 2008, [No title captured], V1, P15
   Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109
   Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001
   Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077
   Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075
   Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669
   Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709
   Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776
   VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480
   von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420
   von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100
   von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825
   Woebken D, 2007, ISME J, V1, P419, DOI 10.1038/ismej.2007.63
   Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667
   Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016
NR 65
TC 104
Z9 105
U1 1
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD MAR
PY 2011
VL 7
AR 473
DI 10.1038/msb.2011.6
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 745XT
UT WOS:000289205600008
PM 21407210
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-05-07
ER

PT J
AU Oscar, TP
AF Oscar, Thomas P.
TI Development and Validation of a Predictive Microbiology Model for
   Survival and Growth of Salmonella on Chicken Stored at 4 to 12 degrees C
SO JOURNAL OF FOOD PROTECTION
LA English
DT Article
ID ARTIFICIAL NEURAL-NETWORKS; ESCHERICHIA-COLI O157-H7; LOW-TEMPERATURE
   GROWTH; RAW POULTRY; CAMPYLOBACTER-JEJUNI; AEROBIC CONDITIONS;
   TYPHIMURIUM DT104; SIMULATION-MODEL; COOKED CHICKEN; CONTAMINATION
AB Salmonella spp. are a leading cause of foodborne illness. Mathematical models that predict Salmonella survival and growth on food from a low initial dose, in response to storage and handling conditions, are valuable tools for helping assess and manage this public health risk. The objective of this study was to develop and to validate the first predictive microbiology model for survival and growth of a low initial dose of Salmonella on chicken during refrigerated storage. Chicken skin was inoculated with a low initial dose (0.9 log) of a multiple antibiotic-resistant strain of Salmonella Typhimurium DT104 (ATCC 700408) and then stored at 4 to 12 degrees C for 0 to 10 days. A general regression neural network (GRNN) model that predicted log change of Salmonella Typhimurium DT104 as a function of time and temperature was developed. Percentage of residuals in an acceptable prediction zone, from - 1 (fail-safe) to 0.5 (fail-dangerous) log, was used to validate the GRNN model by using a criterion of 70% acceptable predictions. Survival but not growth of Salmonella Typhimurium DT104 was observed at 4 to 8 degrees C. Maximum growth of Salmonella Typhimurium DT104 during 10 days of storage was 0.7 log at 9 degrees C, 1.1 log at 10 degrees C, 1.8 log at 11 degrees C, and 2.9 log at 12 degrees C. Performance of the GRNN model for predicting dependent data (n = 163) was 85% acceptable predictions, for predicting independent data for interpolation (n = 77) was 84% acceptable predictions, and for predicting independent data for extrapolation (n = 70) to Salmonella Kentucky was 87% acceptable predictions. Thus, the GRNN model provided valid predictions for survival and growth of Salmonella on chicken during refrigerated storage, and therefore the model can be used with confidence to help assess and manage this public health risk.
C1 Univ Maryland Eastern Shore, Ctr Food Sci & Technol, USDA, ARS,Residue Chem & Predict Microbiol Res Unit, Princess Anne, MD 21853 USA.
RP Oscar, TP (reprint author), Univ Maryland Eastern Shore, Ctr Food Sci & Technol, USDA, ARS,Residue Chem & Predict Microbiol Res Unit, Room 2111, Princess Anne, MD 21853 USA.
EM Thomas.Oscar@ars.usda.gov
CR AIROLDI AA, 1988, J FOOD SCI, V53, P1511, DOI 10.1111/j.1365-2621.1988.tb09311.x
   BRYAN FL, 1995, J FOOD PROTECT, V58, P326, DOI 10.4315/0362-028X-58.3.326
   Burnette CN, 2004, FOOD SCI BIOTECHNOL, V13, P796
   Dominguez SA, 2008, J FOOD PROTECT, V71, P2429, DOI 10.4315/0362-028X-71.12.2429
   Dufrenne J, 2001, J FOOD PROTECT, V64, P538, DOI 10.4315/0362-028X-64.4.538
   Esnoz A, 2006, INT J FOOD MICROBIOL, V106, P153, DOI 10.1016/j.ijfoodmicro.2005.06.016
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Hajmeer M, 2006, FOOD MICROBIOL, V23, P561, DOI 10.1016/j.fm.2005.09.011
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Juneja VK, 2007, FOOD MICROBIOL, V24, P328, DOI 10.1016/j.fm.2006.08.004
   Jung YJ, 2009, FOOD MICROBIOL, V26, P467, DOI 10.1016/j.fm.2009.02.007
   MATCHES JR, 1968, J FOOD SCI, V33, P641, DOI 10.1111/j.1365-2621.1968.tb09092.x
   MATCHES JR, 1972, J MILK FOOD TECHNOL, V35, P49, DOI 10.4315/0022-2747-35.1.49
   MCCULLOUGH NB, 1951, J INFECT DIS, V89, P209, DOI 10.1093/infdis/89.3.209
   MCCULLOUGH NB, 1951, J INFECT DIS, V89, P259, DOI 10.1093/infdis/89.3.259
   MCCULLOUGH NB, 1951, J INFECT DIS, V88, P278, DOI 10.1093/infdis/88.3.278
   MEAD PS, 1999, EMERG INFECT DIS, V5, P840
   Oscar TP, 2006, J FOOD PROTECT, V69, P2048, DOI 10.4315/0362-028X-69.9.2048
   Oscar TP, 2009, J FOOD PROTECT, V72, P304, DOI 10.4315/0362-028X-72.2.304
   Oscar T. P., UNPUB
   Oscar TP, 2009, J FOOD PROTECT, V72, P2078, DOI 10.4315/0362-028X-72.10.2078
   Oscar TP, 2002, INT J FOOD MICROBIOL, V76, P177, DOI 10.1016/S0168-1605(02)00025-9
   Oscar TR, 2005, J FOOD SCI, V70, pM129, DOI 10.1111/j.1365-2621.2005.tb07103.x
   Palanichamy A, 2008, J FOOD PROTECT, V71, P6, DOI 10.4315/0362-028X-71.1.6
   Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   SURKIEWICZ B F, 1969, Food Technology, V23, P80
   Waldroup A. L., 1992, Journal of Applied Poultry Research, V1, P226, DOI 10.1093/japr/1.2.226
   Waldroup AL, 1996, WORLD POULTRY SCI J, V52, P7, DOI 10.1079/WPS19960002
NR 32
TC 15
Z9 16
U1 0
U2 13
PU INT ASSOC FOOD PROTECTION
PI DES MOINES
PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA
SN 0362-028X
J9 J FOOD PROTECT
JI J. Food Prot.
PD FEB
PY 2011
VL 74
IS 2
BP 279
EP 284
DI 10.4315/0362-028X.JFP-10-314
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 719SD
UT WOS:000287228400015
PM 21333149
DA 2020-05-07
ER

PT J
AU Lindqvist, R
   Lindblad, M
AF Lindqvist, Roland
   Lindblad, Mats
TI Time to growth and inactivation of three STEC outbreak strains under
   conditions relevant for fermented sausages
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE Growth/no growth; VTEC; Fermented food; Predictive microbiology;
   Survival analysis; Lactic acid
ID ESCHERICHIA-COLI O157-H7; NEURAL-NETWORK APPROACH; ACID RESISTANCE;
   LISTERIA-MONOCYTOGENES; WATER ACTIVITY; LACTIC-ACID; DRY SAUSAGE; PH;
   SURVIVAL; FOOD
AB Published models predicting growth and survival capabilities of shiga-toxin-producing Escherichia coli (STEC) under a(w) and lactic acid stress were validated by performing experiments with fermented sausage associated outbreak strains. Strain variation in inactivation and time to growth (TIC) were investigated for strains representing three serotypes (0103, 0111, and 0157). The TIC and growth boundaries of each strain were compared with predictions of a model for generic acid adapted E. coli and survival with predictions of two inactivation models. In addition, the influence of strain variation on the performance of the inactivation models, in terms of bias and accuracy factors, was illustrated. Strains with induced acid tolerance were used in broths containing 50 or 110 mM total lactic acid. The concentration of undissociated lactic acid (HLac) was adjusted by setting the pH-value, and water activity (0.900 to 0.995 depending on experiment) was adjusted by adding NaCl. The survival capabilities of the outbreak strains were good compared to the model predictions. The average bias factors of inactivation model predictions were within a factor of 2.2 depending on the strain used to validate the model indicating that inactivation rates of outbreak strains were slower than predicted. However, the observed rates were similar to the rates of a previously studied acid tolerant generic E. coli strain. Similarly, the time to growth of two of the strains (0103 and 0157) was comparable with model predictions, whereas the growth capability of the third strain (0111) was lower than predicted. These results suggest that the properties of the most tolerant sausage outbreak strains are comparable to tolerant generic E. coli strains, which imply that suitable non-pathogenic E. coli strains are valid surrogates for fermented sausage outbreak strains. The relative sensitivity of strains depended on the environmental parameters and the response evaluated. The strain with the smallest log reduction at 20 C was 0157, whereas it was strain 0103 at 8 degrees C. Under conditions unfavorable for growth, the time to growth was much shorter for strains 0103 and O157 than for strain O111, whereas differences between strains were negligible under conditions favorable for growth. Depending on the response variable and the specific application the limitation of not addressing strain variation may lead to biased, fail-dangerous, predictions. Thus, solutions on how to best address strain variation in the development and validation of predictive models are needed. (c) 2010 Elsevier B.V. All rights reserved.
C1 [Lindqvist, Roland; Lindblad, Mats] Natl Food Adm Toxicol Lab, S-75126 Uppsala, Sweden.
   [Lindqvist, Roland] Swedish Univ Agr Sci, Dept Microbiol, S-1307 Uppsala, Sweden.
RP Lindqvist, R (reprint author), Natl Food Adm Toxicol Lab, POB 622, S-75126 Uppsala, Sweden.
EM roland.lindqvist@slv.se
OI Lindqvist, Roland/0000-0001-9732-6055
FU SAFEFOODERA [06458]
FX This work has been carried out with financial support from SAFEFOODERA:
   Pathogen free production chain, under the ERA-Net scheme, administered
   by NICe, The Nordic Innovation Center, to project no. 06458 (Increased
   safety of fermented sausage by the application of production exposure
   assessment for VTEC). The authors wish to acknowledge Dr. L Axelsson
   (Nofima Mat, Norway) for the generous gift of bacterial strains used in
   the study and the skilful technical assistance of Dr. Maria Bergstrom.
CR [Anonymous], 1995, MORBIDITY MORTALITY, V44, P157
   ARNOLD KW, 1995, APPL ENVIRON MICROB, V61, P2037, DOI 10.1128/AEM.61.5.2037-2039.1995
   Bergholz TM, 2007, J APPL MICROBIOL, V102, P352, DOI 10.1111/j.1365-2672.2006.03099.x
   Buchanan RL, 1999, J FOOD PROTECT, V62, P211, DOI 10.4315/0362-028X-62.3.211
   Buchanan RL, 1996, APPL ENVIRON MICROB, V62, P4009, DOI 10.1128/AEM.62.11.4009-4013.1996
   Calicioglu M, 2002, J FOOD PROTECT, V65, P1541, DOI 10.4315/0362-028X-65.10.1541
   Deng Y, 1999, J APPL MICROBIOL, V86, P203, DOI 10.1046/j.1365-2672.1999.00649.x
   Duffy LL, 2000, INT J FOOD MICROBIOL, V60, P83, DOI 10.1016/S0168-1605(00)00353-6
   Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426
   Fehlhaber K, 1998, J APPL MICROBIOL, V84, P945, DOI 10.1046/j.1365-2672.1998.00410.x
   Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038
   GLASS KA, 1992, APPL ENVIRON MICROB, V58, P2513, DOI 10.1128/AEM.58.8.2513-2516.1992
   Hajmeer MN, 2003, INT J FOOD MICROBIOL, V82, P233, DOI 10.1016/S0168-1605(02)00308-2
   Large TM, 2005, APPL ENVIRON MICROB, V71, P2493, DOI 10.1128/AEM.71.5.2493-2500.2005
   Lindblad M, 2010, LETT APPL MICROBIOL, V50, P308, DOI 10.1111/j.1472-765X.2009.02793.x
   Lindqvist R, 2006, APPL ENVIRON MICROB, V72, P4862, DOI 10.1128/AEM.00251-06
   Lindqvist R, 2009, INT J FOOD MICROBIOL, V129, P59, DOI 10.1016/j.ijfoodmicro.2008.11.011
   McKellar RC, 2001, J FOOD PROTECT, V64, P1922, DOI 10.4315/0362-028X-64.12.1922
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V78, P133, DOI 10.1016/S0168-1605(02)00231-3
   McQuestin OJ, 2006, LETT APPL MICROBIOL, V43, P523, DOI 10.1111/j.1472-765X.2006.01993.x
   McQuestin OJ, 2009, APPL ENVIRON MICROB, V75, P6963, DOI 10.1128/AEM.00291-09
   Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7
   Montet MP, 2009, INT J FOOD MICROBIOL, V129, P264, DOI 10.1016/j.ijfoodmicro.2008.12.002
   Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003
   Nissen H, 1998, FOOD MICROBIOL, V15, P273, DOI 10.1006/fmic.1997.0165
   Palanichamy A, 2008, J FOOD PROTECT, V71, P6, DOI 10.4315/0362-028X-71.1.6
   Paton AW, 1996, J CLIN MICROBIOL, V34, P1622, DOI 10.1128/JCM.34.7.1622-1627.1996
   PMP, 2007, PATH MOD PROGR 7 0
   Pond TJ, 2001, J FOOD PROTECT, V64, P759, DOI 10.4315/0362-028X-64.6.759
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773
   Ross T, 2003, RISK ANAL, V23, P179, DOI 10.1111/1539-6924.00299
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ross T., 2004, PRMS 021A PREDICTIVE
   ROSS T, 2001, PREDICTING ESCHERICH
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   Sartz L, 2008, EPIDEMIOL INFECT, V136, P370, DOI 10.1017/S0950268807008473
   Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41
   Seputiene V, 2006, MICROBIOL RES, V161, P65, DOI 10.1016/j.micres.2005.06.002
   Skandamis PN, 2007, INT J FOOD MICROBIOL, V120, P237, DOI 10.1016/j.ijfoodmicro.2007.08.028
   Sortwell DR, 2001, J FOOD PROTECT, V64, P439, DOI 10.4315/0362-028X-64.4.439
   Vose D., 2000, RISK ANAL QUANTITATI, P418
   Whiting RC, 2002, INT J FOOD MICROBIOL, V75, P127, DOI 10.1016/S0168-1605(02)00003-X
   Yu C, 2006, FOOD MICROBIOL, V23, P552, DOI 10.1016/j.fm.2005.09.008
NR 43
TC 9
Z9 9
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JAN 31
PY 2011
VL 145
IS 1
BP 49
EP 56
DI 10.1016/j.ijfoodmicro.2010.11.027
PG 8
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 739PV
UT WOS:000288731100007
PM 21146238
DA 2020-05-07
ER

PT J
AU Nantasenamat, C
   Preeyanon, L
   Isarankura-Na-Ayudhya, C
   Prachayasittikul, V
AF Nantasenamat, Chanin
   Preeyanon, Likit
   Isarankura-Na-Ayudhya, Chartchalerm
   Prachayasittikul, Virapong
TI PYBACT: AN ALGORITHM FOR BACTERIAL IDENTIFICATION
SO EXCLI JOURNAL
LA English
DT Article
DE PyBact; Python; bacteria; bacterial identification; microbiology; data
   mining
ID ARTIFICIAL NEURAL-NETWORK; MOLECULARLY IMPRINTED POLYMERS; PREDICTION;
   COMPUTER
AB PyBact is a software written in Python for bacterial identification. The code simulates the predefined behavior of bacterial species by generating a simulated data set based on the frequency table of biochemical tests from diagnostic microbiology textbook. The generated data was used for predictive model construction by machine learning approaches and results indicated that the classifiers could accurately predict its respective bacterial class with accuracy in excess of 99%.
C1 [Nantasenamat, Chanin; Preeyanon, Likit] Mahidol Univ, Fac Med Technol, Ctr Data Min & Biomed Informat, Bangkok 10700, Thailand.
   [Nantasenamat, Chanin; Preeyanon, Likit; Isarankura-Na-Ayudhya, Chartchalerm; Prachayasittikul, Virapong] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand.
RP Nantasenamat, C (reprint author), Mahidol Univ, Fac Med Technol, Ctr Data Min & Biomed Informat, Bangkok 10700, Thailand.
EM mtcnt@mahidol.ac.th
RI Nantasenamat, Chanin/AAD-1032-2019
OI Nantasenamat, Chanin/0000-0003-1040-663X; Isarankura-Na-Ayudhya,
   Chartchalerm/0000-0003-0010-3379; Prachayasittikul,
   Virapong/0000-0001-7942-1083
FU Mahidol University; Thailand Toray Science Foundation
FX This work was supported in part by the Goal-Oriented Research Grant from
   Mahidol University and the Science and Technology Research Grant from
   the Thailand Toray Science Foundation. Partial support is also
   acknowledged from Office of the Higher Education Commission and Mahidol
   University under the National Research Universities Initiative.
CR Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1
   Bassi S, 2007, PLOS COMPUT BIOL, V3, P2052, DOI 10.1371/journal.pcbi.0030199
   Frederiksen W, 2001, CLIN INFECT DIS, V32, P987, DOI 10.1086/319358
   Giacomini M, 2000, J MICROBIOL METH, V43, P45, DOI 10.1016/S0167-7012(00)00203-7
   Janda JM, 2002, J CLIN MICROBIOL, V40, P1887, DOI 10.1128/JCM.40.6.1887-1891.2002
   LAPAGE SP, 1973, J GEN MICROBIOL, V77, P273, DOI 10.1099/00221287-77-2-273
   LOGAN NA, 1994, BACTERIAL SYSTEMATIC
   Nantasenamat C, 2005, J COMPUT AID MOL DES, V19, P509, DOI 10.1007/s10822-005-9004-4
   Nantasenamat C, 2008, J MOL GRAPH MODEL, V27, P188, DOI 10.1016/j.jmgm.2008.04.005
   Nantasenamat C, 2008, J BIOL SYST, V16, P279, DOI 10.1142/S021833900800254X
   Nantasenamat C, 2007, BIOSENS BIOELECTRON, V22, P3309, DOI 10.1016/j.bios.2007.01.017
   Nantasenamat C, 2007, J COMPUT CHEM, V28, P1275, DOI 10.1002/jcc.20656
   Nantasenamat C, 2010, EXPERT OPIN DRUG DIS, V5, P633, DOI 10.1517/17460441.2010.492827
   Nantasenamat C, 2009, EXCLI J, V8, P74
   Python, APPL DOM
   SNEATH PHA, 1964, ANNU REV MICROBIOL, V18, P335, DOI 10.1146/annurev.mi.18.100164.002003
   Thippakorn C, 2009, MOLECULES, V14, P1869, DOI 10.3390/molecules14051869
   WILLCOX WR, 1980, A VAN LEEUW J MICROB, V46, P233, DOI 10.1007/BF00453024
   WILLCOX WR, 1973, J GEN MICROBIOL, V77, P317, DOI 10.1099/00221287-77-2-317
   Witten I. H., 2005, DATA MINING PRACTICA
   Worachartcheewan A, 2011, CHEMOMETR INTELL LAB, V109, P207, DOI 10.1016/j.chemolab.2011.09.010
   Worachartcheewan A, 2010, ACTA DIABETOL, V47, pS91, DOI 10.1007/s00592-009-0137-0
   Worachartcheewan Apilak, 2010, Diabetes Res Clin Pract, V90, pe15, DOI 10.1016/j.diabres.2010.06.009
   Worachartcheewan A, 2009, EUR J MED CHEM, V44, P1664, DOI 10.1016/j.ejmech.2008.09.028
NR 24
TC 3
Z9 3
U1 0
U2 2
PU EXCLI JOURNAL MANAGING OFFICE
PI DORTMUND
PA LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI
   JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY
SN 1611-2156
J9 EXCLI J
JI EXCLI J.
PY 2011
VL 10
BP 240
EP 245
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 880FW
UT WOS:000299391500021
PM 27857678
OA DOAJ Gold
DA 2020-05-07
ER

PT J
AU Callura, JM
   Dwyer, DJ
   Isaacs, FJ
   Cantor, CR
   Collins, JJ
AF Callura, Jarred M.
   Dwyer, Daniel J.
   Isaacs, Farren J.
   Cantor, Charles R.
   Collins, James J.
TI Tracking, tuning, and terminating microbial physiology using synthetic
   riboregulators
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gene expression; kill switch; RNA engineering; synthetic biology;
   systems biology
ID ESCHERICHIA-COLI; GENE-EXPRESSION; BACTERIAL DEATH; DNA GYRASE;
   F-PLASMID; WILD-TYPE; PROTEIN; MECHANISM; BIOLOGY; MODULATION
AB The development of biomolecular devices that interface with biological systems to reveal new insights and produce novel functions is one of the defining goals of synthetic biology. Our lab previously described a synthetic, riboregulator systemthat affords for modular, tunable, and tight control of gene expression in vivo. Here we highlight several experimental advantages unique to this RNA-based system, including physiologically relevant protein production, component modularity, leakage minimization, rapid response time, tunable gene expression, and independent regulation of multiple genes. We demonstrate this utility in four sets of in vivo experiments with various microbial systems. Specifically, we show that the synthetic riboregulator is well suited for GFP fusion protein tracking in wildtype cells, tight regulation of toxic protein expression, and sensitive perturbation of stress response networks. We also show that the system can be used for logic-based computing of multiple, orthogonal inputs, resulting in the development of a programmable kill switch for bacteria. This work establishes a broad, easy-to-use synthetic biology platform for microbiology experiments and biotechnology applications.
C1 [Callura, Jarred M.; Dwyer, Daniel J.; Cantor, Charles R.; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Callura, Jarred M.; Dwyer, Daniel J.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.
   [Callura, Jarred M.; Dwyer, Daniel J.; Cantor, Charles R.; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA.
   [Callura, Jarred M.; Dwyer, Daniel J.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA.
   [Isaacs, Farren J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA.
   [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA.
RP Cantor, CR (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM crcantor@bu.edu; jcollins@bu.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [DP1 OD003644];
   National Science FoundationNational Science Foundation (NSF); Howard
   Hughes Medical InstituteHoward Hughes Medical Institute
FX We thank Ahmad Khalil for microscopy assistance and advice on data
   presentation. We thank Sheetal Modi for qPCR assistance and Raffi
   Afeyan, Henry Lee, Kevin Litcofsky, and Jonathan Winkler for helpful
   discussions. We are grateful to Mary Berlyn of the Yale Genetic Stock
   Center for help in selecting the appropriate E. coli strains used in the
   CcdB analysis. This work was supported by the National Institutes of
   Health through the National Institutes of Health Director's Pioneer
   Award Program, Grant DP1 OD003644, by the National Science Foundation,
   and by the Howard Hughes Medical Institute.
CR An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106
   Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073
   Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bachmann B.J, 1996, ESCHERICHIA COLI SAL, P2460
   Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069
   Buskirk AR, 2004, CHEM BIOL, V11, P1157, DOI 10.1016/j.chembiol.2004.05.017
   Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021
   Courcelle J, 2001, GENETICS, V158, P41
   Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0
   Davidson EA, 2007, NAT CHEM BIOL, V3, P23, DOI 10.1038/nchembio846
   Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135
   Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125
   Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008
   Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000
   Friedberg E.C., 2006, DNA REPAIR MUTAGENES
   Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005
   Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131
   GARRETT J, 1981, MOL GEN GENET, V182, P326, DOI 10.1007/BF00269678
   GARRETT JM, 1982, J VIROL, V44, P886, DOI 10.1128/JVI.44.3.886-892.1982
   GUYER MS, 1978, J MOL BIOL, V126, P347, DOI 10.1016/0022-2836(78)90045-1
   Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257
   Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986
   Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208
   JAFFE A, 1985, J BACTERIOL, V163, P841
   Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08
   Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775
   Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007
   LAUDER SD, 1993, J MOL BIOL, V234, P72, DOI 10.1006/jmbi.1993.1564
   LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D
   Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591
   Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203
   MAKI S, 1992, J BIOL CHEM, V267, P12244
   MARKHAM BE, 1981, NUCLEIC ACIDS RES, V9, P4149, DOI 10.1093/nar/9.16.4149
   Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697
   POSTLE K, 1990, J BACTERIOL, V172, P2287, DOI 10.1128/jb.172.5.2287-2293.1990
   Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6
   Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07
   Saha S, 2003, NUCLEIC ACIDS RES, V31, P1565, DOI 10.1093/nar/gkg227
   Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156
   Sambrook J., 1989, MOL CLONING LAB MANU
   SOMMER S, 1985, MOL GEN GENET, V198, P456, DOI 10.1007/BF00332939
   Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321
   TAM JE, 1989, J BACTERIOL, V171, P2353, DOI 10.1128/jb.171.5.2353-2360.1989
   Tigges M, 2009, CURR OPIN BIOTECH, V20, P449, DOI 10.1016/j.copbio.2009.07.009
   Topp S, 2008, RNA, V14, P2498, DOI 10.1261/rna.1269008
   Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799
   Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104
   Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844
   YOUNG R, 1979, J MOL BIOL, V132, P307, DOI 10.1016/0022-2836(79)90262-6
NR 51
TC 107
Z9 109
U1 0
U2 30
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 7
PY 2010
VL 107
IS 36
BP 15898
EP 15903
DI 10.1073/pnas.1009747107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 647RY
UT WOS:000281637800050
PM 20713708
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Zhou, JZ
   Deng, Y
   Luo, F
   He, ZL
   Tu, QC
   Zhi, XY
AF Zhou, Jizhong
   Deng, Ye
   Luo, Feng
   He, Zhili
   Tu, Qichao
   Zhi, Xiaoyang
TI Functional Molecular Ecological Networks
SO MBIO
LA English
DT Article
ID ANIMAL MUTUALISTIC NETWORKS; FOOD-WEB STRUCTURE; BIOLOGICAL NETWORKS;
   COMMUNITY STRUCTURE; MICROBIAL COMMUNITIES; COMPLEX NETWORKS; ANALYSIS
   REVEALS; ELEVATED CO2; MODULARITY; DIVERSITY
AB Biodiversity and its responses to environmental changes are central issues in ecology and for society. Almost all microbial biodiversity research focuses on "species" richness and abundance but not on their interactions. Although a network approach is powerful in describing ecological interactions among species, defining the network structure in a microbial community is a great challenge. Also, although the stimulating effects of elevated CO2 (eCO(2)) on plant growth and primary productivity are well established, its influences on belowground microbial communities, especially microbial interactions, are poorly understood. Here, a random matrix theory (RMT)-based conceptual framework for identifying functional molecular ecological networks was developed with the high-throughput functional gene array hybridization data of soil microbial communities in a long-term grassland FACE (free air, CO2 enrichment) experiment. Our results indicate that RMT is powerful in identifying functional molecular ecological networks in microbial communities. Both functional molecular ecological networks under eCO(2) and ambient CO2 (aCO(2)) possessed the general characteristics of complex systems such as scale free, small world, modular, and hierarchical. However, the topological structures of the functional molecular ecological networks are distinctly different between eCO(2) and aCO(2), at the levels of the entire communities, individual functional gene categories/groups, and functional genes/sequences, suggesting that eCO(2) dramatically altered the network interactions among different microbial functional genes/populations. Such a shift in network structure is also significantly correlated with soil geochemical variables. In short, elucidating network interactions in microbial communities and their responses to environmental changes is fundamentally important for research in microbial ecology, systems microbiology, and global change.
   IMPORTANCE Microorganisms are the foundation of the Earth's biosphere and play integral and unique roles in various ecosystem processes and functions. In an ecosystem, various microorganisms interact with each other to form complicated networks. Elucidating network interactions and their responses to environmental changes is difficult due to the lack of appropriate experimental data and an appropriate theoretical framework. This study provides a conceptual framework to construct interaction networks in microbial communities based on high-throughput functional gene array hybridization data. It also first documents that elevated carbon dioxide in the atmosphere dramatically alters the network interactions in soil microbial communities, which could have important implications in assessing the responses of ecosystems to climate change. The conceptual framework developed allows microbiologists to address research questions unapproachable previously by focusing on network interactions beyond the listing of, e.g., the number and abundance of species. Thus, this study could represent transformative research and a paradigm shift in microbial ecology.
C1 [Zhou, Jizhong; Deng, Ye; He, Zhili; Tu, Qichao; Zhi, Xiaoyang] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.
   [Zhou, Jizhong; Deng, Ye; He, Zhili; Tu, Qichao; Zhi, Xiaoyang] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.
   [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA USA.
   [Zhou, Jizhong] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China.
   [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA.
   [Deng, Ye] Glomics Inc, Norman, OK USA.
RP Zhou, JZ (reprint author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.
EM jzhou@ou.edu
RI 吴, 昊/AAB-1620-2020; He, Zhili/C-2879-2012; Deng, Ye/X-4358-2019
OI He, Zhili/0000-0001-8225-7333; Deng, Ye/0000-0002-7584-0632; Tu,
   Qichao/0000-0002-3245-7545
FU US Department of Energy, Office of Science, Office of Biological and
   Environmental ResearchUnited States Department of Energy (DOE)
   [DE-SC0004601, DE-AC02-05CH11231]; GTL Foundational; United States
   Department of Agriculture through the NSF-USDA [2007-35319-18305];
   Oklahoma Bioenergy Center (OBC)
FX This work has been partially supported through contract DE-SC0004601 and
   contract DE-AC02-05CH11231 (as part of ENIGMA, a Scientific Focus Area)
   by the US Department of Energy, Office of Science, Office of Biological
   and Environmental Research, Genomics: GTL Foundational Science, the
   United States Department of Agriculture (project 2007-35319-18305)
   through the NSF-USDA Microbial Observatories Program, and the Oklahoma
   Bioenergy Center (OBC).
CR Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299
   Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100
   Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226
   Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950
   Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106
   Brandes U., 2005, NETWORK ANAL METHODO
   Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I02]
   Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527
   CSARDI G, 2006, IGRAPH LIB
   Curtis D, 2001, ANN HUM GENET, V65, P95, DOI 10.1046/j.1469-1809.2001.6510095.x
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2
   Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699
   Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x
   Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x
   Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222
   Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058
   Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001
   Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592
   Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489
   HANDELSMAN J, 2007, COMMITTEE METAGENOMI
   He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2
   He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x
   Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591
   Holland MD, 2008, NATURE, V456, P792, DOI 10.1038/nature07395
   Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103
   Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117
   Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471
   Krackhardt D, 1994, GRAPH THEORETICAL DI
   Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701
   LEWIN GR, 1994, NATURE, V369, P482, DOI 10.1038/369482a0
   Luo F, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031924
   Luo F, 2006, PHYS LETT A, V357, P420, DOI 10.1016/j.physleta.2006.04.076
   Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299
   Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103
   MEHTA M, 1990, RANDOM MATRICES
   Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927
   Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103
   Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486
   Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062
   Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417
   Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429
   Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   West D, 1996, INTRO GRAPH THEORY
   Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131
   Zhang B, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1128
   ZHOU A, 2010, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462-2920.2010.02234.X
   Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105
NR 58
TC 168
Z9 181
U1 22
U2 89
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2010
VL 1
IS 4
AR e00169-10
DI 10.1128/mBio.00169-10
PG 10
WC Microbiology
SC Microbiology
GA 686TG
UT WOS:000284718000013
PM 20941329
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Bruns, S
   Seidler, M
   Albrecht, D
   Salvenmoser, S
   Remme, N
   Hertweck, C
   Brakhage, AA
   Kniemeyer, O
   Muller, FMC
AF Bruns, Sandra
   Seidler, Marc
   Albrecht, Daniela
   Salvenmoser, Stefanie
   Remme, Nicole
   Hertweck, Christian
   Brakhage, Axel A.
   Kniemeyer, Olaf
   Mueller, Frank-Michael C.
TI Functional genomic profiling of Aspergillus fumigatus biofilm reveals
   enhanced production of the mycotoxin gliotoxin
SO PROTEOMICS
LA English
DT Article
DE 2-D gel electrophoresis; Aspergillus fumigatus; Biofilm; Gliotoxin;
   Microarrays; Microbiology
ID FORMATE DEHYDROGENASE; GENE-EXPRESSION; VIRULENCE; PROTEINS; PROTOCOL;
   FUNGUS; GLIP
AB The opportunistic pathogenic mold Aspergillus fumigatus is an increasing cause of morbidity and mortality in immunocompromized and in part immunocompetent patients. A. fumigatus can grow in multicellular communities by the formation of a hyphal network encased in an extracellular matrix. Here, we describe the proteome and transcriptome of planktonic- and biofilm-grown A. fumigatus mycelium after 24 and 48h. A biofilm- and time-dependent regulation of many proteins and genes of the primary metabolism indicates a developmental stage of the young biofilm at 24 h, which demands energy. At a matured biofilm phase, metabolic activity seems to be reduced. However, genes, which code for hydrophobins, and proteins involved in the biosynthesis of secondary metabolites were significantly upregulated. In particular, proteins of the gliotoxin secondary metabolite gene cluster were induced in biofilm cultures. This was confirmed by real-time PCR and by detection of this immunologically active mycotoxin in culture supernatants using HPLC analysis. The enhanced production of gliotoxin by in vitro formed biofilms reported here may also play a significant role under in vivo conditions. It may confer A. fumigatus protection from the host immune system and also enable its survival and persistence in chronic lung infections such as aspergilloma.
C1 [Bruns, Sandra; Brakhage, Axel A.; Kniemeyer, Olaf] Hans Knoell Inst, Dept Mol & Appl Microbiol, Jena, Germany.
   [Bruns, Sandra; Brakhage, Axel A.; Kniemeyer, Olaf] Univ Jena, Dept Microbiol & Mol Biol, Jena, Germany.
   [Seidler, Marc; Salvenmoser, Stefanie; Mueller, Frank-Michael C.] Heidelberg Univ, Dept Pediat, D-69120 Heidelberg, Germany.
   [Albrecht, Daniela] Hans Knoell Inst, Res Grp Syst Biol Bioinformat, Jena, Germany.
   [Remme, Nicole; Hertweck, Christian] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Biomol Chem, Jena, Germany.
RP Muller, FMC (reprint author), Heidelberg Univ, Dept Pediat, Neuenheimer Feld 430, D-69120 Heidelberg, Germany.
EM olaf.kniemeyer@hki-jena.de; frank-michael_mueller@med.uni-heidelberg.de
RI Hertweck, Christian/G-1896-2014; Kniemeyer, Olaf/K-1253-2013
OI Hertweck, Christian/0000-0002-0367-337X; Kniemeyer,
   Olaf/0000-0002-9493-6402
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [1160];
   HKI; J. Craig Venter Institute (Rockville, USA)
FX This work was supported by the Deutsche Forschungsgemeinschaft (Priority
   Program 1160) to A. A. B., and the HKI. The A. fumigatus microarrays
   were obtained from J. Craig Venter Institute (T1GR) (Rockville, USA) as
   an unrestricted grant to F.-M. C. M. The authors are grateful to Silke
   Steinbach and Maria Potsch as well as Robert Winkler for assistance in
   proteome analysis and MS analysis, respectively. Svenja Simon is
   acknowledged for generating heat maps.
CR ALBRECHT D, 2008, BIRD 08 SCHRIFTENREI, V26, P55
   Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32
   Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009
   Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671
   Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x
   Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003
   Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717
   Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222
   CHOW CM, 1993, J BACTERIOL, V175, P3703, DOI 10.1128/JB.175.12.3703-3709.1993
   Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046
   Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004
   Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117
   Hof Herbert, 2009, Mycotoxin Res, V25, P123, DOI 10.1007/s12550-009-0020-4
   Holdom MD, 2000, J CLIN MICROBIOL, V38, P558, DOI 10.1128/JCM.38.2.558-562.2000
   Hourton-Cabassa C, 1998, PLANT PHYSIOL, V116, P627, DOI 10.1104/pp.116.2.627
   Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9
   Kupfahl C, 2006, MOL MICROBIOL, V62, P292, DOI 10.1111/j.1365-2958.2006.05373.x
   Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012
   Lamanda A, 2004, PROTEOMICS, V4, P599, DOI 10.1002/pmic.200300587
   Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07
   Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154
   Mowat E., 2008, MED MYCOL, V47, P1
   Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0
   Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133
   Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604
   Rocha EMF, 2006, ANTIMICROB AGENTS CH, V50, P2533, DOI 10.1128/AAC.00187-06
   Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894
   SALEEBA JA, 1992, MOL GEN GENET, V235, P349, DOI 10.1007/BF00279380
   Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08
   Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07
   Suzuki K, 1998, PLANT PHYSIOL, V116, P725, DOI 10.1104/pp.116.2.725
   Thomas DP, 2006, PROTEOMICS, V6, P5795, DOI 10.1002/pmic.200600332
   Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0
NR 37
TC 53
Z9 121
U1 0
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD SEP
PY 2010
VL 10
IS 17
BP 3097
EP 3107
DI 10.1002/pmic.201000129
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 651DS
UT WOS:000281905400005
PM 20645385
DA 2020-05-07
ER

PT J
AU Rajagopala, SV
   Yamamoto, N
   Zweifel, AE
   Nakamichi, T
   Huang, HK
   Mendez-Rios, JD
   Franca-Koh, J
   Boorgula, MP
   Fujita, K
   Suzuki, K
   Hu, JC
   Wanner, BL
   Mori, H
   Uetz, P
AF Rajagopala, Seesandra V.
   Yamamoto, Natsuko
   Zweifel, Adrienne E.
   Nakamichi, Tomoko
   Huang, Hsi-Kuang
   Mendez-Rios, Jorge David
   Franca-Koh, Jonathan
   Boorgula, Meher Preethi
   Fujita, Kazutoshi
   Suzuki, Ken-ichirou
   Hu, James C.
   Wanner, Barry L.
   Mori, Hirotada
   Uetz, Peter
TI The Escherichia coli K-12 ORFeome: a resource for comparative molecular
   microbiology
SO BMC GENOMICS
LA English
DT Article
ID NETWORK; SCALE
AB Background: Systems biology and functional genomics require genome-wide datasets and resources. Complete sets of cloned open reading frames (ORFs) have been made for about a dozen bacterial species and allow researchers to express and study complete proteomes in a high-throughput fashion.
   Results: We have constructed an open reading frame (ORFeome) collection of 3974 or 94% of the known Escherichia coli K-12 ORFs in Gateway (R) entry vector pENTR/Zeo. The collection has been used for protein expression and protein interaction studies. For example, we have compared interactions among YgjD, YjeE and YeaZ proteins in E. coli, Streptococcus pneumoniae, and Staphylococcus aureus. We also compare this ORFeome with other Gateway-compatible bacterial ORFeomes and show its utility for comparative functional genomics.
   Conclusions: The E. coli ORFeome provides a useful resource for functional genomics and other areas of protein research in a highly flexible format. Our comparison with other ORFeomes makes comparative analyses straighforward and facilitates direct comparisons of many proteins across many genomes.
C1 [Yamamoto, Natsuko; Nakamichi, Tomoko; Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan.
   [Rajagopala, Seesandra V.; Huang, Hsi-Kuang; Mendez-Rios, Jorge David; Franca-Koh, Jonathan; Boorgula, Meher Preethi; Uetz, Peter] JCVI, Rockville, MD 20850 USA.
   [Zweifel, Adrienne E.; Hu, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.
   [Fujita, Kazutoshi; Suzuki, Ken-ichirou] Natl Inst Technol & Evaluat, Chiba 2920818, Japan.
   [Wanner, Barry L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Mori, Hirotada] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.
   [Uetz, Peter] Proteros Biostruct, Martinsried, Germany.
RP Mori, H (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan.
EM hmori@gtc.naist.jp; peter@uetz.us
RI Mori, Hirotada/B-4934-2011; Uetz, Peter/A-7119-2012
OI Uetz, Peter/0000-0001-6194-4927; Mendez Rios, Jorge/0000-0001-8501-9672;
   Rajagopala, Seesandra/0000-0001-7176-5770; Hu, James/0000-0001-9016-2684
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1GM79710, U24 GM077905, RC1
   GM092047]; Ministry of Education, Culture, Sports, Science and
   Technology of JapanMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT); European UnionEuropean Union (EU)
   [HEALTH-F3-2009-223101]
FX We thank Keehwan Kwon for the pDEST-GST vector. This project was funded
   by NIH grant RO1GM79710 (PU), U24 GM077905 (JH), RC1 GM092047 (BLW),
   Grant-in-Aid for Scientific Research (A) and KAKENHI (Grant-in-Aid for
   Scientific Research) on Priority Areas "System Genomics" from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan
   (HM), and by grant HEALTH-F3-2009-223101 from the Seventh Research
   Framework Programme of the European Union (PU).
CR Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06
   Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09
   Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000
   Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049
   Hilson P, 2006, TRENDS PLANT SCI, V11, P133, DOI 10.1016/j.tplants.2006.01.006
   Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012
   Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166
   Rajagopala SV, 2009, PROTEOMICS, V9, P5296, DOI 10.1002/pmic.200900282
   Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33
   Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493
   von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825
   Yamaguchi K, 2009, ABEL SYMP, V5, P335, DOI 10.1007/978-3-642-00873-3_16
NR 14
TC 28
Z9 30
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD AUG 11
PY 2010
VL 11
AR 470
DI 10.1186/1471-2164-11-470
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 662EB
UT WOS:000282788900004
PM 20701780
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Jones, RN
AF Jones, Ronald N.
TI Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and
   Ventilator-Associated Bacterial Pneumonia
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID SENTRY ANTIMICROBIAL SURVEILLANCE; CARE-ASSOCIATED PNEUMONIA; NOSOCOMIAL
   PNEUMONIA; SUSCEPTIBILITY PATTERNS; SUSPECTED PNEUMONIA; SAFETY NETWORK;
   GUIDELINES; MANAGEMENT; PATHOGENS; EPIDEMIOLOGY
AB Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) can be caused by a wide variety of bacteria that originate from the patient flora or the health care environment. We review the medical and microbiology literature and the results of the SENTRY Antimicrobial Surveillance Program (1997-2008) to establish the pathogens most likely to cause HABP or VABP. In all studies, a consistent 6 organisms (Staphylococcus aureus [28.0%], Pseudomonas aeruginosa [21.8%], Klebsiella species [9.8%], Escherichia coli [6.9%], Acinetobacter species [6.8%], and Enterobacter species [6.3%]) caused similar to 80% of episodes, with lower prevalences of Serratia species, Stenotrophomonas maltophilia, and community-acquired pathogens, such as pneumococci and Haemophilus influenzae. Slight changes in the pathogen order were noted among geographic regions; Latin America had an increased incidence of nonfermentative gram-negative bacilli. In addition, VABP isolates of the same species had a mean of 5%-10% less susceptibility to frequently used extended-spectrum antimicrobials, and the rate of drug resistance among HABP and VABP pathogens has been increasing by 1% per year (2004-2008). In conclusion, the empirical treatment of HABP and VABP due to prevailing bacterial causes and emerging drug resistance has become more challenging and requires use of multidrug empirical treatment regimens for routine clinical practice. These facts have profound impact on the choices of comparison therapies to be applied in contemporary new drug clinical trials for pneumonia.
C1 JMI Labs, N Liberty, IA 52317 USA.
RP Jones, RN (reprint author), JMI Labs, 345 Beaver Kreek Ctr,Ste A, N Liberty, IA 52317 USA.
EM ronald-jones@jmilabs.com
FU AB Bioisk; AbbottAbbott Laboratories; Anacor; API; Arpida;
   AstellasAstellas Pharmaceuticals; Avexa; BayerBayer AG; bioMerieux;
   Cadence; Calixa; Cempra; Cerexa; Cornerstone; Cubist; DaiichiDaiichi
   Sankyo Company Limited; Elan; Elanco; Enanta;
   GlaxoSmithKlineGlaxoSmithKline; Johnson & Johnson (Ortho McNeil)Johnson
   & Johnson USA; MerckMerck & Company; Nabriva; NovartisNovartis; Novexel;
   Optimer; Ordway; Osmotics; Pacific Beach; Peninsula; PfizerPfizer;
   Protez; Schering-PloughMerck & CompanySchering Plough Corporation;
   Shionogi; Targanta (The Medicines Co); Theravance; TREK Diagnostics;
   ViroPharma; WyethWyeth; US Food and Drug Administration; Infectious
   Diseases Society of America; American College of Chest Physicians;
   American Thoracic Society; Society of Critical Care Medicine;
   Pharmaceutical Research and Manufacturers of America; AstraZeneca
   PharmaceuticalsAstraZeneca; Forest Pharmaceuticals
FX Potential conflicts of interest. RNJ and JMI Laboratories have received
   research/educational grants from AB Bioisk, Abbott, Anacor, API, Arpida,
   Astellas, AstraZeneca, Avexa, Bayer, bioMerieux, Cadence, Calixa,
   Cempra, Cerexa, Cornerstone, Cubist, Daiichi, Elan, Elanco, Enanta,
   GlaxoSmithKline, Johnson & Johnson (Ortho McNeil), Merck, Nabriva,
   Novartis, Novexel, Optimer, Ordway, Osmotics, Pacific Beach, Peninsula,
   Pfizer, Protez, Schering-Plough, Shionogi, Targanta (The Medicines Co),
   Theravance, TREK Diagnostics, ViroPharma, and Wyeth.; This article was
   published as part of a supplement entitled "Workshop on Issues in the
   Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired
   Pneumonia and Ventilator-Associated Pneumonia," sponsored by the US Food
   and Drug Administration, Infectious Diseases Society of America,
   American College of Chest Physicians, American Thoracic Society, and the
   Society of Critical Care Medicine, with financial support from the
   Pharmaceutical Research and Manufacturers of America, AstraZeneca
   Pharmaceuticals, and Forest Pharmaceuticals.
CR Abrahamian FM, 2008, AM J EMERG MED, V26, P1, DOI 10.1016/j.ajem.2008.03.015
   [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST
   Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787
   Bergallo C, 2009, DIAGN MICR INFEC DIS, V63, P52, DOI 10.1016/j.diagmicrobio.2008.09.001
   Bradford PA, 2008, CLIN MICROBIOL INFEC, V14, P882, DOI 10.1111/j.1469-0691.2008.02063.x
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Chamot E, 2003, ANTIMICROB AGENTS CH, V47, P2756, DOI 10.1128/AAC.47.9.2756-2764.2003
   Chawla R, 2008, AM J INFECT CONTROL, V36, pS93, DOI 10.1016/j.ajic.2007.05.011
   CLSI, 2009, M07A8 CLSI
   CLSI, 2009, M100S19 CLSI
   Echols RM, 2008, CLIN INFECT DIS, V47, pS166, DOI 10.1086/591399
   Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001
   *EUCAST, 2009, CLIN MIC BREAKP
   Foglia E, 2007, CLIN MICROBIOL REV, V20, P409, DOI 10.1128/CMR.00041-06
   Gales AC, 2002, DIAGN MICR INFEC DIS, V44, P301, DOI 10.1016/S0732-8893(02)00499-6
   Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Hoban DJ, 2003, DIAGN MICR INFEC DIS, V45, P279, DOI 10.1016/S0732-8893(02)00540-0
   Ibrahim EH, 2000, CHEST, V117, P1434, DOI 10.1378/chest.117.5.1434
   Jones RN, 2003, SEM RESP CRIT CARE M, V24, P121, DOI 10.1055/s-2003-37923
   Jones RN, 2000, DIAGN MICR INFEC DIS, V37, P115, DOI 10.1016/S0732-8893(00)00115-2
   JONES RN, 2008, SENTRY ANTIMICROBIAL
   Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854
   Luna CM, 1999, CHEST, V116, P1075, DOI 10.1378/chest.116.4.1075
   Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162
   Mastertonl R, 2007, J ANTIMICROB CHEMOTH, V60, P206, DOI 10.1093/jac/dkm176
   Montravers P, 2002, CRIT CARE MED, V30, P368, DOI 10.1097/00003246-200202000-00017
   Park David R, 2005, Respir Care, V50, P742
   Rea-Neto A, 2008, CURR MED RES OPIN, V24, P2113, DOI [10.1185/03007990802179255, 10.1185/03007990802179255 ]
   Rello J, 2005, CRIT CARE, V9, P259, DOI 10.1186/cc3014
   Rotstein C, 2008, CAN J INFECT DIS MED, V19, P19, DOI 10.1155/2008/593289
   Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9
   Tanaseannu C, 2008, DIAGN MICR INFEC DIS, V61, P329, DOI 10.1016/j.diagmicrobio.2008.04.009
   Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064
   Vidaur Loreto, 2005, Respir Care, V50, P965
NR 35
TC 324
Z9 347
U1 1
U2 26
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG
PY 2010
VL 51
SU 1
BP S81
EP S87
DI 10.1086/653053
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 619RO
UT WOS:000279448000013
PM 20597676
OA Bronze
DA 2020-05-07
ER

PT J
AU Fernandez-Navarro, F
   Valero, A
   Hervas-Martinez, C
   Gutierrez, PA
   Garcia-Gimeno, RM
   Zurera-Cosano, G
AF Fernandez-Navarro, Francisco
   Valero, Antonio
   Hervas-Martinez, Cesar
   Gutierrez, Pedro A.
   Garcia-Gimeno, Rosa M.
   Zurera-Cosano, Gonzalo
TI Development of a multi-classification neural network model to determine
   the microbial growth/no growth interface
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE Multi-Classification; Sensitivity; Growth/no growth interface; Accuracy;
   Memetic algorithm; Imbalanced datasets; Oversampling method; SMOTE; S.
   aureus
ID LEUCONOSTOC-MESENTEROIDES; LOGISTIC-REGRESSION; BACTERIAL-GROWTH;
   PERFORMANCE
AB Boundary models have been recognized as useful tools to predict the ability of microorganisms to grow at limiting conditions. However, at these conditions, microbial behaviour can vary, being difficult to distinguish between growth or no growth. In this paper, the data from the study of Valero et al. [Valero, A., Perez-Rodriguez, F., Carrasco, E., Fuentes-Alventosa, J.M., Garcia-Gimeno, R.M., Zurera, G., 2009. Modelling the growth boundaries of Staphylococcus aureus: Effect of temperature, pH and water activity. International journal of Food Microbiology 133(1-2), 186-194] belonging to growth/no growth conditions of Staphylococcus aureus against temperature, pH and a(w) were divided into three categorical classes: growth (G). growth transition (GT) and no growth (NG). Subsequently, they were modelled by using a Radial Basis Function Neural Network (RBFNN) in order to create a multi-classification model that was able to predict the probability of belonging at one of the three mentioned classes. The model was developed through an over sampling procedure using a memetic algorithm (MA) in order to balance in part the size of the classes and to improve the accuracy of the classifier. The multi-classification model, named Smote M emetic Radial Basis Function (SMRBF) provided a quite good adjustment to data observed, being able to correctly classify the 86.30% of training data and the 82.26% of generalization data for the three observed classes in the best model. Besides, the high number of replicates per condition tested (n = 30) produced a smooth transition between growth and no growth. At the most stringent conditions, the probability of belonging to class GT was higher, thus justifying the inclusion of the class in the new model. The SMRBF model presented in this study can be used to better define microbial growth/no growth interface and the variability associated to these conditions so as to apply this knowledge to a food safety in a decision-making process. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
C1 [Fernandez-Navarro, Francisco; Hervas-Martinez, Cesar; Gutierrez, Pedro A.] Univ Cordoba, Dept Numer Anal & Comp Sci, Cordoba 14014, Spain.
   [Valero, Antonio; Garcia-Gimeno, Rosa M.; Zurera-Cosano, Gonzalo] Univ Cordoba, Dept Food Sci & Technol, Cordoba 14014, Spain.
RP Fernandez-Navarro, F (reprint author), Univ Cordoba, Dept Numer Anal & Comp Sci, Albert Einstein Bldg,3rd Floor, Cordoba 14014, Spain.
EM i22fenaf@uco.es
RI Gutierrez, Pedro Antonio/K-6051-2014; Garcia-Gimeno, Rosa
   Maria/L-4837-2014; Zurera-Cosano, Gonzalo/L-6114-2014; Hervas-Martinez,
   Cesar/A-3979-2009; Valero Diaz, Antonio/K-6777-2014
OI Gutierrez, Pedro Antonio/0000-0002-2657-776X; Garcia-Gimeno, Rosa
   Maria/0000-0001-5241-6348; Zurera-Cosano, Gonzalo/0000-0002-3763-8900;
   Hervas-Martinez, Cesar/0000-0003-4564-1816; Fernandez-Navarro,
   Francisco/0000-0002-5599-6170; Valero Diaz, Antonio/0000-0001-8597-0740
FU Spanish Inter-Ministerial Commission of Science and Technology (MICYT)
   [TIN 2008-06681-C0603]; FEDER fundsEuropean Union (EU); Junta de
   Andalucia (Spain)Junta de Andalucia [AGR-01879, P08-TIC-3745,
   390015-P08-TIC-3745]; HIBRO of the "Plan Andaluz de Investigacion,
   Desarrollo e Innovacion" (PAIDI) [AGR-170]
FX This work has been partially subsidized by the TIN 2008-06681-C0603
   project of the Spanish Inter-Ministerial Commission of Science and
   Technology (MICYT), FEDER funds, by the Excellence Project AGR-01879
   (Junta de Andalucia), by the Research Group AGR-170 HIBRO of the "Plan
   Andaluz de Investigacion, Desarrollo e Innovacion" (PAIDI), and the
   P08-TIC-3745 project of the "Junta de Andalucia" (Spain). The research
   of Francisco Fernandez-Navarro has been funded by the "Junta de
   Andalucia" Predoctoral Program, grant reference 390015-P08-TIC-3745.
CR Alcala-Fdez J, 2009, SOFT COMPUT, V13, P307, DOI 10.1007/s00500-008-0323-y
   Allwein EL, 2001, J MACH LEARN RES, V1, P113, DOI 10.1162/15324430152733133
   ANAND R, 1995, IEEE T NEURAL NETWOR, V6, P117, DOI 10.1109/72.363444
   Gutierrez PA, 2010, SOFT COMPUT, V14, P599, DOI 10.1007/s00500-009-0429-x
   Baranyi J, 1996, FOOD MICROBIOL, V13, P83, DOI 10.1006/fmic.1996.0011
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Bishop C. M., 1996, NEURAL NETWORKS PATT
   Chang C.C., 2001, LIBSVM LIB SUPPORT V
   Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953
   Chen HH, 2009, IEEE T NEURAL NETWOR, V20, P901, DOI 10.1109/TNN.2009.2014161
   Durbin R, 1989, NEURAL COMPUT, V1, P133, DOI 10.1162/neco.1989.1.1.133
   FREEMAN JAS, 1995, NEURAL COMPUT, V7, P1000, DOI 10.1162/neco.1995.7.5.1000
   Fukunaga K., 1999, INTRO STAT PATTERN R
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Gelenbe E, 2002, IEEE T NEURAL NETWOR, V13, P1257, DOI 10.1109/TNN.2002.804228
   Gutierrez PA, 2009, NEUROCOMPUTING, V72, P2731, DOI 10.1016/j.neucom.2008.09.020
   Gysemans KPM, 2007, FOOD AUST, V59, P427
   Gysemans KPM, 2007, INT J FOOD MICROBIOL, V114, P316, DOI 10.1016/j.ijfoodmicro.2006.09.026
   Hajmeer M, 2006, FOOD MICROBIOL, V23, P561, DOI 10.1016/j.fm.2005.09.011
   Hajmeer M, 2003, FOOD MICROBIOL, V20, P43, DOI 10.1016/S0740-0020(02)00104-1
   Hajmeer M, 2002, J MICROBIOL METH, V51, P217, DOI 10.1016/S0167-7012(02)00080-5
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Hastie T, 2001, ELEMENTS STAT LEARNI
   Hervas-Martinez C, 2006, J FOOD SCI, V71, pM31, DOI 10.1111/j.1365-2621.2006.tb08904.x
   Hwang YS, 1997, NEURAL NETWORKS, V10, P1495, DOI 10.1016/S0893-6080(97)00002-6
   Igel C, 2003, NEUROCOMPUTING, V50, P105, DOI 10.1016/S0925-2312(01)00700-7
   Koutsoumanis K, 2005, INT J FOOD MICROBIOL, V100, P253, DOI 10.1016/j.ijfoodmicro.2004.10.024
   Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3
   LE CS, 1992, APPL STAT, V41, P191
   Le Marc Y, 2005, INT J FOOD MICROBIOL, V100, P3, DOI 10.1016/j.ijfoodmicro.2004.10.003
   LESHNO M, 1993, NEURAL NETWORKS, V6, P861, DOI 10.1016/S0893-6080(05)80131-5
   Martinez-Estudillo FJ, 2008, NEUROCOMPUTING, V72, P548, DOI 10.1016/j.neucom.2007.11.019
   MILLER RG, 1996, ANOVA BASICS APP STA
   Mulgrew B, 1996, IEEE SIGNAL PROC MAG, V13, P50, DOI 10.1109/79.487041
   MUSAVI MT, 1992, NEURAL NETWORKS, V5, P595, DOI 10.1016/S0893-6080(05)80038-3
   Nabney Ian T, 2004, Int J Neural Syst, V14, P201, DOI 10.1142/S0129065704001930
   NATARAJAN B, 1991, MACHINE LEARNING THE
   ORR MJL, 1995, NEURAL COMPUT, V7, P606, DOI 10.1162/neco.1995.7.3.606
   PITT RE, 1993, J FOOD PROTECT, V56, P139, DOI 10.4315/0362-028X-56.2.139
   PRESSER K, 1998, APPL ENVIRON MICROB, P1773
   Price D., 1995, Advances in Neural Information Processing Systems 7, P1109
   RATKOWSKY DA, 1995, LETT APPL MICROBIOL, V20, P29, DOI 10.1111/j.1472-765X.1995.tb00400.x
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559
   Skandamis PN, 2007, INT J FOOD MICROBIOL, V120, P237, DOI 10.1016/j.ijfoodmicro.2007.08.028
   TAMHANE A, 2000, STAT DATA ANAL
   Valero A, 2007, FOOD MICROBIOL, V24, P452, DOI 10.1016/j.fm.2006.10.002
   Valero A, 2007, J FOOD SCI, V72, pM16, DOI 10.1111/j.1750-3841.2006.00208.x
   Valero A, 2009, INT J FOOD MICROBIOL, V133, P186, DOI 10.1016/j.ijfoodmicro.2009.05.023
   Vapnik V.N., 1998, STAT LEARNING THEORY
   Whitley D, 1994, LECT NOTES COMPUT SC, V866, P6
   Witten I. H., 2005, DATA MINING PRACTICA
   Yu C, 2006, FOOD MICROBIOL, V23, P552, DOI 10.1016/j.fm.2005.09.008
   Zhou ZH, 2006, IEEE T KNOWL DATA EN, V18, P63, DOI 10.1109/TKDE.2006.17
   Zurera-Cosano G, 2005, EUR FOOD RES TECHNOL, V221, P717, DOI 10.1007/s00217-005-0006-1
NR 56
TC 17
Z9 19
U1 2
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JUL 15
PY 2010
VL 141
IS 3
BP 203
EP 212
DI 10.1016/j.ijfoodmicro.2010.05.013
PG 10
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 631JU
UT WOS:000280343600009
PM 20554339
DA 2020-05-07
ER

PT J
AU Hoenigl, M
   Fussi, P
   Feierl, G
   Wagner-Eibel, U
   Leitner, E
   Masoud, L
   Zarfel, G
   Marth, E
   Grisold, AJ
AF Hoenigl, M.
   Fussi, P.
   Feierl, G.
   Wagner-Eibel, U.
   Leitner, E.
   Masoud, L.
   Zarfel, G.
   Marth, E.
   Grisold, A. J.
TI Antimicrobial resistance of Streptococcus pneumoniae in Southeast
   Austria, 1997-2008
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Streptococcus pneumoniae; Penicillin; Surveillance; Resistance; Austria
ID FLUOROQUINOLONE RESISTANCE; ANTIBIOTIC SUSCEPTIBILITY; MOLECULAR
   EPIDEMIOLOGY; SEROTYPE DISTRIBUTION; PNEUMOCOCCI; IDENTIFICATION;
   CONSUMPTION; INFECTIONS; COMMUNITY
AB Antibiotic resistance in Streptococcus pneumoniae has increased worldwide but varies within geographical regions. We conducted a retrospective analysis of resistance in S. pneumoniae over a 12-year period to assess local and temporal trends in antibacterial resistance. From 1997 to 2008, a total of 1814 non-duplicate S. pneumoniae isolates were identified at the Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Austria. Antibiotic resistance was determined by the Clinical and Laboratory Standards Institute (CLSI) disk diffusion test. For penicillin, the minimum inhibitory concentration was determined by Etest. Susceptibility was defined according to CLSI interpretive criteria. For penicillin, resistance rates were consistently low at 0.2% over the 12-year study period. An increase in resistance was remarkable for erythromycin (3.5% in 1997; 14.7% in 2008), clindamycin (1.8% in 1997; 10.6% in 2008) and tetracycline (1.8% in 2000; 11.0% in 2008). For trimethoprim/sulfamethoxazole, resistance increased slightly to 9.2% in 2008. Quinolones showed a low resistance rate of 0.2% that persisted over the whole study period. In contrast to previously published national data, resistance to penicillin was observed to remain at a remarkably low and constant level. Although international surveillance programmes have set up sustainable and interlinked data networks, our results suggest that regional surveillance may still be needed as decision support for appropriate empirical antibiotic therapy in the local health setting. (C) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
C1 [Hoenigl, M.; Fussi, P.; Feierl, G.; Wagner-Eibel, U.; Leitner, E.; Masoud, L.; Zarfel, G.; Marth, E.; Grisold, A. J.] Med Univ Graz, Inst Hyg Microbiol & Environm Med, A-8010 Graz, Austria.
   [Hoenigl, M.] Med Univ Graz, Div Pulmonol, Infect Dis Sect, A-8010 Graz, Austria.
RP Grisold, AJ (reprint author), Med Univ Graz, Inst Hyg Microbiol & Environm Med, Univ Pl 4, A-8010 Graz, Austria.
EM andrea.grisold@medunigraz.at
RI Leitner, Eva/AAG-8045-2019; Hoenigl, Martin/E-8802-2010
OI Leitner, Eva/0000-0001-8748-2249; Hoenigl, Martin/0000-0002-1653-2824;
   Zarfel, Gernot/0000-0003-1592-4559
CR Adam HJ, 2007, ANTIMICROB AGENTS CH, V51, P198, DOI 10.1128/AAC.00609-06
   Appelbaum PC, 2004, INT J ANTIMICROB AG, V23, P533, DOI 10.1016/j.ijantimicag.2004.02.017
   Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400
   Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004
   Buxbaum A, 2004, J ANTIMICROB CHEMOTH, V54, P247, DOI 10.1093/jac/dkh250
   Canton R, 2003, J ANTIMICROB CHEMOTH, V52, P944, DOI 10.1093/jac/dkg465
   *CLIN LAB STAND I, 2006, M100S16 CLSI
   Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
   Doern GV, 2001, ANTIMICROB AGENTS CH, V45, P1721, DOI 10.1128/AAC.45.6.1721-1729.2001
   *EARRS, 2007, EARSS ANN REP 2006
   *EARSS, 2009, EARSS ANN REP 2008
   *EARSS, 2008, EARSS ANN REP 2007
   Fletcher MA, 2006, INT J CLIN PRACT, V60, P450, DOI 10.1111/j.1368-5031.2006.00858.x
   Garcia-Rey C, 2006, CLIN MICROBIOL INFEC, V12, P55, DOI 10.1111/j.1469-0691.2006.01397.x
   Garcia-Suarez MDM, 2006, JPN J INFECT DIS, V59, P299
   Gardam MA, 1998, J CLIN MICROBIOL, V36, P833, DOI 10.1128/JCM.36.3.833-834.1998
   Goldsmith CE, 1998, J ANTIMICROB CHEMOTH, V41, P420, DOI 10.1093/jac/41.3.420
   Greenberg D, 2008, PEDIATR INFECT DIS J, V27, P776, DOI 10.1097/INF.0b013e3181715184
   Jenkins Stephen G, 2008, Ann Clin Microbiol Antimicrob, V7, P1, DOI 10.1186/1476-0711-7-1
   Lambertsen LM, 2010, INT J ANTIMICROB AG, V35, P72, DOI 10.1016/j.ijantimicag.2009.09.006
   Low DE, 2005, CLIN INFECT DIS, V41, pS228, DOI 10.1086/430782
   Marchese A, 2000, MICROB DRUG RESIST, V6, P163, DOI 10.1089/107662900419483
   Metz-Gercek S, 2008, WIEN KLIN WOCHENSCHR, V120, P264, DOI 10.1007/s00508-008-0967-8
   Metz-Gercek S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-61
   Mittermayer H, 1996, EUR J CLIN MICROBIOL, V15, P817, DOI 10.1007/BF01701526
   MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801
   Pihlajamaki M, 2003, ANTIMICROB AGENTS CH, V47, P1832, DOI 10.1128/AAC.47.6.1832-1835.2003
   Reinert RR, 2005, ANTIMICROB AGENTS CH, V49, P2903, DOI 10.1128/AAC.49.7.2903-2913.2005
   Riedel S, 2007, EUR J CLIN MICROBIOL, V26, P485, DOI 10.1007/s10096-007-0321-5
   Seral C, 2001, J ANTIMICROB CHEMOTH, V47, P863, DOI 10.1093/jac/47.6.863
   Shin JH, 2007, ANTIMICROB AGENTS CH, V51, P2625, DOI 10.1128/AAC.00107-07
   Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242
NR 32
TC 5
Z9 10
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2010
VL 36
IS 1
BP 24
EP 27
DI 10.1016/j.ijantimicag.2010.03.001
PG 4
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 599RL
UT WOS:000277930700004
PM 20409693
DA 2020-05-07
ER

PT J
AU Kaur, A
   Van, PT
   Busch, CR
   Robinson, CK
   Pan, M
   Pang, WL
   Reiss, DJ
   DiRuggiero, J
   Baliga, NS
AF Kaur, Amardeep
   Van, Phu T.
   Busch, Courtney R.
   Robinson, Courtney K.
   Pan, Min
   Pang, Wyming Lee
   Reiss, David J.
   DiRuggiero, Jocelyne
   Baliga, Nitin S.
TI Coordination of frontline defense mechanisms under severe oxidative
   stress
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE gene regulatory network; microbiology; oxidative stress
ID IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE;
   HYDROGEN-PEROXIDE; SULFOLOBUS-SOLFATARICUS; HALOBACTERIUM-HALOBIUM;
   TRANSCRIPTION FACTORS; CELLULAR-RESPONSES; BETA-CAROTENE; OXYGEN
AB Complexity of cellular response to oxidative stress (OS) stems from its wide-ranging damage to nucleic acids, proteins, carbohydrates, and lipids. We have constructed a systems model of OS response (OSR) for Halobacterium salinarum NRC-1 in an attempt to understand the architecture of its regulatory network that coordinates this complex response. This has revealed a multi-tiered OS-management program to transcriptionally coordinate three peroxidase/catalase enzymes, two superoxide dismutases, production of rhodopsins, carotenoids and gas vesicles, metal trafficking, and various other aspects of metabolism. Through experimental validation of interactions within the OSR regulatory network, we show that despite their inability to directly sense reactive oxygen species, general transcription factors have an important function in coordinating this response. Remarkably, a significant fraction of this OSR was accurately recapitulated by a model that was earlier constructed from cellular responses to diverse environmental perturbations-this constitutes the general stress response component. Notwithstanding this observation, comparison of the two models has identified the coordination of frontline defense and repair systems by regulatory mechanisms that are triggered uniquely by severe OS and not by other environmental stressors, including sub-inhibitory levels of redox-active metals, extreme changes in oxygen tension, and a sub-lethal dose of c rays. Molecular Systems Biology 6: 393; published online 27 July 2010; doi:10.1038/msb.2010.50 Subject Categories: metabolic and regulatory networks; microbiology and pathogens
C1 [Baliga, Nitin S.] Inst Syst Biol, Baliga Lab, Seattle, WA 98103 USA.
   [Busch, Courtney R.; Robinson, Courtney K.; DiRuggiero, Jocelyne] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.
RP Baliga, NS (reprint author), Inst Syst Biol, Baliga Lab, 1441 N 34th St, Seattle, WA 98103 USA.
EM nbaliga@systemsbiology.org
OI baliga, nitin/0000-0001-9157-5974
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P50GM076547, 1R01GM077398-01A2];
   DoEUnited States Department of Energy (DOE) [DE-FG02-07ER64327];
   NSFNational Science Foundation (NSF) [EF-0313754, EIA-0220153,
   MCB-0425825, DBI-0640950]; AFOSRUnited States Department of DefenseAir
   Force Office of Scientific Research (AFOSR) [FA95500710158];
   NASANational Aeronautics & Space Administration (NASA) [NNG05GN58G]
FX This work was supported by grants from NIH (P50GM076547 and
   1R01GM077398-01A2), DoE (DOE SFA: ENIGMA: DE-FG02-07ER64327 and
   DE-FG02-07ER64327), and NSF (EF-0313754, EIA-0220153, MCB-0425825,
   DBI-0640950) to NSB; AFOSR (FA95500710158) to JDR and NASA (NNG05GN58G)
   to NSB and JDR. We thank Dan Tenenbaum for help in construction of the
   webpage. We also thank John Spudich for providing us with the
   rhodopsin-deficient strain Pho81.
CR Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701
   Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504
   Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498
   Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997
   BETLACH MC, 1989, CAN J MICROBIOL, V35, P134, DOI 10.1139/m89-020
   Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52
   Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053
   Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36
   Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08
   Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0
   Cabiscol Elisa, 2000, International Microbiology, V3, P3
   CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x
   Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323
   Coulson Richard M. R., 2007, Archaea, V2, P117
   Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861
   Demple B, 1997, METHODS, V11, P267, DOI 10.1006/meth.1996.0421
   DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194
   Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115
   Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104
   FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991
   Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763
   Fomenko DE, 2002, PROTEIN SCI, V11, P2285, DOI 10.1110/ps.0218302
   Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171
   GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997
   Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x
   Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022
   HASSAN HM, 1979, J BIOL CHEM, V254, P846
   Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945
   Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938
   Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x
   Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055
   JOSHI P, 1993, J BACTERIOL, V175, P1561, DOI 10.1128/JB.175.6.1561-1571.1993
   Kaur A, 2006, GENOME RES, V16, P841, DOI 10.1101/gr.5189606
   Kawakami R, 2004, J BIOCHEM, V136, P541, DOI 10.1093/jb/mvh157
   KUSHWAHA SC, 1974, CAN J MICROBIOL, V20, P241, DOI 10.1139/m74-038
   Lee JB, 2006, NATURE, V440, pE2, DOI 10.1038/nature04686
   Limauro D, 2006, FEBS J, V273, P721, DOI 10.1111/j.1742-4658.2006.05104.x
   Limauro D, 2008, FEBS J, V275, P2067, DOI 10.1111/j.1742-4658.2008.06361.x
   Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015
   Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200
   Mate MJ, 1999, J BIOL CHEM, V274, P27717, DOI 10.1074/jbc.274.39.27717
   Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006
   Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007
   Oliver AE, 2001, CRYOBIOLOGY, V43, P151, DOI 10.1006/cryo.2001.2359
   Outten FW, 2007, NAT CHEM BIOL, V3, P206, DOI 10.1038/nchembio0407-206
   Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538
   Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200
   Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023
   Reindel S, 2006, BIOMETALS, V19, P19, DOI 10.1007/s10534-005-3682-1
   Reiss DJ, 2008, BIOINFORMATICS, V24, P396, DOI 10.1093/bioinformatics/btm592
   Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280
   Scheibner M, 2008, APPL MICROBIOL BIOT, V77, P1241, DOI 10.1007/s00253-007-1261-9
   Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007
   Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001
   SHAND RF, 1991, J BACTERIOL, V173, P4692, DOI 10.1128/jb.173.15.4692-4699.1991
   Shukla HD, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-6
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239
   Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2
   Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200
   Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003
   Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101
   Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Valderas MW, 2001, J BACTERIOL, V183, P3399, DOI 10.1128/JB.183.11.3399-3407.2001
   Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x
   Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091
   Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P33, DOI 10.1016/S0304-4165(97)00006-8
   YANG CF, 1990, J BACTERIOL, V172, P4118, DOI 10.1128/jb.172.7.4118-4121.1990
   YAO VJ, 1994, J BACTERIOL, V176, P6931, DOI 10.1128/JB.176.22.6931-6935.1994
   Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0
   Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001
NR 75
TC 42
Z9 43
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD JUL
PY 2010
VL 6
AR 393
DI 10.1038/msb.2010.50
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 684CI
UT WOS:000284524200005
PM 20664639
OA DOAJ Gold, Green Published
DA 2020-05-07
ER

PT J
AU Schmidt, F
   Scharf, SS
   Hildebrandt, P
   Burian, M
   Bernhardt, J
   Dhople, V
   Kalinka, J
   Gutjahr, M
   Hammer, E
   Volker, U
AF Schmidt, Frank
   Scharf, Sandra S.
   Hildebrandt, Petra
   Burian, Marc
   Bernhardt, Joerg
   Dhople, Vishnu
   Kalinka, Julia
   Gutjahr, Melanie
   Hammer, Elke
   Voelker, Uwe
TI Time-resolved quantitative proteome profiling of host-pathogen
   interactions: The response of Staphylococcus aureus RN1HG to
   internalisation by human airway epithelial cells
SO PROTEOMICS
LA English
DT Article
DE Host-pathogen interaction; In vivo proteomics; Microbiology; Pulse-chase
   SILAC; S. aureus; S9 human bronchial epithelial cells
ID RIBOSOMAL-PROTEINS; MASS-SPECTROMETRY; EXPRESSION; VIRULENCE;
   RHINOSINUSITIS; IDENTIFICATION; INFECTIONS; METABOLISM; MECHANISMS;
   BACTERIA
AB Staphylococcus aureus is a versatile Gram-positive pathogen that gains increasing importance due to the rapid spreading of resistances. Functional genomics technologies can provide new insights into the adaptational network of this bacterium and its response to environmental challenges. While functional genomics technologies, including proteomics, have been extensively used to study these phenomena in shake flask cultures, studies of bacteria from in vivo settings lack behind. Particularly for proteomics studies, the major bottleneck is the lack of sufficient proteomic coverage for low numbers of cells. In this study, we introduce a workflow that combines a pulse-chase stable isotope labelling by amino acids in cell culture approach with high capacity cell sorting, on-membrane digestion, and high-sensitivity MS to detect and quantitatively monitor several hundred S. aureus proteins from a few million internalised bacteria. This workflow has been used in a proof-of-principle experiment to reveal changes in levels of proteins with a function in protection against oxidative damage and adaptation of cell wall synthesis in strain RN1HG upon internalisation by S9 human bronchial epithelial cells.
C1 [Schmidt, Frank; Scharf, Sandra S.; Hildebrandt, Petra; Burian, Marc; Dhople, Vishnu; Kalinka, Julia; Gutjahr, Melanie; Hammer, Elke; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany.
   [Bernhardt, Joerg] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany.
RP Volker, U (reprint author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.
EM voelker@uni-greifswald.de
RI Frank, ZIK FunGene Schmidt/B-6075-2009; Dhople, Vishnu M/J-5377-2014
OI Volker, Uwe/0000-0002-5689-3448; Schmidt, Frank/0000-0001-5406-3988;
   Hammer, Elke/0000-0002-1507-0402
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SFBTRR34]
FX The authors are grateful to Ulrike Lissner for excellent technical
   assistance and Leonard Menschner for construction of RN1HG pMV158GFP.
   Work in the Interfaculty Institute of Genetics and Functional Genomics
   (U. V. F. S.) was supported within the framework of the collaborative
   research project SFBTRR34 by the Deutsche Forschungsgemeinschaft. The
   authors are grateful for the contribution of Juliane Siebourg from the
   ETH Zurich for the creation of the Voronoi treemaps and Susann Muller,
   Nico Jehmlich, and Dirk Benndorf for help in establishing the cell
   sorting protocol.
CR BALZER M, IEEE S INF VIS INFOV, P49
   Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004
   BERNHARDT J, 2009, 6 INT S VOR DIAGR, P233
   Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735
   FLOTTE TR, 1993, J BIOL CHEM, V268, P3781
   Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825
   Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325
   Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171
   Gustavsson N, 2005, PROTEOMICS, V5, P3563, DOI 10.1002/pmic.200401193
   Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07
   Iyer LM, 2007, BIOINFORMATICS, V23, P2660, DOI 10.1093/bioinformatics/btm411
   Jevon M, 1999, INFECT IMMUN, V67, P2677, DOI 10.1128/IAI.67.5.2677-2681.1999
   Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099
   Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x
   Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Maltezou HC, 2006, INT J ANTIMICROB AG, V27, P87, DOI 10.1016/j.ijantimicag.2005.11.004
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249
   Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08
   ROBERTSON WR, 1977, MOL GEN GENET, V157, P205, DOI 10.1007/BF00267399
   Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009
   Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296
   Schmidt F, 2009, PROTEOMICS, V9, P1994, DOI 10.1002/pmic.200701028
   Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   SUBRAMANIAN AR, 1977, MOL GEN GENET, V158, P1, DOI 10.1007/BF00455113
   Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070
   Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907
   Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x
   Weber JT, 2005, CLIN INFECT DIS, V41, pS269, DOI 10.1086/430788
   Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062
   ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313
   Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313
NR 42
TC 47
Z9 48
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD JUL
PY 2010
VL 10
IS 15
BP 2801
EP 2811
DI 10.1002/pmic.201000045
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 640LY
UT WOS:000281054300007
PM 20518028
DA 2020-05-07
ER

PT J
AU Dijkshoorn, L
   De Vos, P
   Dedeurwaerdere, T
AF Dijkshoorn, Lenie
   De Vos, Paul
   Dedeurwaerdere, Tom
TI Understanding patterns of use and scientific opportunities in the
   emerging global microbial commons
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE Microbial commons; Public culture collections; Agriculture; Food
   production
ID AD-HOC-COMMITTEE; SPECIES DEFINITION; CLASSIFICATION; INFORMATION;
   BACTERIA
AB Rapidly growing global networking has induced and supported an increased interest in the life sciences in such general issues as health, climate change, food security and biodiversity. Therefore, the need to address and share research data and materials in a systematic way emerged almost simultaneously. This movement has been described as the so-called global research commons. Also in microbiology, where the sharing of microbiological materials is a key issue, microbial commons is attracting attention. Microbiology is currently facing great challenges with the advances of high throughput screening and next-generation whole genome sequencing. Furthermore, the exploration and use of microorganisms in agriculture and food production are increasing so as to safeguard global food and feed production. Further to several meetings on the subject, a special issue of Research in Microbiology is dedicated to Microbial Research Commons with a series of reviews elaborating its major pay-offs and needs in basic and applied microbiology. This paper gives an introduction to these articles covering a range of topics. These include the role of public culture collections and biological resource centers and legal aspects in the exchange of materials, microbial classification, an internet-based platform for data-sharing, applications in agriculture and food production, and challenges in metagenomics and extremophile research. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 [Dijkshoorn, Lenie] Leiden Univ, Med Ctr, Dept Infect Dis C5 P, NL-2300 RC Leiden, Netherlands.
   [De Vos, Paul] Univ Ghent, Dept Biochem & Microbiol WE 10, Microbiol Lab, B-9000 Ghent, Belgium.
   [Dedeurwaerdere, Tom] Catholic Univ Louvain, Ctr Philosophie Droit, Coll Thomas More, B-1348 Louvain, Belgium.
RP Dijkshoorn, L (reprint author), Leiden Univ, Med Ctr, Dept Infect Dis C5 P, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.
EM l.dijkshoorn@lumc.nl; paul.devos@Ugent.be;
   tom.dedeurwaerdere@uclouvain.be
RI De Vos, Paul/J-5392-2013
OI Dedeurwaerdere, Tom/0000-0001-9494-2688
FU Food and Agriculture Organization of the United NationsUnited States
   Agency for International Development (USAID) [PR 40621]; Bioversity
   International [LoA 09/002]; Belgian Science Policy Division of the
   Ministry of Science [IUAPVI/06]; European CommissionEuropean Commission
   Joint Research Centre [RTD CIT3_513420 REFGOV]
FX Authors who contributed a paper to the Microbial Research Commons
   special issue are gratefully acknowledged. The authors gratefully
   acknowledge the financial support of the Food and Agriculture
   Organization of the United Nations (PR 40621), and Bioversity
   International (LoA 09/002) for organization of the two expert workshops
   referred to in this introduction. Further support for this research from
   the Belgian Science Policy Division of the Ministry of Science under
   Grant IUAPVI/06 and the support of the Sixth Framework Program in
   Research and Development of the European Commission under Grant RTD
   CIT3_513420 REFGOV are also acknowledged.
CR Averhoff B, 2010, RES MICROBIOL, V161, P506, DOI 10.1016/j.resmic.2010.05.006
   Barba M, 2010, RES MICROBIOL, V161, P472, DOI 10.1016/j.resmic.2010.04.008
   Christensen H, 2001, INT J SYST EVOL MICR, V51, P2221, DOI 10.1099/00207713-51-6-2221
   Daniel HM, 2010, RES MICROBIOL, V161, P488, DOI 10.1016/j.resmic.2010.01.011
   Dawyndt P, 2005, IEEE T KNOWL DATA EN, V17, P1111, DOI 10.1109/TKDE.2005.131
   Dawyndt P, 2006, INT SOC SCI J, V58, P249, DOI 10.1111/j.1468-2451.2006.00617.x
   Dedeurwaerdere T., 2010, INT J COMMONS, V4, P390, DOI DOI 10.18352/IJC.215
   Dedeurwaerdere T, 2009, 46 COMM GEN RES FOOD
   Dedeurwaerdere T, 2006, INT SOC SCI J, V58, P351, DOI 10.1111/j.1468-2451.2006.00623.x
   Dedeurwaerdere T, 2010, RES MICROBIOL, V161, P414, DOI 10.1016/j.resmic.2010.04.012
   FAUQUET CM, 2005, 8 INT COMM TAX VIR
   Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924
   Giraffa G, 2010, RES MICROBIOL, V161, P480, DOI 10.1016/j.resmic.2010.03.001
   Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0
   HESS C, 2006, UNDERSTANDING KNOWLE, P4
   Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004
   Hofte M, 2010, RES MICROBIOL, V161, P464, DOI 10.1016/j.resmic.2010.04.007
   Janssens D, 2010, RES MICROBIOL, V161, P422, DOI 10.1016/j.resmic.2010.03.009
   Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102
   Kurtzman CP, YEASTS TAXONOMIC STU
   Lindstrom K, 2010, RES MICROBIOL, V161, P453, DOI 10.1016/j.resmic.2010.05.005
   Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446
   McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102
   Miller SA, 2009, ANNU REV PHYTOPATHOL, V47, P15, DOI 10.1146/annurev-phyto-080508-081743
   Mocali S, 2010, RES MICROBIOL, V161, P497, DOI 10.1016/j.resmic.2010.04.010
   Moore ERB, 2010, RES MICROBIOL, V161, P430, DOI 10.1016/j.resmic.2010.05.007
   OECD, 2001, SCI TECHN SER
   Siezen RJ, 2004, CURR OPIN BIOTECH, V15, P105, DOI 10.1016/j.copbio.2004.02.002
   Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z
   Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043
   Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914
   Staley JT, 2010, RES MICROBIOL, V161, P446, DOI 10.1016/j.resmic.2010.05.011
   STALPERS JA, 1990, SYST APPL MICROBIOL, V13, P92, DOI 10.1016/S0723-2020(11)80185-2
   Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0
   Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996
   Verslyppe B, 2010, RES MICROBIOL, V161, P439, DOI 10.1016/j.resmic.2010.02.005
   WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463
NR 37
TC 9
Z9 9
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0923-2508
EI 1769-7123
J9 RES MICROBIOL
JI Res. Microbiol.
PD JUL-AUG
PY 2010
VL 161
IS 6
SI SI
BP 407
EP 413
DI 10.1016/j.resmic.2010.06.001
PG 7
WC Microbiology
SC Microbiology
GA 644EA
UT WOS:000281354500001
PM 20599611
DA 2020-05-07
ER

PT J
AU Raoufy, MR
   Gharibzadeh, S
   Radmehr, B
   Khaksar, R
   Hosseini, H
AF Raoufy, Mohammad Reza
   Gharibzadeh, Shahriar
   Radmehr, Behrad
   Khaksar, Ramin
   Hosseini, Hedayat
TI PREDICTING THE COMBINED EFFECT OF ZATARIA MULTIFLORA ESSENTIAL OIL, PH
   AND TEMPERATURE ON THE GROWTH OF STAPHYLOCOCCUS AUREUS USING ARTIFICIAL
   NEURAL NETWORKS
SO JOURNAL OF FOOD SAFETY
LA English
DT Article
ID BOISS. ESSENTIAL OIL; FOOD MODEL SYSTEM; SALMONELLA-ENTERITIDIS;
   BACILLUS-CEREUS; CARROT BROTH; TYPHIMURIUM; RESISTANCE; DESCRIBE;
   STORAGE; NISIN
AB Zataria multiflora is a plant belonging to the Laminaceae family that grows in Iran, Pakistan and Afghanistan. Although artificial neural network is a sophisticated novel method in predictive microbiology, no study has been fulfilled on Z. multiflora. Therefore, the present study is undertaken to predict the effects of Z. multiflora essential oil (EO), temperature and pH on the probability percentage of growth initiation of Staphylococcus aureus using artificial neural network. For validating the artificial neural network, we used test data which were not utilized for training. For determining the ability of artificial neural network, we obtained the Pearson's correlation between artificial neural network output and experimental log P% (r = 0.998 and P < 0.0001). In conclusion, taking into consideration the importance of S. aureus in food microbiology and the antimicrobial effects of the EOs which are commonly used for flavoring, the development of artificial neural network models are beneficial in order to predict the effects of Z. multiflora EO, temperature and pH on the probability percentage of growth initiation of S. aureus.
   PRACTICAL APPLICATIONS
   Staphylococcus aureus is an important pathogen in food safety. Staphylococcal food poisoning is widespread and quite frequent. It is also among the four most common causes of foodborne illnesses. One of the most important purposes of food safety is inhibition of this microorganism growth.
   Substitution of traditional food preservatives by natural ones is a growing interest in food safety. Essential oils are aromatic oily liquid obtained from plant material. Plant essential oils (EOs) have varying degrees of antimicrobial activity. On the other hand, predictive microbiology is an essential element of modern food microbiology and offers to provide a scientific foundation to meet the ongoing needs of food safety. Over the last few years, artificial neural networks have been proposed as nonlinear modeling techniques in predictive microbiology.
C1 [Khaksar, Ramin; Hosseini, Hedayat] Shahid Beheshti Univ, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Food Microbiol Lab,Dept Food Technol, Tehran 1981619573, Iran.
   [Raoufy, Mohammad Reza] Tarbiat Modares Univ, Dept Physiol, Tehran, Iran.
   [Gharibzadeh, Shahriar] Amirkabir Univ Technol, Biomed Engn Fac, Neuromuscular Syst Lab, Tehran, Iran.
   [Radmehr, Behrad] Islamic Azad Univ, Fac Vet Med, Dept Food Hyg & Qual Control, Tehran, Iran.
   [Hosseini, Hedayat] Minist Hlth Med Educ, Food & Drug Res Ctr, Tehran, Iran.
RP Khaksar, R (reprint author), Shahid Beheshti Univ, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Food Microbiol Lab,Dept Food Technol, Tehran 1981619573, Iran.
EM r.khaksar@sbmu.ac.ir
RI ; Raoufy, Mohammad Reza/M-7809-2017
OI , National Nutrition & Food Technology Research
   Institute/0000-0002-5182-4419; Khaksar, Ramin/0000-0003-3193-4917;
   Raoufy, Mohammad Reza/0000-0002-9292-8564; gharibzade,
   shahriar/0000-0002-9604-8433
CR Ali MS, 2000, PHYTOCHEMISTRY, V55, P933
   Andre MCDPB, 2008, FOOD CONTROL, V19, P200, DOI 10.1016/j.foodcont.2007.03.010
   Basti AA, 2004, FOOD MICROBIOL, V21, P431, DOI 10.1016/j.fm.2003.10.006
   Basti AA, 2007, LWT-FOOD SCI TECHNOL, V40, P973, DOI 10.1016/j.lwt.2006.07.007
   Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022
   Dariani S, 2007, BIOSYSTEMS, V90, P529, DOI 10.1016/j.biosystems.2006.12.004
   Dominguez SA, 2007, INT J FOOD MICROBIOL, V120, P287, DOI 10.1016/j.ijfoodmicro.2007.09.005
   Esnoz A, 2006, INT J FOOD MICROBIOL, V106, P153, DOI 10.1016/j.ijfoodmicro.2005.06.016
   FISHER RA, 1957, STAT TABLES BIOL AGR
   Hosseinzadeh H, 2000, J ETHNOPHARMACOL, V73, P379, DOI 10.1016/S0378-8741(00)00238-5
   Koutsoumanis K, 1999, INT J FOOD MICROBIOL, V49, P63, DOI 10.1016/S0168-1605(99)00054-9
   Koutsoumanis K, 1998, J APPL MICROBIOL, V84, P981, DOI 10.1046/j.1365-2672.1998.00433.x
   Lanciotti R, 2001, FOOD MICROBIOL, V18, P659, DOI 10.1006/fmic.2001.0429
   Lawrynowicz-Paciorek M, 2007, INT J FOOD MICROBIOL, V117, P319, DOI 10.1016/j.ijfoodmicro.2007.03.009
   Lin CS, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P450
   Mann CM, 1998, J APPL MICROBIOL, V84, P538, DOI 10.1046/j.1365-2672.1998.00379.x
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V78, P133, DOI 10.1016/S0168-1605(02)00231-3
   Moosavy MH, 2008, FOOD RES INT, V41, P1050, DOI 10.1016/j.foodres.2008.07.018
   Normanno G, 2007, INT J FOOD MICROBIOL, V115, P290, DOI 10.1016/j.ijfoodmicro.2006.10.049
   Panagou EZ, 2007, INT J FOOD MICROBIOL, V117, P276, DOI 10.1016/j.ijfoodmicro.2007.03.010
   Razavilar V, 1998, INT J FOOD MICROBIOL, V40, P149, DOI 10.1016/S0168-1605(98)00014-2
   Solomakos N, 2008, FOOD MICROBIOL, V25, P120, DOI 10.1016/j.fm.2007.07.002
   Tassou C, 2000, FOOD RES INT, V33, P273, DOI 10.1016/S0963-9969(00)00047-8
   Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9
   Valero M, 2006, INT J FOOD MICROBIOL, V106, P90, DOI 10.1016/j.ijfoodmicro.2005.06.011
   Valero M, 2003, INT J FOOD MICROBIOL, V85, P73, DOI 10.1016/S0168-1605(02)00484-1
NR 26
TC 3
Z9 4
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0149-6085
EI 1745-4565
J9 J FOOD SAFETY
JI J. Food Saf.
PD MAY
PY 2010
VL 30
IS 2
BP 318
EP 329
DI 10.1111/j.1745-4565.2009.00209.x
PG 12
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 584ZG
UT WOS:000276792900007
DA 2020-05-07
ER

PT J
AU Khanzadi, S
   Gharibzadeh, S
   Raoufy, MR
   Razavilar, V
   Khaksar, R
   Radmehr, B
AF Khanzadi, Saeid
   Gharibzadeh, Shahriar
   Raoufy, Mohammad Reza
   Razavilar, Vadud
   Khaksar, Ramin
   Radmehr, Behrad
TI APPLICATION OF ARTIFICIAL NEURAL NETWORKS TO PREDICT CLOSTRIDIUM
   BOTULINUM GROWTH AS A FUNCTION OF ZATARIA MULTIFLORA ESSENTIAL OIL, pH,
   NaCl AND TEMPERATURE
SO JOURNAL OF FOOD SAFETY
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS; BACILLUS-CEREUS; MICROBIOLOGY; MODEL; INHIBITION;
   PARAMETERS; SPORES; BROTH; TIME
AB The present study is undertaken to predict the effects of Zataria multflora essential oil, NaCl, temperature and pH on the probability percentage of growth of Clostridium botulinum using artificial neural network (ANN).
   To assess the effects of essential oil, NaCl, pH and temperature on Log P% of C. botulinum type A spores, the experiment was arranged in a factorial design. This design (4 x 3 x 3 x 3) included four levels of EO (0.0, 0.015, 0.03 and 0.06%), three levels of NaCl (0.5, 4 and 6%), three levels of pH (6, 6.5 and 7.4), three storage temperatures (15, 25 and 35C) and repeated observations (12 times) for growth in BHI broth for up to 43 days (D).
   According to our results, the log P% of C. botulinum was affected significantly (P < 0.01) by Essential oil, pH, NaCl and temperature.
   The numbers of neurons in input hidden and output layers were 5, 11 and 1, respectively.
   The inputs to the ANN were temperature, pH, NaCl, essential oil and the number of days after inoculation. The output of the ANN was log P%.
   Our results show that the ANN is a suitable model for predicting the growth of C. botulinum when it is affected by different levels of pH, temperature, NaCl and essential oil.
   PRACTICAL APPLICATIONS
   Clostridium botulinum is an anaerobic bacterium that produces a powerful neurotoxin. Because there is concern over the safety of some chemical preservatives, an increased interest is started into more natural alternatives. Zataria multiflora has been used traditionally as flavor agent and its antimicrobial activities has been established in previous studies. In addition, predictive food microbiology involves the knowledge of microbial growth responses to environmental factors summarized as mathematical models. Over the last few years, artificial neural networks (ANNs), as nonlinear modeling techniques, have been proposed for use in predictive microbiology. Considering the importance of C. botulinum and using natural preservative in food safety and the power of ANN in predicting purposes, we suggest that ANN can be used as a prediction tool in food safety.
C1 [Khaksar, Ramin] Shahid Beheshti Univ, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Food Microbiol Lab,Dept Food Sci & Technol, Tehran 1981619573, Iran.
   [Khanzadi, Saeid] Ferdowsi Univ Mashhad, Fac Vet Med, Dept Food Hyg, Mashhad, Iran.
   [Gharibzadeh, Shahriar] Amirkabir Univ Technol, Biomed Engn Fac, Neuromuscular Syst Lab, Tehran, Iran.
   [Raoufy, Mohammad Reza] Tarbiat Modares Univ, Dept Physiol, Tehran, Iran.
   [Razavilar, Vadud] Univ Tehran, Fac Vet Med, Dept Food Hyg, Tehran, Iran.
   [Radmehr, Behrad] Islamic Azad Univ, Fac Vet Med, Dept Food Hyg & Qual Control, Karaj Branch, Tehran, Iran.
RP Khaksar, R (reprint author), Shahid Beheshti Univ, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Food Microbiol Lab,Dept Food Sci & Technol, Tehran 1981619573, Iran.
EM r.khaksar@sbmu.ac.ir
RI Khanzadi, Saeid/AAB-4019-2020; Raoufy, Mohammad Reza/M-7809-2017
OI gharibzade, shahriar/0000-0002-9604-8433; , National Nutrition & Food
   Technology Research Institute/0000-0002-5182-4419; Raoufy, Mohammad
   Reza/0000-0002-9292-8564; khanzadi, Saeid/0000-0003-0106-587X; Khaksar,
   Ramin/0000-0003-3193-4917
CR Ali MS, 2000, PHYTOCHEMISTRY, V55, P933
   Basti AA, 2007, LWT-FOOD SCI TECHNOL, V40, P973, DOI 10.1016/j.lwt.2006.07.007
   Brul S, 2007, WOODHEAD PUBL FOOD S, P1, DOI 10.1533/9781845692940
   BUCHANAN RL, 1993, TRENDS FOOD SCI TECH, V4, P6, DOI 10.1016/S0924-2244(05)80004-4
   Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022
   Chaibi A, 1997, FOOD MICROBIOL, V14, P161, DOI 10.1006/fmic.1996.0075
   Daifas DP, 2004, INT J FOOD MICROBIOL, V94, P313, DOI 10.1016/j.ijfoodmicro.2004.01.017
   Dariani S, 2007, BIOSYSTEMS, V90, P529, DOI 10.1016/j.biosystems.2006.12.004
   Dong QL, 2007, FOOD MICROBIOL, V24, P624, DOI 10.1016/j.fm.2006.12.003
   Esnoz A, 2006, INT J FOOD MICROBIOL, V106, P153, DOI 10.1016/j.ijfoodmicro.2005.06.016
   FISHER RA, 1957, STAT TABLES BIOL AGR
   Hosseinzadeh H, 2000, J ETHNOPHARMACOL, V73, P379, DOI 10.1016/S0378-8741(00)00238-5
   Lin CS, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P450
   Mann CM, 1998, J APPL MICROBIOL, V84, P538, DOI 10.1046/j.1365-2672.1998.00379.x
   MCKELLAR RC, 2004, MODELING MICROBIAL R, P95
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V73, P395, DOI 10.1016/S0168-1605(01)00663-8
   McMeekin TA, 1997, EMERG INFECT DIS, V3, P541, DOI 10.3201/eid0304.970419
   Nevas M, 2004, J FOOD PROTECT, V67, P199, DOI 10.4315/0362-028X-67.1.199
   PALMER A. S., 2001, FOOD MICROBIOL, V18, P463, DOI DOI 10.1006/FMIC.2001.0415
   Pauli A., 2001, INT J AROMATHER, V3, P126, DOI DOI 10.1016/S0962-4562(01)80048-5
   Razavilar V, 1998, INT J FOOD MICROBIOL, V40, P149, DOI 10.1016/S0168-1605(98)00014-2
   ROSS T, 1994, INT J FOOD MICROBIOL, V23, P241, DOI 10.1016/0168-1605(94)90155-4
   Smith-Simpson S, 2007, INT J FOOD MICROBIOL, V118, P294, DOI 10.1016/j.ijfoodmicro.2007.08.005
   Tassou C, 2000, FOOD RES INT, V33, P273, DOI 10.1016/S0963-9969(00)00047-8
   Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9
   Ultee A, 2001, INT J FOOD MICROBIOL, V64, P373, DOI 10.1016/S0168-1605(00)00480-3
   Whiting RC, 1998, FOOD MICROBIOL, V15, P449, DOI 10.1006/fmic.1998.0196
NR 27
TC 10
Z9 13
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0149-6085
EI 1745-4565
J9 J FOOD SAFETY
JI J. Food Saf.
PD MAY
PY 2010
VL 30
IS 2
BP 490
EP 505
DI 10.1111/j.1745-4565.2010.00222.x
PG 16
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 584ZG
UT WOS:000276792900020
DA 2020-05-07
ER

PT J
AU Bala, M
   Tapsall, JW
   Limnios, A
   Sood, S
   Ray, K
AF Bala, M.
   Tapsall, J. W.
   Limnios, A.
   Sood, S.
   Ray, K.
TI Experience with an external quality assurance scheme for antimicrobial
   susceptibility testing of Neisseria gonorrhoeae in India, 2001-2007
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Antibiotic resistance; infectious disease control; Neisseria gonorrhoea;
   public health microbiology; sexually transmitted infections
ID ANTIBIOTIC SUSCEPTIBILITY; RESISTANCE; CEFTRIAXONE
AB Antimicrobial resistance (AMR) in Neisseria gonorrhoeae compromises patient treatment and disease control. Epidemiologically based Surveillance of AMR in gonococci is needed to optimize standard treatment regimens. Validation of AMR surveillance data depends on external quality assurance schemes (EQAS). AMR surveillance data quality in India during 2001-2007 was assessed by participants testing panels of reference strains and repeated re-challenge with identical controls, accompanied by educative feedback. Overall, correct results were obtained for 944 (82%) of 1030 tests performed for five 'core' antibiotics. Aggregated error rates decreased from 33% (123 tests) in 2001 to 4.4% (180 tests) in 2007 with improvements in individual laboratory performance. Cephalosporin test results produced high error rates without improvement. Reference centre and network laboratory collaboration produced marked improvements in test performance through annual EQAS integrating proficiency testing and participant education. More frequent EQAS cycles would assist this process. These experiences may be applicable in similar settings elsewhere.
C1 [Tapsall, J. W.; Limnios, A.] Prince Wales Hosp, Dept Microbiol, WHO Collaborating Ctr STD, Sydney, NSW, Australia.
   [Bala, M.; Ray, K.] Vardhman Mahavir Med Coll, Reg STD Teaching Training & Res Ctr, New Delhi, India.
   [Bala, M.; Ray, K.] Safdarjang Hosp, New Delhi, India.
   [Sood, S.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.
RP Tapsall, JW (reprint author), Prince Wales Hosp, Dept Microbiol, WHO Collaborating Ctr STD, Sydney, NSW, Australia.
EM j.tapsall@unsw.edu.au
OI Singh, Vikram/0000-0003-2737-8102; Bala, Manju/0000-0002-1934-8272
FU WHO SEAR, New Delhi
FX We are grateful to WHO SEAR, New Delhi for financial assistance for
   three years (from 2000 to 2002) and to Dr Rajesh Bhatia (WHO SEAR, New
   Delhi) for his support and guidance. We gratefully acknowledge the
   contribution of the Indian participants of GASP EQAS: Dr P. Bhalla
   (Maulana Azad Medical College, New Delhi); Dr Gopi Thawani (Institute of
   Serology, Kolkata): Dr A. R. Risbud (National AIDS Research Institute,
   Punc); Dr Nirmala Devi (institute of Venerology, Madras Medical College,
   Chennai); Dr Shukla Das (University College of Medical Sciences & GTB
   Hospital, Delhi). The authors thank the Medical Superintendent, VMMC &
   Safdarjang Hospital for permission to carry out this study and Smt.
   Leelamma Peter for excellent technical assistance.
CR Bala M, 2005, INDIAN J MED RES, V122, P48
   Bala M, 2003, SEX TRANSM DIS, V30, P523, DOI 10.1097/00007435-200306000-00010
   Bala M, 2007, J ANTIMICROB CHEMOTH, V60, P582, DOI 10.1093/jac/dkm238
   Lindberg R, 2007, ANTIMICROB AGENTS CH, V51, P2117, DOI 10.1128/AAC.01604-06
   Lo JYC, 2008, ANTIMICROB AGENTS CH, V52, P3564, DOI 10.1128/AAC.00198-08
   Martin IMC, 2006, J ANTIMICROB CHEMOTH, V58, P587, DOI 10.1093/jac/dkl265
   Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001
   REYN A, 1965, B WORLD HEALTH ORGAN, V32, P477
   SNELL JJS, 1988, J CLIN PATHOL, V41, P97, DOI 10.1136/jcp.41.1.97
   Tapsall J., 2005, WHAT IS EC BURDEN IM
   TAPSALL J, 2004, ANTIMICROBIAL SUSCEP, P175
   Tapsall J., 2001, WHOCDSCSRDRS20013
   Tapsall JW, 2009, CURR OPIN INFECT DIS, V22, P87, DOI 10.1097/QCO.0b013e328320a836
   TAPSALL JW, 1990, GENITOURIN MED, V66, P8
   Tapsall JW, 1997, GENITOURIN MED, V73, P355
   Tenover FC, 2001, J CLIN MICROBIOL, V39, P241, DOI 10.1128/JCM.39.1.241-250.2001
   Unemo M, 2009, J ANTIMICROB CHEMOTH, V63, P1142, DOI 10.1093/jac/dkp098
   *WHO, 1990, WHOVDT90452
   *WHO GON ANT SURV, 2008, D007040811 WHO COLL
   Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005
NR 20
TC 11
Z9 12
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JAN
PY 2010
VL 138
IS 1
BP 69
EP 75
DI 10.1017/S0950268809990148
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 536YK
UT WOS:000273079600011
PM 19534842
DA 2020-05-07
ER

PT J
AU Wong, I
   Atsumi, S
   Huang, WC
   Wu, TY
   Hanai, T
   Lam, ML
   Tang, P
   Yang, JA
   Liao, JC
   Ho, CM
AF Wong, Ieong
   Atsumi, Shota
   Huang, Wei-Chih
   Wu, Tung-Yun
   Hanai, Taizo
   Lam, Miu-Ling
   Tang, Ping
   Yang, Jian
   Liao, James C.
   Ho, Chih-Ming
TI An agar gel membrane-PDMS hybrid microfluidic device for long term
   single cell dynamic study
SO LAB ON A CHIP
LA English
DT Article
ID GENE-EXPRESSION; BACTERIAL; MICROBIOLOGY; MECHANISMS; TOLERANCE;
   ALCOHOLS; NETWORK; PROTEIN; MEMS
AB Significance of single cell measurements stems from the substantial temporal fluctuations and cell-cell variability possessed by individual cells. A major difficulty in monitoring surface non-adherent cells such as bacteria and yeast is that these cells tend to aggregate into clumps during growth, obstructing the tracking or identification of single-cells over long time periods. Here, we developed a microfluidic platform for long term single-cell tracking and cultivation with continuous media refreshing and dynamic chemical perturbation capability. The design highlights a simple device-assembly process between PDMS microchannel and agar membrane through conformal contact, and can be easily adapted by microbiologists for their routine laboratory use. The device confines cell growth in monolayer between an agar membrane and a glass surface. Efficient nutrient diffusion through the membrane and reliable temperature maintenance provide optimal growth condition for the cells, which exhibited fast exponential growth and constant distribution of cell sizes. More than 24 h of single-cell tracking was demonstrated on a transcription-metabolism integrated synthetic biological model, the gene-metabolic oscillator. Single cell morphology study under alcohol toxicity allowed us to discover and characterize cell filamentation exhibited by different E. coli isobutanol tolerant strains. We believe this novel device will bring new capabilities to quantitative microbiology, providing a versatile platform for single cell dynamic studies.
C1 [Wong, Ieong; Ho, Chih-Ming] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.
   [Atsumi, Shota] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
   [Huang, Wei-Chih; Wu, Tung-Yun; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.
   [Hanai, Taizo] Kyushu Univ, Lab Bioinformat, Grad Sch Syst Life Sci, Fukuoka 812, Japan.
   [Lam, Miu-Ling] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.
   [Yang, Jian] Zhejiang Univ, Inst Chem Engn Proc & Machinery, Hangzhou 310027, Peoples R China.
RP Ho, CM (reprint author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.
EM chihming@ucla.edu
RI Ho, Chih-Ming/I-6537-2012; Hsing-Yen, Su/G-9552-2014
OI Atsumi, Shota/0000-0002-5782-4196; LAM, Miu Ling/0000-0002-5333-7454;
   Ho, Chih-Ming/0000-0001-7369-5446
FU Center for Cell Control through NIH Roadmap for Nanomedicine
   [PN2EY018228]
FX This project is supported by the Center for Cell Control (PN2EY018228)
   through NIH Roadmap for Nanomedicine. We thank Wilson W. Wong, Eileen
   Fung, Prof. Pak Kin Wong and Hideaki Tsutsui for discussions, and Chi K.
   Lam for the automation of the fluidic control. We thank Man-Lai Cheng
   for the help in data analysis.
CR Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5
   Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450
   Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390
   Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211
   Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625
   Bourne R, 2010, FUNDAMENTALS OF DIGITAL IMAGING IN MEDICINE, P1, DOI 10.1007/978-1-84882-087-6
   Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004
   BRINKMAN HC, 1947, APPL SCI RES, V1, P27
   Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106
   Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468
   Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302
   Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032
   Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282
   Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919
   Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125
   FRIED VA, 1973, J BACTERIOL, V114, P239, DOI 10.1128/JB.114.1.239-248.1973
   Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508
   Gefen O, 2008, TRENDS BIOTECHNOL, V26, P345, DOI 10.1016/j.tibtech.2008.03.007
   Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008
   Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784
   Ho CM, 1998, ANNU REV FLUID MECH, V30, P579, DOI 10.1146/annurev.fluid.30.1.579
   Ingham CJ, 2008, LAB CHIP, V8, P1604, DOI 10.1039/b804790a
   INGRAM LO, 1986, TRENDS BIOTECHNOL, V4, P40, DOI 10.1016/0167-7799(86)90152-6
   Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820
   Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056
   Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110
   Parvazinia M, 2006, TRANSPORT POROUS MED, V63, P71, DOI 10.1007/s11242-005-2721-2
   Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038
   Sato J, 2006, J RHEOL, V50, P1, DOI 10.1122/1.2135329
   SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995
   Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045
   Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389
   TAIZO H, UNPUB
   Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Wong I, 2009, MICROFLUID NANOFLUID, V7, P291, DOI 10.1007/s10404-009-0443-4
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 37
TC 16
Z9 18
U1 1
U2 52
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2010
VL 10
IS 20
BP 2710
EP 2719
DI 10.1039/c004719h
PG 10
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology; Instruments & Instrumentation
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics; Instruments & Instrumentation
GA 656FZ
UT WOS:000282314200010
PM 20664845
DA 2020-05-07
ER

PT J
AU Beloqui, A
   Guazzaroni, ME
   Pazos, F
   Vieites, JM
   Godoy, M
   Golyshina, OV
   Chernikova, TN
   Waliczek, A
   Silva-Rocha, R
   Al-ramahi, Y
   La Cono, V
   Mendez, C
   Salas, JA
   Solano, R
   Yakimov, MM
   Timmis, KN
   Golyshin, PN
   Ferrer, M
AF Beloqui, Ana
   Guazzaroni, Maria-Eugenia
   Pazos, Florencio
   Vieites, Jose M.
   Godoy, Marta
   Golyshina, Olga V.
   Chernikova, Tatyana N.
   Waliczek, Agnes
   Silva-Rocha, Rafael
   Al-ramahi, Yamal
   La Cono, Violetta
   Mendez, Carmen
   Salas, Jose A.
   Solano, Roberto
   Yakimov, Michail M.
   Timmis, Kenneth N.
   Golyshin, Peter N.
   Ferrer, Manuel
TI RETRACTED: Reactome Array: Forging a Link Between Metabolome and Genome
   (Retracted article. See vol. 330, pg. 912, 2010)
SO SCIENCE
LA English
DT Article; Retracted Publication
ID SYSTEMS MICROBIOLOGY; ENZYME-ACTIVITY; METAGENOMICS; COMMUNITIES;
   ENVIRONMENT; ECOSYSTEMS; PATHWAYS; ARCHAEA; STRESS
AB We describe a sensitive metabolite array for genome sequence-independent functional analysis of metabolic phenotypes and networks, the reactomes, of cell populations and communities. The array includes 1676 dye-linked substrate compounds collectively representing central metabolic pathways of all forms of life. Application of cell extracts to the array leads to specific binding of enzymes to cognate substrates, transformation to products, and concomitant activation of the dye signals. Proof of principle was shown by reconstruction of the metabolic maps of model bacteria. Utility of the array for unsequenced organisms was demonstrated by reconstruction of the global metabolisms of three microbial communities derived from acidic volcanic pool, deep-sea brine lake, and hydrocarbon-polluted seawater. Enzymes of interest are captured on nanoparticles coated with cognate metabolites, sequenced, and their functions unequivocally established.
C1 [Golyshina, Olga V.; Chernikova, Tatyana N.; Waliczek, Agnes; Timmis, Kenneth N.; Golyshin, Peter N.] HZI Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
   [Pazos, Florencio; Godoy, Marta; Silva-Rocha, Rafael; Solano, Roberto] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain.
   [Beloqui, Ana; Guazzaroni, Maria-Eugenia; Vieites, Jose M.; Al-ramahi, Yamal; Ferrer, Manuel] CSIC, Inst Catalysis, E-28049 Madrid, Spain.
   [La Cono, Violetta; Yakimov, Michail M.] CNR, Inst Coastal Marine Environm, I-98122 Messina, Italy.
   [Mendez, Carmen; Salas, Jose A.] Univ Oviedo, E-33006 Oviedo, Spain.
   [Timmis, Kenneth N.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany.
   [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.
   [Golyshin, Peter N.] Aberystwyth Univ Bangor Univ Partnership CIRRE, Ctr Integrated Res Rural Environm, Aberystwyth, Dyfed, Wales.
RP Golyshin, PN (reprint author), HZI Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
EM p.golyshin@bangor.ac.uk; mferrer@icp.csic.es
RI Ferrer, Manuel/K-4535-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; La
   Cono, Violetta/S-9890-2017; Yakimov, Michail/H-1829-2016
OI Ferrer, Manuel/0000-0003-4962-4714; Mendez-Fernandez, Maria del
   Carmen/0000-0003-2729-841X; Guazzaroni,
   Maria-Eugenia/0000-0002-4657-3731; La Cono,
   Violetta/0000-0002-3306-4938; Yakimov, Michail/0000-0003-1418-363X
FU Spanish MECSpanish Government [BIO2006-15318]; Federal Ministry for
   Science and Education (BMBF)Federal Ministry of Education & Research
   (BMBF); Fonds der Chemischen IndustrieFonds der Chemischen Industrie; 
   [BIO2006-11738];  [CSD2007-00005];  [GEN2006-27750-C-4-E]; 
   [BFU2008-04398-E/BMC];  [KBBE-226977]
FX This research was supported by the BIO2006-11738, CSD2007-00005,
   GEN2006-27750-C-4-E, BFU2008-04398-E/BMC, and KBBE-226977 projects. A. B
   and Y. A-R thank the Spanish MEC for the FPU and FPI fellowships. F. P.
   thanks the Spanish MEC for the BIO2006-15318 project. K. N. T, O. V. G.,
   and P. N. G acknowledge the Federal Ministry for Science and Education
   (BMBF) for a grant in the framework of the BiotechGenoMik program, and
   K. N. T. thanks the Fonds der Chemischen Industrie for generous support.
   Authors are deeply indebted to A. Yanenko for sampling Kolguev Island
   coastal water and to the captain and crew of Research Vessel Urania for
   their assistance in deep-sea sampling in the Mediterranean Sea and to J.
   Manuel Franco for statistical analyses.
CR Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105
   Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106
   Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971
   Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x
   Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3
   Huang EY, 1997, J BACTERIOL, V179, P5648, DOI 10.1128/jb.179.17.5648-5653.1997
   Jiao YYQ, 2005, APPL ENVIRON MICROB, V71, P4487, DOI 10.1128/AEM.71.8.4487-4496.2005
   Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x
   Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Lombardot T, 2006, NUCLEIC ACIDS RES, V34, pD390, DOI 10.1093/nar/gkj070
   Northen TR, 2008, P NATL ACAD SCI USA, V105, P3678, DOI 10.1073/pnas.0712332105
   Pearce DA, 1999, J BACTERIOL, V181, P4774, DOI 10.1128/JB.181.16.4774-4779.1999
   PRONK AF, 1995, J BACTERIOL, V177, P75, DOI 10.1128/jb.177.1.75-81.1995
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544
   Turnbaugh PJ, 2008, CELL, V134, P708, DOI 10.1016/j.cell.2008.08.025
   Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340
   van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569
   Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x
   Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918
   Woodson JD, 2003, J BACTERIOL, V185, P7193, DOI 10.1128/JB.185.24.7193-7201.2003
   Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006
NR 26
TC 30
Z9 33
U1 3
U2 43
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 9
PY 2009
VL 326
IS 5950
BP 252
EP 257
DI 10.1126/science.1174094
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 504EX
UT WOS:000270599500034
PM 19815770
DA 2020-05-07
ER

PT J
AU Kalish, BT
   Gaydos, CA
   Hsieh, YH
   Christensen, BE
   Carroll, KC
   Cannons, A
   Cattani, JA
   Rothman, RE
AF Kalish, Brian T.
   Gaydos, Charlotte A.
   Hsieh, Yu-Hsiang
   Christensen, Bryan E.
   Carroll, Karen C.
   Cannons, Andy
   Cattani, Jacqueline A.
   Rothman, Richard E.
TI National Survey of Laboratory Response Network Sentinel Laboratory
   Preparedness
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
ID BIOTERRORISM
AB Objective: The Laboratory Response Network (LRN) is the United States' laboratory system for detecting, confirming, and reporting potential bioterrorism agents. The first tier-sentinel laboratories-is composed principally of hospital-based laboratories and is tasked with ruling out potential biological threat agents in clinical specimens or the identification of suspicious specimens for further testing in higher tiers of the LRN system. The aim of the present study was to broadly describe preparedness of the first tier of the hospital LRN, the sentinel laboratories, with a specific focus on training, personnel, and communications.
   Methods: A semistructured cross-sectional survey of US sentinel laboratories was designed and conducted. Hospitals with greater than 250 beds and an emergency department were considered eligible for inclusion. A geographically weighted sample of 201 hospitals was selected for inclusion. The survey was administered by telephone to the microbiology managers ( or designees) at the selected hospitals. The survey contained questions related to drill frequency, proficiency survey participation, personnel training, personnel responsibilities, procedures for biological threat response, and overall confidence in preparedness.
   Results: Overall, 179 hospitals (89.1%) identified themselves as sentinel laboratories and participated in the survey; 11.7% reported that they had had an emergency alert within the last 2 years. Although rates of internal drills were low (20.7%), participation in some form of bioterrorism proficiency evaluation was high (79.9%). In all, 83.8% of laboratories reported that they had personnel designated to coordinate response to acts of bioterrorism. More than 73% of respondents indicated that they had sufficient personnel, equipment, and training to respond to a biological terrorism event. By multivariate analysis, sentinel laboratories were 3.4 times more likely to feel confident that they had sufficient personnel, equipment, and training to respond to a biological terrorism event if they had designated personnel for bioterrorism roles.
   Conclusions: This pilot study of sentinel laboratory bioterrorism preparedness demonstrated that hospital laboratory personnel, training, and communication preparedness were not universal, despite designation as sentinel laboratories. A need for unified monitoring of sentinel laboratories exists, and efforts should be made to develop standardized metrics for sentinel laboratory preparedness. ( Disaster Med Public Health Preparedness. 2009; 3(Suppl 1): S17-S23)
C1 [Kalish, Brian T.; Gaydos, Charlotte A.; Hsieh, Yu-Hsiang; Christensen, Bryan E.; Rothman, Richard E.] Johns Hopkins Univ, Dept Emergency Med, Sch Med, Baltimore, MD 21209 USA.
   [Carroll, Karen C.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Sch Med, Baltimore, MD 21209 USA.
   [Cannons, Andy; Cattani, Jacqueline A.] Univ S Florida, Ctr Biol Def, Tampa, FL 33620 USA.
RP Rothman, RE (reprint author), Johns Hopkins Univ, Dept Emergency Med, Sch Med, 5801 Smith Ave,Suite 3220,Davis Bldg, Baltimore, MD 21209 USA.
EM rrothman@jhmi.edu
RI Gaydos, Charlotte A./E-9937-2010
OI Rothman, Richard/0000-0002-1017-9505
CR *ASS PUBL HLTH LAB, 2006, LRN SENT LAB CLIN WE
   *ASS PUBL HLTH LAB, BIOT PREP PUBL HLTH
   *CDC ECS DHCM, 2005, LAB RESP NETW PARTN
   HARMS R, 2005, HLTH MANAG TECHNOL, V12, P18
   Klietmann WF, 2001, CLIN MICROBIOL REV, V14, P364, DOI 10.1128/CMR.14.2.364-381.2001
   Snyder JW, 2003, J CLIN MICROBIOL, V41, P1, DOI 10.1128/JCM.41.1.1-4.2003
   2002, COLL AM PATHOLOGISTS
NR 7
TC 6
Z9 6
U1 1
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD JUN
PY 2009
VL 3
SU 1
BP S17
EP S23
DI 10.1097/DMP.0b013e31819e09b4
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 583QB
UT WOS:000276692300005
PM 19491582
DA 2020-05-07
ER

PT J
AU Guazzaroni, ME
   Beloqui, A
   Golyshin, PN
   Ferrer, M
AF Guazzaroni, Maria-Eugenia
   Beloqui, Ana
   Golyshin, Peter N.
   Ferrer, Manuel
TI Metagenomics as a new technological tool to gain scientific knowledge
SO WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Article
DE Metagenomics; Microbial diversity; Systems microbiology
ID METABOLIC NETWORKS; COMMUNITY; DIVERSITY; MICROBES; GENOMICS; BACTERIA;
   INSIGHTS; ARCHAEA; RARE
AB Metagenomics (also Environmental Genomics, Ecogenomics or Community Genomics) is an emerging approach to studying microbial communities in the environment. This relatively new technique enables studies of organisms that are not easily cultured in a laboratory, thus differing from traditional microbiology that relies almost entirely on cultured organisms. Metagenomics technology thus holds the premise of new depths of understanding of microbes and, importantly, is a new tool for addressing biotechnological problems, without tedious cultivation efforts. DNA sequencing technology has already made a significant breakthrough, and generation of gigabase-pairs of microbial DNA sequences is not posing a challenge any longer. However, conceptual advances in microbial science will not only rely on the availability of innovative sequencing platforms, but also on sequence-independent tools for getting an insight into the functioning of microbial communities. This is an important issue, as we know that even the best annotations of genomes and metagenomes only create hypotheses of the functionality and substrate spectra of encoded proteins which require experimental testing by classical disciplines such as physiology and biochemistry. In this review, we address the following question, how to take advantage of, and how can we improve the, metagenomic technology for accommodating the needs of microbial biologists and enzymologists?.
C1 [Guazzaroni, Maria-Eugenia; Beloqui, Ana; Ferrer, Manuel] CSIC, Inst Catalysis, Madrid 28049, Spain.
   [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.
   [Golyshin, Peter N.] Bangor Univ Partnership, Aberystwyth Univ, Ctr Integrated Res Rural Environm, D-38124 Braunschweig, Germany.
   [Golyshin, Peter N.] HZI Helmholtz Ctr Infect Res, Environm Microbiol Lab, D-38124 Braunschweig, Germany.
RP Ferrer, M (reprint author), CSIC, Inst Catalysis, Marie Curie 2, Madrid 28049, Spain.
EM mferrer@icp.csic.es
RI Guazzaroni, Maria Eugenia MEG/E-2599-2013; Guazzaroni,
   Maria-Eugenia/Y-9268-2019; Beloqui, Ana/C-4512-2012; Ferrer,
   Manuel/K-4535-2014
OI Guazzaroni, Maria Eugenia MEG/0000-0002-4657-3731; Guazzaroni,
   Maria-Eugenia/0000-0002-4657-3731; Beloqui, Ana/0000-0002-7693-4163;
   Ferrer, Manuel/0000-0003-4962-4714; Golyshin, Peter/0000-0002-5433-0350
FU Spanish MECSpanish Government [BIO2006-11738, CSD2007-00005,
   GEN2006-27750-C-4-E]; CDTII + DEA [CENIT-2007-1031, PET2006_0052];
   Federal Ministry for Science and Education (BMBF)Federal Ministry of
   Education & Research (BMBF) [0313751 K]
FX This research was supported by the Spanish MEC BIO2006-11738,
   CSD2007-00005, GEN2006-27750-C-4-E, CDTII + DEA (CENIT-2007-1031) and
   PET2006_0052 projects. A. Beloqui thanks the Spanish MEC for a FPU
   fellowship. P.N. Golyshin acknowledges the Grant 0313751 K from the
   Federal Ministry for Science and Education (BMBF) within the GenoMikPlus
   initiative.
CR Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368
   Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68
   Beloqui A, 2008, CURR OPIN MICROBIOL, V11, P240, DOI 10.1016/j.mib.2008.04.005
   Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07
   Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39
   Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009
   Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105
   Bodrossy L, 2006, APPL ENVIRON MICROB, V72, P1672, DOI 10.1128/AEM.72.2.1672-1676.2006
   Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085
   Chan CKK, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/513701
   CHURCH JM, 2005, MOL SYST BIOL, V1
   Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498
   DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158
   DeLong EF, 2006, P NATL ACAD SCI USA, V103, P6417, DOI 10.1073/pnas.0602079103
   Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57
   Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082
   Farber CR, 2008, ADV GENET, V60, P571, DOI 10.1016/S0065-2660(07)00420-8
   Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034
   Ferrer M, 2009, J MOL MICROB BIOTECH, V16, P109, DOI 10.1159/000142898
   Ferrer M, 2007, CURR OPIN MICROBIOL, V10, P207, DOI 10.1016/j.mib.2007.05.004
   Ferrer M, 2009, MICROB BIOTECHNOL, V2, P31, DOI 10.1111/j.1751-7915.2008.00057.x
   Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07
   Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105
   GARCIAMARTIN H, 2006, NAT BIOTECHNOL, V24, P1229, DOI DOI 10.1038/NBT1006-1229
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Hallin PF, 2008, MOL BIOSYST, V4, P363, DOI 10.1039/b717118h
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004
   Handelsman J, 2008, DNA CELL BIOL, V27, P219, DOI 10.1089/dna.2008.1503
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104
   Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006
   Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206
   Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488
   Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038
   Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005
   Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983
   Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884
   Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624
   Lombardot T, 2006, NUCLEIC ACIDS RES, V34, pD390, DOI 10.1093/nar/gkj070
   Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x
   Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104
   Margulies EH, 2005, P NATL ACAD SCI USA, V102, P3354, DOI 10.1073/pnas.0408539102
   McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004
   Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723
   Poelarends GJ, 2006, BIOCHEMISTRY-US, V45, P7700, DOI 10.1021/bi0600603
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001
   Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x
   Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077
   Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109
   Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34
   Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092
   Schmeisser C, 2007, APPL MICROBIOL BIOT, V75, P955, DOI 10.1007/s00253-007-0945-5
   Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325
   Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103
   STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340
   Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857
   Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x
   Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269
   Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x
   Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456
   Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192
   Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016
   Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003
NR 70
TC 17
Z9 18
U1 0
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0959-3993
EI 1573-0972
J9 WORLD J MICROB BIOT
JI World J. Microbiol. Biotechnol.
PD JUN
PY 2009
VL 25
IS 6
BP 945
EP 954
DI 10.1007/s11274-009-9971-z
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 447CI
UT WOS:000266168800002
DA 2020-05-07
ER

PT J
AU Aguero-Chapin, G
   Varona-Santos, J
   de la Riva, GA
   Antunes, A
   Gonzalez-Villa, T
   Uriarte, E
   Gonzalez-Diaz, H
AF Agueero-Chapin, Guillermin
   Varona-Santos, Javier
   de la Riva, Gustavo A.
   Antunes, Agostinho
   Gonzalez-Villa, Tomas
   Uriarte, Eugenio
   Gonzalez-Diaz, Humberto
TI Alignment-Free Prediction of Polygalacturonases with Pseudofolding
   Topological Indices: Experimental Isolation from Coffea arabica and
   Prediction of a New Sequence
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Markov models; Topological Indices; Protein folding lattice networks;
   QSAR; Spectral moments; Entropy; Artificial Neural Networks;
   Polygalacturonases of plant; bacterial; nematode
ID PROTEIN SUBCELLULAR LOCATION; WEB-SERVER; SCLEROTINIA-SCLEROTIORUM;
   MEMBRANE-PROTEINS; ENZYME-KINETICS; GRAPH-THEORY; RATE LAWS; QSAR;
   NETWORKS; MODEL
AB Polygalacturonases (PGs) have called the attention of microbiology scientists and biotechnology or pharmaceutical industry because they are protein enzymes relevant to phytopathogens invasion, fruit ripening, and potential antimicrobial drug targets. Numeric Topological Indices (TIs) of protein pseudofolding lattices can be used as input for classification algorithms in Quantitative Structure-Activity Relationship (QSAR) studies. However, a comparative study of different QSAR models for PGs has not been reported. In this study, we calculated for the first time two classes of TIs (Spectral moments (pi(k)) and Entropy (theta(k)) values) for the Markov matrices associated to pseudofolding lattices of 108 PGs and 100 non-PGs heterogeneous proteins. Afterward, we developed different linear classifiers based on Linear Discriminant Analysis (LDA) and four types of nonlinear Artificial Neural Networks (ANN). The pi(k)-LDA model correctly classified 98.8% of PGs and 100% non-PGs used to train the model, as well as 98.1% of all sequences used as external validation series. The pi(k)-LDA model was the more accurate and/or simpler found. In addition, we report for the first time the experimental isolation and successful prediction of a new PG sequence from Coffea arabica. This sequence was deposited in the GenBank by our group with accession number GDQ336394. The present type of models are an interesting alignment-free complement to alignment-based procedures.
C1 [Agueero-Chapin, Guillermin; Uriarte, Eugenio; Gonzalez-Diaz, Humberto] Univ Santiago de Compostela, UBICA, Inst Ind Pharm, Dept Organ Chem,Fac Pharm, Santiago De Compostela 15782, Spain.
   [Agueero-Chapin, Guillermin] Cent Univ Las Villas, CBQ, Santa Clara 54830, Cuba.
   [Agueero-Chapin, Guillermin; Antunes, Agostinho] Univ Porto, CIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4050123 Oporto, Portugal.
   [Varona-Santos, Javier] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.
   [de la Riva, Gustavo A.] ITESS, Guanajuato 38900, Mexico.
   [Gonzalez-Villa, Tomas; Gonzalez-Diaz, Humberto] Univ Santiago de Compostela, Dept Microbiol & Parasitol, Fac Pharm, Santiago De Compostela 15782, Spain.
RP Gonzalez-Diaz, H (reprint author), Univ Santiago de Compostela, UBICA, Inst Ind Pharm, Dept Organ Chem,Fac Pharm, Santiago De Compostela 15782, Spain.
EM humberto.gonzalez@usc.es
RI Uriarte, Eugenio/F-5691-2012; , Humbert G. Diaz/A-6785-2012; Gonzalez,
   Tomas/K-5906-2014; Aguero-Chapin, Guillermin/C-8067-2019; Villa, Tomas
   G/E-2216-2012
OI Uriarte, Eugenio/0000-0001-6218-2899; , Humbert G.
   Diaz/0000-0002-9392-2797; Aguero-Chapin, Guillermin/0000-0002-9908-2418;
   Gonzalez Villa, Tomas/0000-0002-9282-6234; Antunes,
   Agostinho/0000-0002-1328-1732
FU Portuguese Foundation for Science and Technology (FCT)Portuguese
   Foundation for Science and Technology [PTDC/BLA-BDE/69144/2006]
FX The authors thank the kind attention and useful comments of the editor
   Prof. Martin W. McIntosh and two unknown reviewers. H. Gonzalez-Diaz
   acknowledges a research contract funded by the program Isidro Parga
   Pondal (Xunta de Galicia). A. Antunes thanks financial support of
   Portuguese Foundation for Science and Technology (FCT) project
   PTDC/BLA-BDE/69144/2006.
CR Aguero-Chapin G, 2008, J CHEM INF MODEL, V48, P434, DOI 10.1021/ci7003225
   Aguero-Chapin GA, 2006, FEBS LETT, V580, P723, DOI 10.1016/j.febslet.2005.12.072
   Althaus IW, 1996, BIOCHEM PHARMACOL, V51, P743, DOI 10.1016/0006-2952(95)02390-9
   Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020
   BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963
   Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12
   Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304
   Caballero J, 2006, J CHEM INF MODEL, V46, P1255, DOI 10.1021/ci050507z
   Casahola-Martin GM, 2007, BIOORGAN MED CHEM, V15, P1483, DOI 10.1016/j.bmc.2006.10.067
   Chen Mao, 2005, Genomics Proteomics & Bioinformatics, V3, P225
   CHOU KC, 1988, P NATL ACAD SCI USA, V85, P4295, DOI 10.1073/pnas.85.12.4295
   CHOU KC, 1979, SCI SINICA, V22, P341
   Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g
   Chou KC, 1996, J PROTEIN CHEM, V15, P59, DOI 10.1007/BF01886811
   CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8
   Chou KC, 2005, CURR PROTEIN PEPT SC, V6, P423, DOI 10.2174/138920305774329368
   Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667
   CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6
   CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D
   CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488
   CHOU KC, 1982, J AM CHEM SOC, V104, P1409, DOI 10.1021/ja00369a043
   Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125
   Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494
   Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006
   Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027
   Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i
   Chou KC, 2006, CURR MED CHEM, V13, P3263, DOI 10.2174/092986706778773077
   Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c
   Cotton P, 2002, FEMS MICROBIOL LETT, V213, P239, DOI 10.1111/j.1574-6968.2002.tb11312.x
   de Armas RR, 2004, PROTEINS, V56, P715, DOI 10.1002/prot.20159
   Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023
   Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670
   Diao YB, 2007, J THEOR BIOL, V247, P608, DOI 10.1016/j.jtbi.2007.04.007
   Dobson PD, 2005, J MOL BIOL, V345, P187, DOI 10.1016/j.jmb.2004.10.024
   Du QS, 2008, CURR PROTEIN PEPT SC, V9, P248, DOI 10.2174/138920308784534005
   Estrada E, 2002, J CHEM INF COMP SCI, V42, P1194, DOI 10.1021/ci0255331
   Fernandez M, 2006, BIOORGAN MED CHEM, V14, P4137, DOI 10.1016/j.bmc.2006.01.072
   Gao L, 2006, J PHARMACEUT BIOMED, V41, P246, DOI 10.1016/j.jpba.2005.09.031
   Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638
   Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771
   Gonzalez-Diaz H, 2007, J COMPUT CHEM, V28, P1049, DOI 10.1002/jcc.20576
   Han LY, 2005, NEW PHYTOL, V168, P109, DOI 10.1111/j.1469-8137.2005.01482.x
   Jain N, 2003, PLANT FOOD HUM NUTR, V58, P309, DOI 10.1023/B:QUAL.0000040285.50062.4b
   Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X
   KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010
   Li RG, 2004, FUNGAL GENET BIOL, V41, P735, DOI 10.1016/j.fgb.2004.03.001
   Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004
   Marrero Ponce Yovani, 2005, Bioorg Med Chem, V13, P3397, DOI 10.1016/j.bmc.2005.03.010
   MEHTA A, 1993, MYCOPATHOLOGIA, V124, P185, DOI 10.1007/BF01103736
   Prado-Prado FJ, 2008, BIOORGAN MED CHEM, V16, P5871, DOI 10.1016/j.bmc.2008.04.068
   Qi XQ, 2007, J THEOR BIOL, V249, P681, DOI 10.1016/j.jtbi.2007.08.025
   Randic M, 2006, J PROTEOME RES, V5, P1575, DOI 10.1021/pr050463+
   RIOU C, 1991, APPL ENVIRON MICROB, V57, P1478, DOI 10.1128/AEM.57.5.1478-1484.1991
   Roper MC, 2007, MOL PLANT MICROBE IN, V20, P411, DOI 10.1094/MPMI-20-4-0411
   Shen HB, 2008, ANAL BIOCHEM, V375, P388, DOI 10.1016/j.ab.2008.01.012
   Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098
   Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140
   Wolfram Stephen, 2002, NEW KIND SCI
   Xiao X, 2006, BIOCHEM BIOPH RES CO, V342, P605, DOI 10.1016/j.bbrc.2006.01.166
   Xiao X, 2005, AMINO ACIDS, V28, P29, DOI 10.1007/s00726-004-0154-9
   Xiao X, 2005, J THEOR BIOL, V235, P555, DOI 10.1016/j.jtbi.2005.02.008
   Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293
   Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163
   ZHANG CT, 1994, J MOL BIOL, V238, P1, DOI 10.1006/jmbi.1994.1263
   Zheng HQ, 2007, MED CHEM, V3, P488, DOI 10.2174/157340607781745492
NR 65
TC 59
Z9 59
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD APR
PY 2009
VL 8
IS 4
SI SI
BP 2122
EP 2128
DI 10.1021/pr800867y
PG 7
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 429NU
UT WOS:000264928200049
PM 19296677
DA 2020-05-07
ER

PT J
AU Batuwanthudawe, R
   Karunarathne, K
   Dassanayake, M
   de Silva, S
   Lalitha, MK
   Thomas, K
   Steinhoff, M
   Abeysinghe, N
AF Batuwanthudawe, R.
   Karunarathne, K.
   Dassanayake, M.
   de Silva, S.
   Lalitha, M. K.
   Thomas, K.
   Steinhoff, M.
   Abeysinghe, N.
TI Surveillance of Invasive Pneumococcal Disease in Colombo, Sri Lanka
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID CONJUGATE VACCINE; CHILDREN
AB The South Asian Pneumococcal Surveillance network uses standard recruitment and laboratory procedures for surveillance of invasive pneumococcal disease in India, Nepal, and Sri Lanka. Children aged 2 months to 5 years who were admitted to the sentinel surveillance site, Lady Ridgeway Hospital for Children, in Colombo, Sri Lanka, and who presented with signs and symptoms of meningitis, pneumonia, or very severe disease were studied. Blood culture and CSF culture specimens were analyzed at the microbiology laboratory at Lady Ridgeway Hospital for Children. Specimens were processed by routine conventional methods. Antigen testing was performed on CSF specimens with use of commercially available latex agglutination test kits. From January 2005 to March 2007, we observed 23 isolates of Streptococcus pneumoniae, and the most common serotypes were 19F, 14, 23F, and 6B. Of the serotypes found, 60% are covered by the currently available 7-valent conjugate pneumococcal vaccine. More than 90% of the isolates were penicillin resistant, and the rate of resistance to third-generation cephalosporins was also high.
C1 [Batuwanthudawe, R.; Abeysinghe, N.] Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka.
   [Karunarathne, K.; Dassanayake, M.; de Silva, S.] Lady Ridgeway Hosp Children, Colombo, Sri Lanka.
   [Lalitha, M. K.; Thomas, K.] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India.
   [Steinhoff, M.] Johns Hopkins Univ, Baltimore, MD USA.
RP Batuwanthudawe, R (reprint author), Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka.
EM ranjithbatu@yahoo.com
FU GAVI Alliance's PneumoADIP of Johns Hopkins Bloomberg School of Public
   Health, Baltimore, Maryland
FX Supplement sponsorship. This article was published as part of a
   supplement entitled "Coordinated Surveillance and Detection of
   Pneumococcal and Hib Disease in Developing Countries," sponsored by the
   GAVI Alliance's PneumoADIP of Johns Hopkins Bloomberg School of Public
   Health, Baltimore, Maryland.
CR [Anonymous], 2003, Wkly Epidemiol Rec, V78, P97
   BATUWANTHUDAWE R, 2006, 5 INT S PNEUM PNEUM, P144
   Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x
   *LAD RIDG HOSP CHI, 2006, ANN HLTH B
   *POP DIV MIN HLTH, EST MID YEAR POP
   THOMAS K, 2006, 5 INT S PNEUM PHEUM, P64
   Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2
   *WHO, 2007, WKLY EPIDEMIOL REC, V82, P93
   2007, WKLY EPIDEMIOL REP, V34, P1
NR 13
TC 27
Z9 31
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2009
VL 48
SU 2
BP S136
EP S140
DI 10.1086/596492
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 403DF
UT WOS:000263061800014
PM 19191609
OA Bronze
DA 2020-05-07
ER

PT J
AU Gianoulis, TA
   Raes, J
   Patel, PV
   Bjornson, R
   Korbel, JO
   Letunic, I
   Yamada, T
   Paccanaro, A
   Jensen, LJ
   Snyder, M
   Bork, P
   Gerstein, MB
AF Gianoulis, Tara A.
   Raes, Jeroen
   Patel, Prianka V.
   Bjornson, Robert
   Korbel, Jan O.
   Letunic, Ivica
   Yamada, Takuji
   Paccanaro, Alberto
   Jensen, Lars J.
   Snyder, Michael
   Bork, Peer
   Gerstein, Mark B.
TI Quantifying environmental adaptation of metabolic pathways in
   metagenomics
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE environmental genomics; network dynamics; microbiology; canonical
   correlation analysis
ID MICROBIAL COMMUNITIES; GENOME; OCEAN; PREDICTION; DYNAMICS; ATLANTIC;
   SEA
AB Recently, approaches have been developed to sample the genetic content of heterogeneous environments (metagenomics). However, by what means these sequences link distinct environmental conditions with specific biological processes is not well understood. Thus, a major challenge is how the usage of particular pathways and subnetworks reflects the adaptation of microbial communities across environments and habitats-i.e., how network dynamics relates to environmental features. Previous research has treated environments as discrete, somewhat simplified classes (e. g., terrestrial vs. marine), and searched for obvious metabolic differences among them (i.e., treating the analysis as a typical classification problem). However, environmental differences result from combinations of many factors, which often vary only slightly. Therefore, we introduce an approach that employs correlation and regression to relate multiple, continuously varying factors defining an environment to the extent of particular microbial pathways present in a geographic site. Moreover, rather than looking only at individual correlations (one-to-one), we adapted canonical correlation analysis and related techniques to define an ensemble of weighted pathways that maximally covaries with a combination of environmental variables (many-to-many), which we term a metabolic footprint. Applied to available aquatic datasets, we identified footprints predictive of their environment that can potentially be used as biosensors. For example, we show a strong multivariate correlation between the energy-conversion strategies of a community and multiple environmental gradients (e. g., temperature). Moreover, we identified covariation in amino acid transport and cofactor synthesis, suggesting that limiting amounts of cofactor can (partially) explain increased import of amino acids in nutrient-limited conditions.
C1 [Raes, Jeroen; Korbel, Jan O.; Letunic, Ivica; Yamada, Takuji; Jensen, Lars J.; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany.
   [Gianoulis, Tara A.; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.
   [Patel, Prianka V.; Korbel, Jan O.; Snyder, Michael; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
   [Bjornson, Robert; Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA.
   [Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.
   [Paccanaro, Alberto] Univ London, Egham TW20 0EX, Surrey, England.
   [Jensen, Lars J.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Protein Res, DK-2200 Copenhagen, Denmark.
   [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.
RP Bork, P (reprint author), European Mol Biol Lab, D-69117 Heidelberg, Germany.
EM peer.bork@embl.de; mark.gerstein@yale.edu
RI Letunic, Ivica/K-1102-2019; raes, jeroen/D-7835-2018; Letunic,
   Ivica/A-6032-2009; Bork, Peer/F-1813-2013; Korbel, Jan O/G-6470-2012
OI Letunic, Ivica/0000-0003-3560-4288; raes, jeroen/0000-0002-1337-041X;
   Bork, Peer/0000-0002-2627-833X; Korbel, Jan O/0000-0002-2798-3794;
   Jensen, Lars Juhl/0000-0001-7885-715X
FU Yale University Biomedical High Performance Computing Center; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RR19895]; Marie Curie
   fellowshipEuropean Union (EU); European Union FP7 ProgramEuropean Union
   (EU) [HEALTH-F4-2007-201052]; Biotechnology and Biological Sciences
   Research CouncilBiotechnology and Biological Sciences Research Council
   (BBSRC) [BB/F00964X/1]
FX We thank Andrea Sboner, Roger Alexander, Albert Colman, and Nick Ornston
   for many thoughtful discussions, and Minoru Kanehisa's team for early
   access to the KEGG module database. The instrumentation was supported by
   the Yale University Biomedical High Performance Computing Center and
   National Institutes of Health Grant RR19895. J.O.K. was supported by a
   Marie Curie fellowship and J.R. and P.B., by the European Union FP7
   Program Contract no. HEALTH-F4-2007-201052.
CR Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157
   Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584
   DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057
   Harrington ED, 2007, P NATL ACAD SCI USA, V104, P13913, DOI 10.1073/pnas.0702636104
   Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052
   Karl DM, 2002, TRENDS MICROBIOL, V10, P410, DOI 10.1016/S0966-842X(02)02430-7
   Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001
   Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782
   Mary I, 2008, FEMS MICROBIOL ECOL, V63, P36, DOI 10.1111/j.1574-6941.2007.00414.x
   MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0
   Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106
   Morgan-Kiss RM, 2006, MICROBIOL MOL BIOL R, V70, P222, DOI 10.1128/MMBR.70.1.222-252.2006
   Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943
   Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10
   Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162
   Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077
   Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74
   Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34
   Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420
   Watson AJ, 1998, PHILOS T R SOC B, V353, P41, DOI 10.1098/rstb.1998.0189
   WICHERN R, 2003, APPL MULTIVARIATE ST
NR 27
TC 121
Z9 124
U1 0
U2 54
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 3
PY 2009
VL 106
IS 5
BP 1374
EP 1379
DI 10.1073/pnas.0808022106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 403HV
UT WOS:000263074600018
PM 19164758
OA Green Published, Bronze
DA 2020-05-07
ER

PT S
AU Hernandez, AJ
   Gutierrez-Gines, MJ
   Pastor, J
AF Hernandez, A. J.
   Gutierrez-Gines, M. J.
   Pastor, J.
BE Brebbia, CA
TI Ecology and health in risk analysis of polluted soils
SO ENVIRONMENTAL HEALTH RISK V
SE WIT Transactions on Biomedicine and Health
LA English
DT Proceedings Paper
CT 5th International Conference on Impact of Environmental Factors on
   Health
CY 2009
CL Wessex Inst Technol, New Forest Campus, New Forest, ENGLAND
HO Wessex Inst Technol, New Forest Campus
DE ecotoxicology; heavy metals; abandoned mines; old landfills
ID COPPER
AB Risk analysis can be used as a scientific tool for addressing the health of ecosystems. Here we describe a protocol for characterizing risks in the ecosystems of several polluted soil scenarios in the Madrid Community (Central Spain). Our starting hypothesis was that to recover the health of degraded ecosystems that could affect public health, an ecotoxicological diagnosis of each site is required. The sites we considered were industrial and urban solid waste landfills and abandoned mines. This diagnosis revealed many interacting processes that need to be assessed if we are to realistically address the issue of restoring impacts on ecosystems affected by soil pollution. These processes are: 1) Geo-edaphic processes, requiring the analysis of geomorphologic factors; 2) Chemical-physical processes occurring in the soils, such as the release of anions or cations; 3) Erosion-pollution processes that require an understanding of the autoecology of plant species that could be used for remediation in scenarios with this dual problem; 4) Bioaccumulation-biodegradation processes, requiring the integration of microbiology and plant biology tools to assess any toxic effects on soil and plant subsystem populations; 5) Edaphic-bioavailability processes, since different ecotypes show a varying response to a given soil; 6) Population-ecopathology development processes, essential for both cultivated and native plant species comprising trophic networks; 7) Secondary-primary ecological succession processes, a commonly observed mechanism in old landfills sealed with soils from the surroundings-ecological knowledge of reference communities is essential for a good ecotoxicological diagnosis.; 8) Climate change-global warming processes, of utmost importance for revegetating polluted soils since success will depend both on the soil seed bank and on stochastic processes.
C1 [Hernandez, A. J.; Gutierrez-Gines, M. J.] Univ Alcala de Henares, Dept Ecol, Alcala De Henares 99775, Spain.
   [Gutierrez-Gines, M. J.; Pastor, J.] CCMA, CSIC, IRN, Dept Syst Ecol, Alcala De Henares, Spain.
RP Hernandez, AJ (reprint author), Univ Alcala de Henares, Dept Ecol, Alcala De Henares 99775, Spain.
OI Gutierrez-Gines, Maria Jesus/0000-0003-0026-2089
FU Spanish Ministry of Science and InnovationSpanish Government
   [CTM2008-04827/TECNO]; Community of MadridComunidad de Madrid
FX This study was funded by Project CTM2008-04827/TECNO of the Spanish
   Ministry of Science and Innovation and the EIADES Program of the
   Community of Madrid.
CR Cuypers A, 2005, J PLANT PHYSIOL, V162, P383, DOI 10.1016/j.jplph.2004.07.018
   Edwards CA, 2002, EUR J SOIL BIOL, V38, P225, DOI 10.1016/S1164-5563(02)01150-0
   *FAO, 2006, WORLD REF BAS SOIL R
   FRIIS RH, 2007, ESSENTIALSD ENV HLTH
   Hapke H. J., 1991, METALS THEIR COMPOUN, P469
   HAPKE HJ, 1976, FERTILIZERS ENV, P431
   Hernandez AJ, 2008, ENVIRON GEOCHEM HLTH, V30, P127, DOI 10.1007/s10653-008-9150-4
   Hernandez A. J., 2008, SOIL CONTAMINATION R, P51
   HERNANDEZ AJ, 2006, NUTR MINERAL ASPECTO, P573
   Hernandez AJ, 2007, SCI TOTAL ENVIRON, V378, P36, DOI 10.1016/j.scitotenv.2007.01.029
   LAKANEN E., 1971, Acta Agralia Fennica, V123, P223
   LIPHADZI MS, 2006, PLANT ENV INTERACTIO, P243
   Miyazawa M, 2002, WATER AIR SOIL POLL, V138, P211, DOI 10.1023/A:1015555116292
NR 13
TC 1
Z9 1
U1 0
U2 10
PU WIT PRESS/COMPUTATIONAL MECHANICS PUBLICATIONS
PI SOUTHAMPTON
PA ASHURST LODGE, ASHURST, SOUTHAMPTON SO40 7AA, ENGLAND
SN 1743-3525
BN 978-1-84564-201-3
J9 WIT TR BIOMED HEALTH
JI WIT Tr. Biomed. Health
PY 2009
VL 14
BP 257
EP +
DI 10.2495/EHR090251
PG 3
WC Engineering, Biomedical; Engineering, Environmental; Public,
   Environmental & Occupational Health
SC Engineering; Public, Environmental & Occupational Health
GA BMO36
UT WOS:000273030300025
OA Bronze
DA 2020-05-07
ER

PT J
AU Keymer, JE
   Galajda, P
   Lambert, G
   Liao, D
   Austin, RH
AF Keymer, Juan E.
   Galajda, Peter
   Lambert, Guillaume
   Liao, David
   Austin, Robert H.
TI Computation of mutual fitness by competing bacteria
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biophysics; competition; ecology; microbiology
ID STATIONARY-PHASE CULTURES; ESCHERICHIA-COLI; RNA-POLYMERASE; EVOLUTION;
   NETWORKS; EMERGENT
AB Competing populations in shared spaces with nonrenewable resources do not necessarily wage a battle for dominance at the cost of extinction of the less-fit strain if there are fitness advantages to the presence of the other strain. We report on the use of nano-fabricated habitat landscapes to study the population dynamics of competing wild type and a growth advantage in stationary phase (GASP) mutant strains of Escherichia coli in a sealed and heterogeneous nutrient environment. Although GASP mutants are competitors with wild-type bacteria, we find that the 2 strains cooperate to maximize fitness (long-term total productivity) via spatial segregation: despite their very close genomic kinship, wild-type populations associate with wild-type populations and GASP populations with GASP populations. Thus, wild-type and GASP strains avoid each other locally, yet fitness is enhanced for both strains globally. This computation of fitness enhancement emerges from the local interaction among cells but maximizes global densities. At present we do not understand how fluctuations in both spatial and temporal dimensions lead to the emergent computation and how multilevel aggregates produce this collective adaptation.
C1 [Keymer, Juan E.] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands.
   [Galajda, Peter] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA.
   [Lambert, Guillaume; Liao, David; Austin, Robert H.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.
   [Austin, Robert H.] Hong Kong Univ Sci & Technol, Inst Adv Study, Hong Kong, Hong Kong, Peoples R China.
RP Keymer, JE (reprint author), Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands.
EM j.e.keymervergara@tudelft.nl; austin@princeton.com
OI Lambert, Guillaume/0000-0003-4779-287X
FU Delft University of Technology Start-up funds; Air Force Office of
   Scientific ResearchUnited States Department of DefenseAir Force Office
   of Scientific Research (AFOSR) [FA9550-05-01-0365]; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HG01506]; National Science Foundation
   Nanobiology Technology CenterNational Science Foundation (NSF)
   [BSCECS9876771]; Cornell NanoScale Science and Technology Facility
   [ECS-9731293]; Department of Defense NDSEG fellowship programUnited
   States Department of Defense; Natural Sciences and Engineering Research
   Council of CanadaNatural Sciences and Engineering Research Council of
   Canada; Defense Advanced Research Planning AgencyUnited States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA)
FX We thank Simon Levin, Roberto Kolter, Stuart West, Ted Cox, Miguel
   Gaspar, Ned Wingreen, Pascal Silberzan, Tom Silhavy, Cees Dekker, Saeed
   Tavazoie, and Michael Desai for valuable discussions and Steve Finkel,
   Juliana Malinverni, Mark Mandel, and Peter Wolanin for assistance with
   the E. coli fluorescent constructs. This work was supported by Delft
   University of Technology Start-up funds, Air Force Office of Scientific
   Research Grant FA9550-05-01-0365, National Institutes of Health Grant
   HG01506, National Science Foundation Nanobiology Technology Center Grant
   BSCECS9876771, Cornell NanoScale Science and Technology Facility (
   National Science Foundation Grant ECS-9731293), the Department of
   Defense NDSEG fellowship program, the Natural Sciences and Engineering
   Research Council of Canada, and the Defense Advanced Research Planning
   Agency.
CR Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3
   BERG HC, 1988, COLD SPRING HARB SYM, V53, P1, DOI 10.1101/SQB.1988.053.01.003
   CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742
   DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032
   Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292
   Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023
   Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01_11833a
   GATES W, 1996, ROAD AHEAD
   HARDIN G, 1968, SCIENCE, V162, P1248
   Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341
   Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499
   Karpinets TV, 2006, CURR GENOMICS, V7, P481, DOI 10.2174/138920206779315764
   Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103
   Mott KA, 2007, ANN BOT-LONDON, V99, P219, DOI 10.1093/aob/mcl234
   O'Donnell AG, 2007, NAT REV MICROBIOL, V5, P689, DOI 10.1038/nrmicro1714
   Peak D, 2004, P NATL ACAD SCI USA, V101, P918, DOI 10.1073/pnas.0307811100
   TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511
   TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0
   Vulic M, 2001, GENETICS, V158, P519
   Wakabayashi Kenichi, 2005, Natural Computing, V4, P275, DOI 10.1007/s11047-004-5236-9
   West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461
   ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219
   Zinser ER, 1999, J BACTERIOL, V181, P5800, DOI 10.1128/JB.181.18.5800-5807.1999
NR 25
TC 44
Z9 44
U1 0
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 23
PY 2008
VL 105
IS 51
BP 20269
EP 20273
DI 10.1073/pnas.0810792105
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 388BP
UT WOS:000261995600047
PM 19074280
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Bosch, A
   Minan, A
   Vescina, C
   Degrossi, J
   Gatti, B
   Montanaro, P
   Messina, M
   Franco, M
   Vay, C
   Schmitt, J
   Naumann, D
   Yantorno, O
AF Bosch, Alejandra
   Minan, Alejandro
   Vescina, Cecilia
   Degrossi, Jose
   Gatti, Blanca
   Montanaro, Patricia
   Messina, Matias
   Franco, Mirta
   Vay, Carlos
   Schmitt, Juergen
   Naumann, Dieter
   Yantorno, Osvaldo
TI Fourier transform infrared spectroscopy for rapid identification of
   nonfermenting gram-negative bacteria isolated from sputum samples from
   cystic fibrosis patients
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID BURKHOLDERIA-CEPACIA COMPLEX; MOLECULAR ANALYSIS; MICROBIAL ECOLOGY;
   SP-NOV; CLASSIFICATION; PCR; MULTIVORANS; GENOMOVARS; DIVERSITY; STRAINS
AB The accurate and rapid identification of bacteria isolated from the respiratory tract of patients with cystic fibrosis (CF) is critical in epidemiological studies, during intrahospital outbreaks, for patient treatment, and for determination of therapeutic options. While the most common organisms isolated from sputum samples are Pseudomonas aeruginosa, Staphylococcus aureus, and Haemophilus influenzae, in recent decades an increasing fraction of CF patients has been colonized by other nonfermenting (NF) gram-negative rods, such as Burkholderia cepacia complex (BCC) bacteria, Stenotrophomonas maltophilia, Ralstonia pickettii, Acinetobacter spp., and Achromobacter spp. In the present study, we developed a novel strategy for the rapid identification of NF rods based on Fourier transform infrared spectroscopy (FTIR) in combination with artificial neural networks (ANNs). A total of 15 reference strains and 169 clinical isolates of NF gram-negative bacteria recovered from sputum samples from 150 CF patients were used in this study. The clinical isolates were identified according to the guidelines for clinical microbiology practices for respiratory tract specimens from CF patients; and particularly, BCC bacteria were further identified by recA-based PCR followed by restriction fragment length polymorphism analysis with HaeIII, and their identities were confirmed by recA species-specific PCR. In addition, some strains belonging to genera different from BCC were identified by 16S rRNA gene sequencing. A standardized experimental protocol was established, and an FTIR spectral database containing more than 2,000 infrared spectra was created. The ANN identification system consisted of two hierarchical levels. The top-level network allowed the identification of P. aeruginosa, S. maltophilia, Achromobacter xylosoxidans, Acinetobacter spp., R. pickettii, and BCC bacteria with an identification success rate of 98.1%. The second-level network was developed to differentiate the four most clinically relevant species of BCC, B. cepacia, B. multivorans, B. cenocepacia, and B. stabilis (genomovars I to IV, respectively), with a correct identification rate of 93.8%. Our results demonstrate the high degree of reliability and strong potential of ANN-based FTIR spectrum analysis for the rapid identification of NF rods suitable for use in routine clinical microbiology laboratories.
C1 [Bosch, Alejandra; Minan, Alejandro; Yantorno, Osvaldo] Natl Univ La Plata, Fac Ciencias Exactas, CONICET, CINDEFI, RA-1900 La Plata, Argentina.
   [Degrossi, Jose; Messina, Matias; Franco, Mirta] Univ Buenos Aires, Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina.
   [Vescina, Cecilia; Gatti, Blanca] Hosp Ninos Sor Maria Ludovica, La Plata, Argentina.
   [Montanaro, Patricia] Hosp Santisima Trinidad, Serv Bacteriol, Cordoba, Argentina.
   [Vay, Carlos] Hosp Clin Buenos Aires, Serv Bacteriol, Buenos Aires, DF, Argentina.
   [Schmitt, Juergen] Synthon GmbH, D-69120 Heidelberg, Germany.
   [Naumann, Dieter] Robert Koch Inst, D-13353 Berlin, Germany.
RP Yantorno, O (reprint author), Natl Univ La Plata, Fac Ciencias Exactas, CONICET, CINDEFI, 50 Entre 115 & 116, RA-1900 La Plata, Argentina.
EM yantorno@quimica.unlp.edu.ar
FU Agencia Nacional de Promocion Cientifica y TecnologicaANPCyT [BID
   1728/OC-AR-PICT 34836]; Comision de Investigaciones Cientificas Gobierno
   de la Provincia de Buenos Aires (CIC-PBA); Buenos Aires
   UniversityUniversity of Buenos Aires [UBA-CYT B082]; CONICETConsejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
FX This work was supported by the Agencia Nacional de Promocion Cientifica
   y Tecnologica ( grant BID 1728/OC-AR-PICT 34836), the Comision de
   Investigaciones Cientificas Gobierno de la Provincia de Buenos Aires
   (CIC-PBA), and Buenos Aires University ( grant UBA-CYT B082). A. Bosch
   is member of the CIC PBA, and A. Minan received a fellowship from
   CONICET.; We are grateful to Laura Galanternik for kindly providing us
   the BCC reference strains. We thank Julio Figari for excellent technical
   assistance.
CR Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005
   Bosch A, 2006, INT J FOOD MICROBIOL, V111, P280, DOI 10.1016/j.ijfoodmicro.2006.05.010
   Bosshard PP, 2006, J CLIN MICROBIOL, V44, P1359, DOI 10.1128/JCM.44.4.1359-1366.2006
   Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998
   Brisse S, 2004, J CLIN MICROBIOL, V42, P4824, DOI 10.1128/JCM.42.10.4824-4827.2004
   Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200
   Coenye T, 2005, J CLIN MICROBIOL, V43, P3463, DOI 10.1128/JCM.43.7.3463-3466.2005
   Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x
   Coenye T, 1999, INT J SYST BACTERIOL, V49, P405, DOI 10.1099/00207713-49-2-405
   Coenye T, 2000, INT J SYST EVOL MICR, V50, P887, DOI 10.1099/00207713-50-2-887
   Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001
   Cunha MV, 2007, J CLIN MICROBIOL, V45, P1628, DOI 10.1128/JCM.00234-07
   Cunha MV, 2003, J CLIN MICROBIOL, V41, P4113, DOI 10.1128/JCM.41.9.4113-4120.2003
   Dalmastri C, 2007, ENVIRON MICROBIOL, V9, P1632, DOI 10.1111/j.1462-2920.2007.01273.x
   de Oliveira-Garcia D, 2002, EMERG INFECT DIS, V8, P918, DOI 10.3201/eid0809.010535
   Detsika MG, 2003, J CLIN MICROBIOL, V41, P4148, DOI 10.1128/JCM.41.9.4148-4153.2003
   Ferroni A, 2002, J CLIN MICROBIOL, V40, P3793, DOI 10.1128/JCM.40.10.3793-3797.2002
   Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001
   Ghol O., 2006, APPL ENVIRON MICROB, V72, P1394
   GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991
   GOLDSTEIN R, 1995, J BACTERIOL, V177, P1039, DOI 10.1128/jb.177.4.1039-1052.1995
   Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0
   Heath DG, 2002, J CLIN MICROBIOL, V40, P1188, DOI 10.1128/JCM.40.4.1188-1193.2002
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   HELM D, 1995, FEMS MICROBIOL LETT, V126, P75, DOI 10.1111/j.1574-6968.1995.tb07393.x
   Henry DA, 2001, J CLIN MICROBIOL, V39, P1073, DOI 10.1128/JCM.39.3.1073-1078.2001
   ISENBERG HD, 2004, CLIN MICROBIOLOGY PR
   Kessler B, 2000, INT J SYST EVOL MICR, V50, P711, DOI 10.1099/00207713-50-2-711
   Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001
   KISKA DL, 2003, MANUAL CLIN MICROBIO, P719
   LIMA TCS, 1999, REV MICROBIOL, V30, P214
   LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153
   Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P3165, DOI 10.1128/JCM.38.9.3165-3173.2000
   Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085
   Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003
   Maquelin K, 2002, HDB VIBRATIONAL SPEC, P1
   Miller MB, 2003, J CLIN MICROBIOL, V41, P4009, DOI 10.1128/JCM.41.9.4009-4015.2003
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   Naumann D, 2001, PRACT SPECTROSC SERI, V24, P323
   Naumann D., 2000, ENCY ANAL CHEM, P102, DOI DOI 10.1002/9780470027318.A0117
   *NCCLS, 1999, M31A NCCLS
   NICHOLS PD, 1985, J MICROBIOL METH, V4, P79, DOI 10.1016/0167-7012(85)90023-5
   PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0
   Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005
   Prieto CI, 2003, VET MICROBIOL, V91, P157, DOI 10.1016/S0378-1135(02)00297-3
   Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006
   Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004
   Saiman L, 2001, J CLIN MICROBIOL, V39, P3942, DOI 10.1128/JCM.39.11.3942-3945.2001
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schmitt J, 2001, PRACT SPECTROSC SERI, V24, P379
   Schreckenberger PC, 2003, MANUAL CLIN MICROBIO, V8, P749
   Seo ST, 2005, FEMS MICROBIOL LETT, V245, P19, DOI 10.1016/j.femsle.2005.02.020
   Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9
   Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103
   Speert DP, 2002, EMERG INFECT DIS, V8, P181
   Udelhoven T, 2000, APPL SPECTROSC, V54, P1471, DOI 10.1366/0003702001948619
   Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3
   Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188
   Vermis K, 2002, J MED MICROBIOL, V51, P937, DOI 10.1099/0022-1317-51-11-937
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   Zhou JY, 2006, J CLIN MICROBIOL, V44, P1547, DOI 10.1128/JCM.44.4.1547-1549.2006
NR 61
TC 67
Z9 69
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD AUG
PY 2008
VL 46
IS 8
BP 2535
EP 2546
DI 10.1128/JCM.02267-07
PG 12
WC Microbiology
SC Microbiology
GA 344EI
UT WOS:000258908700008
PM 18550747
OA Green Published, Other Gold
DA 2020-05-07
ER

PT J
AU Panagou, EZ
AF Panagou, Efstathios Z.
TI A radial basis function neural network approach to determine the
   survival of Listeria monocytogenes in Katiki, a traditional Greek soft
   cheese
SO JOURNAL OF FOOD PROTECTION
LA English
DT Article
ID ESCHERICHIA-COLI O157-H7; RESPONSE-SURFACE MODEL; BACTERIAL-GROWTH;
   MICROBIAL-GROWTH; SODIUM-CHLORIDE; LEUCONOSTOC-MESENTEROIDES; PREDICTIVE
   MODELS; RISK-ASSESSMENT; FOOD; PH
AB A radial basis function neural network was developed to determine the kinetic behavior of Listeria monocytogenes in Katiki, a traditional white acid-curd soft spreadable cheese. The applicability of the neural network approach was compared with the reparameterized Gompertz, the modified Weibull, and the Geeraerd primary models. Model performance was assessed with the root mean square error of the residuals of the model (RMSE), the regression coefficient (R-2), and the F test. Commercially prepared cheese samples were artificially inoculated with a five-strain cocktail of L. monocytogenes, with an initial concentration of 10(6) CFU g(-1) and stored at 5, 10, 15, and 20 degrees C for 40 days. At each storage temperature, a pathogen viability loss profile was evident and included a shoulder, a log-linear phase, and a tailing phase. The developed neural network described the survival of L. monocytogenes equally well or slightly better than did the three primary models. The performance indices for the training subset of the network were R-2 = 0.993 and RMSE = 0.214. The relevant mean values for all storage temperatures were R-2 = 0.981, 0.986, and 0.985 and RMSE = 0.344, 0.256, and 0.262 for the reparameterized Gompertz, modified Weibull, and Geeraerd models, respectively. The results of the F test indicated that none of the primary models were able to describe accurately the survival of the pathogen at 5 degrees C, whereas with the neural network all f values were significant. The neural network and primary models all were validated under constant temperature storage conditions (12 and 17 degrees C). First or second order polynomial models were used to relate the inactivation parameters to temperature, whereas the neural network was used a one-step modeling approach. Comparison of the prediction capability was based on bias and accuracy factors and on the goodness-of-fit index. The prediction performance of the neural network approach was equal to that of the primary models at both validation temperatures. The results of this work could increase the knowledge basis for the applicability of neural networks as an alternative tool in predictive microbiology.
C1 Agr Univ Athens, Dept Food Sci & Technol, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece.
RP Panagou, EZ (reprint author), Agr Univ Athens, Dept Food Sci & Technol, Lab Microbiol & Biotechnol Foods, Iera Odos 75, GR-11855 Athens, Greece.
EM stathispanagou@aua.gr
RI Panagou, Efstathios/I-6537-2019
OI Panagou, Efstathios/0000-0002-0317-1177
CR Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832
   Afaghi M, 2001, FOOD RES INT, V34, P55, DOI 10.1016/S0963-9969(00)00132-0
   Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016
   Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   BHADURI S, 1995, J APPL BACTERIOL, V79, P163, DOI 10.1111/j.1365-2672.1995.tb00930.x
   Booth IR, 2002, INT J FOOD MICROBIOL, V78, P19, DOI 10.1016/S0168-1605(02)00239-8
   Brown Martin, 1994, NEUROFUZZY ADAPTIVE
   BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0
   BUCHANAN RL, 1990, J FOOD PROTECT, V53, P370, DOI 10.4315/0362-028X-53.5.370
   CARDOSOFURTADO NAJ, 2005, MICROBIOL RES, V160, P141
   Cataldo G, 2007, J APPL MICROBIOL, V103, P185, DOI 10.1111/j.1365-2672.2006.03218.x
   Cheroutre-Vialette M, 2002, INT J FOOD MICROBIOL, V73, P107, DOI 10.1016/S0168-1605(01)00642-0
   Cheroutre-Vialette M, 2000, INT J FOOD MICROBIOL, V55, P201, DOI 10.1016/S0168-1605(00)00164-1
   den Besten HMW, 2006, APPL ENVIRON MICROB, V72, P5884, DOI 10.1128/AEM.00780-06
   Esnoz A, 2006, INT J FOOD MICROBIOL, V106, P153, DOI 10.1016/j.ijfoodmicro.2005.06.016
   FARBER JM, 1992, LETT APPL MICROBIOL, V15, P103, DOI 10.1111/j.1472-765X.1992.tb00737.x
   FARBER JM, 1989, LETT APPL MICROBIOL, V9, P181, DOI 10.1111/j.1472-765X.1989.tb00319.x
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7
   Gianfranceschi M, 2003, EUR J EPIDEMIOL, V18, P1001, DOI 10.1023/A:1025849532417
   GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027
   Gueguim-Kana EB, 2007, J IND MICROBIOL BIOT, V34, P491, DOI 10.1007/s10295-007-0220-x
   Guyer D, 2000, COMPUT ELECTRON AGR, V29, P179, DOI 10.1016/S0168-1699(00)00146-0
   Hajmeer M, 2006, FOOD MICROBIOL, V23, P561, DOI 10.1016/j.fm.2005.09.011
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAM FM, 2001, PRINCIPLES NEUROCOMP
   HAYKIN S., 1999, NEURAL NETWORKS COMP
   Hervas C, 2001, FOOD SCI TECHNOL INT, V7, P159, DOI 10.1106/6Q2A-8D7R-JHJU-T7F6
   HICKS SJ, 1991, J APPL BACTERIOL, V70, P308, DOI 10.1111/j.1365-2672.1991.tb02941.x
   Huang YQ, 2007, CRIT REV FOOD SCI, V47, P113, DOI 10.1080/10408390600626453
   HUDSON JA, 1994, J FOOD PROTECT, V57, P204, DOI 10.4315/0362-028X-57.3.204
   JARVIS B, 1989, STAT ASPECTS MICROBI
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   JUNTTILA JR, 1988, J APPL BACTERIOL, V65, P321, DOI 10.1111/j.1365-2672.1988.tb01898.x
   Karayiannis NB, 1999, IEEE T NEURAL NETWOR, V10, P657, DOI 10.1109/72.761725
   Krishnamurthy R, 2007, FOOD QUAL PREFER, V18, P275, DOI 10.1016/j.foodqual.2006.01.001
   Little CL, 2007, FOOD MICROBIOL, V24, P711, DOI 10.1016/j.fm.2007.03.009
   Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   Lunden J., 2004, J DAIRY SCI, V87, pE6, DOI DOI 10.3168/JDS.S0022-0302(04)70056-9
   Manfreda G, 2005, INT J FOOD MICROBIOL, V102, P287, DOI 10.1016/j.ijfoodmicro.2004.11.045
   Margolles A, 1997, J FOOD PROTECT, V60, P689, DOI 10.4315/0362-028X-60.6.689
   Mataragas M, 2006, J FOOD SCI, V71, pM157, DOI 10.1111/j.1750-3841.2006.00058.x
   MCCLURE PJ, 1989, LETT APPL MICROBIOL, V9, P95, DOI 10.1111/j.1472-765X.1989.tb00299.x
   McClure PJ, 1997, INT J FOOD MICROBIOL, V34, P221, DOI 10.1016/S0168-1605(96)01193-2
   McLauchlin J, 2004, INT J FOOD MICROBIOL, V92, P15, DOI 10.1016/S0168-1605(03)00326-X
   Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281
   Morgan F, 2001, INT J FOOD MICROBIOL, V64, P217, DOI 10.1016/S0168-1605(00)00452-9
   Ni HX, 1998, FOOD TECHNOL-CHICAGO, V52, P60
   NOLAN DA, 1992, INT J FOOD MICROBIOL, V16, P323, DOI 10.1016/0168-1605(92)90034-Z
   Panagou EZ, 2007, INT J FOOD MICROBIOL, V117, P276, DOI 10.1016/j.ijfoodmicro.2007.03.010
   PAPAGEORGIOU DK, 1998, B HELLENIC VET MED S, V49, P48
   Pinto B, 1996, ZBL HYG UMWELTMED, V199, P60
   Pitt WM, 1999, AUST J DAIRY TECHNOL, V54, P49
   Ramsaran H, 1998, J DAIRY SCI, V81, P1810, DOI 10.3168/jds.S0022-0302(98)75750-9
   Rocourt J, 2003, FEMS IMMUNOL MED MIC, V35, P263, DOI 10.1016/S0928-8244(02)00468-6
   Rogga KJ, 2005, INT DAIRY J, V15, P59, DOI 10.1016/j.idairyj.2004.05.002
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   ROSS T, 1999, PREDICTIVE MICROBIOL
   Ryser E. T., 1999, Listeria, listeriosis and food safety., P411
   RYSER ET, 1987, J FOOD PROTECT, V48, P747
   Siripatrawan U, 2004, J FOOD PROTECT, V67, P1604, DOI 10.4315/0362-028X-67.8.1604
   STECCHINI ML, 1995, INT J FOOD MICROBIOL, V25, P301, DOI 10.1016/0168-1605(94)00093-L
   te Giffel MC, 1999, INT J FOOD MICROBIOL, V46, P135, DOI 10.1016/S0168-1605(98)00189-5
   Torrecilla JS, 2007, COMPUT ELECTRON AGR, V56, P101, DOI 10.1016/j.compag.2007.01.005
   Valero A, 2007, J FOOD SCI, V72, pM16, DOI 10.1111/j.1750-3841.2006.00208.x
   Wijtzes T, 2001, INT J FOOD MICROBIOL, V63, P57, DOI 10.1016/S0168-1605(00)00401-3
   Xanthiakos K, 2006, J APPL MICROBIOL, V100, P1289, DOI 10.1111/j.1365-2672.2006.02854.x
   Xiong R, 2002, FOOD CONTROL, V13, P525, DOI 10.1016/S0956-7135(02)00040-3
   Zerfiridis G., 2001, TECHNOLOGY MILK PROD
   Zurera-Cosano G, 2005, EUR FOOD RES TECHNOL, V221, P717, DOI 10.1007/s00217-005-0006-1
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 76
TC 9
Z9 9
U1 0
U2 2
PU INT ASSOC FOOD PROTECTION
PI DES MOINES
PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA
SN 0362-028X
EI 1944-9097
J9 J FOOD PROTECT
JI J. Food Prot.
PD APR
PY 2008
VL 71
IS 4
BP 750
EP 759
DI 10.4315/0362-028X-71.4.750
PG 10
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 283ZJ
UT WOS:000254674700011
PM 18468029
DA 2020-05-07
ER

PT J
AU Bingen, E
   Levy, C
   Varon, E
   de la Rocque, F
   Boucherat, M
   d'Athis, P
   Aujard, Y
   Cohen, R
AF Bingen, E.
   Levy, C.
   Varon, E.
   de la Rocque, F.
   Boucherat, M.
   d'Athis, P.
   Aujard, Y.
   Cohen, R.
CA Bacterial Meningitis Study Grp
TI Pneumococcal meningitis in the era of pneumococcal conjugate vaccine
   implementation
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
ID RESISTANT STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-MENINGITIS; UNITED-STATES;
   MULTICENTER SURVEILLANCE; PROGNOSTIC-FACTORS; CHILDREN; DISEASE;
   INFECTIONS; ADULTS; EPIDEMIOLOGY
AB The French Pediatric Infectious Diseases Group set up an active surveillance network to analyze the clinical and biological features of pneumococcal meningitis and the impact of the seven-valent pneumococcal conjugate vaccine (PCV7). From 2001 to 2005, 234 pediatric wards working with 166 microbiology laboratories enrolled all children with pneumococcal meningitis. Risk factors, signs and symptoms, vaccination status, cerebrospinal fluid analysis, treatments and case fatality rates were recorded. One hundred and sixty-nine centers (169/234) reported 616 cases, median age was 0.9 years and 67.2% of children were <= 2 years old. Underlying conditions were present in 13.1% of cases. The proportion of penicillin non-susceptible strains was 48.7%. Vancomycin plus a third-generation cephalosporin was prescribed in 92.7% of cases, and steroids were given before antibiotic treatment in 16.5% of cases. The case fatality rate was 10.8% overall and was not related to age, antibiotic susceptibility or steroid use. In children 2 to 24 months old compared to the prevaccinal period (2001-2002) a decrease of 28.4% of the number of cases was observed in 2005 (P<0.05). Among children 2 to 24 months old, the proportion of serotypes covered by the PCV7 fell from 39/57 (68.4%) in 2001-2002 to 19/45 (42.2%) in 2005, while the proportion of non-vaccine serotypes and related serotypes increased respectively from 9/57 (15.8%) and 9/57 (15.8%) in 2001-2002 to 14/45 (31.1%) and 12/45 (26.7%) in 2005. Among 52 cases of pneumococcal meningitis that have occurred in vaccinated children (>= 1 dose) with PCV7, 7 were due by vaccine serotypes. This study provides data on underlying conditions, penicillin susceptibility, serotype evolution according to vaccination status and risk factors for mortality for pneumococcal meningitis in children from 2001-2005 in France.
C1 [Bingen, E.] Hop Robert Debre, Microbiol Serv, F-75019 Paris, France.
   [Bingen, E.; Levy, C.; de la Rocque, F.; Aujard, Y.; Cohen, R.] Pediat Infect Dis Grp, French Pediat Soc, Paris, France.
   [Levy, C.; de la Rocque, F.; Boucherat, M.; Cohen, R.] ACTIV, Saint Maur Fosses, France.
   [Varon, E.] Hop Georges Pomidou, Natl Reference Ctr Streptococcus Pneumoniae, Paris, France.
   [d'Athis, P.] Ctr Hosp Univ Dijon, Dept Biostat, F-21004 Dijon, France.
RP Bingen, E (reprint author), Hop Robert Debre, Microbiol Serv, 48 Bvd Serurier, F-75019 Paris, France.
EM edouard.bingen@rdb.ap-hop-paris.fr
RI Van de Perre, Philippe/B-9692-2008
OI Van de Perre, Philippe/0000-0002-3912-0427
CR Angoulvant FO, 2005, CLIN INFECT DIS, V40, P494
   Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087
   Bingen E, 2005, CLIN INFECT DIS, V41, P1059, DOI 10.1086/432944
   Clarke SC, 2006, J MED MICROBIOL, V55, P975, DOI 10.1099/jmm.0.46579-0
   COHEN R, 2005, MED ENFANCE, V25, P299
   DAGAN R, 1994, J INFECT DIS, V169, P912, DOI 10.1093/infdis/169.4.912
   Dawson KG, 1999, PEDIATR INFECT DIS J, V18, P816, DOI 10.1097/00006454-199902000-00015
   Doit C, 1997, ANTIMICROB AGENTS CH, V41, P2050, DOI 10.1128/AAC.41.9.2050
   GEORGES S, 2005, BACTERIAL MENINGITIS
   Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38
   Haddy RI, 2005, PEDIATR INFECT DIS J, V24, P320, DOI 10.1097/01.inf.0000157090.40719.9b
   Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443
   Kaplan SL, 2002, PEDIATR INFECT DIS J, V21, P589, DOI 10.1097/00006454-200206000-00034
   Kaplan SL, 2002, PEDIATR INFECT DIS J, V21, P141, DOI 10.1097/00006454-200202000-00011
   Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113
   Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060
   Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642
   LEPOUTRE A, 2006, IMPACT PNEUMOCOCCAL
   MCCRACKEN GH, 1995, PEDIATR INFECT DIS J, V14, P424, DOI 10.1097/00006454-199505001-00004
   McIntyre PB, 2005, ARCH DIS CHILD, V90, P391, DOI 10.1136/adc.2003.037523
   McMillan DA, 2001, CLIN INFECT DIS, V33, P969, DOI 10.1086/322612
   Miller E, 2000, ACTA PAEDIATR, V89, P11, DOI 10.1080/080352500300051477
   *NAT COMM CLIN LAB, 2003, M10013 NAT COMM CLIN
   Neuman HB, 2001, CLIN PEDIATR, V40, P595, DOI 10.1177/000992280104001102
   Olivier C, 2000, PEDIATR INFECT DIS J, V19, P1015, DOI 10.1097/00006454-200010000-00018
   Pebody R G, 2006, Euro Surveill, V11, P171
   Pelton SI, 2005, ARCH DIS CHILD, V90, P333, DOI 10.1136/adc.2004.052928
   PERROCHEAU A, 2006, B EPIDEMIOL HEBD, V2, P16
   PICKERING L, 2003, AM ACAD PEDIAT, P293
   Reinert RR, 2004, INT J MED MICROBIOL, V294, P277, DOI 10.1016/j.ijmm.2004.04.004
   Scheifele D, 2000, CLIN INFECT DIS, V31, P58, DOI 10.1086/313923
   Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404
   TAUBER MG, 1992, AM J PATHOL, V141, P53
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845
   Weightman NC, 2005, EUR J CLIN MICROBIOL, V24, P542, DOI 10.1007/s10096-005-1365-z
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2
   2003, [No title captured], V6, P33
   2006, B EPIDEMIOL HEBD, V20, P212
NR 40
TC 47
Z9 48
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD MAR
PY 2008
VL 27
IS 3
BP 191
EP 199
DI 10.1007/s10096-007-0417-y
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 274IC
UT WOS:000253994000004
PM 18060439
DA 2020-05-07
ER

PT J
AU Palanichamy, A
   Jayas, DS
   Holley, RA
AF Palanichamy, A.
   Jayas, D. S.
   Holley, R. A.
TI Predicting survival of Escherichia coli O157 : H7 in dry fermented
   sausage using artificial neural networks
SO JOURNAL OF FOOD PROTECTION
LA English
DT Article
ID MICROBIAL-GROWTH; BACTERIAL-GROWTH; INACTIVATION; REGRESSION; MODELS;
   FOODS; MEAT
AB he Canadian Food Inspection Agency required the meat industry to ensure Escherichia coli O157:147 does not survive (experiences >= 5 log CFU/g reduction) in dry fermented sausage (salami) during processing after a series of foodborne illness outbreaks resulting from this pathogenic bacterium occurred. The industry is in need of an effective technique like predictive modeling for estimating bacterial viability, because traditional microbiological enumeration is a time-consuming and laborious method. The accuracy and speed of artificial neural networks (ANNs) for this purpose is an attractive alternative (developed from predictive microbiology), especially for on-line processing in industry. Data from a study of interactive effects of different levels of pH, water activity, and the concentrations of allyl isothiocyanate at various times during sausage manufacture in reducing numbers of E. coli O157:H7 were collected. Data were used to develop predictive models using a general regression neural network (GRNN), a form of ANN, and a statistical linear polynomial regression technique. Both models were compared for their predictive error, using various statistical indices. GRNN predictions for training and test data sets had less serious errors when compared with the statistical model predictions. GRNN models were better and slightly better for training and test sets, respectively, than was the statistical model. Also, GRNN accurately predicted the level of allyl isothiocyanate required, ensuring a 5-log reduction, when an appropriate production set was created by interpolation. Because they are simple to generate, fast, and accurate, ANN models may be of value for industrial use in dry fermented sausage manufacture to reduce the hazard associated with E. coli O157:H7 in fresh beef and permit production of consistently safe products from this raw material.
C1 [Palanichamy, A.; Jayas, D. S.] Univ Manitoba, Biosyst Engn Dept, Winnipeg, MB R3T 5V6, Canada.
   [Holley, R. A.] Univ Manitoba, Dept Food Sci, Winnipeg, MB R3T 2N2, Canada.
RP Jayas, DS (reprint author), Univ Manitoba, Biosyst Engn Dept, Winnipeg, MB R3T 5V6, Canada.
EM digvir_jayas@umanitoba.ca
RI Jayas, Digvir/P-6350-2019
OI /0000-0001-8675-8709
CR BRATCHELL N, 1989, INT J FOOD MICROBIOL, V8, P47, DOI 10.1016/0168-1605(89)90079-2
   BRATCHELL N, 1990, INT J FOOD MICROBIOL, V11, P279, DOI 10.1016/0168-1605(90)90021-V
   BUCHANAN RL, 1993, J IND MICROBIOL, V12, P251, DOI 10.1007/BF01584198
   Chacon PA, 2006, APPL ENVIRON MICROB, V72, P3096, DOI 10.1128/AEM.72.5.3096-3102.2006
   Cheroutre-Vialette M, 2000, INT J FOOD MICROBIOL, V55, P201, DOI 10.1016/S0168-1605(00)00164-1
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Geeraerd AH, 1998, J FOOD ENG, V36, P263, DOI 10.1016/S0260-8774(98)00064-8
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   *HLTH CAN, 2000, CANN COMMUN DIS 0701
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Leroy F, 2005, INT J FOOD MICROBIOL, V100, P141, DOI 10.1016/j.ijfoodmicro.2004.10.011
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   Lucke FK, 2000, MEAT SCI, V56, P105, DOI 10.1016/S0309-1740(00)00029-2
   MCCLURE PJ, 1994, INT J FOOD MICROBIOL, V23, P265, DOI 10.1016/0168-1605(94)90156-2
   MCMEEKIN TA, 1993, PREDICTIVE MICROBIOL
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   *NERUOSHELL, 1993, ONL TUT NEUROSHELL 2
   Pidcock K, 2002, INT J FOOD MICROBIOL, V76, P75, DOI 10.1016/S0168-1605(02)00002-8
   Pond TJ, 2001, J FOOD PROTECT, V64, P759, DOI 10.4315/0362-028X-64.6.759
   Ratkowsky D.A., 1990, HDB NONLINEAR REGRES
   RATKOWSKY DA, 1991, J APPL BACTERIOL, V71, P452, DOI 10.1111/j.1365-2672.1991.tb03816.x
   Reed C., 1995, COMMUNICATION
   ROSS T, 2004, MODELING MICROBIAL R, P321
   SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934
   Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9
   Tyopponen S, 2003, INT J FOOD MICROBIOL, V83, P233, DOI 10.1016/S0168-1605(02)00379-3
   1995, [No title captured], V44, P157
NR 28
TC 17
Z9 17
U1 1
U2 11
PU INT ASSOC FOOD PROTECTION
PI DES MOINES
PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA
SN 0362-028X
EI 1944-9097
J9 J FOOD PROTECT
JI J. Food Prot.
PD JAN
PY 2008
VL 71
IS 1
BP 6
EP 12
DI 10.4315/0362-028X-71.1.6
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 248OH
UT WOS:000252162900001
PM 18236656
DA 2020-05-07
ER

PT J
AU Dong, QL
   Tu, K
   Guo, LY
   Hongwen, LW
   Zhao, Y
AF Dong, Qingli
   Tu, Kang
   Guo, Liyang
   Li, Hongwen
   Zhao, Yan
TI Response surface model for prediction of growth parameters from spores
   of Clostridium sporogenes under different experimental conditions
SO FOOD MICROBIOLOGY
LA English
DT Article
DE predictive microbiology; Clostridium sporogenes; response surface model
ID ESCHERICHIA-COLI O157-H7; MICROBIAL-GROWTH; BACTERIAL-GROWTH;
   LISTERIA-MONOCYTOGENES; FOOD MICROBIOLOGY; SODIUM-CHLORIDE;
   NEURAL-NETWORK; WATER ACTIVITY; TEMPERATURE; PH
AB Clostridium sporogenes is considered to be a non-toxingenic equivalent of proteolytic Clostridium botulinium, and it also causes food spoilage. The effects of temperature (16.6-33.4 degrees C), pH value (5.2-6.8) and concentration of sodium chloride (0.6-7.4%) on the growth parameters of C sporogenes spores were investigated. The growth curves generated within different conditions were fitted using Baranyi function. Two growth parameters (growth rate, GR; lag-time, LT) of the growth curves under combined effects of temperature, pH and sodium chloride were modeled using a quadratic polynomial equation of response surface (RS) model. Mathematical evaluation demonstrated that the standard error of prediction (%SEP) obtained by RS model was 1.033% for GR and was 0.166% for LT for model establishing. The %SEP for model validation were 43.717% and 5.895% for GR and LT, respectively. The root-mean-squares error (RMSE) was in acceptable range which was less than 0.1 for GR and was less than 8.0 for LT. Both the bias factor (B-f) and accuracy factor (A(f)) approached 1.0, which were within acceptable range. Therefore, RS model provides a useful and accurate method for predicting the growth parameters of C sporogenes spores, and could be applied to ensure food safety with respect to proteolytic C botulinum control. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Nanjing Agr Univ, Coll Food Sci & Technol, MOA, Keu Lab Foos Proc & Qual Control, Nanjing, Peoples R China.
RP Tu, K (reprint author), Nanjing Agr Univ, Coll Food Sci & Technol, MOA, Keu Lab Foos Proc & Qual Control, Nanjing, Peoples R China.
EM kangtu@njau.edu.cn
RI Dong, Qingli/L-7437-2019; Dong, Qingli/D-6216-2012
OI Dong, Qingli/0000-0001-9019-0001; Dong, Qingli/0000-0001-5563-6178
CR ANELLIS A, 1972, APPL MICROBIOL, V23, P734, DOI 10.1128/AEM.23.4.734-739.1972
   ARMAS AD, 1996, VALIDATION PREDICTIV
   BARANYI J, 1993, J IND MICROBIOL, V12, P190, DOI 10.1007/BF01584189
   BARANYI J, 1995, INT J FOOD MICROBIOL, V26, P199, DOI 10.1016/0168-1605(94)00121-L
   Box G.E.P., 1987, EMPIRICAL MODEL BUIL, P34
   Buchanan RL, 1999, J FOOD PROTECT, V62, P211, DOI 10.4315/0362-028X-62.3.211
   BUCHANAN RL, 1992, FOOD MICROBIOL, V9, P185, DOI 10.1016/0740-0020(92)80046-7
   Buchanan RL, 1997, FOOD MICROBIOL, V14, P413, DOI 10.1006/fmic.1997.0101
   DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1
   Dalgaard P, 2000, SHELF LIFE EVALUATIO, P110
   Farber JM, 1996, INT J FOOD MICROBIOL, V32, P133, DOI 10.1016/0168-1605(96)01117-8
   Fernandez PS, 1996, INT J FOOD MICROBIOL, V32, P225, DOI 10.1016/0168-1605(96)01118-X
   Garcia-Borreguero D, 2006, J SLEEP RES, V15, P30
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Graham AF, 1996, INT J FOOD MICROBIOL, V31, P69, DOI 10.1016/0168-1605(96)00965-8
   Grijspeerdt K, 1999, FOOD MICROBIOL, V16, P593, DOI 10.1006/fmic.1999.0285
   Hervas C, 2001, FOOD SCI TECHNOL INT, V7, P159, DOI 10.1106/6Q2A-8D7R-JHJU-T7F6
   JENSEN MJ, 1987, J FOOD SAFETY, V8, P109
   KALATHENOS P, 1995, INT J FOOD MICROBIOL, V25, P63, DOI 10.1016/0168-1605(94)00085-K
   Lebert I, 2000, INT J FOOD MICROBIOL, V61, P27, DOI 10.1016/S0168-1605(00)00359-7
   LUND BM, 1994, SOC APPL BACTERIOL, V76, pS115
   LUND BM, 2000, MICROBIOLOGICAL SAFE, P1057
   McClure PJ, 1997, INT J FOOD MICROBIOL, V34, P221, DOI 10.1016/S0168-1605(96)01193-2
   MCCLURE PJ, 1994, SOC APPL BACTERIOL S, V76, pS105
   MCMEEKIN TA, 1993, PREDICTIVE MICROBIOL
   Neumeyer K, 1997, INT J FOOD MICROBIOL, V38, P55, DOI 10.1016/S0168-1605(97)00090-1
   Razavilar V, 1998, INT J FOOD MICROBIOL, V40, P149, DOI 10.1016/S0168-1605(98)00014-2
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8
   ROSS T, 1999, PREDICTIVE FOOD MICR
   Sorensen BB, 1997, INT J FOOD MICROBIOL, V34, P209, DOI 10.1016/S0168-1605(96)01192-0
   Whiting RC, 1998, FOOD MICROBIOL, V15, P449, DOI 10.1006/fmic.1998.0196
   WHITING RC, 1993, FOOD MICROBIOL, V10, P295, DOI 10.1006/fmic.1993.1034
   WHITING RC, 1997, INT J FOOD MICROBIOL, V35, P49
   Wilson PDG, 2002, INT J FOOD MICROBIOL, V73, P275, DOI 10.1016/S0168-1605(01)00660-2
   Zhao L, 2002, INT J FOOD MICROBIOL, V77, P187, DOI 10.1016/S0168-1605(02)00111-3
   Zurera-Cosano G, 2006, FOOD CONTROL, V17, P429, DOI 10.1016/j.foodcont.2005.02.003
NR 38
TC 37
Z9 45
U1 0
U2 18
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0740-0020
J9 FOOD MICROBIOL
JI Food Microbiol.
PD SEP
PY 2007
VL 24
IS 6
BP 624
EP 632
DI 10.1016/j.fm.2006.12.003
PG 9
WC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
SC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
GA 181JT
UT WOS:000247433700010
PM 17418314
DA 2020-05-07
ER

PT J
AU Valero, A
   Hervas, C
   Garcia-Gimeno, RM
   Zurera, G
AF Valero, A.
   Hervas, C.
   Garcia-Gimeno, R. M.
   Zurera, G.
TI Product unit neural network models for predicting the growth limits of
   Listeria monocytogenes
SO FOOD MICROBIOLOGY
LA English
DT Article
DE logistic regression; classification; product unit neural networks;
   evolutionary computation; boundary models; Listeria monocytogenes
ID LOGISTIC-REGRESSION; BACTERIAL-GROWTH; PH; TEMPERATURE; INHIBITION;
   SURVIVAL; ACID; NACL
AB A new approach to predict the growth/no growth interface of Listeria monocytogenes as a function of storage temperature, pH, citric acid (CA) and ascorbic acid (AA) is presented. A linear logistic regression procedure was performed and a non-linear model was obtained by adding new variables by means of a Neural Network model based on Product Units (PUNN). The classification efficiency of the training data set and the generalization data of the new Logistic Regression PUNN model (LRPU) were compared with Linear Logistic Regression (LLR) and Polynomial Logistic Regression (PLR) models. 92% of the total cases from the LRPU model were correctly classified, an improvement on the percentage obtained using the PLR model (90%) and significantly higher than the results obtained with the LLR model, 80%. On the other hand predictions of LRPU were closer to data observed which permits to design proper formulations in minimally processed foods. This novel methodology can be applied to predictive microbiology for describing growth/no growth interface of food-borne microorganisms such as L. monocytogenes. The optimal balance is trying to find models with an acceptable interpretation capacity and with good ability to fit the data on the boundaries of variable range. The results obtained conclude that these kinds of models might well be very a valuable tool for mathematical modeling. (C) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Cordoba, Dept Food Sci & Technol, Cordoba 14014, Spain.
   Univ Cordoba, Dept Comp Sci & Numer Anal, Cordoba 14014, Spain.
RP Valero, A (reprint author), Univ Cordoba, Dept Food Sci & Technol, Campus Rabanales,Edif Darwin, Cordoba 14014, Spain.
EM bt2vadia@uco.es
RI Hervas-Martinez, Cesar/A-3979-2009; Garcia-Gimeno, Rosa
   Maria/L-4837-2014; Zurera-Cosano, Gonzalo/L-6114-2014; Valero Diaz,
   Antonio/K-6777-2014
OI Hervas-Martinez, Cesar/0000-0003-4564-1816; Garcia-Gimeno, Rosa
   Maria/0000-0001-5241-6348; Zurera-Cosano, Gonzalo/0000-0002-3763-8900;
   Valero Diaz, Antonio/0000-0001-8597-0740
CR AHAMAD N, 1989, J FOOD PROTECT, V52, P688, DOI 10.4315/0362-028X-52.10.688
   Carrasco E, 2006, FOOD SCI TECHNOL INT, V12, P47, DOI 10.1177/1082013206062234
   Durbin R, 1989, NEURAL COMPUT, V1, P133, DOI 10.1162/neco.1989.1.1.133
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   GEORGE SM, 1988, LETT APPL MICROBIOL, V6, P153, DOI 10.1111/j.1472-765X.1988.tb01237.x
   Giannuzzi L, 1996, FOOD SCI TECHNOL-LEB, V29, P278
   GURNEY KN, 1992, NEURAL NETWORKS, V5, P289, DOI 10.1016/S0893-6080(05)80027-9
   Hajmeer M, 2003, FOOD MICROBIOL, V20, P43, DOI 10.1016/S0740-0020(02)00104-1
   Hajmeer MN, 2003, INT J FOOD MICROBIOL, V82, P233, DOI 10.1016/S0168-1605(02)00308-2
   Hervas-Martinez C, 2006, J FOOD SCI, V71, pM31, DOI 10.1111/j.1365-2621.2006.tb08904.x
   Hwang CA, 2005, INT J FOOD MICROBIOL, V102, P277, DOI 10.1016/j.ijfoodmicro.2004.11.019
   *ICMSF, 1980, [No title captured], V1
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Koutsoumanis KP, 2004, FOOD MICROBIOL, V21, P415, DOI 10.1016/j.fm.2003.11.003
   Lanciotti R, 2001, FOOD MICROBIOL, V18, P659, DOI 10.1006/fmic.2001.0429
   Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7
   Martinez-Estudillo A, 2006, NEURAL NETWORKS, V19, P477, DOI 10.1016/j.neunet.2005.11.001
   McKellar RC, 2002, FOOD MICROBIOL, V19, P235, DOI 10.1006/fmic.2001.0449
   McMeekin TA, 2000, INT J FOOD MICROBIOL, V55, P93, DOI 10.1016/S0168-1605(00)00182-3
   PARISH ME, 1989, J FOOD PROTECT, V52, P144, DOI 10.4315/0362-028X-52.3.144
   PETRAN RL, 1989, J FOOD SCI, V54, P458, DOI 10.1111/j.1365-2621.1989.tb03105.x
   Ratkowsky DA, 2002, INT J FOOD MICROBIOL, V73, P119, DOI 10.1016/S0168-1605(01)00643-2
   RATKOWSKY DA, 1995, LETT APPL MICROBIOL, V20, P29, DOI 10.1111/j.1472-765X.1995.tb00400.x
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   Schaffner DW, 1997, FOOD TECHNOL-CHICAGO, V51, P95
   *SPSS, 2003, [No title captured]
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
   YOUNG KM, 1993, J APPL BACTERIOL, V74, P515
NR 28
TC 17
Z9 17
U1 0
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0740-0020
EI 1095-9998
J9 FOOD MICROBIOL
JI Food Microbiol.
PD AUG
PY 2007
VL 24
IS 5
BP 452
EP 464
DI 10.1016/j.fm.2006.10.002
PG 13
WC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
SC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
GA 171TQ
UT WOS:000246758700003
PM 17367678
DA 2020-05-07
ER

PT J
AU Panagou, EZ
   Tassou, CC
   Saravanos, EKA
   Nychas, GJE
AF Panagou, Efstathios Z.
   Tassou, Chrysoula C.
   Saravanos, Eleftherios K. A.
   Nychas, George-John E.
TI Application of neural networks to simulate the growth profile of lactic
   acid bacteria in green olive fermentation
SO JOURNAL OF FOOD PROTECTION
LA English
DT Article
ID ESCHERICHIA-COLI O157-H7; LACTOBACILLUS-PLANTARUM LPCO10;
   MICROBIAL-GROWTH; TABLE OLIVES; PREDICTIVE MICROBIOLOGY;
   MATHEMATICAL-MODEL; STARTER CULTURES; FOOD; TEMPERATURE; SURVIVAL
AB The growth profile of five strains of lactic acid bacteria (Lactobacillus plantarum ACA-DC 287, L plantarum ACA-DC 146, Lactobacillus paracasei ACA-DC 4037, Lactobacillus sakei LQC 1378, and Leuconostoc mesenteroides LQC 1398) was investigated in controlled fermentation of cv. Conservolea green olives with a multilayer perceptron network, a combined logistic-Fermi function, and a two-term Gompertz function. Neural network training was based on the steepest-descent gradient learning algorithm. Model performance was compared with the experimental data with five statistical indices, namely coefficient of determination (R-2), root mean square error (RMSE), mean relative percentage error (MRPE), mean absolute percentage error (MAPE), and standard error of prediction (SEP). The experimental data set consisted of 125 counts (CFU per milliliter) of lactic acid bacteria during the green olive fermentation process for up to 38 days (5 strains X 25 sampling days). For model development, a standard methodology was followed, dividing the data set into training (120 data) and validation (25 data) subsets. Our results demonstrated that the developed network was able to model the growth and survival profile of all the strains of lactic acid bacteria during fermentation equally well with the statistical models. The performance indices for the training subset of the multilayer perception network were R-2 = 0.987, RMSE = 0.097, MRPE = 0.069, MAPE = 0.933, and SEP = 1.316. The relevant mean values for the logistic-Fermi and two-term Gompertz functions were R-2 = 0.981 and 0.989, RMSE = 0.109 and 0.083, MRPE = 0.026 and 0.030, MAPE = 1.430 and 1.076, and SEP = 1.490 and 1.127, respectively. For the validation subset, the network also gave good predictions (R-2 = 0.968, RMSE = 0.149, MRPE = 0.100, MAPE = 1.411, and SEP = 2.009).
C1 Natl Agr Res Fdn, Inst Technol Agr Prod, GR-14123 Lycovrissi, Greece.
   Agr Univ Athens, Dept Food Sci & Technol, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece.
RP Panagou, EZ (reprint author), Natl Agr Res Fdn, Inst Technol Agr Prod, 1 S Venizelou Str, GR-14123 Lycovrissi, Greece.
EM stathispanagou@nagref.gr
RI Tassou, Chrysoula/H-2899-2016; Panagou, Efstathios/I-6537-2019; Nychas,
   George-John/B-2734-2009
OI Panagou, Efstathios/0000-0002-0317-1177; Nychas,
   George-John/0000-0002-2673-6425; Tassou, Chrysoula/0000-0002-9004-4263
CR BALATSOURAS G, 1983, APPL ENVIRON MICROB, V46, P68, DOI 10.1128/AEM.46.1.68-74.1983
   BALATSOURAS GD, 1995, TABLE OLIVES CULTIVA
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   BELLO J, 1995, INT J FOOD MICROBIOL, V27, P215, DOI 10.1016/0168-1605(95)00002-2
   Chorianopoulos NG, 2005, FOOD MICROBIOL, V22, P117, DOI 10.1016/j.fm.2004.04.010
   CIAFARDINI G, 1994, APPL ENVIRON MICROB, V60, P4142, DOI 10.1128/AEM.60.11.4142-4147.1994
   de Castro A, 2002, FOOD MICROBIOL, V19, P637, DOI 10.1006/fmic.2002.0466
   ETCHELLS JL, 1966, APPL MICROBIOL, V14, P1027, DOI 10.1128/AEM.14.6.1027-1041.1966
   FERNANDEZ AG, 1997, TABLE OLIVES PRODUCT
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Hajmeer M, 2006, FOOD MICROBIOL, V23, P561, DOI 10.1016/j.fm.2005.09.011
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAM FM, 2001, PRINCIPLES NEUROCOMP
   HAYKIN S., 1999, NEURAL NETWORKS COMP
   Hervas C, 2001, FOOD SCI TECHNOL INT, V7, P159, DOI 10.1106/6Q2A-8D7R-JHJU-T7F6
   *ICAP, 2005, SECT STUD OL OIL POM
   JARVIS B, 1989, STAT ASPECTS MICROBI
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   KENNETH MP, 1993, J IND MICROBIOL, V12, P221
   Leal-Sanchez MV, 2003, FOOD MICROBIOL, V20, P421, DOI 10.1016/S0740-0020(02)00147-8
   Lopez FNA, 2006, J APPL MICROBIOL, V101, P913, DOI 10.1111/j.1365-2672.2006.02979.x
   Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   MONTANO A, 1993, J FOOD SCI, V58, P842, DOI 10.1111/j.1365-2621.1993.tb09372.x
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   NOUT MJR, 1992, J APPL BACTERIOL S, V73, P136
   Peleg M, 1996, J SCI FOOD AGR, V71, P225, DOI 10.1002/(SICI)1097-0010(199606)71:2<225::AID-JSFA572>3.3.CO;2-R
   Quintana MCD, 1999, INT J FOOD MICROBIOL, V51, P133, DOI 10.1016/S0168-1605(99)00123-3
   Ross EW, 2005, INT J FOOD MICROBIOL, V99, P157, DOI 10.1016/j.ijfoodmicro.2004.07.019
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   RUIZBARBA JL, 1994, APPL ENVIRON MICROB, V60, P2059, DOI 10.1128/AEM.60.6.2059-2064.1994
   Sanchez AH, 2001, INT J FOOD MICROBIOL, V67, P115, DOI 10.1016/S0168-1605(01)00434-2
   Skandamis PN, 2003, J FOOD PROTECT, V66, P1166, DOI 10.4315/0362-028X-66.7.1166
   Spyropoulou KE, 2001, INT J FOOD MICROBIOL, V66, P3, DOI 10.1016/S0168-1605(00)00510-9
   Taub IA, 2003, J FOOD SCI, V68, P2530, DOI 10.1111/j.1365-2621.2003.tb07056.x
   VANIMPE JF, 1992, APPL ENVIRON MICROB, V58, P2901, DOI 10.1128/AEM.58.9.2901-2909.1992
   WHITING RC, 1993, J IND MICROBIOL, V12, P240, DOI 10.1007/BF01584196
   Yu C, 2006, FOOD MICROBIOL, V23, P552, DOI 10.1016/j.fm.2005.09.008
NR 40
TC 8
Z9 8
U1 0
U2 2
PU INT ASSOC FOOD PROTECTION
PI DES MOINES
PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA
SN 0362-028X
J9 J FOOD PROTECT
JI J. Food Prot.
PD AUG
PY 2007
VL 70
IS 8
BP 1909
EP 1916
DI 10.4315/0362-028X-70.8.1909
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 196YI
UT WOS:000248519000018
PM 17803149
DA 2020-05-07
ER

PT J
AU Panagou, EZ
   Kodogiannis, V
   Nychas, GJE
AF Panagou, E. Z.
   Kodogiannis, V.
   Nychas, G. J. -E.
TI Modelling fungal growth using radial basis function neural networks: The
   case of the ascomycetous fungus Monascus ruber van Tieghem
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE artificial neural networks; Monascus ruber; polynomial regression;
   predictive mycology; radial basis function network
ID FOOD SPOILAGE MOLDS; PYROLYSIS MASS-SPECTROMETRY; WATER ACTIVITY;
   MICROBIAL-GROWTH; ESCHERICHIA-COLI; PREDICTIVE MICROBIOLOGY;
   PENICILLIUM-VERRUCOSUM; ASPERGILLUS-FLAVUS; BACTERIAL-GROWTH; ELECTRONIC
   NOSE
AB A radial basis function (RBF) neural network was developed and evaluated against a quadratic response surface model to predict the maximum specific growth rate of the ascomycetous fungus Monascus ruber in relation to temperature (20-40 degrees C), water activity (0.937-0.970) and pH (3.5-5.0), based on the data of Panagou et al. [Panagou, E.Z., Skandamis, P.N., Nychas, G.-J.E., 2003. Modelling the combined effect of temperature, pH and aw on the growth rate of M ruber, a heat-resistant fungus isolated from green table olives. J. Appl. Microbiol. 94, 146-15 6]. Both RBF network nd polynomial model were compared against the experimental data using five statistical indices namely, coefficient of determination (R-2), root mean square error (RMSE), standard error of prediction (SEP), bias (Bf) and accuracy (A(f)) factors. Graphical plots were also used for model comparison. For training data set the RBF network predictions outperformed the classical statistical model, whereas in the case of test data set the network gave reasonably good predictions, considering its performance for unseen data. Sensitivity analysis showed that from the three environmental factors the most influential on fungal growth was temperature, followed by water activity and pH to a lesser extend. Neural networks offer an alternative and powerful technique to model microbial kinetic parameters and could thus become an additional tool in predictive mycology. (C) 2007 Elsevier B.V. All rights reserved.
C1 Agr Univ Athens, Dept Food Sci & Technol, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece.
   Natl Agr Res Fdn, Inst Technol Agr Prod, GR-14123 Lycovrissi, Greece.
   Univ Westminster, Sch Comp Sci, Ctr Syst Anal, London HA1 3TP, England.
RP Panagou, EZ (reprint author), Agr Univ Athens, Dept Food Sci & Technol, Lab Microbiol & Biotechnol Foods, Iera Odos 75, GR-11855 Athens, Greece.
EM stathispanagou@aua.gr
RI Nychas, George-John/B-2734-2009; Kodogiannis, Vassilis/D-1299-2016;
   Panagou, Efstathios/I-6537-2019
OI Nychas, George-John/0000-0002-2673-6425; Panagou,
   Efstathios/0000-0002-0317-1177
CR Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Battey AS, 2001, FOOD MICROBIOL, V18, P521, DOI 10.1006/fmic.2001.0438
   Belli N, 2004, INT J FOOD MICROBIOL, V96, P19, DOI 10.1016/j.ijfoodmicro.2004.03.004
   Benoudjit N, 2003, NEURAL PROCESS LETT, V18, P139, DOI 10.1023/A:1026289910256
   Brown Martin, 1994, NEUROFUZZY ADAPTIVE
   Cairns-Fuller V, 2005, J APPL MICROBIOL, V99, P1215, DOI 10.1111/j.1365-2672.2005.02695.x
   CHEN S, 1991, IEEE T NEURAL NETWOR, V2, P302, DOI 10.1109/72.80341
   CHUN J, 1993, FEMS MICROBIOL LETT, V107, P321
   Cuppers HGAM, 1997, APPL ENVIRON MICROB, V63, P3764, DOI 10.1128/AEM.63.10.3764-3769.1997
   Dantigny P, 2005, INT J FOOD MICROBIOL, V100, P187, DOI 10.1016/j.ijfoodmicro.2004.10.013
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   GIBSON AM, 1994, INT J FOOD MICROBIOL, V23, P419, DOI 10.1016/0168-1605(94)90167-8
   Gibson AM, 1997, TRENDS FOOD SCI TECH, V8, P353, DOI 10.1016/S0924-2244(97)01065-0
   GOH ATC, 1995, ARTIF INTELL ENG, V9, P143, DOI 10.1016/0954-1810(94)00011-S
   GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027
   Goodacre R, 1997, APPL SPECTROSC, V51, P1144, DOI 10.1366/0003702971941665
   GOODACRE R, 1993, J SCI FOOD AGR, V63, P297, DOI 10.1002/jsfa.2740630306
   GOODACRE R, 1994, ZBL BAKT, V22, P124
   Hajmeer M, 2006, FOOD MICROBIOL, V23, P561, DOI 10.1016/j.fm.2005.09.011
   Hajmeer MN, 1998, J RAPID METH AUT MIC, V6, P103, DOI 10.1111/j.1745-4581.1998.tb00191.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAM FM, 2001, PRINCIPLES NEUROCOMP
   HAWKSWORTH DL, 1983, AUST J BOT, V31, P51, DOI 10.1071/BT9830051
   HAYKIN S., 1999, NEURAL NETWORKS COMP
   Hervas C, 2001, FOOD SCI TECHNOL INT, V7, P159, DOI 10.1106/6Q2A-8D7R-JHJU-T7F6
   HOLMQUIST GU, 1983, J FOOD SCI, V48, P778, DOI 10.1111/j.1365-2621.1983.tb14897.x
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Jonsson A, 1997, INT J FOOD MICROBIOL, V35, P187, DOI 10.1016/S0168-1605(96)01218-4
   Karayiannis NB, 1999, IEEE T NEURAL NETWOR, V10, P657, DOI 10.1109/72.761725
   Kodogiannis VS, 1999, ENG APPL ARTIF INTEL, V12, P159, DOI 10.1016/S0952-1976(98)00064-5
   Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   MASTERS T, 1993, PRACTICAL NEURAL NET
   Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281
   Murphy PA, 2006, J FOOD SCI, V71, pR51, DOI 10.1111/j.1750-3841.2006.00052.x
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   Panagou EZ, 2003, J APPL MICROBIOL, V94, P146, DOI 10.1046/j.1365-2672.2003.01818.x
   Panagou EZ, 2002, INT J FOOD MICROBIOL, V76, P11, DOI 10.1016/S0168-1605(01)00748-6
   Pardo E, 2006, INT J FOOD MICROBIOL, V106, P25, DOI 10.1016/j.ijfoodmicro.2005.07.002
   Parra R, 2004, J APPL MICROBIOL, V97, P429, DOI 10.1111/j.1365-2672.2004.02320.x
   Patriarca A, 2001, INT J FOOD MICROBIOL, V68, P61, DOI 10.1016/S0168-1605(01)00470-6
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   Ross T, 2004, MODELING MICROBIAL R, P64
   Rosso L, 2001, INT J FOOD MICROBIOL, V63, P265, DOI 10.1016/S0168-1605(00)00469-4
   Sautour M, 2002, J IND MICROBIOL BIOT, V28, P311, DOI 10.1038/sj.jim.7000248
   Sautour M, 2001, INT J FOOD MICROBIOL, V67, P63, DOI 10.1016/S0168-1605(01)00471-8
   Siripatrawan U, 2004, J FOOD PROTECT, V67, P1604, DOI 10.4315/0362-028X-67.8.1604
   Siripatrawan U, 2006, J FOOD PROTECT, V69, P1844, DOI 10.4315/0362-028X-69.8.1844
   Valik L, 1999, INT J FOOD MICROBIOL, V47, P141, DOI 10.1016/S0168-1605(98)00201-3
NR 52
TC 35
Z9 37
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JUL 15
PY 2007
VL 117
IS 3
BP 276
EP 286
DI 10.1016/j.ijfoodmicro.2007.03.010
PG 11
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 196OD
UT WOS:000248491000004
PM 17521758
DA 2020-05-07
ER

PT J
AU Birko, Z
   Bialek, S
   Buzas, K
   Szajli, E
   Traag, BA
   Medzihradszky, KF
   Rigali, S
   Vijgenboom, E
   Penyige, A
   Kele, Z
   van Wezel, GP
   Biro, S
AF Birko, Zsuzsanna
   Bialek, Sylwia
   Buzas, Krisztina
   Szajli, Emilia
   Traag, Bjorn A.
   Medzihradszky, Katalin F.
   Rigali, Sebastien
   Vijgenboom, Erik
   Penyige, Andras
   Kele, Zoltan
   van Wezel, Gilles P.
   Biro, Sandor
TI The secreted signaling protein factor C triggers the A-factor response
   regulon in streptomyces griseus - Overlapping signaling routes
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID BIOSYNTHETIC GENE-CLUSTER; FACTOR REGULATORY CASCADE;
   AMINO-ACID-SEQUENCE; SECONDARY METABOLISM; TRANSCRIPTIONAL CONTROL;
   SUPEROXIDE-DISMUTASE; MASS-SPECTROMETRY; DIFFERENTIATION; COELICOLOR;
   EXPRESSION
AB Members of the prokaryotic genus Streptomyces produce over 60% of all known antibiotics and a wide range of industrial enzymes. A leading theme in microbiology is which signals are received and transmitted by these organisms to trigger the onset of morphological differentiation and antibiotic production. The small gamma-butyrolactone A-factor is an important autoregulatory signaling molecule in streptomycetes, and A-factor mutants are blocked in development and antibiotic production. In this study we showed that heterologous expression of the 324-amino acid secreted regulatory protein Factor C resulted in restoration of development and enhanced antibiotic production of an A-factor-deficient bald mutant of Streptomyces griseus, although the parental strain lacks an facC gene. Proteome analysis showed that in the facC transformant the production of several secreted proteins that belong to the A-factor regulon was restored. HPLC-MS/ MS analysis indicated that this was due to restoration of A-factor production to wild-type levels in the transformant. This indicates a connection between two highly divergent types of signaling molecules and possible interplay between their regulatory networks.
C1 Univ Debrecen, Dept Human Genet, Fac Med, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary.
   Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands.
   Hungarian Acad Sci, Proteom Res Grp, Biol Res Ctr, H-6726 Szeged, Hungary.
   Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.
   Kromat Kft, H-1124 Budapest, Hungary.
   Univ Szeged, Fac Med, Dept Med Chem, H-6720 Szeged, Hungary.
RP Birko, Z (reprint author), Univ Debrecen, Dept Human Genet, Fac Med, Med & Hlth Sci Ctr, Nagyerdei Korut 98, H-4032 Debrecen, Hungary.
OI Rigali, Sebastien/0000-0003-4022-7325; van Wezel,
   Gilles/0000-0003-0341-1561; Vijgenboom, Erik/0000-0002-5059-069X
CR Birko Z, 1999, MICROBIOL-SGM, V145, P2245, DOI 10.1099/00221287-145-9-2245
   BIRO S, 1980, EUR J BIOCHEM, V103, P359, DOI 10.1111/j.1432-1033.1980.tb04322.x
   Biro S, 2000, ANTON LEEUW INT J G, V78, P277, DOI 10.1023/A:1010221407340
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   CHATER KF, 1993, ANNU REV MICROBIOL, V47, P685, DOI 10.1146/annurev.mi.47.100193.003345
   Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758
   Diaz M, 2005, MICROBIOL-SGM, V151, P2583, DOI 10.1099/mic.0.27983-0
   Folcher M, 2001, J BIOL CHEM, V276, P44297, DOI 10.1074/jbc.M101109200
   Haebel S, 1998, ELECTROPHORESIS, V19, P679, DOI 10.1002/elps.1150190513
   Halliwell B., 1989, FREE RADICALS BIOL M
   Henderson IR, 2000, TRENDS MICROBIOL, V8, P534, DOI 10.1016/S0966-842X(00)01884-9
   HORINOUCHI S, 1994, MOL MICROBIOL, V12, P859, DOI 10.1111/j.1365-2958.1994.tb01073.x
   HORINOUCHI S, 1989, J BACTERIOL, V171, P1206, DOI 10.1128/jb.171.2.1206-1210.1989
   HORINOUCHI S, 1992, ANNU REV MICROBIOL, V46, P377, DOI 10.1146/annurev.mi.46.100192.002113
   HORINOUCHI S, 1984, J BACTERIOL, V158, P481, DOI 10.1128/JB.158.2.481-487.1984
   HOURDOU ML, 1993, BIOCHEM J, V292, P563, DOI 10.1042/bj2920563
   Kato J, 2002, J BACTERIOL, V184, P6016, DOI 10.1128/JB.184.21.6016-6025.2002
   Kato JY, 2005, J BACTERIOL, V187, P286, DOI 10.1128/JB.187.1.286-295.2005
   Kawamoto S, 1997, MICROBIOL-UK, V143, P1077, DOI 10.1099/00221287-143-4-1077
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212
   Maras B, 1996, EUR J BIOCHEM, V236, P843, DOI 10.1111/j.1432-1033.1996.00843.x
   Miguelez EM, 1999, J CELL BIOL, V145, P515, DOI 10.1083/jcb.145.3.515
   NARAHASHI Y, 1990, J BIOCHEM-TOKYO, V107, P879, DOI 10.1093/oxfordjournals.jbchem.a123142
   OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987
   Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431
   RETZLAFF L, 1995, MOL MICROBIOL, V18, P151, DOI 10.1111/j.1365-2958.1995.mmi_18010151.x
   Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673
   Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x
   Sosinsky A, 2003, NUCLEIC ACIDS RES, V31, P3589, DOI 10.1093/nar/gkg544
   SZABO G, 1962, [No title captured], P282
   SZESZAK F, 1990, ARCH MICROBIOL, V154, P82
   Szeszak F, 1997, ACTA BIOL HUNG, V48, P265
   Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x
   Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x
   Tomono A, 2005, J BACTERIOL, V187, P6341, DOI 10.1128/JB.187.18.6341-6353.2005
   Tomono A, 2005, J BACTERIOL, V187, P5595, DOI 10.1128/JB.187.16.5595-5604.2005
   VUJAKLIJA D, 1993, J BACTERIOL, V175, P2652, DOI 10.1128/JB.175.9.2652-2661.1993
   VUJAKLIJA D, 1991, MOL GEN GENET, V229, P119, DOI 10.1007/BF00264220
   Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003
   Yang YH, 2005, APPL ENVIRON MICROB, V71, P5050, DOI 10.1128/AEM.71.9.5050-5055.2005
   Youn HD, 1996, ARCH BIOCHEM BIOPHYS, V334, P341, DOI 10.1006/abbi.1996.0463
NR 42
TC 15
Z9 16
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD JUL
PY 2007
VL 6
IS 7
BP 1248
EP 1256
DI 10.1074/mcp.M600367-MCP200
PG 9
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 187LW
UT WOS:000247850200013
PM 17376769
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Gysemans, KPM
   Bernaerts, K
   Vermeulen, A
   Geeraerd, AH
   Debevere, J
   Devlieghere, F
   Van Impe, JF
AF Gysemans, K. P. M.
   Bernaerts, K.
   Vermeulen, A.
   Geeraerd, A. H.
   Debevere, J.
   Devlieghere, F.
   Van Impe, J. F.
TI Exploring the performance of logistic regression model types on
   growth/no growth data of Listeria monocytogenes
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE growth/no growth interface; logistic regression models; monoculture
   data; mixed strain data; Listeria monocytogenes
ID LACTIC-ACID CONCENTRATION; NEURAL-NETWORK APPROACH; WATER ACTIVITY;
   ESCHERICHIA-COLI; BACTERIAL-GROWTH; PH; TEMPERATURE; INTERFACE; LIMITS;
   MICROBIOLOGY
AB Several model types have already been developed to describe the boundary between growth and no growth conditions. In this article two types were thoroughly studied and compared, namely (i) the ordinary (linear) logistic regression model, i.e., with a polynomial on the right-hand side of the model equation (type I) and (ii) the (nonlinear) logistic regression model derived from a square root-type kinetic model (type II).
   The examination was carried out on the basis of the data described in Vermeulen et al. [Vermeulen, A., Gysemans, K.P.M., Bernaerts, K., Geeraerd, A.H., Van Impe, J.F., Debevere, J., Devlieghere, F., 2006-this issue. Influence of pH, water activity and acetic acid concentration on Listeria monocytogenes at 7 degrees C: data collection for the development of a growth/no growth model. International Journal of Food Microbiology. doi:10.1016/j.ijfoodmicro.2006.09.023.]. These data sets consist of growth/no growth data for Listeria monocytogenes as a function of water activity (0.960-0.990), pH (5.0-6.0) and acetic acid percentage (0-0.8% (w/w)), both for a monoculture and a mixed strain culture. Numerous replicates, namely twenty, were performed at closely spaced conditions. In this way detailed information was obtained about the position of the interface and the transition zone between growth and no growth.
   The main questions investigated were (i) which model type performs best on the monoculture and the mixed strain data, (ii) are there differences between the growth/no growth interfaces of monocultures and mixed strain cultures, (iii) which parameter estimation approach works best for the type II models, and (iv) how sensitive is the performance of these models to the values of their nonlinear-appearing parameters.
   The results showed that both type I and II models performed well on the monoculture data with respect to goodness-of-fit and predictive power. The type I models were, however, more sensitive to anomalous data points. The situation was different for the mixed strain culture. In that case, the type II models could not describe the curvature in the growth/no growth interface which was reversed to the typical curvatures found for monocultures. This unusual curvature may originate from the fact that (i) an interface of a mixed strain culture can result from the superposition of the interfaces of the individual strains, or that (ii) only a narrow range of the growth/no growth interface was studied (the local trend can be different from the trend over a wider range). It was also observed that the best type II models were obtained with the flexible nonlinear logistic regression, although reasonably good models were obtained with the less flexible linear logistic regression with the nonlinear-appearing parameters fixed at experimentally determined values. Finally, it was found that for some of the nonlinear-appearing parameters, deviations from their experimentally determined values did not influence the model fit. This was probably caused by the fact that only a limited part of the growth/no growth interface was studied. (C) 2006 Elsevier B.V. All rights reserved.
C1 Katholieke Univ Leuven, Dept Chem Engn, BioTeC, B-3001 Louvain, Belgium.
   Univ Ghent, Dept Food Safety & Food Qual, LFMFP, B-9000 Ghent, Belgium.
   Katholieke Univ Leuven, Dept Biosyst, Div Mechatron Biostat & Sensors, B-3001 Louvain, Belgium.
RP Van Impe, JF (reprint author), Katholieke Univ Leuven, Dept Chem Engn, BioTeC, W Croylaan 46, B-3001 Louvain, Belgium.
EM jan.vanimpe@cit.kuleuven.be
RI Geeraerd, Annemie/AAC-5006-2020
OI Geeraerd, Annemie/0000-0001-8473-4092; Bernaerts,
   Kristel/0000-0001-6211-7042
CR Agresti A., 2002, CATEGORICAL DATA ANA
   Augustin JC, 2000, INT J FOOD MICROBIOL, V56, P53, DOI 10.1016/S0168-1605(00)00224-5
   Battey AS, 2001, FOOD MICROBIOL, V18, P521, DOI 10.1006/fmic.2001.0438
   Bolton LF, 1999, J FOOD PROTECT, V62, P601, DOI 10.4315/0362-028X-62.6.601
   Geeraerd AH, 2004, INT J FOOD MICROBIOL, V91, P229, DOI 10.1016/S0168-1605(03)00388-X
   GIBSON AM, 1994, INT J FOOD MICROBIOL, V23, P419, DOI 10.1016/0168-1605(94)90167-8
   GYSEMANS K, 2004, BOOK ABSTR 19 INT IC, P118
   Hajmeer M, 2003, FOOD MICROBIOL, V20, P43, DOI 10.1016/S0740-0020(02)00104-1
   Hajmeer M, 2002, J MICROBIOL METH, V51, P217, DOI 10.1016/S0167-7012(02)00080-5
   Hajmeer MN, 2003, INT J FOOD MICROBIOL, V82, P233, DOI 10.1016/S0168-1605(02)00308-2
   Koutsoumanis KP, 2004, FOOD MICROBIOL, V21, P415, DOI 10.1016/j.fm.2003.11.003
   Koutsoumanis KP, 2004, J FOOD PROTECT, V67, P53, DOI 10.4315/0362-028X-67.1.53
   Lanciotti R, 2001, FOOD MICROBIOL, V18, P659, DOI 10.1006/fmic.2001.0429
   Le Marc Y, 2005, INT J FOOD MICROBIOL, V100, P3, DOI 10.1016/j.ijfoodmicro.2004.10.003
   Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7
   Leistner L, 2000, INT J FOOD MICROBIOL, V55, P181, DOI 10.1016/S0168-1605(00)00161-6
   Masana MO, 2000, FOOD MICROBIOL, V17, P485, DOI 10.1006/fmic.2000.0349
   Membre JM, 2001, FOOD MICROBIOL, V18, P531, DOI 10.1006/fmic.2001.0442
   Neter J, 1996, APPL LINEAR STAT MOD
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773
   Ratkowsky DA, 2002, INT J FOOD MICROBIOL, V73, P119, DOI 10.1016/S0168-1605(01)00643-2
   RATKOWSKY DA, 1995, LETT APPL MICROBIOL, V20, P29, DOI 10.1111/j.1472-765X.1995.tb00400.x
   ROSS T, 1993, J IND MICROBIOL, V12, P180, DOI 10.1007/BF01584188
   Ross T., 2004, Modeling microbial responses in food, P63
   Ross T, 2003, INT J FOOD MICROBIOL, V82, P33, DOI 10.1016/S0168-1605(02)00252-0
   Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   SAS Institute, 1999, SAS STAT US GUID VER
   Stokes ME, 1995, CATEGORICAL DATA ANA
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
   Uljas HE, 2001, APPL ENVIRON MICROB, V67, P133, DOI 10.1128/AEM.67.1.133-141.2001
   Vermeulen A, 2007, INT J FOOD MICROBIOL, V114, P332, DOI 10.1016/j.ijfoodmicro.2006.09.023
   Zhao L, 2002, INT J FOOD MICROBIOL, V77, P187, DOI 10.1016/S0168-1605(02)00111-3
NR 33
TC 35
Z9 40
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD MAR 20
PY 2007
VL 114
IS 3
BP 316
EP 331
DI 10.1016/j.ijfoodmicro.2006.09.026
PG 16
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 167CW
UT WOS:000246429500008
PM 17239980
DA 2020-05-07
ER

PT J
AU Preisner, O
   Lopes, JA
   Guiomar, R
   Machado, J
   Menezes, JC
AF Preisner, Ornella
   Lopes, Joao Almeida
   Guiomar, Raquel
   Machado, Jorge
   Menezes, Jose C.
TI Fourier transform infrared (FT-IR) spectroscopy in bacteriology: towards
   a reference method for bacteria discrimination
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT SPEC 2006
CY MAY 20-24, 2006
CL Heidelberg, GERMANY
DE PFGE typing; FT-IR spectroscopy; partial least-squares (PLS); genetic
   algorithm (GA); PLS-bootstrapping
ID ARTIFICIAL NEURAL-NETWORKS; RAPID IDENTIFICATION; RAMAN-SPECTROSCOPY;
   VARIABLE SELECTION; CELLS; MICROORGANISMS; CHEMOMETRICS; REGRESSION
AB Rapid and reliable discrimination among clinically relevant pathogenic organisms is a crucial task in microbiology. Microorganism resistance to antimicrobial agents increases prevalence of infections. The possibility of Fourier transform infrared (FT-IR) spectroscopy to assess the overall molecular composition of microbial cells in a non-destructive manner is reflected in the specific spectral fingerprints highly typical for different microorganisms. With the objective of using FT-IR spectroscopy for discrimination between diverse microbial species and strains on a routine basis, a wide range of chemometrics techniques need to be applied. Still a major issue in using FT-IR for successful bacteria characterization is the method for spectra pre-processing. We analyzed different spectra pre-processing methods and their impact on the reduction of spectral variability and on the increase of robustness of chemometrics models. Different types of the Enterococcus faecium bacterial strain were classified according to chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis (PFGE). Samples were collected from human patients. Collected FT-IR spectra were used to verify if the same classification was obtained. In order to further optimize bacteria classification we investigated whether a selected combination of the most discriminative spectral regions could improve results. Two different variable selection methods (genetic algorithms (GAs) and bootstrapping) were investigated and their relative merit for bacteria classification is reported by comparing with results obtained using the entire spectra. Discriminant partial least-squares (Di-PLS) models based on corrected spectra showed improved predictive ability up to 40% when compared to equivalent models using the entire spectral range. The uncertainty in estimating scores was reduced by about 50% when compared to models with all wavelengths. Spectral ranges with relevant chemical information for Enterococcus faecium bacteria discrimination were outlined.
C1 Univ Tecn Lisboa, Ctr Biol & Chem Engn, IST, P-1049001 Lisbon, Portugal.
   Univ Porto, REQUIMTE, Dept Phys Chem, P-4050047 Oporto, Portugal.
   Natl Hlth Inst Ricardo Jorge, Bacteriol Ctr, Enterobactereaceae Un, P-1649016 Lisbon, Portugal.
RP Preisner, O (reprint author), Univ Tecn Lisboa, Ctr Biol & Chem Engn, IST, Av Rovisco Pais, P-1049001 Lisbon, Portugal.
EM bsel@ist.utl.pt
RI Menezes, Jose/K-6163-2012; Lopes, Joao A/H-1733-2011
OI Menezes, Jose/0000-0002-6135-1301; Lopes, Joao A/0000-0002-1657-344X;
   Guiomar, Raquel/0000-0002-4563-6315
CR Alsberg BK, 1998, ANAL CHEM, V70, P4126, DOI 10.1021/ac980506o
   Ausubel FM, 1989, CURRENT PROTOCOLS MO
   Bakeev KA, 2005, J NEAR INFRARED SPEC, V13, P339, DOI 10.1255/jnirs.565
   Brereton R., 2003, CHEMOMETRICS DATA AN
   Brown M, 2005, METABOLOMICS, V1, P39, DOI 10.1007/s11306-005-1106-4
   Essendoubi M, 2005, BBA-GEN SUBJECTS, V1724, P239, DOI 10.1016/j.bbagen.2005.04.019
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Goicoechea HC, 2003, J CHEMOMETR, V17, P338, DOI 10.1002/cem.812
   Goodacre R, 1998, MICROBIOL-SGM, V144, P1157, DOI 10.1099/00221287-144-5-1157
   Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8
   Jarvis RM, 2005, BIOINFORMATICS, V21, P860, DOI 10.1093/bioinformatics/bti102
   Lazraq A, 2003, CHEMOMETR INTELL LAB, V66, P117, DOI 10.1016/S0169-7439(03)00027-3
   Lopez-Diez EC, 2004, ANAL CHEM, V76, P585, DOI 10.1021/ac035110d
   Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6
   Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003
   Martens H, 2003, ANAL CHEM, V75, P394, DOI 10.1021/ac020194w
   MARTENS H, 1992, MULTIVARIATE CALIBRA
   MICHALEWICZ Z, 1997, [No title captured]
   Mitchell M., 1999, INTRO GENETIC ALGORI
   Mobley PR, 1996, APPL SPECTROSC REV, V31, P347, DOI 10.1080/05704929608000575
   NAES T, 2002, NIR PUBLICATIONS, P344
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   NAUMANN D, 1995, J MOL STRUCT, V347, P399, DOI 10.1016/0022-2860(95)08562-A
   Naumann D., 2000, ENCY ANAL CHEM, P102, DOI DOI 10.1002/9780470027318.A0117
   NEU HC, 1992, SCIENCE, V257, P1073
   NORRIS K P, 1959, J Hyg (Lond), V57, P326
   RIDDLE JW, 1956, J BACTERIOL, V72, P593, DOI 10.1128/JB.72.5.593-603.1956
   Rosch P, 2006, BIOPOLYMERS, V82, P312, DOI 10.1002/bip.20449
   Sandt C, 2003, J CLIN MICROBIOL, V41, P954, DOI 10.1128/JCM.41.3.954-959.2003
   Udelhoven T, 2000, APPL SPECTROSC, V54, P1471, DOI 10.1366/0003702001948619
   Winder CL, 2004, J APPL MICROBIOL, V96, P328, DOI 10.1046/j.1365-2672.2003.02154.x
   Wu Q, 2001, ANAL CHEM, V73, P3432, DOI 10.1021/ac001268b
   Xie C, 2005, ANAL CHEM, V77, P4390, DOI 10.1021/ac0504971
NR 33
TC 56
Z9 57
U1 2
U2 22
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD MAR
PY 2007
VL 387
IS 5
BP 1739
EP 1748
DI 10.1007/s00216-006-0851-1
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 138AO
UT WOS:000244335000019
PM 17086390
DA 2020-05-07
ER

PT J
AU Ackert, LT
AF Ackert, Lloyd T., Jr.
TI The "cycle of life" in ecology: Sergei Vinogradskii's soil microbiology,
   1885-1940
SO JOURNAL OF THE HISTORY OF BIOLOGY
LA English
DT Article
DE autotrophism; chemosynthesis; cycle of life; ecology; nitrification;
   plant physiology; soil microbiology; Sergei Nikolaevich Vinogradskii
   (Winogradsky)
AB Historians of science have attributed the emergence of ecology as a discipline in the late nineteenth century to the synthesis of Humboldtian botanical geography and Darwinian evolution. In this essay, I begin to explore another, largely neglected but very important dimension of this history. Using Sergei Vinogradskii's career and scientific research trajectory as a point of entry, I illustrate the manner in which microbiologists, chemists, botanists, and plant physiologists inscribed the concept of a "cycle of life" into their investigations. Their research transformed a longstanding notion into the fundamental approaches and concepts that underlay the new ecological disciplines that emerged in the 1920s. Pasteur thus joins Humboldt as a foundational figure in ecological thinking, and the broader picture that emerges of the history of ecology explains some otherwise puzzling features of that discipline - such as its fusion of experimental and natural historical methodologies. Vinogradskii's personal "cycle of life" is also interesting as an example of the interplay between Russian and Western European scientific networks and intellectual traditions. Trained in Russia to investigate nature as a super-organism comprised of circulating energy, matter, and life; over the course of five decades - in contact with scientists and scientific discourses in France, Germany, and Switzerland - he developed a series of research methods that translated the concept of a "cycle of life" into an ecologically conceived soil science and microbiology in the 1920s and 1930s. These methods, bolstered by his authority as a founding father of microbiology, captured the attention of an international network of scientists. Vinogradskii's conceptualization of the "cycle of life" as chemosynthesis, autotrophy, and global nutrient cycles attracted the attention of ecosystem ecologists; and his methods appealed to practitioners at agricultural experiment stations and microbiological institutes in the United States, Western Europe, and the Soviet Union.
C1 Yale Univ, Dept Hist, New Haven, CT 06520 USA.
RP Ackert, LT (reprint author), Yale Univ, Dept Hist, POB 208324, New Haven, CT 06520 USA.
EM lloydackert@sbcglobal.net
CR Ackert L., 2004, THESIS J HOPKINS U
   ACOT P, 1988, HIST ECOLOGIE
   Anker Peder, 2001, IMPERIAL ECOLOGY ENV
   Borges Jorge Luis, 1964, LABYRINTHS SELECTED, P189
   BREFELD O, 1872, BOT UNTERS SCHIMMELP, V1, P1
   BROWNE J., 1983, SECULAR ARK STUDIES
   Bulloch William, 1938, HIST BACTERIOLOGY
   Cittadino Eugene, 1990, NATURE LAB DARWINIAN
   Cohn F., 1872, BEITR BIOL PFLANZ, P127
   COHN F, 1872, SAMML GEM WISS VORTR, V7
   Cohn Ferdinand, 1939, BACTERIA SMALLEST LI
   COHN P, 1901, F COHN BLATTER ERINN
   COLEMAN W, 1986, J HIST BIOL, V19, P181, DOI 10.1007/BF00138875
   COMFORT NC, 2001, TANGLED FIELD B MCCL
   COOPER JE, 1998, MICROBES MEN SCI BAS
   DOETSCH RN, 1960, MICROBIOLOGY HIST CO
   DUMAS JB, 1842, ESSAI STAT ETRES ORG
   FAMINTSYN AS, 1860, ORGANISMY GRANITSE Z
   FAMINTSYN AS, 1883, OBMEN VESHCHESTVO PR
   Fruton J., 1972, MOL LIFE HIST ESSAYS
   GEISON GL, 1970, DICT SCI BIOGRAPHY, V3, P336
   GLAS E, 1979, CHEM PHYSL THEIR HIS
   Golley F. B., 1993, HIST ECOSYSTEM CONCE
   Hagan Joel B., 1992, ENTANGLED BANK ORIGI
   HERAEUS A, 1886, Z HYG, V1, P193
   Holmes F., 1974, C BERNARD ANIMAL CHE
   Ihde AJ, 1964, DEV MODERN CHEM
   KOCH A, 1891, BOT ZEITUNG, V49, P669
   KOCH A, 1891, BOT ZEITUNG, V49, P698
   KOCH A, 1891, BOT ZEITUNG, V49, P680
   KRAINSKY A, 1914, ZENTR BAKTERIOL PARA, V41, P649
   KREMER RL, 1990, THERMODYNAMICS LIFE
   KURSANOV AL, 1981, A SERGEEVICH FAMINTS
   Lenoir Timothy, 1982, STRATEGY LIFE TELEOL
   MANOILENKO KV, 1981, ROL AS FAMINTSYN RAZ, P131
   McIntosh Robert P, 1985, BACKGROUND ECOLOGY C
   Mendelsohn J. A., 1996, THESIS PRINCETON U
   MOBERG CL, 1991, SCI AM, P66
   NICOLSON M, 1996, BRIT J HIST SCI 3, V9, P289
   OMELIANSKII VL, 1927, ARKHIV BIOL NAUK, V27, P10
   OMELIANSKII VL, 1909, OSNOVY MIKROBIOLOGII
   PASTEUR VR, 1939, OEUVRES PASTEUR
   Pfeffer W, 1897, PFLANZENPHYSIOLOGIE
   REIKHBERG GE, 1931, BORBA NAUKU TSARSKOI
   RESSE M, 1870, BOT UNTERSUCHUNGEN A
   ROBINSON G, 1970, DICT SCI BIOGRAPHY, V1, P612
   ROSEN G, 1959, HIST DEV PHYSL THOUG, P243
   RUSSEL EJ, 1956, LAND CALLED ME AUTOB
   Russel EJ, 1923, MICROORGANISMS SOIL
   RUSSEL EJ, 1966, HIST AGR SCI GREAT B
   RUSSEL EJ, 1921, SOIL CONDITIONS PLAN
   SCHLOESING J, 1878, CR HEBD ACAD SCI, V86, P892
   SCHLOESING J, 1879, CR HEBD ACAD SCI, V89, P1074
   Schloesing J, 1877, CR HEBD ACAD SCI, V85, P1018
   SCHLOESING J, 1879, CR HEBD ACAD SCI, V89, P891
   Schloesing J., 1877, CR HEBD ACAD SCI, VLXXXIV, P301
   Stanier R. Y., 1951, Q REV BIOL, V26, P35
   STROGONOV BP, 1996, AS FAMINTSYN 1835 19
   TEICH M, 1970, CHEM LIFE 8 LECT HIS, P171
   Todes DP, 2001, PAVLOVS PHYSL FACTOR
   TSCHULOK S, 1910, SYSTEM BIOL FORSCHUN
   VERNADSKY V, 1930, ZHIVOE VECHESTVO
   VINOGRADSKII SN, 1935, SOIL SCI, V40, P50
   VINOGRADSKII SN, 1897, ARKHIV BIOL NAUK, V7, P1
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P606
   VINOGRADSKII SN, 1891, ANN I PASTEUR, V5, P92
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P489
   VINOGRADSKII SN, 1891, CR HEBD ACAD SCI, V63, P89
   VINOGRADSKII SN, 1919, BIBLIO ZENTRALBLATT
   VINOGRADSKII SN, 1890, ANN I PASTEUR, V4, P215
   VINOGRADSKII SN, 1890, CR HEBD ACAD SCI, V60, P1013
   VINOGRADSKII SN, 1942, COPIE FORMULAIRE ALL
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P585
   VINOGRADSKII SN, 1890, ANN I PASTEUR, V4, P760
   VINOGRADSKII SN, 1883, MYCODERMA TRUDY SANK, V16, P132
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P529
   VINOGRADSKII SN, 1949, ITOGI ARCHIVES RUSSI
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P569
   VINOGRADSKII SN, 1951, MIKROBIOLOGIIA POCHV
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P513
   VINOGRADSKII SN, 1891, ANN I PASTEUR, V5, P577
   VINOGRADSKII SN, 1889, BOT ZEITUNG, V45, P545
   VINOGRADSKII SN, 1949, INFLUENCE SUBSTANCES
   VINOGRADSKY S, 1890, ANN I PAST, V4, P257
   Waksman SA, 1922, J BACTERIOL, V7, P239, DOI 10.1128/JB.7.2.239-256.1922
   WAKSMAN SA, 1932, PRINCIPLES SOIL MICR
   WAKSMAN SA, 1922, J BACTERIOL, P231
   WAKSMAN SA, 1922, J BACTERIOL, P605
   WAKSMAN SA, 1953, S WINOGRADSKY HIS LI
   WAKSMAN SA, 1922, J BACTERIOL, P609
   Waksman Selman A., 1954, MY LIFE MICROBES
   Weiner Douglas R, 1988, MODELS NATURE ECOLOG
   Worster Donald, 1994, NATURES EC HIST ECOL
NR 93
TC 7
Z9 8
U1 0
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-5010
J9 J HIST BIOL
JI J. Hist. Biol.
PD MAR
PY 2007
VL 40
IS 1
BP 109
EP 145
DI 10.1007/s10739-006-9104-6
PG 37
WC Biology; History & Philosophy Of Science
SC Life Sciences & Biomedicine - Other Topics; History & Philosophy of
   Science
GA 137SX
UT WOS:000244313600004
DA 2020-05-07
ER

PT J
AU Poirazi, P
   Leroy, F
   Georgalaki, MD
   Aktypis, A
   De Vuyst, L
   Tsakalidou, E
AF Poirazi, Panayiota
   Leroy, Frederic
   Georgalaki, Marina D.
   Aktypis, Anastassios
   De Vuyst, Luc
   Tsakalidou, Effie
TI Use of artificial neural networks and a gamma-concept-based approach to
   model growth of and bacteriocin production by Streptococcus macedonicus
   ACA-DC 198 under simulated conditions of Kasseri cheese production
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID LACTIC-ACID BACTERIA; PREDICTIVE FOOD MICROBIOLOGY; COOKED
   MEAT-PRODUCTS; LEUCONOSTOC-MESENTEROIDES; PH CONDITIONS; TEMPERATURE;
   FUNCTIONALITY; IDENTIFICATION; FERMENTATION; VALIDATION
AB Growth of and bacteriocin production by Streptococcus macedonicus ACA-DC 198 were assessed and modeled under conditions simulating Kasseri cheese production. Controlled fermentations were performed in milk supplemented with yeast extract at different combinations of temperature (25, 40, and 55 degrees C), constant pH (pHs 5 and 6), and added NaCl (at concentrations of 0, 2, and 4%, wt/vol). The data obtained were used to construct two types of predictive models, namely, a modeling approach based on the gamma concept, as well as a model based on artificial neural networks (ANNs). The latter computational methods were used on 36 control fermentations to quantify the complex relationships between the conditions applied (temperature, pH, and NaCl) and population behavior and to calculate the associated biokinetic parameters, i.e., maximum specific growth and cell count decrease rates and specific bacteriocin production. The functions obtained were able to estimate these biokinetic parameters for four validation fermentation experiments and obtained good agreement between modeled and experimental values. Overall, these experiments show that both methods can be successfully used to unravel complex kinetic patterns within biological data of this kind and to predict population kinetics. Whereas ANNs yield a better correlation between experimental and predicted results, the gamma-concept-based model is more suitable for biological interpretation. Also, while the gamma-concept-based model has not been designed for modeling of other biokinetic parameters than the specific growth rate, ANNs are able to deal with any parameter of relevance, including specific bacteriocin production.
C1 Agr Univ Athens, Lab Dairy Res, Dept Food Sci & Technol, Athens 11855, Greece.
   Vrije Univ Brussel VIB, Res Grp Ind Microbiol & Food Biotechnol, Dept Appl Biol Sci & Engn, B-1050 Brussels, Belgium.
   Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Computat Biol Lab, Iraklion 71110, Greece.
RP Tsakalidou, E (reprint author), Agr Univ Athens, Lab Dairy Res, Dept Food Sci & Technol, Iera Odos 75, Athens 11855, Greece.
EM et@aua.gr
RI Leroy, Frederic/D-2424-2009
OI Leroy, Frederic/0000-0001-8682-9626; De Vuyst, Luc/0000-0002-7534-7186;
   Poirazi, Panayiota/0000-0001-6152-595X
CR Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   BUCHANAN RL, 1993, TRENDS FOOD SCI TECH, V4, P6, DOI 10.1016/S0924-2244(05)80004-4
   Cogan T. M., 1993, Cheese: chemistry, physics and microbiology. Volume 1. General aspects., P193
   de Vuyst L., 1994, BACTERIOCINS LACTIC, P91, DOI DOI 10.1007/978-1-4615-2668-1_3
   DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424
   Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Georgalaki MD, 2002, APPL ENVIRON MICROB, V68, P5891, DOI 10.1128/AEM.68.12.5891-5903.2002
   Georgalaki MD, 2000, J APPL MICROBIOL, V88, P817, DOI 10.1046/j.1365-2672.2000.01055.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004
   Leroy F, 2003, APPL ENVIRON MICROB, V69, P1093, DOI 10.1128/AEM.69.2.1093-1099.2003
   Leroy F, 2002, INT J FOOD MICROBIOL, V73, P251, DOI 10.1016/S0168-1605(01)00657-2
   Leroy F, 1999, APPL ENVIRON MICROB, V65, P974
   Leroy F, 2005, INT J FOOD MICROBIOL, V100, P141, DOI 10.1016/j.ijfoodmicro.2004.10.011
   Lopes MFS, 1999, APPL ENVIRON MICROB, V65, P4484
   Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m
   McDonald K, 1999, INT J FOOD MICROBIOL, V52, P1, DOI 10.1016/S0168-1605(99)00126-9
   Nauta MJ, 2002, INT J FOOD MICROBIOL, V73, P297, DOI 10.1016/S0168-1605(01)00664-X
   NETTLES CG, 1993, J FOOD PROTECT, V56, P338, DOI 10.4315/0362-028X-56.4.338
   O'Sullivan L, 2002, BIOCHIMIE, V84, P593, DOI 10.1016/S0300-9084(02)01457-8
   Papadelli M, 2003, INT J FOOD MICROBIOL, V81, P231, DOI 10.1016/S0168-1605(02)00243-X
   ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995
   Siripatrawan U, 2004, J FOOD PROTECT, V67, P1604, DOI 10.4315/0362-028X-67.8.1604
   STEFFEN C, 1993, CHEESE CHEM PHYSICS, V2, P83, DOI DOI 10.1007/978-1-4615-2648-3_3
   Stiles ME, 1996, ANTON LEEUW INT J G, V70, P331, DOI 10.1007/BF00395940
   TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971
   te Giffel MC, 1999, INT J FOOD MICROBIOL, V46, P135, DOI 10.1016/S0168-1605(98)00189-5
   Tsakalidou E, 1998, INT J SYST BACTERIOL, V48, P519, DOI 10.1099/00207713-48-2-519
   Van den Berghe E, 2006, INT J FOOD MICROBIOL, V107, P138, DOI 10.1016/j.ijfoodmicro.2005.08.023
   WALSTRA P, 1993, CHEESE CHEM PHYSICS, V2, P39
   Wijtzes T, 2001, INT J FOOD MICROBIOL, V63, P57, DOI 10.1016/S0168-1605(00)00401-3
   Zurera-Cosano G, 2005, EUR FOOD RES TECHNOL, V221, P717, DOI 10.1007/s00217-005-0006-1
   Zwietering MH, 1996, INT J FOOD MICROBIOL, V30, P55, DOI 10.1016/0168-1605(96)00991-9
NR 36
TC 22
Z9 22
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD FEB
PY 2007
VL 73
IS 3
BP 768
EP 776
DI 10.1128/AEM.01721-06
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 136ZY
UT WOS:000244263800013
PM 17158625
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Oleskin, AV
   Kirovskaya, TA
AF Oleskin, A. V.
   Kirovskaya, T. A.
TI A network structure in microbiology
SO HERALD OF THE RUSSIAN ACADEMY OF SCIENCES
LA English
DT Article
ID DISTANT INTERACTIONS
C1 Moscow MV Lomonosov State Univ, Fac Biol, Dept Physiol Microorganisms, Moscow, Russia.
RP Oleskin, AV (reprint author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Physiol Microorganisms, Moscow, Russia.
CR CHUCHKEVICH MM, 1999, FDN CONTROL NETWORK
   DEWSBERY D, 1978, ANIMAL BEHAV
   IERUSALIMSKII ND, 1952, THESIS I MIKROBIOLOG
   KIROVSKAYA TA, 2005, THESIS I ISTORII EST
   LOVELOCK JE, 1979, GAIA NEW LOOK LIFE E
   Nikolaev YA, 2000, MICROBIOLOGY+, V69, P497, DOI 10.1007/BF02756798
   Nikolaev YA, 2000, MICROBIOLOGY+, V69, P291, DOI 10.1007/BF02756736
   Nikolaev Yu A., 2000, Mikrobiologiya, V69, P597
   OLESKIN AV, 1998, HERALD RAS, V68, P471
   OLESKIN AV, 1997, RES BIOPOLITICS, V5
   OLESKIN AV, 1996, SOC SCI INFORM, V35
   SHERSTOBAEV KN, 1961, MIKROBIOLOGIYA, V30
   SMIRNOV SG, 1985, PHYSIOCHEMICAL STUDI
   Tambiev A. Kh., 2003, MILLIMETER WAVES PHO
   VINOGRADSKII SN, 1896, ROLE MICROBES TOTAL
NR 15
TC 2
Z9 2
U1 0
U2 1
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1019-3316
J9 HER RUSS ACAD SCI+
JI Her. Russ. Acad. Sci.
PD FEB
PY 2007
VL 77
IS 1
BP 32
EP 40
DI 10.1134/S1019331607010066
PG 9
WC History & Philosophy Of Science; Multidisciplinary Sciences
SC History & Philosophy of Science; Science & Technology - Other Topics
GA 167LS
UT WOS:000246453800006
DA 2020-05-07
ER

PT J
AU McMeekin, TA
   Baranyi, J
   Bowman, J
   Dalgaard, P
   Kirk, M
   Ross, T
   Schmid, S
   Zwietering, MH
AF McMeekin, T. A.
   Baranyi, J.
   Bowman, J.
   Dalgaard, P.
   Kirk, M.
   Ross, T.
   Schmid, S.
   Zwietering, M. H.
TI Information systems in food safety management
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT 19th International ICFMH Symposium on Food Micro
CY 2004
CL Portoroz, SLOVENIA
DE information systems; databases; applied systematics; applications
   software; knowledge management; RFID technology
ID QUANTITATIVE RISK-ASSESSMENT; DECISION-SUPPORT-SYSTEM;
   LISTERIA-MONOCYTOGENES; PREDICTIVE MICROBIOLOGY; CLOSTRIDIUM-BOTULINUM;
   OUTBREAK DETECTION; ESCHERICHIA-COLI; EXPERT-SYSTEMS; UNITED-STATES;
   GROWTH
AB Information systems are concerned with data capture, storage, analysis and retrieval. In the context of food safety management they are vital to assist decision making in a short time frame, potentially allowing decisions to be made and practices to be actioned in real time.
   Databases with information on microorganisms pertinent to the identification of foodborne pathogens, response of microbial populations to the environment and characteristics of foods and processing conditions are the cornerstone of food safety management systems. Such databases find application in:
   Identifying pathogens in food at the genus or species level using applied systematics in automated ways.
   Identifying pathogens below the species level by molecular subtyping, an approach successfully applied in epidemiological investigations of foodborne disease and the basis for national surveillance programs.
   Predictive modelling software, such as the Pathogen Modeling Program and Growth Predictor (that took over the main functions of Food Micromodel) the raw data of which were combined as the genesis of an international web based searchable database (ComBase).
   Expert systems combining databases on microbial characteristics, food composition and processing information with the resulting "pattern match" indicating problems that may arise from changes in product formulation or processing conditions.
   Computer software packages to aid the practical application of HACCP and risk assessment and decision trees to bring logical sequences to establishing and modifying food safety management practices. In addition there are many other uses of information systems that benefit food safety more globally, including:
   Rapid dissemination of information on foodborne disease outbreaks via websites or list servers carrying commentary from many sources, including the press and interest groups, on the reasons for and consequences of foodbome disease incidents.
   Active surveillance networks allowing rapid dissemination of molecular subtyping information between public health agencies to detect foodbome outbreaks and limit the spread of human disease.
   Traceability of individual animals or crops from (or before) conception or germination to the consumer as an integral part of food supply chain management.
   Provision of high quality, online educational packages to food industry personnel otherwise precluded from access to such courses. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Tasmania, Australian Food Safety Ctr Excellence, Hobart, Tas 7001, Australia.
   AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England.
   Tech Univ Denmark, Danish Inst Fisheries Res, Dept Seafood Res, Minist Food Agr & Fisheries, DK-2800 Lyngby, Denmark.
   OzFoodNet, Dept Hlth & Ageing, Canberra, ACT 2601, Australia.
   EAN Australia, Mt Waverley, Vic 3149, Australia.
   Food Microbiol Lab, NL-6700 EV Wageningen, Netherlands.
RP McMeekin, TA (reprint author), Univ Tasmania, Australian Food Safety Ctr Excellence, Private Bag 54, Hobart, Tas 7001, Australia.
EM Tom.McMeekin@utas.edu.au
RI Baranyi, Jozsef/A-7531-2008; Dalgaard, Paw/Y-9193-2018; Zwietering,
   Marcel/C-2479-2008; Bowman, John/C-2414-2014
OI Baranyi, Jozsef/0000-0001-8360-6021; Dalgaard, Paw/0000-0002-9147-1232;
   Zwietering, Marcel/0000-0003-2704-5690; Bowman,
   John/0000-0002-4528-9333; Kirk, Martyn/0000-0001-5432-5984; Ross,
   Tom/0000-0001-9916-7772
CR ADAIR C, 1993, J IND MICROBIOL, V12, P263, DOI 10.1007/BF01584200
   Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1
   *AUSTR FOOD SAF CT, 2004, FOOD SAF TOOLS RISK
   Backer HD, 2001, PUBLIC HEALTH REP, V116, P257, DOI 10.1016/S0033-3549(04)50041-9
   Baranyi J, 2004, J FOOD PROTECT, V67, P1967, DOI 10.4315/0362-028X-67.9.1967
   Barker GC, 2002, INT BIODETER BIODEGR, V50, P167, DOI 10.1016/S0964-8305(02)00083-5
   Bean NH, 2001, EMERG INFECT DIS, V7, P773
   Bigelow WD, 1921, J INFECT DIS, V29, P528, DOI 10.1093/infdis/29.5.528
   BLACK JFP, 2002, THESIS MONASH U VICT
   Bridson EY, 2000, LETT APPL MICROBIOL, V30, P95, DOI 10.1046/j.1472-765x.2000.00673.x
   BROCKLEHURST T, 2003, MODELING MICROBIAL R, P233
   Brown MH, 1998, J FOOD PROTECT, V61, P1446, DOI 10.4315/0362-028X-61.11.1446
   Buche P, 2002, INT J FOOD MICROBIOL, V73, P171, DOI 10.1016/S0168-1605(01)00647-X
   CAC (Codex Alimentarius Commission), 2001, FOOD HYG BAS TEXTS
   Cassin MH, 1998, INT J FOOD MICROBIOL, V41, P21, DOI 10.1016/S0168-1605(98)00028-2
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1129
   Chick H, 1910, J Hyg (Lond), V10, P237
   Denton W, 2003, QUALITY OF FISH FROM CATCH TO CONSUMER: LABELLING, MONITORING AND TRACEABILITY, P75
   Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004
   Effler P, 1999, JAMA-J AM MED ASSOC, V282, P1845, DOI 10.1001/jama.282.19.1845
   Esty JR, 1922, J INFECT DIS, V31, P650, DOI 10.1093/infdis/31.6.650
   Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590
   *EXP, 2004, RPOB RISK ASS US FAR
   Fazil AM, 2002, INT J FOOD MICROBIOL, V73, P315, DOI 10.1016/S0168-1605(01)00667-5
   Frederiksen M., 2002, Journal of Aquatic Food Product Technology, V11, P13, DOI 10.1300/J030v11n02_03
   Furness A., 2003, Food authenticity and traceability, P473, DOI 10.1533/9781855737181.3.473
   Gimenez B, 2004, J APPL MICROBIOL, V96, P96, DOI 10.1046/j.1365-2672.2003.02137.x
   GRAHAM A, 1993, LETT APPL MICROBIOL, V16, P158, DOI 10.1111/j.1472-765X.1993.tb01383.x
   Gyllenberg M, 2002, SYST APPL MICROBIOL, V25, P403, DOI 10.1078/0723-2020-00109
   HEDBERG CW, 2003, WHITE PAPER APPL EPI
   Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038
   *HHS USDA, 2003, QUANT ASS REL RISK P
   Hickey RM, 2003, MICROBIOL-SGM, V149, P655, DOI 10.1099/mic.0.25949-0
   HIGHTOWER AW, 1995, EMERG INFECT DIS, V1, P156, DOI 10.3201/eid0104.950414
   *ILSI, 1997, SIMPL GUID UND APPL
   Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c
   Kirk MD, 2004, EPIDEMIOL INFECT, V132, P571, DOI 10.1017/S095026880400216X
   Koutsoumanis KP, 2004, FOOD MICROBIOL, V21, P415, DOI 10.1016/j.fm.2003.11.003
   Larsen E., 2003, Food authenticity and traceability, P507, DOI 10.1533/9781855737181.3.507
   Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003.abs
   Le Marc Y, 2005, INT J FOOD MICROBIOL, V100, P3, DOI 10.1016/j.ijfoodmicro.2004.10.003
   Liao SH, 2003, EXPERT SYST APPL, V25, P155, DOI 10.1016/S0957-4174(03)00043-5
   Lindsay EA, 2002, EMERG INFECT DIS, V8, P732, DOI 10.3201/eid0807.010414
   Linko S, 1998, TRENDS FOOD SCI TECH, V9, P3, DOI 10.1016/S0924-2244(97)00002-2
   Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9
   McMeekin T. A., 2003, Detecting pathogens in food
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V78, P133, DOI 10.1016/S0168-1605(02)00231-3
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Mermelstein NH, 2000, FOOD TECHNOL-CHICAGO, V54, P56
   MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103
   *NACMCF, 1997, J FOOD PROTECT, V61, P762
   Nagamine K, 2001, CLIN CHEM, V47, P1742
   NAUTA M, 2002, INT J FOOD MICROBIOL, V38, P45
   Neumeyer K, 1997, AUST J DAIRY TECHNOL, V52, P120
   Oscar TP, 2004, INT J FOOD MICROBIOL, V93, P231, DOI 10.1016/j.ijfoodmicro.2003.12.002
   Panackal AA, 2002, EMERG INFECT DIS, V8, P685, DOI 10.3201/eid0807.010493
   Ratkowsky DA, 1996, J APPL BACTERIOL, V80, P131, DOI 10.1111/j.1365-2672.1996.tb03200.x
   RATKOWSKY DA, 2004, MODELING MICROBIAL R, P233
   Raupach Jane C A, 2003, Commun Dis Intell Q Rep, V27, P380
   Ravichandran V, 2004, ELECTROPHORESIS, V25, P297, DOI 10.1002/elps.200305748
   Ross T., 2004, Modeling microbial responses in food, P63
   Ross T, 2003, RISK ANAL, V23, P179, DOI 10.1111/1539-6924.00299
   Ross T, 2003, INT J FOOD MICROBIOL, V82, P33, DOI 10.1016/S0168-1605(02)00252-0
   Ross T, 2002, INT J FOOD MICROBIOL, V77, P39, DOI 10.1016/S0168-1605(02)00061-2
   ROSS T, 1995, HAZARD ANAL CRITICAL, P330
   ROSS T, 2000, [No title captured], P1699
   ROWAN C, 2002, FOOD ENG INGRED 0214
   SANDERSON K, 2003, DETECTING PATHOGENS, P259
   SCHELLEKENS M, 1994, INT J FOOD MICROBIOL, V24, P1, DOI 10.1016/0168-1605(94)90102-3
   Sobel J, 2002, PUBLIC HEALTH REP, V117, P8, DOI 10.1093/phr/117.1.8
   Stern L, 1999, EPIDEMIOL INFECT, V122, P103, DOI 10.1017/S0950268898001939
   Swaminathan B, 2001, EMERG INFECT DIS, V7, P382
   Tamplin M., 2004, Modeling microbial responses in food, P233
   Tuominen P, 2003, FOOD CONTROL, V14, P573, DOI 10.1016/S0956-7135(02)00147-0
   Uyttendaele M., 2003, Detecting pathogens in food, P332, DOI 10.1533/9781855737044.2.332
   van Gerwen SJC, 1997, INT J FOOD MICROBIOL, V38, P1, DOI 10.1016/S0168-1605(97)00077-9
   van Gerwen SJC, 2000, J APPL MICROBIOL, V88, P938, DOI 10.1046/j.1365-2672.2000.01059.x
   Ventura M, 2003, APPL ENVIRON MICROB, V69, P6908, DOI 10.1128/AEM.69.11.6908-6922.2003
   VOYER R, 1993, J IND MICROBIOL, V12, P256, DOI 10.1007/BF01584199
   WHITING RC, 1993, J IND MICROBIOL, V12, P240, DOI 10.1007/BF01584196
   Widdowson MA, 2003, EMERG INFECT DIS, V9, P1046
   Wijtzes T, 1998, INT J FOOD MICROBIOL, V42, P79, DOI 10.1016/S0168-1605(98)00068-3
   Williams TL, 2003, J AM SOC MASS SPECTR, V14, P342, DOI 10.1016/S1044-0305(03)00065-5
   Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0
   ZWIETERING MH, 1992, J FOOD PROTECT, V55, P973, DOI 10.4315/0362-028X-55.12.973
   Zwietering MH, 2002, INT DAIRY J, V12, P263, DOI 10.1016/S0958-6946(01)00156-X
   ZWIETERING MH, 1997, TRANSICHEME, V75, P159
   ZWIETERING MH, 1997, T IND CHEM ENG, V75, P168
   2002, OFFICIAL J EUROPEAN, P1
NR 89
TC 116
Z9 127
U1 3
U2 121
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD DEC 1
PY 2006
VL 112
IS 3
BP 181
EP 194
DI 10.1016/j.ijfoodmicro.2006.04.048
PG 14
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 114AP
UT WOS:000242639400001
PM 16934895
DA 2020-05-07
ER

PT J
AU Mueller, MM
   Seifried, E
AF Mueller, M. M.
   Seifried, E.
TI Blood transfusion in Europe: basic principles for initial and continuous
   training in transfusion medicine: an approach to an European
   harmonisation
SO TRANSFUSION CLINIQUE ET BIOLOGIQUE
LA English
DT Article; Proceedings Paper
CT Euro-SAT 2006 Meeting on Transfusion Safety in Europe
CY OCT 12-13, 2006
CL Paris, FRANCE
DE transfusion medicine; initial training; continuous training; European
   harmonisation
AB Over the past few decades, transfusion medicine and haemotherapy have evolved into complex medical disciplines comprising a broad field of subspecialties such as immunohaematology, blood component production, haemapheresis and haemostaseology. Transfusion medicine is thus an important qualification at the interfaces of analytical laboratory medicine, pharmaceutical production and clinical disciplines such as internal medicine, anaesthesiology or surgery. Physicians specialising in transfusion medicine are valuable and competent partners for these related disciplines when it comes to safe, effective and tailored haemotherapy. Why has transfusion medicine become so complex? On the one hand, one can discern problems such as infectious diseases like the HIV disaster in the past century, resulting in guidelines, directives and laws such as the transfusion law in Germany. Thereby, we now enjoy the highest level of blood product safety ever regarding viral transmission thanks to the broad implementation of PCR testing. On the other hand, there are numerous positive reasons for the increasing complexity of transfusion medicine: Modem medical therapies like stem cell transplantation, cellular therapy, transplantation of solid organs, regenerative medicine and surgery cannot exist without a safe supply of blood products and high quality standard as well as special blood products and laboratory services provided by blood banks and transfusion medicine specialists. Good laboratory practice (GLP), good manufacturing practice (GMP), quality management systems and quality control on the pharmaceutical manufacturer's level are only few examples of the standards in today's blood banking. European directives in the field of blood products, stem cell preparations and tissue have led to higher uniform quality standards for biological preparations in a unified Europe, which is the desired outcome, but which also increases the complexity of this field. In contrast, directives 93/16/EEC and 2001/19/EC, the directives of the European Parliament and of the Council on the mutual recognition of professional qualifications of European doctors currently in force, as well as the impending directive 2005/36/EC, which has to be translated into national law until October 2007, do not include transfusion medicine, blood transfusion or immunohaematology at all. Other medical specialities, which like our field, are not common to all member states of the European Union, are listed in the above mentioned directives with the minimum length of training and minimal requirements for the qualifications. Examples include clinical biology, biological haematology, microbiology-bacteriology, biological chemistry, immunology, thoracic, paediatric or vascular surgery as well as physiotherapy, stomatology, neuro-psychiatry, dermato-venerology, occupational medicine, allergology, geriatrics, gastro-enterological surgery, community medicine, nuclear medicine, pharmacology, accident and emergency medicine or tropical medicine. Most of the above are medical specialities in some member states, but not in all. A concerted initiative inaugurated by the European Network of Transfusion Medicine Societies (EuroNet-TMS) and the European Blood Alliance (EBA) aims to compile the situation of the transfusion medicine speciality throughout Europe. A preliminary summary of the current situation in 15 European states was prepared in 2005 after a first set of questions, which was sent out by us via the EBA platform.
   The authors appreciate Clair Watts' compilation of the answers provided by the 15 Euroean colleagues. A summary of these answers is depicted in Table 1. However, the initiative aims at a more complex analysis of the different requirements and constituent parts of the qualification in transfusion medicine in different countries. A long-term objective of this initiative might be to introduce the transfusion medicine specialisation into the above mentioned EC directives in order to facilitate mutual recognition of transfusion medicine qualifications throughout Europe. (c) 2007 Elsevier Masson SAS. All rights reserved.
C1 Clin Univ Frankfurt, Inst Transfus Med & Immunohaematol, Frankfurt, Germany.
   German Red Cross Blood Transfus Ctr, D-60528 Frankfurt, Germany.
RP Mueller, MM (reprint author), Clin Univ Frankfurt, Inst Transfus Med & Immunohaematol, Frankfurt, Germany.
EM m.mueller@blutspende.de
NR 0
TC 12
Z9 13
U1 0
U2 8
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1246-7820
J9 TRANSFUS CLIN BIOL
JI Transfu. Clin. Biol.
PD NOV
PY 2006
VL 13
IS 5
BP 282
EP 289
DI 10.1016/j.tracli.2006.11.004
PG 8
WC Hematology; Immunology
SC Hematology; Immunology
GA 137HJ
UT WOS:000244283400002
PM 17196864
DA 2020-05-07
ER

PT J
AU Yu, C
   Davidson, VJ
   Yang, SX
AF Yu, Ce
   Davidson, Valerie J.
   Yang, Simon X.
TI A neural network approach to predict survival/death and growth/no-growth
   interfaces for Escherichia coli O157 : H7
SO FOOD MICROBIOLOGY
LA English
DT Article
DE predictive model; neural network; growth/no-growth interface; E. coli
   O157 : H7
ID LOGISTIC-REGRESSION; BACTERIAL-GROWTH; MICROBIAL-GROWTH; TEMPERATURE;
   PROBABILITY; MODEL; SALT
AB An artificial neural network (ANN) model was developed to predict survival/death and growth/no-growth interfaces for Escherichia coli O157:H7 in a mayonnaise-type system. Temperature, pH, acetic acid, sucrose and salt were the inputs to a three-layer back-propagation neural network. The ANN model was trained using the data-set of McKellar et al. [2002. A probability model describing the interface between survival and death of E. coli O157:H7 in a mayonnaise model system. Food Microbiol. 19, 235-247] that consisted of 1820 treatment combinations from controlled experiments with a cocktail of five strains of E coli O157:H7. After training, the model correctly predicted the growth/no-growth in 1810 combinations (99.5%) with 8 false positives and 2 false negatives, and survival/death in 1804 combinations (99.1%) with 13 false positives and 3 false negatives. Classification accuracy was validated using additional literature data-sets for growth of E coli O157:147 under various environmental conditions. The ANN model accurately predicted the survival/ death in 27 of 30 cases (90%) in experimental mayonnaise inoculated with E coli O157:H7, with 3 fail-positive predictions and all observed growth (100%). Simulations were used to estimate the influence of incubation temperature on survival and growth for specific combinations of acetic acid, salt, pH and sucrose. The ANN model is recommended as an alternative tool for classification of survival and growth conditions in predictive microbiology. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Davidson, VJ (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
EM vdavidso@uoguelph.ca
RI Yang, Simon X./A-4399-2008
OI Yang, Simon X./0000-0002-6888-7993
CR CONNER DE, 1995, APPL ENVIRON MICROB, V61, P382, DOI 10.1128/AEM.61.1.382-385.1995
   ENTACHER K, 1998, ACM T MODEL COMPUT S, V7, P61
   Hajmeer M, 2003, FOOD MICROBIOL, V20, P43, DOI 10.1016/S0740-0020(02)00104-1
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAYKIN S., 1999, NEURAL NETWORKS COMP
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   McKellar RC, 2002, FOOD MICROBIOL, V19, P235, DOI 10.1006/fmic.2001.0449
   McKellar RC, 2001, J FOOD PROTECT, V64, P1922, DOI 10.4315/0362-028X-64.12.1922
   RATKOWSKY DA, 1995, LETT APPL MICROBIOL, V20, P29, DOI 10.1111/j.1472-765X.1995.tb00400.x
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
NR 10
TC 10
Z9 15
U1 1
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0740-0020
EI 1095-9998
J9 FOOD MICROBIOL
JI Food Microbiol.
PD SEP
PY 2006
VL 23
IS 6
BP 552
EP 560
DI 10.1016/j.fm.2005.09.008
PG 9
WC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
SC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
GA 043WN
UT WOS:000237633700007
PM 16943051
DA 2020-05-07
ER

PT J
AU Pien, BC
   Saah, JR
   Miller, SE
   Woods, CW
AF Pien, BC
   Saah, JR
   Miller, SE
   Woods, CW
TI Use of sentinel laboratories by clinicians to evaluate potential
   bioterrorism and emerging infections
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID REAL-TIME PCR; BIOLOGICAL WEAPON; INHALATIONAL ANTHRAX; AGENTS;
   DIAGNOSIS; SMALLPOX; ASSAY; SARS; IDENTIFICATION; LIGHTCYCLER
AB With the persistent threat of emerging infectious diseases and bioterrorism, it has become increasingly important that clinicians be able to identify the diseases that might signal the occurrence of these unusual events. Essential to a thoughtful diagnostic approach is understanding when to initiate a public health investigation and how to appropriately use commonly performed microbiology procedures in the sentinel laboratory to evaluate potential pathogens. Although diagnostic test development is evolving rapidly, recognizing many of these pathogens continues to challenge the capabilities of most sentinel laboratories. Therefore, effective, ongoing communication and education among clinicians, infection control personnel, sentinel laboratorians, public health authorities, and Laboratory Response Network reference laboratorians is the key to preparedness.
C1 Duke Univ, Med Ctr, Durham VA Med Ctr, Durham, NC 27705 USA.
   N Carolina State Lab Publ Hlth, Bioterrorism & Emerging Pathogens Unit, Raleigh, NC USA.
   Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA.
   Duke Univ, Med Ctr, Div Infect Dis & Clin Microbiol Lab, Durham, NC 27705 USA.
   Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27705 USA.
   Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27705 USA.
RP Woods, CW (reprint author), Duke Univ, Med Ctr, Durham VA Med Ctr, Durham, NC 27705 USA.
EM woods004@mc.duke.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [UO1AI066569, U01 AI066569]
CR *AM SOC MICR, [No title captured]
   *AM SOC MICR ASS P, [No title captured]
   *AM SOC MICR ASS P, [No title captured]
   Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059
   Beigel H, 2005, NEW ENGL J MED, V353, P1374
   Bell CA, 2002, J CLIN MICROBIOL, V40, P2897, DOI 10.1128/JCM.40.8.2897-2902.2002
   Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391
   Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025
   *CDCP, [No title captured]
   *CDCP, [No title captured]
   *CDCP, AC GEN VES PUST RASH
   Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P127
   Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2
   Christensen DR, 2006, CLIN CHEM, V52, P141, DOI 10.1373/clinchem.2005.052522
   Christian MD, 2004, CLIN INFECT DIS, V38, P1420, DOI 10.1086/420743
   Clarridge JE, 1996, J CLIN MICROBIOL, V34, P1995, DOI 10.1128/JCM.34.8.1995-2000.1996
   *CLSI, 2005, M100S15 CLSI, P136
   Cockerill FR, 2004, J CLIN MICROBIOL, V42, P2359, DOI 10.1128/JCM.42.6.2359-2365.2004
   Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   Freedman A, 2002, JAMA-J AM MED ASSOC, V287, P869, DOI 10.1001/jama.287.7.869
   GARINBASTUJI B, 2004, [No title captured]
   Gerberding JL, 2002, JAMA-J AM MED ASSOC, V287, P898, DOI 10.1001/jama.287.7.898
   Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327
   Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127
   Howell JM, 2004, CLIN INFECT DIS, V39, P1842, DOI 10.1086/426080
   Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236
   Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281
   Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353
   Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604
   Klietmann WF, 2001, CLIN MICROBIOL REV, V14, P364, DOI 10.1128/CMR.14.2.364-381.2001
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035
   Lau SKP, 2005, EMERG INFECT DIS, V11, P1108, DOI 10.3201/eid1107.041045
   Liang GD, 2004, EMERG INFECT DIS, V10, P1774, DOI 10.3201/eid1010.040445
   Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005
   Miller JM, 2001, INFECT DIS CLIN N AM, V15, P1127, DOI 10.1016/S0891-5520(05)70189-6
   Miller SE, 2003, ULTRASTRUCT PATHOL, V27, P133, DOI 10.1080/01913120309932
   Moore ZS, 2004, CLIN INFECT DIS, V39, P1810, DOI 10.1086/426026
   MORSE S, 2004, [No title captured]
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   O'Hara CM, 2005, CLIN MICROBIOL REV, V18, P147, DOI 10.1128/CMR.18.1.147-162.2005
   Olson VA, 2004, J CLIN MICROBIOL, V42, P1940, DOI 10.1128/JCM.42.5.1940-1946.2004
   ROE DE, 2001, 101 GEN M AM SOC MIC, P230
   ROECARPENTER D, 2005, [No title captured]
   Ross JJ, 2004, CLIN INFECT DIS, V38, P1139, DOI 10.1086/383063
   Sejvar JJ, 2005, LANCET INFECT DIS, V5, P287, DOI 10.1016/S1473-3099(05)70113-4
   Snyder JW, 2003, J CLIN MICROBIOL, V41, P1, DOI 10.1128/JCM.41.1.1-4.2003
   Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507
   *US DEP HHS, [No title captured]
   Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003
   WHO, 2002, WHO MAN AN INFL DIAG
   *WHO, [No title captured]
   Wilmoth BA, 1996, J CLIN MICROBIOL, V34, P2829, DOI 10.1128/JCM.34.11.2829-2830.1996
   World Health Organization, CUM NUMB CONF HUM CA
NR 55
TC 15
Z9 17
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 1
PY 2006
VL 42
IS 9
BP 1311
EP 1324
DI 10.1086/503260
PG 14
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 029JD
UT WOS:000236557600015
PM 16586392
OA Bronze, Green Published
DA 2020-05-07
ER

PT J
AU Esnoz, A
   Periago, PM
   Conesa, R
   Palop, A
AF Esnoz, A
   Periago, PM
   Conesa, R
   Palop, A
TI Application of artificial neural networks to describe the combined
   effect of pH and NaCl on the heat resistance of Bacillus
   stearothermophilus
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE neural networks; predictive microbiology; thermal inactivation;
   bacterial spores; Bacillus stearothermophilus
ID MICROBIAL-GROWTH; PREDICTIVE MICROBIOLOGY; BACTERIAL-GROWTH; FOOD;
   INACTIVATION; TEMPERATURE; METHODOLOGY; INTERFACE
AB A model for prediction of bacterial spore inactivation was developed. The influence of temperature, pH and NaCl on the heat resistance of Bacillus stearotherinophilus spores was described using low-complexity, black box models based on artificial neural networks. Literature data were used to build and train the neural network, and new experimental data were used to evaluate it. The neural network models gave better predictions than the classical quadratic response surface model in all the experiments tried. When the neural networks were evaluated using new experimental data, also good predictions were obtained, providing fail-safe predictions of D values in all cases. The weights and biases values of neurons of the neural network that gave the best results are presented, so the reader can use the model for their own purposes. The use of this non-linear modelling technique makes it possible to describe more accurately interacting effects of environmental factors when compared with classical predictive microbial models. (C) 2005 Elsevier B.V. All rights reserved.
C1 Univ Politecn Cartagena, Dept Ingn Alimentos & Equipamiento Agr, Murcia 30203, Spain.
RP Esnoz, A (reprint author), Univ Politecn Cartagena, Dept Ingn Alimentos & Equipamiento Agr, P Alfonso XIII,48, Murcia 30203, Spain.
EM arturo.esnoz@upct.es
CR Bishop C. M., 1995, NEURAL NETWORKS PATT
   Cheroutre-Vialette M, 2002, INT J FOOD MICROBIOL, V73, P107, DOI 10.1016/S0168-1605(01)00642-0
   DELIGNETTEMULLER ML, 1995, INT J FOOD MICROBIOL, V27, P139, DOI 10.1016/0168-1605(94)00158-3
   FERNANDEZ PS, 1994, J FOOD PROTECT, V57, P37, DOI 10.4315/0362-028X-57.1.37
   FORESEE FD, 1997, P 1997 INT JOINT C N, P1930, DOI DOI 10.1109/ICNN.1997.614194
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Geeraerd AH, 1998, J FOOD ENG, V36, P263, DOI 10.1016/S0260-8774(98)00064-8
   Geeraerd AH, 2004, INT J FOOD MICROBIOL, V91, P229, DOI 10.1016/S0168-1605(03)00388-X
   GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI 10.1016/S0168-1605(00)00395-0
   Hagan M. T., 1996, NEURAL NETWORK DESIG
   Hajmeer MN, 2003, INT J FOOD MICROBIOL, V82, P233, DOI 10.1016/S0168-1605(02)00308-2
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V73, P395, DOI 10.1016/S0168-1605(01)00663-8
   McMeekin TA, 1996, J FOOD PROTECT, P37, DOI 10.4315/0362-028X-59.13.37
   Mittal GS, 2002, INT J FOOD MICROBIOL, V79, P153, DOI 10.1016/S0168-1605(02)00109-5
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   Peleg M, 1998, CRIT REV FOOD SCI, V38, P353, DOI 10.1080/10408699891274246
   Periago PM, 1998, INT J FOOD MICROBIOL, V44, P21, DOI 10.1016/S0168-1605(98)00111-1
   RamosNino ME, 1997, J APPL MICROBIOL, V82, P168, DOI 10.1111/j.1365-2672.1997.tb02847.x
   STERN JA, 1954, FOOD TECHNOL-CHICAGO, V8, P139
   WHITING RC, 1995, CRIT REV FOOD SCI, V35, P467, DOI 10.1080/10408399509527711
NR 24
TC 23
Z9 25
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD FEB 1
PY 2006
VL 106
IS 2
BP 153
EP 158
DI 10.1016/j.ijfoodmicro.2005.06.016
PG 6
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 012WM
UT WOS:000235371600007
PM 16216369
DA 2020-05-07
ER

PT J
AU Slonim, N
   Elemento, O
   Tavazoie, S
AF Slonim, Noam
   Elemento, Olivier
   Tavazoie, Saeed
TI Ab initio genotype-phenotype association reveals intrinsic modularity in
   genetic networks
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE comparative genomics; genotype-phenotype association; information
   theory; microbiology; modularity
ID SALMONELLA-TYPHIMURIUM; OUTER-MEMBRANE; HELICOBACTER-PYLORI; GENOME
   SEQUENCE; HOST-CELL; PROTEIN; BACTERIUM; INFORMATION; SECRETION;
   INVASION
AB Microbial species express an astonishing diversity of phenotypic traits, behaviors, and metabolic capacities. However, our molecular understanding of these phenotypes is based almost entirely on studies in a handful of model organisms that together represent only a small fraction of this phenotypic diversity. Furthermore, many microbial species are not amenable to traditional laboratory analysis because of their exotic lifestyles and/or lack of suitable molecular genetic techniques. As an adjunct to experimental analysis, we have developed a computational information-theoretic framework that produces high-confidence gene-phenotype predictions using cross-species distributions of genes and phenotypes across 202 fully sequenced archaea and eubacteria. In addition to identifying the genetic basis of complex traits, our approach reveals the organization of these genes into generic preferentially co-inherited modules, many of which correspond directly to known enzymatic pathways, molecular complexes, signaling pathways, and molecular machines.
C1 Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.
   Princeton Univ, Dept Phys, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.
RP Tavazoie, S (reprint author), Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Washington St,Carl Icahn,Room 245, Princeton, NJ 08544 USA.
EM tavazoie@genomics.princeton.edu
CR Alberts B, 1994, MOL BIOL CELL
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067
   Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x
   Copley SD, 2002, GENOME BIOL, V3
   COVER TM, 1991, ELEMENTS INFORMATION
   Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861
   DREYFUS G, 1993, J BACTERIOL, V175, P3131, DOI 10.1128/JB.175.10.3131-3138.1993
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750
   Fu YX, 1999, NATURE, V401, P293
   Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53
   Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660
   Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174
   Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574
   Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540
   Hegermann J, 2002, NATURWISSENSCHAFTEN, V89, P453, DOI 10.1007/s00114-002-0359-2
   Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004
   Huynen M, 1998, FEBS LETT, V426, P1, DOI 10.1016/S0014-5793(98)00276-2
   Jagannathan A, 2001, J BACTERIOL, V183, P2937, DOI 10.1128/JB.183.9.2937-2942.2001
   Jim K, 2004, GENOME RES, V14, P109
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134
   Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130
   Levesque M, 2003, CURR BIOL, V13, P129, DOI 10.1016/S0960-9822(03)00009-5
   Makarova KS, 2003, TRENDS GENET, V19, P172, DOI 10.1016/S0168-9525(03)00047-7
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Mecsas J, 1996, EMERG INFECT DIS, V2, P271, DOI 10.3201/eid0204.960403
   Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285
   Pittman MS, 2001, MICROBIOL-SGM, V147, P2493, DOI 10.1099/00221287-147-9-2493
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014
   Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389
   Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074
   Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102
   SLONIM N, 2005, ESTIMATING MUTUAL IN
   Sonenshein AL, 2002, CURR BIOL, V12, pR90, DOI 10.1016/S0960-9822(02)00668-1
   Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830
   Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857
   Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060
   Wolfe AJ, 2004, APPL ENVIRON MICROB, V70, P2520, DOI 10.1128/AEM.70.4.2520-2524.2004
   Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015
NR 46
TC 46
Z9 47
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PY 2006
VL 2
AR 2006.0005
DI 10.1038/msb4100047
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 122RX
UT WOS:000243245400007
PM 16732191
OA Green Published
DA 2020-05-07
ER

PT J
AU Vernacchio, L
   Vezina, RM
   Mitchell, AA
   Lesko, SM
   Plaut, AG
   Acheson, DWK
AF Vernacchio, L
   Vezina, RM
   Mitchell, AA
   Lesko, SM
   Plaut, AG
   Acheson, DWK
TI Diarrhea in American infants and young children in the community setting
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
ID ENTEROAGGREGATIVE ESCHERICHIA-COLI; CLOSTRIDIUM-DIFFICILE; HEALTHY
   INFANTS; ETIOLOGY; COLONIZATION; ROTAVIRUS; CHILDHOOD; TOXIN
AB Objective: The characteristics and microbiology of the full spectrum of pediatric diarrhea occurring in the U.S. community setting are not well-understood.
   Methods: Six-month prospective cohort study of 604 healthy 6- to 36-month-old children recruited by the Slone Center Office-based Research Network.
   Results: The incidence of parent-defined diarrhea was 2.2 episodes per person-year. The median duration of diarrhea was 2 days with a median of 6 stools per episode. Outpatient visits and hospitalization were prompted by 9.7 and 0.3% of episodes, respectively. The most common microorganisms identified in healthy baseline stools were atypical enteropathogenic Escherichia coli (12.2%), enteroaggregative Escherichia coli (3.7%), Clostridium difficile (3.5%) and Clostridium perfringens (2.9%), and each of these was no more common in diarrhea stools. In contrast, all of the viruses analyzed were more prevalent in diarrhea specimens than in baseline specimens: enteric adenovirus (5.7% diarrhea versus 1.4% baseline), rotavirus (5.2% versus 1.4%), astrovirus (3.5% versus 1.4%), Sapporo-like virus (3.0% versus 0.8%) and norovirus (1.9% versus 0.8%). A likely pathogen was detected in 20.6% of diarrhea specimens. Vomiting and 16 stools in an episode were predictive of isolating a pathogen from the stool, each with a relative risk of -2.
   Conclusions: Healthy young children in this study experienced more than 2 cases of diarrhea per person-year, but most were brief and do not require medical attention. Although most diarrheaassociated pathogens were viruses, no likely pathogen was found in almost 80% of cases; possible etiologies for these cases include currently unknown gastrointestinal infections, nongastrointestinal illnesses and dietary/environmental factors.
C1 Boston Univ, Slone Epidemiol Ctr, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Tufts Univ New England Med Ctr, GRASP Digest Dis Res Ctr, Boston, MA USA.
   Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
RP Vernacchio, L (reprint author), Boston Univ, Slone Epidemiol Ctr, 1010 Commonwealth Ave, Boston, MA 02115 USA.
EM lvernacchio@slone.bu.edu
OI Vernacchio, Louis/0000-0002-2012-5404; Mitchell,
   Allen/0000-0003-0950-6799
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [P30-DK-034928]
CR Barlow Bradley S, 2002, ASDC J Dent Child, V69, P148
   Caeiro JP, 1999, PEDIATR INFECT DIS J, V18, P94, DOI 10.1097/00006454-199902000-00003
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1
   CERQUETTI M, 1995, PEDIATR INFECT DIS J, V14, P598, DOI 10.1097/00006454-199507000-00009
   COHEN MB, 1991, J PEDIATR-US, V118, pS34, DOI 10.1016/S0022-3476(05)81423-4
   COOPERSTOCK M, 1983, J CLIN MICROBIOL, V17, P830, DOI 10.1128/JCM.17.5.830-833.1983
   Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007
   Denno DM, 2005, PEDIATR INFECT DIS J, V24, P142, DOI 10.1097/01.inf.0000151031.47761.6d
   Forward LJ, 2003, J MED MICROBIOL, V52, P753, DOI 10.1099/jmm.0.05119-0
   GLASS RI, 1991, J PEDIATR-US, V118, pS27, DOI 10.1016/S0022-3476(05)81422-2
   HO MS, 1988, J INFECT DIS, V158, P1112, DOI 10.1093/infdis/158.5.1112
   Huang DB, 2004, AM J GASTROENTEROL, V99, P383, DOI 10.1111/j.1572-0241.2004.04041.x
   HULL AE, 1993, J CLIN MICROBIOL, V31, P1167, DOI 10.1128/JCM.31.5.1167-1172.1993
   KLEINMAN RE, 2004, PEDIAT NUTR HDB, P459
   Kneepkens CMF, 1996, PEDIATR CLIN N AM, V43, P375, DOI 10.1016/S0031-3955(05)70411-9
   Macknin ML, 2000, PEDIATRICS, V105, P747, DOI 10.1542/peds.105.4.747
   MARDH PA, 1982, ACTA PAEDIATR SCAND, V71, P275, DOI 10.1111/j.1651-2227.1982.tb09414.x
   Pass MA, 2000, J CLIN MICROBIOL, V38, P2001, DOI 10.1128/JCM.38.5.2001-2004.2000
   Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2
   Robins-Browne RM, 2002, J GASTROEN HEPATOL, V17, P467, DOI 10.1046/j.1440-1746.2002.02769.x
   Sarantuya J, 2004, J CLIN MICROBIOL, V42, P133, DOI 10.1128/JCM.42.1.133-139.2004
   STARK PL, 1982, INFECT IMMUN, V35, P895, DOI 10.1128/IAI.35.3.895-899.1982
   Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385
   TULLUS K, 1989, EUR J CLIN MICROBIOL, V8, P390, DOI 10.1007/BF01964052
   van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098
   Vanderhoof J A, 1998, Pediatr Rev, V19, P418
   Wake M, 2000, PEDIATRICS, V106, P1374, DOI 10.1542/peds.106.6.1374
   Waters V, 2000, PEDIATR INFECT DIS J, V19, P843, DOI 10.1097/00006454-200009000-00007
   Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472
   Zimmerman CM, 2001, PEDIATR INFECT DIS J, V20, P14, DOI 10.1097/00006454-200101000-00004
NR 30
TC 84
Z9 94
U1 1
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JAN
PY 2006
VL 25
IS 1
BP 2
EP 7
DI 10.1097/01.inf.0000195623.57945.87
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA 004MM
UT WOS:000234756900002
PM 16395094
DA 2020-05-07
ER

PT J
AU Crapoulet, N
   Renesto, P
   Dumler, JS
   Suhre, K
   Ogata, H
   Claverie, JM
   Raoult, D
AF Crapoulet, N
   Renesto, P
   Dumler, JS
   Suhre, K
   Ogata, H
   Claverie, JM
   Raoult, D
TI Tropheryma whipplei genome at the beginning of the post-genomic era
SO CURRENT GENOMICS
LA English
DT Article
DE T. whipplei; reduced genomes; post-genomics
ID MINIMAL-GENE-SET; COXIELLA-BURNETII; ANTIBIOTIC SUSCEPTIBILITY;
   LEGIONELLA-PNEUMOPHILA; ESCHERICHIA-COLI; MOLECULAR EVALUATION;
   BACTERIAL PATHOGENS; REPEATED SEQUENCES; DISEASE; EVOLUTION
AB Tropheryma whipplei is a Gram positive human pathogen that is the causative agent of Whipple's disease. Nearly one century elapsed between the first description of the disease in 1907 and the cultivation of this bacterium within eukaryotic cell cultures in 2000. This achievement has made possible genome sequencing of this poorly studied microorganism. This review summarizes post-genomic knowledge resulting from these genomic data. To compare the theoretical genetic capabilities of T whipplei with those of other sequenced bacteria, a virtual microarray representation was generated. This in silico analysis supports the concept of independent evolution pathways for microbial pathogens. Concrete post-genomic consequences related to clinical microbiology such as the analysis of antibiotic susceptibility or the design of molecular tools convenient for PCR detection and epidemiology studies are described. Analysis of whole-cell metabolic networks of T whipplei also provide clues for designing axenic media for this pathogen that is particularly recalcitrant to cultivation. This opens the way to investigate transcriptome analysis of T. whipplei by microarrays. Future prospects are also discussed.
C1 Fac Med Marseille, IFR 48, UMR 6020, CNRS,Unite Rickettsies, F-13385 Marseille, France.
   Johns Hopkins Univ, Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD 21218 USA.
   CNRS, UPR 2589, F-13409 Marseille, France.
RP Raoult, D (reprint author), Fac Med Marseille, IFR 48, UMR 6020, CNRS,Unite Rickettsies, 27 Bd Jean Moulin, F-13385 Marseille, France.
EM Didier.Raoult@medecine.univ-mrs.fr
RI Renesto, patricia/M-6105-2014; Suhre, Karsten/AAF-1778-2020; Claverie,
   Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019; renesto,
   patricia/T-6446-2019
OI Suhre, Karsten/0000-0001-9638-3912; Claverie,
   Jean-Michel/0000-0003-1424-0315; renesto, patricia/0000-0002-6749-7862
CR Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986
   Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4
   Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453
   Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313
   Boulos A, 2004, ANTIMICROB AGENTS CH, V48, P747, DOI 10.1128/AAC.48.3.747-752.2004
   Boulos A, 2005, J ANTIMICROB CHEMOTH, V55, P178, DOI 10.1093/jac/dkh524
   Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0
   Cannon WR, 2003, LANCET, V361, P1916, DOI 10.1016/S0140-6736(03)13533-7
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   DOBBINS WO, 1987, WHIPPLES DIS
   Doolittle RF, 2002, NATURE, V419, P493, DOI 10.1038/419493a
   ENTLEY SD, 2004, ANNU REV GENET, V38, P771
   Fenollar F, 2004, J CLIN MICROBIOL, V42, P401, DOI 10.1128/JCM.42.1.401-403.2004
   Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002
   Fournier PE, 2004, J CLIN MICROBIOL, V42, P5757, DOI 10.1128/JCM.42.12.5757-5766.2004
   Frank AC, 2002, GENETICA, V115, P1
   FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397
   Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375
   FRASR CM, 1909, NATURE, V390, P580
   Freiberg C, 2004, CURR OPIN MICROBIOL, V7, P451, DOI 10.1016/j.mib.2004.08.010
   Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002
   Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619
   Gogarten JP, 1999, CURR OPIN GENET DEV, V9, P630, DOI 10.1016/S0959-437X(99)00029-5
   Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48
   HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240
   Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803
   Herrgard MJ, 2004, CURR OPIN BIOTECH, V15, P70, DOI 10.1016/j.copbio.2003.11.002
   Hinrikson HP, 2000, INT J SYST EVOL MICR, V50, P1007, DOI 10.1099/00207713-50-3-1007
   Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   Hughes D, 2000, GENOME BIOL, V1
   Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42
   Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189
   Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0
   Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99
   Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751
   La Scola B, 2001, INT J SYST EVOL MICR, V51, P1471, DOI 10.1099/00207713-51-4-1471
   Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9
   Maiwald M, 1996, INT J SYST BACTERIOL, V46, P1078, DOI 10.1099/00207713-46-4-1078
   Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760
   Marth T, 2003, LANCET, V361, P239, DOI 10.1016/S0140-6736(03)12274-X
   Masselot F, 2003, ANTIMICROB AGENTS CH, V47, P1658, DOI 10.1128/AAC.47.5.1658-1664.2003
   McGrath CL, 2004, TRENDS ECOL EVOL, V19, P32, DOI 10.1016/j.tree.2003.10.007
   Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7
   Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268
   Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543
   Peterson SN, 2001, GENOME BIOL, V2
   Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903
   Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603
   Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397
   RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501
   Renesto P, 2003, LANCET, V362, P447, DOI 10.1016/S0140-6736(03)14071-8
   Rovery C, 2005, RES MICROBIOL, V156, P211, DOI 10.1016/j.resmic.2004.09.002
   Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388
   Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0
   Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668
   Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100
   Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074
   Shirai M, 2000, NUCLEIC ACIDS RES, V28, P2311, DOI 10.1093/nar/28.12.2311
   Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33
   Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873
   Wei Y, 2001, J BACTERIOL, V183, P545, DOI 10.1128/JB.183.2.545-556.2001
   Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068
   Wernegreen JJ, 2002, MICROBIOL-SGM, V148, P2551, DOI 10.1099/00221287-148-8-2551
   Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382
   WILLEMS H, 1994, J VET MED B, V41, P580, DOI 10.1111/j.1439-0450.1994.tb00267.x
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x
   Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8
   Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003
NR 73
TC 3
Z9 3
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2029
EI 1875-5488
J9 CURR GENOMICS
JI Curr. Genomics
PD MAY
PY 2005
VL 6
IS 3
BP 195
EP 205
DI 10.2174/1389202053971929
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 930BM
UT WOS:000229390800007
DA 2020-05-07
ER

PT J
AU Swinnen, IAM
   Bernaerts, K
   Dens, EJJ
   Geeraerd, AH
   Van Impe, JF
AF Swinnen, IAM
   Bernaerts, K
   Dens, EJJ
   Geeraerd, AH
   Van Impe, JF
TI Predictive modelling of the microbial lag phase: a review
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE lag phase; temperature; culture history; predictive microbiology;
   modelling
ID OPTICAL-DENSITY MEASUREMENTS; ARTIFICIAL NEURAL-NETWORKS; MILD
   TEMPERATURE INCREASE; BACTERIAL-GROWTH KINETICS; VIABLE COUNT DATA;
   LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; SODIUM-CHLORIDE; INOCULUM
   SIZE; AEROMONAS-HYDROPHILA
AB This paper summarises recent trends in predictive modelling of microbial lag phenomena. The lag phase is approached from both a qualitative and a quantitative point of view. First, a definition of lag and an analysis of the prevailing measuring techniques for the determination of lag time is presented. Furthermore, based on experimental results presented in literature, factors influencing the lag phase are discussed. Major modelling approaches concerning lag phase estimation are critically assessed. In predictive microbiology, a two-step modelling approach is used. Primary models describe the evolution of microbial numbers with time and can be subdivided into deterministic and stochastic models. Primary deterministic models, e.g., Baranyi and Roberts [Int. J. Food Microbiol. 23 (1994) 277], Hills and Wright [J. Theor. Biol. 168 (1994) 31] and McKellar [Int. J. Food Microbiol. 36 (1997) 179], describe the evolution of microorganisms, using one single (deterministic) set of model parameters. In stochastic models, e.g., Buchanan et al. [Food Microbiol. 14 (1997) 313], Baranyi [J. Theor. Biol. 192 (1998) 403] and McKellar [J. Appl. Microbiol. 90 (2001) 407], the model parameters are distributed or random variables. Secondary models describe the relation between primary model parameters and influencing factors (e.g., environmental conditions). This survey mainly focusses on the influence of temperature and culture history on the lag phase during growth of bacteria. (C) 2004 Elsevier B.V. All rights reserved.
C1 Katholieke Univ Leuven, BioTeC Bioproc Technol & Control, B-3001 Louvain, Belgium.
RP Van Impe, JF (reprint author), Katholieke Univ Leuven, BioTeC Bioproc Technol & Control, W de Croylaan 46, B-3001 Louvain, Belgium.
EM jan.vanimpe@cit.kuleuven.ac.be
RI Geeraerd, Annemie/AAC-5006-2020
OI Geeraerd, Annemie/0000-0001-8473-4092; Bernaerts,
   Kristel/0000-0001-6211-7042
CR ADAIR C, 1989, Food Microbiology (London), V6, P7, DOI 10.1016/S0740-0020(89)80033-4
   Alavi SH, 1999, J FOOD PROTECT, V62, P170, DOI 10.4315/0362-028X-62.2.170
   Augustin JC, 2000, INT J FOOD MICROBIOL, V57, P169, DOI 10.1016/S0168-1605(00)00260-9
   Augustin JC, 1999, J MICROBIOL METH, V38, P137, DOI 10.1016/S0167-7012(99)00089-5
   Augustin JC, 2000, APPL ENVIRON MICROB, V66, P1706, DOI 10.1128/AEM.66.4.1706-1710.2000
   BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0
   Baranyi J, 1999, APPL ENVIRON MICROB, V65, P732
   BARANYI J, 1993, J IND MICROBIOL, V12, P190, DOI 10.1007/BF01584189
   Baranyi J, 1998, J THEOR BIOL, V192, P403, DOI 10.1006/jtbi.1998.0673
   Baranyi J, 1997, FOOD MICROBIOL, V14, P189, DOI 10.1006/fmic.1996.0080
   Baty F, 2004, INT J FOOD MICROBIOL, V91, P261, DOI 10.1016/j.ijfoodmicro.2003.07.002
   Baty F, 2002, APPL ENVIRON MICROB, V68, P5816, DOI 10.1128/AEM.68.12.5816-5825.2002
   Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9
   Bernaerts K, 2002, INT J FOOD MICROBIOL, V73, P145, DOI 10.1016/S0168-1605(01)00645-6
   BERNAERTS K, 2003, MODELING MICROBIAL R, V7, P243
   BRATCHELL N, 1989, INT J FOOD MICROBIOL, V8, P47, DOI 10.1016/0168-1605(89)90079-2
   Breand S, 1997, INT J FOOD MICROBIOL, V38, P157, DOI 10.1016/S0168-1605(97)00093-7
   Breand S, 1999, INT J FOOD MICROBIOL, V46, P251, DOI 10.1016/S0168-1605(98)00200-1
   BUCHANAN R L, 1990, Food Microbiology (London), V7, P237, DOI 10.1016/0740-0020(90)90029-H
   Buchanan RL, 1997, FOOD MICROBIOL, V14, P313, DOI 10.1006/fmic.1997.0125
   BUCHANAN RL, 1991, INT J FOOD MICROBIOL, V12, P235, DOI 10.1016/0168-1605(91)90074-Y
   BUCHANAN RL, 1992, FOOD MICROBIOL, V9, P185, DOI 10.1016/0740-0020(92)80046-7
   BUCHANAN RL, 1990, J FOOD PROTECT, V53, P370, DOI 10.4315/0362-028X-53.5.370
   BUCHANAN RL, 1972, J FOOD SCI, V37, P81, DOI 10.1111/j.1365-2621.1972.tb03391.x
   Budde BB, 2001, INT J FOOD MICROBIOL, V63, P65, DOI 10.1016/S0168-1605(00)00399-8
   CASADEI MA, 1995, MED MICROBIOL LETT, V4, P382
   Cheroutre-Vialette M, 2002, INT J FOOD MICROBIOL, V73, P107, DOI 10.1016/S0168-1605(01)00642-0
   Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0
   DAVEY KR, 1991, J APPL BACTERIOL, V70, P253, DOI 10.1111/j.1365-2672.1991.tb02933.x
   Delignette-Muller ML, 1998, INT J FOOD MICROBIOL, V43, P97, DOI 10.1016/S0168-1605(98)00100-7
   DENS EJ, 2003, FOOD PRESERVATION TE, P475
   Devlieghere F, 2000, INT J FOOD MICROBIOL, V58, P93, DOI 10.1016/S0168-1605(00)00291-9
   Dufrenne J, 1997, INT J FOOD MICROBIOL, V34, P89, DOI 10.1016/S0168-1605(96)01170-1
   Francois K, 2003, LETT APPL MICROBIOL, V37, P26, DOI 10.1046/j.1472-765X.2003.01340.x
   FRANCOIS K, 2003, PREDICTIVE MODELLING, P200
   FU B, 1991, J FOOD SCI, V56, P1209, DOI 10.1111/j.1365-2621.1991.tb04736.x
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   GARTHRIGHT WE, 1991, FOOD MICROBIOL, V8, P239, DOI 10.1016/0740-0020(91)90056-8
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7
   GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI 10.1016/S0168-1605(00)00395-0
   HILLS BP, 1995, FOOD MICROBIOL, V12, P333, DOI 10.1016/S0740-0020(95)80114-6
   HILLS BP, 1994, J THEOR BIOL, V168, P31, DOI 10.1006/jtbi.1994.1085
   HUDSON JA, 1994, J FOOD SAFETY, V14, P329, DOI 10.1111/j.1745-4565.1994.tb00604.x
   HUDSON JA, 1993, LETT APPL MICROBIOL, V16, P274, DOI 10.1111/j.1472-765X.1993.tb01417.x
   INGRAHAM JL, 1996, ESCHERICHIA COLI SAL, P1570
   Jacobsen CN, 1997, J MICROBIOL METH, V28, P35
   Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275
   Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7
   McDonald K, 1999, INT J FOOD MICROBIOL, V52, P1, DOI 10.1016/S0168-1605(99)00126-9
   McKellar RC, 1997, INT J FOOD MICROBIOL, V36, P179, DOI 10.1016/S0168-1605(97)01266-X
   McKellar RC, 2000, INT J FOOD MICROBIOL, V54, P171, DOI 10.1016/S0168-1605(99)00204-4
   McKellar RC, 2002, INT J FOOD MICROBIOL, V73, P137, DOI 10.1016/S0168-1605(01)00644-4
   McKellar RC, 2002, INT J FOOD MICROBIOL, V73, P127, DOI 10.1016/S0168-1605(01)00720-6
   McKellar RC, 2001, J APPL MICROBIOL, V90, P407, DOI 10.1046/j.1365-2672.2001.01258.x
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V73, P395, DOI 10.1016/S0168-1605(01)00663-8
   McMeekin TA, 1997, EMERG INFECT DIS, V3, P541, DOI 10.3201/eid0304.970419
   MCMEEKIN TA, 1993, PREDICTIVE MICROBIOL
   MELLEFONT L, 2000, PREDICTIVE MODELILIN, P70
   Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P295, DOI 10.1016/S0168-1605(02)00378-1
   Membre JM, 1999, LETT APPL MICROBIOL, V28, P216, DOI 10.1046/j.1365-2672.1999.00499.x
   Metris A, 2003, J MICROBIOL METH, V55, P821, DOI 10.1016/j.mimet.2003.08.006
   METRIS A, 2002, P 7 EUR C FOOD IND S, P61
   NG H, 1962, J BACTERIOL, V84, P331, DOI 10.1128/JB.84.2.331-339.1962
   Nicolai BM, 1996, MATH COMPUT SIMULAT, V42, P287, DOI 10.1016/0378-4754(95)00129-8
   Pascual C, 2001, LETT APPL MICROBIOL, V33, P357, DOI 10.1046/j.1472-765X.2001.01012.x
   Pirt S.J., 1975, PRINCIPLES MICROBE C
   Poschet F, 2004, MATH COMPUT SIMULAT, V65, P231, DOI 10.1016/j.matcom.2003.12.002
   Rajkowski KT, 1995, J FOOD PROTECT, V58, P1307, DOI 10.4315/0362-028X-58.12.1307
   RATKOWSKY DA, 1991, J APPL BACTERIOL, V71, P452, DOI 10.1111/j.1365-2672.1991.tb03816.x
   RATKOWSKY DA, 1982, J BACTERIOL, V149, P1
   Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2
   Robinson TP, 2001, INT J FOOD MICROBIOL, V70, P163, DOI 10.1016/S0168-1605(01)00541-4
   ROSS T, 1994, INT J FOOD MICROBIOL, V23, P241, DOI 10.1016/0168-1605(94)90155-4
   ROSS T, 1993, THESIS U TASMANIA AU
   ROSS T, 1999, PREDICTIVE MICROBIOL
   ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995
   SHAW MK, 1967, J BACTERIOL, V93, P1332, DOI 10.1128/JB.93.4.1332-1336.1967
   SKINNER GE, 1994, J FOOD SAFETY, V14, P175, DOI 10.1111/j.1745-4565.1994.tb00594.x
   Smelt JPPM, 2002, INT J FOOD MICROBIOL, V73, P207, DOI 10.1016/S0168-1605(01)00651-1
   SMITH MG, 1985, J HYG-CAMBRIDGE, V94, P289, DOI 10.1017/S0022172400061519
   STANAERT AR, 2003, PREDICTIVE MODELLING, P203
   VANIMPE JFM, 2003, PREDICTIVE MODELLING
   WALKER SJ, 1993, J IND MICROBIOL, V12, P273, DOI 10.1007/BF01584202
   Whiting RC, 2002, INT J FOOD MICROBIOL, V73, P291, DOI 10.1016/S0168-1605(01)00662-6
   WHITING RC, 1995, CRIT REV FOOD SCI, V35, P467, DOI 10.1080/10408399509527711
   Wu Y, 2000, LETT APPL MICROBIOL, V30, P468, DOI 10.1046/j.1472-765X.2000.00748.x
   Zaika LL, 1998, INT J FOOD MICROBIOL, V41, P9, DOI 10.1016/S0168-1605(98)00037-3
   ZWIETERING MH, 1991, APPL ENVIRON MICROB, V57, P1094, DOI 10.1128/AEM.57.4.1094-1101.1991
   ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P204, DOI 10.1128/AEM.60.1.204-213.1994
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
   ZWIETERING MH, 1992, J APPL BACTERIOL, V72, P139, DOI 10.1111/j.1365-2672.1992.tb01815.x
NR 92
TC 234
Z9 244
U1 3
U2 96
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JUL 15
PY 2004
VL 94
IS 2
BP 137
EP 159
DI 10.1016/j.ijfoodmicro.2004.01.006
PG 23
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 833XM
UT WOS:000222374900003
PM 15193801
DA 2020-05-07
ER

PT J
AU Charlebois, ED
   Perdreau-Remington, F
   Kreiswirth, B
   Bangsberg, DR
   Ciccarone, D
   Diep, BA
   Ng, VL
   Chansky, K
   Edlin, B
   Chambers, HF
AF Charlebois, ED
   Perdreau-Remington, F
   Kreiswirth, B
   Bangsberg, DR
   Ciccarone, D
   Diep, BA
   Ng, VL
   Chansky, K
   Edlin, B
   Chambers, HF
TI Origins of community strains of methicillin-resistant Staphylococcus
   aureus
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID PANTON-VALENTINE LEUKOCIDIN; RISK-FACTORS; MOLECULAR EPIDEMIOLOGY;
   SAN-FRANCISCO; PREVALENCE; CHILDREN; CLONES; COLONIZATION; MINNESOTA;
   INFECTION
AB To characterize methicillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community, we identified predictors of isolating community MRSA and genotyped a sample of MRSA collected from a community-based, high-risk population. Computerized databases of the Community Health Network of San Francisco and the Clinical Microbiology Laboratory were searched electronically for the years 1992-1999 to identify community-onset infections caused by MRSA. Sequential analyses were performed to identify predictors of MRSA strains. The majority (58%) of infections were caused by strains traceable to the hospital or to long-term care facilities. Injection drug use was associated with infections that were not associated with health care settings. Genotypes for 20 of 35 MRSA isolates recovered from injection drug users did not match any of 1600 genotypes of clinical isolates. In a nonoutbreak setting, the hospital was the main source of community MRSA; however, the presence of genetically distinct and diverse MRSA strains indicates MRSA strains now also originate from the community.
C1 Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA.
   Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   San Francisco Gen Hosp, Clin Lab, San Francisco, CA 94110 USA.
   Univ Calif San Francisco, Urban Hlth Study, San Francisco, CA 94143 USA.
   Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
   Cornell Univ, Weill Med Coll, Ithaca, NY USA.
   NYU, Sch Med, New York, NY USA.
RP Chambers, HF (reprint author), Univ Calif San Francisco, Sch Med, San Francisco Gen Hosp, Div Infect Dis, 3rd & Parnassus Ave,Box 0811,Bldg 30,4th Fl Infect, San Francisco, CA 94143 USA.
EM chipc@itsa.ucsf.edu
RI Edlin, Brian R/F-2966-2018; Ciccarone, Daniel/I-5404-2013
OI Edlin, Brian R/0000-0001-8172-8797; Ciccarone,
   Daniel/0000-0002-2355-5477
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI046610, R01 AI46610-01]; NIDA NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) [R01 DA012109, R01-DA11241-02S1, K23 DA016165, R01 DA009532, K23
   DA016165-01A2, R01-DA09532]; NIMH NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH) [R01 MH054907]
CR Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5
   BERMAN DS, 1993, NEW ENGL J MED, V329, P1896, DOI 10.1056/NEJM199312163292517
   Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623
   CARLETON H, 2003, 43 INT C ANT AG CHEM
   Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204
   Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069
   Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326
   de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003
   Diep BA, 2003, J CLIN MICROBIOL, V41, P4559, DOI 10.1128/JCM.41.10.4559-4564.2003
   Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576
   Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000
   Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599
   Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003
   Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003
   Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437
   Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201
   HAMOUDI AC, 1983, INFECT CONT HOSP EP, V4, P153, DOI 10.1017/S0195941700058070
   Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593
   Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123
   Hussain FM, 2001, PEDIATR INFECT DIS J, V20, P763, DOI 10.1097/00006454-200108000-00009
   Jones ME, 2002, ANTIMICROB AGENTS CH, V46, P3104, DOI 10.1128/AAC.46.9.3104-3105.2002
   Killgore GE, 2000, J CLIN MICROBIOL, V38, P2516, DOI 10.1128/JCM.38.7.2516-2519.2000
   Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1
   Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843
   Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002
   MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153
   MCDOUGAL LK, 1984, J CLIN MICROBIOL, V19, P482, DOI 10.1128/JCM.19.4.482-488.1984
   Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976
   Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693
   *NCCLS, 1999, PERF STAND ANT DISK
   *NCCLS, 2000, M7A5 NCCLS
   Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002
   Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002
   PATE KR, 1995, LANCET, V346, P978, DOI 10.1016/S0140-6736(95)91605-9
   Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436
   Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999
   Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695
   Suggs AH, 1999, PEDIATR INFECT DIS J, V18, P410, DOI 10.1097/00006454-199905000-00003
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Vandenesch F, 2003, EMERG INFECT DIS, V9, P978
NR 40
TC 124
Z9 126
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2004
VL 39
IS 1
BP 47
EP 54
DI 10.1086/421090
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 829YJ
UT WOS:000222087800009
PM 15206052
OA Green Accepted, Bronze
DA 2020-05-07
ER

PT J
AU Gismondo, MR
   De Vecchi, E
   Drago, L
AF Gismondo, MR
   De Vecchi, E
   Drago, L
TI Use of genomics and proteomics to develop better diagnostic tools for
   use in infectious diseases
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE proteome; genome; infections/diagnosis
ID NUCLEIC-ACID AMPLIFICATION; MYCOBACTERIUM-TUBERCULOSIS; CLINICAL
   MICROBIOLOGY; MOLECULAR DIAGNOSTICS; DISCREPANT ANALYSIS;
   MASS-SPECTROMETRY; ESCHERICHIA-COLI; REAL-TIME; MICROARRAYS; GENE
AB The genome is a rather constant entity while the proteome is constantly changing through its biochemical interactions with the genome. One organism will have radically different protein expression in different parts of its body and at different stages of its life cycle. The goal in the post-genome era is to determine how the proteome is organized into functional, higher-order networks, by mapping all constitutive and dynamic protein-protein interactions. The availability of complete genome sequences has dramatically changed the opportunities for developing novel and improved diagnosis of infectious diseases. Proteome databases have been developed for Escherichia coli, Bacillus subtilis, Haemophilus influenzae and Pseudomonas aeruginosa. Study of genomics and proteomics of microbial infections, named infectomics, represents the scientific challenge of the future. The study of infectomics is very exciting, with the limitation that determination of bacterial proteomes should be performed when they are growing in association with their host and its immune system. In conclusion, expectations from proteomics mainly concern development of a 'final solution' allowing for direct diagnosis of infectious diseases by analysis of a specimen's proteins. (C) 2004 Lippincott Williams Wilkins.
C1 L Sacco Univ Milan, Lab Clin Microbiol, Dept Clin Sci, I-20122 Milan, Italy.
RP Gismondo, MR (reprint author), L Sacco Teaching Hosp, Lab Clin Microbiol, Via GB Grassi 74, I-20157 Milan, Italy.
EM mariarita.gismondo@unimi.it
RI De Vecchi, Elena/B-8209-2017; Gismondo, Maria Rita/I-3965-2017
OI De Vecchi, Elena/0000-0001-9781-8607; Lorenzo,
   Drago/0000-0002-5206-540X; Gismondo, Maria Rita/0000-0001-6926-8660
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Bodrossy L, 2004, CURR OPIN MICROBIOL, V7, P245, DOI 10.1016/j.mib.2004.04.005
   Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1
   Boyce JD, 2004, EMERG INFECT DIS, V10, P1357, DOI 10.3201/eid1008.031036
   Burbaum J, 2002, CURR OPIN CHEM BIOL, V6, P427, DOI 10.1016/S1367-5931(02)00337-X
   Busti E, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-27
   Campbell CJ, 2004, J APPL MICROBIOL, V96, P18, DOI 10.1046/j.1365-2672.2003.02112.x
   Cash P, 2003, ADV BIOCHEM ENG BIOT, V83, P93
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Dove AQ, 1999, NAT BIOTECHNOL, V17, P233, DOI 10.1038/6972
   FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800
   Fraser CM, 2000, EMERG INFECT DIS, V6, P505, DOI 10.3201/eid0605.000510
   Gilbert GL, 2002, TRENDS MOL MED, V8, P280, DOI 10.1016/S1471-4914(02)02349-3
   Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514
   Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039
   Isenberg HD, 2003, J CLIN MICROBIOL, V41, P917, DOI 10.1128/JCM.41.3.917-918.2003
   Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x
   Kakinuma K, 2003, BIOTECHNOL BIOENG, V83, P721, DOI 10.1002/bit.10709
   Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401
   Klee SR, 2000, INFECT IMMUN, V68, P2082, DOI 10.1128/IAI.68.4.2082-2095.2000
   KWOH DY, 1989, P NATL ACAD SCI USA, V86, P1173, DOI 10.1073/pnas.86.4.1173
   LO YMD, 1988, LANCET, V2, P679
   Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x
   McAdam AJ, 2000, J CLIN MICROBIOL, V38, P2027
   McNicholl JM, 2000, ANNU REV PUBL HEALTH, V21, P15, DOI 10.1146/annurev.publhealth.21.1.15
   Millar BC, 2004, EUR J CLIN MICROBIOL, V23, P353, DOI 10.1007/s10096-004-1132-6
   Niesters HGM, 2004, CLIN MICROBIOL INFEC, V10, P5, DOI 10.1111/j.1469-0691.2004.00699.x
   Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003
   Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089
   Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891
   Quirk M, 2003, LANCET INFECT DIS, V3, P66, DOI 10.1016/S1473-3099(03)00538-3
   RHODIUS V, 2002, ANNU REV MICROBIOL, V3, P462
   Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004
   Shelburne SA, 2004, CURR OPIN MICROBIOL, V7, P283, DOI 10.1016/j.mib.2004.04.013
   Shoemaker DD, 2002, CURR OPIN MICROBIOL, V5, P334, DOI 10.1016/S1369-5274(02)00327-2
   Sintchenko V, 1999, PATHOLOGY, V31, P436, DOI 10.1080/003130299104909
   Sternberg M, 2001, J CLIN MICROBIOL, V39, P826, DOI 10.1128/JCM.39.2.826-827.2001
   Strauss EJ, 1997, SCIENCE, V276, P707, DOI 10.1126/science.276.5313.707
   Tang CM, 2001, ANNU REV GENOM HUM G, V2, P259, DOI 10.1146/annurev.genom.2.1.259
   Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810
   Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510
   URDEA MS, 1994, BIO-TECHNOL, V12, P926, DOI 10.1038/nbt0994-926
   van Belkum A, 2003, CURR OPIN PHARMACOL, V3, P497, DOI 10.1016/S1471-4892(03)00108-5
   WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691
   Washburn MP, 2000, CURR OPIN MICROBIOL, V3, P292, DOI 10.1016/S1369-5274(00)00092-8
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Whelen AC, 1996, ANNU REV MICROBIOL, V50, P349, DOI 10.1146/annurev.micro.50.1.349
   Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923
   WU DY, 1989, GENOMICS, V4, P560, DOI 10.1016/0888-7543(89)90280-2
   Yates JR, 1997, J PROTEIN CHEM, V16, P495
NR 50
TC 0
Z9 0
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0954-139X
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD JUL
PY 2004
VL 15
IS 3
BP 103
EP 108
PG 6
WC Microbiology
SC Microbiology
GA 899SK
UT WOS:000227165000003
DA 2020-05-07
ER

PT J
AU Shorten, PR
   Membre, JM
   Pleasants, AB
   Kubaczka, M
   Soboleva, TK
AF Shorten, PR
   Membre, JM
   Pleasants, AB
   Kubaczka, M
   Soboleva, TK
TI Partitioning of the variance in the growth parameters of Erwinia
   carotovora on vegetable products
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE predictive microbiology; risk assessment; mixed effects model;
   uncertainty
ID BACTERIAL-GROWTH; RISK-ASSESSMENT; TEMPERATURE
AB The objective of this paper was to estimate and partition the variability in the microbial growth model parameters describing the growth of Erwinia carotovora on pasteurised and non-pasteurised vegetable juice from laboratory experiments performed under different temperature-varying conditions. We partitioned the model parameter variance and covariance components into effects due to temperature profile and replicate using a maximum likelihood technique. Temperature profile and replicate were treated as random effects and the food substrate was treated as a fixed effect. The replicate variance component was small indicating a high level of control in this experiment. Our analysis of the combined E. carotovora growth data sets used the Baranyi primary microbial growth model along with the Ratkowsky secondary growth model. The variability in the microbial growth parameters estimated from these microbial growth experiments is essential for predicting the mean and variance through time of the E. carotovora population size in a product supply chain and is the basis for microbiological risk assessment and food product shelf-life estimation. The variance partitioning made here also assists in the management of optimal product distribution networks by identifying elements of the supply chain contributing most to product variability. (C) 2003 Elsevier B.V. All rights reserved.
C1 AgResearch, Ruakura Res Ctr, Hamilton, New Zealand.
   INRA, LGPTA, F-59651 Villeneuve Dascq, France.
RP Shorten, PR (reprint author), AgResearch, Ruakura Res Ctr, Private Bag 3123, Hamilton, New Zealand.
EM paul.shorten@agresearch.co.nz
OI Shorten, Paul/0000-0001-5938-8837
CR BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0
   BARANYI J, 1995, INT J FOOD MICROBIOL, V26, P199, DOI 10.1016/0168-1605(94)00121-L
   Bernaerts K, 2002, INT J FOOD MICROBIOL, V73, P145, DOI 10.1016/S0168-1605(01)00645-6
   Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7
   Gilks W. R., 1996, MARKOV CHAIN MONTE C
   Leporq B, 2001, ACTA HORTIC, P139
   Nauta MJ, 2000, INT J FOOD MICROBIOL, V57, P9, DOI 10.1016/S0168-1605(00)00225-7
   Nauta MJ, 2002, INT J FOOD MICROBIOL, V73, P297, DOI 10.1016/S0168-1605(01)00664-X
   Pouillot R, 2003, INT J FOOD MICROBIOL, V81, P87, DOI 10.1016/S0168-1605(02)00192-7
   RATKOWSKY DA, 1982, J BACTERIOL, V149, P1
   Soboleva TK, 2001, INT J FOOD MICROBIOL, V64, P317, DOI 10.1016/S0168-1605(00)00481-5
   Soboleva TK, 2000, INT J FOOD MICROBIOL, V57, P183, DOI 10.1016/S0168-1605(00)00265-8
   Vonesh E.F., 1997, LINEAR NONLINEAR MOD
NR 13
TC 20
Z9 22
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JUN 1
PY 2004
VL 93
IS 2
BP 195
EP 208
DI 10.1016/j.ijfoodmicro.2003.11.012
PG 14
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 824YJ
UT WOS:000221722800007
PM 15135958
DA 2020-05-07
ER

PT J
AU Voisin, S
   Terreux, R
   Renaud, FNR
   Freney, J
   Domard, M
   Deruaz, D
AF Voisin, S
   Terreux, R
   Renaud, FNR
   Freney, J
   Domard, M
   Deruaz, D
TI Pyrolysis patterns of 5 close Corynebacterium species analyzed by
   artificial neural networks
SO ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR
   MICROBIOLOGY
LA English
DT Article
DE artificial neural networks; atomic emission detection; chemotaxonomy;
   Corynebacterium; gas chromatography; -pyrolysis
ID GAS-LIQUID CHROMATOGRAPHY; MASS-SPECTROMETRY; CLINICAL MICROBIOLOGY;
   C-MINUTISSIMUM; DIFFERENTIATION; AMYCOLATUM; STRAINS; IDENTIFICATION;
   STRIATUM; CALIBRATION
AB In the present study, an artificial neural network was trained with the Stuttgart Neural Networks Simulator, in order to identify Corynebacterium species by analyzing their pyrolysis patterns. An earlier study described the combination of pyrolysis, gas chromatography and atomic emission detection we used on whole cell bacteria. Carbon, sulfur and nitrogen were detected in the pyrolysis compounds. Pyrolysis patterns were obtained from 52 Corynebacterium strains belonging to 5 close species. These data were previously analyzed by Euclidean distances calculation followed by Unweighted Pair Group Method of Averages, a clustering method. With this early method, strains from 3 of the 5 species (C. xerosis, C. freneyi and C. amycolatum) were correctly characterized even if the 29 strains of C. amycolatum were grouped into 2 subgroups. Strains from the 2 remaining species (C. minutissimum and C. striatum) cannot be separated. To build an artificial neural network, able to discriminate the 5 previous species, the pyrolysis data of 42 selected strains were used as learning set and the 10 remaining strains as testing set. The chosen learning algorithm was Back-Propagation with Momentum. Parameters used to train a correct network are described here, and the results analyzed. The obtained artificial neural network has the following cone-shaped structure: 144 nodes in input, 25 and 9 nodes in 2 successive hidden layers, and then 5 outputs. It could classify all the strains in their species group. This network completes a chemotaxonomic method for Corynebacterium identification.
C1 ISPB, EA 3090, Dept Chim Analyt, F-69373 Lyon 08, France.
   ISPB, Lab Chim Phys & Modelisat Mol, Lyon, France.
   ISPB, EA 3090, Dept Microbiol Pharmaceut, Lyon, France.
RP Deruaz, D (reprint author), ISPB, EA 3090, Dept Chim Analyt, 8 Ave Rockefeller, F-69373 Lyon 08, France.
EM deruaz@rockefeller.univ-lyon1.fr
OI Voisin, Sebastien/0000-0001-5897-333X
CR Bull AT, 2000, MICROBIOL MOL BIOL R, V64, P573, DOI 10.1128/MMBR.64.3.573-606.2000
   CHUN J, 1993, FEMS MICROBIOL LETT, V107, P321
   COLLINS MD, 1988, FEMS MICROBIOL LETT, V49, P349
   EMSWILER BS, 1978, APPL ENVIRON MICROB, V35, P97, DOI 10.1128/AEM.35.1.97-104.1978
   Fox A., 1990, ANAL MICROBIOLOGY ME, P1
   Funke G, 1996, J CLIN MICROBIOL, V34, P1124, DOI 10.1128/JCM.34.5.1124-1128.1996
   Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125
   Goodacre R, 1997, ANAL CHIM ACTA, V348, P511, DOI 10.1016/S0003-2670(97)00062-7
   Goodacre R, 1998, MICROBIOL-SGM, V144, P1157, DOI 10.1099/00221287-144-5-1157
   Goodacre R., 1994, Microbiology Europe, V2, P16
   Goodfellow M, 1997, ZBL BAKT-INT J MED M, V285, P133, DOI 10.1016/S0934-8840(97)80023-0
   Irwin W.J., 1982, ANAL PYROLYSIS COMPR
   Kang SG, 1998, J BIOTECHNOL, V62, P1, DOI 10.1016/S0168-1656(98)00034-0
   Kenyon RGW, 1997, ZBL BAKT-INT J MED M, V285, P267
   Mathers K, 1997, ZBL BAKT-INT J MED M, V285, P311, DOI 10.1016/S0934-8840(97)80040-0
   Patey O, 1997, J CLIN MICROBIOL, V35, P441, DOI 10.1128/JCM.35.2.441-445.1997
   REINER E, 1965, NATURE, V206, P1272, DOI 10.1038/2061272b0
   Renaud FNR, 1998, J CLIN MICROBIOL, V36, P3698, DOI 10.1128/JCM.36.12.3698-3702.1998
   RENAUD FNR, 2001, INT J SYST MICROBIOL, V151, P1723
   Timmins EM, 1997, J APPL MICROBIOL, V83, P208, DOI 10.1046/j.1365-2672.1997.00218.x
   Voisin S, 2002, RES MICROBIOL, V153, P307, DOI 10.1016/S0923-2508(02)01324-4
   Wampler TP, 1999, J CHROMATOGR A, V842, P207, DOI 10.1016/S0021-9673(98)00921-2
   Wauters G, 1996, INT J SYST BACTERIOL, V46, P653, DOI 10.1099/00207713-46-3-653
NR 23
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0003-6072
EI 1572-9699
J9 ANTON LEEUW INT J G
JI Antonie Van Leeuwenhoek
PD MAY
PY 2004
VL 85
IS 4
BP 287
EP 296
DI 10.1023/B:ANTO.0000020165.21866.67
PG 10
WC Microbiology
SC Microbiology
GA 804LK
UT WOS:000220300000004
PM 15028867
DA 2020-05-07
ER

PT J
AU Voetsch, AC
   Angulo, FJ
   Rabatsky-Ehr, T
   Shallow, S
   Cassidy, M
   Thomas, SM
   Swanson, E
   Zansky, SM
   Hawkins, MA
   Jones, TF
   Shillam, PJ
   Van Gilder, TJ
   Wells, JG
   Griffin, PM
AF Voetsch, AC
   Angulo, FJ
   Rabatsky-Ehr, T
   Shallow, S
   Cassidy, M
   Thomas, SM
   Swanson, E
   Zansky, SM
   Hawkins, MA
   Jones, TF
   Shillam, PJ
   Van Gilder, TJ
   Wells, JG
   Griffin, PM
CA Emerging Infections Program FoodNe
TI Laboratory practices for stool-specimen culture for bacterial pathogens,
   including Escherichia coli O157 : H7, in the FoodNet sites, 1995-2000
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID CLINICAL MICROBIOLOGY; SURVEILLANCE; DISEASES; CARE; CRITERIA; NETWORK
AB In 2000, we surveyed microbiologists in 388 clinical laboratories, which tested an estimated 339,000 stool specimens in 1999, about laboratory methods and policies for the routine testing of stool specimens for Salmonella, Shigella, Campylobacter, and Vibrio species, Yersinia entercolitica, and Escherichia coli O157: H7. The results were compared with those of similar surveys conducted in 1995 and 1997. Although these laboratories reported routinely testing for Salmonella, Shigella, and Campylobacter species, only 57% routinely tested for E. coli O157: H7, 50% for Y. entercolitica, and 50% for Vibrio species. The mean proportions of stool specimens that yielded these pathogens were as follows: Campylobacter, 1.3% of specimens; Salmonella, 0.9%; Shigella, 0.4%; and E. coli O157: H7, 0.3%. The proportion of laboratories that routinely tested for E. coli O157: H7 increased from 59% in 1995 to 68% in 2000; however, the proportion of stool specimens tested decreased from 53% to 46%. E. coli O157: H7 should be routinely sought in stool specimens submitted for microbiologic culture.
C1 Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA 30333 USA.
   Georgia Div Publ Hlth, Atlanta, GA USA.
   Yale Univ, Connecticut Emerging Infect Program, New Haven, CT USA.
   Calif Emerging Infect Program, San Francisco, CA USA.
   Oregon Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA.
   Minnesota Dept Hlth, Minneapolis, MN USA.
   New York State Dept Hlth, Albany, NY USA.
   Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   Tennessee Dept Hlth, Nashville, TN USA.
   Colorado Dept Publ Hlth & Environm, Denver, CO USA.
RP Angulo, FJ (reprint author), Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, MS D63,1600 Clifton Rd, Atlanta, GA 30333 USA.
EM fangulo@cdc.gov
CR Angulo FJ, 1998, VET CLIN N AM-FOOD A, V14, P165, DOI 10.1016/S0749-0720(15)30287-5
   Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269
   Bender JB, 1997, NEW ENGL J MED, V337, P388, DOI 10.1056/NEJM199708073370604
   BOPP CA, 2003, MANUAL CLIN MICROBIO, P654
   BOWMAN RA, 1992, J CLIN PATHOL, V45, P838, DOI 10.1136/jcp.45.9.838
   BOYCE TG, 1995, J CLIN MICROBIOL, V33, P3275, DOI 10.1128/JCM.33.12.3275-3277.1995
   BROTMAN M, 1995, GASTROENTEROLOGY, V108, P1923
   *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P201
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P325
   *CSTE, 1993, CSTE POS STAT 4 NAT
   DENEEN V, 1998, 1 INT C EM INF DIS A
   FAN K, 1993, J CLIN MICROBIOL, V31, P2233, DOI 10.1128/JCM.31.8.2233-2235.1993
   Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514
   Hines J, 1996, CLIN INFECT DIS, V23, P1292, DOI 10.1093/clinids/23.6.1292
   Marano NN, 2000, J CLIN MICROBIOL, V38, P2267
   MCGOWAN JE, 1991, J HOSP INFECT, V18, P110, DOI 10.1016/0195-6701(91)90012-W
   Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7
   Morris AJ, 1996, J CLIN MICROBIOL, V34, P1776, DOI 10.1128/JCM.34.7.1776-1778.1996
   Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164
   Scott DR, 1995, DIAGN MICR INFEC DIS, V23, P17, DOI 10.1016/0732-8893(95)00166-2
   SIEGEL DL, 1990, JAMA-J AM MED ASSOC, V263, P979, DOI 10.1001/jama.263.7.979
   Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002
   Subcommittee of the PHLS Advisory Committee on Gastrointestinal Infections, 2000, COMMUN DIS PUBLIC HL, V3, P14
   Swaminathan B, 2001, EMERG INFECT DIS, V7, P382
   Thacker S B, 1989, J Public Health Policy, V10, P187, DOI 10.2307/3342679
   THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021
   Valenstein P, 1996, ARCH PATHOL LAB MED, V120, P206
   Vogt R L, 1996, J Public Health Manag Pract, V2, P28
   YANNELLI B, 1988, AM J INFECT CONTROL, V16, P246, DOI 10.1016/S0196-6553(88)80003-8
NR 29
TC 48
Z9 50
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2004
VL 38
SU 3
BP S190
EP S197
DI 10.1086/381586
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 810WR
UT WOS:000220734900011
PM 15095189
OA Bronze
DA 2020-05-07
ER

PT J
AU Voetsch, AC
   Van Gilder, TJ
   Angulo, FJ
   Farley, MM
   Shallow, S
   Marcus, R
   Cieslak, PR
   Deneen, VC
   Tauxe, RV
AF Voetsch, AC
   Van Gilder, TJ
   Angulo, FJ
   Farley, MM
   Shallow, S
   Marcus, R
   Cieslak, PR
   Deneen, VC
   Tauxe, RV
CA Emerging Infections Program FoodNe
TI FoodNet estimate of the burden of illness caused by nontyphoidal
   Salmonella infections in the United States
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID REPTILE-ASSOCIATED SALMONELLOSIS; PATHOLOGISTS Q-PROBES; PLATING MEDIA;
   ENTERITIDIS INFECTIONS; RESISTANT SALMONELLA; VETERINARY SAMPLES;
   BRILLIANT GREEN; SHIGELLA AGAR; STOOL SAMPLES; PHAGE TYPE-4
AB To determine the burden of Salmonella infections in the United States, Foodborne Diseases Active Surveillance Network (FoodNet) investigators conducted population-based active surveillance for culture-confirmed Salmonella infections during 1996-1999 at FoodNet laboratories. In addition, all clinical microbiology FoodNet laboratories were surveyed to determine their practices for isolating Salmonella. Telephone interviews were also conducted among residents of the FoodNet sites to determine the proportion of persons with diarrheal illness who sought medical care and the proportion who submitted stool specimens for bacterial culture. Using our model, we estimated that there were 1.4 million nontyphoidal Salmonella infections in the United States, resulting in 168,000 physician office visits per year during 1996-1999. Including both culture-confirmed infections and those not confirmed by culture, we estimated that Salmonella infections resulted in 15,000 hospitalizations and 400 deaths annually. These estimates indicate that salmonellosis presents a major ongoing burden to public health.
C1 Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA 30333 USA.
   Emory Univ, Sch Med, Atlanta, GA USA.
   Calif Emerging Infect Program, San Francisco, CA USA.
   Yale Univ, New Haven, CT USA.
   Oregon Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA.
   Minnesota Dept Hlth, Minneapolis, MN USA.
RP Angulo, FJ (reprint author), Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, MS D63,1600 Clifton Rd, Atlanta, GA 30333 USA.
EM fangulo@cdc.gov
CR Angulo FJ, 1997, AM J PUBLIC HEALTH, V87, P580, DOI 10.2105/AJPH.87.4.580
   Angulo FJ, 1998, VET CLIN N AM-FOOD A, V14, P165, DOI 10.1016/S0749-0720(15)30287-5
   [Anonymous], 1990, MMWR Recomm Rep, V39, P1
   ASPINALL ST, 1992, EUR J CLIN MICROBIOL, V11, P936, DOI 10.1007/BF01962379
   Austin CC, 1998, J AM VET MED ASSOC, V212, P866
   BENNETT JV, 1987, CLOSING GAP BURDEN U, P102
   Boyce TG, 1996, EPIDEMIOL INFECT, V117, P29, DOI 10.1017/S0950268800001096
   *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P347
   *CDCP, 1995, BEH RISK FACT SURV S
   *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P201
   *CDCP, 1997, EMERG INFECT DIS, V3, P581
   *CDCP, 1998, SALM SURV ANN TAB SU
   CHALKER RB, 1988, REV INFECT DIS, V10, P111
   COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069
   DUSCH H, 1995, J CLIN MICROBIOL, V33, P802, DOI 10.1128/JCM.33.4.802-804.1995
   DUSCH H, 1993, J CLIN MICROBIOL, V31, P410, DOI 10.1128/JCM.31.2.410-412.1993
   FARRINGTON M, 1995, J HOSP INFECT, V30, P364, DOI 10.1016/0195-6701(95)90040-3
   *FDA CTR FOOD SAF, GUID IND RED MICR FO
   *FDA CTR FOOD SAF, JUIC HACCP
   *FOOD SAF INSP SER, PATH RED HACCP HACCP
   Forward KR, 1997, DIAGN MICR INFEC DIS, V29, P215, DOI 10.1016/S0732-8893(97)00163-6
   Frenzen P. D., 1999, FoodReview, V22, P10
   Gentry E M, 1985, Am J Prev Med, V1, P9
   Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901
   GRAY LD, 1995, MANUAL CLIN MICROBIO, P452
   GRIFFIN CW, 1986, J CLIN MICROBIOL, V23, P246, DOI 10.1128/JCM.23.2.246-250.1986
   HARVEY RWS, 1983, J HYG-CAMBRIDGE, V91, P267, DOI 10.1017/S0022172400060277
   HEDBERG CW, 1992, JAMA-J AM MED ASSOC, V268, P3203, DOI 10.1001/jama.268.22.3203
   HEDBERG CW, 1993, J INFECT DIS, V167, P107, DOI 10.1093/infdis/167.1.107
   Hennessy TW, 1996, NEW ENGL J MED, V334, P1281, DOI 10.1056/NEJM199605163342001
   Herikstad H, 2002, EPIDEMIOL INFECT, V129, P9, DOI 10.1017/S0950268801006628
   HOWANITZ PJ, 1992, ARCH PATHOL LAB MED, V116, P694
   LaVange L M, 1996, Stat Methods Med Res, V5, P311, DOI 10.1177/096228029600500306
   Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Mermin J, 1997, PEDIATRICS, V99, P399, DOI 10.1542/peds.99.3.399
   MORSE DL, 1994, AM J PUBLIC HEALTH, V84, P859, DOI 10.2105/AJPH.84.5.859
   Nunez ML, 1996, EUR J CLIN MICROBIOL, V15, P96, DOI 10.1007/BF01586197
   [Anonymous], 2000, MMWR Recomm Rep, V49, P1
   Osterholm MT, 1997, EMERG INFECT DIS, V3, P575, DOI 10.3201/eid0304.970424
   *PARTN FOOD SAF ED, FIGHT BAC
   Passaro DJ, 1996, WESTERN J MED, V165, P126
   POISSON DM, 1992, PATHOL BIOL, V40, P793
   POISSON DM, 1992, RES MICROBIOL, V143, P211, DOI 10.1016/0923-2508(92)90010-L
   POISSON DM, 1993, PATHOL BIOL, V41, P543
   POISSON DM, 1993, PATHOL BIOL, V41, P906
   POISSON DM, 1992, PATHOL BIOL, V40, P21
   REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366
   ROSENBERG ML, 1977, J INFECT DIS, V136, P458, DOI 10.1093/infdis/136.3.458
   Ruiz J, 1996, EUR J CLIN MICROBIOL, V15, P922, DOI 10.1007/BF01690509
   RUIZ J, 1992, J CLIN MICROBIOL, V30, P525, DOI 10.1128/JCM.30.2.525-526.1992
   Ruiz J, 1996, J CLIN MICROBIOL, V34, P686, DOI 10.1128/JCM.34.3.686-688.1996
   Stull TM, 1998, JAMA-J AM MED ASSOC, V279, P463, DOI 10.1001/jama.279.6.463
   TAYLOR WI, 1975, J CLIN MICROBIOL, V2, P281
   TODD ECD, 1989, INT J FOOD MICROBIOL, V9, P313, DOI 10.1016/0168-1605(89)90099-8
   Valenstein P, 1996, ARCH PATHOL LAB MED, V120, P206
   WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513
   Wheeler JG, 1999, BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046
NR 58
TC 439
Z9 475
U1 0
U2 38
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2004
VL 38
SU 3
BP S127
EP S134
DI 10.1086/381578
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 810WR
UT WOS:000220734900003
PM 15095181
OA Bronze
DA 2020-05-07
ER

PT J
AU Geeraerd, AH
   Valdramidis, VP
   Devlieghere, F
   Bernaert, H
   Debevere, J
   Van Impe, JF
AF Geeraerd, AH
   Valdramidis, VP
   Devlieghere, F
   Bernaert, H
   Debevere, J
   Van Impe, JF
TI Development of a novel approach for secondary modelling in predictive
   microbiology: incorporation of microbiological knowledge in black box
   polynomial modelling
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE predictive microbiology; secondary modelling; polynomial models;
   Belehradek type models; square root models; artificial neural; network
   models; model evaluation; constrained optimisation; modified atmosphere
   packaging; carbon dioxide; sodium lactate; Lactobacillus sakei
ID ARTIFICIAL NEURAL-NETWORKS; COOKED MEAT-PRODUCTS; BACTERIAL-GROWTH;
   SHELF-LIFE; TEMPERATURE; PH; LISTERIA; SPOILAGE; DESCRIBE
AB This research deals with the development of a novel secondary modelling procedure within the framework of predictive microbiology. The procedure consists of three steps: (i) careful formulation of the available microbiological information, both from literature and from the experimental case study at hand, (ii) translation of these requirements in mathematical terms under the form of partial derivatives throughout the complete interpolation region of the experimental design, and (iii) determination of parameter values with suitable optimisation techniques for a flexible black box modelling approach, e.g., a polynomial model or an artificial neural network model. As a vehicle for this procedure, the description of the maximum specific growth rate of Lactobacillus sakei in modified BHI-broth as influenced by suboptimal temperature, water activity, sodium lactate and dissolved carbon dioxide concentration is under study. The procedure results in a constrained polynomial model with excellent descriptive and interpolating features in comparison with an extended Ratkowsky-type model and classical polynomial model, by combining specific properties of both model types. The developed procedure is illustrated on the description of the lag phase as well. It is stressed how the confrontation with experimental data is very important to appreciate the descriptive and interpolating capacities of new or existing models, which is nowadays not always carefully performed. Alternatively, the first two steps of the novel procedure can be used as a tool to demonstrate clearly (possible) interpolative shortcomings of an existing model with straightforward spreadsheet calculations. (C) 2003 Elsevier B.V. All rights reserved.
C1 Katholieke Univ Leuven, Dept Chem Engn, BioTeC Bioproc Technol & Control, B-3001 Heverlee, Belgium.
   Univ Ghent, Dept Food Technol & Nutr, Lab Food Microbiol & Food Preservat, B-9000 Ghent, Belgium.
RP Van Impe, JF (reprint author), Katholieke Univ Leuven, Dept Chem Engn, BioTeC Bioproc Technol & Control, W Croylaan 46, B-3001 Heverlee, Belgium.
EM jan.vanimpe@cit.kuleuven.ac.be
RI Geeraerd, Annemie/AAC-5006-2020
OI Geeraerd, Annemie/0000-0001-8473-4092; Valdramidis,
   Vasilis/0000-0001-6486-3890
CR BARANYI J, 1995, INT J FOOD MICROBIOL, V26, P199, DOI 10.1016/0168-1605(94)00121-L
   Buchanan RL, 1997, J APPL MICROBIOL, V82, P567, DOI 10.1111/j.1365-2672.1997.tb03587.x
   Dalgaard P, 2002, INT J FOOD MICROBIOL, V73, P343, DOI 10.1016/S0168-1605(01)00670-5
   Devlieghere F, 2000, INT J FOOD MICROBIOL, V58, P93, DOI 10.1016/S0168-1605(00)00291-9
   Devlieghere F, 1999, INT J FOOD MICROBIOL, V46, P57, DOI 10.1016/S0168-1605(98)00175-5
   Garcia-Gimeno RM, 2002, INT J FOOD MICROBIOL, V72, P19, DOI 10.1016/S0168-1605(01)00608-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI 10.1016/S0168-1605(00)00395-0
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7
   Le Marc Y., 2001, THESIS U BRETAGNE OC
   McDonald K, 1999, INT J FOOD MICROBIOL, V52, P1, DOI 10.1016/S0168-1605(99)00126-9
   MCMEEKIN TA, 1987, J APPL BACTERIOL, V62, P543, DOI 10.1111/j.1365-2672.1987.tb02687.x
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V73, P395, DOI 10.1016/S0168-1605(01)00663-8
   McMeekin TA, 2002, INT J FOOD MICROBIOL, V78, P133, DOI 10.1016/S0168-1605(02)00231-3
   RATKOWSKY DA, 1982, J BACTERIOL, V149, P1
   ROSS T, 1999, PREDICTIVE MICROBIOL
   ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
   Vereecken K., 2000, Journal A, V41, P45
   WHITING RC, 1995, CRIT REV FOOD SCI, V35, P467, DOI 10.1080/10408399509527711
   WHITING RC, 1993, FOOD MICROBIOL, V10, P175
   ZWIETERING MH, 1992, J FOOD PROTECT, V55, P973, DOI 10.4315/0362-028X-55.12.973
   ZWIETERING MH, 1991, APPL ENVIRON MICROB, V57, P1094, DOI 10.1128/AEM.57.4.1094-1101.1991
NR 25
TC 41
Z9 45
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD MAR 15
PY 2004
VL 91
IS 3
BP 229
EP 244
DI 10.1016/S0168-1605(03)00388-X
PG 16
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 800GW
UT WOS:000220017900001
PM 14984771
DA 2020-05-07
ER

PT J
AU Winder, CL
   Carr, E
   Goodacre, R
   Seviour, R
AF Winder, CL
   Carr, E
   Goodacre, R
   Seviour, R
TI The rapid identification of Acinetobacter species using Fourier
   transform infrared spectroscopy
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE 16S rDNA sequencing; Acinetobacter; Fourier transform infrared
   spectroscopy
ID PYROLYSIS MASS-SPECTROMETRY; ARTIFICIAL NEURAL NETWORKS;
   THIN-LAYER-CHROMATOGRAPHY; FT-IR SPECTROSCOPY; GENUS ACINETOBACTER;
   ACTIVATED-SLUDGE; SP-NOV; BACTERIA; DIFFERENTIATION; STRAINS
AB Aims: Fourier transform infrared (FT-IR) was used to analyse a selection of Acinetobacter isolates in order to determine if this approach could discriminate readily between the known genomic species of this genus and environmental isolates from activated sludge.
   Methods and Results: FT-IR spectroscopy is a rapid whole-organism fingerprinting method, typically taking only 10 s per sample, and generates 'holistic' biochemical profiles (or 'fingerprints') from biological materials. The cluster analysis produced by FT-IR was compared with previous polyphasic taxonomic studies on these isolates and with 16S-23S rDNA intergenic spacer region (ISR) fingerprinting presented in this paper. FT-IR and 16S-23S rDNA ISR analyses together indicate that some of the Acinetobacter genomic species are particularly heterogeneous and poorly defined, making characterization of the unknown environmental isolates with the genomic species difficult.
   Conclusions: Whilst the characterization of the isolates from activated sludge revealed by FT-IR and 16S-23S rDNA ISR were not directly comparable, the dendrogram produced from FT-IR data did correlate well with the outcomes of the other polyphasic taxonomic work (E.L. Carr, P. Kampfer, B.K.C. Patel, V. Gurtler and R.J. Seviour, 2003, International Journal of Systematic and Evolutionary Microbiology53, 953-963).
   Significance and Impact of the Study: We believe it would be advantageous to pursue this approach further and establish a comprehensive database of taxonomically well-defined Acinetobacter species to aid the identification of unknown strains. In this instance, FT-IR may provide the rapid identification method eagerly sought for the routine identification of Acinetobacter isolates from a wide range of environmental sources.
C1 UMIST, Dept Chem, Manchester M60 1QD, Lancs, England.
   La Trobe Univ, Biotechnol Res Ctr, Bendigo, Vic, Australia.
RP Goodacre, R (reprint author), UMIST, Dept Chem, POB 88,Sackville St, Manchester M60 1QD, Lancs, England.
EM r.goodacre@umist.ac.uk
RI Goodacre, Roy/J-1600-2012
OI Goodacre, Roy/0000-0003-2230-645X
CR BOUFFARD SP, 1994, ANAL CHEM, V66, P1937, DOI 10.1021/ac00085a003
   BOUVET PJM, 1989, RES MICROBIOL, V140, P291, DOI 10.1016/0923-2508(89)90021-1
   BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228
   Carr E, 2001, SYST APPL MICROBIOL, V24, P430, DOI 10.1078/0723-2020-00039
   Carr E, 2001, J APPL MICROBIOL, V90, P309, DOI 10.1046/j.1365-2672.2001.01245.x
   Carr EL, 2003, INT J SYST EVOL MICR, V53, P953, DOI 10.1099/ijs.0.02486-0
   Dijkshoorn L, 1996, ACINETOBACTER MICROB, P37
   GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991
   GLAUNINGER G, 1990, FRESEN J ANAL CHEM, V338, P710, DOI 10.1007/BF00323411
   Goodacre R, 1996, ANAL CHEM, V68, P271, DOI 10.1021/ac950671t
   Goodacre R, 1998, MICROBIOL-SGM, V144, P1157, DOI 10.1099/00221287-144-5-1157
   Goodacre R, 1996, FEMS MICROBIOL LETT, V140, P233, DOI 10.1016/0378-1097(96)00186-3
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   Ibrahim A, 1997, INT J SYST BACTERIOL, V47, P837, DOI 10.1099/00207713-47-3-837
   Janssen P, 1997, INT J SYST BACTERIOL, V47, P1179, DOI 10.1099/00207713-47-4-1179
   Jolliffe I. T., 1986, PRINCIPAL COMPONENT, P115
   MACFIE HJH, 1978, J GEN MICROBIOL, V104, P67, DOI 10.1099/00221287-104-1-67
   MAGEE JT, 1993, HDB NEW BACTERIAL SY, P383
   Manly BFJ, 1994, MULTIVARIATE STAT ME
   Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   NAUMANN D, 1994, BACTERIAL DIVERSITY
   Naumann D, 1991, MODERN TECHNIQUES RA, P43
   Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891
   Oberreuter H, 2002, INT J SYST EVOL MICR, V52, P91, DOI 10.1099/00207713-52-1-91
   Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1
   REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1
   Sandt C, 2003, J CLIN MICROBIOL, V41, P954, DOI 10.1128/JCM.41.3.954-959.2003
   Schmitt J, 1998, INT BIODETER BIODEGR, V41, P1, DOI 10.1016/S0964-8305(98)80002-4
   SHUTE LA, 1988, J APPL BACTERIOL, V64, P79, DOI 10.1111/j.1365-2672.1988.tb02431.x
   Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043
   Timmins EM, 1998, J CLIN MICROBIOL, V36, P367, DOI 10.1128/JCM.36.2.367-374.1998
   Timmins EM, 1998, YEAST, V14, P885, DOI 10.1002/(SICI)1097-0061(199807)14:10<885::AID-YEA286>3.0.CO;2-G
   TJERNBERG I, 1989, APMIS, V97, P596
   Towner KJ, 1997, J MED MICROBIOL, V46, P721, DOI 10.1099/00222615-46-9-721
   Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996
   VANEECHOUTTE M, 1995, J CLIN MICROBIOL, V33, P11
   VILA J, 1994, J MED MICROBIOL, V41, P244, DOI 10.1099/00222615-41-4-244
   WIEDMANNALAHMAD M, 1994, APPL ENVIRON MICROB, V60, P4066, DOI 10.1128/AEM.60.11.4066-4071.1994
   WINDIG W, 1983, ANAL CHEM, V55, P81, DOI 10.1021/ac00252a023
   Winson MK, 1997, ANAL CHIM ACTA, V348, P273, DOI 10.1016/S0003-2670(97)00237-7
NR 41
TC 43
Z9 44
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PY 2004
VL 96
IS 2
BP 328
EP 339
DI 10.1046/j.1365-2672.2003.02154.x
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 763YP
UT WOS:000188128300013
PM 14723694
DA 2020-05-07
ER

PT S
AU Baross, JA
   Wilcock, WSD
   Kelley, DS
   DeLong, EF
   Cary, SC
AF Baross, JA
   Wilcock, WSD
   Kelley, DS
   DeLong, EF
   Cary, SC
BE Wilcock, WSD
   DeLong, EF
   Kelley, DS
   Baross, JA
   Cary, SC
TI The subsurface biosphere at mid-ocean ridges: Issues and challenges
SO SUBSEAFLOOR BIOSPHERE AT MID-OCEAN RANGES
SE Geophysical Monograph Book Series
LA English
DT Proceedings Paper
CT 5th Ridge-Theoretical-Institute on the Subsurface Biosphere at Mid-Ocean
   Ridges
CY JUL 28-AUG 01, 2000
CL Big Sky, MT
SP Ridge Theoret Inst
ID TEMPERATURE PETROLEUM RESERVOIRS; HYDROTHERMAL VENT ENVIRONMENTS; SEA
   VOLCANIC-ERUPTION; EAST PACIFIC RISE; DE-FUCA RIDGE; OCEANIC-CRUST;
   PHYLOGENETIC DIVERSITY; SUBSEAFLOOR HABITAT; BACTERIAL DIVERSITY;
   OXIDIZING BACTERIA
AB A recent growth of interest in subsurface microbiology has been fueled by the recognition that the subsurface may have played an important role in the origin and early evolution of life, and may presently sustain a substantial fraction of Earth's biomass. The uppermost igneous oceanic crust is likely to be one of the most habitable subsurface environments because it is porous and the locus of extensive hydrothermal circulation. This circulation is most vigorous at spreading centers where it is driven by the volcanic accretion of oceanic crust. Hot reduced hydrothermal fluids created by water-rock reactions above magma bodies mix with cold seawater in the subsurface and the resulting chemical disequilibria provide energy and carbon sources that support diverse microbial communities. These communities can be sampled in chronic low-temperature hydrothermal vents and in the hydrothermal fluids released following volcanic eruptions. Investigations of the subseafloor environment at mid-ocean ridges integrate biological and geological approaches to understand the characteristics of hydrothermal circulation and how they are modulated by geological events; the sources of carbon, nutrients and energy; and the types and functions of subsurface organisms. They also utilize analogies with accessible sulfide edifices and comparisons with similar subsurface environments elsewhere. Future studies will combine increasingly sophisticated shore-based studies with data from long-term observatories comprising networks of instruments for measuring key physical, chemical and microbial parameters. They will require the development of technology to drill bare rock mid-ocean ridge sites, collect uncontaminated subsurface samples and deploy instruments at different depths in the crust.
C1 Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.
RP Baross, JA (reprint author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.
EM jbaross@u.washington.edu; wilcock@u.washington.edu;
   kelley@ocean.washington.edu; delong@mbari.org; caryc@udel.edu
CR Alt JC, 2003, GEOLOGY, V31, P549, DOI 10.1130/0091-7613(2003)031<0549:ICOGIT>2.0.CO;2
   ALT JC, 1986, J GEOPHYS RES-SOLID, V91, P309, DOI 10.1029/JB091iB10p10309
   Alt JC, 1995, GEOPHYS MONOGR SER, P85, DOI DOI 10.1029/GM091P0085
   Amend JP, 1998, SCIENCE, V281, P1659, DOI 10.1126/science.281.5383.1659
   Balkwill DL, 1997, FEMS MICROBIOL REV, V20, P201, DOI 10.1111/j.1574-6976.1997.tb00309.x
   Baross JA, 1995, MICR EXTREM UNUSUAL, P169
   Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21
   BASTIN ES, 1930, BULL AMER ASS PETROL, V14, P153
   Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2
   BoivinJahns V, 1996, APPL ENVIRON MICROB, V62, P3405, DOI 10.1128/AEM.62.9.3405-3412.1996
   Brock T. D., 1978, THERMOPHILIC MICROOR
   Butterfield DA, 1997, PHILOS T R SOC A, V355, P369, DOI 10.1098/rsta.1997.0013
   Butterfield DA, 2003, ENERGY MASS TRANSFER, P123
   CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340
   Corliss J. B., 1981, Oceanologica Acta, P59
   CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073
   Cowen JP, 2003, SCIENCE, V299, P120, DOI 10.1126/science.1075653
   Cragg BA, 1994, P OCEAN DRILLING PRO, V139, P509
   CRAIG H, 1975, EARTH PLANET SC LETT, V26, P125, DOI 10.1016/0012-821X(75)90079-5
   D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878
   DAVIS E, 2004, IN PRESS HYDROLOGY O
   DAVIS EE, 1992, CAN J EARTH SCI, V29, P925, DOI 10.1139/e92-078
   Delaney J.R., 2001, EOS T, V2, P67
   Delaney J. R., 2001, EOS T AGU, V82, p[67, 72]
   Delaney JR, 1998, SCIENCE, V281, P222, DOI 10.1126/science.281.5374.222
   DEMING JW, 1993, GEOCHIM COSMOCHIM AC, V57, P3219, DOI 10.1016/0016-7037(93)90535-5
   EMBLEY R, 1999, EOS T AM GEOPHYS UN, V80, P213
   Embley R.W., 1999, EOS T AM GEOPHYS UN, V222
   EMBLEY RW, 1999, EOS T AM GEOPHYS UN, V80, P219
   Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997
   Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002
   Emery K. O., 1941, GEOL SOC AM BULL, V52, P1685
   Fisher AT, 2003, NATURE, V421, P618, DOI 10.1038/nature01352
   Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978
   GERMAN CR, 2004, IN PRESS THERMAL REG
   GILLIS KM, 1990, J GEOPHYS RES-SOLID, V95, P21523, DOI 10.1029/JB095iB13p21523
   GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045
   Grassia GS, 1996, FEMS MICROBIOL ECOL, V21, P47
   Halbach P, 2003, ENERGY MASS TRANSFER, P365
   HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W
   Holden JF, 1998, FEMS MICROBIOL ECOL, V25, P33, DOI 10.1111/j.1574-6941.1998.tb00458.x
   Huber JA, 2003, FEMS MICROBIOL ECOL, V43, P393, DOI 10.1111/j.1574-6941.2003.tb01080.x
   Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002
   Inagaki F, 2003, EXTREMOPHILES, V7, P307, DOI 10.1007/s00792-003-0324-9
   Jannasch H.W., 1995, GEOPHYS MONOGR SER, V91, P273, DOI DOI 10.1029/GM091P0273
   JANNASCH HW, 1984, OCEANUS, V27, P73
   JUNIPER SK, 1995, GEOPHYS RES LETT, V22, P179, DOI 10.1029/94GL02436
   Kashefi K, 2003, APPL ENVIRON MICROB, V69, P2985, DOI 10.1128/AEM.69.5.2985-2993.2003
   Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331
   Kerr RA, 2002, SCIENCE, V296, P1056, DOI 10.1126/science.296.5570.1056
   Krumholz LR, 1997, NATURE, V386, P64, DOI 10.1038/386064a0
   LEISKE R, 1929, CENTRALBL F BAKT, V77, P305
   Lilley M. D., 1983, HYDROTHERMAL PROCESS, P411
   Lister C. R. B., 1982, DYNAMIC ENV OCEAN FL, P441
   LISTER CRB, 1972, GEOPHYS J ROY ASTR S, V26, P515, DOI 10.1111/j.1365-246X.1972.tb05766.x
   Lowell RP, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001289
   LOWELL RP, 1995, J GEOPHYS RES-SOL EA, V100, P327, DOI 10.1029/94JB02222
   Marais DJD, 2003, ASTROBIOLOGY, V3, P219, DOI 10.1089/153110703769016299
   McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X
   McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X
   Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003
   Michels PC, 1996, ADV PROTEIN CHEM, V48, P341
   Morita RY, 1999, MICROB ECOL, V38, P307, DOI 10.1007/s002489901002
   ONSTOTT TC, 1999, EOS T AGU, V80, pF79
   Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000
   PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0
   Pedersen K, 1997, FEMS MICROBIOL REV, V20, P399, DOI 10.1111/j.1574-6976.1997.tb00325.x
   Roling WFM, 2003, RES MICROBIOL, V154, P321, DOI 10.1016/S0923-2508(03)00086-X
   Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003
   Sievert SM, 2000, INT J SYST EVOL MICR, V50, P1239, DOI 10.1099/00207713-50-3-1239
   Slobodkin AI, 1999, CURR MICROBIOL, V39, P99, DOI 10.1007/s002849900426
   STEIN CA, 1994, J GEOPHYS RES-SOL EA, V99, P3081, DOI 10.1029/93JB02222
   STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0
   Summit M, 1998, EXTREMOPHILES, V2, P339, DOI 10.1007/s007920050077
   SUMMIT M, 1998, P NATAL ACAD SCI US, V45, P2751
   Summit M, 2000, P ODP SCI RESULTS, V169, P1
   Takai K, 1999, FEMS MICROBIOL ECOL, V28, P177, DOI 10.1111/j.1574-6941.1999.tb00573.x
   Takai K, 1999, GENETICS, V152, P1285
   Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001
   Taylor CD, 1997, SCIENCE, V277, P1483, DOI 10.1126/science.277.5331.1483
   Taylor CD, 1999, APPL ENVIRON MICROB, V65, P2253
   VANDOVER CL, 2000, ECOLOGY DEEP SEA HYD
   Wheat CG, 2002, GEOCHIM COSMOCHIM AC, V66, P3693, DOI 10.1016/S0016-7037(02)00894-3
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   ZIERENBERG RA, 2000, P ODP SCI RES, V169, P21
   ZOBELL CE, 1942, J SEDIMENT PETROL, V12, P127
NR 86
TC 12
Z9 12
U1 0
U2 9
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 0065-8448
BN 0-87590-409-2
J9 GEOPHYS MONOGR SER
PY 2004
VL 144
BP 1
EP 11
DI 10.1029/144GM01
PG 11
WC Ecology; Oceanography
SC Environmental Sciences & Ecology; Oceanography
GA BBC15
UT WOS:000224701400001
DA 2020-05-07
ER

PT J
AU Celardin, F
   Chatenoux, L
AF Celardin, F
   Chatenoux, L
TI Correlations between soil microbiological parameters (CO2 respiration,
   ATP-biomass) and heavy metals in field soils
SO ARCHIVES DES SCIENCES
LA English
DT Article
ID MICROBIAL BIOMASS; ORGANIC-MATTER
AB Correlations between Soil Microbiological Parameters (CO2 Respiration, ATP-Biomass) and Heavy Metals in Field Soils. - The impact of agriculture on soil microbiology in field situation was investigated by chemical and biological analysis of topsoils from a survey network covering cultivated and natural areas in Geneva canton. Microbial respiratory activity was measured by CO2 production, microbial biomass was determined by Adenosine triphosphate (ATP), total heavy metals were determined by extraction with HNO3 (2M) and the bio-available heavy metals soluble in NaNO3 (0.1 M) were calculated using empirical relations. Spearman rank order correlations between these parameters were calculated. The inhibitory effect of Cu on the initial respiratory activity (A(pot)) could be significantly detected in vineyard soils. The apparently stimulating effect of small concentrations of soluble Cd, Pb, Zn on A(pot) could not be clearly established due to interdependence with pH.
C1 Ecole Ingn HES Lullier Filiere Agron, CH-1254 Geneva, Switzerland.
RP Celardin, F (reprint author), Ecole Ingn HES Lullier Filiere Agron, CH-1254 Geneva, Switzerland.
CR Alef K, 1995, METHODS APPL SOIL MI, P214
   BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331
   BABICH H, 1985, ENVIRON RES, V36, P591
   BEE GW, 1990, AGRONOMY SERIES 1, V9
   Celardin F, 1999, COMMUN SOIL SCI PLAN, V30, P843, DOI 10.1080/00103629909370250
   Franzluebbers AJ, 1996, SOIL SCI SOC AM J, V60, P1133, DOI 10.2136/sssaj1996.03615995006000040025x
   GRATIER M, 1994, ARCH SCI, V47, P165
   GUPTA SK, 1987, TOXICOL ENVIRON CHEM, V14, P1, DOI 10.1080/02772248709357189
   GUPTA SK, 1984, TOXICOL ENVIRON CHEM, V8, P173, DOI 10.1080/02772248409357050
   Hani H., 1985, Chemical methods for assessing bio-available metals in sludge and soils., P42
   Insam H, 1996, SOIL BIOL BIOCHEM, V28, P691, DOI 10.1016/0038-0717(95)00182-4
   Jaggi W., 1976, Schweizerische Landwirtschaftliche Forschung, V15, P371
   JENKINSON DS, 1980, SOIL BIOL BIOCHEM, V12, P579, DOI 10.1016/0038-0717(80)90040-1
   Kuperman RG, 1997, SOIL BIOL BIOCHEM, V29, P179, DOI 10.1016/S0038-0717(96)00297-0
   MAIRE N, 1987, SOIL BIOL BIOCHEM, V19, P491, DOI 10.1016/0038-0717(87)90090-3
   MAIRE N, 1984, SOIL BIOL BIOCHEM, V16, P361, DOI 10.1016/0038-0717(84)90033-6
   Maire N., 1990, RECHERCHE AGRONOMIQU, V29, P61
   MARGESIN R, 1996, METHODS SOIL BIOL, P260
   NELSON DW, 1990, AGRONOMY SERIES 2, V9
   Ohlinger R, 1996, METHODS SOIL BIOL, P95
   PAUL EA, 1994, CURRENT PERSPECTIVES, P509
   POWLSON DS, 1980, J SOIL SCI, V31, P77, DOI 10.1111/j.1365-2389.1980.tb02066.x
   Stadelmann F. X., 1983, Landwirtschaftliche Forschung, Sonderheft, V39, P384
   VALSECCHI G, 1995, BIOL FERT SOILS, V20, P253, DOI 10.1007/BF00336086
   WILKE BM, 1986, BAYREUTHER GEOWISSEN, V8
   1986, SWISS ORDINANCE POLL
NR 26
TC 0
Z9 0
U1 0
U2 9
PU SOC PHYS HIST NATURELLE GENEVE
PI GENEVA 6
PA MUSEUM HIST NATURELLE 1 ROUTE DE MALAGNOU CASE POSTALE 6434, CH-1211
   GENEVA 6, SWITZERLAND
SN 0252-9289
J9 ARCH SCI
JI Arch. Sci.
PD DEC
PY 2003
VL 56
IS 3
BP 127
EP 135
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 876VK
UT WOS:000225526300002
DA 2020-05-07
ER

PT J
AU Hajmeer, MN
   Basheer, IA
AF Hajmeer, MN
   Basheer, IA
TI A hybrid Bayesian-neural network approach for probabilistic modeling of
   bacterial growth/no-growth interface
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE artificial neural networks; bacterial growth; Bayesian probability
   estimation; Modeling; Parzen's probability distribution
ID MICROBIAL-GROWTH; PREDICTIVE MICROBIOLOGY; LISTERIA-MONOCYTOGENES;
   ESCHERICHIA-COLI; WATER ACTIVITY; LACTIC-ACID; TEMPERATURE; PH; LIMITS;
   SALT
AB A hybrid probabilistic modeling approach that integrates artificial neural networks (ANNs) with statistical Bayesian conditional probability estimation is proposed. The suggested approach benefits from the power of ANNs as highly flexible nonlinear mapping paradigms, and the Bayes' theorem for computing probabilities of bacterial growth with the aid of Parzen's probability distribution function estimators derived for growth and no-growth (G/NG) states. The proposed modeling approach produces models that can predict the probability of growth of targeted microorganism as affected by a set of parameters pertaining to extrinsic factors and operating conditions. The models also can be used to define the probabilistic boundary (interface) between growth and no-growth, and as such can define and predict the values of critical parameters required to keep a desired pre-specified bacterial growth risk in check. A modular system incorporating the various computational modules was constructed to illustrate the application of the hybrid approach to the probabilistic modeling of growth of pathogenic Escherichia coli strain as affected by temperature and water activity. The proposed approach was compared to other techniques including the traditional linear and nonlinear logistic regression. Results indicated that the hybrid approach outperforms the other approaches in its accuracy as well as flexibility to extract the implicit interrelationships between the various parameters. Advantages and limitations of the approach were also discussed and compared to those of other techniques. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.
   Calif Dept Transportat, Translab, Sacramento, CA 95819 USA.
RP Hajmeer, MN (reprint author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.
CR Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Bolton LF, 1999, J FOOD PROTECT, V62, P601, DOI 10.4315/0362-028X-62.6.601
   Cheroutre-Vialette M, 2002, INT J FOOD MICROBIOL, V73, P107, DOI 10.1016/S0168-1605(01)00642-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   GOODMAN PH, 1998, NEURAL NETWORKS ADVA
   Hajmeer MN, 1998, J RAPID METH AUT MIC, V6, P103, DOI 10.1111/j.1745-4581.1998.tb00191.x
   Hajmeer MN, 2000, J RAPID METH AUT MIC, V8, P265, DOI 10.1111/j.1745-4581.2000.tb00328.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Hosmer D. W., 1989, APPL LOGISTIC REGRES
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   MASTERS T, 1995, ADV ALGORITHMS NEURA
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   Schalkoff R.J., 1997, ARTIFICIAL NEURAL NE
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
NR 18
TC 28
Z9 31
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD MAY 15
PY 2003
VL 82
IS 3
BP 233
EP 243
AR PII S0168-1605(02)00308-2
DI 10.1016/S0168-1605(02)00308-2
PG 11
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 672EN
UT WOS:000182508400004
PM 12593926
DA 2020-05-07
ER

PT J
AU Demarty, M
   Gleyse, B
   Raine, D
   Ripoll, C
   Norris, V
AF Demarty, M
   Gleyse, B
   Raine, D
   Ripoll, C
   Norris, V
TI Modelling autocatalytic networks with artificial microbiology
SO COMPTES RENDUS BIOLOGIES
LA English
DT Article; Proceedings Paper
CT Conference on Modelling and Simulation of Biological Processes in the
   Context of Genomics
CY MAR 18-21, 2002
CL AUTRANS, FRANCE
DE artificial chemistry; autocatalytic networks; hyperstructures
ID ESCHERICHIA-COLI; HYPOTHESIS; ORGANIZATION
AB Cells can usefully be equated to autocatalytic networks that increase in mass and then divide. To begin to model relationships between autocatalytic networks and cell division, we have written a program of artificial chemistry that simulates a cell fed by monomers. These monomers are symbols that can be assembled into linear (non-branched) polymers to give different lengths. A reaction is catalysed by a particular polymer or 'enzyme' that may itself be a reactant of that reaction (autocatalysis). These reactions are only studied within the confines of the 'cell' or 'reaction chamber'. There is a flux of material through the cell and eventually the mass of polymers reaches a threshold at which we analyse the cell. Our results indicate a similarity between the connectivity of the reaction network and that of real metabolic networks. Developing the model will entail attributing increased probabilities of reactions to polymers that are colocalised to evaluate the consequences of the dynamics of large assemblies of diverse molecules (hyperstructures) and of cell division. (C) 2003 Academie des sciences. Published by Editions scientifiques et medicales Elsevier SAS. All rights reserved.
C1 Fac Sci & Tech Rouen, UPRESA CNRS 6037, Lab Proc Integratifs Cellulaires, F-76821 Mont St Aignan, France.
   INSA, F-76800 St Etienne, France.
   Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England.
RP Demarty, M (reprint author), Fac Sci & Tech Rouen, UPRESA CNRS 6037, Lab Proc Integratifs Cellulaires, F-76821 Mont St Aignan, France.
EM Maufice.Demarty@univ-rouen.fr
OI Norris, Vic/0000-0002-1725-7262
CR AMAR P, IN PRESS ACTA BIOTHE
   Dittrich P, 1998, ARTIF LIFE, V4, P203, DOI 10.1162/106454698568521
   FONTANA W, 1994, B MATH BIOL, V56, P1
   Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627
   KAUFFMAN S, 1996, HOME UNIVERSE SEARCH
   Norris V, 1999, BIOCHIMIE, V81, P915, DOI 10.1016/S0300-9084(99)00203-5
   NORRIS V, 1995, MOL MICROBIOL, V15, P985, DOI 10.1111/j.1365-2958.1995.tb02367.x
   Norris V, 2002, BIOCHIMIE, V84, P341, DOI 10.1016/S0300-9084(02)01387-1
   Norris V, 2000, MOL MICROBIOL, V37, P696, DOI 10.1046/j.1365-2958.2000.02019.x
   NORRIS V, 2001, INT C SYST CYB INF O
   Norris Vic, 2001, Journal of Biological Physics and Chemistry, V1, P29, DOI 10.4024/06NO01A.01.01
   Raine D. J., 2001, Journal of Biological Physics and Chemistry, V1, P89, DOI 10.4024/10RA01A.01.02
   RAINE DJ, IN PRESS C R BIOL
   RAINE DJ, 2000, INTERJOURNAL
   Ramsden JJ, 1998, PHYS REV E, V58, P7777, DOI 10.1103/PhysRevE.58.7777
   Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112
NR 16
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1631-0691
EI 1768-3238
J9 CR BIOL
JI C. R. Biol.
PD MAY
PY 2003
VL 326
IS 5
BP 459
EP 466
DI 10.1016/S1631-0691(03)00097-0
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 706FD
UT WOS:000184441900002
PM 12886873
DA 2020-05-07
ER

PT J
AU Figge, RM
   Gober, JW
AF Figge, RM
   Gober, JW
TI Cell shape, division and development: the 2002 American Society for
   Microbiology (ASM) conference on prokaryotic development
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID COMPLETE GENOME SEQUENCE; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS;
   MYXOCOCCUS-XANTHUS; GLIDING MOTILITY; GENE-EXPRESSION; FLAGELLAR GENE;
   TRANSCRIPTION; SPORULATION; BACTERIA
AB In the last decade, the use of cytological techniques, together with the analysis of complete genomes, has dramatically advanced our understanding of bacterial development. Work on several well-developed model systems such as Bacillus subtilis, Caulobacter crescentus, Myxococcus xanthus and Streptomyces spp., has provided us with an in-depth understanding of processes such as sporulation, multicellular behaviour and the bacterial cell cycle. At the same time, these studies have revolutionized our view of the bacterial cell and shown it to be a highly complex entity with spatial and temporal organization. The recent American Society for Microbiology (ASM) conference on prokaryotic development demonstrated that several laboratories have now started to connect data obtained through functional genomic analysis with subcellular organization, thereby generating three-dimensional regulatory networks. This meeting report highlights new findings in the field, such as regulation of protein localization during sporulation and the cell cycle, control of cell-cell interaction and the initiation of cell division.
C1 Aventis Pharma, Funct Genom, F-94400 Vitry Sur Seine, France.
   Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
RP Figge, RM (reprint author), Aventis Pharma, Funct Genom, Bat Magendie,Labo 123,13 Quai Jules Guesde, F-94400 Vitry Sur Seine, France.
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM48417]
CR Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198
   Burkholder WF, 2000, PROKARYOTIC DEVELOPMENT, P151
   Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3
   Claessen D, 2002, MOL MICROBIOL, V44, P1483, DOI 10.1046/j.1365-2958.2002.02980.x
   DRAPER GC, 2001, ANNU REV MICROBIOL, V56, P567
   EASTER J, 2002, MOL CELL, V2, P427
   England JC, 2001, CURR OPIN MICROBIOL, V4, P674, DOI 10.1016/S1369-5274(01)00268-5
   Fontes M, 1999, P NATL ACAD SCI USA, V96, P8052, DOI 10.1073/pnas.96.14.8052
   Fuchs T, 2001, MOL MICROBIOL, V39, P679, DOI 10.1046/j.1365-2958.2001.02238.x
   GRANTCHAROVA N, 2002, MOL MICROBIOL, V47, P645
   Guo DC, 2000, J BACTERIOL, V182, P4564, DOI 10.1128/JB.182.16.4564-4571.2000
   HINZ AJ, 2002, MOL MICROBIOL, V47, P929
   Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099
   Ishikawa S, 2002, J BIOL CHEM, V277, P20483, DOI 10.1074/jbc.M201086200
   Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758
   Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2
   KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525
   Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786
   Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699
   Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478
   Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8
   McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49
   Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)91910-X
   Mohr CD, 1998, J BACTERIOL, V180, P2175, DOI 10.1128/JB.180.8.2175-2185.1998
   Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320
   Muir RE, 2001, MOL MICROBIOL, V41, P117, DOI 10.1046/j.1365-2958.2001.02506.x
   Muir RE, 2001, MOL MICROBIOL, V39, P1623, DOI 10.1046/j.1365-2958.2001.02351.x
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   O'Connor TJ, 2002, MOL MICROBIOL, V45, P45, DOI 10.1046/j.1365-2958.2002.03004.x
   Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x
   Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9
   RodriguezSoto JP, 1997, J BACTERIOL, V179, P4361, DOI 10.1128/jb.179.13.4361-4371.1997
   Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999
   van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   Welch R, 2001, P NATL ACAD SCI USA, V98, P14907, DOI 10.1073/pnas.261574598
   Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627
   WILLEY J, 1991, CELL, V65, P641, DOI 10.1016/0092-8674(91)90096-H
NR 40
TC 7
Z9 7
U1 0
U2 2
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD MAR
PY 2003
VL 47
IS 5
BP 1475
EP 1483
DI 10.1046/j.1365-2958.2003.03397.x
PG 9
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 646VN
UT WOS:000181056400023
PM 12603749
DA 2020-05-07
ER

PT J
AU Hajmeer, M
   Basheer, I
AF Hajmeer, M
   Basheer, I
TI Comparison of logistic regression and neural network-based classifiers
   for bacterial growth
SO FOOD MICROBIOLOGY
LA English
DT Article
DE classifiers; bacterial growth; logistic regression
ID MICROBIAL-GROWTH; WATER ACTIVITY; SACCHAROMYCES-CEREVISIAE; PREDICTIVE
   MICROBIOLOGY; ESCHERICHIA-COLI; LACTIC-ACID; PH; TEMPERATURE; LIMITS;
   NACL
AB In this paper, we introduce two fundamentally different approaches for designing classification models (classifiers); the traditional statistical method based on logistic regression and the emerging computationally powerful techniques based on artificial neural networks (ANNs). Linear and nonlinear logistic regression as well as feedforward error backpropagation artificial neural networks (FEBANN) and probabilistic neural networks (PNN) based classifiers were developed and compared in relation to their accuracy in classification of bacterial growth/no-growth data pertaining to pathogenic Escherichia coli R31 as affected by temperature and water activity. The comparisons between the four developed classifiers were primarily based on analysis of the receiver operating characteristic (ROC) curves as well as a number of scalar performance measures pertaining to the classification contingency matrices. The ANN-based classifiers outperformed the logistic regression based counterparts. Within the same group, the PNN-based classifier was more accurate than the FEBANN-based classifier, and the nonlinear logistic regression-based classifier was more accurate than the linear one. The optimal PNN-based classifier was a perfect classifier with 100% growth detection accuracy and zero false alarm rate. The advantages and limitations pertaining to the development of the various classifiers were discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA.
   Dept Transportat, Sacramento, CA 95819 USA.
RP Hajmeer, M (reprint author), Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, 1 Shields Ave, Davis, CA 95616 USA.
CR Agresti A., 1996, INTRO CATEGORICAL DA
   Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   CACOULLOS T, 1966, ANN I STAT MATH, V18, P179, DOI 10.1007/BF02869528
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Hajmeer MN, 1998, J RAPID METH AUT MIC, V6, P103, DOI 10.1111/j.1745-4581.1998.tb00191.x
   Hajmeer MN, 2000, J RAPID METH AUT MIC, V8, P265, DOI 10.1111/j.1745-4581.2000.tb00328.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAJMEER MN, 1996, INTELLIGENT ENG SYST, V6, P635
   Hosmer D. W., 1989, APPL LOGISTIC REGRES
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Lopez-Malo A, 2000, J FOOD PROTECT, V63, P91, DOI 10.4315/0362-028X-63.1.91
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   MASTERS T, 1995, ADV ALGORITHMS NEURA
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   Schepers AW, 2000, ENZYME MICROB TECH, V26, P431, DOI 10.1016/S0141-0229(99)00183-0
   Simpson PK, 1990, ARTIFICIAL NEURAL SY
   SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
NR 22
TC 59
Z9 62
U1 2
U2 13
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0740-0020
J9 FOOD MICROBIOL
JI Food Microbiol.
PD FEB
PY 2003
VL 20
IS 1
BP 43
EP 55
AR PII S0740-0020(02)00104-1
DI 10.1016/S0740-0020(02)00104-1
PG 13
WC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
SC Biotechnology & Applied Microbiology; Food Science & Technology;
   Microbiology
GA 637NW
UT WOS:000180519700006
DA 2020-05-07
ER

PT J
AU Vogel, U
   Claus, H
AF Vogel, U
   Claus, H
TI Molecular epidemiology of Neisseria meningitidis
SO FRONTIERS IN BIOSCIENCE
LA English
DT Article
DE bacteria; microbiology; infection; Neisseria meningitidis; typing; MLST;
   porin; capsule; review
ID SEROGROUP-A MENINGOCOCCI; OUTER-MEMBRANE PROTEINS; HUMAN
   ENDOTHELIAL-CELLS; FC-GAMMA RECEPTOR; SIAD PCR-ELISA; GROUP-B;
   POLYSIALIC ACID; INTERCONTINENTAL SPREAD; ENZYME ELECTROPHORESIS; ET-37
   COMPLEX
AB Neisseria meningitidis poses a major disease burden on human beings. Meningococcal typing has a longstanding tradition for epidemiological surveillance of the disease. Genetic and antigenetic variability resulting from horizontal genetic exchange has been exploited for this purpose. Neisseria meningitidis served as the bacterial prototype organism for the development of multi locus sequence typing, which has replaced multi locus enzyme electrophoresis as the gold standard for meningococcal typing. Due to the rapid emergence of new porin variants serotyping by monoclonal antibodies is currently being replaced by DNA sequencing of variable regions of the porA gene. Sequence data were used to characterize the population structure of meningococci in carriage and disease. The advances in molecular epidemiology of meningococcal disease, and the rapid exchange of DNA sequence data via curated internet websites have resulted in an interactive international network, which is capable of identifying newly emerging clones within weeks.
C1 Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany.
RP Vogel, U (reprint author), Univ Wurzburg, Inst Hyg & Microbiol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.
CR ABDILLAHI H, 1988, MICROB PATHOGENESIS, V4, P27, DOI 10.1016/0882-4010(88)90045-9
   ACHTMAN M, 1995, [No title captured], P159
   Antignac A, 2001, J ANTIMICROB CHEMOTH, V47, P285, DOI 10.1093/jac/47.3.285
   Antignac A, 2001, ANTIMICROB AGENTS CH, V45, P3625, DOI 10.1128/AAC.45.12.3625-3628.2001
   Bart A, 1998, J CLIN MICROBIOL, V36, P1746, DOI 10.1128/JCM.36.6.1746-1749.1998
   BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S
   BLAKEBROUGH IS, 1982, J INFECT DIS, V146, P626, DOI 10.1093/infdis/146.5.626
   Borrow R, 1998, FEMS MICROBIOL LETT, V159, P209, DOI 10.1016/S0378-1097(97)00572-7
   Borrow R, 1997, EPIDEMIOL INFECT, V118, P111, DOI 10.1017/S0950268896007261
   BREDIUS RGM, 1994, J INFECT DIS, V170, P848, DOI 10.1093/infdis/170.4.848
   BYGRAVES JA, 1992, J GEN MICROBIOL, V138, P523, DOI 10.1099/00221287-138-3-523
   CARTWRIGHT K, 1995, [No title captured], P115
   CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449
   CAUGANT DA, 1987, J BACTERIOL, V169, P2781, DOI 10.1128/jb.169.6.2781-2792.1987
   CAUGANT DA, 1986, P NATL ACAD SCI USA, V83, P4927, DOI 10.1073/pnas.83.13.4927
   CAUGANT DA, 1988, INFECT IMMUN, V56, P2060, DOI 10.1128/IAI.56.8.2060-2068.1988
   CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641
   Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/PL00008618
   Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813
   Coen PG, 2000, INT J EPIDEMIOL, V29, P180, DOI 10.1093/ije/29.1.180
   DENSEN P, 1987, NEW ENGL J MED, V316, P922, DOI 10.1056/NEJM198704093161506
   Derrick JP, 1999, INFECT IMMUN, V67, P2406, DOI 10.1128/IAI.67.5.2406-2413.1999
   Erickson L, 1998, CLIN INFECT DIS, V26, P1159, DOI 10.1086/520303
   Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603
   Feavers IM, 1999, J CLIN MICROBIOL, V37, P3883, DOI 10.1128/JCM.37.12.3883-3887.1999
   FEAVERS IM, 1992, INFECT IMMUN, V60, P3620, DOI 10.1128/IAI.60.9.3620-3629.1992
   Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061
   Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561
   FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991
   FRASCH CE, 1985, REV INFECT DIS, V7, P504
   FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669
   Galimand M, 1998, NEW ENGL J MED, V339, P868, DOI 10.1056/NEJM199809243391302
   Goulding JN, 2000, J CLIN MICROBIOL, V38, P4580, DOI 10.1128/JCM.38.12.4580-4585.2000
   Gupta S, 1999, PARASITOL TODAY, V15, P497, DOI 10.1016/S0169-4758(99)01559-8
   Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437
   Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x
   Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x
   Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5
   Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0
   Hookey JV, 2001, J MED MICROBIOL, V50, P991, DOI 10.1099/0022-1317-50-11-991
   Jelfs J, 2000, EPIDEMIOL INFECT, V125, P285, DOI 10.1017/S0950268899004471
   Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000
   JONES D, 1995, MENINGOCOCCAL DIS, P147
   Jones GR, 1998, J INFECT DIS, V178, P451, DOI 10.1086/515622
   Kaczmarski E B, 1998, Commun Dis Public Health, V1, P54
   Kertesz DA, 1998, J INFECT DIS, V177, P1754, DOI 10.1086/517439
   Kremastinou J, 1999, FEMS IMMUNOL MED MIC, V24, P73, DOI 10.1111/j.1574-695X.1999.tb01267.x
   Kriz P, 1999, EPIDEMIOL INFECT, V123, P193, DOI 10.1017/S095026889900285X
   Kriz P, 1995, EPIDEMIOL INFECT, V115, P411, DOI 10.1017/S0950268800058568
   Kriz P, 2000, EUR J CLIN MICROBIOL, V19, P452, DOI 10.1007/s100960000293
   Kriz P, 2002, EPIDEMIOL INFECT, V128, P157, DOI 10.1017/S0950268801006665
   Kriz P, 1999, RES MICROBIOL, V150, P273, DOI 10.1016/S0923-2508(99)80052-7
   Krizova P, 1997, Cent Eur J Public Health, V5, P214
   LUJAN R, 1991, ANTIMICROB AGENTS CH, V35, P300, DOI 10.1128/AAC.35.2.300
   Maiden MCJ, 2001, MOL BIOTECHNOL, V18, P119, DOI 10.1385/MB:18:2:119
   Maiden MCJ, 1999, CLIN DIAGN LAB IMMUN, V6, P771
   Maiden MCJ, 1999, LANCET, V354, P615, DOI 10.1016/S0140-6736(99)00252-4
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403
   MILLER E, 2001, VACCINE S1, V20, P58
   Molling P, 2000, APMIS, V108, P509, DOI 10.1034/j.1600-0463.2000.d01-90.x
   MOORE PS, 1989, LANCET, V2, P260
   Morelli G, 1997, MOL MICROBIOL, V25, P1047, DOI 10.1046/j.1365-2958.1997.5211882.x
   Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878
   OLSEN SF, 1991, EPIDEMIOL INFECT, V106, P445, DOI 10.1017/S0950268800067492
   Orvelid P, 1999, SCAND J INFECT DIS, V31, P481, DOI 10.1080/00365549950164003
   Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807
   ROTH J, 1988, AM J PATHOL, V133, P227
   ROTH J, 1988, AM J PATHOL, V133, P596
   Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P845, DOI 10.1128/CDLI.5.6.845-855.1998
   SAEZNIETO JA, 1990, ANTIMICROB AGENTS CH, V34, P2269, DOI 10.1128/AAC.34.11.2269
   Sim RJ, 2000, LANCET, V356, P1653, DOI 10.1016/S0140-6736(00)03162-7
   STEVEN N, 1995, MENINGOCOCCAL DIS, P177
   SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x
   SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8
   Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271
   Taha MK, 2001, INFECT IMMUN, V69, P1971, DOI 10.1128/IAI.69.3.1971-1973.2001
   Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9
   Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809
   Troncoso G, 2000, FEMS IMMUNOL MED MIC, V27, P103, DOI 10.1111/j.1574-695X.2000.tb01419.x
   van der Pol WL, 2001, J INFECT DIS, V184, P1548, DOI 10.1086/324662
   VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x
   Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x
   Virji M, 1996, TRENDS MICROBIOL, V4, P466, DOI 10.1016/S0966-842X(97)82905-8
   VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x
   VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x
   Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x
   Vogel U, 2000, NEW ENGL J MED, V342, P219, DOI 10.1056/NEJM200001203420319
   Vogel U, 2000, J CLIN MICROBIOL, V38, P941, DOI 10.1128/JCM.38.2.941-942.2000
   Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998
   VOGEL U, 2001, MENINGOCOCCAL DIS ME, P187
   WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390
   ZHOU P, 2001, P NATL ACAD SCI USA, V98, P5234
   Zorgani AA, 1996, FEMS IMMUNOL MED MIC, V14, P73
NR 96
TC 9
Z9 9
U1 0
U2 1
PU FRONTIERS IN BIOSCIENCE INC
PI MANHASSET
PA C/O NORTH SHORE UNIV HOSPITAL, BIOMEDICAL RESEARCH CENTER, 350 COMMUNITY
   DR, MANHASSET, NY 11030 USA
SN 1093-9946
J9 FRONT BIOSCI
JI Front. Biosci.
PD JAN
PY 2003
VL 8
BP E14
EP E22
DI 10.2741/920
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 633DQ
UT WOS:000180266400049
PM 12456316
DA 2020-05-07
ER

PT J
AU Maquelin, K
   Kirschner, C
   Choo-Smith, LP
   Ngo-Thi, NA
   van Vreeswijk, T
   Stammler, M
   Endtz, HP
   Bruining, HA
   Naumann, D
   Puppels, GJ
AF Maquelin, K
   Kirschner, C
   Choo-Smith, LP
   Ngo-Thi, NA
   van Vreeswijk, T
   Stammler, M
   Endtz, HP
   Bruining, HA
   Naumann, D
   Puppels, GJ
TI Prospective study of the performance of vibrational spectroscopies for
   rapid identification of bacterial and fungal pathogens recovered from
   blood cultures
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID INADEQUATE ANTIMICROBIAL TREATMENT; RAMAN; MICROORGANISMS;
   CLASSIFICATION; SYSTEM
AB Rapid identification of microbial pathogens reduces infection-related morbidity and mortality of hospitalized patients. Raman spectra and Fourier transform infrared (IR) spectra constitute highly specific spectroscopic fingerprints of microorganisms by which they can be identified. Little biomass is required, so that spectra of microcolonies can be obtained. A prospective clinical study was carried out in which the causative pathogens of bloodstream infections in hospitalized patients were identified. Reference libraries of Raman and IR spectra of bacterial and yeast pathogens highly prevalent in bloodstream infections were created. They were used to develop identification models based on linear discriminant analysis and artificial neural networks. These models were tested by carrying out vibrational spectroscopic identification in parallel with routine diagnostic phenotypic identification. Whereas routine identification has a typical turnaround time of 1 to 2 days, Raman and IR spectra of microcolonies were collected 6 to 8 h after microbial growth was detected by an automated blood culture system. One hundred fifteen samples were analyzed by Raman spectroscopy, of which 109 contained bacteria and 6 contained yeasts. One hundred twenty-one samples were analyzed by IR spectroscopy. Of these, 114 yielded bacteria and 7 were positive for yeasts. High identification accuracy was achieved in both the Raman (92.2%, 106 of 115) and IR (98.3%, 119 of 121) studies. Vibrational spectroscopic techniques enable simple, rapid, and accurate microbial identification. These advantages can be easily transferred to other applications in diagnostic microbiology, e.g., to accelerate identification of fastidious microorganisms.
C1 Univ Rotterdam, Med Ctr, Dept Gen Surg 10M, Erasmus MC,Lab Intens Care Res & Opt Spect, NL-3015 GD Rotterdam, Netherlands.
   Univ Rotterdam, Med Ctr, Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands.
   Robert Koch Inst, D-13353 Berlin, Germany.
RP Puppels, GJ (reprint author), Univ Rotterdam, Med Ctr, Dept Gen Surg 10M, Erasmus MC,Lab Intens Care Res & Opt Spect, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
EM puppels@hlkd.azr.nl
CR Amann R, 2001, CURR OPIN BIOTECH, V12, P231, DOI 10.1016/S0958-1669(00)00204-4
   Choo-Smith LP, 2001, APPL ENVIRON MICROB, V67, P1461, DOI 10.1128/AEM.67.4.1461-1469.2001
   DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994
   Goodacre R, 1996, CURR OPIN BIOTECH, V7, P20, DOI 10.1016/S0958-1669(96)80090-5
   Hoerauf A, 1998, CRIT CARE MED, V26, P2010, DOI 10.1097/00003246-199812000-00031
   Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146
   Jones RN, 2001, CHEST, V119, p397S, DOI 10.1378/chest.119.2_suppl.397S
   Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001
   Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079
   Maquelin K, 2002, J CLIN MICROBIOL, V40, P594, DOI 10.1128/JCM.40.2.594-600.2002
   Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h
   MAQUELIN K, 2002, HDB VIBRATIONAL SPEC, V5, P3308
   MILLER JM, 1999, MANUAL CLIN MICROBIO, P193
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   NELSON WH, 1992, APPL SPECTROSC REV, V27, P67, DOI 10.1080/05704929208018270
   Patel JB, 2000, J CLIN MICROBIOL, V38, P246
   Pfaller MA, 2001, EMERG INFECT DIS, V7, P312, DOI 10.3201/eid0702.010234
   PUPPELS GJ, 1991, J RAMAN SPECTROSC, V22, P217, DOI 10.1002/jrs.1250220405
   Sakallah S A, 2000, Biotechnol Annu Rev, V6, P141, DOI 10.1016/S1387-2656(00)06021-X
   STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x
   Thi NAN, 2000, PROC SPIE, V3918, P36
   Thompson RL, 1998, MAYO CLIN PROC, V73, P995, DOI 10.4065/73.10.995
   Udelhoven T, 2000, APPL SPECTROSC, V54, P1471, DOI 10.1366/0003702001948619
   Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307
NR 24
TC 233
Z9 237
U1 0
U2 43
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2003
VL 41
IS 1
BP 324
EP 329
DI 10.1128/JCM.41.1.324-329.2003
PG 6
WC Microbiology
SC Microbiology
GA 635NY
UT WOS:000180406700051
PM 12517868
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Hajmeer, M
   Basheer, I
AF Hajmeer, M
   Basheer, I
TI A probabilistic neural network approach for modeling and classification
   of bacterial growth/no-growth data
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE bacterial growth; logistic regression; modeling; probabilistic neural
   networks
ID LACTIC-ACID CONCENTRATION; ESCHERICHIA-COLI; MICROBIAL-GROWTH; WATER
   ACTIVITY; SACCHAROMYCES-CEREVISIAE; PREDICTIVE MICROBIOLOGY;
   LISTERIA-MONOCYTOGENES; LOGISTIC-REGRESSION; PH; TEMPERATURE
AB In this paper, we propose to use probabilistic neural networks (PNNs) for classification of bacterial growth/no-growth data and modeling the probability of growth. The PNN approach combines both Bayes theorem of conditional probability and Parzen's method for estimating the probability density functions of the random variables. Unlike other neural network training paradigms, PNNs are characterized by high training speed and their ability to produce confidence levels for their classification decision. As a practical application of the proposed approach, PNNs were investigated for their ability in classification of growth/no-growth state of a pathogenic Escherichia coli R31 in response to temperature and water activity. A comparison with the most frequently used traditional statistical method based on logistic regression and multilayer feedforward artificial neural network (MFANN) trained by error backpropagation was also carried out. The PNN-based models were found to outperform linear and nonlinear logistic regression and MFANN in both the classification accuracy and ease by which PNN-based models are developed. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Livermore, CA 95616 USA.
   Dept Transportat, Sacramento, CA 95819 USA.
RP Hajmeer, M (reprint author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, 1 Shields Ave, Livermore, CA 95616 USA.
EM mnhajmeer@ucdavis.edu
CR Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Bolton LF, 1999, J FOOD PROTECT, V62, P601, DOI 10.4315/0362-028X-62.6.601
   CACOULLOS T, 1966, ANN I STAT MATH, V18, P179, DOI 10.1007/BF02869528
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Hajmeer MN, 1998, J RAPID METH AUT MIC, V6, P103, DOI 10.1111/j.1745-4581.1998.tb00191.x
   Hajmeer MN, 2000, J RAPID METH AUT MIC, V8, P265, DOI 10.1111/j.1745-4581.2000.tb00328.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAJMEER MN, 1996, INTELLIGENT ENG SYST, V6, P635
   Hosmer D. W., 1989, APPL LOGISTIC REGRES
   Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9
   Lopez-Malo A, 2000, J FOOD PROTECT, V63, P91, DOI 10.4315/0362-028X-63.1.91
   Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6
   Marzban C, 1996, J APPL METEOROL, V35, P617, DOI 10.1175/1520-0450(1996)035<0617:ANNFTP>2.0.CO;2
   MASTERS T, 1995, ADV ALGORITHMS NEURA
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472
   Presser KA, 1997, APPL ENVIRON MICROB, V63, P2355, DOI 10.1128/AEM.63.6.2355-2360.1997
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773
   RATKOWSKY DA, 1995, LETT APPL MICROBIOL, V20, P29, DOI 10.1111/j.1472-765X.1995.tb00400.x
   Salter MA, 2000, INT J FOOD MICROBIOL, V61, P159, DOI 10.1016/S0168-1605(00)00352-4
   Simon L, 2001, BIOCHEM ENG J, V7, P41, DOI 10.1016/S1369-703X(00)00102-9
   SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q
   Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000
   Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9
NR 24
TC 67
Z9 70
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD OCT
PY 2002
VL 51
IS 2
BP 217
EP 226
AR PII S0167-7012(02)00080-5
DI 10.1016/S0167-7012(02)00080-5
PG 10
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 587HD
UT WOS:000177633700010
PM 12133614
DA 2020-05-07
ER

PT J
AU Karlowsky, JA
   Jones, ME
   Mayfield, DC
   Thornsberry, C
   Sahm, DF
AF Karlowsky, JA
   Jones, ME
   Mayfield, DC
   Thornsberry, C
   Sahm, DF
TI Ceftriaxone activity against Gram-positive and Gram-negative pathogens
   isolated in US clinical microbiology laboratories from 1996 to 2000:
   results from The Surveillance Network (R) (TSN (R)) Database-USA
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE ceftriaxone; surveillance; TSN; gram-positive; gram-negative
ID RESISTANT STREPTOCOCCUS-PNEUMONIAE; COMMUNITY-ACQUIRED PNEUMONIA;
   SPECTRUM BETA-LACTAMASES; UNITED-STATES; ANTIMICROBIAL RESISTANCE;
   PNEUMOCOCCAL PNEUMONIA; ELECTRONIC SURVEILLANCE; HAEMOPHILUS-INFLUENZAE;
   KLEBSIELLA-PNEUMONIAE; MORAXELLA-CATARRHALIS
AB Ceftriaxone was introduced into clinical practice in the USA in 1985 and was the first extended-spectrum (third-generation) cephalosporin approved for once-daily treatment of patients with Gram-positive or Gram-negative infections. Review of ceftriaxone activity is important given its continued use since the mid-1980s and reports of emerging resistance among all antimicrobial agent classes. We reviewed the activity of ceftriaxone and relevant comparative agents against five Gram-positive and 11 Gram-negative species for a 5-year period, 1996-2000, using data from The Surveillance Network(R) (TSN(R)) Database-USA. All MIC results were interpreted using NCCLS breakpoint criteria. Ceftriaxone resistance among isolates of Streptococcus pneumoniae (n = 17 219) remained essentially unchanged over the 5 years studied and in fact was lower from 1998 to 2000 (5.0-5.1%) than in 1996 (6.3%) and 1997 (6.6%). Ceftriaxone resistance (range, 5.1-6.9%) among viridans group streptococci (n = 6621) varied by < 2% from 1997 to 2000. Beta-lactam-resistant Streptococcus pyogenes (n = 935) and group B beta-haemolytic streptococci (n = 2267) were not identified in any year. Among methicillin-susceptible Staphylococcus aureus (n = 39 284) ceftriaxone resistance was 0.1-0.3% per year from 1996 to 2000. Ceftriaxone resistance among Escherichia coli (n = 472 407; range, 0.2-0.4%), Klebsiella oxytoca (n = 16 231; range, 3.5-4.8%), Klebsiella pneumoniae (n = 117 754; range, 1.9-2.6%), Proteus mirabilis (n = 67 692; range, 0.2-0.3%), Morganella morganii (n = 11251; range, 0.3-2.1%) and Serratia marcescens (n = 26 519; range, 1.6-3.8%) was low and consistent from 1996 to 2000. Resistance to ceftriaxone among Enterobacter cloacae (n = 48 114; range, 21.7-23.9%) was relatively high, compared with other Enterobacteriaceae, but unchanged from 1996 to 2000. Rates of resistance to ceftriaxone among Acinetobacter spp. (n = 20 813) increased from 24.8% in 1996 to 45.1% in 2000. All Haemophilus influenzae (n = 7911) and Neisseria gonorrhoeae (n = 218) were susceptible to ceftriaxone, as were 99.7% of Moraxella catarrhalis (n = 312) tested in 1996 and 1997. In summary, ceftriaxone has retained its potent activity against the most commonly encountered Gram-positive and Gram-negative human pathogens despite widespread and ongoing clinical use for more than 15 years. (C) 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
C1 Focus Technol Inc, Herndon, VA 20171 USA.
   Focus Technol Inc, NL-1217 KP Hilversum, Netherlands.
RP Karlowsky, JA (reprint author), Focus Technol Inc, 13665 Dulles Technol Dr, Herndon, VA 20171 USA.
EM jkarlowsky@focusanswers.com
CR Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953
   Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403
   Diekema DJ, 1999, CLIN INFECT DIS, V29, P595
   Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184
   Doern GV, 2001, ANTIMICROB AGENTS CH, V45, P1721, DOI 10.1128/AAC.45.6.1721-1729.2001
   Doern GV, 1996, ANTIMICROB AGENTS CH, V40, P891, DOI 10.1128/AAC.40.4.891
   Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223
   Hadziyannis E, 2000, DIAGN MICR INFEC DIS, V36, P113, DOI 10.1016/S0732-8893(99)00117-0
   Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399
   Hoban DJ, 2001, CLIN INFECT DIS, V32, pS81, DOI 10.1086/320181
   Kaplan SL, 2001, PEDIATR INFECT DIS J, V20, P392, DOI 10.1097/00006454-200104000-00005
   Kelley MA, 2000, CLIN INFECT DIS, V31, P1008, DOI 10.1086/318157
   Leggiadro RJ, 1997, INFECT DIS CLIN N AM, V11, P875, DOI 10.1016/S0891-5520(05)70395-0
   LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557
   Metlay JP, 2000, CLIN INFECT DIS, V30, P520, DOI 10.1086/313716
   Monnet DL, 1997, INFECT CONT HOSP EP, V18, P492
   *NAT COMM CLIN LAB, 2000, PERF STAND ANT SUSC, V20
   *NAT COMM CLIN LAB, 1995, PERF STAND ANT SUSC, V15
   *NAT COMM CLIN LAB, 1998, PERF STAND ANT SUSC, V18
   *NAT COMM CLIN LAB, 2002, PERF STAND ANT SUSC, V22
   *NAT COMM CLIN LAB, 1999, PERF STAND ANT SUSC, V19
   *NAT COMM CLIN LAB, 1997, PERF STAND ANT SUSC, V17
   National Committee for Clinical Laboratory Standards, 2001, PERF STAND ANT SUSC, pM100
   Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010
   PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802
   Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001
   Paterson DL, 2001, CLIN INFECT DIS, V33, P126, DOI 10.1086/320882
   Pfaller MA, 1997, DIAGN MICR INFEC DIS, V29, P273, DOI 10.1016/S0732-8893(97)00139-9
   Roson B, 2001, MICROB DRUG RESIST, V7, P85, DOI 10.1089/107662901750152864
   Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195
   Sahm DF, 2001, ANTIMICROB AGENTS CH, V45, P1037, DOI 10.1128/AAC.45.4.1037-1042.2001
   Sahm DF, 2001, ANTIMICROB AGENTS CH, V45, P267, DOI 10.1128/AAC.45.1.267-274.2001
   Sahm DF, 2001, ANTIMICROB AGENTS CH, V45, P1402, DOI 10.1128/AAC.45.5.1402-1406.2001
   Sahm DF, 2000, ANTIMICROB AGENTS CH, V44, P2521, DOI 10.1128/AAC.44.9.2521-2524.2000
   Thomson K S, 1996, Curr Clin Top Infect Dis, V16, P151
   Thornsberry C, 1999, J ANTIMICROB CHEMOTH, V44, P749, DOI 10.1093/jac/44.6.749
   Thornsberry C, 1996, DIAGN MICR INFEC DIS, V25, P89, DOI 10.1016/S0732-8893(96)00098-3
   Thornsberry C, 1997, DIAGN MICR INFEC DIS, V29, P249, DOI 10.1016/S0732-8893(97)00195-8
   TICE A, 2001, INTRO CHEMOTHER S1, V47, P1
   Tice AD, 2000, DRUGS, V59, P29, DOI 10.2165/00003495-200059003-00004
   Weiss K, 2001, CLIN INFECT DIS, V33, P517, DOI 10.1086/322658
   Winokur PL, 2001, CLIN INFECT DIS, V32, pS94, DOI 10.1086/320182
NR 42
TC 18
Z9 20
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD MAY
PY 2002
VL 19
IS 5
BP 413
EP 426
AR PII S0924-8579(02)00010-9
DI 10.1016/S0924-8579(02)00010-9
PG 14
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 564FX
UT WOS:000176305300008
PM 12007850
DA 2020-05-07
ER

PT J
AU Nicoll, A
   Murray, V
AF Nicoll, A
   Murray, V
TI Invited article - Health protection - a strategy and a national agency
SO PUBLIC HEALTH
LA English
DT Article
DE health protection; public health; microbiology; toxicology; radiation
   science
ID COMMUNICABLE DISEASE; UNITED-STATES; MANAGEMENT
AB The Chief Medical Officer for England has published a strategy for health protection and announced the formation of a new body, the Health Protection Agency, to deal with the threats to health from infectious disease, chemicals, toxins and radiation hazards. This reflects international recognition of the need to combat threats to health from the likes of tuberculosis, HIV, influenza, anti-microbial resistance, chemical accidents and bio-terrorism, and the risks to health associated with increased movements of people, animals and goods, climate change and industrialisation. The strategy will strengthen surveillance and response linking contributions from clinical specialities with public health, microbiology, toxicology and radiation science within the health protection family. The Agency will be formed by combining a number of national and specialist public bodies and personnel delivering local protection services. The strategy represents a unique opportunity to strengthen local and national structures and develop a world-class health protection service. Detailed plans are being developed by the Department of Health with a variety of stakeholders for the launch of the Agency in 2003. A number of challenges will have to be met including developing and training the workforce in health protection, providing career structures for public health scientists and nurses, strengthening electronic communications and developing health protection networks within broader public health structures. Health protection should now be recognised as a sub-speciality of public health.
C1 PHLS Communicable Dis Surveillance Ctr, London NW9 5EQ, England.
   Chem Incident Response Serv, London, England.
RP Nicoll, A (reprint author), PHLS Communicable Dis Surveillance Ctr, 61 Colindale Ave, London NW9 5EQ, England.
EM anicoll@phls.org.uk
CR Acheson D, 1988, REPORT COMMITTEE INQ
   ARDEN K, 2002, REPORT CANC CASES N
   BAXTER PJ, 1990, ROY SOC MED INT CONG, V155, P7
   Brown P, 2000, B WORLD HEALTH ORGAN, V78, P216
   Centers for Disease Control Prevention (CDC), 2001, MMWR-MORBID MORTAL W, V50, P909
   *DEP HLTH, 2001, REP CHIEF MED OFF PR
   *DEP HLTH, SHIFT BAL POW SEC DE
   *DEP HLTH, 2002, GETT AH CURV STRAT C
   *DEP HLTH, 2001, RAP QUAL ASES POSS R
   *DEP HLTH SOC SERV, 1980, COORD EP SERV COMM D
   GALBRAITH NS, 1977, P ROY SOC MED, V70, P889, DOI 10.1177/003591577707001219
   Harling R, 2001, Euro Surveill, V6, P166
   HENDERSON B, 2000, EUROSURVEILLANCE WKL, V46
   Killalea D, 1996, BMJ-BRIT MED J, V313, P1105, DOI 10.1136/bmj.313.7065.1105
   LIEFTUCHT A, 1999, EURSUVEILLANCE WKLY, V44
   Lightfoot N, 2001, BRIT MED J, V323, P877, DOI 10.1136/bmj.323.7318.877
   MacLehose L, 2001, BRIT MED J, V323, P861, DOI 10.1136/bmj.323.7317.861
   MORITA H, 1995, LANCET, V346, P290
   Murray V, 2002, PUBLIC HEALTH, V116, P2, DOI [10.1016/S0033-3506(02)90053-3, 10.1038/sj/ph/1900822]
   Nicoll A, 2001, BRIT MED J, V323, P1321, DOI 10.1136/bmj.323.7325.1321
   Okumura T, 1998, ACAD EMERG MED, V5, P613, DOI 10.1111/j.1553-2712.1998.tb02470.x
   PHILLIPS, 2000, BSE ENQUIRY
   *PUBL HLTH LAB SER, 2001, ANN REV 1999 2000
   Regan M, 1999, J EPIDEMIOL COMMUN H, V53, P517, DOI 10.1136/jech.53.9.517
   ROWLAND A, 1990, J ROY SOC HEALTH, V110, P166, DOI 10.1177/146642409011000507
   *SOC LOC AUTH CHIE, 2001, ROL MOD LOC AUTH CRE
   TROOP P, COMMUNICATION
   *US DEP HHS, 2002, PRES PRES FISC YEAR
   VERITY V, 2000, IN PRESS BR MED J
   VONLOOCK F, 2001, EUROSURVEILLANCE, V3, P37
   *WHO, GLOB OUTBR RESP NETW
   *WHO, INT HLTH REG REN HLT
   *WHO CSR, PUBL HLTH RESP BIOL
   Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9
   2000, EVOLUATION ARRANGEME
   2001, MMWR, V50, P821
   1998, SAVING LIVES OUR HLT
   1997, COMMUNICABLE DIS CON
NR 38
TC 7
Z9 7
U1 0
U2 7
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
J9 PUBLIC HEALTH
JI Public Health
PD MAY
PY 2002
VL 116
IS 3
BP 129
EP 137
DI 10.1038/sj.ph.1900847
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 559WF
UT WOS:000176048400002
PM 12082594
DA 2020-05-07
ER

PT J
AU Cheroutre-Vialette, M
   Lebert, A
AF Cheroutre-Vialette, M
   Lebert, A
TI Application of recurrent neural network to predict bacterial growth in
   dynamic conditions
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Predictive Modelling in Foods
CY SEP 12-15, 2000
CL LEUVEN, BELGIUM
DE Listeria monocytogenes; growth; recurrent neural networks; dynamic
   conditions
ID LISTERIA-MONOCYTOGENES; FOOD MICROBIOLOGY; ENVIRONMENT; TEMPERATURE;
   DESCRIBE; MODEL; PH
AB A combination of a factorial design and two central composite designs was used to assess quantitatively the effects of acid pH (5.6-7.0) or alkaline pH (7.0-9.5) and NaCl (0-8%) variations on the growth of Listeria monocytogenes in a meat broth, at 20 degreesC and lower temperature 10 degreesC. Two principal phenomena were observed when bacteria were submitted to abrupt change of pH and a(w) during growth, whatever the growth temperature: (i) large environmental variations induced a lag phase following the fluctuation, and (ii) the growth continued with a generation time value different from that observed before the change or that associated to the new environment. A dynamic model, based on recurrent neural network (RNN), was developed to describe the growth of L. monocytogenes as a function of temperature and fluctuating conditions of acid pH, alkaline pH and concentration of NaCl. The results showed that the neural network model can be used to represent the complex effects of environmental variable conditions on the microorganism behaviour. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 INRA, Rech Viande Stn, Equipe Genie Procedes, F-63122 St Genes Champanelle, France.
RP Lebert, A (reprint author), INRA, Rech Viande Stn, Equipe Genie Procedes, F-63122 St Genes Champanelle, France.
CR Baranyi J, 1996, APPL ENVIRON MICROB, V62, P1029, DOI 10.1128/AEM.62.3.1029-1035.1996
   Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9
   BUCHANAN RL, 1993, TRENDS FOOD SCI TECH, V4, P6, DOI 10.1016/S0924-2244(05)80004-4
   Cheroutre-Vialette M, 2000, FOOD MICROBIOL, V17, P83, DOI 10.1006/fmic.1999.0290
   Cheroutre-Vialette M, 1998, INT J FOOD MICROBIOL, V42, P71, DOI 10.1016/S0168-1605(98)00064-6
   CHEROUTREVIALET.M, 2000, PREDICTIVE MODELLING, P27
   CHIRIFE J, 1984, J FOOD SCI, V49, P1486, DOI 10.1111/j.1365-2621.1984.tb12827.x
   FOURNAUD J, 1973, 19 REUN EUR CHERCH V, P291
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   McDonald K, 1999, INT J FOOD MICROBIOL, V52, P1, DOI 10.1016/S0168-1605(99)00126-9
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995
   SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840
   VANIMPE JF, 1995, INT J FOOD MICROBIOL, V25, P227, DOI 10.1016/0168-1605(94)00140-2
   ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P204, DOI 10.1128/AEM.60.1.204-213.1994
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 17
TC 24
Z9 26
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD MAR 11
PY 2002
VL 73
IS 2-3
BP 107
EP 118
AR PII S0168-1605(01)00642-0
DI 10.1016/S0168-1605(01)00642-0
PG 12
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 533HQ
UT WOS:000174523900002
PM 11934019
DA 2020-05-07
ER

PT J
AU Maquelin, K
   Choo-Smith, LP
   Endtz, HP
   Bruining, HA
   Puppels, GJ
AF Maquelin, K
   Choo-Smith, LP
   Endtz, HP
   Bruining, HA
   Puppels, GJ
TI Rapid identification of Candida species by confocal Raman micro
   spectroscopy
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID TRANSFORM-INFRARED-SPECTROSCOPY; INTENSIVE-CARE UNIT; PYROLYSIS
   MASS-SPECTROMETRY; ARTIFICIAL NEURAL NETWORKS; FT-IR SPECTROSCOPY;
   BACTERIAL IDENTIFICATION; FUNGAL-INFECTIONS; SURGICAL PATIENTS;
   EPIDEMIOLOGY; SYSTEM
AB Candida species are important nosocomial pathogens associated with high mortality rates. Rapid detection and identification of Candida species can guide a clinician at an early stage to prescribe antifungal drugs or to adjust empirical therapy when resistant species are isolated. Confocal Raman microspectroscopy is highly suitable for the rapid identification of Candida species, since Raman spectra can be directly obtained from microcolonies on a solid culture medium after only 6 h of culturing. In this study, we have used a set of 42 Candida strains comprising five species that are frequently encountered in clinical microbiology to test the feasibility of the technique for the rapid identification of Candida species. The procedure was started either from a culture on Sabouraud medium or from a positive vial of an automated blood culture system. Prior to Raman measurements, strains were subcultured on Sabouraud medium for 6 h to form microcolonies. Using multivariate statistical analyses, a high prediction accuracy (97 to 100%) was obtained with the Raman method. Identification with Raman microspectroscopy may therefore be significantly faster than identification with commercial identification systems that allow various species to be identified and that often require 24 to 48 h before a reliable identification is obtained. We conclude that confocal Raman microspectroscopy offers a rapid, accurate, and easy-to-use alternative for the identification of clinically relevant Candida species.
C1 Univ Rotterdam Hosp, Dept Gen Surg 10M, NL-3015 GD Rotterdam, Netherlands.
   Erasmus Univ, Dept Gen Surg 10M, Lab Intens Care Res & Opt Spect, Rotterdam, Netherlands.
   Erasmus Univ, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
RP Puppels, GJ (reprint author), Univ Rotterdam Hosp, Dept Gen Surg 10M, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
CR Barenfanger J, 1999, J CLIN MICROBIOL, V37, P1415, DOI 10.1128/JCM.37.5.1415-1418.1999
   Berrouane YF, 1999, J CLIN MICROBIOL, V37, P531, DOI 10.1128/JCM.37.3.531-537.1999
   Choo-Smith LP, 2001, APPL ENVIRON MICROB, V67, P1461, DOI 10.1128/AEM.67.4.1461-1469.2001
   CORNWELL EE, 1995, AM SURGEON, V61, P847
   CURK MC, 1994, FEMS MICROBIOL LETT, V123, P241, DOI [10.1016/0378-1097(94)90204-6, 10.1111/j.1574-6968.1994.tb07231.x]
   DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994
   FEHRMANN A, 1995, J MOL STRUCT, V348, P13, DOI 10.1016/0022-2860(94)08577-5
   Goodacre R, 1996, FEMS MICROBIOL LETT, V140, P233, DOI 10.1016/0378-1097(96)00186-3
   Graf B, 2000, J CLIN MICROBIOL, V38, P1782, DOI 10.1128/JCM.38.5.1782-1785.2000
   Heelan JS, 1998, J CLIN MICROBIOL, V36, P1443, DOI 10.1128/JCM.36.5.1443-1445.1998
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   HELM D, 1991, J MICROBIOL METH, V14, P127, DOI 10.1016/0167-7012(91)90042-O
   Hoerauf A, 1998, CRIT CARE MED, V26, P2010, DOI 10.1097/00003246-199812000-00031
   HORBACH I, 1988, J CLIN MICROBIOL, V26, P1106, DOI 10.1128/JCM.26.6.1106-1110.1988
   Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146
   JARVIS WR, 1995, CLIN INFECT DIS, V20, P1526, DOI 10.1093/clinids/20.6.1526
   Jolliffe I. T., 1986, PRINCIPAL COMPONENT, P115
   Kellogg JA, 1998, J CLIN MICROBIOL, V36, P1197, DOI 10.1128/JCM.36.5.1197-1200.1998
   Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001
   Kummerle M, 1998, APPL ENVIRON MICROB, V64, P2207
   LOCHTE T, 1997, THESIS U ESSEN ESSEN
   Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h
   Munoz P, 2000, INT J ANTIMICROB AG, V15, P83, DOI 10.1016/S0924-8579(00)00147-3
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   NAUMANN D, 1995, J MOL STRUCT, V347, P399, DOI 10.1016/0022-2860(95)08562-A
   ODDS FC, 1988, CANDIDA CANDIDOSIS
   Pfaller MA, 1998, DIAGN MICR INFEC DIS, V31, P289, DOI 10.1016/S0732-8893(97)00245-9
   PUPPELS GJ, 1991, J RAMAN SPECTROSC, V22, P217, DOI 10.1002/jrs.1250220405
   Rocco TR, 2000, ARCH SURG-CHICAGO, V135, P160, DOI 10.1001/archsurg.135.2.160
   Safran DB, 1997, ARCH SURG-CHICAGO, V132, P1184, DOI 10.1001/archsurg.1997.01430350034006
   Schrader B, 1997, J MOL STRUCT, V408, P23, DOI 10.1016/S0022-2860(96)09491-4
   Schut TCB, 2000, ANAL CHEM, V72, P6010, DOI 10.1021/ac000780u
   Sheppard DC, 1999, J CLIN MICROBIOL, V37, P2040, DOI 10.1128/JCM.37.6.2040-2041.1999
   STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x
   Timmins EM, 1998, J CLIN MICROBIOL, V36, P367, DOI 10.1128/JCM.36.2.367-374.1998
   Timmins EM, 1998, YEAST, V14, P885, DOI 10.1002/(SICI)1097-0061(199807)14:10<885::AID-YEA286>3.0.CO;2-G
   Tintelnot K, 2000, J CLIN MICROBIOL, V38, P1599, DOI 10.1128/JCM.38.4.1599-1608.2000
   Udelhoven T, 2000, APPL SPECTROSC, V54, P1471, DOI 10.1366/0003702001948619
   VANBELKUM A, 1994, J INFECT DIS, V169, P1062, DOI 10.1093/infdis/169.5.1062
   Vazquez JA, 1998, J CLIN MICROBIOL, V36, P421, DOI 10.1128/JCM.36.2.421-426.1998
   Verweij PE, 1999, J CLIN PATHOL, V52, P271, DOI 10.1136/jcp.52.4.271
   Vincent JL, 1998, INTENS CARE MED, V24, P206, DOI 10.1007/s001340050552
   Voss A, 1997, INFECTION, V25, P8, DOI 10.1007/BF02113499
   Wadlin JK, 1999, J CLIN MICROBIOL, V37, P1967, DOI 10.1128/JCM.37.6.1967-1970.1999
   Warren NG, 1999, MANUAL CLIN MICROBIO, P1184
   Williams DW, 2000, ORAL DIS, V6, P3, DOI 10.1111/j.1601-0825.2000.tb00314.x
   WOLTHUIS R, 1999, FLUORESCENT LUMINESC, P431
NR 47
TC 116
Z9 117
U1 3
U2 31
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD FEB
PY 2002
VL 40
IS 2
BP 594
EP 600
DI 10.1128/JCM.40.2.594-600.2002
PG 7
WC Microbiology
SC Microbiology
GA 519NG
UT WOS:000173731900041
PM 11825976
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Garcia-Gimeno, RM
   Hervas-Martinez, C
   de Siloniz, MI
AF Garcia-Gimeno, RM
   Hervas-Martinez, C
   de Siloniz, MI
TI Improving artificial neural networks with a pruning methodology and
   genetic algorithms for their application in microbial growth prediction
   in food
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE computational neural networks; genetic algorithms; pruning;
   regularization; microbe growth; response surface model; Lactobacillus
   plantarum
ID RESPONSE-SURFACE MODELS; SODIUM-CHLORIDE; BACTERIAL-GROWTH; TEMPERATURE;
   NITRITE; PH
AB The application of Artificial Neural Networks (ANN) in predictive microbiology is presented in this paper. This technique was used to build up a predictive model of the joint effect of NaCl concentration, pH level and storage temperature on kinetic parameters of the growth curve of Lactobacillus plantarum using ANN and Response Surface Model (RSM). Sigmoid functions were fitted to the data and kinetic parameters were estimated and used to build the models in which the independent variables were the factors mentioned above (NaCl. pH. temperature), and in some models, the values of the optical densities (OH) vs. time of the growth curve were also included in order to improve the error of estimation. The determination of the proper size of an ANN was the first step of the estimation. This study shows the usefulness of an ANN pruning methodology. The pruning of the network is a process consisting of removing unnecessary parameters (weights) and nodes during the training process of the network without losing its generalization capacity. The best architecture has been sought using genetic algorithms (GA) in conjunction with pruning algorithms and regularization methods in which the initial distribution of the parameters (weights) of the network is not uniform. The ANN model has been compared with the response surface model by means of the Standard Error of Prediction (SEP). The best values obtained were 14.04% of SEP for the growth rate and 14.84% for the lag estimation by the best ANN model, which were much better than those obtained by the RSM, 35.63% and 39.30%, respectively. These were very promising results that, in our opinion, open tip an extremely important field of research. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Cordoba, Dept Food Sci & Technol, Cordoba 14014, Spain.
   Univ Cordoba, Dept Comp Sci & Numer Anal, Cordoba 14014, Spain.
   Univ Complutense Madrid, Fac Biol, Dept Microbiol 3, E-28040 Madrid, Spain.
RP Garcia-Gimeno, RM (reprint author), Univ Cordoba, Dept Food Sci & Technol, Campus Rabanales,Edif C-1, Cordoba 14014, Spain.
EM bt1gagir@uco.es
RI Hervas-Martinez, Cesar/A-3979-2009; de Siloniz,
   Maria-Isabel/L-1273-2014; Garcia-Gimeno, Rosa Maria/L-4837-2014
OI Hervas-Martinez, Cesar/0000-0003-4564-1816; de Siloniz,
   Maria-Isabel/0000-0002-4204-1244; Garcia-Gimeno, Rosa
   Maria/0000-0001-5241-6348
CR BARANYI J, 1992, FOOD MICROBIOL, V9, P169, DOI 10.1016/0740-0020(92)80024-X
   BARANYI J, 1995, INT J FOOD MICROBIOL, V26, P199, DOI 10.1016/0168-1605(94)00121-L
   BARANYI J, 1998, DRAFT MANUAL DMFIT C
   Bebis G, 1997, NEUROCOMPUTING, V17, P167, DOI 10.1016/S0925-2312(97)00050-7
   BHADURI S, 1995, J APPL BACTERIOL, V79, P163, DOI 10.1111/j.1365-2672.1995.tb00930.x
   BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0
   BUCHANAN RL, 1990, J FOOD PROTECT, V53, P370, DOI 10.4315/0362-028X-53.5.370
   BUCHANAN RL, 1993, FOOD MICROBIOL, V10, P303, DOI 10.1006/fmic.1993.1035
   BUCHANAN RL, 1993, J FOOD SAFETY, V13, P159, DOI 10.1111/j.1745-4565.1993.tb00103.x
   DAVEY KR, 1991, J APPL BACTERIOL, V70, P253, DOI 10.1111/j.1365-2672.1991.tb02933.x
   Devlieghere F, 1998, INT J FOOD MICROBIOL, V41, P231, DOI 10.1016/S0168-1605(98)00052-X
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI 10.1016/S0168-1605(00)00395-0
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Hassibi B., 1993, ADV NEURAL INFORMATI, V5, P164
   Hervas C, 1998, J CHEM INF COMP SCI, V38, P1119, DOI 10.1021/ci980030+
   Hervas C, 2001, FOOD SCI TECHNOL INT, V7, P159, DOI 10.1106/6Q2A-8D7R-JHJU-T7F6
   Hervas C, 2001, J CHEM INF COMP SCI, V41, P1083, DOI 10.1021/ci010012j
   Hervas C, 2000, J CHEM INF COMP SCI, V40, P724, DOI 10.1021/ci9901284
   HUDSON JA, 1992, J FOOD PROTECT, V55, P968, DOI 10.4315/0362-028X-55.12.968
   KALATHENOS P, 1995, INT J FOOD MICROBIOL, V25, P63, DOI 10.1016/0168-1605(94)00085-K
   Krogh A., 1992, ADV NEURAL INFORMATI, P950
   LeCun Y., 1990, ADV NEURAL INFORMATI, P598
   LITTLE CL, 1992, LETT APPL MICROBIOL, V15, P63, DOI 10.1111/j.1472-765X.1992.tb00726.x
   MCCLURE PJ, 1993, INT J FOOD MICROBIOL, V19, P161, DOI 10.1016/0168-1605(93)90074-Q
   MILLER GF, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P379
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   VANIMPE JF, 1992, APPL ENVIRON MICROB, V58, P2901, DOI 10.1128/AEM.58.9.2901-2909.1992
   VANIMPE JR, 1996, COST 914, P31
   WILLIAMS PM, 1995, NEURAL COMPUT, V7, P117, DOI 10.1162/neco.1995.7.1.117
   Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219
   Yao X, 1997, IEEE T NEURAL NETWOR, V8, P694, DOI 10.1109/72.572107
   ZAIKA LL, 1994, INT J FOOD MICROBIOL, V23, P345, DOI 10.1016/0168-1605(94)90162-7
   ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P204, DOI 10.1128/AEM.60.1.204-213.1994
NR 34
TC 62
Z9 66
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JAN 30
PY 2002
VL 72
IS 1-2
BP 19
EP 30
DI 10.1016/S0168-1605(01)00608-0
PG 12
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 518NX
UT WOS:000173675700003
PM 11843410
DA 2020-05-07
ER

PT J
AU Urakawa, H
   Noble, PA
   El Fantroussi, S
   Kelly, JJ
   Stahl, DA
AF Urakawa, H
   Noble, PA
   El Fantroussi, S
   Kelly, JJ
   Stahl, DA
TI Single-base-pair discrimination of terminal mismatches by using
   oligonucleotide microarrays and neural network analyses
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID AMMONIA-OXIDIZING BACTERIA; HYBRIDIZATION PROBES; RIBOSOMAL-RNA; DNA;
   MICROCHIPS; IDENTIFICATION; IMMOBILIZATION; MICROBIOLOGY; COMMUNITIES;
   PREDICTION
AB The effects of single-base-pair near-terminal and terminal mismatches on the dissociation temperature (T-d) and signal intensity of short DNA duplexes were determined by using oligonucleotide microarrays and neural network (NN) analyses. Two perfect-match probes and 29 probes having a single-base-pair mismatch at positions I to 5 from the 5' terminus of the probe were designed to target one of two short sequences representing 16S rRNA. Nonequilibrium dissociation rates (i.e., melting profiles) of all probe-target duplexes were determined simultaneously. Analysis of variance revealed that position of the mismatch, type of mismatch, and formamide concentration significantly affected the T-d and signal intensity. Increasing the concentration of formamide in the washing buffer decreased the T-d and signal intensity, and it decreased the variability of the signal. Although T(d)s of probe-target duplexes with mismatches in the first or second position were not significantly different from one another, duplexes with mismatches in the third to fifth positions had significantly lower T(d)s than those with mismatches in the first or second position. The trained NNs predicted the T-d with high accuracies (R-2 = 0.93). However, the NNs predicted the signal intensity only moderately accurately (R-2 = 0.67), presumably due to increased noise in the signal intensity at low formamide concentrations. Sensitivity analysis revealed that the concentration of formamide explained most (75%) of the variability in T(d)s, followed by position of the mismatch (19%) and type of mismatch (6%). The results suggest that position of the mismatch at or near the 5' terminus plays a greater role in determining the T-d and signal intensity of duplexes than the type of mismatch.
C1 Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.
   Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA.
RP Stahl, DA (reprint author), Univ Washington, Dept Civil & Environm Engn, 302 More Hall,Box 352700, Seattle, WA 98195 USA.
RI Noble, Peter/A-8117-2008; Urakawa, Hidetoshi/B-1337-2013
OI Noble, Peter/0000-0002-6013-2588; Urakawa,
   Hidetoshi/0000-0003-3748-6027; Kelly, John/0000-0002-0894-137X
CR ALEKSANDER I, 1991, INTRO NEURAL COMPUTI, P1
   Almeida JS, 2000, J MICROBIOL METH, V43, P1, DOI 10.1016/S0167-7012(00)00200-1
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Bavykin SG, 2001, APPL ENVIRON MICROB, V67, P922, DOI 10.1128/AEM.67.2.922-928.2001
   Bishop C. M., 1995, NEURAL NETWORKS PATT
   CARSON CA, 1995, J CLIN MICROBIOL, V33, P2894, DOI 10.1128/JCM.33.11.2894-2898.1995
   Dong YM, 2001, APPL ENVIRON MICROB, V67, P1911, DOI 10.1128/AEM.67.4.1911-1921.2001
   FREEMAN R, 1994, J MED MICROBIOL, V40, P170, DOI 10.1099/00222615-40-3-170
   Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209
   Guschin DY, 1997, APPL ENVIRON MICROB, V63, P2397, DOI 10.1128/AEM.63.6.2397-2402.1997
   Hagan M. T., 1996, NEURAL NETWORK DESIG
   HORTON PB, 1992, NUCLEIC ACIDS RES, V20, P4331, DOI 10.1093/nar/20.16.4331
   Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223
   KOOPS HP, 1991, J GEN MICROBIOL, V137, P1689, DOI 10.1099/00221287-137-7-1689
   Liu WT, 2001, ENVIRON MICROBIOL, V3, P619, DOI 10.1046/j.1462-2920.2001.00233.x
   Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173
   MASTERS T, 1993, PRACTICAL NEURAL NET
   MCCONAUG.BL, 1969, BIOCHEMISTRY-US, V8, P3289, DOI 10.1021/bi00836a024
   MILLER RG, 1966, SIMULTANEOUS STAT IN
   Mobarry BK, 1996, APPL ENVIRON MICROB, V62, P2156, DOI 10.1128/AEM.62.6.2156-2162.1996
   Moschetti G, 2001, APPL ENVIRON MICROB, V67, P2156, DOI 10.1128/AEM.67.5.2156-2166.2001
   Noble PA, 1997, APPL ENVIRON MICROB, V63, P1762, DOI 10.1128/AEM.63.5.1762-1770.1997
   Noble PA, 2000, APPL ENVIRON MICROB, V66, P694, DOI 10.1128/AEM.66.2.694-699.2000
   O'Neill MC, 1998, P NATL ACAD SCI USA, V95, P10710, DOI 10.1073/pnas.95.18.10710
   Piceno YM, 1999, MICROBIAL ECOL, V38, P157, DOI 10.1007/s002489900164
   Proudnikov D, 1998, ANAL BIOCHEM, V259, P34, DOI 10.1006/abio.1998.2620
   RAO VB, 1993, C PLUS PLUS NEURAL N
   RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994
   RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1241, DOI 10.1128/AEM.60.4.1241-1248.1994
   RICHIE SE, 1991, INT J SPORTS MED, V12, P27
   Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schutz E, 1999, BIOTECHNIQUES, V27, P1218, DOI 10.2144/99276bc04
   SCHUTZ E, 1999, BIOTECHNIQUES, V27, P1224
   Service RF, 1998, SCIENCE, V282, P396, DOI 10.1126/science.282.5388.396
   SOKAL RR, 1981, BIOMETRY
   STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988
   Stahl DA, 1991, NUCL ACID TECHNIQUES, P205
   Szostak J W, 1979, Methods Enzymol, V68, P419
   Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999
   Tijssen P., 1993, LAB TECHNIQUES BIOCH
   Timofeev EN, 1996, NUCLEIC ACIDS RES, V24, P3142, DOI 10.1093/nar/24.16.3142
   WAGNER M, 1995, SYST APPL MICROBIOL, V18, P251, DOI 10.1016/S0723-2020(11)80396-6
   Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913
   Zart D, 1998, ARCH MICROBIOL, V169, P282, DOI 10.1007/s002030050573
NR 46
TC 94
Z9 99
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JAN
PY 2002
VL 68
IS 1
BP 235
EP 244
DI 10.1128/AEM.68.1.235-244.2002
PG 10
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 508JM
UT WOS:000173085000031
PM 11772632
OA Green Published, Bronze
DA 2020-05-07
ER

PT J
AU Girouard, S
   Levine, G
   Goodrich, K
   Jones, S
   Keyserling, H
   Rathore, M
   Rubens, C
   Williams, E
   Jarvis, W
AF Girouard, S
   Levine, G
   Goodrich, K
   Jones, S
   Keyserling, H
   Rathore, M
   Rubens, C
   Williams, E
   Jarvis, W
TI Infection control programs at children's hospitals: A description of
   structures and processes
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
ID NOSOCOMIAL INFECTIONS; PEDIATRIC-PATIENTS; SURVEILLANCE; EPIDEMIOLOGY
AB Background: Infection control (IC) structures and processes determine the effectiveness of surveillance efforts to prevent infections in health care settings.
   Methods: A survey was sent to 56 children's hospitals collaborating in the Pediatric Prevention Network (PPN).
   Results: Completed surveys were returned from 48 hospitals. Responsibility for the IC program resided with the medical director (21%); vice president for patient care (18%); quality improvement director (17%); other senior hospital administrator (15%); or other hospital personnel (18%). Forty-two hospitals had an IC committee; 32 had antimicrobial restriction/control policies; and 21 had an antimicrobial restriction/control task force or committee. Components of antimicrobial restriction programs included infectious disease specialist approval, restricted formularies, selective susceptibility test reporting, and staff education programs. Many methods were used to detect infections, including microbiology laboratory reports (100%); record reviews (98%); informal reports from providers (90%); and readmission reviews (77%).
   Conclusions: Children's hospitals vary widely in how they design and implement their IC functions. These variations influence adverse event detection and nosocomial infection rate calculations. If medical errors, including nosocomial infections, are to be detected and hospital rates compared, standardized methods to collect, analyze, and report data are needed. The PPN has initiated activities to standardize surveillance and IC practices in participating hospitals.
C1 Natl Assoc Childrens Hosp & Related Inst, Alexandria, VA 22314 USA.
   Childrens Hosp & Med Ctr, Seattle, WA 98105 USA.
   Childrens Healthcare Atlanta, Atlanta, GA USA.
   Wolfson Childrens Hosp, Jacksonville, FL USA.
   Ctr Dis Control & Prevent, Hosp Infect Program, Atlanta, GA USA.
RP Levine, G (reprint author), Natl Assoc Childrens Hosp & Related Inst, 401 Wythe St, Alexandria, VA 22314 USA.
CR *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149
   *CDCP, 2000, FED REGISTER, V65, P38832
   Gaynes RP, 2000, INFECT CONT HOSP EP, V21, P309, DOI 10.1086/501761
   GOLDMANN DA, 1981, AM J MED, V70, P417, DOI 10.1016/0002-9343(81)90782-8
   HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990
   Jarvis W R, 1996, Adv Pediatr Infect Dis, V12, P243
   JARVIS WR, 1987, PEDIATR INFECT DIS J, V6, P344, DOI 10.1097/00006454-198704000-00003
   KOHN LT, 1999, ERR HUMAN BUILDING S
   Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39
   Scheckler WE, 1998, INFECT CONT HOSP EP, V19, P114
NR 10
TC 16
Z9 16
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0196-6553
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD JUN
PY 2001
VL 29
IS 3
BP 145
EP 151
DI 10.1067/mic.2001.115406
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 440XC
UT WOS:000169201100003
PM 11391275
DA 2020-05-07
ER

PT J
AU Jeyamkondan, S
   Jayas, DS
   Holley, RA
AF Jeyamkondan, S
   Jayas, DS
   Holley, RA
TI Microbial growth modelling with artificial neural networks
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE predictive microbiology; artificial neural networks; general regression
   network; microbial modelling; polynomial regression models
ID PREDICTIVE MICROBIOLOGY; BACTERIAL-GROWTH; FOOD MICROBIOLOGY;
   SODIUM-CHLORIDE; PH; TEMPERATURE; NITRITE
AB There is a growing interest in modelling microbial growth as an alternative to time-consuming, traditional, microbiological enumeration techniques. Several statistical models have been reported to describe the growth of different microorganisms, bur there are accuracy problems. An alternate technique 'artificial neural networks' (ANN) for modelling microbial growth is explained and evaluated. Published data were used to build separate general regression neural network (GRNN) structures for modelling growth of Aeromonas hydrophila, Shigella flexneri, and Brochothrix thermosphacta. Both GRNN and published statistical model predictions were compared against the experimental data using six statistical indices. For training data sets, the GRNN predictions were far superior than the statistical model predictions, whereas the GRNN predictions were similar or slightly worse than statistical model predictions for test data sets for all thr three data sits. GRNN predictions can be considered good, considering its performance for unseen data. Graphical plots, mean relative percentage residual, mean absolute relative residual, and root mean squared residual were identified as suitable indices for comparing competing models. ANN can now become a vehicle whereby predictive microbiology can be applied in food product development and food safety risk assessment. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB R3T 5V6, Canada.
   Univ Manitoba, Dept Food Sci, Winnipeg, MB R3T 2N2, Canada.
RP Jayas, DS (reprint author), Univ Manitoba, Dept Biosyst Engn, 438 Engn Bldg, Winnipeg, MB R3T 5V6, Canada.
RI Jayas, Digvir/P-6350-2019
OI /0000-0001-8675-8709
CR BARANYI J, 1993, FOOD MICROBIOL, V10, P43, DOI 10.1006/fmic.1993.1005
   BARANYI J, 1995, INT J FOOD MICROBIOL, V26, P199, DOI 10.1016/0168-1605(94)00121-L
   BISHOP CM, 1994, IEE P-VIS IMAGE SIGN, V141, P217, DOI 10.1049/ip-vis:19941330
   BRATCHELL N, 1989, INT J FOOD MICROBIOL, V8, P47, DOI 10.1016/0168-1605(89)90079-2
   BRATCHELL N, 1990, INT J FOOD MICROBIOL, V11, P279, DOI 10.1016/0168-1605(90)90021-V
   BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Hagan M. T., 1996, NEURAL NETWORK DESIG
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6
   MCCLURE PJ, 1993, INT J FOOD MICROBIOL, V19, P161, DOI 10.1016/0168-1605(93)90074-Q
   MCCLURE PJ, 1994, INT J FOOD MICROBIOL, V23, P359, DOI 10.1016/0168-1605(94)90163-5
   MCMEEKIN TA, 1993, PREDICTIVE MICROBIOL
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   *NEUR 2, 1993, ONL TUT NEUR REL 4 0
   Ratkowsky D.A., 1990, HDB NONLINEAR REGRES
   RATKOWSKY DA, 1991, J APPL BACTERIOL, V71, P452, DOI 10.1111/j.1365-2672.1991.tb03816.x
   Roberto KA, 1996, J WOMEN AGING, V8, P1, DOI 10.1300/J074v08n03_01
   ROBERTS SJ, 1996, NOVELTY CONFIDENCE E
   ROSS T, 1991, FOOD AUST, V43, P202
   Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x
   ROSS T, 1994, INT J FOOD MICROBIOL, V23, P241, DOI 10.1016/0168-1605(94)90155-4
   Schepers AW, 2000, ENZYME MICROB TECH, V26, P431, DOI 10.1016/S0141-0229(99)00183-0
   SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934
   Wilkinson G, 1997, FOOD QUAL PREFER, V8, P439
   ZAIKA LL, 1994, INT J FOOD MICROBIOL, V23, P345, DOI 10.1016/0168-1605(94)90162-7
NR 26
TC 84
Z9 85
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD MAR 20
PY 2001
VL 64
IS 3
BP 343
EP 354
DI 10.1016/S0168-1605(00)00483-9
PG 12
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 415MC
UT WOS:000167724500011
PM 11294356
DA 2020-05-07
ER

PT J
AU Basheer, IA
   Hajmeer, M
AF Basheer, IA
   Hajmeer, M
TI Artificial neural networks: fundamentals, computing, design, and
   application
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE artificial neural networks; backpropagation; growth curves; history;
   modeling; S. flexneri
ID PYROLYSIS MASS-SPECTROMETRY; PREDICTIVE MICROBIOLOGY; REGRESSION;
   IDENTIFICATION; GROWTH; MILK; BACKPROPAGATION; CLASSIFICATION;
   ADULTERATION; KNOWLEDGE
AB Artificial neural networks (ANNs) are relatively new computational tools that have found extensive utilization in solving many complex real-world problems. The attractiveness df ANNs comes from their remarkable information processing characteristics pertinent mainly to nonlinearity, high parallelism, fault and noise tolerance, and learning and generalization capabilities. This paper aims to familiarize the reader with ANN-based computing (neurocomputing) and to serve as a useful companion practical guide and toolkit for the ANNs modeler along the course of ANN project development. The history of the evolution of neurocomputing and its relation to the field of neurobiology is briefly discussed. ANNs are compared to both expert systems and statistical regression and their advantages and limitations are outlined. A bird's eye review of the various types of ANNs and the related learning rules is:presented, with special emphasis on backpropagation (BP) ANNs theory and design. A generalized methodology for developing successful ANNs projects from conceptualization to design, to implementation, is described. The most common problems that BPANNs developers face during training are summarized in conjunction with possible causes and remedies. Finally, as a practical application, BPANNs were used to model the-microbial growth curves of S. flexneri. The developed model was reasonably accurate in simulating both training: and test time-dependent growth curves as affected by temperature and pH. (C) 2000 published by Elsevier Science B.V.
C1 CalTrans, Headquarters Transaportat Lab, Engn Serv Ctr, Sacramento, CA 95819 USA.
   Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.
RP Basheer, IA (reprint author), CalTrans, Headquarters Transaportat Lab, Engn Serv Ctr, Sacramento, CA 95819 USA.
EM imad.basheer@dot.ca.gov
CR ANDERSON JA, 1988, NEUROCOMPUTING FDN R
   ATTOHOKINE N, 1999, EC012 T RES BOARD
   BARRON AR, 1993, IEEE T INFORM THEORY, V39, P930, DOI 10.1109/18.256500
   BASHEER I, 2000, J COMPUT AIDED CIVIL, V5, P445
   BASHEER IA, 1998, THESIS KANSAS STATE
   Baum EB, 1989, NEURAL COMPUT, V1, P151, DOI 10.1162/neco.1989.1.1.151
   Bishop C. M., 1995, NEURAL NETWORKS PATT
   CARPENTER GA, 1988, COMPUTER, V21, P77, DOI 10.1109/2.33
   CARPENTER GA, 1987, APPL OPTICS, V26, P4919, DOI 10.1364/AO.26.004919
   CARSON CA, 1995, J CLIN MICROBIOL, V33, P2894, DOI 10.1128/JCM.33.11.2894-2898.1995
   CHENG B, 1994, STAT SCI, V9, P2, DOI 10.1214/ss/1177010638
   CHUN J, 1993, FEMS MICROBIOL LETT, V114, P115, DOI 10.1016/0378-1097(93)90151-Q
   CHUN J, 1993, FEMS MICROBIOL LETT, V107, P321
   Dowla F. U., 1995, SOLVING PROBLEMS ENV
   EATON HAC, 1992, NEURAL NETWORKS, V5, P283, DOI 10.1016/S0893-6080(05)80026-7
   FAHLMAN SE, 1988, CMUCS88162 CARN MELL
   FU L, 1995, NEURAL NETWORKS COMP
   GARTH ADN, 1996, ARTIFICAL NEURAL NET, V6, P939
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Giacomini M, 1997, IEEE T BIO-MED ENG, V44, P1185, DOI 10.1109/10.649990
   Goodacre R, 1997, APPL SPECTROSC, V51, P1144, DOI 10.1366/0003702971941665
   GOODACRE R, 1993, J SCI FOOD AGR, V63, P297, DOI 10.1002/jsfa.2740630306
   GOODACRE R, 1994, ZBL BAKT, V22, P124
   Govindaraju RS, 2000, J HYDROL ENG, V5, P115
   Hajmeer MN, 1998, J RAPID METH AUT MIC, V6, P103, DOI 10.1111/j.1745-4581.1998.tb00191.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAJMEER MN, 1996, P ANNIE 96 INT ENG S, P635
   HAJMEER MN, 2000, NEW APPROACH MODELIN
   Han J, 1996, ENG APPL ARTIF INTEL, V9, P109, DOI 10.1016/0952-1976(95)00001-1
   HANSON SJ, 1995, BACKPROPAGATION THEO, P237
   Hassoun M. H, 1995, FUNDAMENTALS ARTIFIC
   Haykin S., 1994, NEURAL NETWORKS COMP
   Hebb D, 1949, ORG BEHAV
   HECHTNIELSEN R, 1988, NEURAL NETWORKS, V1, P131, DOI 10.1016/0893-6080(88)90015-9
   HECHTNIESLSEN R, 1990, NEUROCOMPUTING
   Henseler J., 1995, Artificial Neural Networks. An Introduction to ANN Theory and Practice, P37
   Hertz J, 1991, INTRO THEORY NEURAL
   HOFFMAN RR, 1987, AI MAG, V8, P53
   HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256
   HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088
   Horimoto Y, 1997, J AGR FOOD CHEM, V45, P743, DOI 10.1021/jf960660g
   Hudson P. T. W., 1995, Artificial Neural Networks. An Introduction to ANN Theory and Practice, P273
   Jadid MN, 1996, ENG APPL ARTIF INTEL, V9, P309, DOI 10.1016/0952-1976(96)00021-8
   Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891
   Jonsson A, 1997, INT J FOOD MICROBIOL, V35, P187, DOI 10.1016/S0168-1605(96)01218-4
   KANDEL A, 1992, HYDRID ARCHITECTURES
   KERBER R, 1992, P 10 NAT C ART INT, P123
   LACHTERMACHER G, 1995, J FORECASTING, V14, P381, DOI 10.1002/for.3980140405
   LAKSHMANAN V, 1997, ARTIFICAL NEURAL NET, V7, P521
   Lee Y., 1991, IJCNN-91-Seattle: International Joint Conference on Neural Networks (Cat. No.91CH3049-4), P765, DOI 10.1109/IJCNN.1991.155275
   LI G, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P580, DOI 10.1109/ICNN.1993.298622
   Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1109/MASSP.1987.1165576
   Looney CG, 1996, IEEE T KNOWL DATA EN, V8, P211, DOI 10.1109/69.494162
   MAREN AJ, 1991, P 2 WORKSH NEUR NETW
   MASTERS T, 1994, PRACTICAL NEURAL NET
   McCulloch W.S., 1943, B MATH BIOPHYS, V5, P115, DOI [10.1007/BF02478259, DOI 10.1007/BF02478259]
   MINSKY M, 1969, PERCEPTRONS
   MOODY J, 1992, ADV NEUR IN, V4, P1048
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   Nelson M, 1990, PRACTICAL GUIDE NEUR
   NGUYEN D, 1990, P INT JOINT C NEUR N, V3, P21, DOI DOI 10.1109/IJCNN.1990.137819
   Ni HX, 1998, FOOD TECHNOL-CHICAGO, V52, P60
   Pal SK, 1996, COMPUTER, V29, P24, DOI 10.1109/MC.1996.485890
   PHAM DT, 1994, P 9 INT C ART INT EN, P3
   PLANT RE, 1991, KNOWLEDGE BASED SYST
   RamosNino ME, 1997, J APPL MICROBIOL, V82, P168, DOI 10.1111/j.1365-2672.1997.tb02847.x
   RIZZO DM, 1994, WATER RESOUR RES, V30, P483, DOI 10.1029/93WR02477
   Rosenblatt R, 1962, PRINCIPLES NEURODYNA
   Rumelhart DE, 1995, BACKPROPAGATION THEO, P1
   RUMELHART DE, 1986, PARALLEL DISTRIBUTED, V1, pCH8
   SCHALLKOFF RJ, 1997, ARTIFICAL NEURAL NET
   SCHMIDT W, 1993, P IEEE INT C NEUR NE, P598
   Sietsma J., 1988, IEEE International Conference on Neural Networks (IEEE Cat. No.88CH2632-8), P325, DOI 10.1109/ICNN.1988.23864
   SIMPSON PK, 1990, ARTIFICAL NEURAL SYS
   SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934
   STEIN R, 1993, AI EXPERT, V2, P42
   SUI DZ, 1992, P GISLIS 92 SAN JOS
   SUN X, 1997, P INT ENG SYST ART N, P70
   SWINGLER K, 1996, APPLYING NEURAL NETW
   Timmins EM, 1997, J APPL MICROBIOL, V83, P208, DOI 10.1046/j.1365-2672.1997.00218.x
   Twomey J.M., 1997, ARTIFICIAL NEURAL NE, P44
   UPADHYAYA BR, 1992, NUCL TECHNOL, V97, P170, DOI 10.13182/NT92-A34613
   VALLEJOCORDOBA B, 1995, J FOOD SCI, V60, P885, DOI 10.1111/j.1365-2621.1995.tb06253.x
   VANROOIJ AJF, 1996, NEURAL NETWORK TRAIN
   VONNEUMAN J, 1958, COMPUTER BRAIN
   WERBOS P, 1974, THESIS HARVARD U
   WHITE H, 1990, NEURAL NETWORKS, V3, P535, DOI 10.1016/0893-6080(90)90004-5
   White H, 1989, NEURAL COMPUT, V1, P425, DOI 10.1162/neco.1989.1.4.425
   WIDROW B, 1990, P IEEE, V78, P1415, DOI 10.1109/5.58323
   WYTHOFF BJ, 1993, CHEMOMETR INTELL LAB, V18, P115, DOI 10.1016/0169-7439(93)80052-J
   YU X, 1993, P IEEE INT C NEUR NE, P1157
   ZAIKA LL, 1994, INT J FOOD MICROBIOL, V23, P345, DOI 10.1016/0168-1605(94)90162-7
   ZUPAN J, 1991, ANAL CHIM ACTA, V248, P1, DOI 10.1016/S0003-2670(00)80865-X
   Zupan J., 1993, NEURAL NETWORKS CHEM
NR 94
TC 1241
Z9 1281
U1 45
U2 480
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD DEC 1
PY 2000
VL 43
IS 1
BP 3
EP 31
DI 10.1016/S0167-7012(00)00201-3
PG 29
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 379LW
UT WOS:000165644400002
PM 11084225
DA 2020-05-07
ER

PT J
AU Wilkins, MF
   Boddy, L
   Morris, CW
AF Wilkins, MF
   Boddy, L
   Morris, CW
TI Proportion estimation with confidence limits
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE population composition estimation; proportion estimation; bootstrap
   estimation; Monte Carlo techniques
ID STOCK FISHERY COMPOSITION; FLOW-CYTOMETRY; IDENTIFICATION
AB A common task in microbiology involves determining the composition of a mixed population of individuals by drawing a sample from the population and using some procedure to identify the individuals in the sample. There may be a significant probability that the identification procedure misidentifies some members of the sample (for example, because the available data are insufficient unambiguously to identify an individual) which makes finding the proportions in the underlying population non-trivial. A further complication arises where individuals are present in the population that do not belong to any of the subpopulations recognised by use of the identification procedure. A simple algorithm is presented to address these problems and construct a maximum likelihood estimate of the proportions, together with confidence limits. The technique is illustrated using an example drawn from flow cytometry in which phytoplankton cells are identified from flow cytometry data by an RBF neural network, and the limitations of the approach are discussed. (C) 2000 Elsevier Science BN; All rights reserved.
C1 Univ Wales Coll Cardiff, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales.
   Univ Glamorgan, Sch Comp Studies, Pontypridd CF37 1DL, M Glam, Wales.
RP Wilkins, MF (reprint author), Univ Wales Coll Cardiff, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales.
RI Boddy, Lynne/A-7250-2010
OI Boddy, Lynne/0000-0003-1845-6738
CR Bernard RL, 1996, CAN J FISH AQUAT SCI, V53, P1727, DOI 10.1139/cjfas-53-8-1727
   Boddy L, 2000, MAR ECOL PROG SER, V195, P47, DOI 10.3354/meps195047
   BURKILL PH, 1990, PHILOS T ROY SOC A, V333, P99, DOI 10.1098/rsta.1990.0141
   COOK RC, 1983, CAN J FISH AQUAT SCI, V40, P2113, DOI 10.1139/f83-245
   COOK RC, 1978, FISH B-NOAA, V76, P415
   Efron B., 1982, CBMS NSF REGIONAL C, P38
   Efron BTR, 1993, MONOGRAPHS STAT APPL, P57
   Haykin S., 1994, NEURAL NETWORKS COMP
   MILLAR RB, 1990, CAN J FISH AQUAT SCI, V47, P2235, DOI 10.1139/f90-248
   MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071
   MORRIS CW, 1996, INTELLIGENT ENG SYST, V6, P629
   PELLA JJ, 1979, FISH B-NOAA, V77, P387
   Richard MD, 1991, NEURAL COMPUT, V3, P461, DOI 10.1162/neco.1991.3.4.461
   Wilkins MF, 1999, APPL ENVIRON MICROB, V65, P4404
NR 14
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD DEC 1
PY 2000
VL 43
IS 1
BP 55
EP 64
DI 10.1016/S0167-7012(00)00204-9
PG 10
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 379LW
UT WOS:000165644400005
PM 11084228
DA 2020-05-07
ER

PT J
AU Hajmeer, MN
   Basheer, IA
   Marsden, JL
   Fung, DYC
AF Hajmeer, MN
   Basheer, IA
   Marsden, JL
   Fung, DYC
TI New approach for modeling generalized microbial growth curves using
   artificial neural networks
SO JOURNAL OF RAPID METHODS AND AUTOMATION IN MICROBIOLOGY
LA English
DT Article
ID PREDICTIVE MICROBIOLOGY; BACTERIAL-GROWTH; CLASSIFICATION; REGRESSION
AB Microbial growth curves are essential components in microbiological studies and are modeled conventionally by nonlinear fitting to one analytical expression such as the modified Gompertz equation. This paper discusses the potential of artificial neural networks (ANNs) for modeling bacterial growth curves. These ANNs are efficient approximators for highly dimensional complex functions because of their high nonlinearity and tolerance to noisy data. Therefore, ANNs can provide great flexibility in developing generalized models by extracting the real behavior directly from the experimental data. Such models can be designed to include the effect of time as well as a multitude of parameters pertaining to experimental conditions. The approach was applied to modeling time-dependent growth curves of Escherichia coli O157:H7 as affected by sodium chloride concentration and of Shigella flexneri as affected by incubation temperature, pH, and initial count. The developed ANNs were able to approximate the experimental growth curves with high accuracy. The advantages as well as limitations of the proposed methodology are presented.
C1 Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.
   IAB, Sacramento, CA 95819 USA.
RP Hajmeer, MN (reprint author), Kansas State Univ, Dept Anim Sci & Ind, Weber Hall, Manhattan, KS 66506 USA.
EM mhajmeer@oznet.ksu.edu
CR Bardot I., 1994, Food Quality and Preference, V5, P159, DOI 10.1016/0950-3293(94)90023-X
   Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3
   Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5
   Govindaraju RS, 2000, J HYDROL ENG, V5, P115
   Hajmeer MN, 1998, J RAPID METH AUT MIC, V6, P103, DOI 10.1111/j.1745-4581.1998.tb00191.x
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAJMEER MN, 1996, INTELLIGENT ENG SYST, V6, P635
   HAMEER MN, 2001, THESIS KANSAS STATE
   Haykin S., 1994, NEURAL NETWORKS COMP
   Hecht-Nielsen R., 1990, NEUROCOMPUTING
   Horimoto Y, 1997, J AGR FOOD CHEM, V45, P743, DOI 10.1021/jf960660g
   Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891
   Jonsson A, 1997, INT J FOOD MICROBIOL, V35, P187, DOI 10.1016/S0168-1605(96)01218-4
   MCMEEKIN TA, 1993, PREDICTIVE MICROBIOL
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   RamosNino ME, 1997, J APPL MICROBIOL, V82, P168, DOI 10.1111/j.1365-2672.1997.tb02847.x
   Rumelhart D. E., 1986, PARALLEL DISTRIBUTED
   VALLEJOCORDOBA B, 1995, J FOOD SCI, V60, P885, DOI 10.1111/j.1365-2621.1995.tb06253.x
   ZAIKA LL, 1994, INT J FOOD MICROBIOL, V23, P345, DOI 10.1016/0168-1605(94)90162-7
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 20
TC 10
Z9 10
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1060-3999
EI 1745-4581
J9 J RAPID METH AUT MIC
JI J Rapid Methods Autom. Microbiol.
PD DEC
PY 2000
VL 8
IS 4
BP 265
EP 283
DI 10.1111/j.1745-4581.2000.tb00328.x
PG 19
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 402UH
UT WOS:000167006200003
DA 2020-05-07
ER

PT J
AU Cheroutre-Vialette, M
   Lebert, A
AF Cheroutre-Vialette, M
   Lebert, A
TI Modelling the growth of Listeria monocytogenes in dynamic conditions
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT International Symposium on Microbial Stress and Recovery in Food
CY JUN 14-16, 1999
CL QUIMPER, FRANCE
SP Conseil Reg Bretagne, Conseil Gen Finistere, European Community, Ville Quimper, Univ Bretagne Occidentale, Technopole Quimper Cornouaille, CNRS, ADRIA, Soc Francaise Microbiol
DE Listeria monocytogenes; recurrent neural networks; dynamic conditions;
   pH; water activity
ID BACTERIAL-GROWTH; NEURAL NETWORKS; WATER ACTIVITY; PH; TEMPERATURE;
   MICROBIOLOGY
AB A recurrent neural network for the prediction of Listeria monocytogenes growth under pH and a(w) variable conditions was developed. The use of this model offered the possibility to take into account the consequences of the variations of the factors on L. monocytogenes growth. The effects of solutions, such as NaCl, acetic acid and NaOH, and their interactions on the response of L. monocytogenes cells were studied. Furthermore, the results showed the capacity of the recurrent neural network to predict growths carried out in different experimental conditions without using those used for its elaboration. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 INRA, Rech Viande Stn, F-63122 St Genes Champanelle, France.
RP Lebert, A (reprint author), INRA, Rech Viande Stn, F-63122 St Genes Champanelle, France.
CR Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9
   BUCHANAN RL, 1993, TRENDS FOOD SCI TECH, V4, P6, DOI 10.1016/S0924-2244(05)80004-4
   Cheroutre-Vialette M, 1998, INT J FOOD MICROBIOL, V42, P71, DOI 10.1016/S0168-1605(98)00064-6
   CHIRIFE J, 1984, J FOOD SCI, V49, P1486, DOI 10.1111/j.1365-2621.1984.tb12827.x
   DORNIER M, 1995, J MEMBRANE SCI, V98, P263, DOI 10.1016/0376-7388(94)00195-5
   Fernandez PS, 1997, INT J FOOD MICROBIOL, V37, P37, DOI 10.1016/S0168-1605(97)00043-3
   FOURNAUD J, 1973, 19 REUN EUR CHERCH V, P291
   HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554
   KOHONEN T, 1987, SELF ORG ASSOCIATIVE
   Presser KA, 1997, APPL ENVIRON MICROB, V63, P2355, DOI 10.1128/AEM.63.6.2355-2360.1997
   SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840
   VANIMPE JF, 1995, INT J FOOD MICROBIOL, V25, P227, DOI 10.1016/0168-1605(94)00140-2
   WHITING RC, 1994, FOOD TECHNOL-CHICAGO, V48, P113
   WIJTZES T, 1993, INT J FOOD MICROBIOL, V18, P139, DOI 10.1016/0168-1605(93)90218-6
   ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P204, DOI 10.1128/AEM.60.1.204-213.1994
NR 15
TC 12
Z9 12
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD APR 10
PY 2000
VL 55
IS 1-3
BP 201
EP 207
DI 10.1016/S0168-1605(00)00164-1
PG 7
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 308VG
UT WOS:000086733100036
PM 10791744
DA 2020-05-07
ER

PT J
AU Efstratiou, A
   Roure, C
AF Efstratiou, A
   Roure, C
CA European Laboratory Working Grp D
TI The European Laboratory Working Group on Diphtheria: A global
   microbiologic network
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID NEWLY INDEPENDENT STATES; EPIDEMIOLOGY; SITUATION
AB Increasing international travel, migration to and from epidemic areas, and the emergence of epidemic Corynebacterium diphtheriae strains globally have highlighted the need for better microbiologic surveillance and greater clinical and laboratory awareness. As part of the strategy developed by the World Health Organization, one major goal is particularly applicable to the microbiology and epidemiology of diphtheria: to improve surveillance for early detection of emerging and reemerging diseases by establishing a network of national and international laboratories, The European Laboratory Working Group on Diphtheria (ELWGD) was therefore formed in 1993 as a result of the epidemic situation in Eastern Europe. Currently there is participation from 20 different countries from Western and Eastern Europe, the United States, Australia, and Southeast Asia. ELWGD is a prime example of a collaborative and coordinated approach to the microbiology of diphtheria and should serve as a potential model for other infectious diseases networks.
C1 Cent Publ Hlth Lab, PHLS Respiratory & System Infect Lab, WHO, Collaborat Ctr Diphtheria & Streptococcal Infect, London NW9 5HT, England.
   WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark.
RP Efstratiou, A (reprint author), Cent Publ Hlth Lab, PHLS Respiratory & System Infect Lab, WHO, Collaborat Ctr Diphtheria & Streptococcal Infect, 61 Colindale Ave, London NW9 5HT, England.
CR BEGG N, 1994, MANUAL MANAGEMENT CO
   BEGG N, ICPEPI038B
   DEZOYSA A, 1995, J CLIN MICROBIOL, V33, P1080, DOI 10.1128/JCM.33.5.1080-1083.1995
   Dittmann S, 1997, BIOLOGICALS, V25, P179, DOI 10.1006/biol.1997.0081
   Efstratiou A, 1998, METH MOLEC MED, V15, P191, DOI 10.1385/0-89603-498-4:191
   Efstratiou A., 1996, Reviews in Medical Microbiology, V7, P31
   EFSTRATIOU A, 1994, MANUAL LAB DIAGNOSIS
   EFSTRATIOU A, 1995, P 1 INT M EUR LAB WO
   EFSTRATIOU A, 1997, 7 M NATL PROGR MAN C
   Engler KH, 1997, J CLIN MICROBIOL, V35, P495, DOI 10.1128/JCM.35.2.495-498.1997
   ENGLER KH, 1997, CLIN MICROBIOL IN S2, V3, P14
   GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P107, DOI 10.1007/BF01719955
   GRIMONT PAD, 1997, 4 INT M EUR LAB WORK
   Hardy IRB, 1996, LANCET, V347, P1739, DOI 10.1016/S0140-6736(96)90811-9
   MAPLE PAC, 1998, 5 INT M EUR LAB WORK, P28
   Popovic T, 2000, J INFECT DIS, V181, pS168, DOI 10.1086/315556
   SNELL JJJS, 1996, GEN BACTERIOLOGY
   *WHO, 1994, FDN MARC MER DIPHTHE
NR 18
TC 13
Z9 14
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD FEB
PY 2000
VL 181
SU 1
BP S146
EP S151
DI 10.1086/315553
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 293LV
UT WOS:000085854000024
PM 10657206
OA Bronze
DA 2020-05-07
ER

PT J
AU Sahm, DF
   Marsilio, MK
   Piazza, G
AF Sahm, DF
   Marsilio, MK
   Piazza, G
TI Antimicrobial resistance in key bloodstream bacterial isolates:
   Electronic surveillance with The Surveillance Network Database - USA
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT Symposium on Surveillance and Control of Pathogens of Epidemiologic
   Importance
CY APR 03-04, 1998
CL ORLANDO, FL
SP Rhone Poulenc Rorer Pharmaceut
ID SPECTRUM BETA-LACTAMASES; NOSOCOMIAL INFECTIONS; MICROBIOLOGY;
   VANCOMYCIN; SUSCEPTIBILITIES; STAPHYLOCOCCI; PATHOGENS
AB To assess the prevalence of antimicrobial-resistant pathogens among the most common bloodstream isolates, we examined antimicrobial susceptibility data from The Surveillance Network Database-USA, an electronic surveillance system that collects data from 118 clinical microbiology laboratories across the United States. Between 1995 and 1997, resistance to both vancomycin and ampicillin was much more prevalent among Enterococcus faecium than Enterococcus faecalis, suggesting the need for laboratories to identify to species. When staphylococcal isolates were examined for reduced susceptibility to vancomycin (minimum inhibitory concentration = 4 mu g/mL), the frequency was highest in methicillin-resistant coagulase-negative staphylococci. We also learned that nonsusceptibility to ceftazidime in Klebsiella pneumoniae was more prevalent among isolates from blood (12.7%) than among isolates from urine (7.1%) or respiratory sources (9.3%). Although antimicrobial resistance is low overall for isolates of Escherichia coli from blood, the prevalence of cefoxitin resistance among ceftazidime-resistant strains (61.9%) suggests the action of mechanisms other than extended-spectrum beta-lactamase.
C1 MRL Pharmaceut Serv, Herndon, VA 20171 USA.
RP Sahm, DF (reprint author), MRL Pharmaceut Serv, 13665 Dulles Technol Dr,Suite 200, Herndon, VA 20171 USA.
EM dsahm@thetsn.com
CR Bush K, 1997, CIBA F SYMP, V207, P152
   Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P626
   Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192
   EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993
   Fridkin SK, 1997, INFECT DIS CLIN N AM, V11, P479, DOI 10.1016/S0891-5520(05)70366-4
   Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193
   GAYNES R, 1996, INFECT CONT HOSP EP, V17, P18
   Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8
   Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996
   JACOBY GA, 1994, EUR J CLIN MICROBIOL, V13, P2, DOI 10.1007/BF02390679
   Jones RN, 1997, DIAGN MICR INFEC DIS, V29, P95, DOI 10.1016/S0732-8893(97)00115-6
   JONES RN, 1994, DIAGN MICR INFEC DIS, V19, P203, DOI 10.1016/0732-8893(94)90033-7
   Livermore DM, 1996, SCAND J INFECT DIS, P33
   Munro S, 1998, AM J CLIN PATHOL, V109, P144
   *NAT COMM CLIN LAB, 1998, M100S8 NCCLS
   Pfaller MA, 1997, CLIN INFECT DIS, V25, P858, DOI 10.1086/515557
   Sieradzki K, 1998, ANTIMICROB AGENTS CH, V42, P100, DOI 10.1128/AAC.42.1.100
   Tenover FC, 1998, J CLIN MICROBIOL, V36, P1020, DOI 10.1128/JCM.36.4.1020-1027.1998
   Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584
NR 19
TC 161
Z9 164
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG
PY 1999
VL 29
IS 2
BP 259
EP 263
DI 10.1086/520195
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 227YE
UT WOS:000082106900006
PM 10476722
OA Bronze
DA 2020-05-07
ER

PT J
AU De Smedt, JM
AF De Smedt, JM
TI AOAC validation of qualitative and quantitative methods for microbiology
   in foods
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT International Committee for Food Microbiology and Hygiene Food Micro 96
   Meeting
CY 1996
CL BUDAPEST, HUNGARY
SP Int Comm Food Microbiol & Hygiene
DE AOAC; standard methods; validation; official methods
ID RAPPAPORT-VASSILIADIS MEDIUM; SALMONELLA DETECTION; MOTILITY ENRICHMENT;
   INTERNATIONAL OFFICE; SUGAR CONFECTIONERY; CHOCOLATE; COCOA; SAMPLES;
   MILK
AB The purpose of AOAC International is promoting quality measurements and methods validation in the analytical sciences. The actual work of developing and testing methods is done by a network of AOAC members and volunteers. Validation of the methods is established by the AOAC Official Methods Program. The objective of this program is to provide analytical methods for which performance characteristics have been validated to the highest degree of confidence through an independent, multiple laboratory collaborative study. The performance characteristics for quantitative microbiological methods include repeatability, reproducibility and critical relative difference, while the characteristics for qualitative methods are sensitivity and specificity. The Official Methods Program is illustrated by a practical example of a collaborative study through which salmonella detection by motility enrichment on Modified Semi-solid Rappaport-Vassiliadis (MSRV) medium was adopted as an Official Method. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 Micro Smedt, B-2200 Herentals, Belgium.
RP De Smedt, JM (reprint author), Micro Smedt, Lange Eerselstr 25, B-2200 Herentals, Belgium.
CR ANDREWS WH, 1987, J ASSOC OFF ANA CHEM, V70, P931
   [Anonymous], 1989, J ASSOC OFF ANA CHEM, V72, P694
   Bolderdijk RF, 1996, J AOAC INT, V79, P441
   DESMEDT J, 1994, J AOAC INT, V77, P365
   DESMEDT JM, 1986, J FOOD PROTECT, V49, P510, DOI 10.4315/0362-028X-49.7.510
   DESMEDT JM, 1991, INT J FOOD MICROBIOL, V13, P301, DOI 10.1016/0168-1605(91)90088-7
   DESMEDT JM, 1990, J FOOD PROTECT, V53, P659, DOI 10.4315/0362-028X-53.8.659
   DEZUTTER L, 1991, INT J FOOD MICROBIOL, V13, P11, DOI 10.1016/0168-1605(91)90131-8
   PITON C, 1991, J ASSOC OFF ANA CHEM, V74, P92
NR 9
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD NOV 24
PY 1998
VL 45
IS 1
BP 25
EP 28
DI 10.1016/S0168-1605(98)00143-3
PG 4
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 159AY
UT WOS:000078150700006
PM 9923621
DA 2020-05-07
ER

PT J
AU Geeraerd, AH
   Herremans, CH
   Cenens, C
   Van Impe, JF
AF Geeraerd, AH
   Herremans, CH
   Cenens, C
   Van Impe, JF
TI Application of artificial neural networks as a non-linear modular
   modeling technique to describe bacterial growth in chilled food products
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE predictive microbiology; bacterial growth; secondary modeling;
   artificial neural networks; chilled food products
ID MICROBIAL-GROWTH; PREDICTIVE MICROBIOLOGY; SODIUM-CHLORIDE;
   BROCHOTHRIX-THERMOSPHACTA; INITIAL PH; TEMPERATURE; INACTIVATION
AB In many chilled, prepared food products, the effects of temperature, pH and %NaCl on microbial activity interact and this should be taken into account. A grey box model for prediction of microbial growth is developed. The time dependence is modeled by a Gompertz model-based, non-linear differential equation. The influence of temperature, pH and %NaCl reflected in the model parameters is described by using low-complexity, black box artificial neural networks (ANN's). The use of this non-linear modeling technique makes it possible to describe more accurately interacting effects of environmental factors when compared with classical predictive microbiology models. When experimental results on the influence of other environmental factors become available, the ANN models can be extended simply by adding more neurons and/or layers. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 Katholieke Univ Leuven, Dept Food & Microbial Technol, BioTeC Bioproc Technol & Control, B-3001 Heverlee, Belgium.
RP Van Impe, JF (reprint author), Katholieke Univ Leuven, Dept Food & Microbial Technol, BioTeC Bioproc Technol & Control, Kardinaal Mercierlaan 92, B-3001 Heverlee, Belgium.
RI Geeraerd, Annemie/AAC-5006-2020
OI Geeraerd, Annemie/0000-0001-8473-4092
CR ADAMS MR, 1991, J APPL BACTERIOL, V71, P65
   Baranyi J, 1996, APPL ENVIRON MICROB, V62, P1029, DOI 10.1128/AEM.62.3.1029-1035.1996
   BARANYI J, 1993, FOOD MICROBIOL, V10, P43, DOI 10.1006/fmic.1993.1005
   Barber MA, 1908, J INFECT DIS, V5, P379, DOI 10.1093/infdis/5.4.379
   BARRON AR, 1993, IEEE T INFORM THEORY, V39, P930, DOI 10.1109/18.256500
   Bishop C. M., 1995, NEURAL NETWORKS PATT
   BUCHANAN RL, 1992, FOOD MICROBIOL, V9, P185, DOI 10.1016/0740-0020(92)80046-7
   DAVEY KR, 1994, INT J FOOD MICROBIOL, V23, P295, DOI 10.1016/0168-1605(94)90158-9
   DAVIES KW, 1993, J IND MICROBIOL, V12, P295, DOI 10.1007/BF01584206
   DELIGNETTEMULLER ML, 1995, INT J FOOD MICROBIOL, V27, P139, DOI 10.1016/0168-1605(94)00158-3
   GARTHRIGHT WE, 1991, FOOD MICROBIOL, V8, P239, DOI 10.1016/0740-0020(91)90056-8
   GEERAERD AH, 1997, ENG FOOD ICEF7, pN21
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HORNIK K, 1989, [No title captured], V2, P356
   INGRAHAM JL, 1958, J BACTERIOL, V76, P75, DOI 10.1128/JB.76.1.75-80.1958
   Kolmogorov A. N., 1963, AM MATH SOC TRANSL, V28, P55
   KOLMOGOROV AN, 1957, DOKL AKAD NAUK SSSR+, V114, P953
   Leistner L., 1976, In 'Intermediate moisture foods' [see FSTA (1977) 9 5G328]., P120
   LEISTNER L, 1996, 16 INT S INT COMM FO
   MARTENS T, 1996, 2 EUR S SOUS VID P A, P259
   MCCLURE PJ, 1993, INT J FOOD MICROBIOL, V19, P161, DOI 10.1016/0168-1605(93)90074-Q
   MEMEEKIN TA, 1993, PREDICTIVE MICROBIOL
   MOSSEL DA, 1995, ESSENTIALS MICROBIOL
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   Neter J., 1990, APPL LINEAR STAT MOD
   OHYE DF, 1953, AUST J BIOL SCI, V6, P178, DOI 10.1071/BI9530178
   PALUMBO SA, 1991, J FOOD PROTECT, V54, P426
   Patterson D.W., 1996, ARTIFICIAL NEURAL NE
   RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983
   ROSS T, 1994, INT J FOOD MICROBIOL, V23, P241, DOI 10.1016/0168-1605(94)90155-4
   ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995
   VANIMPE JF, 1995, INT J FOOD MICROBIOL, V25, P227, DOI 10.1016/0168-1605(94)00140-2
   VANIMPE JF, 1992, APPL ENVIRON MICROB, V58, P2901, DOI 10.1128/AEM.58.9.2901-2909.1992
   VANIMPE JFM, 1998, FOOD QUALITY MODELLI, P117
   WHITING RC, 1997, FOOD TECHNOL, V51, P81
   WIJTZES T, 1993, INT J FOOD MICROBIOL, V18, P139, DOI 10.1016/0168-1605(93)90218-6
   YOUNG JM, 1977, J APPL BACTERIOL, V42, P345, DOI 10.1111/j.1365-2672.1977.tb00702.x
   ZAIKA LL, 1994, INT J FOOD MICROBIOL, V23, P345, DOI 10.1016/0168-1605(94)90162-7
   ZWIETERING MH, 1991, APPL ENVIRON MICROB, V57, P1094, DOI 10.1128/AEM.57.4.1094-1101.1991
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 40
TC 79
Z9 80
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD OCT 20
PY 1998
VL 44
IS 1-2
BP 49
EP 68
DI 10.1016/S0168-1605(98)00127-5
PG 20
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 142WD
UT WOS:000077222600006
PM 9849784
DA 2020-05-07
ER

PT J
AU Threlfall, EJ
   Ward, LR
   Hampton, MD
   Ridley, AM
   Rowe, B
   Roberts, D
   Gilbert, RJ
   Van Someren, P
   Wall, PG
   Grimont, P
AF Threlfall, EJ
   Ward, LR
   Hampton, MD
   Ridley, AM
   Rowe, B
   Roberts, D
   Gilbert, RJ
   Van Someren, P
   Wall, PG
   Grimont, P
TI Molecular fingerprinting defines a strain of Salmonella enterica
   serotype Anatum responsible for an international outbreak associated
   with formula-dried milk
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; PLASMIDS
AB Molecular analyses based on plasmid profile typing and pulsed-field gel electrophoresis have defined a strain of Salmonella enterica serotype Anatum associated with the consumption of a particular brand of formula-dried milk responsible for an outbreak in late 1996/early 1997 involving 15 infants and 2 relatives in the UK, and 2 infants in France. The study has demonstrated the value of laboratory-based surveillance involving identification of the outbreak strain at the molecular level coupled with food microbiology and targeted epidemiological investigations, and has highlighted the importance of rapid communication and subsequent international collaboration through the European Union-funded Salm-Net salmonella surveillance network.
C1 Cent Publ Hlth Lab, Lab Enter Pathogens, London NW9 5HT, England.
   Cent Publ Hlth Lab, Food Hyg Lab, London NW9 5HT, England.
   Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.
   Inst Pasteur, Unites Enterobacteries, F-75724 Paris 15, France.
RP Threlfall, EJ (reprint author), Cent Publ Hlth Lab, Lab Enter Pathogens, 61 Colindale Ave, London NW9 5HT, England.
RI Ridley, Anne M/E-2294-2011; Ridley, Anne/AAH-5205-2019
OI Grimont, Patrick/0000-0002-6264-136X
CR ANDERSON ES, 1974, J HYG-CAMBRIDGE, V72, P471, DOI 10.1017/S0022172400023718
   Fisher I. S. T., 1994, PHLS Microbiology Digest, V11, P181
   FROST JA, 1994, METHODS PRACTICAL, V6, P73
   Hampton MD, 1998, EMERG INFECT DIS, V4, P317, DOI 10.3201/eid0402.980223
   KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981
   Kauffmann F., 1972, SEROLOGICAL DIAGNOSI
   POWELL NG, 1994, FEMS MICROBIOL LETT, V119, P193, DOI 10.1016/0378-1097(94)90413-8
   Punia P, 1998, J APPL MICROBIOL, V84, P103, DOI 10.1046/j.1365-2672.1997.00325.x
   ROBINSBROWNE RM, 1981, LANCET, V2, P148
   THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609
   THRELFALL EJ, 1990, J APPL BACTERIOL, V68, P5, DOI 10.1111/j.1365-2672.1990.tb02542.x
   Threlfall EJ, 1996, EMERG INFECT DIS, V2, P130, DOI 10.3201/eid0202.960209
   THRELFALL EJ, 1982, LANCET, V1, P740
   1997, EUROSURVEILL, V2, P22
   1997, CDR, V7, P33
NR 15
TC 52
Z9 54
U1 1
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA
SN 0950-2688
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 1998
VL 121
IS 2
BP 289
EP 293
DI 10.1017/S0950268898001149
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 139FV
UT WOS:000077018100007
PM 9825779
OA Green Published
DA 2020-05-07
ER

PT J
AU Fontana, R
   Ligozzi, M
   Mazzariol, A
   Veneri, G
   Cornaglia, G
AF Fontana, R
   Ligozzi, M
   Mazzariol, A
   Veneri, G
   Cornaglia, G
CA Italian Surveillance Grp Antimicrobial Resista
TI Resistance of enterococci to ampicillin and glycopeptide antibiotics in
   Italy
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT Symposium on Bacterial Resistance - Laboratory Explanations and Clinical
   Consequences
CY APR 15-17, 1996
CL SURREY, ENGLAND
AB We report the results of the monitoring of resistance to ampicillin, vancomycin, and teicoplanin in enterococci by an Italian network of clinical microbiology laboratories. A total of 16,226 strains were analyzed; 9,169 of these strains were Enterococcus faecalis, 913 were Enterococcus faecium, and 6,144 were Enterococcus species. The average rate of resistance to ampicillin was 1.9% (range, 0-6.5%) for E. faecalis and 70% (range, 33.3%-98.7%) for E. faecium; the average rate of resistance to vancomycin was 1.1% (range, 0.1%-2%) for E. faecalis and 8.5% (range, 0-36.1%) for E. faecium; and the average rate of resistance to teicoplanin was 0.8% (range, 0-2.4%) for E, faecalis and 8.7% (range, 0-36.1%) for E. faecium.
C1 Univ Verona, Ist Microbiol, I-37134 Verona, Italy.
RP Fontana, R (reprint author), Univ Verona, Ist Microbiol, Strada Grazie 8, I-37134 Verona, Italy.
OI MAZZARIOL, Annarita/0000-0003-2729-1007
CR CORNAGLIA G, 1993, BINARY, V5, P159
   FONTANA R, 1994, ANTIMICROB AGENTS CH, V38, P1980, DOI 10.1128/AAC.38.9.1980
   FONTANA R, 1985, J ANTIMICROB CHEMOTH, V16, P412, DOI 10.1093/jac/16.4.412
   MANSO E, 1993, LANCET, V342, P616
   MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990
   National Committee for Clinical Laboratory Standards, 1995, M100S6 NCCLS
   TENOVER FC, 1993, J CLIN MICROBIOL, V31, P1695, DOI 10.1128/JCM.31.7.1695-1699.1993
   WOODFORD N, 1995, CLIN MICROBIOL REV, V8, P585, DOI 10.1128/CMR.8.4.585
NR 8
TC 22
Z9 22
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA
SN 1058-4838
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG
PY 1998
VL 27
SU 1
BP S84
EP S86
DI 10.1086/514907
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 110BB
UT WOS:000075358400014
PM 9710675
OA Bronze
DA 2020-05-07
ER

PT J
AU Hajmeer, MN
   Basheer, IA
   Fung, DYC
   Marsden, JL
AF Hajmeer, MN
   Basheer, IA
   Fung, DYC
   Marsden, JL
TI Nonlinear response surface model based on artificial neural networks for
   growth of Saccharomyces cerevisiae
SO JOURNAL OF RAPID METHODS AND AUTOMATION IN MICROBIOLOGY
LA English
DT Article
ID PREDICTIVE MICROBIOLOGY
AB Response surface models (RSMs) are used to predict microbial growth as a function of environmental conditions. This study aimed to (1) develop an artificial neural network (ANN) model for predicting the combined effect of pH, and ethanol [E] and fructose [F] concentrations on the growth of Saccharomyces cerevisiae, (2) compare the prediction accuracies of ANN and traditional RSM and (3) determine the relative importance of the three environmental factors in affecting growth of S. cerevisiae. Data used to construct the network were obtained from a literature study in which RSM were developed using linear regression techniques for estimating the growth rate constant (mu(max)). A total of 59 data sets representing the growth of S. cerevisiae in relation to pH, [E] and [F] was utilized. The agreement between experimental and ANN-predicted values for the growth parameter (mu(max)) was assessed quantitatively using three statistical descriptors: the Mean of the Absolute values of the Relative Error (MARE), coefficient-of-determination (COD) and sum-of-squared-errors (SSE). The developed ANN-based RSM predicted the mu(max) of S. cerevisiae with higher accuracy than regression-based RSM. The differentiability of the neural network provided means for studying the sensitivity of the model output (ln mu(max)) to each input parameter averaged over the entire database. The mu(max) was found to be most sensitive to pH, followed by [E] and [F] concentrations.
C1 Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.
   Calif Dept Transportat, Stockton, CA 95205 USA.
RP Fung, DYC (reprint author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.
CR BASHEER LA, 1998, THESIS KANSAS STATE
   FUGELSANG KC, 1997, WINE MICROBIOLOGY, P143
   Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5
   HAJMEER MN, 1996, INTELLIGENT ENG SYST, V6, P635
   HAJMEER MN, 1996, THESIS KANSAS STATE
   KALATHENOS P, 1995, INT J FOOD MICROBIOL, V25, P63, DOI 10.1016/0168-1605(94)00085-K
   MASTERS T, 1993, PRACTICAL NEURAL NET
   MENDENHALL W, 1984, STAT ENG COMPUTER SC
   Najjar YM, 1997, INT J FOOD MICROBIOL, V34, P27, DOI 10.1016/S0168-1605(96)01168-3
   ZURADA JM, 1994, IEEE INT S CIRC SYST, V6, P447, DOI DOI 10.1109/ISCAS.1994.409622
NR 10
TC 9
Z9 12
U1 0
U2 4
PU FOOD NUTRITION PRESS INC
PI TRUMBULL
PA 6527 MAIN ST, P O BOX 374, TRUMBULL, CT 06611 USA
SN 1060-3999
J9 J RAPID METH AUT MIC
JI J. Rapid Methods Autom. Microbiol.
PD AUG
PY 1998
VL 6
IS 2
BP 103
EP 118
DI 10.1111/j.1745-4581.1998.tb00191.x
PG 16
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 117GW
UT WOS:000075774400005
DA 2020-05-07
ER

PT J
AU Najjar, YM
   Basheer, IA
   Hajmeer, MN
AF Najjar, YM
   Basheer, IA
   Hajmeer, MN
TI Computational neural networks for predictive microbiology .1.
   Methodology
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE neural networks; backpropagation; learning algorithm; microbial growth;
   modeling
AB Artificial neural networks are mathematical tools inspired by what is known about the physical structure and mechanism of the biological cognition and learning. Neural networks have attracted considerable attention due to their efficacy to model wide spectrum of challenging problems. In this paper, we present one of the most popular networks, the backpropagation, and discuss its learning algorithm and analyze several issues necessary for designing optimal networks that can generalize after being trained on examples. As an application in the area of predictive microbiology, modeling of microorganism growth by neural networks will be presented in a second paper of this series.
C1 KANSAS STATE UNIV,DEPT ANIM SCI & IND,MANHATTAN,KS 66506.
RP Najjar, YM (reprint author), KANSAS STATE UNIV,DEPT CIVIL ENGN,MANHATTAN,KS 66506, USA.
CR Bardot I., 1994, Food Quality and Preference, V5, P159, DOI 10.1016/0950-3293(94)90023-X
   Basheer IA, 1996, J COMPUT CIVIL ENG, V10, P31, DOI 10.1061/(ASCE)0887-3801(1996)10:1(31)
   BASHEER IA, 1995, J ENV SYS, V24, P291
   BASHEER IA, 1996, J ENV TECH, V17, P795
   BASHEER IA, 1995, P INT ENG SYST ART N, V5, P829
   EERIKAINEN T, 1994, FOOD CONTROL, V5, P111, DOI 10.1016/0956-7135(94)90096-5
   GOODACRE R, 1993, ANAL CHIM ACTA, V279, P17, DOI 10.1016/0003-2670(93)85062-O
   HAJMEER MN, 1996, INT J FOOD MICROBIOL, V34, P51
   HANSON SJ, 1995, BACKPROPAGATION THEO, P237
   Hassoun M. H, 1995, FUNDAMENTALS ARTIFIC
   Linko P., 1992, Kemia-Kemi, V19, P215
   MOODY J, 1992, ADV NEUR IN, V4, P1048
   Naes T., 1993, Journal of Near Infrared Spectroscopy, V1, P1
   NAJJAR YM, 1995, P INT ENG SYST ART N, V5, P817
   Pao Y. H., 1989, ADAPTIVE PATTERN REC
   Sietsma J., 1988, IEEE International Conference on Neural Networks (IEEE Cat. No.88CH2632-8), P325, DOI 10.1109/ICNN.1988.23864
   Simpson PK, 1990, ARTIFICIAL NEURAL SY
   VELLEJOCORDOBA B, 1995, J FOOD SCI, V60, P885
   WYTHOFF BJ, 1993, CHEMOMETR INTELL LAB, V18, P115, DOI 10.1016/0169-7439(93)80052-J
   ZUPAN J, 1991, ANAL CHIM ACTA, V248, P1, DOI 10.1016/S0003-2670(00)80865-X
   Zupan J., 1993, NEURAL NETWORKS CHEM
NR 21
TC 53
Z9 55
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JAN
PY 1997
VL 34
IS 1
BP 27
EP 49
DI 10.1016/S0168-1605(96)01168-3
PG 23
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA WK278
UT WOS:A1997WK27800003
PM 9029254
DA 2020-05-07
ER

PT J
AU Hajmeer, MN
   Basheer, IA
   Najjar, YM
AF Hajmeer, MN
   Basheer, IA
   Najjar, YM
TI Computational neural networks for predictive microbiology .2.
   Application to microbial growth
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE computational neural networks; Gompertz model; microbial growth;
   multiple linear regression; response surface models; Shigella flexneri
ID SODIUM-NITRITE; SHIGELLA-FLEXNERI; LISTERIA-MONOCYTOGENES;
   BACTERIAL-GROWTH; PH; MODEL; TEMPERATURE; CHLORIDE
AB The growth of a specific microorganism on a certain food is influenced by a number of environmental factors such as temperature, pH, and salt concentration. Models that delineate the history of the growth of microorganisms are always subject to a considerable debate and scrutiny in the field of predictive microbiology. Regardless of its type, a growth model (e.g., modified Gompertz model) contains several parameters that vary depending on the microorganisms/food combination and the associated prevailing environmental conditions. The growth model parameters for a set of operating conditions are commonly determined from expressions developed via multiple linear regression. In the present study, a substitute for the nonlinear regression-based equations is developed using computational neural networks. Computational neural networks are applied herein on experimental data pertaining to the anaerobic growth of Shigella flexneri. Results have indicated that predictions by neural networks offer better agreement with experimental data as compared to predictions obtained via corresponding regression equations.
C1 KANSAS STATE UNIV,DEPT CIVIL ENGN,MANHATTAN,KS 66506.
   KANSAS STATE UNIV,DEPT ANIM SCI & IND,MANHATTAN,KS 66506.
CR Basheer IA, 1996, J COMPUT CIVIL ENG, V10, P31, DOI 10.1061/(ASCE)0887-3801(1996)10:1(31)
   BEAN NH, 1990, J FOOD PROTECT, V53, P804, DOI 10.4315/0362-028X-53.9.804
   BHADURI S, 1994, INT J FOOD MICROBIOL, V23, P333, DOI 10.1016/0168-1605(94)90161-9
   BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0
   BUCHANAN RL, 1995, FOOD MICROBIOL, V12, P203, DOI 10.1016/S0740-0020(95)80099-9
   DAVEY KR, 1995, FOOD RES INT, V28, P233, DOI 10.1016/0963-9969(94)00049-E
   *DIFCO, 1980, DIFF ENT BIOCH TESTS
   DUFFY LL, 1994, INT J FOOD MICROBIOL, V23, P377, DOI 10.1016/0168-1605(94)90164-3
   GOH ATC, 1994, J GEOTECH ENG-ASCE, V120, P1467, DOI 10.1061/(ASCE)0733-9410(1994)120:9(1467)
   MCCLURE PJ, 1994, INT J FOOD MICROBIOL, V23, P359, DOI 10.1016/0168-1605(94)90163-5
   NAJJAR YM, 1996, INT J FOOD MICRO, V34, P27
   NAJJAR YM, 1996, 11 ENG MECH SPEC C A, V1, P300
   SATCHELL FB, 1990, J FOOD PROTECT, V53, P558, DOI 10.4315/0362-028X-53.7.558
   TODD ECD, 1989, J FOOD PROTECT, V54, P424
   WALKER S.J, 1994, SHELF LIFE EVALUATIO, P40
   ZAIKA LL, 1989, J FOOD PROTECT, V52, P356, DOI 10.4315/0362-028X-52.5.356
   ZAIKA LL, 1991, J FOOD PROTECT, V54, P424, DOI 10.4315/0362-028X-54.6.424
   ZAIKA LL, 1994, INT J FOOD MICROBIOL, V23, P345, DOI 10.1016/0168-1605(94)90162-7
   ZAIKA LL, 1992, J FOOD PROTECT, V55, P590
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 20
TC 72
Z9 72
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD JAN
PY 1997
VL 34
IS 1
BP 51
EP 66
DI 10.1016/S0168-1605(96)01169-5
PG 16
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA WK278
UT WOS:A1997WK27800004
PM 9029255
DA 2020-05-07
ER

PT J
AU Kenyon, RGW
   Ferguson, EV
   Ward, AC
AF Kenyon, RGW
   Ferguson, EV
   Ward, AC
TI Application of neural networks to the analysis of pyrolysis mass spectra
SO ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL
   MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
ID MULTILAYER FEEDFORWARD NETWORKS; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   ESCHERICHIA-COLI; QUANTITATIVE-ANALYSIS; NOSOCOMIAL INFECTION; RAPID
   IDENTIFICATION; SPECTROMETRY; BACTERIA; DIFFERENTIATION; CLASSIFICATION
AB Pyrolysis mass spectrometry is a data rich analysis technique now becoming widely applied in microbiology. Data analysis is a key step in the exploitation of the technique and the application of neural network analysis to pyrolysis mass spectrometric data offers new opportunities for classification, identification and inter-strain comparison of microorganisms in biotechnology and clinical microbiology. The use of a supervised neural network for the identification of members of a streptomycete species-group is described.
C1 MED SCH NEWCASTLE UPON TYNE,DEPT MICROBIOL,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND.
RI Ward, Alan/AAC-5179-2020
OI Ward, Alan/0000-0003-4102-8694
CR Aleksander I., 1990, INTRO NEURAL COMPUTI
   ARIES RE, 1986, J ANAL APPL PYROL, V9, P81, DOI 10.1016/0165-2370(86)85001-X
   Baum EB, 1989, NEURAL COMPUT, V1, P151, DOI 10.1162/neco.1989.1.1.151
   BEALE R, 1990, NEURAL COMPUTING INT
   BERKELEY RCW, 1990, LAB PRACT, V39, P81
   CARTMILL TDI, 1992, J MED MICROBIOL, V37, P352, DOI 10.1099/00222615-37-5-352
   CHUN J, 1993, FEMS MICROBIOL LETT, V107, P321
   CHUN J, 1995, THESIS U NEWCASTLE U
   Chun JS, 1997, ZBL BAKT-INT J MED M, V285, P258
   CRICK F, 1989, NATURE, V337, P129, DOI 10.1038/337129a0
   EATON HAC, 1992, NEURAL NETWORKS, V5, P283, DOI 10.1016/S0893-6080(05)80026-7
   FAHLMAN SE, 1990, CMUCS90100
   FAHLMAN SE, 1988, CMUCS88162
   Ferguson EV, 1997, ZBL BAKT-INT J MED M, V285, P169, DOI 10.1016/S0934-8840(97)80025-4
   Frean M., 1990, NEURAL COMPUT, V2, P198
   FREEMAN R, 1994, J ANAL APPL PYROL, V28, P29, DOI 10.1016/0165-2370(93)00763-D
   FREEMAN R, 1991, LETT APPL MICROBIOL, V12, P133, DOI 10.1111/j.1472-765X.1991.tb00523.x
   FREEMAN R, 1991, J MED MICROBIOL, V34, P245, DOI 10.1099/00222615-34-5-245
   FREEMAN R, 1995, ANTON LEEUW INT J G, V68, P253, DOI 10.1007/BF00871823
   FREEMAN R, 1991, EPIDEMIOL INFECT, V106, P239, DOI 10.1017/S095026880004838X
   FREEMAN R, 1990, J MED MICROBIOL, V32, P283, DOI 10.1099/00222615-32-4-283
   FREEMAN R, 1994, J MED MICROBIOL, V40, P170, DOI 10.1099/00222615-40-3-170
   Gallant S.I., 1993, NEURAL NETWORK LEARN
   GOODACRE R, 1994, J APPL BACTERIOL, V76, P124, DOI 10.1111/j.1365-2672.1994.tb01607.x
   GOODACRE R, 1993, ANAL CHIM ACTA, V279, P17, DOI 10.1016/0003-2670(93)85062-O
   GOODACRE R, 1990, FEMS MICROBIOL LETT, V71, P133
   Goodacre R., 1994, Microbiology Europe, V2, P16
   Goodacre R, 1996, CURR MICROBIOL, V32, P77, DOI 10.1007/s002849900014
   GOODACRE R, 1993, J ANAL APPL PYROL, V26, P93, DOI 10.1016/0165-2370(93)85020-Y
   GOODACRE R, 1991, J ANAL APPL PYROL, V22, P19, DOI 10.1016/0165-2370(91)85002-O
   GOODACRE R, 1994, J BIOTECHNOL, V34, P185, DOI 10.1016/0168-1656(94)90088-4
   GOULD FK, 1991, J HOSP INFECT, V19, P41, DOI 10.1016/0195-6701(91)90127-T
   Gutteridge C. S, 1985, COMPUTER ASSISTED BA, P369
   GUTTERIDGE CS, 1987, METHOD MICROBIOL, V19, P227
   Hertz J, 1991, INTRO THEORY NEURAL
   HORNIK K, 1990, NEURAL NETWORKS, V3, P551, DOI 10.1016/0893-6080(90)90005-6
   HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8
   Irwin W.J., 1982, ANAL PYROLYSIS COMPR
   Kohonen T., 1989, SELF ORG ASS MEMORY
   LENGELLE T, 1996, NEURAL NETWORKS, V9, P83
   LOW JC, 1992, RES VET SCI, V53, P64, DOI 10.1016/0034-5288(92)90086-H
   MACFIE HJH, 1978, J GEN MICROBIOL, V104, P67, DOI 10.1099/00221287-104-1-67
   MAGEE JT, 1992, J MED MICROBIOL, V37, P56, DOI 10.1099/00222615-37-1-56
   MAGEE JT, 1993, HDB NEW BACTERIAL SY, P383
   MCCLELLAND J, 1988, EXPLORATIONS PARALLE
   Meuzelaar HLC, 1982, PYROLYSIS MASS SPECT
   ORR K, 1991, J HOSP INFECT, V17, P187, DOI 10.1016/0195-6701(91)90230-6
   RUMELHART DE, 1986, [No title captured]
   Salomon R, 1996, NEURAL NETWORKS, V9, P589
   SISSON PR, 1995, J ANAL APPL PYROL, V32, P179, DOI 10.1016/0165-2370(94)00879-6
   SISSON PR, 1991, EPIDEMIOL INFECT, V107, P127, DOI 10.1017/S0950268800048755
   SISSON PR, 1991, J HOSP INFECT, V19, P137, DOI 10.1016/0195-6701(91)90106-I
   WEIGEND AS, 1991, NEURAL INFORMATION P, V3, P875
   WERBOS PJ, 1993, ROOTS BACK PROPAGATI
   WHITE H, 1990, NEURAL NETWORKS, V3, P535, DOI 10.1016/0893-6080(90)90004-5
   WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743
   WINDIG W, 1983, ANAL CHEM, V55, P387
NR 57
TC 4
Z9 4
U1 0
U2 0
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8840
J9 ZBL BAKT-INT J MED M
JI Zent.bl. Bakteriol.-Int. J. Med. Microbiol. Virol. Parasitol. Infect.
   Dis.
PD JAN
PY 1997
VL 285
IS 2
BP 267
EP 277
PG 11
WC Microbiology; Virology
SC Microbiology; Virology
GA WM531
UT WOS:A1997WM53100013
PM 9060159
DA 2020-05-07
ER

PT J
AU Prior, BA
   Kock, JLF
AF Prior, BA
   Kock, JLF
TI UNESCO MIRCEN established in southern Africa
SO SOUTH AFRICAN JOURNAL OF SCIENCE
LA English
DT Article
AB The United Nations Educational, Scientific and Cultural Organisation (UNESCO) recently awarded a MIRCEN (Microbiological Resources Centre) to the Department of Microbiology and Biochemistry, University of the Orange Free State, with the purpose of developing and supporting microbiology and microbial biotechnology in southern Africa. MIRCENS have been located in 31 developed and developing countries around the world and form a network of mutually supporting centres associated with academic or government institutions. These associations encourage and develop national, regional and international co-operation in addressing problems concerned with technological advancement and natural resource management The MIRCENS are concerned primarily with agriculture, biotechnology and biodiversity. The one in Bloemfontein will primarily focus its activities on industrial biotechnology but other areas of endeavour are not excluded. As this is the only centre of its kind in southern Africa, it is our intention to serve the subcontinent in as inclusive a way as possible. We will, in consultation with other national and regional microbiologists, attempt to identify their needs especially with regard to training and microbial resource development.
RP Prior, BA (reprint author), UNIV ORANGE FREE STATE,DEPT MICROBIOL & BIOCHEM,POB 339,ZA-9300 BLOEMFONTEIN,SOUTH AFRICA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BUREAU SCIENTIFIC PUBL
PI PRETORIA
PA P O BOX 2600, PRETORIA 0001, SOUTH AFRICA
SN 0038-2353
J9 S AFR J SCI
JI S. Afr. J. Sci.
PD NOV-DEC
PY 1996
VL 92
IS 11-12
BP 511
EP 512
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA WG895
UT WOS:A1996WG89500003
DA 2020-05-07
ER

PT J
AU deLencastre, H
   Severina, EP
   Roberts, RB
   Kreiswirth, BN
   Tomasz, A
   Larone, D
   Rahal, J
   Urban, C
   Montecalvo, M
   VanHorn, K
   Currie, B
   McKitrick, J
   Greene, W
   Spitzer, E
   Hargrave, J
AF deLencastre, H
   Severina, EP
   Roberts, RB
   Kreiswirth, BN
   Tomasz, A
   Larone, D
   Rahal, J
   Urban, C
   Montecalvo, M
   VanHorn, K
   Currie, B
   McKitrick, J
   Greene, W
   Spitzer, E
   Hargrave, J
TI Testing the efficacy of a molecular surveillance network:
   Methicillin-resistant Staphylococcus aureus (MRSA) and
   vancomycin-resistant Enterococcus faecium (VREF) genotypes in six
   hospitals in the Metropolitan New York City Area
SO MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
LA English
DT Article
ID GEOGRAPHIC SPREAD; CLONE; GENE; DISEASE; VANA
AB Molecular fingerprinting techniques are rapidly becoming indispensable tools for hospital epidemiology, On the other hand, the relative complexity and unfamiliarity of these techniques to most hospital diagnostic laboratories limit their usefulness, In an attempt to provide a solution for this dilemma, we tested the feasibility and efficacy of a cooperative venture in which molecular typing of isolates recovered from patients in six hospitals was performed at two microbiology research laboratories with expertise in these techniques, In a small preliminary study, 30 methicillin-resistant Staphylococcus aureus (MRSA) and 30 vancomycin-resistant Enterococcus faecium (VREF) isolates were collected over a 3-week period from six hospitals in the metropolitan New York area and transported to the Laboratory of Microbiology at The Rockefeller University during the summer months of 1994, Nineteen of the 27 confirmed MRSA isolates mere closely related strains carrying the same mecA and the same Tn554 polymorphs in a pulsed-field gel electrophoresis (PFGE) background represented by closely related subtypes of a single pattern, indicating the wide distribution of this MRSA clone among the participating hospitals, Typing of the same 27 MRSA isolates was also performed at the Tuberculosis Center of the Public Health Research Institute and identical results were obtained, The 29 confirmed VREF isolates were highly heterogeneous and belonged to as many as 23 distinct clonal types as defined by PFGE patterns and probing with vanA. Characterization of the 60 isolates by these methods was completed in one month of full-time effort by a single experienced laboratory assistant guided by a doctoral-level expert in molecular fingerprinting techniques, The collection of samples for both MRSA and VREF was not intended to address epidemiological questions but to determine the feasibility of a multicenter study, On the basis of our preliminary findings we are encouraged that a larger cooperative effort is possible and with the correct sampling method we believe that epidemiological and surveillance studies could be accomplished that would provide a tracking system to assist hospitals, clinics, and chronic care facilities in controlling the spread of multidrug-resistant pathogens.
C1 ROCKEFELLER UNIV,MICROBIOL LAB,NEW YORK,NY 10021.
   INST TECNOL QUIM & BIOL,OEIRAS,PORTUGAL.
   NEW YORK HOSP,CORNELL MED CTR,DEPT MED,NEW YORK,NY 10021.
   PUBL HLTH RES INST TB CTR,NEW YORK,NY 10016.
   RUSSIAN ACAD SCI,INST THEORET & EXPT BIOPHYS,PUSHCHINO 142292,RUSSIA.
   LENOX HILL HOSP,NEW YORK,NY 10021.
   NEW YORK HOSP,QUEENS MED CTR,NEW YORK,NY 10021.
   WESTCHESTER CTY MED CTR,VALHALLA,NY 10595.
   MONTEFIORE MED CTR,BRONX,NY 10467.
   STONY BROOK HLTH SCI CTR,STONY BROOK,NY.
RI Spitzer, Eric/T-7455-2019
OI /0000-0001-6816-8932; Tomasz, Alexander/0000-0003-1520-1983
CR DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129
   DOMINGUEZ MA, 1994, J CLIN MICROBIOL, V32, P2081, DOI 10.1128/JCM.32.9.2081-2087.1994
   GOLD HS, 1993, ANTIMICROB AGENTS CH, V37, P1604, DOI 10.1128/AAC.37.8.1604
   Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234
   HANDWERGER S, 1995, ANTIMICROB AGENTS CH, V39, P362, DOI 10.1128/AAC.39.2.362
   KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647
   KREISWIRTH B, 1996, TUBERCULOSIS
   MATTHEWS P, 1990, ANTIMICROB AGENTS CH, V34, P1777, DOI 10.1128/AAC.34.9.1777
   Montecalvo MA, 1995, INFECT CONT HOSP EP, V16, P680
   MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990
   SANCHES IS, 1995, J CLIN MICROBIOL, V33, P1243, DOI 10.1128/JCM.33.5.1243-1246.1995
   TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995
   TENOVER FC, 1994, J CLIN MICROBIOL, V32, P407, DOI 10.1128/JCM.32.2.407-415.1994
   TOMASZ A, 1996, IN PRESS PREVENTION
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
NR 15
TC 42
Z9 44
U1 0
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 1076-6294
J9 MICROB DRUG RESIST
JI Microb. Drug Resist.-Mechan. Epidemiol. Dis.
PD FAL
PY 1996
VL 2
IS 3
BP 343
EP 351
DI 10.1089/mdr.1996.2.343
PG 9
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA VF856
UT WOS:A1996VF85600007
PM 9158794
DA 2020-05-07
ER

PT J
AU Martins, MA
   Read, DJ
AF Martins, MA
   Read, DJ
TI The role of the external mycelial network of arbuscular mycorrhizal (AM)
   Fungi .2. A study of phosphorous transfer between plants interconnected
   yb a common mycelium
SO REVISTA DE MICROBIOLOGIA
LA English
DT Article
DE arbuscular mycorrhizal fungi; P-32 transfer; soil microbiology
ID NATURAL VEGETATION SYSTEMS; NUTRIENT TRANSFER; LIVING PLANTS; DYING
   ROOTS; INFECTION; GROWTH
AB The transfer of P-32 from Lolium perenne (the donor) to Plantago lanceolata (the receiver) mediated by arbuscular mycorrhizal (AM) fungi was examined when the two species were sown together or separately. The arbuscular mycorrhizal infection led to a significant increase in the amount of P-32 transferred from donor to receiver plants relative to that in uninfected plants, not only when the roots of the two plants were sowing in intimate mixture but also when they were separated by a root-free zone of 2.33 cm. The majority of isotope transfer between the two plant species occurred by a direct pathway via AM mycelium.
RP Martins, MA (reprint author), UNIV ESTADUAL NORTE FLUMINENSE,CTR CIENCIAS & TECNOL AGROPECUARIAS,SETOR MICROBIOL SOLO,BR-28015620 S JOSE CAMPOS,RJ,BRAZIL.
CR BETHLENFALVAY GJ, 1991, PHYSIOL PLANTARUM, V82, P423, DOI 10.1034/j.1399-3054.1991.820315.x
   CAMEL SB, 1991, SOIL SCI SOC AM J, V55, P389, DOI 10.2136/sssaj1991.03615995005500020016x
   EVANS PS, 1971, NEW ZEAL J AGR RES, V14, P552, DOI 10.1080/00288233.1971.10421649
   GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x
   HEAP AJ, 1980, NEW PHYTOL, V85, P173, DOI 10.1111/j.1469-8137.1980.tb04458.x
   IKRAM A, 1994, SOIL BIOL BIOCHEM, V26, P1541, DOI 10.1016/0038-0717(94)90096-5
   NEWMAN EI, 1993, FUNCT ECOL, V7, P242, DOI 10.2307/2389894
   NEWMAN EI, 1989, PLANT SOIL, V115, P211, DOI 10.1007/BF02202589
   NEWMAN EI, 1986, NEW PHYTOL, V104, P77, DOI 10.1111/j.1469-8137.1986.tb00635.x
   READ DJ, 1988, P ROY SOC EDINB B, V94, P13, DOI 10.1017/S0269727000007065
   READ DJ, 1976, NEW PHYTOL, V77, P641, DOI 10.1111/j.1469-8137.1976.tb04657.x
   RITZ K, 1984, OIKOS, V43, P138, DOI 10.2307/3544760
   RITZ K, 1985, OIKOS, V45, P174, DOI 10.2307/3565703
   TOMMERUP IC, 1983, T BRIT MYCOL SOC, V81, P37, DOI 10.1016/S0007-1536(83)80201-0
   WHITTINGHAM J, 1982, NEW PHYTOL, V90, P277, DOI 10.1111/j.1469-8137.1982.tb03259.x
NR 15
TC 9
Z9 9
U1 1
U2 12
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD APR-JUN
PY 1996
VL 27
IS 2
BP 100
EP 105
PG 6
WC Microbiology
SC Microbiology
GA VQ032
UT WOS:A1996VQ03200006
DA 2020-05-07
ER

PT J
AU CARSON, CA
   KELLER, JM
   MCADOO, KK
   WANG, DY
   HIGGINS, B
   BAILEY, CW
   THORNE, JG
   PAYNE, BJ
   SKALA, M
   HAHN, AW
AF CARSON, CA
   KELLER, JM
   MCADOO, KK
   WANG, DY
   HIGGINS, B
   BAILEY, CW
   THORNE, JG
   PAYNE, BJ
   SKALA, M
   HAHN, AW
TI ESCHERICHIA-COLI O157-H7 RESTRICTION PATTERN-RECOGNITION BY ARTIFICIAL
   NEURAL-NETWORK
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; SEPARATION
AB An artificial neural network model for the recognition of Escherichia coli O157:H7 restriction patterns was designed. In the training phase, images of two classes of E. coli isolates (O157:H7 and non-O157:H7) were digitized and transmitted to the neural network. The system was then tested for recognition of images not included in the training set, Promising results were achieved with the designed network configuration, providing a basis for further study. This application of a new generation of computational technology serves as an example of its usefulness in microbiology.
C1 UNIV MISSOURI,DEPT VET MICROBIOL,COLUMBIA,MO 65211.
   UNIV MISSOURI,DEPT ELECT & COMP ENGN,COLUMBIA,MO 65211.
   UNIV MISSOURI,DEPT VET CLIN SCI,COLUMBIA,MO 65211.
   MISSOURI DEPT HLTH,JEFFERSON CITY,MO 65101.
CR ARBEIT RD, 1990, J INFECT DIS, V161, P230, DOI 10.1093/infdis/161.2.230
   BEZDEK J, 1992, FUZZY MODELS PATTERN
   BOHM H, 1992, J CLIN MICROBIOL, V30, P2169
   CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420
   FELDMAN JA, 1992, COGNITIVE SCI, V6, P205
   FREEMAN R, 1994, J MED MICROBIOL, V40, P170, DOI 10.1099/00222615-40-3-170
   GOUBY A, 1994, J CLIN MICROBIOL, V32, P301, DOI 10.1128/JCM.32.2.301-305.1994
   HARSONO KD, 1993, APPL ENVIRON MICROB, V59, P3141, DOI 10.1128/AEM.59.9.3141-3144.1993
   Hecht-Nielsen R., 1989, NEUROCOMPUTING
   Hertz J, 1991, INTRO THEORY NEURAL
   HORTON PB, 1992, NUCLEIC ACIDS RES, V20, P4331, DOI 10.1093/nar/20.16.4331
   KELLER J, 1994, COMPUTER VISION FUZZ, P213
   KELLER JM, 1994, INT J INTELL SYST, V9, P1001, DOI 10.1002/int.4550091103
   KELLER JM, 1992, FUZZY SET SYST, V45, P1, DOI 10.1016/0165-0114(92)90086-J
   KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426
   Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1109/MASSP.1987.1165576
   MOTALEBI MS, 1990, THESIS U WASHINGTON
   OTT M, 1991, INFECT IMMUN, V59, P2664, DOI 10.1128/IAI.59.8.2664-2672.1991
   PIPER J, 1989, CYTOMETRY, V10, P242, DOI 10.1002/cyto.990100303
   PLIKAYTIS BD, 1992, J GEN MICROBIOL, V138, P2265, DOI 10.1099/00221287-138-11-2265
   RUMELHART DE, 1986, EXPLORATIONS MICROST, V1
   SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P55
   SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5
NR 23
TC 20
Z9 20
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 1995
VL 33
IS 11
BP 2894
EP 2898
DI 10.1128/JCM.33.11.2894-2898.1995
PG 5
WC Microbiology
SC Microbiology
GA TA461
UT WOS:A1995TA46100019
PM 8576341
OA Bronze
DA 2020-05-07
ER

PT J
AU GOODACRE, R
   NEAL, MJ
   KELL, DB
   GREENHAM, LW
   NOBLE, WC
   HARVEY, RG
AF GOODACRE, R
   NEAL, MJ
   KELL, DB
   GREENHAM, LW
   NOBLE, WC
   HARVEY, RG
TI RAPID IDENTIFICATION USING PYROLYSIS MASS-SPECTROMETRY AND ARTIFICIAL
   NEURAL NETWORKS OF PROPIONIBACTERIUM-ACNES ISOLATED FROM DOGS
SO JOURNAL OF APPLIED BACTERIOLOGY
LA English
DT Article
ID CUTANEOUS PROPIONIBACTERIA; REGIONAL VARIATIONS; ESCHERICHIA-COLI;
   MICROORGANISMS; BACTERIA
AB Curie-point pyrolysis mass spectra were obtained from reference Propionibacterium strains and canine isolates. Artificial neural networks (ANNs) were trained by supervised learning (with the back-propagation algorithm) to recognize these strains from their pyrolysis mass spectra; all the strains isolated from dogs were identified as human wild type P. acnes. This is an important nosological discovery, and demonstrates that the combination of pyrolysis mass spectrometry and ANNs provides an objective, rapid and accurate identification technique. Bacteria isolated from different biopsy specimens from the same dog were found to be separate strains of P. acnes, demonstrating a within-animal variation in microflora. The classification of the canine isolates by Kohonen artificial neural networks (KANNs) was compared with the classical multivariate techniques of canonical variates analysis and hierarchical cluster analysis, and found to give similar results. This is the first demonstration, within microbiology, of KANNs as an unsupervised clustering technique which has the potential to group pyrolysis mass spectra both automatically and relatively objectively.
C1 UNIV BRISTOL,SCH MED SCI,DEPT PATHOL & MICROBIOL,BRISTOL BS8 1TD,AVON,ENGLAND.
   ST THOMAS HOSP,ST JOHNS INST DERMATOL,DEPT MICROBIAL DIS,LONDON,ENGLAND.
   GODIVA REFERRALS,COVENTRY,W MIDLANDS,ENGLAND.
RP GOODACRE, R (reprint author), UNIV COLL WALES,DEPT BIOL SCI,ABERYSTWYTH SY23 3DA,DYFED,WALES.
RI Kell, Douglas/E-8318-2011; Goodacre, Roy/J-1600-2012
OI Kell, Douglas/0000-0001-5838-7963; Goodacre, Roy/0000-0003-2230-645X;
   Harvey, Richard/0000-0002-7176-5487
CR ARIES RE, 1986, J ANAL APPL PYROL, V9, P81, DOI 10.1016/0165-2370(86)85001-X
   AUSTIN B, 1986, MODERN BACTERIAL TAX, P74
   BERKELEY RCW, 1990, LAB PRACT, V39, P81
   BODDY K, 1993, FLOW CYTOMETRY MICRO, P159
   BROOK I, 1991, REV INFECT DIS, V13, P819
   CAUSTON DR, 1987, BIOL ADV MATH, P48
   CHANTLER SM, 1987, METHOD MICROBIOL, V19, P273
   Chatfield C., 1980, INTRO MULTIVARIATE A, P57
   CHUN J, 1993, FEMS MICROBIOL LETT, V107, P321
   ERWIN E, 1992, BIOL CYBERN, V67, P47, DOI 10.1007/BF00201801
   Everitt B, 1993, CLUSTER ANAL
   FLURY B, 1988, MULTIVARIATE STATIST, P181
   FREEMAN R, 1990, J MED MICROBIOL, V32, P283, DOI 10.1099/00222615-32-4-283
   FREEMAN R, 1993, IN PRESS J MED MICRO
   GOODACRE R, 1993, ANAL CHIM ACTA, V279, P17, DOI 10.1016/0003-2670(93)85062-O
   GOODACRE R, 1990, FEMS MICROBIOL LETT, V71, P133
   GOODACRE R, 1993, J ANAL APPL PYROL, V26, P93, DOI 10.1016/0165-2370(93)85020-Y
   GOODACRE R, 1991, J ANAL APPL PYROL, V22, P19, DOI 10.1016/0165-2370(91)85002-O
   GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823
   Gutteridge C. S, 1985, COMPUTER ASSISTED BA, P369
   GUTTERIDGE CS, 1987, METHOD MICROBIOL, V19, P227
   HARVEY RG, 1993, J SMALL ANIM PRACT, V34, P80, DOI 10.1111/j.1748-5827.1993.tb02614.x
   HECHTNIELSEN R, 1990, NEUROCOMPUTING, P138
   HERTZ J, 1991, INTRO THEORY NEURAL, P236
   HOLLAND KT, 1974, J APPL BACTERIOL, V37, P289, DOI 10.1111/j.1365-2672.1974.tb00443.x
   HOLLAND KT, 1977, BRIT J DERMATOL, V96, P623, DOI 10.1111/j.1365-2133.1977.tb05206.x
   Irwin W.J., 1982, ANAL PYROLYSIS COMPR
   KAJIOKA R, 1984, J ANAL APPL PYROL, V6, P59, DOI 10.1016/0165-2370(84)80005-4
   KEARNEY JN, 1984, J GEN MICROBIOL, V130, P797
   KELL DB, 1992, BIOELECTROCH BIOENER, V28, P425, DOI 10.1016/0302-4598(92)80030-K
   Kohonen T., 1989, SELF ORG ASS MEMORY
   KRZANOWSKI WJ, 1988, PRINCIPLES MULTIVARI, P369
   MACFIE HJH, 1982, J ANAL APPL PYROL, V4, P175, DOI 10.1016/0165-2370(82)80029-6
   MACFIE HJH, 1978, J GEN MICROBIOL, V104, P67, DOI 10.1099/00221287-104-1-67
   MAGEE JT, 1991, J MED MICROBIOL, V35, P304, DOI 10.1099/00222615-35-5-304
   Martens H., 1989, MULTIVARIATE CALIBRA
   MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978
   MCGINLEY KJ, 1980, J CLIN MICROBIOL, V12, P672, DOI 10.1128/JCM.12.5.672-675.1980
   Meuzelaar HLC, 1982, PYROLYSIS MASS SPECT
   MULLER GH, 1989, SMALL ANIMAL DERMATO, P244
   NELDER JA, 1979, GENSTAT REFERENCE MA
   PUHVEL SM, 1975, J INVEST DERMATOL, V65, P525, DOI 10.1111/1523-1747.ep12610239
   RATAJ T, 1991, Binary Computing in Microbiology, V3, P159
   Rumelhart D. E., 1986, PARALLEL DISTRIBUTED
   SAANO A, 1990, SYMBIOSIS, V8, P61
   Simpson PK, 1990, ARTIFICIAL NEURAL SY
   WASSERMAN PD, 1989, NEURAL COMPUTING THE
   WIETEN G, 1981, REV INFECT DIS, V3, P871
   WIETEN G, 1981, J GEN MICROBIOL, V122, P109
   Willis AT, 1977, ANAEROBIC BACTERIOLO
   WINDIG W, 1983, ANAL CHEM, V55, P387
NR 51
TC 75
Z9 76
U1 1
U2 6
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0021-8847
J9 J APPL BACTERIOL
JI J. Appl. Bacteriol.
PD FEB
PY 1994
VL 76
IS 2
BP 124
EP 134
DI 10.1111/j.1365-2672.1994.tb01607.x
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA MV999
UT WOS:A1994MV99900004
PM 8144414
DA 2020-05-07
ER

PT J
AU ESPINASSE, J
AF ESPINASSE, J
TI RESPONSIBLE USE OF ANTIMICROBIALS IN VETERINARY-MEDICINE - PERSPECTIVES
   IN FRANCE
SO VETERINARY MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT CONF ON ANTIMICROBIALS IN VETERINARY MEDICINE : PUBLIC HEALTH AND GOOD
   VETERINARY PRACTICE
CY DEC 02-03, 1991
CL ROYAL COLL PHYSICIANS, LONDON, ENGLAND
HO ROYAL COLL PHYSICIANS
ID SUSCEPTIBILITY PATTERNS; RESISTANT SALMONELLA; ESCHERICHIA-COLI;
   HOSPITALS; BACTERIA; ANIMALS
AB In France a survey of the use of antimicrobials in veterinary medicine was set up in connection with the Committee for the Marketing Authorization of Veterinary Medicinal Products. This survey has emphasized the importance of antimicrobials in veterinary medicine and the reality of antibiotic resistance in both man and animals. Certain epidemiological data tend to demonstrate that the use of antibiotics in animals increases the risk of antibiotic resistance in man, through selection in animals of resistant pathogenic bacteria or of a non-pathogenic resistant bacteria carrying resistance plasmids. Four proposals arc put forward for the control of these different risks: reserve certain antibiotics (life-saving antibiotics) for human medicine, conform to a code of good practices for antibiotic use in animals, strengthen and connect up existing networks for the epidemiosurveillance of antibiotic resistance, provide for studies on the ecological impact of antibiotics in the registration dossiers for veterinary medicinal products. These evolutive measures, based on scientific progress in microbiology, epidemiology and clinical studies should respond satisfactorily to the expectations of all concerned.
RP ESPINASSE, J (reprint author), ECOLE NATL VET TOULOUSE,23 CHEMIN CAPELLES,F-31076 TOULOUSE,FRANCE.
CR ANDERSON JD, 1974, J MED MICROBIOL, V7, P85, DOI 10.1099/00222615-7-1-85
   ATKINSON BA, 1984, J CLIN MICROBIOL, V20, P791, DOI 10.1128/JCM.20.4.791-796.1984
   CHASLUSDANCLA E, 1979, ANN RECH VET, V10, P77
   CORPET DE, 1987, ADV VET MED S, V42, P24
   CORPET DE, 1988, THESIS PARIS
   DERYCKE J, 1982, ANN RECH VET, V13, P101
   GORSE P, 1991, COUT SANTE PRODUCTIO, P48
   GORSE P, 1985, MEDICAMENTS VET
   GUILLOT JF, 1987, THESIS LYON
   HOLMBERG SD, 1984, SCIENCE, V225, P833, DOI 10.1126/science.6382605
   HOLMBERG SD, 1984, NEW ENGL J MED, V311, P617, DOI 10.1056/NEJM198409063111001
   JACKSON G, 1981, VET REC, V108, P325, DOI 10.1136/vr.108.15.325
   KUNIN CM, 1990, REV INFECT DIS, V12, P12
   Langlois B.E, 1986, J ANIM SCI S3, V62, P18
   LEBEK G, 1987, ADV VET MED S42, V42, P21
   LINTON AH, 1977, VET REC, V100, P354, DOI 10.1136/vr.100.17.354
   LINTON AH, 1981, J APPL BACTERIOL, V50, P115, DOI 10.1111/j.1365-2672.1981.tb00876.x
   LINTON AH, 1984, BRIT MED BULL, V40, P91, DOI 10.1093/oxfordjournals.bmb.a071953
   LORIAN V, 1986, J CLIN MICROBIOL, V23, P826, DOI 10.1128/JCM.23.5.826-827.1986
   MARTEL JL, 1986, THESIS LYON
   MOLITORIS E, 1986, J APPL BACTERIOL, V60, P111, DOI 10.1111/j.1365-2672.1986.tb03367.x
   MURRAY BE, 1991, J INFECT DIS, V163, P1185, DOI 10.1093/infdis/163.6.1185
   OBRIEN TF, 1987, REV INFECT DIS, V9, pS244
   Prescott JF, 1988, ANTIMICROBIAL THERAP
   PUYT JD, 1991, UNPUB REFLEXION ANTI
   RAYNAUD JP, 1987, ADV VET MED S, V42, P40
   SABATH LD, 1990, VET ANTIBIOTIC POLIC, P12
   SIKA JS, 1987, NEW ENGL J MED, V316, P565
   SMITH HW, 1969, VET REC, V85, P31, DOI 10.1136/vr.85.2.31
   TANCREDE C, 1983, RECL MED VET, V159, P591
   TANCREDE C, 1987, ADV VET MED S, V42, P35
   TERAKADO N, 1972, NATL I ANIM HEALTH Q, V12, P23
   VANDERMEER JWM, 1990, VET ANTIBIOTIC POLIC, P17
   WALTON JR, 1966, NATURE, V211, P312, DOI 10.1038/211312a0
NR 34
TC 18
Z9 19
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
J9 VET MICROBIOL
JI Vet. Microbiol.
PD JUN
PY 1993
VL 35
IS 3-4
BP 289
EP 301
DI 10.1016/0378-1135(93)90154-Y
PG 13
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA LP348
UT WOS:A1993LP34800013
PM 8212513
DA 2020-05-07
ER

PT J
AU BEYNON, RJ
AF BEYNON, RJ
TI COMPUTERS IN BIOCHEMICAL EDUCATION - MBT-NET, THE LIVERPOOL BIOCHEMISTRY
   MICROBIOLOGY TEACHING NETWORK
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
RP BEYNON, RJ (reprint author), UNIV LIVERPOOL,DEPT BIOCHEM,POB 147,LIVERPOOL L69 3BX,ENGLAND.
RI Beynon, Robert J/K-1408-2014
OI Beynon, Robert J/0000-0003-0857-495X
CR BEYNON RJ, 1985, COMPUT APPL BIOSCI, V1, P111
   BEYNON RJ, 1984, MICROCOMPUTERS BIOCH, P125
   MILLER E, 1985, MANAGE DECIS ECON, V6, P11, DOI 10.1002/mde.4090060104
   MOUNT DW, 1986, NUCLEIC ACIDS RES, V14, P443, DOI 10.1093/nar/14.1.443
   WILD P, 1985, PERSONAL COMPUTE NOV, P164
   WOOD EJ, 1984, MICROCOMPUTERS BIOCH
NR 6
TC 1
Z9 1
U1 0
U2 0
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD JUN
PY 1987
VL 15
IS 3
BP 349
EP 351
DI 10.1042/bst0150349
PG 3
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA H9773
UT WOS:A1987H977300013
PM 3305107
DA 2020-05-07
ER

EF